Psyllid ID: psy7289
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
No hits with e-value below 0.001 by BLAST
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 422 | ||||||
| FB|FBgn0010407 | 685 | Ror "Ror" [Drosophila melanoga | 0.582 | 0.359 | 0.692 | 5.3e-95 | |
| UNIPROTKB|Q01973 | 937 | ROR1 "Tyrosine-protein kinase | 0.599 | 0.270 | 0.626 | 1.8e-93 | |
| UNIPROTKB|G3N302 | 791 | ROR1 "Uncharacterized protein" | 0.599 | 0.319 | 0.630 | 8.1e-92 | |
| UNIPROTKB|F1MZ64 | 714 | ROR1 "Uncharacterized protein" | 0.599 | 0.354 | 0.630 | 8.1e-92 | |
| UNIPROTKB|F1S815 | 874 | ROR1 "Uncharacterized protein" | 0.599 | 0.289 | 0.630 | 8.1e-92 | |
| UNIPROTKB|F1PIX7 | 874 | ROR1 "Uncharacterized protein" | 0.599 | 0.289 | 0.630 | 1.3e-91 | |
| UNIPROTKB|F1NML5 | 896 | ROR1 "Uncharacterized protein" | 0.599 | 0.282 | 0.626 | 1.7e-91 | |
| MGI|MGI:1347520 | 937 | Ror1 "receptor tyrosine kinase | 0.599 | 0.270 | 0.623 | 9.3e-91 | |
| RGD|1559469 | 882 | Ror1 "receptor tyrosine kinase | 0.599 | 0.286 | 0.623 | 9.3e-91 | |
| UNIPROTKB|F1LZQ9 | 901 | Ror1 "Protein Ror1" [Rattus no | 0.599 | 0.280 | 0.623 | 9.3e-91 |
| FB|FBgn0010407 Ror "Ror" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 945 (337.7 bits), Expect = 5.3e-95, P = 5.3e-95
Identities = 176/254 (69%), Positives = 209/254 (82%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPSL-VAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
FL+ELGEGAFGKVYKG++ ++ VAIK LKENA+ KT DF+RE++L+S+L+H NI
Sbjct: 412 FLEELGEGAFGKVYKGQLLQPNKTTITVAIKALKENASVKTQQDFKREIELISDLKHQNI 471
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
VC+LGV L+ EP CMLFE+M GDLHEFL+S SP S LSQ +F IALQ++
Sbjct: 472 VCILGVVLNKEPYCMLFEYMANGDLHEFLISNSPTEGKS-------LSQLEFLQIALQIS 524
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 236
GM YL +HHYVHRDLAARNCLV +GL VKISDFGLSRD+Y+SDYYR+QSKSLLPVRWMP
Sbjct: 525 EGMQYLSAHHYVHRDLAARNCLVNEGLVVKISDFGLSRDIYSSDYYRVQSKSLLPVRWMP 584
Query: 237 PESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPR 296
ESILYGKFTTESDVWS+GVVLWE+YSYG+QPYYG+SNQEVI +IRSRQ+L PE+CP
Sbjct: 585 SESILYGKFTTESDVWSFGVVLWEIYSYGMQPYYGFSNQEVINLIRSRQLLSAPENCPTA 644
Query: 297 MYSLMMECWHEVPV 310
+YSLM+ECWHE V
Sbjct: 645 VYSLMIECWHEQSV 658
|
|
| UNIPROTKB|Q01973 ROR1 "Tyrosine-protein kinase transmembrane receptor ROR1" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 911 (325.7 bits), Expect = 1.8e-93, Sum P(2) = 1.8e-93
Identities = 163/260 (62%), Positives = 211/260 (81%)
Query: 57 RFLQELGEGAFGKVYKGEVCTS--EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHP 114
RF++ELGE AFGK+YKG + + LVAIKTLK+ N + ++F++E LM+EL HP
Sbjct: 474 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDYNNPQQWTEFQQEASLMAELHHP 533
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQ-----VQAPLSQQDFS 169
NIVCLLG +P+CMLFE++ +GDLHEFL+ RSP SD+ S V++ L DF
Sbjct: 534 NIVCLLGAVTQEQPVCMLFEYINQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 593
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 229
HIA+Q+AAGM YL SH +VH+DLAARN L+G+ L VKISD GLSR++Y++DYYR+QSKSL
Sbjct: 594 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQSKSL 653
Query: 230 LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289
LP+RWMPPE+I+YGKF+++SD+WS+GVVLWE++S+GLQPYYG+SNQEVIEM+R RQ+LPC
Sbjct: 654 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPC 713
Query: 290 PEDCPPRMYSLMMECWHEVP 309
EDCPPRMYSLM ECW+E+P
Sbjct: 714 SEDCPPRMYSLMTECWNEIP 733
|
|
| UNIPROTKB|G3N302 ROR1 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 915 (327.2 bits), Expect = 8.1e-92, P = 8.1e-92
Identities = 164/260 (63%), Positives = 211/260 (81%)
Query: 57 RFLQELGEGAFGKVYKGEVCTS--EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHP 114
RF++ELGE AFGK+YKG + + LVAIKTLK+ N + ++F++E LM+EL HP
Sbjct: 328 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDYNNPQQWTEFQQEASLMAELHHP 387
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQ-----VQAPLSQQDFS 169
NIVCLLG +P+CMLFE+M +GDLHEFL+ RSP SD+ S V++ L DF
Sbjct: 388 NIVCLLGAVTQEQPVCMLFEYMNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 447
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 229
HIA+Q+AAGM YL SH +VH+DLAARN L+G+ L VKISD GLSR++Y++DYYR+QSKSL
Sbjct: 448 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQSKSL 507
Query: 230 LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289
LP+RWMPPE+I+YGKF+++SD+WS+GVVLWE++S+GLQPYYG+SNQEVIEM+R RQ+LPC
Sbjct: 508 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPC 567
Query: 290 PEDCPPRMYSLMMECWHEVP 309
EDCPPRMYSLM ECW+E+P
Sbjct: 568 SEDCPPRMYSLMTECWNEIP 587
|
|
| UNIPROTKB|F1MZ64 ROR1 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 915 (327.2 bits), Expect = 8.1e-92, P = 8.1e-92
Identities = 164/260 (63%), Positives = 211/260 (81%)
Query: 57 RFLQELGEGAFGKVYKGEVCTS--EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHP 114
RF++ELGE AFGK+YKG + + LVAIKTLK+ N + ++F++E LM+EL HP
Sbjct: 312 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDYNNPQQWTEFQQEASLMAELHHP 371
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQ-----VQAPLSQQDFS 169
NIVCLLG +P+CMLFE+M +GDLHEFL+ RSP SD+ S V++ L DF
Sbjct: 372 NIVCLLGAVTQEQPVCMLFEYMNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 431
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 229
HIA+Q+AAGM YL SH +VH+DLAARN L+G+ L VKISD GLSR++Y++DYYR+QSKSL
Sbjct: 432 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQSKSL 491
Query: 230 LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289
LP+RWMPPE+I+YGKF+++SD+WS+GVVLWE++S+GLQPYYG+SNQEVIEM+R RQ+LPC
Sbjct: 492 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPC 551
Query: 290 PEDCPPRMYSLMMECWHEVP 309
EDCPPRMYSLM ECW+E+P
Sbjct: 552 SEDCPPRMYSLMTECWNEIP 571
|
|
| UNIPROTKB|F1S815 ROR1 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 915 (327.2 bits), Expect = 8.1e-92, P = 8.1e-92
Identities = 164/260 (63%), Positives = 211/260 (81%)
Query: 57 RFLQELGEGAFGKVYKGEVCTS--EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHP 114
RF++ELGE AFGK+YKG + + LVAIKTLK+ N + ++F++E LM+EL HP
Sbjct: 411 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDYNNPQQWTEFQQEASLMAELHHP 470
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQ-----VQAPLSQQDFS 169
NIVCLLG +P+CMLFE+M +GDLHEFL+ RSP SD+ S V++ L DF
Sbjct: 471 NIVCLLGAVTQEQPVCMLFEYMNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 530
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 229
HIA+Q+AAGM YL SH +VH+DLAARN L+G+ L VKISD GLSR++Y++DYYR+QSKSL
Sbjct: 531 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQSKSL 590
Query: 230 LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289
LP+RWMPPE+I+YGKF+++SD+WS+GVVLWE++S+GLQPYYG+SNQEVIEM+R RQ+LPC
Sbjct: 591 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPC 650
Query: 290 PEDCPPRMYSLMMECWHEVP 309
EDCPPRMYSLM ECW+E+P
Sbjct: 651 SEDCPPRMYSLMTECWNEIP 670
|
|
| UNIPROTKB|F1PIX7 ROR1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 913 (326.5 bits), Expect = 1.3e-91, P = 1.3e-91
Identities = 164/260 (63%), Positives = 211/260 (81%)
Query: 57 RFLQELGEGAFGKVYKGEVCTS--EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHP 114
RF++ELGE AFGK+YKG + + LVAIKTLK+ N + ++F++E LM+EL HP
Sbjct: 411 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDCNNPQQWTEFQQEASLMAELHHP 470
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQ-----VQAPLSQQDFS 169
NIVCLLG +P+CMLFE+M +GDLHEFL+ RSP SD+ S V++ L DF
Sbjct: 471 NIVCLLGAVSQEQPVCMLFEYMNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 530
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 229
HIA+Q+AAGM YL SH +VH+DLAARN L+G+ L VKISD GLSR++Y++DYYR+QSKSL
Sbjct: 531 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQSKSL 590
Query: 230 LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289
LP+RWMPPE+I+YGKF+++SD+WS+GVVLWE++S+GLQPYYG+SNQEVIEM+R RQ+LPC
Sbjct: 591 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPC 650
Query: 290 PEDCPPRMYSLMMECWHEVP 309
EDCPPRMYSLM ECW+E+P
Sbjct: 651 SEDCPPRMYSLMTECWNEIP 670
|
|
| UNIPROTKB|F1NML5 ROR1 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 912 (326.1 bits), Expect = 1.7e-91, P = 1.7e-91
Identities = 163/260 (62%), Positives = 211/260 (81%)
Query: 57 RFLQELGEGAFGKVYKGEVCTS--EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHP 114
RF++ELGE AFGK+YKG + + L+AIKTLK+ N + ++F++E LM+EL HP
Sbjct: 434 RFMEELGECAFGKIYKGHLYLPGMDHAQLIAIKTLKDFNNPQQWAEFQQEASLMAELHHP 493
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQ-----VQAPLSQQDFS 169
NIVCLLGV +P+CMLFE+M +GDLHEFL+ RSP SD+ S V++ L DF
Sbjct: 494 NIVCLLGVVTQEQPVCMLFEYMNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 553
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 229
HIA+Q+AAGM YL SH +VH+DLA RN L+G+ L VKISD GLSR++Y++DYYR+Q+KSL
Sbjct: 554 HIAVQIAAGMEYLSSHFFVHKDLATRNILIGEQLHVKISDLGLSREIYSADYYRVQNKSL 613
Query: 230 LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289
LP+RWMPPE+I+YGKF+++SD+WS+GVVLWE++S+GLQPYYG+SNQEVIEMIR RQ+LPC
Sbjct: 614 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMIRKRQLLPC 673
Query: 290 PEDCPPRMYSLMMECWHEVP 309
EDCPPRMYSLM ECWH++P
Sbjct: 674 SEDCPPRMYSLMTECWHDLP 693
|
|
| MGI|MGI:1347520 Ror1 "receptor tyrosine kinase-like orphan receptor 1" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 905 (323.6 bits), Expect = 9.3e-91, P = 9.3e-91
Identities = 162/260 (62%), Positives = 209/260 (80%)
Query: 57 RFLQELGEGAFGKVYKGEVCTS--EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHP 114
RF++ELGE FGK+YKG + + LVAIKTLK+ N + ++F++E LM+EL HP
Sbjct: 474 RFMEELGECTFGKIYKGHLYLPGMDHAQLVAIKTLKDYNNPQQWTEFQQEASLMAELHHP 533
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQ-----VQAPLSQQDFS 169
NIVCLLG +P+CMLFE+M +GDLHEFL+ RSP SD+ S V++ L DF
Sbjct: 534 NIVCLLGAVTQEQPVCMLFEYMNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 593
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 229
HIA+Q+AAGM YL SH +VH+DLAARN L+G+ L VKISD GLSR++Y++DYYR+QSKS
Sbjct: 594 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQSKSS 653
Query: 230 LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289
LP+RWMPPE+I+YGKF+++SD+WS+GVVLWE++S+GLQPYYG+SNQEVIEM+R RQ+LPC
Sbjct: 654 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPC 713
Query: 290 PEDCPPRMYSLMMECWHEVP 309
EDCPPRMYSLM ECW+E+P
Sbjct: 714 SEDCPPRMYSLMTECWNEIP 733
|
|
| RGD|1559469 Ror1 "receptor tyrosine kinase-like orphan receptor 1" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 905 (323.6 bits), Expect = 9.3e-91, P = 9.3e-91
Identities = 162/260 (62%), Positives = 209/260 (80%)
Query: 57 RFLQELGEGAFGKVYKGEVCTS--EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHP 114
RF++ELGE FGK+YKG + + LVAIKTLK+ N + ++F++E LM+EL HP
Sbjct: 419 RFMEELGECTFGKIYKGHLYLPGMDHAQLVAIKTLKDYNNPQQWTEFQQEASLMAELHHP 478
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQ-----VQAPLSQQDFS 169
NIVCLLG +P+CMLFE+M +GDLHEFL+ RSP SD+ S V++ L DF
Sbjct: 479 NIVCLLGAVTQEQPVCMLFEYMNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 538
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 229
HIA+Q+AAGM YL SH +VH+DLAARN L+G+ L VKISD GLSR++Y++DYYR+QSKS
Sbjct: 539 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQSKSS 598
Query: 230 LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289
LP+RWMPPE+I+YGKF+++SD+WS+GVVLWE++S+GLQPYYG+SNQEVIEM+R RQ+LPC
Sbjct: 599 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPC 658
Query: 290 PEDCPPRMYSLMMECWHEVP 309
EDCPPRMYSLM ECW+E+P
Sbjct: 659 SEDCPPRMYSLMTECWNEIP 678
|
|
| UNIPROTKB|F1LZQ9 Ror1 "Protein Ror1" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 905 (323.6 bits), Expect = 9.3e-91, P = 9.3e-91
Identities = 162/260 (62%), Positives = 209/260 (80%)
Query: 57 RFLQELGEGAFGKVYKGEVCTS--EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHP 114
RF++ELGE FGK+YKG + + LVAIKTLK+ N + ++F++E LM+EL HP
Sbjct: 438 RFMEELGECTFGKIYKGHLYLPGMDHAQLVAIKTLKDYNNPQQWTEFQQEASLMAELHHP 497
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQ-----VQAPLSQQDFS 169
NIVCLLG +P+CMLFE+M +GDLHEFL+ RSP SD+ S V++ L DF
Sbjct: 498 NIVCLLGAVTQEQPVCMLFEYMNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 557
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 229
HIA+Q+AAGM YL SH +VH+DLAARN L+G+ L VKISD GLSR++Y++DYYR+QSKS
Sbjct: 558 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQSKSS 617
Query: 230 LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289
LP+RWMPPE+I+YGKF+++SD+WS+GVVLWE++S+GLQPYYG+SNQEVIEM+R RQ+LPC
Sbjct: 618 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPC 677
Query: 290 PEDCPPRMYSLMMECWHEVP 309
EDCPPRMYSLM ECW+E+P
Sbjct: 678 SEDCPPRMYSLMTECWNEIP 697
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.10.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.10 | 0.691 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 422 | |||
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-163 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-130 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-130 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-126 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-126 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-126 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-125 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-115 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-114 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-101 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-99 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-96 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-96 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-94 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-88 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-87 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-87 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-87 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-87 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-82 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-82 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-79 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-79 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-78 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-78 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-78 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-77 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-77 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-73 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-72 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-71 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-71 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-71 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-70 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-69 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-68 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-67 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-65 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-65 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-65 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-64 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-63 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-63 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-63 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-63 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-63 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-62 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-62 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-62 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-62 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-62 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-62 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-61 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-61 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-61 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-61 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-60 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-60 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-59 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-59 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-59 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-59 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-58 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-58 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-57 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-57 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-56 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-56 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-55 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-55 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-55 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-55 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-54 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-54 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-54 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-53 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-53 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-53 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-53 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-52 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-51 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-51 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-50 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-50 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-50 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-50 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-50 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-50 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-49 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-49 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-49 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-49 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-48 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-48 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-48 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-47 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-47 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-47 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-47 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-46 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-46 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-44 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-43 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-41 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-41 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-41 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-41 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-41 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-40 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-40 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-39 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-39 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-38 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-38 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-37 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-37 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-37 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-36 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-36 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-36 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-36 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-35 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-35 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-34 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-34 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-34 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-34 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-33 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-33 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-33 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-33 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-33 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-33 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-33 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-33 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-32 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-32 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-31 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-31 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-31 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-31 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-30 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-30 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-30 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-30 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-30 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-30 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-30 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-30 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-30 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-29 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-29 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-29 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-29 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-28 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-28 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-28 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-28 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-28 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-28 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-28 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-27 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-27 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-27 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-26 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-26 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-26 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-25 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-25 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-25 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-25 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-25 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-25 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-25 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-24 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-24 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-24 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-24 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-23 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-23 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-22 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-22 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-22 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-22 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-21 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-21 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-21 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-20 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-20 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-20 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-20 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-19 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-19 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-19 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-18 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-18 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-18 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-18 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-18 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-18 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-17 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-17 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-17 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-17 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-17 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-17 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-16 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-16 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-15 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-14 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-14 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-12 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-12 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-11 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-10 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-10 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-10 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-10 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-10 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 6e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-10 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-09 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-09 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-09 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-09 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-09 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-09 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-09 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-08 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-08 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-08 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-08 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-08 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-08 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-08 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-08 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-07 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-07 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-07 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-07 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-07 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-07 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-07 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-07 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-07 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-07 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-07 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-07 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-07 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-07 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-06 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-06 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-06 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-06 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-06 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-06 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-06 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-06 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-06 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-06 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-06 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-06 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 9e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-05 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-05 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-05 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-05 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-05 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-05 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-05 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-05 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-05 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-05 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-04 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-04 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-04 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-04 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-04 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-04 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-04 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-04 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-04 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-04 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-04 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-04 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-04 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-04 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-04 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-04 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-04 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-04 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-04 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-04 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 0.001 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 0.001 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 0.001 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.001 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.001 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 0.001 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.001 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.001 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 0.002 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 0.002 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.002 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 0.002 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 0.002 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.003 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 0.003 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.003 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 0.003 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 0.004 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.004 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 458 bits (1181), Expect = e-163
Identities = 184/261 (70%), Positives = 218/261 (83%), Gaps = 7/261 (2%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPS---LVAIKTLKENANQKTASDFRREVDLMSELRH 113
RFL+ELGEGAFGKVYKGE+ VAIKTLKENA K +FR+E +LMS+L+H
Sbjct: 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQH 67
Query: 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDI----SGSQVQAPLSQQDFS 169
PNIVCLLGVC +P CMLFE++ GDLHEFL+ SP SD+ V++ L DF
Sbjct: 68 PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 229
HIA+Q+AAGM YL SHH+VHRDLAARNCLVG+GLTVKISDFGLSRD+Y++DYYR+QSKSL
Sbjct: 128 HIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSL 187
Query: 230 LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289
LPVRWMPPE+ILYGKFTTESD+WS+GVVLWE++SYGLQPYYG+SNQEVIEMIRSRQ+LPC
Sbjct: 188 LPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPC 247
Query: 290 PEDCPPRMYSLMMECWHEVPV 310
PEDCP R+Y+LM+ECW+E+P
Sbjct: 248 PEDCPARVYALMIECWNEIPA 268
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 375 bits (966), Expect = e-130
Identities = 126/255 (49%), Positives = 169/255 (66%), Gaps = 13/255 (5%)
Query: 57 RFLQELGEGAFGKVYKGE--VCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHP 114
++LGEGAFG+VYKG + VA+KTLKE A+++ +F E +M +L HP
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
NIV LLGVC GEP+ ++ E+M GDL +FL L+ +D +ALQ
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE-----------KLTLKDLLQMALQ 110
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 234
+A GM YL S ++VHRDLAARNCLV + L VKISDFGLSRD+Y DYYR + LP++W
Sbjct: 111 IAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKW 170
Query: 235 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCP 294
M PES+ GKFT++SDVWS+GV+LWE+++ G QPY G SN+EV+E++ LP PE+CP
Sbjct: 171 MAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCP 230
Query: 295 PRMYSLMMECWHEVP 309
+Y LM++CW P
Sbjct: 231 DELYELMLQCWAYDP 245
|
Length = 258 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 375 bits (964), Expect = e-130
Identities = 163/260 (62%), Positives = 208/260 (80%), Gaps = 7/260 (2%)
Query: 57 RFLQELGEGAFGKVYKGEVCTS--EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHP 114
RF++ELGE AFGK+YKG + + LVAIKTLK+ N + +F++E LM+EL HP
Sbjct: 8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHP 67
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQ-----VQAPLSQQDFS 169
NIVCLLGV +P+CMLFE++ +GDLHEFL+ RSP SD+ S V++ L DF
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 229
HIA+Q+AAGM YL SH +VH+DLAARN L+G+ L VKISD GLSR++Y++DYYR+Q KSL
Sbjct: 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 230 LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289
LP+RWMPPE+I+YGKF+++SD+WS+GVVLWE++S+GLQPYYG+SNQEVIEM+R RQ+LPC
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPC 247
Query: 290 PEDCPPRMYSLMMECWHEVP 309
EDCPPRMYSLM ECW E P
Sbjct: 248 SEDCPPRMYSLMTECWQEGP 267
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 366 bits (941), Expect = e-126
Identities = 135/257 (52%), Positives = 172/257 (66%), Gaps = 5/257 (1%)
Query: 58 FLQELGEGAFGKVYKGEVC---TSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHP 114
+ELGEGAFGKV+ GE LVA+KTLKE A+ DF RE +L++ +H
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQA--PLSQQDFSHIA 172
NIV GVC G+P M+FE+M GDL++FL S P + S L+ IA
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 173 LQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV 232
+Q+A+GM YL S H+VHRDLA RNCLVG L VKI DFG+SRDVY +DYYR+ ++LP+
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188
Query: 233 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPED 292
RWMPPESI+Y KFTTESDVWS+GVVLWE+++YG QP+YG SN+EVIE I ++L P
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPRT 248
Query: 293 CPPRMYSLMMECWHEVP 309
CP +Y +M+ CW P
Sbjct: 249 CPSEVYDIMLGCWKRDP 265
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 364 bits (936), Expect = e-126
Identities = 127/250 (50%), Positives = 168/250 (67%), Gaps = 4/250 (1%)
Query: 61 ELGEGAFGKVYKGEV-CTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCL 119
+LGEGAFG+VYKG++ + VA+KTLKE+A+++ DF +E +M +L HPN+V L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 120 LGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGM 179
LGVC EP+ ++ E+M GDL ++L P LS +D A+Q+A GM
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKS---TLSLKDLLSFAIQIAKGM 118
Query: 180 AYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPES 239
YL S +VHRDLAARNCLVG+ L VKISDFGLSRDVY DYYR ++ LP+RWM PES
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178
Query: 240 ILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYS 299
+ G FT++SDVWS+GV+LWE+++ G PY G SN+EV+E +R LP PE CP +Y
Sbjct: 179 LKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYE 238
Query: 300 LMMECWHEVP 309
LM+ CW P
Sbjct: 239 LMLSCWQLDP 248
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 363 bits (935), Expect = e-126
Identities = 127/255 (49%), Positives = 172/255 (67%), Gaps = 13/255 (5%)
Query: 57 RFLQELGEGAFGKVYKGEV--CTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHP 114
++LGEGAFG+VYKG + VA+KTLKE+A+++ +F RE +M +L HP
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
NIV LLGVC EP+ ++ E+M GDL ++L P+ LS D ALQ
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPK----------ELSLSDLLSFALQ 111
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 234
+A GM YL S +++HRDLAARNCLVG+ L VKISDFGLSRD+Y DYY+++ L P+RW
Sbjct: 112 IARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL-PIRW 170
Query: 235 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCP 294
M PES+ GKFT++SDVWS+GV+LWE+++ G +PY G SN EV+E ++ LP P +CP
Sbjct: 171 MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCP 230
Query: 295 PRMYSLMMECWHEVP 309
P +Y LM++CW E P
Sbjct: 231 PELYKLMLQCWAEDP 245
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 362 bits (931), Expect = e-125
Identities = 128/255 (50%), Positives = 174/255 (68%), Gaps = 14/255 (5%)
Query: 57 RFLQELGEGAFGKVYKGEV--CTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHP 114
++LGEGAFG+VYKG++ + VA+KTLKE+A+++ +F RE +M +L HP
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
N+V LLGVC EP+ ++ E+M GDL +L P+ LS D ALQ
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-----------LSLSDLLSFALQ 110
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 234
+A GM YL S +++HRDLAARNCLVG+ L VKISDFGLSRD+Y DYYR + L P+RW
Sbjct: 111 IARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL-PIRW 169
Query: 235 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCP 294
M PES+ GKFT++SDVWS+GV+LWE+++ G QPY G SN+EV+E +++ LP P +CP
Sbjct: 170 MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCP 229
Query: 295 PRMYSLMMECWHEVP 309
P +Y LM++CW E P
Sbjct: 230 PELYDLMLQCWAEDP 244
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 338 bits (868), Expect = e-115
Identities = 138/273 (50%), Positives = 190/273 (69%), Gaps = 13/273 (4%)
Query: 50 EVIETKPRFLQELGEGAFGKVYKGE---VCTSEGPSLVAIKTLKENANQKTASDFRREVD 106
E +++++G+GAFG+V++ + E ++VA+K LKE A+ +DF+RE
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60
Query: 107 LMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQA----- 161
LM+E HPNIV LLGVC G+PMC+LFE+M GDL+EFL RSPR+ S S +
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 162 -----PLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV 216
PLS + IA QVAAGMAYL +VHRDLA RNCLVG+ + VKI+DFGLSR++
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 180
Query: 217 YASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 276
Y++DYY+ +P+RWMPPESI Y ++TTESDVW+YGVVLWE++SYG+QPYYG +++E
Sbjct: 181 YSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240
Query: 277 VIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
VI +R +L CP++CP +Y+LM CW ++P
Sbjct: 241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLP 273
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 336 bits (862), Expect = e-114
Identities = 151/260 (58%), Positives = 190/260 (73%), Gaps = 7/260 (2%)
Query: 57 RFLQELGEGAFGKVYKGEV---CTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRH 113
RF++ELGE FGKVYKG + E VAIKTLK+ A +F+ E + S L+H
Sbjct: 8 RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQH 67
Query: 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQ----VQAPLSQQDFS 169
PNIVCLLGV +P+ M+F + DLHEFL+ RSP SD+ + V++ L DF
Sbjct: 68 PNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 229
HI Q+AAGM +L SHH VH+DLA RN LV D L VKISD GL R+VYA+DYY++ SL
Sbjct: 128 HIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSL 187
Query: 230 LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289
LP+RWM PE+I+YGKF+ +SD+WSYGVVLWEV+SYGLQPY GYSNQ+VIEMIR+RQ+LPC
Sbjct: 188 LPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPC 247
Query: 290 PEDCPPRMYSLMMECWHEVP 309
P+DCP +Y+LM+ECW+E P
Sbjct: 248 PDDCPAWVYTLMLECWNEFP 267
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 301 bits (773), Expect = e-101
Identities = 136/256 (53%), Positives = 177/256 (69%), Gaps = 9/256 (3%)
Query: 61 ELGEGAFGKVYKGEVCTSEGPS----LVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
ELGEGAFGKV+ E C + P LVA+K LKE A++ DF+RE +L++ L+H +I
Sbjct: 12 ELGEGAFGKVFLAE-CHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTVLQHQHI 69
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDI-SGSQVQA--PLSQQDFSHIAL 173
V GVC G P+ M+FE+M GDL+ FL S P + I +G + A L+ IA
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR 233
Q+A+GM YL S H+VHRDLA RNCLVG GL VKI DFG+SRD+Y++DYYR+ +++LP+R
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 234 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDC 293
WMPPESILY KFTTESD+WS+GVVLWE+++YG QP+Y SN E IE I + L P C
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRTC 249
Query: 294 PPRMYSLMMECWHEVP 309
PP +Y++M CW P
Sbjct: 250 PPEVYAIMQGCWQREP 265
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 298 bits (764), Expect = 1e-99
Identities = 121/263 (46%), Positives = 168/263 (63%), Gaps = 5/263 (1%)
Query: 50 EVIETKPRFLQELGEGAFGKVYKG---EVCTSEGPSLVAIKTLKENANQKTASDFRREVD 106
E+ K ++ELG+G+FG VY+G V E + VAIKT+ ENA+ + +F E
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEAS 61
Query: 107 LMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQ 166
+M E ++V LLGV +G+P ++ E M +GDL +L SR P ++ + P + Q
Sbjct: 62 VMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNP--GLGPPTLQ 119
Query: 167 DFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQS 226
F +A ++A GMAYL + +VHRDLAARNC+V + LTVKI DFG++RD+Y +DYYR
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG 179
Query: 227 KSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286
K LLPVRWM PES+ G FTT+SDVWS+GVVLWE+ + QPY G SN+EV++ +
Sbjct: 180 KGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGH 239
Query: 287 LPCPEDCPPRMYSLMMECWHEVP 309
L PE+CP ++ LM CW P
Sbjct: 240 LDLPENCPDKLLELMRMCWQYNP 262
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 290 bits (743), Expect = 3e-96
Identities = 120/276 (43%), Positives = 169/276 (61%), Gaps = 23/276 (8%)
Query: 57 RFLQELGEGAFGKVYKGEV-CTSE-------------GPSLVAIKTLKENANQKTASDFR 102
F+++LGEG FG+V+ E + P LVA+K L+ +A+ DF
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 103 REVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAP 162
+EV ++S L PNI LLGVC P+CM+ E+M GDL++FL + +
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK-S 126
Query: 163 LSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYY 222
LS ++A Q+A+GM YL S ++VHRDLA RNCLVG T+KI+DFG+SR++Y+SDYY
Sbjct: 127 LSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYY 186
Query: 223 RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYG-LQPYYGYSNQEVIE-- 279
R+Q ++ LP+RWM ES+L GKFTT+SDVW++GV LWE+ + QPY ++Q+VIE
Sbjct: 187 RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENA 246
Query: 280 --MIR--SRQM-LPCPEDCPPRMYSLMMECWHEVPV 310
R RQ+ LP P +CP +Y LM+ECW
Sbjct: 247 GHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEE 282
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 289 bits (740), Expect = 5e-96
Identities = 136/254 (53%), Positives = 179/254 (70%), Gaps = 5/254 (1%)
Query: 60 QELGEGAFGKVYKGE---VCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
+ELGEGAFGKV+ E +C + LVA+KTLK+ A+ DF RE +L++ L+H +I
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-ASDNARKDFHREAELLTNLQHEHI 69
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDI-SGSQVQAPLSQQDFSHIALQV 175
V GVC+ G+P+ M+FE+M GDL++FL + P + + + A L+Q HIA Q+
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 176 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM 235
AAGM YL S H+VHRDLA RNCLVG+ L VKI DFG+SRDVY++DYYR+ ++LP+RWM
Sbjct: 130 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 236 PPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPP 295
PPESI+Y KFTTESDVWS GVVLWE+++YG QP+Y SN EVIE I ++L P CP
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPK 249
Query: 296 RMYSLMMECWHEVP 309
+Y LM+ CW P
Sbjct: 250 EVYDLMLGCWQREP 263
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 285 bits (731), Expect = 1e-94
Identities = 133/270 (49%), Positives = 180/270 (66%), Gaps = 15/270 (5%)
Query: 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPS----LVAIKTLKENANQKTASDFRR 103
RR+++ +ELGEGAFGKV+ E C + P+ LVA+K LK+ DF+R
Sbjct: 4 RRDIV-----LKRELGEGAFGKVFLAE-CYNLSPTKDKMLVAVKALKD-PTLAARKDFQR 56
Query: 104 EVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRS----DISGSQV 159
E +L++ L+H +IV GVC G+P+ M+FE+M GDL++FL + P + D Q
Sbjct: 57 EAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 116
Query: 160 QAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS 219
+ L HIA Q+A+GM YL S H+VHRDLA RNCLVG L VKI DFG+SRDVY++
Sbjct: 117 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 176
Query: 220 DYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIE 279
DYYR+ ++LP+RWMPPESI+Y KFTTESDVWS+GV+LWE+++YG QP++ SN EVIE
Sbjct: 177 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236
Query: 280 MIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
I ++L P CP +Y +M+ CW P
Sbjct: 237 CITQGRVLERPRVCPKEVYDIMLGCWQREP 266
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 268 bits (687), Expect = 3e-88
Identities = 123/257 (47%), Positives = 161/257 (62%), Gaps = 14/257 (5%)
Query: 62 LGEGAFGKVYKGEVCT----SEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIV 117
LG GAFG+VY+G GP VA+KTL++ A + +F +E LMS HPNIV
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
LLGVCL EP ++ E M GDL +L R R + G L+ ++ I L VA
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYL--RDARVERFGP---PLLTLKELLDICLDVAK 117
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDG-----LTVKISDFGLSRDVYASDYYRIQSKSLLPV 232
G YL H++HRDLAARNCLV + VKI DFGL+RD+Y SDYYR + + LLPV
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 233 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPED 292
RWM PES+L GKFTT+SDVWS+GV++WE+ + G QPY +NQEV++ + + L PE+
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237
Query: 293 CPPRMYSLMMECWHEVP 309
CP ++Y LM CW + P
Sbjct: 238 CPDKIYQLMTNCWAQDP 254
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 267 bits (685), Expect = 1e-87
Identities = 111/259 (42%), Positives = 158/259 (61%), Gaps = 11/259 (4%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEG---PSLVAIKTLKENANQKTASDFRREVDLMSELRH 113
L+ LG GAFG+VY+G +G VA+KTL E+ +++ SDF E +MS+ H
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68
Query: 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
NIV L+GV P +L E M GDL FL PR + + L+ +D A
Sbjct: 69 QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERP-----SSLTMKDLLFCAR 123
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASDYYRIQSKSLL 230
VA G YL +H++HRD+AARNCL+ G G KI+DFG++RD+Y + YYR +++L
Sbjct: 124 DVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML 183
Query: 231 PVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP 290
P++WMPPE+ L G FT+++DVWS+GV+LWE++S G PY G +NQEV+E + L P
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPP 243
Query: 291 EDCPPRMYSLMMECWHEVP 309
+ CP +Y +M +CW P
Sbjct: 244 KGCPGPVYRIMTDCWQHTP 262
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 267 bits (685), Expect = 2e-87
Identities = 123/273 (45%), Positives = 176/273 (64%), Gaps = 29/273 (10%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEG-----------------PSLVAIKTLKENANQKTASD 100
F ++LGEG FG+V+ +C +EG P LVA+K L+E+AN+ +D
Sbjct: 9 FKEKLGEGQFGEVH---LCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARND 65
Query: 101 FRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQ 160
F +E+ +MS L+ PNI+ LL VC++ +P+CM+ E+M GDL++FL P+ + V
Sbjct: 66 FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125
Query: 161 APLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD 220
+S +A Q+A+GM YL S ++VHRDLA RNCLVG T+KI+DFG+SR++Y+ D
Sbjct: 126 T-ISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGD 184
Query: 221 YYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY-GLQPYYGYSNQEVIE 279
YYRIQ +++LP+RWM ESIL GKFTT SDVW++GV LWE+ + QPY S+++VIE
Sbjct: 185 YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIE 244
Query: 280 MI------RSRQM-LPCPEDCPPRMYSLMMECW 305
+ RQ+ LP P CP +Y LM+ CW
Sbjct: 245 NTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCW 277
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 266 bits (682), Expect = 4e-87
Identities = 121/272 (44%), Positives = 179/272 (65%), Gaps = 26/272 (9%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEG---------------PSLVAIKTLKENANQKTASDF 101
R ++LGEG FG+V+ +C +EG P LVA+K L+ + + +DF
Sbjct: 8 RLKEKLGEGQFGEVH---LCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 102 RREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQA 161
+E+ +MS L++PNI+ LLGVC+S +P+CM+ E+M GDL++FL R S + +
Sbjct: 65 LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124
Query: 162 PLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDY 221
+S + ++A+Q+A+GM YL S ++VHRDLA RNCLVG+ T+KI+DFG+SR++Y+ DY
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184
Query: 222 YRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY-GLQPYYGYSNQEVI-- 278
YRIQ +++LP+RWM ESIL GKFTT SDVW++GV LWE+++ QPY S+++VI
Sbjct: 185 YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIEN 244
Query: 279 --EMIRS--RQM-LPCPEDCPPRMYSLMMECW 305
E R+ RQ+ L CP ++ LMM CW
Sbjct: 245 TGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCW 276
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 264 bits (678), Expect = 5e-87
Identities = 115/252 (45%), Positives = 148/252 (58%), Gaps = 15/252 (5%)
Query: 61 ELGEGAFGKVYKGEVCTSEGPSL-VAIKTLKENANQKTASDFRREVDLMSELRHPNIVCL 119
ELG G FG V KG G + VA+KTLK+ +F RE +M++L HP IV L
Sbjct: 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 120 LGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGM 179
+GVC GEP+ ++ E G L ++L R D +A QVA GM
Sbjct: 62 IGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVS------------DLKELAHQVAMGM 108
Query: 180 AYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA-SDYYRIQSKSLLPVRWMPPE 238
AYL S H+VHRDLAARN L+ + KISDFG+SR + A SDYYR + P++W PE
Sbjct: 109 AYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPE 168
Query: 239 SILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMY 298
I YGKF+++SDVWSYGV LWE +SYG +PY EVI M+ S + LP PE+CP +Y
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIY 228
Query: 299 SLMMECWHEVPV 310
S+M+ CW P
Sbjct: 229 SIMLSCWKYRPE 240
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 254 bits (651), Expect = 1e-82
Identities = 105/254 (41%), Positives = 161/254 (63%), Gaps = 11/254 (4%)
Query: 59 LQE---LGEGAFGKVYKG---EVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR 112
LQE LG G FG+V+ + G +LV +K L++ ++ S+FRRE+D+ +L
Sbjct: 7 LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS 66
Query: 113 HPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIA 172
H N+V LLG+C EP M+ E+ GDL +FL + + + PLS + +
Sbjct: 67 HKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPP---PLSTKQKVALC 123
Query: 173 LQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV 232
Q+A GM +L + +VHRDLAARNCLV VK+S LS+DVY S+YY+++ +L+P+
Sbjct: 124 TQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR-NALIPL 182
Query: 233 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM-LPCPE 291
RW+ PE++ F+T+SDVWS+GV++WEV++ G P+YG S++EV+ +++ ++ LP PE
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPE 242
Query: 292 DCPPRMYSLMMECW 305
CP R+Y LM CW
Sbjct: 243 GCPSRLYKLMTRCW 256
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 254 bits (649), Expect = 5e-82
Identities = 125/278 (44%), Positives = 175/278 (62%), Gaps = 29/278 (10%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEG--------------PSLVAIKTLKENANQKTASDFR 102
F ++LGEG FG+V+ EV + P LVA+K L+ +AN+ +DF
Sbjct: 8 LFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFL 67
Query: 103 REVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSR------SPRSDISG 156
+EV ++S L+ PNI+ LLGVC+ +P+CM+ E+M GDL++FL S +D
Sbjct: 68 KEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127
Query: 157 SQVQAP-LSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRD 215
P +S H+ALQ+A+GM YL S ++VHRDLA RNCLVG+ LT+KI+DFG+SR+
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRN 187
Query: 216 VYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY-GLQPYYGYSN 274
+YA DYYRIQ +++LP+RWM E IL GKFTT SDVW++GV LWE+ QPY ++
Sbjct: 188 LYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTD 247
Query: 275 QEVI----EMIR--SRQM-LPCPEDCPPRMYSLMMECW 305
++VI E R RQ+ L P CP +Y LM++CW
Sbjct: 248 EQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCW 285
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 246 bits (630), Expect = 1e-79
Identities = 101/260 (38%), Positives = 151/260 (58%), Gaps = 16/260 (6%)
Query: 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMS 109
E+ T + L++LG G FG+V++G + VA+KTLK DF E +M
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEG---LWNNTTPVAVKTLK--PGTMDPKDFLAEAQIMK 56
Query: 110 ELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFS 169
+LRHP ++ L VC EP+ ++ E M G L E+L + R+ L
Sbjct: 57 KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRA----------LKLPQLI 106
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 229
+A QVA+GMAYL + +Y+HRDLAARN LVG+ K++DFGL+R V D Y + +
Sbjct: 107 DMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLAR-VIKEDIYEAREGAK 165
Query: 230 LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289
P++W PE+ LY +F+ +SDVWS+G++L E+ +YG PY G +N EV++ + +PC
Sbjct: 166 FPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC 225
Query: 290 PEDCPPRMYSLMMECWHEVP 309
P CP +Y +M++CW E P
Sbjct: 226 PPGCPKELYDIMLDCWKEDP 245
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 247 bits (632), Expect = 1e-79
Identities = 108/274 (39%), Positives = 162/274 (59%), Gaps = 8/274 (2%)
Query: 44 ASDFRREVIETKPRFLQELGEGAFGKVYKGEVCT---SEGPSLVAIKTLKENANQKTASD 100
D E+ + + LGEGAFG+V K E S VA+K LK++A +K SD
Sbjct: 2 PLDPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSD 61
Query: 101 FRREVDLMSEL-RHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPR----SDIS 155
E+++M + +H NI+ LLGVC P+ ++ E+ G+L +FL +R P S
Sbjct: 62 LVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDD 121
Query: 156 GSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRD 215
+ L+Q+D A QVA GM +L S +HRDLAARN LV + +KI+DFGL+RD
Sbjct: 122 PRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARD 181
Query: 216 VYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ 275
++ DYYR + LPV+WM PE++ +T +SDVWS+GV+LWE+++ G PY G +
Sbjct: 182 IHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241
Query: 276 EVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
E+ ++++ + P++C +Y LM +CWHEVP
Sbjct: 242 ELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVP 275
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 244 bits (623), Expect = 1e-78
Identities = 121/263 (46%), Positives = 166/263 (63%), Gaps = 5/263 (1%)
Query: 50 EVIETKPRFLQELGEGAFGKVYKG---EVCTSEGPSLVAIKTLKENANQKTASDFRREVD 106
EV K +ELG+G+FG VY+G V E + VAIKT+ E A+ + +F E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 107 LMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQ 166
+M E ++V LLGV G+P ++ E M RGDL +L RS R ++ + VQAP S +
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVQAPPSLK 119
Query: 167 DFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQS 226
+A ++A GMAYL ++ +VHRDLAARNC+V + TVKI DFG++RD+Y +DYYR
Sbjct: 120 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 227 KSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286
K LLPVRWM PES+ G FTT SDVWS+GVVLWE+ + QPY G SN++V+ + +
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL 239
Query: 287 LPCPEDCPPRMYSLMMECWHEVP 309
L P++CP ++ LM CW P
Sbjct: 240 LDKPDNCPDMLFELMRMCWQYNP 262
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 243 bits (622), Expect = 2e-78
Identities = 103/253 (40%), Positives = 154/253 (60%), Gaps = 16/253 (6%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
+ ++LG G FG+V+ G T G + VA+KTLK A F +E +M +LRH +
Sbjct: 9 KLERKLGAGQFGEVWMG---TWNGTTKVAVKTLKPGTMSPEA--FLQEAQIMKKLRHDKL 63
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V L VC EP+ ++ E+M +G L +FL +S G +++ P +A Q+A
Sbjct: 64 VQLYAVCSEEEPIYIVTEYMSKGSLLDFL--KSG----EGKKLRLP----QLVDMAAQIA 113
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 236
GMAYL S +Y+HRDLAARN LVG+ L KI+DFGL+R + D Y + + P++W
Sbjct: 114 EGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLAR-LIEDDEYTAREGAKFPIKWTA 172
Query: 237 PESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPR 296
PE+ YG+FT +SDVWS+G++L E+ +YG PY G +N+EV+E + +P P +CP
Sbjct: 173 PEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEE 232
Query: 297 MYSLMMECWHEVP 309
+Y LM++CW + P
Sbjct: 233 LYDLMLQCWDKDP 245
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 242 bits (620), Expect = 6e-78
Identities = 116/263 (44%), Positives = 163/263 (61%), Gaps = 5/263 (1%)
Query: 50 EVIETKPRFLQELGEGAFGKVYKG---EVCTSEGPSLVAIKTLKENANQKTASDFRREVD 106
EV K L+ELG+G+FG VY+G ++ E + VA+KT+ E+A+ + +F E
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 107 LMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQ 166
+M ++V LLGV G+P ++ E M GDL +L RS R + + + P + Q
Sbjct: 62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQ 119
Query: 167 DFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQS 226
+ +A ++A GMAYL + +VHRDLAARNC+V TVKI DFG++RD+Y +DYYR
Sbjct: 120 EMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 227 KSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286
K LLPVRWM PES+ G FTT SD+WS+GVVLWE+ S QPY G SN++V++ +
Sbjct: 180 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 239
Query: 287 LPCPEDCPPRMYSLMMECWHEVP 309
L P++CP R+ LM CW P
Sbjct: 240 LDQPDNCPERVTDLMRMCWQFNP 262
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 239 bits (613), Expect = 5e-77
Identities = 103/248 (41%), Positives = 142/248 (57%), Gaps = 12/248 (4%)
Query: 60 QELGEGAFGKVYKGEV-CTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVC 118
+ +G G FG+V +G + + VAIKTLK ++ K DF E +M + HPNI+
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
L GV P+ ++ E+M G L +FL R + Q+ L +A+G
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRG---------IASG 118
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPE 238
M YL +YVHRDLAARN LV L K+SDFGLSR + S+ +P+RW PE
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE 178
Query: 239 SILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMY 298
+I Y KFT+ SDVWS+G+V+WEV SYG +PY+ SNQ+VI+ + LP P DCP +Y
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALY 238
Query: 299 SLMMECWH 306
LM++CW
Sbjct: 239 QLMLDCWQ 246
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 238 bits (610), Expect = 9e-77
Identities = 101/258 (39%), Positives = 146/258 (56%), Gaps = 24/258 (9%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
++LG G FG+V++G VAIK LK + + DF++EV + LRH ++
Sbjct: 9 TLERKLGSGYFGEVWEGLWKNR---VRVAIKILK-SDDLLKQQDFQKEVQALKRLRHKHL 64
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
+ L VC GEP+ ++ E M +G L FL S + L +A QVA
Sbjct: 65 ISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV----------LPVASLIDMACQVA 114
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR----DVYASDYYRIQSKSLLPV 232
GMAYL + +HRDLAARN LVG+ L K++DFGL+R DVY S +I P
Sbjct: 115 EGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI------PY 168
Query: 233 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPED 292
+W PE+ +G F+T+SDVWS+G++L+E+++YG PY G +N EV + I + +PCP
Sbjct: 169 KWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAK 228
Query: 293 CPPRMYSLMMECWHEVPV 310
CP +Y +M+ECW P
Sbjct: 229 CPQEIYKIMLECWAAEPE 246
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 229 bits (585), Expect = 4e-73
Identities = 101/253 (39%), Positives = 144/253 (56%), Gaps = 21/253 (8%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIV 117
+G+G FG V G G VA+K LK++ A F E +M+ LRHPN+V
Sbjct: 10 LGATIGKGEFGDVMLG---DYRGQK-VAVKCLKDD--STAAQAFLAEASVMTTLRHPNLV 63
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
LLGV L G P+ ++ E+M +G L ++L SR R+ I+ +Q Q F AL V
Sbjct: 64 QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG-RAVITLAQ------QLGF---ALDVCE 113
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 237
GM YL ++VHRDLAARN LV + L K+SDFGL+++ Q LPV+W P
Sbjct: 114 GMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-----QDSGKLPVKWTAP 168
Query: 238 ESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRM 297
E++ KF+T+SDVWS+G++LWE+YS+G PY ++V+ + + PE CPP +
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEV 228
Query: 298 YSLMMECWHEVPV 310
Y +M +CW P
Sbjct: 229 YKVMKDCWELDPA 241
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 228 bits (582), Expect = 1e-72
Identities = 92/253 (36%), Positives = 139/253 (54%), Gaps = 14/253 (5%)
Query: 60 QELGEGAFGKVYKGEVCTSEGPSL-VAIKTLKENANQKTASDFRREVDLMSELRHPNIVC 118
++LG+G+FG V +GE TS G + VA+K LK + DF +E +M L H N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
L GV L+ P+ M+ E G L + L + +S A+Q+A G
Sbjct: 61 LYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGH--------FLIST--LCDYAVQIANG 109
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV-YASDYYRIQSKSLLPVRWMPP 237
M YL S ++HRDLAARN L+ VKI DFGL R + D+Y ++ +P W P
Sbjct: 110 MRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAP 169
Query: 238 ESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI-RSRQMLPCPEDCPPR 296
ES+ F+ SDVW +GV LWE+++YG +P+ G S ++++ I + + L PE CP
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQD 229
Query: 297 MYSLMMECWHEVP 309
+Y++M++CW P
Sbjct: 230 IYNVMLQCWAHNP 242
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 225 bits (575), Expect = 2e-71
Identities = 103/252 (40%), Positives = 144/252 (57%), Gaps = 17/252 (6%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIV 117
FL+ELG G FG V+ G+ G VAIK ++E A + DF E +M +L HPN+V
Sbjct: 8 FLKELGSGQFGVVHLGK---WRGKIDVAIKMIREGA--MSEDDFIEEAKVMMKLSHPNLV 62
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
L GVC P+ ++ E+M G L +L R + L + + V
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGK-----------LGTEWLLDMCSDVCE 111
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 237
M YL S+ ++HRDLAARNCLVG+ VK+SDFGL+R V D Y + PV+W PP
Sbjct: 112 AMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVL-DDQYTSSQGTKFPVKWAPP 170
Query: 238 ESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRM 297
E Y +F+++SDVWS+GV++WEV+S G PY +SN EV+E + + L P+ P +
Sbjct: 171 EVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEV 230
Query: 298 YSLMMECWHEVP 309
Y++M CWHE P
Sbjct: 231 YTIMYSCWHEKP 242
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 224 bits (572), Expect = 4e-71
Identities = 100/250 (40%), Positives = 148/250 (59%), Gaps = 14/250 (5%)
Query: 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCL 119
+++G+G FG VYKG +G + VA+KT + F +E +++ + HPNIV L
Sbjct: 1 EKIGKGNFGDVYKG---VLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL 57
Query: 120 LGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGM 179
+GVC+ +P+ ++ E + G L FL + R L+ + ++L AAGM
Sbjct: 58 IGVCVQKQPIYIVMELVPGGSLLTFLRKKKNR-----------LTVKKLLQMSLDAAAGM 106
Query: 180 AYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPES 239
YL S + +HRDLAARNCLVG+ +KISDFG+SR+ Y +P++W PE+
Sbjct: 107 EYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEA 166
Query: 240 ILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYS 299
+ YG++T+ESDVWSYG++LWE +S G PY G SNQ+ E I S +P P+ CP +Y
Sbjct: 167 LNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYR 226
Query: 300 LMMECWHEVP 309
LM++CW P
Sbjct: 227 LMLQCWAYDP 236
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 224 bits (572), Expect = 6e-71
Identities = 98/263 (37%), Positives = 143/263 (54%), Gaps = 18/263 (6%)
Query: 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSL-VAIKTLKENANQKTASDFRREVD 106
+RE I + +GEG FG VY+G + E + VA+KT K + F +E
Sbjct: 4 QREDITLG----RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAY 59
Query: 107 LMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQ 166
+M + HP+IV L+GV + P+ ++ E G+L +L L
Sbjct: 60 IMRQFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYS-----------LDLA 107
Query: 167 DFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQS 226
+ Q++ +AYL S +VHRD+AARN LV VK+ DFGLSR + YY+ S
Sbjct: 108 SLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK-AS 166
Query: 227 KSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286
K LP++WM PESI + +FT+ SDVW +GV +WE+ G++P+ G N +VI I + +
Sbjct: 167 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGER 226
Query: 287 LPCPEDCPPRMYSLMMECWHEVP 309
LP P +CPP +YSLM +CW P
Sbjct: 227 LPMPPNCPPTLYSLMTKCWAYDP 249
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 223 bits (569), Expect = 3e-70
Identities = 87/102 (85%), Positives = 100/102 (98%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+AAGM YL SHH+VHRDLAARNCLVG+GLTVKISDFGLSRD+Y++DYYR+QSKSLLPVRW
Sbjct: 133 IAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRW 192
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
MPPE+ILYGKFTTESD+WS+GVVLWE++SYGLQPYYG+SNQE
Sbjct: 193 MPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE 234
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 219 bits (559), Expect = 5e-69
Identities = 99/257 (38%), Positives = 147/257 (57%), Gaps = 16/257 (6%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSL-VAIKTLK-ENANQKTASDFRREVDLMSELRHPNIVCL 119
LGEG FG V +G++ +G L VA+KT+K + +F E M + HPN++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 120 LGVCLSGE-------PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIA 172
+GVC PM +L FM GDLH FL+ S + G + PL Q
Sbjct: 67 IGVCFEASSLQKIPKPMVIL-PFMKHGDLHSFLLY----SRLGGLPEKLPL--QTLLKFM 119
Query: 173 LQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV 232
+ +A GM YL + +++HRDLAARNC++ + +TV ++DFGLS+ +Y+ DYYR + +PV
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 233 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPED 292
+W+ ES+ +T++SDVW++GV +WE+ + G PY G N E+ + +R L PED
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPED 239
Query: 293 CPPRMYSLMMECWHEVP 309
C +Y LM CW P
Sbjct: 240 CLDELYDLMYSCWRADP 256
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 219 bits (558), Expect = 3e-68
Identities = 106/259 (40%), Positives = 154/259 (59%), Gaps = 12/259 (4%)
Query: 62 LGEGAFGKVYKGEVC-----TSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPN 115
LGEG FG+V + E + VA+K LK+NA K +D E++LM + +H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 116 IVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRS-----DISGSQVQAPLSQQDFSH 170
I+ LLGVC P+ ++ E+ +G+L EFL +R P DI+ + LS +D
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVP-EEQLSFKDLVS 138
Query: 171 IALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL 230
A QVA GM YL S +HRDLAARN LV + +KI+DFGL+R V+ DYY+ S L
Sbjct: 139 CAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRL 198
Query: 231 PVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP 290
PV+WM PE++ +T +SDVWS+G+++WE+++ G PY G +E+ +++R + P
Sbjct: 199 PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKP 258
Query: 291 EDCPPRMYSLMMECWHEVP 309
+C +Y LM ECWH VP
Sbjct: 259 SNCTHELYMLMRECWHAVP 277
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 213 bits (545), Expect = 4e-67
Identities = 101/254 (39%), Positives = 150/254 (59%), Gaps = 17/254 (6%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSL-VAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLL 120
+G+G FG VY G + S+G + A+K+L + + F +E +M + HPN++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 121 GVCL--SGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
G+CL G P+ +L +M GDL F+ RS + P + +D LQVA G
Sbjct: 63 GICLPSEGSPLVVL-PYMKHGDLRNFI--RSETHN--------P-TVKDLIGFGLQVAKG 110
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKS--LLPVRWMP 236
M YL S +VHRDLAARNC++ + TVK++DFGL+RD+Y +YY + + + LPV+WM
Sbjct: 111 MEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170
Query: 237 PESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPR 296
ES+ KFTT+SDVWS+GV+LWE+ + G PY + ++ + + L PE CP
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDP 230
Query: 297 MYSLMMECWHEVPV 310
+Y +M+ CWH P
Sbjct: 231 LYEVMLSCWHPKPE 244
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 211 bits (538), Expect = 1e-65
Identities = 103/263 (39%), Positives = 148/263 (56%), Gaps = 15/263 (5%)
Query: 62 LGEGAFGKVYKG---EVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVC 118
LGEG FGKV K + G + VA+K LKENA+ D E +L+ ++ HP+++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFL-MSR-----------SPRSDISGSQVQAPLSQQ 166
L G C P+ ++ E+ G L FL SR + S + + L+
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 167 DFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQS 226
D A Q++ GM YL VHRDLAARN LV +G +KISDFGLSRDVY D Y +S
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRS 187
Query: 227 KSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286
K +PV+WM ES+ +TT+SDVWS+GV+LWE+ + G PY G + + + ++++
Sbjct: 188 KGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYR 247
Query: 287 LPCPEDCPPRMYSLMMECWHEVP 309
+ PE+C MY+LM+ CW + P
Sbjct: 248 MERPENCSEEMYNLMLTCWKQEP 270
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 212 bits (541), Expect = 1e-65
Identities = 108/275 (39%), Positives = 162/275 (58%), Gaps = 10/275 (3%)
Query: 45 SDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEG-----PSLVAIKTLKENANQKTAS 99
+D + E+ T+ + LGEG FG+V E + P VA+K LK++A K S
Sbjct: 3 ADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLS 62
Query: 100 DFRREVDLMSEL-RHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRS-DISGS 157
D E+++M + +H NI+ LLG C P+ +L E+ +G+L E+L +R P D S
Sbjct: 63 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFD 122
Query: 158 QVQAP---LSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR 214
+ P L+ +D A QVA GM YL S +HRDLAARN LV + +KI+DFGL+R
Sbjct: 123 TCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
Query: 215 DVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN 274
DV+ DYY+ + LPV+WM PE++ +T +SDVWS+GV+LWE+++ G PY G
Sbjct: 183 DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242
Query: 275 QEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
+E+ ++++ + P +C +Y +M ECWH VP
Sbjct: 243 EELFKLLKEGHRMDKPANCTHELYMIMRECWHAVP 277
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 208 bits (531), Expect = 5e-65
Identities = 103/253 (40%), Positives = 143/253 (56%), Gaps = 17/253 (6%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
+QE+G G FG V+ G VAIKT++E A + DF E +M +L HP +
Sbjct: 7 TLVQEIGSGQFGLVWLG---YWLEKRKVAIKTIREGA--MSEEDFIEEAQVMMKLSHPKL 61
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V L GVC P+C++FEFM G L ++L ++ + SQ+ + L V
Sbjct: 62 VQLYGVCTERSPICLVFEFMEHGCLSDYLRAQ-----------RGKFSQETLLGMCLDVC 110
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 236
GMAYL S + +HRDLAARNCLVG+ VK+SDFG++R V D Y + + PV+W
Sbjct: 111 EGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSS 169
Query: 237 PESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPR 296
PE + K++++SDVWS+GV++WEV+S G PY SN EV+E I + L P
Sbjct: 170 PEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQS 229
Query: 297 MYSLMMECWHEVP 309
+Y LM CW E P
Sbjct: 230 VYELMQHCWKERP 242
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 208 bits (531), Expect = 1e-64
Identities = 96/262 (36%), Positives = 150/262 (57%), Gaps = 16/262 (6%)
Query: 49 REVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSL---VAIKTLKENANQKTASDFRREV 105
R + ET+ ++ LG GAFG VYKG V EG + VAIK L+E + K + E
Sbjct: 2 RILKETELEKIKVLGSGAFGTVYKG-VWIPEGEKVKIPVAIKVLREETSPKANKEILDEA 60
Query: 106 DLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQ 165
+M+ + HP++V LLG+CLS + ++ + M G L +++ R+ + +I GSQ
Sbjct: 61 YVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYV--RNHKDNI-GSQ------- 109
Query: 166 QDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQ 225
+ +Q+A GM+YL VHRDLAARN LV VKI+DFGL++ + +
Sbjct: 110 -YLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHA 168
Query: 226 SKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ 285
+P++WM ESIL+ +T +SDVWSYGV +WE+ ++G +PY G E+ +++ +
Sbjct: 169 EGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE 228
Query: 286 MLPCPEDCPPRMYSLMMECWHE 307
LP P C +Y ++++CW
Sbjct: 229 RLPQPPICTIDVYMVLVKCWMI 250
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 205 bits (522), Expect = 1e-63
Identities = 107/253 (42%), Positives = 139/253 (54%), Gaps = 25/253 (9%)
Query: 62 LGEGAFGKVYKGEV-CTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLL 120
+G G FG+V +G + + VAIKTLK +K DF E +M + HPNI+ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 121 GVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL-----QV 175
GV P+ ++ EFM G L FL + F+ I L +
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLR----------------QNDGQFTVIQLVGMLRGI 115
Query: 176 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL---LPV 232
AAGM YL +YVHRDLAARN LV L K+SDFGLSR + + SL +P+
Sbjct: 116 AAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPI 175
Query: 233 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPED 292
RW PE+I Y KFT+ SDVWSYG+V+WEV SYG +PY+ SNQ+VI I LP P D
Sbjct: 176 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMD 235
Query: 293 CPPRMYSLMMECW 305
CP ++ LM++CW
Sbjct: 236 CPTALHQLMLDCW 248
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 205 bits (522), Expect = 1e-63
Identities = 104/250 (41%), Positives = 140/250 (56%), Gaps = 17/250 (6%)
Query: 62 LGEGAFGKVYKGEVCTS-EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLL 120
+G G FG+V++G + VAIKTLK +K DF E +M + H NI+ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 121 GVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMA 180
GV +P ++ E+M G L ++L R + S Q+ L +AAGM
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYL--RDHDGEFSSYQLVGMLRG---------IAAGMK 121
Query: 181 YLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR---DVYASDYYRIQSKSLLPVRWMPP 237
YL +YVHRDLAARN LV L K+SDFGLSR D Y K +P+RW P
Sbjct: 122 YLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGK--IPIRWTAP 179
Query: 238 ESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRM 297
E+I Y KFT+ SDVWS+G+V+WEV S+G +PY+ SN EV++ I LP P DCP +
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAV 239
Query: 298 YSLMMECWHE 307
Y LM++CW +
Sbjct: 240 YQLMLQCWQQ 249
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 205 bits (523), Expect = 3e-63
Identities = 100/257 (38%), Positives = 141/257 (54%), Gaps = 15/257 (5%)
Query: 58 FLQELGEGAFGKVYKGEV--CTSEGPSL-VAIKTLKENANQKTASDFRREVDLMSEL-RH 113
F + LG GAFGKV + + + VA+K LK A+ E+ +MS L H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
NIV LLG C G P+ ++ E+ GDL FL + ++ L+ +D +
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR----------ESFLTLEDLLSFSY 148
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR 233
QVA GMA+L S + +HRDLAARN L+ G VKI DFGL+RD+ Y ++ + LPV+
Sbjct: 149 QVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208
Query: 234 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS-NQEVIEMIRSRQMLPCPED 292
WM PESI +T ESDVWSYG++LWE++S G PY G + + ++I+ + PE
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEH 268
Query: 293 CPPRMYSLMMECWHEVP 309
P +Y +M CW P
Sbjct: 269 APAEIYDIMKTCWDADP 285
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 4e-63
Identities = 73/113 (64%), Positives = 90/113 (79%), Gaps = 2/113 (1%)
Query: 305 WHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 364
V +A+GM YL S H+VHRDLA RNCLVG L VKI DFG+SRDVY +DYYR+ ++
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185
Query: 365 LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE--EFLK 415
LP+RWMPPESI+Y KFTTESDVWS+GVVLWE+++YG QP+YG SN+E E +
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 203 bits (517), Expect = 8e-63
Identities = 95/245 (38%), Positives = 149/245 (60%), Gaps = 15/245 (6%)
Query: 61 ELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLL 120
+LG G +G+VY+G + VA+KTLKE+ + +F +E +M E++HPN+V LL
Sbjct: 13 KLGGGQYGEVYEG--VWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLL 68
Query: 121 GVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMA 180
GVC P ++ EFM G+L ++L + + ++ ++A Q+++ M
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQE----------VNAVVLLYMATQISSAME 118
Query: 181 YLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESI 240
YL +++HRDLAARNCLVG+ VK++DFGLSR + D Y + + P++W PES+
Sbjct: 119 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESL 177
Query: 241 LYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSL 300
Y KF+ +SDVW++GV+LWE+ +YG+ PY G +V E++ + PE CPP++Y L
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYEL 237
Query: 301 MMECW 305
M CW
Sbjct: 238 MRACW 242
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 1e-62
Identities = 90/275 (32%), Positives = 139/275 (50%), Gaps = 36/275 (13%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPS-----LVAIKTLKENANQKTASDFRREVDLMSEL 111
+F+++LGEG FGKV C + VA+K+L + ++ SDF RE++++ L
Sbjct: 7 KFIKQLGEGHFGKVEL---CRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL 63
Query: 112 RHPNIVCLLGVCLS--GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFS 169
H NIV GVC G + ++ E++ G L ++L + + +
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQIN-LKRLLL--------- 113
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV-YASDYYRIQSKS 228
+ Q+ GM YL S Y+HRDLAARN LV VKISDFGL++ + DYY ++
Sbjct: 114 -FSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPG 172
Query: 229 LLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYG-------------LQPYYGYSNQ 275
P+ W PE + KF++ SDVWS+GV L+E+++YG + G
Sbjct: 173 ESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIV 232
Query: 276 E-VIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
++E+++ + LP P CP +Y LM CW P
Sbjct: 233 TRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEP 267
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 201 bits (515), Expect = 2e-62
Identities = 66/108 (61%), Positives = 84/108 (77%), Gaps = 2/108 (1%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+A GM YL S ++VHRDLAARNCLV + L VKISDFGLSRD+Y DYYR + LP++W
Sbjct: 111 IAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKW 170
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE--EFLK 415
M PES+ GKFT++SDVWS+GV+LWE+++ G QPY G SN+E E L+
Sbjct: 171 MAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLE 218
|
Length = 258 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 2e-62
Identities = 107/274 (39%), Positives = 161/274 (58%), Gaps = 10/274 (3%)
Query: 46 DFRREVIETKPRFLQELGEGAFGKVYKGEVC--TSEGP---SLVAIKTLKENANQKTASD 100
D R EV + + LGEG FG+V E E P + VA+K LK +A +K SD
Sbjct: 10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSD 69
Query: 101 FRREVDLMSEL-RHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRS-DISGSQ 158
E+++M + +H NI+ LLG C P+ ++ E+ +G+L E+L +R P + +
Sbjct: 70 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNP 129
Query: 159 VQAP---LSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRD 215
Q P LS +D A QVA GM YL S +HRDLAARN LV + +KI+DFGL+RD
Sbjct: 130 TQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 189
Query: 216 VYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ 275
++ DYY+ + LPV+WM PE++ +T +SDVWS+GV+LWE+++ G PY G +
Sbjct: 190 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249
Query: 276 EVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
E+ ++++ + P +C +Y +M +CWH VP
Sbjct: 250 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVP 283
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 3e-62
Identities = 105/250 (42%), Positives = 141/250 (56%), Gaps = 17/250 (6%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSL-VAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLL 120
+G G FG+V G + + VAIKTLK +K DF E +M + HPNI+ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 121 GVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMA 180
GV +P+ ++ E+M G L FL + D + +Q + +A+GM
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLR----KHDGQFTVIQ-------LVGMLRGIASGMK 120
Query: 181 YLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR---DVYASDYYRIQSKSLLPVRWMPP 237
YL YVHRDLAARN LV L K+SDFGLSR D + Y K +P+RW P
Sbjct: 121 YLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK--IPIRWTAP 178
Query: 238 ESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRM 297
E+I Y KFT+ SDVWSYG+V+WEV SYG +PY+ SNQ+VI+ I LP P DCP +
Sbjct: 179 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAAL 238
Query: 298 YSLMMECWHE 307
+ LM++CW +
Sbjct: 239 HQLMLDCWQK 248
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 201 bits (512), Expect = 3e-62
Identities = 98/247 (39%), Positives = 143/247 (57%), Gaps = 15/247 (6%)
Query: 61 ELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASD-FRREVDLMSELRHPNIVCL 119
ELG G FG V KG + VA+K LK + N D RE ++M +L +P IV +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 120 LGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGM 179
+G+C E ++ E G L++FL Q +++++ + + QV+ GM
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFL------------QKNKHVTEKNITELVHQVSMGM 108
Query: 180 AYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD-YYRIQSKSLLPVRWMPPE 238
YL ++VHRDLAARN L+ KISDFGLS+ + A + YY+ ++ PV+W PE
Sbjct: 109 KYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE 168
Query: 239 SILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMY 298
+ Y KF+++SDVWS+GV++WE +SYG +PY G EV +MI S + + CP+ CPP MY
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMY 228
Query: 299 SLMMECW 305
LM CW
Sbjct: 229 DLMKLCW 235
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 200 bits (511), Expect = 3e-62
Identities = 101/252 (40%), Positives = 150/252 (59%), Gaps = 23/252 (9%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLG 121
LG+G FG+V+KG T + + VA+KT KE+ Q+ F E ++ + HPNIV L+G
Sbjct: 3 LGKGNFGEVFKG---TLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 122 VCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAY 181
VC +P+ ++ E + GD FL R + ++ Q+ AL AAGMAY
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQL---------VKFALDAAAGMAY 108
Query: 182 LCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRD----VYASDYYRIQSKSLLPVRWMPP 237
L S + +HRDLAARNCLVG+ +KISDFG+SR +Y+S + +P++W P
Sbjct: 109 LESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK-----QIPIKWTAP 163
Query: 238 ESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRM 297
E++ YG++++ESDVWSYG++LWE +S G+ PY G +NQ+ E + + CP+ CP +
Sbjct: 164 EALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDV 223
Query: 298 YSLMMECWHEVP 309
Y +M CW P
Sbjct: 224 YKVMQRCWDYKP 235
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 199 bits (508), Expect = 1e-61
Identities = 98/250 (39%), Positives = 140/250 (56%), Gaps = 13/250 (5%)
Query: 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCL 119
+ +G G FG+V+ G + P VA+K+ +E + F +E ++ + HPNIV L
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTP--VAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 58
Query: 120 LGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGM 179
+GVC +P+ ++ E + GD FL + PR L ++ + AAGM
Sbjct: 59 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR-----------LKVKELIQMVENAAAGM 107
Query: 180 AYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPES 239
YL S H +HRDLAARNCLV + +KISDFG+SR+ Y +PV+W PE+
Sbjct: 108 EYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEA 167
Query: 240 ILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYS 299
+ YG++++ESDVWS+G++LWE +S G PY SNQ+ E I LPCPE CP +Y
Sbjct: 168 LNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYR 227
Query: 300 LMMECWHEVP 309
LM CW P
Sbjct: 228 LMERCWEYDP 237
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 199 bits (507), Expect = 2e-61
Identities = 102/252 (40%), Positives = 136/252 (53%), Gaps = 17/252 (6%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIV 117
FL+ELG G FG V G+ G VAIK +KE + + +F E +M +L H +V
Sbjct: 8 FLKELGTGQFGVVKYGK---WRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLV 62
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
L GVC P+ ++ E+M G L +L R + V
Sbjct: 63 QLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKR-----------FQPSQLLEMCKDVCE 111
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 237
GMAYL S ++HRDLAARNCLV D VK+SDFGLSR V D Y S PVRW PP
Sbjct: 112 GMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPP 170
Query: 238 ESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRM 297
E +LY KF+++SDVW++GV++WEVYS G PY ++N E +E + L P ++
Sbjct: 171 EVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKV 230
Query: 298 YSLMMECWHEVP 309
Y++M CWHE
Sbjct: 231 YAIMYSCWHEKA 242
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 2e-61
Identities = 102/275 (37%), Positives = 157/275 (57%), Gaps = 12/275 (4%)
Query: 46 DFRREVIETKPRFLQELGEGAFGKVYKGEVC--TSEGPS---LVAIKTLKENANQKTASD 100
D R E K + LGEG FG+V E + P VA+K LK++A +K SD
Sbjct: 7 DPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSD 66
Query: 101 FRREVDLMSEL-RHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRS-----DI 154
E+++M + +H NI+ LLG C P+ ++ E+ +G+L E+L +R P DI
Sbjct: 67 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 126
Query: 155 SGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR 214
+ ++ +D QVA GM YL S +HRDLAARN LV + +KI+DFGL+R
Sbjct: 127 ARVP-DEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
Query: 215 DVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN 274
DV DYY+ + LPV+WM PE++ +T +SDVWS+GV++WE+++ G PY G
Sbjct: 186 DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245
Query: 275 QEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
+E+ ++++ + P +C +Y +M +CWH +P
Sbjct: 246 EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIP 280
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 198 bits (505), Expect = 7e-61
Identities = 100/258 (38%), Positives = 143/258 (55%), Gaps = 18/258 (6%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSL-VAIKTLKENANQKT-ASDFRREVDLMSELRHPNIVCL 119
LG+G FG V + ++ + +G VA+K LK + + +F RE M E HPN++ L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 120 LGVCLSGE-------PMCMLFEFMVRGDLHEFL-MSRSPRSDISGSQVQAPLSQQDFSHI 171
+GV L PM +L FM GDLH FL MSR + L Q
Sbjct: 67 IGVSLRSRAKGRLPIPMVIL-PFMKHGDLHTFLLMSRIGEEPFT-------LPLQTLVRF 118
Query: 172 ALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 231
+ +A+GM YL S +++HRDLAARNC++ + +TV ++DFGLS+ +Y+ DYYR S LP
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP 178
Query: 232 VRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPE 291
V+W+ ES+ +TT SDVW++GV +WE+ + G PY G N E+ + L P
Sbjct: 179 VKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238
Query: 292 DCPPRMYSLMMECWHEVP 309
DC +Y LM +CW P
Sbjct: 239 DCLEDVYELMCQCWSPEP 256
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 197 bits (501), Expect = 1e-60
Identities = 103/260 (39%), Positives = 157/260 (60%), Gaps = 17/260 (6%)
Query: 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMS 109
E+ + +++LG G FG+V+ G T G + VA+KTLK + F E +M
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMG---TWNGNTKVAVKTLKPGTMSPES--FLEEAQIMK 56
Query: 110 ELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFS 169
+LRH +V L V +S EP+ ++ E+M +G L +FL D G ++ P +
Sbjct: 57 KLRHDKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFL------KDGEGRALKLP----NLV 105
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 229
+A QVAAGMAY+ +Y+HRDL + N LVGDGL KI+DFGL+R + ++Y Q
Sbjct: 106 DMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF 165
Query: 230 LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289
P++W PE+ LYG+FT +SDVWS+G++L E+ + G PY G +N+EV+E + +PC
Sbjct: 166 -PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPC 224
Query: 290 PEDCPPRMYSLMMECWHEVP 309
P+DCP ++ LM++CW + P
Sbjct: 225 PQDCPISLHELMLQCWKKDP 244
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 195 bits (496), Expect = 7e-60
Identities = 100/252 (39%), Positives = 139/252 (55%), Gaps = 17/252 (6%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIV 117
F++ELG G FG V+ G+ VAIK + E A + DF E +M +L HP +V
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIK---VAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLV 62
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
L GVC +P+ ++ EFM G L +L R Q LS+ + V
Sbjct: 63 QLYGVCTQQKPLYIVTEFMENGCLLNYLRQR-----------QGKLSKDMLLSMCQDVCE 111
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 237
GM YL + ++HRDLAARNCLV VK+SDFG++R V D Y S + PV+W PP
Sbjct: 112 GMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVL-DDEYTSSSGAKFPVKWSPP 170
Query: 238 ESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRM 297
E + K++++SDVWS+GV++WEV++ G P+ SN EV+EMI L P+ +
Sbjct: 171 EVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTV 230
Query: 298 YSLMMECWHEVP 309
Y +M CWHE P
Sbjct: 231 YEVMYSCWHEKP 242
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 195 bits (496), Expect = 1e-59
Identities = 98/260 (37%), Positives = 151/260 (58%), Gaps = 17/260 (6%)
Query: 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMS 109
EV + +++LG G FG+V+ G G + VAIK+LK+ + A F E +LM
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMG---YYNGHTKVAIKSLKQGSMSPEA--FLAEANLMK 56
Query: 110 ELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFS 169
+L+HP +V L V ++ EP+ ++ E+M G L +FL + G + L+
Sbjct: 57 QLQHPRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPE------GIK----LTINKLI 105
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 229
+A Q+A GMA++ +Y+HRDL A N LV + L KI+DFGL+R + + Y + +
Sbjct: 106 DMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLAR-LIEDNEYTAREGAK 164
Query: 230 LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289
P++W PE+I YG FT +SDVWS+G++L E+ +YG PY G +N EVI+ + +P
Sbjct: 165 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPR 224
Query: 290 PEDCPPRMYSLMMECWHEVP 309
P++CP +Y LM CW E P
Sbjct: 225 PDNCPEELYELMRLCWKEKP 244
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 193 bits (494), Expect = 2e-59
Identities = 65/102 (63%), Positives = 80/102 (78%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+A GM YL S +VHRDLAARNCLVG+ L VKISDFGLSRDVY DYYR ++ LP+RW
Sbjct: 114 IAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRW 173
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
M PES+ G FT++SDVWS+GV+LWE+++ G PY G SN+E
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE 215
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 6e-59
Identities = 99/246 (40%), Positives = 141/246 (57%), Gaps = 13/246 (5%)
Query: 61 ELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLL 120
ELG G FG V KG + VAIK LK + + RE ++M +L +P IV ++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 121 GVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMA 180
GVC E + ++ E G L++FL + + +I+ S V + QV+ GM
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGK--KDEITVSNV---------VELMHQVSMGMK 109
Query: 181 YLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD-YYRIQSKSLLPVRWMPPES 239
YL ++VHRDLAARN L+ + KISDFGLS+ + A D YY+ +S P++W PE
Sbjct: 110 YLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPEC 169
Query: 240 ILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYS 299
I + KF++ SDVWSYG+ +WE +SYG +PY EV+ I + L CP +CPP MY+
Sbjct: 170 INFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYA 229
Query: 300 LMMECW 305
LM +CW
Sbjct: 230 LMKDCW 235
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 192 bits (491), Expect = 7e-59
Identities = 68/109 (62%), Positives = 86/109 (78%), Gaps = 3/109 (2%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+A GM YL S +++HRDLAARNCLVG+ L VKISDFGLSRD+Y DYYR + LP+RW
Sbjct: 111 IARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGK-LPIRW 169
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE--EFLKT 416
M PES+ GKFT++SDVWS+GV+LWE+++ G QPY G SN+E E+LK
Sbjct: 170 MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKN 218
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 1e-58
Identities = 66/109 (60%), Positives = 86/109 (78%), Gaps = 3/109 (2%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+A GM YL S +++HRDLAARNCLVG+ L VKISDFGLSRD+Y DYY+++ LP+RW
Sbjct: 112 IARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGK-LPIRW 170
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE--EFLKT 416
M PES+ GKFT++SDVWS+GV+LWE+++ G +PY G SN E E+LK
Sbjct: 171 MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKK 219
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 191 bits (486), Expect = 5e-58
Identities = 89/257 (34%), Positives = 146/257 (56%), Gaps = 9/257 (3%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSL---VAIKTLKENANQKTASDFRREVDLMSELRH 113
L EG FG+++ G + E P V +KT+K++A++ + +E L+ L H
Sbjct: 9 TLSDLLQEGTFGRIFYG-ILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH 67
Query: 114 PNIVCLLGVCLS-GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIA 172
NI+ +L VC+ GEP +L+ +M G+L FL + R + + LS Q H+A
Sbjct: 68 QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFL--QQCR--LGEANNPQALSTQQLVHMA 123
Query: 173 LQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV 232
+Q+A GM+YL +H+D+AARNC++ + L VKI+D LSRD++ DY+ + PV
Sbjct: 124 IQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183
Query: 233 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPED 292
+WM ES++ ++++ SDVWS+GV+LWE+ + G PY E+ ++ L P +
Sbjct: 184 KWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPIN 243
Query: 293 CPPRMYSLMMECWHEVP 309
CP ++++M CW P
Sbjct: 244 CPDELFAVMACCWALDP 260
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 189 bits (480), Expect = 2e-57
Identities = 101/250 (40%), Positives = 136/250 (54%), Gaps = 23/250 (9%)
Query: 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCL 119
+ +GEG FG V +GE + VA+K +K + TA F E +M++L H N+V L
Sbjct: 12 EIIGEGEFGAVLQGEYTGQK----VAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRL 64
Query: 120 LGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGM 179
LGV L + ++ E M +G+L FL +R +A +S +L VA GM
Sbjct: 65 LGVILH-NGLYIVMELMSKGNLVNFLRTRG----------RALVSVIQLLQFSLDVAEGM 113
Query: 180 AYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPES 239
YL S VHRDLAARN LV + K+SDFGL A S LPV+W PE+
Sbjct: 114 EYLESKKLVHRDLAARNILVSEDGVAKVSDFGL-----ARVGSMGVDNSKLPVKWTAPEA 168
Query: 240 ILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYS 299
+ + KF+++SDVWSYGV+LWEV+SYG PY S +EV E + + PE CP +Y
Sbjct: 169 LKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYV 228
Query: 300 LMMECWHEVP 309
LM CW P
Sbjct: 229 LMTSCWETEP 238
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 189 bits (480), Expect = 2e-57
Identities = 102/259 (39%), Positives = 144/259 (55%), Gaps = 17/259 (6%)
Query: 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTA-SDFRREVDLMSELRHPNIVC 118
+ LGEG FG V +G++ + VA+KT+K ++ DF E M E HPN++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 119 LLGVCLSG-------EPMCMLFEFMVRGDLHEFLM-SRSPRSDISGSQVQAPLSQQDFSH 170
L+GVCL P+ +L FM GDLH FL+ SR G Q L Q
Sbjct: 65 LIGVCLQTVESEGYPSPVVIL-PFMKHGDLHSFLLYSRL------GDCPQY-LPTQMLVK 116
Query: 171 IALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL 230
+A+GM YL S ++HRDLAARNC++ + + V ++DFGLS+ +Y DYYR + +
Sbjct: 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176
Query: 231 PVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP 290
PV+W+ ES+ +TT+SDVWS+GV +WE+ + G PY G N E+ + +R L P
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQP 236
Query: 291 EDCPPRMYSLMMECWHEVP 309
DC +YSLM CW P
Sbjct: 237 PDCLDGLYSLMSSCWLLNP 255
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 186 bits (473), Expect = 2e-56
Identities = 93/256 (36%), Positives = 147/256 (57%), Gaps = 23/256 (8%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
+ LQ +G+G FG V G+ ++ VA+K +K +A TA F E +M++LRH N+
Sbjct: 9 KLLQTIGKGEFGDVMLGDYRGNK----VAVKCIKNDA---TAQAFLAEASVMTQLRHSNL 61
Query: 117 VCLLGVCLSGE-PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQV 175
V LLGV + + + ++ E+M +G L ++L SR RS + G + +L V
Sbjct: 62 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLL---------KFSLDV 111
Query: 176 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM 235
M YL ++++VHRDLAARN LV + K+SDFGL+++ + Q LPV+W
Sbjct: 112 CEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWT 166
Query: 236 PPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPP 295
PE++ KF+T+SDVWS+G++LWE+YS+G PY ++V+ + + P+ CPP
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP 226
Query: 296 RMYSLMMECWHEVPVA 311
+Y +M +CWH
Sbjct: 227 VVYDVMKQCWHLDAAT 242
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 3e-56
Identities = 66/102 (64%), Positives = 86/102 (84%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
VAAGMAYL +VHRDLA RNCLVG+ + VKI+DFGLSR++Y++DYY+ +P+RW
Sbjct: 139 VAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRW 198
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
MPPESI Y ++TTESDVW+YGVVLWE++SYG+QPYYG +++E
Sbjct: 199 MPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 184 bits (467), Expect = 2e-55
Identities = 98/260 (37%), Positives = 146/260 (56%), Gaps = 16/260 (6%)
Query: 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMS 109
E+ + +++LG G FG+V+ G S + VA+KTLK A F E +LM
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNS---TKVAVKTLKPGTMSVQA--FLEEANLMK 56
Query: 110 ELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFS 169
L+H +V L V EP+ ++ E+M +G L +FL S G +V P DFS
Sbjct: 57 TLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDE------GGKVLLPKLI-DFS 109
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 229
Q+A GMAY+ +Y+HRDL A N LV + L KI+DFGL+R V + Y + +
Sbjct: 110 ---AQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAK 165
Query: 230 LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289
P++W PE+I +G FT +SDVWS+G++L+E+ +YG PY G SN +V+ ++ +P
Sbjct: 166 FPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPR 225
Query: 290 PEDCPPRMYSLMMECWHEVP 309
E+CP +Y +M CW E
Sbjct: 226 MENCPDELYDIMKTCWKEKA 245
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 186 bits (473), Expect = 5e-55
Identities = 105/319 (32%), Positives = 151/319 (47%), Gaps = 63/319 (19%)
Query: 50 EVIETKPRFLQELGEGAFGKVYKGE---VCTSEGPSLVAIKTLKENANQKTASDFRREVD 106
E +F + LG GAFGKV + + + VA+K LK +A+ E+
Sbjct: 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELK 93
Query: 107 LMSEL-RHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSP--------------- 150
++S L +H NIV LLG C G P+ ++ E+ GDL FL ++
Sbjct: 94 ILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISET 153
Query: 151 --------------RSD----------------ISGSQVQA-------------PLSQQD 167
RSD +S S Q+ PL D
Sbjct: 154 SSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDD 213
Query: 168 FSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSK 227
+ QVA GM +L S + +HRD+AARN L+ DG KI DFGL+RD+ Y ++
Sbjct: 214 LLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273
Query: 228 SLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS-NQEVIEMIRSRQM 286
+ LPV+WM PESI +T +SDVWSYG++LWE++S G PY G N + +M++
Sbjct: 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ 333
Query: 287 LPCPEDCPPRMYSLMMECW 305
+ P+ PP +YS+M CW
Sbjct: 334 MSRPDFAPPEIYSIMKMCW 352
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 182 bits (463), Expect = 6e-55
Identities = 100/260 (38%), Positives = 151/260 (58%), Gaps = 17/260 (6%)
Query: 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMS 109
E+ R +LG+G FG+V+ G T G + VAIKTLK A F +E +M
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMG---TWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMK 56
Query: 110 ELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFS 169
+LRH +V L V +S EP+ ++ E+M +G L +FL G ++ P
Sbjct: 57 KLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEM------GKYLRLP----QLV 105
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 229
+A Q+A+GMAY+ +YVHRDL A N LVG+ L K++DFGL+R + ++Y Q
Sbjct: 106 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 165
Query: 230 LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289
P++W PE+ LYG+FT +SDVWS+G++L E+ + G PY G N+EV++ + +PC
Sbjct: 166 -PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 224
Query: 290 PEDCPPRMYSLMMECWHEVP 309
P +CP ++ LM +CW + P
Sbjct: 225 PPECPESLHDLMCQCWRKEP 244
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 181 bits (463), Expect = 7e-55
Identities = 73/256 (28%), Positives = 118/256 (46%), Gaps = 21/256 (8%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
L++LGEG+FGKVY + LVAIK +K+ +K RE+ ++ +L+HPNI
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTG--KLVAIKVIKKKKIKKDRERILREIKILKKLKHPNI 59
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V L V + + ++ E+ GDL + L R LS+ + Q+
Sbjct: 60 VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG------------RLSEDEARFYLRQIL 107
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 236
+ + YL S VHRDL N L+ + VK++DFGL+R + + + +M
Sbjct: 108 SALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPE---YMA 164
Query: 237 PESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVI-EMIRSR--QMLPCPEDC 293
PE +L + D+WS GV+L+E+ + G P+ G + + I P D
Sbjct: 165 PEVLLGKGYGKAVDIWSLGVILYELLT-GKPPFPGDDQLLELFKKIGKPKPPFPPPEWDI 223
Query: 294 PPRMYSLMMECWHEVP 309
P L+ + + P
Sbjct: 224 SPEAKDLIRKLLVKDP 239
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 182 bits (463), Expect = 2e-54
Identities = 104/258 (40%), Positives = 143/258 (55%), Gaps = 8/258 (3%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPN 115
+F +GEG FG+V K + AIK +KE A++ DF E++++ +L HPN
Sbjct: 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 69
Query: 116 IVCLLGVCLSGEPMCMLFEFMVRGDLHEFL-MSRSPRSDIS---GSQVQAPLSQQDFSHI 171
I+ LLG C + + E+ G+L +FL SR +D + + + LS Q H
Sbjct: 70 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 172 ALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 231
A VA GM YL ++HRDLAARN LVG+ KI+DFGLSR + Y ++ LP
Sbjct: 130 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 186
Query: 232 VRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPE 291
VRWM ES+ Y +TT SDVWSYGV+LWE+ S G PY G + E+ E + L P
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 246
Query: 292 DCPPRMYSLMMECWHEVP 309
+C +Y LM +CW E P
Sbjct: 247 NCDDEVYDLMRQCWREKP 264
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 5e-54
Identities = 72/104 (69%), Positives = 95/104 (91%)
Query: 308 VPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV 367
+ +AAGM YL SH +VH+DLAARN L+G+ L VKISD GLSR++Y++DYYR+Q KSLLP+
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190
Query: 368 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
RWMPPE+I+YGKF+++SD+WS+GVVLWE++S+GLQPYYG+SNQE
Sbjct: 191 RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE 234
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 180 bits (457), Expect = 5e-54
Identities = 103/260 (39%), Positives = 150/260 (57%), Gaps = 17/260 (6%)
Query: 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMS 109
E+ R +LG+G FG+V+ G T G + VAIKTLK A F +E +M
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMG---TWNGTTKVAIKTLKPGTMMPEA--FLQEAQIMK 56
Query: 110 ELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFS 169
+LRH +V L V +S EP+ ++ EFM +G L +FL + G ++ P
Sbjct: 57 KLRHDKLVPLYAV-VSEEPIYIVTEFMGKGSLLDFL------KEGDGKYLKLP----QLV 105
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 229
+A Q+A GMAY+ +Y+HRDL A N LVGD L KI+DFGL+R + ++Y Q
Sbjct: 106 DMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF 165
Query: 230 LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289
P++W PE+ LYG+FT +SDVWS+G++L E+ + G PY G N+EV+E + +PC
Sbjct: 166 -PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPC 224
Query: 290 PEDCPPRMYSLMMECWHEVP 309
P+ CP ++ LM CW + P
Sbjct: 225 PQGCPESLHELMKLCWKKDP 244
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 1e-53
Identities = 70/131 (53%), Positives = 88/131 (67%), Gaps = 5/131 (3%)
Query: 284 RQMLPCPEDCPPR---MYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 340
R P E+ P ++ E+ A GMAYL + +VHRDLAARNC+V + LTV
Sbjct: 101 RSRRPEAENNPGLGPPTLQKFIQMAAEI--ADGMAYLAAKKFVHRDLAARNCMVAEDLTV 158
Query: 341 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYG 400
KI DFG++RD+Y +DYYR K LLPVRWM PES+ G FTT+SDVWS+GVVLWE+ +
Sbjct: 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLA 218
Query: 401 LQPYYGYSNQE 411
QPY G SN+E
Sbjct: 219 EQPYQGLSNEE 229
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 2e-53
Identities = 100/258 (38%), Positives = 146/258 (56%), Gaps = 8/258 (3%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPN 115
+F +GEG FG+V + + AIK LKE A++ DF E++++ +L HPN
Sbjct: 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64
Query: 116 IVCLLGVCLSGEPMCMLFEFMVRGDLHEFL-MSRSPRSDISGSQ---VQAPLSQQDFSHI 171
I+ LLG C + + + E+ G+L +FL SR +D + ++ + L+ Q
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 172 ALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 231
A VA GM YL ++HRDLAARN LVG+ L KI+DFGLSR + Y ++ LP
Sbjct: 125 ASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLP 181
Query: 232 VRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPE 291
VRWM ES+ Y +TT+SDVWS+GV+LWE+ S G PY G + E+ E + + P
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPR 241
Query: 292 DCPPRMYSLMMECWHEVP 309
+C +Y LM +CW + P
Sbjct: 242 NCDDEVYELMRQCWRDRP 259
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 3e-53
Identities = 71/127 (55%), Positives = 96/127 (75%), Gaps = 6/127 (4%)
Query: 285 QMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISD 344
+ + + +M ++ + +A+GM YL S H+VHRDLA RNCLVG GL VKI D
Sbjct: 112 EDVAPGQLTLGQMLAIASQ------IASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGD 165
Query: 345 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPY 404
FG+SRD+Y++DYYR+ +++LP+RWMPPESILY KFTTESD+WS+GVVLWE+++YG QP+
Sbjct: 166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPW 225
Query: 405 YGYSNQE 411
Y SN E
Sbjct: 226 YQLSNTE 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 180 bits (457), Expect = 5e-53
Identities = 111/315 (35%), Positives = 156/315 (49%), Gaps = 69/315 (21%)
Query: 57 RFLQELGEGAFGKVYKGE-VCTSEGPS--LVAIKTLKENANQKTASDFRREVDLMSELR- 112
+ + LG GAFGKV + + S VA+K LKE A TAS+++ LM+EL+
Sbjct: 10 KLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA---TASEYKA---LMTELKI 63
Query: 113 ------HPNIVCLLGVCL-SGEPMCMLFEFMVRGDL--------HEF------------- 144
H N+V LLG C G P+ ++ E+ G+L F
Sbjct: 64 LIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREM 123
Query: 145 ---------LMSRSPR---------SDISGSQVQA----------PLSQQDFSHIALQVA 176
L S S D S S V+ PL+ +D + QVA
Sbjct: 124 KQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVA 183
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS-DYYRIQSKSLLPVRWM 235
GM +L S +HRDLAARN L+ + VKI DFGL+RD+Y DY R + + LP++WM
Sbjct: 184 RGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR-KGDARLPLKWM 242
Query: 236 PPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS-NQEVIEMIRSRQMLPCPEDCP 294
PESI +TT+SDVWS+GV+LWE++S G PY G ++E ++ + PE
Sbjct: 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYAT 302
Query: 295 PRMYSLMMECWHEVP 309
P +YS+M++CWH P
Sbjct: 303 PEIYSIMLDCWHNNP 317
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 176 bits (447), Expect = 2e-52
Identities = 87/258 (33%), Positives = 137/258 (53%), Gaps = 19/258 (7%)
Query: 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCL 119
E+G G FGKV GE + V +K L+ +A F +EV EL HPN++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 120 LGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGM 179
LG C+ P ++ EF GDL +L RS R ++ Q+ Q + +VA+G+
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYL--RSNRGMVA--QMAQKDVLQRMAC---EVASGL 113
Query: 180 AYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPE- 238
+L ++H DLA RNC + L+VKI D+GL+ + Y DYY + +P+RW+ PE
Sbjct: 114 LWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL 173
Query: 239 ------SILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVI-EMIRSRQM-LPCP 290
+L T +S++WS GV +WE+++ QPY S+++V+ +++R + + LP P
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP 233
Query: 291 E-DCP--PRMYSLMMECW 305
+ D R Y +M CW
Sbjct: 234 QLDLKYSDRWYEVMQFCW 251
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 172 bits (436), Expect = 6e-51
Identities = 97/250 (38%), Positives = 145/250 (58%), Gaps = 17/250 (6%)
Query: 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCL 119
++LG G FG+V+ + T + VA+KT+K + + F E ++M L+H +V L
Sbjct: 12 KKLGAGQFGEVW---MATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKL 66
Query: 120 LGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGM 179
V ++ EP+ ++ EFM +G L +FL S GS+ P DFS Q+A GM
Sbjct: 67 HAV-VTKEPIYIITEFMAKGSLLDFLKSDE------GSKQPLP-KLIDFS---AQIAEGM 115
Query: 180 AYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPES 239
A++ +Y+HRDL A N LV L KI+DFGL+R V + Y + + P++W PE+
Sbjct: 116 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEA 174
Query: 240 ILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYS 299
I +G FT +SDVWS+G++L E+ +YG PY G SN EVI + +P PE+CP +Y+
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 234
Query: 300 LMMECWHEVP 309
+MM CW P
Sbjct: 235 IMMRCWKNRP 244
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 9e-51
Identities = 83/280 (29%), Positives = 132/280 (47%), Gaps = 34/280 (12%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTL-KENANQKTASDFRREVDLMSELRHPN 115
L++LG G+FG VYK +VA+K L K + K RRE+ ++ L HPN
Sbjct: 2 ELLRKLGSGSFGTVYKA--KHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPN 59
Query: 116 IVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQV 175
IV L+ + + ++ E+ GDL ++L P LS+ + IALQ+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP------------LSEDEAKKIALQI 107
Query: 176 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV--- 232
G+ YL S+ +HRDL N L+ + VKI+DFGL++ + S S SL
Sbjct: 108 LRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKS------SSSLTTFVGT 161
Query: 233 -RWMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP 290
+M PE +L G + + DVWS GV+L+E+ + G P+ G + + +++IR P
Sbjct: 162 PWYMAPEVLLGGNGYGPKVDVWSLGVILYELLT-GKPPFSGENILDQLQLIRRILGPPLE 220
Query: 291 EDCP------PRMYSLMMECWHEVPVA-AGMAYLCSHHYV 323
D P L+ +C ++ P + H +
Sbjct: 221 FDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (434), Expect = 2e-50
Identities = 103/253 (40%), Positives = 141/253 (55%), Gaps = 8/253 (3%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLL 120
+GEG FG+V K + AIK +KE A++ DF E++++ +L HPNI+ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 121 GVCLSGEPMCMLFEFMVRGDLHEFL-MSRSPRSDISGSQ---VQAPLSQQDFSHIALQVA 176
G C + + E+ G+L +FL SR +D + + + LS Q H A VA
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 236
GM YL ++HRDLAARN LVG+ KI+DFGLSR + Y ++ LPVRWM
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWMA 179
Query: 237 PESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPR 296
ES+ Y +TT SDVWSYGV+LWE+ S G PY G + E+ E + L P +C
Sbjct: 180 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDE 239
Query: 297 MYSLMMECWHEVP 309
+Y LM +CW E P
Sbjct: 240 VYDLMRQCWREKP 252
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 3e-50
Identities = 108/315 (34%), Positives = 154/315 (48%), Gaps = 78/315 (24%)
Query: 62 LGEGAFGKV--------YKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR- 112
LG GAFGKV K C + VA+K LKE A TAS+ + LMSEL+
Sbjct: 15 LGHGAFGKVVEASAFGIDKKSSCNT-----VAVKMLKEGA---TASEHKA---LMSELKI 63
Query: 113 ------HPNIVCLLGVCLSGE-PMCMLFEFMVRGDLHEFLMS----------RSPR---- 151
H N+V LLG C P+ ++ EF G+L FL + +SP+
Sbjct: 64 LIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGR 123
Query: 152 --SDISGSQV----------------------------------QAPLSQQDFSHIALQV 175
+ + S+V ++PL+ +D + QV
Sbjct: 124 FRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQV 183
Query: 176 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM 235
A GM +L S +HRDLAARN L+ + VKI DFGL+RD+Y Y + + LP++WM
Sbjct: 184 ARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243
Query: 236 PPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS-NQEVIEMIRSRQMLPCPEDCP 294
PESI +TT+SDVWS+GV+LWE++S G PY G N+E + ++ + PE+
Sbjct: 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENAT 303
Query: 295 PRMYSLMMECWHEVP 309
P +Y +M+ CW P
Sbjct: 304 PEIYRIMLACWQGDP 318
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 5e-50
Identities = 96/262 (36%), Positives = 153/262 (58%), Gaps = 20/262 (7%)
Query: 49 REVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSL---VAIKTLKENANQKTASDFRREV 105
R + ET+ + ++ LG GAFG VYKG + +G ++ VAIK L+EN + K + E
Sbjct: 2 RILKETELKKVKVLGSGAFGTVYKG-IWIPDGENVKIPVAIKVLRENTSPKANKEILDEA 60
Query: 106 DLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQ 165
+M+ + P + LLG+CL+ + ++ + M G L +++ R +
Sbjct: 61 YVMAGVGSPYVCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDR-----------IGS 108
Query: 166 QDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR--DVYASDYYR 223
QD + +Q+A GM+YL VHRDLAARN LV VKI+DFGL+R D+ ++Y+
Sbjct: 109 QDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA 168
Query: 224 IQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS 283
K +P++WM ESIL+ +FT +SDVWSYGV +WE+ ++G +PY G +E+ +++
Sbjct: 169 DGGK--VPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK 226
Query: 284 RQMLPCPEDCPPRMYSLMMECW 305
+ LP P C +Y +M++CW
Sbjct: 227 GERLPQPPICTIDVYMIMVKCW 248
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 170 bits (431), Expect = 6e-50
Identities = 71/102 (69%), Positives = 86/102 (84%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+AAGM YL S H+VHRDLA RNCLVG+ L VKI DFG+SRDVY++DYYR+ ++LP+RW
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
MPPESI+Y KFTTESDVWS GVVLWE+++YG QP+Y SN E
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE 230
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 6e-50
Identities = 68/102 (66%), Positives = 86/102 (84%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+A+GM YL S H+VHRDLA RNCLVG L VKI DFG+SRDVY++DYYR+ ++LP+RW
Sbjct: 132 IASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 191
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
MPPESI+Y KFTTESDVWS+GV+LWE+++YG QP++ SN E
Sbjct: 192 MPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 233
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 6e-50
Identities = 92/250 (36%), Positives = 128/250 (51%), Gaps = 15/250 (6%)
Query: 62 LGEGAFGKVYKGEV-CTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLL 120
LG G FG++ +G + S+ VAI TL+ + K F E + + H NIV L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 121 GVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMA 180
GV G M ++ E+M G L FL R + Q+ L +A+GM
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPG---------LASGMK 121
Query: 181 YLCSHHYVHRDLAARNCLVGDGLTVKISDFG-LSRDVYASDYYRIQSKSLLPVRWMPPES 239
YL YVH+ LAA LV L KIS F L D + Y + KS PV W PE+
Sbjct: 122 YLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKS--PVLWAAPEA 179
Query: 240 ILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYS 299
I Y F++ SDVWS+G+V+WEV SYG +PY+ S Q+VI+ + LP P +CP ++
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQ 239
Query: 300 LMMECWHEVP 309
LM++CW +
Sbjct: 240 LMLDCWQKER 249
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 2e-49
Identities = 75/123 (60%), Positives = 93/123 (75%), Gaps = 11/123 (8%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+AAGM +L SHH VH+DLA RN LV D L VKISD GL R+VYA+DYY++ SLLP+RW
Sbjct: 133 IAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRW 192
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE--------EFLKTP---P 418
M PE+I+YGKF+ +SD+WSYGVVLWEV+SYGLQPY GYSNQ+ + L P P
Sbjct: 193 MSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCP 252
Query: 419 SWI 421
+W+
Sbjct: 253 AWV 255
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 7e-49
Identities = 94/256 (36%), Positives = 144/256 (56%), Gaps = 16/256 (6%)
Query: 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSL---VAIKTLKENANQKTASDFRREVDLMS 109
ET+ R L+ LG G FG V+KG + EG S+ VAIKT+++ + ++T + + M
Sbjct: 6 ETELRKLKLLGSGVFGTVHKG-IWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMG 64
Query: 110 ELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFS 169
L H IV LLG+C G + ++ + G L + + Q + L Q
Sbjct: 65 SLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHV-----------RQHRDSLDPQRLL 112
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 229
+ +Q+A GM YL H VHR+LAARN L+ V+I+DFG++ +Y D S+
Sbjct: 113 NWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHK 172
Query: 230 LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289
P++WM ESIL+G++T +SDVWSYGV +WE+ SYG +PY G EV +++ + L
Sbjct: 173 TPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQ 232
Query: 290 PEDCPPRMYSLMMECW 305
P+ C +Y +M++CW
Sbjct: 233 PQICTIDVYMVMVKCW 248
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 7e-49
Identities = 99/260 (38%), Positives = 147/260 (56%), Gaps = 16/260 (6%)
Query: 49 REVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSL---VAIKTLKENANQKTASDFRREV 105
R + ET+ + ++ LG GAFG VYKG + EG ++ VAIK L E K +F E
Sbjct: 2 RILKETELKRVKVLGSGAFGTVYKG-IWVPEGETVKIPVAIKILNETTGPKANVEFMDEA 60
Query: 106 DLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQ 165
+M+ + HP++V LLGVCLS + ++ + M G L +++ D GSQ+
Sbjct: 61 LIMASMDHPHLVRLLGVCLS-PTIQLVTQLMPHGCLLDYVHEHK---DNIGSQL------ 110
Query: 166 QDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQ 225
+ +Q+A GM YL VHRDLAARN LV VKI+DFGL+R + +
Sbjct: 111 --LLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA 168
Query: 226 SKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ 285
+P++WM E I Y KFT +SDVWSYGV +WE+ ++G +PY G +E+ +++ +
Sbjct: 169 DGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE 228
Query: 286 MLPCPEDCPPRMYSLMMECW 305
LP P C +Y +M++CW
Sbjct: 229 RLPQPPICTIDVYMVMVKCW 248
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 9e-49
Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLG 121
LGEG FG VY + VAIK +K+ + + RE++++ +L HPNIV L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKK--VAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 122 VCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAY 181
V + ++ E+ G L + L LS+ + I LQ+ G+ Y
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEG-----------KLSEDEILRILLQILEGLEY 107
Query: 182 LCSHHYVHRDLAARNCLVGDG-LTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESI 240
L S+ +HRDL N L+ VK++DFGLS+ + + + + +M PE +
Sbjct: 108 LHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLL--TSDKSLLKTIVGTPAYMAPEVL 165
Query: 241 L-YGKFTTESDVWSYGVVLWE 260
L G ++ +SD+WS GV+L+E
Sbjct: 166 LGKGYYSEKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 2e-48
Identities = 112/339 (33%), Positives = 151/339 (44%), Gaps = 80/339 (23%)
Query: 46 DFRREVIETKPRFLQELGEGAFGKVYKGE---VCTSEGPSLVAIKTLKENANQKTASDFR 102
D + E + F + LG GAFGKV + + S+ VA+K LK +A+
Sbjct: 27 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLT-----E 81
Query: 103 REVDLMSELR-------HPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEF----------- 144
RE LMSEL+ H NIV LLG C G P ++ E+ GDL F
Sbjct: 82 REA-LMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICP 140
Query: 145 --------------LMSRSP--------------------------RSDISGSQVQA--- 161
L R RS SGS +
Sbjct: 141 KHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVT 200
Query: 162 ---------PLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212
L +D + QVA GM++L S + +HRDLAARN L+ G KI DFGL
Sbjct: 201 SEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGL 260
Query: 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY 272
+RD+ Y ++ + LPV+WM PESI +T ESDVWSYG++LWE++S G PY G
Sbjct: 261 ARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320
Query: 273 S-NQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPV 310
+ + +MI+ + PE P MY +M CW P+
Sbjct: 321 PVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPL 359
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 7e-48
Identities = 59/103 (57%), Positives = 82/103 (79%), Gaps = 1/103 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+A+GM YL S ++VHRDLA RNCLVG T+KI+DFG+SR++Y+SDYYR+Q ++ LP+RW
Sbjct: 139 IASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRW 198
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYG-LQPYYGYSNQE 411
M ES+L GKFTT+SDVW++GV LWE+ + QPY ++Q+
Sbjct: 199 MAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 7e-48
Identities = 94/271 (34%), Positives = 143/271 (52%), Gaps = 35/271 (12%)
Query: 57 RFL---QELGEGAFGKV--YKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL 111
R+L + LGEG FGKV Y + +VA+KTLK Q+ S +++E++++ L
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL 63
Query: 112 RHPNIVCLLGVCLS--GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFS 169
H NIV G C G+ + ++ E++ G L ++L P+ ++ +Q+
Sbjct: 64 YHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLL-------- 111
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV-YASDYYRIQSKS 228
A Q+ GMAYL S HY+HRDLAARN L+ + VKI DFGL++ V +YYR++
Sbjct: 112 -FAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 170
Query: 229 LLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYG-------------LQPYYGYSNQ 275
PV W E + KF+ SDVWS+GV L+E+ ++ + P G
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTV 230
Query: 276 -EVIEMIRSRQMLPCPEDCPPRMYSLMMECW 305
+IE++ LPCP++CP +Y LM CW
Sbjct: 231 VRLIELLERGMRLPCPKNCPQEVYILMKNCW 261
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 1e-47
Identities = 95/279 (34%), Positives = 144/279 (51%), Gaps = 44/279 (15%)
Query: 57 RFLQELGEGAFGKVYKGEVC--------TSEGPSLVAIKTLKENANQKTASDFRREVDLM 108
+F+Q+LG+G FG V E+C T E +VA+K L +++ + DF RE++++
Sbjct: 7 KFIQQLGKGNFGSV---ELCRYDPLQDNTGE---VVAVKKL-QHSTAEHLRDFEREIEIL 59
Query: 109 SELRHPNIVCLLGVCLS-GEP-MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQ 166
L+H NIV GVC S G + ++ E++ G L ++L R D
Sbjct: 60 KSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHR----------- 108
Query: 167 DFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV-YASDYYRIQ 225
A Q+ GM YL S YVHRDLA RN LV VKI DFGL++ + +YY+++
Sbjct: 109 KLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVR 168
Query: 226 SKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY---GLQPYYGYSNQ------- 275
P+ W PES+ KF+ SDVWS+GVVL+E+++Y P +
Sbjct: 169 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQG 228
Query: 276 -----EVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
+IE++++ LP P CP +Y++M ECW+ P
Sbjct: 229 QMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDP 267
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 2e-47
Identities = 88/259 (33%), Positives = 139/259 (53%), Gaps = 22/259 (8%)
Query: 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCL 119
QE+G G FGKV E+ T G + V +K LK NA+ K ++F ++ D L+HPNI+
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 120 LGVCLSGEPMCMLFEFMVRGDLHEFLMSRS-PRSDISGSQVQAPLSQQDFSHIALQVAAG 178
LG C+ P ++FE+ GDL +L R + +Q +A ++AAG
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---------RMACEIAAG 111
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPE 238
+ ++ H+++H DLA RNC + LTVK+ D+G+ Y DY + +P+RW+ PE
Sbjct: 112 VTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE 171
Query: 239 SI--LYGKF-----TTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVI-EMIRSRQM-LPC 289
+ +G T S+VW+ GV LWE++ QPY S++EV+ +I+ +Q+ L
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFK 231
Query: 290 PEDCPP---RMYSLMMECW 305
P+ P R Y ++ CW
Sbjct: 232 PQLELPYSERWYEVLQFCW 250
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 3e-47
Identities = 93/258 (36%), Positives = 140/258 (54%), Gaps = 19/258 (7%)
Query: 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCL 119
+E+G G FGKV GEV + P+ V +K L+ +A+ + F E L+H N++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 120 LGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGM 179
LG C P ++ EF GDL +L RS R + P + Q +A ++A G+
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYL--RSCR--KAELMTPDPTTLQ---RMACEIALGL 113
Query: 180 AYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPE- 238
+L ++++H DLA RNCL+ LTVKI D+GLS + Y DYY + +P+RW+ PE
Sbjct: 114 LHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPEL 173
Query: 239 ------SILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIE-MIRSRQM-LPCP 290
++L T ES+VWS GV +WE++ G QPY S+++V+ +R +Q+ LP P
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP 233
Query: 291 EDCPP---RMYSLMMECW 305
P R Y +M CW
Sbjct: 234 RLKLPLSDRWYEVMQFCW 251
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 3e-47
Identities = 96/278 (34%), Positives = 146/278 (52%), Gaps = 39/278 (14%)
Query: 57 RFLQ---ELGEGAFGKVYKGEVC--TSEGPS---LVAIKTLKENANQKTASDFRREVDLM 108
RFL+ +LGEG FGKV E+C EG + VA+K+LK + +D ++E++++
Sbjct: 4 RFLKRIRDLGEGHFGKV---ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEIL 60
Query: 109 SELRHPNIVCLLGVCL--SGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQ 166
L H NIV G+C G + ++ EF+ G L E+L PR+ + ++ +
Sbjct: 61 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL----PRN-------KNKINLK 109
Query: 167 DFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS-DYYRIQ 225
A+Q+ GM YL S YVHRDLAARN LV VKI DFGL++ + +YY ++
Sbjct: 110 QQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK 169
Query: 226 SKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYG-------------LQPYYG- 271
PV W PE ++ KF SDVWS+GV L+E+ +Y + P +G
Sbjct: 170 DDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQ 229
Query: 272 YSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
+ ++ ++ + LP P +CP +Y LM +CW P
Sbjct: 230 MTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQP 267
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 3e-46
Identities = 92/260 (35%), Positives = 146/260 (56%), Gaps = 16/260 (6%)
Query: 49 REVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSL---VAIKTLKENANQKTASDFRREV 105
R + ET+ + ++ LG GAFG VYKG + EG + VAIK L+E + K + E
Sbjct: 2 RILKETEFKKIKVLGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKANKEILDEA 60
Query: 106 DLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQ 165
+M+ + +P++ LLG+CL+ + ++ + M G L +++ R + +I
Sbjct: 61 YVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYV--REHKDNIGS--------- 108
Query: 166 QDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQ 225
Q + +Q+A GM YL VHRDLAARN LV VKI+DFGL++ + A +
Sbjct: 109 QYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHA 168
Query: 226 SKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ 285
+P++WM ESIL+ +T +SDVWSYGV +WE+ ++G +PY G E+ ++ +
Sbjct: 169 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 228
Query: 286 MLPCPEDCPPRMYSLMMECW 305
LP P C +Y +M++CW
Sbjct: 229 RLPQPPICTIDVYMIMVKCW 248
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 4e-46
Identities = 105/322 (32%), Positives = 151/322 (46%), Gaps = 77/322 (23%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSL---VAIKTLKENANQKTASDFRREVDLMSELR- 112
+ + LG GAFG+V + + + + VA+K LKE A T S+ R LMSEL+
Sbjct: 10 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRA---LMSELKI 63
Query: 113 ------HPNIVCLLGVCLS-GEPMCMLFEFMVRGDLHEFLMSRSPRSD------------ 153
H N+V LLG C G P+ ++ EF G+L +L RS R +
Sbjct: 64 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYL--RSKRGEFVPYKTKDARFR 121
Query: 154 -------------------ISGSQVQA--------------------------PLSQQDF 168
I+ SQ A L+ +D
Sbjct: 122 QGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDL 181
Query: 169 SHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKS 228
+ QVA GM +L S +HRDLAARN L+ + VKI DFGL+RD+Y Y + +
Sbjct: 182 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 229 LLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS-NQEVIEMIRSRQML 287
LP++WM PE+I +T +SDVWS+GV+LWE++S G PY G ++E ++ +
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 301
Query: 288 PCPEDCPPRMYSLMMECWHEVP 309
P+ P MY M++CWH P
Sbjct: 302 RAPDYTTPEMYQTMLDCWHGEP 323
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 3e-44
Identities = 69/185 (37%), Positives = 107/185 (57%), Gaps = 25/185 (13%)
Query: 238 ESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPR- 296
E+++ KF ++ V GV S+ P + ++E++ + + PR
Sbjct: 59 EALIMSKFNHQNIVRLIGV------SFERLPRF-----ILLELMAGGDLKSFLRENRPRP 107
Query: 297 -------MYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFG 346
M L+ VA G YL +H++HRD+AARNCL+ G G KI+DFG
Sbjct: 108 ERPSSLTMKDLLFCA---RDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFG 164
Query: 347 LSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG 406
++RD+Y + YYR +++LP++WMPPE+ L G FT+++DVWS+GV+LWE++S G PY G
Sbjct: 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPG 224
Query: 407 YSNQE 411
+NQE
Sbjct: 225 RTNQE 229
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 4e-43
Identities = 64/109 (58%), Positives = 80/109 (73%), Gaps = 5/109 (4%)
Query: 308 VPVAAGMAYLCSHHYVHRDLAARNCLVGDG-----LTVKISDFGLSRDVYASDYYRIQSK 362
+ VA G YL H++HRDLAARNCLV + VKI DFGL+RD+Y SDYYR + +
Sbjct: 113 LDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGE 172
Query: 363 SLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
LLPVRWM PES+L GKFTT+SDVWS+GV++WE+ + G QPY +NQE
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE 221
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 2e-41
Identities = 70/126 (55%), Positives = 85/126 (67%), Gaps = 3/126 (2%)
Query: 290 PEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR 349
PP M++ E+ A GMAYL + +VHRDLAARNC+V TVKI DFG++R
Sbjct: 110 NPGRPPPTLQEMIQMAAEI--ADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
Query: 350 DVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN 409
D+Y +DYYR K LLPVRWM PES+ G FTT SD+WS+GVVLWE+ S QPY G SN
Sbjct: 168 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN 227
Query: 410 QEEFLK 415
E+ LK
Sbjct: 228 -EQVLK 232
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 3e-41
Identities = 60/109 (55%), Positives = 82/109 (75%), Gaps = 1/109 (0%)
Query: 304 CWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKS 363
+ +A+GM YL S ++VHRDLA RNCLVG T+KI+DFG+SR++Y+ DYYRIQ ++
Sbjct: 133 IFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRA 192
Query: 364 LLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY-GLQPYYGYSNQE 411
+LP+RWM ESIL GKFTT SDVW++GV LWE+ + QPY S+++
Sbjct: 193 VLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 3e-41
Identities = 61/105 (58%), Positives = 84/105 (80%), Gaps = 1/105 (0%)
Query: 308 VPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV 367
V +A+GM YL S ++VHRDLA RNCLVG+ T+KI+DFG+SR++Y+ DYYRIQ +++LP+
Sbjct: 136 VQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPI 195
Query: 368 RWMPPESILYGKFTTESDVWSYGVVLWEVYSY-GLQPYYGYSNQE 411
RWM ESIL GKFTT SDVW++GV LWE+++ QPY S+++
Sbjct: 196 RWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 5e-41
Identities = 64/249 (25%), Positives = 106/249 (42%), Gaps = 22/249 (8%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPNIVCLL 120
LG G+FG VY + L+A+K+++ +++ RE+ ++S L+HPNIV
Sbjct: 8 LGRGSFGSVYLALDKDT--GELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 121 GVCLSGEPMCM-LF-EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
G E + +F E++ G L L L + Q+ G
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK------------LPEPVIRKYTRQILEG 113
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL-PVRWMPP 237
+AYL S+ VHRD+ N LV VK++DFG ++ + + S+ WM P
Sbjct: 114 LAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRL-GDIETGEGTGSVRGTPYWMAP 172
Query: 238 ESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ-EVIEMI-RSRQMLPCPEDCPP 295
E I ++ +D+WS G + E+ + G P+ N + I S + PE
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMAT-GKPPWSELGNPMAALYKIGSSGEPPEIPEHLSE 231
Query: 296 RMYSLMMEC 304
+ +C
Sbjct: 232 EAKDFLRKC 240
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 6e-41
Identities = 68/122 (55%), Positives = 87/122 (71%), Gaps = 3/122 (2%)
Query: 290 PEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR 349
P PP + M++ E+ A GMAYL ++ +VHRDLAARNC+V + TVKI DFG++R
Sbjct: 111 PVQAPPSL-KKMIQMAGEI--ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
Query: 350 DVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN 409
D+Y +DYYR K LLPVRWM PES+ G FTT SDVWS+GVVLWE+ + QPY G SN
Sbjct: 168 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227
Query: 410 QE 411
++
Sbjct: 228 EQ 229
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 3e-40
Identities = 59/103 (57%), Positives = 72/103 (69%), Gaps = 1/103 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA-SDYYRIQSKSLLPVR 368
VA GMAYL S H+VHRDLAARN L+ + KISDFG+SR + A SDYYR + P++
Sbjct: 104 VAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK 163
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
W PE I YGKF+++SDVWSYGV LWE +SYG +PY E
Sbjct: 164 WYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE 206
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 6e-40
Identities = 55/102 (53%), Positives = 71/102 (69%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+A+GM YL +YVHRDLAARN LV L K+SDFGLSR + S+ +P+RW
Sbjct: 115 IASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRW 174
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
PE+I Y KFT+ SDVWS+G+V+WEV SYG +PY+ SNQ+
Sbjct: 175 TAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 1e-39
Identities = 60/103 (58%), Positives = 81/103 (78%), Gaps = 1/103 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+A+GM YL S ++VHRDLA RNCLVG+ LT+KI+DFG+SR++YA DYYRIQ +++LP+RW
Sbjct: 147 IASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRW 206
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSY-GLQPYYGYSNQE 411
M E IL GKFTT SDVW++GV LWE+ QPY ++++
Sbjct: 207 MAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQ 249
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 2e-39
Identities = 51/102 (50%), Positives = 77/102 (75%), Gaps = 1/102 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+A GM +L + +VHRDLAARNCLV VK+S LS+DVY S+YY+++ +L+P+RW
Sbjct: 126 IALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR-NALIPLRW 184
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
+ PE++ F+T+SDVWS+GV++WEV++ G P+YG S++E
Sbjct: 185 LAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE 226
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 3e-38
Identities = 52/102 (50%), Positives = 73/102 (71%), Gaps = 1/102 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+A GMAYL S +Y+HRDLAARN LVG+ L KI+DFGL+R + D Y + + P++W
Sbjct: 112 IAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLAR-LIEDDEYTAREGAKFPIKW 170
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
PE+ YG+FT +SDVWS+G++L E+ +YG PY G +N+E
Sbjct: 171 TAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE 212
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 6e-38
Identities = 50/102 (49%), Positives = 72/102 (70%), Gaps = 1/102 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
VA+GMAYL + +Y+HRDLAARN LVG+ K++DFGL+R V D Y + + P++W
Sbjct: 112 VASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLAR-VIKEDIYEAREGAKFPIKW 170
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
PE+ LY +F+ +SDVWS+G++L E+ +YG PY G +N E
Sbjct: 171 TAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE 212
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 2e-37
Identities = 60/106 (56%), Positives = 73/106 (68%), Gaps = 1/106 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
V GMAYL S ++HRDLAARNCLV D VK+SDFGLSR V D Y S PVRW
Sbjct: 109 VCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVL-DDEYTSSVGSKFPVRW 167
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
PPE +LY KF+++SDVW++GV++WEVYS G PY ++N E K
Sbjct: 168 SPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK 213
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 6e-37
Identities = 52/109 (47%), Positives = 73/109 (66%), Gaps = 10/109 (9%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR----DVYASDYYRIQSKSLL 365
VA GMAYL + +HRDLAARN LVG+ L K++DFGL+R DVY S +I
Sbjct: 113 VAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI------ 166
Query: 366 PVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFL 414
P +W PE+ +G F+T+SDVWS+G++L+E+++YG PY G +N E +
Sbjct: 167 PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYD 215
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 7e-37
Identities = 58/145 (40%), Positives = 84/145 (57%), Gaps = 15/145 (10%)
Query: 279 EMIRSRQMLPCPEDCPP----------RMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328
+ +R+R+ P E P L+ + VA GM +L S +HRDLA
Sbjct: 105 DFLRARR--PPGEYASPDDPRPPEETLTQKDLVSFAYQ---VARGMEFLASKKCIHRDLA 159
Query: 329 ARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWS 388
ARN LV + +KI+DFGL+RD++ DYYR + LPV+WM PE++ +T +SDVWS
Sbjct: 160 ARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 219
Query: 389 YGVVLWEVYSYGLQPYYGYSNQEEF 413
+GV+LWE+++ G PY G +E F
Sbjct: 220 FGVLLWEIFTLGGSPYPGIPVEELF 244
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 1e-36
Identities = 54/101 (53%), Positives = 72/101 (71%)
Query: 311 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM 370
AAGM YL S + +HRDLAARNCLVG+ +KISDFG+SR+ Y +P++W
Sbjct: 103 AAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWT 162
Query: 371 PPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
PE++ YG++T+ESDVWSYG++LWE +S G PY G SNQ+
Sbjct: 163 APEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ 203
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 3e-36
Identities = 55/156 (35%), Positives = 78/156 (50%), Gaps = 13/156 (8%)
Query: 254 YGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG 313
YGVVL + V E+ +L + + C + V +A G
Sbjct: 62 YGVVL------------THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANG 109
Query: 314 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV-YASDYYRIQSKSLLPVRWMPP 372
M YL S ++HRDLAARN L+ VKI DFGL R + D+Y ++ +P W P
Sbjct: 110 MRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAP 169
Query: 373 ESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS 408
ES+ F+ SDVW +GV LWE+++YG +P+ G S
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS 205
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 4e-36
Identities = 53/102 (51%), Positives = 70/102 (68%), Gaps = 1/102 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
V M YL S+ ++HRDLAARNCLVG+ VK+SDFGL+R V D Y + PV+W
Sbjct: 109 VCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVL-DDQYTSSQGTKFPVKW 167
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
PPE Y +F+++SDVWS+GV++WEV+S G PY +SN E
Sbjct: 168 APPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 6e-36
Identities = 55/106 (51%), Positives = 71/106 (66%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
VA GMA+L S + +HRDLAARN L+ G VKI DFGL+RD+ Y ++ + LPV+W
Sbjct: 150 VAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKW 209
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
M PESI +T ESDVWSYG++LWE++S G PY G +F K
Sbjct: 210 MAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK 255
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 1e-35
Identities = 53/97 (54%), Positives = 72/97 (74%), Gaps = 2/97 (2%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKS--LLPV 367
VA GM YL S +VHRDLAARNC++ + TVK++DFGL+RD+Y +YY + + + LPV
Sbjct: 107 VAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV 166
Query: 368 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPY 404
+WM ES+ KFTT+SDVWS+GV+LWE+ + G PY
Sbjct: 167 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 1e-35
Identities = 64/148 (43%), Positives = 87/148 (58%), Gaps = 1/148 (0%)
Query: 163 LSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYY 222
L+ D QVA GM +L S + VHRDLAARN L+ G VKI DFGL+RD+ Y
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNY 293
Query: 223 RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY-SNQEVIEMI 281
+ + LPV+WM PESI +TT SDVWSYG++LWE++S G PY G + I
Sbjct: 294 VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKI 353
Query: 282 RSRQMLPCPEDCPPRMYSLMMECWHEVP 309
+S + P+ +Y +M++CW+ P
Sbjct: 354 KSGYRMAKPDHATQEVYDIMVKCWNSEP 381
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 1e-34
Identities = 54/137 (39%), Positives = 83/137 (60%), Gaps = 13/137 (9%)
Query: 290 PEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR 349
PE P + M V +A GM YL + +++HRDLAARNC++ + +TV ++DFGLS+
Sbjct: 107 PEKLPLQTLLKFM-----VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
Query: 350 DVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN 409
+Y+ DYYR + +PV+W+ ES+ +T++SDVW++GV +WE+ + G PY G N
Sbjct: 162 KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN 221
Query: 410 QEEF--------LKTPP 418
E + LK P
Sbjct: 222 HEIYDYLRHGNRLKQPE 238
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 4e-34
Identities = 58/105 (55%), Positives = 72/105 (68%), Gaps = 3/105 (2%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL---LP 366
+AAGM YL +YVHRDLAARN LV L K+SDFGLSR + + SL +P
Sbjct: 115 IAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIP 174
Query: 367 VRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
+RW PE+I Y KFT+ SDVWSYG+V+WEV SYG +PY+ SNQ+
Sbjct: 175 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 219
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 5e-34
Identities = 68/213 (31%), Positives = 106/213 (49%), Gaps = 36/213 (16%)
Query: 59 LQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLK----ENANQKTASDFRREVDLMSELRH 113
L++LGEG +G VYK + T E +VA+K ++ E TA RE+ L+ EL+H
Sbjct: 4 LEKLGEGTYGVVYKARDKKTGE---IVALKKIRLDNEEEGIPSTAL---REISLLKELKH 57
Query: 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
PNIV LL V + + ++FE+ DL ++L +S + ++ I
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYL--DKRPGPLSPNLIK---------SIMY 105
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV- 232
Q+ G+AY SH +HRDL +N L+ +K++DFGL+R + I ++
Sbjct: 106 QLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLAR------AFGIPLRTYTHEV 159
Query: 233 --RWM-PPESILYG--KFTTESDVWSYGVVLWE 260
W PE IL G ++T D+WS G + E
Sbjct: 160 VTLWYRAPE-ILLGSKHYSTAVDIWSVGCIFAE 191
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 8e-34
Identities = 64/137 (46%), Positives = 84/137 (61%), Gaps = 5/137 (3%)
Query: 282 RSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 341
R+ L P++ M L+ W ++ GM YL VHRDLAARN LV +G +K
Sbjct: 111 RNSSYLDNPDERALTMGDLISFAWQ---ISRGMQYLAEMKLVHRDLAARNVLVAEGRKMK 167
Query: 342 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGL 401
ISDFGLSRDVY D Y +SK +PV+WM ES+ +TT+SDVWS+GV+LWE+ + G
Sbjct: 168 ISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 227
Query: 402 QPYYGYSNQEEF--LKT 416
PY G + + F LKT
Sbjct: 228 NPYPGIAPERLFNLLKT 244
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 61/118 (51%), Positives = 74/118 (62%), Gaps = 11/118 (9%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR---DVYASDYYRIQSKSLLP 366
+A+GM YL YVHRDLAARN LV L K+SDFGLSR D + Y K +P
Sbjct: 115 IASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK--IP 172
Query: 367 VRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ------EEFLKTPP 418
+RW PE+I Y KFT+ SDVWSYG+V+WEV SYG +PY+ SNQ EE + P
Sbjct: 173 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPA 230
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 54/119 (45%), Positives = 78/119 (65%), Gaps = 8/119 (6%)
Query: 308 VPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV 367
+ +A+GM YL S +++HRDLAARNC++ + +TV ++DFGLS+ +Y+ DYYR S LPV
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179
Query: 368 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE--------EFLKTPP 418
+W+ ES+ +TT SDVW++GV +WE+ + G PY G N E LK PP
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 4e-33
Identities = 47/95 (49%), Positives = 64/95 (67%), Gaps = 5/95 (5%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
V GM YL ++VHRDLAARN LV + L K+SDFGL+++ Q LPV+W
Sbjct: 111 VCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-----QDSGKLPVKW 165
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPY 404
PE++ KF+T+SDVWS+G++LWE+YS+G PY
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 5e-33
Identities = 57/105 (54%), Positives = 70/105 (66%), Gaps = 5/105 (4%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR---DVYASDYYRIQSKSLLP 366
+AAGM YL +YVHRDLAARN LV L K+SDFGLSR D Y K +P
Sbjct: 116 IAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGK--IP 173
Query: 367 VRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
+RW PE+I Y KFT+ SDVWS+G+V+WEV S+G +PY+ SN E
Sbjct: 174 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE 218
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 5e-33
Identities = 52/106 (49%), Positives = 70/106 (66%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
VA GM +L S + +HRD+AARN L+ DG KI DFGL+RD+ Y ++ + LPV+W
Sbjct: 221 VAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKW 280
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
M PESI +T +SDVWSYG++LWE++S G PY G +F K
Sbjct: 281 MAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK 326
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 5e-33
Identities = 56/105 (53%), Positives = 72/105 (68%), Gaps = 2/105 (1%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS-DYYRIQSKSLLPVR 368
VA GM +L S +HRDLAARN L+ + VKI DFGL+RD+Y DY R + + LP++
Sbjct: 182 VARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR-KGDARLPLK 240
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
WM PESI +TT+SDVWS+GV+LWE++S G PY G EEF
Sbjct: 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF 285
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 7e-33
Identities = 61/146 (41%), Positives = 86/146 (58%), Gaps = 1/146 (0%)
Query: 163 LSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYY 222
LS D + QVA GM +L S + VHRDLAARN L+ +G VKI DFGL+RD+ Y
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNY 295
Query: 223 RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS-NQEVIEMI 281
+ + LP++WM PESI +TT SDVWS+G++LWE+++ G PY N++ I
Sbjct: 296 ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAI 355
Query: 282 RSRQMLPCPEDCPPRMYSLMMECWHE 307
+ + P +Y +M +CW E
Sbjct: 356 KRGYRMAKPAHASDEIYEIMQKCWEE 381
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 8e-33
Identities = 47/97 (48%), Positives = 70/97 (72%), Gaps = 1/97 (1%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+++ M YL +++HRDLAARNCLVG+ VK++DFGLSR + D Y + + P++W
Sbjct: 113 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKW 171
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG 406
PES+ Y KF+ +SDVW++GV+LWE+ +YG+ PY G
Sbjct: 172 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 5e-32
Identities = 54/108 (50%), Positives = 78/108 (72%), Gaps = 9/108 (8%)
Query: 308 VPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRD----VYASDYYRIQSKS 363
+ AAGMAYL S + +HRDLAARNCLVG+ +KISDFG+SR +Y+S +
Sbjct: 100 LDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK----- 154
Query: 364 LLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
+P++W PE++ YG++++ESDVWSYG++LWE +S G+ PY G +NQ+
Sbjct: 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ 202
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 6e-32
Identities = 48/98 (48%), Positives = 66/98 (67%), Gaps = 1/98 (1%)
Query: 314 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPE 373
+AYL S +VHRD+AARN LV VK+ DFGLSR + YY+ SK LP++WM PE
Sbjct: 120 LAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK-ASKGKLPIKWMAPE 178
Query: 374 SILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
SI + +FT+ SDVW +GV +WE+ G++P+ G N +
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND 216
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 52/102 (50%), Positives = 70/102 (68%), Gaps = 1/102 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
V GMAYL S + +HRDLAARNCLVG+ VK+SDFG++R V D Y + + PV+W
Sbjct: 109 VCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKW 167
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
PE + K++++SDVWS+GV++WEV+S G PY SN E
Sbjct: 168 SSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 54/106 (50%), Positives = 71/106 (66%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
VA GM +L S +HRDLAARN L+ + VKI DFGL+RD+Y Y + + LP++W
Sbjct: 183 VARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
M PESI +TT+SDVWS+GV+LWE++S G PY G EEF +
Sbjct: 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ 288
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 57/138 (41%), Positives = 83/138 (60%), Gaps = 13/138 (9%)
Query: 289 CPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 348
CP+ P +M M +A+GM YL S ++HRDLAARNC++ + + V ++DFGLS
Sbjct: 105 CPQYLPTQMLVKFM-----TDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159
Query: 349 RDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS 408
+ +Y DYYR + +PV+W+ ES+ +TT+SDVWS+GV +WE+ + G PY G
Sbjct: 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE 219
Query: 409 NQEEF--------LKTPP 418
N E + LK PP
Sbjct: 220 NSEIYDYLRQGNRLKQPP 237
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 52/101 (51%), Positives = 70/101 (69%)
Query: 311 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM 370
AAGM YL S H +HRDLAARNCLV + +KISDFG+SR+ Y +PV+W
Sbjct: 104 AAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWT 163
Query: 371 PPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
PE++ YG++++ESDVWS+G++LWE +S G PY SNQ+
Sbjct: 164 APEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ 204
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 5e-31
Identities = 44/92 (47%), Positives = 60/92 (65%), Gaps = 1/92 (1%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV-YASDYYRIQSKSLLPVR 368
+ GM YL S Y+HRDLAARN LV VKISDFGL++ + DYY ++ P+
Sbjct: 118 ICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYG 400
W PE + KF++ SDVWS+GV L+E+++YG
Sbjct: 178 WYAPECLRTSKFSSASDVWSFGVTLYELFTYG 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 1e-30
Identities = 49/102 (48%), Positives = 68/102 (66%), Gaps = 1/102 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
V GM YL + ++HRDLAARNCLV VK+SDFG++R V D Y S + PV+W
Sbjct: 109 VCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVL-DDEYTSSSGAKFPVKW 167
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
PPE + K++++SDVWS+GV++WEV++ G P+ SN E
Sbjct: 168 SPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 53/106 (50%), Positives = 70/106 (66%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
VA GM++L S + +HRDLAARN L+ G KI DFGL+RD+ Y ++ + LPV+W
Sbjct: 223 VAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKW 282
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
M PESI +T ESDVWSYG++LWE++S G PY G +F K
Sbjct: 283 MAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYK 328
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 57/143 (39%), Positives = 86/143 (60%), Gaps = 11/143 (7%)
Query: 279 EMIRSRQMLPCPEDCP--------PRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAAR 330
E +R+R+ P P+ + ++ C ++V A GM YL S +HRDLAAR
Sbjct: 107 EFLRARRP-PGPDYTFDITKVPEEQLSFKDLVSCAYQV--ARGMEYLESRRCIHRDLAAR 163
Query: 331 NCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYG 390
N LV + +KI+DFGL+R V+ DYY+ S LPV+WM PE++ +T +SDVWS+G
Sbjct: 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223
Query: 391 VVLWEVYSYGLQPYYGYSNQEEF 413
+++WE+++ G PY G +E F
Sbjct: 224 ILMWEIFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 53/104 (50%), Positives = 72/104 (69%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
VA GM YL S +HRDLAARN LV + +KI+DFGL+RDV+ DYY+ + LPV+W
Sbjct: 143 VARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKW 202
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
M PE++ +T +SDVWS+GV+LWE+++ G PY G +E F
Sbjct: 203 MAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 46/99 (46%), Positives = 64/99 (64%)
Query: 308 VPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV 367
V +A GM+YL VHRDLAARN LV VKI+DFGL++ + + +P+
Sbjct: 116 VQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPI 175
Query: 368 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG 406
+WM ESIL+ +T +SDVWSYGV +WE+ ++G +PY G
Sbjct: 176 KWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 52/104 (50%), Positives = 69/104 (66%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
VA GM +L S +HRDLAARN L+ + VKI DFGL+RD+Y Y + + LP++W
Sbjct: 188 VAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 247
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
M PE+I +T +SDVWS+GV+LWE++S G PY G EEF
Sbjct: 248 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 291
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-30
Identities = 56/126 (44%), Positives = 80/126 (63%), Gaps = 4/126 (3%)
Query: 290 PEDCPPRMYSL--MMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 347
P P S ++ C ++V A GM YL S +HRDLAARN LV + +KI+DFGL
Sbjct: 129 PTQVPEEQLSFKDLVSCAYQV--ARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL 186
Query: 348 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY 407
+RD++ DYY+ + LPV+WM PE++ +T +SDVWS+GV+LWE+++ G PY G
Sbjct: 187 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246
Query: 408 SNQEEF 413
+E F
Sbjct: 247 PVEELF 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 6e-30
Identities = 51/95 (53%), Positives = 62/95 (65%), Gaps = 5/95 (5%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
VA GM YL S VHRDLAARN LV + K+SDFGL A S LPV+W
Sbjct: 109 VAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGL-----ARVGSMGVDNSKLPVKW 163
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPY 404
PE++ + KF+++SDVWSYGV+LWEV+SYG PY
Sbjct: 164 TAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 7e-30
Identities = 53/119 (44%), Positives = 77/119 (64%), Gaps = 2/119 (1%)
Query: 295 PRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS 354
+ ++ C ++V A GM YL S +HRDLAARN LV + +KI+DFGL+RDV
Sbjct: 133 QMTFKDLVSCTYQV--ARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNI 190
Query: 355 DYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
DYY+ + LPV+WM PE++ +T +SDVWS+GV++WE+++ G PY G +E F
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 1e-29
Identities = 50/103 (48%), Positives = 70/103 (67%), Gaps = 1/103 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD-YYRIQSKSLLPVR 368
V+ GM YL ++VHRDLAARN L+ KISDFGLS+ + A + YY+ ++ PV+
Sbjct: 104 VSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK 163
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
W PE + Y KF+++SDVWS+GV++WE +SYG +PY G E
Sbjct: 164 WYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE 206
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 56/110 (50%), Positives = 71/110 (64%), Gaps = 3/110 (2%)
Query: 308 VPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV 367
VA GM YL ++HRDLAARN LVG+ L KI+DFGLSR + Y ++ LPV
Sbjct: 126 SDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLPV 182
Query: 368 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLKTP 417
RWM ES+ Y +TT+SDVWS+GV+LWE+ S G PY G + E + K P
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP 232
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
L+++G+G FG+VYK G VAIK +K + +K E+ ++ + +HPNI
Sbjct: 3 EILEKIGKGGFGEVYKAR-HKRTG-KEVAIKVIKLESKEKKEKIIN-EIQILKKCKHPNI 59
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V G L + + ++ EF G L D+ S Q L++ +++ ++
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSL----------KDLLKSTNQ-TLTESQIAYVCKELL 108
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR-WM 235
G+ YL S+ +HRD+ A N L+ VK+ DFGLS + SD +++ WM
Sbjct: 109 KGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SD--TKARNTMVGTPYWM 164
Query: 236 PPESILYGKFTTESDVWSYGVVLWE 260
PE I + ++D+WS G+ E
Sbjct: 165 APEVINGKPYDYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-29
Identities = 56/108 (51%), Positives = 69/108 (63%), Gaps = 3/108 (2%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
VA GM YL ++HRDLAARN LVG+ KI+DFGLSR + Y ++ LPVRW
Sbjct: 133 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRW 189
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLKTP 417
M ES+ Y +TT SDVWSYGV+LWE+ S G PY G + E + K P
Sbjct: 190 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 4e-29
Identities = 42/95 (44%), Positives = 66/95 (69%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+A GM+YL +H+D+AARNC++ + L VKI+D LSRD++ DY+ + PV+W
Sbjct: 126 IACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKW 185
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPY 404
M ES++ ++++ SDVWS+GV+LWE+ + G PY
Sbjct: 186 MALESLVNKEYSSASDVWSFGVLLWELMTLGQTPY 220
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-29
Identities = 65/254 (25%), Positives = 111/254 (43%), Gaps = 43/254 (16%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPNIV 117
++++G+G+FGKVY S+G L +K + N ++K D EV ++ +L HPNI+
Sbjct: 5 IKQIGKGSFGKVYLVR-RKSDG-KLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNII 62
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
+C++ E+ GDL + + + P ++ +Q+
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGK--------PFPEEQILDWFVQLCL 114
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD-----------YYRIQS 226
+ YL S +HRD+ +N + VK+ DFG+S+ V +S YY
Sbjct: 115 ALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISK-VLSSTVDLAKTVVGTPYY---- 169
Query: 227 KSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQ-PYYGYSNQEVIEMIRSRQ 285
+ PE + +SD+WS G VL+E+ + L+ P+ G + E+ I Q
Sbjct: 170 --------LSPELCQNKPYNYKSDIWSLGCVLYELCT--LKHPFEGENLLELALKILKGQ 219
Query: 286 MLPCPEDCPPRMYS 299
P P YS
Sbjct: 220 YPPIPS-----QYS 228
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 49/96 (51%), Positives = 67/96 (69%), Gaps = 1/96 (1%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD-YYRIQSKSLLPVR 368
V+ GM YL ++VHRDLAARN L+ + KISDFGLS+ + A D YY+ +S P++
Sbjct: 104 VSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK 163
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPY 404
W PE I + KF++ SDVWSYG+ +WE +SYG +PY
Sbjct: 164 WYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-28
Identities = 53/97 (54%), Positives = 66/97 (68%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
VA GM +L S + VHRDLAARN L+ G VKI DFGL+RD+ Y + + LPV+W
Sbjct: 246 VARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKW 305
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG 406
M PESI +TT SDVWSYG++LWE++S G PY G
Sbjct: 306 MAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 55/110 (50%), Positives = 69/110 (62%), Gaps = 3/110 (2%)
Query: 311 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM 370
A GM YL ++HRDLAARN LVG+ KI+DFGLSR + Y ++ LPVRWM
Sbjct: 122 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWM 178
Query: 371 PPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLKTPPSW 420
ES+ Y +TT SDVWSYGV+LWE+ S G PY G + E + K P +
Sbjct: 179 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 228
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 51/104 (49%), Positives = 69/104 (66%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
VA GM +L S + VHRDLAARN L+ +G VKI DFGL+RD+ Y + + LP++W
Sbjct: 248 VANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKW 307
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
M PESI +TT SDVWS+G++LWE+++ G PY E+F
Sbjct: 308 MAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-28
Identities = 51/102 (50%), Positives = 72/102 (70%), Gaps = 1/102 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
VAAGMAY+ +Y+HRDL + N LVGDGL KI+DFGL+R + ++Y Q P++W
Sbjct: 111 VAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF-PIKW 169
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
PE+ LYG+FT +SDVWS+G++L E+ + G PY G +N+E
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE 211
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-28
Identities = 45/95 (47%), Positives = 65/95 (68%), Gaps = 5/95 (5%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
V M YL ++++VHRDLAARN LV + K+SDFGL+++ + Q LPV+W
Sbjct: 111 VCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKW 165
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPY 404
PE++ KF+T+SDVWS+G++LWE+YS+G PY
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 8e-28
Identities = 50/104 (48%), Positives = 68/104 (65%)
Query: 308 VPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV 367
V +A GM YL H VHR+LAARN L+ V+I+DFG++ +Y D S+ P+
Sbjct: 116 VQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPI 175
Query: 368 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
+WM ESIL+G++T +SDVWSYGV +WE+ SYG +PY G E
Sbjct: 176 KWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE 219
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 46/102 (45%), Positives = 68/102 (66%), Gaps = 1/102 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+A GMA++ +Y+HRDL A N LV + L KI+DFGL+R + + Y + + P++W
Sbjct: 111 IAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLAR-LIEDNEYTAREGAKFPIKW 169
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
PE+I YG FT +SDVWS+G++L E+ +YG PY G +N E
Sbjct: 170 TAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE 211
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 25/206 (12%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFR--REVDLMSELRHPNIV 117
LGEG + VYK G +VAIK +K K +F RE+ L+ EL+HPNI+
Sbjct: 8 LGEGTYAVVYKARD-KETG-RIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
LL V + ++FEFM DL + + +S L+ D L
Sbjct: 66 GLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIV-----------LTPADIKSYMLMTLR 113
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM-P 236
G+ YL S+ +HRDL N L+ +K++DFGL+R + S ++ + + RW
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARS-FGSPNRKMTHQVV--TRWYRA 170
Query: 237 PESILYG--KFTTESDVWSYGVVLWE 260
PE +L+G + D+WS G + E
Sbjct: 171 PE-LLFGARHYGVGVDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 47/102 (46%), Positives = 69/102 (67%), Gaps = 1/102 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+A GMAY+ +Y+HRDL A N LV + L KI+DFGL+R V + Y + + P++W
Sbjct: 112 IAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKW 170
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
PE+I +G FT +SDVWS+G++L+E+ +YG PY G SN +
Sbjct: 171 TAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-27
Identities = 71/247 (28%), Positives = 112/247 (45%), Gaps = 20/247 (8%)
Query: 60 QELGEGAFGKVYKGE-VCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPNIV 117
+G GAFG VYKG + T + VAIK + E ++ +E+DL+ L+HPNIV
Sbjct: 6 DLIGRGAFGVVYKGLNLETGD---FVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIV 62
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
+G + + + ++ E+ G L + + S V + QV
Sbjct: 63 KYIGSIETSDSLYIILEYAENGSLRQII---KKFGPFPESLVAVYVY---------QVLQ 110
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 237
G+AYL +HRD+ A N L VK++DFG++ +D + + + WM P
Sbjct: 111 GLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAP 168
Query: 238 ESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRM 297
E I +T SD+WS G + E+ + G PYY + + I P PE P +
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLT-GNPPYYDLNPMAALFRIVQDDHPPLPEGISPEL 227
Query: 298 YSLMMEC 304
+M+C
Sbjct: 228 KDFLMQC 234
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 73/263 (27%), Positives = 118/263 (44%), Gaps = 30/263 (11%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASD--FRREVDLMSELRHP 114
R L++LGEG+FG+VY LVA+K L + K+ F RE+ +++ L HP
Sbjct: 3 RILRKLGEGSFGEVYLARD-----RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 115 -NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
NIV L + ++ E++ G L + L + PLS+ + I
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKG---------PLSESEALFILA 108
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVG-DGLTVKISDFGLSR----DVYASDYYRIQSKS 228
Q+ + + YL S +HRD+ N L+ DG VK+ DFGL++ S + S S
Sbjct: 109 QILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTS 168
Query: 229 LLPVRWMPPESIL---YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN----QEVIEMI 281
+ +M PE +L ++ SD+WS G+ L+E GL P+ G N + +++I
Sbjct: 169 VGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYE-LLTGLPPFEGEKNSSATSQTLKII 227
Query: 282 RSRQMLPCPEDCPPRMYSLMMEC 304
P L+ +
Sbjct: 228 LELPTPSLASPLSPSNPELISKA 250
|
Length = 384 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 56/121 (46%), Positives = 76/121 (62%), Gaps = 12/121 (9%)
Query: 308 VPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR--DVYASDYYRIQSKSLL 365
V +A GM+YL VHRDLAARN LV VKI+DFGL+R D+ ++Y+ K +
Sbjct: 116 VQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGK--V 173
Query: 366 PVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE--------EFLKTP 417
P++WM ESIL+ +FT +SDVWSYGV +WE+ ++G +PY G +E E L P
Sbjct: 174 PIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQP 233
Query: 418 P 418
P
Sbjct: 234 P 234
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 75/250 (30%), Positives = 115/250 (46%), Gaps = 30/250 (12%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKT-ASDFRREVDLMSELRHPNIV 117
L ++GEG +G VYK +VAIK +K + RE+ L+ EL HPNI+
Sbjct: 4 LGKIGEGTYGVVYKAR--DKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNII 61
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
LL V + ++FEFM DL++ + R Q L + Q+
Sbjct: 62 KLLDVFRHKGDLYLVFEFM-DTDLYKLIKDR-----------QRGLPESLIKSYLYQLLQ 109
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS-DYYRIQSKSLLPVRWM- 235
G+A+ SH +HRDL N L+ +K++DFGL+R + Y + RW
Sbjct: 110 GLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY----VVTRWYR 165
Query: 236 PPESILYGKFTTES-DVWSYGVVLWEVYSYGLQPYY-GYSNQEVIEMIRSRQML--PCPE 291
PE +L K + D+WS G + E+ S +P + G S E+ ++ + + L P PE
Sbjct: 166 APELLLGDKGYSTPVDIWSVGCIFAELLS--RRPLFPGKS--EIDQLFKIFRTLGTPDPE 221
Query: 292 DCPPRMYSLM 301
P+ SL
Sbjct: 222 VW-PKFTSLA 230
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 74/239 (30%), Positives = 116/239 (48%), Gaps = 44/239 (18%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPNIV 117
+ ++GEG +G+VYK G LVA+K ++ EN + RE+ L+ +LRHPNIV
Sbjct: 4 IAQIGEGTYGQVYKAR-NKKTG-ELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIV 61
Query: 118 CLLGVCLSGEP--MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQV 175
L + S + M+FE+M DL L SP + SQ++ Q+
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYM-DHDLTGLL--DSPEVKFTESQIK---------CYMKQL 109
Query: 176 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR---DVYASDY--------YRI 224
G+ YL S+ +HRD+ N L+ + +K++DFGL+R ++DY YR
Sbjct: 110 LEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYR- 168
Query: 225 QSKSLLPVRWMPPESILYG--KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281
PPE +L G ++ E D+WS G +L E++ G + G + E +E I
Sbjct: 169 -----------PPE-LLLGATRYGPEVDMWSVGCILAELFL-GKPIFQGSTELEQLEKI 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-26
Identities = 47/102 (46%), Positives = 67/102 (65%), Gaps = 1/102 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+A GMA++ +Y+HRDL A N LV L KI+DFGL+R V + Y + + P++W
Sbjct: 111 IAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKW 169
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
PE+I +G FT +SDVWS+G++L E+ +YG PY G SN E
Sbjct: 170 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE 211
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 48/102 (47%), Positives = 70/102 (68%), Gaps = 1/102 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+A+GMAY+ +YVHRDL A N LVG+ L K++DFGL+R + ++Y Q P++W
Sbjct: 111 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKW 169
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
PE+ LYG+FT +SDVWS+G++L E+ + G PY G N+E
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 211
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 2e-25
Identities = 52/119 (43%), Positives = 69/119 (57%), Gaps = 8/119 (6%)
Query: 308 VPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV 367
V +A GM YL VHRDLAARN LV VKI+DFGL++ + A + +P+
Sbjct: 116 VQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPI 175
Query: 368 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE--------EFLKTPP 418
+WM ESIL+ +T +SDVWSYGV +WE+ ++G +PY G E E L PP
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 234
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPNIVCLL 120
+GEGA G V+K + + VA+K + + RE+ + +HP +V LL
Sbjct: 8 IGEGAHGIVFKAKDRET--GETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 121 GVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMA 180
V G ++ E+M DL E L + PL + + G+A
Sbjct: 66 DVFPHGSGFVLVMEYMPS-DLSEVLRDE-----------ERPLPEAQVKSYMRMLLKGVA 113
Query: 181 YLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESI 240
Y+ ++ +HRDL N L+ +KI+DFGL+R +++ + R+ S + + PE +
Sbjct: 114 YMHANGIMHRDLKPANLLISADGVLKIADFGLAR-LFSEEEPRLYSHQVATRWYRAPE-L 171
Query: 241 LYG--KFTTESDVWSYGVVLWE 260
LYG K+ D+W+ G + E
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAE 193
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 63/227 (27%), Positives = 111/227 (48%), Gaps = 38/227 (16%)
Query: 57 RFLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPN 115
+ L+++GEGA G+VYK + T + VAIK K ++ E+ +M + +HPN
Sbjct: 22 KNLEKIGEGASGEVYKATDRATGK---EVAIK--KMRLRKQNKELIINEILIMKDCKHPN 76
Query: 116 IVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQV 175
IV L G+ + ++ E+M G L + + +Q +++ +++ +V
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDII-----------TQNFVRMNEPQIAYVCREV 125
Query: 176 AAGMAYLCSHHYVHRDLAARNCLVG-DGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR- 233
G+ YL S + +HRD+ + N L+ DG +VK++DFG +A+ + +SK R
Sbjct: 126 LQGLEYLHSQNVIHRDIKSDNILLSKDG-SVKLADFG-----FAAQLTKEKSK-----RN 174
Query: 234 -------WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS 273
WM PE I + + D+WS G++ E+ + G PY
Sbjct: 175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEM-AEGEPPYLREP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 5e-25
Identities = 48/103 (46%), Positives = 62/103 (60%), Gaps = 3/103 (2%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG-LSRDVYASDYYRIQSKSLLPVR 368
+A+GM YL YVH+ LAA LV L KIS F L D + Y + KS PV
Sbjct: 116 LASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKS--PVL 173
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
W PE+I Y F++ SDVWS+G+V+WEV SYG +PY+ S Q+
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-25
Identities = 75/258 (29%), Positives = 121/258 (46%), Gaps = 43/258 (16%)
Query: 60 QELGEGAFGKVYKG-EVCTSEGPSLVAIK------TLKENANQK---TASDFRREVDLMS 109
+ +G+G +G+VY V T E ++A+K T+ + + R E++ +
Sbjct: 7 ELIGKGTYGRVYLALNVTTGE---MMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLK 63
Query: 110 ELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFS 169
+L H NIV LG + E + + E++ G + L R+ +Q
Sbjct: 64 DLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL--RTY----------GRFEEQLVR 111
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR---DVYASDYYRIQS 226
QV G+AYL S +HRDL A N LV KISDFG+S+ D+Y +D Q+
Sbjct: 112 FFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDND----QN 167
Query: 227 KSLL-PVRWMPPESI-LYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI-- 281
S+ V WM PE I Y + ++ + D+WS G V+ E+++ G +P +S++E I +
Sbjct: 168 MSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFA-GRRP---WSDEEAIAAMFK 223
Query: 282 --RSRQMLPCPEDCPPRM 297
R P P D +
Sbjct: 224 LGNKRSAPPIPPDVSMNL 241
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 8e-25
Identities = 42/125 (33%), Positives = 68/125 (54%), Gaps = 11/125 (8%)
Query: 294 PPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA 353
+ M C VA+G+ +L ++H DLA RNC + L+VKI D+GL+ + Y
Sbjct: 97 AQKDVLQRMAC----EVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYP 152
Query: 354 SDYYRIQSKSLLPVRWMPPE-------SILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG 406
DYY + +P+RW+ PE +L T +S++WS GV +WE+++ QPY
Sbjct: 153 EDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212
Query: 407 YSNQE 411
S+++
Sbjct: 213 LSDEQ 217
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 9e-25
Identities = 49/102 (48%), Positives = 69/102 (67%), Gaps = 1/102 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+A GMAY+ +Y+HRDL A N LVGD L KI+DFGL+R + ++Y Q P++W
Sbjct: 111 IADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKW 169
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
PE+ LYG+FT +SDVWS+G++L E+ + G PY G N+E
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE 211
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 45/109 (41%), Positives = 68/109 (62%), Gaps = 7/109 (6%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+A G+ +L ++++H DLA RNCL+ LTVKI D+GLS + Y DYY + +P+RW
Sbjct: 109 IALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRW 168
Query: 370 MPPE-------SILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
+ PE ++L T ES+VWS GV +WE++ G QPY S+++
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ 217
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 79/251 (31%), Positives = 119/251 (47%), Gaps = 36/251 (14%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELR---HP 114
L E+GEGA+G VYK + G VA+K ++ + + RE+ L+ +L HP
Sbjct: 4 LAEIGEGAYGTVYKARD-LNTG-RFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHP 61
Query: 115 NIVCLLGVC----LSGEPMCML-FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFS 169
NIV LL VC E L FE V DL +L S+ P+ + ++
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEH-VDQDLATYL-SKCPKPGLPPETIK--------- 110
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 229
+ Q+ G+ +L SH VHRDL +N LV VKI+DFGL+R +Y+ + +L
Sbjct: 111 DLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLAR-IYSFEM------AL 163
Query: 230 LPV---RWM-PPESILYGKFTTESDVWSYGVVLWEVYSYGLQP-YYGYSNQEVIEMIRSR 284
V W PE +L + T D+WS G + E++ +P + G S + ++ I
Sbjct: 164 TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR--RRPLFRGTSEADQLDKIFDV 221
Query: 285 QMLPCPEDCPP 295
LP E+ P
Sbjct: 222 IGLPSEEEWPR 232
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 64/256 (25%), Positives = 110/256 (42%), Gaps = 24/256 (9%)
Query: 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTA----SDFRREVDLMSELRHPN 115
+ LG G+FG VY+G A+K + + +T +E+ L+S+L+HPN
Sbjct: 6 ELLGSGSFGSVYEGLNLDDG--DFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN 63
Query: 116 IVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQV 175
IV LG + + + E + G L + L + + Q+
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLL------------KKYGSFPEPVIRLYTRQI 111
Query: 176 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM 235
G+ YL + VHRD+ N LV VK++DFG+++ V + + S WM
Sbjct: 112 LLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGS---PYWM 168
Query: 236 PPESIL-YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN-QEVIEMIRSRQMLPCPEDC 293
PE I G + +D+WS G + E+ + G P+ V ++ RS+++ P P+
Sbjct: 169 APEVIAQQGGYGLAADIWSLGCTVLEMAT-GKPPWSQLEGVAAVFKIGRSKELPPIPDHL 227
Query: 294 PPRMYSLMMECWHEVP 309
+++C P
Sbjct: 228 SDEAKDFILKCLQRDP 243
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 63/245 (25%), Positives = 111/245 (45%), Gaps = 26/245 (10%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTL-KENANQKTASDF-RREVDLMSELRHPNIVCL 119
LG+G+FGKV + L A+K L K+ ++ + E +++S + HP IV L
Sbjct: 1 LGKGSFGKVLLVRKKDTGK--LYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58
Query: 120 LGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGM 179
+ E + ++ E+ G+L +S+ R S++ A ++ +
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELF-SHLSKEGR-----------FSEERARFYAAEIVLAL 106
Query: 180 AYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR---WMP 236
YL S ++RDL N L+ +K++DFGL++++ S+ R + ++
Sbjct: 107 EYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELS-SEGSRTNT----FCGTPEYLA 161
Query: 237 PESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPR 296
PE +L + D WS GV+L+E+ G P+Y +E+ E I L PE P
Sbjct: 162 PEVLLGKGYGKAVDWWSLGVLLYEML-TGKPPFYAEDRKEIYEKILKDP-LRFPEFLSPE 219
Query: 297 MYSLM 301
L+
Sbjct: 220 ARDLI 224
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 65/232 (28%), Positives = 120/232 (51%), Gaps = 32/232 (13%)
Query: 59 LQELGEGAFGKVYKGEV-CTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIV 117
L++LGEG + VYKG T E +VA+K + +A + T S RE+ LM EL+H NIV
Sbjct: 5 LEKLGEGTYATVYKGRNRTTGE---IVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
L V + + ++FE+M DL +++ + R + + V++ F++ L+
Sbjct: 62 RLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKS------FTYQLLK--- 111
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR------DVYASDYYRIQSKSLLP 231
G+A+ + +HRDL +N L+ +K++DFGL+R + ++++ +
Sbjct: 112 GIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTL------- 164
Query: 232 VRWMPPESILYGK--FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281
W +L G ++T D+WS G ++ E+ + G + G +N++ + I
Sbjct: 165 --WYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT-GRPLFPGTNNEDQLLKI 213
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 8e-24
Identities = 73/273 (26%), Positives = 128/273 (46%), Gaps = 48/273 (17%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPNIV 117
L+++GEG +G V+K + E +VA+K ++ ++ ++ S RE+ L+ EL+H NIV
Sbjct: 5 LEKIGEGTYGTVFKAK--NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 62
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
L V S + + ++FE+ + DL ++ S DI V++ Q+
Sbjct: 63 RLYDVLHSDKKLTLVFEYCDQ-DLKKYF--DSCNGDIDPEIVKS---------FMFQLLK 110
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR---- 233
G+A+ SH+ +HRDL +N L+ +K++DFGL+R + I PVR
Sbjct: 111 GLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARA------FGI------PVRCYSA 158
Query: 234 -----WMPPESILYGK--FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI----- 281
W P +L+G ++T D+WS G + E+ + G + G + ++ I
Sbjct: 159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 218
Query: 282 -RSRQMLP----CPEDCPPRMYSLMMECWHEVP 309
+ + P P+ P MY + VP
Sbjct: 219 TPTEESWPGVSKLPDYKPYPMYPATTSLVNVVP 251
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 1e-23
Identities = 53/119 (44%), Positives = 68/119 (57%), Gaps = 8/119 (6%)
Query: 308 VPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV 367
V +A GM YL VHRDLAARN LV VKI+DFGL+R + + +P+
Sbjct: 116 VQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI 175
Query: 368 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE--------EFLKTPP 418
+WM E I Y KFT +SDVWSYGV +WE+ ++G +PY G +E E L PP
Sbjct: 176 KWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPP 234
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 2e-23
Identities = 43/88 (48%), Positives = 58/88 (65%), Gaps = 1/88 (1%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV-YASDYYRIQSKSLLPVRWMP 371
GM YL S YVHRDLA RN LV VKI DFGL++ + +YY+++ P+ W
Sbjct: 120 GMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA 179
Query: 372 PESILYGKFTTESDVWSYGVVLWEVYSY 399
PES+ KF+ SDVWS+GVVL+E+++Y
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYELFTY 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-23
Identities = 74/285 (25%), Positives = 119/285 (41%), Gaps = 44/285 (15%)
Query: 60 QELGEGAFGKVYKG---EVCTSEGPS-----LVAIKTLKENANQKTASDFRREVDLMSEL 111
+ LG+G F +YKG + V +K L + A F LMS+L
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLA--FFETASLMSQL 58
Query: 112 RHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHI 171
H ++V L GVC+ + M+ E++ G L FL ++++S +
Sbjct: 59 SHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFL--HREKNNVSLHW---------KLDV 106
Query: 172 ALQVAAGMAYLCSHHYVHRDLAARNCLV-------GDGLTVKISDFGLSRDVYASDYYRI 224
A Q+A+ + YL VH ++ +N LV G +K+SD G+ V + +
Sbjct: 107 AKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREE--- 163
Query: 225 QSKSLLPVRWMPPESI--LYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282
+ + W+ PE I T +D WS+G L E+ S G +P S+ E +
Sbjct: 164 ---RVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ 220
Query: 283 SRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327
+ LP P DC + +L+ +CW P S + RDL
Sbjct: 221 DQHRLPMP-DCAE-LANLINQCWTYDP-----TKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 2e-23
Identities = 69/226 (30%), Positives = 107/226 (47%), Gaps = 48/226 (21%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFR-----REVD-LMSELR 112
+++LG+G FG VY G LVAIK +K +K S + REV L
Sbjct: 4 IKQLGDGTFGSVYLARN-KETGE-LVAIKKMK----KKFYS-WEECMNLREVKSLRKLNE 56
Query: 113 HPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIA 172
HPNIV L V + + +FE+M G+L++ + R + P S+ I
Sbjct: 57 HPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGK----------PFSESVIRSII 105
Query: 173 LQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV--------YASD-YYR 223
Q+ G+A++ H + HRDL N LV VKI+DFGL+R++ Y S +YR
Sbjct: 106 YQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYR 165
Query: 224 IQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQP 268
PE +L +++ D+W+ G ++ E+Y+ L+P
Sbjct: 166 ------------APEILLRSTSYSSPVDIWALGCIMAELYT--LRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 1e-22
Identities = 57/263 (21%), Positives = 108/263 (41%), Gaps = 43/263 (16%)
Query: 57 RFLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTL-KENANQKTASDF-RREVDLMSEL-R 112
+F + +GEG+F V E T+ AIK L K ++ + + E ++++ L
Sbjct: 4 KFGKIIGEGSFSTVVLAKEKETN---KEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 113 HPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIA 172
HP I+ L E + + E+ G+L +++ GS L ++ A
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY-------GS-----LDEKCTRFYA 108
Query: 173 LQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD------------ 220
++ + YL S +HRDL N L+ + +KI+DFG ++ + +
Sbjct: 109 AEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168
Query: 221 -----YYRIQSKSLLPV---RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY 272
R + S V ++ PE + SD+W+ G +++++ G P+ G
Sbjct: 169 DSQIEKNRRRFASF--VGTAEYVSPELLNEKPAGKSSDLWALGCIIYQML-TGKPPFRGS 225
Query: 273 SNQEVIEMIRSRQMLPCPEDCPP 295
+ + I + P + PP
Sbjct: 226 NEYLTFQKILKLE-YSFPPNFPP 247
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 63/236 (26%), Positives = 104/236 (44%), Gaps = 24/236 (10%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIV 117
+Q +G G +G VYK + LVAIK +K ++E+ ++ E RHPNIV
Sbjct: 7 LIQRIGSGTYGDVYKARDIATG--ELVAIKVIKLEP-GDDFEIIQQEISMLKECRHPNIV 63
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
G L + + ++ E+ G L DI + PLS+ +++ +
Sbjct: 64 AYFGSYLRRDKLWIVMEYCGGGSL----------QDIY-QVTRGPLSELQIAYVCRETLK 112
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL--PVRWM 235
G+AYL +HRD+ N L+ + VK++DFG+S + A+ R KS + P WM
Sbjct: 113 GLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR---KSFIGTPY-WM 168
Query: 236 PPESI---LYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP 288
PE G + + D+W+ G+ E + P + + +I P
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIE-LAELQPPMFDLHPMRALFLISKSNFPP 223
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-22
Identities = 64/205 (31%), Positives = 108/205 (52%), Gaps = 17/205 (8%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPNIV 117
++++GEG +G VYK +VA+K ++ + + S RE+ L+ EL HPNIV
Sbjct: 5 VEKIGEGTYGVVYKAR--NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 62
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
LL V + + ++FEF+ + DL +F M SP S I +++ L Q+
Sbjct: 63 KLLDVIHTENKLYLVFEFLHQ-DLKKF-MDASPLSGIPLPLIKSYL---------FQLLQ 111
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 237
G+A+ SH +HRDL +N L+ +K++DFGL+R R + ++ + + P
Sbjct: 112 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTLWYRAP 169
Query: 238 ESILYGKF-TTESDVWSYGVVLWEV 261
E +L K+ +T D+WS G + E+
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEM 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 4e-22
Identities = 40/109 (36%), Positives = 63/109 (57%), Gaps = 7/109 (6%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+AAG+ ++ H+++H DLA RNC + LTVK+ D+G+ Y DY + +P+RW
Sbjct: 108 IAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRW 167
Query: 370 MPPESI--LYGKF-----TTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
+ PE + +G T S+VW+ GV LWE++ QPY S++E
Sbjct: 168 LAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE 216
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 4e-22
Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 39/214 (18%)
Query: 61 ELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLL 120
ELG+GAFGKVYK + + L A + + +++ DF E+D++SE +HPNIV L
Sbjct: 12 ELGDGAFGKVYKAQ---HKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLY 68
Query: 121 GVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMA 180
+ +L EF G L ++ +++ L++ ++ Q+ +
Sbjct: 69 EAYFYENKLWILIEFCDGGALDSIML-----------ELERGLTEPQIRYVCRQMLEALN 117
Query: 181 YLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS---------RDVYASDYYRIQSKSLLP 231
+L SH +HRDL A N L+ VK++DFG+S RD + Y
Sbjct: 118 FLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPY--------- 168
Query: 232 VRWMPPESILYGKFTTE-----SDVWSYGVVLWE 260
WM PE + F +D+WS G+ L E
Sbjct: 169 --WMAPEVVACETFKDNPYDYKADIWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 9e-22
Identities = 76/266 (28%), Positives = 124/266 (46%), Gaps = 39/266 (14%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRH--- 113
+ L+ +G GA+G VY+G G +VA+K + + SD +REV L+S+LR
Sbjct: 4 QRLELIGRGAYGAVYRG-KHVPTG-RVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP 61
Query: 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
PNI G L G + ++ E+ G + LM P ++++ S I
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEYAEGGSVRT-LMKAGP------------IAEKYISVIIR 108
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR 233
+V + Y+ +HRD+ A N LV + VK+ DFG++ + + R + P
Sbjct: 109 EVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR-STFVGTPY- 166
Query: 234 WMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPED 292
WM PE I GK + T++D+WS G+ ++E+ + G PY + +I P+
Sbjct: 167 WMAPEVITEGKYYDTKADIWSLGITIYEM-ATGNPPYSDVDAFRAMMLI--------PKS 217
Query: 293 CPPRM----YSLMME-----CWHEVP 309
PPR+ YS ++ C E P
Sbjct: 218 KPPRLEDNGYSKLLREFVAACLDEEP 243
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 1e-21
Identities = 48/111 (43%), Positives = 62/111 (55%), Gaps = 4/111 (3%)
Query: 306 HEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS-DYYRIQSKSL 364
+ V + GM YL S YVHRDLAARN LV VKI DFGL++ + +YY ++
Sbjct: 114 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLD 173
Query: 365 LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
PV W PE ++ KF SDVWS+GV L+E+ +Y S FLK
Sbjct: 174 SPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE---SSPMTLFLK 221
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 1e-21
Identities = 57/231 (24%), Positives = 105/231 (45%), Gaps = 23/231 (9%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
L++LGEG++G VYK + G +VAIK + + +E+ ++ + P I
Sbjct: 6 DILEKLGEGSYGSVYKA-IHKETG-QVVAIKVVPVEE---DLQEIIKEISILKQCDSPYI 60
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V G + ++ E+ G + + + L++++ + I Q
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKIT-----------NKTLTEEEIAAILYQTL 109
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL--PVRW 234
G+ YL S+ +HRD+ A N L+ + K++DFG+S +D + +++ P W
Sbjct: 110 KGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQ--LTDTMA-KRNTVIGTPF-W 165
Query: 235 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ 285
M PE I + ++D+WS G+ E+ + G PY I MI ++
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEM-AEGKPPYSDIHPMRAIFMIPNKP 215
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 2e-21
Identities = 81/301 (26%), Positives = 129/301 (42%), Gaps = 39/301 (12%)
Query: 46 DFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREV 105
D R E +ET + +LG G G V K + + +++A K + A RE+
Sbjct: 1 DLRNEDLET----ISDLGAGNGGSVSKVKHIPTG--TVMAKKVVHIGAKSSVRKQILREL 54
Query: 106 DLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQ 165
+M E R P IV G L+ +CM EFM G L + P+
Sbjct: 55 QIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIY------------KKGGPIPV 102
Query: 166 QDFSHIALQVAAGMAYLCS-HHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRI 224
+ IA+ V G+ YL + H +HRD+ N LV +K+ DFG+S ++ S I
Sbjct: 103 EILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----I 158
Query: 225 QSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE-------- 276
+ +M PE I GK+T +SDVWS G+ + E+ + G P + +SN +
Sbjct: 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIEL-ALGKFP-FAFSNIDDDGQDDPM 216
Query: 277 -VIEMIRSRQMLPCP----EDCPPRMYSLMMECWHEVPVA-AGMAYLCSHHYVHRDLAAR 330
++++++ P P D P + + C + P LC+ + L A
Sbjct: 217 GILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRAS 276
Query: 331 N 331
N
Sbjct: 277 N 277
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 62/240 (25%), Positives = 103/240 (42%), Gaps = 44/240 (18%)
Query: 53 ETKPRFLQ---ELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFR------- 102
R++Q LGEG +GKV K + +VAIK +K + R
Sbjct: 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTG--KIVAIKKVKIIEISNDVTKDRQLVGMCG 62
Query: 103 ------REVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISG 156
RE+ +M+E++H NI+ L+ V + G+ + ++ + M DL + + + ++
Sbjct: 63 IHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTE--- 118
Query: 157 SQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV 216
SQV+ I LQ+ G+ L +++HRDL+ N + KI+DFGL+R
Sbjct: 119 SQVKC---------ILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRY 169
Query: 217 YASDYYRIQSKSLLPVR-----------WMPPESILYG--KFTTESDVWSYGVVLWEVYS 263
Y SK R W +L G K+ D+WS G + E+ +
Sbjct: 170 GYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229
|
Length = 335 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 6e-21
Identities = 43/91 (47%), Positives = 59/91 (64%), Gaps = 1/91 (1%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV-YASDYYRIQSKSLLPVR 368
+ GMAYL S HY+HRDLAARN L+ + VKI DFGL++ V +YYR++ PV
Sbjct: 116 ICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 175
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSY 399
W E + KF+ SDVWS+GV L+E+ ++
Sbjct: 176 WYAVECLKENKFSYASDVWSFGVTLYELLTH 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 6e-21
Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASD-----FRREVDLMSELRHPNI 116
LG+GA+G VY G + L+A+K ++ + + A++ + EVDL+ L+H NI
Sbjct: 8 LGKGAYGTVYCGLTNQGQ---LIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V LG CL + + EF+ G + L PL + F Q+
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSIL------------NRFGPLPEPVFCKYTKQIL 112
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR--- 233
G+AYL ++ VHRD+ N ++ +K+ DFG +R + + S L +
Sbjct: 113 DGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTP 172
Query: 234 -WMPPESILYGKFTTESDVWSYGVVLWEV 261
WM PE I + +SD+WS G ++E+
Sbjct: 173 YWMAPEVINESGYGRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 6e-21
Identities = 68/230 (29%), Positives = 110/230 (47%), Gaps = 43/230 (18%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQK-----TASDFRREVDLMSEL 111
L +LGEG FG+VYK G +VA+K + N+K TA RE+ ++ +L
Sbjct: 11 EILGKLGEGTFGEVYKA-RQIKTG-RVVALKKIL-MHNEKDGFPITA---LREIKILKKL 64
Query: 112 RHPNIVCLLGVCLSGEP--------MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPL 163
+HPN+V L+ + + + M+ +M DL L +P ++ SQ++
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLL--ENPSVKLTESQIKC-- 119
Query: 164 SQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYR 223
LQ+ G+ YL +H +HRD+ A N L+ + +KI+DFGL+R Y
Sbjct: 120 -------YMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR-PYDGPPPN 171
Query: 224 IQSK---------SLLPVRWM-PPESILYGK-FTTESDVWSYGVVLWEVY 262
+ +L+ RW PPE +L + +TT D+W G V E++
Sbjct: 172 PKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF 221
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 7e-21
Identities = 68/251 (27%), Positives = 115/251 (45%), Gaps = 44/251 (17%)
Query: 60 QELGEGAFGKVYKG---------EVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSE 110
+ LG+G F K++KG E+ +E V +K L + +++ + F +MS+
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTE----VLLKVL-DKSHRNYSESFFEAASMMSQ 55
Query: 111 LRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSH 170
L H ++V GVC+ G+ M+ E++ G L +L +IS
Sbjct: 56 LSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKL-----------E 104
Query: 171 IALQVAAGMAYLCSHHYVHRDLAARNCLV---GDGLT-----VKISDFGLSRDVYASDYY 222
+A Q+A + +L H ++ A+N L+ D T +K+SD G+S V
Sbjct: 105 VAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV------ 158
Query: 223 RIQSKSLLPVR--WMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIE 279
K +L R W+PPE I + + +D WS+G LWE++S G +P +Q+ ++
Sbjct: 159 --LPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ 216
Query: 280 MIRSRQMLPCP 290
R LP P
Sbjct: 217 FYEDRHQLPAP 227
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 9e-21
Identities = 70/245 (28%), Positives = 130/245 (53%), Gaps = 20/245 (8%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPNIV 117
++++GEG +G VYKG + +VA+K ++ E+ + S RE+ L+ EL+HPNIV
Sbjct: 5 IEKIGEGTYGVVYKGRNKKTGQ--IVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIV 62
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
CL V + + ++FEF+ DL ++L S + V++ L Q+
Sbjct: 63 CLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYL---------YQILQ 112
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 237
G+ + S +HRDL +N L+ + +K++DFGL+R R+ + ++ + + P
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VRVYTHEVVTLWYRAP 170
Query: 238 ESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP-EDCPP 295
E +L +++T D+WS G + E+ + +P + + + E+ ++ R ++L P ED P
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMATK--KPLF-HGDSEIDQLFRIFRILGTPTEDVWP 227
Query: 296 RMYSL 300
+ SL
Sbjct: 228 GVTSL 232
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 1e-20
Identities = 61/233 (26%), Positives = 114/233 (48%), Gaps = 16/233 (6%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPNIV 117
L++LG+G++G VYK V A+K + + +QK D E+ +++ + HPNI+
Sbjct: 5 LKKLGKGSYGSVYK--VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNII 62
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
L G +C++ E+ GDL + + R + + + +Q+ I +Q+
Sbjct: 63 SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRK--------KKRKLIPEQEIWRIFIQLLR 114
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 237
G+ L +HRDL + N L+ VKI D G+S+ V + + Q + +M P
Sbjct: 115 GLQALHEQKILHRDLKSANILLVANDLVKIGDLGISK-VLKKNMAKTQIGTPH---YMAP 170
Query: 238 ESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP 290
E ++ +SD+WS G +L+E+ ++ P+ S Q++ ++ + P P
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAP-PFEARSMQDLRYKVQRGKYPPIP 222
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 2e-20
Identities = 64/248 (25%), Positives = 105/248 (42%), Gaps = 35/248 (14%)
Query: 62 LGEGAFGKVY------KGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPN 115
+G G+FG VY GE+ + L ++ ++ + RE+ L+ EL+H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 116 IVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL-- 173
IV LG L + + + E+ + G V A L+ L
Sbjct: 68 IVQYLGSSLDADHLNIFLEY------------------VPGGSVAALLNNYGAFEETLVR 109
Query: 174 ----QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA---SDYYRIQS 226
Q+ G+ YL + +HRD+ N LV + +KISDFG+S+ + A S
Sbjct: 110 NFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGAR 169
Query: 227 KSLL-PVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ 285
SL V WM PE + +T ++D+WS G ++ E+ + G P+ + + I I
Sbjct: 170 PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLT-GKHPFPDCTQLQAIFKIGENA 228
Query: 286 MLPCPEDC 293
P +
Sbjct: 229 SPEIPSNI 236
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 2e-20
Identities = 66/214 (30%), Positives = 106/214 (49%), Gaps = 37/214 (17%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPNIV 117
++++GEG +G VYK +VA+K ++ E ++ S RE+ L+ EL HPNIV
Sbjct: 4 VEKIGEGTYGVVYKA--RDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIV 61
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
LL V S + ++FEF + DL ++ M SP + + +++ L Q +
Sbjct: 62 RLLDVVHSENKLYLVFEF-LDLDLKKY-MDSSPLTGLDPPLIKSYLYQ---------LLQ 110
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR---- 233
G+AY SH +HRDL +N L+ +K++DFGL+R +PVR
Sbjct: 111 GIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFG------------VPVRTYTH 158
Query: 234 -----WM-PPESILYGK-FTTESDVWSYGVVLWE 260
W PE +L + ++T D+WS G + E
Sbjct: 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAE 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 2e-20
Identities = 55/226 (24%), Positives = 99/226 (43%), Gaps = 27/226 (11%)
Query: 45 SDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRRE 104
SD R ++ LG+G+ G VYK V + A+K + + +++ RE
Sbjct: 1 SDLER---------VKVLGQGSSGVVYK--VRHKPTGKIYALKKIHVDGDEEFRKQLLRE 49
Query: 105 VDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLS 164
+ + P +V G + ++ E+M G L + L + +
Sbjct: 50 LKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLL------------KKVGKIP 97
Query: 165 QQDFSHIALQVAAGMAYLCS-HHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYR 223
+ ++IA Q+ G+ YL + H +HRD+ N L+ VKI+DFG+S+ + +
Sbjct: 98 EPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC 157
Query: 224 IQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPY 269
+ + V +M PE I ++ +D+WS G+ L E G P+
Sbjct: 158 --NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECAL-GKFPF 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 2e-20
Identities = 62/229 (27%), Positives = 106/229 (46%), Gaps = 19/229 (8%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIV 117
++ +G GA VY C VAIK + Q + + R+EV MS+ HPN+V
Sbjct: 5 LIEVIGVGATAVVYAAI-CLPNN-EKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV 62
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
+ G+ + ++ ++ G L + + S PR + + + L + V
Sbjct: 63 KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKE---------VLK 113
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR---- 233
G+ YL S+ +HRD+ A N L+G+ +VKI+DFG+S + D K
Sbjct: 114 GLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLA--DGGDRTRKVRKTFVGTPC 171
Query: 234 WMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281
WM PE + + ++D+WS+G+ E+ + G PY Y +V+ +
Sbjct: 172 WMAPEVMEQVHGYDFKADIWSFGITAIEL-ATGAAPYSKYPPMKVLMLT 219
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 88.7 bits (221), Expect = 5e-20
Identities = 33/106 (31%), Positives = 53/106 (50%), Gaps = 4/106 (3%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+ + + YL S VHRDL N L+ + VK++DFGL+R + + + +
Sbjct: 106 ILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPE---Y 162
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
M PE +L + D+WS GV+L+E+ + G P+ G E K
Sbjct: 163 MAPEVLLGKGYGKAVDIWSLGVILYELLT-GKPPFPGDDQLLELFK 207
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 7e-20
Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLK--ENANQKTASDFRREVDLMSELRHPNIVCL 119
+G+G F VYK C +G +VA+K ++ E + K D +E+DL+ +L HPN++
Sbjct: 10 IGKGQFSVVYKAI-CLLDG-RVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKY 67
Query: 120 LGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGM 179
L + + ++ E GDL M + + + + ++ +Q+ + +
Sbjct: 68 LASFIENNELNIVLELADAGDLSR--MIKHFKKQ------KRLIPERTIWKYFVQLCSAL 119
Query: 180 AYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPES 239
++ S +HRD+ N + VK+ D GL R ++S S P +M PE
Sbjct: 120 EHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPY-YMSPER 177
Query: 240 ILYGKFTTESDVWSYGVVLWEVYSYGLQ-PYYG 271
I + +SD+WS G +L+E+ + LQ P+YG
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAA--LQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 71/245 (28%), Positives = 118/245 (48%), Gaps = 29/245 (11%)
Query: 61 ELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELR---HPNI 116
E+GEGA+GKV+K + G VA+K ++ + + REV ++ L HPN+
Sbjct: 8 EIGEGAYGKVFKARDLKNGG-RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66
Query: 117 VCLLGVCLSGE-----PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHI 171
V L VC + ++FE V DL +L + P + ++ +
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYL-DKVPEPGVPTETIK---------DM 115
Query: 172 ALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 231
Q+ G+ +L SH VHRDL +N LV +K++DFGL+R +Y+ +++ S++
Sbjct: 116 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYS---FQMALTSVVV 171
Query: 232 VRWM-PPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYY-GYSNQEVIEMIRSRQMLPC 289
W PE +L + T D+WS G + E++ +P + G S+ + + I LP
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR--KPLFRGSSDVDQLGKILDVIGLPG 229
Query: 290 PEDCP 294
ED P
Sbjct: 230 EEDWP 234
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (221), Expect = 1e-19
Identities = 65/225 (28%), Positives = 94/225 (41%), Gaps = 49/225 (21%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFR--REVDLMSELRHP 114
L+ +G GA+G V V G VAIK + N R RE+ L+ LRH
Sbjct: 3 ELLKPIGSGAYGVVCSA-VDKRTG-RKVAIKKI-SNVFDDLIDAKRILREIKLLRHLRHE 59
Query: 115 NIVCLLGVCLSGEPMC-----MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFS 169
NI+ LL + P ++ E M DLH+ + +SP+ PL+
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVI--KSPQ----------PLTDDHIQ 106
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD--------- 220
+ Q+ G+ YL S + +HRDL N LV +KI DFGL+R V +
Sbjct: 107 YFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166
Query: 221 ----YYRIQSKSLLPVRWMPPESIL-YGKFTTESDVWSYGVVLWE 260
+YR PE +L ++T D+WS G + E
Sbjct: 167 VVTRWYR------------APELLLSSSRYTKAIDIWSVGCIFAE 199
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 2e-19
Identities = 32/103 (31%), Positives = 50/103 (48%), Gaps = 3/103 (2%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL-PVRWMP 371
G+AYL S+ VHRD+ N LV VK++DFG ++ + + S+ WM
Sbjct: 113 GLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRL-GDIETGEGTGSVRGTPYWMA 171
Query: 372 PESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFL 414
PE I ++ +D+WS G + E+ + G P+ N L
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMAT-GKPPWSELGNPMAAL 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 7e-19
Identities = 73/243 (30%), Positives = 116/243 (47%), Gaps = 33/243 (13%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPNIV 117
L +GEG +G VY+ TS +VA+K ++ +N RE+ L+ LRHPNIV
Sbjct: 12 LNRIGEGTYGIVYRARDTTSG--EIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIV 69
Query: 118 CLLGVCLSGEPMCMLFEFM--VRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQV 175
L V + G+ + +F M DL L + + P S+ + LQ+
Sbjct: 70 ELKEV-VVGKHLDSIFLVMEYCEQDLASLLDN-----------MPTPFSESQVKCLMLQL 117
Query: 176 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV--- 232
G+ YL + +HRDL N L+ D +KI+DFGL+R Y + +K + P
Sbjct: 118 LRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLART------YGLPAKPMTPKVVT 171
Query: 233 RWMPPESILYG--KFTTESDVWSYGVVLWEVYSYGLQPYY-GYSNQEVIEMIRSRQMLPC 289
W +L G +TT D+W+ G +L E+ ++ +P G S E +++I Q+L
Sbjct: 172 LWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH--KPLLPGKSEIEQLDLI--IQLLGT 227
Query: 290 PED 292
P +
Sbjct: 228 PNE 230
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 9e-19
Identities = 55/210 (26%), Positives = 86/210 (40%), Gaps = 29/210 (13%)
Query: 62 LGEGAFGKVYKGEVC--TSEGPSLVAIKTLKENANQKTASD----FRREVDLMSELRHPN 115
LG+GAFG+VY +C G L A+K + + + E+ L+ L+H
Sbjct: 10 LGQGAFGRVY---LCYDVDTGREL-AVKQVPFDPDSPETKKEVNALECEIQLLKNLQHER 65
Query: 116 IVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQV 175
IV G E + + E+M G + + L + L++ Q+
Sbjct: 66 IVQYYGCLRDDETLSIFMEYMPGGSVKDQL------------KAYGALTETVTRKYTRQI 113
Query: 176 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR-- 233
G+ YL S+ VHRD+ N L VK+ DFG S+ + + V
Sbjct: 114 LEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT---ICSSGTGMKSVTGT 170
Query: 234 --WMPPESILYGKFTTESDVWSYGVVLWEV 261
WM PE I + ++DVWS G + E+
Sbjct: 171 PYWMSPEVISGEGYGRKADVWSVGCTVVEM 200
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 63/237 (26%), Positives = 122/237 (51%), Gaps = 18/237 (7%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVC 118
L++LGEG + V+KG +E +LVA+K ++ + REV L+ +L+H NIV
Sbjct: 11 LEKLGEGTYATVFKGRSKLTE--NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 68
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
L + + + + ++FE++ + DL +++ D G+ +S + Q+ G
Sbjct: 69 LHDIVHTDKSLTLVFEYLDK-DLKQYM-------DDCGN----IMSMHNVKIFLYQILRG 116
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPE 238
+AY +HRDL +N L+ + +K++DFGL+R S + S ++ + + PP+
Sbjct: 117 LAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPD 174
Query: 239 SIL-YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCP 294
+L +++T+ D+W G + +E+ S G + G + ++ + +I P E P
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMAS-GRPLFPGSTVEDELHLIFRLLGTPTEETWP 230
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 66/221 (29%), Positives = 95/221 (42%), Gaps = 43/221 (19%)
Query: 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKE----NANQKTASDFRREVDLMSE 110
K L +GEGA+G V K +VAIK KE +KTA REV ++ +
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRN--KATGEIVAIKKFKESEDDEDVKKTAL---REVKVLRQ 56
Query: 111 LRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSH 170
LRH NIV L + ++FE++ R L L+ SP L
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLLE--LLEASPGG----------LPPDAVRS 104
Query: 171 IALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR------DVYASDYYRI 224
Q+ +AY SH+ +HRD+ N LV + +K+ DFG +R +DY
Sbjct: 105 YIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDY--- 161
Query: 225 QSKSLLPVRWM-PPESIL----YGKFTTESDVWSYGVVLWE 260
+ RW PE ++ YGK DVW+ G ++ E
Sbjct: 162 -----VATRWYRAPELLVGDTNYGK---PVDVWAIGCIMAE 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 37/216 (17%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVC 118
L +LGEG++ VYKG + LVA+K ++ + RE L+ +L+H NIV
Sbjct: 10 LDKLGEGSYATVYKGRSKLTG--QLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVT 67
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
L + + + + ++FE++ DL ++ M +S V+ L Q+ G
Sbjct: 68 LHDIIHTKKTLTLVFEYLDT-DLKQY-MDDCGGG-LSMHNVRLFL---------FQLLRG 115
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR----- 233
+AY +HRDL +N L+ + +K++DFGL+R +KS +P +
Sbjct: 116 LAYCHQRRVLHRDLKPQNLLISERGELKLADFGLAR-----------AKS-VPSKTYSNE 163
Query: 234 ----WMPPESILYG--KFTTESDVWSYGVVLWEVYS 263
W P +L G +++T D+W G + +E+ +
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 30/88 (34%), Positives = 50/88 (56%), Gaps = 4/88 (4%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDG-LTVKISDFGLSRDVYASDYYRIQSKSLLPVR 368
+ G+ YL S+ +HRDL N L+ VK++DFGLS+ + + + +
Sbjct: 101 ILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLL--TSDKSLLKTIVGTPA 158
Query: 369 WMPPESIL-YGKFTTESDVWSYGVVLWE 395
+M PE +L G ++ +SD+WS GV+L+E
Sbjct: 159 YMAPEVLLGKGYYSEKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 28/211 (13%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPS--LVAIKTLKENANQKTASDFRREVDLMSELRHP 114
+L ELG G G V K P+ ++A+KT++ N+ RE+D++ + P
Sbjct: 4 EYLGELGAGNSGVVSK----VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSP 59
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
IV G + + + E+M G L + L +VQ + ++ IA+
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKIL-----------KEVQGRIPERILGKIAVA 108
Query: 175 VAAGMAYLCS-HHYVHRDLAARNCLVGDGLTVKISDFGLSR---DVYASDYYRIQSKSLL 230
V G+ YL H +HRD+ N LV +K+ DFG+S + A + S
Sbjct: 109 VLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSS---- 164
Query: 231 PVRWMPPESILYGKFTTESDVWSYGVVLWEV 261
+M PE I ++ +SD+WS G+ L E+
Sbjct: 165 ---YMAPERIQGNDYSVKSDIWSLGLSLIEL 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-18
Identities = 60/240 (25%), Positives = 112/240 (46%), Gaps = 28/240 (11%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVC 118
L+ +G+G+FG+VYKG + +VAIK + + D ++E+ ++S+ P I
Sbjct: 9 LERIGKGSFGEVYKG--IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITR 66
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
G L G + ++ E++ G + L PL + + I ++ G
Sbjct: 67 YYGSYLKGTKLWIIMEYLGGGSALDLLKP-------------GPLEETYIATILREILKG 113
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR-WMPP 237
+ YL S +HRD+ A N L+ + VK++DFG++ + + +I+ + + WM P
Sbjct: 114 LDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT---QIKRNTFVGTPFWMAP 170
Query: 238 ESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRM 297
E I + ++D+WS G+ E+ + G P V+ +I P++ PP +
Sbjct: 171 EVIKQSAYDFKADIWSLGITAIEL-AKGEPPNSDLHPMRVLFLI--------PKNSPPTL 221
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 69/230 (30%), Positives = 105/230 (45%), Gaps = 38/230 (16%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKT---ASDFRREVDLMSELRHP 114
+G G +G+VYK + + AIK K + Q T S R E+ L+ EL+H
Sbjct: 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR-EIALLRELKHE 62
Query: 115 NIVCLLGVCLSGEPMC--MLFEFMVRGDLHEFLM--SRSPRSDISGSQVQAPLSQQDFSH 170
N+V L+ V L +LF++ DL + + ++ R I S V++
Sbjct: 63 NVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKS--------- 112
Query: 171 IALQVAAGMAYLCSHHYVHRDLAARNCLV-GDGL---TVKISDFGLSRDVYASDYYRIQS 226
+ Q+ G+ YL S+ +HRDL N LV G+G VKI D GL+R A
Sbjct: 113 LLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP------L 166
Query: 227 KSLL---PVR---WM-PPESILYGK-FTTESDVWSYGVVLWEVYSYGLQP 268
K L PV W PE +L + +T D+W+ G + E+ + L+P
Sbjct: 167 KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT--LEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 4e-18
Identities = 66/228 (28%), Positives = 103/228 (45%), Gaps = 26/228 (11%)
Query: 46 DFRREVIETKPRFLQELGEGAFGKVYKGE-VCTSEGPSLVAIKTLKENANQKTASDFRRE 104
D R + +Q +G G +G VYK V T E L AIK +K + A ++E
Sbjct: 1 DLSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGE---LAAIKVIKLEPGEDFAV-VQQE 56
Query: 105 VDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLS 164
+ +M + +H NIV G L + + + EF G L + V PLS
Sbjct: 57 IIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIY------------HVTGPLS 104
Query: 165 QQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRI 224
+ ++++ + G+ YL S +HRD+ N L+ D VK++DFG+S + A+ R
Sbjct: 105 ESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR- 163
Query: 225 QSKSLLPV-RWMPPESILY---GKFTTESDVWSYGVVLWEVYSYGLQP 268
KS + WM PE G + D+W+ G+ E+ LQP
Sbjct: 164 --KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAE--LQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 4e-18
Identities = 72/247 (29%), Positives = 124/247 (50%), Gaps = 26/247 (10%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVC 118
L++LGEG++ VYKG+ + LVA+K ++ + T RE L+ L+H NIV
Sbjct: 10 LEKLGEGSYATVYKGK--SKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVL 67
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
L + + E + ++FE+ V DL ++ M + P L ++ Q+ G
Sbjct: 68 LHDIIHTKETLTLVFEY-VHTDLCQY-MDKHP----------GGLHPENVKLFLFQLLRG 115
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR-DVYASDYYRIQSKSLLPVRWMPP 237
++Y+ + +HRDL +N L+ D +K++DFGL+R S Y + +L W P
Sbjct: 116 LSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTL----WYRP 171
Query: 238 ESILYG--KFTTESDVWSYGVVLWEVYSYGLQPYYGYSN-QEVIEMIRSRQMLPCP-EDC 293
+L G +++T D+W G + E+ G+ + G + Q+ +E R +L P ED
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQ-GVAAFPGMKDIQDQLE--RIFLVLGTPNEDT 228
Query: 294 PPRMYSL 300
P ++SL
Sbjct: 229 WPGVHSL 235
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-18
Identities = 65/238 (27%), Positives = 119/238 (50%), Gaps = 20/238 (8%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVC 118
L +LGEG + VYKG ++ +LVA+K ++ + REV L+ +L+H NIV
Sbjct: 11 LDKLGEGTYATVYKGRSKLTD--NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 68
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
L + + + + ++FE++ + DL ++L D G+ + + + Q+ G
Sbjct: 69 LHDIIHTEKSLTLVFEYLDK-DLKQYL-------DDCGNSI----NMHNVKLFLFQLLRG 116
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPE 238
+ Y +HRDL +N L+ + +K++DFGL+R S + S ++ + + PP+
Sbjct: 117 LNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA--KSIPTKTYSNEVVTLWYRPPD 174
Query: 239 SILYG--KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCP 294
IL G ++T+ D+W G + +E+ S G + G + +E + I P E P
Sbjct: 175 -ILLGSTDYSTQIDMWGVGCIFYEM-STGRPLFPGSTVEEQLHFIFRILGTPTEETWP 230
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 7e-18
Identities = 70/209 (33%), Positives = 102/209 (48%), Gaps = 27/209 (12%)
Query: 59 LQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTA--SDFRREVDLMSELRHPN 115
L+E+G G+FG VY +V T+E +VAIK + + Q D +EV + +LRHPN
Sbjct: 20 LREIGHGSFGAVYFARDVRTNE---VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 116 IVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQV 175
+ G C E L + E+ + + SDI + PL + + + I
Sbjct: 77 TIEYKG-CYLREHTAWL--------VMEYCLGSA--SDILEVH-KKPLQEVEIAAICHGA 124
Query: 176 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM 235
G+AYL SH +HRD+ A N L+ + TVK++DFG AS S P WM
Sbjct: 125 LQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFG-----SASLVSPANSFVGTPY-WM 178
Query: 236 PPESILY---GKFTTESDVWSYGVVLWEV 261
PE IL G++ + DVWS G+ E+
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 7e-18
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 25/208 (12%)
Query: 61 ELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLL 120
ELG+GAFGKVYK + E L A K + + +++ D+ E+D+++ HPNIV LL
Sbjct: 12 ELGDGAFGKVYKAQ--NKETGVLAAAKVI-DTKSEEELEDYMVEIDILASCDHPNIVKLL 68
Query: 121 GVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMA 180
+ +L EF G + ++ +++ PL++ + Q +
Sbjct: 69 DAFYYENNLWILIEFCAGGAVDAVML-----------ELERPLTEPQIRVVCKQTLEALN 117
Query: 181 YLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL--PVRWMPPE 238
YL + +HRDL A N L +K++DFG+S A + IQ + WM PE
Sbjct: 118 YLHENKIIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRTIQRRDSFIGTPYWMAPE 173
Query: 239 SILYGK-----FTTESDVWSYGVVLWEV 261
++ + ++DVWS G+ L E+
Sbjct: 174 VVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 37/102 (36%), Positives = 56/102 (54%), Gaps = 12/102 (11%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV-- 367
+ G+ YL S+ +HRDL N L+ + VKI+DFGL++ + S S SL
Sbjct: 107 ILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKS------SSSLTTFVG 160
Query: 368 --RWMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYG 406
+M PE +L G + + DVWS GV+L+E+ + G P+ G
Sbjct: 161 TPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLT-GKPPFSG 201
|
Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-17
Identities = 47/203 (23%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVC 118
L ++G+G+FG V+K V ++ + N++ + E ++++L I+
Sbjct: 5 LNKIGKGSFGVVFKV-VRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR 63
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
L + ++ E+ GDLH+ L Q PL + +Q+ G
Sbjct: 64 YYESFLDKGKLNIVMEYAENGDLHKLLKM----------QRGRPLPEDQVWRFFIQILLG 113
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV-RWMPP 237
+A+L S +HRD+ + N + VKI D G+++ + + + + +++ ++ P
Sbjct: 114 LAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF---ANTIVGTPYYLSP 170
Query: 238 ESILYGKFTTESDVWSYGVVLWE 260
E + +SDVW+ GVVL+E
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 27/212 (12%)
Query: 61 ELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTAS-DFRREVDLMSELR---HPNI 116
E+G GA+G VYK VA+K+++ N+ REV L+ L HPNI
Sbjct: 7 EIGVGAYGTVYKAR--DPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNI 64
Query: 117 VCLLGVCLSGE-----PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAP-LSQQDFSH 170
V L+ VC + + ++FE V DL +L +V P L +
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEH-VDQDLRTYL-----------DKVPPPGLPAETIKD 112
Query: 171 IALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL 230
+ Q G+ +L ++ VHRDL N LV G VK++DFGL+R +Y+ + ++
Sbjct: 113 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR-IYS--CQMALTPVVV 169
Query: 231 PVRWMPPESILYGKFTTESDVWSYGVVLWEVY 262
+ + PE +L + T D+WS G + E++
Sbjct: 170 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 68/225 (30%), Positives = 98/225 (43%), Gaps = 44/225 (19%)
Query: 51 VIETKPRF--LQELGEGAFGKVYKGEVCTSE----GPSLVAIKTLKENANQKTASDFRRE 104
V E R+ LQ +G GAFG V C++ G ++ K +K + A RE
Sbjct: 5 VFEITNRYVDLQPVGMGAFGLV-----CSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRE 59
Query: 105 VDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLS 164
+ L+ LRH NI+ L + +S ++ DLH L SR PL
Sbjct: 60 LKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSR-------------PLE 106
Query: 165 QQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR------DVYA 218
+Q + Q+ G+ Y+ S VHRDL N L+ + +KI DFGL+R Y
Sbjct: 107 KQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYV 166
Query: 219 SD-YYRIQSKSLLPVRWMPPESIL-YGKFTTESDVWSYGVVLWEV 261
S YYR PE +L + K+ E D+WS G + E+
Sbjct: 167 STRYYR------------APEIMLTWQKYDVEVDIWSAGCIFAEM 199
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 61/230 (26%), Positives = 103/230 (44%), Gaps = 37/230 (16%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPNIV 117
++G G FGKVY V G L+A+K ++ ++ + KT + E+ ++ L+HPN+V
Sbjct: 5 GNKIGGGTFGKVYTA-VNLDTG-ELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
GV + E + + E+ G L E L G + + + LQ+
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEELLEH--------GRILDEHVIRV----YTLQLLE 110
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR---- 233
G+AYL SH VHRD+ N + +K+ DFG + ++++ +
Sbjct: 111 GLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAV--------KLKNNTTTMGEEVQS 162
Query: 234 ------WMPPESILYGKFTTE---SDVWSYGVVLWEVYSYGLQPYYGYSN 274
+M PE I GK +D+WS G V+ E+ + G +P+ N
Sbjct: 163 LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMAT-GKRPWSELDN 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVC 118
L++LGEG++ VYKG + LVA+K + + RE L+ L+H NIV
Sbjct: 10 LEKLGEGSYATVYKG--ISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVL 67
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
L + + E + +FE+M DL ++ M + P L + Q+ G
Sbjct: 68 LHDIIHTKETLTFVFEYM-HTDLAQY-MIQHP----------GGLHPYNVRLFMFQLLRG 115
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR-DVYASDYYRIQSKSLLPVRWMPP 237
+AY+ H +HRDL +N L+ +K++DFGL+R S Y + +L W P
Sbjct: 116 LAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTL----WYRP 171
Query: 238 ESILYG--KFTTESDVWSYGVVLWEVY 262
+L G +++ D+W G + E+
Sbjct: 172 PDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 67/223 (30%), Positives = 99/223 (44%), Gaps = 26/223 (11%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFR--REVDLMSELR-HP 114
++ELG+GA+G V + VAIK + N K R RE+ L+ R H
Sbjct: 4 LIKELGQGAYGIVCSARNAETSEEETVAIKKIT-NVFSKKILAKRALRELKLLRHFRGHK 62
Query: 115 NIVCLLG---VCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHI 171
NI CL V L+E ++ DLH+ + S Q PL+ F
Sbjct: 63 NITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRS---------GQ---PLTDAHFQSF 110
Query: 172 ALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQS--KSL 229
Q+ G+ Y+ S + +HRDL N LV +KI DFGL+R ++ +
Sbjct: 111 IYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARG-FSENPGENAGFMTEY 169
Query: 230 LPVRWM-PPESIL-YGKFTTESDVWSYGVVLWEVYSYGLQPYY 270
+ RW PE +L + +T DVWS G +L E+ G +P +
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL--LGRKPVF 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 3e-17
Identities = 49/204 (24%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVC 118
L+ +G+G+FG+V+KG + +VAIK + + D ++E+ ++S+ P +
Sbjct: 9 LERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 66
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
G L G + ++ E++ G + L + P + + + ++ G
Sbjct: 67 YYGSYLKGTKLWIIMEYLGGGSALDLLRA-------------GPFDEFQIATMLKEILKG 113
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR-WMPP 237
+ YL S +HRD+ A N L+ + VK++DFG++ + + +I+ + + WM P
Sbjct: 114 LDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT---QIKRNTFVGTPFWMAP 170
Query: 238 ESILYGKFTTESDVWSYGVVLWEV 261
E I + +++D+WS G+ E+
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 64/237 (27%), Positives = 118/237 (49%), Gaps = 18/237 (7%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVC 118
L +LGEG + V+KG +E +LVA+K ++ + REV L+ L+H NIV
Sbjct: 10 LDKLGEGTYATVFKGRSKLTE--NLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVT 67
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
L + + + ++FE++ DL ++L D G+ +S + Q+ G
Sbjct: 68 LHDIIHTERCLTLVFEYL-DSDLKQYL-------DNCGNL----MSMHNVKIFMFQLLRG 115
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPE 238
++Y +HRDL +N L+ + +K++DFGL+R S + S ++ + + PP+
Sbjct: 116 LSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPD 173
Query: 239 SIL-YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCP 294
+L +++T D+W G +L+E+ + G + G + +E + +I P E P
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMAT-GRPMFPGSTVKEELHLIFRLLGTPTEETWP 229
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 69/253 (27%), Positives = 121/253 (47%), Gaps = 36/253 (14%)
Query: 58 FLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPN 115
+ ++GEG +G+VYK + T E LVA+K ++ +N + RE+ ++ +L H N
Sbjct: 11 IIGQIGEGTYGQVYKARDKDTGE---LVALKKVRLDNEKEGFPITAIREIKILRQLNHRN 67
Query: 116 IVCLLGVCLSG----------EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQ 165
IV L + ++FE+M DL L S S+
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-----------LVHFSE 115
Query: 166 QDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQ 225
Q+ G+ Y +++HRD+ N L+ + +K++DFGL+R +Y S+ R
Sbjct: 116 DHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR-LYNSEESRPY 174
Query: 226 SKSLLPVRWMPPESILYG--KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEV--IEMI 281
+ ++ + + PPE +L G ++ DVWS G +L E+++ +P + +NQE+ +E+I
Sbjct: 175 TNKVITLWYRPPE-LLLGEERYGPAIDVWSCGCILGELFTK--KPIFQ-ANQELAQLELI 230
Query: 282 RSRQMLPCPEDCP 294
PCP P
Sbjct: 231 SRLCGSPCPAVWP 243
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 4e-17
Identities = 63/230 (27%), Positives = 111/230 (48%), Gaps = 35/230 (15%)
Query: 61 ELGEGAFGKVYKGEVCTSEGPS---LVAIKTLKENANQKTASDFRREVDLMSELRHPNIV 117
++GEG+ G VC + S VA+K + Q+ F EV +M + +HPNIV
Sbjct: 26 KIGEGS-----TGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN-EVVIMRDYQHPNIV 79
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
+ L G+ + ++ EF+ G L +DI ++++ + + L V
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGAL----------TDIV---THTRMNEEQIATVCLAVLK 126
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG----LSRDVYASDYYRIQSKSLLPV- 232
+++L + +HRD+ + + L+ VK+SDFG +S++V + KSL+
Sbjct: 127 ALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-------PRRKSLVGTP 179
Query: 233 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282
WM PE I + TE D+WS G+++ E+ G PY+ + ++ IR
Sbjct: 180 YWMAPEVISRLPYGTEVDIWSLGIMVIEMVD-GEPPYFNEPPLQAMKRIR 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 5e-17
Identities = 57/239 (23%), Positives = 113/239 (47%), Gaps = 26/239 (10%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVC 118
L+++G+G+FG+V+KG + +VAIK + + D ++E+ ++S+ P +
Sbjct: 9 LEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 66
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
G L + ++ E++ G + L PL + + I ++ G
Sbjct: 67 YYGSYLKDTKLWIIMEYLGGGSALDLLEP-------------GPLDETQIATILREILKG 113
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPE 238
+ YL S +HRD+ A N L+ + VK++DFG++ + + R + + WM PE
Sbjct: 114 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPE 171
Query: 239 SILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRM 297
I + +++D+WS G+ E+ + G P+ +V+ +I P++ PP +
Sbjct: 172 VIKQSAYDSKADIWSLGITAIEL-AKGEPPHSELHPMKVLFLI--------PKNNPPTL 221
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 8e-17
Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 39/215 (18%)
Query: 61 ELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLL 120
ELG+GAFGKVYK + E +L A K + E +++ D+ E+++++ HP IV LL
Sbjct: 19 ELGDGAFGKVYKAK--NKETGALAAAKVI-ETKSEEELEDYMVEIEILATCNHPYIVKLL 75
Query: 121 GVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMA 180
G + ++ EF G + ++ ++ L++ I Q+ +
Sbjct: 76 GAFYWDGKLWIMIEFCPGGAVDAIML-----------ELDRGLTEPQIQVICRQMLEALQ 124
Query: 181 YLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS---------RDVYASDYYRIQSKSLLP 231
YL S +HRDL A N L+ +K++DFG+S RD + Y
Sbjct: 125 YLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPY--------- 175
Query: 232 VRWMPPESILY-----GKFTTESDVWSYGVVLWEV 261
WM PE ++ + ++D+WS G+ L E+
Sbjct: 176 --WMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 8e-17
Identities = 60/263 (22%), Positives = 106/263 (40%), Gaps = 54/263 (20%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPNIV 117
L+ +G+G+FG V K V ++ K + N +K EV+++ EL+HPNIV
Sbjct: 5 LETIGKGSFGTVRK--VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 118 CLLG--VCLSGEPMCMLFEFMVRGDLHEFLM-SRSPRSDISGSQVQAPLSQQDFSHIALQ 174
+ S + + ++ E+ GDL + + + R I + L+Q +AL
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQ---LLLALY 119
Query: 175 VAAGMAYLCSHHY--------VHRDLAARNCLVGDGLTVKISDFGLSRDVYASD------ 220
C H +HRDL N + VK+ DFGL++ +
Sbjct: 120 E-------C--HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY 170
Query: 221 ----YYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 276
YY M PE + + + +SD+WS G +++E+ + P+ + +
Sbjct: 171 VGTPYY------------MSPEQLNHMSYDEKSDIWSLGCLIYELCA-LSPPFTARNQLQ 217
Query: 277 VIEMIRSRQMLPCPEDCPPRMYS 299
+ I+ + P YS
Sbjct: 218 LASKIKEGKFRRIPY-----RYS 235
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 9e-17
Identities = 63/250 (25%), Positives = 109/250 (43%), Gaps = 48/250 (19%)
Query: 59 LQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPNI 116
L+ +G+G+FG+VYK + T++ +VAIK + E A + D ++E+ +S+ R P I
Sbjct: 6 LECIGKGSFGEVYKAIDKRTNQ---VVAIKVIDLEEAEDEIE-DIQQEIQFLSQCRSPYI 61
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
G L G + ++ E+ G + L L + + I +V
Sbjct: 62 TKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG-------------KLDETYIAFILREVL 108
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS---------RDVYASDYYRIQSK 227
G+ YL +HRD+ A N L+ + VK++DFG+S R+ + +
Sbjct: 109 LGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPF----- 163
Query: 228 SLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287
WM PE I + ++D+WS G+ E+ G P V+ +I
Sbjct: 164 ------WMAPEVIKQSGYDEKADIWSLGITAIELAK-GEPPLSDLHPMRVLFLI------ 210
Query: 288 PCPEDCPPRM 297
P++ PP +
Sbjct: 211 --PKNNPPSL 218
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 58 FLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASDF---RREVDLMSELRH 113
+Q +G G +G VYK + T E L A+K +K + DF ++E+ ++ E +H
Sbjct: 13 LIQRVGSGTYGDVYKARNLHTGE---LAAVKIIK----LEPGDDFSLIQQEIFMVKECKH 65
Query: 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
NIV G LS E + + E+ G L + V PLS+ +++
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIY------------HVTGPLSELQIAYVCR 113
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV- 232
+ G+AYL S +HRD+ N L+ D VK++DFG++ + A+ R KS +
Sbjct: 114 ETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR---KSFIGTP 170
Query: 233 RWMPPESILY---GKFTTESDVWSYGVVLWEVYSYGLQP 268
WM PE G + D+W+ G+ E+ LQP
Sbjct: 171 YWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAE--LQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 25/208 (12%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTA--SDFRREVDLMSELRHPNI 116
L+E+G G+FG VY + +VAIK + + Q D +EV + +LRHPN
Sbjct: 20 LREIGHGSFGAVYFARDVRNS--EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 77
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
+ G L ++ E+ + + + P ++ + V +H ALQ
Sbjct: 78 IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---------THGALQ-- 126
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 236
G+AYL SH+ +HRD+ A N L+ + VK+ DFG + + ++ + + WM
Sbjct: 127 -GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF------VGTPYWMA 179
Query: 237 PESILY---GKFTTESDVWSYGVVLWEV 261
PE IL G++ + DVWS G+ E+
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 27/209 (12%)
Query: 59 LQELGEGAFGKVY-KGEVCTSEGPSLVAIKTLKENANQKTA--SDFRREVDLMSELRHPN 115
L+E+G G+FG VY +V T+E +VAIK + + Q D +EV + ++HPN
Sbjct: 30 LREIGHGSFGAVYFARDVRTNE---VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 116 IVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQV 175
+ G L ++ E+ + + + P ++ + + +H ALQ
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI---------THGALQ- 136
Query: 176 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM 235
G+AYL SH+ +HRD+ A N L+ + VK++DFG + ++ + + WM
Sbjct: 137 --GLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF------VGTPYWM 188
Query: 236 PPESILY---GKFTTESDVWSYGVVLWEV 261
PE IL G++ + DVWS G+ E+
Sbjct: 189 APEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTA--SDFRREVDLMSELRHPNI 116
L E+G G+FG VY + +VA+K + + Q D +EV + +L+HPN
Sbjct: 26 LHEIGHGSFGAVYFATNSHTN--EVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNT 83
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
+ G L ++ E+ + + + P ++ + + +H ALQ
Sbjct: 84 IEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI---------THGALQ-- 132
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 236
G+AYL SH+ +HRD+ A N L+ + VK++DFG + ++ + + WM
Sbjct: 133 -GLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF------VGTPYWMA 185
Query: 237 PESILY---GKFTTESDVWSYGVVLWEV 261
PE IL G++ + DVWS G+ E+
Sbjct: 186 PEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 29/208 (13%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLG 121
+G GA G VYK V L A+K + N RE++++ ++ HPN+V
Sbjct: 82 IGSGAGGTVYK--VIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 122 VCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAY 181
+ + +L EFM G L G+ + +Q + +A Q+ +G+AY
Sbjct: 140 MFDHNGEIQVLLEFMDGGSL-------------EGTHIA---DEQFLADVARQILSGIAY 183
Query: 182 LCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESI- 240
L H VHRD+ N L+ VKI+DFG+SR + A S S+ + +M PE I
Sbjct: 184 LHRRHIVHRDIKPSNLLINSAKNVKIADFGVSR-ILAQTMDPCNS-SVGTIAYMSPERIN 241
Query: 241 ------LYGKFTTESDVWSYGVVLWEVY 262
Y + D+WS GV + E Y
Sbjct: 242 TDLNHGAYDGYA--GDIWSLGVSILEFY 267
|
Length = 353 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 5e-16
Identities = 60/235 (25%), Positives = 101/235 (42%), Gaps = 36/235 (15%)
Query: 32 IKTLKENANQKTASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEG-PSLVAIKTLK 90
+ K+ A ++ + VI+T L G+ G+V+ V T G P V +K
Sbjct: 52 LIPTKQKA-REVVASLGYTVIKT-------LTPGSEGRVF---VATKPGQPDPVVLKI-- 98
Query: 91 ENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSP 150
QK + E L+ + HP+++ + +SG CM+ DL+ +L RS
Sbjct: 99 ---GQKGTTLI--EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRS- 151
Query: 151 RSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210
PL I Q+ G+ YL + +HRD+ N + D V I D
Sbjct: 152 ----------RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDL 201
Query: 211 GLSR-DVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY 264
G ++ V A + + V PE + K+ +++D+WS G+VL+E+ +Y
Sbjct: 202 GAAQFPVVAPAFLGLAGT----VETNAPEVLARDKYNSKADIWSAGIVLFEMLAY 252
|
Length = 357 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 7e-16
Identities = 61/232 (26%), Positives = 103/232 (44%), Gaps = 23/232 (9%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTL---KENANQKTASDFRREVDLMSELRH 113
L+ +G+GAFGKV V + + A+K + K + E ++ EL H
Sbjct: 3 ELLRVIGKGAFGKVCI--VQKRDTKKMFAMKYMNKQKCVEKGSVRN-VLNERRILQELNH 59
Query: 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
P +V L E M ++ + ++ GDL + +S+ + S QV+
Sbjct: 60 PFLVNLWYSFQDEENMYLVVDLLLGGDL-RYHLSQKVK--FSEEQVKF---------WIC 107
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR 233
++ + YL S +HRD+ N L+ + V I+DF ++ V S S P
Sbjct: 108 EIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPG- 164
Query: 234 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ 285
+M PE + ++ D WS GV +E G +PY G+S + + IR++Q
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECL-RGKRPYRGHSR-TIRDQIRAKQ 214
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 9e-16
Identities = 61/262 (23%), Positives = 115/262 (43%), Gaps = 41/262 (15%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTL-KENANQKTASDFRREVDLMSELRHPNIV 117
++ +G GA+G V + T G VAIK + A RE+ ++ +H NI+
Sbjct: 10 IENIGSGAYGVVCSA-IDTRSGKK-VAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNII 67
Query: 118 CLLGVCLS----GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
+ + + + ++ + M DLH + S P L+++ +
Sbjct: 68 AIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQP------------LTEEHIRYFLY 114
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD----YYRIQSKSL 229
Q+ G+ Y+ S + +HRDL N LV + ++I DFG++R + +S Y+ + +
Sbjct: 115 QLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 230 LPVRWMPPESIL-YGKFTTESDVWSYGVVLWEV-----------YSYGLQ---PYYGYSN 274
R PE +L ++TT D+WS G + E+ Y + L+ G +
Sbjct: 175 RWYR--APELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS 232
Query: 275 QEVIEMIRSRQMLPCPEDCPPR 296
+EV+ I S ++ ++ P +
Sbjct: 233 EEVLNRIGSDRVRKYIQNLPRK 254
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 26/224 (11%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR-HPN 115
+ L ++GEG F +V K + G AIK +K++ + RE+ + L HPN
Sbjct: 2 KILGKIGEGTFSEVLKAQ-SRKTG-KYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPN 59
Query: 116 IVCLLGVCLSGEPMC--MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
I+ L+ V + ++FE M +L+E + R + PL ++
Sbjct: 60 ILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGR-----------KRPLPEKRVKSYMY 107
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR 233
Q+ + ++ + HRD+ N L+ D +K++DFG R +Y+ Y + R
Sbjct: 108 QLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTE----YISTR 162
Query: 234 WM-PPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ 275
W PE +L G + + D+W+ G V +E+ S L P + +N+
Sbjct: 163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS--LFPLFPGTNE 204
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-15
Identities = 63/241 (26%), Positives = 113/241 (46%), Gaps = 29/241 (12%)
Query: 61 ELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLL 120
++GEG+ G V V +S LVA+K + Q+ F EV +M + +H N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSG--KLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHENVVEMY 83
Query: 121 GVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMA 180
L G+ + ++ EF+ G L + + ++++ + + L V ++
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTDIV-------------THTRMNEEQIAAVCLAVLKALS 130
Query: 181 YLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV-RWMPPES 239
L + +HRD+ + + L+ VK+SDFG V R KSL+ WM PE
Sbjct: 131 VLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPEL 187
Query: 240 ILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYS 299
I + E D+WS G+++ E+ G PY+ + ++MIR ++ PP++ +
Sbjct: 188 ISRLPYGPEVDIWSLGIMVIEMVD-GEPPYFNEPPLKAMKMIR--------DNLPPKLKN 238
Query: 300 L 300
L
Sbjct: 239 L 239
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 4e-15
Identities = 57/232 (24%), Positives = 101/232 (43%), Gaps = 26/232 (11%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA----NQKTASDFRREVDLMSELRHP 114
L+ + +GAFG VY + ++ AIK LK++ NQ T R + +M + P
Sbjct: 1 LKPISKGAFGSVYLAKKRSTG--DYFAIKVLKKSDMIAKNQVTNVKAERAI-MMIQGESP 57
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
+ L S + + ++ E++ GD + + L + +
Sbjct: 58 YVAKLYYSFQSKDYLYLVMEYLNGGDCASLI------------KTLGGLPEDWAKQYIAE 105
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 234
V G+ L +HRD+ N L+ +K++DFGLSR+ K + +
Sbjct: 106 VVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL------ENKKFVGTPDY 159
Query: 235 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286
+ PE+IL SD WS G V++E + +G P++ + V + I SR++
Sbjct: 160 LAPETILGVGDDKMSDWWSLGCVIFE-FLFGYPPFHAETPDAVFDNILSRRI 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 6e-15
Identities = 53/214 (24%), Positives = 100/214 (46%), Gaps = 15/214 (7%)
Query: 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLK--ENANQKTASDFRREVDLMSELRHPNIV 117
+++G G F +VY+ P VA+K ++ E + K D +E+DL+ +L HPN++
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKP--VALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVI 65
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
L + + ++ E GDL + + + + + ++ +Q+ +
Sbjct: 66 KYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRL--------IPERTVWKYFVQLCS 117
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 237
+ ++ S +HRD+ N + VK+ D GL R ++S S P +M P
Sbjct: 118 AVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPY-YMSP 175
Query: 238 ESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG 271
E I + +SD+WS G +L+E+ + P+YG
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQ-SPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 6e-15
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 56/214 (26%)
Query: 64 EGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASDFR----REVDLMSELRHPNIVC 118
EG +G VY+ + T E +VA+K LK +K F RE++++ +L+HPNIV
Sbjct: 15 EGTYGVVYRARDKKTGE---IVALKKLK---MEKEKEGFPITSLREINILLKLQHPNIVT 68
Query: 119 LLGVCLSGEPM---CMLFEFMVRGDLHEF--LMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
+ V + G + M+ E++ H+ LM + P Q + + L
Sbjct: 69 VKEVVV-GSNLDKIYMVMEYVE----HDLKSLMETMKQ----------PFLQSEVKCLML 113
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR------DVYASD----YYR 223
Q+ +G+A+L + +HRDL N L+ + +KI DFGL+R Y +YR
Sbjct: 114 QLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYR 173
Query: 224 IQSKSLLPVRWMPPESILYG--KFTTESDVWSYG 255
PE +L G +++T D+WS G
Sbjct: 174 ------------APE-LLLGAKEYSTAIDMWSVG 194
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 6e-15
Identities = 60/244 (24%), Positives = 106/244 (43%), Gaps = 38/244 (15%)
Query: 65 GAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRR---------EVDLMSELRHPN 115
GA+G+V+ + S G + AIK +K +D R E D++S+ + P
Sbjct: 4 GAYGRVFLAKK-KSTG-DIYAIKVIK-------KADMIRKNQVDQVLTERDILSQAQSPY 54
Query: 116 IVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQV 175
+V L + + ++ E++ GDL L + GS L + ++
Sbjct: 55 VVKLYYSFQGKKNLYLVMEYLPGGDLASLL-------ENVGS-----LDEDVARIYIAEI 102
Query: 176 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR-- 233
+ YL S+ +HRDL N L+ +K++DFGLS+ + R
Sbjct: 103 VLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV 162
Query: 234 ----WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289
++ PE IL + D WS G +L+E G+ P++G + +E+ + I + + +
Sbjct: 163 GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV-GIPPFHGETPEEIFQNILNGK-IEW 220
Query: 290 PEDC 293
PED
Sbjct: 221 PEDV 224
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 7e-15
Identities = 67/246 (27%), Positives = 121/246 (49%), Gaps = 20/246 (8%)
Query: 59 LQELGEGAFGKVY-KGEVCTSEGPSLVAIKTLKENANQKTASDFR--REVDLMSELRHPN 115
L+ LG+G+FGKV+ ++ + L A+K LK+ A K R E D+++E+ HP
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKK-ATLKVRDRVRTKMERDILAEVNHPF 59
Query: 116 IVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQV 175
IV L + + ++ +F+ GDL L + +++D ++
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK------------EVMFTEEDVKFYLAEL 107
Query: 176 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM 235
A + +L S ++RDL N L+ + +K++DFGLS++ + D+ + V +M
Sbjct: 108 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGTVEYM 165
Query: 236 PPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPP 295
PE + T +D WS+GV+++E+ + G P+ G +E + MI + L P+ P
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLT-GSLPFQGKDRKETMTMIL-KAKLGMPQFLSP 223
Query: 296 RMYSLM 301
SL+
Sbjct: 224 EAQSLL 229
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 7e-15
Identities = 77/261 (29%), Positives = 119/261 (45%), Gaps = 48/261 (18%)
Query: 47 FRREVIETKPRFLQE----LGEGAFGKVYKGEVCTSE---GPSLVAIKTLKENANQKTAS 99
R V + PR L E +GEG+ G VC + VA+K + Q+
Sbjct: 10 LRMVVDQGDPRSLLENYIKIGEGS-----TGIVCIAREKHSGRQVAVKMMDLRKQQRREL 64
Query: 100 DFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQV 159
F EV +M + +H N+V + L GE + +L EF+ G L + + SQ
Sbjct: 65 LFN-EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIV-----------SQT 112
Query: 160 QAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG----LSRD 215
+ L+++ + + V + YL S +HRD+ + + L+ VK+SDFG +S+D
Sbjct: 113 R--LNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD 170
Query: 216 VYASDYYRIQSKSLLPV-RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN 274
V + KSL+ WM PE I + TE D+WS G+++ E+ G PY +S+
Sbjct: 171 V-------PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVD-GEPPY--FSD 220
Query: 275 QEVIEMIRSRQMLPCPEDCPP 295
V M R R D PP
Sbjct: 221 SPVQAMKRLR-------DSPP 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 65/216 (30%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIK-TLKENANQKTASDFRREVDLMSELRH-PNI 116
L+++GEG +GKVYK + LVA+K T E + RE+ L+ L I
Sbjct: 6 LEKIGEGTYGKVYKARDKNTG--KLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI 63
Query: 117 VCLLGV----CLSGEPMCML-FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHI 171
V LL V +G+P L FE++ DL +F+ D +G PL +
Sbjct: 64 VRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-------DSNGRGPGRPLPAKTIKSF 115
Query: 172 ALQVAAGMAYLCSHHYVHRDLAARNCLVG-DGLTVKISDFGLSRDVYASDYYRIQSKS-- 228
Q+ G+A+ H +HRDL +N LV +KI+D GL R + I KS
Sbjct: 116 MYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA------FSIPVKSYT 169
Query: 229 --LLPVRWMPPESILYGK-FTTESDVWSYGVVLWEV 261
++ + + PE +L ++T D+WS G + E+
Sbjct: 170 HEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 60/215 (27%), Positives = 84/215 (39%), Gaps = 36/215 (16%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVC 118
L LGEGA G V K + A+KT+ + N RE+++ + P IV
Sbjct: 6 LSRLGEGAGGSVTK--CRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVK 63
Query: 119 LLGVCLSGEP----MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
G L + M E+ G L R G +V IA
Sbjct: 64 YYGAFLDESSSSIGIAM--EYCEGGSLDSIYKKVKKRGGRIGEKV--------LGKIAES 113
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS--------DYYRIQS 226
V G++YL S +HRD+ N L+ VK+ DFG+S ++ S +Y
Sbjct: 114 VLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFY---- 169
Query: 227 KSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEV 261
M PE I ++ SDVWS G+ L EV
Sbjct: 170 --------MAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 72/257 (28%), Positives = 125/257 (48%), Gaps = 44/257 (17%)
Query: 59 LQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPNI 116
++++GEG +G VYK + T+E +A+K ++ E ++ S RE+ L+ E++H NI
Sbjct: 7 VEKIGEGTYGVVYKARDRVTNE---TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V L V S + + ++FE++ DL + M SP + ++ L Q+
Sbjct: 64 VRLQDVVHSEKRLYLVFEYL-DLDLKKH-MDSSPDFAKNPRLIKTYL---------YQIL 112
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGL-TVKISDFGLSRDVYASDYYRIQSKSLLPVR-- 233
G+AY SH +HRDL +N L+ +K++DFGL+R +PVR
Sbjct: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG------------IPVRTF 160
Query: 234 -------WMPPESILYGK--FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR 284
W IL G ++T D+WS G + E+ + +P + + E+ E+ +
Sbjct: 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQ--KPLFP-GDSEIDELFKIF 217
Query: 285 QMLPCP-EDCPPRMYSL 300
++L P E+ P + SL
Sbjct: 218 RILGTPNEETWPGVTSL 234
|
Length = 294 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 28/213 (13%)
Query: 60 QELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASD-----FRREVDLMSELRH 113
Q+LG GAF Y+ +V T +L+A+K + N + + R+E+ LM+ L H
Sbjct: 6 QQLGTGAFSSCYQARDVKTG---TLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNH 62
Query: 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
P+I+ +LG + E+M G + L + +
Sbjct: 63 PHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK------------YGAFKEAVIINYTE 110
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFG----LSRDVYASDYYRIQSKS 228
Q+ G++YL + +HRD+ N L+ G ++I+DFG L+ + + Q +
Sbjct: 111 QLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEF--QGQL 168
Query: 229 LLPVRWMPPESILYGKFTTESDVWSYGVVLWEV 261
L + +M PE + ++ DVWS G V+ E+
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEM 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 38/214 (17%)
Query: 59 LQELGEGAFGKVYKGEVCTS-EGPSLVAIKTLKENANQKTASDFR-REVDLMSELRHPNI 116
L +GEG++G V K C E +VAIK E+ + K RE+ ++ +LRH N+
Sbjct: 6 LGLVGEGSYGMVMK---CKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENL 62
Query: 117 VCLLGVCLSGEPMCMLFEFM---VRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
V L+ V + + ++FEF+ V DL ++ L +
Sbjct: 63 VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---------------LDESRVRKYLF 107
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA-----SDYYRIQSKS 228
Q+ G+ + SH+ +HRD+ N LV VK+ DFG +R + A +DY
Sbjct: 108 QILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY------- 160
Query: 229 LLPVRWMPPESILYG--KFTTESDVWSYGVVLWE 260
+ RW +L G K+ D+W+ G ++ E
Sbjct: 161 -VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTE 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 3e-14
Identities = 66/250 (26%), Positives = 112/250 (44%), Gaps = 23/250 (9%)
Query: 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKE------NANQKTASDFRREVDLMSELRH 113
Q LG+G+FG VY V + + +K LKE N N+ ++ +E L+S+L H
Sbjct: 6 QRLGKGSFGTVYL--VKDKKAVAEERLKVLKEIPVGELNPNETVQAN--QEAQLLSKLDH 61
Query: 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
P IV L + C++ E+ DL L LS+ +
Sbjct: 62 PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELK--------HTGKTLSENQVCEWFI 113
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR 233
Q+ G+ Y+ +HRDL A+N + + L +KI DFG+SR + S + +
Sbjct: 114 QLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGS--CDLATTFTGTPY 170
Query: 234 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDC 293
+M PE++ + + ++SD+WS G +L+E+ + G + V+ I PE
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEMCCLA-HAFEGQNFLSVVLRIVEGPTPSLPE-T 228
Query: 294 PPRMYSLMME 303
R + +M+
Sbjct: 229 YSRQLNSIMQ 238
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-14
Identities = 76/241 (31%), Positives = 112/241 (46%), Gaps = 30/241 (12%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSL---VAIKTL-KENANQKTASDFRREVDLMSELRHP 114
L+ +G GA +G VC + L VAIK L + NQ A RE+ LM + H
Sbjct: 22 LKPIGSGA-----QGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQV-QAPLSQQDFSHIAL 173
NI+ LL V P L EF + E + D + QV Q L + S++
Sbjct: 77 NIISLLNVF---TPQKSLEEFQDVYLVMELM-------DANLCQVIQMELDHERMSYLLY 126
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR 233
Q+ G+ +L S +HRDL N +V T+KI DFGL+R S + + ++
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRY 183
Query: 234 WMPPESILYGKFTTESDVWSYGVVLWEVYSYG-LQPYYGYSNQ--EVIEMIRSRQMLPCP 290
+ PE IL + D+WS G ++ E+ + L P Y +Q +VIE + + PCP
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT----PCP 239
Query: 291 E 291
E
Sbjct: 240 E 240
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 4e-14
Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 29/220 (13%)
Query: 55 KPRFLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASDFR-REVDLMSELR 112
K +++G+GA G VY +V T + VAIK + N Q+ + E+ +M E +
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQE---VAIKQM--NLQQQPKKELIINEILVMRENK 74
Query: 113 HPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIA 172
HPNIV L L G+ + ++ E++ G L + + + + + + +
Sbjct: 75 HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-------------TETCMDEGQIAAVC 121
Query: 173 LQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV 232
+ + +L S+ +HRD+ + N L+G +VK++DFG + QSK V
Sbjct: 122 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-----QSKRSTMV 176
Query: 233 ---RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPY 269
WM PE + + + D+WS G++ E+ G PY
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-14
Identities = 76/241 (31%), Positives = 112/241 (46%), Gaps = 30/241 (12%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSL---VAIKTL-KENANQKTASDFRREVDLMSELRHP 114
L+ +G GA +G VC + L VAIK L + NQ A RE+ LM + H
Sbjct: 29 LKPIGSGA-----QGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQV-QAPLSQQDFSHIAL 173
NI+ LL V P L EF + E + D + QV Q L + S++
Sbjct: 84 NIIGLLNVF---TPQKSLEEFQDVYIVMELM-------DANLCQVIQMELDHERMSYLLY 133
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR 233
Q+ G+ +L S +HRDL N +V T+KI DFGL+R S + + ++
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRY 190
Query: 234 WMPPESILYGKFTTESDVWSYGVVLWEVYSYG-LQPYYGYSNQ--EVIEMIRSRQMLPCP 290
+ PE IL + D+WS G ++ E+ G L P + +Q +VIE + + PCP
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT----PCP 246
Query: 291 E 291
E
Sbjct: 247 E 247
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 4e-14
Identities = 58/226 (25%), Positives = 112/226 (49%), Gaps = 19/226 (8%)
Query: 59 LQELGEGAFGKVY--KGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
++++GEG+FGK+Y K + SE + I K +K AS ++EV L+++++HPNI
Sbjct: 5 IKKIGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEAS--KKEVILLAKMKHPNI 61
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V + ++ E+ GD LM R R Q S+ +Q++
Sbjct: 62 VTFFASFQENGRLFIVMEYCDGGD----LMKRINR------QRGVLFSEDQILSWFVQIS 111
Query: 177 AGMAYLCSHHYVHRDLAARNC-LVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM 235
G+ ++ +HRD+ ++N L +G+ K+ DFG++R + +D + + ++
Sbjct: 112 LGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSMELAYTCVGTPYYL 169
Query: 236 PPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281
PE + ++D+WS G VL+E+ + P+ G + +++ I
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLK-HPFEGNNLHQLVLKI 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 7e-14
Identities = 56/217 (25%), Positives = 88/217 (40%), Gaps = 35/217 (16%)
Query: 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKT-ASDFRREVDLMSELRH 113
+ + L +G GA+G+V ++ VAIK L A RE+ L+ + H
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFD--TKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDH 73
Query: 114 PNIVCLLGVCLSGEP------MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQD 167
N++ LL V + ++ M DL+ I Q LS
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNN----------IVKCQK---LSDDH 119
Query: 168 FSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR--DVYASDYYRIQ 225
+ Q+ G+ Y+ S +HRDL N V + +KI DFGL+R D + Y
Sbjct: 120 IQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGY---- 175
Query: 226 SKSLLPVRW-MPPESIL-YGKFTTESDVWSYGVVLWE 260
+ RW PE +L + + D+WS G ++ E
Sbjct: 176 ----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 208
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 9e-14
Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 59 LQELGEGAFGKVYKGEVCTS-EGPSLVAIKTLKENAN----QKTASDFRREVDLMSELRH 113
L ++GEG++G V+K C + E +VAIK E+ + +K A RE+ ++ +L+H
Sbjct: 6 LSKIGEGSYGVVFK---CRNRETGQIVAIKKFVESEDDPVIKKIA---LREIRMLKQLKH 59
Query: 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
PN+V L+ V + ++FE+ L+E + ++PR + + I
Sbjct: 60 PNLVNLIEVFRRKRKLHLVFEYCDHTVLNE--LEKNPRG----------VPEHLIKKIIW 107
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR-----DVYASDYYRIQSKS 228
Q + + H+ +HRD+ N L+ +K+ DFG +R +DY
Sbjct: 108 QTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY------- 160
Query: 229 LLPVRWMPPESILYG--KFTTESDVWSYGVVLWE 260
+ RW +L G ++ DVW+ G V E
Sbjct: 161 -VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAE 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 9e-14
Identities = 73/239 (30%), Positives = 106/239 (44%), Gaps = 64/239 (26%)
Query: 50 EVIETKPRFLQELGEGAFGKVYK------GEVCTSEGPSLVAIKTLKENANQKTASDFR- 102
+ I K LQ+LG+GA+G V+K EV VA+K K FR
Sbjct: 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEV--------VALK--------KIFDAFRN 46
Query: 103 --------REVDLMSELR-HPNIVCLLGV--CLSGEPMCMLFEFMVRGDLHEFLMSRSPR 151
RE+ + EL HPNIV LL V + + + ++FE+M DLH + R
Sbjct: 47 ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM-ETDLHAVI-----R 100
Query: 152 SDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211
++I L +I Q+ + Y+ S + +HRDL N L+ VK++DFG
Sbjct: 101 ANI--------LEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFG 152
Query: 212 LSRDVYASDYYRIQSKSLLPV-------RWM-PPESILYG--KFTTESDVWSYGVVLWE 260
L+R + + PV RW PE IL G ++T D+WS G +L E
Sbjct: 153 LARSLSELEENPEN-----PVLTDYVATRWYRAPE-ILLGSTRYTKGVDMWSVGCILGE 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 55/218 (25%), Positives = 104/218 (47%), Gaps = 17/218 (7%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK--ENANQKTASDFRREVDLMSELRHP 114
R +++G G F +VY+ C +G VA+K ++ + + K +D +E+DL+ +L HP
Sbjct: 5 RIEKKIGRGQFSEVYRA-TCLLDG-VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
N++ + + ++ E GDL + + + + ++ +Q
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL--------IPEKTVWKYFVQ 114
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 234
+ + + ++ S +HRD+ N + VK+ D GL R ++S S P +
Sbjct: 115 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPY-Y 172
Query: 235 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQ-PYYG 271
M PE I + +SD+WS G +L+E+ + LQ P+YG
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAA--LQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 63/226 (27%), Positives = 99/226 (43%), Gaps = 34/226 (15%)
Query: 84 VAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLL--GVCLSGEPMCMLFEFMVRG 139
VAIK L+ +A + + FRRE L + L HPNIV LL G G F V
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG------LLFAV-- 57
Query: 140 DLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHH--YVHRDLAARNC 197
E++ R+ R + L + + LQV +A C+H+ VHRDL +N
Sbjct: 58 --FEYVPGRTLREVL---AADGALPAGETGRLMLQVLDALA--CAHNQGIVHRDLKPQNI 110
Query: 198 LV---GDGLTVKISDFGLSR---DVYASDYYRI--QSKSLLPVRWMPPESILYGKFTTES 249
+V G K+ DFG+ V +D + ++ L + PE + T S
Sbjct: 111 MVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNS 170
Query: 250 DVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPP 295
D++++G++ E + G + G S E++ +Q+ P PP
Sbjct: 171 DLYAWGLIFLECLT-GQRVVQGASVAEILY----QQLSPVDVSLPP 211
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.8 bits (170), Expect = 3e-13
Identities = 55/215 (25%), Positives = 102/215 (47%), Gaps = 24/215 (11%)
Query: 57 RFLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASDFR-REVDLMSELRHP 114
RF +++G+GA G VY +V T + VAI+ + N Q+ + E+ +M E ++P
Sbjct: 24 RF-EKIGQGASGTVYTAMDVATGQE---VAIRQM--NLQQQPKKELIINEILVMRENKNP 77
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
NIV L L G+ + ++ E++ G L + + + + + + + +
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-------------TETCMDEGQIAAVCRE 124
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 234
+ +L S+ +HRD+ + N L+G +VK++DFG + R S + W
Sbjct: 125 CLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYW 182
Query: 235 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPY 269
M PE + + + D+WS G++ E+ G PY
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 61/264 (23%), Positives = 113/264 (42%), Gaps = 57/264 (21%)
Query: 58 FLQELGEGAFGKVYKGE-VCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPN 115
++ +G G +G+VYKG V T + L AIK + + + + + E++++ + H N
Sbjct: 20 LVEVVGNGTYGQVYKGRHVKTGQ---LAAIKVM--DVTEDEEEEIKLEINMLKKYSHHRN 74
Query: 116 IVCLLGVCLSGEP------MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFS 169
I G + P + ++ EF G + +D+ + L + +
Sbjct: 75 IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSV----------TDLVKNTKGNALKEDWIA 124
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS---------RDVYASD 220
+I ++ G+A+L +H +HRD+ +N L+ + VK+ DFG+S R+ +
Sbjct: 125 YICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGT 184
Query: 221 YYRIQSKSLLPVRWMPPESILY-----GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ 275
Y WM PE I + SD+WS G+ E+ + G P
Sbjct: 185 PY-----------WMAPEVIACDENPDATYDYRSDIWSLGITAIEM-AEGAPP------- 225
Query: 276 EVIEMIRSRQMLPCPEDCPPRMYS 299
+ +M R + P + PP++ S
Sbjct: 226 -LCDMHPMRALFLIPRNPPPKLKS 248
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-13
Identities = 61/240 (25%), Positives = 98/240 (40%), Gaps = 27/240 (11%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
++ + LG G G VYK + ++A+K + + + E++++ + P I
Sbjct: 4 QYQEILGHGNGGTVYKAYHLLTR--RILAVKVIPLDITVELQKQIMSELEILYKCDSPYI 61
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
+ G + + EFM G L D+ + + IA+ V
Sbjct: 62 IGFYGAFFVENRISICTEFMDGGSL-----------DVYRK-----IPEHVLGRIAVAVV 105
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 236
G+ YL S +HRD+ N LV VK+ DFG+S + S I + +M
Sbjct: 106 KGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMA 161
Query: 237 PESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC--PEDCP 294
PE I ++ SDVWS G+ E+ + G PY + M Q+L C ED P
Sbjct: 162 PERISGEQYGIHSDVWSLGISFMEL-ALGRFPYPQIQKNQGSLM--PLQLLQCIVDEDPP 218
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 4e-13
Identities = 58/248 (23%), Positives = 109/248 (43%), Gaps = 23/248 (9%)
Query: 60 QELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVC 118
+++G+GA G V+ +V T + VAIK + Q E+ +M EL++PNIV
Sbjct: 25 EKIGQGASGTVFTAIDVATGQE---VAIKQINLQ-KQPKKELIINEILVMKELKNPNIVN 80
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
L L G+ + ++ E++ G L + + + + + + + +
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSLTDVV-------------TETCMDEAQIAAVCRECLQA 127
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPE 238
+ +L ++ +HRD+ + N L+G +VK++DFG + R S + WM PE
Sbjct: 128 LEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPE 185
Query: 239 SILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM--LPCPEDCPPR 296
+ + + D+WS G++ E+ G PY + + +I + L PE P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVE-GEPPYLNENPLRALYLIATNGTPELQNPEKLSPI 244
Query: 297 MYSLMMEC 304
+ C
Sbjct: 245 FRDFLNRC 252
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 62/233 (26%), Positives = 110/233 (47%), Gaps = 38/233 (16%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-----NQKTASDFRREVDLMSELRHPNI 116
LG+G+FGKV+ E+ + AIK LK++ + + +R + L E HP +
Sbjct: 3 LGKGSFGKVFLAELKGTN--QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE--HPFL 58
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDL-------HEFLMSRSPRSDISGSQVQAPLSQQDFS 169
L + E + + E++ GDL H+F + R+ +
Sbjct: 59 THLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRA-------------------T 99
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 229
A ++ G+ +L S V+RDL N L+ +KI+DFG+ ++ D + +
Sbjct: 100 FYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTFCG 158
Query: 230 LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282
P ++ PE +L K+ T D WS+GV+L+E+ G P++G+ +E+ + IR
Sbjct: 159 TP-DYIAPEILLGQKYNTSVDWWSFGVLLYEML-IGQSPFHGHDEEELFQSIR 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 4e-13
Identities = 55/215 (25%), Positives = 102/215 (47%), Gaps = 24/215 (11%)
Query: 57 RFLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASDFR-REVDLMSELRHP 114
RF +++G+GA G VY ++ T + VAIK + N Q+ + E+ +M E ++P
Sbjct: 23 RF-EKIGQGASGTVYTAIDIATGQE---VAIKQM--NLQQQPKKELIINEILVMRENKNP 76
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
NIV L L G+ + ++ E++ G L + + + + + + + +
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-------------TETCMDEGQIAAVCRE 123
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 234
+ +L S+ +HRD+ + N L+G +VK++DFG + R S + W
Sbjct: 124 CLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYW 181
Query: 235 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPY 269
M PE + + + D+WS G++ E+ G PY
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 5e-13
Identities = 61/244 (25%), Positives = 108/244 (44%), Gaps = 35/244 (14%)
Query: 61 ELGEGAFGKVYKGEVCTS---EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIV 117
++GEG+ G VC + VA+K + Q+ F EV +M + H N+V
Sbjct: 29 KIGEGS-----TGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN-EVVIMRDYHHENVV 82
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
+ L G+ + ++ EF+ G L + + ++++ + + L V
Sbjct: 83 DMYNSYLVGDELWVVMEFLEGGALTDIV-------------THTRMNEEQIATVCLSVLR 129
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV-RWMP 236
++YL + +HRD+ + + L+ +K+SDFG V R KSL+ WM
Sbjct: 130 ALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR---KSLVGTPYWMA 186
Query: 237 PESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPR 296
PE I + TE D+WS G+++ E+ G PY+ + + IR ++ PPR
Sbjct: 187 PEVISRLPYGTEVDIWSLGIMVIEMID-GEPPYFNEPPLQAMRRIR--------DNLPPR 237
Query: 297 MYSL 300
+
Sbjct: 238 VKDS 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 6e-13
Identities = 64/230 (27%), Positives = 100/230 (43%), Gaps = 24/230 (10%)
Query: 46 DFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREV 105
++ E E R + LG+G +G VY +++ +AIK + E + + E+
Sbjct: 2 EYEYEYDENGERVV--LGKGTYGIVYAARDLSTQ--VRIAIKEIPER-DSRYVQPLHEEI 56
Query: 106 DLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSR-SPRSDISGSQVQAPLS 164
L S L+H NIV LG + E + G L L S+ P D +
Sbjct: 57 ALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKD----------N 106
Query: 165 QQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVG--DGLTVKISDFGLSRDVYASDYY 222
+Q Q+ G+ YL + VHRD+ N LV G+ VKISDFG S+ + +
Sbjct: 107 EQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGV-VKISDFGTSKRLAGINPC 165
Query: 223 RIQSKSLLPVRWMPPESILYGK--FTTESDVWSYGVVLWEVYSYGLQPYY 270
L ++M PE I G + +D+WS G + E+ + G P+
Sbjct: 166 TETFTGTL--QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMAT-GKPPFI 212
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 68/251 (27%), Positives = 113/251 (45%), Gaps = 50/251 (19%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGP-SLVAIKTLKENA--NQKTASDFRREVDLMSELRHP 114
++ +G GAFG+V+ + + + A+K L+++ + + R E D++++ P
Sbjct: 5 VIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSP 61
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
IV L E + ++ E+M GDL L+ R D+ P F +IA
Sbjct: 62 WIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLI----RKDV------FPEETARF-YIAEL 110
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVG-DGLTVKISDFGLS---RDVYASDYYRIQSKSLL 230
V A + + ++HRD+ N L+ DG +K++DFGL +YY S +LL
Sbjct: 111 VLA-LDSVHKLGFIHRDIKPDNILIDADG-HIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 231 ---------------PVR---------WMPPESILYGK-FTTESDVWSYGVVLWEVYSYG 265
VR ++ PE +L G + E D WS GV+L+E+ YG
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILYEML-YG 226
Query: 266 LQPYYGYSNQE 276
P+Y + QE
Sbjct: 227 FPPFYSDTLQE 237
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 57/252 (22%), Positives = 112/252 (44%), Gaps = 22/252 (8%)
Query: 62 LGEGAFGK--VYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPNIVC 118
LG+GAFG+ +Y+ +E SLV K + ++K D E+ ++S L+HPNI+
Sbjct: 8 LGKGAFGEATLYR----RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIA 63
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
+ + + E+ G L++ ++ Q ++ Q+ +
Sbjct: 64 YYNHFMDDNTLLIEMEYANGGTLYDKIVR----------QKGQLFEEEMVLWYLFQIVSA 113
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPE 238
++Y+ +HRD+ N + +K+ DFG+S+ + S+Y ++ P +M PE
Sbjct: 114 VSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISK-ILGSEYSMAETVVGTPY-YMSPE 171
Query: 239 SILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ-EVIEMIRSRQMLPCPEDCPPRM 297
K+ +SD+W+ G VL+E+ + L+ + +N ++ I P +
Sbjct: 172 LCQGVKYNFKSDIWALGCVLYELLT--LKRTFDATNPLNLVVKIVQGNYTPVVSVYSSEL 229
Query: 298 YSLMMECWHEVP 309
SL+ + P
Sbjct: 230 ISLVHSLLQQDP 241
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 59/227 (25%), Positives = 107/227 (47%), Gaps = 25/227 (11%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIK--TLKENANQKTASDFRREV-DLMSE----- 110
L+ LG GAFG VYK + G +L+A+K + A K + + + D++SE
Sbjct: 5 LEHLGSGAFGCVYKVRK-KNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIK 63
Query: 111 --LRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDF 168
LRHPNIV L + + ++ + + L E S + + +++
Sbjct: 64 EQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHF--------NSLKEKKQRFTEERI 115
Query: 169 SHIALQVAAGMAYLCSHHY-VHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSK 227
+I +Q+ + YL VHRDL N ++G+ V I+DFGL++
Sbjct: 116 WNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVG 175
Query: 228 SLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN 274
++L + PE + + ++DVW++G +L+++ + LQP + +N
Sbjct: 176 TIL---YSCPEIVKNEPYGEKADVWAFGCILYQMCT--LQPPFYSTN 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 43/110 (39%), Positives = 64/110 (58%), Gaps = 14/110 (12%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR---DVYASDYYRIQSKSLL- 365
V G+AYL S +HRDL A N LV KISDFG+S+ D+Y +D Q+ S+
Sbjct: 117 VLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDND----QNMSMQG 172
Query: 366 PVRWMPPESI-LYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
V WM PE I Y + ++ + D+WS G V+ E+++ G +P +S++E
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFA-GRRP---WSDEEAI 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 63/224 (28%), Positives = 103/224 (45%), Gaps = 38/224 (16%)
Query: 52 IETKPRFLQELGEGAFGKVYKGEVCT---SEGPSLVAIKTLKENA--NQKTASDFRREVD 106
++TK ++ +G GA+G V C+ SE VAIK + NA N+ A RE+
Sbjct: 3 VDTKYVPIKPIGRGAYGIV-----CSAKNSETNEKVAIKKIA-NAFDNRIDAKRTLREIK 56
Query: 107 LMSELRHPNIVCLLGVCLSGEPMCM--------LFEFMVRGDLHEFLMSRSPRSDISGSQ 158
L+ L H N++ + + P ++E M DLH+ + RS +
Sbjct: 57 LLRHLDHENVIAIKDIM---PPPHREAFNDVYIVYELM-DTDLHQII--RSSQ------- 103
Query: 159 VQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA 218
LS + Q+ G+ Y+ S + +HRDL N L+ +KI DFGL+R
Sbjct: 104 ---TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART--T 158
Query: 219 SDYYRIQSKSLLPVRWMPPESIL-YGKFTTESDVWSYGVVLWEV 261
S+ ++ ++ + PE +L ++TT DVWS G + E+
Sbjct: 159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAEL 202
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 23/219 (10%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIV 117
L ELG+G +G VYK V +A+K ++ ++ + E+D++ + P IV
Sbjct: 5 VLDELGKGNYGSVYK--VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIV 62
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
G + M E+M G L + +G + + I V
Sbjct: 63 DFYGAFFIEGAVYMCMEYMDAGSLDKLY---------AGGVATEGIPEDVLRRITYAVVK 113
Query: 178 GMAYLC-SHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 236
G+ +L H+ +HRD+ N LV VK+ DFG+S ++ AS + ++ +M
Sbjct: 114 GLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS----LAKTNIGCQSYMA 169
Query: 237 PESILYG------KFTTESDVWSYGVVLWEVYSYGLQPY 269
PE I G +T +SDVWS G+ + E+ + G PY
Sbjct: 170 PERIKSGGPNQNPTYTVQSDVWSLGLSILEM-ALGRYPY 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 32/213 (15%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIV 117
++ +GEG +GKVYK + LVAIK + +++ + + E +++ + HPNI
Sbjct: 11 VEVIGEGTYGKVYKAR--HKKTGQLVAIKIMDIIEDEEE--EIKEEYNILRKYSNHPNIA 66
Query: 118 CLLGVCLSGEPMC------MLFEFMVRG---DLHEFLMSRSPRSDISGSQVQAPLSQQDF 168
G + P ++ E G DL + L + R L ++
Sbjct: 67 TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKR-----------LKEEWI 115
Query: 169 SHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKS 228
++I + G+AYL + +HRD+ +N L+ VK+ DFG+S + S R +
Sbjct: 116 AYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL-DSTLGRRNTFI 174
Query: 229 LLPVRWMPPESILYGK-----FTTESDVWSYGV 256
P WM PE I + + SDVWS G+
Sbjct: 175 GTPY-WMAPEVIACDEQPDASYDARSDVWSLGI 206
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 59/235 (25%), Positives = 101/235 (42%), Gaps = 40/235 (17%)
Query: 47 FRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIK-TLKENANQKTASDFRREV 105
F EV +K L ++G+G FG+V+K +VA+K L EN + RE+
Sbjct: 7 FCDEV--SKYEKLAKIGQGTFGEVFKAR-HKKTK-QIVALKKVLMENEKEGFPITALREI 62
Query: 106 DLMSELRHPNIVCLLGVCLSGEPMC--------MLFEFMVRGDLHEFLMSRSPRSDISGS 157
++ L+H N+V L+ +C + ++FEF DL L S
Sbjct: 63 KILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL-----------S 110
Query: 158 QVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVY 217
+ + + + G+ Y+ + +HRD+ A N L+ +K++DFGL+R
Sbjct: 111 NKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR--- 167
Query: 218 ASDYYRIQSKSLLPVR----WM-PPESIL----YGKFTTESDVWSYGVVLWEVYS 263
A + + R W PPE +L YG D+W G ++ E+++
Sbjct: 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGP---PIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 33/214 (15%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFR--REVDLMSELRHPNIVCL 119
+G GAFG V+ V VA+K + N Q S R RE+ ++ +H N++
Sbjct: 8 IGYGAFGVVW--SVTDPRDGKRVALKKMP-NVFQNLVSCKRVFRELKMLCFFKHDNVLSA 64
Query: 120 LGVCLSGEPMC-----MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL- 173
L + ++ E M + DLH+ ++S P S H+ +
Sbjct: 65 LDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQPLSS---------------DHVKVF 108
Query: 174 --QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 231
Q+ G+ YL S +HRD+ N LV +KI DFGL+R V D + ++ ++
Sbjct: 109 LYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVT 167
Query: 232 VRWMPPESILYG--KFTTESDVWSYGVVLWEVYS 263
+ PE IL G +T+ D+WS G + E+
Sbjct: 168 QYYRAPE-ILMGSRHYTSAVDIWSVGCIFAELLG 200
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 6e-12
Identities = 33/134 (24%), Positives = 62/134 (46%), Gaps = 21/134 (15%)
Query: 281 IRSRQMLPCP-------EDCPPRMYSLMMECWHEVPVA----------AGMAYLCSHHYV 323
++ + P E P + ++ + +P A G+AY+ ++ +
Sbjct: 62 VKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIM 121
Query: 324 HRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG--KFT 381
HRDL N L+ +KI+DFGL+R +++ + R+ S + + PE +LYG K+
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLAR-LFSEEEPRLYSHQVATRWYRAPE-LLYGARKYD 179
Query: 382 TESDVWSYGVVLWE 395
D+W+ G + E
Sbjct: 180 PGVDLWAVGCIFAE 193
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 33/230 (14%)
Query: 47 FRREVIET------KPRFLQELGEGAFGKVYKGEVCTS---EGPSLVAIKTL-KENANQK 96
+R+EV +T + R L+++G GA+G V C++ + VAIK L + ++
Sbjct: 2 YRQEVNKTIWEVPDRYRDLKQVGSGAYGTV-----CSALDRRTGAKVAIKKLYRPFQSEL 56
Query: 97 TASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEF-LMSRSPRSDIS 155
A RE+ L+ ++H N++ LL V + H+F L+ +D+
Sbjct: 57 FAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL---------DRFHDFYLVMPFMGTDLG 107
Query: 156 GSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRD 215
LS+ + Q+ G+ Y+ + +HRDL N V + +KI DFGL+R
Sbjct: 108 KLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167
Query: 216 VYASDYYRIQSKSLLPVRWM-PPESIL-YGKFTTESDVWSYGVVLWEVYS 263
+ + + RW PE IL + +T D+WS G ++ E+ +
Sbjct: 168 TDS------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 28/216 (12%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK---ENANQKTASDFRREVDLMSELRH 113
+ + +G+G++G V + T G VAIK + E+ + A+ RE+ L+ LRH
Sbjct: 3 KIQEVIGKGSYGVVCSA-IDTHTG-EKVAIKKINDVFEHVSD--ATRILREIKLLRLLRH 58
Query: 114 PNIVCLLGVCLSGEP-----MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDF 168
P+IV + + L + ++FE M DLH+ I + P Q F
Sbjct: 59 PDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQV---------IKANDDLTPEHHQFF 108
Query: 169 SHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKS 228
+ Q+ + Y+ + + HRDL +N L +KI DFGL+R + I
Sbjct: 109 LY---QLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 165
Query: 229 LLPVRWM-PPE--SILYGKFTTESDVWSYGVVLWEV 261
+ RW PE + K+T D+WS G + EV
Sbjct: 166 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 201
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 50/212 (23%), Positives = 84/212 (39%), Gaps = 24/212 (11%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCL 119
LG G FG+V V A+K +K+ E +++ E HP IV L
Sbjct: 1 LGVGGFGRVEL--VKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL 58
Query: 120 LGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGM 179
+ + ML E+ + G+L L R + V
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGELWTILRDR------------GLFDEYTARFYIACVVLAF 106
Query: 180 AYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL--PVRWMPP 237
YL + ++RDL N L+ VK+ DFG ++ + + ++ + P ++ P
Sbjct: 107 EYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS----GQKTWTFCGTP-EYVAP 161
Query: 238 ESILYGKFTTESDVWSYGVVLWEVYSYGLQPY 269
E IL + D WS G++L+E+ + G P+
Sbjct: 162 EIILNKGYDFSVDYWSLGILLYELLT-GRPPF 192
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 2e-11
Identities = 58/255 (22%), Positives = 116/255 (45%), Gaps = 39/255 (15%)
Query: 58 FLQELGEGAFGKVYKGE-VCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPN 115
++ +G G +G+VYKG V T + L AIK + +++ + ++E++++ + H N
Sbjct: 10 LVELVGNGTYGQVYKGRHVKTGQ---LAAIKVMDVTGDEE--EEIKQEINMLKKYSHHRN 64
Query: 116 IVCLLGVCLSGEP------MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFS 169
I G + P + ++ EF G + + + + + L ++ +
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT----------LKEEWIA 114
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 229
+I ++ G+++L H +HRD+ +N L+ + VK+ DFG+S + + R + +
Sbjct: 115 YICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFI 172
Query: 230 LPVRWMPPESILY-----GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR 284
WM PE I + +SD+WS G+ E+ + G P + +M R
Sbjct: 173 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM-AEGAPP--------LCDMHPMR 223
Query: 285 QMLPCPEDCPPRMYS 299
+ P + PR+ S
Sbjct: 224 ALFLIPRNPAPRLKS 238
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 57/224 (25%), Positives = 97/224 (43%), Gaps = 32/224 (14%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRH--PN 115
L E+G G G+VYK + ++A+K ++ N++ ++D++ H P
Sbjct: 19 NLGEIGSGTCGQVYKMRFKKTG--HVMAVKQMRRTGNKEENKRILMDLDVVL-KSHDCPY 75
Query: 116 IVCLLGVCLSGEP---MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIA 172
IV G + +CM E M + L+ R +Q P+ + +
Sbjct: 76 IVKCYG-YFITDSDVFICM--ELM--STCLDKLLKR----------IQGPIPEDILGKMT 120
Query: 173 LQVAAGMAYLCSHHYV-HRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 231
+ + + YL H V HRD+ N L+ VK+ DFG+S + S + +++S
Sbjct: 121 VAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS---KAKTRSAGC 177
Query: 232 VRWMPPESI----LYGKFTTESDVWSYGVVLWEVYSYGLQPYYG 271
+M PE I K+ +DVWS G+ L E+ + G PY
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELAT-GQFPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 3e-11
Identities = 29/84 (34%), Positives = 44/84 (52%), Gaps = 5/84 (5%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR-WMP 371
G+ YL S+ +HRD+ A N L+ VK+ DFGLS + SD +++ WM
Sbjct: 110 GLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SD--TKARNTMVGTPYWMA 165
Query: 372 PESILYGKFTTESDVWSYGVVLWE 395
PE I + ++D+WS G+ E
Sbjct: 166 PEVINGKPYDYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 61/241 (25%), Positives = 91/241 (37%), Gaps = 69/241 (28%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVD-LMSELRHPNIV 117
L E+G GAFG V K + +++A+K ++ ++K ++D +M P IV
Sbjct: 9 LGEIGRGAFGTVNK--MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIV 66
Query: 118 CLLG------VCLSGEPMCMLFEFMVRGDL---------HEFLMSRSPRSDISGSQVQAP 162
G C +CM E M D+ +E L S P
Sbjct: 67 KFYGALFREGDCW----ICM--ELM---DISLDKFYKYVYEVLKSVIP------------ 105
Query: 163 LSQQDFSHIALQVAAGMAYL-CSHHYVHRDLAARNCLVGDGLTVKISDFGLS-------- 213
++ IA+ + YL +HRD+ N L+ +K+ DFG+S
Sbjct: 106 --EEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163
Query: 214 --RDVYASDYYRIQSKSLLPVRWMPPESIL---YGKFTTESDVWSYGVVLWEVYSYGLQP 268
RD Y M PE I + SDVWS G+ L+EV + G P
Sbjct: 164 KTRDAGCRPY-------------MAPERIDPSARDGYDVRSDVWSLGITLYEV-ATGKFP 209
Query: 269 Y 269
Y
Sbjct: 210 Y 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-11
Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 27/209 (12%)
Query: 62 LGEGAFGKVYKGEVCTSEGPS-LVAIKTLK-ENANQKTASDFRREVDLMSELRHPNIVCL 119
+G GAFG V+ +C + LV IK + E + + E ++ L HPNI+
Sbjct: 8 VGRGAFGIVH---LCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEY 64
Query: 120 LGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGM 179
L + + ++ E+ G L E++ R + L + H +Q+ +
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRC----------NSLLDEDTILHFFVQILLAL 114
Query: 180 AYLCSHHYVHRDLAARNCLVGDGLTV-KISDFGLSRDVYASDYYRIQSKSLLPV---RWM 235
++ + +HRDL +N L+ V KI DFG+S+ + + +SK+ V ++
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS------KSKAYTVVGTPCYI 168
Query: 236 PPESILYGK-FTTESDVWSYGVVLWEVYS 263
PE + GK + +SD+W+ G VL+E+ S
Sbjct: 169 SPE-LCEGKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 71/246 (28%), Positives = 97/246 (39%), Gaps = 64/246 (26%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSL---VAIKTLKEN-ANQKTASDFRREVDLMSELRHP 114
L+ +G GA +G VC + VAIK L N A RE+ LM + H
Sbjct: 21 LKPIGSGA-----QGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEF--LMSRSPRSDISGSQV-QAPLSQQDFSHI 171
NI+ LL V P L EF D++ LM D + QV Q L + S++
Sbjct: 76 NIIGLLNVF---TPQKSLEEFQ---DVYLVMELM------DANLCQVIQMDLDHERMSYL 123
Query: 172 ALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR---------DVYASDYY 222
Q+ G+ +L S +HRDL N +V T+KI DFGL+R + YY
Sbjct: 124 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 183
Query: 223 RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282
R PE IL + D+WS G ++ EMIR
Sbjct: 184 R------------APEVILGMGYKENVDIWSVGCIMG-------------------EMIR 212
Query: 283 SRQMLP 288
+ P
Sbjct: 213 GTVLFP 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 61/259 (23%), Positives = 113/259 (43%), Gaps = 41/259 (15%)
Query: 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMS 109
E+IET +G+G +GKV+K V + S A+K L + + E +++
Sbjct: 21 EIIET-------IGKGTYGKVFK--VLNKKNGSKAAVKIL--DPIHDIDEEIEAEYNILK 69
Query: 110 ELR-HPNIVCLLGV-----CLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPL 163
L HPN+V G+ +G+ + ++ E G + + + R G +++ P+
Sbjct: 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR----GERMEEPI 125
Query: 164 SQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYR 223
++I + G+ +L + +HRD+ N L+ VK+ DFG+S + ++ R
Sbjct: 126 ----IAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 181
Query: 224 IQSKSLLPVRWMPPESI-----LYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVI 278
+ S+ WM PE I L + DVWS G+ E+ G + +
Sbjct: 182 --NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL---------GDGDPPLA 230
Query: 279 EMIRSRQMLPCPEDCPPRM 297
++ R + P + PP +
Sbjct: 231 DLHPMRALFKIPRNPPPTL 249
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 72/240 (30%), Positives = 101/240 (42%), Gaps = 43/240 (17%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVD-LMSE----- 110
R L LG G FGKV E + L AIK LK K R EV+ LM E
Sbjct: 2 RCLAVLGRGHFGKVLLAEYKKTGE--LYAIKALK-----KGDIIARDEVESLMCEKRIFE 54
Query: 111 ----LRHPNIVCLLGVCLSGEPMCMLFEFMVRGDL----HEFLMSRSPRSDISGSQVQAP 162
RHP +V L + + +C + E+ GDL H + S PR+
Sbjct: 55 TANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSE-PRAVF-------- 105
Query: 163 LSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR-DVYASDY 221
A V G+ YL + V+RDL N L+ VKI+DFGL + + D
Sbjct: 106 --------YAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD- 156
Query: 222 YRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281
R + P ++ PE + +T D W GV+++E+ G P+ G +EV + I
Sbjct: 157 -RTSTFCGTP-EFLAPEVLTETSYTRAVDWWGLGVLIYEML-VGESPFPGDDEEEVFDSI 213
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 8e-11
Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSL---VAIKTL-KENANQKTASDFRREVDLMSELRHP 114
L+ +G GA +G VC + L VA+K L + NQ A RE+ L+ + H
Sbjct: 26 LKPIGSGA-----QGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 80
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQV-QAPLSQQDFSHIAL 173
NI+ LL V P L EF + E + D + QV L + S++
Sbjct: 81 NIISLLNVF---TPQKSLEEFQDVYLVMELM-------DANLCQVIHMELDHERMSYLLY 130
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR 233
Q+ G+ +L S +HRDL N +V T+KI DFGL+R A + + + ++
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--ACTNF-MMTPYVVTRY 187
Query: 234 WMPPESILYGKFTTESDVWSYGVVLWEV 261
+ PE IL + D+WS G ++ E+
Sbjct: 188 YRAPEVILGMGYKENVDIWSVGCIMGEL 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 9e-11
Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 56 PRF--LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRH 113
PR+ L +GEGA+G V + VAIK + +Q RE+ ++ +H
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTG--VKVAIKKISPFEHQTFCQRTLREIKILRRFKH 62
Query: 114 PNIVCLLGVC--LSGEPMCMLF---EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDF 168
NI+ +L + S E ++ E M DL++ + ++ LS
Sbjct: 63 ENIIGILDIIRPPSFESFNDVYIVQELM-ETDLYKLIKTQ-------------HLSNDHI 108
Query: 169 SHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR-DVYASDYYRIQSK 227
+ Q+ G+ Y+ S + +HRDL N L+ +KI DFGL+R D+ ++
Sbjct: 109 QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTE 168
Query: 228 SLLPVRWM-PPESILYGK-FTTESDVWSYGVVLWEVYS 263
+ RW PE +L K +T D+WS G +L E+ S
Sbjct: 169 -YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 37/117 (31%), Positives = 57/117 (48%), Gaps = 20/117 (17%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV---RW 369
G+ +L SH VHRDL +N LV VKI+DFGL+R +Y+ + +L V W
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLAR-IYSFEM------ALTSVVVTLW 171
Query: 370 M-PPESILYGKFTTESDVWSYGVVLWEVYSYGLQP-YYGYSNQE------EFLKTPP 418
PE +L + T D+WS G + E++ +P + G S + + + P
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAELFR--RRPLFRGTSEADQLDKIFDVIGLPS 226
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 12/97 (12%)
Query: 312 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSK--------- 362
G+ YL +H +HRD+ A N L+ + +KI+DFGL+R Y +
Sbjct: 126 EGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR-PYDGPPPNPKGGGGGGTRKYT 184
Query: 363 SLLPVRWM-PPESILYGK-FTTESDVWSYGVVLWEVY 397
+L+ RW PPE +L + +TT D+W G V E++
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF 221
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 62 LGEGAFGKVYKGEVC--TSEGPSLVAIKTLKENANQKTA---SDFRREVDLMSELRHPNI 116
LG+GAFG+VY +C G L A + + + +T+ S E+ L+ L+H I
Sbjct: 10 LGQGAFGRVY---LCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 117 VCLLGVCLS--GEPMCMLF-EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
V G CL E +F E+M G + + L + L++
Sbjct: 67 VQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL------------KAYGALTESVTRKYTR 113
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR--DVYASDYYRIQSKSLLP 231
Q+ GM+YL S+ VHRD+ N L VK+ DFG S+ I+S + P
Sbjct: 114 QILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTP 173
Query: 232 VRWMPPESILYGKFTTESDVWSYGVVLWEVYS 263
WM PE I + ++DVWS G + E+ +
Sbjct: 174 Y-WMSPEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 64/249 (25%), Positives = 113/249 (45%), Gaps = 23/249 (9%)
Query: 61 ELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLL 120
++G G +G VYK + + A+K ++ +A RE+ L+ EL+HPN++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC---REIALLRELKHPNVIALQ 64
Query: 121 GVCL--SGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
V L S + +LF++ H R+ +++ +Q P S + Q+ G
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN--KKPMQLPRSM--VKSLLYQILDG 120
Query: 179 MAYLCSHHYVHRDLAARNCLV-GDGLT---VKISDFGLSRDVYASDYYRIQSKSLLPVRW 234
+ YL ++ +HRDL N LV G+G VKI+D G +R + ++ W
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 235 MPPESILYG--KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPED 292
+L G +T D+W+ G + E+ + +P + + QE I+ P D
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTS--EPIF-HCRQEDIKTSN-----PFHHD 232
Query: 293 CPPRMYSLM 301
R++S+M
Sbjct: 233 QLDRIFSVM 241
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (150), Expect = 2e-10
Identities = 30/89 (33%), Positives = 45/89 (50%), Gaps = 13/89 (14%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV---RW 369
G+AY SH +HRDL +N L+ +K++DFGL+R + I ++ W
Sbjct: 110 GLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLAR------AFGIPLRTYTHEVVTLW 163
Query: 370 M-PPESILYG--KFTTESDVWSYGVVLWE 395
PE IL G ++T D+WS G + E
Sbjct: 164 YRAPE-ILLGSKHYSTAVDIWSVGCIFAE 191
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 5/96 (5%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA---SDYYRIQSKSLL-PVR 368
G+ YL + +HRD+ N LV + +KISDFG+S+ + A S SL V
Sbjct: 118 GLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPY 404
WM PE + +T ++D+WS G ++ E+ + G P+
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLT-GKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 37/116 (31%), Positives = 58/116 (50%), Gaps = 12/116 (10%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR---- 368
G+ YL S+ +HRD+ A N L+G+ +VKI+DFG+S + D K
Sbjct: 114 GLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLA--DGGDRTRKVRKTFVGTPC 171
Query: 369 WMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLKT----PPS 419
WM PE + + ++D+WS+G+ E+ + G PY Y + + T PPS
Sbjct: 172 WMAPEVMEQVHGYDFKADIWSFGITAIEL-ATGAAPYSKYPPMKVLMLTLQNDPPS 226
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 66/263 (25%), Positives = 110/263 (41%), Gaps = 49/263 (18%)
Query: 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVD--- 106
E+IET +G+G +GKVYK V + SL A+K L SD E++
Sbjct: 25 EIIET-------IGKGTYGKVYK--VTNKKDGSLAAVKILD------PISDVDEEIEAEY 69
Query: 107 --LMSELRHPNIVCLLGVC-----LSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQV 159
L S HPN+V G+ L G + ++ E G + E + G ++
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC----GQRL 125
Query: 160 QAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS 219
+ S+I G+ +L ++ +HRD+ N L+ VK+ DFG+S + ++
Sbjct: 126 DEAM----ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181
Query: 220 DYYRIQSKSLLPVRWMPPESILYGK-----FTTESDVWSYGVVLWEVYSYGLQPYYGYSN 274
R + S+ WM PE I + + DVWS G+ E+ G +
Sbjct: 182 RLRR--NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL---------GDGD 230
Query: 275 QEVIEMIRSRQMLPCPEDCPPRM 297
+ +M + + P + PP +
Sbjct: 231 PPLFDMHPVKTLFKIPRNPPPTL 253
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 57/247 (23%), Positives = 108/247 (43%), Gaps = 19/247 (7%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIV 117
F++ +G+G++G+V ++G V K NA+++ +E L+S+L+HPNIV
Sbjct: 4 FVRVVGKGSYGEVSLVR-HRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV 62
Query: 118 CLLGVCLSGEPMCMLF---EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
+ +L+ F GDL+ L Q L + +Q
Sbjct: 63 AYRESWEGED--GLLYIVMGFCEGGDLYHKLKE----------QKGKLLPENQVVEWFVQ 110
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 234
+A + YL H +HRDL +N + +K+ D G++R + + + S + +
Sbjct: 111 IAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLIGTPYY 168
Query: 235 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCP 294
M PE + +SDVW+ G ++E+ + + ++ I ++ P P+D
Sbjct: 169 MSPELFSNKPYNYKSDVWALGCCVYEMATLK-HAFNAKDMNSLVYRIIEGKLPPMPKDYS 227
Query: 295 PRMYSLM 301
P + L+
Sbjct: 228 PELGELI 234
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 15/211 (7%)
Query: 61 ELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLL 120
++G G +G VYK + + A+K ++ +A RE+ L+ EL+HPN++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC---REIALLRELKHPNVISLQ 64
Query: 121 GVCLS--GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
V LS + +LF++ H R+ +++ VQ P + Q+ G
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN--KKPVQLPRGM--VKSLLYQILDG 120
Query: 179 MAYLCSHHYVHRDLAARNCLV-GDGLT---VKISDFGLSRDVYASDYYRIQSKSLLPVRW 234
+ YL ++ +HRDL N LV G+G VKI+D G +R + ++ W
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 235 MPPESILYG--KFTTESDVWSYGVVLWEVYS 263
+L G +T D+W+ G + E+ +
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 50/245 (20%), Positives = 104/245 (42%), Gaps = 28/245 (11%)
Query: 70 VYKGEVCTSEGPSLVAIKTLKE-NANQKTASD-FRREVDLMSELRHPNIVCLLG----VC 123
+YKG V I+T K+ + K D E+ + + NI+ + G +
Sbjct: 36 IYKGIF----NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV 91
Query: 124 LSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLC 183
+ ++ E+ RG L E L + LS + +A+ G+ L
Sbjct: 92 DDLPRLSLILEYCTRGYLREVLDK------------EKDLSFKTKLDMAIDCCKGLYNLY 139
Query: 184 SHHYV-HRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY 242
+ +++L + + LV + +KI GL + + + + + + + + ++
Sbjct: 140 KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKML---NDIF 196
Query: 243 GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEM-IRSRQMLPCPEDCPPRMYSLM 301
++T + D++S GVVLWE+++ G P+ + +E+ ++ I L P DCP + ++
Sbjct: 197 SEYTIKDDIYSLGVVLWEIFT-GKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIV 255
Query: 302 MECWH 306
C
Sbjct: 256 EACTS 260
|
Length = 283 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 33/105 (31%), Positives = 53/105 (50%), Gaps = 21/105 (20%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVG-DGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR--- 368
G+ YL S + +HRD+ + N L+ DG +VK++DFG +A+ + +SK R
Sbjct: 128 GLEYLHSQNVIHRDIKSDNILLSKDG-SVKLADFG-----FAAQLTKEKSK-----RNSV 176
Query: 369 -----WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS 408
WM PE I + + D+WS G++ E+ + G PY
Sbjct: 177 VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEM-AEGEPPYLREP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 58/235 (24%), Positives = 107/235 (45%), Gaps = 36/235 (15%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVD-LMSELR------- 112
LG+G+FGKV E+ ++ L A+K LK++ Q +V+ M+E R
Sbjct: 3 LGKGSFGKVLLAELKGTD--ELYAVKVLKKDVILQ------DDDVECTMTEKRVLALAGK 54
Query: 113 HPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIA 172
HP + L + + + + E++ GDL F + RS R + F A
Sbjct: 55 HPFLTQLHSCFQTKDRLFFVMEYVNGGDLM-FHIQRSGR---------FDEPRARF--YA 102
Query: 173 LQVAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 231
++ G+ +L ++RDL N L+ +G +KI+DFG+ ++ + + +
Sbjct: 103 AEIVLGLQFLHERGIIYRDLKLDNVLLDSEG-HIKIADFGMCKE---GILGGVTTSTFCG 158
Query: 232 V-RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ 285
++ PE + Y + D W+ GV+L+E+ + G P+ G E+ + I +
Sbjct: 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLA-GQSPFEGDDEDELFQSILEDE 212
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (148), Expect = 3e-10
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 29/209 (13%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGP-SLVAIKTLKEN--ANQKTASDFRREVDLMSELRHP 114
F++ LG G+FG+V + +G A+K L + K E ++ +RHP
Sbjct: 5 FIKTLGTGSFGRVM---LVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHP 61
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
+V L G + ++ E++ G+L L +S R ++ A Q
Sbjct: 62 FLVNLYGSFQDDSNLYLVMEYVPGGELFSHL-RKSGRFPEPVARFYAA-----------Q 109
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 234
V + YL S V+RDL N L+ +KI+DFG ++ V R + P +
Sbjct: 110 VVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV----KGRTYTLCGTP-EY 164
Query: 235 MPPESIL---YGKFTTESDVWSYGVVLWE 260
+ PE IL YGK D W+ G++++E
Sbjct: 165 LAPEIILSKGYGK---AVDWWALGILIYE 190
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 65/263 (24%), Positives = 111/263 (42%), Gaps = 50/263 (19%)
Query: 59 LQELGEGAFGKVY------KGEVCTSEGPSLVAIKTLKENANQKTASDFRREV----DLM 108
L ++G+G +G+V+ GE+ A+K +K++ K + R V D++
Sbjct: 6 LTQVGQGGYGQVFLAKKKDTGEIV--------ALKRMKKSLLFKL--NEVRHVLTERDIL 55
Query: 109 SELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLM-SRSPRSDISGSQVQAPLSQQD 167
+ + +V LL E + + E++ GD L D
Sbjct: 56 TTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED-----------HAR 104
Query: 168 FSHIALQVAAGMAYLCSHH---YVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRI 224
F ++A A + + H Y+HRDL N L+ +K++DFGLS+ + +
Sbjct: 105 F-YMAEMFEA----VDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV 159
Query: 225 QSKSLLPVRWMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS 283
S +M PE +L GK + D WS G +L+E G P+ G + E E ++
Sbjct: 160 GSPD-----YMAPE-VLRGKGYDFTVDYWSLGCMLYEFLC-GFPPFSGSTPNETWENLKY 212
Query: 284 -RQMLPCPEDCPPRMYSLMMECW 305
++ L P PR ++L E W
Sbjct: 213 WKETLQRPVYDDPR-FNLSDEAW 234
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 29/213 (13%)
Query: 62 LGEGAFGKVYKGEVC--TSEGPSLVAIKTLKENANQKTASDFRR---EVDLMSELRHPNI 116
LG GAFG+VY +C G L + + +Q+T+ + E+ L+ LRH I
Sbjct: 10 LGRGAFGEVY---LCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 117 VCLLGVCL---SGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
V G CL + + + E+M G + + L + L++
Sbjct: 67 VQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL------------KAYGALTENVTRRYTR 113
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR---DVYASDYYRIQSKSLL 230
Q+ G++YL S+ VHRD+ N L VK+ DFG S+ + S I+S +
Sbjct: 114 QILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSG-TGIKSVTGT 172
Query: 231 PVRWMPPESILYGKFTTESDVWSYGVVLWEVYS 263
P WM PE I + ++DVWS + E+ +
Sbjct: 173 PY-WMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 51/220 (23%), Positives = 93/220 (42%), Gaps = 18/220 (8%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLG 121
+G G FG+V+ SE + + + E K E ++ E+ HP I+ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 122 VCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAY 181
+ ML E++ G+L +L + S+ +G A ++ + Y
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGL------------FYASEIVCALEY 116
Query: 182 LCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL 241
L S V+RDL N L+ +K++DFG ++ + D R + P ++ PE I
Sbjct: 117 LHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL--RD--RTWTLCGTP-EYLAPEVIQ 171
Query: 242 YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281
D W+ G++++E+ G P++ + + E I
Sbjct: 172 SKGHNKAVDWWALGILIYEMLV-GYPPFFDDNPFGIYEKI 210
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 3/93 (3%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 372
G+AYL +HRD+ A N L VK++DFG++ +D + + + WM P
Sbjct: 111 GLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAP 168
Query: 373 ESILYGKFTTESDVWSYGVVLWEVYSYGLQPYY 405
E I +T SD+WS G + E+ + G PYY
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLT-GNPPYY 200
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 61/246 (24%), Positives = 104/246 (42%), Gaps = 33/246 (13%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPS--LVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
+ ELG G G V+K S PS ++A K + + RE+ ++ E P I
Sbjct: 10 ISELGAGNGGVVFK----VSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V G S + + E M G L + L + + +Q +++ V
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVL------------KKAGRIPEQILGKVSIAVI 113
Query: 177 AGMAYLCSHHYV-HRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR-W 234
G+ YL H + HRD+ N LV +K+ DFG+S + S + S + R +
Sbjct: 114 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSY 168
Query: 235 MPPESILYGKFTTESDVWSYGVVLWE--VYSYGLQPYYGYSNQEVIEMIRSRQML--PCP 290
M PE + ++ +SD+WS G+ L E + Y + P + + +E++ + P
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP----PDAKELELMFGCPVEGDPAE 224
Query: 291 EDCPPR 296
+ PR
Sbjct: 225 SETSPR 230
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 4e-10
Identities = 60/220 (27%), Positives = 93/220 (42%), Gaps = 27/220 (12%)
Query: 54 TKPRFLQELGEGAFGKVYKGEVC--TSEGPSLVAIKTLKENANQ----KTASDFRREVDL 107
T R + LG+GAFG+VY +C G L A+K ++ + K + E+ L
Sbjct: 2 TNWRLGKLLGQGAFGRVY---LCYDADTGREL-AVKQVQFDPESPETSKEVNALECEIQL 57
Query: 108 MSELRHPNIVCLLGVCLSGEP---MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLS 164
+ L H IV G CL + + E M G + + L S L+
Sbjct: 58 LKNLLHERIVQYYG-CLRDPMERTLSIFMEHMPGGSIKDQLKS------------YGALT 104
Query: 165 QQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRI 224
+ Q+ G++YL S+ VHRD+ N L VK+ DFG S+ +
Sbjct: 105 ENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGT 164
Query: 225 QSKSLLPV-RWMPPESILYGKFTTESDVWSYGVVLWEVYS 263
KS+ WM PE I + ++D+WS G + E+ +
Sbjct: 165 GMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 25/218 (11%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPN 115
F++ LG G+FG+V + P VAIK +++ QK E +++ + HP
Sbjct: 34 FIRTLGTGSFGRVILATYKNEDFPP-VAIKRFEKSKIIKQKQVDHVFSERKILNYINHPF 92
Query: 116 IVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPR--SDISGSQVQAPLSQQDFSHIAL 173
V L G + ++ EF++ G+ FL R+ R +D+ A
Sbjct: 93 CVNLYGSFKDESYLYLVLEFVIGGEFFTFL-RRNKRFPNDVG-------------CFYAA 138
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR 233
Q+ YL S + V+RDL N L+ +K++DFG ++ V Y +
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTP-----E 193
Query: 234 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG 271
++ PE +L +D W+ G+ ++E+ G P+Y
Sbjct: 194 YIAPEILLNVGHGKAADWWTLGIFIYEIL-VGCPPFYA 230
|
Length = 340 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 6e-10
Identities = 62/262 (23%), Positives = 109/262 (41%), Gaps = 36/262 (13%)
Query: 60 QELGEGAFGKVYKG---------EVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSE 110
+ LG G ++Y G + S + I + + +++ + F +M +
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60
Query: 111 LRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSH 170
+ H +IV L GVC+ M+ EF+ G L F+ +S L+
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS-----------DVLTTPWKFK 109
Query: 171 IALQVAAGMAYLCSHHYVHRDLAARNCLVG-DGLT------VKISDFGLSRDVYASDYYR 223
+A Q+A+ ++YL VH ++ +N L+ +G+ +K+SD G+ V + R
Sbjct: 110 VAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS----R 165
Query: 224 IQSKSLLPVRWMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282
+ +P W+ PE + K + +D WS+G LWE+ G P + E
Sbjct: 166 QECVERIP--WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYE 223
Query: 283 SRQMLPCPEDCPPRMYSLMMEC 304
+ ML P C + LM C
Sbjct: 224 GQCMLVTP-SC-KELADLMTHC 243
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 9e-10
Identities = 47/208 (22%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVC 118
L+ +GEG+FG+ V A+K ++ + D R+E L+++++HPNIV
Sbjct: 5 LRVVGEGSFGRALL--VQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVA 62
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
+ + ++ E+ GDL + + + + + +Q+ G
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKL----------FPEDTILQWFVQMCLG 112
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV-----YASDYYRIQSKSLLPVR 233
+ ++ +HRD+ ++N + VK+ DFG +R + YA Y
Sbjct: 113 VQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPY------- 165
Query: 234 WMPPESILYGKFTTESDVWSYGVVLWEV 261
++PPE + +SD+WS G +L+E+
Sbjct: 166 YVPPEIWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 1e-09
Identities = 31/99 (31%), Positives = 50/99 (50%), Gaps = 26/99 (26%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR---DVYASDY--------YRIQS 361
G+ YL S+ +HRD+ N L+ + +K++DFGL+R ++DY YR
Sbjct: 112 GLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYR--- 168
Query: 362 KSLLPVRWMPPESILYG--KFTTESDVWSYGVVLWEVYS 398
PPE +L G ++ E D+WS G +L E++
Sbjct: 169 ---------PPE-LLLGATRYGPEVDMWSVGCILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 7/96 (7%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL--PVRWM 370
G+ YL S+ +HRD+ A N L+ + K++DFG+S +D + +++ P WM
Sbjct: 111 GLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQ--LTDTMA-KRNTVIGTPF-WM 166
Query: 371 PPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG 406
PE I + ++D+WS G+ E+ + G PY
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEM-AEGKPPYSD 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 308 VPVAAGMAYLCS-HHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 366
V V G+ YL + H +HRD+ N LV +K+ DFG+S ++ S I +
Sbjct: 110 VAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----IADTFVGT 165
Query: 367 VRWMPPESILYGKFTTESDVWSYGVVLWEV 396
+M PE I GK+T +SDVWS G+ + E+
Sbjct: 166 STYMSPERIQGGKYTVKSDVWSLGISIIEL 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 47/214 (21%), Positives = 92/214 (42%), Gaps = 35/214 (16%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPNIV 117
++++GEG+FGK V + E IK + + K + R+EV ++S ++HPNIV
Sbjct: 5 VKKIGEGSFGKAIL--VKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIV 62
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
+ ++ ++ GDL++ + +Q + +Q+
Sbjct: 63 QYQESFEENGNLYIVMDYCEGGDLYKKI----------NAQRGVLFPEDQILDWFVQICL 112
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG----------LSRDVYASDYYRIQSK 227
+ ++ +HRD+ ++N + T+K+ DFG L+R + YY
Sbjct: 113 ALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYY----- 167
Query: 228 SLLPVRWMPPESILYGKFTTESDVWSYGVVLWEV 261
+ PE + +SD+W+ G VL+E+
Sbjct: 168 -------LSPEICENRPYNNKSDIWALGCVLYEM 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 25/225 (11%)
Query: 62 LGEGAFGKVYKGEVCTSEGPS--LVAIKTLKEN---ANQKTASDFRREVDLMSELRHPNI 116
LG+G FGKV + E S A+K LK+ A + A E ++ RHP +
Sbjct: 3 LGKGTFGKV----ILVREKASGKYYAMKILKKEVIIAKDEVAHTLT-ESRVLKNTRHPFL 57
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
L + + +C + E++ G+L F +SR + S+ ++
Sbjct: 58 TSLKYSFQTKDRLCFVMEYVNGGELF-FHLSR-----------ERVFSEDRTRFYGAEIV 105
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 236
+ + YL S V+RDL N ++ +KI+DFGL ++ +D +++ P ++
Sbjct: 106 SALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKE-GITDAATMKTFCGTP-EYLA 163
Query: 237 PESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281
PE + + D W GVV++E+ G P+Y ++++ E+I
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 28/86 (32%), Positives = 46/86 (53%), Gaps = 7/86 (8%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM-P 371
G+ YL S+ +HRDL N L+ +K++DFGL+R + S ++ + + RW
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARS-FGSPNRKMTHQVV--TRWYRA 170
Query: 372 PESILYG--KFTTESDVWSYGVVLWE 395
PE +L+G + D+WS G + E
Sbjct: 171 PE-LLFGARHYGVGVDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 30/86 (34%), Positives = 50/86 (58%), Gaps = 5/86 (5%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM-P 371
G+ +L SH VHRDL +N LV +K++DFGL+R +Y+ +++ S++ W
Sbjct: 122 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYS---FQMALTSVVVTLWYRA 177
Query: 372 PESILYGKFTTESDVWSYGVVLWEVY 397
PE +L + T D+WS G + E++
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 2e-09
Identities = 30/97 (30%), Positives = 42/97 (43%), Gaps = 26/97 (26%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD-------------YYRI 359
G+ YL S + +HRDL N LV +KI DFGL+R V + +YR
Sbjct: 115 GLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR- 173
Query: 360 QSKSLLPVRWMPPESIL-YGKFTTESDVWSYGVVLWE 395
PE +L ++T D+WS G + E
Sbjct: 174 -----------APELLLSSSRYTKAIDIWSVGCIFAE 199
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 39/101 (38%), Positives = 52/101 (51%), Gaps = 16/101 (15%)
Query: 306 HEVPVAA-------GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYR 358
EV +AA G+AYL SH +HRD+ A N L+ + TVK++DFG AS
Sbjct: 113 QEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFG-----SASLVSP 167
Query: 359 IQSKSLLPVRWMPPESILY---GKFTTESDVWSYGVVLWEV 396
S P WM PE IL G++ + DVWS G+ E+
Sbjct: 168 ANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 59/247 (23%), Positives = 111/247 (44%), Gaps = 25/247 (10%)
Query: 62 LGEGAFGKVY---KGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVC 118
+G G FG+VY K + + K +K + A + R + L+S P IVC
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
+ + + +C + + M GDLH L SQ S+++ A ++ G
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHL-----------SQ-HGVFSEKEMRFYATEIILG 109
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR-WMPP 237
+ ++ + V+RDL N L+ + V+ISD GL A D+ + + + + +M P
Sbjct: 110 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL-----ACDFSKKKPHASVGTHGYMAP 164
Query: 238 ESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML--PCPEDCP 294
E + G + + +D +S G +L+++ G P+ + ++ E+ R + P+
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEIDRMTLTVNVELPDSFS 223
Query: 295 PRMYSLM 301
P + SL+
Sbjct: 224 PELKSLL 230
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 53/203 (26%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 62 LGEGAFGKVYKGEVCT-SEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCL 119
+GEGA+G V K C E +VAIK K++ N++ RE+ ++ L+ NIV L
Sbjct: 9 VGEGAYGVVLK---CRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 120 LGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGM 179
+ ++FE++ + L L+ P ++ S+I Q+ +
Sbjct: 66 KEAFRRRGKLYLVFEYVEKNMLE--LLEEMP---------NGVPPEKVRSYI-YQLIKAI 113
Query: 180 AYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM-PPE 238
+ + VHRD+ N L+ +K+ DFG +R++ S+ + RW PE
Sbjct: 114 HWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNL--SEGSNANYTEYVATRWYRSPE 171
Query: 239 SILYGKFTTESDVWSYGVVLWEV 261
+L + D+WS G +L E+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 25/207 (12%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPS--LVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
+ ELG G G V K PS ++A K + + RE+ ++ E P I
Sbjct: 10 ISELGAGNGGVVTK----VQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V G S + + E M G L + L + + ++ +++ V
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVL------------KEAKRIPEEILGKVSIAVL 113
Query: 177 AGMAYLCSHHYV-HRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR-W 234
G+AYL H + HRD+ N LV +K+ DFG+S + S + S + R +
Sbjct: 114 RGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSY 168
Query: 235 MPPESILYGKFTTESDVWSYGVVLWEV 261
M PE + ++ +SD+WS G+ L E+
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 26/209 (12%)
Query: 59 LQELGEGAFGKVYKGEVCTS---EGPSLVAIKTL-KENANQKTASDFRREVDLMSELRHP 114
L+++G GA+G VC++ VAIK L + ++ A RE+ L+ ++H
Sbjct: 20 LKQVGSGAYG-----SVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
N++ LL V S +F +L+ ++D+ + PLS+ ++ Q
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDF--------YLVMPYMQTDLQ-KIMGHPLSEDKVQYLVYQ 125
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 234
+ G+ Y+ S +HRDL N V + +KI DFGL+R A + + RW
Sbjct: 126 MLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA------EMTGYVVTRW 179
Query: 235 M-PPESIL-YGKFTTESDVWSYGVVLWEV 261
PE IL + + D+WS G ++ E+
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEM 208
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 58/247 (23%), Positives = 109/247 (44%), Gaps = 25/247 (10%)
Query: 62 LGEGAFGKVY---KGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVC 118
+G G FG+VY K + + K +K + A + R + L+S P IVC
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
+ + + + + + M GDLH L SQ S+ + A ++ G
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHL-----------SQ-HGVFSEAEMRFYAAEIILG 109
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR-WMPP 237
+ ++ + V+RDL N L+ + V+ISD GL A D+ + + + + +M P
Sbjct: 110 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL-----ACDFSKKKPHASVGTHGYMAP 164
Query: 238 ESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS--RQMLPCPEDCP 294
E + G + + +D +S G +L+++ G P+ + ++ E+ R + P+
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 223
Query: 295 PRMYSLM 301
P + SL+
Sbjct: 224 PELRSLL 230
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 26/227 (11%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-----NQKTASDFRREVDLMSELRHPNI 116
LG+G+FGKV E+ +G A+K LK++ + + +R + L E +P +
Sbjct: 3 LGKGSFGKVLLAEL-KGKG-EYFAVKALKKDVVLIDDDVECTMVEKRVLALAWE--NPFL 58
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
L + E + + EF+ GDL F + R D+ + + A ++
Sbjct: 59 THLYCTFQTKEHLFFVMEFLNGGDLM-FHIQDKGRFDLYRA-----------TFYAAEIV 106
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRD-VYASDYYRIQSKSLLPVRWM 235
G+ +L S ++RDL N ++ +KI+DFG+ ++ V+ + R + P ++
Sbjct: 107 CGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RASTFCGTP-DYI 163
Query: 236 PPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282
PE + K+T D WS+GV+L+E+ G P++G E+ E IR
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEML-IGQSPFHGDDEDELFESIR 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 4e-09
Identities = 29/100 (29%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 316 YLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR---WMPP 372
YL S ++RDL N L+ +K++DFGL++++ S+ R + ++ P
Sbjct: 108 YLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELS-SEGSRTNT----FCGTPEYLAP 162
Query: 373 ESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEE 412
E +L + D WS GV+L+E+ G P+Y +++E
Sbjct: 163 EVLLGKGYGKAVDWWSLGVLLYEML-TGKPPFYA-EDRKE 200
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 4e-09
Identities = 28/123 (22%), Positives = 51/123 (41%), Gaps = 23/123 (18%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD----------------- 355
+ YL S +HRDL N L+ + +KI+DFG ++ + +
Sbjct: 114 ALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 356 YYRIQSKSLLPV---RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEE 412
R + S V ++ PE + SD+W+ G +++++ G P+ G +
Sbjct: 174 KNRRRFASF--VGTAEYVSPELLNEKPAGKSSDLWALGCIIYQML-TGKPPFRGSNEYLT 230
Query: 413 FLK 415
F K
Sbjct: 231 FQK 233
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 55/246 (22%), Positives = 98/246 (39%), Gaps = 25/246 (10%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTL--KENANQKTASDFRREVDLMSELRHPNIVCL 119
LG+G FG+V +V + + A K L K +K E ++ ++ IV L
Sbjct: 1 LGKGGFGEVCACQVKATG--KMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL 58
Query: 120 LGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAP-LSQQDFSHIALQVAAG 178
+ + +C++ M GDL + V P + A Q+ G
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHI-----------YNVGEPGFPEARAIFYAAQIICG 107
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPE 238
+ +L V+RDL N L+ D V+ISD GL+ ++ +I+ ++ P +M PE
Sbjct: 108 LEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVEL--KGGKKIKGRAGTP-GYMAPE 164
Query: 239 SILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY----SNQEVIEMIRSRQMLPCPEDCP 294
+ + D ++ G L+E+ + G P+ +E+ + P+
Sbjct: 165 VLQGEVYDFSVDWFALGCTLYEMIA-GRSPFRQRKEKVEKEELKRRTLE-MAVEYPDKFS 222
Query: 295 PRMYSL 300
P L
Sbjct: 223 PEAKDL 228
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 5e-09
Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 28/229 (12%)
Query: 84 VAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHE 143
V +K L + +++ A F LMS++ H ++ + GVC+ G M+ EF+ G L
Sbjct: 47 VVLKVL-DPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDV 105
Query: 144 FLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCL----- 198
L R ++ +A Q+A+ ++YL + VH ++ A+N L
Sbjct: 106 CLRKEKGRVPVAWKIT-----------VAQQLASALSYLEDKNLVHGNVCAKNILLARLG 154
Query: 199 VGDGLT--VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYG 255
+ +G + +K+SD G+S + R + +P W+ PE + G +T +D WS+G
Sbjct: 155 LAEGTSPFIKLSDPGVSFTALS----REERVERIP--WIAPECVPGGNSLSTAADKWSFG 208
Query: 256 VVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMEC 304
L E+ G P + E + LP P C + +L+ +C
Sbjct: 209 TTLLEICFDGEVPLKERTPSEKERFYEKKHRLPEPS-C-KELATLISQC 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 72/261 (27%), Positives = 113/261 (43%), Gaps = 51/261 (19%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPS---LVAIKTLKENA---NQKTASDFRREVDLMSEL 111
L+ LG GA+GKV+ V G L A+K L++ A KT R E +++ +
Sbjct: 4 LLKVLGTGAYGKVFL--VRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 112 RH-PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQD-FS 169
R P +V L + F LH L +SG ++ L Q+D FS
Sbjct: 62 RQSPFLVTLH------------YAFQTEAKLHLIL------DYVSGGEMFTHLYQRDNFS 103
Query: 170 HIALQVAAGMAYLCSHHY-----VHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRI 224
++ +G L H V+RD+ N L+ V ++DFGLS++ + + R
Sbjct: 104 EDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERT 163
Query: 225 QSKSLLPVRWMPPESIL----YGKFTTESDVWSYGVVLWEVYSYGLQPYY--GYSN--QE 276
S + +M PE I +GK D WS G++++E+ + G P+ G N E
Sbjct: 164 YS-FCGTIEYMAPEIIRGKGGHGKAV---DWWSLGILIFELLT-GASPFTLEGERNTQSE 218
Query: 277 VIEMIRSRQMLPCPEDCPPRM 297
V SR++L C P +
Sbjct: 219 V-----SRRILKCDPPFPSFI 234
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 57.1 bits (136), Expect = 6e-09
Identities = 45/175 (25%), Positives = 75/175 (42%), Gaps = 21/175 (12%)
Query: 251 VWSYGVVLWEVYSYGLQPYY-GYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
V Y E Y + Y G S +++++ I + L ++ +
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLS-----ESEALFILAQ------ 109
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVG-DGLTVKISDFGLSR----DVYASDYYRIQSKSL 364
+ + + YL S +HRD+ N L+ DG VK+ DFGL++ S + S S+
Sbjct: 110 ILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV 169
Query: 365 LPVRWMPPESIL---YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLKT 416
+M PE +L ++ SD+WS G+ L+E GL P+ G N +T
Sbjct: 170 GTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYE-LLTGLPPFEGEKNSSATSQT 223
|
Length = 384 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 6e-09
Identities = 30/114 (26%), Positives = 49/114 (42%), Gaps = 15/114 (13%)
Query: 311 AAGMAYLCSHHYVHRDLAARNCLV-------GDGLTVKISDFGLSRDVYASDYYRIQSKS 363
A+ + YL VH ++ +N LV G +K+SD G+ V + +
Sbjct: 111 ASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREE------R 164
Query: 364 LLPVRWMPPESI--LYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
+ + W+ PE I T +D WS+G L E+ S G +P S+ E+
Sbjct: 165 VERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 44/201 (21%), Positives = 92/201 (45%), Gaps = 11/201 (5%)
Query: 94 NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSD 153
+++ A+ R E+ ++ H IV S + + ++ E+ GDL++ + R
Sbjct: 105 DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKE-- 162
Query: 154 ISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213
P + + + Q+ + + S +HRDL + N + +K+ DFG S
Sbjct: 163 ------HLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFS 216
Query: 214 RDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS 273
+ S + S ++ PE +++ ++D+WS GV+L+E+ + +P+ G S
Sbjct: 217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLH-RPFKGPS 275
Query: 274 NQEVIEMIRSRQMLPCPEDCP 294
+E+++ + + P P CP
Sbjct: 276 QREIMQQVLYGKYDPFP--CP 294
|
Length = 478 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 8e-09
Identities = 53/207 (25%), Positives = 86/207 (41%), Gaps = 29/207 (14%)
Query: 103 REVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAP 162
RE+ ++ E P IV G S + + E M G L + ++ ++ R
Sbjct: 48 RELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGR----------- 95
Query: 163 LSQQDFSHIALQVAAGMAYLCSHHYV-HRDLAARNCLVGDGLTVKISDFGLSRDVYASDY 221
+ + I++ V G+ YL H + HRD+ N LV +K+ DFG+S + S
Sbjct: 96 IPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153
Query: 222 YRIQSKSLLPVR-WMPPESILYGKFTTESDVWSYGVVLWE----VY------SYGLQPYY 270
+ S + R +M PE + +T +SD+WS G+ L E Y + L+ +
Sbjct: 154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMF 210
Query: 271 GYSNQEVIEMIRSRQMLPCPEDCPPRM 297
G E R + P D P M
Sbjct: 211 GRPVSEGEAKESHRPVSGHPPDSPRPM 237
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 1e-08
Identities = 27/94 (28%), Positives = 41/94 (43%), Gaps = 24/94 (25%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD-----------YYRIQS 361
+ YL S +HRD+ +N + VK+ DFG+S+ V +S YY
Sbjct: 115 ALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISK-VLSSTVDLAKTVVGTPYY---- 169
Query: 362 KSLLPVRWMPPESILYGKFTTESDVWSYGVVLWE 395
+ PE + +SD+WS G VL+E
Sbjct: 170 --------LSPELCQNKPYNYKSDIWSLGCVLYE 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 29/89 (32%), Positives = 44/89 (49%), Gaps = 7/89 (7%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS-DYYRIQSKSLLPVRWM- 370
G+A+ SH +HRDL N L+ +K++DFGL+R + Y + RW
Sbjct: 110 GLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY----VVTRWYR 165
Query: 371 PPESILYGKFTTES-DVWSYGVVLWEVYS 398
PE +L K + D+WS G + E+ S
Sbjct: 166 APELLLGDKGYSTPVDIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 3/85 (3%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 372
G+ +L ++ VHRDL N LV G VK++DFGL+R +Y+ + ++ + + P
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR-IYS--CQMALTPVVVTLWYRAP 176
Query: 373 ESILYGKFTTESDVWSYGVVLWEVY 397
E +L + T D+WS G + E++
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 26/88 (29%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR-DVYASDYYRIQSKSLLPVRWMP 371
G+ YL + +HRD+ N + D V I D G ++ V A + + V
Sbjct: 169 GLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGT----VETNA 224
Query: 372 PESILYGKFTTESDVWSYGVVLWEVYSY 399
PE + K+ +++D+WS G+VL+E+ +Y
Sbjct: 225 PEVLARDKYNSKADIWSAGIVLFEMLAY 252
|
Length = 357 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 34/97 (35%), Positives = 47/97 (48%), Gaps = 5/97 (5%)
Query: 308 VPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV 367
V V G+ YL S +HRD+ N LV VK+ DFG+S + S I +
Sbjct: 102 VAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTN 157
Query: 368 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPY 404
+M PE I ++ SDVWS G+ E+ + G PY
Sbjct: 158 AYMAPERISGEQYGIHSDVWSLGISFMEL-ALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (133), Expect = 2e-08
Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 34/155 (21%)
Query: 272 YSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARN 331
Y + ++++ R+ P E + S++ + + G+A++ H + HRDL N
Sbjct: 79 YMEGNLYQLMKDRKGKPFSE---SVIRSIIYQ------ILQGLAHIHKHGFFHRDLKPEN 129
Query: 332 CLVGDGLTVKISDFGLSRDV--------YASD-YYRIQSKSLLPVRWMPPESILY-GKFT 381
LV VKI+DFGL+R++ Y S +YR PE +L ++
Sbjct: 130 LLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYR------------APEILLRSTSYS 177
Query: 382 TESDVWSYGVVLWEVYSYGLQPYY-GYSNQEEFLK 415
+ D+W+ G ++ E+Y+ L+P + G S ++ K
Sbjct: 178 SPVDIWALGCIMAELYT--LRPLFPGSSEIDQLYK 210
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 28/88 (31%), Positives = 53/88 (60%), Gaps = 4/88 (4%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 372
G+ Y +++HRD+ N L+ + +K++DFGL+R +Y S+ R + ++ + + PP
Sbjct: 128 GLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR-LYNSEESRPYTNKVITLWYRPP 186
Query: 373 ESILYG--KFTTESDVWSYGVVLWEVYS 398
E +L G ++ DVWS G +L E+++
Sbjct: 187 E-LLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 44/152 (28%), Positives = 72/152 (47%), Gaps = 16/152 (10%)
Query: 65 GAFGKVYKGEVCTSEGPSLVAIKTLK--ENANQKTASDFRREVDLMSELRHPNIVCLLGV 122
GAFGKVY G + L A+K +K + N+ + E D ++ + P IV L
Sbjct: 15 GAFGKVYLGRKKNNS--KLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYS 72
Query: 123 CLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYL 182
S + ++ E+++ GD+ L I G ++ + S +AL + YL
Sbjct: 73 LQSANNVYLVMEYLIGGDVKSLL-------HIYG-YFDEEMAVKYISEVAL----ALDYL 120
Query: 183 CSHHYVHRDLAARNCLVGDGLTVKISDFGLSR 214
H +HRDL N L+ + +K++DFGLS+
Sbjct: 121 HRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 60/252 (23%), Positives = 108/252 (42%), Gaps = 41/252 (16%)
Query: 65 GAFGKVYKGEVCTSEGPSLVAIKTLKENA----NQKTASDFRREVDLMSELRHPNIVCLL 120
GA+G VY V E A+K + + NQ R++ +E +P +V +
Sbjct: 12 GAYGAVYL--VRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE--NPFVVSMF 67
Query: 121 GVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMA 180
+ +CM+ E++ GD L + + +++ F+ L +
Sbjct: 68 CSFETKRHLCMVMEYVEGGDCATLLKNIGA--------LPVDMARMYFAETVLALE---- 115
Query: 181 YLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR--------DVY----ASDYYRIQSKS 228
YL ++ VHRDL N L+ +K++DFGLS+ ++Y D K
Sbjct: 116 YLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 229 LLPV-RWMPPESIL---YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVI-EMIRS 283
+ ++ PE IL YGK D W+ G++L+E + G P++G + +E+ ++I
Sbjct: 176 VCGTPEYIAPEVILRQGYGK---PVDWWAMGIILYE-FLVGCVPFFGDTPEELFGQVISD 231
Query: 284 RQMLPCPEDCPP 295
P ++ P
Sbjct: 232 DIEWPEGDEALP 243
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 60/233 (25%), Positives = 105/233 (45%), Gaps = 32/233 (13%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-----ENANQKTASDFRREVDLMSELR 112
FL LG+G+FGKV E ++ L AIK LK ++ + + +R + L +
Sbjct: 4 FLMVLGKGSFGKVMLAERKGTD--ELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK-- 59
Query: 113 HPNIVCLLGVCLSGEPMCMLF---EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFS 169
P + L C + M L+ E++ GDL M Q +
Sbjct: 60 -PPFLTQLHSCF--QTMDRLYFVMEYVNGGDL----MYHI--------QQVGKFKEPHAV 104
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRD-VYASDYYRIQSKS 228
A ++A G+ +L S ++RDL N ++ +KI+DFG+ ++ ++ R +
Sbjct: 105 FYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGT 164
Query: 229 LLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281
P ++ PE I Y + D W++GV+L+E+ + G P+ G E+ + I
Sbjct: 165 --P-DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 62/225 (27%), Positives = 98/225 (43%), Gaps = 28/225 (12%)
Query: 62 LGEGAFGKVYKGEVCTSEGPS-LVAIKTLK--ENANQKTASDFRREVDLMSELRHPNIVC 118
LG G+FG+V + +G AIK LK E K +E ++ EL HP IV
Sbjct: 26 LGTGSFGRV---RIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVN 82
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMS--RSPRSDISGSQVQAPLSQQDFSHIALQVA 176
++ + L EF+V G+L L R P +D++ F H L +A
Sbjct: 83 MMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFP-NDVA-----------KFYHAELVLA 130
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 236
YL S ++RDL N L+ + VK++DFG ++ V + + ++
Sbjct: 131 --FEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTP-----EYLA 183
Query: 237 PESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281
PE I D W+ GV+L+E + G P++ + + E I
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIA-GYPPFFDDTPFRIYEKI 227
|
Length = 329 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 34/231 (14%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLK-----ENANQKTASDFRREVDLMSELRHPNI 116
LG+G+FGKV E+ + AIK LK E+ + + RR + L E HP +
Sbjct: 3 LGKGSFGKVMLAELKGTN--EFFAIKALKKDVVLEDDDVECTMVERRVLALAWE--HPFL 58
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
L + E + + E++ GDL F + S R D ++ F A ++
Sbjct: 59 THLFCTFQTKEHLFFVMEYLNGGDLM-FHIQSSGRFD---------EARARF--YAAEII 106
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS-----RDVYASDYYRIQSKSLLP 231
G+ +L ++RDL N L+ +KI+DFG+ + AS +
Sbjct: 107 CGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPD----- 161
Query: 232 VRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282
++ PE + K+ D WS+GV+L+E+ G P++G E+ + I
Sbjct: 162 --YIAPEILKGQKYNESVDWWSFGVLLYEML-IGQSPFHGEDEDELFDSIL 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 37/108 (34%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 307 EVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 366
EV VA + Y+ +HRD+ A N LV + VK+ DFG++ + + R + P
Sbjct: 109 EVLVA--LKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR-STFVGTP 165
Query: 367 VRWMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
WM PE I GK + T++D+WS G+ ++E+ + G P YS+ + F
Sbjct: 166 Y-WMAPEVITEGKYYDTKADIWSLGITIYEM-ATGNPP---YSDVDAF 208
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 34/95 (35%), Positives = 48/95 (50%), Gaps = 11/95 (11%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+ +G+AYL H VHRD+ N L+ VKI+DFG+SR + A S S+ + +
Sbjct: 177 ILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSR-ILAQTMDPCNS-SVGTIAY 234
Query: 370 MPPESI-------LYGKFTTESDVWSYGVVLWEVY 397
M PE I Y + D+WS GV + E Y
Sbjct: 235 MSPERINTDLNHGAYDGYA--GDIWSLGVSILEFY 267
|
Length = 353 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 30/100 (30%), Positives = 46/100 (46%), Gaps = 4/100 (4%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+ + YL S +HRD+ N L+ + V I+DF ++ V S S P +
Sbjct: 109 IVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPG-Y 165
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN 409
M PE + ++ D WS GV +E G +PY G+S
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECL-RGKRPYRGHSR 204
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 4e-08
Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 313 GMAYLCS-HHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 371
G+ YL + H +HRD+ N L+ VKI+DFG+S+ + + + + V +M
Sbjct: 111 GLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC--NTFVGTVTYMS 168
Query: 372 PESILYGKFTTESDVWSYGVVLWEVYSYGLQPY 404
PE I ++ +D+WS G+ L E G P+
Sbjct: 169 PERIQGESYSYAADIWSLGLTLLECAL-GKFPF 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 59/225 (26%), Positives = 100/225 (44%), Gaps = 33/225 (14%)
Query: 58 FLQELGEGAFGKVY-KGEVCTSEGPSLVAIKTLKENA---NQKTASDFRREVDLMSELRH 113
L+ LG GA+GKV+ +V + L A+K LK+ KT R E ++ +R
Sbjct: 4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 63
Query: 114 -PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQD-FSHI 171
P +V L + F LH L I+G ++ LSQ++ F
Sbjct: 64 SPFLVTLH------------YAFQTDTKLHLIL------DYINGGELFTHLSQRERFKEQ 105
Query: 172 ALQVAAGMAYLCSHHY-----VHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQS 226
+Q+ +G L H ++RD+ N L+ V ++DFGLS++ + + R S
Sbjct: 106 EVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS 165
Query: 227 KSLLPVRWMPPESILYGKFTTES--DVWSYGVVLWEVYSYGLQPY 269
+ +M P+ + G + D WS GV+++E+ + G P+
Sbjct: 166 -FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT-GASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 25/211 (11%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSL---VAIKTLKENANQKT-ASDFRREVDLMSELRHP 114
L +G GA+G VC + VA+K L A RE+ L+ ++H
Sbjct: 22 LSPVGSGAYG-----SVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
N++ LL V P L EF D+ +L++ +D++ L+ + Q
Sbjct: 77 NVIGLLDVF---TPARSLEEF---NDV--YLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 128
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 234
+ G+ Y+ S +HRDL N V + +KI DFGL+R + D + + RW
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDD----EMTGYVATRW 182
Query: 235 M-PPESIL-YGKFTTESDVWSYGVVLWEVYS 263
PE +L + + D+WS G ++ E+ +
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 4e-08
Identities = 56/241 (23%), Positives = 114/241 (47%), Gaps = 32/241 (13%)
Query: 59 LQELGEGAFGKVYKGEVCT-SEGPSLVAIKTLKENA---NQKTASDFRREVDLMSELRHP 114
L+ LG+G +GKV++ T ++ + A+K LK+ NQK + + E +++ ++HP
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL- 173
IV L+ +G + ++ E++ G+L L R I +D + L
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHL----EREGI---------FMEDTACFYLS 107
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL--- 230
+++ + +L ++RDL N L+ VK++DFGL ++ I ++
Sbjct: 108 EISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKE-------SIHEGTVTHTF 160
Query: 231 --PVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI-RSRQML 287
+ +M PE ++ D WS G +++++ + G P+ + ++ I+ I + + L
Sbjct: 161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLT-GAPPFTAENRKKTIDKILKGKLNL 219
Query: 288 P 288
P
Sbjct: 220 P 220
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 5e-08
Identities = 37/127 (29%), Positives = 59/127 (46%), Gaps = 31/127 (24%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR---- 368
G+A+ SH+ +HRDL +N L+ +K++DFGL+R + I PVR
Sbjct: 111 GLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARA------FGI------PVRCYSA 158
Query: 369 -----WMPPESILYGK--FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF------LK 415
W P +L+G ++T D+WS G + E+ + G + G ++ L
Sbjct: 159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 218
Query: 416 TP--PSW 420
TP SW
Sbjct: 219 TPTEESW 225
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 30/93 (32%), Positives = 45/93 (48%), Gaps = 11/93 (11%)
Query: 308 VPVAAGMAYLCS-HHYVHRDLAARNCLVGDGLTVKISDFGLSR---DVYASDYYRIQSKS 363
V V G+ YL H +HRD+ N LV +K+ DFG+S + A + S
Sbjct: 107 VAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSS-- 164
Query: 364 LLPVRWMPPESILYGKFTTESDVWSYGVVLWEV 396
+M PE I ++ +SD+WS G+ L E+
Sbjct: 165 -----YMAPERIQGNDYSVKSDIWSLGLSLIEL 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 54/259 (20%), Positives = 99/259 (38%), Gaps = 48/259 (18%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLV-AIKTL--KENANQKTASDFRREVDLMSELRHPN 115
++ LG+G G+V+ + +G + A+K L KE + E ++++ L HP
Sbjct: 6 IKLLGKGDVGRVF---LVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62
Query: 116 IVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQV 175
+ L + +C++ ++ G+L L + + LS++ A +V
Sbjct: 63 LPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKC----------LSEEVARFYAAEV 112
Query: 176 AAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 234
+ YL V+RDL N L+ G + +SDF LS+ ++ R
Sbjct: 113 LLALEYLHLLGIVYRDLKPENILLHESG-HIMLSDFDLSKQSDVEPPPVSKALRKGS-RR 170
Query: 235 MPPESILYGKFTTES----------------------------DVWSYGVVLWEVYSYGL 266
SI F+ E D W+ G++L+E+ YG
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML-YGT 229
Query: 267 QPYYGYSNQEVIEMIRSRQ 285
P+ G + E I ++
Sbjct: 230 TPFKGSNRDETFSNILKKE 248
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 26/220 (11%)
Query: 56 PRF--LQELGEGAFGKVYKGEVCTSEGPSLVAIK--TLKENANQKTASDFRREVDLMSEL 111
R+ L+ LG G+ G V+ S+ VA+K L + + K A RE+ ++ L
Sbjct: 5 SRYMDLRPLGCGSNGLVFSA--VDSDCDKRVAVKKIVLTDPQSVKHA---LREIKIIRRL 59
Query: 112 RHPNIVCLLGVCLSG-----EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQ 166
H NIV + V E + L E + E++ +D++ Q PLS++
Sbjct: 60 DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLSEE 114
Query: 167 DFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVG-DGLTVKISDFGLSRDV---YASDYY 222
Q+ G+ Y+ S + +HRDL N + + L +KI DFGL+R V Y+ Y
Sbjct: 115 HARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 223 RIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEV 261
S+ L+ + P +L +T D+W+ G + E+
Sbjct: 175 --LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 56/236 (23%), Positives = 102/236 (43%), Gaps = 36/236 (15%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSE-------LRHP 114
+G+G+FGKV E A+K L++ A K + E +MSE ++HP
Sbjct: 3 IGKGSFGKVLLARHKAEE--KFYAVKVLQKKAILKK----KEEKHIMSERNVLLKNVKHP 56
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSR----SPRSDISGSQVQAPLSQQDFSH 170
+V L + + + + +++ G+L L PR+
Sbjct: 57 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF---------------- 100
Query: 171 IALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL 230
A ++A+ + YL S + V+RDL N L+ + ++DFGL ++ + S
Sbjct: 101 YAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTSTFCG 158
Query: 231 PVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286
++ PE + + D W G VL+E+ YGL P+Y + E+ + I ++ +
Sbjct: 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML-YGLPPFYSRNTAEMYDNILNKPL 213
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 7e-08
Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 5/100 (5%)
Query: 308 VPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV 367
V + + + ++ S +HRD+ N + VK+ D GL R ++S S P
Sbjct: 113 VQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPY 171
Query: 368 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQ-PYYG 406
+M PE I + +SD+WS G +L+E+ + LQ P+YG
Sbjct: 172 -YMSPERIHENGYNFKSDIWSLGCLLYEMAA--LQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 38/124 (30%), Positives = 57/124 (45%), Gaps = 32/124 (25%)
Query: 321 HYVHRDLAARNCLVG-DGLTVKISDFGLS---RDVYASDYYRIQSKSLL----------- 365
++HRD+ N L+ DG +K++DFGL +YY S +LL
Sbjct: 121 GFIHRDIKPDNILIDADG-HIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179
Query: 366 ----PVR---------WMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
VR ++ PE +L G + E D WS GV+L+E+ YG P+Y + QE
Sbjct: 180 HKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILYEML-YGFPPFYSDTLQE 237
Query: 412 EFLK 415
+ K
Sbjct: 238 TYNK 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 54/225 (24%), Positives = 102/225 (45%), Gaps = 25/225 (11%)
Query: 62 LGEGAFGKVYKGEVCTSEGPS--LVAIKTLKEN---ANQKTASDFRREVDLMSELRHPNI 116
LG+G FGKV + E + A+K L++ A + A E ++ RHP +
Sbjct: 3 LGKGTFGKV----ILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-ESRVLQNTRHPFL 57
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
L + + +C + E+ G+L F +SR + +++ ++
Sbjct: 58 TALKYAFQTHDRLCFVMEYANGGELF-FHLSR-----------ERVFTEERARFYGAEIV 105
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 236
+ + YL S V+RD+ N ++ +KI+DFGL ++ SD +++ P ++
Sbjct: 106 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTP-EYLA 163
Query: 237 PESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281
PE + + D W GVV++E+ G P+Y ++ + E+I
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 48/138 (34%), Positives = 64/138 (46%), Gaps = 20/138 (14%)
Query: 62 LGEGAFGKVYKGE---VCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIV 117
LG GAFG+V + + S+ VA+K LK A E+ +MS L H NIV
Sbjct: 45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDL--------HEFLMS-----RSPRSDISGSQVQAPLS 164
LLG C G P+ ++ E+ GDL H FL R S ISG PLS
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGST--PLS 162
Query: 165 QQDFSHIALQVAAGMAYL 182
Q+ SH++L + Y+
Sbjct: 163 QRK-SHVSLGSESDGGYM 179
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-08
Identities = 34/101 (33%), Positives = 53/101 (52%), Gaps = 16/101 (15%)
Query: 306 HEVPVAA-------GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYR 358
EV +AA G+AYL SH+ +HRD+ A N L+ + VK++DFG + ++ +
Sbjct: 119 QEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF- 177
Query: 359 IQSKSLLPVRWMPPESILY---GKFTTESDVWSYGVVLWEV 396
+ WM PE IL G++ + DVWS G+ E+
Sbjct: 178 -----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 28/85 (32%), Positives = 42/85 (49%), Gaps = 4/85 (4%)
Query: 312 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 371
G+ YL + VHRD+ N LV VK++DFG+++ V + + S WM
Sbjct: 113 LGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGS---PYWMA 169
Query: 372 PESIL-YGKFTTESDVWSYGVVLWE 395
PE I G + +D+WS G + E
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLE 194
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 37/130 (28%), Positives = 59/130 (45%), Gaps = 26/130 (20%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLT-----VKISDFGLSRDVYASDYYRIQS 361
+A + +L H ++ A+N L+ D T +K+SD G+S V
Sbjct: 109 LAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV--------LP 160
Query: 362 KSLLPVR--WMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ------EE 412
K +L R W+PPE I + + +D WS+G LWE++S G +P +Q E+
Sbjct: 161 KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED 220
Query: 413 FLKTP-PSWI 421
+ P P W
Sbjct: 221 RHQLPAPKWT 230
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 28/88 (31%), Positives = 40/88 (45%), Gaps = 7/88 (7%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR---- 368
G+ YL S+ VHRD+ N L VK+ DFG S+ + + V
Sbjct: 116 GVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT---ICSSGTGMKSVTGTPY 172
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEV 396
WM PE I + ++DVWS G + E+
Sbjct: 173 WMSPEVISGEGYGRKADVWSVGCTVVEM 200
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 37/117 (31%), Positives = 56/117 (47%), Gaps = 14/117 (11%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQS--KSLLPVRWM 370
G+ Y+ S + +HRDL N LV +KI DFGL+R ++ + + RW
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARG-FSENPGENAGFMTEYVATRWY 175
Query: 371 -PPESIL-YGKFTTESDVWSYGVVLWEVYSYGLQPYY---GYSNQE----EFLKTPP 418
PE +L + +T DVWS G +L E+ G +P + Y +Q + L TP
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAEL--LGRKPVFKGKDYVDQLNQILQVLGTPD 230
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 31/97 (31%), Positives = 53/97 (54%), Gaps = 13/97 (13%)
Query: 314 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG----LSRDVYASDYYRIQSKSLLPV-R 368
+++L + +HRD+ + + L+ VK+SDFG +S++V + KSL+
Sbjct: 128 LSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-------PRRKSLVGTPY 180
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYY 405
WM PE I + TE D+WS G+++ E+ G PY+
Sbjct: 181 WMAPEVISRLPYGTEVDIWSLGIMVIEMVD-GEPPYF 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 23/99 (23%), Positives = 42/99 (42%), Gaps = 23/99 (23%)
Query: 323 VHRDLAARNCLVGDGLTVKISDFGLSRDVYASD----------YYRIQSKSLLPVRWMPP 372
+HRDL N + VK+ DFGL++ + YY M P
Sbjct: 132 LHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYY------------MSP 179
Query: 373 ESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
E + + + +SD+WS G +++E+ + P+ + +
Sbjct: 180 EQLNHMSYDEKSDIWSLGCLIYELCA-LSPPFTARNQLQ 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 1e-07
Identities = 34/101 (33%), Positives = 53/101 (52%), Gaps = 16/101 (15%)
Query: 306 HEVPVAA-------GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYR 358
EV +AA G+AYL SH+ +HRD+ A N L+ + VK++DFG + ++ +
Sbjct: 123 QEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF- 181
Query: 359 IQSKSLLPVRWMPPESILY---GKFTTESDVWSYGVVLWEV 396
+ WM PE IL G++ + DVWS G+ E+
Sbjct: 182 -----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 31/113 (27%), Positives = 51/113 (45%), Gaps = 7/113 (6%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR- 368
+ + YL S+ +HRDL N L+ +K++DFGLS+ + R
Sbjct: 102 IVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161
Query: 369 -----WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLKT 416
++ PE IL + D WS G +L+E G+ P++G + +E F
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV-GIPPFHGETPEEIFQNI 213
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 36/104 (34%), Positives = 54/104 (51%), Gaps = 13/104 (12%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG----LSRDVYASDYYRIQSKSLL 365
V + YL S +HRD+ + + L+ VK+SDFG +S+DV + KSL+
Sbjct: 126 VLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-------PKRKSLV 178
Query: 366 PV-RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS 408
WM PE I + TE D+WS G+++ E+ G PY+ S
Sbjct: 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVD-GEPPYFSDS 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 38/131 (29%), Positives = 67/131 (51%), Gaps = 9/131 (6%)
Query: 298 YSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYY 357
+ L ++ + G+ +L S V+RDL N L+ +KI+DFG+ ++ D
Sbjct: 93 FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA- 151
Query: 358 RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF---- 413
+ + P ++ PE +L K+ T D WS+GV+L+E+ G P++G+ +E F
Sbjct: 152 KTCTFCGTP-DYIAPEILLGQKYNTSVDWWSFGVLLYEML-IGQSPFHGHDEEELFQSIR 209
Query: 414 LKTP--PSWIT 422
+ P P W+T
Sbjct: 210 MDNPCYPRWLT 220
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 59/254 (23%), Positives = 111/254 (43%), Gaps = 30/254 (11%)
Query: 62 LGEGAFGKVYKG--EVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHPNIV 117
+G+G G+VY VC+ VA+K ++E+ N F RE + ++L HP IV
Sbjct: 10 IGKGGMGEVYLAYDPVCSRR----VALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV 65
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
+ +C G+P+ + + G + L+ + + ++ S F I ++ A
Sbjct: 66 PVYSICSDGDPVYYTMPY-IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR----------DVYASDYYRIQSK 227
+ Y+ S +HRDL N L+G V I D+G + D+ + S
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 228 SLLPVR------WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281
+P + +M PE +L + +D+++ GV+L+++ + PY ++ I
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSF-PY----RRKKGRKI 239
Query: 282 RSRQMLPCPEDCPP 295
R ++ P + P
Sbjct: 240 SYRDVILSPIEVAP 253
|
Length = 932 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 53/228 (23%), Positives = 99/228 (43%), Gaps = 22/228 (9%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPN 115
FL LG+G+FGKV E ++ L AIK LK++ E +++ P
Sbjct: 4 FLMVLGKGSFGKVMLAERKGTD--ELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 116 IVCLLGVCLSG-EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
+ L C + + + E++ GDL + Q + A +
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI------------QQVGKFKEPQAVFYAAE 109
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV-R 233
++ G+ +L ++RDL N ++ +KI+DFG+ ++ + +++
Sbjct: 110 ISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE---HMVDGVTTRTFCGTPD 166
Query: 234 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281
++ PE I Y + D W+YGV+L+E+ + G P+ G E+ + I
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLA-GQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 61/233 (26%), Positives = 106/233 (45%), Gaps = 22/233 (9%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVD-LMSELRHPNIVC 118
+G+G+FGKV + A+K L++ N+K E + L+ ++HP +V
Sbjct: 3 IGKGSFGKVLLAK--RKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
L + E + + +F+ G+L F + RS P + F A ++A+
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGEL--FFHLQRERS--------FPEPRARF--YAAEIASA 108
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRD-VYASDYYRIQSKSLLPVRWMPP 237
+ YL S + V+RDL N L+ V ++DFGL ++ + SD + ++ P
Sbjct: 109 LGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---TTTTFCGTPEYLAP 165
Query: 238 ESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP 290
E I + D W G VL+E+ YGL P+Y E+ + I + ++ P
Sbjct: 166 EVIRKQPYDNTVDWWCLGAVLYEML-YGLPPFYCRDVAEMYDNILHKPLVLRP 217
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 55/223 (24%), Positives = 100/223 (44%), Gaps = 25/223 (11%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVD-LMSELRHPNIVC 118
+G+G+FGKV + A+K L++ A +K E + L+ ++HP +V
Sbjct: 3 IGKGSFGKVLLAK--HKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
L + + + + +++ G+L F + R P + F A ++A+
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELF-FHLQRERS---------FPEPRARF--YAAEIASA 108
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR-DVYASDYYRIQSKSLLPVRWMPP 237
+ YL S + ++RDL N L+ V ++DFGL + + S S ++ P
Sbjct: 109 LGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK---TTSTFCGTPEYLAP 165
Query: 238 ESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEM 280
E + + D W G VL+E+ YGL P+Y +++ EM
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEML-YGLPPFY---SRDTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 30/89 (33%), Positives = 45/89 (50%), Gaps = 11/89 (12%)
Query: 312 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV---R 368
G+ YL + +HRDL N L+ D +KI+DFGL+R Y + +K + P
Sbjct: 119 RGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLART------YGLPAKPMTPKVVTL 172
Query: 369 WMPPESILYG--KFTTESDVWSYGVVLWE 395
W +L G +TT D+W+ G +L E
Sbjct: 173 WYRAPELLLGCTTYTTAIDMWAVGCILAE 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 29/84 (34%), Positives = 42/84 (50%), Gaps = 7/84 (8%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 372
G+AYL + +HRD+ +N L+ VK+ DFG+S + S R + P WM P
Sbjct: 125 GLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL-DSTLGRRNTFIGTPY-WMAP 182
Query: 373 ESILYGK-----FTTESDVWSYGV 391
E I + + SDVWS G+
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGI 206
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIV 117
FL LG+G+FGKV E ++ L AIK LK ++V + + +V
Sbjct: 4 FLMVLGKGSFGKVMLAERKGTD--ELYAIKILK------------KDVVIQDDDVECTMV 49
Query: 118 CLLGVCLSGEP--MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQ--APLSQQDFSHIAL 173
+ LSG+P + L D F+M D+ Q+Q + A
Sbjct: 50 EKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLM-YQIQQVGRFKEPHAVFYAA 108
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV- 232
++A G+ +L S ++RDL N ++ +KI+DFG+ ++ + + + +K+
Sbjct: 109 EIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE---NMWDGVTTKTFCGTP 165
Query: 233 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281
++ PE I Y + D W++GV+L+E+ + G P+ G E+ + I
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQAPFEGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 27/224 (12%)
Query: 46 DFRREVIETKPRF--LQELGEGAFGKVYKGEVCTSEGPSL---VAIKTLKENANQKT-AS 99
+ + V E R+ L +G GA+G VC++ L VA+K L A
Sbjct: 5 ELNKTVWEVPERYQNLTPVGSGAYG-----SVCSAYDTRLRQKVAVKKLSRPFQSLIHAR 59
Query: 100 DFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQV 159
RE+ L+ ++H N++ LL V P + F +L++ +D++
Sbjct: 60 RTYRELRLLKHMKHENVIGLLDVF---TPATSIENFN-----EVYLVTNLMGADLNNIVK 111
Query: 160 QAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS 219
LS + + Q+ G+ Y+ S +HRDL N V + ++I DFGL+R A
Sbjct: 112 CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ--AD 169
Query: 220 DYYRIQSKSLLPVRWM-PPESIL-YGKFTTESDVWSYGVVLWEV 261
D + + RW PE +L + + D+WS G ++ E+
Sbjct: 170 D----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 66/244 (27%), Positives = 117/244 (47%), Gaps = 38/244 (15%)
Query: 62 LGEGAFGKVYKGEVC--TSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCL 119
+G G+FG VY+ +C TSE VAIK + ++ K RE+ +M L H NI+ L
Sbjct: 74 IGNGSFGVVYEA-ICIDTSEK---VAIKKVLQDPQYKN-----RELLIMKNLNHINIIFL 124
Query: 120 LGV----CLSGEP----MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHI 171
C + ++ EF+ + +H++ M R++ + L +S+
Sbjct: 125 KDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKY-MKHYARNNHALPLFLVKL----YSY- 177
Query: 172 ALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL-TVKISDFGLSRDVYASDYYRIQSKSLL 230
Q+ +AY+ S HRDL +N L+ T+K+ DFG ++++ A +S S +
Sbjct: 178 --QLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ----RSVSYI 231
Query: 231 PVRWMPPESILYG--KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP 288
R+ ++ G +TT D+WS G ++ E+ G + G S+ V +++R Q+L
Sbjct: 232 CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI-LGYPIFSGQSS--VDQLVRIIQVLG 288
Query: 289 CPED 292
P +
Sbjct: 289 TPTE 292
|
Length = 440 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 30/87 (34%), Positives = 48/87 (55%), Gaps = 9/87 (10%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 372
G+AYL SH+ +HRD+ A N L+ + VK+ DFG + + ++ + + WM P
Sbjct: 127 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF------VGTPYWMAP 180
Query: 373 ESILY---GKFTTESDVWSYGVVLWEV 396
E IL G++ + DVWS G+ E+
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 31/95 (32%), Positives = 44/95 (46%), Gaps = 20/95 (21%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS--------DYYRIQS 361
V G++YL S +HRD+ N L+ VK+ DFG+S ++ S +Y
Sbjct: 114 VLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFY---- 169
Query: 362 KSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEV 396
M PE I ++ SDVWS G+ L EV
Sbjct: 170 --------MAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 38/132 (28%), Positives = 67/132 (50%), Gaps = 11/132 (8%)
Query: 298 YSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRD-VYASDY 356
+ L ++ + G+ +L S ++RDL N ++ +KI+DFG+ ++ V+ +
Sbjct: 93 FDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN- 151
Query: 357 YRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF--- 413
R + P ++ PE + K+T D WS+GV+L+E+ G P++G E F
Sbjct: 152 -RASTFCGTP-DYIAPEILQGLKYTFSVDWWSFGVLLYEML-IGQSPFHGDDEDELFESI 208
Query: 414 -LKTP--PSWIT 422
+ TP P WIT
Sbjct: 209 RVDTPHYPRWIT 220
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 41/221 (18%)
Query: 82 SLVAIK-TLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGD 140
+LV ++ T EN ++ + EV L RHPNI+ V +G + ++ FM G
Sbjct: 26 TLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGS 85
Query: 141 LHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV- 199
+ L + P +S+ +I G+ YL + Y+HR++ A + L+
Sbjct: 86 ANSLLKTYFPEG----------MSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS 135
Query: 200 GDGLTVKISDFGLS----------RDVYASDYYRIQSKSLLPVRWMPPESI---LYGKFT 246
GDGL +S GLS + D+ + S S+LP W+ PE + LYG +
Sbjct: 136 GDGL---VSLSGLSHLYSLVRNGQKAKVVYDFPQF-STSVLP--WLSPELLRQDLYG-YN 188
Query: 247 TESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287
+SD++S G+ E+ + G P+ +M+R++ +L
Sbjct: 189 VKSDIYSVGITACELAT-GRVPF--------QDMLRTQMLL 220
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 29/88 (32%), Positives = 45/88 (51%), Gaps = 9/88 (10%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL--PVRWM 370
G+AYL +HRD+ N L+ + VK++DFG+S + A+ R KS + P WM
Sbjct: 113 GLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR---KSFIGTPY-WM 168
Query: 371 PPESI---LYGKFTTESDVWSYGVVLWE 395
PE G + + D+W+ G+ E
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 30/110 (27%), Positives = 49/110 (44%), Gaps = 22/110 (20%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR---- 368
G+AYL SH VHRD+ N + +K+ DFG + ++++ +
Sbjct: 111 GLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAV--------KLKNNTTTMGEEVQS 162
Query: 369 ------WMPPESILYGKFTTE---SDVWSYGVVLWEVYSYGLQPYYGYSN 409
+M PE I GK +D+WS G V+ E+ + G +P+ N
Sbjct: 163 LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMAT-GKRPWSELDN 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 26/88 (29%), Positives = 49/88 (55%), Gaps = 4/88 (4%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR- 368
+ G+ YL S +HRD+ A N L+ + VK++DFG++ + + +I+ + +
Sbjct: 110 ILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT---QIKRNTFVGTPF 166
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEV 396
WM PE I + +++D+WS G+ E+
Sbjct: 167 WMAPEVIQQSAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 55/248 (22%), Positives = 105/248 (42%), Gaps = 61/248 (24%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTL--KENANQKTASDFRREVDLMSELRHPNI 116
++ +G GAFG+V V + +L A+KTL + + A+ + E D+++E + +
Sbjct: 6 IKTIGIGAFGEVCL--VRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWV 63
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFS--HIALQ 174
V L + F + +L+ F+M P D+ ++ + ++D + +IA +
Sbjct: 64 VKLY------------YSFQDKDNLY-FVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-E 109
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS---RDVYASDYY--------- 222
+ + + ++HRD+ N L+ +K++DFGL R + S YY
Sbjct: 110 LTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQD 169
Query: 223 ----------------------------RIQSKSLLPV-RWMPPESILYGKFTTESDVWS 253
R + SL+ ++ PE +L +T D WS
Sbjct: 170 SMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 229
Query: 254 YGVVLWEV 261
GV+L+E+
Sbjct: 230 VGVILYEM 237
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 54/228 (23%), Positives = 101/228 (44%), Gaps = 20/228 (8%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVD-LMSELRHPNIVC 118
+G+G+FGKV + + S A+K L++ +K + E + L+ L+HP +V
Sbjct: 3 IGKGSFGKVLLAKRKSDG--SFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
L + E + + +++ G+L L Q + + A +VA+
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHL------------QRERCFLEPRARFYAAEVASA 108
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPE 238
+ YL S + ++RDL N L+ V ++DFGL ++ + S ++ PE
Sbjct: 109 IGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTSTFCGTPEYLAPE 166
Query: 239 SILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286
+ + D W G VL+E+ YGL P+Y ++ + I + +
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEML-YGLPPFYSRDVSQMYDNILHKPL 213
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 55/239 (23%), Positives = 97/239 (40%), Gaps = 48/239 (20%)
Query: 104 EVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPL 163
E L+ L HP ++ LL V + G C++ R DL+ +L +R PL
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLP-KYRSDLYTYLGARL-----------RPL 257
Query: 164 SQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG---LSRDVYASD 220
+ +A Q+ + + Y+ +HRD+ N LV + + DFG +R +++
Sbjct: 258 GLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317
Query: 221 -YYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWE-------VYSYGLQPYYGY 272
+Y I V PE + +T D+WS G+V++E ++S
Sbjct: 318 FHYGIAGT----VDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRP 373
Query: 273 SNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARN 331
+ +++ +IR Q+ ++ P S ++ Y HR AARN
Sbjct: 374 YDAQILRIIRQAQVH--VDEFPQHAGSRLVS-----------------QYRHR--AARN 411
|
Length = 461 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 29/95 (30%), Positives = 46/95 (48%), Gaps = 7/95 (7%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
V G+ L +HRD+ N L+ +K++DFGLSR+ K + +
Sbjct: 106 VVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL------ENKKFVGTPDY 159
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPY 404
+ PE+IL SD WS G V++E + +G P+
Sbjct: 160 LAPETILGVGDDKMSDWWSLGCVIFE-FLFGYPPF 193
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 8/93 (8%)
Query: 322 YVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK-F 380
Y+HRDL N L+ +K++DFGLS+ + + S +M PE +L GK +
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPD-----YMAPE-VLRGKGY 175
Query: 381 TTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
D WS G +L+E G P+ G + E +
Sbjct: 176 DFTVDYWSLGCMLYEFLC-GFPPFSGSTPNETW 207
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 38/170 (22%), Positives = 83/170 (48%), Gaps = 11/170 (6%)
Query: 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYV 188
+ ++ ++ GDL + + SR+ + + + + +QV + ++ S H +
Sbjct: 114 IALVLDYANAGDLRQEIKSRA--------KTNRTFREHEAGLLFIQVLLAVHHVHSKHMI 165
Query: 189 HRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV-RWMPPESILYGKFTT 247
HRD+ + N L+ VK+ DFG S+ +YA+ ++ ++ PE ++
Sbjct: 166 HRDIKSANILLCSNGLVKLGDFGFSK-MYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSK 224
Query: 248 ESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRM 297
++D++S GV+L+E+ + +P+ G + +EV+ + + P P P M
Sbjct: 225 KADMFSLGVLLYELLTLK-RPFDGENMEEVMHKTLAGRYDPLPPSISPEM 273
|
Length = 496 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 50/220 (22%), Positives = 93/220 (42%), Gaps = 22/220 (10%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTL--KENANQKTASDFRREVDLMSELRHP 114
R + LG+G FG+V +V + + A K L K +K + E ++ ++
Sbjct: 3 RHYRVLGKGGFGEVCACQVRATG--KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDL--HEFLMSRSPRSDISGSQVQAPLSQQDFSHIA 172
+V L + + +C++ M GDL H + M ++ A
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMG------------NPGFDEERAVFYA 108
Query: 173 LQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV 232
++ G+ L V+RDL N L+ D ++ISD GL+ ++ + R + + V
Sbjct: 109 AEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGT---V 165
Query: 233 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY 272
+M PE + ++T D W G +++E+ G P+
Sbjct: 166 GYMAPEVVKNERYTFSPDWWGLGCLIYEMIE-GKSPFRQR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 7e-07
Identities = 40/119 (33%), Positives = 54/119 (45%), Gaps = 25/119 (21%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR------DVYASD-YYRIQSKSLL 365
G+ Y+ S VHRDL N L+ + +KI DFGL+R Y S YYR
Sbjct: 120 GLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRYYR------- 172
Query: 366 PVRWMPPESIL-YGKFTTESDVWSYGVVLWEVYS-YGLQPYYGYSNQ----EEFLKTPP 418
PE +L + K+ E D+WS G + E+ L P + NQ + L TPP
Sbjct: 173 -----APEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPP 226
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTL--KENANQKTASDFRREVDLMSELRHPNIVCL 119
LG+G FG+V +V + + A K L K +K S E ++ ++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATG--KMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 120 LGVCLSGEPMCMLFEFMVRGDL--HEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
+ + +C++ M GDL H + M +A + A ++
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMG------------EAGFEEGRAVFYAAEICC 113
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 237
G+ L V+RDL N L+ D ++ISD GL+ V+ + I+ + + V +M P
Sbjct: 114 GLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR-VGTVGYMAP 170
Query: 238 ESILYGKFTTESDVWSYGVVLWEVYSYGLQPY 269
E + ++T D W+ G +L+E+ + G P+
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIA-GQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 8e-07
Identities = 30/124 (24%), Positives = 63/124 (50%), Gaps = 13/124 (10%)
Query: 273 SNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNC 332
N ++ ++++ ++ P PED R + + + G+A+L S +HRD+ + N
Sbjct: 82 ENGDLHKLLKMQRGRPLPEDQVWRFF---------IQILLGLAHLHSKKILHRDIKSLNL 132
Query: 333 LVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV-RWMPPESILYGKFTTESDVWSYGV 391
+ VKI D G+++ + + + + +++ ++ PE + +SDVW+ GV
Sbjct: 133 FLDAYDNVKIGDLGVAKLLSDNTNF---ANTIVGTPYYLSPELCEDKPYNEKSDVWALGV 189
Query: 392 VLWE 395
VL+E
Sbjct: 190 VLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 8e-07
Identities = 26/87 (29%), Positives = 47/87 (54%), Gaps = 2/87 (2%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+ G+ YL S +HRD+ A N L+ + VK++DFG++ + + R + + W
Sbjct: 110 ILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFW 167
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEV 396
M PE I + +++D+WS G+ E+
Sbjct: 168 MAPEVIKQSAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 33/88 (37%), Positives = 45/88 (51%), Gaps = 4/88 (4%)
Query: 62 LGEGAFGKVYKGE---VCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIV 117
LG GAFGKV +G + S+ VA+K LK A E+ +M+ L H NIV
Sbjct: 45 LGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIV 104
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFL 145
LLG C P+ ++ E+ GDL +L
Sbjct: 105 NLLGACTKSGPIYIITEYCFYGDLVNYL 132
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 28/100 (28%), Positives = 49/100 (49%), Gaps = 4/100 (4%)
Query: 301 MMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQ 360
+ C + + G+AYL ++ VHRD+ N ++ +K+ DFG +R + +
Sbjct: 102 PVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTH 161
Query: 361 SKSLLPVR----WMPPESILYGKFTTESDVWSYGVVLWEV 396
S L + WM PE I + +SD+WS G ++E+
Sbjct: 162 SNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 28/96 (29%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR- 368
+ G+ YL S +HRD+ A N L+ + VK++DFG++ + + +I+ + +
Sbjct: 110 ILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT---QIKRNTFVGTPF 166
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPY 404
WM PE I + ++D+WS G+ E+ + G P
Sbjct: 167 WMAPEVIKQSAYDFKADIWSLGITAIEL-AKGEPPN 201
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 30/102 (29%), Positives = 56/102 (54%), Gaps = 3/102 (2%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+A + +L S ++RDL N L+ + +K++DFGLS++ + D+ + V +
Sbjct: 107 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGTVEY 164
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
M PE + T +D WS+GV+++E+ + G P+ G +E
Sbjct: 165 MAPEVVNRRGHTQSADWWSFGVLMFEMLT-GSLPFQGKDRKE 205
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 27/84 (32%), Positives = 49/84 (58%), Gaps = 3/84 (3%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 372
G+ Y+ +HRDL A+N + + L +KI DFG+SR + S + + +M P
Sbjct: 118 GVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGS--CDLATTFTGTPYYMSP 174
Query: 373 ESILYGKFTTESDVWSYGVVLWEV 396
E++ + + ++SD+WS G +L+E+
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 30/88 (34%), Positives = 46/88 (52%), Gaps = 4/88 (4%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 372
G+ YL S +HRD+ N LV +KI DFGL+R V D + ++ ++ + P
Sbjct: 115 GLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQYYRAP 173
Query: 373 ESILYG--KFTTESDVWSYGVVLWEVYS 398
E IL G +T+ D+WS G + E+
Sbjct: 174 E-ILMGSRHYTSAVDIWSVGCIFAELLG 200
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 53/227 (23%), Positives = 96/227 (42%), Gaps = 22/227 (9%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTL--KENANQKTASDFRREVDLMSELRHPNIVCL 119
LG+G FG+V +V + + A K L K +K S E ++ ++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATG--KMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 120 LGVCLSGEPMCMLFEFMVRGDL--HEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
+ + +C++ M GDL H + M ++ A ++
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMG------------NPGFEEERALFYAAEILC 113
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 237
G+ L + V+RDL N L+ D ++ISD GL+ + + R + + V +M P
Sbjct: 114 GLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGT---VGYMAP 170
Query: 238 ESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR 284
E + ++T D W G +++E+ G P+ G + E + R
Sbjct: 171 EVLNNQRYTLSPDYWGLGCLIYEMIE-GQSPFRGRKEKVKREEVDRR 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 67/256 (26%), Positives = 108/256 (42%), Gaps = 56/256 (21%)
Query: 62 LGEGAFGKVY------KGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRH 113
+G G FG+V G++ A+K +K++ Q+T S F E D++S
Sbjct: 9 VGRGHFGEVQVVREKATGDIY--------AMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
P I L + + ++ E+ GDL L++R Q D
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLS-LLNRYE-------------DQFDEDMAQF 106
Query: 174 QVAAGMAYLCSHH---YVHRDLAARNCLVGDGLTVKISDFG----LSRDVYASDYYRIQS 226
+A + + S H YVHRD+ N L+ +K++DFG L+ + +
Sbjct: 107 YLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN------- 159
Query: 227 KSLLPV---RWMPPESIL----YGKFT--TESDVWSYGVVLWEVYSYGLQPYYGYSNQEV 277
S LPV ++ PE + GK T E D WS GV+ +E+ YG P++ ++ +
Sbjct: 160 -SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI-YGRSPFHEGTSAKT 217
Query: 278 IEMIRSRQ-MLPCPED 292
I + Q L PED
Sbjct: 218 YNNIMNFQRFLKFPED 233
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 27/99 (27%), Positives = 41/99 (41%), Gaps = 13/99 (13%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR---- 368
G+ L +++HRDL+ N + KI+DFGL+R Y SK R
Sbjct: 131 GLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190
Query: 369 -------WMPPESILYG--KFTTESDVWSYGVVLWEVYS 398
W +L G K+ D+WS G + E+ +
Sbjct: 191 TSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229
|
Length = 335 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 31/108 (28%), Positives = 51/108 (47%), Gaps = 10/108 (9%)
Query: 304 CWHEVPVAA-------GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDY 356
C E +AA + +L S+ +HRD+ + N L+G +VK++DFG +
Sbjct: 112 CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171
Query: 357 YRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPY 404
R S + WM PE + + + D+WS G++ E+ G PY
Sbjct: 172 KR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 48.6 bits (115), Expect = 2e-06
Identities = 30/108 (27%), Positives = 51/108 (47%), Gaps = 10/108 (9%)
Query: 304 CWHEVPVAA-------GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDY 356
C E +AA + +L ++ +HRD+ + N L+G +VK++DFG +
Sbjct: 111 CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170
Query: 357 YRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPY 404
R S + WM PE + + + D+WS G++ E+ G PY
Sbjct: 171 KR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV-R 368
V ++YL + +HRD+ + + L+ +K+SDFG V R KSL+
Sbjct: 127 VLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR---KSLVGTPY 183
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYY 405
WM PE I + TE D+WS G+++ E+ G PY+
Sbjct: 184 WMAPEVISRLPYGTEVDIWSLGIMVIEMID-GEPPYF 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 35/117 (29%), Positives = 57/117 (48%), Gaps = 20/117 (17%)
Query: 316 YLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR--------DVY----ASDYYRIQSKS 363
YL ++ VHRDL N L+ +K++DFGLS+ ++Y D K
Sbjct: 116 YLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 364 LLPV-RWMPPESIL---YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLKT 416
+ ++ PE IL YGK D W+ G++L+E + G P++G + +E F +
Sbjct: 176 VCGTPEYIAPEVILRQGYGK---PVDWWAMGIILYE-FLVGCVPFFGDTPEELFGQV 228
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 62/250 (24%), Positives = 110/250 (44%), Gaps = 35/250 (14%)
Query: 62 LGEGAFGKVYKGEVCTSEGPS--LVAIKTLKEN---ANQKTASDFRREVDLMSELRHPNI 116
LG+G FGKV + E + A+K LK+ A + A E ++ RHP +
Sbjct: 3 LGKGTFGKV----ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT-ENRVLQNSRHPFL 57
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSR-----SPRSDISGSQVQAPLSQQDFSHI 171
L + + +C + E+ G+L F +SR R+ G+++ + L D+ H
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELF-FHLSRERVFSEDRARFYGAEIVSAL---DYLHS 113
Query: 172 ALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 231
V V+RDL N ++ +KI+DFGL ++ D +++ P
Sbjct: 114 EKNV------------VYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGATMKTFCGTP 160
Query: 232 VRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPE 291
++ PE + + D W GVV++E+ G P+Y ++++ E+I + + P
Sbjct: 161 -EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELILMEE-IRFPR 217
Query: 292 DCPPRMYSLM 301
P SL+
Sbjct: 218 TLSPEAKSLL 227
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 54/253 (21%), Positives = 104/253 (41%), Gaps = 38/253 (15%)
Query: 58 FLQELGE----GAFGKVYKGEVCTSEGPSLVAIK-TLKENANQKTASDFRREVDLMSELR 112
L +G+ + K +LVA+K ++ +++ ++E+ +L+
Sbjct: 2 LLTLIGKCFEDLMIVHLAK---HKPTN-TLVAVKKINLDSCSKEDLKLLQQEIITSRQLQ 57
Query: 113 HPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIA 172
HPNI+ + + + ++ M G + L + P G L + + I
Sbjct: 58 HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP----EG------LPELAIAFIL 107
Query: 173 LQVAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFGLSRDVYASDY-------YRI 224
V + Y+ S ++HR + A + L+ GDG V +S S + +
Sbjct: 108 KDVLNALDYIHSKGFIHRSVKASHILLSGDGK-VVLSGLRYSVSMIKHGKRQRVVHDFPK 166
Query: 225 QSKSLLPVRWMPPESI---LYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY-SNQEVIEM 280
S LP W+ PE + L G + +SD++S G+ E+ + G P+ + Q ++E
Sbjct: 167 SSVKNLP--WLSPEVLQQNLQG-YNEKSDIYSVGITACELAN-GHVPFKDMPATQMLLEK 222
Query: 281 IRSRQMLPCPEDC 293
+R +PC D
Sbjct: 223 VRG--TVPCLLDK 233
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 59/227 (25%), Positives = 94/227 (41%), Gaps = 39/227 (17%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRH---P 114
++ELG GA+G V K + +++A+K ++ N + R +DL +R P
Sbjct: 5 VIEELGRGAYGVVDKMRHVPTG--TIMAVKRIRATVN--SQEQKRLLMDLDISMRSVDCP 60
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEF--LMSRS-----PRSDISGSQVQAPLSQQD 167
V G LF GD+ +M S + G + +
Sbjct: 61 YTVTFYGA---------LFR---EGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDI---- 104
Query: 168 FSHIALQVAAGMAYLCSH-HYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQS 226
IA+ + + YL S +HRD+ N L+ VK+ DFG+S + S I +
Sbjct: 105 LGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA 164
Query: 227 KSLLPVRWMPPESI---LYGK-FTTESDVWSYGVVLWEVYSYGLQPY 269
+M PE I L K + +SDVWS G+ + E+ + G PY
Sbjct: 165 GC---KPYMAPERINPELNQKGYDVKSDVWSLGITMIEL-ATGRFPY 207
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 64/251 (25%), Positives = 107/251 (42%), Gaps = 32/251 (12%)
Query: 59 LQELGEGAFGKVY-KGEVCTSEGPSLVAIKTLKENA---NQKTASDFRREVDLMSELRH- 113
L+ LG GA+GKV+ +V + L A+K LK+ KTA R E ++ +R
Sbjct: 5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRC 64
Query: 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
P +V L + + ++ +++ G+L L R + F+ +
Sbjct: 65 PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQR-----------------EHFTESEV 107
Query: 174 QVAAG---MAYLCSHHY--VHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKS 228
+V +A H ++RD+ N L+ V ++DFGLS++ A + R S
Sbjct: 108 RVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-F 166
Query: 229 LLPVRWMPPESILYGKFTTES--DVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286
+ +M PE I G + D WS GV+ +E+ + G P+ Q I SR++
Sbjct: 167 CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT-GASPFTVDGEQNSQSEI-SRRI 224
Query: 287 LPCPEDCPPRM 297
L P M
Sbjct: 225 LKSKPPFPKTM 235
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 30/97 (30%), Positives = 42/97 (43%), Gaps = 25/97 (25%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS---------RDVYASDYYRIQSKS 363
+ +L SH +HRDL A N L+ VK++DFG+S RD + Y
Sbjct: 115 ALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPY------ 168
Query: 364 LLPVRWMPPESILYGKFTTE-----SDVWSYGVVLWE 395
WM PE + F +D+WS G+ L E
Sbjct: 169 -----WMAPEVVACETFKDNPYDYKADIWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 32/105 (30%), Positives = 52/105 (49%), Gaps = 8/105 (7%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR-DVYASDYYRIQSKSLLPVRWMP 371
G+AY+ H +HRDL +N L+ +K++DFGL+R S Y + +L W
Sbjct: 115 GLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTL----WYR 170
Query: 372 PESILYG--KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFL 414
P +L G +++ D+W G + E+ G + G S+ E L
Sbjct: 171 PPDVLLGATDYSSALDIWGAGCIFIEMLQ-GQPAFPGVSDVFEQL 214
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 33/111 (29%), Positives = 52/111 (46%), Gaps = 16/111 (14%)
Query: 304 CWHEVPVAA-------GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDY 356
C E +AA + +L S+ +HRD+ + N L+G +VK++DFG +
Sbjct: 111 CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 168
Query: 357 YRIQSKSLLPV---RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPY 404
QSK V WM PE + + + D+WS G++ E+ G PY
Sbjct: 169 ---QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 3e-06
Identities = 31/108 (28%), Positives = 51/108 (47%), Gaps = 10/108 (9%)
Query: 304 CWHEVPVAA-------GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDY 356
C E +AA + +L S+ +HRD+ + N L+G +VK++DFG +
Sbjct: 111 CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170
Query: 357 YRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPY 404
R S + WM PE + + + D+WS G++ E+ G PY
Sbjct: 171 KR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 11/91 (12%)
Query: 320 HHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG- 378
H+ +HRD+ N LV VK+ DFG+S ++ AS + ++ +M PE I G
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS----LAKTNIGCQSYMAPERIKSGG 177
Query: 379 -----KFTTESDVWSYGVVLWEVYSYGLQPY 404
+T +SDVWS G+ + E+ + G PY
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEM-ALGRYPY 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 51/177 (28%), Positives = 76/177 (42%), Gaps = 36/177 (20%)
Query: 242 YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLM 301
YG F T+SDV+ + E+ S L + + R P PED +M
Sbjct: 80 YGYFITDSDVF----ICMELMSTCL------------DKLLKRIQGPIPEDILGKM---- 119
Query: 302 MECWHEVPVAAGMAYLCSHHYV-HRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQ 360
V + + YL H V HRD+ N L+ VK+ DFG+S + S + +
Sbjct: 120 -----TVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS---KAK 171
Query: 361 SKSLLPVRWMPPESI----LYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
++S +M PE I K+ +DVWS G+ L E+ + G PY + EF
Sbjct: 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELAT-GQFPYKN--CKTEF 225
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 7/91 (7%)
Query: 308 VPVAAGMAYLCSHHYV-HRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 366
+ V G+AYL H + HRD+ N LV +K+ DFG+S + S + S +
Sbjct: 110 IAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVG 164
Query: 367 VR-WMPPESILYGKFTTESDVWSYGVVLWEV 396
R +M PE + ++ +SD+WS G+ L E+
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 27/85 (31%), Positives = 47/85 (55%), Gaps = 3/85 (3%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 372
G+A+ SH +HRDL +N L+ +K++DFGL+R R + ++ + + P
Sbjct: 112 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTLWYRAP 169
Query: 373 ESILYGKF-TTESDVWSYGVVLWEV 396
E +L K+ +T D+WS G + E+
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEM 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 35/142 (24%), Positives = 64/142 (45%), Gaps = 16/142 (11%)
Query: 276 EVIEMIRSRQML--PCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCL 333
++ + I R+ PE R++ + + G+ L +HRDL + N L
Sbjct: 85 DLSKAISKRKKKRKLIPEQEIWRIF---------IQLLRGLQALHEQKILHRDLKSANIL 135
Query: 334 VGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVL 393
+ VKI D G+S+ V + + Q + +M PE ++ +SD+WS G +L
Sbjct: 136 LVANDLVKIGDLGISK-VLKKNMAKTQIGTPH---YMAPEVWKGRPYSYKSDIWSLGCLL 191
Query: 394 WEVYSYGLQPYYGYSNQEEFLK 415
+E+ ++ P+ S Q+ K
Sbjct: 192 YEMATFAP-PFEARSMQDLRYK 212
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 26/87 (29%), Positives = 50/87 (57%), Gaps = 3/87 (3%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 372
G+AY +HRDL +N L+ + +K++DFGL+R S + S ++ + + PP
Sbjct: 116 GLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPP 173
Query: 373 ESIL-YGKFTTESDVWSYGVVLWEVYS 398
+ +L +++T+ D+W G + +E+ S
Sbjct: 174 DVLLGSSEYSTQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 16/92 (17%)
Query: 314 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV------ 367
+ Y+ S + +HRDL N L+ VK++DFGL+R + + PV
Sbjct: 120 LKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPEN-----PVLTDYVA 174
Query: 368 -RWM-PPESILYG--KFTTESDVWSYGVVLWE 395
RW PE IL G ++T D+WS G +L E
Sbjct: 175 TRWYRAPE-ILLGSTRYTKGVDMWSVGCILGE 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 31/89 (34%), Positives = 47/89 (52%), Gaps = 4/89 (4%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR-DVYASDYYRIQSKSLLPVRWM- 370
G+ Y+ S + +HRDL N L+ +KI DFGL+R D+ ++ + RW
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTE-YVATRWYR 176
Query: 371 PPESILYGK-FTTESDVWSYGVVLWEVYS 398
PE +L K +T D+WS G +L E+ S
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 53/228 (23%), Positives = 100/228 (43%), Gaps = 20/228 (8%)
Query: 62 LGEGAFGKVYKGEVCTS---EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVC 118
LG+G FG+V +V + + K LK+ + +K A E +++ ++ P IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMA---LLEKEILEKVNSPFIVN 57
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
L S +C++ M GDL + + R L + H + Q+ G
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG----------LEMERVIHYSAQITCG 107
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPE 238
+ +L S V+RD+ N L+ D ++SD GL+ V D I ++ +M PE
Sbjct: 108 ILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTN-GYMAPE 164
Query: 239 SILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286
+ ++ D ++ G ++E+ + G P+ + + E ++ R +
Sbjct: 165 ILKEEPYSYPVDWFAMGCSIYEMVA-GRTPFKDHKEKVAKEELKRRTL 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 5e-06
Identities = 28/111 (25%), Positives = 57/111 (51%), Gaps = 18/111 (16%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR------DVYASDYYRIQSKSLLP 366
G+A+ + +HRDL +N L+ +K++DFGL+R + ++++ +
Sbjct: 112 GIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTL------- 164
Query: 367 VRWMPPESILYGK--FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
W +L G ++T D+WS G ++ E+ + G + G +N+++ LK
Sbjct: 165 --WYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT-GRPLFPGTNNEDQLLK 212
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 31/104 (29%), Positives = 56/104 (53%), Gaps = 7/104 (6%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 372
G+ Y +HRDL +N L+ + +K++DFGL+R S + S ++ + + PP
Sbjct: 116 GLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA--KSIPTKTYSNEVVTLWYRPP 173
Query: 373 ESILYG--KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFL 414
+ IL G ++T+ D+W G + +E+ + +P + S EE L
Sbjct: 174 D-ILLGSTDYSTQIDMWGVGCIFYEMSTG--RPLFPGSTVEEQL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 28/98 (28%), Positives = 44/98 (44%), Gaps = 25/98 (25%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS---------RDVYASDYYRIQSKS 363
G+A+L +H +HRD+ +N L+ + VK+ DFG+S R+ + Y
Sbjct: 133 GLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY------ 186
Query: 364 LLPVRWMPPESILY-----GKFTTESDVWSYGVVLWEV 396
WM PE I + SD+WS G+ E+
Sbjct: 187 -----WMAPEVIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 5e-06
Identities = 59/228 (25%), Positives = 107/228 (46%), Gaps = 32/228 (14%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVD-------LMSELRHP 114
+G+G+FGKV +V + + A+KT++ K R EV +++++ P
Sbjct: 1 IGKGSFGKVM--QVRKRDTQRIYALKTIR-----KAHIVSRSEVTHTLAERTVLAQVNCP 53
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
IV L S E + ++ F+ G+L L R R D+S ++ + A +
Sbjct: 54 FIVPLKFSFQSPEKLYLVLAFINGGELFHHL-QREGRFDLSRARF----------YTA-E 101
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 234
+ + L + ++RDL N L+ + + DFGL + + D + + P +
Sbjct: 102 LLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTP-EY 159
Query: 235 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282
+ PE +L +T D W+ GV+L+E+ + GL P+Y ++ V EM R
Sbjct: 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLT-GLPPFY---DENVNEMYR 203
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 6e-06
Identities = 28/91 (30%), Positives = 43/91 (47%), Gaps = 25/91 (27%)
Query: 312 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR------DVYASD----YYRIQS 361
+G+A+L + +HRDL N L+ + +KI DFGL+R Y +YR
Sbjct: 117 SGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYR--- 173
Query: 362 KSLLPVRWMPPESILYG--KFTTESDVWSYG 390
PE +L G +++T D+WS G
Sbjct: 174 ---------APE-LLLGAKEYSTAIDMWSVG 194
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 6e-06
Identities = 56/228 (24%), Positives = 95/228 (41%), Gaps = 31/228 (13%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN---ANQKTASDFRREVDLMSELRHPNIVC 118
LG+G FGKV V A+K LK+ A + A E ++ RHP +
Sbjct: 3 LGKGTFGKVIL--VREKATGKYYAMKILKKEVIIAKDEVAHTLT-ESRVLQNTRHPFLTA 59
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSR-----SPRSDISGSQVQAPLSQQDFSHIAL 173
L + + +C + E+ G+L F +SR R+ G+++ + L
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELF-FHLSRERVFSEDRARFYGAEIVSALG--------- 109
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR 233
YL S V+RDL N ++ +KI+DFGL ++
Sbjct: 110 -------YLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPE 160
Query: 234 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281
++ PE + + D W GVV++E+ G P+Y ++++ E+I
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 29/102 (28%), Positives = 57/102 (55%), Gaps = 4/102 (3%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 372
G++Y +HRDL +N L+ + +K++DFGL+R S + S ++ + + PP
Sbjct: 115 GLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPP 172
Query: 373 ESIL-YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
+ +L +++T D+W G +L+E+ + G + G + +EE
Sbjct: 173 DVLLGSTEYSTPIDMWGVGCILYEMAT-GRPMFPGSTVKEEL 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 30/90 (33%), Positives = 46/90 (51%), Gaps = 7/90 (7%)
Query: 308 VPVAAGMAYLCSHHYV-HRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 366
+ V G+ YL H + HRD+ N LV +K+ DFG+S + S + S +
Sbjct: 106 IAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVG 160
Query: 367 VR-WMPPESILYGKFTTESDVWSYGVVLWE 395
R +M PE + +T +SD+WS G+ L E
Sbjct: 161 TRSYMSPERLQGTHYTVQSDIWSLGLSLVE 190
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 7e-06
Identities = 30/105 (28%), Positives = 55/105 (52%), Gaps = 5/105 (4%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRD-VYASDYYRIQSKSLLPVR 368
+A G+ +L S ++RDL N ++ +KI+DFG+ ++ ++ R + P
Sbjct: 110 IAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGT--P-D 166
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
++ PE I Y + D W++GV+L+E+ + G P+ G E F
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQPPFDGEDEDELF 210
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 55/232 (23%), Positives = 96/232 (41%), Gaps = 22/232 (9%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTL--KENANQKTASDFRREVDLMSELRHP 114
R + LG+G FG+V +V + + A K L K +K + E ++ ++
Sbjct: 3 RHYRVLGKGGFGEVCACQVRATG--KMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDL--HEFLMSRSPRSDISGSQVQAPLSQQDFSHIA 172
+V L + + +C++ M GDL H + M +Q A
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG------------FDEQRAIFYA 108
Query: 173 LQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV 232
++ G+ L V+RDL N L+ D ++ISD GL+ + + R + + V
Sbjct: 109 AELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGT---V 165
Query: 233 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR 284
+M PE I K+T D W G +++E+ G P+ + E + R
Sbjct: 166 GYMAPEVINNEKYTFSPDWWGLGCLIYEMIQ-GQSPFRKRKERVKREEVDRR 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 7e-06
Identities = 66/263 (25%), Positives = 114/263 (43%), Gaps = 50/263 (19%)
Query: 59 LQELGEGAFGKVY-KGEVCTSEGPSLVAI--KTLKENANQKTASDFRREVDLMSELRHPN 115
++++G G FG+V+ T E AI + LKE + S EV++M EL+H N
Sbjct: 18 IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE----REKSQLVIEVNVMRELKHKN 73
Query: 116 IVCLLGVCL--SGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
IV + L + + + +L EF GDL R+ ++ + + I
Sbjct: 74 IVRYIDRFLNKANQKLYILMEFCDAGDL--------SRNIQKCYKMFGKIEEHAIVDITR 125
Query: 174 QVAAGMAYLCSH--------HYVHRDLAARNCLVGDGL-----------------TVKIS 208
Q+ +AY C + +HRDL +N + G+ KI
Sbjct: 126 QLLHALAY-CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184
Query: 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY--GKFTTESDVWSYGVVLWEVYSYGL 266
DFGLS+++ S P W PE +L+ + +SD+W+ G +++E+ S G
Sbjct: 185 DFGLSKNIGIESM--AHSCVGTPYYW-SPELLLHETKSYDDKSDMWALGCIIYELCS-GK 240
Query: 267 QPYYGYSN-QEVIEMIRSRQMLP 288
P++ +N ++I ++ LP
Sbjct: 241 TPFHKANNFSQLISELKRGPDLP 263
|
Length = 1021 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 36/119 (30%), Positives = 59/119 (49%), Gaps = 14/119 (11%)
Query: 279 EMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGL 338
++IRS Q L + C +Y L+ G+ Y+ S + +HRDL N L+
Sbjct: 97 QIIRSSQTL-SDDHCQYFLYQLLR----------GLKYIHSANVLHRDLKPSNLLLNANC 145
Query: 339 TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL-YGKFTTESDVWSYGVVLWEV 396
+KI DFGL+R S+ ++ ++ + PE +L ++TT DVWS G + E+
Sbjct: 146 DLKICDFGLART--TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAEL 202
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 9e-06
Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 5/100 (5%)
Query: 308 VPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV 367
V + + + ++ S +HRD+ N + VK+ D GL R ++S S P
Sbjct: 113 VQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPY 171
Query: 368 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQ-PYYG 406
+M PE I + +SD+WS G +L+E+ + LQ P+YG
Sbjct: 172 -YMSPERIHENGYNFKSDIWSLGCLLYEMAA--LQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 61/277 (22%), Positives = 110/277 (39%), Gaps = 64/277 (23%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLK--ENANQKTASDFRREVDLMSELRHPNIVCL 119
+G GAFG+V V + + A+K L+ E ++ + R E D+++E +P +V L
Sbjct: 9 IGRGAFGEVRL--VQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 120 LGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGM 179
+ ++ E++ GD+ LM + D F+ +
Sbjct: 67 YYSFQDENYLYLIMEYLPGGDMMTLLM----KKDT-------------FTEEETRFYIAE 109
Query: 180 AYLC-----SHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV---YASDYYRIQSKSLLP 231
L Y+HRD+ N L+ +K+SDFGL + + +++YRI S +L
Sbjct: 110 TILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169
Query: 232 VR---------------------------------WMPPESILYGKFTTESDVWSYGVVL 258
++ PE L + E D WS GV++
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229
Query: 259 WEVYSYGLQPYYGYSNQEV-IEMIRSRQMLPCPEDCP 294
+E+ G P+ + QE ++I ++ L P++ P
Sbjct: 230 YEML-VGYPPFCSDNPQETYRKIINWKETLQFPDEVP 265
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 36/133 (27%), Positives = 59/133 (44%), Gaps = 31/133 (23%)
Query: 276 EVIEMIRSRQMLPCPED--CPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCL 333
E +++ + M P PP + S + + + G+AY SH +HRDL +N L
Sbjct: 78 EFLDLDLKKYMDSSPLTGLDPPLIKSYLYQ------LLQGIAYCHSHRVLHRDLKPQNLL 131
Query: 334 VGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR---------WM-PPESILYGK-FTT 382
+ +K++DFGL+R +PVR W PE +L + ++T
Sbjct: 132 IDREGALKLADFGLARAFG------------VPVRTYTHEVVTLWYRAPEILLGSRQYST 179
Query: 383 ESDVWSYGVVLWE 395
D+WS G + E
Sbjct: 180 PVDIWSIGCIFAE 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 32/95 (33%), Positives = 48/95 (50%), Gaps = 9/95 (9%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV-RWMP 371
G+AYL S +HRD+ N L+ D VK++DFG++ + A+ R KS + WM
Sbjct: 118 GLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR---KSFIGTPYWMA 174
Query: 372 PESILY---GKFTTESDVWSYGVVLWEVYSYGLQP 403
PE G + D+W+ G+ E+ LQP
Sbjct: 175 PEVAAVEKNGGYNQLCDIWAVGITAIELAE--LQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 5/99 (5%)
Query: 308 VPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV 367
+ V ++ L + +HRD+ + + L+ VK+SDFG V R KSL+
Sbjct: 123 LAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR---KSLVGT 179
Query: 368 -RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYY 405
WM PE I + E D+WS G+++ E+ G PY+
Sbjct: 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVD-GEPPYF 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 26/89 (29%), Positives = 46/89 (51%), Gaps = 7/89 (7%)
Query: 313 GMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFG----LSRDVYASDYYRIQSKSLLPV 367
G++YL + +HRD+ N L+ G ++I+DFG L+ + + Q + L +
Sbjct: 115 GLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEF--QGQLLGTI 172
Query: 368 RWMPPESILYGKFTTESDVWSYGVVLWEV 396
+M PE + ++ DVWS G V+ E+
Sbjct: 173 AFMAPEVLRGEQYGRSCDVWSVGCVIIEM 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 28/113 (24%), Positives = 58/113 (51%), Gaps = 5/113 (4%)
Query: 304 CWHEVPVAAGMAYLCSHHYVHRDLAARNC-LVGDGLTVKISDFGLSRDVYASDYYRIQSK 362
W V ++ G+ ++ +HRD+ ++N L +G+ K+ DFG++R + +D +
Sbjct: 105 SWF-VQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSMELAYT 161
Query: 363 SLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
+ ++ PE + ++D+WS G VL+E+ + P+ G + + LK
Sbjct: 162 CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK-HPFEGNNLHQLVLK 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 25/92 (27%), Positives = 49/92 (53%), Gaps = 2/92 (2%)
Query: 305 WHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 364
W+ + + ++Y+ +HRD+ N + +K+ DFG+S+ + S+Y ++
Sbjct: 105 WYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISK-ILGSEYSMAETVVG 163
Query: 365 LPVRWMPPESILYGKFTTESDVWSYGVVLWEV 396
P +M PE K+ +SD+W+ G VL+E+
Sbjct: 164 TPY-YMSPELCQGVKYNFKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 3/87 (3%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM-P 371
+ Y+ + + HRDL +N L +KI DFGL+R + I + RW
Sbjct: 115 ALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 372 PE--SILYGKFTTESDVWSYGVVLWEV 396
PE + K+T D+WS G + EV
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEV 201
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 31/91 (34%), Positives = 45/91 (49%), Gaps = 3/91 (3%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR--DVYASDYYRIQSKSLLPV 367
+ GM+YL S+ VHRD+ N L VK+ DFG S+ I+S + P
Sbjct: 115 ILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPY 174
Query: 368 RWMPPESILYGKFTTESDVWSYGVVLWEVYS 398
WM PE I + ++DVWS G + E+ +
Sbjct: 175 -WMSPEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 7/91 (7%)
Query: 308 VPVAAGMAYLCSHHYV-HRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 366
+ V G+ YL H + HRD+ N LV +K+ DFG+S + S + S +
Sbjct: 110 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVG 164
Query: 367 VR-WMPPESILYGKFTTESDVWSYGVVLWEV 396
R +M PE + ++ +SD+WS G+ L E+
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 33/121 (27%), Positives = 54/121 (44%), Gaps = 19/121 (15%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS-----RDVYASDYYRIQSKSLLPV 367
G+ +L ++RDL N L+ +KI+DFG+ + AS +
Sbjct: 108 GLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPD------ 161
Query: 368 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF----LKTP--PSWI 421
++ PE + K+ D WS+GV+L+E+ G P++G E F P P WI
Sbjct: 162 -YIAPEILKGQKYNESVDWWSFGVLLYEML-IGQSPFHGEDEDELFDSILNDRPHFPRWI 219
Query: 422 T 422
+
Sbjct: 220 S 220
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 54/221 (24%), Positives = 89/221 (40%), Gaps = 20/221 (9%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK--ENANQKTASDFRREVDLMSELRHPNI 116
L+ +G GAFG+V V + A+K L E + + FR E D++ + I
Sbjct: 6 LKVIGRGAFGEV--AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWI 63
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
L + ++ ++ V GDL L S + + P F + +A
Sbjct: 64 TTLHYAFQDENNLYLVMDYYVGGDLLTLL---------SKFEDRLPEDMARFYLAEMVIA 114
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG----LSRDVYASDYYRIQSKSLLPV 232
+ HYVHRD+ N L+ ++++DFG L D + + +
Sbjct: 115 IDSVH--QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 172
Query: 233 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS 273
+ GK+ E D WS GV ++E+ YG P+Y S
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEML-YGETPFYAES 212
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 32/171 (18%), Positives = 60/171 (35%), Gaps = 23/171 (13%)
Query: 161 APLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD 220
PL++++ + LQ + +HR + N L+ +K+ + S
Sbjct: 12 RPLNEEEIWAVCLQCLGAL------RELHRQAKSGNILLTWDGLLKLDGSVAFKTPEQSR 65
Query: 221 YYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN-QEVIE 279
+M PE I +T ++D++S G+ L+E Y L Y+ +E+
Sbjct: 66 PDPY---------FMAPEVIQGQSYTEKADIYSLGITLYEALDYEL----PYNEERELSA 112
Query: 280 MIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAAR 330
++ +D R +E LC+ R AA
Sbjct: 113 ILEILLNGMPADDPRDRS---NLEGVSAARSFEDFMRLCASRLPQRREAAN 160
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 27/87 (31%), Positives = 47/87 (54%), Gaps = 7/87 (8%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR-DVYASDYYRIQSKSLLPVRWMP 371
G++Y+ + +HRDL +N L+ D +K++DFGL+R S Y + +L W
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTL----WYR 170
Query: 372 PESILYG--KFTTESDVWSYGVVLWEV 396
P +L G +++T D+W G + E+
Sbjct: 171 PPDVLLGSTEYSTCLDMWGVGCIFVEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 25/88 (28%), Positives = 41/88 (46%), Gaps = 20/88 (22%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS---------RDVYASDYYRIQSKS 363
G+ YL +HRD+ A N L+ + VK++DFG+S R+ + +
Sbjct: 110 GLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPF------ 163
Query: 364 LLPVRWMPPESILYGKFTTESDVWSYGV 391
WM PE I + ++D+WS G+
Sbjct: 164 -----WMAPEVIKQSGYDEKADIWSLGI 186
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 29/99 (29%), Positives = 49/99 (49%), Gaps = 3/99 (3%)
Query: 308 VPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV 367
V + + + ++ S +HRD+ N + VK+ D GL R ++S S P
Sbjct: 113 VQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPY 171
Query: 368 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG 406
+M PE I + +SD+WS G +L+E+ + P+YG
Sbjct: 172 -YMSPERIHENGYNFKSDIWSLGCLLYEMAALQ-SPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 28/89 (31%), Positives = 45/89 (50%), Gaps = 3/89 (3%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 372
G+ +L S +HRDL N +V T+KI DFGL+R S + + ++ + P
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAP 194
Query: 373 ESILYGKFTTESDVWSYGVVLWEVYSYGL 401
E IL + D+WS G ++ E+ G+
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKGGV 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 29/105 (27%), Positives = 56/105 (53%), Gaps = 5/105 (4%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV-R 368
+A G+ +L S ++RDL N ++ +KI+DFG+ ++ + + + +K+
Sbjct: 110 IAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE---NMWDGVTTKTFCGTPD 166
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
++ PE I Y + D W++GV+L+E+ + G P+ G E F
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQAPFEGEDEDELF 210
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 28/88 (31%), Positives = 47/88 (53%), Gaps = 7/88 (7%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD----YYRIQSKSLLPVR 368
G+ Y+ S + +HRDL N LV + ++I DFG++R + +S Y+ + + R
Sbjct: 119 GLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178
Query: 369 WMPPESIL-YGKFTTESDVWSYGVVLWE 395
PE +L ++TT D+WS G + E
Sbjct: 179 --APELLLSLPEYTTAIDMWSVGCIFAE 204
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM-P 371
G+ Y+ + +HRDL N V + +KI DFGL+R + + + RW
Sbjct: 130 GLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS------EMTGYVVTRWYRA 183
Query: 372 PESIL-YGKFTTESDVWSYGVVLWEVYS 398
PE IL + +T D+WS G ++ E+ +
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 27/84 (32%), Positives = 44/84 (52%), Gaps = 3/84 (3%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 372
G+ +L S +HRDL N +V T+KI DFGL+R A + + + ++ + P
Sbjct: 135 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--ACTNF-MMTPYVVTRYYRAP 191
Query: 373 ESILYGKFTTESDVWSYGVVLWEV 396
E IL + D+WS G ++ E+
Sbjct: 192 EVILGMGYKENVDIWSVGCIMGEL 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 54/228 (23%), Positives = 103/228 (45%), Gaps = 30/228 (13%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVD-LMSELR-------H 113
LG+G+FGKV E+ ++ + AIK LK++ + +VD M+E R H
Sbjct: 3 LGKGSFGKVMLAELKGTD--EVYAIKVLKKDVILQD-----DDVDCTMTEKRILALAAKH 55
Query: 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
P + L + + + + E++ GDL F + RS + D S+ A
Sbjct: 56 PFLTALHCCFQTKDRLFFVMEYVNGGDLM-FQIQRSRKFDEPRSRFYAA----------- 103
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR 233
+V + +L H ++RDL N L+ K++DFG+ ++ + +
Sbjct: 104 EVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPD 161
Query: 234 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281
++ PE + ++ D W+ GV+++E+ + G P+ + ++ E I
Sbjct: 162 YIAPEILQELEYGPSVDWWALGVLMYEMMA-GQPPFEADNEDDLFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 23/218 (10%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLK--ENANQKTASDFRREVDLMSELRHPNIVCL 119
+G GAFG+V +S+ + A+K L E + ++ F E D+M+ P +V L
Sbjct: 51 IGRGAFGEVQLVRHKSSQ--KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 120 LGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGM 179
+ + M+ E+M GDL + S P F +V +
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLM-----------SNYDVPEKWAKF--YTAEVVLAL 155
Query: 180 AYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPES 239
+ S +HRD+ N L+ +K++DFG + + R + P ++ PE
Sbjct: 156 DAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTP-DYISPEV 214
Query: 240 ILY----GKFTTESDVWSYGVVLWEVYSYGLQPYYGYS 273
+ G + E D WS GV L+E+ G P+Y S
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEML-VGDTPFYADS 251
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 25/219 (11%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLV-AIKTLK--ENANQKTASDFRREVDLMSELRHPNIVC 118
+G GAFG+V ++ + V A+K L E + ++ F E D+M+ P +V
Sbjct: 51 IGRGAFGEV---QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
L + M+ E+M GDL + S P F +V
Sbjct: 108 LFYAFQDDRYLYMVMEYMPGGDLVNLM-----------SNYDVPEKWARF--YTAEVVLA 154
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPE 238
+ + S ++HRD+ N L+ +K++DFG + R + P ++ PE
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP-DYISPE 213
Query: 239 SILY----GKFTTESDVWSYGVVLWEVYSYGLQPYYGYS 273
+ G + E D WS GV L+E+ G P+Y S
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEML-VGDTPFYADS 251
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 31/113 (27%), Positives = 56/113 (49%), Gaps = 24/113 (21%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR---- 368
G+AY +HRDL +N L+ + +K++DFGL+R +KS +P +
Sbjct: 115 GLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLAR-----------AKS-VPSKTYSN 162
Query: 369 -----WMPPESILYG--KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFL 414
W P +L G +++T D+W G + +E+ + G + G ++ E+ L
Sbjct: 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT-GRPLFPGSTDVEDQL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 4e-05
Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 9/95 (9%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV-RWMP 371
G+ YL S +HRD+ N L+ D VK++DFG+S + A+ R KS + WM
Sbjct: 118 GLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR---KSFIGTPYWMA 174
Query: 372 PESILY---GKFTTESDVWSYGVVLWEVYSYGLQP 403
PE G + D+W+ G+ E+ LQP
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIELAE--LQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 40/151 (26%), Positives = 68/151 (45%), Gaps = 28/151 (18%)
Query: 279 EMIRSRQMLPCPEDCPPR-MYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDG 337
E+I+ R+ P PE MY L+ + ++ + HRD+ N L+ D
Sbjct: 88 ELIKGRKR-PLPEKRVKSYMYQLL----------KSLDHMHRNGIFHRDIKPENILIKDD 136
Query: 338 LTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM-PPESILY-GKFTTESDVWSYGVVLWE 395
+K++DFG R +Y+ Y + RW PE +L G + + D+W+ G V +E
Sbjct: 137 -ILKLADFGSCRGIYSKPPYTE----YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFE 191
Query: 396 VYSYGLQPYYGYSNQ-------EEFLKTPPS 419
+ S L P + +N+ + L TP +
Sbjct: 192 ILS--LFPLFPGTNELDQIAKIHDVLGTPDA 220
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 24/89 (26%), Positives = 44/89 (49%), Gaps = 2/89 (2%)
Query: 308 VPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV 367
V +A + YL H +HRDL +N + +K+ D G++R + + + S +
Sbjct: 109 VQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLIGTP 166
Query: 368 RWMPPESILYGKFTTESDVWSYGVVLWEV 396
+M PE + +SDVW+ G ++E+
Sbjct: 167 YYMSPELFSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 62/286 (21%), Positives = 117/286 (40%), Gaps = 75/286 (26%)
Query: 59 LQELGEGAFGKVYKGEVCTS---EGPSLVAIKTLKEN----ANQKTASDFRREVDLMSEL 111
++ LG GAFG EVC + + +L A+KTL++ NQ + + E D+++E
Sbjct: 6 IKTLGIGAFG-----EVCLARKVDTKALYAMKTLRKKDVLLRNQ--VAHVKAERDILAEA 58
Query: 112 RHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHI 171
+ +V L + F + +L+ F+M P D+ ++ + +D +
Sbjct: 59 DNEWVVRLY------------YSFQDKDNLY-FVMDYIPGGDMMSLLIRMGIFPEDLARF 105
Query: 172 AL-QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS---RDVYASDYYR---- 223
+ ++ + + ++HRD+ N L+ +K++DFGL R + S YY+
Sbjct: 106 YIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDH 165
Query: 224 IQSKS------------------LLPVRW--------------------MPPESILYGKF 245
++ S L P+ + PE +L +
Sbjct: 166 VRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY 225
Query: 246 TTESDVWSYGVVLWEVYSYGLQPYYGYSNQEV-IEMIRSRQMLPCP 290
T D WS GV+L+E+ G P+ + E +++I + L P
Sbjct: 226 TQLCDWWSVGVILYEML-VGQPPFLAQTPLETQMKVINWQTSLHIP 270
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 28/90 (31%), Positives = 45/90 (50%), Gaps = 12/90 (13%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVG-DGLTVKISDFGLSRDVYASDYYRIQSKS----LLPV 367
G+A+ H +HRDL +N LV +KI+D GL R + I KS ++ +
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA------FSIPVKSYTHEIVTL 175
Query: 368 RWMPPESILYGK-FTTESDVWSYGVVLWEV 396
+ PE +L ++T D+WS G + E+
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 5e-05
Identities = 27/84 (32%), Positives = 43/84 (51%), Gaps = 3/84 (3%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 372
G+ +L S +HRDL N +V T+KI DFGL+R S + + ++ + P
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAP 187
Query: 373 ESILYGKFTTESDVWSYGVVLWEV 396
E IL + D+WS G ++ E+
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 27/105 (25%), Positives = 53/105 (50%), Gaps = 5/105 (4%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV-R 368
++ G+ +L ++RDL N ++ +KI+DFG+ ++ + +++
Sbjct: 110 ISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE---HMVDGVTTRTFCGTPD 166
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
++ PE I Y + D W+YGV+L+E+ + G P+ G E F
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLA-GQPPFDGEDEDELF 210
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 49/211 (23%), Positives = 86/211 (40%), Gaps = 19/211 (9%)
Query: 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSE 110
V+ + L L G+ G+V+ VCT G +K KT RE+D++
Sbjct: 89 VVRMQYNILSSLTPGSEGEVF---VCTKHGDEQRKKVIVKAVTGGKTPG---REIDILKT 142
Query: 111 LRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSH 170
+ H I+ L+ +CM+ + DL ++ D SG PL +
Sbjct: 143 ISHRAIINLIHAYRWKSTVCMVMP-KYKCDLFTYV-------DRSG-----PLPLEQAIT 189
Query: 171 IALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL 230
I ++ +AYL +HRD+ N + + + DFG + + A
Sbjct: 190 IQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSG 249
Query: 231 PVRWMPPESILYGKFTTESDVWSYGVVLWEV 261
+ PE + + ++D+WS G+VL+E+
Sbjct: 250 TLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 6e-05
Identities = 25/63 (39%), Positives = 35/63 (55%), Gaps = 4/63 (6%)
Query: 6 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRRE----VIETKPRFLQE 61
QE+G G FGKV E+ T G + V +K LK NA+ K ++F ++ I P LQ
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 62 LGE 64
LG+
Sbjct: 61 LGQ 63
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 41/123 (33%), Positives = 58/123 (47%), Gaps = 27/123 (21%)
Query: 294 PPRMY-SLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLV-GDGL---TVKISDFGLS 348
PP M SL+ + + G+ YL S+ +HRDL N LV G+G VKI D GL+
Sbjct: 106 PPSMVKSLLWQILN------GVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159
Query: 349 RDVYASDYYRIQSKSLL---PVR---WM-PPESILYGK-FTTESDVWSYGVVLWEVYSYG 400
R A K L PV W PE +L + +T D+W+ G + E+ +
Sbjct: 160 RLFNAP------LKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-- 211
Query: 401 LQP 403
L+P
Sbjct: 212 LEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 29/92 (31%), Positives = 40/92 (43%), Gaps = 21/92 (22%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR---------DVYASDYYRIQSKS 363
G+ +L S +HRDL N +V T+KI DFGL+R + YYR
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR----- 184
Query: 364 LLPVRWMPPESILYGKFTTESDVWSYGVVLWE 395
PE IL + D+WS G ++ E
Sbjct: 185 -------APEVILGMGYKENVDIWSVGCIMGE 209
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 29/109 (26%), Positives = 52/109 (47%), Gaps = 3/109 (2%)
Query: 305 WHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 364
++ +A+ + YL S + V+RDL N L+ + ++DFGL ++ + S
Sbjct: 100 FYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTSTFC 157
Query: 365 LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
++ PE + + D W G VL+E+ YGL P+Y + E +
Sbjct: 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML-YGLPPFYSRNTAEMY 205
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 41/180 (22%), Positives = 75/180 (41%), Gaps = 32/180 (17%)
Query: 89 LKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSR 148
+K TA+ E ++ + HP+I+ L G + C++ + DL+ +L ++
Sbjct: 122 IKAGQRGGTAT----EAHILRAINHPSIIQLKGTFTYNKFTCLILP-RYKTDLYCYLAAK 176
Query: 149 SPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208
++ D I V + YL + +HRD+ A N + V +
Sbjct: 177 RN------------IAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLG 224
Query: 209 DFGLS---RDVYASDYY----RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEV 261
DFG + D+ A+ YY I + + PE + + D+WS G+VL+E+
Sbjct: 225 DFGAACFPVDINANKYYGWAGTIATNA--------PELLARDPYGPAVDIWSAGIVLFEM 276
|
Length = 391 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 7e-05
Identities = 25/87 (28%), Positives = 47/87 (54%), Gaps = 5/87 (5%)
Query: 323 VHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTT 382
VHRDL N ++G+ V I+DFGL++ ++L + PE + +
Sbjct: 136 VHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTIL---YSCPEIVKNEPYGE 192
Query: 383 ESDVWSYGVVLWEVYSYGLQPYYGYSN 409
++DVW++G +L+++ + LQP + +N
Sbjct: 193 KADVWAFGCILYQMCT--LQPPFYSTN 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 7e-05
Identities = 52/253 (20%), Positives = 101/253 (39%), Gaps = 42/253 (16%)
Query: 42 KTASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEG-PSLVAIKTLKENANQKTASD 100
K+ S+ + + + +L +G FGKV V + L K +K A +
Sbjct: 4 KSLSELVQFLKNCEIVKKLKLIDGKFGKVS---VLKHKPTQKLFVQKIIK-------AKN 53
Query: 101 FRR-EV---DLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISG 156
F E LM + +PN + L + + ++ +++ GDL + L
Sbjct: 54 FNAIEPMVHQLMKD--NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL----------- 100
Query: 157 SQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLT-VKISDFGLSRD 215
+ + LS+ + I Q+ + L H+ +H D+ N L + + D+GL +
Sbjct: 101 -KKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK- 158
Query: 216 VYASDYYRIQSKSLL--PVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS 273
I + S + + PE I + D W+ GV+ +E+ + P+
Sbjct: 159 -------IIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK-HPFKEDE 210
Query: 274 NQEV-IEMIRSRQ 285
++E+ +E + RQ
Sbjct: 211 DEELDLESLLKRQ 223
|
Length = 267 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 7e-05
Identities = 55/273 (20%), Positives = 109/273 (39%), Gaps = 53/273 (19%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK--ENANQKTASDFRREVDLMSELRHPNI 116
L+ +G GAFG+V V + + A+K L+ + ++ R E D++ E +
Sbjct: 6 LKVIGRGAFGEVRL--VQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWV 63
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V + + ++ EF+ GD+ LM + L++++ +
Sbjct: 64 VKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT------------LTEEETQFYIAETV 111
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS---RDVYASDYYRIQSKSL---- 229
+ + ++HRD+ N L+ VK+SDFGL + + +++YR + SL
Sbjct: 112 LAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 230 ---------------------------LPVRWMPPESILYGKFTTESDVWSYGVVLWEVY 262
P ++ PE + + D WS GV+++E+
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTP-DYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
Query: 263 SYGLQPYYGYSNQEVIEMIRS-RQMLPCPEDCP 294
G P+ + QE + + + ++ L P + P
Sbjct: 231 -IGYPPFCSETPQETYKKVMNWKETLIFPPEVP 262
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 27/97 (27%), Positives = 48/97 (49%), Gaps = 4/97 (4%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+ G+ L + V+RDL N L+ D ++ISD GL+ + + R + + V +
Sbjct: 111 ILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGT---VGY 167
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG 406
M PE + ++T D W G +++E+ G P+ G
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIE-GQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 55/272 (20%), Positives = 109/272 (40%), Gaps = 51/272 (18%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHPNI 116
L+ +G GAFG+V V + + A+K L++ ++ + R E D++ E +
Sbjct: 6 LKVIGRGAFGEVRL--VQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWV 63
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V + + ++ EF+ GD+ LM + LS++ +
Sbjct: 64 VKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT------------LSEEATQFYIAETV 111
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS---RDVYASDYYR---------- 223
+ + ++HRD+ N L+ VK+SDFGL + + +++YR
Sbjct: 112 LAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF 171
Query: 224 ----IQSK----------------SLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYS 263
+ SK ++ ++ PE + + D WS GV+++E+
Sbjct: 172 SFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML- 230
Query: 264 YGLQPYYGYSNQEVIEMIRS-RQMLPCPEDCP 294
G P+ + QE + + ++ L P + P
Sbjct: 231 IGYPPFCSETPQETYRKVMNWKETLVFPPEVP 262
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 9e-05
Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 5/97 (5%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR-DVYASDYYRIQSKSLLPVR 368
+A+ + YL S + ++RDL N L+ V ++DFGL + + S S
Sbjct: 105 IASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK---TTSTFCGTPE 161
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYY 405
++ PE + + D W G VL+E+ YGL P+Y
Sbjct: 162 YLAPEVLRKQPYDRTVDWWCLGAVLYEML-YGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 9e-05
Identities = 55/221 (24%), Positives = 96/221 (43%), Gaps = 20/221 (9%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASD--FRREVDLMSELRHPNI 116
++ +G GAFG+V ++ +E + A+K L + K A FR E +++ I
Sbjct: 6 IKVIGRGAFGEVAVVKMKHTE--RIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWI 63
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
L + ++ ++ V GDL L S + + P F +IA V
Sbjct: 64 TTLHYAFQDENYLYLVMDYYVGGDLLTLL---------SKFEDRLPEDMARF-YIAEMVL 113
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG----LSRDVYASDYYRIQSKSLLPV 232
A + + HYVHRD+ N L+ ++++DFG +++D + + +
Sbjct: 114 A-IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISP 172
Query: 233 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS 273
+ GK+ E D WS GV ++E+ YG P+Y S
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEML-YGETPFYAES 212
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 29/94 (30%), Positives = 44/94 (46%), Gaps = 22/94 (23%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR------DVYASDYYRIQSKSLLP 366
+AY SH+ +HRD+ N LV + +K+ DFG +R +DY +
Sbjct: 112 AIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDY--------VA 163
Query: 367 VRWM-PPESIL----YGKFTTESDVWSYGVVLWE 395
RW PE ++ YGK DVW+ G ++ E
Sbjct: 164 TRWYRAPELLVGDTNYGK---PVDVWAIGCIMAE 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 28/97 (28%), Positives = 44/97 (45%), Gaps = 25/97 (25%)
Query: 314 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS---------RDVYASDYYRIQSKSL 364
+ YL S +HRDL A N L+ +K++DFG+S RD + Y
Sbjct: 123 LQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPY------- 175
Query: 365 LPVRWMPPESILY-----GKFTTESDVWSYGVVLWEV 396
WM PE ++ + ++D+WS G+ L E+
Sbjct: 176 ----WMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 30/96 (31%), Positives = 44/96 (45%), Gaps = 24/96 (25%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGL-TVKISDFGLSRDVYASDYYRIQSKSLLPVR--- 368
G+AY SH +HRDL +N L+ +K++DFGL+R +PVR
Sbjct: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG------------IPVRTFT 161
Query: 369 ------WMPPESILYGK--FTTESDVWSYGVVLWEV 396
W IL G ++T D+WS G + E+
Sbjct: 162 HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEM 197
|
Length = 294 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 28/87 (32%), Positives = 42/87 (48%), Gaps = 12/87 (13%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR--DVYASDYYRIQSKSLLPVRW- 369
G+ Y+ S +HRDL N V + +KI DFGL+R D + Y + RW
Sbjct: 130 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGY--------VATRWY 181
Query: 370 MPPESIL-YGKFTTESDVWSYGVVLWE 395
PE +L + + D+WS G ++ E
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAE 208
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 1e-04
Identities = 26/89 (29%), Positives = 45/89 (50%), Gaps = 7/89 (7%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 372
G+++L H +HRD+ +N L+ + VK+ DFG+S + + R + + WM P
Sbjct: 123 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPYWMAP 180
Query: 373 ESILY-----GKFTTESDVWSYGVVLWEV 396
E I + +SD+WS G+ E+
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 29/98 (29%), Positives = 39/98 (39%), Gaps = 27/98 (27%)
Query: 320 HHYVHRDLAARNCLVGDGLTVKISDFGLS----------RDVYASDYYRIQSKSLLPVRW 369
+HRD+ N L+ +K+ DFG+S RD Y
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPY------------- 173
Query: 370 MPPESIL---YGKFTTESDVWSYGVVLWEVYSYGLQPY 404
M PE I + SDVWS G+ L+EV + G PY
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEV-ATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 27/89 (30%), Positives = 43/89 (48%), Gaps = 7/89 (7%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 372
G+ +L + +HRD+ N L+ VK+ DFG+S + ++ R + S+ WM P
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR--NTSVGTPFWMAP 193
Query: 373 ESI-----LYGKFTTESDVWSYGVVLWEV 396
E I L + DVWS G+ E+
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 30/89 (33%), Positives = 45/89 (50%), Gaps = 5/89 (5%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR---DVYASDYYRIQSKSLLPVRW 369
G++YL S+ VHRD+ N L VK+ DFG S+ + S I+S + P W
Sbjct: 118 GVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSG-TGIKSVTGTPY-W 175
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYS 398
M PE I + ++DVWS + E+ +
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 1/87 (1%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV-RWMP 371
G++YL S+ VHRD+ N L VK+ DFG S+ + KS+ WM
Sbjct: 118 GVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177
Query: 372 PESILYGKFTTESDVWSYGVVLWEVYS 398
PE I + ++D+WS G + E+ +
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 32/105 (30%), Positives = 51/105 (48%), Gaps = 5/105 (4%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRD-VYASDYYRIQSKSLLPVR 368
+A+ + YL S + V+RDL N L+ V ++DFGL ++ + SD +
Sbjct: 105 IASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---TTTTFCGTPE 161
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
++ PE I + D W G VL+E+ YGL P+Y E +
Sbjct: 162 YLAPEVIRKQPYDNTVDWWCLGAVLYEML-YGLPPFYCRDVAEMY 205
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 23/223 (10%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK--ENANQKTASDFRREVDLMSELRHP 114
++ +G GAFG+V +S+ + A+K L E + ++ F E D+M+
Sbjct: 46 DVIKVIGRGAFGEVQLVRHKSSK--QVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSE 103
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
IV L + + M+ E+M GDL + S P F + A +
Sbjct: 104 WIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM-----------SNYDIPEKWARF-YTA-E 150
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 234
V + + S ++HRD+ N L+ +K++DFG + A+ R + P +
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTP-DY 209
Query: 235 MPPESIL----YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS 273
+ PE + G + E D WS GV L+E+ G P+Y S
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEML-VGDTPFYADS 251
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 5/113 (4%)
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 229
+IA V A + +L + V+RDL N L+ + + DFGLS+ + + +
Sbjct: 101 YIAELVLA-LEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNTFC 157
Query: 230 LPVRWMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281
++ PE +L K +T D WS GV+++E+ G P+Y Q++ I
Sbjct: 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEM-CCGWSPFYAEDTQQMYRNI 209
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 59/264 (22%), Positives = 103/264 (39%), Gaps = 45/264 (17%)
Query: 57 RFLQELGEGAFGKV-------YKGEVCTSEGPSLVAIKTLKEN--------ANQKTASDF 101
R + +L GAFGK+ E G + K A + A
Sbjct: 151 RVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQL 210
Query: 102 RREVDLMSELRHPNIVCLLGVCLSGEPMCML---FEFMVRGDLHEFLMSRSPRSDISGSQ 158
E+ + L H NI+ + + S M+ ++F DL+ F+ D +
Sbjct: 211 ENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMY------DEAFDW 260
Query: 159 VQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNC-LVGDGLTVKISDFG----LS 213
PL +Q I Q+ + Y+ +HRD+ N L DG V + DFG
Sbjct: 261 KDRPLLKQT-RAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIV-LGDFGTAMPFE 318
Query: 214 RDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS 273
++ A DY + + V PE + + +D+WS G++L ++ S+ P
Sbjct: 319 KEREAFDYGWVGT-----VATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGG 373
Query: 274 ---NQEVIEMIRSRQMLPCPEDCP 294
++++++I S + C E+ P
Sbjct: 374 GKPGKQLLKIIDSLSV--CDEEFP 395
|
Length = 501 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 24/85 (28%), Positives = 47/85 (55%), Gaps = 3/85 (3%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 372
G+ + S +HRDL +N L+ + +K++DFGL+R R+ + ++ + + P
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VRVYTHEVVTLWYRAP 170
Query: 373 ESILYG-KFTTESDVWSYGVVLWEV 396
E +L +++T D+WS G + E+
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEM 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 25/93 (26%), Positives = 46/93 (49%), Gaps = 8/93 (8%)
Query: 314 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL--PVRWMP 371
YL + ++RDL N L+ VK+ DFG ++ + + ++ + P ++
Sbjct: 106 FEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS----GQKTWTFCGTP-EYVA 160
Query: 372 PESILYGKFTTESDVWSYGVVLWEVYSYGLQPY 404
PE IL + D WS G++L+E+ + G P+
Sbjct: 161 PEIILNKGYDFSVDYWSLGILLYELLT-GRPPF 192
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 27/106 (25%), Positives = 52/106 (49%), Gaps = 7/106 (6%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV- 367
+ G+ +L ++RDL N L+ +G +KI+DFG+ ++ + + +
Sbjct: 105 IVLGLQFLHERGIIYRDLKLDNVLLDSEG-HIKIADFGMCKE---GILGGVTTSTFCGTP 160
Query: 368 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
++ PE + Y + D W+ GV+L+E+ + G P+ G E F
Sbjct: 161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLA-GQSPFEGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 30/118 (25%), Positives = 59/118 (50%), Gaps = 3/118 (2%)
Query: 296 RMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD 355
R++S ++ + + + YL S V+RDL N ++ +KI+DFGL ++ +D
Sbjct: 90 RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKE-GITD 148
Query: 356 YYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
+++ P ++ PE + + D W GVV++E+ G P+Y +++ F
Sbjct: 149 AATMKTFCGTP-EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLF 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 28/86 (32%), Positives = 42/86 (48%), Gaps = 8/86 (9%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM-P 371
G+ Y+ S +HRDL N V + +KI DFGL+R A + + RW
Sbjct: 129 GLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA------EMTGYVVTRWYRA 182
Query: 372 PESIL-YGKFTTESDVWSYGVVLWEV 396
PE IL + + D+WS G ++ E+
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEM 208
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 26/93 (27%), Positives = 48/93 (51%), Gaps = 1/93 (1%)
Query: 319 SHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG 378
S +HRDL + N + +K+ DFG S+ S + S ++ PE
Sbjct: 187 SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERK 246
Query: 379 KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
+++ ++D+WS GV+L+E+ + +P+ G S +E
Sbjct: 247 RYSKKADMWSLGVILYELLTLH-RPFKGPSQRE 278
|
Length = 478 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 28/95 (29%), Positives = 50/95 (52%), Gaps = 4/95 (4%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+ G+ L V+RDL N L+ D ++ISD GL+ V+ + I+ + + V +
Sbjct: 111 ICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR-VGTVGY 167
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPY 404
M PE + ++T D W+ G +L+E+ + G P+
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIA-GQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 28/99 (28%), Positives = 47/99 (47%), Gaps = 5/99 (5%)
Query: 321 HYVHRDLAARNCLVGDGLTVKISDFG----LSRDVYASDYYRIQSKSLLPVRWMPPESIL 376
HYVHRD+ N L+ ++++DFG +++D + + + +
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDG 181
Query: 377 YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
GK+ E D WS GV ++E+ YG P+Y S E + K
Sbjct: 182 MGKYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGK 219
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 55/250 (22%), Positives = 102/250 (40%), Gaps = 61/250 (24%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTL--KENANQKTASDFRREVDLMSELRHPNI 116
++ LG GAFG+V C + +L A+KTL K+ N+ + + E D+++E + +
Sbjct: 6 IKTLGIGAFGEVCL--ACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWV 63
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V L + + + +++ GD+ L+ ++ A L+ +A++
Sbjct: 64 VKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELT------LAIESV 117
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS---RDVYASDYYR----IQSKSL 229
M + +HRD+ N L+ +K++DFGL R + S YY+ I+ S+
Sbjct: 118 HKMGF------IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSM 171
Query: 230 LPV--------------------------------------RWMPPESILYGKFTTESDV 251
P ++ PE +L +T D
Sbjct: 172 EPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW 231
Query: 252 WSYGVVLWEV 261
WS GV+L+E+
Sbjct: 232 WSVGVILFEM 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 19/47 (40%), Positives = 28/47 (59%), Gaps = 1/47 (2%)
Query: 6 QELGEGAFGKVYKGEVCTSEGPSL-VAIKTLKENANQKTASDFRREV 51
++LG+G+FG V +GE TS G + VA+K LK + DF +E
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEA 47
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 27/90 (30%), Positives = 43/90 (47%), Gaps = 15/90 (16%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA-----SDYYRIQSKSLLPV 367
G+ + SH+ +HRD+ N LV VK+ DFG +R + A +DY +
Sbjct: 112 GIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY--------VAT 163
Query: 368 RWMPPESILYG--KFTTESDVWSYGVVLWE 395
RW +L G K+ D+W+ G ++ E
Sbjct: 164 RWYRAPELLVGDTKYGRAVDIWAVGCLVTE 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 24/87 (27%), Positives = 44/87 (50%), Gaps = 3/87 (3%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+ G+ +L V+RDL N L+ D V+ISD GL+ ++ +I+ ++ P +
Sbjct: 104 IICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVEL--KGGKKIKGRAGTP-GY 160
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEV 396
M PE + + D ++ G L+E+
Sbjct: 161 MAPEVLQGEVYDFSVDWFALGCTLYEM 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM-P 371
G+ Y+ S +HRDL N V + +KI DFGL+R + D + + RW
Sbjct: 132 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDD----EMTGYVATRWYRA 185
Query: 372 PESIL-YGKFTTESDVWSYGVVLWEVYS 398
PE +L + + D+WS G ++ E+ +
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 26/98 (26%), Positives = 47/98 (47%), Gaps = 4/98 (4%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+ G+ L V+RDL N L+ D ++ISD GL+ ++ + R + + V +
Sbjct: 111 ITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGT---VGY 167
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY 407
M PE + ++T D W G +++E+ G P+
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIE-GKSPFRQR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 29/99 (29%), Positives = 45/99 (45%), Gaps = 5/99 (5%)
Query: 321 HYVHRDLAARNCLVGDGLTVKISDFG----LSRDVYASDYYRIQSKSLLPVRWMPPESIL 376
HYVHRD+ N L+ ++++DFG L D + + + +
Sbjct: 122 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDG 181
Query: 377 YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
GK+ E D WS GV ++E+ YG P+Y S E + K
Sbjct: 182 KGKYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGK 219
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 53/232 (22%), Positives = 102/232 (43%), Gaps = 34/232 (14%)
Query: 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDL---MSELR---- 112
+ LG+G+FGKV + E L A+K LK++ ++ D+ M+E R
Sbjct: 1 RVLGKGSFGKVMLARL--KESGRLYAVKVLKKDV-------ILQDDDVECTMTEKRILSL 51
Query: 113 ---HPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFS 169
HP + L + + + + EF+ GDL F + +S R D + ++ A
Sbjct: 52 ARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLM-FHIQKSRRFDEARARFYAA------- 103
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 229
++ + + +L ++RDL N L+ K++DFG+ ++ + + S
Sbjct: 104 ----EITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFC 157
Query: 230 LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281
++ PE + + D W+ GV+L+E+ G P+ + ++ E I
Sbjct: 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLC-GHAPFEAENEDDLFEAI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 28/91 (30%), Positives = 44/91 (48%), Gaps = 11/91 (12%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL--PVRWM 370
+ YL + +HRDL A N L +K++DFG+S A + IQ + WM
Sbjct: 115 ALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRTIQRRDSFIGTPYWM 170
Query: 371 PPESILYGK-----FTTESDVWSYGVVLWEV 396
PE ++ + ++DVWS G+ L E+
Sbjct: 171 APEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 4e-04
Identities = 28/85 (32%), Positives = 47/85 (55%), Gaps = 12/85 (14%)
Query: 319 SHHYVHRDLAARNCLVGDGLTV-KISDFGLSRDVYASDYYRIQSKSLLPV---RWMPPES 374
+ +HRDL +N L+ V KI DFG+S+ + + +SK+ V ++ PE
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS------KSKAYTVVGTPCYISPE- 171
Query: 375 ILYGK-FTTESDVWSYGVVLWEVYS 398
+ GK + +SD+W+ G VL+E+ S
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 28/104 (26%), Positives = 52/104 (50%), Gaps = 3/104 (2%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+ + + YL S V+RD+ N ++ +KI+DFGL ++ SD +++ P +
Sbjct: 104 IVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTP-EY 161
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
+ PE + + D W GVV++E+ G P+Y ++ F
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLF 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 3/96 (3%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
VA+ + YL S + ++RDL N L+ V ++DFGL ++ + S +
Sbjct: 105 VASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTSTFCGTPEY 162
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYY 405
+ PE + + D W G VL+E+ YGL P+Y
Sbjct: 163 LAPEVLRKEPYDRTVDWWCLGAVLYEML-YGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 5e-04
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 7/89 (7%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVG-DGLTVKISDFGLSRDV---YASDYYRIQSKSLLPVR 368
G+ Y+ S + +HRDL N + + L +KI DFGL+R V Y+ Y S+ L+
Sbjct: 126 GLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY--LSEGLVTKW 183
Query: 369 WMPPESILY-GKFTTESDVWSYGVVLWEV 396
+ P +L +T D+W+ G + E+
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEM 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 27/101 (26%), Positives = 49/101 (48%), Gaps = 4/101 (3%)
Query: 314 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPE 373
+ +L + V+RDL N L+ + + DFGLS+ + + + ++ PE
Sbjct: 109 LEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNTFCGTTEYLAPE 166
Query: 374 SILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
+L K +T D WS GV+++E+ G P+Y Q+ +
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEM-CCGWSPFYAEDTQQMY 206
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 17/46 (36%), Positives = 25/46 (54%), Gaps = 1/46 (2%)
Query: 6 QELGEGAFGKVYKGEV-CTSEGPSLVAIKTLKENANQKTASDFRRE 50
+ +G G FG+V +G + + VAIKTLK ++ K DF E
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTE 55
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 26/103 (25%), Positives = 48/103 (46%), Gaps = 6/103 (5%)
Query: 304 CWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKS 363
C++ + YL S + V+RDL N L+ +K++DFG ++ V Y +
Sbjct: 134 CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTP- 192
Query: 364 LLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG 406
++ PE +L +D W+ G+ ++E+ G P+Y
Sbjct: 193 ----EYIAPEILLNVGHGKAADWWTLGIFIYEIL-VGCPPFYA 230
|
Length = 340 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 7e-04
Identities = 26/101 (25%), Positives = 47/101 (46%), Gaps = 13/101 (12%)
Query: 301 MMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV-----YASD 355
+ W V + G+ ++ +HRD+ ++N + VK+ DFG +R + YA
Sbjct: 101 TILQWF-VQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT 159
Query: 356 YYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEV 396
Y ++PPE + +SD+WS G +L+E+
Sbjct: 160 YVGTPY-------YVPPEIWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 65/281 (23%), Positives = 110/281 (39%), Gaps = 67/281 (23%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTL--KENANQKTASDFRREVDLMSELRHPNIVCL 119
+G+GAFG+V V + + A+KTL E + + + E D+++E P +V L
Sbjct: 9 IGKGAFGEVRL--VQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 120 LGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGM 179
+ + ++ EF+ GDL L+ + D V ++ + L + A
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLI----KYDTFSEDV----TRFYMAECVLAIEA-- 116
Query: 180 AYLCSHH--YVHRDLAARNCLVGDGLTVKISDFGLSRDVYA---SDYYR--IQSKSLLPV 232
H ++HRD+ N L+ G +K+SDFGLS + S YY+ +Q KS
Sbjct: 117 ----VHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNR 172
Query: 233 R----------------------------------------WMPPESILYGKFTTESDVW 252
++ PE L + E D W
Sbjct: 173 IDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232
Query: 253 SYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS-RQMLPCPED 292
S G +++E G P+ ++ E I + R+ L P+D
Sbjct: 233 SLGAIMFECL-IGWPPFCSENSHETYRKIINWRETLYFPDD 272
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 9e-04
Identities = 48/179 (26%), Positives = 73/179 (40%), Gaps = 31/179 (17%)
Query: 242 YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLM 301
YG E DVW + EV L +Y + + + PED ++
Sbjct: 66 YGALFREGDVW----ICMEVMDTSLDKFYKKVYDKGLTI---------PEDILGKI---- 108
Query: 302 MECWHEVPVAAGMAYLCSH-HYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQ 360
V + + YL S +HRD+ N L+ VK+ DFG+S + S I
Sbjct: 109 -----AVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID 163
Query: 361 SKSLLPVRWMPPESI---LYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
+ +M PE I L K + +SDVWS G+ + E+ + G PY + + LK
Sbjct: 164 AGC---KPYMAPERINPELNQKGYDVKSDVWSLGITMIEL-ATGRFPYDSWKTPFQQLK 218
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.001
Identities = 19/45 (42%), Positives = 23/45 (51%), Gaps = 1/45 (2%)
Query: 7 ELGEGAFGKVYKGEVCTSEGPSL-VAIKTLKENANQKTASDFRRE 50
ELG G FG V KG G + VA+KTLK+ +F RE
Sbjct: 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLRE 46
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 8/97 (8%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVG--DGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM 370
G+ YL + VHRD+ N LV G+ VKISDFG S+ + + L ++M
Sbjct: 120 GLKYLHDNQIVHRDIKGDNVLVNTYSGV-VKISDFGTSKRLAGINPCTETFTGTL--QYM 176
Query: 371 PPESILYGK--FTTESDVWSYGVVLWEVYSYGLQPYY 405
PE I G + +D+WS G + E+ + G P+
Sbjct: 177 APEVIDKGPRGYGAPADIWSLGCTIVEMAT-GKPPFI 212
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 23/75 (30%), Positives = 37/75 (49%), Gaps = 3/75 (4%)
Query: 323 VHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM-PPESILYGKFT 381
VHRD+ N L+ +K+ DFG +R++ S+ + RW PE +L +
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNL--SEGSNANYTEYVATRWYRSPELLLGAPYG 179
Query: 382 TESDVWSYGVVLWEV 396
D+WS G +L E+
Sbjct: 180 KAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 8/86 (9%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM-P 371
G+ Y+ S +HRDL N V + ++I DFGL+R A D + + RW
Sbjct: 130 GLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ--ADD----EMTGYVATRWYRA 183
Query: 372 PESIL-YGKFTTESDVWSYGVVLWEV 396
PE +L + + D+WS G ++ E+
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAEL 209
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 26/86 (30%), Positives = 46/86 (53%), Gaps = 7/86 (8%)
Query: 314 MAYLCSHHYVHRDLAARNCLVGDGL-TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 372
+AY+ S HRDL +N L+ T+K+ DFG ++++ A +S S + R+
Sbjct: 183 LAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ----RSVSYICSRFYRA 238
Query: 373 ESILYG--KFTTESDVWSYGVVLWEV 396
++ G +TT D+WS G ++ E+
Sbjct: 239 PELMLGATNYTTHIDLWSLGCIIAEM 264
|
Length = 440 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 28/101 (27%), Positives = 47/101 (46%), Gaps = 4/101 (3%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+ G+ L V+RDL N L+ D ++ISD GL+ + + R + + V +
Sbjct: 111 LCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGT---VGY 167
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ 410
M PE I K+T D W G +++E+ G P+ +
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQ-GQSPFRKRKER 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.001
Identities = 32/133 (24%), Positives = 53/133 (39%), Gaps = 37/133 (27%)
Query: 319 SHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV---YASDYYRIQSKSLLPVR------- 368
Y+HRD+ N L+ +K+SDFGL + + +++YRI S +L
Sbjct: 119 KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKP 178
Query: 369 --------------------------WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQ 402
++ PE L + E D WS GV+++E+ G
Sbjct: 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML-VGYP 237
Query: 403 PYYGYSNQEEFLK 415
P+ + QE + K
Sbjct: 238 PFCSDNPQETYRK 250
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 34/116 (29%), Positives = 53/116 (45%), Gaps = 24/116 (20%)
Query: 321 HYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV---RWMPPESILY 377
YVHRD+ N L+ ++++DFG + A + S + V ++ PE IL
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ----SNVAVGTPDYISPE-ILQ 176
Query: 378 ------GKFTTESDVWSYGVVLWEVYSYGLQPYYGYS---------NQEEFLKTPP 418
G++ E D WS GV ++E+ YG P+Y S N +E + PP
Sbjct: 177 AMEDGKGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMNHKEHFQFPP 231
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 15/95 (15%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR---- 368
G+ Y+ + +HRD+ A N L+ +K++DFGL+R A + + R
Sbjct: 131 GLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR---AFSLSKNSKPNRYTNRVVTL 187
Query: 369 WM-PPESIL----YGKFTTESDVWSYGVVLWEVYS 398
W PPE +L YG D+W G ++ E+++
Sbjct: 188 WYRPPELLLGERDYGP---PIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 26/89 (29%), Positives = 44/89 (49%), Gaps = 7/89 (7%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 372
G+ +L ++ +HRD+ N L+ VK+ DFG+S + ++ R + S+ WM P
Sbjct: 140 GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR--NTSVGTPFWMAP 197
Query: 373 ESILYGK-----FTTESDVWSYGVVLWEV 396
E I + + DVWS G+ E+
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 32/124 (25%), Positives = 56/124 (45%), Gaps = 19/124 (15%)
Query: 296 RMYS----LMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV 351
R Y+ +E H+ V ++RDL N L+ + + DFGL + +
Sbjct: 96 RFYTAELLCALENLHKFNV------------IYRDLKPENILLDYQGHIALCDFGLCK-L 142
Query: 352 YASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
D + + P ++ PE +L +T D W+ GV+L+E+ + GL P+Y + E
Sbjct: 143 NMKDDDKTNTFCGTP-EYLAPELLLGHGYTKAVDWWTLGVLLYEMLT-GLPPFYDENVNE 200
Query: 412 EFLK 415
+ K
Sbjct: 201 MYRK 204
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 24/207 (11%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTL--KENANQKTASDFRREVDLMSELRHPNIVCL 119
LG+G FG+V ++ + L A K L K +K E +++++ IV L
Sbjct: 1 LGKGGFGEVSACQMRATG--KLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL 58
Query: 120 LGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAP-LSQQDFSHIALQVAAG 178
+ +C++ M GDL R I + P + Q+ +G
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDL---------RYHIYNVDEENPGFPEPRACFYTAQIISG 109
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL----LPVRW 234
+ +L ++RDL N L+ + V+ISD GL+ ++ QSK+ P +
Sbjct: 110 LEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG-----QSKTKGYAGTP-GF 163
Query: 235 MPPESILYGKFTTESDVWSYGVVLWEV 261
M PE + ++ D ++ GV L+E+
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEM 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 26/97 (26%), Positives = 49/97 (50%), Gaps = 10/97 (10%)
Query: 304 CWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKS 363
C++ + +G+ +L ++RDL N L+ + V+ISD GL+ ++ QSK+
Sbjct: 100 CFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG-----QSKT 154
Query: 364 L----LPVRWMPPESILYGKFTTESDVWSYGVVLWEV 396
P +M PE + ++ D ++ GV L+E+
Sbjct: 155 KGYAGTP-GFMAPELLQGEEYDFSVDYFALGVTLYEM 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 19/88 (21%), Positives = 47/88 (53%), Gaps = 4/88 (4%)
Query: 324 HRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTE 383
+++L + + LV + +KI GL + + + + + + + + ++ ++T +
Sbjct: 146 YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKML---NDIFSEYTIK 202
Query: 384 SDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
D++S GVVLWE+++ G P+ + +E
Sbjct: 203 DDIYSLGVVLWEIFT-GKIPFENLTTKE 229
|
Length = 283 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 25/93 (26%), Positives = 45/93 (48%), Gaps = 6/93 (6%)
Query: 314 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPE 373
+ YL S V+RDL N L+ +K++DFG ++ + D R + P ++ PE
Sbjct: 114 LEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL--RD--RTWTLCGTP-EYLAPE 168
Query: 374 SILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG 406
I D W+ G++++E+ G P++
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLV-GYPPFFD 200
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 17/40 (42%), Positives = 25/40 (62%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR 349
VA + YL H +HRDL N L+ + +K++DFGLS+
Sbjct: 113 VALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 28/106 (26%), Positives = 51/106 (48%), Gaps = 9/106 (8%)
Query: 306 HEVPVAAGMAYLCSHHY-----VHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQ 360
EV + +G L H ++RD+ N L+ V ++DFGLS++ + + R
Sbjct: 105 QEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAY 164
Query: 361 SKSLLPVRWMPPESILYGKFTTES--DVWSYGVVLWEVYSYGLQPY 404
S + +M P+ + G + D WS GV+++E+ + G P+
Sbjct: 165 S-FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT-GASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.004
Identities = 33/105 (31%), Positives = 51/105 (48%), Gaps = 5/105 (4%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR-DVYASDYYRIQSKSLLPVR 368
V G+ YL + V+RDL N L+ VKI+DFGL + + D R + P
Sbjct: 110 VVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD--RTSTFCGTP-E 166
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
++ PE + +T D W GV+++E+ G P+ G +E F
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEML-VGESPFPGDDEEEVF 210
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.004
Identities = 34/119 (28%), Positives = 53/119 (44%), Gaps = 16/119 (13%)
Query: 186 HYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV---RWMPPESILY 242
YVHRD+ N L+ ++++DFG + A + S + V ++ PE IL
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ----SNVAVGTPDYISPE-ILQ 176
Query: 243 ------GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ-MLPCPEDCP 294
G++ E D WS GV ++E+ YG P+Y S E I + + P D
Sbjct: 177 AMEDGKGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMNHKEHFQFPPDVT 234
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 422 | |||
| KOG1026|consensus | 774 | 100.0 | ||
| KOG0197|consensus | 468 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| KOG1095|consensus | 1025 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0196|consensus | 996 | 100.0 | ||
| KOG4257|consensus | 974 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0194|consensus | 474 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG4278|consensus | 1157 | 100.0 | ||
| KOG1094|consensus | 807 | 100.0 | ||
| KOG0199|consensus | 1039 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG4721|consensus | 904 | 100.0 | ||
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0193|consensus | 678 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0583|consensus | 370 | 100.0 | ||
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0597|consensus | 808 | 100.0 | ||
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0200|consensus | 609 | 100.0 | ||
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578|consensus | 550 | 100.0 | ||
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0580|consensus | 281 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0661|consensus | 538 | 100.0 | ||
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0593|consensus | 396 | 100.0 | ||
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0582|consensus | 516 | 100.0 | ||
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0611|consensus | 668 | 100.0 | ||
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1025|consensus | 1177 | 100.0 | ||
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0600|consensus | 560 | 100.0 | ||
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0033|consensus | 355 | 100.0 | ||
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0659|consensus | 318 | 100.0 | ||
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0610|consensus | 459 | 100.0 | ||
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0663|consensus | 419 | 100.0 | ||
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1024|consensus | 563 | 100.0 | ||
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0658|consensus | 364 | 100.0 | ||
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660|consensus | 359 | 100.0 | ||
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0599|consensus | 411 | 100.0 | ||
| KOG4279|consensus | 1226 | 100.0 | ||
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2052|consensus | 513 | 100.0 | ||
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| KOG0612|consensus | 1317 | 100.0 | ||
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| KOG4250|consensus | 732 | 100.0 | ||
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG3653|consensus | 534 | 100.0 | ||
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1151|consensus | 775 | 100.0 | ||
| KOG1006|consensus | 361 | 100.0 | ||
| KOG0662|consensus | 292 | 100.0 | ||
| KOG0666|consensus | 438 | 100.0 | ||
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| KOG1035|consensus | 1351 | 100.0 | ||
| KOG0695|consensus | 593 | 100.0 | ||
| KOG4236|consensus | 888 | 100.0 | ||
| KOG0608|consensus | 1034 | 100.0 | ||
| KOG0984|consensus | 282 | 100.0 | ||
| KOG0603|consensus | 612 | 100.0 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0576|consensus | 829 | 100.0 | ||
| KOG0587|consensus | 953 | 100.0 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0669|consensus | 376 | 100.0 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0671|consensus | 415 | 99.98 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1152|consensus | 772 | 99.97 | ||
| KOG1027|consensus | 903 | 99.97 | ||
| KOG0664|consensus | 449 | 99.97 | ||
| KOG0668|consensus | 338 | 99.96 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1345|consensus | 378 | 99.96 | ||
| KOG0670|consensus | 752 | 99.96 | ||
| KOG0665|consensus | 369 | 99.95 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG0590|consensus | 601 | 99.95 | ||
| KOG0195|consensus | 448 | 99.94 | ||
| KOG1290|consensus | 590 | 99.94 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG1167|consensus | 418 | 99.93 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1164|consensus | 322 | 99.93 | ||
| KOG1163|consensus | 341 | 99.92 | ||
| KOG0197|consensus | 468 | 99.92 | ||
| KOG1026|consensus | 774 | 99.91 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| KOG1165|consensus | 449 | 99.89 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| KOG0598|consensus | 357 | 99.88 | ||
| KOG1095|consensus | 1025 | 99.88 | ||
| KOG0590|consensus | 601 | 99.87 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| KOG1023|consensus | 484 | 99.86 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG0616|consensus | 355 | 99.85 | ||
| KOG0694|consensus | 694 | 99.85 | ||
| KOG0595|consensus | 429 | 99.84 | ||
| KOG0581|consensus | 364 | 99.83 | ||
| KOG0192|consensus | 362 | 99.83 | ||
| KOG0606|consensus | 1205 | 99.83 | ||
| KOG0661|consensus | 538 | 99.83 | ||
| KOG0196|consensus | 996 | 99.83 | ||
| KOG0575|consensus | 592 | 99.83 | ||
| KOG0600|consensus | 560 | 99.82 | ||
| KOG4721|consensus | 904 | 99.82 | ||
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG4158|consensus | 598 | 99.82 | ||
| KOG0660|consensus | 359 | 99.82 | ||
| KOG0594|consensus | 323 | 99.81 | ||
| KOG0667|consensus | 586 | 99.81 | ||
| KOG0591|consensus | 375 | 99.81 | ||
| KOG4278|consensus | 1157 | 99.81 | ||
| KOG0592|consensus | 604 | 99.81 | ||
| KOG0663|consensus | 419 | 99.81 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| KOG0194|consensus | 474 | 99.8 | ||
| KOG0659|consensus | 318 | 99.8 | ||
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.8 | |
| KOG0605|consensus | 550 | 99.8 | ||
| KOG1240|consensus | 1431 | 99.8 | ||
| KOG1035|consensus | 1351 | 99.8 | ||
| KOG0593|consensus | 396 | 99.8 | ||
| KOG0696|consensus | 683 | 99.79 | ||
| KOG1033|consensus | 516 | 99.79 | ||
| KOG0984|consensus | 282 | 99.79 | ||
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.79 | |
| KOG0986|consensus | 591 | 99.79 | ||
| KOG0583|consensus | 370 | 99.78 | ||
| KOG0582|consensus | 516 | 99.78 | ||
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| KOG0199|consensus | 1039 | 99.78 | ||
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| KOG0597|consensus | 808 | 99.78 | ||
| KOG0588|consensus | 786 | 99.78 | ||
| KOG0599|consensus | 411 | 99.77 | ||
| KOG4257|consensus | 974 | 99.77 | ||
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.77 | |
| KOG0615|consensus | 475 | 99.77 | ||
| KOG0200|consensus | 609 | 99.77 | ||
| KOG0033|consensus | 355 | 99.77 | ||
| KOG0983|consensus | 391 | 99.76 | ||
| KOG1094|consensus | 807 | 99.75 | ||
| KOG0601|consensus | 524 | 99.75 | ||
| KOG1024|consensus | 563 | 99.75 | ||
| KOG0578|consensus | 550 | 99.75 | ||
| KOG0610|consensus | 459 | 99.75 | ||
| KOG0658|consensus | 364 | 99.75 | ||
| KOG0198|consensus | 313 | 99.75 | ||
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.74 | |
| KOG0596|consensus | 677 | 99.74 | ||
| KOG0193|consensus | 678 | 99.74 | ||
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.73 | |
| KOG0614|consensus | 732 | 99.73 | ||
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.73 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.73 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.73 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.72 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.72 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.72 | |
| KOG1006|consensus | 361 | 99.72 | ||
| KOG1166|consensus | 974 | 99.72 | ||
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.72 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.72 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.71 | |
| KOG0690|consensus | 516 | 99.71 | ||
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.71 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.71 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.71 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.71 |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-63 Score=504.14 Aligned_cols=281 Identities=60% Similarity=1.086 Sum_probs=260.5
Q ss_pred cccchhhccccCcccccccccccceeEEEEEEec---CCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEe
Q psy7289 44 ASDFRREVIETKPRFLQELGEGAFGKVYKGEVCT---SEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLL 120 (422)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~ 120 (422)
+.....++...++++.++||+|+||+||+|+... .+....||||.++...+....++|.||+++|..|+|||||+|+
T Consensus 476 ~~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLl 555 (774)
T KOG1026|consen 476 PDLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLL 555 (774)
T ss_pred CccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence 3444567888889999999999999999998643 2346789999999888888889999999999999999999999
Q ss_pred eEEEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCC--CCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcee
Q psy7289 121 GVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISG--SQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCL 198 (422)
Q Consensus 121 g~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~--~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiL 198 (422)
|+|.+++++|||+|||..|||.+||+.+.+..+... .....+|+..+...|+.|||.||+||.++.+|||||..+|||
T Consensus 556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCL 635 (774)
T KOG1026|consen 556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCL 635 (774)
T ss_pred EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhce
Confidence 999999999999999999999999999888766542 122467999999999999999999999999999999999999
Q ss_pred ecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHH
Q psy7289 199 VGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVI 278 (422)
Q Consensus 199 l~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~ 278 (422)
|+++..|||+||||+|.++..+||...+....+++|||||.|..++||++||||||||+|||++|+|++||++.+++|++
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI 715 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI 715 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence 99999999999999999999999999888899999999999999999999999999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhccc
Q psy7289 279 EMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAA 329 (422)
Q Consensus 279 ~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk~ 329 (422)
+.|+.|+.+++|++||.++++||.+||+.+|..|+ ++..||..|+.
T Consensus 716 e~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RP-----sF~eI~~~L~~ 761 (774)
T KOG1026|consen 716 ECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRP-----SFKEIHSRLQA 761 (774)
T ss_pred HHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCC-----CHHHHHHHHHH
Confidence 99999999999999999999999999999999999 99999988765
|
|
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-60 Score=463.63 Aligned_cols=256 Identities=43% Similarity=0.818 Sum_probs=232.0
Q ss_pred hhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
.+++....++++++||+|.||+|+.|+|... ..||+|.++... ...++|.+|+++|++|+|+|||+++|+|..+.
T Consensus 200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~---~~vavk~ik~~~--m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 200 PWEIPREELKLIRELGSGQFGEVWLGKWNGS---TKVAVKTIKEGS--MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred CeeecHHHHHHHHHhcCCccceEEEEEEcCC---CcccceEEeccc--cChhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 5677788889999999999999999999643 459999987642 23468999999999999999999999999989
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
++|||||||+.|+|.+||+.+. ...++..++..++.|||+||+||+++++|||||.++||||+++..+||
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~----------~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKI 344 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTRE----------GGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKI 344 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcC----------CCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEE
Confidence 9999999999999999998732 135888899999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+||||||. ..++.|........|..|.|||++..+.|+.|||||||||+||||+|+|..||.++++.++++.|.+|.++
T Consensus 345 sDFGLAr~-~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRl 423 (468)
T KOG0197|consen 345 SDFGLARL-IGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRL 423 (468)
T ss_pred cccccccc-cCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcC
Confidence 99999994 44556666667777999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCcchhhhcccccccccchhhHHHHhhhhhhh
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVH 324 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~ 324 (422)
|+|+.||++++++|..||+.+|..|| ++....
T Consensus 424 p~P~~CP~~vY~lM~~CW~~~P~~RP-----tF~~L~ 455 (468)
T KOG0197|consen 424 PRPEGCPDEVYELMKSCWHEDPEDRP-----TFETLR 455 (468)
T ss_pred CCCCCCCHHHHHHHHHHhhCCcccCC-----CHHHHH
Confidence 99999999999999999999999999 776443
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-54 Score=421.17 Aligned_cols=261 Identities=36% Similarity=0.614 Sum_probs=224.7
Q ss_pred hhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSG 126 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~ 126 (422)
.+++......+.+.||+|+||+||+|.|+.. ..||||++.... +....+.|.+|+.+|++|+|||||+++|+|.++
T Consensus 35 ~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~---~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 35 EEEIDPDELPIEEVLGSGSFGTVYKGKWRGT---DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred ceecChHHhhhhhhcccCCceeEEEEEeCCc---eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 3455556677788899999999999999643 349999987533 333367999999999999999999999999988
Q ss_pred C-CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCceeecCCC-
Q psy7289 127 E-PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHH-YVHRDLAARNCLVGDGL- 203 (422)
Q Consensus 127 ~-~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-ivHrDlKp~NiLl~~~~- 203 (422)
. .+++||||+++|+|.++|.... ...++...+.+++.|||.||+|||+++ ||||||||+|||++.+.
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~----------~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~ 181 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKR----------KRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGK 181 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcc----------cCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCC
Confidence 8 7999999999999999998731 146999999999999999999999999 99999999999999997
Q ss_pred eEEEecCcccccccCCcceEeccCCCCCccccCccccc--cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHH
Q psy7289 204 TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL--YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281 (422)
Q Consensus 204 ~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i 281 (422)
++||+|||+++...... ...+...||+.|||||++. ...|+.|+|||||||++|||+| |..||.+..+.++...+
T Consensus 182 ~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t-~~~Pf~~~~~~~~~~~v 258 (362)
T KOG0192|consen 182 TLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLT-GEIPFEDLAPVQVASAV 258 (362)
T ss_pred EEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHH-CCCCCCCCCHHHHHHHH
Confidence 99999999998765432 1223367899999999999 5689999999999999999999 88999999997777666
Q ss_pred H-cCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhccc
Q psy7289 282 R-SRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAA 329 (422)
Q Consensus 282 ~-~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk~ 329 (422)
. .+.+++.|..||+.+..||.+||+.+|..|| ++..|...|..
T Consensus 259 ~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP-----~f~ei~~~l~~ 302 (362)
T KOG0192|consen 259 VVGGLRPPIPKECPPHLSSLMERCWLVDPSRRP-----SFLEIVSRLES 302 (362)
T ss_pred HhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCC-----CHHHHHHHHHH
Confidence 5 6777788999999999999999999999999 88888776654
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-54 Score=456.14 Aligned_cols=277 Identities=46% Similarity=0.816 Sum_probs=248.6
Q ss_pred ccccCcccccccccccceeEEEEEEecCCC---CeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEG---PSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
+....+.+.+.||+|+||.||.|......+ ...||||.+++..+.....+|++|+.+|++++|||||+++|+|.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 445677889999999999999999875543 45699999998888888999999999999999999999999999999
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
..++++|||++|||..||++.++.... ...++..++..++.|||+|++||+++++|||||..+||||+....|||
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~-----~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKI 843 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQ-----PSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKI 843 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCC-----CCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEE
Confidence 999999999999999999886443221 356899999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+||||||.+...++|+.......+++|||||.+..+.|++|+|||||||++||++|+|..||.+.++.+++..+..+.++
T Consensus 844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL 923 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRL 923 (1025)
T ss_pred cccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCcc
Confidence 99999999999999988877778899999999999999999999999999999999999999999999999988888899
Q ss_pred CCCCCCCcchhhhcccccccccchhhHHHHhhhhhhh-hhcccccccccCC
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVH-RDLAARNCLVGDG 337 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~-~dLk~~nil~~~~ 337 (422)
+.|..||..+++||.+||+.+|..|| ++..+. +|-+..|-+++..
T Consensus 924 ~~P~~CP~~ly~lM~~CW~~~pe~RP-----~F~~i~~q~~~i~~~~~~~~ 969 (1025)
T KOG1095|consen 924 DPPSYCPEKLYQLMLQCWKHDPEDRP-----SFRTIVEQDPAISNAALGTI 969 (1025)
T ss_pred CCCCCCChHHHHHHHHHccCChhhCc-----cHHHHHhhhhhhhhhhccCc
Confidence 99999999999999999999999999 776554 4444555555543
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-53 Score=395.19 Aligned_cols=257 Identities=26% Similarity=0.391 Sum_probs=231.7
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC-eEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP-MCML 132 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~-~~lv 132 (422)
++++.+..||+|..|+|||++++.+ ++.+|+|++....+....+++.+|++++++.+|||||.+||+|..+.. .+++
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t--~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~ 156 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPT--GKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC 156 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCC--CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence 4677889999999999999998765 588999999777777788899999999999999999999999999885 9999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCCeEEEecCc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCS-HHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
||||.+|||++++... +.+++..+.+++.+|++||.|||. ++||||||||+|||++..|.|||||||
T Consensus 157 mEYMDgGSLd~~~k~~------------g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRV------------GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred hhhcCCCCHHHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEecccc
Confidence 9999999999999753 468999999999999999999995 999999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCC-----ChHHHHHHHHcCCC
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY-----SNQEVIEMIRSRQM 286 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~-----~~~~~~~~i~~~~~ 286 (422)
.|+.+.++ ...+..||..|||||.+.++.|+.++||||||++++|+++ |+.||... +..+++..|..+..
T Consensus 225 VS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~-GrfP~~~~~~~~~~~~~Ll~~Iv~~pp 299 (364)
T KOG0581|consen 225 VSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAI-GRFPYPPPNPPYLDIFELLCAIVDEPP 299 (364)
T ss_pred ccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhh-CCCCCCCcCCCCCCHHHHHHHHhcCCC
Confidence 99987654 4456788999999999999999999999999999999998 99999874 66789999999988
Q ss_pred CCCCCC-CCcchhhhcccccccccchhh-HHHHhhhhhhhhhccc
Q psy7289 287 LPCPED-CPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRDLAA 329 (422)
Q Consensus 287 ~~~p~~-~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~dLk~ 329 (422)
+..|++ |+++++.++..|++++|..|+ ...|.+|.++.+..++
T Consensus 300 P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~ 344 (364)
T KOG0581|consen 300 PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDP 344 (364)
T ss_pred CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence 888987 999999999999999999986 4457788888765554
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-53 Score=397.31 Aligned_cols=241 Identities=26% Similarity=0.482 Sum_probs=208.5
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
.+|.+.++||+|+||+||+|+++.+. ..||||.+.... ..+..+.+..|+.+|+.|+|||||++++++.+++.+|+|
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~--~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSG--TEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCC--ceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 46788899999999999999987654 789999986543 666778889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC------CeEE
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG------LTVK 206 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~------~~vK 206 (422)
||||.||||.+||+.+. .+++..++.++.|||.||++||+++||||||||+||||+.. -.+|
T Consensus 88 MEyC~gGDLs~yi~~~~------------~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LK 155 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG------------RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLK 155 (429)
T ss_pred EEeCCCCCHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEE
Confidence 99999999999998863 59999999999999999999999999999999999999764 5799
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~ 286 (422)
|+|||+||.+.... ...+.+|++.|||||++..+.|+.|+|+||.|+++|||++ |..||...+..|+...++.+..
T Consensus 156 IADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~-g~~Pf~a~t~~eL~~~~~k~~~ 231 (429)
T KOG0595|consen 156 IADFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLT-GKPPFDAETPKELLLYIKKGNE 231 (429)
T ss_pred ecccchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHh-CCCCccccCHHHHHHHHhcccc
Confidence 99999999876443 3456678999999999999999999999999999999998 9999999999999998886543
Q ss_pred --CCCCCCCCcchhhhcccccccccchh
Q psy7289 287 --LPCPEDCPPRMYSLMMECWHEVPVAA 312 (422)
Q Consensus 287 --~~~p~~~p~~~~~l~~~cw~~~P~~r 312 (422)
+..|..+.+...+|+..-+..+|..+
T Consensus 232 ~~~~~~~~~s~~~~~Ll~~ll~~~~~~~ 259 (429)
T KOG0595|consen 232 IVPVLPAELSNPLRELLISLLQRNPKDR 259 (429)
T ss_pred ccCchhhhccCchhhhhhHHHhcCcccc
Confidence 23455566666677666666655443
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-54 Score=430.55 Aligned_cols=264 Identities=39% Similarity=0.701 Sum_probs=239.1
Q ss_pred cchhhccccCcccccccccccceeEEEEEEecC-CCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEE
Q psy7289 46 DFRREVIETKPRFLQELGEGAFGKVYKGEVCTS-EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCL 124 (422)
Q Consensus 46 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~ 124 (422)
.|.+|+..+.+.+.+.||.|.||+|++|+++.. +....||||.++....+++..+|+.|+.||-+++||||++|.|+..
T Consensus 621 eFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT 700 (996)
T KOG0196|consen 621 EFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT 700 (996)
T ss_pred HhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence 366788888899999999999999999998743 3456799999999888899999999999999999999999999999
Q ss_pred cCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCe
Q psy7289 125 SGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLT 204 (422)
Q Consensus 125 ~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~ 204 (422)
...+++||+|||++|+|+.||+.+. +.|+.-++..+++.||+||.||.+.+.|||||.++|||++.+..
T Consensus 701 ks~PvMIiTEyMENGsLDsFLR~~D-----------GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLv 769 (996)
T KOG0196|consen 701 KSKPVMIITEYMENGSLDSFLRQND-----------GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLV 769 (996)
T ss_pred cCceeEEEhhhhhCCcHHHHHhhcC-----------CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceE
Confidence 9999999999999999999998864 34788889999999999999999999999999999999999999
Q ss_pred EEEecCcccccccCCc-ceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc
Q psy7289 205 VKISDFGLSRDVYASD-YYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS 283 (422)
Q Consensus 205 vKl~DFGla~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~ 283 (422)
+|++||||+|....+. ....+.+...+.+|.|||.|..++++.+||||||||+|||.+++|..||.+++++++++.|..
T Consensus 770 CKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~ 849 (996)
T KOG0196|consen 770 CKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQ 849 (996)
T ss_pred EEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHh
Confidence 9999999999765433 222333444589999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhh
Q psy7289 284 RQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHR 325 (422)
Q Consensus 284 ~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~ 325 (422)
+.++|.|-+||..+++||..||+++-..|| ++..|..
T Consensus 850 gyRLPpPmDCP~aL~qLMldCWqkdR~~RP-----~F~qiV~ 886 (996)
T KOG0196|consen 850 GYRLPPPMDCPAALYQLMLDCWQKDRNRRP-----KFAQIVS 886 (996)
T ss_pred ccCCCCCCCCcHHHHHHHHHHHHHHhhcCC-----CHHHHHH
Confidence 999999999999999999999999999998 6665554
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-53 Score=411.59 Aligned_cols=251 Identities=40% Similarity=0.783 Sum_probs=228.9
Q ss_pred hccccCcccccccccccceeEEEEEEecC--CCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTS--EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
++....+.+.+.||.|.||.||+|.+... +..-.||||+.+.+.+....+.|+.|+.+|++++|||||+|+|+|.+ .
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 44445556778999999999999998654 33457999999988888888999999999999999999999999975 5
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
+.++|||+++-|.|.+||..+. ..|+...+..++.||+.||+|||+.++|||||..+|||+.+...|||
T Consensus 464 P~WivmEL~~~GELr~yLq~nk-----------~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKL 532 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNK-----------DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKL 532 (974)
T ss_pred ceeEEEecccchhHHHHHHhcc-----------ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeee
Confidence 7899999999999999998753 35888899999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+||||+|.+..+.+|.. +....+..|||||.+....++++||||-|||++||+++.|..||.+..+.+++-.|.+|.++
T Consensus 533 aDFGLSR~~ed~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRl 611 (974)
T KOG4257|consen 533 ADFGLSRYLEDDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERL 611 (974)
T ss_pred cccchhhhccccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCC
Confidence 99999999888777754 35667899999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCcchhhhcccccccccchhh
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
|+|++||+.++.||.+||+.+|..||
T Consensus 612 P~P~nCPp~LYslmskcWayeP~kRP 637 (974)
T KOG4257|consen 612 PCPPNCPPALYSLMSKCWAYEPSKRP 637 (974)
T ss_pred CCCCCCChHHHHHHHHHhccCcccCC
Confidence 99999999999999999999999987
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-52 Score=387.03 Aligned_cols=245 Identities=22% Similarity=0.398 Sum_probs=220.2
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP 128 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 128 (422)
+..+.+++++.||+|+||+||+++.+ +.++.+|+|++++.. ..........|..||.+++||+||+++-.|++.+.
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~--dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k 99 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKK--DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK 99 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEc--ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe
Confidence 33467889999999999999998765 456889999997542 23456788899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
+|+|+||+.||+|+..|.+. +.+++..++.++.+|+.||.|||++|||||||||+|||||.+|+++|+
T Consensus 100 LylVld~~~GGeLf~hL~~e------------g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~Lt 167 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQRE------------GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLT 167 (357)
T ss_pred EEEEEeccCCccHHHHHHhc------------CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEe
Confidence 99999999999999999764 469999999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP 288 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 288 (422)
|||||+...... ..+++.+||+.|||||++....|+..+|+||+||++|||++ |.+||.+.+..++++.|..+..+.
T Consensus 168 DFgL~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~-G~pPF~~~~~~~~~~~I~~~k~~~ 244 (357)
T KOG0598|consen 168 DFGLCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLT-GKPPFYAEDVKKMYDKILKGKLPL 244 (357)
T ss_pred ccccchhcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhh-CCCCCcCccHHHHHHHHhcCcCCC
Confidence 999999654332 23455789999999999999999999999999999999998 999999999999999999998777
Q ss_pred CCCCCCcchhhhcccccccccchh
Q psy7289 289 CPEDCPPRMYSLMMECWHEVPVAA 312 (422)
Q Consensus 289 ~p~~~p~~~~~l~~~cw~~~P~~r 312 (422)
.|...+++.+++++..+..+|..|
T Consensus 245 ~p~~ls~~ardll~~LL~rdp~~R 268 (357)
T KOG0598|consen 245 PPGYLSEEARDLLKKLLKRDPRQR 268 (357)
T ss_pred CCccCCHHHHHHHHHHhccCHHHh
Confidence 777799999999999999999887
|
|
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-52 Score=407.49 Aligned_cols=265 Identities=35% Similarity=0.660 Sum_probs=234.4
Q ss_pred chhhccccCcccccccccccceeEEEEEEecCCC--CeEEEEEEccC--cCCHHhHHHHHHHHHHHhcCCCCceeeEeeE
Q psy7289 47 FRREVIETKPRFLQELGEGAFGKVYKGEVCTSEG--PSLVAIKTLKE--NANQKTASDFRREVDLMSELRHPNIVCLLGV 122 (422)
Q Consensus 47 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~--~~~vavK~~~~--~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~ 122 (422)
..|++..+++.+.++||+|+||+||+|+++..+. ...||||..+. .........|.+|+++|++++|||||++||+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 4567778888889999999999999999976544 22389999875 3556778899999999999999999999999
Q ss_pred EEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC
Q psy7289 123 CLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG 202 (422)
Q Consensus 123 ~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~ 202 (422)
+....++++|||+|+||+|.+||.+.. ..++..+..+++.++|.||+|||++++|||||.++|||++.+
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~-----------~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~ 298 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNK-----------KSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKK 298 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCC-----------CCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCC
Confidence 999999999999999999999998753 248899999999999999999999999999999999999999
Q ss_pred CeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHH-
Q psy7289 203 LTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI- 281 (422)
Q Consensus 203 ~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i- 281 (422)
+.+||+||||++... .+.........+.+|+|||.+..+.|+.++|||||||++||+++.|..||.+.++.++...|
T Consensus 299 ~~vKISDFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~ 376 (474)
T KOG0194|consen 299 GVVKISDFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV 376 (474)
T ss_pred CeEEeCccccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH
Confidence 999999999998643 22212213346889999999999999999999999999999999999999999999999999
Q ss_pred HcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhccc
Q psy7289 282 RSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAA 329 (422)
Q Consensus 282 ~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk~ 329 (422)
.++.+.+.|..+|+.+..+|.+||..+|..|+ ++..+.+.+..
T Consensus 377 ~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~-----tm~~i~~~l~~ 419 (474)
T KOG0194|consen 377 KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRP-----TMSTIKKKLEA 419 (474)
T ss_pred hcCccCCCCCCCHHHHHHHHHHhccCChhhcc-----CHHHHHHHHHH
Confidence 78999999999999999999999999999999 88777776654
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-53 Score=378.41 Aligned_cols=247 Identities=24% Similarity=0.419 Sum_probs=217.8
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEcc-CcCCHHhHHHHHHHHHHHhcCCCCceeeEee-EEEcCCC-eE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPNIVCLLG-VCLSGEP-MC 130 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~-~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g-~~~~~~~-~~ 130 (422)
..|+++++||+|+||+|||++...+ +..||.|.+. ...+.+..++...|+.+|++|+|||||++++ .+.++.. ++
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~--g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLD--GKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccC--cchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 4688999999999999999987554 5779999886 3346677889999999999999999999998 5555444 89
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHh--CC--ccccCCCCCceeecCCCeEE
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCS--HH--YVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~--~~--ivHrDlKp~NiLl~~~~~vK 206 (422)
||||||.+|||.+.++..... ...++++.+++++.|++.||..+|+ .. |+||||||.||+|+.+|.||
T Consensus 97 ivmE~c~~GDLsqmIk~~K~q--------kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvK 168 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQ--------KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVK 168 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhc--------cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCcee
Confidence 999999999999999765322 2469999999999999999999999 45 99999999999999999999
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~ 286 (422)
|+||||+|....... ....-.|||.||+||.+....|+.+|||||+||++|||++ -.+||++.+-.++-..|..+..
T Consensus 169 LGDfGL~r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMca-L~~PF~g~n~~~L~~KI~qgd~ 245 (375)
T KOG0591|consen 169 LGDFGLGRFLSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCA-LQSPFYGDNLLSLCKKIEQGDY 245 (375)
T ss_pred eccchhHhHhcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHh-cCCCcccccHHHHHHHHHcCCC
Confidence 999999997754432 3445679999999999999999999999999999999998 6799999999999999999999
Q ss_pred CCCC-CCCCcchhhhcccccccccchhh
Q psy7289 287 LPCP-EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 287 ~~~p-~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+|+| +..+.++.+|+.-|+..||..||
T Consensus 246 ~~~p~~~YS~~l~~li~~ci~vd~~~RP 273 (375)
T KOG0591|consen 246 PPLPDEHYSTDLRELINMCIAVDPEQRP 273 (375)
T ss_pred CCCcHHHhhhHHHHHHHHHccCCcccCC
Confidence 9999 67889999999999999999998
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-50 Score=396.27 Aligned_cols=258 Identities=22% Similarity=0.399 Sum_probs=226.7
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc--CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
.+|...+.||+|||+.||+++... .++.||+|++.+. ....+.+...+|++|.+.|+|||||+++++|++.+++||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~--tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLD--TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcC--CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence 568889999999999999998644 4578999998653 244566788999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
|.|+|.+|+|.++++.+ .+++|.+++.++.||+.||.|||+++|||||||..|++|+++.+|||+|||
T Consensus 96 vLELC~~~sL~el~Krr------------k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFG 163 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRR------------KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFG 163 (592)
T ss_pred EEEecCCccHHHHHHhc------------CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccc
Confidence 99999999999999854 469999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCC
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPE 291 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~ 291 (422)
||..+..+.. ...+.+|||.|+|||++....++..+||||+||+||-|+. |++||...+..+++.+|+... ...|.
T Consensus 164 LAt~le~~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~-G~PPFetk~vkety~~Ik~~~-Y~~P~ 239 (592)
T KOG0575|consen 164 LATQLEYDGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLV-GRPPFETKTVKETYNKIKLNE-YSMPS 239 (592)
T ss_pred eeeeecCccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhh-CCCCcccchHHHHHHHHHhcC-ccccc
Confidence 9987764422 2345789999999999999999999999999999999998 999999999999999998654 34577
Q ss_pred CCCcchhhhcccccccccchhh-HHHHhhhhhhhhhccc
Q psy7289 292 DCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRDLAA 329 (422)
Q Consensus 292 ~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~dLk~ 329 (422)
..+.+..+||.+.++.+|..|+ +..+..|.++++...|
T Consensus 240 ~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p 278 (592)
T KOG0575|consen 240 HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTP 278 (592)
T ss_pred ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcC
Confidence 9999999999999999999987 4456666776554433
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-51 Score=398.98 Aligned_cols=260 Identities=37% Similarity=0.749 Sum_probs=234.9
Q ss_pred hhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
.||+..+++.+-.+||-|.||.||.|.|+.- ...||||.++... ....+|+.|+.+|+.++|||+|+|+|+|..+.
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKky--slTvAVKtLKEDt--MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKY--SLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeecc--ceeeehhhhhhcc--hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 5677777888889999999999999999754 3669999998643 45789999999999999999999999999999
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
++|||+|||..|+|.+||++... ..++.-.+..++.||++||+||..+++|||||..+|||+.++..|||
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr----------~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKv 406 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNR----------SEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKV 406 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhch----------hhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEe
Confidence 99999999999999999987532 23666677899999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+||||+|.+..+. |....+...++.|.|||.+....++.|+|||+|||+|||+.|+|..||.+.+..+++..+..+.++
T Consensus 407 ADFGLsRlMtgDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM 485 (1157)
T KOG4278|consen 407 ADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRM 485 (1157)
T ss_pred eccchhhhhcCCc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccc
Confidence 9999999887654 445555667889999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
.-|+.||+.+++||+.||+.+|..|+ ++..||..+
T Consensus 486 ~~PeGCPpkVYeLMraCW~WsPsDRP-----sFaeiHqaf 520 (1157)
T KOG4278|consen 486 DGPEGCPPKVYELMRACWNWSPSDRP-----SFAEIHQAF 520 (1157)
T ss_pred cCCCCCCHHHHHHHHHHhcCCcccCc-----cHHHHHHHH
Confidence 99999999999999999999999999 887777654
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-51 Score=394.94 Aligned_cols=263 Identities=45% Similarity=0.842 Sum_probs=235.3
Q ss_pred hhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
..|.+.+++.+.++||+|.||+|.++.. ++...||||+++..+......+|.+|+++|.+|+|||||+++|+|..++
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCev---eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De 608 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEV---EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD 608 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEe---cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC
Confidence 4577788899999999999999999876 3468899999998877777889999999999999999999999999999
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
++++|+|||++|+|.+||.++... .+......+|+.||++||+||.+.++|||||.++|||++.++++||
T Consensus 609 PicmI~EYmEnGDLnqFl~aheap----------t~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKi 678 (807)
T KOG1094|consen 609 PLCMITEYMENGDLNQFLSAHELP----------TAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKI 678 (807)
T ss_pred chHHHHHHHhcCcHHHHHHhccCc----------ccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEe
Confidence 999999999999999999876421 1234455679999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhC-CCCCCCCCChHHHHHHHHc---
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY-GLQPYYGYSNQEVIEMIRS--- 283 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~-g~~Pf~~~~~~~~~~~i~~--- 283 (422)
+|||++|.++..+++..+.....+.+|||||.+..++++++||||+||+++||+++. ...||...+++++.+....
T Consensus 679 adfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~ 758 (807)
T KOG1094|consen 679 ADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFR 758 (807)
T ss_pred cCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcC
Confidence 999999999999999999999999999999999999999999999999999998863 4689999999998877642
Q ss_pred ----CCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 284 ----RQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 284 ----~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
...++.|.-||..+++||.+||..+...|| ++..+|+-|.
T Consensus 759 ~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RP-----sFe~lh~~lq 802 (807)
T KOG1094|consen 759 DQGRQVVLSRPPACPQGLYELMLRCWRRESEQRP-----SFEQLHLFLQ 802 (807)
T ss_pred CCCcceeccCCCcCcHHHHHHHHHHhchhhhcCC-----CHHHHHHHHH
Confidence 223567899999999999999999999999 8888887664
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-50 Score=396.65 Aligned_cols=264 Identities=35% Similarity=0.643 Sum_probs=236.0
Q ss_pred ccchhhccccCcccccccccccceeEEEEEEecCC-CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEE
Q psy7289 45 SDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSE-GPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVC 123 (422)
Q Consensus 45 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~ 123 (422)
.+...-|.+..+++.++||+|+||+|++|.|.... +...||||.++.........+|++|+.+|.+|+|||+|+|||+.
T Consensus 101 ~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvV 180 (1039)
T KOG0199|consen 101 IDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVV 180 (1039)
T ss_pred CCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeee
Confidence 33445566788899999999999999999997543 35679999998655445788999999999999999999999999
Q ss_pred EcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC
Q psy7289 124 LSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL 203 (422)
Q Consensus 124 ~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~ 203 (422)
.+ ....||||+++.|+|.+.|++ .+ ...|....+..++.|||.||.||.++++|||||..+|+||....
T Consensus 181 l~-qp~mMV~ELaplGSLldrLrk-a~---------~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllaspr 249 (1039)
T KOG0199|consen 181 LD-QPAMMVFELAPLGSLLDRLRK-AK---------KAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPR 249 (1039)
T ss_pred cc-chhhHHhhhcccchHHHHHhh-cc---------ccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccc
Confidence 87 788999999999999999987 22 23577788899999999999999999999999999999999999
Q ss_pred eEEEecCcccccccCC-cceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q psy7289 204 TVKISDFGLSRDVYAS-DYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282 (422)
Q Consensus 204 ~vKl~DFGla~~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~ 282 (422)
.|||+||||.|.+..+ +.|........+..|.|||++...+++.+||||+|||++|||+|+|..||.|.+..+++++|.
T Consensus 250 tVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD 329 (1039)
T KOG0199|consen 250 TVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID 329 (1039)
T ss_pred eeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc
Confidence 9999999999988654 456666667778899999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhh
Q psy7289 283 SRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVH 324 (422)
Q Consensus 283 ~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~ 324 (422)
.+.+++.|+.||.+++++|++||..+|..|+ +|..+.
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRp-----tFsair 366 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRP-----TFSAIR 366 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccc-----cHHHHH
Confidence 9999999999999999999999999999998 666665
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=359.65 Aligned_cols=240 Identities=23% Similarity=0.367 Sum_probs=215.7
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
.-.++++++.||.|+||+|.+.+.+.+ +..+|+|+++... ..++.++..+|.++|+.+.||+++++++.|.+...+
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~--g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~l 119 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHS--GNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNL 119 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccC--CceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeE
Confidence 345678899999999999999887654 5679999997542 445677899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEec
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISD 209 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~D 209 (422)
||||||.+||.|+.+|++. +.+++..++.++.||+.||+|||+++|++|||||+|||||.+|++||+|
T Consensus 120 ymvmeyv~GGElFS~Lrk~------------~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitD 187 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKS------------GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITD 187 (355)
T ss_pred EEEEeccCCccHHHHHHhc------------CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEe
Confidence 9999999999999999874 4699999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 289 (422)
||+|+.+... +.+-+|||.|+|||.+....|+.++|.|||||++|||++ |.+||++.++.+++++|.++. ...
T Consensus 188 FGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMla-G~pPF~~~~~~~iY~KI~~~~-v~f 260 (355)
T KOG0616|consen 188 FGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLA-GYPPFYDDNPIQIYEKILEGK-VKF 260 (355)
T ss_pred ccceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHc-CCCCCcCCChHHHHHHHHhCc-ccC
Confidence 9999977543 234678999999999999999999999999999999998 999999999999999999886 567
Q ss_pred CCCCCcchhhhcccccccccchh
Q psy7289 290 PEDCPPRMYSLMMECWHEVPVAA 312 (422)
Q Consensus 290 p~~~p~~~~~l~~~cw~~~P~~r 312 (422)
|...++++.+|++..++.|-..|
T Consensus 261 P~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 261 PSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CcccCHHHHHHHHHHHhhhhHhh
Confidence 88899999999998887776665
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-50 Score=374.72 Aligned_cols=256 Identities=22% Similarity=0.328 Sum_probs=213.3
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHH------hHHHHHHHHHHHhcCCCCceeeEeeEEE
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQK------TASDFRREVDLMSELRHPNIVCLLGVCL 124 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~E~~il~~l~HpnIv~l~g~~~ 124 (422)
...+.|.+.+.||+|+||.|-+|..+.+ ++.||||+++...... ......+|++||++|+|||||++++++.
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~t--gk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKT--GKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE 246 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEccc--CcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee
Confidence 3556788899999999999999987654 5779999997543211 2234579999999999999999999999
Q ss_pred cCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC--
Q psy7289 125 SGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG-- 202 (422)
Q Consensus 125 ~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~-- 202 (422)
.++..||||||+.||+|++++... +.+.++.-.-++.|++.|+.|||++||+||||||+|||+..+
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv~n------------k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e 314 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVVAN------------KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAE 314 (475)
T ss_pred cCCceEEEEEEecCccHHHHHHhc------------cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCc
Confidence 999999999999999999999764 357788888999999999999999999999999999999766
Q ss_pred -CeEEEecCcccccccCCcceEeccCCCCCccccCccccccCC---CCCchhHHhHHHHHHHHHhCCCCCCCCCChHH-H
Q psy7289 203 -LTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK---FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE-V 277 (422)
Q Consensus 203 -~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~-~ 277 (422)
..+||+|||+|+..... ....+.+|||.|.|||++.... +..++|+||+||+||-++| |.+||.+...+. +
T Consensus 315 ~~llKItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLs-G~pPFS~~~~~~sl 390 (475)
T KOG0615|consen 315 DCLLKITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLS-GYPPFSEEYTDPSL 390 (475)
T ss_pred ceEEEecccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEec-cCCCcccccCCccH
Confidence 78999999999976543 3456778999999999998765 3458899999999999998 999999877666 8
Q ss_pred HHHHHcCCCCCCC---CCCCcchhhhcccccccccchhhHH-HHhhhhhhh
Q psy7289 278 IEMIRSRQMLPCP---EDCPPRMYSLMMECWHEVPVAAGMA-YLCSHHYVH 324 (422)
Q Consensus 278 ~~~i~~~~~~~~p---~~~p~~~~~l~~~cw~~~P~~r~~~-~lh~~~~i~ 324 (422)
.++|..|...--| ...+.+..+|+...+.-||..|+-. -..+|+|+.
T Consensus 391 ~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~ 441 (475)
T KOG0615|consen 391 KEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK 441 (475)
T ss_pred HHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence 8999988765544 3567888999999999999998632 344555543
|
|
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=384.89 Aligned_cols=249 Identities=33% Similarity=0.591 Sum_probs=213.1
Q ss_pred hhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
.|++.-..+.-++-||+|+-|.||+|+.+ ++.||||+++... ..+|+-|++|+||||+.+.|+|....
T Consensus 118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl~----netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 118 LWEIPFEEISELEWLGSGAQGAVFLGRLH----NETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred hccCCHHHhhhhhhhccCcccceeeeecc----CceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecCCc
Confidence 35666555556778999999999999975 3569999875421 24788999999999999999999999
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
.+|||||||..|-|.+.|+.+. ++....+..|..+||.||+|||.+.|||||||.-||||..+..|||
T Consensus 186 cyCIiMEfCa~GqL~~VLka~~------------~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKI 253 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLKAGR------------PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKI 253 (904)
T ss_pred eeEEeeeccccccHHHHHhccC------------ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEe
Confidence 9999999999999999998753 5788889999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC-CC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR-QM 286 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~-~~ 286 (422)
+|||-++...... ..-...||+.|||||+|.++..++|+|||||||+||||+| |..||.+.+...++.-+-+. -.
T Consensus 254 sDFGTS~e~~~~S---TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT-~EiPYkdVdssAIIwGVGsNsL~ 329 (904)
T KOG4721|consen 254 SDFGTSKELSDKS---TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLT-GEIPYKDVDSSAIIWGVGSNSLH 329 (904)
T ss_pred ccccchHhhhhhh---hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHh-cCCCccccchheeEEeccCCccc
Confidence 9999998654321 1224568999999999999999999999999999999999 99999999888888776543 35
Q ss_pred CCCCCCCCcchhhhcccccccccchhhHHHHhhhhhh--hhhccc
Q psy7289 287 LPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYV--HRDLAA 329 (422)
Q Consensus 287 ~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i--~~dLk~ 329 (422)
+|.|..||+.+.-||++||...|-.|+ +|..| |-|+..
T Consensus 330 LpvPstcP~GfklL~Kqcw~sKpRNRP-----SFrqil~HldIa~ 369 (904)
T KOG4721|consen 330 LPVPSTCPDGFKLLLKQCWNSKPRNRP-----SFRQILLHLDIAS 369 (904)
T ss_pred ccCcccCchHHHHHHHHHHhcCCCCCc-----cHHHHHHHHhhcC
Confidence 789999999999999999999999998 55443 555543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=375.54 Aligned_cols=273 Identities=35% Similarity=0.646 Sum_probs=218.3
Q ss_pred hhccccCcccccccccccceeEEEEEEec---CCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEEE
Q psy7289 49 REVIETKPRFLQELGEGAFGKVYKGEVCT---SEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVCL 124 (422)
Q Consensus 49 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~ 124 (422)
+++...+|++.+.||+|+||.||+|++.. ......||||+++..........+.+|+.++..+ +|||||+++++|.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 45566789999999999999999998642 2234579999987655555567899999999999 8999999999987
Q ss_pred cCC-CeEEEEEecCCCCHHHHHhhcCCCCCC-------------------------------------------------
Q psy7289 125 SGE-PMCMLFEFMVRGDLHEFLMSRSPRSDI------------------------------------------------- 154 (422)
Q Consensus 125 ~~~-~~~lv~E~~~~G~L~~~l~~~~~~~~~------------------------------------------------- 154 (422)
..+ .+++||||+++|+|.+++.........
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 644 589999999999999999753211000
Q ss_pred -CCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccccCCcceEeccCCCCCcc
Q psy7289 155 -SGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR 233 (422)
Q Consensus 155 -~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~ 233 (422)
.......++++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...............+++.
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 0000123588889999999999999999999999999999999999999999999999986543332222233445678
Q ss_pred ccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChH-HHHHHHHcCCCCCCCCCCCcchhhhcccccccccchh
Q psy7289 234 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ-EVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAA 312 (422)
Q Consensus 234 y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~-~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r 312 (422)
|||||++....++.++|||||||++|||++.|..||.+.... ++...+..+.....|..+++.+.+++.+||+.+|..|
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 321 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKER 321 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 999999998899999999999999999998899999886543 4556666676777788999999999999999999999
Q ss_pred hHHHHhhhhhhhhh
Q psy7289 313 GMAYLCSHHYVHRD 326 (422)
Q Consensus 313 ~~~~lh~~~~i~~d 326 (422)
+ +...+...
T Consensus 322 P-----s~~el~~~ 330 (338)
T cd05102 322 P-----TFSALVEI 330 (338)
T ss_pred c-----CHHHHHHH
Confidence 8 55554443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=370.51 Aligned_cols=265 Identities=23% Similarity=0.387 Sum_probs=221.6
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP 128 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 128 (422)
+-..++++++.||+|+||.||+|+-+.+ +..+|+|++++.. ...+..+.+.|-.+|...++|+||+||-.|++.++
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~T--g~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~ 215 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDT--GEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY 215 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccC--CcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence 3456788999999999999999986654 5789999997542 34567789999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
+||||||++|||+..+|... ..|+++.++.++.+++.|++-||+.|+|||||||+|+|||..|++||+
T Consensus 216 LYLiMEylPGGD~mTLL~~~------------~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLS 283 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRK------------DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLS 283 (550)
T ss_pred eEEEEEecCCccHHHHHHhc------------CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeec
Confidence 99999999999999999875 469999999999999999999999999999999999999999999999
Q ss_pred cCcccccccC----------------------Ccce-----Ee------------------ccCCCCCccccCccccccC
Q psy7289 209 DFGLSRDVYA----------------------SDYY-----RI------------------QSKSLLPVRWMPPESILYG 243 (422)
Q Consensus 209 DFGla~~~~~----------------------~~~~-----~~------------------~~~~~~t~~y~aPE~~~~~ 243 (422)
|||||..... .+.. .. .-..+|||.|||||++.+.
T Consensus 284 DFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k 363 (550)
T KOG0605|consen 284 DFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK 363 (550)
T ss_pred cccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC
Confidence 9999853211 0000 00 0135689999999999999
Q ss_pred CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC-CCCCC--CCCCcchhhhcccccccccchh----hHHH
Q psy7289 244 KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ-MLPCP--EDCPPRMYSLMMECWHEVPVAA----GMAY 316 (422)
Q Consensus 244 ~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~-~~~~p--~~~p~~~~~l~~~cw~~~P~~r----~~~~ 316 (422)
.|+..+|+||+|||+|||+. |.+||.+.+++++...|.+-. .+..| ..++++..+||.+|+. +|..| +++.
T Consensus 364 gY~~~cDwWSLG~ImyEmLv-GyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~E 441 (550)
T KOG0605|consen 364 GYGKECDWWSLGCIMYEMLV-GYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEE 441 (550)
T ss_pred CCCccccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHH
Confidence 99999999999999999998 999999999999999987643 34444 4677899999999998 77665 6777
Q ss_pred Hhhhhhhhhhcccccc
Q psy7289 317 LCSHHYVHRDLAARNC 332 (422)
Q Consensus 317 lh~~~~i~~dLk~~ni 332 (422)
+.+|+++. .+.-+++
T Consensus 442 IK~HPfF~-~v~W~~l 456 (550)
T KOG0605|consen 442 IKKHPFFK-GVDWDHL 456 (550)
T ss_pred HhcCCccc-cCCcchh
Confidence 77777753 3333333
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-48 Score=363.85 Aligned_cols=260 Identities=25% Similarity=0.419 Sum_probs=213.8
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC--CeEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE--PMCM 131 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~--~~~l 131 (422)
.++...+.||+|+||.||++...++ +...|||.+....... .+.+.+|+++|++|+|||||+++|.....+ .+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~--g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKT--GELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCC--Ccceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 4567789999999999999987543 5779999987553332 677899999999999999999999755444 5899
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC-CCeEEEecC
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD-GLTVKISDF 210 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~-~~~vKl~DF 210 (422)
.|||+++|+|.+++.+.. ..|++..++++++||+.||+|||++|||||||||+|||++. ++.+||+||
T Consensus 94 ~mEy~~~GsL~~~~~~~g-----------~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDF 162 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYG-----------GKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADF 162 (313)
T ss_pred eeeccCCCcHHHHHHHcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccC
Confidence 999999999999998742 25999999999999999999999999999999999999999 799999999
Q ss_pred cccccccC-CcceEeccCCCCCccccCccccccCC-CCCchhHHhHHHHHHHHHhCCCCCCCC-CChHHH-HHHHHcCCC
Q psy7289 211 GLSRDVYA-SDYYRIQSKSLLPVRWMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYG-YSNQEV-IEMIRSRQM 286 (422)
Q Consensus 211 Gla~~~~~-~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwS~Gvil~El~t~g~~Pf~~-~~~~~~-~~~i~~~~~ 286 (422)
|+++.... ...........||+.|||||++..+. ...++|||||||++.||+| |.+||.. ....+. .........
T Consensus 163 G~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~T-g~~PW~~~~~~~~~~~~ig~~~~~ 241 (313)
T KOG0198|consen 163 GLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLT-GKPPWSEFFEEAEALLLIGREDSL 241 (313)
T ss_pred ccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccC-CCCcchhhcchHHHHHHHhccCCC
Confidence 99987653 11122334567899999999998643 3359999999999999999 8999987 344443 333344556
Q ss_pred CCCCCCCCcchhhhcccccccccchhh-HHHHhhhhhhhhhcc
Q psy7289 287 LPCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRDLA 328 (422)
Q Consensus 287 ~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~dLk 328 (422)
+++|+.+|++..+++.+|+..+|..|+ +..|..|.+++.+..
T Consensus 242 P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 242 PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 778999999999999999999999988 667777877766543
|
|
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=381.85 Aligned_cols=249 Identities=27% Similarity=0.486 Sum_probs=212.3
Q ss_pred chhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc
Q psy7289 47 FRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLS 125 (422)
Q Consensus 47 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 125 (422)
-.|++....+.+...||+|+||+||+|+|.. .||||+++.. .++...+.|.+|+.++++-||.||+-+.|+|..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-----dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-----DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc-----ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 4667888888899999999999999999964 3999999744 356678999999999999999999999999987
Q ss_pred CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 126 GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 126 ~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
++. .||+.+|+|.+|+.+|+... ..|...+.+.|+.|||+||.|||.++|||||||..||+|.+++.|
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~e-----------tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kV 527 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQE-----------TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKV 527 (678)
T ss_pred Cce-eeeehhccCchhhhhccchh-----------hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcE
Confidence 766 99999999999999998653 347778899999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCccccccC---CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG---KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~ 282 (422)
||+||||+..-..-..........+...|||||+++.+ .|+..+|||||||++|||+| |..||...+.++++.++-
T Consensus 528 kIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELlt-g~lPysi~~~dqIifmVG 606 (678)
T KOG0193|consen 528 KIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLT-GELPYSIQNRDQIIFMVG 606 (678)
T ss_pred EEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHh-CcCCcCCCChhheEEEec
Confidence 99999998532110000011223345679999999854 58999999999999999999 999999777888888998
Q ss_pred cCCCCCCC----CCCCcchhhhcccccccccchhh
Q psy7289 283 SRQMLPCP----EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 283 ~~~~~~~p----~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.|...|.+ .+||.+|.+|+..||..++..||
T Consensus 607 rG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP 641 (678)
T KOG0193|consen 607 RGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERP 641 (678)
T ss_pred ccccCccchhhhccCHHHHHHHHHHHHhcCcccCc
Confidence 88666543 58999999999999999999998
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=371.15 Aligned_cols=255 Identities=22% Similarity=0.365 Sum_probs=221.0
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCCeE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~ 130 (422)
.++.+.+.||.|+|++|++|+.+.+ +..+|||++.+.. .+....-..+|-.+|.+| .||.||+|+-.|++...+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t--~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKAT--GKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred hhcchhheeccccceeEEEeeecCC--CceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 4678999999999999999987654 5789999986532 222344567899999999 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+|+||+++|+|.++|++. +.|++..++.++.||+.||+|||++|||||||||+|||||+++++||+||
T Consensus 151 FvLe~A~nGdll~~i~K~------------Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDF 218 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY------------GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDF 218 (604)
T ss_pred EEEEecCCCcHHHHHHHh------------CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeec
Confidence 999999999999999875 46999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcc---------eEe--ccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHH
Q psy7289 211 GLSRDVYASDY---------YRI--QSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIE 279 (422)
Q Consensus 211 Gla~~~~~~~~---------~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~ 279 (422)
|.|+.+..... ... ....+||..|.+||++.....+..+|+|+|||++|+|++ |.+||.+.+.--+.+
T Consensus 219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmla-G~PPFra~NeyliFq 297 (604)
T KOG0592|consen 219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLA-GQPPFRAANEYLIFQ 297 (604)
T ss_pred cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhc-CCCCCccccHHHHHH
Confidence 99987642211 011 134678999999999999999999999999999999998 999999999999999
Q ss_pred HHHcCCCCCCCCCCCcchhhhcccccccccchh-hHHHHhhhhhhh
Q psy7289 280 MIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAA-GMAYLCSHHYVH 324 (422)
Q Consensus 280 ~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r-~~~~lh~~~~i~ 324 (422)
.|..-. .++|++.|+.+.+|+++.+..+|..| +++.++.|.+++
T Consensus 298 kI~~l~-y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~ 342 (604)
T KOG0592|consen 298 KIQALD-YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFE 342 (604)
T ss_pred HHHHhc-ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccc
Confidence 887654 56789999999999999999999887 566777777765
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=357.59 Aligned_cols=271 Identities=69% Similarity=1.246 Sum_probs=230.3
Q ss_pred ccCcccccccccccceeEEEEEEecCC---CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSE---GPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
..++++.+.||+|+||.||+|...... ....||+|.++..........|.+|+.+++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 346788999999999999999875432 23579999987665556667899999999999999999999999998999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCC----CCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISG----SQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~----~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
+++|||+++|+|.+++....+...... ......+++.++..++.|++.||+|||+++++||||||+||++++++.+
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcE
Confidence 999999999999999987543221100 0112458899999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ 285 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~ 285 (422)
||+|||+++...............+++.|||||.+....++.++|||||||++|||++.|..||.+.+..++...+..+.
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~ 243 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ 243 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999876544433334445567889999999888999999999999999999988999999999999999999888
Q ss_pred CCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 286 MLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 286 ~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
.++.|..||+++.+|+.+||+.+|..|+ +...+...|+
T Consensus 244 ~~~~~~~~~~~~~~l~~~c~~~~p~~Rp-----~~~~i~~~l~ 281 (283)
T cd05048 244 LLPCPEDCPARVYALMIECWNEIPARRP-----RFKDIHTRLR 281 (283)
T ss_pred cCCCcccCCHHHHHHHHHHccCChhhCc-----CHHHHHHHHh
Confidence 8888999999999999999999999999 7666666554
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=356.86 Aligned_cols=254 Identities=37% Similarity=0.747 Sum_probs=217.8
Q ss_pred ccccccccccceeEEEEEEe--cCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEE
Q psy7289 57 RFLQELGEGAFGKVYKGEVC--TSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFE 134 (422)
Q Consensus 57 ~~~~~LG~G~fg~Vy~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E 134 (422)
.+.+.||.|+||.||+|.+. .......|+||.++........+.|.+|++++++++||||++++|++...+..++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35678999999999999998 4445678999999766566667899999999999999999999999998888999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccc
Q psy7289 135 FMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR 214 (422)
Q Consensus 135 ~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~ 214 (422)
||++|+|.++|.... ...+++..+..++.||+.||+|||+++++|+||+++||++++++.+||+|||+++
T Consensus 82 ~~~~g~L~~~L~~~~----------~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~ 151 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKN----------KEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSR 151 (259)
T ss_dssp --TTEBHHHHHHHTC----------TTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGE
T ss_pred ccccccccccccccc----------ccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999998752 1358899999999999999999999999999999999999999999999999998
Q ss_pred cccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q psy7289 215 DVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCP 294 (422)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p 294 (422)
................+..|+|||.+....++.++||||||+++|||++.|..||.+.+..++...+..+.+++.|..||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (259)
T PF07714_consen 152 PISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCP 231 (259)
T ss_dssp ETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSB
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchh
Confidence 77444444444555567889999999988899999999999999999998889999999999999999888888899999
Q ss_pred cchhhhcccccccccchhhHHHHhhhhhhhh
Q psy7289 295 PRMYSLMMECWHEVPVAAGMAYLCSHHYVHR 325 (422)
Q Consensus 295 ~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~ 325 (422)
..+++++.+||+.+|..|| ++..++.
T Consensus 232 ~~~~~li~~C~~~~p~~RP-----s~~~i~~ 257 (259)
T PF07714_consen 232 KDIYSLIQQCWSHDPEKRP-----SFQEILQ 257 (259)
T ss_dssp HHHHHHHHHHT-SSGGGS-------HHHHHH
T ss_pred HHHHHHHHHHcCCChhhCc-----CHHHHHh
Confidence 9999999999999999999 6665544
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-47 Score=370.86 Aligned_cols=257 Identities=26% Similarity=0.406 Sum_probs=220.8
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC----CHHhHHHHHHHHHHHhcCC-CCceeeEeeEEEc
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA----NQKTASDFRREVDLMSELR-HPNIVCLLGVCLS 125 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~ 125 (422)
.....|++.+.||+|+||.|+.|+...++ ..||+|++.... .....+.+.+|+.+++.++ ||||++++.++..
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~--~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t 91 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTG--EKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT 91 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCC--CeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence 34568899999999999999999876554 789999776531 1123456678999999999 9999999999999
Q ss_pred CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC-Ce
Q psy7289 126 GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG-LT 204 (422)
Q Consensus 126 ~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~-~~ 204 (422)
...+++|||||.+|+|++++.++ +.+++.++..++.|+++|++|||++||+||||||+|+|++.+ ++
T Consensus 92 ~~~~~ivmEy~~gGdL~~~i~~~------------g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~ 159 (370)
T KOG0583|consen 92 PTKIYIVMEYCSGGDLFDYIVNK------------GRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGN 159 (370)
T ss_pred CCeEEEEEEecCCccHHHHHHHc------------CCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCC
Confidence 99999999999999999999873 468999999999999999999999999999999999999999 99
Q ss_pred EEEecCcccccccCCcceEeccCCCCCccccCccccccCC-CC-CchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q psy7289 205 VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK-FT-TESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282 (422)
Q Consensus 205 vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~-~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~ 282 (422)
+||+|||++..... ......+..||+.|+|||++.... |+ .++||||+||+||-|++ |..||.+.+...+...|.
T Consensus 160 ~Kl~DFG~s~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~-G~~PF~d~~~~~l~~ki~ 236 (370)
T KOG0583|consen 160 LKLSDFGLSAISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLC-GRLPFDDSNVPNLYRKIR 236 (370)
T ss_pred EEEeccccccccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHh-CCCCCCCccHHHHHHHHh
Confidence 99999999987631 112445678999999999999877 86 78999999999999998 999999999999998887
Q ss_pred cCCCCCCCCCC-Ccchhhhcccccccccchhh-HHHHhhhhhhhh
Q psy7289 283 SRQMLPCPEDC-PPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHR 325 (422)
Q Consensus 283 ~~~~~~~p~~~-p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~ 325 (422)
.+. ..+|..+ +++...|+.+|+..+|..|. +..++.|.++..
T Consensus 237 ~~~-~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 237 KGE-FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred cCC-ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 664 6788888 99999999999999999874 444556666655
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=353.67 Aligned_cols=250 Identities=34% Similarity=0.612 Sum_probs=216.9
Q ss_pred cccCcccccccccccceeEEEEEEec-CCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCT-SEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
...+|++.+.||+|+||.||+|.+.. ......||+|.++...+......|.+|+.++++++||||+++++++..++..+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 34568899999999999999998753 23457899999987655556678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+||||+++|+|.+++.... ..+++.++..++.|++.||+|||+++++||||||+|||++.++.+|++||
T Consensus 83 lv~e~~~~~~L~~~l~~~~-----------~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~df 151 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHE-----------GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGF 151 (266)
T ss_pred EEEEeCCCCcHHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCC
Confidence 9999999999999997532 25889999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP 290 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p 290 (422)
|++......... ......++..|+|||++....++.++|||||||++||+++.|..||.+.+..++...+..+..++.|
T Consensus 152 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 230 (266)
T cd05064 152 RRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAP 230 (266)
T ss_pred cccccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCC
Confidence 987654222111 1112334578999999998999999999999999999887799999999999999999888888889
Q ss_pred CCCCcchhhhcccccccccchhh
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..||..+.+++.+||..+|..||
T Consensus 231 ~~~~~~~~~li~~c~~~~p~~RP 253 (266)
T cd05064 231 RNCPNLLHQLMLDCWQKERGERP 253 (266)
T ss_pred CCCCHHHHHHHHHHcCCCchhCC
Confidence 99999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=370.91 Aligned_cols=251 Identities=27% Similarity=0.488 Sum_probs=219.8
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
+|.+.+.||+|+||.||||+.+. ..+.||+|.+.+. ...++...+.+|++|+++|+|||||.++++|.+..++++|+
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~--t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKY--TIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred chhHHHHhcCCccceeeeccccc--ceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 57788999999999999998654 4578999998654 45567788999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
|||.| +|+.+|... +.++++.+..++.|+.+||.|||+.+|+|||+||.|||++.++++|+||||+|
T Consensus 81 e~a~g-~L~~il~~d------------~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~A 147 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQD------------GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLA 147 (808)
T ss_pred hhhhh-hHHHHHHhc------------cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhh
Confidence 99987 999999764 46999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDC 293 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~ 293 (422)
|.+..+. ...+...|||-|||||...++.|+..+|.||+||++||+++ |.+||+..+.-++.+.|...... .|...
T Consensus 148 r~m~~~t--~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~-G~PPF~a~si~~Lv~~I~~d~v~-~p~~~ 223 (808)
T KOG0597|consen 148 RAMSTNT--SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYV-GQPPFYARSITQLVKSILKDPVK-PPSTA 223 (808)
T ss_pred hhcccCc--eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhc-CCCCchHHHHHHHHHHHhcCCCC-Ccccc
Confidence 9876543 34455678999999999999999999999999999999998 99999999999999999877644 45688
Q ss_pred Ccchhhhcccccccccchh-hHHHHhhhhhhh
Q psy7289 294 PPRMYSLMMECWHEVPVAA-GMAYLCSHHYVH 324 (422)
Q Consensus 294 p~~~~~l~~~cw~~~P~~r-~~~~lh~~~~i~ 324 (422)
+..+..++.-.+.+||..| ....|..|.++.
T Consensus 224 S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k 255 (808)
T KOG0597|consen 224 SSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWK 255 (808)
T ss_pred cHHHHHHHHHHhhcChhhcccHHHHhcChHHh
Confidence 8899999999999999876 233355555543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=358.35 Aligned_cols=271 Identities=45% Similarity=0.822 Sum_probs=218.8
Q ss_pred cccCcccccccccccceeEEEEEEec--------------CCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCcee
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCT--------------SEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIV 117 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~--------------~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv 117 (422)
...+|++.++||+|+||.||+|.+.. .+.+..||+|.+...........|.+|+.++++++||||+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence 45678899999999999999998642 2234579999987655555667899999999999999999
Q ss_pred eEeeEEEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCC-------CCCccCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q psy7289 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDIS-------GSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHR 190 (422)
Q Consensus 118 ~l~g~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHr 190 (422)
++++++.+.+..++||||+++|+|.+++.......... .......+++..+.+++.||+.||+|||+++|+||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~ 162 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 99999999999999999999999999996542111000 00112357888999999999999999999999999
Q ss_pred CCCCCceeecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhC-CCCCC
Q psy7289 191 DLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY-GLQPY 269 (422)
Q Consensus 191 DlKp~NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~-g~~Pf 269 (422)
||||+|||+++++.+||+|||+++...............++..|||||++..+.++.++|||||||++|||++. +..||
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 99999999999999999999999876554444444445567889999999888999999999999999999863 66799
Q ss_pred CCCChHHHHHHHHc-------CCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 270 YGYSNQEVIEMIRS-------RQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 270 ~~~~~~~~~~~i~~-------~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
.+.+..+++..+.. ......|+.||+.+.++|.+||..+|..|+ +...+++-|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-----s~~~i~~~l 302 (304)
T cd05096 243 GELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERP-----SFSDIHAFL 302 (304)
T ss_pred CcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCc-----CHHHHHHHH
Confidence 98888777655432 112234678999999999999999999999 766666544
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=353.58 Aligned_cols=271 Identities=56% Similarity=1.037 Sum_probs=229.3
Q ss_pred ccCcccccccccccceeEEEEEEecC---CCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTS---EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
-.++++.++||+|+||.||+|++..+ .....||+|.++..........|.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 34678899999999999999987543 235679999987655555567789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCC----CCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISG----SQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~----~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
++++||+++++|.+++..+.+..+... ......+++..+.+++.|++.||+|||+++|+||||||+||++++++.+
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCce
Confidence 999999999999999975433222111 1112458888999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ 285 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~ 285 (422)
||+|||+++...............+++.|+|||.+..+.++.++|||||||++|||++.|..||.+.+..++...+..+.
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~ 243 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ 243 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999876544433333444557889999999888899999999999999999988999999999999999999988
Q ss_pred CCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 286 MLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 286 ~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
..+.|.+||..+.+++.+||+.+|..|| +...+...|+
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~RP-----~~~~i~~~l~ 281 (283)
T cd05091 244 VLPCPDDCPAWVYTLMLECWNEFPSRRP-----RFKDIHSRLR 281 (283)
T ss_pred cCCCCCCCCHHHHHHHHHHhCCCcccCC-----CHHHHHHHhh
Confidence 8888999999999999999999999999 7776666543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=368.76 Aligned_cols=280 Identities=36% Similarity=0.634 Sum_probs=224.2
Q ss_pred ccccchhhccccCcccccccccccceeEEEEEEec---CCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceee
Q psy7289 43 TASDFRREVIETKPRFLQELGEGAFGKVYKGEVCT---SEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVC 118 (422)
Q Consensus 43 ~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~ 118 (422)
.+.+..+++...+|++.+.||+|+||.||+|++.. .+....||||+++........+.+.+|+++|+.+ +|||||+
T Consensus 24 ~~~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~ 103 (375)
T cd05104 24 LPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVN 103 (375)
T ss_pred CCCccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceee
Confidence 33444556667789999999999999999998632 2345689999987655445567899999999999 8999999
Q ss_pred EeeEEEcCCCeEEEEEecCCCCHHHHHhhcCCCCCC----------------------------------------C---
Q psy7289 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDI----------------------------------------S--- 155 (422)
Q Consensus 119 l~g~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~----------------------------------------~--- 155 (422)
++++|.+....++|||||++|+|.+++......... .
T Consensus 104 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 183 (375)
T cd05104 104 LLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKA 183 (375)
T ss_pred eeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccc
Confidence 999999999999999999999999999754211000 0
Q ss_pred --------------------CCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccccc
Q psy7289 156 --------------------GSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRD 215 (422)
Q Consensus 156 --------------------~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~ 215 (422)
.......+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 263 (375)
T cd05104 184 DKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 263 (375)
T ss_pred ccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCcccee
Confidence 000012578889999999999999999999999999999999999999999999999986
Q ss_pred ccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChH-HHHHHHHcCCCCCCCCCCC
Q psy7289 216 VYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ-EVIEMIRSRQMLPCPEDCP 294 (422)
Q Consensus 216 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~-~~~~~i~~~~~~~~p~~~p 294 (422)
..............++..|||||++....++.++|||||||++|||++.|..||.+.... .....+..+.+...|..+|
T Consensus 264 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (375)
T cd05104 264 IRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAP 343 (375)
T ss_pred ccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCC
Confidence 644332222233345678999999998899999999999999999998889999877644 5566666666666777889
Q ss_pred cchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 295 PRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 295 ~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
.++.+|+..||+.+|..|+ +...+.+.|
T Consensus 344 ~~l~~li~~cl~~dP~~RP-----s~~eil~~l 371 (375)
T cd05104 344 SEMYDIMKSCWDADPLKRP-----TFKQIVQLI 371 (375)
T ss_pred HHHHHHHHHHccCChhHCc-----CHHHHHHHH
Confidence 9999999999999999998 655554433
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=373.24 Aligned_cols=254 Identities=24% Similarity=0.392 Sum_probs=220.9
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCC-CCceeeEeeEEEcCC
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELR-HPNIVCLLGVCLSGE 127 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~ 127 (422)
+-..+++++++||+|+||+|++++.+.++ +.+|||++++.. ..++++....|.+|+...+ ||.+++|+..|++.+
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~--e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTN--EYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCC--cEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 34467889999999999999999987654 689999998653 4456778889999988875 999999999999999
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
++|+||||+.|||+..+.+. ..+++..++.++.+|+.||+|||++|||+||||.+|||||.+|++||
T Consensus 443 ~l~fvmey~~Ggdm~~~~~~-------------~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~ki 509 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIHT-------------DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKI 509 (694)
T ss_pred eEEEEEEecCCCcEEEEEec-------------ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEe
Confidence 99999999999995544432 35999999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+||||++..-... ..+++.+|||.|||||++....|+.++|+|||||+||||+. |..||.+.+.+|+.+.|.+.. +
T Consensus 510 ADFGlcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~-Gq~PF~gddEee~FdsI~~d~-~ 585 (694)
T KOG0694|consen 510 ADFGLCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLV-GESPFPGDDEEEVFDSIVNDE-V 585 (694)
T ss_pred cccccccccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-C
Confidence 9999999754322 25678899999999999999999999999999999999998 999999999999999999865 5
Q ss_pred CCCCCCCcchhhhcccccccccchh------hHHHHhhhhhh
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAA------GMAYLCSHHYV 323 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r------~~~~lh~~~~i 323 (422)
..|..++.+..++|++.+..+|..| ...-++.|.++
T Consensus 586 ~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFF 627 (694)
T KOG0694|consen 586 RYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFF 627 (694)
T ss_pred CCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCcc
Confidence 5689999999999999999999775 23445555544
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=387.17 Aligned_cols=277 Identities=40% Similarity=0.718 Sum_probs=239.7
Q ss_pred hhhccccCcccccccccccceeEEEEEEecCC-----CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEee
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSE-----GPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLG 121 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g 121 (422)
.+|+......+.+.||+|.||.|++|...... ....||||.++......+.+.+..|+++|..+ +|||||.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 67777777888889999999999999865322 25689999999877777888999999999999 5999999999
Q ss_pred EEEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCC--Ccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q psy7289 122 VCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGS--QVQ--APLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNC 197 (422)
Q Consensus 122 ~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~--~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~Ni 197 (422)
+|..+.++++|+||+..|+|.+||+........... ... ..++..++..++.|||.||+||++..+|||||..+||
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV 449 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence 999999999999999999999999886511111000 001 2489999999999999999999999999999999999
Q ss_pred eecCCCeEEEecCcccccccCCcceEeccCC-CCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCC-hH
Q psy7289 198 LVGDGLTVKISDFGLSRDVYASDYYRIQSKS-LLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS-NQ 275 (422)
Q Consensus 198 Ll~~~~~vKl~DFGla~~~~~~~~~~~~~~~-~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~-~~ 275 (422)
|+.++..+||+|||+||.....+++...... ..+.+|||||.+....|+.+||||||||+||||+|.|..||.+.. ..
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~ 529 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE 529 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence 9999999999999999988777777644322 267889999999999999999999999999999999999999977 78
Q ss_pred HHHHHHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhccc
Q psy7289 276 EVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAA 329 (422)
Q Consensus 276 ~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk~ 329 (422)
++.+.++.|.++..|..|+++++++|+.||+.+|..|| ++..+...+..
T Consensus 530 ~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP-----~F~~~~~~~~~ 578 (609)
T KOG0200|consen 530 ELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRP-----TFSECVEFFEK 578 (609)
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCC-----CHHHHHHHHHH
Confidence 88899999999999999999999999999999999999 77766665554
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=366.45 Aligned_cols=274 Identities=36% Similarity=0.654 Sum_probs=220.3
Q ss_pred hhccccCcccccccccccceeEEEEEEecC---CCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEEE
Q psy7289 49 REVIETKPRFLQELGEGAFGKVYKGEVCTS---EGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVCL 124 (422)
Q Consensus 49 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~ 124 (422)
+.....+|++.+.||+|+||.||+|++... .....||||.++..........+.+|+++++.+ +|||||+++++|.
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 345566889999999999999999986432 233579999997655555567899999999999 8999999999999
Q ss_pred cCCCeEEEEEecCCCCHHHHHhhcCCCCC---------------------------------------------------
Q psy7289 125 SGEPMCMLFEFMVRGDLHEFLMSRSPRSD--------------------------------------------------- 153 (422)
Q Consensus 125 ~~~~~~lv~E~~~~G~L~~~l~~~~~~~~--------------------------------------------------- 153 (422)
....+++|||||++|+|.+++........
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 99999999999999999999965321000
Q ss_pred -------CCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccccCCcceEecc
Q psy7289 154 -------ISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQS 226 (422)
Q Consensus 154 -------~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~ 226 (422)
........++++.++.+++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++............
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 0000112357889999999999999999999999999999999999999999999999998664433222333
Q ss_pred CCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHH-HHHHHHcCCCCCCCCCCCcchhhhccccc
Q psy7289 227 KSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE-VIEMIRSRQMLPCPEDCPPRMYSLMMECW 305 (422)
Q Consensus 227 ~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~-~~~~i~~~~~~~~p~~~p~~~~~l~~~cw 305 (422)
...+++.|||||++....++.++|||||||++|||++.|..||......+ ....+..+...+.|...|+++.+++.+||
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 352 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCW 352 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHc
Confidence 33456789999999888999999999999999999987999998776544 44455555566677788999999999999
Q ss_pred ccccchhhHHHHhhhhhhhhhc
Q psy7289 306 HEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 306 ~~~P~~r~~~~lh~~~~i~~dL 327 (422)
+.+|..|+ +...+.+.|
T Consensus 353 ~~dp~~RP-----s~~~l~~~l 369 (374)
T cd05106 353 NLEPTERP-----TFSQISQLI 369 (374)
T ss_pred CCChhhCc-----CHHHHHHHH
Confidence 99999998 665555444
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=348.43 Aligned_cols=270 Identities=61% Similarity=1.143 Sum_probs=225.5
Q ss_pred cCcccccccccccceeEEEEEEecC--CCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTS--EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
+.+++.+.||+|+||.||+|.+... .....|++|.++..........|.+|+.++++++||||+++++++..+...|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999986432 34578999998755555555789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCC-----CCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEE
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISG-----SQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~-----~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vK 206 (422)
+|||+++|+|.+++..+.+...... ......+++.++..++.|++.||+|||+++++||||||+|||+++++.+|
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~k 164 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVK 164 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEE
Confidence 9999999999999975432211110 01123578899999999999999999999999999999999999999999
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~ 286 (422)
|+|||+++...............++..|+|||++....++.++|||||||++|||++.|..||.+.+..++...+..+..
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 244 (283)
T cd05090 165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL 244 (283)
T ss_pred eccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 99999998765443333333444567899999998888999999999999999999889999999988899999998888
Q ss_pred CCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 287 LPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 287 ~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
++.|..+|+++.+++.+||..+|..|+ +...+.+.++
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp-----~~~~i~~~l~ 281 (283)
T cd05090 245 LPCSEDCPPRMYSLMTECWQEGPSRRP-----RFKDIHTRLR 281 (283)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCc-----CHHHHHHHhh
Confidence 888999999999999999999999998 6665555443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=354.35 Aligned_cols=259 Identities=34% Similarity=0.589 Sum_probs=218.7
Q ss_pred ccccCcccccccccccceeEEEEEEecCCC--CeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEG--PSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP 128 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 128 (422)
+...+|++.+.||+|+||.||+|++..++. ...||+|.++........+.+.+|+.+++.++||||++++|+|... .
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 345678999999999999999998754332 2358999987655555667899999999999999999999999764 5
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
.++++||+++|+|.+++.... ..+++..+.+++.||+.||+|||+++|+||||||+|||+++++.+||+
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~ 151 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHK-----------DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKIT 151 (316)
T ss_pred ceeeeecCCCCCHHHHHHhcc-----------ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEc
Confidence 789999999999999997642 247888899999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP 288 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 288 (422)
|||+++................+..|||||.+....++.++|||||||++|||++.|..||.+.+..++...+..+..++
T Consensus 152 DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 231 (316)
T cd05108 152 DFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 231 (316)
T ss_pred cccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCC
Confidence 99999876543322222233346789999999989999999999999999999988999999988888887777787888
Q ss_pred CCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhh
Q psy7289 289 CPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRD 326 (422)
Q Consensus 289 ~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~d 326 (422)
.|..|+.++.+++.+||..+|..|+ +...+...
T Consensus 232 ~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~~l~~~ 264 (316)
T cd05108 232 QPPICTIDVYMIMVKCWMIDADSRP-----KFRELIIE 264 (316)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCc-----CHHHHHHH
Confidence 8889999999999999999999998 55544443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-45 Score=344.78 Aligned_cols=262 Identities=45% Similarity=0.810 Sum_probs=220.5
Q ss_pred hccccCcccccccccccceeEEEEEEec---CCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCT---SEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG 126 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~ 126 (422)
++...+|++.+.||+|+||.||+|.+.. ......||||.+...........|.+|+.+++.++||||+++++++.++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 4556778999999999999999998642 2234679999986544445566799999999999999999999999999
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEE
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vK 206 (422)
...++||||+++|+|.+++........ .......++...+..++.|++.||+|||+.+++||||||+||++++++.+|
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEME--NNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCcccc--ccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence 999999999999999999976432111 001123567888999999999999999999999999999999999999999
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~ 286 (422)
|+|||+++...............+++.|||||.+....++.++|||||||++|||++.|..||.+.+..+....+..+..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL 239 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 99999998665544433333344577899999999888999999999999999999878899999999898888888777
Q ss_pred CCCCCCCCcchhhhcccccccccchhh
Q psy7289 287 LPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 287 ~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.+.|..+|+.+.+++.+||..+|..|+
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rp 266 (277)
T cd05062 240 LDKPDNCPDMLFELMRMCWQYNPKMRP 266 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCc
Confidence 778889999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=345.75 Aligned_cols=261 Identities=51% Similarity=0.965 Sum_probs=222.0
Q ss_pred ccCcccccccccccceeEEEEEEecC---CCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTS---EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
..+|.+.+.||+|+||.||+|++... .....||||.++........+.|.+|+++++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 35678899999999999999987543 345789999987655555667899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCC--CCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDIS--GSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~--~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
++||||+++|+|.+++.......... .......+++.++..++.|++.||+|||+++++||||||+||+++.++.+||
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl 163 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKI 163 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEE
Confidence 99999999999999997653221110 0111245889999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+|||+++...............+++.|+|||++....++.++|||||||++|||++.|..||.+.+..+....+..+...
T Consensus 164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~ 243 (280)
T cd05049 164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLL 243 (280)
T ss_pred CCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99999986544433333334455788999999999999999999999999999998899999999999999999888777
Q ss_pred CCCCCCCcchhhhcccccccccchhh
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+.|..+|..+.+++++||..+|..|+
T Consensus 244 ~~~~~~~~~~~~li~~~l~~~p~~Rp 269 (280)
T cd05049 244 QRPRTCPSEVYDIMLGCWKRDPQQRI 269 (280)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCC
Confidence 77888999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=362.33 Aligned_cols=279 Identities=36% Similarity=0.594 Sum_probs=224.8
Q ss_pred cccchhhccccCcccccccccccceeEEEEEEecCC---CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC-CCceeeE
Q psy7289 44 ASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSE---GPSLVAIKTLKENANQKTASDFRREVDLMSELR-HPNIVCL 119 (422)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l 119 (422)
+.+-+++....+|++.+.||+|+||.||+|++.... ....||||+++........+.|.+|+++|++++ |||||++
T Consensus 27 ~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l 106 (400)
T cd05105 27 PYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNL 106 (400)
T ss_pred CCCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 344566778889999999999999999999864322 234699999976555556678999999999996 9999999
Q ss_pred eeEEEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCC--------------------------------------------
Q psy7289 120 LGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDIS-------------------------------------------- 155 (422)
Q Consensus 120 ~g~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~-------------------------------------------- 155 (422)
+++|.+.+..|+|||||++|+|.++|..........
T Consensus 107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (400)
T cd05105 107 LGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTT 186 (400)
T ss_pred EEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccc
Confidence 999999999999999999999999997642100000
Q ss_pred ----------------------------------------CCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy7289 156 ----------------------------------------GSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAAR 195 (422)
Q Consensus 156 ----------------------------------------~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~ 195 (422)
.......+++.++..++.|++.||+|||+++|+||||||+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~ 266 (400)
T cd05105 187 QYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAAR 266 (400)
T ss_pred ccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChH
Confidence 0001134788889999999999999999999999999999
Q ss_pred ceeecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChH
Q psy7289 196 NCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ 275 (422)
Q Consensus 196 NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~ 275 (422)
|||+++++.+||+|||+++...............+++.|||||.+....++.++|||||||++|||++.|..||.+....
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 99999999999999999986543332222233445678999999988889999999999999999998788999876543
Q ss_pred -HHHHHHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 276 -EVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 276 -~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
.+...+..+..++.|..+|+++.+++.+||..+|..|+ ++..+.+-|
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~l~~~l 394 (400)
T cd05105 347 STFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRP-----SFLHLSDIV 394 (400)
T ss_pred HHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCc-----CHHHHHHHH
Confidence 45566677767778889999999999999999999998 655555443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=358.34 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=216.8
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
...|++.+.||+|+||.||+|++..+ ++.||+|+++... .....+.+.+|+.++++++||||+++++++.+++..|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGT--GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCC--CCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 45788999999999999999987543 4679999986432 2234567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+||
T Consensus 95 lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Df 162 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKA------------GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDF 162 (329)
T ss_pred EEEcCCCCChHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeec
Confidence 999999999999999763 35788899999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP 290 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p 290 (422)
|+++...... ....+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..++...+..+. ++.|
T Consensus 163 g~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~-~~~p 235 (329)
T PTZ00263 163 GFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIA-GYPPFFDDTPFRIYEKILAGR-LKFP 235 (329)
T ss_pred cCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-cCCC
Confidence 9998654322 12357889999999998889999999999999999998 999999999888888887664 5678
Q ss_pred CCCCcchhhhcccccccccchhh------HHHHhhhhhhh
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAG------MAYLCSHHYVH 324 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~------~~~lh~~~~i~ 324 (422)
..+++.+.+|+.+||..+|..|. +..+.+|.++.
T Consensus 236 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~ 275 (329)
T PTZ00263 236 NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFH 275 (329)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccC
Confidence 88999999999999999999996 45666666654
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=351.32 Aligned_cols=248 Identities=21% Similarity=0.317 Sum_probs=212.7
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
+|++.+.||+|+||.||+|+...+ ++.||+|++.... ..+..+.+.+|+.++++++||||+++++++.+...+++|
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRIS--EHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCC--CCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence 578899999999999999987543 5679999985422 223456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||+++++.+||+|||+
T Consensus 80 ~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~ 147 (291)
T cd05612 80 MEYVPGGELFSYLRNS------------GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGF 147 (291)
T ss_pred EeCCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCc
Confidence 9999999999999764 3588899999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPED 292 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~ 292 (422)
++...... ....+++.|+|||++....++.++|||||||++|||++ |..||.+.+..++...+..+. .+.|..
T Consensus 148 ~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~ 220 (291)
T cd05612 148 AKKLRDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLV-GYPPFFDDNPFGIYEKILAGK-LEFPRH 220 (291)
T ss_pred chhccCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-cCCCcc
Confidence 98653321 22356889999999998889999999999999999998 999999999888888887664 556778
Q ss_pred CCcchhhhcccccccccchhh------HHHHhhhhhh
Q psy7289 293 CPPRMYSLMMECWHEVPVAAG------MAYLCSHHYV 323 (422)
Q Consensus 293 ~p~~~~~l~~~cw~~~P~~r~------~~~lh~~~~i 323 (422)
+++.+.+|+++||..||..|. +..+.+|.++
T Consensus 221 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~ 257 (291)
T cd05612 221 LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF 257 (291)
T ss_pred CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccc
Confidence 899999999999999999997 4445444443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=339.04 Aligned_cols=250 Identities=38% Similarity=0.720 Sum_probs=213.4
Q ss_pred ccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEecCCCC
Q psy7289 61 ELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGD 140 (422)
Q Consensus 61 ~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~~~G~ 140 (422)
.||+|+||.||+|++...+.+..||+|.+.........+.|.+|+.++++++||||+++++++. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999887655567799999876555555678999999999999999999999885 457899999999999
Q ss_pred HHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccccCCc
Q psy7289 141 LHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD 220 (422)
Q Consensus 141 L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~~~ 220 (422)
|.+++.... ..+++.++.+++.|++.||+|||+++++||||||+|||++.++.+||+|||+++......
T Consensus 81 L~~~l~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 149 (257)
T cd05115 81 LNKFLSGKK-----------DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149 (257)
T ss_pred HHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCc
Confidence 999986532 358899999999999999999999999999999999999999999999999997554332
Q ss_pred c-eEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcchhh
Q psy7289 221 Y-YRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYS 299 (422)
Q Consensus 221 ~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~~~~ 299 (422)
. .........++.|+|||.+....++.++|||||||++||+++.|..||.+.+..++...+..+.++++|..+++++.+
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 229 (257)
T cd05115 150 SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYA 229 (257)
T ss_pred cceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 2 111222233578999999988889999999999999999997799999999999999999888888889999999999
Q ss_pred hcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 300 LMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 300 l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
++.+||..+|..|+ +...+...|
T Consensus 230 li~~c~~~~~~~Rp-----~~~~i~~~l 252 (257)
T cd05115 230 LMKDCWIYKWEDRP-----NFAKVEERM 252 (257)
T ss_pred HHHHHcCCChhhCc-----CHHHHHHHH
Confidence 99999999999998 655554433
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=361.78 Aligned_cols=252 Identities=23% Similarity=0.431 Sum_probs=219.4
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
...|....+||+|+-|.||.|+...+ +..||||.+...... ..+-+.+|+.+|+.++|+|||++++.+...+.+++|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~--~~~VaiK~m~l~~Q~-~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKIST--KQEVAIKRMDLRKQP-KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccC--CceEEEEEEEeccCC-chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 35677788999999999999986544 467999998754432 345678999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
||||++|+|.+.+... .++|.++..++++++.||+|||.+||+|||||.+|||++.++.+||+|||+
T Consensus 349 MEym~ggsLTDvVt~~-------------~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGF 415 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKT-------------RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGF 415 (550)
T ss_pred EeecCCCchhhhhhcc-------------cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeee
Confidence 9999999999988653 489999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC--CC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP--CP 290 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~--~p 290 (422)
+........ ..++..|||.|||||++....|++++||||||++++||+- |.+||...++-..+..|.....+. .|
T Consensus 416 caqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMve-GEPPYlnE~PlrAlyLIa~ng~P~lk~~ 492 (550)
T KOG0578|consen 416 CAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVE-GEPPYLNENPLRALYLIATNGTPKLKNP 492 (550)
T ss_pred eeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhc-CCCCccCCChHHHHHHHhhcCCCCcCCc
Confidence 987754432 5567889999999999999999999999999999999996 999999888877777777655444 57
Q ss_pred CCCCcchhhhcccccccccchhhH-HHHhhhhhh
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAGM-AYLCSHHYV 323 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~~-~~lh~~~~i 323 (422)
+..++.+++++.+|+..|+..|+- ..|..|.++
T Consensus 493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl 526 (550)
T KOG0578|consen 493 EKLSPELKDFLDRCLVVDVEQRASAKELLEHPFL 526 (550)
T ss_pred cccCHHHHHHHHHHhhcchhcCCCHHHHhcChhh
Confidence 889999999999999999999974 356666666
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=357.99 Aligned_cols=255 Identities=22% Similarity=0.337 Sum_probs=217.6
Q ss_pred hhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC
Q psy7289 49 REVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSG 126 (422)
Q Consensus 49 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~ 126 (422)
..+....|++.+.||+|+||.||+|++... +...||+|.+.... .....+.+.+|+.+++.++|||||++++++.++
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 103 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNE-DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECC-CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence 344556789999999999999999986543 34679999885321 233456788999999999999999999999999
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEE
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vK 206 (422)
+.+++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+|
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ik 171 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRN------------KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIK 171 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEE
Confidence 9999999999999999999754 3588999999999999999999999999999999999999999999
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~ 286 (422)
|+|||+++...... ....+|+.|||||++....++.++|||||||++|||++ |..||.+.+...+...+..+.
T Consensus 172 L~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i~~~~- 244 (340)
T PTZ00426 172 MTDFGFAKVVDTRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILV-GCPPFYANEPLLIYQKILEGI- 244 (340)
T ss_pred EecCCCCeecCCCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhc-CCCCCCCCCHHHHHHHHhcCC-
Confidence 99999998653221 23457889999999998889999999999999999998 999999998888888887664
Q ss_pred CCCCCCCCcchhhhcccccccccchh------hHHHHhhhhhh
Q psy7289 287 LPCPEDCPPRMYSLMMECWHEVPVAA------GMAYLCSHHYV 323 (422)
Q Consensus 287 ~~~p~~~p~~~~~l~~~cw~~~P~~r------~~~~lh~~~~i 323 (422)
...|..+++.+.+++++|+..+|..| .++.+.+|.++
T Consensus 245 ~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f 287 (340)
T PTZ00426 245 IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287 (340)
T ss_pred CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCc
Confidence 44677889999999999999999998 45666666654
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=342.10 Aligned_cols=270 Identities=44% Similarity=0.791 Sum_probs=227.2
Q ss_pred hccccCcccccccccccceeEEEEEEecCC---CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSE---GPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG 126 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~ 126 (422)
++...+|++.+.||+|+||.||+|.+.... ....||+|.+...........+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 455667889999999999999999876432 34679999987655555567899999999999999999999999999
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEE
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vK 206 (422)
...++||||+++|+|.+++....+.... ......+++..+..++.|++.||.|||+++++||||||+||++++++.+|
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAEN--NPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhh--ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 9999999999999999999764321110 01123578889999999999999999999999999999999999999999
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~ 286 (422)
|+|||+++...............++..|+|||.+....++.++|||||||++||+++.|..||.+.+..+....+..+..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGH 239 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCC
Confidence 99999998765544333334445678899999998888999999999999999999889999999999999988887777
Q ss_pred CCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhh
Q psy7289 287 LPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRD 326 (422)
Q Consensus 287 ~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~d 326 (422)
.+.|..+|.++.+++.+||..+|..|+ +...+...
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~l~~~ 274 (277)
T cd05032 240 LDLPENCPDKLLELMRMCWQYNPKMRP-----TFLEIVSS 274 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCC-----CHHHHHHH
Confidence 788899999999999999999999998 55544433
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=362.44 Aligned_cols=253 Identities=22% Similarity=0.400 Sum_probs=223.1
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc--CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
.-+++.+.||.|+-|.|..|++..+ ++.+|||++... ........+.+|+-||+-|.||||+++|+++.+...+|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~T--GqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAET--GQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cceeccccccCCCCceehhhhcccc--cceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 3478899999999999999987654 588999998654 233344578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
|.||+++|.|+++|..+ +++++.++.+++.||+.|+.|||..+|+||||||+|+||+..+++||+|||
T Consensus 90 vlEyv~gGELFdylv~k------------G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFG 157 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRK------------GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFG 157 (786)
T ss_pred EEEecCCchhHHHHHhh------------CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccc
Confidence 99999999999999875 479999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccccCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFT-TESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP 290 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p 290 (422)
+|.....+. ...+.+|+|.|.|||++.+..|+ .++||||.|||||.|+| |..||.+.+...++.+|+.|. ...|
T Consensus 158 MAsLe~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLt-G~LPFdDdNir~LLlKV~~G~-f~MP 232 (786)
T KOG0588|consen 158 MASLEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLT-GKLPFDDDNIRVLLLKVQRGV-FEMP 232 (786)
T ss_pred eeecccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHh-CCCCCCCccHHHHHHHHHcCc-ccCC
Confidence 997544433 33467889999999999999885 78999999999999999 999999999999999999886 5678
Q ss_pred CCCCcchhhhcccccccccchh-hHHHHhhhhhhhh
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAA-GMAYLCSHHYVHR 325 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r-~~~~lh~~~~i~~ 325 (422)
...|++.++|+++++.-||..| .++.+.+|.++-.
T Consensus 233 s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g 268 (786)
T KOG0588|consen 233 SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSG 268 (786)
T ss_pred CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhc
Confidence 9999999999999999999877 4666667776654
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-46 Score=325.57 Aligned_cols=255 Identities=26% Similarity=0.416 Sum_probs=219.9
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
.-+++++.+.||+|.||.||.|+.+.+ .-.||+|++-+.. .....+++.||++|.+.|+||||+++|++|.+....
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks--~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKS--LFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI 97 (281)
T ss_pred chhhccccccccCCccccEeEeeeccC--CcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence 345678899999999999999987654 4679999985432 223456789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEec
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISD 209 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~D 209 (422)
|+++||.++|+|+..|.... ...+++.....++.|+|.||.|+|.++||||||||+|+|++..+.+||+|
T Consensus 98 yLilEya~~gel~k~L~~~~----------~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAd 167 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGR----------MKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIAD 167 (281)
T ss_pred EEEEEecCCchHHHHHHhcc----------cccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccC
Confidence 99999999999999998542 24588889999999999999999999999999999999999999999999
Q ss_pred CcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 289 (422)
||-+..... ....+.+||.-|.|||...+..++..+|+|++|++.||++. |.+||...+..+.+++|..-. ...
T Consensus 168 fGwsV~~p~----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflv-g~ppFes~~~~etYkrI~k~~-~~~ 241 (281)
T KOG0580|consen 168 FGWSVHAPS----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLV-GLPPFESQSHSETYKRIRKVD-LKF 241 (281)
T ss_pred CCceeecCC----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHh-cCCchhhhhhHHHHHHHHHcc-ccC
Confidence 998865432 23456678999999999999999999999999999999997 999999999999999997643 556
Q ss_pred CCCCCcchhhhcccccccccchh-hHHHHhhhhhhh
Q psy7289 290 PEDCPPRMYSLMMECWHEVPVAA-GMAYLCSHHYVH 324 (422)
Q Consensus 290 p~~~p~~~~~l~~~cw~~~P~~r-~~~~lh~~~~i~ 324 (422)
|+..+.+..+++.+|+..+|..| ++.....|.+|.
T Consensus 242 p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 242 PSTISGGAADLISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred CcccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence 78999999999999999999876 555555666654
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=353.90 Aligned_cols=247 Identities=22% Similarity=0.385 Sum_probs=210.1
Q ss_pred cccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEecC
Q psy7289 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMV 137 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~~ 137 (422)
+.||+|+||.||+++... .+..||+|+++... .......+.+|+.++++++||||+++++++...+.+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKA--TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence 469999999999998654 35789999986432 23345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccccccc
Q psy7289 138 RGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVY 217 (422)
Q Consensus 138 ~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~ 217 (422)
+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 79 ~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~ 146 (323)
T cd05571 79 GGELFFHLSRE------------RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred CCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence 99999998753 358899999999999999999999999999999999999999999999999997532
Q ss_pred CCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcch
Q psy7289 218 ASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRM 297 (422)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~~ 297 (422)
.... ......+|+.|||||++....++.++|||||||++|||++ |..||.+.+..++...+..+. ...|..+++++
T Consensus 147 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~ 222 (323)
T cd05571 147 SDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELILMEE-IRFPRTLSPEA 222 (323)
T ss_pred cCCC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHH
Confidence 2211 1223457889999999998899999999999999999998 999999988888887776553 46678899999
Q ss_pred hhhcccccccccchhh------HHHHhhhhhhh
Q psy7289 298 YSLMMECWHEVPVAAG------MAYLCSHHYVH 324 (422)
Q Consensus 298 ~~l~~~cw~~~P~~r~------~~~lh~~~~i~ 324 (422)
.+++.+||..+|..|+ +..+.+|.++.
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~ 255 (323)
T cd05571 223 KSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFA 255 (323)
T ss_pred HHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcC
Confidence 9999999999999996 66666666653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=337.89 Aligned_cols=249 Identities=40% Similarity=0.734 Sum_probs=217.3
Q ss_pred cCcccccccccccceeEEEEEEecC-CCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTS-EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
.+|++.+.||+|+||.||+|++... .....||||.++..........|.+|+.++++++||||+++++++...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 4578889999999999999998644 335679999987655556667899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++|+|.+++.... ..+++..+.+++.|++.||+|||+++|+||||||+||++++++.+||+|||+
T Consensus 84 ~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~ 152 (266)
T cd05033 84 TEYMENGSLDKFLREND-----------GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGL 152 (266)
T ss_pred EEcCCCCCHHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccch
Confidence 99999999999996532 2588999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPED 292 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~ 292 (422)
++................++.|+|||.+....++.++||||||+++|||++.|..||...+..++...+..+...+.|..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 232 (266)
T cd05033 153 SRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMD 232 (266)
T ss_pred hhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 98764222111222334467899999999889999999999999999999889999999999999988888877788889
Q ss_pred CCcchhhhcccccccccchhh
Q psy7289 293 CPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 293 ~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+|+.+.+++.+||..+|..|+
T Consensus 233 ~~~~l~~li~~cl~~~p~~Rp 253 (266)
T cd05033 233 CPSALYQLMLDCWQKDRNERP 253 (266)
T ss_pred CCHHHHHHHHHHcCCCcccCc
Confidence 999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=335.59 Aligned_cols=249 Identities=39% Similarity=0.730 Sum_probs=213.4
Q ss_pred ccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEecCCC
Q psy7289 61 ELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRG 139 (422)
Q Consensus 61 ~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~~~G 139 (422)
+||+|+||.||+|.+........+|+|+++... .....+.+.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999987666667889999986433 3345678999999999999999999999885 45678999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccccCC
Q psy7289 140 DLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS 219 (422)
Q Consensus 140 ~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~~ 219 (422)
+|.+++... ..++++.+..++.|++.||+|||+++|+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~------------~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 81 PLNKFLQKN------------KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred cHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 999999653 25789999999999999999999999999999999999999999999999999876443
Q ss_pred cce-EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcchh
Q psy7289 220 DYY-RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMY 298 (422)
Q Consensus 220 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~~~ 298 (422)
... .......+++.|+|||.+....++.++|||||||++|||++.|..||.+.+..++...+.++..++.|..+|+++.
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 228 (257)
T cd05116 149 ENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMY 228 (257)
T ss_pred CCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 322 1122233457899999998888999999999999999999878999999989999999998888888999999999
Q ss_pred hhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 299 SLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 299 ~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
++|..||..+|..|+ +...|...|
T Consensus 229 ~li~~~~~~~p~~Rp-----~~~~i~~~l 252 (257)
T cd05116 229 DLMKLCWTYGVDERP-----GFAVVELRL 252 (257)
T ss_pred HHHHHHhccCchhCc-----CHHHHHHHH
Confidence 999999999999999 666665443
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=352.95 Aligned_cols=257 Identities=28% Similarity=0.431 Sum_probs=210.0
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC-CCceeeEeeEEEcCC-C
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR-HPNIVCLLGVCLSGE-P 128 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~-~ 128 (422)
+...+|.++++||.|+||.||+|+-.. .+..||||+++.....-+.-.=+||+..|++|+ |||||+|.+++.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~--~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKE--TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecC--CCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 345689999999999999999998654 456799999986554333334578999999999 999999999999988 8
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
+|+|||||.. +|+++++.|. ..|++.+++.|+.||++||+|+|.+|+.|||+||+|||+.....+||+
T Consensus 85 L~fVfE~Md~-NLYqLmK~R~-----------r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKia 152 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDRN-----------RLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIA 152 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhcC-----------CcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEec
Confidence 9999999975 9999998763 479999999999999999999999999999999999999988899999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccc-cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc--C-
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL-YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS--R- 284 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~--~- 284 (422)
||||||.+.....| +.-+.|..|.|||++. .+-|+.+.||||+|||++|+.+ -++-|.|.+..+-+.+|.. |
T Consensus 153 DFGLARev~SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~s-LrPLFPG~sE~Dqi~KIc~VLGt 228 (538)
T KOG0661|consen 153 DFGLAREVRSKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYS-LRPLFPGASEIDQIYKICEVLGT 228 (538)
T ss_pred ccccccccccCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHH-hcccCCCCcHHHHHHHHHHHhCC
Confidence 99999988765533 2334467899999976 4679999999999999999998 5677888887766655532 0
Q ss_pred -----------------CCCC-CC--------CCCCcchhhhcccccccccchhhHH-HHhhhhhhhh
Q psy7289 285 -----------------QMLP-CP--------EDCPPRMYSLMMECWHEVPVAAGMA-YLCSHHYVHR 325 (422)
Q Consensus 285 -----------------~~~~-~p--------~~~p~~~~~l~~~cw~~~P~~r~~~-~lh~~~~i~~ 325 (422)
.+.| ++ +.++++..+||.+|+..||..|+-+ ++..|.++.-
T Consensus 229 P~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~ 296 (538)
T KOG0661|consen 229 PDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQV 296 (538)
T ss_pred CccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccc
Confidence 0111 11 2378889999999999999998744 5666666543
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=341.96 Aligned_cols=275 Identities=39% Similarity=0.755 Sum_probs=230.0
Q ss_pred hhhccccCcccccccccccceeEEEEEEecC---CCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEE
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTS---EGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVC 123 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~ 123 (422)
..++...+|++.+.||+|+||.||++.+... .....+|+|.+...........+.+|+.+++++ +||||+++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 4556667888999999999999999987643 234679999987655555567799999999999 799999999999
Q ss_pred EcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCC----CCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceee
Q psy7289 124 LSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISG----SQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV 199 (422)
Q Consensus 124 ~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~----~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl 199 (422)
..+..++++|||+++|+|.+++..+.+...... ......+++..+..++.|++.||+|||+++|+||||||+||++
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 999999999999999999999976543211111 0123468999999999999999999999999999999999999
Q ss_pred cCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHH
Q psy7289 200 GDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIE 279 (422)
Q Consensus 200 ~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~ 279 (422)
++++.+||+|||+++...............++..|+|||++....++.++|||||||++|||++.|..||.+.+..++..
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 99999999999999876544433333333456789999999888899999999999999999988999999999999999
Q ss_pred HHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 280 MIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 280 ~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
.+..+...+.|..++..+.+|+.+||..+|..|+ +...+..+|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~eil~~l 288 (293)
T cd05053 246 LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRP-----TFKQLVEDL 288 (293)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCc-----CHHHHHHHH
Confidence 8888887788889999999999999999999998 555555444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=333.65 Aligned_cols=251 Identities=25% Similarity=0.411 Sum_probs=200.9
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC-HHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN-QKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
+|+.+.++|+|+||+|||++.+. .++.||||++....+ +...+--+||+++|++|+|||+|.|+++|.....+++|+
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~--TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKD--TGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred HHhhhhccccCcceEEEEeccCC--cccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 57778899999999999998754 468899999876554 444556789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
|||..--|++ |... ...++...+.+++.|++.|+.|+|++++|||||||+||||+.++.+||||||+|
T Consensus 81 E~~dhTvL~e-Le~~-----------p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFA 148 (396)
T KOG0593|consen 81 EYCDHTVLHE-LERY-----------PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFA 148 (396)
T ss_pred eecchHHHHH-HHhc-----------cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhh
Confidence 9999855544 3322 135889999999999999999999999999999999999999999999999999
Q ss_pred ccccCC-cceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc--------
Q psy7289 214 RDVYAS-DYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS-------- 283 (422)
Q Consensus 214 ~~~~~~-~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~-------- 283 (422)
|.+... +.| +.-..|..|.|||.+.+ -.|+..+||||.||++.||++ |.+-|.|.+.-+.+-.|+.
T Consensus 149 R~L~~pgd~Y---TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~-G~pL~PG~SDiDQLy~I~ktLG~L~pr 224 (396)
T KOG0593|consen 149 RTLSAPGDNY---TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLT-GEPLWPGRSDIDQLYLIRKTLGNLIPR 224 (396)
T ss_pred HhhcCCcchh---hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhc-CCcCCCCcchHHHHHHHHHHHcccCHH
Confidence 987632 222 23345678999999987 579999999999999999998 9988889887665544421
Q ss_pred ------------CCCCCCCCC----------CCcchhhhcccccccccchhhH-HHHhhhhhh
Q psy7289 284 ------------RQMLPCPED----------CPPRMYSLMMECWHEVPVAAGM-AYLCSHHYV 323 (422)
Q Consensus 284 ------------~~~~~~p~~----------~p~~~~~l~~~cw~~~P~~r~~-~~lh~~~~i 323 (422)
|.++|.|++ .+..+.++|+.|++.||..|.. +.|..|..+
T Consensus 225 hq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF 287 (396)
T KOG0593|consen 225 HQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF 287 (396)
T ss_pred HHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence 223343332 2345678999999999998852 334445444
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=344.68 Aligned_cols=276 Identities=36% Similarity=0.710 Sum_probs=228.3
Q ss_pred hhhccccCcccccccccccceeEEEEEEec-----CCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEee
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCT-----SEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLG 121 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g 121 (422)
++++...+|++.+.||+|+||.||+|++.. ......||+|..+........+.+.+|+.+++.+ +||||+++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 345667788999999999999999998642 1234579999887554455567899999999999 8999999999
Q ss_pred EEEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCC----CCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q psy7289 122 VCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISG----SQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNC 197 (422)
Q Consensus 122 ~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~----~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~Ni 197 (422)
++......+++|||+++|+|.+++..+.+...... ......++..++..++.||+.||+|||++|++||||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 99999999999999999999999987533211000 01123578889999999999999999999999999999999
Q ss_pred eecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHH
Q psy7289 198 LVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEV 277 (422)
Q Consensus 198 Ll~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~ 277 (422)
++++++.+||+|||+++...............+++.|+|||++....++.++|||||||++|||++.|..||.+.+..++
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 99999999999999998764433222233334567899999998888999999999999999999878899999999999
Q ss_pred HHHHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 278 IEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 278 ~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
...+..+.+...|..++..+.+++.+||+.+|..|+ +...+...|+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~e~l~~l~ 294 (304)
T cd05101 249 FKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRP-----TFKQLVEDLD 294 (304)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCC-----CHHHHHHHHH
Confidence 999988887788889999999999999999999998 6666655543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=342.16 Aligned_cols=251 Identities=22% Similarity=0.315 Sum_probs=205.3
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
|+..+.||+|+||.||+|....+ +..||+|.+.... .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecC--CceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEE
Confidence 56788999999999999987654 4679999876432 1223346789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||+++|+|.+++.... ...+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|||++
T Consensus 80 e~~~~g~L~~~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~ 149 (285)
T cd05631 80 TIMNGGDLKFHIYNMG----------NPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLA 149 (285)
T ss_pred EecCCCcHHHHHHhhC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 9999999998886432 125889999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHH----HHHHHcCCCCCC
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEV----IEMIRSRQMLPC 289 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~----~~~i~~~~~~~~ 289 (422)
+....... .....+|+.|||||++....++.++|||||||++|||++ |..||.+.+.... ...+. ....+.
T Consensus 150 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~-g~~pf~~~~~~~~~~~~~~~~~-~~~~~~ 224 (285)
T cd05631 150 VQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQ-GQSPFRKRKERVKREEVDRRVK-EDQEEY 224 (285)
T ss_pred EEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHh-CCCCCCCCCcchhHHHHHHHhh-cccccC
Confidence 76533221 123457899999999999999999999999999999998 9999987665332 22232 233456
Q ss_pred CCCCCcchhhhcccccccccchhh------HHHHhhhhhh
Q psy7289 290 PEDCPPRMYSLMMECWHEVPVAAG------MAYLCSHHYV 323 (422)
Q Consensus 290 p~~~p~~~~~l~~~cw~~~P~~r~------~~~lh~~~~i 323 (422)
|...++.+.+|+++||..+|..|. +..+.+|.++
T Consensus 225 ~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~ 264 (285)
T cd05631 225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIF 264 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhh
Confidence 777899999999999999999996 3445555443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=355.63 Aligned_cols=257 Identities=26% Similarity=0.424 Sum_probs=223.2
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
....|+.++.||+|+||.||||....+ .+.||+|++..........++.+|+.+|..+++|||.++||.+..+..+++
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t--~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwi 88 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKT--KKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWI 88 (467)
T ss_pred cccccccchhccccccceeeeeeeccc--cceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHH
Confidence 345667779999999999999987654 577999999877777778899999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
+||||.+|++.+.|... ..+.+..+.-++++++.||.|||+++.+|||||+.|||+..++.+||+|||
T Consensus 89 iMey~~gGsv~~lL~~~------------~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~Dfg 156 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSG------------NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFG 156 (467)
T ss_pred HHHHhcCcchhhhhccC------------CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecc
Confidence 99999999999999653 235777888899999999999999999999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCC
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPE 291 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~ 291 (422)
++-++...... ..+..||+.|||||++....|+.|+||||||++.+||++ |.+|+.+..+..++-.|-....+..-.
T Consensus 157 Va~ql~~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~-GePP~s~~hPmrvlflIpk~~PP~L~~ 233 (467)
T KOG0201|consen 157 VAGQLTNTVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAK-GEPPHSKLHPMRVLFLIPKSAPPRLDG 233 (467)
T ss_pred eeeeeechhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhc-CCCCCcccCcceEEEeccCCCCCcccc
Confidence 99877654432 367889999999999998899999999999999999998 999999999876666565444333445
Q ss_pred CCCcchhhhcccccccccchhhHH-HHhhhhhhhh
Q psy7289 292 DCPPRMYSLMMECWHEVPVAAGMA-YLCSHHYVHR 325 (422)
Q Consensus 292 ~~p~~~~~l~~~cw~~~P~~r~~~-~lh~~~~i~~ 325 (422)
.+++.+++++..|++++|..|+-+ .|.+|.+|.+
T Consensus 234 ~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 234 DFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 788999999999999999999754 5777777776
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=339.54 Aligned_cols=249 Identities=36% Similarity=0.635 Sum_probs=211.3
Q ss_pred ccCcccccccccccceeEEEEEEecCCCC--eEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGP--SLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
..++++.+.||+|+||.||+|++..++.. ..+++|.+..........++..|+.++++++||||+++++++. ....+
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~ 84 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ 84 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence 35678889999999999999988544322 2478888765444445567888999999999999999999885 45678
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+++||+++|+|.+++.... ..+++..+..++.||+.||+|||+++++||||||+|||+++++.+||+||
T Consensus 85 ~i~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Df 153 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHR-----------DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADF 153 (279)
T ss_pred EEEEeCCCCcHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCC
Confidence 9999999999999997532 35889999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP 290 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p 290 (422)
|+++...............++..|+|||.+..+.++.++|||||||++||+++.|..||.+....++.+.+..+..++.|
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (279)
T cd05111 154 GVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQP 233 (279)
T ss_pred ccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCC
Confidence 99986543322112233445678999999998899999999999999999998899999999888888888888888888
Q ss_pred CCCCcchhhhcccccccccchhh
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..|+.++.+++.+||..+|..|+
T Consensus 234 ~~~~~~~~~li~~c~~~~p~~Rp 256 (279)
T cd05111 234 QICTIDVYMVMVKCWMIDENVRP 256 (279)
T ss_pred CCCCHHHHHHHHHHcCCCcccCc
Confidence 89999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=338.52 Aligned_cols=258 Identities=35% Similarity=0.612 Sum_probs=217.8
Q ss_pred cccCcccccccccccceeEEEEEEecCCCC--eEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGP--SLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
...++++.+.||+|+||.||+|++..++.. ..||+|.++..........+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 345678899999999999999987654332 25899998766666666789999999999999999999999875 457
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEec
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISD 209 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~D 209 (422)
+++|||+++|+|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~-----------~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~d 152 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENK-----------DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITD 152 (279)
T ss_pred EEEEEcCCCCCHHHHHhhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECC
Confidence 89999999999999997532 3588999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 289 (422)
||+++...............+++.|+|||.+....++.++|||||||++|||++.|..||......++...+..+...+.
T Consensus 153 fG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 232 (279)
T cd05109 153 FGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ 232 (279)
T ss_pred CCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC
Confidence 99998764332221222233467899999998888999999999999999999889999998888888888888877788
Q ss_pred CCCCCcchhhhcccccccccchhhHHHHhhhhhhhhh
Q psy7289 290 PEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRD 326 (422)
Q Consensus 290 p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~d 326 (422)
|..+++++.+++.+||..+|..|+ +...+...
T Consensus 233 ~~~~~~~~~~li~~~l~~dp~~Rp-----~~~~l~~~ 264 (279)
T cd05109 233 PPICTIDVYMIMVKCWMIDSECRP-----RFRELVDE 264 (279)
T ss_pred CccCCHHHHHHHHHHcCCChhhCc-----CHHHHHHH
Confidence 889999999999999999999998 55555443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=339.79 Aligned_cols=263 Identities=44% Similarity=0.794 Sum_probs=220.2
Q ss_pred hhccccCcccccccccccceeEEEEEEecC---CCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc
Q psy7289 49 REVIETKPRFLQELGEGAFGKVYKGEVCTS---EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLS 125 (422)
Q Consensus 49 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 125 (422)
|++...+|++.+.||+|+||.||+|..+.. .....||+|.++..........+.+|+.+++.++||||+++++++.+
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 356677899999999999999999976532 23457999998755544555678899999999999999999999999
Q ss_pred CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 126 GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 126 ~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
....++||||+++|+|.+++......... ......++...+..++.|++.||.|||+++|+||||||+|||+++++.+
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAEN--NPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhcccccc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence 99999999999999999999764321110 0112345677889999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ 285 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~ 285 (422)
||+|||+++...............++..|+|||.+..+.++.++|||||||++|||++.|..||.+.+..++...+..+.
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 238 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 238 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999866544332222333456789999999888899999999999999999987889999999889888888777
Q ss_pred CCCCCCCCCcchhhhcccccccccchhh
Q psy7289 286 MLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 286 ~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..+.|..+|+.+.+++..||+.+|..|+
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp 266 (288)
T cd05061 239 YLDQPDNCPERVTDLMRMCWQFNPKMRP 266 (288)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhHCc
Confidence 7778889999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=348.05 Aligned_cols=245 Identities=21% Similarity=0.345 Sum_probs=207.8
Q ss_pred cccccceeEEEEEEecCCCCeEEEEEEccCc--CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEecCCC
Q psy7289 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRG 139 (422)
Q Consensus 62 LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~~~G 139 (422)
||+|+||.||+|+... .+..||+|.++.. ........+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~--~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRD--TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence 7999999999998654 3567999998642 23344567889999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccccCC
Q psy7289 140 DLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS 219 (422)
Q Consensus 140 ~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~~ 219 (422)
+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 146 (312)
T cd05585 79 ELFHHLQRE------------GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD 146 (312)
T ss_pred cHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC
Confidence 999999653 35889999999999999999999999999999999999999999999999999754322
Q ss_pred cceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcchhh
Q psy7289 220 DYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYS 299 (422)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~~~~ 299 (422)
.. ......+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..++...+..+. ...|..+++++.+
T Consensus 147 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 222 (312)
T cd05585 147 DD--KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLT-GLPPFYDENVNEMYRKILQEP-LRFPDGFDRDAKD 222 (312)
T ss_pred CC--ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHh-CCCCcCCCCHHHHHHHHHcCC-CCCCCcCCHHHHH
Confidence 11 1233457889999999998899999999999999999998 999999998888888776553 5567889999999
Q ss_pred hcccccccccchhh----HHHHhhhhhhh
Q psy7289 300 LMMECWHEVPVAAG----MAYLCSHHYVH 324 (422)
Q Consensus 300 l~~~cw~~~P~~r~----~~~lh~~~~i~ 324 (422)
++.+||..+|..|. +..+.+|.++.
T Consensus 223 li~~~L~~dp~~R~~~~~~~e~l~hp~~~ 251 (312)
T cd05585 223 LLIGLLSRDPTRRLGYNGAQEIKNHPFFS 251 (312)
T ss_pred HHHHHcCCCHHHcCCCCCHHHHHcCCCcC
Confidence 99999999999994 44555555543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=341.19 Aligned_cols=241 Identities=21% Similarity=0.359 Sum_probs=203.2
Q ss_pred cccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc----CCCeEEEE
Q psy7289 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLS----GEPMCMLF 133 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~~~lv~ 133 (422)
..||+|++|.||+|++ ++..||||.++... .....+.|.+|+.+|++++|||||+++|++.+ ...+++||
T Consensus 26 ~~i~~g~~~~v~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~ 101 (283)
T PHA02988 26 VLIKENDQNSIYKGIF----NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL 101 (283)
T ss_pred eEEeeCCceEEEEEEE----CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEE
Confidence 5699999999999987 35689999986532 22235678899999999999999999999876 34689999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCS-HHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
||+++|+|.+++... ..+++....+++.|++.||.|||+ .+++||||||+|||+++++.+||+|||+
T Consensus 102 Ey~~~g~L~~~l~~~------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~ 169 (283)
T PHA02988 102 EYCTRGYLREVLDKE------------KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGL 169 (283)
T ss_pred EeCCCCcHHHHHhhC------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccch
Confidence 999999999999753 247888899999999999999998 4899999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCcccccc--CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH-cCCCCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILY--GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR-SRQMLPC 289 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~ 289 (422)
++...... ....+++.|+|||.+.. ..++.++|||||||++|||++ |..||.+.+..++...+. .+.+++.
T Consensus 170 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~ 243 (283)
T PHA02988 170 EKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFT-GKIPFENLTTKEIYDLIINKNNSLKL 243 (283)
T ss_pred Hhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHhcCCCCCC
Confidence 98653321 23456788999999875 679999999999999999999 999999999888887775 3455667
Q ss_pred CCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 290 PEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 290 p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
|..||+.+.+++.+||+.+|..|+ +...+...|
T Consensus 244 ~~~~~~~l~~li~~cl~~dp~~Rp-----s~~ell~~l 276 (283)
T PHA02988 244 PLDCPLEIKCIVEACTSHDSIKRP-----NIKEILYNL 276 (283)
T ss_pred CCcCcHHHHHHHHHHhcCCcccCc-----CHHHHHHHH
Confidence 778999999999999999999998 555544433
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=348.78 Aligned_cols=246 Identities=21% Similarity=0.386 Sum_probs=207.3
Q ss_pred cccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEecC
Q psy7289 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMV 137 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~~ 137 (422)
+.||+|+||.||+++... .+..||+|+++... .......+.+|+++++.++||||+++++++...+.+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKA--TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence 469999999999998644 35779999986432 23345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccccccc
Q psy7289 138 RGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVY 217 (422)
Q Consensus 138 ~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~ 217 (422)
+|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++...
T Consensus 79 ~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 146 (323)
T cd05595 79 GGELFFHLSRE------------RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred CCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence 99999988653 358899999999999999999999999999999999999999999999999987543
Q ss_pred CCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcch
Q psy7289 218 ASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRM 297 (422)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~~ 297 (422)
.... ......+|+.|||||++....++.++|||||||++|||++ |..||.+.+..+....+.... ...|..+++++
T Consensus 147 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~ 222 (323)
T cd05595 147 SDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFELILMEE-IRFPRTLSPEA 222 (323)
T ss_pred CCCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHH
Confidence 2211 1123457889999999998899999999999999999998 999999988888877776543 45678899999
Q ss_pred hhhcccccccccchhh------HHHHhhhhhh
Q psy7289 298 YSLMMECWHEVPVAAG------MAYLCSHHYV 323 (422)
Q Consensus 298 ~~l~~~cw~~~P~~r~------~~~lh~~~~i 323 (422)
.+++.+||..+|..|. +..+.+|.++
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~ 254 (323)
T cd05595 223 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 254 (323)
T ss_pred HHHHHHHccCCHHHhCCCCCCCHHHHHcCCCc
Confidence 9999999999999994 5555555443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=335.15 Aligned_cols=259 Identities=37% Similarity=0.708 Sum_probs=214.5
Q ss_pred ccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC------CCe
Q psy7289 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG------EPM 129 (422)
Q Consensus 57 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------~~~ 129 (422)
.+.+.||+|+||.||+|++........||+|.++.. ......+.|.+|+.+++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 457889999999999998865544457999988654 3445567899999999999999999999987532 246
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEec
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISD 209 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~D 209 (422)
+++|||+++|+|.+++...... .....+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~D 155 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLG------DCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVAD 155 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhccc------CCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECC
Confidence 8999999999999988542111 0113588999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 289 (422)
||+++................++.|+|||++....++.++|||||||++|||++.|..||.+.+..++...+..+..++.
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 235 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ 235 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99998765443332223334567899999999888999999999999999999878999999988899999988887777
Q ss_pred CCCCCcchhhhcccccccccchhhHHHHhhhhhhhhh
Q psy7289 290 PEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRD 326 (422)
Q Consensus 290 p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~d 326 (422)
+..++..+.+++.+||..+|..|+ +...+...
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~l~~~ 267 (272)
T cd05075 236 PPDCLDGLYSLMSSCWLLNPKDRP-----SFETLRCE 267 (272)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCc-----CHHHHHHH
Confidence 889999999999999999999998 55544433
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=336.81 Aligned_cols=255 Identities=42% Similarity=0.809 Sum_probs=216.5
Q ss_pred cCcccccccccccceeEEEEEEecCC---CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSE---GPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
..+++.+.||+|+||.||+|.+.... ....||+|.............|.+|+.+++.++||||+++++++.+....+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 45788899999999999999886522 456799998876555555678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC---eEEE
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL---TVKI 207 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~---~vKl 207 (422)
+||||+++|+|.+++....+... ....+++..+.+++.||+.||+|||+++++||||||+||+++.++ .+||
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPE-----RPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 99999999999999976532211 123588999999999999999999999999999999999998654 6999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+|||+++................+..|+|||++....++.++|||||||++|||++.|..||.+.+..++...+......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99999987644333322223334568999999988899999999999999999998799999999999988888877777
Q ss_pred CCCCCCCcchhhhcccccccccchhh
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+.|..+|+.+.+++.+||..+|..|+
T Consensus 241 ~~~~~~~~~~~~~i~~cl~~~p~~Rp 266 (277)
T cd05036 241 DPPKGCPGPVYRIMTDCWQHTPEDRP 266 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCc
Confidence 77889999999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=342.85 Aligned_cols=276 Identities=38% Similarity=0.711 Sum_probs=226.2
Q ss_pred hhhccccCcccccccccccceeEEEEEEecCC-----CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEee
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSE-----GPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLG 121 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g 121 (422)
++++...+|.+.+.||+|+||.||++++.... ....+|+|.++..........+.+|+.+++.+ +||||+++++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 45677788999999999999999999864322 23469999987654445567788999999999 7999999999
Q ss_pred EEEcCCCeEEEEEecCCCCHHHHHhhcCCCCCC----CCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q psy7289 122 VCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDI----SGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNC 197 (422)
Q Consensus 122 ~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~----~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~Ni 197 (422)
++......++||||+++|+|.+++..+.+.... ........+++.++.+++.|++.||+|||+++++||||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 999999999999999999999999875332100 0001123588899999999999999999999999999999999
Q ss_pred eecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHH
Q psy7289 198 LVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEV 277 (422)
Q Consensus 198 Ll~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~ 277 (422)
+++.++.+||+|||+++...............+++.|||||.+....++.++|||||||++|||++.|..||.+.+..++
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~ 251 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 99999999999999997654322222222233456899999998888999999999999999999878999999888888
Q ss_pred HHHHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 278 IEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 278 ~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
...+..+...+.|..++.++.+++.+||..+|..|+ +...+..+|+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~evl~~l~ 297 (307)
T cd05098 252 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP-----TFKQLVEDLD 297 (307)
T ss_pred HHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCc-----CHHHHHHHHH
Confidence 888888877788889999999999999999999998 5555555443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=335.04 Aligned_cols=261 Identities=35% Similarity=0.720 Sum_probs=218.4
Q ss_pred cccccccccccceeEEEEEEecCC-CCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC-----
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSE-GPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP----- 128 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~----- 128 (422)
|++.+.||+|+||.||+|++.... ....||+|.++... .......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 457889999999999999876433 34679999987532 34456789999999999999999999998876554
Q ss_pred -eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 129 -MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 129 -~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
.+++|||+++|+|.+++....... ....+++..+..++.|++.||+|||+++++||||||+||++++++.+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~------~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl 154 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGG------LPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCV 154 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccC------CcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEE
Confidence 799999999999999986542110 1235889999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+|||+++.......+........+..|+|||.+....++.++|||||||++|||++.|..||.+.++.++.+.+..+...
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 234 (273)
T cd05035 155 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL 234 (273)
T ss_pred CCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999987654443322223334678999999988889999999999999999998899999999999999999888888
Q ss_pred CCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
+.|..+++.+.+++.+||..+|..|+ +...+.+.|
T Consensus 235 ~~~~~~~~~~~~li~~~l~~~p~~Rp-----~~~e~~~~l 269 (273)
T cd05035 235 KQPEDCLDELYDLMYSCWRADPKDRP-----TFTKLREVL 269 (273)
T ss_pred CCCcCCCHHHHHHHHHHcCCChhhCc-----CHHHHHHHH
Confidence 88899999999999999999999998 655555544
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=340.20 Aligned_cols=263 Identities=24% Similarity=0.402 Sum_probs=221.4
Q ss_pred chhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC
Q psy7289 47 FRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG 126 (422)
Q Consensus 47 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~ 126 (422)
..+.+....|++..+||.|.-+.||+|+....+ +.||||++...........+.+|+..|+.++||||++++..|..+
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~--e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTN--EVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccC--CEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 345566788999999999999999999987654 789999997655555578899999999999999999999999999
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEE
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vK 206 (422)
..+|+||.||.+|++.+.++..-+ ..++|..+..|+++++.||.|||.+|.||||||+.||||+++|.||
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~----------~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~Vk 166 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYP----------DGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVK 166 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHcc----------ccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEE
Confidence 999999999999999999987643 2489999999999999999999999999999999999999999999
Q ss_pred EecCcccccccCCcce-Eec-cCCCCCccccCcccccc--CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q psy7289 207 ISDFGLSRDVYASDYY-RIQ-SKSLLPVRWMPPESILY--GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282 (422)
Q Consensus 207 l~DFGla~~~~~~~~~-~~~-~~~~~t~~y~aPE~~~~--~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~ 282 (422)
|+|||.+-.+..+... ... ....+|+.|||||++.. ..|+.|+|||||||+..|+.+ |..||..+.+.+++-+-.
T Consensus 167 LadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~-G~aPf~k~pPmkvLl~tL 245 (516)
T KOG0582|consen 167 LADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAH-GHAPFSKYPPMKVLLLTL 245 (516)
T ss_pred EcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhc-CCCCcccCChHHHHHHHh
Confidence 9999998776554321 222 55678999999999654 469999999999999999998 999999999998876665
Q ss_pred cCCCCCCC----------CCCCcchhhhcccccccccchhhHH-HHhhhhhh
Q psy7289 283 SRQMLPCP----------EDCPPRMYSLMMECWHEVPVAAGMA-YLCSHHYV 323 (422)
Q Consensus 283 ~~~~~~~p----------~~~p~~~~~l~~~cw~~~P~~r~~~-~lh~~~~i 323 (422)
.+.. |.| ...+..+++++..|+..||..||-+ -|.+|.++
T Consensus 246 qn~p-p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FF 296 (516)
T KOG0582|consen 246 QNDP-PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFF 296 (516)
T ss_pred cCCC-CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHH
Confidence 5543 222 1245678999999999999998743 35555544
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=339.28 Aligned_cols=262 Identities=52% Similarity=1.010 Sum_probs=220.9
Q ss_pred cccCcccccccccccceeEEEEEEec---CCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCT---SEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP 128 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 128 (422)
...+|++.+.||+|+||.||+++... ......||+|.+...........|.+|+.++++++||||+++++++..+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 45678889999999999999998643 234578999998766555566789999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCC----------CCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcee
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISG----------SQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCL 198 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~----------~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiL 198 (422)
.+++|||+++|+|.+++....+...... ......+++.++..++.|++.||+|||+++++||||||+||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 9999999999999999976432211100 011235788999999999999999999999999999999999
Q ss_pred ecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHH
Q psy7289 199 VGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVI 278 (422)
Q Consensus 199 l~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~ 278 (422)
+++++.+||+|||+++................++.|+|||.+....++.++|||||||++|||++.|..||.+.+..++.
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~ 242 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI 242 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999986544333222233344677999999988899999999999999999998888999999999999
Q ss_pred HHHHcCCCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 279 EMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 279 ~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..+..+..++.|..+|.++.+++.+||..+|..|+
T Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 277 (288)
T cd05050 243 YYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRP 277 (288)
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCC
Confidence 99988888888889999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=337.69 Aligned_cols=269 Identities=51% Similarity=0.946 Sum_probs=223.0
Q ss_pred ccCcccccccccccceeEEEEEEec---CCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCT---SEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
...+.+.+.||+|+||.||++.... ......+|+|.+... .......+.+|+.++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3467888999999999999997533 233466899988643 344567899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCC-CCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISG-SQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
++||||+++|+|.+++....+...... ......+++..+..++.|++.||+|||+++++||||||+||++++++.+||+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEec
Confidence 999999999999999976532211100 1112358999999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP 288 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 288 (422)
|||+++...............+++.|+|||++....++.++|||||||++|||++.|..||.+.+..+....+..+...+
T Consensus 163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~ 242 (288)
T cd05093 163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ 242 (288)
T ss_pred cCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 99999876544333333344456789999999988899999999999999999987999999999999999998888777
Q ss_pred CCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 289 CPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 289 ~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
.|..+|+++.+++.+||..+|..|+ +...++.-|
T Consensus 243 ~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~v~~~l 276 (288)
T cd05093 243 RPRTCPKEVYDLMLGCWQREPHMRL-----NIKEIHSLL 276 (288)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCC-----CHHHHHHHH
Confidence 7888999999999999999999998 555554433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=353.13 Aligned_cols=279 Identities=34% Similarity=0.573 Sum_probs=223.2
Q ss_pred ccchhhccccCcccccccccccceeEEEEEEec---CCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC-CCceeeEe
Q psy7289 45 SDFRREVIETKPRFLQELGEGAFGKVYKGEVCT---SEGPSLVAIKTLKENANQKTASDFRREVDLMSELR-HPNIVCLL 120 (422)
Q Consensus 45 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~ 120 (422)
.+..+++...++.+.+.||+|+||.||+|++.. ......||+|+++........+.+.+|+++|.++. |||||+++
T Consensus 28 ~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~ 107 (401)
T cd05107 28 YDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLL 107 (401)
T ss_pred CCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence 344567777888899999999999999998753 23346799999976554555567999999999997 99999999
Q ss_pred eEEEcCCCeEEEEEecCCCCHHHHHhhcCCCCC---------C-------------------------------------
Q psy7289 121 GVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSD---------I------------------------------------- 154 (422)
Q Consensus 121 g~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~---------~------------------------------------- 154 (422)
++|......++|||||++|+|.++++....... .
T Consensus 108 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (401)
T cd05107 108 GACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA 187 (401)
T ss_pred EEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence 999999999999999999999999975421000 0
Q ss_pred ----------------------------------------CCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy7289 155 ----------------------------------------SGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAA 194 (422)
Q Consensus 155 ----------------------------------------~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp 194 (422)
........+++..+..++.|++.||+|||+.+++||||||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp 267 (401)
T cd05107 188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAA 267 (401)
T ss_pred CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCc
Confidence 0001113477888999999999999999999999999999
Q ss_pred CceeecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh
Q psy7289 195 RNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN 274 (422)
Q Consensus 195 ~NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~ 274 (422)
+|||+++++.+||+|||+++...............+++.|||||.+....++.++|||||||++|||++.|..||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 99999999999999999998643322211222334577899999998888999999999999999999878899987665
Q ss_pred HHH-HHHHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 275 QEV-IEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 275 ~~~-~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
.+. ...+..+.+++.|..++.++.+++.+||..+|..|| +...+...|+
T Consensus 348 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RP-----s~~ell~~L~ 397 (401)
T cd05107 348 NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRP-----DFSQLVHLVG 397 (401)
T ss_pred hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCc-----CHHHHHHHHH
Confidence 554 455566666778889999999999999999999998 6665555443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=346.98 Aligned_cols=249 Identities=23% Similarity=0.416 Sum_probs=209.9
Q ss_pred ccccccccceeEEEEEEec-CCCCeEEEEEEccCcC---CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEE
Q psy7289 59 LQELGEGAFGKVYKGEVCT-SEGPSLVAIKTLKENA---NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFE 134 (422)
Q Consensus 59 ~~~LG~G~fg~Vy~~~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E 134 (422)
++.||+|+||.||+++... ...+..||||+++... .......+.+|+.+|+.++||||+++++++..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 3679999999999997643 2356789999986431 22334567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccc
Q psy7289 135 FMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR 214 (422)
Q Consensus 135 ~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~ 214 (422)
|+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~~L~~~~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 148 (323)
T cd05584 81 YLSGGELFMHLERE------------GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCK 148 (323)
T ss_pred CCCCchHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCe
Confidence 99999999999754 357888899999999999999999999999999999999999999999999987
Q ss_pred cccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q psy7289 215 DVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCP 294 (422)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p 294 (422)
....... ......+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..+....+..+. .+.|..++
T Consensus 149 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~ 224 (323)
T cd05584 149 ESIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLT-GAPPFTAENRKKTIDKILKGK-LNLPPYLT 224 (323)
T ss_pred ecccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCC
Confidence 5432221 1223457889999999998889999999999999999998 999999988888888877654 56788899
Q ss_pred cchhhhcccccccccchhh------HHHHhhhhhh
Q psy7289 295 PRMYSLMMECWHEVPVAAG------MAYLCSHHYV 323 (422)
Q Consensus 295 ~~~~~l~~~cw~~~P~~r~------~~~lh~~~~i 323 (422)
+.+.+++.+||..+|..|. +..+.+|.++
T Consensus 225 ~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~ 259 (323)
T cd05584 225 PEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259 (323)
T ss_pred HHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCc
Confidence 9999999999999999995 5566666554
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=330.51 Aligned_cols=249 Identities=39% Similarity=0.772 Sum_probs=211.0
Q ss_pred cccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEecCCC
Q psy7289 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRG 139 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~~~G 139 (422)
+.||+|+||.||+|++..+ +..||+|.............|.+|+++++.++||||+++++++......++||||+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~--~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRAD--NTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecC--CceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 4699999999999987543 46799998865555555678999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccccCC
Q psy7289 140 DLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS 219 (422)
Q Consensus 140 ~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~~ 219 (422)
+|.+++.... ..+++.++..++.|++.||+|||+++++||||||+||+++.++.+||+|||+++.....
T Consensus 79 ~L~~~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 147 (252)
T cd05084 79 DFLTFLRTEG-----------PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG 147 (252)
T ss_pred cHHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccc
Confidence 9999996532 24788999999999999999999999999999999999999999999999999764432
Q ss_pred cceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcchhh
Q psy7289 220 DYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYS 299 (422)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~~~~ 299 (422)
...........+..|+|||.+..+.++.++|||||||++|||++.|..||...+..+....+......+.|..+|..+.+
T Consensus 148 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (252)
T cd05084 148 VYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYR 227 (252)
T ss_pred cccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHH
Confidence 21111111223457999999988889999999999999999998799999988888888888777777888899999999
Q ss_pred hcccccccccchhhHHHHhhhhhhhhh
Q psy7289 300 LMMECWHEVPVAAGMAYLCSHHYVHRD 326 (422)
Q Consensus 300 l~~~cw~~~P~~r~~~~lh~~~~i~~d 326 (422)
++.+||..+|..|+ +...+...
T Consensus 228 li~~~l~~~p~~Rp-----s~~~~~~~ 249 (252)
T cd05084 228 LMERCWEYDPGQRP-----SFSTVHQE 249 (252)
T ss_pred HHHHHcCCChhhCc-----CHHHHHHH
Confidence 99999999999998 55554443
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=337.19 Aligned_cols=267 Identities=37% Similarity=0.691 Sum_probs=220.3
Q ss_pred CcccccccccccceeEEEEEEecCC---CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSE---GPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
++++.+.||+|+||.||+|+..... ....+++|.+...........+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 3677899999999999999865322 2357999988765555556789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCC------------CCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceee
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDI------------SGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV 199 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~------------~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl 199 (422)
+|||+++|+|.+++......... ........+++..+..++.|++.||+|||+++++||||||+|||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999999999998753211000 001112468899999999999999999999999999999999999
Q ss_pred cCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHH
Q psy7289 200 GDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIE 279 (422)
Q Consensus 200 ~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~ 279 (422)
++++.+||+|||+++.......+.......++..|+|||.+....++.++||||||+++|||++.|..||.+....++.+
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~ 240 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN 240 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 99999999999999865433322222333456789999999888899999999999999999988999999999999988
Q ss_pred HHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhh
Q psy7289 280 MIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRD 326 (422)
Q Consensus 280 ~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~d 326 (422)
.+..+...+.|..++.++.+++..||+.+|..|+ +...+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp-----~~~~i~~~ 282 (290)
T cd05045 241 LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRP-----TFADISKE 282 (290)
T ss_pred HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCC-----CHHHHHHH
Confidence 8887777778889999999999999999999998 55544443
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=347.49 Aligned_cols=246 Identities=22% Similarity=0.372 Sum_probs=208.2
Q ss_pred cccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEecC
Q psy7289 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMV 137 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~~ 137 (422)
+.||+|+||.||+++... .+..||+|++.... .......+.+|+++++.++||||+++++++...+.+++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKA--SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence 469999999999998643 35789999986432 23345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccccccc
Q psy7289 138 RGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVY 217 (422)
Q Consensus 138 ~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~ 217 (422)
+|+|.+++... ..+++.++..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++...
T Consensus 79 ~g~L~~~l~~~------------~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 79 GGELFFHLSRE------------RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (328)
T ss_pred CCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence 99999988653 358899999999999999999999999999999999999999999999999987543
Q ss_pred CCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcch
Q psy7289 218 ASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRM 297 (422)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~~ 297 (422)
.... ......+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..++...+.... .+.|..+++++
T Consensus 147 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~ 222 (328)
T cd05593 147 TDAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELILMED-IKFPRTLSADA 222 (328)
T ss_pred Cccc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhh-CCCCCCCCCHHHHHHHhccCC-ccCCCCCCHHH
Confidence 2211 1223457889999999998899999999999999999998 999999988888877776543 45678899999
Q ss_pred hhhcccccccccchhh------HHHHhhhhhh
Q psy7289 298 YSLMMECWHEVPVAAG------MAYLCSHHYV 323 (422)
Q Consensus 298 ~~l~~~cw~~~P~~r~------~~~lh~~~~i 323 (422)
.+++.+||..+|..|. +..+.+|.++
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~ 254 (328)
T cd05593 223 KSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFF 254 (328)
T ss_pred HHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCc
Confidence 9999999999999984 5556655554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=337.82 Aligned_cols=266 Identities=36% Similarity=0.639 Sum_probs=218.1
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCCeEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lv 132 (422)
++|++.+.||+|+||.||+|+...+.....+++|.++........+.|.+|+.+++++ +||||+++++++.+....+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 3578889999999999999987655444568888887544455567899999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCC----CCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDI----SGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~----~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
|||+++|+|.+++......... ........+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEEC
Confidence 9999999999999764321100 001112358899999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP 288 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 288 (422)
|||++...... ........+..|+|||++....++.++|||||||++|||++.|..||.+.+..++...+..+...+
T Consensus 162 dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (297)
T cd05089 162 DFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRME 238 (297)
T ss_pred CcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 99998643211 111122235679999999888899999999999999999987999999999999888888877777
Q ss_pred CCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 289 CPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 289 ~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
.|..+++.+.+++.+||..+|..|+ +...+.+.|
T Consensus 239 ~~~~~~~~~~~li~~~l~~~p~~Rp-----~~~~i~~~l 272 (297)
T cd05089 239 KPRNCDDEVYELMRQCWRDRPYERP-----PFAQISVQL 272 (297)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCc-----CHHHHHHHH
Confidence 7888999999999999999999998 555554443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=335.50 Aligned_cols=268 Identities=49% Similarity=0.925 Sum_probs=221.7
Q ss_pred ccCcccccccccccceeEEEEEEec---CCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCT---SEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
..++++.++||+|+||.||+++... ......+|+|.+... .......|.+|+++++.++||||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 4567889999999999999987532 233567899987643 345567899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCC---CCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEE
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDIS---GSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~---~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vK 206 (422)
+++|||+++|+|.+++....+..... .......+++..+..++.|++.||+|||+++++||||||+|||+++++.+|
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEE
Confidence 99999999999999997653211100 001113588999999999999999999999999999999999999999999
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~ 286 (422)
|+|||+++.......+.......+++.|+|||.+....++.++|||||||++|||++.|.+||...+..+....+..+..
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 242 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRE 242 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCcc
Confidence 99999998665444333333444567899999999889999999999999999999889999999888888888887777
Q ss_pred CCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhh
Q psy7289 287 LPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRD 326 (422)
Q Consensus 287 ~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~d 326 (422)
.+.|..+|+.+.+++.+||..+|..|+ +...+...
T Consensus 243 ~~~~~~~~~~~~~li~~cl~~~P~~Rp-----~~~~l~~~ 277 (280)
T cd05092 243 LERPRTCPPEVYAIMQGCWQREPQQRM-----VIKDIHSR 277 (280)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCC-----CHHHHHHH
Confidence 777889999999999999999999998 55555443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=341.37 Aligned_cols=266 Identities=39% Similarity=0.739 Sum_probs=220.9
Q ss_pred hhhccccCcccccccccccceeEEEEEEec-----CCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEee
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCT-----SEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLG 121 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g 121 (422)
.+++...++.+.+.||+|+||.||+++... ......||+|.++..........+.+|+.+++.+ +||||+++++
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 345566788899999999999999997632 2234579999987655555667899999999999 6999999999
Q ss_pred EEEcCCCeEEEEEecCCCCHHHHHhhcCCCCCC-C---CCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q psy7289 122 VCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDI-S---GSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNC 197 (422)
Q Consensus 122 ~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~-~---~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~Ni 197 (422)
++......+++|||+++|+|.+++....+.... . .......+++.++.+++.|++.||+|||++|++||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 999989999999999999999999775321100 0 011123588999999999999999999999999999999999
Q ss_pred eecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHH
Q psy7289 198 LVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEV 277 (422)
Q Consensus 198 Ll~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~ 277 (422)
|+++++.+||+|||+++...............+++.|||||.+....++.++|||||||++|||++.|..||.+.+..++
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 245 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999998664433222222233456799999998888999999999999999999988999999999999
Q ss_pred HHHHHcCCCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 278 IEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 278 ~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
...+..+...+.|..+|.++.+++.+||..+|..|+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 281 (314)
T cd05099 246 FKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRP 281 (314)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCc
Confidence 998888877777889999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=362.02 Aligned_cols=250 Identities=20% Similarity=0.301 Sum_probs=214.0
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
...|.+.+.||+|+||.||+|....+ ....||+|.+... .......+.+|+.+|+.++|||||++++++..++.+|+|
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~-~~~~vv~K~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSD-PKEKVVAKFVMLN-DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCC-CCeEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 34588999999999999999976443 2456788876433 334455778899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++|+|.++|..+... ..++++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 144 ~E~~~gg~L~~~l~~~~~~--------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgl 215 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKE--------HLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGF 215 (478)
T ss_pred EECCCCCCHHHHHHHHHhc--------cCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcC
Confidence 9999999999998653211 13688999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPED 292 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~ 292 (422)
++...............+|+.|||||++....++.++|||||||++|||++ |..||.+.+..+++..+..+...+.|..
T Consensus 216 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 294 (478)
T PTZ00267 216 SKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT-LHRPFKGPSQREIMQQVLYGKYDPFPCP 294 (478)
T ss_pred ceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 986543322222334567899999999998899999999999999999998 9999999999999998888887788888
Q ss_pred CCcchhhhcccccccccchhh
Q psy7289 293 CPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 293 ~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+++++.+++..||..+|..|+
T Consensus 295 ~s~~~~~li~~~L~~dP~~Rp 315 (478)
T PTZ00267 295 VSSGMKALLDPLLSKNPALRP 315 (478)
T ss_pred CCHHHHHHHHHHhccChhhCc
Confidence 999999999999999999886
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=338.12 Aligned_cols=273 Identities=43% Similarity=0.795 Sum_probs=217.3
Q ss_pred ccccCcccccccccccceeEEEEEEecC------------CCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceee
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTS------------EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVC 118 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~ 118 (422)
+...+|++.+.||+|+||.||+++.... +....||+|.++..........|.+|++++++++||||++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 3456789999999999999999876432 2234689999876555556678999999999999999999
Q ss_pred EeeEEEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcee
Q psy7289 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCL 198 (422)
Q Consensus 119 l~g~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiL 198 (422)
+++++...+..++||||+++++|.+++.................+++..+..++.|++.||+|||+++++||||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 99999999999999999999999999965421111111111124788899999999999999999999999999999999
Q ss_pred ecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhC-CCCCCCCCChHHH
Q psy7289 199 VGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY-GLQPYYGYSNQEV 277 (422)
Q Consensus 199 l~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~-g~~Pf~~~~~~~~ 277 (422)
+++++.+||+|||+++...............++..|+|||++..+.++.++|||||||++|||++. +..||...+..++
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 999999999999999866544333333344456789999999888999999999999999999873 5679988887776
Q ss_pred HHHHHc----C---CCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 278 IEMIRS----R---QMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 278 ~~~i~~----~---~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
+..+.. . .....+..+|+.+.+++.+||..+|..|+ +...++.-|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~i~~~l~ 294 (295)
T cd05097 242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRP-----TFNKIHHFLR 294 (295)
T ss_pred HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCc-----CHHHHHHHHh
Confidence 655432 1 12334667899999999999999999999 7766665443
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=330.78 Aligned_cols=243 Identities=40% Similarity=0.729 Sum_probs=209.8
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
..+++.+.||+|+||.||++++.. ...+|+|.+.... .....|.+|+.++++++||||+++++++.+....++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~---~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA---QIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc---CceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 357788999999999999998743 3468999876432 22457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+++++||||||+||++++++.+||+|||++
T Consensus 79 e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~ 147 (256)
T cd05114 79 EFMENGCLLNYLRQRQ-----------GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMT 147 (256)
T ss_pred EcCCCCcHHHHHHhCc-----------cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCc
Confidence 9999999999987532 24788999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDC 293 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~ 293 (422)
+........ ......++..|+|||.+....++.++||||||+++|||++.|..||...+..+....+..+..++.|...
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 226 (256)
T cd05114 148 RYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLA 226 (256)
T ss_pred cccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Confidence 865433221 1222334568999999988889999999999999999998789999999999999999888777778888
Q ss_pred Ccchhhhcccccccccchhh
Q psy7289 294 PPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 294 p~~~~~l~~~cw~~~P~~r~ 313 (422)
+.++.+++.+||..+|..|+
T Consensus 227 ~~~~~~li~~c~~~~p~~Rp 246 (256)
T cd05114 227 SMTVYEVMYSCWHEKPEGRP 246 (256)
T ss_pred CHHHHHHHHHHccCCcccCc
Confidence 99999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=338.01 Aligned_cols=243 Identities=25% Similarity=0.432 Sum_probs=211.1
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP 128 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 128 (422)
....+|++.+.||+|.||.|-+|..+.. ++.||||.+++.. +....-++.+|++||+.|+||||+.+|.+|...+.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~s--gR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK 127 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKS--GREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK 127 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccC--CcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence 3456799999999999999999876443 5789999987543 44556688999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
..+||||..+|+|++|+.++ +.|++.+++.+++||.+|+.|||.++++|||||.+|||||+++++||+
T Consensus 128 IvivMEYaS~GeLYDYiSer------------~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIA 195 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISER------------GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIA 195 (668)
T ss_pred EEEEEEecCCccHHHHHHHh------------ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeee
Confidence 99999999999999999876 369999999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccccCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFT-TESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
||||+....... ...+.+|++-|.+||.+.+..|. +.+|-|||||+||-++ +|..||.|.+...++.+|.+|...
T Consensus 196 DFGLSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLV-yGtMPFDG~Dhk~lvrQIs~GaYr 271 (668)
T KOG0611|consen 196 DFGLSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLV-YGTMPFDGRDHKRLVRQISRGAYR 271 (668)
T ss_pred ccchhhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHh-hcccccCCchHHHHHHHhhccccc
Confidence 999997544332 23467788999999999988875 7899999999999988 599999999999999999988765
Q ss_pred CCCCCCCcchhhhcccccccccchhh
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..+ .|....-||+.++.-||..|+
T Consensus 272 EP~--~PSdA~gLIRwmLmVNP~RRA 295 (668)
T KOG0611|consen 272 EPE--TPSDASGLIRWMLMVNPERRA 295 (668)
T ss_pred CCC--CCchHHHHHHHHHhcCcccch
Confidence 532 356677788888888888775
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=362.17 Aligned_cols=252 Identities=20% Similarity=0.275 Sum_probs=215.5
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC--
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE-- 127 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-- 127 (422)
....+|++.+.||+|+||.||+|+...+ +..||||.+... .+......+.+|+.++..++|+||+++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~--g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSD--GEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCC--CCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3457899999999999999999986543 578999998643 34455667889999999999999999988775432
Q ss_pred ------CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC
Q psy7289 128 ------PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD 201 (422)
Q Consensus 128 ------~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~ 201 (422)
.+++||||+++|+|.+++..+... ...+++..+..++.|++.||+|||+++|+||||||+|||+++
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~--------~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~ 178 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKT--------NRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCS 178 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhcc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeC
Confidence 268999999999999999764321 236899999999999999999999999999999999999999
Q ss_pred CCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHH
Q psy7289 202 GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281 (422)
Q Consensus 202 ~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i 281 (422)
++.+||+|||+++...............+|+.|||||++....++.++|||||||++|||++ |..||.+.+..+++..+
T Consensus 179 ~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLlt-G~~Pf~~~~~~~~~~~~ 257 (496)
T PTZ00283 179 NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT-LKRPFDGENMEEVMHKT 257 (496)
T ss_pred CCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHH
Confidence 99999999999986543222222334567899999999999899999999999999999998 99999999999999988
Q ss_pred HcCCCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 282 RSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 282 ~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..+...+.|..+|+++.+++.+||+.+|..|+
T Consensus 258 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RP 289 (496)
T PTZ00283 258 LAGRYDPLPPSISPEMQEIVTALLSSDPKRRP 289 (496)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcccChhhCc
Confidence 88888888999999999999999999999886
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=343.69 Aligned_cols=276 Identities=38% Similarity=0.723 Sum_probs=227.7
Q ss_pred chhhccccCcccccccccccceeEEEEEEecCC-----CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEe
Q psy7289 47 FRREVIETKPRFLQELGEGAFGKVYKGEVCTSE-----GPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLL 120 (422)
Q Consensus 47 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~ 120 (422)
..+++...+|++.+.||+|+||.||++++.... ....||+|.++........+.+.+|+++++++ +||||++++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 456777888999999999999999999864322 22468999887655555667899999999999 799999999
Q ss_pred eEEEcCCCeEEEEEecCCCCHHHHHhhcCCCCC----CCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy7289 121 GVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSD----ISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARN 196 (422)
Q Consensus 121 g~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~----~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~N 196 (422)
+++......+++|||+++|+|.+++..+.+... ..+......++..++..++.|++.||+|||+++++||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 164 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN 164 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence 999999999999999999999999986532110 0001112357888899999999999999999999999999999
Q ss_pred eeecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHH
Q psy7289 197 CLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 276 (422)
Q Consensus 197 iLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~ 276 (422)
||++.++.+||+|||+++...............++..|||||++....++.++|||||||++|||++.|..||.+.+..+
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999999999866443322222233345679999999988999999999999999999988899999999999
Q ss_pred HHHHHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 277 VIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 277 ~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
....+..+...+.|..++..+.+++.+||+.+|..|+ +...+...|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~ell~~l 290 (334)
T cd05100 245 LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRP-----TFKQLVEDL 290 (334)
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCc-----CHHHHHHHH
Confidence 9998888877788889999999999999999999998 555554444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=332.07 Aligned_cols=259 Identities=39% Similarity=0.684 Sum_probs=220.0
Q ss_pred ccCcccccccccccceeEEEEEEecCC-CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSE-GPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
..+|++.+.||+|+||.||+|++..++ ....+|+|.++..........|.+|+.+++.++||||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 346788999999999999999875433 3457999998765555566789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
||||+++|+|.+++.... ..+++.++..++.|++.||+|||+++++||||||+|||++.++.+||+|||
T Consensus 83 v~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg 151 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD-----------GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFG 151 (267)
T ss_pred EEEcCCCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCC
Confidence 999999999999997532 247889999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceE-eccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC
Q psy7289 212 LSRDVYASDYYR-IQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP 290 (422)
Q Consensus 212 la~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p 290 (422)
+++......... .......+..|+|||.+....++.++|+|||||++||+++.|..||.+.+..+....+..+...+.+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 231 (267)
T cd05066 152 LSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAP 231 (267)
T ss_pred cccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCC
Confidence 998664332211 1122233568999999998889999999999999999987799999998888888888887777778
Q ss_pred CCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
..+|+.+.+++.+||..+|..|+ +...+...|
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp-----~~~~i~~~l 263 (267)
T cd05066 232 MDCPAALHQLMLDCWQKDRNERP-----KFEQIVSIL 263 (267)
T ss_pred CCCCHHHHHHHHHHcccCchhCC-----CHHHHHHHH
Confidence 88999999999999999999998 666655543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=337.07 Aligned_cols=269 Identities=45% Similarity=0.842 Sum_probs=216.3
Q ss_pred cccCcccccccccccceeEEEEEEec--------------CCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCcee
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCT--------------SEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIV 117 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~--------------~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv 117 (422)
...+|++.+.||+|+||.||++++.. .++...||+|.++........+.|.+|+.+++.++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 34568899999999999999986432 2234579999987655555667899999999999999999
Q ss_pred eEeeEEEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q psy7289 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNC 197 (422)
Q Consensus 118 ~l~g~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~Ni 197 (422)
++++++...+..+++|||+++|+|.+++.......... ......+++.++..++.|++.||+|||+++++||||||+||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAE-KADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccc-cccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 99999999999999999999999999997653221110 11123578889999999999999999999999999999999
Q ss_pred eecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHh-CCCCCCCCCChHH
Q psy7289 198 LVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYS-YGLQPYYGYSNQE 276 (422)
Q Consensus 198 Ll~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t-~g~~Pf~~~~~~~ 276 (422)
|+++++.+||+|||+++................++.|+|||+...+.++.++|||||||++|||++ .|..||...+..+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999987654433333333444678999999888889999999999999999997 3778998888777
Q ss_pred HHHHHHc-------CCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhh
Q psy7289 277 VIEMIRS-------RQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRD 326 (422)
Q Consensus 277 ~~~~i~~-------~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~d 326 (422)
.+..+.. ....+.|..||+.+.+++..||..+|..|+ +...++.-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----~~~~i~~~ 293 (296)
T cd05095 242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERP-----SFQEIHAT 293 (296)
T ss_pred HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCC-----CHHHHHHH
Confidence 6654421 223455678999999999999999999998 65555443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=344.74 Aligned_cols=249 Identities=26% Similarity=0.382 Sum_probs=207.8
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHH---hcCCCCceeeEeeEEEcCCCeE
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLM---SELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il---~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
|++++.||+|+||.||+|+... .+..||||.++... .....+.+.+|++++ +.++||||+++++++.+.+..|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKK--TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence 5678999999999999998754 35679999986432 223345677777665 5678999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+||||+++|+|..++.. ..+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+||
T Consensus 79 lv~E~~~~~~L~~~~~~-------------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Df 145 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT-------------DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADF 145 (324)
T ss_pred EEEcCCCCCcHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcc
Confidence 99999999999988753 24899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP 290 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p 290 (422)
|+++....... ......+++.|||||.+.+..++.++|||||||++|||++ |..||.+.+..++...+..+. ...|
T Consensus 146 g~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-G~~pf~~~~~~~~~~~i~~~~-~~~p 221 (324)
T cd05589 146 GLCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLV-GESPFPGDDEEEVFDSIVNDE-VRYP 221 (324)
T ss_pred cCCccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCC
Confidence 99875432211 1233457889999999998899999999999999999998 999999998888888887654 3467
Q ss_pred CCCCcchhhhcccccccccchhh------HHHHhhhhhh
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAG------MAYLCSHHYV 323 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~------~~~lh~~~~i 323 (422)
..+|+.+.+++.+||..+|..|+ +.-+.+|.++
T Consensus 222 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f 260 (324)
T cd05589 222 RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFF 260 (324)
T ss_pred CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCc
Confidence 78999999999999999999995 4455555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=331.10 Aligned_cols=258 Identities=38% Similarity=0.762 Sum_probs=219.1
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
++....+++.+.||+|+||.||+|.+... +..||+|.++.. ......+.+|+++++.++||||+++++++...+.+
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~--~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWKKY--SLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEecC--CceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 34556678889999999999999987643 467999988643 23356789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEec
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISD 209 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~D 209 (422)
+++|||+++|+|.+++.... ...+++..+..++.|++.||+|||+++++||||||+||++++++.+||+|
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~----------~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~d 147 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECN----------RQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVAD 147 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCC
Confidence 99999999999999996532 12478889999999999999999999999999999999999999999999
Q ss_pred CcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 289 (422)
||+++....... ........+..|+|||.+....++.++|||||||++|||++.|..||.+.+..+....+..+...+.
T Consensus 148 f~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 226 (263)
T cd05052 148 FGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMER 226 (263)
T ss_pred Ccccccccccee-eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC
Confidence 999986544322 1222233456899999998889999999999999999999889999999988888888888777778
Q ss_pred CCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 290 PEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 290 p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
|..+|+++.+++.+||..+|..|+ +...+...|
T Consensus 227 ~~~~~~~~~~li~~cl~~~p~~Rp-----~~~~l~~~l 259 (263)
T cd05052 227 PEGCPPKVYELMRACWQWNPSDRP-----SFAEIHQAF 259 (263)
T ss_pred CCCCCHHHHHHHHHHccCCcccCC-----CHHHHHHHH
Confidence 889999999999999999999998 665555443
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=330.33 Aligned_cols=255 Identities=36% Similarity=0.616 Sum_probs=203.3
Q ss_pred cccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEecCCC
Q psy7289 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRG 139 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~~~G 139 (422)
+.||+|+||.||+|++........+|+|.++..........|.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46999999999999876555566799998876554445567999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccccCC
Q psy7289 140 DLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS 219 (422)
Q Consensus 140 ~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~~ 219 (422)
+|.+++....... ....++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~~~~-------~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 81 DLKGYLRSCRKAE-------LMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred cHHHHHHHhhhcc-------cccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCc
Confidence 9999997642211 124567778899999999999999999999999999999999999999999999765443
Q ss_pred cceEeccCCCCCccccCccccccC-------CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC--CCC
Q psy7289 220 DYYRIQSKSLLPVRWMPPESILYG-------KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML--PCP 290 (422)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~--~~p 290 (422)
..........++..|+|||++... .++.++|||||||++|||++.|..||...++.+.......+... +.|
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP 233 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC
Confidence 333222334457789999988632 35789999999999999997799999888777765544333222 222
Q ss_pred ---CCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 291 ---EDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 291 ---~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
..+++.+.++|..|| .+|..|+ +...+++.|
T Consensus 234 ~~~~~~~~~~~~l~~~c~-~~P~~Rp-----t~~~l~~~l 267 (269)
T cd05087 234 RLKLPLSDRWYEVMQFCW-LQPEQRP-----SAEEVHLLL 267 (269)
T ss_pred ccCCCCChHHHHHHHHHh-cCcccCC-----CHHHHHHHh
Confidence 246778899999999 5799999 777777654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=349.01 Aligned_cols=246 Identities=23% Similarity=0.372 Sum_probs=220.4
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccC-cCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC-eEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKE-NANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP-MCM 131 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~-~~l 131 (422)
++|.+++++|+|+||.++..+++.. ...+++|.+.. ..+....+...+|+.++++++|||||.+.+.|..++. ++|
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~--~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSD--DKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccC--CceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 5788999999999999998776443 45788888764 3345556678899999999999999999999998888 999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
||+||+||+|.+.+.+.. ...++++.+..++.|++.|++|||+++|+|||||+.||+++.+..|||+|||
T Consensus 82 vm~Y~eGg~l~~~i~~~k----------~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfG 151 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQK----------GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFG 151 (426)
T ss_pred EEeecCCCCHHHHHHHHh----------hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchh
Confidence 999999999999998753 2468999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCC
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPE 291 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~ 291 (422)
+|+.+.... ...++..||+.||.||.+.+..|+.|+|||||||++|||++ -+++|.+.+..+++..|..+...|.|.
T Consensus 152 laK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~-lk~aF~a~~m~~Li~ki~~~~~~Plp~ 228 (426)
T KOG0589|consen 152 LAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCT-LKPAFKASNMSELILKINRGLYSPLPS 228 (426)
T ss_pred hhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHh-cccccCccchHHHHHHHhhccCCCCCc
Confidence 999876554 24566789999999999999999999999999999999998 778999999999999999999999999
Q ss_pred CCCcchhhhcccccccccchhhH
Q psy7289 292 DCPPRMYSLMMECWHEVPVAAGM 314 (422)
Q Consensus 292 ~~p~~~~~l~~~cw~~~P~~r~~ 314 (422)
..+.++..|++.|+..+|..|+.
T Consensus 229 ~ys~el~~lv~~~l~~~P~~RPs 251 (426)
T KOG0589|consen 229 MYSSELRSLVKSMLRKNPEHRPS 251 (426)
T ss_pred cccHHHHHHHHHHhhcCCccCCC
Confidence 99999999999999999988863
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=341.63 Aligned_cols=263 Identities=25% Similarity=0.405 Sum_probs=210.6
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC--------H-----HhHHHHHHHHHHHhcCCCCce
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN--------Q-----KTASDFRREVDLMSELRHPNI 116 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~--------~-----~~~~~~~~E~~il~~l~HpnI 116 (422)
...-..|++++.||+|.||.|-+|+.. ..++.||||++.+... . ...+...+|+.||++|+||||
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~--~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDE--VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeec--CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 344567899999999999999999754 4468899999864211 0 123578899999999999999
Q ss_pred eeEeeEEEcC--CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy7289 117 VCLLGVCLSG--EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAP-LSQQDFSHIALQVAAGMAYLCSHHYVHRDLA 193 (422)
Q Consensus 117 v~l~g~~~~~--~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~-l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlK 193 (422)
|+|+++..++ +.+|||+|||..|.+...= ...+ +++.+++++++++..||+|||.+||||||||
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p-------------~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIK 237 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCP-------------PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIK 237 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCC-------------CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccc
Confidence 9999998765 4799999999998874311 1134 8999999999999999999999999999999
Q ss_pred CCceeecCCCeEEEecCcccccccCCc---ceEeccCCCCCccccCccccccCC----CCCchhHHhHHHHHHHHHhCCC
Q psy7289 194 ARNCLVGDGLTVKISDFGLSRDVYASD---YYRIQSKSLLPVRWMPPESILYGK----FTTESDVWSYGVVLWEVYSYGL 266 (422)
Q Consensus 194 p~NiLl~~~~~vKl~DFGla~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~DvwS~Gvil~El~t~g~ 266 (422)
|+|+||+++|+|||+|||.+....... .........|||.|||||.+..+. .+.+.||||+||+||.++ +|.
T Consensus 238 PsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCll-fG~ 316 (576)
T KOG0585|consen 238 PSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLL-FGQ 316 (576)
T ss_pred hhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhh-hcc
Confidence 999999999999999999987552221 111223478999999999988743 356889999999999999 599
Q ss_pred CCCCCCChHHHHHHHHcCCCCCCCC--CCCcchhhhcccccccccchh-hHHHHhhhhhhhhhccc
Q psy7289 267 QPYYGYSNQEVIEMIRSRQMLPCPE--DCPPRMYSLMMECWHEVPVAA-GMAYLCSHHYVHRDLAA 329 (422)
Q Consensus 267 ~Pf~~~~~~~~~~~i~~~~~~~~p~--~~p~~~~~l~~~cw~~~P~~r-~~~~lh~~~~i~~dLk~ 329 (422)
.||.+....++...|.+... .+|. +....+.+|+++.+.+||..| .+..+..|.++-++.+.
T Consensus 317 ~PF~~~~~~~l~~KIvn~pL-~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~ 381 (576)
T KOG0585|consen 317 LPFFDDFELELFDKIVNDPL-EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDS 381 (576)
T ss_pred CCcccchHHHHHHHHhcCcc-cCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCC
Confidence 99999999999999987653 3443 467889999999999999877 34455566777666543
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=330.13 Aligned_cols=253 Identities=32% Similarity=0.602 Sum_probs=202.2
Q ss_pred cccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEecCCC
Q psy7289 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRG 139 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~~~G 139 (422)
++||+|+||.||+|+.........+++|.+...........|.+|+.+++.++||||+++++.+.+...+++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 46999999999999875554556789998765555555667899999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccccCC
Q psy7289 140 DLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS 219 (422)
Q Consensus 140 ~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~~ 219 (422)
+|.+++....... ....++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 81 DLKNYLRSNRGMV-------AQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPE 153 (269)
T ss_pred cHHHHHHhccccc-------cccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccc
Confidence 9999997643211 123567788899999999999999999999999999999999999999999999765443
Q ss_pred cceEeccCCCCCccccCcccccc-------CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC----
Q psy7289 220 DYYRIQSKSLLPVRWMPPESILY-------GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP---- 288 (422)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~---- 288 (422)
..........+++.|+|||++.. ..++.++|||||||++|||++.|..||....+.+.+..+......+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP 233 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC
Confidence 33322333445678999998743 3568899999999999999987889999888777666654433222
Q ss_pred -CCCCCCcchhhhcccccccccchhhHHHHhhhhhhhh
Q psy7289 289 -CPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHR 325 (422)
Q Consensus 289 -~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~ 325 (422)
.+..+++.+.+++..||. +|..|+ +...+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~-dp~~Rp-----t~~~v~~ 265 (269)
T cd05042 234 QLDLKYSDRWYEVMQFCWL-DPETRP-----TAEEVHE 265 (269)
T ss_pred cccccCCHHHHHHHHHHhc-Cccccc-----CHHHHHH
Confidence 234678888999999994 999998 5554443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=362.90 Aligned_cols=248 Identities=35% Similarity=0.601 Sum_probs=221.4
Q ss_pred cCcccccccccccceeEEEEEEecCCC--CeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEG--PSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
+..+..++||+|+||.||+|.|..... ..+||||++......+...+++.|+-+|.+|+|||+++|+|+|..+. +.|
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 445567899999999999999976533 34799999987776777789999999999999999999999998766 889
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
|++|++.|+|.+|++.+. ..+..+....|..|||+||.|||.+++|||||..+|||+.+-.++||.|||
T Consensus 775 vtq~mP~G~LlDyvr~hr-----------~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfg 843 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHR-----------DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFG 843 (1177)
T ss_pred HHHhcccchHHHHHHHhh-----------ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecc
Confidence 999999999999998753 357888999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCC
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPE 291 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~ 291 (422)
+++....+...........++.|||-|.+....|+.++|||||||++||++|+|..||.+.+.+|+-+.++.+.+++.|+
T Consensus 844 la~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPp 923 (1177)
T KOG1025|consen 844 LAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPP 923 (1177)
T ss_pred hhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCC
Confidence 99977654433333344457889999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcchhhhcccccccccchhh
Q psy7289 292 DCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 292 ~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.|+-+++.+|.+||..|+..|+
T Consensus 924 iCtiDVy~~mvkCwmid~~~rp 945 (1177)
T KOG1025|consen 924 ICTIDVYMVMVKCWMIDADSRP 945 (1177)
T ss_pred CccHHHHHHHHHHhccCcccCc
Confidence 9999999999999999987765
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=345.06 Aligned_cols=249 Identities=22% Similarity=0.396 Sum_probs=208.2
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
+|++.+.||+|+||.||+|++..+ +..||||+++... .......+.+|+.++..++||||+++++++.+++..|+|
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDT--GEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCC--CCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence 578899999999999999987543 4679999986432 223456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||+++++.+||+|||+
T Consensus 80 ~e~~~g~~L~~~l~~~------------~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~ 147 (333)
T cd05600 80 MEYVPGGDFRTLLNNL------------GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGL 147 (333)
T ss_pred EeCCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcC
Confidence 9999999999999653 3588999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC-CCCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM-LPCPE 291 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~-~~~p~ 291 (422)
++.... ......+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..+....+..... ...|.
T Consensus 148 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 221 (333)
T cd05600 148 SKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLC-GFPPFSGSTPNETWENLKYWKETLQRPV 221 (333)
T ss_pred Cccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhh-CCCCCCCCCHHHHHHHHHhccccccCCC
Confidence 975432 2234567889999999998899999999999999999998 9999999988888777764321 11221
Q ss_pred ------CCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 292 ------DCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 292 ------~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
.+++++.+++.+||..+|..|+ +..+.+|.++
T Consensus 222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~ 260 (333)
T cd05600 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFF 260 (333)
T ss_pred CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCccc
Confidence 4588999999999998888774 4445555544
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=330.65 Aligned_cols=249 Identities=41% Similarity=0.726 Sum_probs=213.8
Q ss_pred cCcccccccccccceeEEEEEEecCCC-CeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEG-PSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
..+++.+.||+|+||.||+|++..+.. ...||||.++..........|.+|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 457889999999999999998765432 3579999987655566677899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++|+|.+++.... ..+++.++..++.|++.||+|||+++++||||||+||+++.++.+||+|||+
T Consensus 84 ~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~ 152 (269)
T cd05065 84 TEFMENGALDSFLRQND-----------GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGL 152 (269)
T ss_pred EecCCCCcHHHHHhhCC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcc
Confidence 99999999999997532 2478899999999999999999999999999999999999999999999999
Q ss_pred cccccCCcce-Eec--cCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy7289 213 SRDVYASDYY-RIQ--SKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289 (422)
Q Consensus 213 a~~~~~~~~~-~~~--~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 289 (422)
++........ ... .....+..|+|||.+....++.++|||||||++||+++.|..||.+.+..++...+......+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~ 232 (269)
T cd05065 153 SRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP 232 (269)
T ss_pred ccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 8765432211 111 1111245799999999889999999999999999999879999999998888888887777778
Q ss_pred CCCCCcchhhhcccccccccchhh
Q psy7289 290 PEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 290 p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
|.++|..+.+++.+||..+|..||
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp 256 (269)
T cd05065 233 PMDCPTALHQLMLDCWQKDRNARP 256 (269)
T ss_pred cccCCHHHHHHHHHHcCCChhhCc
Confidence 889999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=343.80 Aligned_cols=245 Identities=27% Similarity=0.446 Sum_probs=198.4
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC--CCe
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSG--EPM 129 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~~ 129 (422)
.+.|+.+++||+|.||.||+|+... .+..||+|+++-.. ......-..|||.||++|+||||++|.+...+. ..+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~--tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLE--TGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecc--cCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 4567889999999999999998654 46889999987433 233344567999999999999999999998876 589
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEec
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISD 209 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~D 209 (422)
|||+|||++ ||.-++... ...|++.++..++.|++.||+|||++||+|||||.+|||||++|.+||+|
T Consensus 194 YlVFeYMdh-DL~GLl~~p-----------~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaD 261 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSP-----------GVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIAD 261 (560)
T ss_pred EEEEecccc-hhhhhhcCC-----------CcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEecc
Confidence 999999987 888877543 23699999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc--C--
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS--R-- 284 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~--~-- 284 (422)
||||+........ .-+..+.|+.|.|||.+++. .|+.++|+||.||||.||++ |++.|.|.+..+.+..|-. |
T Consensus 262 FGLAr~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~-gkPI~~G~tEveQl~kIfklcGSP 339 (560)
T KOG0600|consen 262 FGLARFYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFL-GKPILQGRTEVEQLHKIFKLCGSP 339 (560)
T ss_pred ccceeeccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHc-CCCCcCCccHHHHHHHHHHHhCCC
Confidence 9999965443321 23445678999999998875 59999999999999999998 9999999998877766632 1
Q ss_pred -------CCCCC-----C------------CCCCcchhhhcccccccccchhh
Q psy7289 285 -------QMLPC-----P------------EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 285 -------~~~~~-----p------------~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..+|. | ...|+..-+|+...+..||..|+
T Consensus 340 ~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~ 392 (560)
T KOG0600|consen 340 TEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRG 392 (560)
T ss_pred ChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccc
Confidence 01110 0 13455666788888888888774
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=347.95 Aligned_cols=255 Identities=21% Similarity=0.382 Sum_probs=204.9
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
+|++.+.||+|+||.||+++...+ +..||||+++... .......+.+|+.++..++||||+++++.+.+...+|+|
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDT--GHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCC--CCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEE
Confidence 578899999999999999986543 5689999986432 223446788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
||||++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 80 ~E~~~gg~L~~~l~~~------------~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGl 147 (363)
T cd05628 80 MEFLPGGDMMTLLMKK------------DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147 (363)
T ss_pred EcCCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccC
Confidence 9999999999999753 3589999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcce---------------------------------EeccCCCCCccccCccccccCCCCCchhHHhHHHHHH
Q psy7289 213 SRDVYASDYY---------------------------------RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLW 259 (422)
Q Consensus 213 a~~~~~~~~~---------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~ 259 (422)
++........ .......||+.|||||++....++.++|||||||++|
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 227 (363)
T cd05628 148 CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (363)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHH
Confidence 8754321100 0011346789999999999889999999999999999
Q ss_pred HHHhCCCCCCCCCChHHHHHHHHcCC-CCCCCC--CCCcchhhhccc--ccccccchh-hHHHHhhhhhhh
Q psy7289 260 EVYSYGLQPYYGYSNQEVIEMIRSRQ-MLPCPE--DCPPRMYSLMME--CWHEVPVAA-GMAYLCSHHYVH 324 (422)
Q Consensus 260 El~t~g~~Pf~~~~~~~~~~~i~~~~-~~~~p~--~~p~~~~~l~~~--cw~~~P~~r-~~~~lh~~~~i~ 324 (422)
||++ |..||.+.+..+....+.... ....|+ .+++++.+++.+ |...++..| .+..+.+|.++.
T Consensus 228 ell~-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~ 297 (363)
T cd05628 228 EMLI-GYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFE 297 (363)
T ss_pred HHHh-CCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCC
Confidence 9998 999999999988888887532 233343 356778888876 322233322 456666666654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=342.10 Aligned_cols=236 Identities=23% Similarity=0.378 Sum_probs=200.1
Q ss_pred cccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCCeEEEEEec
Q psy7289 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPMCMLFEFM 136 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lv~E~~ 136 (422)
+.||+|+||.||+|+...+ +..||+|.++... .....+.+..|..++..+ +||||+++++++..+..+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGT--NEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCC--CCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 4699999999999987543 5679999986432 223345566777777654 8999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccc
Q psy7289 137 VRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV 216 (422)
Q Consensus 137 ~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~ 216 (422)
++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 79 ~gg~L~~~~~~~------------~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~ 146 (316)
T cd05592 79 NGGDLMFHIQSS------------GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKEN 146 (316)
T ss_pred CCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence 999999998653 25889999999999999999999999999999999999999999999999999754
Q ss_pred cCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcc
Q psy7289 217 YASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPR 296 (422)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~ 296 (422)
.... .......+|+.|||||++....++.++|||||||++|||++ |..||.+.+..++...+... .+..|..++++
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~ 222 (316)
T cd05592 147 MNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLI-GQSPFHGEDEDELFDSILND-RPHFPRWISKE 222 (316)
T ss_pred CCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHH
Confidence 3222 12233457899999999998889999999999999999998 99999999988888887654 45567889999
Q ss_pred hhhhcccccccccchhh
Q psy7289 297 MYSLMMECWHEVPVAAG 313 (422)
Q Consensus 297 ~~~l~~~cw~~~P~~r~ 313 (422)
+.+++.+||+.+|..|+
T Consensus 223 ~~~ll~~~l~~~P~~R~ 239 (316)
T cd05592 223 AKDCLSKLFERDPTKRL 239 (316)
T ss_pred HHHHHHHHccCCHHHcC
Confidence 99999999999999996
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=344.08 Aligned_cols=265 Identities=37% Similarity=0.674 Sum_probs=212.6
Q ss_pred hhccccCcccccccccccceeEEEEEEecCC---CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEEE
Q psy7289 49 REVIETKPRFLQELGEGAFGKVYKGEVCTSE---GPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVCL 124 (422)
Q Consensus 49 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~ 124 (422)
|++..++|++.+.||+|+||.||+|+....+ ..+.||+|+++........+.+.+|+.++.++ +||||++++++|.
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 4566778999999999999999999754332 24679999987554455556788999999999 8999999999886
Q ss_pred cC-CCeEEEEEecCCCCHHHHHhhcCCCCCC----C--------------------------------------------
Q psy7289 125 SG-EPMCMLFEFMVRGDLHEFLMSRSPRSDI----S-------------------------------------------- 155 (422)
Q Consensus 125 ~~-~~~~lv~E~~~~G~L~~~l~~~~~~~~~----~-------------------------------------------- 155 (422)
.. ..++++|||+++|+|.+++......... .
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 44 5689999999999999999653211000 0
Q ss_pred -CCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccccCCcceEeccCCCCCccc
Q psy7289 156 -GSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 234 (422)
Q Consensus 156 -~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y 234 (422)
.......+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++.+.............++..|
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 0000136889999999999999999999999999999999999999999999999999876433222222334456789
Q ss_pred cCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHH-HHHHHHcCCCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 235 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE-VIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 235 ~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~-~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
||||++....++.++|||||||++|||++.|..||.+....+ ....+..+.....|..+++++.+++.+||+.+|..|+
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP 321 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRP 321 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCc
Confidence 999999999999999999999999999987999998765544 4455566666667788899999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=331.34 Aligned_cols=266 Identities=33% Similarity=0.622 Sum_probs=222.6
Q ss_pred ccCcccccccccccceeEEEEEEecCC--CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc-CCCe
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSE--GPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLS-GEPM 129 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 129 (422)
..+|++.+.||+|+||.||+|.+..+. ....|++|.++..........+.+|+.++++++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 457888999999999999999876522 2577999998766666677889999999999999999999998776 4678
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEec
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISD 209 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~D 209 (422)
++++||+++|+|.+++........ .....+++.++..++.|++.||+|||+++++||||||+||++++++.+||+|
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEA----NNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred EEEEEcCCCCcHHHHHHhcccccc----ccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 999999999999999976421100 0113589999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 289 (422)
||+++...............++..|+|||++....++.++|||||||++||+++.|..||.+.+..++...+..+...+.
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 240 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQ 240 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCC
Confidence 99998765443332233344567899999998888999999999999999999889999999888888888888777777
Q ss_pred CCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 290 PEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 290 p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
+..+|+++.+++.+||..+|..|+ +...+...|
T Consensus 241 ~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~~~~l 273 (280)
T cd05043 241 PINCPDELFAVMACCWALDPEERP-----SFSQLVQCL 273 (280)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCC-----CHHHHHHHH
Confidence 888999999999999999999998 555554433
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=332.90 Aligned_cols=268 Identities=49% Similarity=0.915 Sum_probs=221.4
Q ss_pred cCcccccccccccceeEEEEEEecC---CCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTS---EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
.++.+.+.||+|+||.||+|++... .....+++|.++.. .....+.+.+|+.++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc-cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 3567789999999999999986432 23456888887643 2344567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCC----CCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEE
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDI----SGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~----~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vK 206 (422)
+||||+++|+|.+++....+.... ........+++..+..++.||+.||+|||+++|+||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 999999999999999765431100 0011123588999999999999999999999999999999999999999999
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~ 286 (422)
|+|||+++...............++..|+|||.+....++.++|||||||++|||++.|..||...+..+..+.+..+..
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~ 243 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRV 243 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCC
Confidence 99999998665444333334445678899999999889999999999999999999889999999999898888888877
Q ss_pred CCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 287 LPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 287 ~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
...+..+|..+.+++.+||..+|..|+ +...+...|
T Consensus 244 ~~~~~~~~~~~~~li~~~l~~~P~~Rp-----t~~~v~~~l 279 (291)
T cd05094 244 LERPRVCPKEVYDIMLGCWQREPQQRL-----NIKEIYKIL 279 (291)
T ss_pred CCCCccCCHHHHHHHHHHcccChhhCc-----CHHHHHHHH
Confidence 777888999999999999999999998 555554444
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=330.88 Aligned_cols=251 Identities=35% Similarity=0.625 Sum_probs=216.0
Q ss_pred ccccCcccccccccccceeEEEEEEecCCC--CeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEG--PSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP 128 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 128 (422)
+...+|++.+.||+|+||.||+|.+..++. ...+|+|.++..........+.+|+.++.+++||||+++++++.. ..
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 345678899999999999999998765432 346899988766555566789999999999999999999999987 78
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++++||||||+||++++++.+||+
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~ 151 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHK-----------DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKIT 151 (279)
T ss_pred eEEEEecCCCCcHHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEEC
Confidence 899999999999999997532 248899999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP 288 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 288 (422)
|||+++................+..|+|||.+....++.++|+|||||++||+++.|..||.+.+..++...+..+...+
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 231 (279)
T cd05057 152 DFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLP 231 (279)
T ss_pred CCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCC
Confidence 99999866533222122223345689999999888899999999999999999987999999999999998888888888
Q ss_pred CCCCCCcchhhhcccccccccchhh
Q psy7289 289 CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 289 ~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.|..++..+.+++.+||..+|..|+
T Consensus 232 ~~~~~~~~~~~~~~~~l~~~p~~Rp 256 (279)
T cd05057 232 QPPICTIDVYMVLVKCWMIDAESRP 256 (279)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCC
Confidence 8889999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=328.84 Aligned_cols=257 Identities=39% Similarity=0.681 Sum_probs=217.7
Q ss_pred ccCcccccccccccceeEEEEEEecCC-CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSE-GPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
..+++..+.||+|+||.||+|+...+. ....+|+|.++........+.+.+|++++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 346677899999999999999876433 2357999998765555566789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
||||+++|+|.+++.... ..+++.++..++.|++.||+|||+.+++||||||+||++++++.+||+|||
T Consensus 84 v~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg 152 (268)
T cd05063 84 ITEYMENGALDKYLRDHD-----------GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFG 152 (268)
T ss_pred EEEcCCCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCc
Confidence 999999999999996532 357889999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceE-eccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC
Q psy7289 212 LSRDVYASDYYR-IQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP 290 (422)
Q Consensus 212 la~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p 290 (422)
+++......... .......++.|+|||++....++.++|||||||++|||++.|..||...+..++...+..+...|.+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 232 (268)
T cd05063 153 LSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAP 232 (268)
T ss_pred cceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCC
Confidence 997654322111 1112223467999999988889999999999999999998799999998888888888887777888
Q ss_pred CCCCcchhhhcccccccccchhhHHHHhhhhhhhh
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHR 325 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~ 325 (422)
.++|.++.+++.+||..+|..|+ +...+..
T Consensus 233 ~~~~~~~~~li~~c~~~~p~~Rp-----~~~~i~~ 262 (268)
T cd05063 233 MDCPSAVYQLMLQCWQQDRARRP-----RFVDIVN 262 (268)
T ss_pred CCCCHHHHHHHHHHcCCCcccCc-----CHHHHHH
Confidence 89999999999999999999998 5554443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=341.64 Aligned_cols=241 Identities=23% Similarity=0.368 Sum_probs=205.2
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCC-ceeeEeeEEEcCCCeEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHP-NIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~Hp-nIv~l~g~~~~~~~~~l 131 (422)
+|++++.||+|+||.||+|+...+ +..||||+++... .....+.+..|++++..++|+ +|+++++++.+.+.+|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGT--DELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCC--CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence 367889999999999999986543 4679999986432 233456788999999999764 68899999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||
T Consensus 79 v~E~~~~g~L~~~~~~~------------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg 146 (324)
T cd05587 79 VMEYVNGGDLMYHIQQV------------GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFG 146 (324)
T ss_pred EEcCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecC
Confidence 99999999999998653 357899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCC
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPE 291 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~ 291 (422)
+++....... ......+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..++...+.... .+.|.
T Consensus 147 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-G~~pf~~~~~~~~~~~i~~~~-~~~~~ 222 (324)
T cd05587 147 MCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQPPFDGEDEDELFQSIMEHN-VSYPK 222 (324)
T ss_pred cceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCC
Confidence 9875322111 1123457889999999999899999999999999999998 999999999888888887643 55678
Q ss_pred CCCcchhhhcccccccccchhh
Q psy7289 292 DCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 292 ~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.+++++.+++.+||..+|..|.
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~ 244 (324)
T cd05587 223 SLSKEAVSICKGLLTKHPAKRL 244 (324)
T ss_pred CCCHHHHHHHHHHhhcCHHHcC
Confidence 8899999999999999999885
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=332.28 Aligned_cols=269 Identities=44% Similarity=0.800 Sum_probs=219.5
Q ss_pred ccCcccccccccccceeEEEEEEecCC--------------CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceee
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSE--------------GPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVC 118 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~--------------~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~ 118 (422)
..+|++.++||+|+||.||+|+..... ....||+|.+.........+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 457889999999999999998865432 234689999876665666778999999999999999999
Q ss_pred EeeEEEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcee
Q psy7289 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCL 198 (422)
Q Consensus 119 l~g~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiL 198 (422)
+++++..++..+++|||+++++|.+++.......... ......+++..+..++.|++.||+|||+++++||||||+||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL-ACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccc-cccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 9999999999999999999999999997643211110 011236899999999999999999999999999999999999
Q ss_pred ecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhC-CCCCCCCCChHHH
Q psy7289 199 VGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY-GLQPYYGYSNQEV 277 (422)
Q Consensus 199 l~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~-g~~Pf~~~~~~~~ 277 (422)
+++++.+||+|||+++...............+++.|||||.+....++.++|||||||++|||++. +..||...+..++
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV 242 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHH
Confidence 999999999999999876554444444445567789999999888899999999999999999973 6789988888877
Q ss_pred HHHHHcC-------CCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 278 IEMIRSR-------QMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 278 ~~~i~~~-------~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
+..+... ...+.|..+|+++.+++.+||..+|..|+ +...++..|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----t~~el~~~L 294 (296)
T cd05051 243 IENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRP-----TFREIHLFL 294 (296)
T ss_pred HHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCC-----CHHHHHHHh
Confidence 7666432 12344667889999999999999999998 666665544
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=326.02 Aligned_cols=252 Identities=38% Similarity=0.749 Sum_probs=208.8
Q ss_pred cccccccceeEEEEEEecC-CCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc-CCCeEEEEEecC
Q psy7289 60 QELGEGAFGKVYKGEVCTS-EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLS-GEPMCMLFEFMV 137 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~~lv~E~~~ 137 (422)
+.||+|+||.||+|++... .....||+|.+.........+.+.+|+.+++.++||||+++++++.. +...+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 4689999999999987543 23467999988654455566789999999999999999999998764 456899999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccccccc
Q psy7289 138 RGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVY 217 (422)
Q Consensus 138 ~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~ 217 (422)
+|+|.+++.... ..+++..+..++.|++.||+|||+.+++||||||+|||+++++.+||+|||+++...
T Consensus 81 ~~~L~~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 81 HGDLRNFIRSET-----------HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred CCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCcccccccc
Confidence 999999997532 235677788999999999999999999999999999999999999999999998654
Q ss_pred CCcceEec--cCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCc
Q psy7289 218 ASDYYRIQ--SKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPP 295 (422)
Q Consensus 218 ~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~ 295 (422)
........ ....++..|+|||.+....++.++|||||||++|||++.|.+||...+..++...+..+..++.|..+|+
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (262)
T cd05058 150 DKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPD 229 (262)
T ss_pred CCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCH
Confidence 33221111 1233467899999998888999999999999999999977889988888888888888877777888999
Q ss_pred chhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 296 RMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 296 ~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
.+.+++.+||..+|..|+ +...+...+
T Consensus 230 ~~~~li~~cl~~~p~~Rp-----~~~~il~~l 256 (262)
T cd05058 230 PLYEVMLSCWHPKPEMRP-----TFSELVSRI 256 (262)
T ss_pred HHHHHHHHHcCCChhhCC-----CHHHHHHHH
Confidence 999999999999999998 555444433
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=344.56 Aligned_cols=246 Identities=22% Similarity=0.385 Sum_probs=206.4
Q ss_pred cccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEecC
Q psy7289 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMV 137 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~~ 137 (422)
+.||+|+||.||+++... .+..||+|.++... .......+.+|++++..++||||+++++++...+.+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~--~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKA--TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 469999999999998643 45789999986432 23345677889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCCeEEEecCcccccc
Q psy7289 138 RGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCS-HHYVHRDLAARNCLVGDGLTVKISDFGLSRDV 216 (422)
Q Consensus 138 ~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~ 216 (422)
+|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++..
T Consensus 79 ~~~L~~~l~~~------------~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 79 GGELFFHLSRE------------RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG 146 (325)
T ss_pred CCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence 99999988653 358899999999999999999997 79999999999999999999999999998754
Q ss_pred cCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcc
Q psy7289 217 YASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPR 296 (422)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~ 296 (422)
..... ......+|+.|||||++....++.++|||||||++|||++ |..||.+.+..+....+.... ...|..++++
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~ 222 (325)
T cd05594 147 IKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELILMEE-IRFPRTLSPE 222 (325)
T ss_pred CCCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeecc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHH
Confidence 32211 1123457889999999998899999999999999999998 999999988888877776543 4567788999
Q ss_pred hhhhcccccccccchhh------HHHHhhhhhh
Q psy7289 297 MYSLMMECWHEVPVAAG------MAYLCSHHYV 323 (422)
Q Consensus 297 ~~~l~~~cw~~~P~~r~------~~~lh~~~~i 323 (422)
+.+++.+||..+|..|. ...+.+|.++
T Consensus 223 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~ 255 (325)
T cd05594 223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255 (325)
T ss_pred HHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCc
Confidence 99999999999999993 4555555543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=350.21 Aligned_cols=254 Identities=22% Similarity=0.361 Sum_probs=206.2
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
+|++++.||+|+||.||+++... .++.||||++.... .....+.+.+|+++++.++|||||++++++.++..+|+|
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKD--TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECC--CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEE
Confidence 57889999999999999998654 35779999885421 233456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 80 ~E~~~gg~L~~~l~~~------------~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGl 147 (377)
T cd05629 80 MEFLPGGDLMTMLIKY------------DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGL 147 (377)
T ss_pred EeCCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999653 3588999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcc---e------------------------------------------EeccCCCCCccccCccccccCCCCC
Q psy7289 213 SRDVYASDY---Y------------------------------------------RIQSKSLLPVRWMPPESILYGKFTT 247 (422)
Q Consensus 213 a~~~~~~~~---~------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~ 247 (422)
++....... + .......+|+.|+|||++....++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 227 (377)
T cd05629 148 STGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCC
Confidence 963211000 0 0001235788999999999889999
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC-CCCCCCC--CCCcchhhhcccccccccchh----hHHHHhhh
Q psy7289 248 ESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR-QMLPCPE--DCPPRMYSLMMECWHEVPVAA----GMAYLCSH 320 (422)
Q Consensus 248 ~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~-~~~~~p~--~~p~~~~~l~~~cw~~~P~~r----~~~~lh~~ 320 (422)
++|||||||++|||++ |..||.+.+..+....+... .....|. .+++++.+++.+|+. +|..| .+..+..|
T Consensus 228 ~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 228 ECDWWSLGAIMFECLI-GWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred ceeeEecchhhhhhhc-CCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 9999999999999998 99999998888877777642 3344444 478889999999997 66655 45555566
Q ss_pred hhhh
Q psy7289 321 HYVH 324 (422)
Q Consensus 321 ~~i~ 324 (422)
.++.
T Consensus 306 p~~~ 309 (377)
T cd05629 306 PFFR 309 (377)
T ss_pred CCcC
Confidence 6553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=341.74 Aligned_cols=246 Identities=20% Similarity=0.323 Sum_probs=207.5
Q ss_pred cccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCCeEEEEEec
Q psy7289 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPMCMLFEFM 136 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lv~E~~ 136 (422)
+.||+|+||.||+|+... .+..||+|+++... .....+.+..|.+++..+ +||||+++++++.+++..|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKG--TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECC--CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence 469999999999998754 35679999986432 233455678899998876 7999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccc
Q psy7289 137 VRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV 216 (422)
Q Consensus 137 ~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~ 216 (422)
++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++..
T Consensus 79 ~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 79 NGGDLMFQIQRS------------RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEG 146 (321)
T ss_pred CCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceec
Confidence 999999998653 25888999999999999999999999999999999999999999999999998754
Q ss_pred cCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcc
Q psy7289 217 YASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPR 296 (422)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~ 296 (422)
..... ......+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..++...+..+. ...|..++++
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~ 222 (321)
T cd05591 147 ILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMA-GQPPFEADNEDDLFESILHDD-VLYPVWLSKE 222 (321)
T ss_pred ccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHH
Confidence 32221 1223457889999999998899999999999999999998 999999999999988887765 4456778999
Q ss_pred hhhhcccccccccchhh--------HHHHhhhhhh
Q psy7289 297 MYSLMMECWHEVPVAAG--------MAYLCSHHYV 323 (422)
Q Consensus 297 ~~~l~~~cw~~~P~~r~--------~~~lh~~~~i 323 (422)
+.+++..||..+|..|. +..+.+|.++
T Consensus 223 ~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~ 257 (321)
T cd05591 223 AVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFF 257 (321)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCcc
Confidence 99999999999999985 4556566655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=338.84 Aligned_cols=254 Identities=23% Similarity=0.379 Sum_probs=207.1
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
+...+|++++.||+|+||.||+++...+ +..||+|.+.........+.+.+|+++|++++||||+++++++..++..+
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPS--GLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCC--CcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 4567899999999999999999987543 46799999876555556678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeecCCCeEEEec
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSH-HYVHRDLAARNCLVGDGLTVKISD 209 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~ivHrDlKp~NiLl~~~~~vKl~D 209 (422)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|
T Consensus 80 lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~D 147 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEA------------KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCD 147 (331)
T ss_pred EEeecCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEcc
Confidence 999999999999999753 2478899999999999999999986 699999999999999999999999
Q ss_pred CcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH-------
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR------- 282 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~------- 282 (422)
||+++..... ......+++.|+|||++.+..++.++|||||||++|||++ |..||...+..++...+.
T Consensus 148 fg~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 222 (331)
T cd06649 148 FGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAI-GRYPIPPPDAKELEAIFGRPVVDGE 222 (331)
T ss_pred Cccccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhcccccccc
Confidence 9999765332 1223457889999999998889999999999999999998 999998766555433221
Q ss_pred ---------------------------------------cCCCCCCC-CCCCcchhhhcccccccccchhh-HHHHhhhh
Q psy7289 283 ---------------------------------------SRQMLPCP-EDCPPRMYSLMMECWHEVPVAAG-MAYLCSHH 321 (422)
Q Consensus 283 ---------------------------------------~~~~~~~p-~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~ 321 (422)
....+..| ..+++++.+|+.+||..+|..|+ +..+.+|.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 223 EGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 11111111 23577899999999999999997 22344444
Q ss_pred hh
Q psy7289 322 YV 323 (422)
Q Consensus 322 ~i 323 (422)
++
T Consensus 303 ~~ 304 (331)
T cd06649 303 FI 304 (331)
T ss_pred HH
Confidence 43
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=336.03 Aligned_cols=257 Identities=39% Similarity=0.673 Sum_probs=212.6
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCCeEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lv 132 (422)
..|++.+.||+|+||.||+|++..++....+|+|.++..........|.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 4577889999999999999998655445567888876555555667899999999999 899999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCC----CCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDIS----GSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~----~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
|||+++|+|.+++.......... .......+++.++..++.|++.||+|||++|++||||||+|||+++++.+||+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~ 166 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 166 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeC
Confidence 99999999999997643211000 00112358899999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP 288 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 288 (422)
|||+++..... ........+..|+|||.+....++.++|||||||++|||+|.|..||.+.+..+....+..+...+
T Consensus 167 dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 243 (303)
T cd05088 167 DFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 243 (303)
T ss_pred ccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcCC
Confidence 99998643211 111122335679999999888899999999999999999987899999988888888887776666
Q ss_pred CCCCCCcchhhhcccccccccchhh
Q psy7289 289 CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 289 ~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.|..+++.+.+++.+||..+|..|+
T Consensus 244 ~~~~~~~~~~~li~~~l~~~p~~Rp 268 (303)
T cd05088 244 KPLNCDDEVYDLMRQCWREKPYERP 268 (303)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCc
Confidence 7778899999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=325.59 Aligned_cols=241 Identities=46% Similarity=0.819 Sum_probs=208.1
Q ss_pred cccccccceeEEEEEEecCC-CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEecCC
Q psy7289 60 QELGEGAFGKVYKGEVCTSE-GPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVR 138 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~~~ 138 (422)
++||+|+||.||+|++...+ ....+|+|.+.........+.+.+|+.+++.++|||||++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999876554 347899999876554445678999999999999999999999876 4568999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccccC
Q psy7289 139 GDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA 218 (422)
Q Consensus 139 G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~ 218 (422)
|+|.+++... ..+++..+..++.|++.||+|||+++++||||||+|||+++++.+||+|||+++....
T Consensus 80 ~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~ 147 (257)
T cd05060 80 GPLLKYLKKR------------REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGA 147 (257)
T ss_pred CcHHHHHHhC------------CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeec
Confidence 9999999754 2478999999999999999999999999999999999999999999999999986643
Q ss_pred Ccce-EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcch
Q psy7289 219 SDYY-RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRM 297 (422)
Q Consensus 219 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~~ 297 (422)
.... .......++..|+|||.+....++.++|||||||++|||++.|..||...+..++...+......+.|..+|+.+
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 227 (257)
T cd05060 148 GSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEI 227 (257)
T ss_pred CCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHH
Confidence 3221 111222235679999999888899999999999999999987999999999999999998888888899999999
Q ss_pred hhhcccccccccchhh
Q psy7289 298 YSLMMECWHEVPVAAG 313 (422)
Q Consensus 298 ~~l~~~cw~~~P~~r~ 313 (422)
.+++.+||..+|..|+
T Consensus 228 ~~li~~cl~~~p~~Rp 243 (257)
T cd05060 228 YSIMLSCWKYRPEDRP 243 (257)
T ss_pred HHHHHHHhcCChhhCc
Confidence 9999999999999998
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=348.13 Aligned_cols=254 Identities=22% Similarity=0.390 Sum_probs=208.5
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
+|++.+.||+|+||.||+|+...+ +..||||+++... .......+.+|+.+|+.++||||+++++++.+++.+++|
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDT--GHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCC--CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEE
Confidence 578899999999999999987543 4679999986432 223446788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
||||++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 80 ~E~~~~g~L~~~l~~~------------~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 147 (364)
T cd05599 80 MEYLPGGDMMTLLMKK------------DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147 (364)
T ss_pred ECCCCCcHHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeeccc
Confidence 9999999999999763 2589999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcce---E---------------------------------eccCCCCCccccCccccccCCCCCchhHHhHHH
Q psy7289 213 SRDVYASDYY---R---------------------------------IQSKSLLPVRWMPPESILYGKFTTESDVWSYGV 256 (422)
Q Consensus 213 a~~~~~~~~~---~---------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gv 256 (422)
++........ . ......+|+.|||||++....++.++|||||||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 227 (364)
T cd05599 148 CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227 (364)
T ss_pred ceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchh
Confidence 8754321100 0 001235789999999999889999999999999
Q ss_pred HHHHHHhCCCCCCCCCChHHHHHHHHcC-CCCCCCC--CCCcchhhhcccccccccchhh----HHHHhhhhhhh
Q psy7289 257 VLWEVYSYGLQPYYGYSNQEVIEMIRSR-QMLPCPE--DCPPRMYSLMMECWHEVPVAAG----MAYLCSHHYVH 324 (422)
Q Consensus 257 il~El~t~g~~Pf~~~~~~~~~~~i~~~-~~~~~p~--~~p~~~~~l~~~cw~~~P~~r~----~~~lh~~~~i~ 324 (422)
++|||++ |..||.+.+..+....+... ...+.|. .+++.+.+++.+|+. +|..|. +..+.+|.++.
T Consensus 228 il~el~~-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~ 300 (364)
T cd05599 228 IMYEMLV-GYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFK 300 (364)
T ss_pred HHHHhhc-CCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcC
Confidence 9999998 99999999888887777653 2334444 467889999999996 676665 55666666553
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=342.19 Aligned_cols=274 Identities=34% Similarity=0.628 Sum_probs=216.3
Q ss_pred hhccccCcccccccccccceeEEEEEEecC---CCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEEE
Q psy7289 49 REVIETKPRFLQELGEGAFGKVYKGEVCTS---EGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVCL 124 (422)
Q Consensus 49 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~ 124 (422)
++...++|++.+.||+|+||.||+|++... ...+.||||.++..........+.+|+.++.++ +||||+++++++.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 455667899999999999999999986432 235689999997655455567889999999999 6899999999886
Q ss_pred cC-CCeEEEEEecCCCCHHHHHhhcCCCCCC------------------C------------------------------
Q psy7289 125 SG-EPMCMLFEFMVRGDLHEFLMSRSPRSDI------------------S------------------------------ 155 (422)
Q Consensus 125 ~~-~~~~lv~E~~~~G~L~~~l~~~~~~~~~------------------~------------------------------ 155 (422)
.. ..++++||||++|+|.+++......... .
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 54 4689999999999999999753211000 0
Q ss_pred -------CCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccccCCcceEeccCC
Q psy7289 156 -------GSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKS 228 (422)
Q Consensus 156 -------~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~ 228 (422)
.......++..++..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++..............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 0000124788888999999999999999999999999999999999999999999999865433222222233
Q ss_pred CCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHcCCCCCCCCCCCcchhhhccccccc
Q psy7289 229 LLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN-QEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHE 307 (422)
Q Consensus 229 ~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~-~~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~ 307 (422)
.+++.|+|||.+....++.++|||||||++|||++.|..||.+... .++...+..+.+++.|..+++++.++|..||+.
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~ 321 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 321 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccC
Confidence 4567799999998888999999999999999999889999987654 345566667777777888889999999999999
Q ss_pred ccchhhHHHHhhhhhhhhhc
Q psy7289 308 VPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 308 ~P~~r~~~~lh~~~~i~~dL 327 (422)
+|..|+ +...+...|
T Consensus 322 ~p~~Rp-----s~~eil~~l 336 (343)
T cd05103 322 EPSQRP-----TFSELVEHL 336 (343)
T ss_pred ChhhCc-----CHHHHHHHH
Confidence 999998 555544433
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=327.05 Aligned_cols=248 Identities=36% Similarity=0.710 Sum_probs=212.7
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
++...+|++.++||+|+||.||+|.... ...||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYNN---STKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI 76 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEecC---CceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 3455678999999999999999998532 3569999876432 2356899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEec
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISD 209 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~D 209 (422)
+++|||+++|+|.+++.... ...++...+..++.|++.||+|||+++++||||||+||++++++.+||+|
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~d 146 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDE----------GGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIAD 146 (261)
T ss_pred EEEEecCCCCcHHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECC
Confidence 99999999999999997532 13578888999999999999999999999999999999999999999999
Q ss_pred CcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 289 (422)
||+++........ ......++..|+|||++....++.++|||||||++|||++.|..||.+.+..+....+..+...+.
T Consensus 147 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 225 (261)
T cd05072 147 FGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPR 225 (261)
T ss_pred CccceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 9999865433221 122233466799999998888999999999999999999879999999988888888888777777
Q ss_pred CCCCCcchhhhcccccccccchhh
Q psy7289 290 PEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 290 p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+..+|.++.+++.+||+.+|..|+
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp 249 (261)
T cd05072 226 MENCPDELYDIMKTCWKEKAEERP 249 (261)
T ss_pred CCCCCHHHHHHHHHHccCCcccCc
Confidence 788999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=348.17 Aligned_cols=254 Identities=22% Similarity=0.379 Sum_probs=203.7
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
.|++++.||+|+||+||+|+... .+..||||++.... .......+.+|+.+++.++|||||++++++.+.+.+|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~--~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVD--THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence 57789999999999999998654 35789999986432 234456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 80 ~E~~~gg~L~~~l~~~------------~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl 147 (381)
T cd05626 80 MDYIPGGDMMSLLIRM------------EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGL 147 (381)
T ss_pred EecCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcC
Confidence 9999999999999753 2588899999999999999999999999999999999999999999999999
Q ss_pred cccccCCc---ce------------------------------------------EeccCCCCCccccCccccccCCCCC
Q psy7289 213 SRDVYASD---YY------------------------------------------RIQSKSLLPVRWMPPESILYGKFTT 247 (422)
Q Consensus 213 a~~~~~~~---~~------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~ 247 (422)
++...... .+ .......+|+.|||||++....++.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (381)
T cd05626 148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ 227 (381)
T ss_pred CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence 86431100 00 0011235789999999999888999
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc-CCCCCCC--CCCCcchhhhccc--ccccccchh-hHHHHhhhh
Q psy7289 248 ESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS-RQMLPCP--EDCPPRMYSLMME--CWHEVPVAA-GMAYLCSHH 321 (422)
Q Consensus 248 ~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~-~~~~~~p--~~~p~~~~~l~~~--cw~~~P~~r-~~~~lh~~~ 321 (422)
++|||||||++|||++ |..||...+..+....+.. ......| ..+++++.+|+.+ |+..+|..| ....+.+|.
T Consensus 228 ~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp 306 (381)
T cd05626 228 LCDWWSVGVILFEMLV-GQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHP 306 (381)
T ss_pred ccceeehhhHHHHHHh-CCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCc
Confidence 9999999999999998 9999998887776665543 2223333 3578899999987 666666544 344455555
Q ss_pred hh
Q psy7289 322 YV 323 (422)
Q Consensus 322 ~i 323 (422)
++
T Consensus 307 ~f 308 (381)
T cd05626 307 FF 308 (381)
T ss_pred cc
Confidence 54
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=340.80 Aligned_cols=236 Identities=20% Similarity=0.330 Sum_probs=201.8
Q ss_pred cccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCCeEEEEEec
Q psy7289 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPMCMLFEFM 136 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lv~E~~ 136 (422)
+.||+|+||.||+|+... .+..||||+++... .......+.+|..++..+ +||||+++++++.+.+.+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKE--SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcC--CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence 469999999999998654 35679999986432 223456678899988876 6999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccc
Q psy7289 137 VRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV 216 (422)
Q Consensus 137 ~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~ 216 (422)
++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++..
T Consensus 79 ~~g~L~~~i~~~------------~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 79 NGGDLMFHIQKS------------RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred CCchHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 999999998653 25889999999999999999999999999999999999999999999999998754
Q ss_pred cCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcc
Q psy7289 217 YASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPR 296 (422)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~ 296 (422)
..... ......+|+.|||||++....++.++|||||||++|||++ |..||.+.+..++...+..+. ...|..++++
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~ 222 (320)
T cd05590 147 IFNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLC-GHAPFEAENEDDLFEAILNDE-VVYPTWLSQD 222 (320)
T ss_pred CcCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHH
Confidence 32211 1233457889999999998889999999999999999998 999999999999888887654 4557788999
Q ss_pred hhhhcccccccccchhh
Q psy7289 297 MYSLMMECWHEVPVAAG 313 (422)
Q Consensus 297 ~~~l~~~cw~~~P~~r~ 313 (422)
+.+++++|+..+|..|.
T Consensus 223 ~~~li~~~L~~dP~~R~ 239 (320)
T cd05590 223 AVDILKAFMTKNPTMRL 239 (320)
T ss_pred HHHHHHHHcccCHHHCC
Confidence 99999999999999886
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=326.14 Aligned_cols=243 Identities=41% Similarity=0.738 Sum_probs=209.8
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
.+|++.+.||+|+||.||+|++.. ...+|+|.++... .....|.+|+.++++++||||+++++++.+....+++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~---~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG---QYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC---CCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 457889999999999999997643 3459999886432 23457899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||+++|+|.+++.... ..+++..+..++.||+.||+|||+++++||||||+||++++++.+||+|||++
T Consensus 79 e~~~~~~l~~~i~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~ 147 (256)
T cd05113 79 EYMSNGCLLNYLREHG-----------KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLS 147 (256)
T ss_pred EcCCCCcHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccc
Confidence 9999999999997532 24789999999999999999999999999999999999999999999999998
Q ss_pred ccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDC 293 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~ 293 (422)
+....... .......++..|+|||.+....++.++|||||||++|||++.|..||...+..++...+..+.+.+.|...
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (256)
T cd05113 148 RYVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLA 226 (256)
T ss_pred eecCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCC
Confidence 86544322 12223345678999999988889999999999999999998899999998888888888888777778888
Q ss_pred Ccchhhhcccccccccchhh
Q psy7289 294 PPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 294 p~~~~~l~~~cw~~~P~~r~ 313 (422)
+..+.+++.+||+.+|..|+
T Consensus 227 ~~~~~~li~~cl~~~p~~Rp 246 (256)
T cd05113 227 SEKVYAIMYSCWHEKAEERP 246 (256)
T ss_pred CHHHHHHHHHHcCCCcccCC
Confidence 99999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=342.28 Aligned_cols=249 Identities=32% Similarity=0.560 Sum_probs=195.1
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC-eEEEEE
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP-MCMLFE 134 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~-~~lv~E 134 (422)
+.-...||+|+||.||+|...+ +..||||++....... ..+|.+|+.++.+++|||+|+|+|+|.+.+. .++|+|
T Consensus 77 Fs~~~~ig~Ggfg~VYkG~l~~---~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYE 152 (361)
T KOG1187|consen 77 FSESNLIGEGGFGTVYKGVLSD---GTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYE 152 (361)
T ss_pred CchhcceecCCCeEEEEEEECC---CCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEE
Confidence 3334789999999999998743 2779999887654432 4569999999999999999999999999984 999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCceeecCCCeEEEecCc
Q psy7289 135 FMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHH---YVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 135 ~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~---ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
||++|+|.++|..... . +++|..+.+|+.++|.||+|||... ||||||||+|||||++.++||+|||
T Consensus 153 ym~nGsL~d~L~~~~~---------~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFG 222 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKG---------E-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFG 222 (361)
T ss_pred ccCCCCHHHHhCCCCC---------C-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCcc
Confidence 9999999999986431 1 6899999999999999999999854 9999999999999999999999999
Q ss_pred ccccccC-CcceEeccCC-CCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCC---hHHHH----HHHH
Q psy7289 212 LSRDVYA-SDYYRIQSKS-LLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS---NQEVI----EMIR 282 (422)
Q Consensus 212 la~~~~~-~~~~~~~~~~-~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~---~~~~~----~~i~ 282 (422)
+|+.... .... ... .+|..|+|||++..+..+.|+|||||||+|.|++| |+.|..... ...+. ..+.
T Consensus 223 La~~~~~~~~~~---~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElit-gr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 223 LAKLGPEGDTSV---STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELIT-GRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred CcccCCccccce---eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHh-CCcccCCCCCcccccHHHHHHHHHH
Confidence 9976543 2211 112 68899999999999999999999999999999999 887776432 11122 2333
Q ss_pred cCCCCCC--C----CCCC-----cchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 283 SRQMLPC--P----EDCP-----PRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 283 ~~~~~~~--p----~~~p-----~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
.+....+ | ...+ ..+..+...|.+.+|..|| ++..+...|
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP-----~m~~Vv~~L 349 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERP-----TMSQVVKEL 349 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCc-----CHHHHHHHH
Confidence 3322111 1 1122 2356677899999999998 666665555
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=339.68 Aligned_cols=241 Identities=22% Similarity=0.360 Sum_probs=205.2
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCCeEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~l 131 (422)
+|++.+.||+|+||.||+|+... .+..||||.++... .......+..|..++..+ +||||+++++++.+.+.+++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKG--TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence 36788999999999999998654 35679999986432 223345677888888877 58999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
||||+++|+|.+++... ..+++.++..++.||+.||+|||+++|+||||||+|||+++++.+||+|||
T Consensus 79 v~E~~~~g~L~~~~~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG 146 (323)
T cd05616 79 VMEYVNGGDLMYQIQQV------------GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred EEcCCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCC
Confidence 99999999999998653 358899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCC
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPE 291 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~ 291 (422)
+++....... ......+|+.|||||++....++.++|||||||++|||++ |..||.+.+..++...+.... ...|.
T Consensus 147 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~p~ 222 (323)
T cd05616 147 MCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQAPFEGEDEDELFQSIMEHN-VAYPK 222 (323)
T ss_pred CceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCC
Confidence 9975432211 1223457889999999999999999999999999999998 999999999988888887654 45677
Q ss_pred CCCcchhhhcccccccccchhh
Q psy7289 292 DCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 292 ~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..++++.+++.+|+..+|..|.
T Consensus 223 ~~s~~~~~li~~~l~~~p~~R~ 244 (323)
T cd05616 223 SMSKEAVAICKGLMTKHPGKRL 244 (323)
T ss_pred cCCHHHHHHHHHHcccCHHhcC
Confidence 8999999999999999999885
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=327.18 Aligned_cols=258 Identities=39% Similarity=0.662 Sum_probs=211.8
Q ss_pred cccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCCeEEEEEecCC
Q psy7289 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPMCMLFEFMVR 138 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lv~E~~~~ 138 (422)
+.||+|+||.||+|++..++....+++|.++........+.+.+|++++.++ +||||+++++++......+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 3689999999999988665444568899887655555667899999999999 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCC----CCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccc
Q psy7289 139 GDLHEFLMSRSPRSD----ISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR 214 (422)
Q Consensus 139 G~L~~~l~~~~~~~~----~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~ 214 (422)
|+|.+++........ .........++++++..++.|++.||+|||+++++||||||+|||+++++.+||+|||+++
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 999999976432110 0001112358899999999999999999999999999999999999999999999999986
Q ss_pred cccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q psy7289 215 DVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCP 294 (422)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p 294 (422)
..... ........+..|+|||++....++.++|||||||++|||++.|..||.+.+..+....+..+..++.|..++
T Consensus 161 ~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (270)
T cd05047 161 GQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD 237 (270)
T ss_pred ccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCC
Confidence 42211 111122335679999999888899999999999999999977999999998888888888777777788899
Q ss_pred cchhhhcccccccccchhhHHHHhhhhhhhh
Q psy7289 295 PRMYSLMMECWHEVPVAAGMAYLCSHHYVHR 325 (422)
Q Consensus 295 ~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~ 325 (422)
.++.+++.+||..+|..|+ +...+..
T Consensus 238 ~~~~~li~~~l~~~p~~Rp-----s~~~il~ 263 (270)
T cd05047 238 DEVYDLMRQCWREKPYERP-----SFAQILV 263 (270)
T ss_pred HHHHHHHHHHcccChhhCC-----CHHHHHH
Confidence 9999999999999999998 5554443
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=327.44 Aligned_cols=249 Identities=38% Similarity=0.713 Sum_probs=214.2
Q ss_pred cccCcccccccccccceeEEEEEEecC-CCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTS-EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
...++.+.+.||+|+||.||+|.+... .....|+||...........+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 345677889999999999999987654 33456999988765555566789999999999999999999999875 5578
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+||
T Consensus 83 lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~ 151 (270)
T cd05056 83 IVMELAPLGELRSYLQVNK-----------YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDF 151 (270)
T ss_pred EEEEcCCCCcHHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccC
Confidence 9999999999999996532 24788999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP 290 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p 290 (422)
|+++.......+. ......+..|+|||.+....++.++|||||||++||+++.|..||.+.+..+....+..+..++.|
T Consensus 152 g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 230 (270)
T cd05056 152 GLSRYLEDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMP 230 (270)
T ss_pred ceeeeccccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence 9998665443222 223334567999999988889999999999999999997799999999988888888888888889
Q ss_pred CCCCcchhhhcccccccccchhh
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..+|+.+.+++.+||..+|..|+
T Consensus 231 ~~~~~~~~~li~~~l~~~P~~Rp 253 (270)
T cd05056 231 PNCPPTLYSLMTKCWAYDPSKRP 253 (270)
T ss_pred CCCCHHHHHHHHHHcCCChhhCc
Confidence 99999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=326.05 Aligned_cols=248 Identities=40% Similarity=0.776 Sum_probs=212.6
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
++...++++.+.||+|+||.||+|.+.. +..||+|.++... ...+.+.+|+.++++++||||+++++++...+..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~---~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNN---TTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPI 76 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecC---CeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCe
Confidence 4556678999999999999999997532 3579999986432 2346789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEec
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISD 209 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~D 209 (422)
+++|||+++|+|.+++.... ...+++.++..++.|++.||.|||+++++||||||+||++++++.+||+|
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d 146 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGA----------GRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVAD 146 (261)
T ss_pred eeeeecccCCcHHHHHhccC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECC
Confidence 99999999999999996532 12578999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 289 (422)
||+++....... ........+..|+|||.+....++.++||||||+++|||++.|..||.+.+..++...+......+.
T Consensus 147 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 225 (261)
T cd05068 147 FGLARVIKEDIY-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC 225 (261)
T ss_pred cceEEEccCCcc-cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 999986643221 1112222345799999999889999999999999999999889999999998888888887777777
Q ss_pred CCCCCcchhhhcccccccccchhh
Q psy7289 290 PEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 290 p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
|..+|..+.+++.+||..+|..|+
T Consensus 226 ~~~~~~~~~~li~~~l~~~P~~Rp 249 (261)
T cd05068 226 PPGCPKELYDIMLDCWKEDPDDRP 249 (261)
T ss_pred CCcCCHHHHHHHHHHhhcCcccCC
Confidence 888999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=327.49 Aligned_cols=257 Identities=39% Similarity=0.734 Sum_probs=220.1
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
....+|++.++||+|+||.||+|+... +..+++|.+.... ......+.+|+.+++.++||||+++++++.+....+
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~---~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 78 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKN---RVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY 78 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecC---CCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeE
Confidence 345578899999999999999998754 4679999986533 234567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+||||+++|+|.+++.... ...+++..+.+++.|++.||+|||+++++||||||+||++++++.+||+||
T Consensus 79 lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~ 148 (261)
T cd05148 79 IITELMEKGSLLAFLRSPE----------GQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADF 148 (261)
T ss_pred EEEeecccCCHHHHHhcCC----------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccc
Confidence 9999999999999997532 135788999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP 290 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p 290 (422)
|++........ ......++..|+|||.+....++.++||||||+++|||++.|..||.+.+..++...+..+.+.+.|
T Consensus 149 g~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 226 (261)
T cd05148 149 GLARLIKEDVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCP 226 (261)
T ss_pred cchhhcCCccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCC
Confidence 99976543221 1223345678999999988889999999999999999998789999999888888888888778888
Q ss_pred CCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
..+|+.+.++|.+||..+|..|+ +...+...|+
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rp-----t~~~l~~~L~ 259 (261)
T cd05148 227 AKCPQEIYKIMLECWAAEPEDRP-----SFKALREELD 259 (261)
T ss_pred CCCCHHHHHHHHHHcCCCchhCc-----CHHHHHHHHh
Confidence 89999999999999999999998 6666655543
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=340.39 Aligned_cols=246 Identities=18% Similarity=0.335 Sum_probs=201.1
Q ss_pred cccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCCeEEEEEec
Q psy7289 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPMCMLFEFM 136 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lv~E~~ 136 (422)
+.||+|+||.||+++...+ +..||+|+++... .......+.+|..++..+ +||||+++++++.+...+|+|||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~--~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKT--RRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCC--CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence 4699999999999987543 5679999987532 223445688999999998 6999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccc
Q psy7289 137 VRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV 216 (422)
Q Consensus 137 ~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~ 216 (422)
++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++..
T Consensus 79 ~~g~L~~~~~~~------------~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 146 (329)
T cd05588 79 SGGDLMFHMQRQ------------RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence 999999988653 35899999999999999999999999999999999999999999999999998753
Q ss_pred cCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCC--------hHH-HHHHHHcCCCC
Q psy7289 217 YASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS--------NQE-VIEMIRSRQML 287 (422)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~--------~~~-~~~~i~~~~~~ 287 (422)
..... ......+|+.|+|||++....++.++|||||||++|||++ |..||.... ..+ +.+.+.. ...
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~ 222 (329)
T cd05588 147 IRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDIVGMSDNPDQNTEDYLFQVILE-KQI 222 (329)
T ss_pred ccCCC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHH-CCCCcccccccccccccchHHHHHHHHc-CCC
Confidence 22111 1223457889999999999899999999999999999998 999996321 122 3334443 345
Q ss_pred CCCCCCCcchhhhcccccccccchhh-------HHHHhhhhhh
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAG-------MAYLCSHHYV 323 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~-------~~~lh~~~~i 323 (422)
..|..+++++.+++++|+..+|..|. +..+.+|.++
T Consensus 223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~ 265 (329)
T cd05588 223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFF 265 (329)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCC
Confidence 67888999999999999999999995 4455555555
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=326.49 Aligned_cols=253 Identities=34% Similarity=0.618 Sum_probs=201.3
Q ss_pred cccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEecCCC
Q psy7289 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRG 139 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~~~G 139 (422)
++||+|+||.||+|++........+++|.++..........|.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999999876555455677887765554555678999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccccCC
Q psy7289 140 DLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS 219 (422)
Q Consensus 140 ~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~~ 219 (422)
+|.+++.+.... ...+++..+..++.||+.||+|||+++++||||||+|||++.++.+||+|||++......
T Consensus 81 ~L~~~l~~~~~~--------~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~ 152 (268)
T cd05086 81 DLKSYLSQEQWH--------RRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE 152 (268)
T ss_pred cHHHHHHhhhcc--------cccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcc
Confidence 999999764211 124567778899999999999999999999999999999999999999999998654332
Q ss_pred cceEeccCCCCCccccCcccccc-------CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC-----
Q psy7289 220 DYYRIQSKSLLPVRWMPPESILY-------GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML----- 287 (422)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~----- 287 (422)
..........++..|+|||++.. ..++.++|||||||++|||++.+..||...+..+.+..+..+...
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 232 (268)
T cd05086 153 DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKP 232 (268)
T ss_pred hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCC
Confidence 22222234456788999998753 235789999999999999998788899888888777765443221
Q ss_pred CCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhh
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRD 326 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~d 326 (422)
..+...++.+.+++..|| .+|..|| +...+++.
T Consensus 233 ~~~~~~~~~~~~l~~~c~-~~P~~Rp-----~~~~i~~~ 265 (268)
T cd05086 233 QLELPYSERWYEVLQFCW-LSPEKRA-----TAEEVHRL 265 (268)
T ss_pred ccCCCCcHHHHHHHHHHh-hCcccCC-----CHHHHHHH
Confidence 223456778899999999 5699998 66666554
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=325.04 Aligned_cols=243 Identities=42% Similarity=0.758 Sum_probs=209.2
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
.++++.+.||+|+||.||+|++.. ...+|+|.+..... ....|.+|+.+++.++||||+++++++......++||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~---~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG---KIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC---CccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 457889999999999999998642 35689998764322 2356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||+++++|.+++..+. ..++++.+..++.|++.||+|||+++++||||||+||++++++.+||+|||++
T Consensus 79 e~~~~~~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~ 147 (256)
T cd05059 79 EYMANGCLLNYLRERK-----------GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLA 147 (256)
T ss_pred ecCCCCCHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccc
Confidence 9999999999997542 25789999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDC 293 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~ 293 (422)
+........ .......+..|+|||.+....++.++|||||||++|||++.|..||...++.+....+..+.+.+.|..+
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (256)
T cd05059 148 RYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLA 226 (256)
T ss_pred eeccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCC
Confidence 865432211 1122234567999999998899999999999999999998789999998888988888888777888889
Q ss_pred Ccchhhhcccccccccchhh
Q psy7289 294 PPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 294 p~~~~~l~~~cw~~~P~~r~ 313 (422)
|+++.+++.+||..+|..|+
T Consensus 227 ~~~~~~li~~cl~~~p~~Rp 246 (256)
T cd05059 227 PTEVYTIMYSCWHEKPEDRP 246 (256)
T ss_pred CHHHHHHHHHHhcCChhhCc
Confidence 99999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=342.27 Aligned_cols=239 Identities=27% Similarity=0.438 Sum_probs=204.2
Q ss_pred ccccccccceeEEEEEEec-CCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEec
Q psy7289 59 LQELGEGAFGKVYKGEVCT-SEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFM 136 (422)
Q Consensus 59 ~~~LG~G~fg~Vy~~~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~ 136 (422)
++.||+|+||.||+++... ...+..||+|+++... .......+.+|++++++++||||+++++++.+++..|+||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 3679999999999987642 2356789999986432 2233456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccc
Q psy7289 137 VRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV 216 (422)
Q Consensus 137 ~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~ 216 (422)
++|+|.+++... ..+++.++..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~~~L~~~l~~~------------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 148 (318)
T cd05582 81 RGGDLFTRLSKE------------VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES 148 (318)
T ss_pred CCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCccc
Confidence 999999999653 35899999999999999999999999999999999999999999999999999765
Q ss_pred cCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcc
Q psy7289 217 YASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPR 296 (422)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~ 296 (422)
..... ......+++.|+|||.+....++.++|||||||++|||++ |..||.+.+..+....+.... ...|..+++.
T Consensus 149 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~i~~~~-~~~p~~~~~~ 224 (318)
T cd05582 149 IDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT-GSLPFQGKDRKETMTMILKAK-LGMPQFLSPE 224 (318)
T ss_pred CCCCC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeecc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHH
Confidence 33211 1223457889999999988889999999999999999998 999999998888888776543 4567889999
Q ss_pred hhhhcccccccccchhh
Q psy7289 297 MYSLMMECWHEVPVAAG 313 (422)
Q Consensus 297 ~~~l~~~cw~~~P~~r~ 313 (422)
+.++++.||+.+|..|+
T Consensus 225 ~~~li~~~l~~~P~~R~ 241 (318)
T cd05582 225 AQSLLRALFKRNPANRL 241 (318)
T ss_pred HHHHHHHHhhcCHhHcC
Confidence 99999999999999987
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=347.58 Aligned_cols=253 Identities=21% Similarity=0.363 Sum_probs=203.3
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
.|++++.||+|+||.||+|+...+ +..||+|++.... .......+.+|+.++++++|||||++++++.+++.+|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~--~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDT--KALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCC--CCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence 577899999999999999986543 5779999986432 233456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
||||++|+|.+++.+. ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 80 ~E~~~gg~L~~~l~~~------------~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGl 147 (382)
T cd05625 80 MDYIPGGDMMSLLIRM------------GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL 147 (382)
T ss_pred EeCCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCC
Confidence 9999999999999653 2478899999999999999999999999999999999999999999999999
Q ss_pred cccccCCc---ce------------------------------------------EeccCCCCCccccCccccccCCCCC
Q psy7289 213 SRDVYASD---YY------------------------------------------RIQSKSLLPVRWMPPESILYGKFTT 247 (422)
Q Consensus 213 a~~~~~~~---~~------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~ 247 (422)
++...... .. .......+|+.|||||++....++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (382)
T cd05625 148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 227 (382)
T ss_pred CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence 75321000 00 0011235788999999999889999
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC-CCCCCC--CCCCcchhhhcccccccccchhh----HHHHhhh
Q psy7289 248 ESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR-QMLPCP--EDCPPRMYSLMMECWHEVPVAAG----MAYLCSH 320 (422)
Q Consensus 248 ~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~-~~~~~p--~~~p~~~~~l~~~cw~~~P~~r~----~~~lh~~ 320 (422)
++|||||||++|||++ |..||.+.++.+....+... ...+.| ...+++..+++.++. .+|..|. ...+.+|
T Consensus 228 ~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 228 LCDWWSVGVILYEMLV-GQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred eeeEEechHHHHHHHh-CCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 9999999999999998 99999998887777666542 223333 456788888887754 4787774 4455555
Q ss_pred hhh
Q psy7289 321 HYV 323 (422)
Q Consensus 321 ~~i 323 (422)
.++
T Consensus 306 p~f 308 (382)
T cd05625 306 PFF 308 (382)
T ss_pred CCc
Confidence 554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=339.83 Aligned_cols=254 Identities=23% Similarity=0.351 Sum_probs=205.2
Q ss_pred CcccccccccccceeEEEEEEec-CCCCeEEEEEEccCcC---CHHhHHHHHHHHHHHhcCC-CCceeeEeeEEEcCCCe
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCT-SEGPSLVAIKTLKENA---NQKTASDFRREVDLMSELR-HPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~ 129 (422)
+|++.+.||+|+||.||+++... ...+..||+|++.... .....+.+.+|+.+++.++ ||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 36788999999999999987643 2346789999986421 2233456889999999994 89999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEec
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISD 209 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~D 209 (422)
++||||+++|+|.+++..+ ..+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 81 ~lv~e~~~~g~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~D 148 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR------------DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTD 148 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEee
Confidence 9999999999999999764 2588999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCC----hHHHHHHHHcC
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYS----NQEVIEMIRSR 284 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~----~~~~~~~i~~~ 284 (422)
||+++........ ......+|+.|||||++... .++.++|||||||++|||++ |..||.... ..++...+..
T Consensus 149 fG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~- 225 (332)
T cd05614 149 FGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLT-GASPFTLEGERNTQSEVSRRILK- 225 (332)
T ss_pred CcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhc-CCCCCCCCCCCCCHHHHHHHHhc-
Confidence 9999764332211 12234578899999998765 47889999999999999998 999996432 2334444433
Q ss_pred CCCCCCCCCCcchhhhcccccccccchhh------HHHHhhhhhh
Q psy7289 285 QMLPCPEDCPPRMYSLMMECWHEVPVAAG------MAYLCSHHYV 323 (422)
Q Consensus 285 ~~~~~p~~~p~~~~~l~~~cw~~~P~~r~------~~~lh~~~~i 323 (422)
..++.|..+++.+.+++.+||..+|..|+ ++.+.+|.++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~ 270 (332)
T cd05614 226 CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFF 270 (332)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCc
Confidence 34566778899999999999999999996 4455555554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=331.78 Aligned_cols=265 Identities=38% Similarity=0.693 Sum_probs=217.3
Q ss_pred chhhccccCcccccccccccceeEEEEEEec---CCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeE
Q psy7289 47 FRREVIETKPRFLQELGEGAFGKVYKGEVCT---SEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGV 122 (422)
Q Consensus 47 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~ 122 (422)
..+.+...++++.+.||+|+||.||+|.+.. ......||||.++........+.+.+|+.+++++ +||||++++++
T Consensus 28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 4455666778899999999999999998642 2234579999987655455567899999999999 79999999999
Q ss_pred EEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC
Q psy7289 123 CLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG 202 (422)
Q Consensus 123 ~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~ 202 (422)
+...+..+++|||+++|+|.+++..... ..+++.++..++.|++.||+|||+++|+|+||||+|||++.+
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~----------~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~ 177 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRE----------SFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHG 177 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCC----------CCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCC
Confidence 9999999999999999999999975321 237899999999999999999999999999999999999999
Q ss_pred CeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHH-HHHH
Q psy7289 203 LTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEV-IEMI 281 (422)
Q Consensus 203 ~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~-~~~i 281 (422)
+.+||+|||+++...............++..|+|||.+....++.++|||||||++|||++.|..||.+.+..+. ...+
T Consensus 178 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~ 257 (302)
T cd05055 178 KIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI 257 (302)
T ss_pred CeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHH
Confidence 999999999998654433222223334567899999999888999999999999999999878999988776543 4445
Q ss_pred HcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhh
Q psy7289 282 RSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRD 326 (422)
Q Consensus 282 ~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~d 326 (422)
..+...+.|...++++.+++.+||+.+|..|+ +...+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----t~~ell~~ 297 (302)
T cd05055 258 KEGYRMAQPEHAPAEIYDIMKTCWDADPLKRP-----TFKQIVQL 297 (302)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcCCCchhCc-----CHHHHHHH
Confidence 55555556777889999999999999999998 55544433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=337.97 Aligned_cols=246 Identities=23% Similarity=0.361 Sum_probs=204.4
Q ss_pred cccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCCeEEEEEec
Q psy7289 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPMCMLFEFM 136 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lv~E~~ 136 (422)
+.||+|+||.||+|+...+ +..||+|.++... .......+..|..++..+ +||||+++++++.+.+.+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGK--GEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCC--CCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence 4699999999999987543 5679999986432 122345667788888754 8999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccc
Q psy7289 137 VRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV 216 (422)
Q Consensus 137 ~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~ 216 (422)
++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++..
T Consensus 79 ~~g~L~~~i~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 79 NGGDLMFHIQDK------------GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred CCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 999999998653 25788999999999999999999999999999999999999999999999998753
Q ss_pred cCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcc
Q psy7289 217 YASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPR 296 (422)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~ 296 (422)
..... ......+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..++...+.... +..|..++++
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~-g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~ 222 (316)
T cd05620 147 VFGDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLI-GQSPFHGDDEDELFESIRVDT-PHYPRWITKE 222 (316)
T ss_pred ccCCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHH
Confidence 22111 1223457889999999998899999999999999999998 999999999888888876543 4567788999
Q ss_pred hhhhcccccccccchhhH--HHHhhhhhh
Q psy7289 297 MYSLMMECWHEVPVAAGM--AYLCSHHYV 323 (422)
Q Consensus 297 ~~~l~~~cw~~~P~~r~~--~~lh~~~~i 323 (422)
+.+++.+||+.+|..|.- ..+.+|.++
T Consensus 223 ~~~li~~~l~~dP~~R~~~~~~~~~h~~f 251 (316)
T cd05620 223 SKDILEKLFERDPTRRLGVVGNIRGHPFF 251 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHHHcCCCc
Confidence 999999999999999962 345455544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=330.58 Aligned_cols=242 Identities=20% Similarity=0.324 Sum_probs=200.6
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
.|++.+.||+|+||.||++.... .+..||+|.+.... .......+.+|+.+++.++||||+++++.+.+++.+++|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRA--TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcC--CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence 36778999999999999998643 35789999886432 122235678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++|+|.+++.... ...+++..+..++.|++.||+|||+++++||||||+||++++++.++|+|||+
T Consensus 79 ~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05605 79 LTLMNGGDLKFHIYNMG----------NPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred EeccCCCcHHHHHHhcC----------cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCC
Confidence 99999999999886532 13589999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHH----HHHHcCCCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVI----EMIRSRQMLP 288 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~----~~i~~~~~~~ 288 (422)
++....... .....+++.|||||++....++.++||||+||++|||++ |..||.+.+..... ..+.. ....
T Consensus 149 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~~ 223 (285)
T cd05605 149 AVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIE-GKSPFRQRKEKVKREEVERRVKE-DQEE 223 (285)
T ss_pred ceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHH-CCCCCCCCchhhHHHHHHHHhhh-cccc
Confidence 976533221 123356889999999998889999999999999999998 99999887664433 33322 2344
Q ss_pred CCCCCCcchhhhcccccccccchhh
Q psy7289 289 CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 289 ~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.|...++.+.+|+.+||..||..|+
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~ 248 (285)
T cd05605 224 YSEKFSEAARSICRQLLTKDPGFRL 248 (285)
T ss_pred cCcccCHHHHHHHHHHccCCHHHhc
Confidence 5667889999999999999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=332.64 Aligned_cols=249 Identities=37% Similarity=0.653 Sum_probs=210.4
Q ss_pred ccCcccccccccccceeEEEEEEecCCCC--eEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGP--SLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
...++..+.||+|+||.||+|++..++.. ..||+|.+...........+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 45677889999999999999987654432 357899887655445556789999999999999999999998754 467
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+++||+++|+|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+||++++++.+||+||
T Consensus 85 ~v~e~~~~g~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Df 153 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHK-----------DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDF 153 (303)
T ss_pred eeehhcCCCCHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccc
Confidence 9999999999999987532 24788899999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP 290 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p 290 (422)
|+++................+..|+|||++....++.++|||||||++|||++.|..||.+....+....+..+..++.|
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd05110 154 GLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQP 233 (303)
T ss_pred cccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCC
Confidence 99986543222111222334678999999988889999999999999999998888999988888888888888778888
Q ss_pred CCCCcchhhhcccccccccchhh
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..++..+.+++.+||..+|..|+
T Consensus 234 ~~~~~~~~~li~~c~~~~p~~Rp 256 (303)
T cd05110 234 PICTIDVYMVMVKCWMIDADSRP 256 (303)
T ss_pred CCCCHHHHHHHHHHcCCChhhCc
Confidence 88999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=336.90 Aligned_cols=236 Identities=25% Similarity=0.394 Sum_probs=199.1
Q ss_pred cccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhc-CCCCceeeEeeEEEcCCCeEEEEEec
Q psy7289 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSE-LRHPNIVCLLGVCLSGEPMCMLFEFM 136 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~-l~HpnIv~l~g~~~~~~~~~lv~E~~ 136 (422)
+.||+|+||.||+|+... .+..||||.++... .......+..|..++.. ++||||+++++++.+.+.+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKG--TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECC--CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCC
Confidence 469999999999998754 35679999986532 12234566778888876 48999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccc
Q psy7289 137 VRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV 216 (422)
Q Consensus 137 ~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~ 216 (422)
++|+|.+++... ..+++.++..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++..
T Consensus 79 ~~g~L~~~l~~~------------~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 79 NGGDLMFHIQSC------------HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred CCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 999999999753 24788899999999999999999999999999999999999999999999998753
Q ss_pred cCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcc
Q psy7289 217 YASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPR 296 (422)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~ 296 (422)
..... ......+|+.|||||++....++.++|||||||++|||++ |..||.+.+..++...+.... +..|..++.+
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~ 222 (316)
T cd05619 147 MLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLI-GQSPFHGHDEEELFQSIRMDN-PCYPRWLTRE 222 (316)
T ss_pred CCCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCccCCHH
Confidence 22111 1123457889999999998899999999999999999998 999999999888888877554 4456778899
Q ss_pred hhhhcccccccccchhh
Q psy7289 297 MYSLMMECWHEVPVAAG 313 (422)
Q Consensus 297 ~~~l~~~cw~~~P~~r~ 313 (422)
+.+++.+||..+|..|.
T Consensus 223 ~~~li~~~l~~~P~~R~ 239 (316)
T cd05619 223 AKDILVKLFVREPERRL 239 (316)
T ss_pred HHHHHHHHhccCHhhcC
Confidence 99999999999999995
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=318.20 Aligned_cols=245 Identities=25% Similarity=0.384 Sum_probs=209.7
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
...+.|++-+.||+|.|+.||++....+ ++.+|+|++... .+....+.+.+|++|.+.|+|||||+|.....+....
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~t--g~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ 85 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTT--GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 85 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccc--hHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccccee
Confidence 3456788899999999999999876544 456888877532 2333567889999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC---CCeEE
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD---GLTVK 206 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~---~~~vK 206 (422)
|+|+|+|.||+|..-+-.+ ..+|+..+..+++||+.||+|+|.++|||||+||+|+||.+ ..-+|
T Consensus 86 ylvFe~m~G~dl~~eIV~R------------~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vK 153 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAR------------EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVK 153 (355)
T ss_pred EEEEecccchHHHHHHHHH------------HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCcee
Confidence 9999999999998877665 25899999999999999999999999999999999999964 34699
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~ 286 (422)
|+|||+|..+... ....+..|||.|||||++....|+..+||||.||+||-+++ |.+||.+.+...+++.|..+..
T Consensus 154 L~~FGvAi~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~-G~~PF~~~~~~rlye~I~~g~y 229 (355)
T KOG0033|consen 154 LADFGLAIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV-GYPPFWDEDQHRLYEQIKAGAY 229 (355)
T ss_pred ecccceEEEeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhcccc
Confidence 9999999987632 23456788999999999999999999999999999999998 9999999999999999988754
Q ss_pred CCCC---CCCCcchhhhcccccccccchhh
Q psy7289 287 LPCP---EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 287 ~~~p---~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
--.+ +..+++..+|+++++..||..|-
T Consensus 230 d~~~~~w~~is~~Ak~LvrrML~~dP~kRI 259 (355)
T KOG0033|consen 230 DYPSPEWDTVTPEAKSLIRRMLTVNPKKRI 259 (355)
T ss_pred CCCCcccCcCCHHHHHHHHHHhccChhhhc
Confidence 3222 46778999999999999998764
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=321.26 Aligned_cols=251 Identities=51% Similarity=0.931 Sum_probs=215.8
Q ss_pred cccccccceeEEEEEEecC-CCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEecCC
Q psy7289 60 QELGEGAFGKVYKGEVCTS-EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVR 138 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~~~ 138 (422)
+.||+|+||.||+|..... .....|++|.++........+.+.+|+++++.++||||+++++++.+...++++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4699999999999987643 335679999987655444567899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccccC
Q psy7289 139 GDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA 218 (422)
Q Consensus 139 G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~ 218 (422)
|+|.+++....... .......+++.++..++.|++.||+|||+++++||||||+||++++++.+||+|||.++....
T Consensus 81 ~~L~~~l~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVF---PSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccc---cccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999997642110 000114689999999999999999999999999999999999999999999999999987654
Q ss_pred CcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcchh
Q psy7289 219 SDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMY 298 (422)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~~~ 298 (422)
...........+++.|+|||.+....++.++||||+||++|||++.|..||.+.+..++...+..+...+.|..+|+++.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 43222333445678899999998888999999999999999999977999999999999999998888888999999999
Q ss_pred hhcccccccccchhh
Q psy7289 299 SLMMECWHEVPVAAG 313 (422)
Q Consensus 299 ~l~~~cw~~~P~~r~ 313 (422)
+++.+||..+|..|+
T Consensus 238 ~li~~~l~~~p~~Rp 252 (262)
T cd00192 238 ELMLSCWQLDPEDRP 252 (262)
T ss_pred HHHHHHccCCcccCc
Confidence 999999999999998
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=310.91 Aligned_cols=243 Identities=28% Similarity=0.417 Sum_probs=194.6
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
.+|..++.||+|.||.||+|+... .++.||||+++... .+......+||++.|+.++||||+.++++|.....+.+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~--t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTE--TGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecC--CCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEE
Confidence 367778999999999999998654 46789999987542 222344678999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
+||++. ||...++... ..++..++..++.++++||+|||++.|+||||||.|+|++++|.+||+|||+
T Consensus 80 fEfm~t-dLe~vIkd~~-----------i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGL 147 (318)
T KOG0659|consen 80 FEFMPT-DLEVVIKDKN-----------IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGL 147 (318)
T ss_pred EEeccc-cHHHHhcccc-----------cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccc
Confidence 999985 9999987642 4799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC---
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP--- 288 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~--- 288 (422)
|+........ ......|..|.|||.+.+ ..|+..+||||.|||+.||+- +.+-|.|.+.-+.+..|-..---|
T Consensus 148 Ar~f~~p~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELll-r~P~fpG~sDidQL~~If~~LGTP~~~ 224 (318)
T KOG0659|consen 148 ARFFGSPNRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLL-RVPFFPGDSDIDQLSKIFRALGTPTPD 224 (318)
T ss_pred hhccCCCCcc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHc-cCCCCCCCchHHHHHHHHHHcCCCCcc
Confidence 9977544321 222356788999998875 469999999999999999995 777777887777666653211111
Q ss_pred ------------------CC------CCCCcchhhhcccccccccchhh
Q psy7289 289 ------------------CP------EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 289 ------------------~p------~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.| ..++.+.-+||...|..||..|-
T Consensus 225 ~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Ri 273 (318)
T KOG0659|consen 225 QWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRI 273 (318)
T ss_pred cCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcc
Confidence 11 12344556777777777777663
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=347.59 Aligned_cols=254 Identities=19% Similarity=0.314 Sum_probs=205.9
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
.|++++.||+|+||.||+|+...+ +..||||++.... .......+.+|+.+|++++||||+++++.+.+++.+|+|
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDT--NALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCC--CCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEE
Confidence 688999999999999999986543 5789999985421 123346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
||||++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 80 ~E~~~~g~L~~~i~~~------------~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~ 147 (376)
T cd05598 80 MDYIPGGDMMSLLIRL------------GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL 147 (376)
T ss_pred EeCCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCC
Confidence 9999999999999753 3578889999999999999999999999999999999999999999999999
Q ss_pred cccccCCc---c--------------------------------------eEeccCCCCCccccCccccccCCCCCchhH
Q psy7289 213 SRDVYASD---Y--------------------------------------YRIQSKSLLPVRWMPPESILYGKFTTESDV 251 (422)
Q Consensus 213 a~~~~~~~---~--------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv 251 (422)
|....... . ........+|+.|||||++....++.++||
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 227 (376)
T cd05598 148 CTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 227 (376)
T ss_pred CccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceee
Confidence 75321000 0 000112357889999999998899999999
Q ss_pred HhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC-CCC--CCCCCCcchhhhcccccccccchhh----HHHHhhhhhhh
Q psy7289 252 WSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ-MLP--CPEDCPPRMYSLMMECWHEVPVAAG----MAYLCSHHYVH 324 (422)
Q Consensus 252 wS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~-~~~--~p~~~p~~~~~l~~~cw~~~P~~r~----~~~lh~~~~i~ 324 (422)
|||||++|||++ |..||.+.+..+....+.... ..+ ....+++++.+++.+|+ .+|..|. +.-+.+|.++.
T Consensus 228 wSlGvilyell~-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~ 305 (376)
T cd05598 228 WSVGVILYEMLV-GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFK 305 (376)
T ss_pred eeccceeeehhh-CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcC
Confidence 999999999998 999999988887776665432 222 23467888999999876 4888875 56666666543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=322.53 Aligned_cols=247 Identities=40% Similarity=0.767 Sum_probs=210.0
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
++...+|++.++||+|+||.||+|... .+..||+|.++.... ..+.|.+|+.++++++||||+++++++. ....
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~---~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~ 75 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWN---GNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPI 75 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEec---CCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCc
Confidence 455678899999999999999999754 234589998865332 2357899999999999999999999875 4568
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEec
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISD 209 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~D 209 (422)
+++|||+++|+|.+++.... ...++++++..++.|++.||+|||+++++||||||+||++++++.+||+|
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~d 145 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKDGE----------GRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIAD 145 (260)
T ss_pred EEEEEecCCCcHHHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCC
Confidence 99999999999999997532 13478999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 289 (422)
||+++........ ......++..|+|||.+....++.++||||||+++|||++.|..||.+.+..+....+..+..++.
T Consensus 146 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 224 (260)
T cd05070 146 FGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPC 224 (260)
T ss_pred ceeeeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 9999765433211 112233456799999998888999999999999999999878999999998898888888777888
Q ss_pred CCCCCcchhhhcccccccccchhh
Q psy7289 290 PEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 290 p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
|..+|..+.+++.+||..+|..|+
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp 248 (260)
T cd05070 225 PQDCPISLHELMLQCWKKDPEERP 248 (260)
T ss_pred CCcCCHHHHHHHHHHcccCcccCc
Confidence 889999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=340.73 Aligned_cols=240 Identities=27% Similarity=0.381 Sum_probs=196.9
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
...++.++.||+|+||.||+|++..+ ++.||||++...........+.+|+++++.++||||+++++++...+.+++|
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPT--GRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCC--CCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 34677889999999999999986543 4679999987655555567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++|+|.+.. ..++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+
T Consensus 151 ~e~~~~~~L~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 214 (353)
T PLN00034 151 LEFMDGGSLEGTH----------------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGV 214 (353)
T ss_pred EecCCCCcccccc----------------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccccc
Confidence 9999999986432 256777889999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccC-----CCCCchhHHhHHHHHHHHHhCCCCCCCCCCh---HHHHHHHHcC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYG-----KFTTESDVWSYGVVLWEVYSYGLQPYYGYSN---QEVIEMIRSR 284 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~---~~~~~~i~~~ 284 (422)
++....... ......+|..|+|||++... ..+.++|||||||++|||++ |..||..... ..+...+...
T Consensus 215 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~-g~~pf~~~~~~~~~~~~~~~~~~ 291 (353)
T PLN00034 215 SRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYL-GRFPFGVGRQGDWASLMCAICMS 291 (353)
T ss_pred ceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHHHHhcc
Confidence 986543211 12334678899999987532 23568999999999999998 9999974332 2334444445
Q ss_pred CCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 285 QMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 285 ~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.....+..+++++.+|+.+||..+|..|+
T Consensus 292 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rp 320 (353)
T PLN00034 292 QPPEAPATASREFRHFISCCLQREPAKRW 320 (353)
T ss_pred CCCCCCCccCHHHHHHHHHHccCChhhCc
Confidence 55566778999999999999999999997
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=343.28 Aligned_cols=256 Identities=21% Similarity=0.312 Sum_probs=208.4
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc--CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
++...+|++.+.||+|+||.||+++...+ +..||+|.+... ........+.+|+.+++.++||||+++++++.++.
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~--~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKST--RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCC--CcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 44567899999999999999999987543 577999988532 12233456789999999999999999999999999
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
.+++|||||++|+|.+++... .+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL 183 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY-------------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKL 183 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-------------CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEE
Confidence 999999999999999998642 4788889999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccC----CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG----KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS 283 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~ 283 (422)
+|||+++........ ......+|+.|||||++... .++.++|||||||++|||++ |..||.+.+.......+..
T Consensus 184 ~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~-G~~Pf~~~~~~~~~~~i~~ 261 (371)
T cd05622 184 ADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV-GDTPFYADSLVGTYSKIMN 261 (371)
T ss_pred EeCCceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHc
Confidence 999999865432211 12345678999999998754 37899999999999999998 9999999888888888775
Q ss_pred CC-CCCC--CCCCCcchhhhcccccccccchh----hHHHHhhhhhh
Q psy7289 284 RQ-MLPC--PEDCPPRMYSLMMECWHEVPVAA----GMAYLCSHHYV 323 (422)
Q Consensus 284 ~~-~~~~--p~~~p~~~~~l~~~cw~~~P~~r----~~~~lh~~~~i 323 (422)
.. ..+. +..+++.+.+++..|+. +|..| .+..+.+|.++
T Consensus 262 ~~~~~~~~~~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei~~h~~~ 307 (371)
T cd05622 262 HKNSLTFPDDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFF 307 (371)
T ss_pred CCCcccCCCcCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHHhcCccc
Confidence 43 2333 34688899999999997 44433 45555555554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=336.58 Aligned_cols=240 Identities=23% Similarity=0.371 Sum_probs=204.2
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCC-CCceeeEeeEEEcCCCeEEE
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELR-HPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~lv 132 (422)
+++.+.||+|+||.||+|+... ++..||+|+++... .....+.+..|..++..+. ||+|+++++++.+.+.+|+|
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKG--TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFV 79 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEE
Confidence 5678899999999999998654 35779999986432 2234456788999998886 57788899999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++|+|.+++... ..+++.++..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+
T Consensus 80 ~Ey~~~g~L~~~i~~~------------~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~ 147 (323)
T cd05615 80 MEYVNGGDLMYHIQQV------------GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGM 147 (323)
T ss_pred EcCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEecccc
Confidence 9999999999998653 3589999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPED 292 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~ 292 (422)
++....... ......+|+.|||||++....++.++|||||||++|||++ |..||.+.+..++...+.... ...|..
T Consensus 148 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-G~~pf~~~~~~~~~~~i~~~~-~~~p~~ 223 (323)
T cd05615 148 CKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLA-GQPPFDGEDEDELFQSIMEHN-VSYPKS 223 (323)
T ss_pred ccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCCcc
Confidence 875432221 1223457889999999998889999999999999999998 999999999888888887654 456778
Q ss_pred CCcchhhhcccccccccchhh
Q psy7289 293 CPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 293 ~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+++++.+++.+||..+|..|.
T Consensus 224 ~~~~~~~li~~~l~~~p~~R~ 244 (323)
T cd05615 224 LSKEAVSICKGLMTKHPSKRL 244 (323)
T ss_pred CCHHHHHHHHHHcccCHhhCC
Confidence 899999999999999999885
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=323.63 Aligned_cols=247 Identities=38% Similarity=0.723 Sum_probs=209.3
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
++...+|++.++||+|+||.||+|++..+ ..||+|.++.... ....|.+|+++++.++||||+++++.+. ....
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~---~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~ 75 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPI 75 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEecCC---ceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCc
Confidence 34566799999999999999999976432 4599999864322 2357899999999999999999999875 4568
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEec
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISD 209 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~D 209 (422)
++||||+++|+|.+++.... ...++++.+..++.|++.||+|||+.+++||||||+||++++++.+||+|
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~d 145 (262)
T cd05071 76 YIVTEYMSKGSLLDFLKGEM----------GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVAD 145 (262)
T ss_pred EEEEEcCCCCcHHHHHhhcc----------ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEecc
Confidence 99999999999999997531 12478899999999999999999999999999999999999999999999
Q ss_pred CcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 289 (422)
||+++........ ......++..|+|||++....++.++|||||||++|||++.|..||.+.+..++...+..+...+.
T Consensus 146 fg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~ 224 (262)
T cd05071 146 FGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 224 (262)
T ss_pred CCceeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCC
Confidence 9999765433221 122334567899999998888999999999999999999888899999888888888887777777
Q ss_pred CCCCCcchhhhcccccccccchhh
Q psy7289 290 PEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 290 p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+..+|..+.+++.+||+.+|..|+
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~Rp 248 (262)
T cd05071 225 PPECPESLHDLMCQCWRKEPEERP 248 (262)
T ss_pred ccccCHHHHHHHHHHccCCcccCC
Confidence 888999999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=318.36 Aligned_cols=247 Identities=40% Similarity=0.792 Sum_probs=210.2
Q ss_pred cccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEecCCC
Q psy7289 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRG 139 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~~~G 139 (422)
+.||+|+||.||+|... ++..+|+|.++..........|.+|++++++++||||+++++++......++||||+++|
T Consensus 1 ~~ig~g~~g~vy~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK---DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec---CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 36899999999999753 346799999876655555668999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccccCC
Q psy7289 140 DLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS 219 (422)
Q Consensus 140 ~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~~ 219 (422)
+|.+++.... ..+++..+..++.|++.||.|||+++++||||||+||++++++.+||+|||+++.....
T Consensus 78 ~L~~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (250)
T cd05085 78 DFLSFLRKKK-----------DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG 146 (250)
T ss_pred cHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccc
Confidence 9999986532 24788999999999999999999999999999999999999999999999999754332
Q ss_pred cceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcchhh
Q psy7289 220 DYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYS 299 (422)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~~~~ 299 (422)
.. ........++.|+|||++....++.++||||||+++||+++.|..||.+.+..+....+..+.+...|..+|..+.+
T Consensus 147 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (250)
T cd05085 147 IY-SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYK 225 (250)
T ss_pred cc-ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 21 11122233567999999988889999999999999999998899999999888888888887777778889999999
Q ss_pred hcccccccccchhhHHHHhhhhhhhhh
Q psy7289 300 LMMECWHEVPVAAGMAYLCSHHYVHRD 326 (422)
Q Consensus 300 l~~~cw~~~P~~r~~~~lh~~~~i~~d 326 (422)
++.+||..+|..|+ +...+...
T Consensus 226 li~~~l~~~p~~Rp-----~~~~l~~~ 247 (250)
T cd05085 226 VMQRCWDYKPENRP-----KFSELQKE 247 (250)
T ss_pred HHHHHcccCcccCC-----CHHHHHHH
Confidence 99999999999998 55544443
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=329.47 Aligned_cols=243 Identities=24% Similarity=0.410 Sum_probs=196.0
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
.+|++.+.||+|+||.||+|+... .+..||+|.++..........+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKL--TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECC--CCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 468889999999999999998654 356799999865433333456789999999999999999999999988999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||++ |+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||++
T Consensus 83 e~~~-~~l~~~l~~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~ 150 (288)
T cd07871 83 EYLD-SDLKQYLDNCG-----------NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLA 150 (288)
T ss_pred eCCC-cCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcce
Confidence 9998 59999986532 24788899999999999999999999999999999999999999999999999
Q ss_pred ccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC----
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP---- 288 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~---- 288 (422)
+....... ......+++.|+|||.+.+ ..++.++||||+||++|||++ |.+||.+.+..+.+..+......|
T Consensus 151 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07871 151 RAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMAT-GRPMFPGSTVKEELHLIFRLLGTPTEET 227 (288)
T ss_pred eeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChHH
Confidence 75432211 1223456788999998865 468999999999999999998 999999888777665543211100
Q ss_pred --------------C-----------CCCCCcchhhhcccccccccchhh
Q psy7289 289 --------------C-----------PEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 289 --------------~-----------p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
. ...++++..+|+.+|+..+|..|+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~ 277 (288)
T cd07871 228 WPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRI 277 (288)
T ss_pred hhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCC
Confidence 0 123456778899999999998886
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=343.62 Aligned_cols=259 Identities=21% Similarity=0.329 Sum_probs=210.2
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc--CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
.+...+|++.+.||+|+||.||+++... .+..||+|.+... ........+.+|+.+++.++||||+++++++.++.
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKS--SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 3445679999999999999999998754 3567999988532 12233456889999999999999999999999999
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
.+|+|||||++|+|.+++... .+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~-------------~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL 183 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY-------------DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKL 183 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-------------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEE
Confidence 999999999999999998642 4788899999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCC----CCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK----FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS 283 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~ 283 (422)
+|||+++........ ......+|+.|||||++.... ++.++||||+||++|||++ |..||.+.+..+....+..
T Consensus 184 ~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~-G~~Pf~~~~~~~~~~~i~~ 261 (370)
T cd05621 184 ADFGTCMKMDETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLV-GDTPFYADSLVGTYSKIMD 261 (370)
T ss_pred EecccceecccCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Confidence 999999865432221 223456789999999987543 7889999999999999998 9999999988888777765
Q ss_pred CC-CCCCCC--CCCcchhhhcccccccccch---hhHHHHhhhhhhhh
Q psy7289 284 RQ-MLPCPE--DCPPRMYSLMMECWHEVPVA---AGMAYLCSHHYVHR 325 (422)
Q Consensus 284 ~~-~~~~p~--~~p~~~~~l~~~cw~~~P~~---r~~~~lh~~~~i~~ 325 (422)
.. ....|. ..++.+.+++..|+...+.. ..+..+.+|.++..
T Consensus 262 ~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 262 HKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred CCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 33 334444 45788899999999754432 24666767776644
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=325.33 Aligned_cols=249 Identities=48% Similarity=0.882 Sum_probs=210.3
Q ss_pred cccccccceeEEEEEEecC----CCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEe
Q psy7289 60 QELGEGAFGKVYKGEVCTS----EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEF 135 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~ 135 (422)
+.||+|+||.||+|++... .+...+|||.+...........+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 3699999999999987532 233679999876544444566899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC-----eEEEecC
Q psy7289 136 MVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL-----TVKISDF 210 (422)
Q Consensus 136 ~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~-----~vKl~DF 210 (422)
+++|+|.+++....... .....+++.++..++.|++.||+|||+++++|+||||+||+++.++ .+||+||
T Consensus 81 ~~~~~L~~~l~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 81 MEGGDLLSYLRDARVER-----FGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred cCCCcHHHHHHHhhhcc-----cCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCc
Confidence 99999999997642111 0123478899999999999999999999999999999999999877 8999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP 290 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p 290 (422)
|+++................+..|+|||.+..+.++.++|||||||++|||++.|..||...++.+....+..+.....|
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKP 235 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCc
Confidence 99987654433333333445678999999998899999999999999999998899999988888888888877777778
Q ss_pred CCCCcchhhhcccccccccchhh
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..+|..+.+++.+||..+|..|+
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rp 258 (269)
T cd05044 236 ENCPDKIYQLMTNCWAQDPSERP 258 (269)
T ss_pred ccchHHHHHHHHHHcCCCcccCC
Confidence 88999999999999999999998
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=334.62 Aligned_cols=245 Identities=24% Similarity=0.365 Sum_probs=201.0
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
|+...+|++.++||+|+||.||++++..+ +..+|+|.+...........+.+|++++++++||||+++++++.+++..
T Consensus 1 ~l~~~~y~~~~~lg~g~~g~V~~~~~~~~--~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (333)
T cd06650 1 ELKDDDFEKISELGAGNGGVVFKVSHKPS--GLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 78 (333)
T ss_pred CcchhhhheeccccCCCCEEEEEEEECCC--CcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEE
Confidence 35567899999999999999999987543 4679999887655555567899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeecCCCeEEEe
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSH-HYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~ 146 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKA------------GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC 146 (333)
T ss_pred EEEEecCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEe
Confidence 9999999999999999753 2478889999999999999999985 79999999999999999999999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHH-------
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI------- 281 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i------- 281 (422)
|||+++..... ......++..|+|||++.+..++.++|||||||++|||++ |..||...+..++...+
T Consensus 147 Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 221 (333)
T cd06650 147 DFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAI-GRYPIPPPDAKELELMFGCPVEGD 221 (333)
T ss_pred eCCcchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcchhHHHHHhcCcccCC
Confidence 99998754322 1123356789999999988889999999999999999998 99999866554443222
Q ss_pred -------------------------------------HcCCCCCCCC-CCCcchhhhcccccccccchhh
Q psy7289 282 -------------------------------------RSRQMLPCPE-DCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 282 -------------------------------------~~~~~~~~p~-~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.+...+..+. ..++++.+|+.+||+.+|..|+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rp 291 (333)
T cd06650 222 PAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERA 291 (333)
T ss_pred ccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCc
Confidence 1111111221 2456788999999999999997
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=342.59 Aligned_cols=257 Identities=22% Similarity=0.331 Sum_probs=210.2
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP 128 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 128 (422)
+....|++.+.||+|+||.||+++... .+..||+|.++... .......+.+|+.+++.++||||+++++++.++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKS--SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 445678999999999999999998654 35679999986421 22234567899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
+++||||+++|+|.+++... .+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~-------------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~ 184 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSNY-------------DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLA 184 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc-------------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEE
Confidence 99999999999999998642 47888899999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccccC----CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG----KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR 284 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~ 284 (422)
|||+++....... .......+|+.|||||++... .++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 185 DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~ 262 (370)
T cd05596 185 DFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV-GDTPFYADSLVGTYSKIMDH 262 (370)
T ss_pred eccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHh-CCCCcCCCCHHHHHHHHHcC
Confidence 9999976543221 122345678999999998653 47899999999999999998 99999999888888777654
Q ss_pred C-CCCCCC--CCCcchhhhcccccccccch--h-hHHHHhhhhhhh
Q psy7289 285 Q-MLPCPE--DCPPRMYSLMMECWHEVPVA--A-GMAYLCSHHYVH 324 (422)
Q Consensus 285 ~-~~~~p~--~~p~~~~~l~~~cw~~~P~~--r-~~~~lh~~~~i~ 324 (422)
. ....|. .++.++.+++..|+..+|.. | .+..+.+|.++.
T Consensus 263 ~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~ 308 (370)
T cd05596 263 KNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFK 308 (370)
T ss_pred CCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccC
Confidence 3 333444 57889999999999988864 2 455666666654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=336.52 Aligned_cols=236 Identities=17% Similarity=0.326 Sum_probs=194.8
Q ss_pred cccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCCeEEEEEec
Q psy7289 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPMCMLFEFM 136 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lv~E~~ 136 (422)
+.||+|+||.||+|+...+ +..||+|+++... .......+.+|+.++.++ +||||+++++++.+.+..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKT--ERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCC--CCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence 4699999999999986543 5679999986532 233455678899988877 7999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccc
Q psy7289 137 VRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV 216 (422)
Q Consensus 137 ~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~ 216 (422)
++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 79 ~~~~L~~~~~~~------------~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 79 NGGDLMFHMQRQ------------RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 999999988653 35889999999999999999999999999999999999999999999999999753
Q ss_pred cCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCC--------C-hHHHHHHHHcCCCC
Q psy7289 217 YASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY--------S-NQEVIEMIRSRQML 287 (422)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~--------~-~~~~~~~i~~~~~~ 287 (422)
..... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||... . ...+...+.. ...
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~~~ 222 (329)
T cd05618 147 LRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDIVGSSDNPDQNTEDYLFQVILE-KQI 222 (329)
T ss_pred cCCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhh-CCCCCccCCCcCCcccccHHHHHHHHhc-CCC
Confidence 22211 1223457889999999999899999999999999999998 99999521 1 1223344433 345
Q ss_pred CCCCCCCcchhhhcccccccccchhh
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..|..++..+.+++.+||..+|..|.
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~ 248 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERL 248 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcC
Confidence 67888899999999999999999996
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=334.96 Aligned_cols=236 Identities=22% Similarity=0.379 Sum_probs=201.4
Q ss_pred cccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCCeEEEEEec
Q psy7289 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPMCMLFEFM 136 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lv~E~~ 136 (422)
+.||+|+||.||+|+...+ +..||||+++... .......+.+|..+++.+ +||||+++++++.+.+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGT--DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCC--CCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 4699999999999987543 4679999986432 223455678899999888 6999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccc
Q psy7289 137 VRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV 216 (422)
Q Consensus 137 ~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~ 216 (422)
++|+|.+++... ..+++.++..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++..
T Consensus 79 ~~~~L~~~~~~~------------~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 79 NGGDLMFHIQRS------------GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred CCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 999999988653 25899999999999999999999999999999999999999999999999998753
Q ss_pred cCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcc
Q psy7289 217 YASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPR 296 (422)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~ 296 (422)
..... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+.... ...|..+++.
T Consensus 147 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~-G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~ 222 (318)
T cd05570 147 ILGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLA-GQSPFEGDDEDELFQSILEDE-VRYPRWLSKE 222 (318)
T ss_pred CcCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCC-CCCCCcCCHH
Confidence 22221 1123346889999999999999999999999999999998 999999988888888777654 4567788999
Q ss_pred hhhhcccccccccchhh
Q psy7289 297 MYSLMMECWHEVPVAAG 313 (422)
Q Consensus 297 ~~~l~~~cw~~~P~~r~ 313 (422)
+.+++++||..+|..|+
T Consensus 223 ~~~li~~~l~~dP~~R~ 239 (318)
T cd05570 223 AKSILKSFLTKNPEKRL 239 (318)
T ss_pred HHHHHHHHccCCHHHcC
Confidence 99999999999999996
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=336.01 Aligned_cols=236 Identities=22% Similarity=0.373 Sum_probs=198.2
Q ss_pred cccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHH-HHhcCCCCceeeEeeEEEcCCCeEEEEEec
Q psy7289 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVD-LMSELRHPNIVCLLGVCLSGEPMCMLFEFM 136 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~-il~~l~HpnIv~l~g~~~~~~~~~lv~E~~ 136 (422)
+.||+|+||.||+|+... .+..||+|++.... .......+.+|.. +++.++||||+++++++.+.+..++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKA--DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence 469999999999998654 35779999986432 1223345556655 567899999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccc
Q psy7289 137 VRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV 216 (422)
Q Consensus 137 ~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~ 216 (422)
++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||+++..
T Consensus 79 ~~g~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 79 NGGELFFHLQRE------------RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred CCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 999999998653 35889999999999999999999999999999999999999999999999998754
Q ss_pred cCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcc
Q psy7289 217 YASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPR 296 (422)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~ 296 (422)
..... ......+|+.|||||++....++.++|||||||++|||++ |..||.+.+..++...+..+. ...+...++.
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~ 222 (323)
T cd05575 147 IEHSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLY-GLPPFYSRDTAEMYDNILNKP-LRLKPNISVS 222 (323)
T ss_pred ccCCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhc-CCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHH
Confidence 32211 1233457889999999998899999999999999999998 999999999888888887654 3455677999
Q ss_pred hhhhcccccccccchhh
Q psy7289 297 MYSLMMECWHEVPVAAG 313 (422)
Q Consensus 297 ~~~l~~~cw~~~P~~r~ 313 (422)
+.+++++|+..+|..|+
T Consensus 223 ~~~li~~~l~~~p~~R~ 239 (323)
T cd05575 223 ARHLLEGLLQKDRTKRL 239 (323)
T ss_pred HHHHHHHHhhcCHHhCC
Confidence 99999999999999986
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=342.66 Aligned_cols=254 Identities=20% Similarity=0.352 Sum_probs=207.3
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
.|++++.||+|+||.||+++... .+..||+|+++... .......+.+|+.++..++||||+++++.+.+.+.+|+|
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKD--TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECC--CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 57788999999999999998754 35679999986421 233456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
||||++|+|.+++.+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 80 ~E~~~gg~L~~~l~~~------------~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~ 147 (360)
T cd05627 80 MEFLPGGDMMTLLMKK------------DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147 (360)
T ss_pred EeCCCCccHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccC
Confidence 9999999999999753 3588999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcce---------------------------------EeccCCCCCccccCccccccCCCCCchhHHhHHHHHH
Q psy7289 213 SRDVYASDYY---------------------------------RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLW 259 (422)
Q Consensus 213 a~~~~~~~~~---------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~ 259 (422)
++........ .......+|+.|||||++.+..++.++|||||||++|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvily 227 (360)
T cd05627 148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (360)
T ss_pred CcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceee
Confidence 8754221100 0011235789999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCChHHHHHHHHcC-CCCCCCC--CCCcchhhhcccccccccchhh----HHHHhhhhhhh
Q psy7289 260 EVYSYGLQPYYGYSNQEVIEMIRSR-QMLPCPE--DCPPRMYSLMMECWHEVPVAAG----MAYLCSHHYVH 324 (422)
Q Consensus 260 El~t~g~~Pf~~~~~~~~~~~i~~~-~~~~~p~--~~p~~~~~l~~~cw~~~P~~r~----~~~lh~~~~i~ 324 (422)
||++ |..||.+.+..+....+... .....|+ .+++++.+++.++. .+|..|. +..+.+|.++.
T Consensus 228 el~t-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~ 297 (360)
T cd05627 228 EMLI-GYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFE 297 (360)
T ss_pred eccc-CCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCC
Confidence 9998 99999999998888887753 2333443 35778888888765 3776663 56666777654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=325.56 Aligned_cols=238 Identities=21% Similarity=0.316 Sum_probs=194.8
Q ss_pred cccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEecCCC
Q psy7289 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRG 139 (422)
Q Consensus 62 LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~~~G 139 (422)
||+|+||+||+++...+ ++.||+|.+.... .....+.+..|+++++.++||||+++.+++......++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRAT--GKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccC--CcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence 79999999999986543 4679999886432 1223456788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccccCC
Q psy7289 140 DLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS 219 (422)
Q Consensus 140 ~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~~ 219 (422)
+|.+++...... ...+++..+..++.||+.||+|||+++|+||||||+||++++++.+||+|||+++.....
T Consensus 79 ~L~~~~~~~~~~--------~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 79 DLRYHIYNVDEE--------NPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150 (280)
T ss_pred CHHHHHHhcccc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence 999888543211 135899999999999999999999999999999999999999999999999999765432
Q ss_pred cceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh----HHHHHHHHcCCCCCCCCCCCc
Q psy7289 220 DYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN----QEVIEMIRSRQMLPCPEDCPP 295 (422)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~----~~~~~~i~~~~~~~~p~~~p~ 295 (422)
.. ......+|+.|+|||++....++.++|||||||++|||++ |..||...+. .++...+... ....|..+|+
T Consensus 151 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 226 (280)
T cd05608 151 QS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIA-ARGPFRARGEKVENKELKQRILND-SVTYPDKFSP 226 (280)
T ss_pred Cc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCcchhHHHHHHhhccc-CCCCcccCCH
Confidence 21 1223457889999999999999999999999999999998 9999986543 2333333322 3455678899
Q ss_pred chhhhcccccccccchhh
Q psy7289 296 RMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 296 ~~~~l~~~cw~~~P~~r~ 313 (422)
.+.+++.+||+.+|..|+
T Consensus 227 ~~~~li~~~l~~~P~~R~ 244 (280)
T cd05608 227 ASKSFCEALLAKDPEKRL 244 (280)
T ss_pred HHHHHHHHHhcCCHHHhc
Confidence 999999999999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=335.56 Aligned_cols=236 Identities=22% Similarity=0.370 Sum_probs=196.9
Q ss_pred cccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHH-HHhcCCCCceeeEeeEEEcCCCeEEEEEec
Q psy7289 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVD-LMSELRHPNIVCLLGVCLSGEPMCMLFEFM 136 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~-il~~l~HpnIv~l~g~~~~~~~~~lv~E~~ 136 (422)
+.||+|+||.||+|+... ++..||+|++.... .......+.+|.. +++.++||||+++++++.+.+.+|+||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKA--EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence 469999999999998654 34679999986432 1222334555554 567899999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccc
Q psy7289 137 VRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV 216 (422)
Q Consensus 137 ~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~ 216 (422)
++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||+++..
T Consensus 79 ~~~~L~~~~~~~------------~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 79 NGGELFYHLQRE------------RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred CCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 999999999653 24788889999999999999999999999999999999999999999999999754
Q ss_pred cCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcc
Q psy7289 217 YASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPR 296 (422)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~ 296 (422)
..... ......+|+.|||||++....++.++|||||||++|||++ |..||.+.+..+....+.... ...++.+++.
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~ 222 (325)
T cd05602 147 IEHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY-GLPPFYSRNTAEMYDNILNKP-LQLKPNITNS 222 (325)
T ss_pred ccCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhc-CCCCCCCCCHHHHHHHHHhCC-cCCCCCCCHH
Confidence 32211 1223457889999999998899999999999999999998 999999999888888877654 3455678999
Q ss_pred hhhhcccccccccchhh
Q psy7289 297 MYSLMMECWHEVPVAAG 313 (422)
Q Consensus 297 ~~~l~~~cw~~~P~~r~ 313 (422)
+.+++.+|+..+|..|.
T Consensus 223 ~~~li~~~l~~~p~~R~ 239 (325)
T cd05602 223 ARHLLEGLLQKDRTKRL 239 (325)
T ss_pred HHHHHHHHcccCHHHCC
Confidence 99999999999998886
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=320.64 Aligned_cols=247 Identities=39% Similarity=0.741 Sum_probs=211.2
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
++....|++.++||+|+||.||+|... ++..||+|.+..... ....|.+|+.++++++||||+++++++. .+..
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~---~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 75 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYN---GHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPI 75 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecC---CCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCc
Confidence 566778999999999999999999753 246799998864332 3457899999999999999999999874 4578
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEec
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISD 209 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~D 209 (422)
+++|||+++|+|.+++.... ...+++.++..++.|++.||+|||+.+++||||||+||++++++.++|+|
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~d 145 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPE----------GIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIAD 145 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEcc
Confidence 99999999999999986532 13578899999999999999999999999999999999999999999999
Q ss_pred CcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 289 (422)
||+++........ ......++..|+|||++....++.++||||||+++||+++.|..||.+.+..++...+..+...+.
T Consensus 146 fg~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 224 (260)
T cd05067 146 FGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPR 224 (260)
T ss_pred CcceeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC
Confidence 9999765432221 122233467899999998888999999999999999999879999999998888888888877888
Q ss_pred CCCCCcchhhhcccccccccchhh
Q psy7289 290 PEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 290 p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
|..+|.++.+++.+||+.+|..|+
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp 248 (260)
T cd05067 225 PDNCPEELYELMRLCWKEKPEERP 248 (260)
T ss_pred CCCCCHHHHHHHHHHccCChhhCC
Confidence 889999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=334.71 Aligned_cols=236 Identities=24% Similarity=0.385 Sum_probs=198.3
Q ss_pred cccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHH-HHhcCCCCceeeEeeEEEcCCCeEEEEEec
Q psy7289 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVD-LMSELRHPNIVCLLGVCLSGEPMCMLFEFM 136 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~-il~~l~HpnIv~l~g~~~~~~~~~lv~E~~ 136 (422)
+.||+|+||.||+|+... .+..||+|++.... .......+.+|.. +++.++||||+++++++.+.+..|+||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKS--DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECC--CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence 469999999999998653 35789999986432 2223345666654 678899999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccc
Q psy7289 137 VRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV 216 (422)
Q Consensus 137 ~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~ 216 (422)
++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++..
T Consensus 79 ~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 79 NGGELFFHLQRE------------RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred CCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 999999888653 35788899999999999999999999999999999999999999999999998753
Q ss_pred cCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcc
Q psy7289 217 YASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPR 296 (422)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~ 296 (422)
..... ......+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..++...+.... .+.|...+..
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~ 222 (321)
T cd05603 147 VEPEE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLY-GLPPFYSRDVSQMYDNILHKP-LQLPGGKTVA 222 (321)
T ss_pred CCCCC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHH
Confidence 22211 1233457889999999998889999999999999999998 999999998888888877653 5567788889
Q ss_pred hhhhcccccccccchhh
Q psy7289 297 MYSLMMECWHEVPVAAG 313 (422)
Q Consensus 297 ~~~l~~~cw~~~P~~r~ 313 (422)
+.+++.+|++.+|..|.
T Consensus 223 ~~~li~~~l~~~p~~R~ 239 (321)
T cd05603 223 ACDLLVGLLHKDQRRRL 239 (321)
T ss_pred HHHHHHHHccCCHhhcC
Confidence 99999999999999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=320.28 Aligned_cols=244 Identities=21% Similarity=0.370 Sum_probs=212.1
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFE 134 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E 134 (422)
+|++.+.||+|+||.||+++...+ +..+|+|.++........+.+.+|+.+++.++||||+++++.+.+.+.++++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNS--DQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCC--CceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 467889999999999999986543 567999988654444556788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccc
Q psy7289 135 FMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR 214 (422)
Q Consensus 135 ~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~ 214 (422)
|+++|+|.+++.... ...++++.+..++.|++.||.|||+++|+|+||||+||++++++.++|+|||+++
T Consensus 79 ~~~~~~l~~~~~~~~----------~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 148 (255)
T cd08219 79 YCDGGDLMQKIKLQR----------GKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148 (255)
T ss_pred eCCCCcHHHHHHhcc----------CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcce
Confidence 999999999986532 1347889999999999999999999999999999999999999999999999987
Q ss_pred cccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q psy7289 215 DVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCP 294 (422)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p 294 (422)
....... ......+++.|+|||++....++.++|+||||+++|+|++ |..||...+.......+..+...+.|..++
T Consensus 149 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (255)
T cd08219 149 LLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCT-LKHPFQANSWKNLILKVCQGSYKPLPSHYS 225 (255)
T ss_pred eeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhh-ccCCCCCCCHHHHHHHHhcCCCCCCCcccC
Confidence 6543221 1223446788999999988889999999999999999998 999999988888888888888888888899
Q ss_pred cchhhhcccccccccchhh
Q psy7289 295 PRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 295 ~~~~~l~~~cw~~~P~~r~ 313 (422)
..+.+++.+||+.+|..|+
T Consensus 226 ~~~~~li~~~l~~~P~~Rp 244 (255)
T cd08219 226 YELRSLIKQMFKRNPRSRP 244 (255)
T ss_pred HHHHHHHHHHHhCCcccCC
Confidence 9999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=340.75 Aligned_cols=253 Identities=22% Similarity=0.385 Sum_probs=208.5
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
+|++.+.||+|+||.||+|+... .+..||||+++... .......+.+|+.++..++||||+++++++.+++..++|
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKD--TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECC--CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence 57889999999999999998754 35779999986432 223456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 80 ~e~~~~~~L~~~l~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~ 147 (350)
T cd05573 80 MEYMPGGDLMNLLIRK------------DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGL 147 (350)
T ss_pred EcCCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCC
Confidence 9999999999999764 2588999999999999999999999999999999999999999999999999
Q ss_pred cccccCCc---------------------------ceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCC
Q psy7289 213 SRDVYASD---------------------------YYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYG 265 (422)
Q Consensus 213 a~~~~~~~---------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g 265 (422)
++...... .........+|+.|+|||++....++.++|||||||++|||++ |
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g 226 (350)
T cd05573 148 CKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY-G 226 (350)
T ss_pred CccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhcc-C
Confidence 97654322 0011223457889999999999999999999999999999998 9
Q ss_pred CCCCCCCChHHHHHHHHcC-C--CCCCCCCCCcchhhhcccccccccchhh--HHHHhhhhhh
Q psy7289 266 LQPYYGYSNQEVIEMIRSR-Q--MLPCPEDCPPRMYSLMMECWHEVPVAAG--MAYLCSHHYV 323 (422)
Q Consensus 266 ~~Pf~~~~~~~~~~~i~~~-~--~~~~p~~~p~~~~~l~~~cw~~~P~~r~--~~~lh~~~~i 323 (422)
..||.+.+..+....+... . ..|....+|+++.+++..|+. +|..|. +..+.+|.++
T Consensus 227 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~ 288 (350)
T cd05573 227 FPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFF 288 (350)
T ss_pred CCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCc
Confidence 9999999888877777651 1 222233469999999999997 888775 3344445444
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=318.02 Aligned_cols=243 Identities=37% Similarity=0.684 Sum_probs=206.6
Q ss_pred cccccccceeEEEEEEecCC-CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEecCC
Q psy7289 60 QELGEGAFGKVYKGEVCTSE-GPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVR 138 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~~~ 138 (422)
+.||+|+||.||+|.+.... ....||||.+.........+.|.+|+.++++++||||+++++.+.+ ...+++|||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 46899999999999986533 2346999998765543566789999999999999999999999988 889999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccccC
Q psy7289 139 GDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA 218 (422)
Q Consensus 139 G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~ 218 (422)
|+|.+++..... ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||+++....
T Consensus 80 ~~L~~~l~~~~~----------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 80 GSLLDRLRKDAL----------GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred CcHHHHHHhccc----------ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccc
Confidence 999999976421 2578999999999999999999999999999999999999999999999999987644
Q ss_pred Cc-ceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH-cCCCCCCCCCCCcc
Q psy7289 219 SD-YYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR-SRQMLPCPEDCPPR 296 (422)
Q Consensus 219 ~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~p~~ 296 (422)
.. .+.......++..|+|||.+....++.++|||||||++|||++.|..||...+..++...+. .....+.|..+|..
T Consensus 150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (257)
T cd05040 150 NEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQD 229 (257)
T ss_pred cccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHH
Confidence 22 12222233456789999999888899999999999999999988999999888888777666 34455567788999
Q ss_pred hhhhcccccccccchhh
Q psy7289 297 MYSLMMECWHEVPVAAG 313 (422)
Q Consensus 297 ~~~l~~~cw~~~P~~r~ 313 (422)
+.+++.+||..+|..|+
T Consensus 230 ~~~li~~~l~~~p~~Rp 246 (257)
T cd05040 230 IYNVMLQCWAHNPADRP 246 (257)
T ss_pred HHHHHHHHCCCCcccCC
Confidence 99999999999999998
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=319.51 Aligned_cols=247 Identities=39% Similarity=0.715 Sum_probs=208.7
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
++...+|++.+.||+|+||.||+|.+..+ ..+|+|.+.... ...+.+.+|+++++.++||||+++++++. .+..
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~---~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 75 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGT---TKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPI 75 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEcCC---ceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCc
Confidence 45566788999999999999999976432 358999875432 23467889999999999999999999875 4568
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEec
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISD 209 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~D 209 (422)
+++|||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+++||||||+||++++++.+||+|
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~d 145 (260)
T cd05069 76 YIVTEFMGKGSLLDFLKEGD----------GKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIAD 145 (260)
T ss_pred EEEEEcCCCCCHHHHHhhCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECC
Confidence 99999999999999997532 12478889999999999999999999999999999999999999999999
Q ss_pred CcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 289 (422)
||+++........ ......++..|+|||.+....++.++|||||||++|||++.|..||.+.+..+....+..+...+.
T Consensus 146 fg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 224 (260)
T cd05069 146 FGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPC 224 (260)
T ss_pred CccceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 9999765433211 112233467899999998888999999999999999999878999999988888888887777778
Q ss_pred CCCCCcchhhhcccccccccchhh
Q psy7289 290 PEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 290 p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
|...|..+.+++.+||..+|..|+
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp 248 (260)
T cd05069 225 PQGCPESLHELMKLCWKKDPDERP 248 (260)
T ss_pred CcccCHHHHHHHHHHccCCcccCc
Confidence 888999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=334.09 Aligned_cols=237 Identities=16% Similarity=0.296 Sum_probs=196.0
Q ss_pred cccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCCeEEEEEec
Q psy7289 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPMCMLFEFM 136 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lv~E~~ 136 (422)
+.||+|+||.||+|+... ++..||+|+++... .....+.+.+|+.++.++ +||||+++++++.+.+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKK--NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence 469999999999998654 35779999987532 223456788999999888 6999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccc
Q psy7289 137 VRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV 216 (422)
Q Consensus 137 ~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~ 216 (422)
++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++..
T Consensus 79 ~~~~L~~~~~~~------------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 79 NGGDLMFHMQRQ------------RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred CCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 999999988653 35899999999999999999999999999999999999999999999999999753
Q ss_pred cCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCC------ChHHHHHHHHcCCCCCCC
Q psy7289 217 YASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY------SNQEVIEMIRSRQMLPCP 290 (422)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~------~~~~~~~~i~~~~~~~~p 290 (422)
..... ......+|+.|+|||++....++.++|||||||++|||++ |..||... +..+....+......+.|
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p 223 (327)
T cd05617 147 LGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMA-GRSPFDIITDNPDMNTEDYLFQVILEKPIRIP 223 (327)
T ss_pred cCCCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHh-CCCCCCccCCCcccccHHHHHHHHHhCCCCCC
Confidence 22211 1223457889999999998999999999999999999998 99999642 222333333333445678
Q ss_pred CCCCcchhhhcccccccccchhh
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..++..+.+++.+||..+|..|.
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~ 246 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERL 246 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcC
Confidence 88899999999999999999885
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=326.64 Aligned_cols=243 Identities=27% Similarity=0.464 Sum_probs=194.3
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC-HHhHHHHHHHHHHHhcC---CCCceeeEeeEEEc-----
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN-QKTASDFRREVDLMSEL---RHPNIVCLLGVCLS----- 125 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l---~HpnIv~l~g~~~~----- 125 (422)
+|++.+.||+|+||.||+|+.... ++..||+|.++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKN-GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCC-CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 688899999999999999986433 356799998864322 22334567788877765 69999999999852
Q ss_pred CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 126 GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 126 ~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
...+++||||+. |+|.+++.... ...+++..+..++.|++.||+|||+++|+||||||+|||+++++.+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~----------~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~ 149 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP----------EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI 149 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC----------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCE
Confidence 346899999997 69999986532 1248899999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ 285 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~ 285 (422)
||+|||+++...... ......+|+.|+|||++....++.++|||||||++|||++ |.+||.+.+..+.+..+....
T Consensus 150 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~~f~~~~~~~~~~~i~~~~ 225 (290)
T cd07862 150 KLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGKILDVI 225 (290)
T ss_pred EEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHc-CCCCcCCCCHHHHHHHHHHHh
Confidence 999999997653321 2234457889999999988889999999999999999998 999999888777766664322
Q ss_pred CCCCC--------------------------CCCCcchhhhcccccccccchhh
Q psy7289 286 MLPCP--------------------------EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 286 ~~~~p--------------------------~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..+.| .++++.+.+++.+|+..+|..|+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 279 (290)
T cd07862 226 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 279 (290)
T ss_pred CCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcC
Confidence 21111 23556678999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=322.85 Aligned_cols=257 Identities=25% Similarity=0.394 Sum_probs=211.7
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
-..+++++.||+|.-|+||+++.+.++ ...|+|++.+.. ..+...+...|.+||+.++||.++.||..+..+...|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~--~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c 153 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTN--CLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC 153 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCC--ceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence 356788999999999999999886543 789999997542 2344556778999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
++||||+||+|+..++++. ...+++..++.++.+|+.||+|||-.|||.|||||+||||.++|++.|+||
T Consensus 154 l~meyCpGGdL~~LrqkQp----------~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDF 223 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQP----------GKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDF 223 (459)
T ss_pred EEEecCCCccHHHHHhhCC----------CCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeec
Confidence 9999999999999887642 357999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcc--------------------------------e----------------------EeccCCCCCccccC
Q psy7289 211 GLSRDVYASDY--------------------------------Y----------------------RIQSKSLLPVRWMP 236 (422)
Q Consensus 211 Gla~~~~~~~~--------------------------------~----------------------~~~~~~~~t~~y~a 236 (422)
-|+........ . ......+||-.|+|
T Consensus 224 DLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlA 303 (459)
T KOG0610|consen 224 DLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLA 303 (459)
T ss_pred cccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccc
Confidence 98753211000 0 00011345667999
Q ss_pred ccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC--CCCCcchhhhcccccccccchh--
Q psy7289 237 PESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP--EDCPPRMYSLMMECWHEVPVAA-- 312 (422)
Q Consensus 237 PE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p--~~~p~~~~~l~~~cw~~~P~~r-- 312 (422)
||++.++.++.++|+|+|||++|||+ +|..||.|.++.+.+.+|.... +.+| ...+...++||++.+.+||..|
T Consensus 304 PEvI~G~GHgsAVDWWtfGIflYEmL-yG~TPFKG~~~~~Tl~NIv~~~-l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg 381 (459)
T KOG0610|consen 304 PEVIRGEGHGSAVDWWTFGIFLYEML-YGTTPFKGSNNKETLRNIVGQP-LKFPEEPEVSSAAKDLIRKLLVKDPSKRLG 381 (459)
T ss_pred ceeeecCCCCchhhHHHHHHHHHHHH-hCCCCcCCCCchhhHHHHhcCC-CcCCCCCcchhHHHHHHHHHhccChhhhhc
Confidence 99999999999999999999999999 5999999999999999887654 2233 2556788999999999999764
Q ss_pred ---hHHHHhhhhhh
Q psy7289 313 ---GMAYLCSHHYV 323 (422)
Q Consensus 313 ---~~~~lh~~~~i 323 (422)
|.+-+..|.++
T Consensus 382 ~~rGA~eIK~HpFF 395 (459)
T KOG0610|consen 382 SKRGAAEIKRHPFF 395 (459)
T ss_pred cccchHHhhcCccc
Confidence 55556555554
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=322.72 Aligned_cols=244 Identities=35% Similarity=0.632 Sum_probs=198.8
Q ss_pred cccccccccccceeEEEEEEe--cCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC--CCeEE
Q psy7289 56 PRFLQELGEGAFGKVYKGEVC--TSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG--EPMCM 131 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~~~l 131 (422)
|++.+.||+|+||+||++... ....+..||+|.++..........|.+|++++++++||||+++++++... ..+++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 478899999999999887643 22345679999987654444567889999999999999999999988654 35899
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
+|||+++|+|.+++... .+++.++..++.|++.||+|||+++|+||||||+|||+++++.+||+|||
T Consensus 86 v~e~~~~~~l~~~~~~~-------------~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg 152 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-------------KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFG 152 (283)
T ss_pred EecCCCCCCHHHHHHHc-------------CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecc
Confidence 99999999999999642 48999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcc-eEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh---------------H
Q psy7289 212 LSRDVYASDY-YRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN---------------Q 275 (422)
Q Consensus 212 la~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~---------------~ 275 (422)
+++....... ........++..|+|||.+....++.++|||||||++|||++ |..||..... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05080 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIGPKQGQMTVV 231 (283)
T ss_pred cccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHh-CCCCCCCCcchhhhhhcccccccchh
Confidence 9986543221 111222334567999999988889999999999999999998 8888854321 1
Q ss_pred HHHHHHHcCCCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 276 EVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 276 ~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.+...+..+...+.|..+|..+.+++.+||..+|..|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 269 (283)
T cd05080 232 RLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRP 269 (283)
T ss_pred hhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCC
Confidence 22233334455667888999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=333.26 Aligned_cols=253 Identities=24% Similarity=0.392 Sum_probs=195.2
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC-----C
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE-----P 128 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-----~ 128 (422)
+|++.+.||+|+||.||+|+... .+..||||.++... .......+.+|+++++.++||||+++++++.... .
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTH--TGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECC--CCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence 47888999999999999998643 35789999886432 2233457889999999999999999999886433 4
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
+|+|||||. ++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+
T Consensus 79 ~~lv~e~~~-~~L~~~l~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~ 145 (338)
T cd07859 79 IYVVFELME-SDLHQVIKAN------------DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKIC 145 (338)
T ss_pred EEEEEecCC-CCHHHHHHhc------------ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEc
Confidence 799999995 6999988653 258899999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcce-EeccCCCCCccccCcccccc--CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHH----
Q psy7289 209 DFGLSRDVYASDYY-RIQSKSLLPVRWMPPESILY--GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI---- 281 (422)
Q Consensus 209 DFGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i---- 281 (422)
|||+++........ .......+|+.|+|||++.. ..++.++|||||||++|||++ |.+||.+.+..+....+
T Consensus 146 Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~t-g~~pf~~~~~~~~~~~~~~~~ 224 (338)
T cd07859 146 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLITDLL 224 (338)
T ss_pred cCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHh
Confidence 99999864322111 11233457889999999865 678999999999999999998 99999876644322211
Q ss_pred -----------Hc------------CCCCCC---CCCCCcchhhhcccccccccchhhH-HHHhhhhhh
Q psy7289 282 -----------RS------------RQMLPC---PEDCPPRMYSLMMECWHEVPVAAGM-AYLCSHHYV 323 (422)
Q Consensus 282 -----------~~------------~~~~~~---p~~~p~~~~~l~~~cw~~~P~~r~~-~~lh~~~~i 323 (422)
.. ....+. -+.+++.+.+++.+||..+|..|+- ..+.+|.++
T Consensus 225 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f 293 (338)
T cd07859 225 GTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF 293 (338)
T ss_pred CCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchh
Confidence 10 010111 1246778899999999999999972 233444444
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=318.55 Aligned_cols=248 Identities=40% Similarity=0.768 Sum_probs=213.5
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
++...+|++.+.||+|+||.||+|.... ...||||.+.... .....+.+|+.++++++||||+++++++......
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~---~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNG---TTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI 76 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcC---CceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence 4667789999999999999999997532 3569999886432 2346789999999999999999999999988899
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEec
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISD 209 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~D 209 (422)
++||||+++++|.+++.... ...+++.++..++.|++.||+|||+++++|+||||+||++++++.+||+|
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~----------~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d 146 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGE----------GKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIAD 146 (261)
T ss_pred EEEEeccCCCCHHHHHhccc----------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECc
Confidence 99999999999999997632 12588999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 289 (422)
||+++........ .......+..|+|||.+....++.++|||||||++||+++.|..||.+.+..+....+..+...+.
T Consensus 147 ~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 225 (261)
T cd05034 147 FGLARLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR 225 (261)
T ss_pred cccceeccchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 9998765432211 112223456799999998888999999999999999999889999999998889988888777788
Q ss_pred CCCCCcchhhhcccccccccchhh
Q psy7289 290 PEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 290 p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
|..+|.++.+++.+||..+|..|+
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rp 249 (261)
T cd05034 226 PPNCPEELYDLMLQCWDKDPEERP 249 (261)
T ss_pred CCCCCHHHHHHHHHHcccCcccCC
Confidence 889999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=316.08 Aligned_cols=243 Identities=22% Similarity=0.374 Sum_probs=211.2
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEE
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFE 134 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E 134 (422)
|.+.+.||+|+||.||+|+...+ +..|++|.+... ........+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKAD--KRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCC--CcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 56778999999999999987543 567999987532 344566789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccc
Q psy7289 135 FMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR 214 (422)
Q Consensus 135 ~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~ 214 (422)
|+++++|.+++.... ...+++..+..++.|++.||.|||+++++||||||+||++++++.+||+|||+++
T Consensus 80 ~~~~~~L~~~l~~~~----------~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~ 149 (256)
T cd08529 80 YAENGDLHKLLKMQR----------GRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAK 149 (256)
T ss_pred eCCCCcHHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccce
Confidence 999999999997642 1358889999999999999999999999999999999999999999999999988
Q ss_pred cccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q psy7289 215 DVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCP 294 (422)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p 294 (422)
....... ......+++.|+|||++....++.++|+|||||++|||++ |..||...+..+....+..+...+.+..++
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (256)
T cd08529 150 LLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCT-GKHPFDANNQGALILKIIRGVFPPVSQMYS 226 (256)
T ss_pred eccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCccccC
Confidence 6543321 1122346778999999998889999999999999999998 999999988888888888887777788899
Q ss_pred cchhhhcccccccccchhh
Q psy7289 295 PRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 295 ~~~~~l~~~cw~~~P~~r~ 313 (422)
..+.+++.+||..+|..|+
T Consensus 227 ~~~~~~i~~~l~~~p~~Rp 245 (256)
T cd08529 227 QQLAQLIDQCLTKDYRQRP 245 (256)
T ss_pred HHHHHHHHHHccCCcccCc
Confidence 9999999999999999998
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=333.27 Aligned_cols=254 Identities=21% Similarity=0.333 Sum_probs=205.3
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCc--CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
+|++.+.||+|+||.||+++... .+..||+|.+... ........+.+|+.++..++||||+++++++.+.+..|+|
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKH--TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 67889999999999999998654 3567999998642 1223345688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++|+|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 80 ~Ey~~gg~L~~~l~~~~-----------~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~ 148 (331)
T cd05624 80 MDYYVGGDLLTLLSKFE-----------DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGS 148 (331)
T ss_pred EeCCCCCcHHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccc
Confidence 99999999999997532 2588999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCcccccc-----CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC-C
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILY-----GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ-M 286 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~-~ 286 (422)
++........ ......+|+.|||||++.. +.++.++|||||||++|||++ |..||.+.+..+....+.... +
T Consensus 149 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~~ 226 (331)
T cd05624 149 CLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHEER 226 (331)
T ss_pred eeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhh-CCCCccCCCHHHHHHHHHcCCCc
Confidence 9765433221 1223457899999998875 468899999999999999998 999999988888877776543 3
Q ss_pred CCCCC---CCCcchhhhcccccccccchh---hHHHHhhhhhh
Q psy7289 287 LPCPE---DCPPRMYSLMMECWHEVPVAA---GMAYLCSHHYV 323 (422)
Q Consensus 287 ~~~p~---~~p~~~~~l~~~cw~~~P~~r---~~~~lh~~~~i 323 (422)
.+.|. ++++++.+++.+|+...+..+ .++.+.+|.++
T Consensus 227 ~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f 269 (331)
T cd05624 227 FQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFF 269 (331)
T ss_pred ccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCc
Confidence 33443 468899999999987654332 34445555544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=332.42 Aligned_cols=255 Identities=22% Similarity=0.344 Sum_probs=205.6
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCc--CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
+|++.+.||+|+||.||+++...+ +..+|+|.+... ........+.+|+.++..++||||+++++++.+.+.+++|
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNA--DKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCC--CCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence 578899999999999999987543 567999988532 1223345688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++|+|.+++.+.. ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 80 ~ey~~~g~L~~~l~~~~-----------~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~ 148 (332)
T cd05623 80 MDYYVGGDLLTLLSKFE-----------DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS 148 (332)
T ss_pred EeccCCCcHHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecch
Confidence 99999999999997532 2588899999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccc-----cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC-C
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESIL-----YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ-M 286 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~-~ 286 (422)
++........ ......+|+.|||||++. ...++.++|||||||++|||++ |..||.+.+..+....+.... .
T Consensus 149 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~~ 226 (332)
T cd05623 149 CLKLMEDGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHKER 226 (332)
T ss_pred heecccCCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhc-CCCCCCCCCHHHHHHHHhCCCcc
Confidence 8764332211 122345789999999986 3468899999999999999998 999999999888888876543 2
Q ss_pred CCCC---CCCCcchhhhcccccccccchh---hHHHHhhhhhhh
Q psy7289 287 LPCP---EDCPPRMYSLMMECWHEVPVAA---GMAYLCSHHYVH 324 (422)
Q Consensus 287 ~~~p---~~~p~~~~~l~~~cw~~~P~~r---~~~~lh~~~~i~ 324 (422)
.+.| ..+++++.+|+++|+..++... .+..+.+|.++.
T Consensus 227 ~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~ 270 (332)
T cd05623 227 FQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFT 270 (332)
T ss_pred ccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcC
Confidence 2333 4678999999999886544432 345555565543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=332.67 Aligned_cols=258 Identities=26% Similarity=0.378 Sum_probs=218.6
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC--HHhHHHHHHHHHHHhcCC-CCceeeEeeEEEcC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN--QKTASDFRREVDLMSELR-HPNIVCLLGVCLSG 126 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~ 126 (422)
+-....|++.+.||+|.||.||+++.+.+ +..+|+|.+..... ......+.+|+++|++|. |||||.+++++.+.
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~t--g~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~ 108 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKST--GKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP 108 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCC--CceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence 34566799999999999999999987654 57799999865432 224468899999999998 99999999999999
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC----
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG---- 202 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~---- 202 (422)
..+++|||+|.||+|++.+... .+++.++..++.|++.|++|||+.||+||||||+|+|+...
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~-------------~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~ 175 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKK-------------HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGS 175 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHc-------------cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCC
Confidence 9999999999999999999763 28999999999999999999999999999999999999643
Q ss_pred CeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q psy7289 203 LTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282 (422)
Q Consensus 203 ~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~ 282 (422)
+.+|++|||++...... .......||+.|+|||++....|+..+||||+||++|.|++ |.+||.+.+..+....|.
T Consensus 176 ~~ik~~DFGla~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~-G~~PF~~~~~~~~~~~i~ 251 (382)
T KOG0032|consen 176 GRIKLIDFGLAKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLS-GVPPFWGETEFEIFLAIL 251 (382)
T ss_pred CcEEEeeCCCceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhh-CCCCCcCCChhHHHHHHH
Confidence 47999999999876552 23456788999999999999999999999999999999998 999999999999988888
Q ss_pred cCCCCC---CCCCCCcchhhhcccccccccchhh-HHHHhhhhhhhhh
Q psy7289 283 SRQMLP---CPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRD 326 (422)
Q Consensus 283 ~~~~~~---~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~d 326 (422)
.+...- .-++.+..+.++++.++..||..|. ...+.+|.|+...
T Consensus 252 ~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 252 RGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred cCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 775421 1235678899999999999998874 3445566665543
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=316.72 Aligned_cols=239 Identities=38% Similarity=0.734 Sum_probs=205.4
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEE-cCCCeEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCL-SGEPMCM 131 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-~~~~~~l 131 (422)
..+|++.+.||+|+||.||++... +..||+|..+... ..+.|.+|+.++++++||||+++++++. .++..++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~----~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR----GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc----CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence 346788999999999999998753 3568999876432 3467899999999999999999999765 4567899
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
+|||+++|+|.+++..+.. ..+++..+..++.|++.||+|||+++++||||||+||++++++.+||+|||
T Consensus 78 v~e~~~~~~L~~~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg 147 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGR----------SVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFG 147 (256)
T ss_pred EEECCCCCcHHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCc
Confidence 9999999999999976421 247889999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCC
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPE 291 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~ 291 (422)
+++...... .....+..|+|||++....++.++|||||||++|||++.|..||...+..++...+..+.....+.
T Consensus 148 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 222 (256)
T cd05082 148 LTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 222 (256)
T ss_pred cceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence 987543211 122335679999999888899999999999999999987999999988888888888877777788
Q ss_pred CCCcchhhhcccccccccchhh
Q psy7289 292 DCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 292 ~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.+|+.+.+++.+||+.+|..|+
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rp 244 (256)
T cd05082 223 GCPPVVYDVMKQCWHLDAATRP 244 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCc
Confidence 9999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=325.68 Aligned_cols=243 Identities=22% Similarity=0.326 Sum_probs=195.9
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
+|++.+.||+|+||.||+|+... .+..||+|+++... .....+.+.+|+.+++.++||||+++++++...+.+++||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKE--TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CceEEEEecccCCEEEEEEEECC--CCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 57889999999999999998754 35679999886432 2334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||++++.+..+.... ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||++
T Consensus 80 e~~~~~~l~~~~~~~------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 147 (287)
T cd07848 80 EYVEKNMLELLEEMP------------NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFA 147 (287)
T ss_pred ecCCCCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCc
Confidence 999988776544321 25889999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC--C------
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR--Q------ 285 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~--~------ 285 (422)
+........ ......+++.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+... .
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (287)
T cd07848 148 RNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSD-GQPLFPGESEIDQLFTIQKVLGPLPAEQM 225 (287)
T ss_pred ccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCHHHH
Confidence 865432211 1123456788999999988889999999999999999998 99999987765544333211 0
Q ss_pred ------------CCCC-----------CCCCCcchhhhcccccccccchhh
Q psy7289 286 ------------MLPC-----------PEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 286 ------------~~~~-----------p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..+. +..+++.+.+|+++|++.+|..|+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~ 276 (287)
T cd07848 226 KLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRY 276 (287)
T ss_pred HhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCC
Confidence 0000 113567799999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=335.51 Aligned_cols=245 Identities=20% Similarity=0.311 Sum_probs=200.6
Q ss_pred cccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcC---CCCceeeEeeEEEcCCCeEEEEEec
Q psy7289 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSEL---RHPNIVCLLGVCLSGEPMCMLFEFM 136 (422)
Q Consensus 62 LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l---~HpnIv~l~g~~~~~~~~~lv~E~~ 136 (422)
||+|+||.||+|+... .+..||||++.... .......+.+|..++..+ +||||+++++++.++..+|+||||+
T Consensus 1 lG~G~~g~Vy~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKD--TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECC--CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence 7999999999998654 35679999985321 122334566677777665 6999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccc
Q psy7289 137 VRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV 216 (422)
Q Consensus 137 ~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~ 216 (422)
++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 79 ~~g~L~~~l~~~------------~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 79 SGGELFWHLQKE------------GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred CCChHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 999999998653 35889999999999999999999999999999999999999999999999998754
Q ss_pred cCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCc
Q psy7289 217 YASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPP 295 (422)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~ 295 (422)
..... ......+|+.|||||++... .++.++|||||||++|||++ |..||.+.+..++...+..+........+++
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 223 (330)
T cd05586 147 LTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCC-GWSPFYAEDTQQMYRNIAFGKVRFPKNVLSD 223 (330)
T ss_pred CCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEecc-CCCCCCCCCHHHHHHHHHcCCCCCCCccCCH
Confidence 32221 12334578899999998754 48999999999999999998 9999999998888888876654333345788
Q ss_pred chhhhcccccccccchhh-----HHHHhhhhhh
Q psy7289 296 RMYSLMMECWHEVPVAAG-----MAYLCSHHYV 323 (422)
Q Consensus 296 ~~~~l~~~cw~~~P~~r~-----~~~lh~~~~i 323 (422)
++.+++++||..+|..|. +..+..|.++
T Consensus 224 ~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~ 256 (330)
T cd05586 224 EGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFF 256 (330)
T ss_pred HHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccc
Confidence 999999999999999995 4555555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=332.61 Aligned_cols=236 Identities=24% Similarity=0.372 Sum_probs=197.8
Q ss_pred cccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHH-HHhcCCCCceeeEeeEEEcCCCeEEEEEec
Q psy7289 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVD-LMSELRHPNIVCLLGVCLSGEPMCMLFEFM 136 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~-il~~l~HpnIv~l~g~~~~~~~~~lv~E~~ 136 (422)
+.||+|+||.||+|+... ++..||+|++.... .......+.+|.. +++.++||||+++++++..++..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKL--DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence 469999999999998643 35789999986432 2233445666665 467799999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccc
Q psy7289 137 VRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV 216 (422)
Q Consensus 137 ~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~ 216 (422)
++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||+++..
T Consensus 79 ~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 79 NGGELFFHLQRE------------RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred CCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 999999988653 35889999999999999999999999999999999999999999999999998753
Q ss_pred cCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcc
Q psy7289 217 YASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPR 296 (422)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~ 296 (422)
..... ......+|+.|||||++....++.++|||||||++|||++ |..||.+.+..++...+.... ...+...+..
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~ 222 (325)
T cd05604 147 IAQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLY-GLPPFYCRDVAEMYDNILHKP-LVLRPGASLT 222 (325)
T ss_pred CCCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhc-CCCCCCCCCHHHHHHHHHcCC-ccCCCCCCHH
Confidence 22111 1223457889999999999999999999999999999998 999999999888888887654 3345567888
Q ss_pred hhhhcccccccccchhh
Q psy7289 297 MYSLMMECWHEVPVAAG 313 (422)
Q Consensus 297 ~~~l~~~cw~~~P~~r~ 313 (422)
+.+++++|+..+|..|+
T Consensus 223 ~~~ll~~ll~~~p~~R~ 239 (325)
T cd05604 223 AWSILEELLEKDRQRRL 239 (325)
T ss_pred HHHHHHHHhccCHHhcC
Confidence 99999999999998886
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=331.21 Aligned_cols=254 Identities=21% Similarity=0.342 Sum_probs=203.5
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCc--CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
+|++.+.||+|+||.||+++...+ +..||+|++... ......+.|.+|+.++..++||||+++++++.+++.+|+|
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNT--GQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCC--CCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence 688899999999999999987543 467999998632 2233456688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++|+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 80 ~e~~~g~~L~~~l~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 148 (331)
T cd05597 80 MDYYVGGDLLTLLSKFE-----------DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGS 148 (331)
T ss_pred EecCCCCcHHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCc
Confidence 99999999999996532 2588999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCcccccc-----CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC-C
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILY-----GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ-M 286 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~-~ 286 (422)
++........ ......+|+.|||||++.. ..++.++|||||||++|||++ |..||.+.+..+....+.... .
T Consensus 149 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~Pf~~~~~~~~~~~i~~~~~~ 226 (331)
T cd05597 149 CLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHKEH 226 (331)
T ss_pred eeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhh-CCCCCCCCCHHHHHHHHHcCCCc
Confidence 8765432211 1122357889999999863 457889999999999999998 999999988888777776432 2
Q ss_pred CCCC---CCCCcchhhhcccccccccch--h-hHHHHhhhhhh
Q psy7289 287 LPCP---EDCPPRMYSLMMECWHEVPVA--A-GMAYLCSHHYV 323 (422)
Q Consensus 287 ~~~p---~~~p~~~~~l~~~cw~~~P~~--r-~~~~lh~~~~i 323 (422)
.+.| ..+|+.+.+++++|+...+.. | .+..+.+|.++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~ 269 (331)
T cd05597 227 FQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFF 269 (331)
T ss_pred ccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCC
Confidence 2333 357888999999977543322 2 45555566655
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=322.36 Aligned_cols=253 Identities=23% Similarity=0.333 Sum_probs=205.2
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
|+..+.||+|+||.||++.+..+ ++.||||.+.... .......+.+|+.+++.++|+||+.+++.+.+.+..++||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCC--CceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence 56678899999999999987654 4679999876432 2223456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||+++|+|.+++..... ..+++.++..++.|++.||.|||+++|+||||||+||++++++.++|+|||++
T Consensus 80 e~~~g~~L~~~l~~~~~----------~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05630 80 TLMNGGDLKFHIYHMGE----------AGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLA 149 (285)
T ss_pred EecCCCcHHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccce
Confidence 99999999999865321 24889999999999999999999999999999999999999999999999998
Q ss_pred ccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChH---HHHHHHHcCCCCCCC
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ---EVIEMIRSRQMLPCP 290 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~---~~~~~i~~~~~~~~p 290 (422)
........ .....++..|+|||++....++.++|||||||++|||++ |..||.+.... +....+........+
T Consensus 150 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
T cd05630 150 VHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA-GQSPFQQRKKKIKREEVERLVKEVQEEYS 225 (285)
T ss_pred eecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHh-CCCCCCCCCccchHHHHHhhhhhhhhhcC
Confidence 75432221 123357889999999998899999999999999999998 99999875432 222222222223456
Q ss_pred CCCCcchhhhcccccccccchhh------HHHHhhhhhhh
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAG------MAYLCSHHYVH 324 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~------~~~lh~~~~i~ 324 (422)
..+++++.+|+.+||..+|..|+ +..+++|.++.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~ 265 (285)
T cd05630 226 EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFK 265 (285)
T ss_pred ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhh
Confidence 77889999999999999999997 45666666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=314.69 Aligned_cols=240 Identities=40% Similarity=0.773 Sum_probs=210.2
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
...+++.+.||+|+||.||+|... +..||+|.++.... ..+++.+|+.++++++||||+++++++.+....++|
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~----~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR----GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec----CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 456788999999999999999753 46799999875433 467899999999999999999999999988999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++|+|.+++..... ..+++..+..++.|++.||.|||+++++||||||+||++++++.+||+|||+
T Consensus 79 ~e~~~~~~L~~~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~ 148 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGR----------AVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGL 148 (256)
T ss_pred EEecCCCcHHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccc
Confidence 999999999999976421 2588999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPED 292 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~ 292 (422)
++...... .....+..|+|||.+..+.++.++||||||+++||+++.|..||...+..++...+..+.....|..
T Consensus 149 ~~~~~~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 223 (256)
T cd05039 149 AKEASQGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEG 223 (256)
T ss_pred cccccccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccC
Confidence 98653221 1223356799999998888999999999999999999889999999998888888887777777888
Q ss_pred CCcchhhhcccccccccchhh
Q psy7289 293 CPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 293 ~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+|+.+.+++.+||..+|..|+
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rp 244 (256)
T cd05039 224 CPPEVYKVMKDCWELDPAKRP 244 (256)
T ss_pred CCHHHHHHHHHHhccChhhCc
Confidence 999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=334.74 Aligned_cols=253 Identities=22% Similarity=0.318 Sum_probs=207.9
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
+|++.+.||+|+||.||+++... .+..||+|+++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKA--TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence 57889999999999999998654 35689999986432 233456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++|+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 80 ~e~~~~~~L~~~l~~~~-----------~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~ 148 (330)
T cd05601 80 MEYQPGGDLLSLLNRYE-----------DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGS 148 (330)
T ss_pred ECCCCCCCHHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCC
Confidence 99999999999997642 3589999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccc------cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESIL------YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~------~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~ 286 (422)
++........ ......+|+.|+|||++. ...++.++|||||||++|||++ |..||.+.+..+....+.+...
T Consensus 149 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~-g~~Pf~~~~~~~~~~~i~~~~~ 226 (330)
T cd05601 149 AARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIY-GRSPFHEGTSAKTYNNIMNFQR 226 (330)
T ss_pred CeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeecc-CCCCCCCCCHHHHHHHHHcCCC
Confidence 9865433222 222345788999999986 4567899999999999999998 9999998888888777765433
Q ss_pred -CCCC--CCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 287 -LPCP--EDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 287 -~~~p--~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
...| ..+++.+.+|+..|+. +|..|. ++.+.+|.++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~ 266 (330)
T cd05601 227 FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFF 266 (330)
T ss_pred ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCc
Confidence 2223 3578899999999997 888775 3444455444
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=315.93 Aligned_cols=248 Identities=36% Similarity=0.705 Sum_probs=211.2
Q ss_pred hhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC
Q psy7289 49 REVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP 128 (422)
Q Consensus 49 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 128 (422)
+++...++++.+.||+|+||.||++.+.. ...+++|.+... ....+.|.+|+.++++++|+||+++++++.+ ..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~---~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~ 74 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNK---HTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EP 74 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecC---CccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CC
Confidence 45677899999999999999999997532 345999987643 2345679999999999999999999999887 77
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
.+++|||+++|+|.+++.... ...++...+..++.|++.||+|||+.+++||||||+||+++.++.+||+
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~ 144 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDE----------GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIA 144 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCC----------ccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEEC
Confidence 899999999999999997532 1247788899999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP 288 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 288 (422)
|||+++....... .......++..|+|||++....++.++|+|||||++||+++.|..||.+.+..++...+..+...+
T Consensus 145 d~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~ 223 (260)
T cd05073 145 DFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP 223 (260)
T ss_pred CCcceeeccCCCc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC
Confidence 9999876543221 112223345679999999888899999999999999999987999999988888888888887777
Q ss_pred CCCCCCcchhhhcccccccccchhh
Q psy7289 289 CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 289 ~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.+...|.++.+++.+||+.+|..|+
T Consensus 224 ~~~~~~~~~~~~i~~~l~~~p~~Rp 248 (260)
T cd05073 224 RPENCPEELYNIMMRCWKNRPEERP 248 (260)
T ss_pred CcccCCHHHHHHHHHHcccCcccCc
Confidence 7888999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=316.82 Aligned_cols=260 Identities=36% Similarity=0.691 Sum_probs=212.8
Q ss_pred cccccccccccceeEEEEEEecC-CCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC------
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTS-EGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE------ 127 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~------ 127 (422)
|++.+.||+|+||.||+|.+... ..+..||||.+.... .....+++.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 45678999999999999987643 345789999886543 3345667899999999999999999999886542
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
..++++||+++|+|.+++....... ....++...+.+++.|++.||+|||+++|+||||||+||++++++.+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~------~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl 154 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGE------EPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCV 154 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEE
Confidence 2478899999999999885422110 0124788999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+|||+++................++.|++||.+....++.++|||||||++|||++.|.+||.+.+..++...+.....+
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 234 (273)
T cd05074 155 ADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRL 234 (273)
T ss_pred CcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99999987654433333333445678999999988889999999999999999998899999999888888888777767
Q ss_pred CCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhh
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRD 326 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~d 326 (422)
+.+..++..+.+++.+||..+|..|+ +...+...
T Consensus 235 ~~~~~~~~~~~~l~~~~l~~~p~~Rp-----s~~~~~~~ 268 (273)
T cd05074 235 KQPPDCLEDVYELMCQCWSPEPKCRP-----SFQHLRDQ 268 (273)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCc-----CHHHHHHH
Confidence 77778999999999999999999998 55544433
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=317.37 Aligned_cols=257 Identities=23% Similarity=0.392 Sum_probs=210.3
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccC--cCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKE--NANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
.+|++.+.||+|+||.||+|+...+ +..||||.++. .........+.+|+.+++.++||||+++++++.+.+..++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLD--RKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCC--CCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence 3678899999999999999987544 46799998753 2334455678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
+|||+++|+|.+++...... ...++++.+..++.|++.||+|||+++++||||||+||+++.++.++|+|||
T Consensus 80 v~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g 151 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQ--------KRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EEEecCCCcHHHHHHHhhhc--------cCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccc
Confidence 99999999999988653211 1357889999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCC--hHHHHHHHHcCCCCCC
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS--NQEVIEMIRSRQMLPC 289 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~--~~~~~~~i~~~~~~~~ 289 (422)
+++....... ......+++.|+|||.+....++.++|+||||+++|||++ |..||.... ..++...+.....++.
T Consensus 152 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 228 (267)
T cd08228 152 LGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-LQSPFYGDKMNLFSLCQKIEQCDYPPL 228 (267)
T ss_pred cceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhc-CCCCCccccccHHHHHHHHhcCCCCCC
Confidence 9876543221 1122346778999999988889999999999999999998 888886543 3456666666555554
Q ss_pred C-CCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 290 P-EDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 290 p-~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
| ..++..+.++|.+||..+|..|+ +...+.+-++
T Consensus 229 ~~~~~~~~~~~li~~cl~~~p~~Rp-----~~~~vl~~~~ 263 (267)
T cd08228 229 PTEHYSEKLRELVSMCIYPDPDQRP-----DIGYVHQIAK 263 (267)
T ss_pred ChhhcCHHHHHHHHHHCCCCcccCc-----CHHHHHHHHH
Confidence 4 46788899999999999999999 7777666544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=318.45 Aligned_cols=257 Identities=40% Similarity=0.808 Sum_probs=212.3
Q ss_pred ccCcccccccccccceeEEEEEEecCC---CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSE---GPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
..+++..+.||+|+||.||+|+..... ....|++|.+.........+.+.+|++++++++||||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 356788999999999999999875432 34679999886544444567899999999999999999999999998999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEec
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISD 209 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~D 209 (422)
++||||+++|+|.+++......... .....+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~---~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEK---LKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhccccccc---ccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence 9999999999999999764321100 0112589999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC-CC
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM-LP 288 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~-~~ 288 (422)
||+++........ ......++..|+|||.+....++.++|||||||++|||++.|..||.+.+..++...+..+.. .+
T Consensus 161 ~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 239 (275)
T cd05046 161 LSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP 239 (275)
T ss_pred cccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC
Confidence 9998755433222 122334567799999998888899999999999999999888899998888888887775543 34
Q ss_pred CCCCCCcchhhhcccccccccchhh
Q psy7289 289 CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 289 ~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.+..+|..+.+++.+||..+|..|+
T Consensus 240 ~~~~~~~~l~~~i~~~l~~~p~~Rp 264 (275)
T cd05046 240 VPEGCPSRLYKLMTRCWAVNPKDRP 264 (275)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCC
Confidence 5678999999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=312.30 Aligned_cols=240 Identities=41% Similarity=0.799 Sum_probs=206.7
Q ss_pred cccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEecCCC
Q psy7289 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRG 139 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~~~G 139 (422)
++||+|+||.||++.... +..|++|.++..........+.+|++++++++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~---~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG---NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC---CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 469999999999998643 46799998876554445678999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccccCC
Q psy7289 140 DLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS 219 (422)
Q Consensus 140 ~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~~ 219 (422)
+|.+++.... ..++...+..++.|++.||+|||+++++||||||+||+++.++.+||+|||+++.....
T Consensus 78 ~l~~~l~~~~-----------~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (251)
T cd05041 78 SLLTFLRKKK-----------NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGG 146 (251)
T ss_pred cHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence 9999996532 24788899999999999999999999999999999999999999999999999765432
Q ss_pred cceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcchhh
Q psy7289 220 DYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYS 299 (422)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~~~~ 299 (422)
...........+..|+|||.+..+.++.++|+|||||++|||++.|..||.+.+..+....+......+.|..+|..+.+
T Consensus 147 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (251)
T cd05041 147 IYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYR 226 (251)
T ss_pred cceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHH
Confidence 22111122233567999999988889999999999999999998788999999888888888877777788899999999
Q ss_pred hcccccccccchhh
Q psy7289 300 LMMECWHEVPVAAG 313 (422)
Q Consensus 300 l~~~cw~~~P~~r~ 313 (422)
++.+||..+|..|+
T Consensus 227 li~~~l~~~p~~Rp 240 (251)
T cd05041 227 LMLQCWAYDPENRP 240 (251)
T ss_pred HHHHHhccChhhCc
Confidence 99999999999998
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=325.08 Aligned_cols=244 Identities=25% Similarity=0.424 Sum_probs=191.8
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
..+|++.+.||+|+||.||+|+... .+..||||+++..........+.+|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKV--NGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECC--CCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 3578899999999999999998754 35679999986543333345678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+. |+|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+
T Consensus 82 ~e~~~-~~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 149 (303)
T cd07869 82 FEYVH-TDLCQYMDKHP-----------GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGL 149 (303)
T ss_pred EECCC-cCHHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCc
Confidence 99995 68888886532 3578899999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChH-HHHHHHHcC-CCC--
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ-EVIEMIRSR-QML-- 287 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~-~~~~~i~~~-~~~-- 287 (422)
++....... ......+|+.|+|||++.. ..++.++|||||||++|||++ |..||.+..+. +.+..+... ..+
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
T cd07869 150 ARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQ-GVAAFPGMKDIQDQLERIFLVLGTPNE 226 (303)
T ss_pred ceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCccHHHHHHHHHHHhCCCCh
Confidence 875432211 1223456789999998865 458899999999999999998 99999876442 333222110 000
Q ss_pred -------------------CCC---------CCCCcchhhhcccccccccchhh
Q psy7289 288 -------------------PCP---------EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 288 -------------------~~p---------~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..| ...++.+.+|+.+|+..+|..|.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~ 280 (303)
T cd07869 227 DTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRL 280 (303)
T ss_pred hhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhcc
Confidence 001 01345677899999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=312.89 Aligned_cols=246 Identities=52% Similarity=0.963 Sum_probs=214.6
Q ss_pred ccccccccccceeEEEEEEecCC--CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEE
Q psy7289 57 RFLQELGEGAFGKVYKGEVCTSE--GPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFE 134 (422)
Q Consensus 57 ~~~~~LG~G~fg~Vy~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E 134 (422)
++.+.||.|+||.||++++.... ....||+|.++........+.+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 46788999999999999875432 2477999999765554466789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccc
Q psy7289 135 FMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR 214 (422)
Q Consensus 135 ~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~ 214 (422)
|+++++|.+++..... ..+++.++..++.|++.||+|||+++++||||||+||++++++.+||+|||+++
T Consensus 82 ~~~~~~l~~~~~~~~~----------~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~ 151 (258)
T smart00219 82 YMEGGDLLDYLRKNRP----------KELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR 151 (258)
T ss_pred ccCCCCHHHHHHhhhh----------ccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCce
Confidence 9999999999976421 128999999999999999999999999999999999999999999999999998
Q ss_pred cccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q psy7289 215 DVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCP 294 (422)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p 294 (422)
.......+... ...+++.|+|||.+....++.++||||+||++|||++.|..||.+.+..++...+..+...+.|..+|
T Consensus 152 ~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (258)
T smart00219 152 DLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCP 230 (258)
T ss_pred ecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCC
Confidence 76544333221 23367889999999888899999999999999999988899999999999999998888888888899
Q ss_pred cchhhhcccccccccchhh
Q psy7289 295 PRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 295 ~~~~~l~~~cw~~~P~~r~ 313 (422)
.++.+++.+||..+|..|+
T Consensus 231 ~~~~~~i~~~l~~~p~~Rp 249 (258)
T smart00219 231 PEIYKLMLQCWAEDPEDRP 249 (258)
T ss_pred HHHHHHHHHHCcCChhhCc
Confidence 9999999999999999997
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=322.79 Aligned_cols=252 Identities=24% Similarity=0.437 Sum_probs=217.8
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
.-+.++.+||+|+||.||||.++. .+..||||.+.-. ...+++.+|+.||.+...|+||++||.+.....+++||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~E--sG~v~AIK~VPV~---sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRE--SGHVLAIKKVPVD---TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM 107 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhc--cCcEEEEEecCcc---chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence 345788999999999999998654 4678999988643 35678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
|||..|++.+.++.+. .+|+++++..+++..+.||+|||...-||||||..||||+.+|++||+|||++
T Consensus 108 EYCGAGSiSDI~R~R~-----------K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVA 176 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARR-----------KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVA 176 (502)
T ss_pred hhcCCCcHHHHHHHhc-----------CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhcccc
Confidence 9999999999998764 47999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC--CCC
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP--CPE 291 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~--~p~ 291 (422)
-.+.. ......+..|||.|||||++..-.|+.++||||||++..||.. |++||.+..+.-.+-+|.....+. .|+
T Consensus 177 GQLTD--TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAE-G~PPYsDIHPMRAIFMIPT~PPPTF~KPE 253 (502)
T KOG0574|consen 177 GQLTD--TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAE-GRPPYSDIHPMRAIFMIPTKPPPTFKKPE 253 (502)
T ss_pred chhhh--hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhc-CCCCcccccccceeEeccCCCCCCCCChH
Confidence 76543 2334567789999999999999999999999999999999996 999999998887777775544332 367
Q ss_pred CCCcchhhhcccccccccchhhHH-HHhhhhhhh
Q psy7289 292 DCPPRMYSLMMECWHEVPVAAGMA-YLCSHHYVH 324 (422)
Q Consensus 292 ~~p~~~~~l~~~cw~~~P~~r~~~-~lh~~~~i~ 324 (422)
..+.++.++++.|+-++|..|.-+ .|+.|.+|.
T Consensus 254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fik 287 (502)
T KOG0574|consen 254 EWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIK 287 (502)
T ss_pred hhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhc
Confidence 788899999999999999988644 466666654
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=312.12 Aligned_cols=243 Identities=42% Similarity=0.774 Sum_probs=208.4
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
.++++.+.||+|+||.||+|.+.. +..+|+|.++.... ....|.+|++++++++||||+++++++......+++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~---~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE---KRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC---CCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 467888999999999999998742 35689998764322 2357889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||+++|+|.+++.... ..++++.+..++.|++.||+|||+++++||||||+||+++.++.+||+|||++
T Consensus 79 e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 147 (256)
T cd05112 79 EFMEHGCLSDYLRAQR-----------GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMT 147 (256)
T ss_pred EcCCCCcHHHHHHhCc-----------cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcce
Confidence 9999999999986532 24788999999999999999999999999999999999999999999999998
Q ss_pred ccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDC 293 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~ 293 (422)
+....... ........+..|+|||.+..+.++.++|||||||++|||++.|..||......++...+..+.....|...
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (256)
T cd05112 148 RFVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLA 226 (256)
T ss_pred eecccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCC
Confidence 76533221 11222334678999999988889999999999999999998799999998888888888877666677888
Q ss_pred Ccchhhhcccccccccchhh
Q psy7289 294 PPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 294 p~~~~~l~~~cw~~~P~~r~ 313 (422)
+..+.+++.+||..+|..|+
T Consensus 227 ~~~~~~l~~~~l~~~p~~Rp 246 (256)
T cd05112 227 SQSVYELMQHCWKERPEDRP 246 (256)
T ss_pred CHHHHHHHHHHcccChhhCC
Confidence 99999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=317.70 Aligned_cols=236 Identities=20% Similarity=0.285 Sum_probs=192.3
Q ss_pred cccccceeEEEEEEecCCCCeEEEEEEccCcCC--HHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEecCCC
Q psy7289 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN--QKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRG 139 (422)
Q Consensus 62 LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~~~G 139 (422)
||+|+||.||+++...+ +..||+|.+..... ......+..|++++++++||||+++++++.++...++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~--~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNT--GKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccC--CcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence 79999999999986543 57799998854221 122345667999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccccCC
Q psy7289 140 DLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS 219 (422)
Q Consensus 140 ~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~~ 219 (422)
+|.+++..... ..+++..+..++.|++.||+|||+++|+||||||+||++++++.+||+|||++......
T Consensus 79 ~L~~~~~~~~~----------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 79 DLKYHIYNVGE----------RGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG 148 (277)
T ss_pred CHHHHHHhccc----------cCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence 99998865321 24788889999999999999999999999999999999999999999999998765432
Q ss_pred cceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh----HHHHHHHHcCCCCCCCCCCCc
Q psy7289 220 DYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN----QEVIEMIRSRQMLPCPEDCPP 295 (422)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~----~~~~~~i~~~~~~~~p~~~p~ 295 (422)
.. .....+++.|+|||++....++.++|||||||++|||++ |..||.+... .++...+...........+++
T Consensus 149 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (277)
T cd05607 149 KT---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVA-GRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTE 224 (277)
T ss_pred ce---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHHHhhccccccccccCCH
Confidence 21 123456789999999998889999999999999999998 9999976533 334444433333223346788
Q ss_pred chhhhcccccccccchhh
Q psy7289 296 RMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 296 ~~~~l~~~cw~~~P~~r~ 313 (422)
++.+|+.+||..+|..|+
T Consensus 225 ~~~~li~~~L~~~P~~R~ 242 (277)
T cd05607 225 ESKDICRLFLAKKPEDRL 242 (277)
T ss_pred HHHHHHHHHhccCHhhCC
Confidence 999999999999999997
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=317.11 Aligned_cols=242 Identities=25% Similarity=0.403 Sum_probs=193.7
Q ss_pred ccccccceeEEEEEEecC----------------------CCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceee
Q psy7289 61 ELGEGAFGKVYKGEVCTS----------------------EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVC 118 (422)
Q Consensus 61 ~LG~G~fg~Vy~~~~~~~----------------------~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~ 118 (422)
.||+|+||.||+|.+..+ .....|++|.+.... ......|.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 599999999999986421 112458888876432 234467889999999999999999
Q ss_pred EeeEEEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcee
Q psy7289 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCL 198 (422)
Q Consensus 119 l~g~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiL 198 (422)
+++++.+....++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nil 149 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-----------GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNIL 149 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEE
Confidence 9999999999999999999999999986532 35788899999999999999999999999999999999
Q ss_pred ecCCC-------eEEEecCcccccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCC
Q psy7289 199 VGDGL-------TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYY 270 (422)
Q Consensus 199 l~~~~-------~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~ 270 (422)
+++.+ .+|++|||++...... ....++..|+|||.+.. ..++.++|||||||++|||+..|..||.
T Consensus 150 l~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 223 (274)
T cd05076 150 LARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLK 223 (274)
T ss_pred EeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcc
Confidence 97543 4899999998643221 12245677999998865 5689999999999999999755999999
Q ss_pred CCChHHHHHHHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 271 GYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 271 ~~~~~~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
+.+..+....+.... ..|...++.+.++|.+||..+|..|+ ++..+.++|
T Consensus 224 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~~il~~L 273 (274)
T cd05076 224 ERTPSEKERFYEKKH--RLPEPSCKELATLISQCLTYEPTQRP-----SFRTILRDL 273 (274)
T ss_pred ccChHHHHHHHHhcc--CCCCCCChHHHHHHHHHcccChhhCc-----CHHHHHHhh
Confidence 887776655544332 33444567899999999999999998 666665544
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=317.87 Aligned_cols=242 Identities=21% Similarity=0.319 Sum_probs=199.6
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
|+..+.||+|+||+||+|.+..+ ++.||+|.+.... .......+.+|+++|+.++|+||+.+++++..++..+++|
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRAT--GKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCC--CcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEE
Confidence 56678899999999999987543 5679999885432 1223356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||+++|+|.+++.... ...+++..+..++.|++.||.|||+++|+||||||+||++++++.+||+|||++
T Consensus 80 e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~ 149 (285)
T cd05632 80 TIMNGGDLKFHIYNMG----------NPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred EeccCccHHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcc
Confidence 9999999999886432 125899999999999999999999999999999999999999999999999998
Q ss_pred ccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc---CCCCCCC
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS---RQMLPCP 290 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~---~~~~~~p 290 (422)
+....... .....++..|+|||++....++.++|+|||||++|||++ |..||.+.........+.. ......+
T Consensus 150 ~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
T cd05632 150 VKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIE-GQSPFRGRKEKVKREEVDRRVLETEEVYS 225 (285)
T ss_pred eecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhhccccccC
Confidence 75432211 123457889999999988889999999999999999998 9999988776544333322 1123456
Q ss_pred CCCCcchhhhcccccccccchhh
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..+++.+.+|+..||..+|..|+
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~ 248 (285)
T cd05632 226 AKFSEEAKSICKMLLTKDPKQRL 248 (285)
T ss_pred ccCCHHHHHHHHHHccCCHhHcC
Confidence 67888999999999999999887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=315.78 Aligned_cols=257 Identities=34% Similarity=0.647 Sum_probs=203.7
Q ss_pred ccCcccccccccccceeEEEEEEe--cCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC--CC
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVC--TSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG--EP 128 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~ 128 (422)
+.++++.+.||+|+||.||+++.. ....+..||+|.+... .....+.|.+|++++++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 346888999999999999999764 3345678999998643 334557889999999999999999999987543 46
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
+++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++++||||||+||++++++.+||+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~-----------~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~ 150 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHR-----------ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIG 150 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcC-----------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEEC
Confidence 899999999999999996531 247889999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcce-EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh-------------
Q psy7289 209 DFGLSRDVYASDYY-RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN------------- 274 (422)
Q Consensus 209 DFGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~------------- 274 (422)
|||+++........ ........+..|+|||++....++.++|||||||++|||++ +..|+.....
T Consensus 151 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd05081 151 DFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-YSDKSCSPPAEFMRMMGNDKQGQ 229 (284)
T ss_pred CCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhh-cCCcCCCcchhhhhhcccccccc
Confidence 99999865433221 11222223456999999988889999999999999999998 5445432211
Q ss_pred ---HHHHHHHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 275 ---QEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 275 ---~~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
..+.+.+..+..++.+..+|..+.+++.+||..+|..|+ +...+...|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----t~~ei~~~l 280 (284)
T cd05081 230 MIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRP-----SFSELALQV 280 (284)
T ss_pred cchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCC-----CHHHHHHHH
Confidence 112334445556677788999999999999999999998 666555443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=316.64 Aligned_cols=247 Identities=33% Similarity=0.613 Sum_probs=200.7
Q ss_pred CcccccccccccceeEEEEEEe--cCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC--CCeE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVC--TSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG--EPMC 130 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~~~ 130 (422)
.|++++.||+|+||.||++++. ....+..||+|.++..........+.+|+.+++.++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 4678899999999999999764 23446789999987655555567899999999999999999999998775 5689
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+||||+++|+|.+++.... ..+++.++..++.|++.||+|||+++++||||||+||+++.++.+||+||
T Consensus 85 lv~e~~~g~~L~~~l~~~~-----------~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~df 153 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK-----------NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDF 153 (284)
T ss_pred EEEEccCCCCHHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCC
Confidence 9999999999999986531 24788999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcc-eEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCC---------------Ch
Q psy7289 211 GLSRDVYASDY-YRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY---------------SN 274 (422)
Q Consensus 211 Gla~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~---------------~~ 274 (422)
|+++....... ........++..|+|||++.+..++.++|||||||++|||++ +..|+... ..
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd05079 154 GLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT-YCDSESSPMTLFLKMIGPTHGQMTV 232 (284)
T ss_pred ccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhc-CCCCCccccchhhhhcccccccccH
Confidence 99986543322 122223445677999999988889999999999999999998 54443211 11
Q ss_pred HHHHHHHHcCCCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 275 QEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 275 ~~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
......+..+...+.+..++..+.+++.+||+.+|..|+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 271 (284)
T cd05079 233 TRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRT 271 (284)
T ss_pred HHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCc
Confidence 223334445566667788999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=317.94 Aligned_cols=238 Identities=23% Similarity=0.376 Sum_probs=206.5
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
+|++.+.||+|+||.||++++.. .++.||+|.+.... .......+.+|++++++++||||+++++++.+++..++|
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKG--SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence 57889999999999999998754 35779999886432 233456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+++++||||+|+||++++++.+||+|||+
T Consensus 80 ~e~~~~~~L~~~~~~~------------~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~ 147 (290)
T cd05580 80 MEYVPGGELFSHLRKS------------GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGF 147 (290)
T ss_pred EecCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCC
Confidence 9999999999999764 3588999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPED 292 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~ 292 (422)
++..... .....+++.|+|||.+....++.++||||||+++|||++ |..||...+..+....+..+ ..+.|..
T Consensus 148 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~ 220 (290)
T cd05580 148 AKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLA-GYPPFFDDNPIQIYEKILEG-KVRFPSF 220 (290)
T ss_pred ccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CccCCcc
Confidence 9865433 223456788999999988888999999999999999998 99999988877777776644 4567788
Q ss_pred CCcchhhhcccccccccchhh
Q psy7289 293 CPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 293 ~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.++.+.+++.+||..+|..|.
T Consensus 221 ~~~~l~~li~~~l~~~p~~R~ 241 (290)
T cd05580 221 FSPDAKDLIRNLLQVDLTKRL 241 (290)
T ss_pred CCHHHHHHHHHHccCCHHHcc
Confidence 899999999999999999884
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=313.44 Aligned_cols=241 Identities=24% Similarity=0.388 Sum_probs=191.9
Q ss_pred cccccccceeEEEEEEecCC----------CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 60 QELGEGAFGKVYKGEVCTSE----------GPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
+.||+|+||.||+|++..+. ....|++|.+.... ......|.+|+.+++.++||||+++++++.+....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 46899999999999864321 23458888875432 33456788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCe-----
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLT----- 204 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~----- 204 (422)
++||||+++|+|..++.... ..+++..+.+++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~ 148 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKS-----------DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECG 148 (262)
T ss_pred EEEEecccCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCC
Confidence 99999999999999886532 35889999999999999999999999999999999999986653
Q ss_pred --EEEecCcccccccCCcceEeccCCCCCccccCccccc-cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHH
Q psy7289 205 --VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL-YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281 (422)
Q Consensus 205 --vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i 281 (422)
+|++|||++...... ....++..|||||++. ...++.++|||||||++|||++.|..||.+....+.....
T Consensus 149 ~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 222 (262)
T cd05077 149 PFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY 222 (262)
T ss_pred ceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH
Confidence 899999998754321 2234567899999887 4668999999999999999986688999877666654433
Q ss_pred HcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhh
Q psy7289 282 RSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHR 325 (422)
Q Consensus 282 ~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~ 325 (422)
.... +.+...++++.+||.+||+.+|..|+ ++..+-+
T Consensus 223 ~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp-----~~~~il~ 259 (262)
T cd05077 223 EGQC--MLVTPSCKELADLMTHCMNYDPNQRP-----FFRAIMR 259 (262)
T ss_pred hcCc--cCCCCChHHHHHHHHHHcCCChhhCc-----CHHHHHH
Confidence 3222 22233457899999999999999998 5555443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=312.36 Aligned_cols=238 Identities=43% Similarity=0.710 Sum_probs=204.2
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
..+|++.+.||+|+||.||++.. .+..||+|..+... ..+.+.+|+.+++.++||||+++++++... ..+++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~----~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY----TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc----CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence 35678899999999999999864 24569999886432 346789999999999999999999998754 57999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++|+|.+++..... ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||+
T Consensus 77 ~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~ 146 (254)
T cd05083 77 MELMSKGNLVNFLRTRGR----------ALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGL 146 (254)
T ss_pred EECCCCCCHHHHHHhcCc----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCcc
Confidence 999999999999976421 2478889999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPED 292 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~ 292 (422)
++..... ......+..|+|||.+....++.++|+|||||++|||++.|..||.+.+..+....+..+..++.+..
T Consensus 147 ~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 221 (254)
T cd05083 147 ARVGSMG-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEG 221 (254)
T ss_pred ceecccc-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCc
Confidence 8754221 11223356799999998888999999999999999999889999999999888888888777777788
Q ss_pred CCcchhhhcccccccccchhh
Q psy7289 293 CPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 293 ~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+|+.+.+++.+||..+|..|+
T Consensus 222 ~~~~~~~li~~~l~~~p~~Rp 242 (254)
T cd05083 222 CPADVYVLMTSCWETEPKKRP 242 (254)
T ss_pred CCHHHHHHHHHHcCCChhhCc
Confidence 999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=316.06 Aligned_cols=242 Identities=22% Similarity=0.431 Sum_probs=208.5
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
..|+..+.||+|+||.||+|.+.. .+..||+|.+...........+.+|+.+++.++||||+++++++.++...++||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNR--TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEcc--CCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 457778999999999999998654 357799999875554556678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||+++|+|.+++.. .++++.++..++.|++.||+|||+.+++|+||+|+||++++++.++|+|||++
T Consensus 82 e~~~~~~L~~~i~~-------------~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~ 148 (277)
T cd06640 82 EYLGGGSALDLLRA-------------GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred ecCCCCcHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccc
Confidence 99999999999854 24788899999999999999999999999999999999999999999999999
Q ss_pred ccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDC 293 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~ 293 (422)
........ ......++..|+|||.+....++.++|+|||||++|||++ |..||.+.+..+....+.....+..+..+
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (277)
T cd06640 149 GQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAK-GEPPNSDMHPMRVLFLIPKNNPPTLTGEF 225 (277)
T ss_pred eeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHH-CCCCCCCcChHhHhhhhhcCCCCCCchhh
Confidence 76543221 1122345678999999988889999999999999999998 99999988888777777666556667788
Q ss_pred Ccchhhhcccccccccchhh
Q psy7289 294 PPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 294 p~~~~~l~~~cw~~~P~~r~ 313 (422)
|..+.+++.+||..+|..|+
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp 245 (277)
T cd06640 226 SKPFKEFIDACLNKDPSFRP 245 (277)
T ss_pred hHHHHHHHHHHcccCcccCc
Confidence 99999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=344.30 Aligned_cols=328 Identities=24% Similarity=0.433 Sum_probs=245.2
Q ss_pred ccccccceeEEEEEEe-cCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCC-CCceeeEeeEEEcCCCeEEEEEecC
Q psy7289 61 ELGEGAFGKVYKGEVC-TSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELR-HPNIVCLLGVCLSGEPMCMLFEFMV 137 (422)
Q Consensus 61 ~LG~G~fg~Vy~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~lv~E~~~ 137 (422)
.+|+|+||.|+..+-. ....+..+|+|+++... ..+.......|..++...+ ||.+|++.-.++.+..+++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 3799999999875422 22335678888875432 1112225566888888887 9999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccccccc
Q psy7289 138 RGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVY 217 (422)
Q Consensus 138 ~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~ 217 (422)
+|+|...+... ..+.+.....+...++.|++++|+.+|+|||+|++||+++.+|++|+.|||+++...
T Consensus 81 gg~lft~l~~~------------~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v 148 (612)
T KOG0603|consen 81 GGDLFTRLSKE------------VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAV 148 (612)
T ss_pred cchhhhccccC------------CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhH
Confidence 99999887654 246777888899999999999999999999999999999999999999999998754
Q ss_pred CCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHH------------------
Q psy7289 218 ASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIE------------------ 279 (422)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~------------------ 279 (422)
.... .+||..|||||++. .+...+|.||||++++||+| |..||.+.....+..
T Consensus 149 ~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~fellt-g~~pf~~~~~~~Il~~~~~~p~~l~~~a~~~~~ 219 (612)
T KOG0603|consen 149 KEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLT-GTLPFGGDTMKRILKAELEMPRELSAEARSLFR 219 (612)
T ss_pred hhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhh-CCCCCchHHHHHHhhhccCCchhhhHHHHHHHH
Confidence 3321 26788999999987 56888999999999999999 999998721111110
Q ss_pred H-------------------HH--------------cCCCCC----------------------CCCC----CCc-----
Q psy7289 280 M-------------------IR--------------SRQMLP----------------------CPED----CPP----- 295 (422)
Q Consensus 280 ~-------------------i~--------------~~~~~~----------------------~p~~----~p~----- 295 (422)
+ |. .+.+.+ .|.+ +++
T Consensus 220 ~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~~~~~fd~eft~~~P~dsp~~~~~~s~~~ 299 (612)
T KOG0603|consen 220 QLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITERDVAQFDPEFTSQVPADSPLLSASGSDHT 299 (612)
T ss_pred HHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccchhhhhhcCchhccCCcccCCCCCCCccccc
Confidence 0 00 000000 0100 000
Q ss_pred ---------------------------------chhhhcccccc---------------------ccc------------
Q psy7289 296 ---------------------------------RMYSLMMECWH---------------------EVP------------ 309 (422)
Q Consensus 296 ---------------------------------~~~~l~~~cw~---------------------~~P------------ 309 (422)
.-+...+.|-+ ..|
T Consensus 300 if~g~sfva~~il~~~~~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv 379 (612)
T KOG0603|consen 300 IFSGPSFVAPGVLEDAVTAPFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIV 379 (612)
T ss_pred hhcCCCccChHHhhccccCCcchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcce
Confidence 00011222221 111
Q ss_pred --------------------------------------------chhhHHHHhhhhhhhhhcccccccc-cCCcceeecc
Q psy7289 310 --------------------------------------------VAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKISD 344 (422)
Q Consensus 310 --------------------------------------------~~r~~~~lh~~~~i~~dLk~~nil~-~~~~~~ki~D 344 (422)
...++.+||.++++||||||.|||+ ++..+++++|
T Consensus 380 ~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrlty 459 (612)
T KOG0603|consen 380 KSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTY 459 (612)
T ss_pred eecceecCCceeeeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEE
Confidence 1246889999999999999999999 6889999999
Q ss_pred cccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHHHHHHHHHHhcCCCCCCCCCchhhhhc
Q psy7289 345 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415 (422)
Q Consensus 345 fgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~~~~~ 415 (422)
||+++....+ .-+...|..|.|||++....||.++|||||||+||||++ |..||..-++..+..+
T Consensus 460 FG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~-G~tp~~~~P~~~ei~~ 524 (612)
T KOG0603|consen 460 FGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLT-GRTLFAAHPAGIEIHT 524 (612)
T ss_pred echhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCccccCCchHHHHH
Confidence 9999865433 223456788999999997789999999999999999996 9999998887754433
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=338.01 Aligned_cols=253 Identities=22% Similarity=0.341 Sum_probs=195.2
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC-----
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG----- 126 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~----- 126 (422)
...+|++.+.||+|+||.||+|+...+ +..||||++.... ....+|+.+|+.++|||||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~--~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDT--SEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCC--CCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 345789999999999999999986543 4679999875432 2235799999999999999999876432
Q ss_pred ---CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC-
Q psy7289 127 ---EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG- 202 (422)
Q Consensus 127 ---~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~- 202 (422)
..+++||||+++ +|.+++...... ...+++..+..++.||+.||+|||+++|+||||||+|||++.+
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~--------~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~ 207 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARN--------NHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT 207 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCC
Confidence 246799999985 787777542111 1358899999999999999999999999999999999999865
Q ss_pred CeEEEecCcccccccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHH
Q psy7289 203 LTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281 (422)
Q Consensus 203 ~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i 281 (422)
+.+||+|||+|+....... .....+|+.|||||++.+. .++.++|||||||++|||++ |.+||.+.+..+.+..+
T Consensus 208 ~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i 283 (440)
T PTZ00036 208 HTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMIL-GYPIFSGQSSVDQLVRI 283 (440)
T ss_pred CceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Confidence 4799999999986543221 1234568889999998754 68999999999999999998 99999988776555444
Q ss_pred HcCC------------------C----------CCCCCCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 282 RSRQ------------------M----------LPCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 282 ~~~~------------------~----------~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
.... . ...|..+|+++.+|+.+||..+|..|+ ...+..|.++.
T Consensus 284 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~ 355 (440)
T PTZ00036 284 IQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD 355 (440)
T ss_pred HHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHH
Confidence 2210 0 013456788899999999999999985 33455566553
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=308.89 Aligned_cols=244 Identities=20% Similarity=0.311 Sum_probs=211.0
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
+|++++.||+|+||.||.++... .+..+++|.+... .+......+.+|+.++++++||||+++++++.+.+.++++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTE--DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcC--CCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEE
Confidence 47889999999999999987643 4567999987543 34455678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||+++|+|.+++.... ...+++.++..++.|++.||.|||+.+++||||||+||++++++.+||+|||++
T Consensus 79 e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~ 148 (256)
T cd08221 79 EYANGGTLYDKIVRQK----------GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGIS 148 (256)
T ss_pred EecCCCcHHHHHHhcc----------ccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcce
Confidence 9999999999997542 135889999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDC 293 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~ 293 (422)
+....... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||...+..+....+..+...+.+..+
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (256)
T cd08221 149 KILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT-LKRTFDATNPLNLVVKIVQGNYTPVVSVY 225 (256)
T ss_pred EEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHcCCCCCCcccc
Confidence 76543221 1233456789999999988888999999999999999998 88999998888888888888777777888
Q ss_pred Ccchhhhcccccccccchhh
Q psy7289 294 PPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 294 p~~~~~l~~~cw~~~P~~r~ 313 (422)
+.++.+++.+||..+|..|+
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~ 245 (256)
T cd08221 226 SSELISLVHSLLQQDPEKRP 245 (256)
T ss_pred CHHHHHHHHHHcccCcccCC
Confidence 99999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=352.16 Aligned_cols=256 Identities=22% Similarity=0.320 Sum_probs=202.2
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
.+|++.++||+|+||.||+|+... .+..||+|+++... .....+.|.+|++++++++||||+++++++.+++..++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~--tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPV--CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECC--CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEE
Confidence 468899999999999999998644 35679999986532 23445689999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
+|||+++|+|.+++........ ........++...+.+++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~-l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKES-LSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccc-cchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999999975321111 001112346778889999999999999999999999999999999999999999999
Q ss_pred ccccccCCcc----------------eEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChH
Q psy7289 212 LSRDVYASDY----------------YRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ 275 (422)
Q Consensus 212 la~~~~~~~~----------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~ 275 (422)
+++....... ........+|+.|||||++.+..++.++|||||||++|||++ |..||...+..
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLT-G~~PF~~~~~~ 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT-LSFPYRRKKGR 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHH-CCCCCCCcchh
Confidence 9986521110 001112357899999999998899999999999999999999 99999886655
Q ss_pred HHHHHHHcCC--CCCCCCCCCcchhhhcccccccccchhh
Q psy7289 276 EVIEMIRSRQ--MLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 276 ~~~~~i~~~~--~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
++........ .......+|+.+.+++.+||..+|..|.
T Consensus 238 ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ 277 (932)
T PRK13184 238 KISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERY 277 (932)
T ss_pred hhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCc
Confidence 5433221111 1112246888999999999999999984
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=310.67 Aligned_cols=212 Identities=25% Similarity=0.444 Sum_probs=176.5
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHH-hHHHHHHHHHHHhcCCCCceeeEeeEEEcC--CCeE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQK-TASDFRREVDLMSELRHPNIVCLLGVCLSG--EPMC 130 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~~~ 130 (422)
+.|+.+..|++|+||.||+|+.+.+ ++.||+|+++-..... .--.-+||+.+|.+++|||||.+..+.... +.+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t--~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKT--DEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCc--ceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 4577889999999999999987554 5889999987543211 112457999999999999999999887643 4699
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+|||||++ ||...+.... .+++..++..++.|+++|++|||.+.|+||||||+|+|+++.|.+||+||
T Consensus 154 ~VMe~~Eh-DLksl~d~m~-----------q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDF 221 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMK-----------QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADF 221 (419)
T ss_pred eeHHHHHh-hHHHHHHhcc-----------CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEeccc
Confidence 99999987 8998887642 36899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~ 282 (422)
||||...... ...+....|..|.|||.+.+. .|+++.|+||+|||+.||++ +.+-|.|.+..+.+.+|-
T Consensus 222 GLAR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~-~kPlf~G~sE~dQl~~If 291 (419)
T KOG0663|consen 222 GLAREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLT-QKPLFPGKSEIDQLDKIF 291 (419)
T ss_pred chhhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHh-cCCCCCCCchHHHHHHHH
Confidence 9999765431 122334568899999998864 69999999999999999998 888899988777666663
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=310.39 Aligned_cols=241 Identities=29% Similarity=0.502 Sum_probs=195.0
Q ss_pred cccccccceeEEEEEEecCCC--------CeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 60 QELGEGAFGKVYKGEVCTSEG--------PSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
+.||+|+||.||+|.+..... ...|++|.+...... ...|.+|+.+++.++||||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 469999999999999865431 135777776543322 5789999999999999999999999988 77899
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC-------e
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL-------T 204 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~-------~ 204 (422)
||||+++|+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++ .
T Consensus 78 v~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~ 146 (259)
T cd05037 78 VEEYVKFGPLDVFLHREK-----------NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPF 146 (259)
T ss_pred EEEcCCCCcHHHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCcee
Confidence 999999999999997642 2578889999999999999999999999999999999999887 8
Q ss_pred EEEecCcccccccCCcceEeccCCCCCccccCccccccC--CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q psy7289 205 VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG--KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282 (422)
Q Consensus 205 vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~ 282 (422)
+||+|||+++..... ....++..|+|||++... .++.++|||||||++|||++.|..||...+..+......
T Consensus 147 ~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~ 220 (259)
T cd05037 147 IKLSDPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ 220 (259)
T ss_pred EEeCCCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh
Confidence 999999999865431 123345679999998876 789999999999999999987788998877665555554
Q ss_pred cCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 283 SRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 283 ~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
.....+.|. ...+.+++.+||..+|..|+ +...+.++|
T Consensus 221 ~~~~~~~~~--~~~~~~li~~~l~~~p~~Rp-----t~~~il~~l 258 (259)
T cd05037 221 DQHRLPMPD--CAELANLINQCWTYDPTKRP-----SFRAILRDL 258 (259)
T ss_pred cCCCCCCCC--chHHHHHHHHHhccChhhCC-----CHHHHHHhc
Confidence 444334333 37899999999999999998 665555544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=313.81 Aligned_cols=242 Identities=26% Similarity=0.422 Sum_probs=201.6
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFE 134 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E 134 (422)
.|++.+.||+|+||.||+|+... .+..+++|.+... .....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~--~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKE--TGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECC--CCeEEEEEEeCCC-CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 36778999999999999998654 3467888887543 34456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccc
Q psy7289 135 FMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR 214 (422)
Q Consensus 135 ~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~ 214 (422)
|+++|+|.+++.... .++++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++
T Consensus 83 ~~~~~~l~~~~~~~~-----------~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~ 151 (282)
T cd06643 83 FCAGGAVDAVMLELE-----------RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSA 151 (282)
T ss_pred ecCCCcHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccc
Confidence 999999999886421 358999999999999999999999999999999999999999999999999987
Q ss_pred cccCCcceEeccCCCCCccccCccccc-----cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC--CC
Q psy7289 215 DVYASDYYRIQSKSLLPVRWMPPESIL-----YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ--ML 287 (422)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~--~~ 287 (422)
...... .......+++.|+|||++. ...++.++|||||||++|||++ |.+||...+..+....+.... ..
T Consensus 152 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd06643 152 KNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQ-IEPPHHELNPMRVLLKIAKSEPPTL 228 (282)
T ss_pred cccccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHcc-CCCCccccCHHHHHHHHhhcCCCCC
Confidence 543221 1122345678899999874 3457889999999999999998 889999888777666655433 33
Q ss_pred CCCCCCCcchhhhcccccccccchhh
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+.|..+|..+.+++.+||+.+|..|+
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rp 254 (282)
T cd06643 229 AQPSRWSSEFKDFLKKCLEKNVDARW 254 (282)
T ss_pred CCccccCHHHHHHHHHHccCChhhCc
Confidence 45677889999999999999999997
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=313.28 Aligned_cols=241 Identities=24% Similarity=0.411 Sum_probs=208.0
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFE 134 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E 134 (422)
+|++.+.||.|+||.||+|+... .+..||+|.+...........+.+|+++++.++||||+++++++.++..+++|+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKR--TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECC--CCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 57888999999999999998754 3578999998654444455678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccc
Q psy7289 135 FMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR 214 (422)
Q Consensus 135 ~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~ 214 (422)
|+++|+|.+++... ++++..+..++.|++.||.|||+++++||||+|+||++++++.++|+|||+++
T Consensus 80 ~~~~~~L~~~~~~~-------------~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 146 (274)
T cd06609 80 YCGGGSCLDLLKPG-------------KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSG 146 (274)
T ss_pred eeCCCcHHHHHhhc-------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccce
Confidence 99999999998642 58899999999999999999999999999999999999999999999999998
Q ss_pred cccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCC-C
Q psy7289 215 DVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPED-C 293 (422)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~-~ 293 (422)
...... .......+++.|+|||.+....++.++|||||||++|||++ |..||...+..+....+..+..+..+.. +
T Consensus 147 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (274)
T cd06609 147 QLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAK-GEPPLSDLHPMRVLFLIPKNNPPSLEGNKF 223 (274)
T ss_pred eecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccCchHHHHHHhhhcCCCCCccccc
Confidence 664321 11223345678999999998889999999999999999998 9999988887777777766655555555 8
Q ss_pred Ccchhhhcccccccccchhh
Q psy7289 294 PPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 294 p~~~~~l~~~cw~~~P~~r~ 313 (422)
|+.+.+++.+||..+|..|+
T Consensus 224 ~~~~~~~l~~~l~~~p~~Rp 243 (274)
T cd06609 224 SKPFKDFVSLCLNKDPKERP 243 (274)
T ss_pred CHHHHHHHHHHhhCChhhCc
Confidence 89999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=309.49 Aligned_cols=244 Identities=24% Similarity=0.359 Sum_probs=202.9
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC----HHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN----QKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
.|++.+.||+|+||.||+|.... .+..||+|.+..... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~--~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVD--TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLS 80 (263)
T ss_pred cccccceecCCCceEEEEEEEcC--CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEE
Confidence 57788999999999999997643 356799998754321 223457889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+++||||||+||++++++.+||+||
T Consensus 81 ~v~e~~~~~~l~~~~~~~------------~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~df 148 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAY------------GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDF 148 (263)
T ss_pred EEEEECCCCcHHHHHHHh------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeec
Confidence 999999999999998753 25788899999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEe-ccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc-CCCCC
Q psy7289 211 GLSRDVYASDYYRI-QSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS-RQMLP 288 (422)
Q Consensus 211 Gla~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~-~~~~~ 288 (422)
|+++.......... .....++..|+|||.+....++.++|||||||++|||++ |..||...+..+....+.. ....+
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 227 (263)
T cd06625 149 GASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT-EKPPWAEFEAMAAIFKIATQPTNPQ 227 (263)
T ss_pred ccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHh-CCCCccccchHHHHHHHhccCCCCC
Confidence 99875432211111 022345678999999998889999999999999999998 9999988776655544443 34455
Q ss_pred CCCCCCcchhhhcccccccccchhh
Q psy7289 289 CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 289 ~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.|..++..+.+++.+||..+|..|+
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rp 252 (263)
T cd06625 228 LPSHVSPDARNFLRRTFVENAKKRP 252 (263)
T ss_pred CCccCCHHHHHHHHHHhhcCcccCC
Confidence 7788999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=310.83 Aligned_cols=243 Identities=24% Similarity=0.415 Sum_probs=204.3
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC--------HHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN--------QKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
|.+.+.||+|+||.||+|.... .+..||+|.+..... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNAS--SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD 79 (267)
T ss_pred ccccceeecCCCeEEEEEEecC--CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Confidence 5667899999999999998643 346799998754321 112357889999999999999999999999999
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
..+++|||+++++|.+++... ..+++..+..++.|++.||+|||+++++||||+|+||++++++.+||
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~------------~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l 147 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNY------------GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKI 147 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhc------------cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEe
Confidence 999999999999999999653 35788899999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceE----eccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc
Q psy7289 208 SDFGLSRDVYASDYYR----IQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS 283 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~ 283 (422)
+|||+++......... ......++..|+|||.+....++.++|+|||||++|||++ |..||.+.+..+.+..+..
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~ 226 (267)
T cd06628 148 SDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLT-GKHPFPDCTQLQAIFKIGE 226 (267)
T ss_pred cccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhh-CCCCCCCccHHHHHHHHhc
Confidence 9999998664221110 1112345678999999988889999999999999999998 9999998877666666666
Q ss_pred CCCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 284 RQMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 284 ~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
...+..|..+|..+.+++++||+.+|..|+
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 256 (267)
T cd06628 227 NASPEIPSNISSEAIDFLEKTFEIDHNKRP 256 (267)
T ss_pred cCCCcCCcccCHHHHHHHHHHccCCchhCc
Confidence 666677888999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=320.66 Aligned_cols=243 Identities=24% Similarity=0.433 Sum_probs=195.7
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
.+|++.++||+|+||.||+|+...+ +..||+|.++..........+.+|+.++++++||||+++++++..++..++||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLT--ENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCC--CCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 4688899999999999999986543 46799999875443334456789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||+++ +|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|||++
T Consensus 84 e~~~~-~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 151 (309)
T cd07872 84 EYLDK-DLKQYMDDCG-----------NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLA 151 (309)
T ss_pred eCCCC-CHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccc
Confidence 99985 8988886532 24788899999999999999999999999999999999999999999999998
Q ss_pred ccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC-----
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML----- 287 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~----- 287 (422)
+....... ......+++.|+|||.+.. ..++.++|||||||++|||++ |..||.+.+..+....+......
T Consensus 152 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 228 (309)
T cd07872 152 RAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMAS-GRPLFPGSTVEDELHLIFRLLGTPTEET 228 (309)
T ss_pred eecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 75432211 1123346788999998865 468999999999999999998 99999988776554444221000
Q ss_pred ---------------C---------CCCCCCcchhhhcccccccccchhh
Q psy7289 288 ---------------P---------CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 288 ---------------~---------~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+ ....+++++.+|+.+|+..+|..|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 278 (309)
T cd07872 229 WPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRI 278 (309)
T ss_pred HhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCC
Confidence 0 0124677888999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=315.83 Aligned_cols=264 Identities=30% Similarity=0.549 Sum_probs=232.6
Q ss_pred ccCcccccccccccceeEEEEEEecCC---CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC-CC
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSE---GPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG-EP 128 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~ 128 (422)
..++++...+-+|.||+||.|.|+..+ +.+.|-||.++..+++-+...|+.|...+..+.|||+..+.+++.+. ..
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 355677778999999999999886433 34678899999989888889999999999999999999999998754 45
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
.+.++.++.-|+|..||..-.. .+. .....++..++..++.|++.||+|||+++|||.||..+|++|++...|||+
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~-~~~---~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRG-DDP---SYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ceEEEeccCcchHHHHHHHhcc-CCC---ccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 6788899999999999973211 111 112357888899999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP 288 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 288 (422)
|=.|+|.....++.........+.+||+||.+.+..|+.++|||||||+||||+|.|..||...++.|+...++.|.++.
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRla 518 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLA 518 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceec
Confidence 99999999888887777777789999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCcchhhhcccccccccchhhHHHHhhhhhhhh
Q psy7289 289 CPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHR 325 (422)
Q Consensus 289 ~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~ 325 (422)
.|.+||++++++|.-||...|..|| ++..+..
T Consensus 519 QP~NCPDeLf~vMacCWallpeeRP-----sf~Qlv~ 550 (563)
T KOG1024|consen 519 QPFNCPDELFTVMACCWALLPEERP-----SFSQLVI 550 (563)
T ss_pred CCCCCcHHHHHHHHHHHhcCcccCC-----CHHHHHH
Confidence 9999999999999999999999998 6554443
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=307.98 Aligned_cols=244 Identities=23% Similarity=0.366 Sum_probs=206.9
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC-CCeEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG-EPMCML 132 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~~lv 132 (422)
.|++.+.||+|+||.||+++...+ ++.||+|.+... ......+.+.+|++++++++||||+++++.+... ..++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTD--GKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCC--CcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEE
Confidence 378899999999999999987543 467999988643 2334556788999999999999999999987643 457999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++++|.+++.... ...+++.++..++.|++.|++|||+++++||||||+||++++++.+||+|||+
T Consensus 79 ~e~~~~~~l~~~l~~~~----------~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~ 148 (257)
T cd08223 79 MGFCEGGDLYHKLKEQK----------GKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGI 148 (257)
T ss_pred ecccCCCcHHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccc
Confidence 99999999999997532 13588999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPED 292 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~ 292 (422)
++....... ......+++.|+|||.+....++.++|||||||++|||++ |..||.+.+..+....+..+..++.|..
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
T cd08223 149 ARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT-LKHAFNAKDMNSLVYRIIEGKLPPMPKD 225 (257)
T ss_pred eEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCccc
Confidence 976533221 1223446788999999998889999999999999999998 8899998888777777777776677788
Q ss_pred CCcchhhhcccccccccchhh
Q psy7289 293 CPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 293 ~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.++.+.+++.+||..+|..|+
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rp 246 (257)
T cd08223 226 YSPELGELIATMLSKRPEKRP 246 (257)
T ss_pred cCHHHHHHHHHHhccCcccCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=313.69 Aligned_cols=244 Identities=26% Similarity=0.415 Sum_probs=205.7
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
.++|++.+.||+|+||.||++++.. .+..||+|..+.. .....+.|.+|+.++++++||||+++++++..+...++|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKE--TGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcC--CCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 4568899999999999999998754 3567999988643 344567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++|+|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+
T Consensus 81 ~e~~~~~~L~~~~~~~~-----------~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~ 149 (280)
T cd06611 81 IEFCDGGALDSIMLELE-----------RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGV 149 (280)
T ss_pred eeccCCCcHHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCcc
Confidence 99999999999986532 3589999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCcccccc-----CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILY-----GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+........ ......+++.|+|||.+.. ..++.++|+|||||++|||++ |..||.+.+..+.+..+..+..+
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 226 (280)
T cd06611 150 SAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQ-MEPPHHELNPMRVLLKILKSEPP 226 (280)
T ss_pred chhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHh-CCCCcccCCHHHHHHHHhcCCCC
Confidence 865432211 1123346788999998753 346789999999999999998 99999988887777777655432
Q ss_pred --CCCCCCCcchhhhcccccccccchhh
Q psy7289 288 --PCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 288 --~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..|..++.++.+++.+||..+|..|+
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp 254 (280)
T cd06611 227 TLDQPSKWSSSFNDFLKSCLVKDPDDRP 254 (280)
T ss_pred CcCCcccCCHHHHHHHHHHhccChhhCc
Confidence 34667899999999999999999997
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=316.01 Aligned_cols=242 Identities=24% Similarity=0.428 Sum_probs=206.2
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
..|+..+.||+|+||.||+|.+.. .+..||+|.++........+.+.+|+.++++++||||+++++++..++..++||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNR--TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcC--CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 346678899999999999998643 356799998875544455678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||+++|+|.+++.. ..+++..+..++.|++.||.|||+++++|+||+|+||++++++.+||+|||++
T Consensus 82 e~~~~~~L~~~~~~-------------~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06642 82 EYLGGGSALDLLKP-------------GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred EccCCCcHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEcccccc
Confidence 99999999998853 24788999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDC 293 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~ 293 (422)
+....... ......++..|+|||++....++.++|||||||++|||++ |..||......+....+..+..+..+..+
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (277)
T cd06642 149 GQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAK-GEPPNSDLHPMRVLFLIPKNSPPTLEGQY 225 (277)
T ss_pred ccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHh-CCCCCcccchhhHHhhhhcCCCCCCCccc
Confidence 76543221 1122345678999999998889999999999999999998 99999887777777666655555556678
Q ss_pred Ccchhhhcccccccccchhh
Q psy7289 294 PPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 294 p~~~~~l~~~cw~~~P~~r~ 313 (422)
+.++.+++.+||..+|..|+
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp 245 (277)
T cd06642 226 SKPFKEFVEACLNKDPRFRP 245 (277)
T ss_pred CHHHHHHHHHHccCCcccCc
Confidence 88999999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=316.19 Aligned_cols=244 Identities=21% Similarity=0.339 Sum_probs=203.2
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC--HHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN--QKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
.|++.+.||+|+||.||+++...+ +..|++|.+..... ......+.+|+++++.++||||+++++.+..++.+++|
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~--~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKET--RQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCC--CcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence 577889999999999999986543 46799998865421 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||+
T Consensus 80 ~e~~~g~~L~~~l~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~ 147 (305)
T cd05609 80 MEYVEGGDCATLLKNI------------GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGL 147 (305)
T ss_pred EecCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCC
Confidence 9999999999999653 2588899999999999999999999999999999999999999999999999
Q ss_pred cccccCCcce-------------EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHH
Q psy7289 213 SRDVYASDYY-------------RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIE 279 (422)
Q Consensus 213 a~~~~~~~~~-------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~ 279 (422)
++....+... .......++..|+|||.+....++.++|+|||||++|||++ |..||.+.++.++..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~-g~~pf~~~~~~~~~~ 226 (305)
T cd05609 148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLV-GCVPFFGDTPEELFG 226 (305)
T ss_pred ccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Confidence 8742111000 01112345678999999988889999999999999999998 999999998888888
Q ss_pred HHHcCCCC--CCCCCCCcchhhhcccccccccchhh
Q psy7289 280 MIRSRQML--PCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 280 ~i~~~~~~--~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.+..+... ..+..+|+++.+++.+||+.+|..|+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 262 (305)
T cd05609 227 QVISDDIEWPEGDEALPADAQDLISRLLRQNPLERL 262 (305)
T ss_pred HHHhcccCCCCccccCCHHHHHHHHHHhccChhhcc
Confidence 77665422 22235788999999999999999997
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=312.49 Aligned_cols=244 Identities=23% Similarity=0.397 Sum_probs=196.9
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
...+|++.+.||+|+||.||+|+...+ +..||+|++..... .....+.+|+.++++++||||+++++++...+..++
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~--~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHT--GELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCC--CeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 345789999999999999999986443 56799998864322 234567899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
||||+++|+|.+++... ..+++.++..++.|++.||+|||+++|+||||||+||++++++.+||+|||
T Consensus 84 v~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg 151 (267)
T cd06646 84 CMEYCGGGSLQDIYHVT------------GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFG 151 (267)
T ss_pred EEeCCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCc
Confidence 99999999999998653 257899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccc---cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC-CC
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESIL---YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ-ML 287 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~-~~ 287 (422)
+++....... ......+++.|+|||.+. ...++.++|||||||++|||++ |..||...++.+....+.... .+
T Consensus 152 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 228 (267)
T cd06646 152 VAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAE-LQPPMFDLHPMRALFLMSKSNFQP 228 (267)
T ss_pred cceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHh-CCCCccccchhhhheeeecCCCCC
Confidence 9986532211 112334678899999874 3457889999999999999998 888997666554433332221 11
Q ss_pred CC---CCCCCcchhhhcccccccccchhh
Q psy7289 288 PC---PEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 288 ~~---p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+. +...+..+.+++++||..+|..|+
T Consensus 229 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 257 (267)
T cd06646 229 PKLKDKTKWSSTFHNFVKISLTKNPKKRP 257 (267)
T ss_pred CCCccccccCHHHHHHHHHHhhCChhhCc
Confidence 21 234678899999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=313.47 Aligned_cols=257 Identities=34% Similarity=0.639 Sum_probs=209.0
Q ss_pred cCcccccccccccceeEEEEEEec--CCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc--CCCe
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCT--SEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLS--GEPM 129 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~~ 129 (422)
..+++.+.||+|+||.||+|++.. ...+..+|||.++..........|.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 457788999999999999998753 234678999998755443456789999999999999999999999877 5578
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEec
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISD 209 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~D 209 (422)
+++|||+++|+|.+++.... ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~-----------~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~d 152 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR-----------DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISD 152 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc-----------cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcc
Confidence 99999999999999997542 2488899999999999999999999999999999999999999999999
Q ss_pred CcccccccCCc-ceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh--------------
Q psy7289 210 FGLSRDVYASD-YYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN-------------- 274 (422)
Q Consensus 210 FGla~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~-------------- 274 (422)
||+++...... ..........+..|+|||.+....++.++||||||+++|||++ |..|+.....
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd05038 153 FGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT-YGDPSQSPPAEFLRMIGIAQGQMI 231 (284)
T ss_pred cccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeec-cCCCcccccchhcccccccccccc
Confidence 99998765322 2222222334567999999988889999999999999999998 7788765432
Q ss_pred -HHHHHHHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 275 -QEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 275 -~~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
..+...+......+.|..||.++.+++.+||..+|..|+ +...+-..|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----t~~ei~~~l 280 (284)
T cd05038 232 VTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRP-----SFADLILIV 280 (284)
T ss_pred HHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCC-----CHHHHHHHH
Confidence 223444555666677888999999999999999999998 555444433
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=314.35 Aligned_cols=261 Identities=26% Similarity=0.392 Sum_probs=195.1
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC-----Ce
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE-----PM 129 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-----~~ 129 (422)
.|+-.+.+|+|+||.||+|....+ .+.||||+.-.....+ .+|+++|+.++|||||+|.-+|.... .+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~--~~~vAIKKv~~d~r~k-----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRET--EEEVAIKKVLQDKRYK-----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCC--CceeEEEEecCCCCcC-----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 456678999999999999998765 5779999875433222 36999999999999999998875322 45
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC-CeEEEe
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG-LTVKIS 208 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~-~~vKl~ 208 (422)
.+||||++. +|.++++..... ...++.-.+.-++.||.+||.|||+.||+||||||+|+|+|.+ +.+|||
T Consensus 98 nlVleymP~-tL~~~~r~~~~~--------~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKic 168 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRA--------NQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKIC 168 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhc--------CCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEec
Confidence 789999996 999999853211 1246777788899999999999999999999999999999965 899999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc--C-
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS--R- 284 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~--~- 284 (422)
|||.|+.+..+.. ...-..|..|.|||.+.+. .|+.+.||||.||++.||+- |.+-|.|.+..+.+..|.. |
T Consensus 169 DFGSAK~L~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~-g~plFpG~s~~dQL~eIik~lG~ 244 (364)
T KOG0658|consen 169 DFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLK-GQPLFPGDSSVDQLVEIIKVLGT 244 (364)
T ss_pred cCCcceeeccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhc-CCcccCCCCHHHHHHHHHHHhCC
Confidence 9999997754331 1122345679999998864 69999999999999999996 9999999877654443321 0
Q ss_pred -----------C-----CC-----C----CCCCCCcchhhhcccccccccchhhHH-HHhhhhhhhhhcccccccccC
Q psy7289 285 -----------Q-----ML-----P----CPEDCPPRMYSLMMECWHEVPVAAGMA-YLCSHHYVHRDLAARNCLVGD 336 (422)
Q Consensus 285 -----------~-----~~-----~----~p~~~p~~~~~l~~~cw~~~P~~r~~~-~lh~~~~i~~dLk~~nil~~~ 336 (422)
. .+ + ....+|++..+|+.+++..+|..|--. .+++|.++ ..|...+..+..
T Consensus 245 Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fF-delr~~~~~l~~ 321 (364)
T KOG0658|consen 245 PTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFF-DELRDPNTKLPN 321 (364)
T ss_pred CCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhh-HHhhCcCccCcC
Confidence 0 00 0 124578889999999999999887422 23344443 333333554433
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=313.07 Aligned_cols=245 Identities=24% Similarity=0.390 Sum_probs=202.6
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
+.+.|++++.||+|+||.||+|+... .+..|++|.+... +....+.+.+|+.+++.++||||+++++.+..+...++
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~--~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKE--TGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI 86 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECC--CCceEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence 34678999999999999999998654 3467999988643 34456789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
||||+++|+|..++.+.. ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||
T Consensus 87 v~e~~~~~~l~~~~~~~~-----------~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg 155 (292)
T cd06644 87 MIEFCPGGAVDAIMLELD-----------RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFG 155 (292)
T ss_pred EEecCCCCcHHHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCc
Confidence 999999999998876432 358899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccc-----cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESIL-----YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~ 286 (422)
++........ ......+++.|+|||.+. ...++.++|||||||++|||++ |..||...+..+....+.....
T Consensus 156 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~ 232 (292)
T cd06644 156 VSAKNVKTLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ-IEPPHHELNPMRVLLKIAKSEP 232 (292)
T ss_pred cceecccccc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhc-CCCCCccccHHHHHHHHhcCCC
Confidence 9875322111 112234567899999885 3347889999999999999998 8999988877766666654432
Q ss_pred C--CCCCCCCcchhhhcccccccccchhh
Q psy7289 287 L--PCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 287 ~--~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+ +.|..++.++.+++++||..+|..|+
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 261 (292)
T cd06644 233 PTLSQPSKWSMEFRDFLKTALDKHPETRP 261 (292)
T ss_pred ccCCCCcccCHHHHHHHHHHhcCCcccCc
Confidence 2 34567888999999999999999997
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=313.80 Aligned_cols=242 Identities=28% Similarity=0.460 Sum_probs=201.7
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
..+|++++.||+|+||.||++++..+ +..||+|++...........+.+|+++++.++||||+++++++.....+++|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~--~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPT--GTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCC--CcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 35688999999999999999987543 4679999876554445567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCCeEEEecCc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCS-HHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++++||||||+||++++++.++|+|||
T Consensus 82 ~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~g 149 (284)
T cd06620 82 MEFMDCGSLDRIYKKG------------GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFG 149 (284)
T ss_pred EecCCCCCHHHHHHhc------------cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCC
Confidence 9999999999998653 258899999999999999999997 689999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChH-----------HHHHH
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ-----------EVIEM 280 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~-----------~~~~~ 280 (422)
++....... .....++..|+|||++....++.++|||||||++||+++ |..||...+.. +....
T Consensus 150 l~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
T cd06620 150 VSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELAL-GKFPFAFSNIDDDGQDDPMGILDLLQQ 224 (284)
T ss_pred cccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHh-CCCCCcccchhhhhhhhhhHHHHHHHH
Confidence 987542211 123356789999999988889999999999999999998 99999865542 23333
Q ss_pred HHcCCCCCCCCC-CCcchhhhcccccccccchhh
Q psy7289 281 IRSRQMLPCPED-CPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 281 i~~~~~~~~p~~-~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+.....+..|.. +|..+.+|+.+||..+|..|+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 258 (284)
T cd06620 225 IVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERP 258 (284)
T ss_pred HhhccCCCCCchhcCHHHHHHHHHHhcCCcccCc
Confidence 433333344443 888999999999999999997
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=308.17 Aligned_cols=215 Identities=28% Similarity=0.481 Sum_probs=179.1
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC-HHhHHHHHHHHHHHhcCCCCc-eeeEeeEEEcCC----
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN-QKTASDFRREVDLMSELRHPN-IVCLLGVCLSGE---- 127 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~Hpn-Iv~l~g~~~~~~---- 127 (422)
..|+.+++||+|+||+||+|+.+.++ ..||+|+++.... +..-..-.+|+.+|+.|+|+| ||+|++++.+.+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g--~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTG--KFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCC--CEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 34667888999999999999987654 7799999875443 222345679999999999999 999999998877
Q ss_pred --CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 128 --PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 128 --~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
.+++|+||+.. +|.+|+....+.. ..++...+..++.||+.||+|||+++|+||||||+||||++.|.+
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~--------~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~l 159 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKP--------QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVL 159 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccc--------cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcE
Confidence 79999999975 9999997754211 246778899999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~ 282 (422)
||+|||+|+...-.. ..-+...+|..|.|||++.+. .|++..||||+|||+.||++ +.+-|.+.+..+.+..|-
T Consensus 160 KlaDFGlAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~-~~~LFpG~se~~ql~~If 234 (323)
T KOG0594|consen 160 KLADFGLARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFT-RRPLFPGDSEIDQLFRIF 234 (323)
T ss_pred eeeccchHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHh-CCCCCCCCcHHHHHHHHH
Confidence 999999998543221 123445678899999999876 69999999999999999998 888898988877666664
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=311.68 Aligned_cols=236 Identities=24% Similarity=0.404 Sum_probs=195.0
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFE 134 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E 134 (422)
++++.+.||+|+||.||+|+...+ +..||+|.+.........+.+.+|++++++++||||+++++.+...+..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLT--RRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCC--CcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 467889999999999999986543 467999998655445556789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccc
Q psy7289 135 FMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR 214 (422)
Q Consensus 135 ~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~ 214 (422)
|+++|+|..+. .+++..+..++.|++.||+|||+++|+|+||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~l~~~~----------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~ 143 (279)
T cd06619 80 FMDGGSLDVYR----------------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVST 143 (279)
T ss_pred cCCCCChHHhh----------------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcce
Confidence 99999997542 36788889999999999999999999999999999999999999999999997
Q ss_pred cccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh-------HHHHHHHHcCCCC
Q psy7289 215 DVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN-------QEVIEMIRSRQML 287 (422)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~-------~~~~~~i~~~~~~ 287 (422)
..... ......++..|+|||++....++.++|||||||++|||++ |..||..... .+....+......
T Consensus 144 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (279)
T cd06619 144 QLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELAL-GRFPYPQIQKNQGSLMPLQLLQCIVDEDPP 218 (279)
T ss_pred ecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHh-CCCCchhhcccccccchHHHHHHHhccCCC
Confidence 65322 1223456789999999998889999999999999999998 9999975432 2233333333222
Q ss_pred CC-CCCCCcchhhhcccccccccchhh
Q psy7289 288 PC-PEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 288 ~~-p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.. ....++++.+++.+||+.+|..|+
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~P~~Rp 245 (279)
T cd06619 219 VLPVGQFSEKFVHFITQCMRKQPKERP 245 (279)
T ss_pred CCCCCcCCHHHHHHHHHHhhCChhhCC
Confidence 22 234677899999999999999997
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=322.09 Aligned_cols=244 Identities=24% Similarity=0.367 Sum_probs=212.5
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
++.-|.+.+.||+|.|.+|-+|++.-+ +..||||++.+. .+.....++.+|++.|+-++|||||+||++......+|
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFT--GekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly 93 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFT--GEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY 93 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcc--cceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence 455688899999999999999987654 467999999643 33444567889999999999999999999999989999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec-CCCeEEEec
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVG-DGLTVKISD 209 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~-~~~~vKl~D 209 (422)
+|+|+-.+|+|++||.++. ..++++.+.+++.||+.|+.|+|+..+|||||||+||.+- .-|-|||.|
T Consensus 94 LiLELGD~GDl~DyImKHe-----------~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTD 162 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKHE-----------EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTD 162 (864)
T ss_pred EEEEecCCchHHHHHHhhh-----------ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeee
Confidence 9999999999999999874 3589999999999999999999999999999999999775 558999999
Q ss_pred CcccccccCCcceEeccCCCCCccccCccccccCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFT-TESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP 288 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 288 (422)
||++....... ...+.+|++.|-|||.+.+..|+ +++||||||||||-+++ |++||...+..|.+.+|..-. ..
T Consensus 163 FGFSNkf~PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVC-Gq~PFqeANDSETLTmImDCK-Yt 237 (864)
T KOG4717|consen 163 FGFSNKFQPGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVC-GQPPFQEANDSETLTMIMDCK-YT 237 (864)
T ss_pred ccccccCCCcc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHh-CCCccccccchhhhhhhhccc-cc
Confidence 99997655432 33466788999999999999887 57899999999998887 999999999999999997643 45
Q ss_pred CCCCCCcchhhhcccccccccchhh
Q psy7289 289 CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 289 ~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.|...+.+.++||..++..+|..|+
T Consensus 238 vPshvS~eCrdLI~sMLvRdPkkRA 262 (864)
T KOG4717|consen 238 VPSHVSKECRDLIQSMLVRDPKKRA 262 (864)
T ss_pred CchhhhHHHHHHHHHHHhcCchhhc
Confidence 6888899999999999999998886
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=322.90 Aligned_cols=240 Identities=25% Similarity=0.323 Sum_probs=190.2
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC----
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE---- 127 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~---- 127 (422)
..+|++.+.||+|+||.||+++... .+..||||.+... ........+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTV--LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcC--CCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 4678999999999999999997643 3577999998643 23344567889999999999999999999986543
Q ss_pred --CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 128 --PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 128 --~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
.+|+||||+.+ +|.+.+.. .+++..+..++.|++.||+|||+++|+||||||+|||++.++.+
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~--------------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~ 162 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM--------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 162 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc--------------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCE
Confidence 47999999975 66666632 37888899999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH---
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR--- 282 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~--- 282 (422)
||+|||+++...... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.
T Consensus 163 kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~ 238 (359)
T cd07876 163 KILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVK-GSVIFQGTDHIDQWNKVIEQL 238 (359)
T ss_pred EEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhc
Confidence 999999997543221 1233456888999999999899999999999999999998 999998776543322211
Q ss_pred --------------------cCCCCC------------------CCCCCCcchhhhcccccccccchhh
Q psy7289 283 --------------------SRQMLP------------------CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 283 --------------------~~~~~~------------------~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.....+ .+...++.+.+|+.+||..+|..|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~ 307 (359)
T cd07876 239 GTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRI 307 (359)
T ss_pred CCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCC
Confidence 100000 0112356788999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=313.97 Aligned_cols=243 Identities=25% Similarity=0.434 Sum_probs=202.8
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFE 134 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E 134 (422)
+|++++.||+|+||.||++++.. .+..||+|.++..........+.+|+.++++++||||+++++++...+..++|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~--~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRP--TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcC--CCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 57889999999999999998753 3567999988755455556789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 135 FMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCS-HHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 135 ~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
|+++++|.+++..... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 80 ~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 150 (286)
T cd06622 80 YMDAGSLDKLYAGGVA---------TEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150 (286)
T ss_pred ecCCCCHHHHHHhccc---------cCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCc
Confidence 9999999999865311 1358999999999999999999997 59999999999999999999999999998
Q ss_pred ccccCCcceEeccCCCCCccccCccccccC------CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHH---HHHcC
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYG------KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIE---MIRSR 284 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~------~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~---~i~~~ 284 (422)
+..... ......+++.|+|||.+... .++.++|+|||||++|||++ |..||...+...... .+..+
T Consensus 151 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 225 (286)
T cd06622 151 GNLVAS----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMAL-GRYPYPPETYANIFAQLSAIVDG 225 (286)
T ss_pred ccccCC----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHh-CCCCCCCcchhhHHHHHHHHhhc
Confidence 765322 12233456789999988543 35889999999999999998 999998766555443 34455
Q ss_pred CCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 285 QMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 285 ~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.....|..+++++.+++.+||..+|..|+
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 254 (286)
T cd06622 226 DPPTLPSGYSDDAQDFVAKCLNKIPNRRP 254 (286)
T ss_pred CCCCCCcccCHHHHHHHHHHcccCcccCC
Confidence 55667778999999999999999999996
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=307.81 Aligned_cols=242 Identities=26% Similarity=0.441 Sum_probs=200.6
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-----CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-----NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
|++.+.||+|+||.||+|... .+..+|+|.++... .......+.+|+++++.++||||+++++++.+....+
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~---~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 78 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTN---QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTIS 78 (265)
T ss_pred ccccceEeccCCeEEEEEEEc---CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEE
Confidence 667889999999999999752 35679999876432 1233457889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
++|||+++|+|.+++.+. ..+++..+..++.|++.||+|||+.+|+|+||||+||++++++.+||+||
T Consensus 79 lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~df 146 (265)
T cd06631 79 IFMEFVPGGSISSILNRF------------GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDF 146 (265)
T ss_pred EEEecCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccc
Confidence 999999999999999653 24788999999999999999999999999999999999999999999999
Q ss_pred cccccccCCc----ceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc--C
Q psy7289 211 GLSRDVYASD----YYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS--R 284 (422)
Q Consensus 211 Gla~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~--~ 284 (422)
|+++...... .........++..|+|||.+....++.++|||||||++|||++ |..||...+..+....+.. +
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 225 (265)
T cd06631 147 GCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMAT-GKPPLASMDRLAAMFYIGAHRG 225 (265)
T ss_pred hhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHh-CCCccccCChHHHHHHhhhccC
Confidence 9987543211 1111123346788999999998889999999999999999998 9999988776554444433 2
Q ss_pred CCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 285 QMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 285 ~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..++.|..++.++.+++++||..+|..|+
T Consensus 226 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp 254 (265)
T cd06631 226 LMPRLPDSFSAAAIDFVTSCLTRDQHERP 254 (265)
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCCcccCC
Confidence 34456778899999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=315.43 Aligned_cols=240 Identities=25% Similarity=0.366 Sum_probs=197.5
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFE 134 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E 134 (422)
+|++.+.||+|+||.||++++..+ +..+|+|.++..........+.+|++++++++||||+++++++.+++.+++|||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~--~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPS--GLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCC--CeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 578899999999999999986543 467999988755455556678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 135 FMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCS-HHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 135 ~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
|+++|+|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+|||+++++.+||+|||++
T Consensus 80 y~~~~~L~~~l~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (308)
T cd06615 80 HMDGGSLDQVLKKA------------GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 147 (308)
T ss_pred ccCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCc
Confidence 99999999999753 257889999999999999999998 58999999999999999999999999998
Q ss_pred ccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc----------
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS---------- 283 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~---------- 283 (422)
+..... ......++..|+|||++.+..++.++|+|||||++|||++ |..||...+.......+..
T Consensus 148 ~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (308)
T cd06615 148 GQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAI-GRYPIPPPDAKELEAMFGRPVSEGEAKES 222 (308)
T ss_pred cccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCcchhhHHHhhcCccccccccCC
Confidence 754322 1223456788999999888889999999999999999998 9999976654443332221
Q ss_pred --------------------------CCCCCCC-CCCCcchhhhcccccccccchhh
Q psy7289 284 --------------------------RQMLPCP-EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 284 --------------------------~~~~~~p-~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
...+..| ..+++++.+++.+||..+|..|+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 279 (308)
T cd06615 223 HRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERA 279 (308)
T ss_pred cccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCc
Confidence 1111111 13567899999999999999997
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=313.78 Aligned_cols=242 Identities=23% Similarity=0.421 Sum_probs=201.1
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
..+|++.+.||+|+||.||+|+... .+..|++|.+...... ..+.+.+|+.+++.++||||+++++.+..+...++|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~--~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVA--TGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECC--CCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 4578889999999999999997543 3467999988654332 346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++|+|.+++... .+++.++..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+
T Consensus 96 ~e~~~~~~L~~~~~~~-------------~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~ 162 (296)
T cd06654 96 MEYLAGGSLTDVVTET-------------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF 162 (296)
T ss_pred ecccCCCCHHHHHHhc-------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECcccc
Confidence 9999999999998642 478889999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC--CCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM--LPCP 290 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~--~~~p 290 (422)
++....... ......+++.|+|||.+....++.++|||||||++|||++ |..||...++.+....+..... .+.|
T Consensus 163 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T cd06654 163 CAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNENPLRALYLIATNGTPELQNP 239 (296)
T ss_pred chhcccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHhHHHHhcCCCCCCCCc
Confidence 876432211 1223356788999999988889999999999999999998 9999988776544333332222 2345
Q ss_pred CCCCcchhhhcccccccccchhh
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
...++.+.+++.+||..+|..|+
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rp 262 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRG 262 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCc
Confidence 67788899999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=326.99 Aligned_cols=197 Identities=20% Similarity=0.288 Sum_probs=166.9
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
+...+|++++.||+|+||.||+++...+ ++.||+|... ...+.+|+++|++|+|||||++++++......+
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~--~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKT--CEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCC--CCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 3446799999999999999999986543 5679999643 234678999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+|||++. ++|.+++... ..+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 160 lv~e~~~-~~L~~~l~~~------------~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DF 226 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAK------------RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDF 226 (391)
T ss_pred EEEecCC-CCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeC
Confidence 9999985 7999988653 24788999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG 271 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~ 271 (422)
|+++....... .......+|+.|+|||++....++.++|||||||++|||++ |..||.+
T Consensus 227 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~ 285 (391)
T PHA03212 227 GAACFPVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT-CHDSLFE 285 (391)
T ss_pred Ccccccccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHH-CCCCcCC
Confidence 99974322111 11223457899999999998899999999999999999998 8777754
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=309.76 Aligned_cols=245 Identities=23% Similarity=0.401 Sum_probs=198.5
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
....+|++.+.||+|+||.||+|+... .+..||+|.++.... .....+.+|+.+++.++||||+++++++...+..+
T Consensus 6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06645 6 NPQEDFELIQRIGSGTYGDVYKARNVN--TGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW 82 (267)
T ss_pred CcHHHHHHHHHhCCCCCeEEEEEEEcC--CCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence 344578889999999999999998654 356799998865432 33456789999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
++|||+++|+|.+++... ..+++.++..++.|++.||+|||++|++||||||+||+++.++.+||+||
T Consensus 83 lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~df 150 (267)
T cd06645 83 ICMEFCGGGSLQDIYHVT------------GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADF 150 (267)
T ss_pred EEEeccCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcc
Confidence 999999999999998653 35899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccc---cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESIL---YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
|++....... .......++..|+|||++. ...++.++|+|||||++|||++ |..||....+.............
T Consensus 151 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~-~~~p~~~~~~~~~~~~~~~~~~~ 227 (267)
T cd06645 151 GVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAE-LQPPMFDLHPMRALFLMTKSNFQ 227 (267)
T ss_pred eeeeEccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhc-CCCCcccccchhhHHhhhccCCC
Confidence 9987543221 1122345678999999874 4558899999999999999998 88898776655444333322221
Q ss_pred C-C---CCCCCcchhhhcccccccccchhh
Q psy7289 288 P-C---PEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 288 ~-~---p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+ . ...+|..+.+++.+||..+|..|+
T Consensus 228 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 257 (267)
T cd06645 228 PPKLKDKMKWSNSFHHFVKMALTKNPKKRP 257 (267)
T ss_pred CCcccccCCCCHHHHHHHHHHccCCchhCc
Confidence 1 1 124677899999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=304.75 Aligned_cols=243 Identities=23% Similarity=0.365 Sum_probs=208.5
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
+|++.+.||+|+||.||++.... ....+|+|.+... ........+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKA--DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcC--CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEE
Confidence 47788999999999999998654 4577999987543 23445678999999999999999999999999889999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC-CeEEEecCcc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG-LTVKISDFGL 212 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~-~~vKl~DFGl 212 (422)
||+++++|.+++.... ...+++..+..++.|++.||+|||+++++||||||+||+++++ +.+||+|||+
T Consensus 79 e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~ 148 (256)
T cd08220 79 EYAPGGTLAEYIQKRC----------NSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGI 148 (256)
T ss_pred ecCCCCCHHHHHHHhc----------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCC
Confidence 9999999999997642 1247899999999999999999999999999999999999854 5789999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPED 292 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~ 292 (422)
++...... ......++..|+|||.+....++.++||||||+++|||++ |..||.+.+.......+..+...+.|..
T Consensus 149 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (256)
T cd08220 149 SKILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELAS-LKRAFEAANLPALVLKIMSGTFAPISDR 224 (256)
T ss_pred ceecCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHh-CCCCcccCchHHHHHHHHhcCCCCCCCC
Confidence 98654321 1122345778999999988889999999999999999998 8899999888888888887777778888
Q ss_pred CCcchhhhcccccccccchhh
Q psy7289 293 CPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 293 ~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+++.+.+++.+||..+|..|+
T Consensus 225 ~~~~l~~li~~~l~~~p~~Rp 245 (256)
T cd08220 225 YSPDLRQLILSMLNLDPSKRP 245 (256)
T ss_pred cCHHHHHHHHHHccCChhhCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=309.44 Aligned_cols=247 Identities=22% Similarity=0.395 Sum_probs=202.6
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc--CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
.+|++.+.||+|+||.||+|+...+ +..++||.+... ........+.+|+.+++.++||||+++++++.+++..++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~--~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLD--GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCC--CceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence 3577889999999999999986543 467999987542 233445689999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
+|||+++++|.+++...... ...+++..+..++.||+.||+|||+++++|+||||+||+++.++.+||+|||
T Consensus 80 v~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg 151 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQ--------KRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EEEecCCCCHHHHHHHhhcc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcch
Confidence 99999999999998643211 1358899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh--HHHHHHHHcCCCCCC
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN--QEVIEMIRSRQMLPC 289 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~--~~~~~~i~~~~~~~~ 289 (422)
+++....... ......++..|+|||.+....++.++|+||||+++|||++ |..||.+... .+....+.....++.
T Consensus 152 ~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 228 (267)
T cd08229 152 LGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-LQSPFYGDKMNLYSLCKKIEQCDYPPL 228 (267)
T ss_pred hhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHh-CCCCcccccchHHHHhhhhhcCCCCCC
Confidence 9876533221 1122346778999999988889999999999999999998 8899976543 355555555444443
Q ss_pred C-CCCCcchhhhcccccccccchhh
Q psy7289 290 P-EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 290 p-~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
| ..+++.+.+++.+||..+|..|+
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~Rp 253 (267)
T cd08229 229 PSDHYSEELRQLVNMCINPDPEKRP 253 (267)
T ss_pred CcccccHHHHHHHHHhcCCCcccCC
Confidence 3 46788999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=306.87 Aligned_cols=247 Identities=22% Similarity=0.398 Sum_probs=206.2
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccC--cCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKE--NANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
.+|++.+.||+|+||.||+|.... .+..||+|.++. .........+.+|++++++++|+||+++++++.+.+..++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLL--DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcC--CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 367889999999999999998753 356799998753 2233446789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
||||+++|+|.+++...... ...+++.++..++.|++.||.|||+.+++||||||+||+++.++.+||+|||
T Consensus 80 v~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~ 151 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQ--------KRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EEecCCCCCHHHHHHHhccc--------CCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccc
Confidence 99999999999998653211 1358899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCC--ChHHHHHHHHcCCCCCC
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY--SNQEVIEMIRSRQMLPC 289 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~--~~~~~~~~i~~~~~~~~ 289 (422)
+++....... ......+++.|+|||.+....++.++|||||||++|||++ |..||... +..++...+..+...+.
T Consensus 152 ~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 228 (267)
T cd08224 152 LGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-LQSPFYGDKMNLYSLCKKIEKCDYPPL 228 (267)
T ss_pred eeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHH-CCCCcccCCccHHHHHhhhhcCCCCCC
Confidence 9875433211 1122345678999999988889999999999999999998 88998654 34566677777777777
Q ss_pred CC-CCCcchhhhcccccccccchhh
Q psy7289 290 PE-DCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 290 p~-~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
|. .++..+.+++..||..+|..|+
T Consensus 229 ~~~~~~~~~~~~i~~cl~~~p~~Rp 253 (267)
T cd08224 229 PADHYSEELRDLVSRCINPDPEKRP 253 (267)
T ss_pred ChhhcCHHHHHHHHHHcCCCcccCC
Confidence 66 7888999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=327.64 Aligned_cols=253 Identities=20% Similarity=0.267 Sum_probs=198.0
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
+...+|++++.||+|+||.||++..........||+|.+... ..+.+|+++|++++|||||++++++......|
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 344579999999999999999998765555678999987543 23458999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
++||++. ++|.+++... ..+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 163 lv~e~~~-~~l~~~l~~~------------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~Df 229 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRS------------GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDF 229 (392)
T ss_pred EEehhcC-CCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccC
Confidence 9999986 6899988432 35899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChH----HHHHHHHc---
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ----EVIEMIRS--- 283 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~----~~~~~i~~--- 283 (422)
|+++...............+|+.|+|||++....++.++|||||||++|||++ |..||.+.... .+...+..
T Consensus 230 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~-g~~pf~~~~~~~~~~~l~~i~~~~~~ 308 (392)
T PHA03207 230 GAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSV-KNVTLFGKQVKSSSSQLRSIIRCMQV 308 (392)
T ss_pred ccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHH-CCCCCCCCCCCCcHHHHHHHHHHhcc
Confidence 99976544332222234567899999999998899999999999999999998 88999775432 11111110
Q ss_pred ----------------------CCCCC--CC-----CCCCcchhhhcccccccccchhhHH-HHhhhhhh
Q psy7289 284 ----------------------RQMLP--CP-----EDCPPRMYSLMMECWHEVPVAAGMA-YLCSHHYV 323 (422)
Q Consensus 284 ----------------------~~~~~--~p-----~~~p~~~~~l~~~cw~~~P~~r~~~-~lh~~~~i 323 (422)
..+++ .| ...+.++.+++.+||..+|..|+-. -+..|.++
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f 378 (392)
T PHA03207 309 HPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLF 378 (392)
T ss_pred CccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchh
Confidence 00111 11 1345677889999999999988722 23444444
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=309.39 Aligned_cols=242 Identities=23% Similarity=0.429 Sum_probs=207.5
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
+-|++.+.||+|+||.||+|.... .+..||+|.............+.+|+.++++++||||+++++++..++..++||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNR--TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECC--CCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence 346778899999999999997643 357899998765444455678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||+++|+|.+++.. ..+++..+..++.|++.|+.|||+++++|+||||+||++++++.++|+|||++
T Consensus 82 e~~~~~~l~~~i~~-------------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06641 82 EYLGGGSALDLLEP-------------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA 148 (277)
T ss_pred EeCCCCcHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccc
Confidence 99999999999854 24788999999999999999999999999999999999999999999999998
Q ss_pred ccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDC 293 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~ 293 (422)
+....... ......++..|+|||.+....++.++|+|||||++|||++ |..||...+.......+..+..+..+..+
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (277)
T cd06641 149 GQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPHSELHPMKVLFLIPKNNPPTLEGNY 225 (277)
T ss_pred eecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCccchHHHHHHHhcCCCCCCCccc
Confidence 76543221 1122345678999999988888999999999999999998 99999988887777777766666677788
Q ss_pred Ccchhhhcccccccccchhh
Q psy7289 294 PPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 294 p~~~~~l~~~cw~~~P~~r~ 313 (422)
|.++.+++.+||..+|..|+
T Consensus 226 ~~~~~~~i~~~l~~~p~~Rp 245 (277)
T cd06641 226 SKPLKEFVEACLNKEPSFRP 245 (277)
T ss_pred CHHHHHHHHHHccCChhhCc
Confidence 99999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=330.10 Aligned_cols=252 Identities=26% Similarity=0.453 Sum_probs=210.3
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
+..|.-++.||.|+||.||-|+...+ .+.||||++.-.. +...-+++++|++.|++|+|||+|.+.|+|......+
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~n--~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaW 102 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVRN--SEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAW 102 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccCc--cceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHH
Confidence 34455678999999999999987544 5789999986443 2334578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+|||||-| +-.|+|.-+. .++-+-++..|+.+.+.||+|||+++.||||||..||||++.|.|||+||
T Consensus 103 LVMEYClG-SAsDlleVhk-----------KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDF 170 (948)
T KOG0577|consen 103 LVMEYCLG-SASDLLEVHK-----------KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADF 170 (948)
T ss_pred HHHHHHhc-cHHHHHHHHh-----------ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccc
Confidence 99999975 6566664432 46889999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccc---cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESIL---YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
|.|..+. .....+|||.|||||++. .+.|+-++|||||||+..|+.. .++|++.++....+-.|.....+
T Consensus 171 GSAsi~~------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAE-RkPPlFnMNAMSALYHIAQNesP 243 (948)
T KOG0577|consen 171 GSASIMA------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNESP 243 (948)
T ss_pred cchhhcC------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhh-cCCCccCchHHHHHHHHHhcCCC
Confidence 9986543 234568999999999986 4679999999999999999997 78999999999888888766555
Q ss_pred CCC-CCCCcchhhhcccccccccchhhHH-HHhhhhhhhh
Q psy7289 288 PCP-EDCPPRMYSLMMECWHEVPVAAGMA-YLCSHHYVHR 325 (422)
Q Consensus 288 ~~p-~~~p~~~~~l~~~cw~~~P~~r~~~-~lh~~~~i~~ 325 (422)
..+ .+.+..+..++..|+.+-|..|+-. -|..|.+|.|
T Consensus 244 tLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 244 TLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred CCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 444 3577889999999999999888643 4556666654
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=305.24 Aligned_cols=244 Identities=19% Similarity=0.332 Sum_probs=210.3
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
+|++.+.||+|+||.||+++... ++..|++|.+... ........+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKE--DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcC--CCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEE
Confidence 47889999999999999988643 3567999987642 23445568899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||+++++|.+++..... ..+++.++.+++.|++.||.|||+++++|+||+|+||+++.++.+||+|||++
T Consensus 79 e~~~~~~l~~~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~ 148 (256)
T cd08218 79 DYCEGGDLYKKINAQRG----------VLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIA 148 (256)
T ss_pred ecCCCCcHHHHHHhccC----------CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccce
Confidence 99999999999875321 24788999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDC 293 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~ 293 (422)
........ ......+++.|+|||++....++.++|+|||||++|||++ |..||...+..+....+..+..++.|..+
T Consensus 149 ~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (256)
T cd08218 149 RVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT-LKHAFEAGNMKNLVLKIIRGSYPPVSSHY 225 (256)
T ss_pred eecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHc-CCCCccCCCHHHHHHHHhcCCCCCCcccC
Confidence 76533221 1122345778999999988889999999999999999998 99999988888888888888877888899
Q ss_pred Ccchhhhcccccccccchhh
Q psy7289 294 PPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 294 p~~~~~l~~~cw~~~P~~r~ 313 (422)
+.++.+++.+||+.+|..|+
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp 245 (256)
T cd08218 226 SYDLRNLVSQLFKRNPRDRP 245 (256)
T ss_pred CHHHHHHHHHHhhCChhhCc
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=347.84 Aligned_cols=249 Identities=22% Similarity=0.377 Sum_probs=200.0
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC--
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG-- 126 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-- 126 (422)
+....+|++++.||+|+||.||+|+... ....||+|.+... ........|.+|+.+|+.|+|||||++++++...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~--tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKR--TQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECC--CCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 4555689999999999999999998754 3567999988643 3444567899999999999999999999988643
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhC-------CccccCCCCCceee
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSH-------HYVHRDLAARNCLV 199 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-------~ivHrDlKp~NiLl 199 (422)
..+|+||||+++|+|.++|...... ...+++..++.|+.||+.||+|||+. +||||||||+||||
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~--------~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL 158 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKM--------FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL 158 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhc--------cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEe
Confidence 4689999999999999999753211 13589999999999999999999984 49999999999999
Q ss_pred cC-----------------CCeEEEecCcccccccCCcceEeccCCCCCccccCcccccc--CCCCCchhHHhHHHHHHH
Q psy7289 200 GD-----------------GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY--GKFTTESDVWSYGVVLWE 260 (422)
Q Consensus 200 ~~-----------------~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwS~Gvil~E 260 (422)
+. ...+||+|||+++...... ......+|+.|+|||++.. ..++.++|||||||++||
T Consensus 159 ~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYE 235 (1021)
T PTZ00266 159 STGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE 235 (1021)
T ss_pred ecCccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHH
Confidence 64 2358999999998653322 1233467899999999864 458899999999999999
Q ss_pred HHhCCCCCCCCCChH-HHHHHHHcCCCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 261 VYSYGLQPYYGYSNQ-EVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 261 l~t~g~~Pf~~~~~~-~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
|++ |..||...+.. +++..+..+..++ ....++++.+||..||..+|..|+
T Consensus 236 LLT-Gk~PF~~~~~~~qli~~lk~~p~lp-i~~~S~eL~dLI~~~L~~dPeeRP 287 (1021)
T PTZ00266 236 LCS-GKTPFHKANNFSQLISELKRGPDLP-IKGKSKELNILIKNLLNLSAKERP 287 (1021)
T ss_pred HHH-CCCCCCcCCcHHHHHHHHhcCCCCC-cCCCCHHHHHHHHHHhcCChhHCc
Confidence 998 99999866554 4445555443333 245788999999999999999997
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=308.52 Aligned_cols=244 Identities=25% Similarity=0.404 Sum_probs=214.9
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP 128 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 128 (422)
+--.++++++.||+|.||+|.+++-+.+ ++.+|+|++++.. ...+..+-+.|-++|...+||.+..|.-.|+..+.
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat--~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr 242 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKAT--GKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR 242 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeeccc--CceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence 3445678999999999999999876544 5789999997643 34556778889999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
+|+||||..||.|+-+|... ..++++..+.+..+|.+||.|||+++||.||||.+|.|||.+|++||+
T Consensus 243 lCFVMeyanGGeLf~HLsre------------r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKit 310 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSRE------------RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKIT 310 (516)
T ss_pred EEEEEEEccCceEeeehhhh------------hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEee
Confidence 99999999999999888653 368999999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP 288 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 288 (422)
||||++..-.. .....+.+|||.|+|||++....|+.++|+|.+||++|||++ |+.||+..+...+.+.|.... +.
T Consensus 311 DFGLCKE~I~~--g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmC-GRLPFyn~dh~kLFeLIl~ed-~k 386 (516)
T KOG0690|consen 311 DFGLCKEEIKY--GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMC-GRLPFYNKDHEKLFELILMED-LK 386 (516)
T ss_pred ecccchhcccc--cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHh-ccCcccccchhHHHHHHHhhh-cc
Confidence 99999864322 234567889999999999999999999999999999999998 999999999999998887654 55
Q ss_pred CCCCCCcchhhhcccccccccchh
Q psy7289 289 CPEDCPPRMYSLMMECWHEVPVAA 312 (422)
Q Consensus 289 ~p~~~p~~~~~l~~~cw~~~P~~r 312 (422)
+|...+++...|+.-.+.++|..|
T Consensus 387 FPr~ls~eAktLLsGLL~kdP~kR 410 (516)
T KOG0690|consen 387 FPRTLSPEAKTLLSGLLKKDPKKR 410 (516)
T ss_pred CCccCCHHHHHHHHHHhhcChHhh
Confidence 788999999999999999999775
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=324.29 Aligned_cols=241 Identities=22% Similarity=0.342 Sum_probs=194.2
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC-----Ce
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE-----PM 129 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-----~~ 129 (422)
+++.+.||+|+||.||+++... .+..||||.+.... .....+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPR--DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CcccceeeeCCCEEEEEEEECC--CCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 5678999999999999998643 45779999886432 2334567889999999999999999999998776 78
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEec
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISD 209 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~D 209 (422)
|+||||+. ++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+|
T Consensus 80 ~lv~e~~~-~~l~~~~~~~------------~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~D 146 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSP------------QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICD 146 (372)
T ss_pred EEEeeccc-cCHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEecc
Confidence 99999997 6888887543 3588999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc-----
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS----- 283 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~----- 283 (422)
||+++....... .......+++.|+|||.+.+. .++.++|||||||++|||++ |..||.+.+..+.+..+..
T Consensus 147 fg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~~g~~ 224 (372)
T cd07853 147 FGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLG-RRILFQAQSPIQQLDLITDLLGTP 224 (372)
T ss_pred ccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHHcCCC
Confidence 999976432221 112233567889999998764 47899999999999999998 9999998877665554432
Q ss_pred ------------------C-CCC-------CCCCCCCcchhhhcccccccccchhh
Q psy7289 284 ------------------R-QML-------PCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 284 ------------------~-~~~-------~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
. ..+ .....+++++.+|+.+||..||..|+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~ 280 (372)
T cd07853 225 SLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRI 280 (372)
T ss_pred CHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCc
Confidence 0 011 12234577889999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=305.01 Aligned_cols=244 Identities=23% Similarity=0.339 Sum_probs=204.9
Q ss_pred cccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEecCCC
Q psy7289 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRG 139 (422)
Q Consensus 62 LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~~~G 139 (422)
||.|+||.||+++... .+..|++|.+.... .....+.+.+|+.+++.++||||+++++.+.++..++++|||+++|
T Consensus 1 lg~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKS--KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECC--CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence 7999999999998754 35679999986433 2244568999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccccCC
Q psy7289 140 DLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS 219 (422)
Q Consensus 140 ~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~~ 219 (422)
+|.+++.+. ..+++..+..++.|++.||+|||+++++|+||+|+||++++++.+||+|||+++.....
T Consensus 79 ~L~~~l~~~------------~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 79 ELWTILRDR------------GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred cHHHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence 999999753 24788999999999999999999999999999999999999999999999999866443
Q ss_pred cceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCC--hHHHHHHHHc-CCCCCCCCCCCcc
Q psy7289 220 DYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS--NQEVIEMIRS-RQMLPCPEDCPPR 296 (422)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~--~~~~~~~i~~-~~~~~~p~~~p~~ 296 (422)
. ......++..|+|||.+....++.++|+||||+++|||++ |..||.... ..+....+.. ....+.|..++++
T Consensus 147 ~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (262)
T cd05572 147 Q---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLT-GRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKA 222 (262)
T ss_pred c---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHh-CCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHH
Confidence 2 1122345678999999988889999999999999999998 999998777 5666666654 3456677788999
Q ss_pred hhhhcccccccccchhh------HHHHhhhhhh
Q psy7289 297 MYSLMMECWHEVPVAAG------MAYLCSHHYV 323 (422)
Q Consensus 297 ~~~l~~~cw~~~P~~r~------~~~lh~~~~i 323 (422)
+.+++.+||..+|..|+ +..+.+|.++
T Consensus 223 ~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~ 255 (262)
T cd05572 223 AKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255 (262)
T ss_pred HHHHHHHHccCChhhCcCCcccCHHHHhcChhh
Confidence 99999999999999987 3555555554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=331.86 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=214.9
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
.+.++++-.||.|+||.||+|+.+ +.....|-|++.. .+.....+|+-|+.||....||+||+|++.|...+.++|+
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nk--et~~lAAaKvIet-kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNK--ETKLLAAAKVIET-KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcc--cchhhhhhhhhcc-cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 445678889999999999999865 3345566777653 3456778999999999999999999999999989999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
.|||.||-....+..- ..+|.+.++.-+++|++.||.|||+++|||||||+.|||++-+|.++|+|||+
T Consensus 108 iEFC~GGAVDaimlEL-----------~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGV 176 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLEL-----------GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGV 176 (1187)
T ss_pred EeecCCchHhHHHHHh-----------ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccc
Confidence 9999999998887653 24799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCcccccc-----CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILY-----GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+..... .........|||.|||||+... ..|+.++||||||++|.||.- +.+|....++.-++-.|.....+
T Consensus 177 SAKn~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAq-iEPPHhelnpMRVllKiaKSePP 253 (1187)
T KOG0579|consen 177 SAKNKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQ-IEPPHHELNPMRVLLKIAKSEPP 253 (1187)
T ss_pred cccchh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhc-cCCCccccchHHHHHHHhhcCCC
Confidence 854322 1123456789999999999875 469999999999999999996 99999999999988888754433
Q ss_pred --CCCCCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 288 --PCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 288 --~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
..|...+..+.+++++|+..||..|+ ...|..|.++.
T Consensus 254 TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~ 293 (1187)
T KOG0579|consen 254 TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ 293 (1187)
T ss_pred cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence 35888899999999999999999886 44566677665
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=307.20 Aligned_cols=244 Identities=21% Similarity=0.411 Sum_probs=197.5
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcC-----
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSG----- 126 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~----- 126 (422)
...|++.+.||+|+||.||+|+...+ +..||+|.+.... .....+.+|+.+++++ +||||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~--~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKT--GQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCC--CcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 45678889999999999999987543 5789999886432 2345788999999998 699999999998753
Q ss_pred -CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 127 -EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 127 -~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
...+++|||+++|+|.+++.... ...+++..+..++.|++.||+|||+++|+||||||+||++++++.+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~----------~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~ 150 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTK----------GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEV 150 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhcc----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCE
Confidence 35799999999999999987532 1358899999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCccccc-----cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHH
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL-----YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEM 280 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~ 280 (422)
||+|||+++...... .......+++.|+|||++. ...++.++|||||||++|||++ |..||...........
T Consensus 151 ~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~-g~~p~~~~~~~~~~~~ 227 (272)
T cd06637 151 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE-GAPPLCDMHPMRALFL 227 (272)
T ss_pred EEccCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHh-CCCCccccCHHHHHHH
Confidence 999999997643221 1122345678899999986 3358889999999999999998 8899987766555544
Q ss_pred HHcCC-CCCCCCCCCcchhhhcccccccccchhh
Q psy7289 281 IRSRQ-MLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 281 i~~~~-~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+.... ....+..++..+.+|+.+||..+|..|+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 261 (272)
T cd06637 228 IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRP 261 (272)
T ss_pred HhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCC
Confidence 44332 2233457889999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=311.06 Aligned_cols=241 Identities=23% Similarity=0.435 Sum_probs=202.8
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
.+|++.+.||.|+||.||+|.... .+..|++|.+..... ...+.+.+|+.+++.++||||+++++++...+.+++|+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~--~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVA--TGQEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcC--CCcEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 468889999999999999997643 356799998864332 23467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||+++|+|.+++... .+++.++..++.|++.||+|||+++++||||||+||+++.++.+||+|||++
T Consensus 96 e~~~~~~L~~~~~~~-------------~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~ 162 (296)
T cd06655 96 EYLAGGSLTDVVTET-------------CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFC 162 (296)
T ss_pred EecCCCcHHHHHHhc-------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccc
Confidence 999999999988642 4789999999999999999999999999999999999999999999999998
Q ss_pred ccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC--CCCCCC
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ--MLPCPE 291 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~--~~~~p~ 291 (422)
+....... ......++..|+|||.+....++.++|||||||++|||++ |..||.+.+..+....+.... ....|.
T Consensus 163 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T cd06655 163 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPYLNENPLRALYLIATNGTPELQNPE 239 (296)
T ss_pred hhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCcccCCcc
Confidence 76543221 1223346778999999988889999999999999999998 999998887765554444332 233567
Q ss_pred CCCcchhhhcccccccccchhh
Q psy7289 292 DCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 292 ~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.+++.+.+++.+||..+|..|+
T Consensus 240 ~~~~~~~~li~~~l~~dp~~Rp 261 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEKRG 261 (296)
T ss_pred cCCHHHHHHHHHHhhcChhhCC
Confidence 7889999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=306.84 Aligned_cols=244 Identities=27% Similarity=0.396 Sum_probs=191.5
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc-----CC
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLS-----GE 127 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-----~~ 127 (422)
..|..++.||+|+||.|..+..+.++ ..||||++... .+....++-.||+++|+.++|+||+.+++++.. -+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~--~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTG--EKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCC--CEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 44555789999999999999876554 78999998633 344556788999999999999999999999875 23
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
.+|+|+|+| .-||++.++.. ..|+++.+..++.|++.||.|+||.+|+||||||+|+|++.+..+||
T Consensus 100 DvYiV~elM-etDL~~iik~~------------~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI 166 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQ------------QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKI 166 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcC------------ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEe
Confidence 589999999 45999999764 24899999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc---
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS--- 283 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~--- 283 (422)
+||||||...........+....|..|.|||.+.. ..|+.+.||||.|||+.||++ |++-|.|.+.-+-+..|..
T Consensus 167 ~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~-gkplFpG~d~v~Ql~lI~~~lG 245 (359)
T KOG0660|consen 167 CDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLT-GKPLFPGKDYVHQLQLILELLG 245 (359)
T ss_pred ccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHc-CCCCCCCCchHHHHHHHHHhcC
Confidence 99999997754311122244556788999998764 579999999999999999998 9888888765444333321
Q ss_pred ----------------------CCCCCCC-----CCCCcchhhhcccccccccchhh
Q psy7289 284 ----------------------RQMLPCP-----EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 284 ----------------------~~~~~~p-----~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
...++.| +++++...+|+.+.+..||..|.
T Consensus 246 tP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRi 302 (359)
T KOG0660|consen 246 TPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRI 302 (359)
T ss_pred CCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccC
Confidence 1111111 24556667777777777777663
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=304.61 Aligned_cols=244 Identities=25% Similarity=0.461 Sum_probs=202.0
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
..+|++.+.||+|+||.||+|....+ ...+++|.+..... ...+.+.+|+.++++++||||+++++++.+...++++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~--~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIAT--GELVAIKVIKLEPG-DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCC--CCEEEEEEEEcCch-hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 35688899999999999999987543 35699998865432 2457889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++++|.+++.... ..+++.++..++.|++.||+|||+++++|+||||+||++++++.+||+|||+
T Consensus 79 ~e~~~~~~l~~~~~~~~-----------~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~ 147 (262)
T cd06613 79 MEYCGGGSLQDIYQVTR-----------GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGV 147 (262)
T ss_pred EeCCCCCcHHHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECcccc
Confidence 99999999999986531 3588999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccC---CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC-
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYG---KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP- 288 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~- 288 (422)
+........ ......++..|+|||.+... .++.++|+|||||++|||++ |..||.+.+..+....+......+
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 224 (262)
T cd06613 148 SAQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAE-LQPPMFDLHPMRALFLISKSNFPPP 224 (262)
T ss_pred chhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCc
Confidence 876533211 11223456789999998776 78999999999999999998 999999887766655554432211
Q ss_pred ---CCCCCCcchhhhcccccccccchhh
Q psy7289 289 ---CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 289 ---~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.+...+.++.+++++||..+|..|+
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp 252 (262)
T cd06613 225 KLKDKEKWSPVFHDFIKKCLTKDPKKRP 252 (262)
T ss_pred cccchhhhhHHHHHHHHHHcCCChhhCC
Confidence 2334567899999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=308.21 Aligned_cols=243 Identities=26% Similarity=0.448 Sum_probs=194.0
Q ss_pred cccccccceeEEEEEEecCCC-----CeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEE
Q psy7289 60 QELGEGAFGKVYKGEVCTSEG-----PSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFE 134 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E 134 (422)
+.||+|+||.||+|....... ...|++|.+... .....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS-HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch-hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 469999999999998753321 234777776432 23345678899999999999999999999999899999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCe--------EE
Q psy7289 135 FMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLT--------VK 206 (422)
Q Consensus 135 ~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~--------vK 206 (422)
|+++|+|.+++..+. ..+++..+..++.||+.||+|||+++|+||||||+||+++.++. +|
T Consensus 80 ~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~ 148 (258)
T cd05078 80 YVKFGSLDTYLKKNK-----------NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIK 148 (258)
T ss_pred cCCCCcHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEE
Confidence 999999999997542 24788889999999999999999999999999999999987654 69
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ 285 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~ 285 (422)
++|||++...... ....+++.|+|||++.. ..++.++|||||||++|||++.+..||...+..........
T Consensus 149 l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~-- 220 (258)
T cd05078 149 LSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED-- 220 (258)
T ss_pred ecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc--
Confidence 9999998754322 12335678999999986 45899999999999999999844678877776665544333
Q ss_pred CCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 286 MLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 286 ~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
..+.|...+.++.+++.+||+.+|..|+ +...+.+.|
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~l 257 (258)
T cd05078 221 RHQLPAPKWTELANLINQCMDYEPDFRP-----SFRAIIRDL 257 (258)
T ss_pred cccCCCCCcHHHHHHHHHHhccChhhCC-----CHHHHHHhc
Confidence 3445666778899999999999999998 665554443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=320.71 Aligned_cols=204 Identities=28% Similarity=0.366 Sum_probs=169.8
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC----
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE---- 127 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~---- 127 (422)
..+|++.+.||+|+||.||+++... .+..||||.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAV--LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecC--CCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3578899999999999999997643 35679999886532 3344567889999999999999999999886433
Q ss_pred --CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 128 --PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 128 --~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
..++||||+++ +|.+++.. .+++..+..++.|++.||+|||++||+||||||+|||+++++.+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~--------------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~ 158 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM--------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 158 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh--------------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCE
Confidence 47999999975 67776642 37888899999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHH
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEV 277 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~ 277 (422)
||+|||+++...... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.
T Consensus 159 kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~ 226 (355)
T cd07874 159 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQ 226 (355)
T ss_pred EEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Confidence 999999998643321 1223456889999999998899999999999999999998 9999988765443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=312.40 Aligned_cols=243 Identities=23% Similarity=0.408 Sum_probs=195.7
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
.+|++.+.||+|+||.||+|+...+ +..||+|.++..........+.+|+.+++.++||||+++++++..+...++||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLT--DNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCC--CcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 4688899999999999999986543 46799999865443334456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||++ ++|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+||++++++.+||+|||++
T Consensus 84 e~~~-~~l~~~l~~~~-----------~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 151 (301)
T cd07873 84 EYLD-KDLKQYLDDCG-----------NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLA 151 (301)
T ss_pred eccc-cCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcch
Confidence 9997 69999886532 24788999999999999999999999999999999999999999999999998
Q ss_pred ccccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC------
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM------ 286 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~------ 286 (422)
+....... ......+++.|+|||.+... .++.++|||||||++|||++ |.+||.+.+..+....+.....
T Consensus 152 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t-g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 228 (301)
T cd07873 152 RAKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMST-GRPLFPGSTVEEQLHFIFRILGTPTEET 228 (301)
T ss_pred hccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhh
Confidence 75432211 11223457889999988653 57889999999999999998 9999998877655544321100
Q ss_pred ------------CCC-----------CCCCCcchhhhcccccccccchhh
Q psy7289 287 ------------LPC-----------PEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 287 ------------~~~-----------p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
... ...+++.+.+|+.+|+..+|..|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~ 278 (301)
T cd07873 229 WPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRI 278 (301)
T ss_pred chhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCc
Confidence 001 124677888999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=298.62 Aligned_cols=251 Identities=24% Similarity=0.410 Sum_probs=208.5
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC-------HHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcC
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN-------QKTASDFRREVDLMSEL-RHPNIVCLLGVCLSG 126 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~ 126 (422)
.|.-.+.||.|..+.|.++..+.+ +...|+|++..... ....++-.+|+.||+++ .||||+.+.+++.++
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t--~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKET--GKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred hcChHHHhcccchhhhhhhhhccc--ccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 445567899999999998766544 45678887743211 12345667899999998 599999999999999
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEE
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vK 206 (422)
..+++|+|+|+.|.|+|||.+. ..+|+.+.+++++|+..|++|||.++||||||||+|||++++.++|
T Consensus 96 sF~FlVFdl~prGELFDyLts~------------VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~ 163 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK------------VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIK 163 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh------------eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceE
Confidence 9999999999999999999764 3699999999999999999999999999999999999999999999
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCcccccc------CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHH
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY------GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEM 280 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~ 280 (422)
|+|||+|..+.... ....-+|||.|+|||.+.. ..|+..+|+||+|||||-++. |.+||.+....-++.+
T Consensus 164 isDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLa-GcpPFwHRkQmlMLR~ 239 (411)
T KOG0599|consen 164 ISDFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLA-GCPPFWHRKQMLMLRM 239 (411)
T ss_pred EeccceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHc-CCCchhHHHHHHHHHH
Confidence 99999998876543 2345678999999998864 358889999999999999998 9999999988888999
Q ss_pred HHcCCCC-CCC--CCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 281 IRSRQML-PCP--EDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 281 i~~~~~~-~~p--~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
|.+|+.. ..| .+.+....+|+.+|+.-||..|- ...+..|.++
T Consensus 240 ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 240 IMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred HHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 9988643 223 46788899999999999998763 3345555655
|
|
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=332.38 Aligned_cols=237 Identities=27% Similarity=0.477 Sum_probs=201.0
Q ss_pred ccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEecCCCC
Q psy7289 61 ELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGD 140 (422)
Q Consensus 61 ~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~~~G~ 140 (422)
.||+|.||+||-|+...+ ...+|||.+....+ +..+-+..|+.+-+.|+|.|||+++|.+.++.++-|.||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~t--qvrIaIKEIpekds-r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDT--QVRIAIKEIPEKDS-REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccc--eeEEEeeecccccc-hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 599999999999987654 46799999875433 456778899999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCccCCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC-CCeEEEecCccccccc
Q psy7289 141 LHEFLMSRSPRSDISGSQVQAPL--SQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD-GLTVKISDFGLSRDVY 217 (422)
Q Consensus 141 L~~~l~~~~~~~~~~~~~~~~~l--~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~-~~~vKl~DFGla~~~~ 217 (422)
|.++|+.. -+++ ++.++..+.+||+.||.|||.+.|||||||-+|||++. .|.+||+|||-++.+.
T Consensus 659 LSsLLrsk-----------WGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA 727 (1226)
T KOG4279|consen 659 LSSLLRSK-----------WGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA 727 (1226)
T ss_pred HHHHHHhc-----------cCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhc
Confidence 99999763 1456 78889999999999999999999999999999999974 6899999999998765
Q ss_pred CCcceEeccCCCCCccccCccccccC--CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHH-HHHHH-HcCCCCCCCCCC
Q psy7289 218 ASDYYRIQSKSLLPVRWMPPESILYG--KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE-VIEMI-RSRQMLPCPEDC 293 (422)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~-~~~~i-~~~~~~~~p~~~ 293 (422)
.-. ..+.+..||+.|||||++..+ .|+.++|||||||++.||.| |++||......+ .+-++ .-...+|+|+..
T Consensus 728 gin--P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMAT-GrPPF~ElgspqAAMFkVGmyKvHP~iPeel 804 (1226)
T KOG4279|consen 728 GIN--PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMAT-GRPPFVELGSPQAAMFKVGMYKVHPPIPEEL 804 (1226)
T ss_pred cCC--ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeecc-CCCCeeecCChhHhhhhhcceecCCCCcHHH
Confidence 322 234456789999999999876 48999999999999999999 999998765433 22222 234568899999
Q ss_pred CcchhhhcccccccccchhhH
Q psy7289 294 PPRMYSLMMECWHEVPVAAGM 314 (422)
Q Consensus 294 p~~~~~l~~~cw~~~P~~r~~ 314 (422)
+.+.+.++.+|+..+|..|+.
T Consensus 805 saeak~FilrcFepd~~~R~s 825 (1226)
T KOG4279|consen 805 SAEAKNFILRCFEPDPCDRPS 825 (1226)
T ss_pred HHHHHHHHHHHcCCCcccCcc
Confidence 999999999999999999883
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=314.07 Aligned_cols=243 Identities=18% Similarity=0.310 Sum_probs=190.1
Q ss_pred cccccccc--cceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEE
Q psy7289 58 FLQELGEG--AFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFE 134 (422)
Q Consensus 58 ~~~~LG~G--~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E 134 (422)
++++||+| +|++||+++... +++.||+|.++... .......+.+|+.+++.++||||+++++++..++..++|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKP--TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecc--cCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence 56889999 788999987654 45789999987543 23345567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccc
Q psy7289 135 FMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR 214 (422)
Q Consensus 135 ~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~ 214 (422)
|+++|+|.+++..+.. ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.++++|||.+.
T Consensus 80 ~~~~~~l~~~~~~~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 80 FMAYGSAKDLICTHFM----------DGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred ccCCCcHHHHHHhhcc----------CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhh
Confidence 9999999999965421 248899999999999999999999999999999999999999999999998754
Q ss_pred cccCCcc-e----EeccCCCCCccccCcccccc--CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 215 DVYASDY-Y----RIQSKSLLPVRWMPPESILY--GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 215 ~~~~~~~-~----~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
....... . .......++..|+|||++.. ..++.++|||||||++|||++ |..||...+..+.......+..+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~ 228 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN-GHVPFKDMPATQMLLEKLNGTVP 228 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHH-CCCCCCCcchhHHHHHHhcCCcc
Confidence 4321110 0 01112234567999999875 458999999999999999998 99999876655443332221110
Q ss_pred ---------------------------------------------CCCCCCCcchhhhcccccccccchhh
Q psy7289 288 ---------------------------------------------PCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 288 ---------------------------------------------~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+....+++.+.+++.+||..||..|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 299 (327)
T cd08227 229 CLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARP 299 (327)
T ss_pred ccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcC
Confidence 01112456788999999999999997
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=306.49 Aligned_cols=241 Identities=27% Similarity=0.485 Sum_probs=201.3
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC---CCceeeEeeEEEcCCCeEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR---HPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~g~~~~~~~~~l 131 (422)
.|++.+.||+|+||.||+|.+..+ +..||+|.++..........+.+|+.+++.++ ||||+++++++..+...++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPT--GRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCC--CcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 367788999999999999987543 56799999875544455677889999999997 9999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
||||+++++|.+++... .+++..+..++.|++.||.|||+.+++||||+|+||++++++.++|+|||
T Consensus 80 v~e~~~~~~L~~~~~~~-------------~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg 146 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG-------------PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFG 146 (277)
T ss_pred EEecCCCCcHHHHHHcc-------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCC
Confidence 99999999999998542 48899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP 290 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p 290 (422)
++........ ......++..|+|||.+..+ .++.++|+|||||++|||++ |..||.+.+.......+.....+..+
T Consensus 147 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (277)
T cd06917 147 VAALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMAT-GNPPYSDVDAFRAMMLIPKSKPPRLE 223 (277)
T ss_pred ceeecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHh-CCCCCCCCChhhhhhccccCCCCCCC
Confidence 9976544321 12233567889999988654 47899999999999999998 99999888776665555444333344
Q ss_pred C-CCCcchhhhcccccccccchhh
Q psy7289 291 E-DCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 291 ~-~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
. ..++++.+++.+||..+|..|+
T Consensus 224 ~~~~~~~~~~~i~~~l~~~p~~R~ 247 (277)
T cd06917 224 DNGYSKLLREFVAACLDEEPKERL 247 (277)
T ss_pred cccCCHHHHHHHHHHcCCCcccCc
Confidence 4 3788999999999999999997
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=320.94 Aligned_cols=240 Identities=26% Similarity=0.333 Sum_probs=192.0
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC-----
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSG----- 126 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~----- 126 (422)
..+|++.+.||+|+||.||+++.... +..||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCC--CcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 46789999999999999999986543 4679999986432 334456788999999999999999999987543
Q ss_pred -CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 127 -EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 127 -~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
..+|+||||+++ +|.+++.. .+++..+..++.|++.||+|||+++|+||||||+|||++.++.+
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~--------------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 165 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM--------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh--------------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcE
Confidence 357999999975 77777742 37788899999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ 285 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~ 285 (422)
||+|||+++...... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+....
T Consensus 166 kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~ 241 (364)
T cd07875 166 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK-GGVLFPGTDHIDQWNKVIEQL 241 (364)
T ss_pred EEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhc
Confidence 999999998653321 1223456889999999999899999999999999999998 999999887766555543221
Q ss_pred CCCCC-----------------------------------------CCCCcchhhhcccccccccchhh
Q psy7289 286 MLPCP-----------------------------------------EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 286 ~~~~p-----------------------------------------~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..|+| ...+..+.+|+.+|+..||..|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~ 310 (364)
T cd07875 242 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310 (364)
T ss_pred CCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCC
Confidence 11111 01134567899999999999887
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=302.84 Aligned_cols=247 Identities=24% Similarity=0.439 Sum_probs=205.2
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFE 134 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E 134 (422)
+|++.+.||+|+||.||+|.... ++..+++|.+...........+.+|+.+++.++||||+++++.+..++..+++||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLP--NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcC--CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 57889999999999999998654 3567999998654433456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccc
Q psy7289 135 FMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR 214 (422)
Q Consensus 135 ~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~ 214 (422)
++++++|.+++....+ ...+++..+..++.|++.||+|||+.+++||||||+||++++++.+||+|||++.
T Consensus 80 ~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~ 150 (267)
T cd06610 80 YLSGGSLLDIMKSSYP---------RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSA 150 (267)
T ss_pred ccCCCcHHHHHHHhcc---------cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHH
Confidence 9999999999976432 1257899999999999999999999999999999999999999999999999987
Q ss_pred cccCCcceE--eccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC-
Q psy7289 215 DVYASDYYR--IQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP- 290 (422)
Q Consensus 215 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p- 290 (422)
......... ......++..|+|||++... .++.++|+|||||++|||++ |..||...+..+....+........+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (267)
T cd06610 151 SLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELAT-GAAPYSKYPPMKVLMLTLQNDPPSLET 229 (267)
T ss_pred HhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHh-CCCCccccChhhhHHHHhcCCCCCcCC
Confidence 665432211 12233467789999998876 78999999999999999998 99999988877766665544332222
Q ss_pred ----CCCCcchhhhcccccccccchhh
Q psy7289 291 ----EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 291 ----~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..+++.+.+++.+||..+|..|+
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp 256 (267)
T cd06610 230 GADYKKYSKSFRKMISLCLQKDPSKRP 256 (267)
T ss_pred ccccccccHHHHHHHHHHcCCChhhCc
Confidence 25678899999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=305.03 Aligned_cols=241 Identities=26% Similarity=0.420 Sum_probs=204.0
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFE 134 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E 134 (422)
+|++.+.||+|+||.||++.... .+..|++|.+...........+.+|++++++++||||+++++++......++++|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRP--TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcC--CCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 46788999999999999998754 3567999988765555566789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 135 FMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCS-HHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 135 ~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
|+++++|.+++.... ..+++..+.+++.|++.||+|||+ .+++||||||+||++++++.+||+|||++
T Consensus 80 ~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~ 148 (265)
T cd06605 80 YMDGGSLDKILKEVQ-----------GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVS 148 (265)
T ss_pred ecCCCcHHHHHHHcc-----------CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence 999999999997532 358889999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCC-----ChHHHHHHHHcCCCCC
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY-----SNQEVIEMIRSRQMLP 288 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~-----~~~~~~~~i~~~~~~~ 288 (422)
........ ....++..|+|||.+....++.++||||||+++|||++ |..||... ...+....+.....+.
T Consensus 149 ~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (265)
T cd06605 149 GQLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELAT-GRFPYPPENDPPDGIFELLQYIVNEPPPR 223 (265)
T ss_pred hhhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHHHhcCCCCC
Confidence 75532211 11445678999999988899999999999999999998 88999765 3344555555555555
Q ss_pred CCCC-CCcchhhhcccccccccchhh
Q psy7289 289 CPED-CPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 289 ~p~~-~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.|.. +++++.+++.+||..+|..|+
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp 249 (265)
T cd06605 224 LPSGKFSPDFQDFVNLCLIKDPRERP 249 (265)
T ss_pred CChhhcCHHHHHHHHHHcCCCchhCc
Confidence 5555 888999999999999999997
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=311.04 Aligned_cols=242 Identities=23% Similarity=0.416 Sum_probs=200.3
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
..+|++.+.||+|+||.||+|+... .+..||+|.+..... ...+.+.+|+.+++.++||||+++++++..+...++|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIA--TGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECC--CCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 3578889999999999999998543 356799998864332 2346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++|+|.+++.+. .+++.++..++.|++.||.|||+.+++||||||+||+++.++.+||+|||+
T Consensus 95 ~e~~~~~~L~~~~~~~-------------~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~ 161 (297)
T cd06656 95 MEYLAGGSLTDVVTET-------------CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF 161 (297)
T ss_pred ecccCCCCHHHHHHhC-------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCcc
Confidence 9999999999998642 478889999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC--CCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM--LPCP 290 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~--~~~p 290 (422)
+........ ......+++.|+|||.+....++.++|+|||||++|||++ |..||.+.+..+....+..... ...|
T Consensus 162 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (297)
T cd06656 162 CAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPYLNENPLRALYLIATNGTPELQNP 238 (297)
T ss_pred ceEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCcchheeeeccCCCCCCCCc
Confidence 876433221 1123346778999999988889999999999999999998 9999987665443333332222 2245
Q ss_pred CCCCcchhhhcccccccccchhh
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
...++.+.+++.+||..+|..|+
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rp 261 (297)
T cd06656 239 ERLSAVFRDFLNRCLEMDVDRRG 261 (297)
T ss_pred cccCHHHHHHHHHHccCChhhCc
Confidence 67788899999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=301.36 Aligned_cols=242 Identities=25% Similarity=0.454 Sum_probs=203.5
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
+..|++.+.||+|+||.||+|++..+ +..+++|.++... ..+.+.+|++++++++||||+++++.+.+....|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~--~~~~~~k~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKET--GQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCC--CcEEEEEEeecHH---HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 45788999999999999999987543 4679999886432 267899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
+||+++++|.+++.... ..+++..+..++.|++.||.|||+.+++||||+|+||++++++.+||+|||+
T Consensus 77 ~e~~~~~~L~~~l~~~~-----------~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~ 145 (256)
T cd06612 77 MEYCGAGSVSDIMKITN-----------KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGV 145 (256)
T ss_pred EecCCCCcHHHHHHhCc-----------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEccccc
Confidence 99999999999986532 3588999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC--CCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM--LPCP 290 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~--~~~p 290 (422)
+........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+..... ...|
T Consensus 146 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 222 (256)
T cd06612 146 SGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAE-GKPPYSDIHPMRAIFMIPNKPPPTLSDP 222 (256)
T ss_pred chhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCcchhhhhhhhccCCCCCCCch
Confidence 886543221 1122335678999999988889999999999999999998 9999988777665555543322 2235
Q ss_pred CCCCcchhhhcccccccccchhh
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..++..+.+++.+||..+|..|+
T Consensus 223 ~~~~~~~~~~i~~~l~~~P~~Rp 245 (256)
T cd06612 223 EKWSPEFNDFVKKCLVKDPEERP 245 (256)
T ss_pred hhcCHHHHHHHHHHHhcChhhCc
Confidence 56778999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=306.81 Aligned_cols=241 Identities=29% Similarity=0.498 Sum_probs=195.3
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHH-hHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEE
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQK-TASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFE 134 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E 134 (422)
|++.+.||+|+||.||+++... ++..||+|.+....... ......+|+.++++++||||+++++++.+....++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKK--NGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETT--TTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECC--CCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccc
Confidence 6788999999999999998643 45689999987654322 22345669999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccc
Q psy7289 135 FMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR 214 (422)
Q Consensus 135 ~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~ 214 (422)
|+++++|.+++... ..+++..+..++.|++.||+|||+++++||||||+||++++++.++|+|||++.
T Consensus 79 ~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~ 146 (260)
T PF00069_consen 79 YCPGGSLQDYLQKN------------KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSV 146 (260)
T ss_dssp EETTEBHHHHHHHH------------SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred cccccccccccccc------------cccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999743 358999999999999999999999999999999999999999999999999997
Q ss_pred cccCCcceEeccCCCCCccccCccccc-cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHH---HHHHHcCCCC---
Q psy7289 215 DVYASDYYRIQSKSLLPVRWMPPESIL-YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEV---IEMIRSRQML--- 287 (422)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~---~~~i~~~~~~--- 287 (422)
...... .......++..|+|||++. ...++.++||||+|+++|||++ |..||......+. ..........
T Consensus 147 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (260)
T PF00069_consen 147 KLSENN--ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLT-GKLPFEESNSDDQLEIIEKILKRPLPSSS 223 (260)
T ss_dssp ESTSTT--SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHH-SSSSSTTSSHHHHHHHHHHHHHTHHHHHT
T ss_pred cccccc--cccccccccccccccccccccccccccccccccccccccccc-cccccccccchhhhhhhhhcccccccccc
Confidence 531111 1233455688999999988 7789999999999999999999 8899998743333 3222221110
Q ss_pred CCCCCCCcchhhhcccccccccchhh
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
......++.+.+++.+||+.+|..|+
T Consensus 224 ~~~~~~~~~l~~li~~~l~~~p~~R~ 249 (260)
T PF00069_consen 224 QQSREKSEELRDLIKKMLSKDPEQRP 249 (260)
T ss_dssp TSHTTSHHHHHHHHHHHSSSSGGGST
T ss_pred cccchhHHHHHHHHHHHccCChhHCc
Confidence 11112347899999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=310.04 Aligned_cols=246 Identities=21% Similarity=0.326 Sum_probs=202.5
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCH--HhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQ--KTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
+|++.+.||+|+||.||+|+... .+..||+|.+...... ...+.+.+|+++++.++||||+++++.+.++...++|
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKG--TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcC--CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence 57888999999999999998754 3567999998654322 3456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+.+++|.+++.... ...+++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||+
T Consensus 80 ~e~~~~~~L~~~~~~~~----------~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~ 149 (316)
T cd05574 80 MDYCPGGELFRLLQRQP----------GKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDL 149 (316)
T ss_pred EEecCCCCHHHHHHhCC----------CCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecch
Confidence 99999999999986532 13588999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceE---------------------------eccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCC
Q psy7289 213 SRDVYASDYYR---------------------------IQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYG 265 (422)
Q Consensus 213 a~~~~~~~~~~---------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g 265 (422)
+.......... ......++..|+|||++....++.++|||||||++|||++ |
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~-g 228 (316)
T cd05574 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLY-G 228 (316)
T ss_pred hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhh-C
Confidence 87543211000 0112245778999999988889999999999999999998 9
Q ss_pred CCCCCCCChHHHHHHHHcCCC-CCCCCCCCcchhhhcccccccccchhh
Q psy7289 266 LQPYYGYSNQEVIEMIRSRQM-LPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 266 ~~Pf~~~~~~~~~~~i~~~~~-~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..||.+.+..+....+..... .+.....|+.+.+++.+||..+|..|+
T Consensus 229 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 277 (316)
T cd05574 229 TTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRL 277 (316)
T ss_pred CCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCC
Confidence 999998888777666654332 222223688999999999999999997
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=307.95 Aligned_cols=242 Identities=28% Similarity=0.428 Sum_probs=189.8
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC-HHhHHHHHHHHHHHhcC---CCCceeeEeeEEEcC----
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN-QKTASDFRREVDLMSEL---RHPNIVCLLGVCLSG---- 126 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l---~HpnIv~l~g~~~~~---- 126 (422)
+|++.+.||+|+||.||+|+...+ +..||+|.++.... ......+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~ 78 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHS--GHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR 78 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCC--CcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence 477889999999999999987543 57799998864322 12233566788777665 799999999988643
Q ss_pred -CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 127 -EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 127 -~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
...+++|||++ ++|.+++..... ..+++..+..++.|++.||+|||+++|+||||||+|||+++++.+
T Consensus 79 ~~~~~lv~e~~~-~~l~~~~~~~~~----------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~ 147 (288)
T cd07863 79 ETKVTLVFEHVD-QDLRTYLDKVPP----------PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQV 147 (288)
T ss_pred CceEEEEEcccc-cCHHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCE
Confidence 35799999998 589998865321 248999999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ 285 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~ 285 (422)
||+|||+++...... ......+|..|+|||++....++.++|||||||++|||++ |.+||.+.+..+.+..+....
T Consensus 148 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~~f~~~~~~~~~~~~~~~~ 223 (288)
T cd07863 148 KLADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQLGKIFDLI 223 (288)
T ss_pred EECccCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHh-CCcCcCCCCHHHHHHHHHHHh
Confidence 999999997653221 1223456788999999988889999999999999999997 999998877665554443210
Q ss_pred C------------------C--------CCCCCCCcchhhhcccccccccchhh
Q psy7289 286 M------------------L--------PCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 286 ~------------------~--------~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
. . .+.+.++..+.+++.+|+..||..|+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 277 (288)
T cd07863 224 GLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRI 277 (288)
T ss_pred CCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCC
Confidence 0 0 01124566778999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=300.01 Aligned_cols=241 Identities=25% Similarity=0.458 Sum_probs=202.4
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC----CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA----NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
+|+..+.||+|+||.||+|.... .+..|++|.+.... .....+.+.+|+.+++.++||||+++++++.+...++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLD--DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcC--CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEE
Confidence 35667889999999999998643 35679999875322 2334567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
++|||+++++|.+++... ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.+||+||
T Consensus 79 lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~ 146 (258)
T cd06632 79 IFLELVPGGSLAKLLKKY------------GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADF 146 (258)
T ss_pred EEEEecCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccC
Confidence 999999999999999653 24788899999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc-CCCCC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS-RQMLP 288 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~-~~~~~ 288 (422)
|++....... ......++..|+|||.+.... ++.++|+|||||++|||++ |..||......+....+.. .....
T Consensus 147 ~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 222 (258)
T cd06632 147 GMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMAT-GKPPWSQLEGVAAVFKIGRSKELPP 222 (258)
T ss_pred ccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHh-CCCCcccCcHHHHHHHHHhcccCCC
Confidence 9987653322 122344678899999987766 8999999999999999998 9999988776665555554 44555
Q ss_pred CCCCCCcchhhhcccccccccchhh
Q psy7289 289 CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 289 ~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.|..+++.+.+++.+||..+|..|+
T Consensus 223 ~~~~~~~~~~~li~~~l~~~p~~Rp 247 (258)
T cd06632 223 IPDHLSDEAKDFILKCLQRDPSLRP 247 (258)
T ss_pred cCCCcCHHHHHHHHHHhhcCcccCc
Confidence 6778899999999999999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=300.33 Aligned_cols=246 Identities=20% Similarity=0.350 Sum_probs=209.7
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc--CCCeEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLS--GEPMCM 131 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~~~l 131 (422)
+|++.+.||.|+||.||++.... .+..||+|.+... ......+.+.+|+.++++++||||+++++++.. ....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKS--DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecC--CCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEE
Confidence 46788999999999999997654 3467999988643 344556788999999999999999999998764 345799
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHH-----hCCccccCCCCCceeecCCCeEE
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLC-----SHHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH-----~~~ivHrDlKp~NiLl~~~~~vK 206 (422)
+|||+++|+|.+++...... ...+++..+..++.|++.||+||| +.+++|+||||+||++++++.+|
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~--------~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~k 150 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKE--------RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVK 150 (265)
T ss_pred EehhccCCCHHHHHHHHhhc--------ccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEE
Confidence 99999999999999764211 236889999999999999999999 88999999999999999999999
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~ 286 (422)
|+|||+++........ .....+++.|+|||.+....++.++|+||||+++|+|++ |..||...+..++...+..+..
T Consensus 151 l~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 227 (265)
T cd08217 151 LGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCA-LSPPFTARNQLQLASKIKEGKF 227 (265)
T ss_pred EecccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHH-CCCcccCcCHHHHHHHHhcCCC
Confidence 9999999865433211 223356788999999988889999999999999999998 9999999888888888888877
Q ss_pred CCCCCCCCcchhhhcccccccccchhh
Q psy7289 287 LPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 287 ~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
++.|...+..+.+++.+||..+|..|+
T Consensus 228 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp 254 (265)
T cd08217 228 RRIPYRYSSELNEVIKSMLNVDPDKRP 254 (265)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCC
Confidence 778888999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=304.41 Aligned_cols=240 Identities=22% Similarity=0.378 Sum_probs=203.5
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
.|++.+.||+|+||.||+|+... .+..||+|.+.... .....+.+.+|++++++++||||+++++.+.++...++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRD--TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEcc--CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence 36788999999999999998643 35679999886432 224567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
+||+.+++|.+++... .++++..+..++.|++.||.|||+++++|+||||+||++++++.++|+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~------------~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~ 146 (258)
T cd05578 79 VDLLLGGDLRYHLSQK------------VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNI 146 (258)
T ss_pred EeCCCCCCHHHHHHhc------------CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeeccc
Confidence 9999999999999653 2588999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh---HHHHHHHHcCCCCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN---QEVIEMIRSRQMLPC 289 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~---~~~~~~i~~~~~~~~ 289 (422)
+....... ......++..|+|||.+....++.++|+||||+++|+|++ |..||...+. .++...... ...+.
T Consensus 147 ~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~ 221 (258)
T cd05578 147 ATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLR-GKRPYRGHSRTIRDQIRAKQET-ADVLY 221 (258)
T ss_pred ccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHh-CCCCCCCCCccHHHHHHHHhcc-ccccC
Confidence 87654332 1123445678999999988889999999999999999998 9999988774 444443332 45667
Q ss_pred CCCCCcchhhhcccccccccchhh
Q psy7289 290 PEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 290 p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
|..+|..+.+++.+||..+|..|+
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~ 245 (258)
T cd05578 222 PATWSTEAIDAINKLLERDPQKRL 245 (258)
T ss_pred cccCcHHHHHHHHHHccCChhHcC
Confidence 788999999999999999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=312.81 Aligned_cols=246 Identities=26% Similarity=0.443 Sum_probs=193.9
Q ss_pred chhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhc--CCCCceeeEeeEEE
Q psy7289 47 FRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSE--LRHPNIVCLLGVCL 124 (422)
Q Consensus 47 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~g~~~ 124 (422)
+.++.++..+++.+.||+|.||+||+|+|+. +.||||++... +...+.||.+|... |||+||+.+++.-.
T Consensus 204 LVQRTiarqI~L~e~IGkGRyGEVwrG~wrG----e~VAVKiF~sr----dE~SWfrEtEIYqTvmLRHENILgFIaaD~ 275 (513)
T KOG2052|consen 204 LVQRTIARQIVLQEIIGKGRFGEVWRGRWRG----EDVAVKIFSSR----DERSWFRETEIYQTVMLRHENILGFIAADN 275 (513)
T ss_pred HhHHhhhheeEEEEEecCccccceeeccccC----CceEEEEeccc----chhhhhhHHHHHHHHHhccchhhhhhhccc
Confidence 5667778889999999999999999999974 45999998542 34578888888765 59999999999866
Q ss_pred cCC----CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCC
Q psy7289 125 SGE----PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSH--------HYVHRDL 192 (422)
Q Consensus 125 ~~~----~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~--------~ivHrDl 192 (422)
.+. .++||++|-++|||+|||... .++.....+++..+|+||++||.. .|.||||
T Consensus 276 ~~~gs~TQLwLvTdYHe~GSL~DyL~r~-------------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDl 342 (513)
T KOG2052|consen 276 KDNGSWTQLWLVTDYHEHGSLYDYLNRN-------------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDL 342 (513)
T ss_pred cCCCceEEEEEeeecccCCcHHHHHhhc-------------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccc
Confidence 544 489999999999999999863 588999999999999999999952 3999999
Q ss_pred CCCceeecCCCeEEEecCcccccccCCc--ceEeccCCCCCccccCccccccCC----CC--CchhHHhHHHHHHHHHhC
Q psy7289 193 AARNCLVGDGLTVKISDFGLSRDVYASD--YYRIQSKSLLPVRWMPPESILYGK----FT--TESDVWSYGVVLWEVYSY 264 (422)
Q Consensus 193 Kp~NiLl~~~~~vKl~DFGla~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~----~~--~~~DvwS~Gvil~El~t~ 264 (422)
|+.|||+.+++.+-|+|+|||....+.. .........||.+|||||++.... +. ..+||||||.++||++.+
T Consensus 343 KSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarR 422 (513)
T KOG2052|consen 343 KSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARR 422 (513)
T ss_pred ccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999997554331 222344567899999999986432 21 368999999999999742
Q ss_pred ----C-----CCCCCCCC-----hHHHHHHHHcCC-CCCCCCCC-----Ccchhhhcccccccccchhh
Q psy7289 265 ----G-----LQPYYGYS-----NQEVIEMIRSRQ-MLPCPEDC-----PPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 265 ----g-----~~Pf~~~~-----~~~~~~~i~~~~-~~~~p~~~-----p~~~~~l~~~cw~~~P~~r~ 313 (422)
| ..||++.. .+++.+-+.-.+ ++++|... -..+.+||++||..||.+|-
T Consensus 423 c~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRl 491 (513)
T KOG2052|consen 423 CESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARL 491 (513)
T ss_pred hhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhh
Confidence 2 57998653 345555554443 44444322 23578899999999999985
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=303.51 Aligned_cols=244 Identities=22% Similarity=0.359 Sum_probs=191.3
Q ss_pred ccccccceeEEEEEEecCCCCeEEEEEEccCcCC--HHhHHHHHHHHHHH---hcCCCCceeeEeeEEEcCCCeEEEEEe
Q psy7289 61 ELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN--QKTASDFRREVDLM---SELRHPNIVCLLGVCLSGEPMCMLFEF 135 (422)
Q Consensus 61 ~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il---~~l~HpnIv~l~g~~~~~~~~~lv~E~ 135 (422)
.||+|+||.||++.... .+..+|+|.+..... ......+.+|..++ ...+||||+.+++++..++..++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECC--CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence 48999999999998643 356899998864321 12223344554443 345799999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccccc
Q psy7289 136 MVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRD 215 (422)
Q Consensus 136 ~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~ 215 (422)
+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|||++..
T Consensus 79 ~~~~~L~~~i~~~------------~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~ 146 (279)
T cd05633 79 MNGGDLHYHLSQH------------GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD 146 (279)
T ss_pred CCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCccee
Confidence 9999999998653 3589999999999999999999999999999999999999999999999999875
Q ss_pred ccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh--HHHHHHHHcCCCCCCCCC
Q psy7289 216 VYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN--QEVIEMIRSRQMLPCPED 292 (422)
Q Consensus 216 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~--~~~~~~i~~~~~~~~p~~ 292 (422)
..... .....++..|+|||.+.. ..++.++|||||||++|||++ |..||..... .+.............|..
T Consensus 147 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (279)
T cd05633 147 FSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEIDRMTLTVNVELPDS 221 (279)
T ss_pred ccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHh-CCCCcCCCCCcCHHHHHHHhhcCCcCCccc
Confidence 43221 123356889999998864 558999999999999999998 9999975432 222333333334456778
Q ss_pred CCcchhhhcccccccccchhh------HHHHhhhhhh
Q psy7289 293 CPPRMYSLMMECWHEVPVAAG------MAYLCSHHYV 323 (422)
Q Consensus 293 ~p~~~~~l~~~cw~~~P~~r~------~~~lh~~~~i 323 (422)
+++++.+++.+||..+|..|. +..+.+|.++
T Consensus 222 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~ 258 (279)
T cd05633 222 FSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFF 258 (279)
T ss_pred cCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccc
Confidence 899999999999999999996 5555555544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=301.13 Aligned_cols=245 Identities=25% Similarity=0.454 Sum_probs=204.1
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCc---------CCHHhHHHHHHHHHHHhc-CCCCceeeEeeEEEc
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN---------ANQKTASDFRREVDLMSE-LRHPNIVCLLGVCLS 125 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~~~E~~il~~-l~HpnIv~l~g~~~~ 125 (422)
|++.+.||+|+||.||+|.+... .+..+|+|.+... .......++.+|+.++.+ ++||||+++++++.+
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNN-GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCC-CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 67788999999999999987542 3567999987532 122344667889998875 799999999999999
Q ss_pred CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCCe
Q psy7289 126 GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCS-HHYVHRDLAARNCLVGDGLT 204 (422)
Q Consensus 126 ~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlKp~NiLl~~~~~ 204 (422)
.+..+++|||+++++|.+++...... ...+++..+..++.|++.||.|||+ .+++||||||+||++++++.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~ 152 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEK--------KQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK 152 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhc--------cCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc
Confidence 99999999999999999988542111 1358899999999999999999996 78999999999999999999
Q ss_pred EEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC
Q psy7289 205 VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR 284 (422)
Q Consensus 205 vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~ 284 (422)
+||+|||++....... ......++..|+|||.+....++.++||||||+++|||++ |..||...+.......+..+
T Consensus 153 ~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~ 228 (269)
T cd08528 153 VTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT-LQPPFYSTNMLSLATKIVEA 228 (269)
T ss_pred EEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHh-CCCcccccCHHHHHHHHhhc
Confidence 9999999997654332 1223456788999999998889999999999999999998 89999888877777777776
Q ss_pred CCCCCCC-CCCcchhhhcccccccccchhh
Q psy7289 285 QMLPCPE-DCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 285 ~~~~~p~-~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
...+.+. .+++.+.+++.+||..+|..|+
T Consensus 229 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 258 (269)
T cd08528 229 VYEPLPEGMYSEDVTDVITSCLTPDAEARP 258 (269)
T ss_pred cCCcCCcccCCHHHHHHHHHHCCCCCccCC
Confidence 6665554 6788999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=304.14 Aligned_cols=244 Identities=25% Similarity=0.433 Sum_probs=192.8
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
+|++.+.||+|+||.||+|+...+ +..||+|.++... .......+.+|+.+++.++||||+++++++.++...++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~--~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKT--GQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCC--CcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEE
Confidence 367889999999999999986533 5679999886432 2223457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||++ |+|.+++..... ...+++..+..++.|++.||+|||+++++||||||+||++++++.+||+|||++
T Consensus 79 e~~~-~~l~~~~~~~~~---------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 148 (285)
T cd07861 79 EFLS-MDLKKYLDSLPK---------GQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLA 148 (285)
T ss_pred ecCC-CCHHHHHhcCCC---------CCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccce
Confidence 9997 689998865321 135899999999999999999999999999999999999999999999999998
Q ss_pred ccccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc-C-------
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS-R------- 284 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~-~------- 284 (422)
+...... .......+++.|+|||.+... .++.++|||||||++|||++ |.+||.+.+..+....+.. .
T Consensus 149 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
T cd07861 149 RAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPLFHGDSEIDQLFRIFRILGTPTEDV 225 (285)
T ss_pred eecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 7543221 112233457889999988654 57899999999999999999 8999987665433222110 0
Q ss_pred --------------------CCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 285 --------------------QMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 285 --------------------~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
........+++++.+++++||..+|..|+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 274 (285)
T cd07861 226 WPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRI 274 (285)
T ss_pred hhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCC
Confidence 00011234678889999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=299.54 Aligned_cols=244 Identities=26% Similarity=0.431 Sum_probs=201.6
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC-HHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN-QKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
+|++.+.||+|+||.||+|.... .+..|++|.++.... ....+.+.+|+.+++.++||||+++++++...+.+++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLD--TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECC--CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEE
Confidence 47788999999999999998643 346799999865432 346678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||+++++|.+++... ..+++..+..++.|++.||+|||+++++|+||+|+||++++++.+||+|||++
T Consensus 79 e~~~~~~L~~~~~~~------------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~ 146 (264)
T cd06626 79 EYCSGGTLEELLEHG------------RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCA 146 (264)
T ss_pred ecCCCCcHHHHHhhc------------CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccc
Confidence 999999999998653 24778889999999999999999999999999999999999999999999998
Q ss_pred ccccCCcceEe--ccCCCCCccccCccccccCC---CCCchhHHhHHHHHHHHHhCCCCCCCCCC-hHHHHHHHHcCCCC
Q psy7289 214 RDVYASDYYRI--QSKSLLPVRWMPPESILYGK---FTTESDVWSYGVVLWEVYSYGLQPYYGYS-NQEVIEMIRSRQML 287 (422)
Q Consensus 214 ~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~---~~~~~DvwS~Gvil~El~t~g~~Pf~~~~-~~~~~~~i~~~~~~ 287 (422)
........... .....++..|+|||++.... ++.++||||||+++||+++ |..||...+ .......+..+..+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 225 (264)
T cd06626 147 VKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMAT-GKRPWSELDNEFQIMFHVGAGHKP 225 (264)
T ss_pred cccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHh-CCCCccCCcchHHHHHHHhcCCCC
Confidence 76543322111 11234567899999988766 8899999999999999998 999997763 34444455555555
Q ss_pred CCCCC--CCcchhhhcccccccccchhh
Q psy7289 288 PCPED--CPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 288 ~~p~~--~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..|.. +++.+.+++++||..+|..|+
T Consensus 226 ~~~~~~~~~~~~~~li~~~l~~~p~~R~ 253 (264)
T cd06626 226 PIPDSLQLSPEGKDFLDRCLESDPKKRP 253 (264)
T ss_pred CCCcccccCHHHHHHHHHHccCCcccCC
Confidence 55554 488999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=316.75 Aligned_cols=249 Identities=22% Similarity=0.339 Sum_probs=194.4
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC-----
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSG----- 126 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~----- 126 (422)
..+|++++.||+|+||.||+|+... .+..||||.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTR--LRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECC--CCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3578999999999999999998654 35679999986432 223345678999999999999999999987543
Q ss_pred -CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 127 -EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 127 -~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
...|++||++ +++|.+++.. ..+++..+..++.||+.||+|||+++|+||||||+|||+++++.+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~ 157 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-------------QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCEL 157 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCE
Confidence 3478999987 7899888753 248999999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR 284 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~ 284 (422)
||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+.+..+...
T Consensus 158 kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~ 231 (343)
T cd07878 158 RILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLK-GKALFPGNDYIDQLKRIMEV 231 (343)
T ss_pred EEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHH
Confidence 99999999865322 123456788999999876 468999999999999999998 99999877655544433211
Q ss_pred CC----------------------CCCC--------CCCCcchhhhcccccccccchhhH-HHHhhhhhh
Q psy7289 285 QM----------------------LPCP--------EDCPPRMYSLMMECWHEVPVAAGM-AYLCSHHYV 323 (422)
Q Consensus 285 ~~----------------------~~~p--------~~~p~~~~~l~~~cw~~~P~~r~~-~~lh~~~~i 323 (422)
.. ...| ..+++.+.+|+.+|+..+|..|+- ..+..|.++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~ 301 (343)
T cd07878 232 VGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301 (343)
T ss_pred hCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence 00 0011 134556789999999999998862 334444444
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=324.66 Aligned_cols=240 Identities=21% Similarity=0.291 Sum_probs=188.6
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
....|.+.+.||+|+||.||+|++... +..||||... ...+.+|+++|++|+|||||++++++..+...++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~--~~~vavK~~~-------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDY--PQRVVVKAGW-------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCC--CCEEEEeccc-------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 345789999999999999999987543 4679999532 1245689999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
|||++. |+|.+++.... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 238 v~e~~~-~~L~~~l~~~~-----------~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFG 305 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARL-----------RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFG 305 (461)
T ss_pred EEEccC-CCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccC
Confidence 999995 79999986531 358999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCC--------ChHHHHHHHHc
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY--------SNQEVIEMIRS 283 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~--------~~~~~~~~i~~ 283 (422)
+++...............+|+.|||||++.+..++.++|||||||++|||++ |..|+... ...++...+..
T Consensus 306 la~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~-g~~~lf~~~~~~~~~~~~~~l~~~i~~ 384 (461)
T PHA03211 306 AACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAV-HTASLFSASRGDERRPYDAQILRIIRQ 384 (461)
T ss_pred CceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHH-cCCCcccCCcccccCCcHHHHHHHHHh
Confidence 9976543222112223457899999999998899999999999999999998 54444322 12344444433
Q ss_pred CCCC--CCCC-------------------------------CCCcchhhhcccccccccchhh
Q psy7289 284 RQML--PCPE-------------------------------DCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 284 ~~~~--~~p~-------------------------------~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.... ..|. ..+..+.+|+..||..||..|+
T Consensus 385 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RP 447 (461)
T PHA03211 385 AQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRP 447 (461)
T ss_pred hccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCc
Confidence 2210 0110 1234678899999999999987
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=316.19 Aligned_cols=195 Identities=25% Similarity=0.395 Sum_probs=165.2
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
...|++++.||+|+||.||+|+...+ +..||+|+.... ....|+.++++++||||+++++++......++|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~--~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQ--PDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCC--CceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 45689999999999999999987543 467999975432 234699999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+. |+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 136 ~e~~~-~~l~~~l~~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~ 203 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRS-----------RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGA 203 (357)
T ss_pred EEccC-CcHHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcc
Confidence 99995 69999986532 3589999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG 271 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~ 271 (422)
++...... ......+|+.|+|||++....++.++|||||||++|||++.+..+|..
T Consensus 204 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 204 AQFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred ccccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence 97533221 112345788999999999889999999999999999999977666654
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=303.15 Aligned_cols=256 Identities=22% Similarity=0.385 Sum_probs=198.2
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHH-HhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDL-MSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~i-l~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
+|++.+.||+|+||.||+++...+ +..||+|.++..........+..|+.+ ++.++||||+++++++..+..++++|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPT--GTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCC--CcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 577889999999999999986543 578999998754433334456667765 66678999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeecCCCeEEEecCcc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSH-HYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
||++ |+|.+++...... ...+++..+..++.||+.||+|||++ +++||||||+||+++.++.+||+|||+
T Consensus 80 e~~~-~~l~~~l~~~~~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~ 150 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDK--------GLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGI 150 (283)
T ss_pred hhhc-ccHHHHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence 9997 7898888653211 13589999999999999999999997 999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCcccccc----CCCCCchhHHhHHHHHHHHHhCCCCCCCCCC-hHHHHHHHHcCCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILY----GKFTTESDVWSYGVVLWEVYSYGLQPYYGYS-NQEVIEMIRSRQML 287 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~-~~~~~~~i~~~~~~ 287 (422)
++...... ......++..|+|||.+.. ..++.++|+|||||++|||++ |..||.... ..+.+..+..+...
T Consensus 151 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd06617 151 SGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELAT-GRFPYDSWKTPFQQLKQVVEEPSP 226 (283)
T ss_pred cccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHh-CCCCCCccccCHHHHHHHHhcCCC
Confidence 87653221 1122345678999998864 457889999999999999998 999997532 33444444444444
Q ss_pred CCC-CCCCcchhhhcccccccccchhh-HHHHhhhhhhhh
Q psy7289 288 PCP-EDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHR 325 (422)
Q Consensus 288 ~~p-~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~ 325 (422)
..| ..+|.++.+++.+||..+|..|+ +..+.++.++..
T Consensus 227 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 266 (283)
T cd06617 227 QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266 (283)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence 444 35788999999999999999997 223334444443
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=304.71 Aligned_cols=247 Identities=22% Similarity=0.361 Sum_probs=197.3
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEEE-----c
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVCL-----S 125 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~-----~ 125 (422)
...+|++.+.||+|+||.||+++...+ +..+|+|.++... .....+.+|+.+++++ +||||+++++++. .
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~--~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKN--GSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCC--CceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 456788999999999999999987543 4679999875422 2235678899999999 6999999999884 3
Q ss_pred CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 126 GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 126 ~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
++..++||||+++|+|.+++...... ...+++..+..++.|++.||.|||+++++||||||+||++++++.+
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKR--------GERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhcc--------CccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCE
Confidence 45689999999999999988643211 1357889999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCcccccc-----CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHH
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-----GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEM 280 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~ 280 (422)
||+|||+++....... ......+++.|+|||++.. ..++.++|||||||++|||++ |..||...+..+.+..
T Consensus 164 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~-g~~p~~~~~~~~~~~~ 240 (286)
T cd06638 164 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGD-GDPPLADLHPMRALFK 240 (286)
T ss_pred EEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhc-CCCCCCCCchhHHHhh
Confidence 9999999876543221 1123356788999998753 447889999999999999998 9999988776554444
Q ss_pred HHcCCC--CCCCCCCCcchhhhcccccccccchhh
Q psy7289 281 IRSRQM--LPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 281 i~~~~~--~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+..... ...|..++..+.++|.+||..+|..|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 275 (286)
T cd06638 241 IPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRP 275 (286)
T ss_pred ccccCCCcccCCCCcCHHHHHHHHHHccCCcccCC
Confidence 433322 224566788899999999999999998
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=299.84 Aligned_cols=243 Identities=25% Similarity=0.353 Sum_probs=196.3
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC----CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC--CC
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA----NQKTASDFRREVDLMSELRHPNIVCLLGVCLSG--EP 128 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~ 128 (422)
.|+..+.||+|+||.||+|....+ +..|++|.+.... ..+....+.+|+.+++.++||||+++++++.+. ..
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDT--GRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCC--CcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCE
Confidence 467789999999999999986543 4679999875321 223456788999999999999999999988753 56
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
++++|||+++++|.+++... ..+++.....++.|++.||+|||+++|+||||||+||++++++.+||+
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~------------~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~ 148 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAY------------GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLG 148 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEc
Confidence 88999999999999999653 247888899999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcce-EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc-CCC
Q psy7289 209 DFGLSRDVYASDYY-RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS-RQM 286 (422)
Q Consensus 209 DFGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~-~~~ 286 (422)
|||+++........ .......++..|+|||.+....++.++|||||||++|||++ |..||.+.+..+.+..+.. ...
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~-g~~pf~~~~~~~~~~~~~~~~~~ 227 (266)
T cd06651 149 DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT-EKPPWAEYEAMAAIFKIATQPTN 227 (266)
T ss_pred cCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHH-CCCCccccchHHHHHHHhcCCCC
Confidence 99999765321111 01112345778999999988889999999999999999998 9999988766554444433 333
Q ss_pred CCCCCCCCcchhhhcccccccccchhh
Q psy7289 287 LPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 287 ~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+..|..+++.+.+++ .||..+|..|+
T Consensus 228 ~~~~~~~~~~~~~li-~~~~~~p~~Rp 253 (266)
T cd06651 228 PQLPSHISEHARDFL-GCIFVEARHRP 253 (266)
T ss_pred CCCchhcCHHHHHHH-HHhcCChhhCc
Confidence 445667788888888 79989999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=299.96 Aligned_cols=238 Identities=26% Similarity=0.425 Sum_probs=192.5
Q ss_pred ccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEecCC
Q psy7289 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVR 138 (422)
Q Consensus 59 ~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~~~ 138 (422)
...||+|+||.||+|+... ++..|++|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 13 ~~~lg~g~~g~v~~~~~~~--~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 89 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLS--TQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPG 89 (268)
T ss_pred eEEEecCCceEEEEeEecC--CCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCC
Confidence 4579999999999998654 35679999876443 33456899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCccCCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC-CCeEEEecCccccc
Q psy7289 139 GDLHEFLMSRSPRSDISGSQVQAPL--SQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD-GLTVKISDFGLSRD 215 (422)
Q Consensus 139 G~L~~~l~~~~~~~~~~~~~~~~~l--~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~-~~~vKl~DFGla~~ 215 (422)
++|.+++.... ..+ ++..+..++.||+.||+|||+++|+||||||+||+++. ++.+||+|||++..
T Consensus 90 ~~L~~~l~~~~-----------~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 90 GSLSALLRSKW-----------GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred CCHHHHHHHhc-----------ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 99999997531 124 77888899999999999999999999999999999976 67999999999875
Q ss_pred ccCCcceEeccCCCCCccccCccccccCC--CCCchhHHhHHHHHHHHHhCCCCCCCCCChHH-HHHHH-HcCCCCCCCC
Q psy7289 216 VYASDYYRIQSKSLLPVRWMPPESILYGK--FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE-VIEMI-RSRQMLPCPE 291 (422)
Q Consensus 216 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~-~~~~i-~~~~~~~~p~ 291 (422)
...... ......+++.|+|||.+.... ++.++|||||||++|||++ |..||....... ....+ .....+..|.
T Consensus 159 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd06624 159 LAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMAT-GKPPFIELGEPQAAMFKVGMFKIHPEIPE 235 (268)
T ss_pred cccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHh-CCCCCccccChhhhHhhhhhhccCCCCCc
Confidence 532211 112234578899999986543 7899999999999999998 999997654332 22222 2233445677
Q ss_pred CCCcchhhhcccccccccchhh
Q psy7289 292 DCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 292 ~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.+++++.+++.+||+.+|..|+
T Consensus 236 ~~~~~~~~li~~~l~~~p~~Rp 257 (268)
T cd06624 236 SLSAEAKNFILRCFEPDPDKRA 257 (268)
T ss_pred ccCHHHHHHHHHHcCCCchhCC
Confidence 8899999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=297.81 Aligned_cols=242 Identities=24% Similarity=0.398 Sum_probs=208.3
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFE 134 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E 134 (422)
.|++.+.||+|+||.||+|+... .+..|+||.+...........+.+|+..+.+++||||+++++++..+...++|||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~--~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKP--TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcC--CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 46788999999999999998754 3577999988765443456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 135 FMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCS-HHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 135 ~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
|+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++
T Consensus 80 ~~~~~~L~~~l~~~------------~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~ 147 (264)
T cd06623 80 YMDGGSLADLLKKV------------GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGIS 147 (264)
T ss_pred ecCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccc
Confidence 99999999999754 358899999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCC---ChHHHHHHHHcCCCCCCC
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY---SNQEVIEMIRSRQMLPCP 290 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~---~~~~~~~~i~~~~~~~~p 290 (422)
+........ .....++..|+|||.+....++.++|+||||+++|||++ |..||... ...+....+.....++.+
T Consensus 148 ~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (264)
T cd06623 148 KVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECAL-GKFPFLPPGQPSFFELMQAICDGPPPSLP 224 (264)
T ss_pred eecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCccccccCHHHHHHHHhcCCCCCCC
Confidence 865432211 112345678999999988889999999999999999998 99999877 456677777766666677
Q ss_pred CC-CCcchhhhcccccccccchhh
Q psy7289 291 ED-CPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 291 ~~-~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.. +|..+.+++.+||..+|..|+
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~R~ 248 (264)
T cd06623 225 AEEFSPEFRDFISACLQKDPKKRP 248 (264)
T ss_pred cccCCHHHHHHHHHHccCChhhCC
Confidence 77 899999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=299.01 Aligned_cols=244 Identities=23% Similarity=0.334 Sum_probs=195.7
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc----CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC--C
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN----ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG--E 127 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~ 127 (422)
..|++.+.||+|+||.||+|+...+ +..||||.+... ......+.+.+|+.++++++||||+++++++.+. .
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~--~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 79 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADT--GRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMER 79 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCC--CcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCc
Confidence 3578889999999999999986543 467999987532 1223456788999999999999999999988764 4
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
.++++|||+++|+|.+++... ..+++..+.+++.|++.||+|||+++++|+||||+||++++++.+||
T Consensus 80 ~~~~v~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l 147 (265)
T cd06652 80 TLSIFMEHMPGGSIKDQLKSY------------GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKL 147 (265)
T ss_pred eEEEEEEecCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEE
Confidence 588999999999999998753 24788889999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcce-EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC-C
Q psy7289 208 SDFGLSRDVYASDYY-RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR-Q 285 (422)
Q Consensus 208 ~DFGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~-~ 285 (422)
+|||+++........ .......++..|+|||++....++.++|||||||++|||++ |..||...+....+..+... .
T Consensus 148 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~ 226 (265)
T cd06652 148 GDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLT-EKPPWAEFEAMAAIFKIATQPT 226 (265)
T ss_pred CcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhh-CCCCCCccchHHHHHHHhcCCC
Confidence 999999765321111 01122346778999999988889999999999999999998 99999877665555444433 2
Q ss_pred CCCCCCCCCcchhhhcccccccccchhh
Q psy7289 286 MLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 286 ~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.+..|...+..+.+++.+||. +|..|+
T Consensus 227 ~~~~~~~~~~~~~~~i~~~l~-~p~~Rp 253 (265)
T cd06652 227 NPVLPPHVSDHCRDFLKRIFV-EAKLRP 253 (265)
T ss_pred CCCCchhhCHHHHHHHHHHhc-ChhhCC
Confidence 334566667788899999995 787776
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=297.39 Aligned_cols=243 Identities=25% Similarity=0.378 Sum_probs=197.6
Q ss_pred cccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHH-hcCCCCceeeEeeEEEcCCCeEEEEEec
Q psy7289 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLM-SELRHPNIVCLLGVCLSGEPMCMLFEFM 136 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il-~~l~HpnIv~l~g~~~~~~~~~lv~E~~ 136 (422)
+.||+|+||.||+|....+ ++.||+|.++... .......+..|..++ ..++||||+++++++..++..++||||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRST--GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCC--CCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence 5799999999999986543 4679999886432 122233455565554 4558999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccc
Q psy7289 137 VRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV 216 (422)
Q Consensus 137 ~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~ 216 (422)
++|+|.+++... ..+++..+..++.|++.||.|||+.+++||||+|+||++++++.+||+|||+++..
T Consensus 80 ~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 147 (260)
T cd05611 80 NGGDCASLIKTL------------GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG 147 (260)
T ss_pred CCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceec
Confidence 999999999653 25889999999999999999999999999999999999999999999999998754
Q ss_pred cCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC---CCCCCC
Q psy7289 217 YASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML---PCPEDC 293 (422)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~ 293 (422)
.. .....+++.|+|||.+.+..++.++||||||+++|||++ |..||...+..++...+..+... ..+..+
T Consensus 148 ~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (260)
T cd05611 148 LE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLF-GYPPFHAETPDAVFDNILSRRINWPEEVKEFC 220 (260)
T ss_pred cc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHhcccCCCCcccccC
Confidence 32 123345678999999988888999999999999999998 99999998888887777654322 233468
Q ss_pred Ccchhhhcccccccccchhh----HHHHhhhhhh
Q psy7289 294 PPRMYSLMMECWHEVPVAAG----MAYLCSHHYV 323 (422)
Q Consensus 294 p~~~~~l~~~cw~~~P~~r~----~~~lh~~~~i 323 (422)
|+.+.+++.+||..+|..|+ ++.+.+|.++
T Consensus 221 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~ 254 (260)
T cd05611 221 SPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254 (260)
T ss_pred CHHHHHHHHHHccCCHHHccCCCcHHHHHcChHh
Confidence 99999999999999999986 2345555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=305.49 Aligned_cols=242 Identities=27% Similarity=0.455 Sum_probs=200.0
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc--CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP 128 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 128 (422)
.+...|+..+.||+|+||.||+|+... .+..||+|.+... ......+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~ 89 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVR--TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHT 89 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcC--CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCe
Confidence 345668889999999999999998654 3567999987532 233445678999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
.++||||+. |+|.+++.... ..+++..+..++.|++.||.|||+.+++||||+|+||++++++.+||+
T Consensus 90 ~~lv~e~~~-g~l~~~~~~~~-----------~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~ 157 (307)
T cd06607 90 AWLVMEYCL-GSASDILEVHK-----------KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLA 157 (307)
T ss_pred EEEEHHhhC-CCHHHHHHHcc-----------cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEe
Confidence 999999997 67877775421 258899999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccc---cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL---YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ 285 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~ 285 (422)
|||+++..... ....+++.|+|||++. .+.++.++||||||+++|||++ |..||.+.+.......+....
T Consensus 158 dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 230 (307)
T cd06607 158 DFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQND 230 (307)
T ss_pred ecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCC
Confidence 99998754322 2234567899999874 3568899999999999999998 999999888777665555443
Q ss_pred CCCC-CCCCCcchhhhcccccccccchhh
Q psy7289 286 MLPC-PEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 286 ~~~~-p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.+.. +..++..+.+++.+||..+|..|+
T Consensus 231 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 259 (307)
T cd06607 231 SPTLSSNDWSDYFRNFVDSCLQKIPQDRP 259 (307)
T ss_pred CCCCCchhhCHHHHHHHHHHhcCChhhCc
Confidence 3332 345788999999999999999997
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=297.96 Aligned_cols=244 Identities=24% Similarity=0.346 Sum_probs=197.7
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc----CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC--C
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN----ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG--E 127 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~ 127 (422)
..|++.+.||+|+||.||+|+... .+..||+|.+... ........+.+|+.++++++||||+++++++.+. .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 79 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDAD--TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEK 79 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcC--CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCC
Confidence 357889999999999999998653 3567999987422 1234456889999999999999999999998764 3
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
.++++|||+++++|.+++... ..+++..+.+++.|++.||.|||+++++||||||+||+++.++.+||
T Consensus 80 ~~~~v~e~~~~~~L~~~~~~~------------~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l 147 (264)
T cd06653 80 KLSIFVEYMPGGSIKDQLKAY------------GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKL 147 (264)
T ss_pred EEEEEEEeCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEE
Confidence 588999999999999998653 24788889999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcce-EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC-C
Q psy7289 208 SDFGLSRDVYASDYY-RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR-Q 285 (422)
Q Consensus 208 ~DFGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~-~ 285 (422)
+|||+++........ .......++..|+|||.+....++.++|+|||||++|||++ |..||......+.+..+... .
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 226 (264)
T cd06653 148 GDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT-EKPPWAEYEAMAAIFKIATQPT 226 (264)
T ss_pred CccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHh-CCCCCCccCHHHHHHHHHcCCC
Confidence 999999865321100 01112346788999999988889999999999999999998 99999887766655555433 3
Q ss_pred CCCCCCCCCcchhhhcccccccccchhh
Q psy7289 286 MLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 286 ~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.+..|...++.+.+++.+||.. |..|+
T Consensus 227 ~~~~p~~~~~~~~~~i~~~l~~-~~~r~ 253 (264)
T cd06653 227 KPMLPDGVSDACRDFLKQIFVE-EKRRP 253 (264)
T ss_pred CCCCCcccCHHHHHHHHHHhcC-cccCc
Confidence 3456788889999999999985 55554
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=309.11 Aligned_cols=206 Identities=24% Similarity=0.405 Sum_probs=162.8
Q ss_pred ccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc--CCCeEEEEEec
Q psy7289 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLS--GEPMCMLFEFM 136 (422)
Q Consensus 59 ~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~~~lv~E~~ 136 (422)
.++||+|+||.||+|+.........||+|.+.... ....+.+|+++|++++||||+++++++.. +..++++|||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 46899999999999987655566789999886432 22456789999999999999999998864 34689999998
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceee----cCCCeEEEecCcc
Q psy7289 137 VRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV----GDGLTVKISDFGL 212 (422)
Q Consensus 137 ~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl----~~~~~vKl~DFGl 212 (422)
. ++|.+++........ ......+++..+..++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~-~~l~~~~~~~~~~~~---~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 E-HDLWHIIKFHRASKA---NKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-CCHHHHHHhcccccc---cCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 6 589888764321110 0112358999999999999999999999999999999999999 4567899999999
Q ss_pred cccccCCcc-eEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCC
Q psy7289 213 SRDVYASDY-YRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGY 272 (422)
Q Consensus 213 a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~ 272 (422)
++....... ........+|+.|||||++.+. .++.++||||+||++|||++ |.+||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~~f~~~ 219 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCR 219 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHh-CCCCccCC
Confidence 986543211 1112334568899999998764 58999999999999999998 99999653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=320.45 Aligned_cols=214 Identities=29% Similarity=0.408 Sum_probs=182.3
Q ss_pred hhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC-CC-----ceeeEeeE
Q psy7289 49 REVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR-HP-----NIVCLLGV 122 (422)
Q Consensus 49 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-Hp-----nIv~l~g~ 122 (422)
.+.+..+|.+++.||+|+||.|.+|....+ ++.||||+++... ....+-..|+.+|..|+ |. |||+++++
T Consensus 181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T--~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~ 256 (586)
T KOG0667|consen 181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKT--GEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY 256 (586)
T ss_pred cceeEEEEEEEEEecccccceeEEEEecCC--CcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence 355667899999999999999999986544 5889999998653 23445567999999997 53 89999999
Q ss_pred EEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC
Q psy7289 123 CLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG 202 (422)
Q Consensus 123 ~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~ 202 (422)
|...+++|||+|++.. +|+++|+.+.- ..|+...++.++.||+.||.+||+.+|||+||||+||||.+-
T Consensus 257 F~fr~HlciVfELL~~-NLYellK~n~f----------~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~ 325 (586)
T KOG0667|consen 257 FYFRNHLCIVFELLST-NLYELLKNNKF----------RGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP 325 (586)
T ss_pred cccccceeeeehhhhh-hHHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC
Confidence 9999999999999864 99999987642 358999999999999999999999999999999999999753
Q ss_pred --CeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHH
Q psy7289 203 --LTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEM 280 (422)
Q Consensus 203 --~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~ 280 (422)
..|||+|||+|.......+..+++ ..|.|||++.+..|+.+.||||||||+.||++ |.+-|.|.+..+.+..
T Consensus 326 ~r~~vKVIDFGSSc~~~q~vytYiQS-----RfYRAPEVILGlpY~~~IDmWSLGCIlAEL~t-G~PLfpG~ne~DQl~~ 399 (586)
T KOG0667|consen 326 KRSRIKVIDFGSSCFESQRVYTYIQS-----RFYRAPEVILGLPYDTAIDMWSLGCILAELFT-GEPLFPGDNEYDQLAR 399 (586)
T ss_pred CcCceeEEecccccccCCcceeeeec-----cccccchhhccCCCCCccceeehhhhHHhHhc-CccccCCCCHHHHHHH
Confidence 479999999998765544433333 46999999999999999999999999999998 9988999998888877
Q ss_pred HHc
Q psy7289 281 IRS 283 (422)
Q Consensus 281 i~~ 283 (422)
|..
T Consensus 400 I~e 402 (586)
T KOG0667|consen 400 IIE 402 (586)
T ss_pred HHH
Confidence 753
|
|
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=340.79 Aligned_cols=260 Identities=24% Similarity=0.343 Sum_probs=220.9
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc--CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
.+..++|++++.||+|+||.|...+.+.+ ...+|+|++++. .......-|..|-.+|..-+.+-||+++-+|+++.
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t--~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKST--EKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeecc--ccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 34567899999999999999999887665 477999998652 12223456888999999999999999999999999
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
++|+||||++||||..++.+. .+++++-++.++.+|..||.-||+.|+|||||||+|||||..|++||
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~------------~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikL 216 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKF------------DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKL 216 (1317)
T ss_pred ceEEEEecccCchHHHHHhhc------------CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEee
Confidence 999999999999999999764 25899999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCcccccc-----CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-----GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~ 282 (422)
+|||.+-.+..+.. ...+..+|||-|++||++.. +.|+..+|+||+||++|||+. |..||+..+..+.+..|.
T Consensus 217 ADFGsClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMly-G~TPFYadslveTY~KIm 294 (1317)
T KOG0612|consen 217 ADFGSCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLY-GETPFYADSLVETYGKIM 294 (1317)
T ss_pred ccchhHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHc-CCCcchHHHHHHHHHHHh
Confidence 99999987765543 34567789999999999863 569999999999999999995 999999999999999887
Q ss_pred cC-CCCCCC--CCCCcchhhhcccccccccchhh---HHHHhhhhhhhh
Q psy7289 283 SR-QMLPCP--EDCPPRMYSLMMECWHEVPVAAG---MAYLCSHHYVHR 325 (422)
Q Consensus 283 ~~-~~~~~p--~~~p~~~~~l~~~cw~~~P~~r~---~~~lh~~~~i~~ 325 (422)
+. ..+.+| .+++.+..+||..-+..-+...| ++.+.+|.++..
T Consensus 295 ~hk~~l~FP~~~~VSeeakdLI~~ll~~~e~RLgrngiedik~HpFF~g 343 (1317)
T KOG0612|consen 295 NHKESLSFPDETDVSEEAKDLIEALLCDREVRLGRNGIEDIKNHPFFEG 343 (1317)
T ss_pred chhhhcCCCcccccCHHHHHHHHHHhcChhhhcccccHHHHHhCccccC
Confidence 64 345566 56899999999987766555544 777777777653
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=302.86 Aligned_cols=242 Identities=24% Similarity=0.395 Sum_probs=194.7
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
+|++.+.||+|+||.||+|+... .+..||+|.+.... .....+.+.+|+.+++.++||||+++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRE--TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECC--CCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 57888999999999999998753 35679999875432 2223456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||+++++|..++... ..+++..+..++.|++.||+|||+++++||||||+||++++++.+||+|||++
T Consensus 80 e~~~~~~l~~~~~~~------------~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (286)
T cd07847 80 EYCDHTVLNELEKNP------------RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFA 147 (286)
T ss_pred eccCccHHHHHHhCC------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccc
Confidence 999999888876432 24889999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC--------
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR-------- 284 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~-------- 284 (422)
........ ......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (286)
T cd07847 148 RILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLT-GQPLWPGKSDVDQLYLIRKTLGDLIPRH 224 (286)
T ss_pred eecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence 86543221 1122345678999999875 457899999999999999998 99999988766554443210
Q ss_pred ------------CCCCCC----------CCCCcchhhhcccccccccchhh
Q psy7289 285 ------------QMLPCP----------EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 285 ------------~~~~~p----------~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
...+.| +..+..+.+++.+||..+|..|+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 275 (286)
T cd07847 225 QQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERL 275 (286)
T ss_pred hhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccC
Confidence 011111 23467788999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=297.42 Aligned_cols=244 Identities=21% Similarity=0.406 Sum_probs=205.3
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
+|++.+.||+|+||.||+|....+ +..||+|.+... ......+.+.+|+.+++.++||||+++++.+......++|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~--~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSD--SEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCC--CceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEE
Confidence 467789999999999999987543 466899987543 12234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC-eEEEecCcc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL-TVKISDFGL 212 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~-~vKl~DFGl 212 (422)
||+++++|.+++..... ..+++..+..++.|++.||.|||+.+++|+||||+||++++++ .+||+|||.
T Consensus 79 e~~~~~~L~~~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~ 148 (257)
T cd08225 79 EYCDGGDLMKRINRQRG----------VLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGI 148 (257)
T ss_pred ecCCCCcHHHHHHhccC----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEeccccc
Confidence 99999999999965321 2478999999999999999999999999999999999998775 579999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPED 292 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~ 292 (422)
+........ ......+++.|+|||++....++.++|+|||||++|||++ |..||...+..+....+..+...+.+..
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
T cd08225 149 ARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT-LKHPFEGNNLHQLVLKICQGYFAPISPN 225 (257)
T ss_pred chhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCccHHHHHHHHhcccCCCCCCC
Confidence 876543221 1122346788999999988889999999999999999998 8899988887777777777666666777
Q ss_pred CCcchhhhcccccccccchhh
Q psy7289 293 CPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 293 ~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.+..+.+++.+||..+|..|+
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rp 246 (257)
T cd08225 226 FSRDLRSLISQLFKVSPRDRP 246 (257)
T ss_pred CCHHHHHHHHHHhccChhhCc
Confidence 888999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=313.65 Aligned_cols=246 Identities=23% Similarity=0.356 Sum_probs=199.0
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEcc-CcCCHHhHHHHHHHHHHHhcCC-CCceeeEeeEEEcCCC
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELR-HPNIVCLLGVCLSGEP 128 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~-~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~ 128 (422)
+....|+++++||+||-+.||++.. + +...+|+|.+. ...+......|.+|+.+|.+|+ |.+||+|+++-..++.
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~--s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLN--S-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeec--C-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 4457799999999999999999753 2 23456666654 4567778899999999999995 9999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
+||||||- .-||..+|.++.. .++.-.++.+..|++.++.++|.+||||.||||.|.|+.+ |.+||+
T Consensus 435 lYmvmE~G-d~DL~kiL~k~~~-----------~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLI 501 (677)
T KOG0596|consen 435 LYMVMECG-DIDLNKILKKKKS-----------IDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLI 501 (677)
T ss_pred EEEEeecc-cccHHHHHHhccC-----------CCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEee
Confidence 99999975 4599999987532 2333367899999999999999999999999999999985 589999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccccCC-----------CCCchhHHhHHHHHHHHHhCCCCCCCCCChH-H
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK-----------FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ-E 276 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-----------~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~-~ 276 (422)
|||+|..+..+..........||+.||+||.+.... .+++|||||+|||||+|+ +|++||....+. .
T Consensus 502 DFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMv-YgktPf~~~~n~~a 580 (677)
T KOG0596|consen 502 DFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMV-YGKTPFGQIINQIA 580 (677)
T ss_pred eechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHH-hcCCchHHHHHHHH
Confidence 999999887776655666778999999999986432 568899999999999999 599999877643 3
Q ss_pred HHHHHHcC-CCCCCCCCCCcc-hhhhcccccccccchhh
Q psy7289 277 VIEMIRSR-QMLPCPEDCPPR-MYSLMMECWHEVPVAAG 313 (422)
Q Consensus 277 ~~~~i~~~-~~~~~p~~~p~~-~~~l~~~cw~~~P~~r~ 313 (422)
-+.+|..- ...++|..-++. +.++|+.|+..||..|+
T Consensus 581 Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~ 619 (677)
T KOG0596|consen 581 KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRW 619 (677)
T ss_pred HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCC
Confidence 33444332 334555544444 89999999999999986
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=300.71 Aligned_cols=235 Identities=22% Similarity=0.318 Sum_probs=192.8
Q ss_pred cccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEecCCC
Q psy7289 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRG 139 (422)
Q Consensus 62 LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~~~G 139 (422)
||+|+||.||++.... .+..||+|.+.... .....+.+.+|+.+++.++||||+++++++...+..|+||||+++|
T Consensus 1 lg~g~~g~vy~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKA--TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcC--CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence 6999999999987654 35679999885432 1223456788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccccCC
Q psy7289 140 DLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS 219 (422)
Q Consensus 140 ~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~~ 219 (422)
+|.+++..... ..+++.++..++.|++.||.|||+++++||||+|+||++++++.+||+|||+++.....
T Consensus 79 ~L~~~l~~~~~----------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~ 148 (277)
T cd05577 79 DLKYHIYNVGE----------PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG 148 (277)
T ss_pred cHHHHHHHcCc----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence 99999976421 25899999999999999999999999999999999999999999999999998764322
Q ss_pred cceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh----HHHHHHHHcCCCCCCCCCCCc
Q psy7289 220 DYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN----QEVIEMIRSRQMLPCPEDCPP 295 (422)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~----~~~~~~i~~~~~~~~p~~~p~ 295 (422)
. ......++..|+|||++....++.++|||||||++|||++ |..||..... .++...+. ....+.|..+++
T Consensus 149 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 223 (277)
T cd05577 149 K---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIA-GRSPFRQRKEKVEKEELKRRTL-EMAVEYPDKFSP 223 (277)
T ss_pred C---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhh-CCCCCCCCcccccHHHHHhccc-cccccCCccCCH
Confidence 1 1123345678999999988889999999999999999998 9999977644 23333222 223445677899
Q ss_pred chhhhcccccccccchhh
Q psy7289 296 RMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 296 ~~~~l~~~cw~~~P~~r~ 313 (422)
.+.+++.+||..+|..|+
T Consensus 224 ~~~~li~~~l~~~p~~R~ 241 (277)
T cd05577 224 EAKDLCEALLQKDPEKRL 241 (277)
T ss_pred HHHHHHHHHccCChhHcc
Confidence 999999999999999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=319.02 Aligned_cols=336 Identities=24% Similarity=0.384 Sum_probs=248.7
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
-..|.+.+.||+|.|++|.+|++..+ +..||||.+.+.. +....+.+.+|+++|..|+|||||+++.+......+|+
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t--~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILT--GTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCC--CceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 35678899999999999999998765 4679999987543 34445679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
||||+.+|++++||.++. .+.+..+..++.|+.+|++|||+++|||||||++||||+.+.++||+|||
T Consensus 133 V~eya~~ge~~~yl~~~g------------r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfg 200 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHG------------RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFG 200 (596)
T ss_pred EEEeccCchhHHHHHhcc------------cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccc
Confidence 999999999999998763 46778899999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccccCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC-CCCC
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFT-TESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ-MLPC 289 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~-~~~~ 289 (422)
++....... ...+.++++.|.|||++.+..|+ +.+|+||+|+++|-|++ |..||.+.+..++...+..+. +.|.
T Consensus 201 fS~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~-GsLPFDG~~lk~Lr~rvl~gk~rIp~ 276 (596)
T KOG0586|consen 201 FSTFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVE-GSLPFDGQNLKELRPRVLRGKYRIPF 276 (596)
T ss_pred cceeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeee-cccccCCcccccccchheeeeecccc
Confidence 998765332 33456788999999999988765 78999999999999997 999999998888777665543 2222
Q ss_pred C--CCC--------------Ccchhhhccccccccc---------------chhhHHHHhhhhhhhhhcccccccccCCc
Q psy7289 290 P--EDC--------------PPRMYSLMMECWHEVP---------------VAAGMAYLCSHHYVHRDLAARNCLVGDGL 338 (422)
Q Consensus 290 p--~~~--------------p~~~~~l~~~cw~~~P---------------~~r~~~~lh~~~~i~~dLk~~nil~~~~~ 338 (422)
+ .+| -..+.++|..||.-.- ....-.+.|.+.+.|++++.++.+.....
T Consensus 277 ~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~~~l~p~~e~~~~~~~~~r~~~m~~~G~~~~~i~~sL~~~k~ 356 (596)
T KOG0586|consen 277 YMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEARLLAPLIERSTPFILAKRILHMNSIGHRRLKIEESLAKQKF 356 (596)
T ss_pred eeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhhhhhhcccccCccchhhHHHHHHHhhccchhhHHHHHhhhhH
Confidence 1 111 1235667788885321 11223345666777888877666543211
Q ss_pred ----------------ceeecccccccccccCcceeeccccCCCcccCCccccccCCC-CcchhHHHHHHHHHHHHhcCC
Q psy7289 339 ----------------TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKF-TTESDVWSYGVVLWEVYSYGL 401 (422)
Q Consensus 339 ----------------~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~~~g~ 401 (422)
....+|++.... ... ...+.......|--++.+..-.+ ..-.+-|+.+++.++.+.-.+
T Consensus 357 d~i~a~y~ll~~~~~~s~~~~~~~~~~~--~~~--~~~~~~~~s~~~~~~d~~~p~~~~~~~~~~~~~~~~~~s~~~e~~ 432 (596)
T KOG0586|consen 357 DDINATYLLLGYRKQRSIESADFGLKTI--ELN--YMCSARCGSPDYVSVDRLMPVPYDGHLTDTWDGSVILYSLLDEDR 432 (596)
T ss_pred HHHHHHHhhcchhhhccchhhhcCCCcc--ccc--cccccccCCCCcccccccCCCCcccccccccccCccchhhhhccc
Confidence 123445554221 111 11122222333555554443333 245689999999999987557
Q ss_pred CCCCCCCch
Q psy7289 402 QPYYGYSNQ 410 (422)
Q Consensus 402 ~p~~~~~~~ 410 (422)
.|+..-.+.
T Consensus 433 ~~a~~~~~~ 441 (596)
T KOG0586|consen 433 LPARDLPNA 441 (596)
T ss_pred CCCCCcccc
Confidence 777765544
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=300.49 Aligned_cols=244 Identities=25% Similarity=0.365 Sum_probs=197.4
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC--CCeEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG--EPMCML 132 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~~~lv 132 (422)
+++..+.||.|++|.||++.... .+..+|+|.+...........+.+|+++++.++||||+++++++.+. ..+++|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKN--TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECC--CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 46778999999999999998754 45789999987554445567899999999999999999999998654 368999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++|+|.+++...... ...+++..+..++.|++.||.|||+.+++|+||+|+||++++++.+||+|||+
T Consensus 80 ~e~~~~~~L~~~l~~~~~~--------~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 151 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKR--------GGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGV 151 (287)
T ss_pred EEecCCCCHHHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccc
Confidence 9999999999988653211 13588899999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCC-----ChHHHHHHHHcCCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY-----SNQEVIEMIRSRQML 287 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~-----~~~~~~~~i~~~~~~ 287 (422)
+....... .....++..|+|||.+....++.++|||||||++|||++ |..||... ...+....+.....+
T Consensus 152 ~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd06621 152 SGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQ-NRFPFPPEGEPPLGPIELLSYIVNMPNP 226 (287)
T ss_pred cccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCcccCCCCChHHHHHHHhcCCch
Confidence 87543221 112335678999999988899999999999999999998 99999765 334555555543322
Q ss_pred CCCC------CCCcchhhhcccccccccchhh
Q psy7289 288 PCPE------DCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 288 ~~p~------~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..+. ..++.+.+++.+||..+|..|+
T Consensus 227 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 258 (287)
T cd06621 227 ELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRP 258 (287)
T ss_pred hhccCCCCCCchHHHHHHHHHHHcCCCcccCC
Confidence 2221 2356789999999999999997
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=309.38 Aligned_cols=275 Identities=22% Similarity=0.347 Sum_probs=224.9
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSG 126 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~ 126 (422)
.+..+++.++..||+|+||.|.+|..+.+ .+.+|||++++.. .....+--..|-++|... +-|.+++++.++++-
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgt--dELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm 422 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGT--DELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM 422 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCc--chhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence 56678889999999999999999986544 4789999997642 122334445688888776 468999999999999
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEE
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vK 206 (422)
+.+|+||||+.||+|.-.+++- +.+.+..+..++.+||-||=+||++|||.||||.+||+|+.+|++|
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~------------GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiK 490 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQV------------GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIK 490 (683)
T ss_pred hheeeEEEEecCchhhhHHHHh------------cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceE
Confidence 9999999999999999988764 4688899999999999999999999999999999999999999999
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~ 286 (422)
|+|||+++..-.... .+.+..|||.|+|||.+..+.|+..+|+|||||+||||+. |.+||.+.+..++.+.|....
T Consensus 491 i~DFGmcKEni~~~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmla-GQpPFdGeDE~elF~aI~ehn- 566 (683)
T KOG0696|consen 491 IADFGMCKENIFDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQPPFDGEDEDELFQAIMEHN- 566 (683)
T ss_pred eeecccccccccCCc--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcc-
Confidence 999999986433322 3456778999999999999999999999999999999998 999999999999999998654
Q ss_pred CCCCCCCCcchhhhcccccccccchh------hHHHHhhhhhhhh--hcccccccccCCcceee
Q psy7289 287 LPCPEDCPPRMYSLMMECWHEVPVAA------GMAYLCSHHYVHR--DLAARNCLVGDGLTVKI 342 (422)
Q Consensus 287 ~~~p~~~p~~~~~l~~~cw~~~P~~r------~~~~lh~~~~i~~--dLk~~nil~~~~~~~ki 342 (422)
...|...+.+..++.+.-+.+.|..| +=..+..|.++.+ .-|.++.-+..+...|+
T Consensus 567 vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~ 630 (683)
T KOG0696|consen 567 VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKI 630 (683)
T ss_pred CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCcc
Confidence 55688888888888888888888654 1123334555543 23556666666666665
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=301.07 Aligned_cols=246 Identities=23% Similarity=0.376 Sum_probs=198.7
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCC----
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGE---- 127 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~---- 127 (422)
..+|++.+.||+|+||.||++.... .+..+|+|.+.... .....+.+|+.+++++ +||||+++++++...+
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~--~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKK--DGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECC--CCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 4568899999999999999998643 35679999885432 2235677899999999 7999999999987543
Q ss_pred -CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEE
Q psy7289 128 -PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 128 -~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vK 206 (422)
..++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+++++||||||+||++++++.+|
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~--------~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLIC--------GQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEE
Confidence 589999999999999998643111 13588999999999999999999999999999999999999999999
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCccccccC-----CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHH
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-----KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i 281 (422)
|+|||+++....... ......++..|+|||++... .++.++|||||||++|||++ |..||...+..+.+..+
T Consensus 169 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~-g~~p~~~~~~~~~~~~~ 245 (291)
T cd06639 169 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGD-GDPPLFDMHPVKTLFKI 245 (291)
T ss_pred Eeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhh-CCCCCCCCcHHHHHHHH
Confidence 999999876543221 11233467889999987643 36889999999999999998 99999988776666666
Q ss_pred HcCCCCC--CCCCCCcchhhhcccccccccchhh
Q psy7289 282 RSRQMLP--CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 282 ~~~~~~~--~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
....... .|+..+..+.+++.+||..+|..|+
T Consensus 246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 279 (291)
T cd06639 246 PRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARP 279 (291)
T ss_pred hcCCCCCCCcccccCHHHHHHHHHHhhcChhhCc
Confidence 5544332 3556777899999999999999997
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=301.27 Aligned_cols=244 Identities=21% Similarity=0.409 Sum_probs=196.2
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEc------
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVCLS------ 125 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~------ 125 (422)
...|++.+.||+|+||.||+|+... .+..+|+|..... ......+.+|+.+++++ +||||+++++++..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~--~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVK--TGQLAAIKVMDVT--EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcC--CCcEEEEEEEecC--hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 4578889999999999999998754 3467999987542 23445788999999998 69999999999853
Q ss_pred CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 126 GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 126 ~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
....+++|||+++|+|.+++.... ...+++..+..++.||+.||+|||+++|+||||||+||++++++.+
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTK----------GNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHcc----------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCE
Confidence 356899999999999999986532 1247888889999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCccccc-----cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHH
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL-----YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEM 280 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~ 280 (422)
||+|||+++...... .......+++.|+|||.+. ...++.++|||||||++|||++ |..||....+.+....
T Consensus 161 ~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~ 237 (282)
T cd06636 161 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAE-GAPPLCDMHPMRALFL 237 (282)
T ss_pred EEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHh-CCCCccccCHHhhhhh
Confidence 999999987543211 1112344678899999876 3458889999999999999998 8999987776555444
Q ss_pred HHcCCCC-CCCCCCCcchhhhcccccccccchhh
Q psy7289 281 IRSRQML-PCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 281 i~~~~~~-~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+...... ..+..+|+.+.++|.+||..+|..|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 271 (282)
T cd06636 238 IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRP 271 (282)
T ss_pred HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCc
Confidence 4433222 23456889999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=309.86 Aligned_cols=255 Identities=22% Similarity=0.333 Sum_probs=209.2
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
...++.-+.||+|+||.||-++.+.+ ++.+|.|.+.+.. ......--++|..||.+++.|.||.+--++.+.+.+|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraT--GKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRAT--GKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecc--hhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 34566778999999999999887655 4678888774321 1122334578999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+||..|.||||.-+|.+... ..++++.++.++.+|+.||++||+.+||.|||||+|||||+.|+++|+|.
T Consensus 262 lVLtlMNGGDLkfHiyn~g~----------~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDL 331 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGN----------PGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDL 331 (591)
T ss_pred EEEEeecCCceeEEeeccCC----------CCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeecc
Confidence 99999999999988876532 36999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCC----hHHHHHHHHcCCC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS----NQEVIEMIRSRQM 286 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~----~~~~~~~i~~~~~ 286 (422)
|||..+..... .....||..|||||++.++.|+..+|+||+||++|||+. |+.||.... .+|+-.++.+..
T Consensus 332 GLAvei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~-G~sPFr~~KeKvk~eEvdrr~~~~~- 406 (591)
T KOG0986|consen 332 GLAVEIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIA-GHSPFRQRKEKVKREEVDRRTLEDP- 406 (591)
T ss_pred ceEEecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHc-ccCchhhhhhhhhHHHHHHHHhcch-
Confidence 99987765542 234488999999999999999999999999999999997 999997543 345656665443
Q ss_pred CCCCCCCCcchhhhcccccccccchh------hHHHHhhhhhhh
Q psy7289 287 LPCPEDCPPRMYSLMMECWHEVPVAA------GMAYLCSHHYVH 324 (422)
Q Consensus 287 ~~~p~~~p~~~~~l~~~cw~~~P~~r------~~~~lh~~~~i~ 324 (422)
...|+..+++..++.+.-+.++|..| +.+-...|++++
T Consensus 407 ~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk 450 (591)
T KOG0986|consen 407 EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFK 450 (591)
T ss_pred hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccc
Confidence 44578889999999999999999764 333344555543
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=301.61 Aligned_cols=243 Identities=21% Similarity=0.365 Sum_probs=196.8
Q ss_pred cccccccccccceeEEEEEEecC-CCCeEEEEEEccCcC---CHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCCeE
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTS-EGPSLVAIKTLKENA---NQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~ 130 (422)
|++.+.||+|+||.||+++.... ..+..||+|.++... .....+.+.+|+++++.+ +||||+++++++..+..++
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 67889999999999999986432 346789999986432 122346788999999999 5899999999999888999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+++||||||+|||+++++.+||+||
T Consensus 82 lv~e~~~~~~L~~~l~~~------------~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~df 149 (290)
T cd05613 82 LILDYINGGELFTHLSQR------------ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDF 149 (290)
T ss_pred EEEecCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeC
Confidence 999999999999999753 24788899999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccC--CCCCchhHHhHHHHHHHHHhCCCCCCCCCC----hHHHHHHHHcC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYG--KFTTESDVWSYGVVLWEVYSYGLQPYYGYS----NQEVIEMIRSR 284 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~----~~~~~~~i~~~ 284 (422)
|+++....... .......++..|+|||.+... .++.++||||||+++|||++ |..||.... ..++...+...
T Consensus 150 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 227 (290)
T cd05613 150 GLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT-GASPFTVDGEKNSQAEISRRILKS 227 (290)
T ss_pred ccceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhc-CCCCCCcCCccccHHHHHHHhhcc
Confidence 99976533221 111233467889999998753 47789999999999999998 999996432 23444444333
Q ss_pred CCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 285 QMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 285 ~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..+.|..+++.+.+++.+||..+|..|.
T Consensus 228 -~~~~~~~~~~~~~~ll~~~l~~~p~~R~ 255 (290)
T cd05613 228 -EPPYPQEMSALAKDIIQRLLMKDPKKRL 255 (290)
T ss_pred -CCCCCccCCHHHHHHHHHHhcCCHHHhc
Confidence 3566778899999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=332.09 Aligned_cols=246 Identities=23% Similarity=0.342 Sum_probs=197.5
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC-CCceeeEeeEE-Ec--
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR-HPNIVCLLGVC-LS-- 125 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~-~~-- 125 (422)
++-..++++.+.|.+|||+.||.|+.... +..+|+|++-.. +....+...+|+.+|++|+ |||||.+++.. ..
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~--~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKG--GKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCC--CceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence 45567788999999999999999987543 267999987655 6677888999999999997 99999999932 21
Q ss_pred -C---CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceee
Q psy7289 126 -G---EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHH--YVHRDLAARNCLV 199 (422)
Q Consensus 126 -~---~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--ivHrDlKp~NiLl 199 (422)
. -.+.|+||||.+|.|-|++..+- +..|++.++.+|+.|+|+|+.+||... |||||||-+||||
T Consensus 110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rl----------q~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl 179 (738)
T KOG1989|consen 110 SNNGVWEVLLLMEYCKGGSLVDFMNTRL----------QTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL 179 (738)
T ss_pred CCCceeEEEeehhhccCCcHHHHHHHHH----------hccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE
Confidence 1 24789999999999999998763 245999999999999999999999987 9999999999999
Q ss_pred cCCCeEEEecCcccccccCCcc-------eEeccCCCCCccccCccccc---cCCCCCchhHHhHHHHHHHHHhCCCCCC
Q psy7289 200 GDGLTVKISDFGLSRDVYASDY-------YRIQSKSLLPVRWMPPESIL---YGKFTTESDVWSYGVVLWEVYSYGLQPY 269 (422)
Q Consensus 200 ~~~~~vKl~DFGla~~~~~~~~-------~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwS~Gvil~El~t~g~~Pf 269 (422)
+.++..||||||.+........ ....-....|+.|.|||++. +..+++|+|||||||+||-|+ +...||
T Consensus 180 s~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLC-y~t~PF 258 (738)
T KOG1989|consen 180 SADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLC-YFTTPF 258 (738)
T ss_pred cCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHH-HhCCCc
Confidence 9999999999999864322110 00011223478999999874 567899999999999999998 588999
Q ss_pred CCCChHHHHHHHHcC-CCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 270 YGYSNQEVIEMIRSR-QMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 270 ~~~~~~~~~~~i~~~-~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.+...- +|.++ ...|..+..+..+.+||+.|+..+|..|+
T Consensus 259 e~sg~l----aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RP 299 (738)
T KOG1989|consen 259 EESGKL----AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERP 299 (738)
T ss_pred CcCcce----eEEeccccCCCCccHHHHHHHHHHHHhccCcccCC
Confidence 865332 23333 33444467889999999999999999987
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=298.09 Aligned_cols=244 Identities=27% Similarity=0.426 Sum_probs=195.5
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC---------HHhHHHHHHHHHHHhcCCCCceeeEeeEEEc
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN---------QKTASDFRREVDLMSELRHPNIVCLLGVCLS 125 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 125 (422)
+|.+.+.||+|+||.||+|....+ +..||+|.++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~--~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTT--GEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCC--CceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc
Confidence 356678999999999999986433 56799998753211 1123568889999999999999999999999
Q ss_pred CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 126 GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 126 ~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
.+..++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++++||||+|+||+++.++.+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~------------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~ 147 (272)
T cd06629 80 EEYLSIFLEYVPGGSIGSCLRTY------------GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGIC 147 (272)
T ss_pred CCceEEEEecCCCCcHHHHHhhc------------cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeE
Confidence 99999999999999999999753 357888999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCccccccCC--CCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK--FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS 283 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~ 283 (422)
||+|||+++...............++..|+|||.+.... ++.++|+||||+++||+++ |..||...+..+....+..
T Consensus 148 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~ 226 (272)
T cd06629 148 KISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFA-GRRPWSDEEAIAAMFKLGN 226 (272)
T ss_pred EEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHh-CCCCCcCcchHHHHHHhhc
Confidence 999999987543211111122334678899999987654 8899999999999999998 9999977665554443332
Q ss_pred -CCCCCCCC----CCCcchhhhcccccccccchhh
Q psy7289 284 -RQMLPCPE----DCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 284 -~~~~~~p~----~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
....+.|. .++..+.+++.+||..+|..|+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 261 (272)
T cd06629 227 KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRP 261 (272)
T ss_pred cccCCcCCccccccCCHHHHHHHHHHhcCChhhCC
Confidence 22233333 4688899999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=305.44 Aligned_cols=240 Identities=22% Similarity=0.368 Sum_probs=198.2
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFE 134 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E 134 (422)
.+.....||+|+||.||++.... .+..||||.+.... ....+.+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKH--TGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECC--CCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 34446789999999999987643 35679999875432 3345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccc
Q psy7289 135 FMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR 214 (422)
Q Consensus 135 ~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~ 214 (422)
|+++++|.+++.. ..+++.++..++.||+.||+|||+++|+||||||+||++++++.+||+|||++.
T Consensus 100 ~~~~~~L~~~~~~-------------~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~ 166 (292)
T cd06658 100 FLEGGALTDIVTH-------------TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCA 166 (292)
T ss_pred CCCCCcHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchh
Confidence 9999999998853 247889999999999999999999999999999999999999999999999987
Q ss_pred cccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC--CCCCC
Q psy7289 215 DVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML--PCPED 292 (422)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~--~~p~~ 292 (422)
....... ......++..|+|||.+....++.++|||||||++|||++ |..||.+.+..+....+...... +.+..
T Consensus 167 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (292)
T cd06658 167 QVSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMID-GEPPYFNEPPLQAMRRIRDNLPPRVKDSHK 243 (292)
T ss_pred hcccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCccccccc
Confidence 5432211 1122346788999999988889999999999999999998 99999988877766666543222 22335
Q ss_pred CCcchhhhcccccccccchhh
Q psy7289 293 CPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 293 ~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.+..+.+++..||..+|..|+
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rp 264 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRA 264 (292)
T ss_pred cCHHHHHHHHHHccCChhHCc
Confidence 677899999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=303.86 Aligned_cols=243 Identities=26% Similarity=0.406 Sum_probs=189.8
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
+|++.+.||+|+||.||+|+...+ +..||+|.++... .......+.+|+.++++++||||+++++++.+....++|+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~--g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRET--HEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCC--CcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEE
Confidence 467889999999999999987543 4679999886432 2223356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||+. ++|.+++.... ..+++..+..++.||+.||.|||+++++||||||+||+++.++.+||+|||++
T Consensus 79 e~~~-~~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 146 (284)
T cd07839 79 EYCD-QDLKKYFDSCN-----------GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLA 146 (284)
T ss_pred ecCC-CCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchh
Confidence 9997 58888876532 35899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC-------
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ------- 285 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~------- 285 (422)
+...... .......+++.|+|||++.+. .++.++|||||||++|||++.+.++|.+.+..+.+..+....
T Consensus 147 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
T cd07839 147 RAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEES 224 (284)
T ss_pred hccCCCC--CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHH
Confidence 7543221 111233457889999988764 478999999999999999994444455555544444332110
Q ss_pred ------------CC---------CCCCCCCcchhhhcccccccccchhh
Q psy7289 286 ------------ML---------PCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 286 ------------~~---------~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.. +..+.+++++.+++++||..+|..|+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 273 (284)
T cd07839 225 WPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRI 273 (284)
T ss_pred hHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcC
Confidence 00 01124567888999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=304.48 Aligned_cols=239 Identities=23% Similarity=0.387 Sum_probs=198.7
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEe
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEF 135 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~ 135 (422)
++....||+|+||.||++.... .+..||+|.+..... .....+.+|+.+++.++||||+++++++..++..+++|||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~--~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKH--SGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcC--CCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 3445689999999999998643 346799998854322 2345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccccc
Q psy7289 136 MVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRD 215 (422)
Q Consensus 136 ~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~ 215 (422)
+++++|.+++.. ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||+++.
T Consensus 100 ~~~~~L~~~~~~-------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~ 166 (297)
T cd06659 100 LQGGALTDIVSQ-------------TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQ 166 (297)
T ss_pred CCCCCHHHHHhh-------------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhh
Confidence 999999998754 2478999999999999999999999999999999999999999999999999875
Q ss_pred ccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC--CCCCCC
Q psy7289 216 VYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML--PCPEDC 293 (422)
Q Consensus 216 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~--~~p~~~ 293 (422)
...... ......++..|+|||++....++.++|||||||++|||++ |..||...+..+....+...... ..+...
T Consensus 167 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (297)
T cd06659 167 ISKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVD-GEPPYFSDSPVQAMKRLRDSPPPKLKNAHKI 243 (297)
T ss_pred cccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCccccCCC
Confidence 432211 1123346788999999988889999999999999999998 99999988877777766543322 123457
Q ss_pred Ccchhhhcccccccccchhh
Q psy7289 294 PPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 294 p~~~~~l~~~cw~~~P~~r~ 313 (422)
++.+.+++.+||..+|..|+
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rp 263 (297)
T cd06659 244 SPVLRDFLERMLTREPQERA 263 (297)
T ss_pred CHHHHHHHHHHhcCCcccCc
Confidence 78899999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=318.75 Aligned_cols=251 Identities=23% Similarity=0.358 Sum_probs=204.3
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEcc---CcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC--eE
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK---ENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP--MC 130 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~---~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~--~~ 130 (422)
.++..+||+|+|-+||||.+ ...+..||--.++ ...+....++|..|+.+|+.|+|||||++|.++.+... ..
T Consensus 42 ~k~~evLGrGafKtVYka~D--e~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in 119 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFD--EEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTIN 119 (632)
T ss_pred eehhhhcccccceeeeeccc--cccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceee
Confidence 35677899999999999976 3445566643332 23455667899999999999999999999999987766 88
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceeecC-CCeEEE
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHH--YVHRDLAARNCLVGD-GLTVKI 207 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--ivHrDlKp~NiLl~~-~~~vKl 207 (422)
+|+|++..|+|+.|+++.. .++.+.+..|++||+.||.|||++. |||||||.+||+|+. -|.|||
T Consensus 120 ~iTEL~TSGtLr~Y~kk~~------------~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKI 187 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKHR------------RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKI 187 (632)
T ss_pred eeeecccCCcHHHHHHHhc------------cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceee
Confidence 9999999999999998863 5788899999999999999999985 999999999999975 589999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCC-hHHHHHHHHcCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS-NQEVIEMIRSRQM 286 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~-~~~~~~~i~~~~~ 286 (422)
+|+|||..+..+.. ....|||.|||||+.. +.|+..+||||||++|.||+| +..||...+ +.+++++|.+|..
T Consensus 188 GDLGLAtl~r~s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT-~eYPYsEC~n~AQIYKKV~SGiK 261 (632)
T KOG0584|consen 188 GDLGLATLLRKSHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVT-SEYPYSECTNPAQIYKKVTSGIK 261 (632)
T ss_pred cchhHHHHhhcccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHh-ccCChhhhCCHHHHHHHHHcCCC
Confidence 99999987654432 2357899999999776 889999999999999999999 889998764 5689999999876
Q ss_pred CCCCCC-CCcchhhhcccccccccchhhHHHHhhhhhhhhh
Q psy7289 287 LPCPED-CPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRD 326 (422)
Q Consensus 287 ~~~p~~-~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~d 326 (422)
+..-.. --++++++|.+|+.....+....-|..+.++-.|
T Consensus 262 P~sl~kV~dPevr~fIekCl~~~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 262 PAALSKVKDPEVREFIEKCLATKSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHhhccCCHHHHHHHHHHhcCchhccCHHHHhhChhhccc
Confidence 542221 2467999999999885555555566666655443
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=320.65 Aligned_cols=211 Identities=28% Similarity=0.490 Sum_probs=176.4
Q ss_pred ccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC------CeE
Q psy7289 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE------PMC 130 (422)
Q Consensus 57 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~------~~~ 130 (422)
..-+.||+|+||.||+|+.+ +.++.||||.++.....+..+...+|+++|++|+|||||+++++-.+.. ...
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnk--etG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNK--ETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eehhhhcCCccceeeeeccc--ccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 34578999999999998765 4468899999987766677788999999999999999999999865433 467
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC--C--CeEE
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD--G--LTVK 206 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~--~--~~vK 206 (422)
++||||.+|||+..|.+... ...|++.++..++.+++.||.|||++||+||||||.||++-. + ..-|
T Consensus 94 lvmEyC~gGsL~~~L~~PEN---------~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyK 164 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPEN---------AYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYK 164 (732)
T ss_pred EEEeecCCCcHHHHhcCccc---------ccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEe
Confidence 99999999999999976432 246999999999999999999999999999999999999843 2 3579
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCC----ChHHHHHHH
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGY----SNQEVIEMI 281 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~----~~~~~~~~i 281 (422)
|+|||.||....+. ......||..|.+||.... +.|+..+|.|||||++||++| |..||-.. ++.++...+
T Consensus 165 LtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caT-G~lPF~p~~~pk~~~~~~~~~ 240 (732)
T KOG4250|consen 165 LTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECAT-GELPFIPFGGPKNNKEIMWHI 240 (732)
T ss_pred eecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhc-cCCCCCcCCCccccchhhhhh
Confidence 99999999887665 2345678999999999884 789999999999999999999 99999643 344565555
Q ss_pred H
Q psy7289 282 R 282 (422)
Q Consensus 282 ~ 282 (422)
.
T Consensus 241 ~ 241 (732)
T KOG4250|consen 241 I 241 (732)
T ss_pred h
Confidence 3
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=303.15 Aligned_cols=241 Identities=24% Similarity=0.424 Sum_probs=199.1
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
.+|++.+.||+|+||.||++....+ +..|++|.+.... ....+.+.+|+.++++++||||+++++++...+..++|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~--~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVAT--GQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCC--CCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 5788899999999999999975433 4679999875432 233467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||+++|+|.+++.+. .+++.++..++.|++.||.|||+++++||||||+||+++.++.+||+|||++
T Consensus 96 e~~~~~~L~~~~~~~-------------~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~ 162 (293)
T cd06647 96 EYLAGGSLTDVVTET-------------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 162 (293)
T ss_pred ecCCCCcHHHHHhhc-------------CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcce
Confidence 999999999998642 4778889999999999999999999999999999999999999999999998
Q ss_pred ccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC--CCCC
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML--PCPE 291 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~--~~p~ 291 (422)
........ ......+++.|+|||.+....++.++|+|||||++||+++ |..||...+..+....+.....+ +.+.
T Consensus 163 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd06647 163 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPYLNENPLRALYLIATNGTPELQNPE 239 (293)
T ss_pred eccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhheeehhcCCCCCCCCcc
Confidence 75433221 1122346778999999988889999999999999999998 99999887665544433322222 2344
Q ss_pred CCCcchhhhcccccccccchhh
Q psy7289 292 DCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 292 ~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..+..+.+++.+||..+|..|+
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp 261 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRG 261 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCc
Confidence 5677899999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=322.43 Aligned_cols=249 Identities=23% Similarity=0.387 Sum_probs=189.4
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCC------CceeeEeeEEEcC
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRH------PNIVCLLGVCLSG 126 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~H------pnIv~l~g~~~~~ 126 (422)
..+|++++.||+|+||.||+|+... .+..||||+++... .....+..|+.+++.++| ++|+++++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~--~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRK--RKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcC--CCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 4678999999999999999998654 35779999986422 223445667777777654 4588999988754
Q ss_pred -CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCC-
Q psy7289 127 -EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCS-HHYVHRDLAARNCLVGDGL- 203 (422)
Q Consensus 127 -~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlKp~NiLl~~~~- 203 (422)
..+|+|||++ +++|.+++..+ ..+++..+..++.||+.||+|||+ .|||||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~------------~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~ 270 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKH------------GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDT 270 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCc
Confidence 4688999987 77899988754 358899999999999999999998 5999999999999998665
Q ss_pred ---------------eEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCC
Q psy7289 204 ---------------TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQP 268 (422)
Q Consensus 204 ---------------~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~P 268 (422)
.+||+|||++..... ......+|+.|||||++.+..++.++|||||||++|||++ |..|
T Consensus 271 ~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~p 344 (467)
T PTZ00284 271 VVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYT-GKLL 344 (467)
T ss_pred ccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHh-CCCC
Confidence 499999998864321 1234567889999999999999999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHcCC--C-----------------------CCC--CC--------------CCCcchhhhccccccc
Q psy7289 269 YYGYSNQEVIEMIRSRQ--M-----------------------LPC--PE--------------DCPPRMYSLMMECWHE 307 (422)
Q Consensus 269 f~~~~~~~~~~~i~~~~--~-----------------------~~~--p~--------------~~p~~~~~l~~~cw~~ 307 (422)
|.+.+..+.+..+.... . .++ |. ...+.+.+|+..|+..
T Consensus 345 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 424 (467)
T PTZ00284 345 YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY 424 (467)
T ss_pred CCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCc
Confidence 99887766554442210 0 000 00 0123456899999999
Q ss_pred ccchhh-HHHHhhhhhhh
Q psy7289 308 VPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 308 ~P~~r~-~~~lh~~~~i~ 324 (422)
||..|+ +..+.+|.++.
T Consensus 425 dP~~R~ta~e~L~Hp~~~ 442 (467)
T PTZ00284 425 DRQKRLNARQMTTHPYVL 442 (467)
T ss_pred ChhhCCCHHHHhcCcccc
Confidence 999886 33455555553
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=302.81 Aligned_cols=242 Identities=24% Similarity=0.369 Sum_probs=194.0
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC-HHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN-QKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
+|++.+.||+|+||.||+|.+.. .+..||+|.+..... ....+.+.+|+++++.++||||+++++++.++...++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKE--TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECC--CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 57788999999999999998753 357799998764332 223457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||+++++|.++.... ..+++.++..++.||+.||+|||+.+++||||+|+||++++++.+||+|||++
T Consensus 80 e~~~~~~l~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~ 147 (286)
T cd07846 80 EFVDHTVLDDLEKYP------------NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFA 147 (286)
T ss_pred ecCCccHHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeee
Confidence 999999998876532 24789999999999999999999999999999999999999999999999998
Q ss_pred ccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc---------
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS--------- 283 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~--------- 283 (422)
+....... ......++..|+|||.+.. ..++.++|||||||++|||++ |.+||.+.+..+....+..
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (286)
T cd07846 148 RTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT-GEPLFPGDSDIDQLYHIIKCLGNLIPRH 224 (286)
T ss_pred eeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHhCCCchhh
Confidence 76543221 1122345778999998865 347889999999999999998 8899987665443333221
Q ss_pred -----------CCCC----------CCCCCCCcchhhhcccccccccchhh
Q psy7289 284 -----------RQML----------PCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 284 -----------~~~~----------~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+... ..++.++..+.+++.+||..+|..|+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 275 (286)
T cd07846 225 QEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRP 275 (286)
T ss_pred HHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccch
Confidence 0000 01235678899999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=298.85 Aligned_cols=239 Identities=24% Similarity=0.410 Sum_probs=200.1
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEe
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEF 135 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~ 135 (422)
+...+.||+|+||.||++.... .+..+++|.+... .....+.+.+|+.+++.++||||+++++++..++..++++||
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~--~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKS--TGRQVAVKKMDLR-KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhcceEeccCCCeEEEEEEECC--CCCEEEEEEEecc-chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 4446799999999999998643 3467999987543 223456688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccccc
Q psy7289 136 MVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRD 215 (422)
Q Consensus 136 ~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~ 215 (422)
+++++|.+++... .+++.++..++.|++.||+|||+++++||||+|+||+++.++.+||+|||++..
T Consensus 98 ~~~~~L~~~~~~~-------------~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~ 164 (285)
T cd06648 98 LEGGALTDIVTHT-------------RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQ 164 (285)
T ss_pred cCCCCHHHHHHhC-------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchh
Confidence 9999999998652 478889999999999999999999999999999999999999999999998875
Q ss_pred ccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC--CCCC
Q psy7289 216 VYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC--PEDC 293 (422)
Q Consensus 216 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~--p~~~ 293 (422)
...... ......+++.|+|||.+....++.++|||||||++|||++ |..||.+.+..+....+........ +..+
T Consensus 165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (285)
T cd06648 165 VSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVD-GEPPYFNEPPLQAMKRIRDNLPPKLKNLHKV 241 (285)
T ss_pred hccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHh-CCCCCcCCCHHHHHHHHHhcCCCCCcccccC
Confidence 433211 1122346788999999988889999999999999999998 9999998887777777766533222 3347
Q ss_pred Ccchhhhcccccccccchhh
Q psy7289 294 PPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 294 p~~~~~l~~~cw~~~P~~r~ 313 (422)
|..+.+++.+||..+|..|+
T Consensus 242 ~~~l~~li~~~l~~~p~~Rp 261 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRA 261 (285)
T ss_pred CHHHHHHHHHHcccChhhCc
Confidence 88999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=316.37 Aligned_cols=253 Identities=22% Similarity=0.346 Sum_probs=220.4
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc--CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
-+.++.+..||-|+||.|-+.+..... ..+|+|++++. .+.++.++...|-+||...+.|.||++|..|.++..+|
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~--~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQK--ATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccc--hHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 355677889999999999887764432 24788888643 34566778999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
++||-|-||+|...|+.+ +.|.+.++..++..++.|++|||++|||.|||||+|++|+.+|.+||.||
T Consensus 497 mLmEaClGGElWTiLrdR------------g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDF 564 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDR------------GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDF 564 (732)
T ss_pred hhHHhhcCchhhhhhhhc------------CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeeh
Confidence 999999999999999876 36888899999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC-CCCC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ-MLPC 289 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~-~~~~ 289 (422)
|+|+.+..+. .+.+.+|||.|.|||.+.+..++.++|.||||+++||+++ |.+||.+.++...++.|..|. ...+
T Consensus 565 GFAKki~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~-G~pPFs~~dpmktYn~ILkGid~i~~ 640 (732)
T KOG0614|consen 565 GFAKKIGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLT-GSPPFSGVDPMKTYNLILKGIDKIEF 640 (732)
T ss_pred hhHHHhccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHhhhhhhhc
Confidence 9999886654 3456789999999999999999999999999999999998 999999999999999998875 3567
Q ss_pred CCCCCcchhhhcccccccccchh------hHHHHhhhhhh
Q psy7289 290 PEDCPPRMYSLMMECWHEVPVAA------GMAYLCSHHYV 323 (422)
Q Consensus 290 p~~~p~~~~~l~~~cw~~~P~~r------~~~~lh~~~~i 323 (422)
|...+....+||++....+|..| +++.+..|.++
T Consensus 641 Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf 680 (732)
T KOG0614|consen 641 PRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWF 680 (732)
T ss_pred ccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhh
Confidence 88899999999999999999775 44555555444
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=299.07 Aligned_cols=243 Identities=25% Similarity=0.402 Sum_probs=197.0
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
+|++.+.||+|+||.||+|++..+ +..|++|++.... .......+.+|+.++++++||||+++++++..+...++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~--~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRET--GETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCC--CceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEe
Confidence 477889999999999999987543 5679999886433 2334567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||+ +++|.+++.... ..+++.++..++.||+.||+|||+++++|+||||+||++++++.++|+|||++
T Consensus 79 e~~-~~~L~~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~ 146 (286)
T cd07832 79 EYM-PSDLSEVLRDEE-----------RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLA 146 (286)
T ss_pred ccc-CCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeec
Confidence 999 999999986532 35899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC----
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP---- 288 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~---- 288 (422)
+....... .......++..|+|||.+... .++.++||||+||++|||++ |.+||.+.++.+....+......+
T Consensus 147 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (286)
T cd07832 147 RLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLN-GSPLFPGENDIEQLAIVFRTLGTPNEET 224 (286)
T ss_pred ccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHc-CCcCcCCCCHHHHHHHHHHHcCCCChHH
Confidence 86543321 112234567889999988654 46899999999999999998 888888777665554443211100
Q ss_pred -------------------------CCCCCCcchhhhcccccccccchhh
Q psy7289 289 -------------------------CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 289 -------------------------~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..++.+..+.+++++||..+|..|+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 274 (286)
T cd07832 225 WPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRL 274 (286)
T ss_pred HhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCC
Confidence 0124567889999999999999987
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=295.84 Aligned_cols=243 Identities=24% Similarity=0.422 Sum_probs=196.9
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC-----HHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN-----QKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
|+..+.||+|+||.||+|.... ++..||+|.+..... ....+.+.+|+++++.++||||+++++++.+++..+
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~--~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVK--TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFN 79 (268)
T ss_pred ccccceecCcCceEEEEEEEcC--CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEE
Confidence 5677899999999999997643 356799998864321 223568899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC-eEEEec
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL-TVKISD 209 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~-~vKl~D 209 (422)
+||||+++++|.+++... .++++..+..++.|++.||+|||+++++||||||+||+++.++ .+||+|
T Consensus 80 ~v~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~d 147 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKY------------GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIAD 147 (268)
T ss_pred EEEeccCCCcHHHHHHHh------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcc
Confidence 999999999999999753 3578899999999999999999999999999999999998765 699999
Q ss_pred CcccccccCCcce--EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChH---HHHHHHH-c
Q psy7289 210 FGLSRDVYASDYY--RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ---EVIEMIR-S 283 (422)
Q Consensus 210 FGla~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~---~~~~~i~-~ 283 (422)
||+++........ .......++..|+|||.+....++.++||||+||++|||++ |..||...+.. .....+. .
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 226 (268)
T cd06630 148 FGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMAT-AKPPWNAEKHSNHLALIFKIASA 226 (268)
T ss_pred cccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcchHHHHHHHhcc
Confidence 9998765432110 01122345778999999988889999999999999999998 99999755432 2222222 2
Q ss_pred CCCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 284 RQMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 284 ~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
......|...++++.+++.+||..+|..|+
T Consensus 227 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~ 256 (268)
T cd06630 227 TTAPSIPEHLSPGLRDVTLRCLELQPEDRP 256 (268)
T ss_pred CCCCCCchhhCHHHHHHHHHHcCCCcccCc
Confidence 334456677889999999999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=291.32 Aligned_cols=246 Identities=24% Similarity=0.420 Sum_probs=212.1
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
+|++.+.||+|+||.||++.... ++..+++|.+.... .......+.+|+++++.++|||++++++.+......++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKS--DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcC--CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEE
Confidence 46788999999999999998753 35679999986533 2345667889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||+++++|.+++...... ...+++..+..++.|++.||.|||+++++|+||+|+||++++++.+||+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~ 150 (258)
T cd08215 79 EYADGGDLSQKIKKQKKE--------GKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGIS 150 (258)
T ss_pred EecCCCcHHHHHHHhhcc--------CCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccce
Confidence 999999999999764211 136899999999999999999999999999999999999999999999999998
Q ss_pred ccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDC 293 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~ 293 (422)
....... .......+++.|+|||.+....++.++|+||+|+++|+|++ |..||...+..++...+..+...+.|..+
T Consensus 151 ~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (258)
T cd08215 151 KVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCT-LKHPFEGENLLELALKILKGQYPPIPSQY 227 (258)
T ss_pred eecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHc-CCCCCCCCcHHHHHHHHhcCCCCCCCCCC
Confidence 7654332 12223356778999999988889999999999999999997 99999988888888888877777888899
Q ss_pred Ccchhhhcccccccccchhh
Q psy7289 294 PPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 294 p~~~~~l~~~cw~~~P~~r~ 313 (422)
+..+.+++.+||..+|..|+
T Consensus 228 ~~~~~~~i~~~l~~~p~~Rp 247 (258)
T cd08215 228 SSELRNLVSSLLQKDPEERP 247 (258)
T ss_pred CHHHHHHHHHHcCCChhhCc
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=295.09 Aligned_cols=236 Identities=23% Similarity=0.404 Sum_probs=199.7
Q ss_pred cccccceeEEEEEEecCCCCeEEEEEEccCcCC--HHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEecCCC
Q psy7289 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN--QKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRG 139 (422)
Q Consensus 62 LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~~~G 139 (422)
||+|+||.||+++...+ +..+++|.+..... ......+.+|++++++++||||+++++.+..+...|++|||+++|
T Consensus 1 lg~g~~~~vy~~~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCC--CCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence 68999999999987533 46799998864322 244567899999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccccCC
Q psy7289 140 DLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS 219 (422)
Q Consensus 140 ~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~~ 219 (422)
+|.+++... ..+++..+..++.|++.||+|||+++++||||+|+||++++++.+||+|||++......
T Consensus 79 ~L~~~l~~~------------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~ 146 (265)
T cd05579 79 DLASLLENV------------GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR 146 (265)
T ss_pred cHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence 999999753 25889999999999999999999999999999999999999999999999998754332
Q ss_pred cc------eEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q psy7289 220 DY------YRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDC 293 (422)
Q Consensus 220 ~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~ 293 (422)
.. ........++..|+|||.+....++.++||||||+++||+++ |..||...+..+....+..+. .+.|..+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~ 224 (265)
T cd05579 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV-GIPPFHGETPEEIFQNILNGK-IEWPEDV 224 (265)
T ss_pred cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-cCCCccc
Confidence 11 011223345678999999988889999999999999999998 999999998888888877644 4455665
Q ss_pred --Ccchhhhcccccccccchhh
Q psy7289 294 --PPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 294 --p~~~~~l~~~cw~~~P~~r~ 313 (422)
++.+.+++.+||+.+|..|+
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rp 246 (265)
T cd05579 225 EVSDEAIDLISKLLVPDPEKRL 246 (265)
T ss_pred cCCHHHHHHHHHHhcCCHhhcC
Confidence 89999999999999999997
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=300.84 Aligned_cols=240 Identities=25% Similarity=0.452 Sum_probs=198.9
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc--CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
...|+..+.||+|+||.||+++... .+..||+|.+... ........+.+|++++++++||||+++++++.++...+
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVR--TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAW 101 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcC--CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEE
Confidence 3446778899999999999998654 3567999987643 22344567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+||||++ |+|.+++.... .++++.++..++.|++.||.|||+++|+||||+|+||++++++.+||+||
T Consensus 102 lv~e~~~-g~l~~~~~~~~-----------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~df 169 (317)
T cd06635 102 LVMEYCL-GSASDLLEVHK-----------KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADF 169 (317)
T ss_pred EEEeCCC-CCHHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecC
Confidence 9999997 58888775431 35889999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccc---cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESIL---YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
|++..... .....+++.|+|||.+. .+.++.++|||||||++|||++ |..||.+.+..+....+......
T Consensus 170 g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd06635 170 GSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNESP 242 (317)
T ss_pred CCccccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhccCC
Confidence 99865322 12334677899999874 4568899999999999999998 99999888777766666654443
Q ss_pred C-CCCCCCcchhhhcccccccccchhh
Q psy7289 288 P-CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 288 ~-~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+ .+..+++.+.+++.+||..+|..|+
T Consensus 243 ~~~~~~~~~~l~~li~~~l~~~p~~Rp 269 (317)
T cd06635 243 TLQSNEWSDYFRNFVDSCLQKIPQDRP 269 (317)
T ss_pred CCCCccccHHHHHHHHHHccCCcccCc
Confidence 3 3446788899999999999999997
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=301.41 Aligned_cols=255 Identities=13% Similarity=0.134 Sum_probs=186.3
Q ss_pred hccccCcccccccccccceeEEEEEEecCCC-CeEEEEEEccCcCCHH--h--------HHHHHHHHHHHhcCCCCceee
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEG-PSLVAIKTLKENANQK--T--------ASDFRREVDLMSELRHPNIVC 118 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~-~~~vavK~~~~~~~~~--~--------~~~~~~E~~il~~l~HpnIv~ 118 (422)
++...+|++.+.||+|+||.||+|++..+.. ...+++|......... . ......+...+..++|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 3556789999999999999999998754421 3446666543221110 0 112233445567789999999
Q ss_pred EeeEEEcCC----CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy7289 119 LLGVCLSGE----PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAA 194 (422)
Q Consensus 119 l~g~~~~~~----~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp 194 (422)
+++++.... ..++++|++.. ++.+.+... ...++..+..++.|++.||+|||+++|+||||||
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp 154 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI------------KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKP 154 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhcc-CHHHHHHhh------------ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 999766543 34677887643 666665432 1356788899999999999999999999999999
Q ss_pred CceeecCCCeEEEecCcccccccCCcce-----EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCC
Q psy7289 195 RNCLVGDGLTVKISDFGLSRDVYASDYY-----RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPY 269 (422)
Q Consensus 195 ~NiLl~~~~~vKl~DFGla~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf 269 (422)
+|||++.++.+||+|||+|+....+... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 155 ~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~-g~~P~ 233 (294)
T PHA02882 155 ENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAG-IKLPW 233 (294)
T ss_pred HHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCCCC
Confidence 9999999999999999999865322111 01122357899999999998899999999999999999998 99999
Q ss_pred CCCC-hHHH--------HHHHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhh
Q psy7289 270 YGYS-NQEV--------IEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHR 325 (422)
Q Consensus 270 ~~~~-~~~~--------~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~ 325 (422)
.+.+ ..+. +..+..+.. .+..||+.+.++|..||..+|..|| +...+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp-----~~~~l~~ 291 (294)
T PHA02882 234 KGFGHNGNLIHAAKCDFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKP-----DYDALIK 291 (294)
T ss_pred CccccchHHHHHhHHHHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCC-----CHHHHHH
Confidence 8874 2222 233333221 2457899999999999999999998 5554443
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=296.98 Aligned_cols=243 Identities=25% Similarity=0.467 Sum_probs=204.2
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
...|++.+.||+|+||.||+|.+..+ +..|++|.+..... ....+.+|+++++.++||||+++++++......+++
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~--~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRAT--GKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccC--CcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 34578889999999999999987543 46799998865432 456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
+||+++++|.+++.... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||+
T Consensus 94 ~e~~~~~~L~~~l~~~~-----------~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~ 162 (286)
T cd06614 94 MEYMDGGSLTDIITQNF-----------VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGF 162 (286)
T ss_pred EeccCCCcHHHHHHHhc-----------cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccch
Confidence 99999999999997642 2588999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC--C
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC--P 290 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~--p 290 (422)
+........ ......++..|+|||.+....++.++|+|||||++|||++ |..||...++.+....+......+. +
T Consensus 163 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd06614 163 AAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAE-GEPPYLREPPLRALFLITTKGIPPLKNP 239 (286)
T ss_pred hhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCcch
Confidence 865432211 1122335678999999988889999999999999999998 9999998887766666655444333 3
Q ss_pred CCCCcchhhhcccccccccchhh
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..+|..+.+++.+||+.+|..|+
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rp 262 (286)
T cd06614 240 EKWSPEFKDFLNKCLVKDPEKRP 262 (286)
T ss_pred hhCCHHHHHHHHHHhccChhhCc
Confidence 34889999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=345.70 Aligned_cols=244 Identities=25% Similarity=0.360 Sum_probs=206.8
Q ss_pred ccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEe
Q psy7289 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEF 135 (422)
Q Consensus 57 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~ 135 (422)
+-...||.|.||.||-|... ++++..|||.++... ..+......+|..++..|+|||+|++||+-...+.++|.|||
T Consensus 1238 qrg~~Ig~G~fG~VYtavN~--~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1238 QRGNFIGGGTFGKVYTAVNL--DTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred ccccccCCcceeeeEEeecC--CccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 44568999999999998754 446789999886432 244556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccccc
Q psy7289 136 MVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRD 215 (422)
Q Consensus 136 ~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~ 215 (422)
|++|+|.+.+... ....+.....+..|++.|+.|||++|||||||||+||+|+.+|.+|++|||.|+.
T Consensus 1316 C~~GsLa~ll~~g------------ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHG------------RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred hccCcHHHHHHhc------------chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeE
Confidence 9999999998653 2355556677899999999999999999999999999999999999999999987
Q ss_pred ccCCcce--EeccCCCCCccccCccccccC---CCCCchhHHhHHHHHHHHHhCCCCCCCCCChH-HHHHHHHcCCCCCC
Q psy7289 216 VYASDYY--RIQSKSLLPVRWMPPESILYG---KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ-EVIEMIRSRQMLPC 289 (422)
Q Consensus 216 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~---~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~-~~~~~i~~~~~~~~ 289 (422)
+..+... .......||+.|||||++.+. ....++||||+||++.||+| |+.||...++. .++-.+..|..+++
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~t-GkrPW~~~dne~aIMy~V~~gh~Pq~ 1462 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMAT-GKRPWAELDNEWAIMYHVAAGHKPQI 1462 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeec-CCCchhhccchhHHHhHHhccCCCCC
Confidence 7654211 111245689999999999753 46778999999999999999 99999987765 67778889999999
Q ss_pred CCCCCcchhhhcccccccccchhhHH
Q psy7289 290 PEDCPPRMYSLMMECWHEVPVAAGMA 315 (422)
Q Consensus 290 p~~~p~~~~~l~~~cw~~~P~~r~~~ 315 (422)
|+..+++-++++..|+..||..|.+.
T Consensus 1463 P~~ls~~g~dFle~Cl~~dP~~Rw~~ 1488 (1509)
T KOG4645|consen 1463 PERLSSEGRDFLEHCLEQDPKMRWTA 1488 (1509)
T ss_pred chhhhHhHHHHHHHHHhcCchhhhHH
Confidence 99999999999999999999999654
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=299.21 Aligned_cols=243 Identities=25% Similarity=0.433 Sum_probs=188.6
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
..|++.+.||+|+||.||+|+... .+..||||.+...........+.+|+++++.++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKL--TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcC--CCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 568889999999999999998643 346799999865433323345778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||+. ++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+||++++++.+||+|||++
T Consensus 83 e~~~-~~L~~~~~~~~-----------~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 150 (291)
T cd07844 83 EYLD-TDLKQYMDDCG-----------GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLA 150 (291)
T ss_pred ecCC-CCHHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccc
Confidence 9998 49999886532 25788999999999999999999999999999999999999999999999998
Q ss_pred ccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCC-hHHHHHHHHcCCCC----
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYS-NQEVIEMIRSRQML---- 287 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~-~~~~~~~i~~~~~~---- 287 (422)
+....... ......++..|+|||.+.+ ..++.++||||+||++|||++ |..||.+.. ..+....+......
T Consensus 151 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (291)
T cd07844 151 RAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT-GRPLFPGSTDVEDQLHKIFRVLGTPTEE 227 (291)
T ss_pred cccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHh-CCCCCCCCccHHHHHHHHHHhcCCCChh
Confidence 75432111 1122235678999998865 458899999999999999998 999997665 22322222110000
Q ss_pred --------------------CC-----CCCCC--cchhhhcccccccccchhh
Q psy7289 288 --------------------PC-----PEDCP--PRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 288 --------------------~~-----p~~~p--~~~~~l~~~cw~~~P~~r~ 313 (422)
+. ..... ....+++.+|++.+|..|+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rp 280 (291)
T cd07844 228 TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRI 280 (291)
T ss_pred hhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCccccc
Confidence 00 01122 5667899999999999887
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=295.35 Aligned_cols=245 Identities=26% Similarity=0.394 Sum_probs=201.3
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccC----cCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKE----NANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
+|.+.+.||+|+||.||+++..... ..+++|.++. .........+.+|+.+++.++||||+++++++.+....+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAV--AEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCC--CcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceE
Confidence 4778899999999999999875443 2344454432 112233456778999999999999999999999989999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+||||+++++|.+++...... ...+++.++..++.|++.||.|||+++++|+||||+||++++ +.+||+||
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~ 149 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHT--------GKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDF 149 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhc--------ccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeeccc
Confidence 999999999999998653211 135899999999999999999999999999999999999976 46999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP 290 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p 290 (422)
|+++....... ......+++.|+|||.+....++.++|+||||+++|+|++ |..||...+..+....+..+..+..|
T Consensus 150 g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T cd08222 150 GVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCC-LAHAFEGQNFLSVVLRIVEGPTPSLP 226 (260)
T ss_pred CceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHcCCCCCCc
Confidence 99876543321 1223345778999999988888999999999999999998 88999888877777777777777778
Q ss_pred CCCCcchhhhcccccccccchhh
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..+|.++.++|.+||..+|..|+
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rp 249 (260)
T cd08222 227 ETYSRQLNSIMQSMLNKDPSLRP 249 (260)
T ss_pred chhcHHHHHHHHHHhcCChhhCc
Confidence 88999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=302.44 Aligned_cols=206 Identities=24% Similarity=0.402 Sum_probs=162.3
Q ss_pred ccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc--CCCeEEEEEec
Q psy7289 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLS--GEPMCMLFEFM 136 (422)
Q Consensus 59 ~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~~~lv~E~~ 136 (422)
..+||+|+||.||+|+.........||+|.+.... ....+.+|+.++++++||||+++++++.. +...++||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 35799999999999987655556789999886432 22457889999999999999999998854 45689999998
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceee----cCCCeEEEecCcc
Q psy7289 137 VRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV----GDGLTVKISDFGL 212 (422)
Q Consensus 137 ~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl----~~~~~vKl~DFGl 212 (422)
. ++|.+++........ ......+++..+..++.||+.||+|||+++|+||||||+|||+ ++++.+||+|||+
T Consensus 83 ~-~~l~~~~~~~~~~~~---~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 E-HDLWHIIKFHRASKA---NKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-CcHHHHHHhhhcccc---CCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 7 488888754321100 0112358899999999999999999999999999999999999 4567899999999
Q ss_pred cccccCCcce-EeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Q psy7289 213 SRDVYASDYY-RIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGY 272 (422)
Q Consensus 213 a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~ 272 (422)
++........ .......+|+.|+|||++.. ..++.++|||||||++|||++ |.+||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~t-g~~~f~~~ 219 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCR 219 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHh-CCCCcccc
Confidence 9865432211 11223456788999999876 458999999999999999998 99999654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=331.33 Aligned_cols=188 Identities=24% Similarity=0.346 Sum_probs=155.2
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc--CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
..|+++++||+|+||.||+|+... .+..||||+++.. ........+.+|+.+++.++||||+++++++.....+|+
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~--~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKN--NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECC--CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 468889999999999999998753 3567999998643 233445678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
||||+.+|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 82 VmEy~~g~~L~~li~~~------------~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFG 149 (669)
T cd05610 82 VMEYLIGGDVKSLLHIY------------GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFG 149 (669)
T ss_pred EEeCCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCC
Confidence 99999999999999653 247888999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccccCC-CCCchhHHhHHHH
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYGK-FTTESDVWSYGVV 257 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwS~Gvi 257 (422)
+++........ .....+|+.|++||...... -...+++||+|.-
T Consensus 150 ls~~~~~~~~~--~~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~g~~ 194 (669)
T cd05610 150 LSKVTLNRELN--MMDILTTPSMAKPKNDYSRTPGQVLSLISSLGFN 194 (669)
T ss_pred CCccccCCccc--ccccccCccccCccccccCCCCceeeeeeecCcC
Confidence 99865433221 22345678899999765433 2345788888853
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=285.64 Aligned_cols=255 Identities=24% Similarity=0.436 Sum_probs=207.8
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC-CCceeeEeeEEEcCCCeEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR-HPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~l 131 (422)
...++.+..||.|+-|.|++++.+.+ +...|||.+.+..+..+.++++..+.++.+-+ .|.||+.+|+|..+..+.+
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~--~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I 168 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRST--GHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI 168 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEccc--ceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence 34567788999999999999998765 47899999998888888888999999877664 7999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCCeEEEecC
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCS-HHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
.||.|. ...+.|..+. ..+++|.-+-++...+.+||.||-. ++|||||+||+|||+|+.|++|+|||
T Consensus 169 cMelMs--~C~ekLlkri----------k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDF 236 (391)
T KOG0983|consen 169 CMELMS--TCAEKLLKRI----------KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDF 236 (391)
T ss_pred HHHHHH--HHHHHHHHHh----------cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecc
Confidence 999884 3444444432 3579999999999999999999976 68999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCcccccc---CCCCCchhHHhHHHHHHHHHhCCCCCCCCC-ChHHHHHHHHcCCC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILY---GKFTTESDVWSYGVVLWEVYSYGLQPYYGY-SNQEVIEMIRSRQM 286 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~-~~~~~~~~i~~~~~ 286 (422)
|++-.+..+. ..+...|-+.|||||.+.- ..|+-++||||||++++|+.| |..||.+. +..+++..|.+...
T Consensus 237 GIsGrlvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaT-g~yPy~~c~tdFe~ltkvln~eP 312 (391)
T KOG0983|consen 237 GISGRLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELAT-GQYPYKGCKTDFEVLTKVLNEEP 312 (391)
T ss_pred cccceeeccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhc-ccCCCCCCCccHHHHHHHHhcCC
Confidence 9997765443 3445667788999999864 368899999999999999999 99999985 45688888877543
Q ss_pred CCCC--CCCCcchhhhcccccccccchhh-HHHHhhhhhhhh
Q psy7289 287 LPCP--EDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHR 325 (422)
Q Consensus 287 ~~~p--~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~ 325 (422)
+..| ...++.+.+++..|+.+|+..|+ ...|.+|.++.+
T Consensus 313 P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 313 PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence 3333 34789999999999999999887 233555555543
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=298.12 Aligned_cols=243 Identities=26% Similarity=0.395 Sum_probs=196.3
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
+|++.+.||+|+||.||+|....+ +..|++|.++... .......+.+|++++++++||||+++++++..++..+++|
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKAT--GEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCC--CcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 578899999999999999987543 5679999886432 2334567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||++++.+..++... ..+++.++..++.||+.||+|||+++++||||+|+||++++++.+||+|||++
T Consensus 80 e~~~~~~l~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~ 147 (288)
T cd07833 80 EYVERTLLELLEASP------------GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFA 147 (288)
T ss_pred ecCCCCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecc
Confidence 999987777665432 24789999999999999999999999999999999999999999999999998
Q ss_pred ccccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc---------
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS--------- 283 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~--------- 283 (422)
........ .......++..|+|||++... .++.++||||||+++|||++ |.+||.+.+..+.+..+..
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (288)
T cd07833 148 RALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD-GEPLFPGDSDIDQLYLIQKCLGPLPPSH 225 (288)
T ss_pred cccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 76544321 011223456789999999887 78999999999999999998 9999987765544333221
Q ss_pred -----------CCCC-----------CCCCCCCcchhhhcccccccccchhh
Q psy7289 284 -----------RQML-----------PCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 284 -----------~~~~-----------~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+... ..|..+|+++.+++++||..+|..|+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 277 (288)
T cd07833 226 QELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL 277 (288)
T ss_pred hhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcc
Confidence 0000 12334588899999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=292.85 Aligned_cols=244 Identities=24% Similarity=0.428 Sum_probs=210.4
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
+|++.+.||+|+||.||+++... .+..+++|.+... ........+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLS--DNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECC--CCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEe
Confidence 36788999999999999997653 3467999988643 23445567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||+++++|.+++...... ...+++..+..++.|++.||+|||+.+++|+||+|+||++++++.+||+|||++
T Consensus 79 e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~ 150 (256)
T cd08530 79 EYAPFGDLSKAISKRKKK--------RKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGIS 150 (256)
T ss_pred hhcCCCCHHHHHHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccch
Confidence 999999999998763211 135888999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDC 293 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~ 293 (422)
+..... ......+++.|+|||.+....++.++|+||||+++|||++ |..||...+..++...+..+...+.+..+
T Consensus 151 ~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (256)
T cd08530 151 KVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMAT-FAPPFEARSMQDLRYKVQRGKYPPIPPIY 225 (256)
T ss_pred hhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCchhh
Confidence 765433 1223446778999999988889999999999999999998 99999999988888888888777778889
Q ss_pred Ccchhhhcccccccccchhh
Q psy7289 294 PPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 294 p~~~~~l~~~cw~~~P~~r~ 313 (422)
+.++.+++.+||..+|..|+
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp 245 (256)
T cd08530 226 SQDLQNFIRSMLQVKPKLRP 245 (256)
T ss_pred CHHHHHHHHHHcCCCcccCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=294.87 Aligned_cols=233 Identities=24% Similarity=0.370 Sum_probs=186.4
Q ss_pred ccccccceeEEEEEEecCCCCeEEEEEEccCcCC--HHhHHHHHHHH---HHHhcCCCCceeeEeeEEEcCCCeEEEEEe
Q psy7289 61 ELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN--QKTASDFRREV---DLMSELRHPNIVCLLGVCLSGEPMCMLFEF 135 (422)
Q Consensus 61 ~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~---~il~~l~HpnIv~l~g~~~~~~~~~lv~E~ 135 (422)
.||+|+||.||+|+... .++.||+|.+..... ......+..|. .+++...||||+++++++.+.+..++||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEec--CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEec
Confidence 48999999999997643 356799998764321 11122234443 345556899999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccccc
Q psy7289 136 MVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRD 215 (422)
Q Consensus 136 ~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~ 215 (422)
+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+||++++++.+||+|||+++.
T Consensus 79 ~~g~~L~~~l~~~------------~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~ 146 (278)
T cd05606 79 MNGGDLHYHLSQH------------GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD 146 (278)
T ss_pred CCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence 9999999988643 3589999999999999999999999999999999999999999999999999875
Q ss_pred ccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCC---hHHHHHHHHcCCCCCCCC
Q psy7289 216 VYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYS---NQEVIEMIRSRQMLPCPE 291 (422)
Q Consensus 216 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~---~~~~~~~i~~~~~~~~p~ 291 (422)
..... .....++..|+|||++..+ .++.++||||+||++|||++ |..||.+.. ..+....+ .....+.|.
T Consensus 147 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 220 (278)
T cd05606 147 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEIDRMT-LTMAVELPD 220 (278)
T ss_pred cCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCccchHHHHHHh-hccCCCCCC
Confidence 43221 1234578899999998754 58999999999999999998 999998763 33333232 333456677
Q ss_pred CCCcchhhhcccccccccchhh
Q psy7289 292 DCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 292 ~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.+++.+.+++.+|+..+|..|+
T Consensus 221 ~~s~~~~~li~~~l~~~p~~R~ 242 (278)
T cd05606 221 SFSPELRSLLEGLLQRDVNRRL 242 (278)
T ss_pred cCCHHHHHHHHHHhhcCHHhcc
Confidence 8899999999999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=306.27 Aligned_cols=244 Identities=24% Similarity=0.357 Sum_probs=190.6
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC-----
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE----- 127 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~----- 127 (422)
..+|++.+.||+|+||.||+|+...+ +..||+|.++..........+.+|+.++++++||||+++++++....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPT--GVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCC--CCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 35788999999999999999987543 46799999864333345567889999999999999999999876543
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
..++++||+. ++|.+++.. ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~-------------~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl 147 (336)
T cd07849 82 DVYIVQELME-TDLYKLIKT-------------QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKI 147 (336)
T ss_pred eEEEEehhcc-cCHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEE
Confidence 4799999997 488887754 25899999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceE-eccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc--
Q psy7289 208 SDFGLSRDVYASDYYR-IQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS-- 283 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~-- 283 (422)
+|||+++......... ......++..|+|||.+.. ..++.++|||||||++|||++ |..||.+.+.......+..
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~-G~~~f~~~~~~~~~~~~~~~~ 226 (336)
T cd07849 148 CDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLS-NRPLFPGKDYLHQLNLILGVL 226 (336)
T ss_pred CcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHc
Confidence 9999997653322111 1122356788999998754 468999999999999999998 9999977654332222110
Q ss_pred -------------C------------CCCC---CCCCCCcchhhhcccccccccchhh
Q psy7289 284 -------------R------------QMLP---CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 284 -------------~------------~~~~---~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
. ...+ ..+..++++.++|.+||+.+|..|+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 284 (336)
T cd07849 227 GTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRI 284 (336)
T ss_pred CCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCc
Confidence 0 0000 0123467789999999999999997
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=296.73 Aligned_cols=244 Identities=27% Similarity=0.425 Sum_probs=196.2
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFE 134 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E 134 (422)
+|++.+.||+|+||.||+|+... .+..||||.++..........+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRT--TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECC--CCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 36788999999999999998743 3577999998754433345667889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccc
Q psy7289 135 FMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR 214 (422)
Q Consensus 135 ~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~ 214 (422)
|+++ +|.+++..... ...+++..+..++.|++.||+|||+++++||||||+||++++++.+||+|||+++
T Consensus 79 ~~~~-~l~~~~~~~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~ 148 (284)
T cd07836 79 YMDK-DLKKYMDTHGV---------RGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLAR 148 (284)
T ss_pred cCCc-cHHHHHHhcCC---------CCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhh
Confidence 9984 89998865431 1358999999999999999999999999999999999999999999999999997
Q ss_pred cccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC------
Q psy7289 215 DVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML------ 287 (422)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~------ 287 (422)
....... ......++..|+|||++... .++.++|||||||++|||++ |..||.+.+..+....+......
T Consensus 149 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07836 149 AFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT-GRPLFPGTNNEDQLLKIFRIMGTPTESTW 225 (284)
T ss_pred hhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhH
Confidence 5432211 11223456789999988653 57899999999999999998 99999988776655444321000
Q ss_pred -----------C-----------CCCCCCcchhhhcccccccccchhh
Q psy7289 288 -----------P-----------CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 288 -----------~-----------~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
. ..+.+++.+.+++..||+.+|..|+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~ 273 (284)
T cd07836 226 PGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRI 273 (284)
T ss_pred HHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCC
Confidence 0 1124577888999999999999997
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=297.33 Aligned_cols=243 Identities=28% Similarity=0.496 Sum_probs=188.6
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
..|++.+.||+|+||.||+|....+ +..||+|.+...........+.+|+.+++.++||||+++++++..+...++||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRIN--GQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCC--CcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 5688899999999999999987544 45799999865443333446788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||+. ++|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||++
T Consensus 83 e~~~-~~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~ 150 (291)
T cd07870 83 EYMH-TDLAQYMIQHP-----------GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLA 150 (291)
T ss_pred eccc-CCHHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccc
Confidence 9996 78888775431 24678888999999999999999999999999999999999999999999998
Q ss_pred ccccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChH-HHHHHHHc--CC----
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ-EVIEMIRS--RQ---- 285 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~-~~~~~i~~--~~---- 285 (422)
+....... ......+++.|+|||.+.+. .++.++|||||||++|||++ |..||.+.+.. +.+..+.. +.
T Consensus 151 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 227 (291)
T cd07870 151 RAKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQ-GQPAFPGVSDVFEQLEKIWTVLGVPTED 227 (291)
T ss_pred cccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHHHHcCCCChh
Confidence 75432211 11223457889999998754 57889999999999999998 99999866542 22222210 00
Q ss_pred ------C---------CCC-C---------CCCCcchhhhcccccccccchhh
Q psy7289 286 ------M---------LPC-P---------EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 286 ------~---------~~~-p---------~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
. ..+ | -..++.+.+++.+|+..+|..|+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~ 280 (291)
T cd07870 228 TWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRI 280 (291)
T ss_pred hhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCc
Confidence 0 000 0 01245678899999999999987
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=298.62 Aligned_cols=246 Identities=22% Similarity=0.357 Sum_probs=191.3
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC-CCceeeEeeEEEcCCCeEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR-HPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~lv 132 (422)
++++..+.||+|+||.||+++... .+..||+|.+...........+.+|+.++.++. ||||+++++++..+...+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKP--SGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECC--CCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 345677899999999999988654 357899999875444455678899999999996 99999999999998899999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeecCCCeEEEecCc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSH-HYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
|||+.. +|.++...... .....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 82 ~e~~~~-~l~~l~~~~~~-------~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg 153 (288)
T cd06616 82 MELMDI-SLDKFYKYVYE-------VLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFG 153 (288)
T ss_pred EecccC-CHHHHHHHHHH-------hhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecc
Confidence 999864 55554321100 0013589999999999999999999974 99999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccccC---CCCCchhHHhHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHcCCCC
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYG---KFTTESDVWSYGVVLWEVYSYGLQPYYGYSN-QEVIEMIRSRQML 287 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~-~~~~~~i~~~~~~ 287 (422)
+++....... .....++..|+|||++... .++.++|||||||++|||++ |..||..... .+.+..+..+..+
T Consensus 154 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd06616 154 ISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVAT-GKFPYPKWNSVFDQLTQVVKGDPP 229 (288)
T ss_pred hhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHh-CCCCchhcchHHHHHhhhcCCCCC
Confidence 9976543221 1223467789999998765 68999999999999999998 9999976642 2222333333222
Q ss_pred CC----CCCCCcchhhhcccccccccchhh
Q psy7289 288 PC----PEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 288 ~~----p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.. +..++.++.+|+.+||..+|..|+
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 259 (288)
T cd06616 230 ILSNSEEREFSPSFVNFINLCLIKDESKRP 259 (288)
T ss_pred cCCCcCCCccCHHHHHHHHHHccCChhhCc
Confidence 22 234788899999999999999997
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=294.99 Aligned_cols=239 Identities=24% Similarity=0.402 Sum_probs=189.9
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC-CCceeeEeeEEEcC--CCeEEE
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR-HPNIVCLLGVCLSG--EPMCML 132 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~--~~~~lv 132 (422)
|++.+.||+|+||.||+|+... .+..||+|.++............+|+.+++++. ||||+++++++.++ +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~--~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRK--TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcC--CCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 5678899999999999998654 356799998865433223334567999999985 99999999999987 889999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||++ |+|.+++.... ..+++.++..++.|++.||+|||+++++||||||+||++++ +.+||+|||+
T Consensus 79 ~e~~~-~~l~~~l~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~ 145 (282)
T cd07831 79 FELMD-MNLYELIKGRK-----------RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGS 145 (282)
T ss_pred EecCC-ccHHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccc
Confidence 99997 58888886532 25889999999999999999999999999999999999999 9999999999
Q ss_pred cccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC------
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ------ 285 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~------ 285 (422)
++........ ....++..|+|||.+.. ..++.++|||||||++|||++ |.+||.+.+..+....+....
T Consensus 146 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~ 221 (282)
T cd07831 146 CRGIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS-LFPLFPGTNELDQIAKIHDVLGTPDAE 221 (282)
T ss_pred ccccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHc-CCcCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 9865432211 12345778999997654 457889999999999999998 999998877665544442210
Q ss_pred -----------CCCC-----------CCCCCcchhhhcccccccccchhh
Q psy7289 286 -----------MLPC-----------PEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 286 -----------~~~~-----------p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.... ...+|..+.+++.+||..+|..|+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 271 (282)
T cd07831 222 VLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERI 271 (282)
T ss_pred HHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCccccc
Confidence 0011 124678899999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=293.34 Aligned_cols=246 Identities=24% Similarity=0.426 Sum_probs=198.6
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCC---
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEP--- 128 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~--- 128 (422)
..+|++.+.||+|+||.||+|....+ +..+++|.+.... ...+.+.+|+.+++++ +||||+++++++.+...
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~--~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKT--GQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCC--CcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 35788999999999999999987543 4679999876433 2346789999999999 69999999999976553
Q ss_pred ---eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 129 ---MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 129 ---~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
+++||||+++++|.+++...... ...+++..+..++.|++.||+|||+++++|+||+|+||++++++.+
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~ 152 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKK--------GKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEV 152 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeE
Confidence 89999999999999998653210 1358899999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCcccccc-----CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHH
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-----GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEM 280 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~ 280 (422)
||+|||++....... .......++..|+|||.+.. ..++.++|||||||++|||++ |..||...+..+....
T Consensus 153 ~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~ 229 (275)
T cd06608 153 KLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELAD-GKPPLCDMHPMRALFK 229 (275)
T ss_pred EECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHh-CCCCccccchHHHHHH
Confidence 999999987543221 11223446788999998753 346789999999999999998 9999987776666555
Q ss_pred HHcCCCCC--CCCCCCcchhhhcccccccccchhh
Q psy7289 281 IRSRQMLP--CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 281 i~~~~~~~--~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+....... .+..++.++.+++.+||..+|..|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 264 (275)
T cd06608 230 IPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRP 264 (275)
T ss_pred hhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCc
Confidence 55443322 2345778999999999999999997
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=287.36 Aligned_cols=242 Identities=28% Similarity=0.513 Sum_probs=207.2
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
+|++.+.||+|+||.||+++.... +..|++|...... .......+.+|++++++++||||+++++++.+.+..+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~--~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLET--GDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCC--CcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Confidence 367789999999999999986533 4679999886543 2245678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++
T Consensus 79 e~~~~~~L~~~~~~~------------~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~ 146 (254)
T cd06627 79 EYAENGSLRQIIKKF------------GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVA 146 (254)
T ss_pred ecCCCCcHHHHHHhc------------cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccc
Confidence 999999999998653 35889999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDC 293 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~ 293 (422)
......... .....++..|+|||......++.++||||+|+++|||++ |..||...+.......+......+.|..+
T Consensus 147 ~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (254)
T cd06627 147 TKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLT-GNPPYYDLNPMAALFRIVQDDHPPLPEGI 223 (254)
T ss_pred eecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCccHHHHHHHHhccCCCCCCCCC
Confidence 865433221 122345778999999887778999999999999999998 89999888777666666666667778889
Q ss_pred Ccchhhhcccccccccchhh
Q psy7289 294 PPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 294 p~~~~~l~~~cw~~~P~~r~ 313 (422)
+..+.+++.+||..+|..|+
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~ 243 (254)
T cd06627 224 SPELKDFLMQCFQKDPNLRP 243 (254)
T ss_pred CHHHHHHHHHHHhCChhhCc
Confidence 99999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=302.94 Aligned_cols=239 Identities=28% Similarity=0.443 Sum_probs=189.9
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC--CCCceeeEeeEEEcCC----
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL--RHPNIVCLLGVCLSGE---- 127 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l--~HpnIv~l~g~~~~~~---- 127 (422)
..+++++.||+|.||.||||++. ++.||||++.. ...+.|.+|-+|.+.. +|+||++++++-....
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~----~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD----NRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc----CceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 45678899999999999999874 36799999853 4567899999987764 7999999999876554
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhC---------CccccCCCCCcee
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSH---------HYVHRDLAARNCL 198 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~---------~ivHrDlKp~NiL 198 (422)
.++||+||.++|+|.+||..+ .+++.++.+++..+++||+|||+. .|+|||||++|||
T Consensus 282 eywLVt~fh~kGsL~dyL~~n-------------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVL 348 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKAN-------------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVL 348 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhc-------------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceE
Confidence 789999999999999999875 589999999999999999999963 4999999999999
Q ss_pred ecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCC-CC-----CchhHHhHHHHHHHHHhCC------C
Q psy7289 199 VGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK-FT-----TESDVWSYGVVLWEVYSYG------L 266 (422)
Q Consensus 199 l~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~-----~~~DvwS~Gvil~El~t~g------~ 266 (422)
|.+++++-|+|||||..+.............||.+|||||++.+.. +. .+.||||+|.+||||+++- .
T Consensus 349 vK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~ 428 (534)
T KOG3653|consen 349 VKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGP 428 (534)
T ss_pred EccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCC
Confidence 9999999999999998765433323334578999999999987532 22 3579999999999999852 1
Q ss_pred -----CCCC-----CCChHHHHHHHHc-CCCCCCCCCC-----Ccchhhhcccccccccchhh
Q psy7289 267 -----QPYY-----GYSNQEVIEMIRS-RQMLPCPEDC-----PPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 267 -----~Pf~-----~~~~~~~~~~i~~-~~~~~~p~~~-----p~~~~~l~~~cw~~~P~~r~ 313 (422)
.||. +.+.+++.+.+.. +.|+.+|+.. ..-+.+.+.+||+.||.+|=
T Consensus 429 vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARL 491 (534)
T KOG3653|consen 429 VPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARL 491 (534)
T ss_pred CCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhh
Confidence 1332 2234456555544 4455566532 34578899999999999985
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=299.18 Aligned_cols=242 Identities=26% Similarity=0.382 Sum_probs=193.5
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC----HHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN----QKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
+|++.+.||+|+||.||+|....+ +..|+||.++.... ......+.+|+.++++++||||+++++++.+.+..+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~--~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKET--GRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCC--CcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEE
Confidence 367788999999999999986543 56799999865432 223456778999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+||||+ +|+|.+++.... ..+++..+..++.||+.||+|||+++++|+||||+||+++.++.+||+||
T Consensus 79 lv~e~~-~~~L~~~i~~~~-----------~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~df 146 (298)
T cd07841 79 LVFEFM-ETDLEKVIKDKS-----------IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADF 146 (298)
T ss_pred EEEccc-CCCHHHHHhccC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccc
Confidence 999999 999999996531 25889999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC--
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML-- 287 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~-- 287 (422)
|+++....... ......+++.|+|||.+.. ..++.++|||||||++|||++ |.+||.+.+..+.+..+......
T Consensus 147 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~-g~~~~~~~~~~~~~~~~~~~~~~~~ 223 (298)
T cd07841 147 GLARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVPFLPGDSDIDQLGKIFEALGTPT 223 (298)
T ss_pred eeeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHc-CCccccCCccHHHHHHHHHHcCCCc
Confidence 99976543221 1122344678999998854 457899999999999999998 78888877766555444321100
Q ss_pred --------------------CC-----CCCCCcchhhhcccccccccchhh
Q psy7289 288 --------------------PC-----PEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 288 --------------------~~-----p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+. ....+..+.+++.+||..+|..|+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 274 (298)
T cd07841 224 EENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRI 274 (298)
T ss_pred hhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCc
Confidence 00 123466788999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=285.08 Aligned_cols=240 Identities=25% Similarity=0.453 Sum_probs=202.0
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEe
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEF 135 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~ 135 (422)
|++.+.||+|+||.||++.... ++..+++|.+..... .....+.+|+.+++.++||||+++++.+......++++||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKR--TGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred ceeeeeeccCCceEEEEEEECC--CCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 6678899999999999998754 356799998865433 3557899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccccc
Q psy7289 136 MVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRD 215 (422)
Q Consensus 136 ~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~ 215 (422)
+++++|.+++.... ..+++..+..++.|++.||.|||+++++|+||+|+||++++++.+||+|||++..
T Consensus 79 ~~~~~L~~~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~ 147 (253)
T cd05122 79 CSGGSLKDLLKSTN-----------QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQ 147 (253)
T ss_pred CCCCcHHHHHhhcC-----------CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccc
Confidence 99999999987542 3589999999999999999999999999999999999999999999999999876
Q ss_pred ccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCC--CC
Q psy7289 216 VYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPE--DC 293 (422)
Q Consensus 216 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~--~~ 293 (422)
...... .....++..|+|||.+....++.++||||||+++|||++ |..||...+..+....+........+. .+
T Consensus 148 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (253)
T cd05122 148 LSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAE-GKPPYSELPPMKALFKIATNGPPGLRNPEKW 223 (253)
T ss_pred cccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhcCCCCcCccccc
Confidence 543321 123345678999999988889999999999999999998 999999887666665555443333333 34
Q ss_pred Ccchhhhcccccccccchhh
Q psy7289 294 PPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 294 p~~~~~l~~~cw~~~P~~r~ 313 (422)
+..+.+++.+||..+|..|+
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~ 243 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRP 243 (253)
T ss_pred CHHHHHHHHHHccCChhhCC
Confidence 88899999999999999997
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=295.20 Aligned_cols=242 Identities=26% Similarity=0.411 Sum_probs=191.3
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEE
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFE 134 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E 134 (422)
|+..+.||+|+||.||+|+...+ +..||||.++... .......+.+|++++++++||||+++++++.+....++|||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~--~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLT--GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCC--CCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 67789999999999999986543 4679999886432 22234578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccc
Q psy7289 135 FMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR 214 (422)
Q Consensus 135 ~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~ 214 (422)
|+. ++|.+++.... ...+++..+..++.|++.||+|||+++++||||+|+||++++++.+||+|||+++
T Consensus 80 ~~~-~~l~~~~~~~~----------~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~ 148 (284)
T cd07860 80 FLH-QDLKKFMDASP----------LSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 148 (284)
T ss_pred ccc-cCHHHHHHhCC----------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchh
Confidence 996 68999886532 1358899999999999999999999999999999999999999999999999987
Q ss_pred cccCCcceEeccCCCCCccccCccccccCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc-CCCC-----
Q psy7289 215 DVYASDYYRIQSKSLLPVRWMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS-RQML----- 287 (422)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~-~~~~----- 287 (422)
...... .......+++.|+|||.+.... ++.++|||||||++|||+| |..||.+.+..+....+.. ...+
T Consensus 149 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07860 149 AFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVW 225 (284)
T ss_pred hcccCc--cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHhCCCChhhh
Confidence 543221 1112234567899999887544 6889999999999999999 8999987765443332221 0000
Q ss_pred ----------------------CCCCCCCcchhhhcccccccccchhh
Q psy7289 288 ----------------------PCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 288 ----------------------~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..+..+++++.+++.+||+.+|..|+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 273 (284)
T cd07860 226 PGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRI 273 (284)
T ss_pred hhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCC
Confidence 01224567788999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=302.72 Aligned_cols=241 Identities=26% Similarity=0.318 Sum_probs=190.6
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC----
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG---- 126 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~---- 126 (422)
...+|++.+.||+|+||.||+|+...+ +..||+|.+... ........+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCC--CCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 346789999999999999999986543 567999998643 2333456778899999999999999999988643
Q ss_pred --CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCe
Q psy7289 127 --EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLT 204 (422)
Q Consensus 127 --~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~ 204 (422)
...|+||||+. |+|.+++.. .+++..+..++.|++.||+|||++||+||||||+||+++.++.
T Consensus 92 ~~~~~~lv~e~~~-~~l~~~~~~--------------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~ 156 (353)
T cd07850 92 EFQDVYLVMELMD-ANLCQVIQM--------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 156 (353)
T ss_pred ccCcEEEEEeccC-CCHHHHHhh--------------cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC
Confidence 35799999996 588888743 2788889999999999999999999999999999999999999
Q ss_pred EEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC
Q psy7289 205 VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR 284 (422)
Q Consensus 205 vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~ 284 (422)
+||+|||+++....... .....++..|+|||.+....++.++|||||||++|||++ |..||.+.+.......+...
T Consensus 157 ~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~ 232 (353)
T cd07850 157 LKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GTVLFPGTDHIDQWNKIIEQ 232 (353)
T ss_pred EEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHh
Confidence 99999999986533211 122345778999999998899999999999999999998 99999877654433332110
Q ss_pred CC---------------------C----------------C-----CCCCCCcchhhhcccccccccchhh
Q psy7289 285 QM---------------------L----------------P-----CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 285 ~~---------------------~----------------~-----~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.. . + .+...++.+.+++.+||..+|..|+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 303 (353)
T cd07850 233 LGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRI 303 (353)
T ss_pred cCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCc
Confidence 00 0 0 0112355678999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=295.51 Aligned_cols=243 Identities=24% Similarity=0.384 Sum_probs=193.9
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC-HHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC--CCeE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN-QKTASDFRREVDLMSELRHPNIVCLLGVCLSG--EPMC 130 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~~~ 130 (422)
..|++.+.||+|+||.||+|++..+ +..+++|.++.... ......+.+|+.++++++||||+++++++... ...|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~--~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKT--GEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCC--CcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 3578889999999999999987543 46799998864322 22334677899999999999999999998877 7899
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+||||++ ++|.+++.... ..+++..+..++.||+.||+|||+++++||||||+||++++++.+||+||
T Consensus 83 lv~e~~~-~~L~~~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~ 150 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMK-----------QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDF 150 (293)
T ss_pred EEehhcC-cCHHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeec
Confidence 9999997 59999886532 24899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC---
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM--- 286 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~--- 286 (422)
|+++....... ......+++.|+|||.+... .++.++|+|||||++|||++ |.+||.+.+..+....+.....
T Consensus 151 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~~f~~~~~~~~~~~~~~~~~~~~ 227 (293)
T cd07843 151 GLAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPLFPGKSEIDQLNKIFKLLGTPT 227 (293)
T ss_pred CceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCc
Confidence 99986543311 11223456789999988754 46899999999999999998 9999998877665544421100
Q ss_pred ---------------------------CCCCCC-CCcchhhhcccccccccchhh
Q psy7289 287 ---------------------------LPCPED-CPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 287 ---------------------------~~~p~~-~p~~~~~l~~~cw~~~P~~r~ 313 (422)
...|.. .++.+.+++++||..+|..|+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 282 (293)
T cd07843 228 EKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRI 282 (293)
T ss_pred hHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccC
Confidence 011222 467788999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=290.81 Aligned_cols=242 Identities=19% Similarity=0.297 Sum_probs=189.3
Q ss_pred Ccccccc--cccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCCeEE
Q psy7289 55 KPRFLQE--LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 55 ~~~~~~~--LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~l 131 (422)
.+++.+. ||+|+||.||+++... .+..+|+|......... .|+.....+ +||||+++++.+..++..++
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~--~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKP--TQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcC--CCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 4455555 4999999999987644 35678999875422111 122222222 79999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC-eEEEecC
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL-TVKISDF 210 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~-~vKl~DF 210 (422)
||||+++|+|.+++... ..++++++..++.|++.||+|||+.+++||||||+||+++.++ .++|+||
T Consensus 87 v~e~~~~~~L~~~l~~~------------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKE------------GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred EEEcCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecC
Confidence 99999999999999753 2589999999999999999999999999999999999999888 9999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHH-HHHH--cCCCC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVI-EMIR--SRQML 287 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~-~~i~--~~~~~ 287 (422)
|+++..... ....++..|+|||++....++.++|||||||++|||++ |..||......++. ..+. .....
T Consensus 155 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 227 (267)
T PHA03390 155 GLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLT-GKHPFKEDEDEELDLESLLKRQQKKL 227 (267)
T ss_pred ccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHH-CCCCCCCCCcchhhHHHHHHhhcccC
Confidence 998754322 12346788999999998889999999999999999998 99999865543321 1111 12334
Q ss_pred CCCCCCCcchhhhcccccccccchhh--HHHHhhhhhh
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAG--MAYLCSHHYV 323 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~--~~~lh~~~~i 323 (422)
+.+..+++.+.+++.+||+.+|..|+ +.-+.+|.++
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~ 265 (267)
T PHA03390 228 PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265 (267)
T ss_pred CcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcc
Confidence 55667899999999999999999996 3555555543
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=293.52 Aligned_cols=243 Identities=22% Similarity=0.368 Sum_probs=204.9
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCC-CCceeeEeeEEEcCCCeEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELR-HPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~l 131 (422)
+|++.+.||+|+||.||+|+... ++..|++|++.... .......+.+|+.++++++ ||||+++++++..++..++
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 79 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKE--TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF 79 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcC--CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence 57888999999999999998754 35679999886422 2334567889999999998 9999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
||||+++++|.+++.+. ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||
T Consensus 80 v~e~~~~~~L~~~l~~~------------~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~ 147 (280)
T cd05581 80 VLEYAPNGELLQYIRKY------------GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFG 147 (280)
T ss_pred EEcCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCc
Confidence 99999999999999764 258999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcce------------------EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCC
Q psy7289 212 LSRDVYASDYY------------------RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS 273 (422)
Q Consensus 212 la~~~~~~~~~------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~ 273 (422)
++......... .......++..|+|||++....++.++|+||||+++||+++ |..||...+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~ 226 (280)
T cd05581 148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLT-GKPPFRGSN 226 (280)
T ss_pred cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHh-CCCCCCCcc
Confidence 98765432210 11122345678999999888889999999999999999998 999999888
Q ss_pred hHHHHHHHHcCCCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 274 NQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 274 ~~~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.......+.. .....|...|+.+.+++.+||+.+|..|+
T Consensus 227 ~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 265 (280)
T cd05581 227 EYLTFQKILK-LEYSFPPNFPPDAKDLIEKLLVLDPQDRL 265 (280)
T ss_pred HHHHHHHHHh-cCCCCCCccCHHHHHHHHHHhcCCHhhCC
Confidence 7666666653 33456778899999999999999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=294.35 Aligned_cols=243 Identities=23% Similarity=0.365 Sum_probs=197.7
Q ss_pred cccccccccccceeEEEEEEecC-CCCeEEEEEEccCcC---CHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCCeE
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTS-EGPSLVAIKTLKENA---NQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~ 130 (422)
|++.+.||+|+||.||+++.... ..+..||||.++... .....+.+.+|+.++.++ +||||+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 67789999999999999986532 345779999886422 123345788999999999 5999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+||
T Consensus 82 lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~df 149 (288)
T cd05583 82 LILDYVNGGELFTHLYQR------------EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDF 149 (288)
T ss_pred EEEecCCCCcHHHHHhhc------------CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEEC
Confidence 999999999999998653 24788999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCC--CCCchhHHhHHHHHHHHHhCCCCCCCCCC----hHHHHHHHHcC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK--FTTESDVWSYGVVLWEVYSYGLQPYYGYS----NQEVIEMIRSR 284 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DvwS~Gvil~El~t~g~~Pf~~~~----~~~~~~~i~~~ 284 (422)
|+++........ ......++..|+|||.+.... .+.++||||||+++|||++ |..||.... ..++...+...
T Consensus 150 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd05583 150 GLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT-GASPFTVDGEQNSQSEISRRILKS 227 (288)
T ss_pred cccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHh-CCCCcccCcccchHHHHHHHHHcc
Confidence 998765433211 112234678899999987654 7889999999999999998 999996432 23444444333
Q ss_pred CCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 285 QMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 285 ~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..+.|..+++.+.+++.+||..+|..|+
T Consensus 228 -~~~~~~~~~~~l~~li~~~l~~~p~~R~ 255 (288)
T cd05583 228 -KPPFPKTMSAEARDFIQKLLEKDPKKRL 255 (288)
T ss_pred -CCCCCcccCHHHHHHHHHHhcCCHhhcc
Confidence 3566778899999999999999999997
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=294.67 Aligned_cols=238 Identities=24% Similarity=0.410 Sum_probs=197.9
Q ss_pred ccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEec
Q psy7289 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFM 136 (422)
Q Consensus 57 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~ 136 (422)
+...+||+|+||.||++.... .+..||||.+.... ......+.+|+.+++.++||||+++++.+..++..+++|||+
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~--~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKS--SGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcC--CCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 345789999999999998654 35789999875432 334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccc
Q psy7289 137 VRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV 216 (422)
Q Consensus 137 ~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~ 216 (422)
++++|.+++... .+++..+..++.|++.||+|||++|++|+||||+||++++++.++|+|||++...
T Consensus 100 ~~~~L~~~~~~~-------------~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~ 166 (292)
T cd06657 100 EGGALTDIVTHT-------------RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 166 (292)
T ss_pred CCCcHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceec
Confidence 999999987532 4788999999999999999999999999999999999999999999999998755
Q ss_pred cCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC--CCCCCCCC
Q psy7289 217 YASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM--LPCPEDCP 294 (422)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~--~~~p~~~p 294 (422)
..... ......+++.|+|||.+....++.++|+|||||++|||++ |..||.+.+..+....+..... .+.+..++
T Consensus 167 ~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (292)
T cd06657 167 SKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVD-GEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVS 243 (292)
T ss_pred ccccc--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCcccCCcccCC
Confidence 33211 1122345778999999988888999999999999999998 9999998877777666654322 22344678
Q ss_pred cchhhhcccccccccchhh
Q psy7289 295 PRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 295 ~~~~~l~~~cw~~~P~~r~ 313 (422)
+.+.+++.+||..+|..|+
T Consensus 244 ~~l~~li~~~l~~~P~~R~ 262 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRA 262 (292)
T ss_pred HHHHHHHHHHHhCCcccCc
Confidence 8999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=296.40 Aligned_cols=247 Identities=24% Similarity=0.403 Sum_probs=194.4
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC--
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE-- 127 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-- 127 (422)
....+|++.+.||+|+||.||+|....+ +..||+|.++... .......+.+|+++++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~--~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDT--GELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCC--CcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 3446788899999999999999987543 4679999986432 2223356788999999999999999999987655
Q ss_pred --------CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceee
Q psy7289 128 --------PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV 199 (422)
Q Consensus 128 --------~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl 199 (422)
.+++|+||+++ +|.+++... ...++++.+..++.||+.||+|||+.+|+||||||+||++
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-----------~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili 149 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESG-----------LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL 149 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 78999999986 777777543 1358999999999999999999999999999999999999
Q ss_pred cCCCeEEEecCcccccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHH
Q psy7289 200 GDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVI 278 (422)
Q Consensus 200 ~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~ 278 (422)
++++.+||+|||+++....... ........+..|+|||.+.. ..++.++|||||||++|||++ |.+||...+..+.+
T Consensus 150 ~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~-g~~~~~~~~~~~~~ 227 (302)
T cd07864 150 NNKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQANQELAQL 227 (302)
T ss_pred CCCCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHH
Confidence 9999999999999976543221 11122234678999998864 357899999999999999998 99999877666555
Q ss_pred HHHHcCCCCC-----------------------------CCCCCCcchhhhcccccccccchhh
Q psy7289 279 EMIRSRQMLP-----------------------------CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 279 ~~i~~~~~~~-----------------------------~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..+......+ ....+|+.+.+++..||..+|..|+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 291 (302)
T cd07864 228 ELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRC 291 (302)
T ss_pred HHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCC
Confidence 4443211000 1124688899999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=297.02 Aligned_cols=244 Identities=27% Similarity=0.406 Sum_probs=193.7
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC-HHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC--CCe
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN-QKTASDFRREVDLMSELRHPNIVCLLGVCLSG--EPM 129 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~~ 129 (422)
..+|++.+.||+|+||.||+|+... .+..||+|.++.... ......+.+|+.++++++||||+++++++.+. +..
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTT--SGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECC--CCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 3568889999999999999998754 356799998864322 22233567899999999999999999998755 468
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEec
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISD 209 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~D 209 (422)
++||||+. ++|.+++.... ..+++.++..++.|++.||+|||+.+++||||||+||++++++.+||+|
T Consensus 84 ~lv~e~~~-~~l~~~l~~~~-----------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~d 151 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNMP-----------TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIAD 151 (309)
T ss_pred EEEEecCC-CCHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECc
Confidence 99999997 48988886531 3589999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP 288 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 288 (422)
||+++....... .......++.|+|||.+.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+......+
T Consensus 152 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~~f~~~~~~~~~~~~~~~~~~~ 228 (309)
T cd07845 152 FGLARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLA-HKPLLPGKSEIEQLDLIIQLLGTP 228 (309)
T ss_pred cceeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999986543211 1122234677999998865 458899999999999999998 999999988887776665421100
Q ss_pred ------------------C---C--------CCCCcchhhhcccccccccchhh
Q psy7289 289 ------------------C---P--------EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 289 ------------------~---p--------~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
. + ...++.+.+++.+|+..||..|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~ 282 (309)
T cd07845 229 NESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRA 282 (309)
T ss_pred ChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCc
Confidence 0 0 12356778899999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=284.32 Aligned_cols=243 Identities=25% Similarity=0.391 Sum_probs=203.2
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC--CCeEEE
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSG--EPMCML 132 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~~~lv 132 (422)
|+..+.||+|+||.||+|.... ++..|++|...... .....+.+.+|+.++++++||||+++++.+... ...+++
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKD--TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred ceeeeEeeecCceEEEEEEECC--CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 5677899999999999998754 35679999886433 234567899999999999999999999999988 889999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
+||+++++|.+++.+. ..+++.++..++.|++.||+|||+.+++|+||+|+||+++.++.+||+|||.
T Consensus 80 ~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~ 147 (260)
T cd06606 80 LEYVSGGSLSSLLKKF------------GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGC 147 (260)
T ss_pred EEecCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccccc
Confidence 9999999999999764 2588999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCC-hHHHHHHHHc-CCCCCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS-NQEVIEMIRS-RQMLPCP 290 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~-~~~~~~~i~~-~~~~~~p 290 (422)
+................++..|+|||.+....++.++||||||+++|||++ |..||.... .......+.. ......|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T cd06606 148 AKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMAT-GKPPWSELGNPMAALYKIGSSGEPPEIP 226 (260)
T ss_pred EEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHhccccCCCcCCC
Confidence 886654332111223446778999999988889999999999999999998 999998776 3333333332 3445677
Q ss_pred CCCCcchhhhcccccccccchhh
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
...|+.+.+++.+||..+|..|+
T Consensus 227 ~~~~~~l~~~i~~~l~~~p~~Rp 249 (260)
T cd06606 227 EHLSEEAKDFLRKCLRRDPKKRP 249 (260)
T ss_pred cccCHHHHHHHHHhCcCChhhCC
Confidence 88899999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=293.51 Aligned_cols=246 Identities=24% Similarity=0.391 Sum_probs=195.4
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC-CCceeeEeeEEEcCCC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR-HPNIVCLLGVCLSGEP 128 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~ 128 (422)
.+....|++.+.||+|+||.||+|++..+ +..||||.++..........+.+|+.++.++. ||||+++++++.+...
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~--~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKT--GHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCC--CeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 34456788899999999999999987543 57799999875444444566777887776664 9999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCCeEEE
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCS-HHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
.+++|||++ ++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||+|+||++++++.+||
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~~-----------~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL 156 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRIQ-----------GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKL 156 (296)
T ss_pred EEEEeeccC-cCHHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEE
Confidence 999999985 57777765421 358899999999999999999997 59999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCC----CCCchhHHhHHHHHHHHHhCCCCCCCCCCh-HHHHHHHH
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK----FTTESDVWSYGVVLWEVYSYGLQPYYGYSN-QEVIEMIR 282 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~-~~~~~~i~ 282 (422)
+|||++........ .....++..|+|||.+.... ++.++||||||+++|||++ |..||..... .+.+..+.
T Consensus 157 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~ 232 (296)
T cd06618 157 CDFGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELAT-GQFPYKNCKTEFEVLTKIL 232 (296)
T ss_pred CccccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHh-CCCCCCcchhHHHHHHHHh
Confidence 99999876533221 12234567899999987553 7889999999999999998 9999976433 35555555
Q ss_pred cCCCCCCC--CCCCcchhhhcccccccccchhh
Q psy7289 283 SRQMLPCP--EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 283 ~~~~~~~p--~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.......| ..++.++.+++.+||+.+|..|+
T Consensus 233 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 265 (296)
T cd06618 233 QEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRP 265 (296)
T ss_pred cCCCCCCCCCCCCCHHHHHHHHHHccCChhhCC
Confidence 44333333 34788999999999999999998
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=292.95 Aligned_cols=246 Identities=26% Similarity=0.372 Sum_probs=191.0
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC-HHhHHHHHHHHHHHhcCC-CCceeeEeeEEEcCCC----
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN-QKTASDFRREVDLMSELR-HPNIVCLLGVCLSGEP---- 128 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~---- 128 (422)
+|++.+.||+|+||.||+|++..+ +..||+|..+.... ......+.+|+.+++.++ ||||+++++++...+.
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~--~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNT--GKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCC--CcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 577889999999999999987543 56799998764322 223457888999999995 6999999999887665
Q ss_pred -eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC-CCeEE
Q psy7289 129 -MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD-GLTVK 206 (422)
Q Consensus 129 -~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~-~~~vK 206 (422)
.|+||||+++ +|.+++...... ....+++..+..++.||+.||+|||+++|+||||||+||+++. ++.+|
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~-------~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~k 151 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRG-------PGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLK 151 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhccc-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEE
Confidence 8999999985 899988654211 0135899999999999999999999999999999999999998 88999
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ 285 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~ 285 (422)
|+|||+++....... ......+++.|+|||.+.. ..++.++|||||||++|||++ |..||.+.+..+....+....
T Consensus 152 l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~~~~~~~~~~~~~~~~~~~ 228 (295)
T cd07837 152 IADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR-KQPLFPGDSELQQLLHIFKLL 228 (295)
T ss_pred EeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHHh
Confidence 999999875432211 1112234678999998865 457899999999999999998 899998877655443332110
Q ss_pred C----------------------CC-----CCCCCCcchhhhcccccccccchhh
Q psy7289 286 M----------------------LP-----CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 286 ~----------------------~~-----~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
. .+ ..+.+++++.+++.+||..+|..|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~ 283 (295)
T cd07837 229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRI 283 (295)
T ss_pred CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcC
Confidence 0 00 0124677889999999999999997
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=296.02 Aligned_cols=240 Identities=26% Similarity=0.457 Sum_probs=197.4
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc--CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
...|...+.||+|+||.||+|+... .+..+++|.+... ......+++.+|+++++.++||||+++++++......+
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVR--NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcC--CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence 3446778899999999999998754 3567999987532 23344567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+||||+. |+|.+++.... .++++.++..++.|++.||.|||+++++||||||+||++++++.+||+||
T Consensus 92 lv~e~~~-~~l~~~~~~~~-----------~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~df 159 (308)
T cd06634 92 LVMEYCL-GSASDLLEVHK-----------KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF 159 (308)
T ss_pred EEEEccC-CCHHHHHHHcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCc
Confidence 9999996 68888775432 24788999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccc---cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESIL---YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
|++...... ....+++.|+|||.+. ...++.++|||||||++|||++ |..||...+..+....+..+..+
T Consensus 160 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06634 160 GSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNESP 232 (308)
T ss_pred ccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHc-CCCCCccccHHHHHHHHhhcCCC
Confidence 998754321 2234577899999874 3567889999999999999998 99999887776666555544433
Q ss_pred C-CCCCCCcchhhhcccccccccchhh
Q psy7289 288 P-CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 288 ~-~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
. .+..++..+.+++.+||..+|..|+
T Consensus 233 ~~~~~~~~~~~~~li~~cl~~~P~~Rp 259 (308)
T cd06634 233 ALQSGHWSEYFRNFVDSCLQKIPQDRP 259 (308)
T ss_pred CcCcccccHHHHHHHHHHhhCCcccCC
Confidence 3 2446788899999999999999997
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=297.77 Aligned_cols=252 Identities=21% Similarity=0.365 Sum_probs=191.9
Q ss_pred cccccc--cceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEec
Q psy7289 60 QELGEG--AFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFM 136 (422)
Q Consensus 60 ~~LG~G--~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~ 136 (422)
..||+| +||+||+++... .+..||+|++.... .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTP--TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcC--CCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecc
Confidence 457777 999999998643 35789999986433 3444578899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccc
Q psy7289 137 VRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV 216 (422)
Q Consensus 137 ~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~ 216 (422)
.+|+|.+++..... ..+++..+..++.|++.||+|||+++++||||||+|||++.++.+|++||+.+...
T Consensus 82 ~~~~l~~~l~~~~~----------~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~ 151 (328)
T cd08226 82 AYGSANSLLKTYFP----------EGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSL 151 (328)
T ss_pred cCCCHHHHHHhhcc----------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence 99999999876421 24889999999999999999999999999999999999999999999999865332
Q ss_pred cCCcc-----eEeccCCCCCccccCccccccC--CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC---
Q psy7289 217 YASDY-----YRIQSKSLLPVRWMPPESILYG--KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM--- 286 (422)
Q Consensus 217 ~~~~~-----~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~--- 286 (422)
..... ........++..|||||++... .++.++|||||||++|||++ |..||.+....+....+..+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd08226 152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELAT-GRVPFQDMLRTQMLLQKLKGPPYSP 230 (328)
T ss_pred hccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHhcCCCCCC
Confidence 21110 0001112234579999998763 47899999999999999998 9999988765554433322110
Q ss_pred -------------------------------------------CCCCCCCCcchhhhcccccccccchhhH-HHHhhhhh
Q psy7289 287 -------------------------------------------LPCPEDCPPRMYSLMMECWHEVPVAAGM-AYLCSHHY 322 (422)
Q Consensus 287 -------------------------------------------~~~p~~~p~~~~~l~~~cw~~~P~~r~~-~~lh~~~~ 322 (422)
.+.+..+++.+.+|+++||..+|..|+- ..+.+|.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 231 LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred ccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 1112345677899999999999999872 23334444
Q ss_pred hh
Q psy7289 323 VH 324 (422)
Q Consensus 323 i~ 324 (422)
+.
T Consensus 311 ~~ 312 (328)
T cd08226 311 FK 312 (328)
T ss_pred HH
Confidence 43
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=296.24 Aligned_cols=211 Identities=26% Similarity=0.410 Sum_probs=170.0
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC--CCeE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSG--EPMC 130 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~~~ 130 (422)
+|++.++||+|+||.||+|+......+..||+|.+.... .....+.+.+|+.+++.++||||+++++++.+. ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 467889999999999999987653346789999987532 122345678899999999999999999999988 7899
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC----CCeEE
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD----GLTVK 206 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~----~~~vK 206 (422)
+||||+++ +|.+++....... ...+++..+..++.|++.||+|||+++|+||||||+||+++. ++.+|
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~k 152 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAK-------RVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVK 152 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCC-------CcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEE
Confidence 99999975 7777775432111 136899999999999999999999999999999999999999 89999
Q ss_pred EecCcccccccCCcc-eEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCCh
Q psy7289 207 ISDFGLSRDVYASDY-YRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSN 274 (422)
Q Consensus 207 l~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~ 274 (422)
|+|||+++....... ........++..|+|||++.+. .++.++|||||||++|||++ |.+||.+...
T Consensus 153 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-~~~~~~~~~~ 221 (316)
T cd07842 153 IGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPIFKGREA 221 (316)
T ss_pred ECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh-cCCCCcCCcc
Confidence 999999986543221 1112233457789999988764 58899999999999999998 8999976543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=285.04 Aligned_cols=234 Identities=26% Similarity=0.418 Sum_probs=200.8
Q ss_pred cccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEecCCC
Q psy7289 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRG 139 (422)
Q Consensus 62 LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~~~G 139 (422)
||+|+||.||++.... .+..+++|.+.... .......+.+|+.++++++||||+++++.+..+...++||||++++
T Consensus 1 lg~G~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKD--TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECC--CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCC
Confidence 7999999999998643 35679999886532 2234567899999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccccCC
Q psy7289 140 DLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS 219 (422)
Q Consensus 140 ~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~~ 219 (422)
+|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||++++++.++|+|||++......
T Consensus 79 ~L~~~l~~~------------~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 79 ELFSHLSKE------------GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE 146 (250)
T ss_pred cHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence 999999753 25889999999999999999999999999999999999999999999999998765432
Q ss_pred cceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcchhh
Q psy7289 220 DYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYS 299 (422)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~~~~ 299 (422)
.. ......++..|+|||.+.....+.++|+||||+++||+++ |..||...+..+....+.. ...+.|...|..+.+
T Consensus 147 ~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~-g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ 222 (250)
T cd05123 147 GS--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLT-GKPPFYAEDRKEIYEKILK-DPLRFPEFLSPEARD 222 (250)
T ss_pred CC--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHHH
Confidence 11 1223345678999999988888999999999999999998 9999988887777777766 456778888999999
Q ss_pred hcccccccccchhh
Q psy7289 300 LMMECWHEVPVAAG 313 (422)
Q Consensus 300 l~~~cw~~~P~~r~ 313 (422)
++++||..+|..|+
T Consensus 223 ~i~~~l~~~p~~R~ 236 (250)
T cd05123 223 LISGLLQKDPTKRL 236 (250)
T ss_pred HHHHHhcCCHhhCC
Confidence 99999999999987
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=290.41 Aligned_cols=242 Identities=28% Similarity=0.442 Sum_probs=193.8
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC--CCeEEE
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSG--EPMCML 132 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~~~lv 132 (422)
|++.+.||+|+||.||+|+...+ +..+|+|.+.... .......+.+|+.+++.++||||+++++++.+. ...++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKT--GELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCC--CeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence 46788999999999999987543 4679999987543 233446788999999999999999999999988 789999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++ +|.+++.... ..+++..+..++.||+.||+|||+++++|+||||+||++++++.+||+|||+
T Consensus 79 ~e~~~~-~l~~~~~~~~-----------~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~ 146 (287)
T cd07840 79 FEYMDH-DLTGLLDSPE-----------VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGL 146 (287)
T ss_pred eccccc-cHHHHHhccC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccc
Confidence 999974 8998886531 2588999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC---
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP--- 288 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~--- 288 (422)
++....... .......++..|+|||.+.+ ..++.++||||||+++|||++ |..||...+..+....+......+
T Consensus 147 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t-~~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd07840 147 ARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFL-GKPIFQGSTELEQLEKIFELCGSPTDE 224 (287)
T ss_pred eeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchh
Confidence 976543321 11122345678999998764 457899999999999999998 899998887665555443211000
Q ss_pred ---------------------------CCCCCCcchhhhcccccccccchhh
Q psy7289 289 ---------------------------CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 289 ---------------------------~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
....+++.+.+++++||..+|..|+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp 276 (287)
T cd07840 225 NWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRI 276 (287)
T ss_pred hccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCc
Confidence 0111377888999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=317.18 Aligned_cols=262 Identities=18% Similarity=0.204 Sum_probs=187.7
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEE--------------ccC--cCCHHhHHHHHHHHHHHhcCCCCce
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKT--------------LKE--NANQKTASDFRREVDLMSELRHPNI 116 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~--------------~~~--~~~~~~~~~~~~E~~il~~l~HpnI 116 (422)
..+|++++.||+|+||+||++.++... ...+++|. +.. .........+.+|+.+|++++||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRAST-EEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccc-hhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 467999999999999999998765322 11122221 100 1112234568899999999999999
Q ss_pred eeEeeEEEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy7289 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARN 196 (422)
Q Consensus 117 v~l~g~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~N 196 (422)
|++++++...+..|+|+|++. ++|.+++....... .......++..++.||+.||+|||+++||||||||+|
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~-------~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~N 297 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDW-------KDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLEN 297 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccc-------cccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 999999999999999999985 68888876432110 1123456778899999999999999999999999999
Q ss_pred eeecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCC---
Q psy7289 197 CLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS--- 273 (422)
Q Consensus 197 iLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~--- 273 (422)
||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++.+..|+.+..
T Consensus 298 ILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~ 376 (501)
T PHA03210 298 IFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP 376 (501)
T ss_pred EEECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence 9999999999999999986543221 112234678999999999999999999999999999999995556665432
Q ss_pred hHHHHHHHHcCCC--CCC-------------------C---------CCCCcchhhhcccccccccchhhHH-HHhhhhh
Q psy7289 274 NQEVIEMIRSRQM--LPC-------------------P---------EDCPPRMYSLMMECWHEVPVAAGMA-YLCSHHY 322 (422)
Q Consensus 274 ~~~~~~~i~~~~~--~~~-------------------p---------~~~p~~~~~l~~~cw~~~P~~r~~~-~lh~~~~ 322 (422)
..++...+..-.. ..+ + ...+..+.+++.+|+..||..|+-. .+.+|.+
T Consensus 377 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 1223322221100 000 0 1245566777889999999988632 3455555
Q ss_pred hh
Q psy7289 323 VH 324 (422)
Q Consensus 323 i~ 324 (422)
+.
T Consensus 457 f~ 458 (501)
T PHA03210 457 FS 458 (501)
T ss_pred hh
Confidence 53
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=289.90 Aligned_cols=242 Identities=27% Similarity=0.406 Sum_probs=191.3
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC-HHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEE
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN-QKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFE 134 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E 134 (422)
|++.+.||.|++|.||+|....+ +..|++|++..... ......+.+|+.+++.++||||+++++++.+++..+++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~--~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLT--GEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCC--CCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEe
Confidence 46778999999999999987543 56799998864322 2234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccc
Q psy7289 135 FMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR 214 (422)
Q Consensus 135 ~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~ 214 (422)
|++ ++|.+++..... ..+++..+..++.|++.||+|||+++++||||+|+||++++++.+||+|||+++
T Consensus 79 ~~~-~~l~~~~~~~~~----------~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~ 147 (283)
T cd07835 79 FLD-LDLKKYMDSSPL----------TGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR 147 (283)
T ss_pred ccC-cCHHHHHhhCCC----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence 995 699999865421 258899999999999999999999999999999999999999999999999997
Q ss_pred cccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC---------
Q psy7289 215 DVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR--------- 284 (422)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~--------- 284 (422)
...... .......+++.|+|||++... .++.++|||||||++|||++ |.+||.+.+..+....+...
T Consensus 148 ~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 224 (283)
T cd07835 148 AFGVPV--RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRPLFPGDSEIDQLFRIFRTLGTPDEDVW 224 (283)
T ss_pred ccCCCc--cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChHHh
Confidence 543221 111223446789999988654 57899999999999999998 89999877654332222110
Q ss_pred ----------------CC---CCCCCCCCcchhhhcccccccccchhh
Q psy7289 285 ----------------QM---LPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 285 ----------------~~---~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.. ....+..+..+.+++.+||+.+|..|+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 272 (283)
T cd07835 225 PGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRI 272 (283)
T ss_pred hhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCc
Confidence 00 011234567889999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=293.81 Aligned_cols=246 Identities=22% Similarity=0.408 Sum_probs=188.9
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC---
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP--- 128 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~--- 128 (422)
..+|++.+.||+|+||.||+|+... .+..||||.+.... .......+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~--~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKK--TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECC--CCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 3568899999999999999998654 35789999875432 22223456789999999999999999999876543
Q ss_pred -----eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC
Q psy7289 129 -----MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL 203 (422)
Q Consensus 129 -----~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~ 203 (422)
.++||||+. ++|.+++.... ..+++.++..++.||+.||+|||+++++||||||+||+++.++
T Consensus 89 ~~~~~~~lv~e~~~-~~l~~~l~~~~-----------~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~ 156 (310)
T cd07865 89 RYKGSFYLVFEFCE-HDLAGLLSNKN-----------VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG 156 (310)
T ss_pred CCCceEEEEEcCCC-cCHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC
Confidence 499999997 48888886431 2589999999999999999999999999999999999999999
Q ss_pred eEEEecCcccccccCCcce--EeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHH
Q psy7289 204 TVKISDFGLSRDVYASDYY--RIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEM 280 (422)
Q Consensus 204 ~vKl~DFGla~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~ 280 (422)
.+||+|||+++........ .......++..|+|||.+... .++.++||||||+++|||++ |.+||.+.+..+....
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t-~~~~~~~~~~~~~~~~ 235 (310)
T cd07865 157 ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQHQLTL 235 (310)
T ss_pred cEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence 9999999999765332211 111223456789999987654 47889999999999999998 9999988776654443
Q ss_pred HHc--CCCC----------------CCCC-------------CCCcchhhhcccccccccchhh
Q psy7289 281 IRS--RQML----------------PCPE-------------DCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 281 i~~--~~~~----------------~~p~-------------~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+.. +..+ ..|. ..++.+.+++.+||..+|..|+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~ 299 (310)
T cd07865 236 ISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRI 299 (310)
T ss_pred HHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhcc
Confidence 332 1100 0011 1234566899999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=290.34 Aligned_cols=244 Identities=25% Similarity=0.381 Sum_probs=190.4
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
.+|++.+.||+|+||.||+|+... .++.||+|.+.... .......+.+|++++++++||||+++++++.+....++|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRV--TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecC--CCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 357888999999999999998654 35679999885432 223345788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC-CCeEEEecCc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD-GLTVKISDFG 211 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~-~~~vKl~DFG 211 (422)
|||++ ++|.+++..... ..+++..+..++.||+.||+|||+++++||||||+||++++ ++.+||+|||
T Consensus 80 ~e~~~-~~l~~~~~~~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg 148 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPD----------FAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFG 148 (294)
T ss_pred Eeccc-ccHHHHHHhCCC----------CCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccc
Confidence 99996 588888754321 23578888899999999999999999999999999999985 5689999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC--C---
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR--Q--- 285 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~--~--- 285 (422)
+++...... .......+++.|+|||++... .++.++|||||||++|||+| |.+||.+.+..+.+..+... .
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 225 (294)
T PLN00009 149 LARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPLFPGDSEIDELFKIFRILGTPNE 225 (294)
T ss_pred cccccCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 997543221 111223456789999988653 57899999999999999998 99999877665544433210 0
Q ss_pred -----------------CCC------CCCCCCcchhhhcccccccccchhh
Q psy7289 286 -----------------MLP------CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 286 -----------------~~~------~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..+ .....++++.+++.+|++.+|..|+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp 276 (294)
T PLN00009 226 ETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRI 276 (294)
T ss_pred hhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCc
Confidence 000 0134567788999999999999997
|
|
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=280.30 Aligned_cols=251 Identities=20% Similarity=0.307 Sum_probs=196.4
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC---
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE--- 127 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~--- 127 (422)
+...+|++.+.||+|||+-||.++...+ +..+|+|++.-.. .+..+..++|++..++++||||++++++...+.
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~--~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLST--GHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCc--ccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 4578999999999999999999875443 4679999886543 456678899999999999999999998765443
Q ss_pred --CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceeecCCC
Q psy7289 128 --PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHH--YVHRDLAARNCLVGDGL 203 (422)
Q Consensus 128 --~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--ivHrDlKp~NiLl~~~~ 203 (422)
..|+++.|...|+|.+.+...... ...+++.++..|+.+|++||++||+.. ..||||||.|||+.+.+
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~k--------g~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~ 166 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIK--------GNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG 166 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhc--------CCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC
Confidence 489999999999999999875422 236999999999999999999999998 99999999999999999
Q ss_pred eEEEecCcccccccCCcc-----e--EeccCCCCCccccCcccccc---CCCCCchhHHhHHHHHHHHHhCCCCCCCCCC
Q psy7289 204 TVKISDFGLSRDVYASDY-----Y--RIQSKSLLPVRWMPPESILY---GKFTTESDVWSYGVVLWEVYSYGLQPYYGYS 273 (422)
Q Consensus 204 ~vKl~DFGla~~~~~~~~-----~--~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~ 273 (422)
.++|.|||.+....-.-. . ........|..|.|||.+.. ...++++|||||||++|+|+ +|..||...-
T Consensus 167 ~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~m-f~~sPfe~~~ 245 (302)
T KOG2345|consen 167 LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMM-FGESPFERIY 245 (302)
T ss_pred ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHH-HcCCcchHHh
Confidence 999999999875421100 0 00112345788999998864 45789999999999999999 4999995321
Q ss_pred h--HHHHHHHHcCCC-CCCCCCCCcchhhhcccccccccchhh
Q psy7289 274 N--QEVIEMIRSRQM-LPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 274 ~--~~~~~~i~~~~~-~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
. ..+.-++.+++. .|.....+..+.++++.|+..||..||
T Consensus 246 ~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP 288 (302)
T KOG2345|consen 246 QQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRP 288 (302)
T ss_pred hcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCC
Confidence 1 112222333321 222233778899999999999999998
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=299.27 Aligned_cols=243 Identities=25% Similarity=0.373 Sum_probs=191.8
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC-----
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSG----- 126 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~----- 126 (422)
..+|++.+.||+|+||.||+|+... .+..||||.++... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSE--TNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecC--CCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 3468889999999999999998643 45779999886432 233345678899999999999999999988654
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEE
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vK 206 (422)
...++++||+. ++|.+++... ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+|
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~k 148 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSS------------QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLK 148 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEE
Confidence 24799999996 7899888643 3589999999999999999999999999999999999999999999
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc--
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS-- 283 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~-- 283 (422)
|+|||+++....... ......++..|+|||.+.. ..++.++|||||||++|||++ |.+||.+.+..+....+..
T Consensus 149 L~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~ 225 (337)
T cd07858 149 ICDFGLARTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLG-RKPLFPGKDYVHQLKLITELL 225 (337)
T ss_pred ECcCccccccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHh
Confidence 999999986543221 1123345778999998865 468999999999999999997 9999987654333222210
Q ss_pred ----------------------C---CCC---CCCCCCCcchhhhcccccccccchhh
Q psy7289 284 ----------------------R---QML---PCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 284 ----------------------~---~~~---~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
. ... ...+++++++.+++++||..+|..|+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 283 (337)
T cd07858 226 GSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRI 283 (337)
T ss_pred CCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhcc
Confidence 0 000 11246788899999999999999997
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=297.50 Aligned_cols=245 Identities=29% Similarity=0.404 Sum_probs=191.6
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcC--C
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSG--E 127 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~--~ 127 (422)
+..+|++.+.||+|+||.||+|.... .+..+|+|.+... ........+.+|+.+++++ +||||+++++++... .
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRR--TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcC--CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 34578889999999999999998653 3577999987532 2233445678899999999 999999999998654 3
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
..++||||++ ++|.+++... .+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-------------~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl 148 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN-------------ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKL 148 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEE
Confidence 5899999997 5999988642 4678888899999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcce---EeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc
Q psy7289 208 SDFGLSRDVYASDYY---RIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS 283 (422)
Q Consensus 208 ~DFGla~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~ 283 (422)
+|||+++........ .......++..|+|||.+.. ..++.++|||||||++|||++ |..||.+.+..+....+..
T Consensus 149 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~t-g~~pf~~~~~~~~~~~~~~ 227 (337)
T cd07852 149 ADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLL-GKPLFPGTSTLNQLEKIIE 227 (337)
T ss_pred eeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Confidence 999999865433211 11122345778999998765 457899999999999999998 9999987665544333211
Q ss_pred C---------------------------CCCC---CCCCCCcchhhhcccccccccchhh
Q psy7289 284 R---------------------------QMLP---CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 284 ~---------------------------~~~~---~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
. ...+ ....++.++.+++.+||..+|..|+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp 287 (337)
T cd07852 228 VIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRL 287 (337)
T ss_pred HhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCccccc
Confidence 1 1111 1123678899999999999999997
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=290.46 Aligned_cols=237 Identities=25% Similarity=0.459 Sum_probs=193.8
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
+...++||+|+||.||+|+... .+..|++|.+.... .......+.+|+++++.++||||+++++++.+....++||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~--~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSH--TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred hhcceeeccCCCeEEEEEEECC--CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 4556789999999999998643 35779999885432 2334467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||+. |+|.+++.... .++++.++..++.|++.||.|||++|++||||||+||++++++.+||+|||++
T Consensus 101 e~~~-~~l~~~l~~~~-----------~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~ 168 (313)
T cd06633 101 EYCL-GSASDLLEVHK-----------KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSA 168 (313)
T ss_pred ecCC-CCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCC
Confidence 9996 68888875432 35888999999999999999999999999999999999999999999999998
Q ss_pred ccccCCcceEeccCCCCCccccCccccc---cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC-
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESIL---YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC- 289 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~- 289 (422)
..... .....++..|+|||++. ...++.++|||||||++|||++ |..||.+.+.......+.....+..
T Consensus 169 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
T cd06633 169 SKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNDSPTLQ 241 (313)
T ss_pred cccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCC
Confidence 64321 12334677899999974 3568889999999999999998 9999988877666655554433322
Q ss_pred CCCCCcchhhhcccccccccchhh
Q psy7289 290 PEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 290 p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
...++..+.+++.+||+.+|..|+
T Consensus 242 ~~~~~~~l~~li~~~l~~~P~~Rp 265 (313)
T cd06633 242 SNEWTDSFRGFVDYCLQKIPQERP 265 (313)
T ss_pred ccccCHHHHHHHHHHccCChhhCc
Confidence 235677899999999999999987
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=295.33 Aligned_cols=244 Identities=24% Similarity=0.362 Sum_probs=191.2
Q ss_pred cCcc-cccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHH-------------hHHHHHHHHHHHhcCCCCceeeE
Q psy7289 54 TKPR-FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQK-------------TASDFRREVDLMSELRHPNIVCL 119 (422)
Q Consensus 54 ~~~~-~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~il~~l~HpnIv~l 119 (422)
.+|. +.+.||+|+||.||+|+... .++.||||.++...... ....+.+|+++++.++||||+++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTL--TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECC--CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 4554 45679999999999998643 35779999875432111 01247789999999999999999
Q ss_pred eeEEEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceee
Q psy7289 120 LGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV 199 (422)
Q Consensus 120 ~g~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl 199 (422)
++++...+..++||||+. |+|.+++... ..++++.+..++.|++.||+|||+++++||||||+||++
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~------------~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill 152 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDRK------------IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI 152 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE
Confidence 999999999999999997 6999998653 248899999999999999999999999999999999999
Q ss_pred cCCCeEEEecCcccccccCCcce------------EeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCC
Q psy7289 200 GDGLTVKISDFGLSRDVYASDYY------------RIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGL 266 (422)
Q Consensus 200 ~~~~~vKl~DFGla~~~~~~~~~------------~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~ 266 (422)
+.++.+||+|||+++........ .......++..|+|||.+.+. .++.++|||||||++|||++ |.
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~t-g~ 231 (335)
T PTZ00024 153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT-GK 231 (335)
T ss_pred CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHh-CC
Confidence 99999999999998765411100 011122346789999998754 47899999999999999999 99
Q ss_pred CCCCCCChHHHHHHHHcCCCCC---------------------------CCCCCCcchhhhcccccccccchhh
Q psy7289 267 QPYYGYSNQEVIEMIRSRQMLP---------------------------CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 267 ~Pf~~~~~~~~~~~i~~~~~~~---------------------------~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+||.+.+..+.+..+......+ ....++..+.+++.+||+.+|..|+
T Consensus 232 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 305 (335)
T PTZ00024 232 PLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI 305 (335)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhcc
Confidence 9999888776655443211000 0124567788999999999999996
|
|
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=283.99 Aligned_cols=254 Identities=24% Similarity=0.403 Sum_probs=202.4
Q ss_pred ccccCcccc-cccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEc---
Q psy7289 51 VIETKPRFL-QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVCLS--- 125 (422)
Q Consensus 51 ~~~~~~~~~-~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--- 125 (422)
-+-.+|.+. ++||-|-.|.|..+..+.++ +.+|+|++... +.-++|+++--.. .|||||++++++..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~--ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQ--EKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccch--hhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 344556664 57999999999998876654 66999988542 2346788875444 69999999998753
Q ss_pred -CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC---
Q psy7289 126 -GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD--- 201 (422)
Q Consensus 126 -~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~--- 201 (422)
...+.+|||.|+||+|++.+.+++. ..++++++..|+.||+.|+.|||+.+|.||||||+|+|...
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~----------~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~ 199 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGD----------QAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSP 199 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHccc----------ccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCC
Confidence 3457899999999999999988652 46999999999999999999999999999999999999964
Q ss_pred CCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChH----HH
Q psy7289 202 GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ----EV 277 (422)
Q Consensus 202 ~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~----~~ 277 (422)
+..+||+|||+|+....+. ...+...||.|.|||++..++|+..+|+||+||++|-|++ |.+||+..... .+
T Consensus 200 na~lKLtDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLC-GyPPFYS~hg~aispgM 275 (400)
T KOG0604|consen 200 NAPLKLTDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC-GYPPFYSNHGLAISPGM 275 (400)
T ss_pred CcceEecccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhc-CCCcccccCCccCChhH
Confidence 5689999999998755322 2234567899999999999999999999999999999998 99999976543 45
Q ss_pred HHHHHcCCC-CCCCC--CCCcchhhhcccccccccchh-hHHHHhhhhhhhhh
Q psy7289 278 IEMIRSRQM-LPCPE--DCPPRMYSLMMECWHEVPVAA-GMAYLCSHHYVHRD 326 (422)
Q Consensus 278 ~~~i~~~~~-~~~p~--~~p~~~~~l~~~cw~~~P~~r-~~~~lh~~~~i~~d 326 (422)
..+|+.|+. .|-|+ ..+....++++..+.-+|..| .++...+|.+|-..
T Consensus 276 k~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 276 KRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred HhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 677777764 34343 356778899999999999876 45555666666543
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=296.40 Aligned_cols=253 Identities=26% Similarity=0.396 Sum_probs=201.5
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC-HHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC-----C
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN-QKTASDFRREVDLMSELRHPNIVCLLGVCLSGE-----P 128 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-----~ 128 (422)
+|++.+.||+|+||.||+|+... .+..||||.+..... ....+.+.+|+.+++.++||||+++++++.... .
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKR--TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCC--CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence 47788999999999999998643 356799998865432 344567899999999999999999999988775 7
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
+|++|||++ ++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~------------~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~ 145 (330)
T cd07834 79 VYIVTELME-TDLHKVIKSP------------QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKIC 145 (330)
T ss_pred eEEEecchh-hhHHHHHhCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEc
Confidence 899999998 5898888653 258999999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcce-EeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC
Q psy7289 209 DFGLSRDVYASDYY-RIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286 (422)
Q Consensus 209 DFGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~ 286 (422)
|||++......... .......++..|+|||.+... .++.++|+||||+++|||++ |.+||.+.+..+....+.....
T Consensus 146 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~ 224 (330)
T cd07834 146 DFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLT-RKPLFPGRDYIDQLNLIVEVLG 224 (330)
T ss_pred ccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHc-CCCCcCCCCHHHHHHHHHHhcC
Confidence 99999865433210 112233457789999999877 78999999999999999998 9999998887766555443111
Q ss_pred CC------------------------------CCCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 287 LP------------------------------CPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 287 ~~------------------------------~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
.+ .....|+.+.+++++||+.+|..|+ +..+..|.++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 292 (330)
T cd07834 225 TPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292 (330)
T ss_pred CCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccH
Confidence 10 1123577889999999999999987 2334444444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=298.97 Aligned_cols=244 Identities=24% Similarity=0.393 Sum_probs=191.9
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc----CCC
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLS----GEP 128 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~ 128 (422)
.+|++.+.||+|+||.||+|....+ +..||+|.+.... .......+.+|+.+|+.++||||+++++++.. ...
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~--~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRS--GKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCC--CCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 5788889999999999999986543 5679999886532 22345677889999999999999999998763 346
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
.++||||+. |+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+||++++++.+||+
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~ 149 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSD------------QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIG 149 (334)
T ss_pred EEEEEehhh-hhHHHHhccC------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEec
Confidence 899999996 6899988643 348999999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcce--EeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc--
Q psy7289 209 DFGLSRDVYASDYY--RIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS-- 283 (422)
Q Consensus 209 DFGla~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~-- 283 (422)
|||+++........ .......++..|+|||.+.. ..++.++|||||||++|||++ |..||.+.+..+.+..+..
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~ 228 (334)
T cd07855 150 DFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLG-RRQLFPGKNYVHQLKLILSVL 228 (334)
T ss_pred ccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHc-CCCccCCCChHHHHHHHHHHh
Confidence 99999765332211 11123356778999998765 458899999999999999998 9999987765433322211
Q ss_pred -----------------------CCCCCC-----CCCCCcchhhhcccccccccchhh
Q psy7289 284 -----------------------RQMLPC-----PEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 284 -----------------------~~~~~~-----p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
....+. .+..++++.+++++||+.+|..|+
T Consensus 229 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 286 (334)
T cd07855 229 GSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERI 286 (334)
T ss_pred CCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCc
Confidence 000111 134678899999999999999997
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=293.83 Aligned_cols=245 Identities=26% Similarity=0.399 Sum_probs=189.4
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcC----CC
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSG----EP 128 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~----~~ 128 (422)
+|++.+.||+|+||.||+++.....++..||+|.+.... .....+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 367789999999999999987655336789999886432 222356788999999999 599999999975432 35
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
+++++||+. ++|.+++... ..+++..+..++.||+.||+|||++|++||||||+||++++++.+||+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~ 147 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG------------QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKIC 147 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeC
Confidence 788899886 6999988643 358899999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcce--EeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC-
Q psy7289 209 DFGLSRDVYASDYY--RIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR- 284 (422)
Q Consensus 209 DFGla~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~- 284 (422)
|||+++........ .......+++.|+|||.+.. ..++.++|||||||++|||++ |.+||.+.+..+....+...
T Consensus 148 Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~-g~~pf~~~~~~~~~~~~~~~~ 226 (332)
T cd07857 148 DFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLG-RKPVFKGKDYVDQLNQILQVL 226 (332)
T ss_pred cCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCcCCCCCCHHHHHHHHHHHh
Confidence 99999865432111 11123456788999998765 468999999999999999998 99999876644333322110
Q ss_pred --------------------------CCCC---CCCCCCcchhhhcccccccccchhh
Q psy7289 285 --------------------------QMLP---CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 285 --------------------------~~~~---~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
...+ ....++..+.+++.+||+.+|..|+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 284 (332)
T cd07857 227 GTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRI 284 (332)
T ss_pred CCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCC
Confidence 0001 1123567899999999999999997
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=288.11 Aligned_cols=241 Identities=29% Similarity=0.416 Sum_probs=194.6
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC-HHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEE
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN-QKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFE 134 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E 134 (422)
|++.+.||+|++|.||+|... .++..+++|.++.... ......+.+|+.++++++||||+++++++.++...++|||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDK--LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcC--CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEe
Confidence 456789999999999999864 3457799998865432 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccc
Q psy7289 135 FMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR 214 (422)
Q Consensus 135 ~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~ 214 (422)
|+++ +|.+++.... ..+++..+..++.|++.||.|||+++|+|+||||+||++++++.+||+|||.+.
T Consensus 79 ~~~~-~l~~~l~~~~-----------~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~ 146 (283)
T cd05118 79 FMDT-DLYKLIKDRQ-----------RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLAR 146 (283)
T ss_pred ccCC-CHHHHHHhhc-----------ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence 9975 8988886532 358899999999999999999999999999999999999999999999999987
Q ss_pred cccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC-----
Q psy7289 215 DVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP----- 288 (422)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~----- 288 (422)
...... .......++..|+|||.+... .++.++|+||||+++|||++ |..||.+.+..+.+..+......+
T Consensus 147 ~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (283)
T cd05118 147 SFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLS-RRPLFPGKSEIDQLFKIFRTLGTPDPEVW 223 (283)
T ss_pred ecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCchHhc
Confidence 654332 111223456789999998776 78999999999999999998 899998877655444432210000
Q ss_pred ------------------------CCCCCCcchhhhcccccccccchhh
Q psy7289 289 ------------------------CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 289 ------------------------~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..+.++.++.+++.+||..+|..|+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp 272 (283)
T cd05118 224 PKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI 272 (283)
T ss_pred ccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCc
Confidence 1124677899999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=291.60 Aligned_cols=242 Identities=18% Similarity=0.315 Sum_probs=184.9
Q ss_pred ccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEe
Q psy7289 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEF 135 (422)
Q Consensus 57 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~ 135 (422)
.+.+.+|.|+++.|++++ . .+..||||+++.. ........+.+|+.+++.++||||+++++++.+.+..+++|||
T Consensus 5 ~i~~~~~~~~~v~~~~~~--~--~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~ 80 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHK--P--TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPL 80 (314)
T ss_pred hhhHhhcCCceEEEEEec--C--CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEec
Confidence 344555666666555543 3 4577999998654 3445667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccccc
Q psy7289 136 MVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRD 215 (422)
Q Consensus 136 ~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~ 215 (422)
+++|+|.+++..... ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||.+..
T Consensus 81 ~~~~~l~~~l~~~~~----------~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~ 150 (314)
T cd08216 81 MAYGSCEDLLKTHFP----------EGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVS 150 (314)
T ss_pred cCCCCHHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCcccee
Confidence 999999999976421 2478899999999999999999999999999999999999999999999999875
Q ss_pred ccCCcce-----EeccCCCCCccccCcccccc--CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHH-HHHHcCCCC
Q psy7289 216 VYASDYY-----RIQSKSLLPVRWMPPESILY--GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVI-EMIRSRQML 287 (422)
Q Consensus 216 ~~~~~~~-----~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~-~~i~~~~~~ 287 (422)
....... .......++..|+|||.+.. ..++.++|||||||++|||++ |..||...+..... +.+......
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~ 229 (314)
T cd08216 151 MIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELAN-GHVPFKDMPATQMLLEKVRGTVPC 229 (314)
T ss_pred eccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCcc
Confidence 5322110 11122334667999999875 358899999999999999998 99999877654433 222211000
Q ss_pred --------------------------------CCCCCCCcchhhhcccccccccchhh
Q psy7289 288 --------------------------------PCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 288 --------------------------------~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+.+...+.++.+++.+||..+|..|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 287 (314)
T cd08216 230 LLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRP 287 (314)
T ss_pred ccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCc
Confidence 00011124577899999999999997
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=285.97 Aligned_cols=241 Identities=28% Similarity=0.440 Sum_probs=191.1
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC-CCceeeEeeEEEcCCCeEEEEE
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR-HPNIVCLLGVCLSGEPMCMLFE 134 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~lv~E 134 (422)
|++.+.||+|+||.||+|+...+ +..|+||.+.............+|+..+++++ ||||+++++++.+++..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~--~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKET--GELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCC--CcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 46788999999999999987543 46799998865433223334567999999999 9999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccc
Q psy7289 135 FMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR 214 (422)
Q Consensus 135 ~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~ 214 (422)
|+ +|+|.+++.... ...+++.++..++.|++.||.|||+++++|+||+|+||++++++.+||+|||+++
T Consensus 79 ~~-~~~l~~~~~~~~----------~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~ 147 (283)
T cd07830 79 YM-EGNLYQLMKDRK----------GKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR 147 (283)
T ss_pred cC-CCCHHHHHHhcc----------cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccce
Confidence 99 889999987642 1257899999999999999999999999999999999999999999999999997
Q ss_pred cccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC------
Q psy7289 215 DVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML------ 287 (422)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~------ 287 (422)
....... .....++..|+|||.+.. ..++.++|+||||+++|||++ |.+||...+..+....+.+....
T Consensus 148 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (283)
T cd07830 148 EIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYT-LRPLFPGSSEIDQLYKICSVLGTPTKQDW 223 (283)
T ss_pred eccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHh-CCCccCCCChHHHHHHHHHhcCCCChhhh
Confidence 6543221 122345678999998754 457899999999999999998 88999877665444332210000
Q ss_pred ------------C-----------CCCCCCcchhhhcccccccccchhh
Q psy7289 288 ------------P-----------CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 288 ------------~-----------~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
. ..+..++.+.+++++||..+|..|+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 272 (283)
T cd07830 224 PEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRP 272 (283)
T ss_pred hhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCC
Confidence 0 0112257789999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=294.97 Aligned_cols=243 Identities=24% Similarity=0.355 Sum_probs=188.3
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC------
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG------ 126 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------ 126 (422)
..+|++.+.||.|+||.||+|+... .+..||+|.+..... ...+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~--~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSD--CDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECC--CCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 4678999999999999999998653 356799998754332 3456788999999999999999999876543
Q ss_pred --------CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcee
Q psy7289 127 --------EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCL 198 (422)
Q Consensus 127 --------~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiL 198 (422)
...++||||++ ++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||+
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-------------~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nil 146 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQ-------------GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVF 146 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE
Confidence 34789999997 599888853 24889999999999999999999999999999999999
Q ss_pred ec-CCCeEEEecCcccccccCCcce-EeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChH
Q psy7289 199 VG-DGLTVKISDFGLSRDVYASDYY-RIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ 275 (422)
Q Consensus 199 l~-~~~~vKl~DFGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~ 275 (422)
++ +++.+||+|||+++........ .......++..|+|||.+.. ..++.++|||||||++|||++ |..||.+.+..
T Consensus 147 i~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~-g~~pf~~~~~~ 225 (342)
T cd07854 147 INTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT-GKPLFAGAHEL 225 (342)
T ss_pred EcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Confidence 97 4568999999999764321111 11122345778999998754 458889999999999999998 99999877655
Q ss_pred HHHHHHHcCC------------------------CCC-----CCCCCCcchhhhcccccccccchhh
Q psy7289 276 EVIEMIRSRQ------------------------MLP-----CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 276 ~~~~~i~~~~------------------------~~~-----~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+....+.... ... .....+.++.+++.+||..+|..|+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 292 (342)
T cd07854 226 EQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRL 292 (342)
T ss_pred HHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhcc
Confidence 4443332110 000 1124567788999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=294.51 Aligned_cols=238 Identities=25% Similarity=0.365 Sum_probs=187.8
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC----
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE---- 127 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~---- 127 (422)
..+|.+.+.||+|+||.||+|+... .+..||||.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKR--TGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCC--CCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 3578889999999999999998643 35679999886432 2233456889999999999999999999987543
Q ss_pred --CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 128 --PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 128 --~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
..++||||+.. +|.+++. ..++++.+..++.|++.||+|||+++++||||||+||+++.++.+
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~~--------------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~ 156 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIMG--------------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCEL 156 (342)
T ss_pred CceEEEEeccccc-CHHHHHc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCE
Confidence 46999999864 7776652 247889999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR 284 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~ 284 (422)
||+|||+++..... .....++..|+|||.+.. ..++.++|||||||++|||++ |..||.+.+....+..+...
T Consensus 157 kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~-g~~pf~~~~~~~~~~~~~~~ 230 (342)
T cd07879 157 KILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLT-GKTLFKGKDYLDQLTQILKV 230 (342)
T ss_pred EEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Confidence 99999998754321 122345678999999876 458899999999999999998 99999987755544433221
Q ss_pred CC----------------------CCC--------CCCCCcchhhhcccccccccchhh
Q psy7289 285 QM----------------------LPC--------PEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 285 ~~----------------------~~~--------p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.. +.. .+..++.+.+++.+||..+|..|+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 289 (342)
T cd07879 231 TGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRL 289 (342)
T ss_pred cCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCc
Confidence 10 000 124567788999999999999986
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=284.04 Aligned_cols=241 Identities=28% Similarity=0.422 Sum_probs=190.9
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC-HHhHHHHHHHHHHHhcC---CCCceeeEeeEEEcCCC---
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN-QKTASDFRREVDLMSEL---RHPNIVCLLGVCLSGEP--- 128 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l---~HpnIv~l~g~~~~~~~--- 128 (422)
|++.+.||+|+||.||+|++.. .+..||+|.++.... ......+.+|+.+++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN--TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred CeEEEEecccCceEEEEEEECC--CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 4678899999999999998754 356799999864322 22234567788877666 69999999999988777
Q ss_pred --eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEE
Q psy7289 129 --MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 129 --~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vK 206 (422)
.+++|||+. ++|.+++..... ..+++..+..++.|++.||.|||+.+++|+||+|+||++++++.+|
T Consensus 79 ~~~~l~~e~~~-~~l~~~l~~~~~----------~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~ 147 (287)
T cd07838 79 LKLTLVFEHVD-QDLATYLSKCPK----------PGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVK 147 (287)
T ss_pred ceeEEEehhcc-cCHHHHHHHccC----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEE
Confidence 999999997 489998865321 2488999999999999999999999999999999999999999999
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~ 286 (422)
|+|||+++....... .....++..|+|||.+....++.++|+|||||++|||++ |.+||.+.+..+.+..+.....
T Consensus 148 l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~-~~~~~~~~~~~~~~~~~~~~~~ 223 (287)
T cd07838 148 IADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRPLFRGTSEADQLDKIFDVIG 223 (287)
T ss_pred EeccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHh-CCCcccCCChHHHHHHHHHHcC
Confidence 999999876533211 122335678999999998889999999999999999998 8999998887776655532110
Q ss_pred C------------------C----C----CCCCCcchhhhcccccccccchhh
Q psy7289 287 L------------------P----C----PEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 287 ~------------------~----~----p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
. . . .+..++.+.+++.+||..+|..|+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 276 (287)
T cd07838 224 LPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRI 276 (287)
T ss_pred CCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCC
Confidence 0 0 0 012345678899999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=292.97 Aligned_cols=240 Identities=24% Similarity=0.367 Sum_probs=191.2
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC---
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE--- 127 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~--- 127 (422)
...+|++.+.||+|+||.||+|.... .+..||||.+.... .......+.+|+.+|++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRR--TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECC--CCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 35678999999999999999998643 35779999885432 2334457889999999999999999999987654
Q ss_pred ---CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCe
Q psy7289 128 ---PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLT 204 (422)
Q Consensus 128 ---~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~ 204 (422)
..++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+++|+||||||+||++++++.
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~-------------~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~ 156 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH-------------EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE 156 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC
Confidence 358999998 7799888753 24889999999999999999999999999999999999999999
Q ss_pred EEEecCcccccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc
Q psy7289 205 VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS 283 (422)
Q Consensus 205 vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~ 283 (422)
+||+|||+++..... .....+++.|+|||.+.. ..++.++|+|||||++||+++ |..||.+.+.......+..
T Consensus 157 ~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~ 230 (343)
T cd07880 157 LKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLT-GKPLFKGHDHLDQLMEIMK 230 (343)
T ss_pred EEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Confidence 999999999764322 122345778999998875 458899999999999999998 9999987765443332221
Q ss_pred CCC---------------------C---------CCCCCCCcchhhhcccccccccchhh
Q psy7289 284 RQM---------------------L---------PCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 284 ~~~---------------------~---------~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
... . .....+++.+.+++.+|++.+|..|+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 290 (343)
T cd07880 231 VTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRI 290 (343)
T ss_pred hcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCC
Confidence 100 0 01235677889999999999999986
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=294.09 Aligned_cols=239 Identities=23% Similarity=0.355 Sum_probs=188.6
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC-----
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSG----- 126 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~----- 126 (422)
..+|++.+.||+|+||.||+|.... .+..||+|+++... .....+.+.+|+.++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcC--CCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 4678899999999999999997643 35789999886432 233356788999999999999999999988643
Q ss_pred -CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 127 -EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 127 -~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
...++++|++ +++|.+++... .+++..+..++.|++.||+|||+++|+||||||+||++++++.+
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~~-------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKCQ-------------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCE
Confidence 3467888876 78998887542 47889999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR 284 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~ 284 (422)
||+|||+++..... .....++..|+|||.+.. ..++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 160 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~ 233 (345)
T cd07877 160 KILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLILRL 233 (345)
T ss_pred EEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Confidence 99999998754321 122345778999998765 468899999999999999998 99999876654433332211
Q ss_pred C------------------------CCC------CCCCCCcchhhhcccccccccchhh
Q psy7289 285 Q------------------------MLP------CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 285 ~------------------------~~~------~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
. ..+ ....+++.+.+++.+|++.+|..|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 292 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 292 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcC
Confidence 0 000 0123577889999999999999986
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=289.32 Aligned_cols=246 Identities=27% Similarity=0.430 Sum_probs=188.2
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC-HHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC----
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN-QKTASDFRREVDLMSELRHPNIVCLLGVCLSGE---- 127 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~---- 127 (422)
..+|++.+.||+|+||.||+|++..+ +..+|+|.+..... ......+.+|+++++.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~--~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKT--GRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCC--CcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 35788999999999999999987543 46789998754322 222346778999999999999999999875433
Q ss_pred ----CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC
Q psy7289 128 ----PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL 203 (422)
Q Consensus 128 ----~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~ 203 (422)
.+++||||+.+ +|.+.+.... ..+++..+..++.|+++||+|||+++|+||||||+||++++++
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~-----------~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~ 152 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPS-----------VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG 152 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccc-----------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 46999999875 7777775421 3589999999999999999999999999999999999999999
Q ss_pred eEEEecCcccccccCCcceEe---------ccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCC
Q psy7289 204 TVKISDFGLSRDVYASDYYRI---------QSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYS 273 (422)
Q Consensus 204 ~vKl~DFGla~~~~~~~~~~~---------~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~ 273 (422)
.+||+|||+++.......... .....+++.|+|||.+... .++.++|||||||++|||++ |.+||.+.+
T Consensus 153 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~-g~~~~~~~~ 231 (311)
T cd07866 153 ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRPILQGKS 231 (311)
T ss_pred CEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHh-CCCCCCCCC
Confidence 999999999976532211100 1122346779999987654 58899999999999999998 999998887
Q ss_pred hHHHHHHHHcCCCCC----------------------CC-------CCCCcchhhhcccccccccchhh
Q psy7289 274 NQEVIEMIRSRQMLP----------------------CP-------EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 274 ~~~~~~~i~~~~~~~----------------------~p-------~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..+....+......+ .| ...++.+.+++.+|+..+|..|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~ 300 (311)
T cd07866 232 DIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRL 300 (311)
T ss_pred HHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCc
Confidence 766555443211100 00 12335677899999999999987
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=288.73 Aligned_cols=240 Identities=30% Similarity=0.416 Sum_probs=189.5
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc-CCCe
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLS-GEPM 129 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 129 (422)
...+|++.+.||+|+||.||+|+... .+..||+|.+... ......+.+.+|+.+++.++||||+++++++.. ....
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQL--TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECC--CCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 34578899999999999999998643 3567999987542 223345678899999999999999999999875 5578
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEec
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISD 209 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~D 209 (422)
+++|||+ +++|.+++.. ..+++..+..++.|++.||+|||+++|+||||||+||++++++.+||+|
T Consensus 86 ~lv~e~~-~~~L~~~~~~-------------~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~d 151 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS-------------RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICD 151 (328)
T ss_pred EEEeehh-ccCHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCc
Confidence 9999998 5689888853 2477888889999999999999999999999999999999999999999
Q ss_pred CcccccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH------
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR------ 282 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~------ 282 (422)
||+++..... .....++..|+|||.+.. ..++.++|||||||++|||++ |.+||.+.+.......+.
T Consensus 152 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~~f~~~~~~~~~~~~~~~~~~~ 225 (328)
T cd07856 152 FGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLE-GKPLFPGKDHVNQFSIITDLLGTP 225 (328)
T ss_pred cccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9998754321 122345678999998765 568999999999999999998 999998766532221111
Q ss_pred ---------c------------CCCCCC---CCCCCcchhhhcccccccccchhh
Q psy7289 283 ---------S------------RQMLPC---PEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 283 ---------~------------~~~~~~---p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
. ....+. .+.+++.+.++|++||..+|..|+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 280 (328)
T cd07856 226 PDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRI 280 (328)
T ss_pred CHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCC
Confidence 0 001111 134678899999999999999997
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=293.12 Aligned_cols=239 Identities=24% Similarity=0.361 Sum_probs=193.4
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC---
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP--- 128 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~--- 128 (422)
..+|++.+.||+|+||.||+|+... .+..||||.+.... .......+.+|+.++++++||||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTK--TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECC--CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 4578899999999999999998754 34679999876432 23344667889999999999999999998776554
Q ss_pred ---eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 129 ---MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 129 ---~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+.||+||||||+||++++++.+
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-------------~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~ 157 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-------------QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 157 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCE
Confidence 89999998 5799998864 258999999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR 284 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~ 284 (422)
||+|||++...... .....++..|+|||.+.. ..++.++|||||||++|||++ |..||.+.+..+.+..+.+.
T Consensus 158 kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~ 231 (343)
T cd07851 158 KILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GKTLFPGSDHIDQLKRIMNL 231 (343)
T ss_pred EEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Confidence 99999999765322 123345778999998865 367899999999999999998 99999887766655544332
Q ss_pred CCCC------------------------------CCCCCCcchhhhcccccccccchhh
Q psy7289 285 QMLP------------------------------CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 285 ~~~~------------------------------~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
...+ .....++.+.+++.+||..+|..|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rp 290 (343)
T cd07851 232 VGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRI 290 (343)
T ss_pred cCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCC
Confidence 1110 0123577889999999999999997
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=277.79 Aligned_cols=218 Identities=20% Similarity=0.250 Sum_probs=178.3
Q ss_pred ccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEecCCCCHHHH
Q psy7289 65 GAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEF 144 (422)
Q Consensus 65 G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~~~G~L~~~ 144 (422)
|.||.||+++...+ ++.||+|.++... .+.+|...+....||||+++++++.+.+..++||||+++|+|.++
T Consensus 4 g~~~~v~~~~~~~~--~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRT--QQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccC--CcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 89999999986544 4679999986432 234555666667899999999999999999999999999999999
Q ss_pred HhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccccCCcceEe
Q psy7289 145 LMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRI 224 (422)
Q Consensus 145 l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~~~~~~~ 224 (422)
+... ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.++++|||++.......
T Consensus 76 l~~~------------~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---- 139 (237)
T cd05576 76 ISKF------------LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---- 139 (237)
T ss_pred HHHh------------cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----
Confidence 9754 248899999999999999999999999999999999999999999999999886543221
Q ss_pred ccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcchhhhcccc
Q psy7289 225 QSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMEC 304 (422)
Q Consensus 225 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~~~~l~~~c 304 (422)
....++..|+|||.+....++.++||||+||++|||++ |..|+...... +........|..+++.+.+++.+|
T Consensus 140 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~ 212 (237)
T cd05576 140 -DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLT-GKTLVECHPSG-----INTHTTLNIPEWVSEEARSLLQQL 212 (237)
T ss_pred -ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHH-CcchhhcCchh-----cccccccCCcccCCHHHHHHHHHH
Confidence 12234567999999988889999999999999999998 88777543211 112223446777889999999999
Q ss_pred cccccchhh
Q psy7289 305 WHEVPVAAG 313 (422)
Q Consensus 305 w~~~P~~r~ 313 (422)
|+.+|..|.
T Consensus 213 l~~dp~~R~ 221 (237)
T cd05576 213 LQFNPTERL 221 (237)
T ss_pred ccCCHHHhc
Confidence 999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=288.89 Aligned_cols=259 Identities=25% Similarity=0.420 Sum_probs=202.2
Q ss_pred cccccccchhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC------HHhHHHHHHHHHHHhcCCC
Q psy7289 40 NQKTASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN------QKTASDFRREVDLMSELRH 113 (422)
Q Consensus 40 ~~~~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~il~~l~H 113 (422)
|..+...-.......+|-++..||+|||++||+|.... ..+.||||+-..+.+ ....+...+|.+|-+.|+|
T Consensus 449 NEdnSQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~--EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDH 526 (775)
T KOG1151|consen 449 NEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLT--EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDH 526 (775)
T ss_pred ccchhhhccCcchHHHHHHHHHhccccHHHHHHhcccc--hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCc
Confidence 33333333345667889999999999999999997653 346788887543322 1223566789999999999
Q ss_pred CceeeEeeEEE-cCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhC--Ccccc
Q psy7289 114 PNIVCLLGVCL-SGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSH--HYVHR 190 (422)
Q Consensus 114 pnIv~l~g~~~-~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~--~ivHr 190 (422)
|.||++|+++. +.+.+|-|+|||+|.||.-||+.+ ..+++.+++.|+-||+.||.||... .|||-
T Consensus 527 pRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQh------------klmSEKEARSIiMQiVnAL~YLNEikpPIIHY 594 (775)
T KOG1151|consen 527 PRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQH------------KLMSEKEARSIIMQIVNALKYLNEIKPPIIHY 594 (775)
T ss_pred ceeeeeeeeeeeccccceeeeeecCCCchhHHHHhh------------hhhhHHHHHHHHHHHHHHHHHHhccCCCeeee
Confidence 99999999985 667899999999999999999875 3589999999999999999999976 49999
Q ss_pred CCCCCceeecC---CCeEEEecCcccccccCCcc-----eEeccCCCCCccccCccccccC----CCCCchhHHhHHHHH
Q psy7289 191 DLAARNCLVGD---GLTVKISDFGLSRDVYASDY-----YRIQSKSLLPVRWMPPESILYG----KFTTESDVWSYGVVL 258 (422)
Q Consensus 191 DlKp~NiLl~~---~~~vKl~DFGla~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~----~~~~~~DvwS~Gvil 258 (422)
||||.||||.+ .|.+||+||||++.+..+.+ ...++...||..|++||++.-+ +++.|+||||.|||+
T Consensus 595 DLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIF 674 (775)
T KOG1151|consen 595 DLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIF 674 (775)
T ss_pred ccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhh
Confidence 99999999964 47899999999998865433 3456677889999999998755 478999999999999
Q ss_pred HHHHhCCCCCCCCCCh-HHHHHH--HHcCCC--CCCCCCCCcchhhhcccccccccchhh
Q psy7289 259 WEVYSYGLQPYYGYSN-QEVIEM--IRSRQM--LPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 259 ~El~t~g~~Pf~~~~~-~~~~~~--i~~~~~--~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
|.++ +|+.||...-. +++++. |..... .|.-+-++++..++|++|+...-..|.
T Consensus 675 yQCl-YGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~ 733 (775)
T KOG1151|consen 675 YQCL-YGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRI 733 (775)
T ss_pred hhhh-ccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhh
Confidence 9999 59999986543 344331 222222 232345778899999999986655554
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=279.92 Aligned_cols=269 Identities=22% Similarity=0.302 Sum_probs=203.7
Q ss_pred HHHHhhhhccccccccchhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHh-
Q psy7289 31 AIKTLKENANQKTASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMS- 109 (422)
Q Consensus 31 ~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~- 109 (422)
-++................+...+.++-+..||.|+||.|+|..++. .++..|||.++.....++.++++.|.....
T Consensus 41 ~lr~~s~g~l~~p~~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~--sg~~mAVKrIr~~n~~keq~rll~e~d~~mk 118 (361)
T KOG1006|consen 41 RLRSYSTGTLKLPDDAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKP--SGKLMAVKRIRSNNIEKEQKRLLMEHDTVMK 118 (361)
T ss_pred HHHHhccCceecCCcccccccccchHHHHHHhcCCcchhhhhhhcCc--cCcEEEEEEeeeccchHHHHHHHHHHHHHHh
Confidence 33433334333344444455666777888999999999999987654 458899999987777778889999998654
Q ss_pred cCCCCceeeEeeEEEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHh-CCcc
Q psy7289 110 ELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCS-HHYV 188 (422)
Q Consensus 110 ~l~HpnIv~l~g~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iv 188 (422)
.-+.||||++||++..+...++.||+|.- ||..+-+.-- ......+++.-+-.|+.....||+||-. ..||
T Consensus 119 s~~cp~IVkfyGa~F~EGdcWiCMELMd~-SlDklYk~vy-------~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiI 190 (361)
T KOG1006|consen 119 SSNCPNIVKFYGALFSEGDCWICMELMDI-SLDKLYKRVY-------SVQKSRIPENILGHITVATVDALDYLKEELKII 190 (361)
T ss_pred hcCCcHHHHHhhhhhcCCceeeeHHHHhh-hHHHHHHHHH-------HHHhccCcHhhhhheeeeehhHHHHHHHHhhhh
Confidence 45789999999999999999999999863 5544322100 0012358888888899999999999975 6899
Q ss_pred ccCCCCCceeecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccC--CCCCchhHHhHHHHHHHHHhCCC
Q psy7289 189 HRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG--KFTTESDVWSYGVVLWEVYSYGL 266 (422)
Q Consensus 189 HrDlKp~NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwS~Gvil~El~t~g~ 266 (422)
|||+||+||||+..|.+||||||++-.+..+-. .+...|-..|||||.+... .|+-+|||||||++|||+.| |.
T Consensus 191 HRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAt-G~ 266 (361)
T KOG1006|consen 191 HRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVAT-GN 266 (361)
T ss_pred hccCChhheEEecCCCEeeecccchHhHHHHHH---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeec-CC
Confidence 999999999999999999999999976654321 2223444569999998643 48999999999999999998 99
Q ss_pred CCCCCCCh-HHHHHHHHcCCCCC--CCCC---CCcchhhhcccccccccchhh
Q psy7289 267 QPYYGYSN-QEVIEMIRSRQMLP--CPED---CPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 267 ~Pf~~~~~-~~~~~~i~~~~~~~--~p~~---~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.||.+.+. .+.+.++..|..+- .+.+ .+..+..++..|+.++-..||
T Consensus 267 fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rp 319 (361)
T KOG1006|consen 267 FPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRP 319 (361)
T ss_pred CCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCc
Confidence 99998875 35555666665332 2333 567789999999999988887
|
|
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=254.35 Aligned_cols=212 Identities=29% Similarity=0.495 Sum_probs=179.4
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC-HHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN-QKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
.|.-+++||+|.||+||+|+.+ +..+.||+|.++...+ +..-..-++|+-+|+.|+|.|||+++++...+..+-+|+
T Consensus 3 ~ydkmekigegtygtvfkarn~--~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNR--ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccC--CccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 4566789999999999999865 4468899999875443 233456789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
|||.. +|..|..+- .+.+..+.++.++.|+++||.|+|+++++||||||.|.||+.+|.+|++|||++
T Consensus 81 e~cdq-dlkkyfdsl-----------ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfgla 148 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSL-----------NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLA 148 (292)
T ss_pred HHhhH-HHHHHHHhc-----------CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchh
Confidence 99964 787777543 246888999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcceEeccCCCCCccccCccccccCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~ 282 (422)
|...-.. +.-+....|..|.+|.++.+.+ |++..|+||-||++.|+...|.+-|.+.+..+.+.+|-
T Consensus 149 rafgipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif 216 (292)
T KOG0662|consen 149 RAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216 (292)
T ss_pred hhcCCce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHH
Confidence 8754332 2234556788999999988754 89999999999999999988999999988887777664
|
|
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=278.89 Aligned_cols=207 Identities=28% Similarity=0.423 Sum_probs=167.9
Q ss_pred cCcccccccccccceeEEEEEEecCCC--CeEEEEEEccCcCCH-HhHHHHHHHHHHHhcCCCCceeeEeeEEEc-CCCe
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEG--PSLVAIKTLKENANQ-KTASDFRREVDLMSELRHPNIVCLLGVCLS-GEPM 129 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~--~~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 129 (422)
..|+.+..||+|.||.||+|...+++. ...+|+|.++...+. .....-.||+.+++.|+||||+.|..++.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 357788999999999999997666655 348999999765332 223566799999999999999999999987 6789
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC----CeE
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG----LTV 205 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~----~~v 205 (422)
++++||.+. ||.+.++-++... ...++...+..++.||+.|+.|||++-|+||||||.|||+..+ |.|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~-------~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASK-------AKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccch-------hccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCee
Confidence 999999987 8999887653211 1358889999999999999999999999999999999999877 899
Q ss_pred EEecCcccccccCCcceE-eccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCC
Q psy7289 206 KISDFGLSRDVYASDYYR-IQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPY 269 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf 269 (422)
||+|||++|...+.-..- .......|..|.|||.+.+. .|+.+.||||.|||+.||+| -.+-|
T Consensus 176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLt-l~PlF 240 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLT-LEPLF 240 (438)
T ss_pred EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHc-cCccc
Confidence 999999999765432111 12234558899999998875 58999999999999999997 33334
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=281.95 Aligned_cols=241 Identities=29% Similarity=0.461 Sum_probs=193.2
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEE
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFE 134 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E 134 (422)
|++.+.||+|+||.||+|+...+ +..+|+|.+.... .....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKT--GEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCC--CcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEec
Confidence 45678899999999999987543 5679999886543 23334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccc
Q psy7289 135 FMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR 214 (422)
Q Consensus 135 ~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~ 214 (422)
|++ ++|.+++.... ..+++..+..++.|++.||+|||+++|+||||+|+||++++++.+||+|||+++
T Consensus 79 ~~~-~~l~~~i~~~~-----------~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~ 146 (282)
T cd07829 79 YCD-MDLKKYLDKRP-----------GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLAR 146 (282)
T ss_pred CcC-cCHHHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCccc
Confidence 998 59999997642 258899999999999999999999999999999999999999999999999997
Q ss_pred cccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC-------
Q psy7289 215 DVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM------- 286 (422)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~------- 286 (422)
....... .......+..|+|||.+... .++.++|||||||++|||++ |.+||.+.+..+.+..+.....
T Consensus 147 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (282)
T cd07829 147 AFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMIT-GKPLFPGDSEIDQLFKIFQILGTPTEESW 223 (282)
T ss_pred ccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHHHhCCCcHHHH
Confidence 6543221 11223345679999998766 78999999999999999998 8899988776655444322100
Q ss_pred ------------CC-C--------CCCCCcchhhhcccccccccchhh
Q psy7289 287 ------------LP-C--------PEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 287 ------------~~-~--------p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.+ . .+..+..+.+++++||..+|..|+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp 271 (282)
T cd07829 224 PGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRI 271 (282)
T ss_pred HhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCC
Confidence 00 0 012366789999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=273.91 Aligned_cols=253 Identities=23% Similarity=0.359 Sum_probs=194.8
Q ss_pred ccc-ccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC-CCceeeEeeEEEcCCCeEEEE
Q psy7289 56 PRF-LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR-HPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 56 ~~~-~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~lv~ 133 (422)
|++ .+.||+|+|+.|--+.... .+..+|||++.+.. .-...+..||++++...+ |+||++|+++|.++..+|+||
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~--t~~EYAVKiidKq~-gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf 155 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQ--TGKEYAVKIIDKQP-GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF 155 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeec--cchhhhhhhhhcCC-chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence 444 3579999999998776543 35779999997653 335677889999999985 999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC---eEEEecC
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL---TVKISDF 210 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~---~vKl~DF 210 (422)
|-|.||+|...|.++ ..+++.++.++..+|+.||.|||.+||.||||||+|||-.+.. -||||||
T Consensus 156 EKm~GGplLshI~~~------------~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQKR------------KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred ecccCchHHHHHHHh------------hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecc
Confidence 999999999999876 3699999999999999999999999999999999999987554 4899999
Q ss_pred cccccccCCcceE-----eccCCCCCccccCccccc-----cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCC-------
Q psy7289 211 GLSRDVYASDYYR-----IQSKSLLPVRWMPPESIL-----YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS------- 273 (422)
Q Consensus 211 Gla~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~------- 273 (422)
.|...+..+.... ...+..|+..|||||+.. ...|+.++|.||||||+|-|++ |.+||.|.=
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLs-GYpPFvG~Cg~dCGWd 302 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLS-GYPPFVGHCGADCGWD 302 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHh-CCCCccCccCCcCCcc
Confidence 9876543222111 112344566799999764 2358999999999999999998 999998642
Q ss_pred --------hHHHHHHHHcCCCCCCCC----CCCcchhhhcccccccccchhhHH-HHhhhhhhhh
Q psy7289 274 --------NQEVIEMIRSRQMLPCPE----DCPPRMYSLMMECWHEVPVAAGMA-YLCSHHYVHR 325 (422)
Q Consensus 274 --------~~~~~~~i~~~~~~~~p~----~~p~~~~~l~~~cw~~~P~~r~~~-~lh~~~~i~~ 325 (422)
.+.+.+.|..|.. .+|+ ..+.+..+|+...+-.++..|-.+ ....|+++.+
T Consensus 303 rGe~Cr~CQ~~LFesIQEGkY-eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~ 366 (463)
T KOG0607|consen 303 RGEVCRVCQNKLFESIQEGKY-EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQR 366 (463)
T ss_pred CCCccHHHHHHHHHHHhccCC-cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccc
Confidence 2356777877763 4443 356667777777777777665321 1224455544
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=314.58 Aligned_cols=242 Identities=25% Similarity=0.380 Sum_probs=184.8
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC--------
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG-------- 126 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-------- 126 (422)
+++.++.||+||||.|||++.+- +++.+|||++....+......+.+|+.+|++|+|||||+++..+.+.
T Consensus 480 DFEEL~lLGkGGFG~VvkVRNKl--DGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 480 DFEELELLGKGGFGSVVKVRNKL--DGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhHHHHHhcCCCCceEEEEeecc--cchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 45667899999999999988654 46789999998766666777899999999999999999988654210
Q ss_pred --------------------------------------------------------------------------------
Q psy7289 127 -------------------------------------------------------------------------------- 126 (422)
Q Consensus 127 -------------------------------------------------------------------------------- 126 (422)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred -------------------------------CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHH
Q psy7289 127 -------------------------------EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQV 175 (422)
Q Consensus 127 -------------------------------~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 175 (422)
..+||-||||+.-.|.+++....... ....++++++||
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-----------~~d~~wrLFreI 706 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-----------QRDEAWRLFREI 706 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-----------hhHHHHHHHHHH
Confidence 12477788888877777776532100 256789999999
Q ss_pred HHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccccccc----C------------CcceEeccCCCCCccccCccc
Q psy7289 176 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVY----A------------SDYYRIQSKSLLPVRWMPPES 239 (422)
Q Consensus 176 ~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~----~------------~~~~~~~~~~~~t~~y~aPE~ 239 (422)
+.||.|+|++|||||||||.||+|+++..|||+|||+|.... . .......+...||.-|+|||+
T Consensus 707 lEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 707 LEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 999999999999999999999999999999999999998621 0 001112345678889999999
Q ss_pred cccC---CCCCchhHHhHHHHHHHHHhCCCCCCCC-CChHHHHHHHHcCCCCCCCCCC----Ccchhhhcccccccccch
Q psy7289 240 ILYG---KFTTESDVWSYGVVLWEVYSYGLQPYYG-YSNQEVIEMIRSRQMLPCPEDC----PPRMYSLMMECWHEVPVA 311 (422)
Q Consensus 240 ~~~~---~~~~~~DvwS~Gvil~El~t~g~~Pf~~-~~~~~~~~~i~~~~~~~~p~~~----p~~~~~l~~~cw~~~P~~ 311 (422)
+... .|+.|+|+||+|||++||+ .||.. +.-..++..++.+.. |.|++. -+.-..+++..++.||..
T Consensus 787 l~~~~~~~Yn~KiDmYSLGIVlFEM~----yPF~TsMERa~iL~~LR~g~i-P~~~~f~~~~~~~e~slI~~Ll~hdP~k 861 (1351)
T KOG1035|consen 787 LSDTSSNKYNSKIDMYSLGIVLFEML----YPFGTSMERASILTNLRKGSI-PEPADFFDPEHPEEASLIRWLLSHDPSK 861 (1351)
T ss_pred hcccccccccchhhhHHHHHHHHHHh----ccCCchHHHHHHHHhcccCCC-CCCcccccccchHHHHHHHHHhcCCCcc
Confidence 8765 4999999999999999998 37653 233456777775554 333222 223467888889999988
Q ss_pred hhH
Q psy7289 312 AGM 314 (422)
Q Consensus 312 r~~ 314 (422)
||-
T Consensus 862 RPt 864 (1351)
T KOG1035|consen 862 RPT 864 (1351)
T ss_pred CCC
Confidence 873
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=274.42 Aligned_cols=247 Identities=16% Similarity=0.328 Sum_probs=203.4
Q ss_pred hhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcC-CCCceeeEeeEEE
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSEL-RHPNIVCLLGVCL 124 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~ 124 (422)
.+.+-..++++++.||+|+|++|..++++.+ .+.+|+|++++.. +.....-...|..+..+- +||.+|.++.+|+
T Consensus 244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t--~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq 321 (593)
T KOG0695|consen 244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKT--DQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ 321 (593)
T ss_pred ccccccccceeeeeecCcchhhhhheehccc--ceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc
Confidence 3445556788999999999999999988765 4789999987543 222334455677777665 7999999999999
Q ss_pred cCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCe
Q psy7289 125 SGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLT 204 (422)
Q Consensus 125 ~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~ 204 (422)
++..+++|.||++||+|.-.+++. ..++++.++.+..+|+.||.|||++|||.||||..||||+..|+
T Consensus 322 tesrlffvieyv~ggdlmfhmqrq------------rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaegh 389 (593)
T KOG0695|consen 322 TESRLFFVIEYVNGGDLMFHMQRQ------------RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGH 389 (593)
T ss_pred ccceEEEEEEEecCcceeeehhhh------------hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCc
Confidence 999999999999999998766542 46999999999999999999999999999999999999999999
Q ss_pred EEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCC--C-----CChHHH
Q psy7289 205 VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYY--G-----YSNQEV 277 (422)
Q Consensus 205 vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~--~-----~~~~~~ 277 (422)
+||+|+|+++....+. ..+++..|||.|+|||.+++..|...+|+|++||+++||++ |+.||. + .+.++.
T Consensus 390 ikltdygmcke~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemma-grspfdivgm~n~d~ntedy 466 (593)
T KOG0695|consen 390 IKLTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMA-GRSPFDIVGMDNPDMNTEDY 466 (593)
T ss_pred eeecccchhhcCCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHc-CCCCcceecCCCcccchhHH
Confidence 9999999998654433 34677889999999999999999999999999999999998 999995 2 233343
Q ss_pred H-HHHHcCCCCCCCCCCCcchhhhcccccccccchh
Q psy7289 278 I-EMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAA 312 (422)
Q Consensus 278 ~-~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r 312 (422)
+ +.|..+ ...+|...+-....+++.-+++||..|
T Consensus 467 lfqvilek-qiriprslsvkas~vlkgflnkdp~er 501 (593)
T KOG0695|consen 467 LFQVILEK-QIRIPRSLSVKASHVLKGFLNKDPKER 501 (593)
T ss_pred HHHHHhhh-cccccceeehhhHHHHHHhhcCCcHHh
Confidence 3 344443 355677777777888888999999765
|
|
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=290.43 Aligned_cols=233 Identities=25% Similarity=0.441 Sum_probs=190.9
Q ss_pred Cccc--ccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 55 KPRF--LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 55 ~~~~--~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
-|++ -+.||+|.||+||-|+++.+ ++.||||++.+. ...+....+++|+.||.+++||.||.+--.|.+.+.+++
T Consensus 563 vYQif~devLGSGQFG~VYgg~hRkt--GrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFV 640 (888)
T KOG4236|consen 563 VYQIFADEVLGSGQFGTVYGGKHRKT--GRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFV 640 (888)
T ss_pred HHHhhhHhhccCCcceeeecceeccc--CceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEE
Confidence 3444 36899999999999998765 467999999654 344556788999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC---CeEEEe
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG---LTVKIS 208 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~---~~vKl~ 208 (422)
|||-+ +||..+.+.... .+.|+++....+..||+.||.|||-++|+|+||||+||||.+. -.+|||
T Consensus 641 VMEKl-~GDMLEMILSsE----------kgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlC 709 (888)
T KOG4236|consen 641 VMEKL-HGDMLEMILSSE----------KGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLC 709 (888)
T ss_pred Eehhh-cchHHHHHHHhh----------cccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeec
Confidence 99988 467777765532 2569999999999999999999999999999999999999754 379999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP 288 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 288 (422)
|||+||.+.+... .....|||.|+|||+++...|+..-|+||.|||+|--++ |..||... +++-++|.+...+-
T Consensus 710 DFGfARiIgEksF---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLS-GTFPFNEd--EdIndQIQNAaFMy 783 (888)
T KOG4236|consen 710 DFGFARIIGEKSF---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLS-GTFPFNED--EDINDQIQNAAFMY 783 (888)
T ss_pred cccceeecchhhh---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEec-ccccCCCc--cchhHHhhcccccc
Confidence 9999998876543 446788999999999999999999999999999999998 99999643 46667777665443
Q ss_pred CC---CCCCcchhhhcccccc
Q psy7289 289 CP---EDCPPRMYSLMMECWH 306 (422)
Q Consensus 289 ~p---~~~p~~~~~l~~~cw~ 306 (422)
.| ...++...+||...++
T Consensus 784 Pp~PW~eis~~AidlIn~LLq 804 (888)
T KOG4236|consen 784 PPNPWSEISPEAIDLINNLLQ 804 (888)
T ss_pred CCCchhhcCHHHHHHHHHHHH
Confidence 33 2455666677765553
|
|
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=293.66 Aligned_cols=236 Identities=21% Similarity=0.387 Sum_probs=190.3
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
.+-+..++.||-|+||+|.+++-.++ ...+|+|.+++.. ...+..+...|-.||..-+.+-||+||-.|.+.+.+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT--~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDT--RALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecch--hhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 34455678899999999999875444 5789999986432 2344567788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+||||++|||+..+|.+. +.|.|..++.++.++..|+++.|..|+|||||||+|||||.+|++||+||
T Consensus 706 FVMdYIPGGDmMSLLIrm------------gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDF 773 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRM------------GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDF 773 (1034)
T ss_pred EEEeccCCccHHHHHHHh------------ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeec
Confidence 999999999999999764 46899999999999999999999999999999999999999999999999
Q ss_pred ccccccc---CCcceE-------------------------------------eccCCCCCccccCccccccCCCCCchh
Q psy7289 211 GLSRDVY---ASDYYR-------------------------------------IQSKSLLPVRWMPPESILYGKFTTESD 250 (422)
Q Consensus 211 Gla~~~~---~~~~~~-------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~D 250 (422)
||+.-+. .+.+|. ....-.||+.|+|||++....|+..+|
T Consensus 774 GLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cd 853 (1034)
T KOG0608|consen 774 GLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCD 853 (1034)
T ss_pred cccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccch
Confidence 9985321 111111 011235688999999999999999999
Q ss_pred HHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc-CCCCCCC--CCCCcchhhhccc
Q psy7289 251 VWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS-RQMLPCP--EDCPPRMYSLMME 303 (422)
Q Consensus 251 vwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~-~~~~~~p--~~~p~~~~~l~~~ 303 (422)
+||.|||||||+. |.+||...++.+...+|.+ +..+.+| .+.+++..+||++
T Consensus 854 wws~gvil~em~~-g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~k 908 (1034)
T KOG0608|consen 854 WWSVGVILYEMLV-GQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQK 908 (1034)
T ss_pred hhHhhHHHHHHhh-CCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHH
Confidence 9999999999996 9999999888776555543 2233333 3556666666654
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=254.55 Aligned_cols=228 Identities=23% Similarity=0.340 Sum_probs=183.1
Q ss_pred hhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhc-CCCCceeeEeeEEEcCC
Q psy7289 49 REVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSE-LRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 49 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~-l~HpnIv~l~g~~~~~~ 127 (422)
.++.++.+.-+..||+|++|.|-+-++.. ++...|+|.++...+.+...+.++|+.+..+ ...|.+|.+||......
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~--sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQ--SGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeecc--CCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 56777888888999999999998876654 4688999999877777777888999987554 57999999999998889
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeecCCCeEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSH-HYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~ivHrDlKp~NiLl~~~~~vK 206 (422)
.+++.||.|.. ||..+-.+--.+ ...+++.-+-+|+..+..||.|||++ .+||||+||+||||+.+|.||
T Consensus 119 dvwIcME~M~t-Sldkfy~~v~~~--------g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVK 189 (282)
T KOG0984|consen 119 DVWICMELMDT-SLDKFYRKVLKK--------GGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVK 189 (282)
T ss_pred cEEEeHHHhhh-hHHHHHHHHHhc--------CCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEE
Confidence 99999999864 777665432111 24688999999999999999999985 799999999999999999999
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCcccccc----CCCCCchhHHhHHHHHHHHHhCCCCCCCC-CChHHHHHHH
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY----GKFTTESDVWSYGVVLWEVYSYGLQPYYG-YSNQEVIEMI 281 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~DvwS~Gvil~El~t~g~~Pf~~-~~~~~~~~~i 281 (422)
+||||++-.+..+-.... ..|--.|||||.+.. ..|+-+|||||||+++.||.+ ++.||.. .++.+.+.++
T Consensus 190 iCDFGIsG~L~dSiAkt~---daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~-lr~PY~~w~tpF~qLkqv 265 (282)
T KOG0984|consen 190 ICDFGISGYLVDSIAKTM---DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAI-LRFPYESWGTPFQQLKQV 265 (282)
T ss_pred EcccccceeehhhhHHHH---hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhh-ccccccccCCHHHHHHHH
Confidence 999999976554322111 223346999998863 369999999999999999998 8999975 4677888888
Q ss_pred HcCCCCCCCC
Q psy7289 282 RSRQMLPCPE 291 (422)
Q Consensus 282 ~~~~~~~~p~ 291 (422)
.....+..|.
T Consensus 266 Veep~P~Lp~ 275 (282)
T KOG0984|consen 266 VEEPSPQLPA 275 (282)
T ss_pred hcCCCCCCcc
Confidence 7765554443
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=292.00 Aligned_cols=242 Identities=24% Similarity=0.386 Sum_probs=196.4
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCCeEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~l 131 (422)
...|.+...+|.|+|+.|-.+....++ ...+||++.+... +-.+|+.++... +||||+++.+++.++...|+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~--~~~~vkii~~~~~-----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTD--QEPAVKIISKRAD-----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred chhhccccccCCCCccceeeeeccccc--cchhheecccccc-----ccccccchhhhhcCCCcceeecceecCCceeee
Confidence 346777888999999999988766554 5688998865522 223577666665 69999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceee-cCCCeEEEecC
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDF 210 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl-~~~~~vKl~DF 210 (422)
|||++.+|.|.+.+... +....++..|+.||+.|+.|||++|||||||||+|||+ ++.++++|+||
T Consensus 394 v~e~l~g~ell~ri~~~-------------~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyF 460 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSK-------------PEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYF 460 (612)
T ss_pred eehhccccHHHHHHHhc-------------chhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEe
Confidence 99999999988877653 12226778899999999999999999999999999999 68899999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChH-HHHHHHHcCCCCCC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ-EVIEMIRSRQMLPC 289 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~-~~~~~i~~~~~~~~ 289 (422)
|.++..... ..+...|..|.|||++....|+.++|+||||++||||++ |..||.....+ ++..+|..+. .
T Consensus 461 G~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~-G~tp~~~~P~~~ei~~~i~~~~---~ 531 (612)
T KOG0603|consen 461 GFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLT-GRTLFAAHPAGIEIHTRIQMPK---F 531 (612)
T ss_pred chhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCccccCCchHHHHHhhcCCc---c
Confidence 999876443 223456788999999999999999999999999999999 99999877766 6776665443 2
Q ss_pred CCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 290 PEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 290 p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
-...+.+.++|++.|++.+|..|. +.-+..|.++
T Consensus 532 s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 532 SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 367889999999999999999885 3333334444
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=321.94 Aligned_cols=238 Identities=22% Similarity=0.355 Sum_probs=183.2
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEe
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEF 135 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~ 135 (422)
+...+.||+|+||.||+|+... .+..||||.++..... ..+|++++++++|||||+++|+|.+.+..++||||
T Consensus 692 ~~~~~~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 692 LKEENVISRGKKGASYKGKSIK--NGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred CCcccEEccCCCeeEEEEEECC--CCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 4456789999999999998744 3467999988643221 13468899999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 136 MVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLC---SHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 136 ~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH---~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
+++|+|.++++. +++.++.+++.|++.||+||| +.+|+||||||+||+++.++.+++. ||.
T Consensus 765 ~~~g~L~~~l~~---------------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~ 828 (968)
T PLN00113 765 IEGKNLSEVLRN---------------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL 828 (968)
T ss_pred CCCCcHHHHHhc---------------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecc
Confidence 999999999942 678889999999999999999 6699999999999999998888875 666
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh--HHHHHHHH---cC---
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN--QEVIEMIR---SR--- 284 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~--~~~~~~i~---~~--- 284 (422)
+..... .....+|+.|||||++....++.++|||||||++|||+| |..||..... ..+..... ..
T Consensus 829 ~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 901 (968)
T PLN00113 829 PGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLT-GKSPADAEFGVHGSIVEWARYCYSDCHL 901 (968)
T ss_pred cccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCCCcHHHHHHHhcCccch
Confidence 543221 122356789999999998899999999999999999999 8899853221 11111111 00
Q ss_pred -----CCC----CCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 285 -----QML----PCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 285 -----~~~----~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
... +.+.....++.+++.+||+.+|..|+ ++..+.+.|+
T Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~~L~ 949 (968)
T PLN00113 902 DMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP-----CANDVLKTLE 949 (968)
T ss_pred hheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCc-----CHHHHHHHHH
Confidence 000 11112233567899999999999999 7777766554
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=297.67 Aligned_cols=331 Identities=25% Similarity=0.379 Sum_probs=242.6
Q ss_pred hhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC
Q psy7289 49 REVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP 128 (422)
Q Consensus 49 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 128 (422)
+.-+..+|+++..+|+|+||.|||++...+ ++.+|||+++..... ..+-...|+-+++..+|||||.++|.+...+.
T Consensus 10 rrnP~ddyellqrvgsgTygdvyKaRd~~s--~elaavkvVkLep~d-d~~~iqqei~~~~dc~h~nivay~gsylr~dk 86 (829)
T KOG0576|consen 10 RRNPQDDYELLQRVGSGTYGDVYKARDKRS--GELAAVKVVKLEPGD-DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK 86 (829)
T ss_pred hcCCccchhheeeecCCcccchhhhccccc--CchhhheeeeccCCc-cccccccceeeeecCCCcChHHHHhhhhhhcC
Confidence 335677899999999999999999987654 578999998765432 34456789999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
+++.||||.+|+|.+.-+. .+++++.++..+.++.+.||+|||+.|=+|||||-.|||+++.+.+|++
T Consensus 87 lwicMEycgggslQdiy~~------------TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvkla 154 (829)
T KOG0576|consen 87 LWICMEYCGGGSLQDIYHV------------TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLA 154 (829)
T ss_pred cEEEEEecCCCcccceeee------------cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeec
Confidence 9999999999999886543 3579999999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccc---cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH-cC
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL---YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR-SR 284 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~-~~ 284 (422)
|||.+-.....- .......||+.|||||+.. .+.|...+|||+.|++..|+-. -.+|..+..++..+..+. ++
T Consensus 155 Dfgvsaqitati--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~e-Lqpplfdlhpmr~l~LmTkS~ 231 (829)
T KOG0576|consen 155 DFGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGE-LQPPLFDLHPMRALFLMTKSG 231 (829)
T ss_pred ccCchhhhhhhh--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhh-cCCcccccchHHHHHHhhccC
Confidence 999987654322 2334567899999999864 4579999999999999999875 567777766665554443 33
Q ss_pred CCCC---CCCCCCcchhhhcccccccccchhh------------------------------------------------
Q psy7289 285 QMLP---CPEDCPPRMYSLMMECWHEVPVAAG------------------------------------------------ 313 (422)
Q Consensus 285 ~~~~---~p~~~p~~~~~l~~~cw~~~P~~r~------------------------------------------------ 313 (422)
..+| .+....+.+.++++.|+.++|..|+
T Consensus 232 ~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 232 FQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred CCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 3322 2334555666677777666665443
Q ss_pred -------------------------------------HHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcc
Q psy7289 314 -------------------------------------MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDY 356 (422)
Q Consensus 314 -------------------------------------~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~ 356 (422)
++++|+-.-+|+| |++..+ ...|..||+....+...
T Consensus 312 ~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~-- 384 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT-- 384 (829)
T ss_pred hhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcc--
Confidence 2222222222222 222221 23444555554332211
Q ss_pred eeeccccCCCcccCCccccccCCCCcchhHHHHHHHHHHHHhcCCCCCCC
Q psy7289 357 YRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG 406 (422)
Q Consensus 357 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~~~g~~p~~~ 406 (422)
. .......+..|+|||++..+.++...|+||.|+--.++.. |..|--.
T Consensus 385 ~-~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap-~~pPr~~ 432 (829)
T KOG0576|consen 385 M-KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAP-GLPPRSS 432 (829)
T ss_pred c-ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCC-CCCCCCC
Confidence 1 1222334567999999999999999999999987777753 6666533
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=292.09 Aligned_cols=256 Identities=21% Similarity=0.424 Sum_probs=205.0
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEc-----
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVCLS----- 125 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~----- 125 (422)
....+++.+.||.|.+|.||+++.+..+ +.+|+|++....+ ..++...|.++|+.+ .|||++.++|++..
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~--~~aa~kI~~~~~d--~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTG--QLAAIKIMDPTED--EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecC--ceeeeEeecCCcc--ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 3456788999999999999999877654 5577777654332 234566788899888 59999999999863
Q ss_pred CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 126 GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 126 ~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
++.+++|||||.+|+..|+++... ...+.|..+..|++.++.||.+||.+.++|||+|-.|||++.++.|
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~----------g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTK----------GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhc----------ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcE
Confidence 457999999999999999997643 2468999999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCccccccC-----CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHH
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-----KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEM 280 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~ 280 (422)
||+|||++.++.... ....+..||+.|||||++... .|+..+|+||||++..||.. |.+|+.++.+.-.+-.
T Consensus 163 KLvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIElad-G~PPl~DmHPmraLF~ 239 (953)
T KOG0587|consen 163 KLVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAE-GAPPLCDMHPMRALFL 239 (953)
T ss_pred EEeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcC-CCCCccCcchhhhhcc
Confidence 999999998765432 344567889999999999754 37789999999999999986 9999999887766655
Q ss_pred HHcCCCCC--CCCCCCcchhhhcccccccccchhhHH-HHhhhhhhh
Q psy7289 281 IRSRQMLP--CPEDCPPRMYSLMMECWHEVPVAAGMA-YLCSHHYVH 324 (422)
Q Consensus 281 i~~~~~~~--~p~~~p~~~~~l~~~cw~~~P~~r~~~-~lh~~~~i~ 324 (422)
|...+.+. .|+....++-++|..|+.++-..|+.. .|..|.++.
T Consensus 240 IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 240 IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 54332221 256677788999999999998888743 344444443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=256.44 Aligned_cols=230 Identities=30% Similarity=0.484 Sum_probs=192.1
Q ss_pred cceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEecCCCCHHHHH
Q psy7289 66 AFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFL 145 (422)
Q Consensus 66 ~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~~~G~L~~~l 145 (422)
+||.||+|++.. ++..+++|.+.........+.+.+|++.+++++|+||+++++.+......++++||+++++|.+++
T Consensus 1 ~~g~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKK--TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECC--CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999998754 346799999865443322678999999999999999999999999989999999999999999998
Q ss_pred hhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccccCCcceEec
Q psy7289 146 MSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQ 225 (422)
Q Consensus 146 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~~~~~~~~ 225 (422)
.... .++...+..++.+++.++.|||+.+++|+||+|+||++++++.++|+|||++....... ..
T Consensus 79 ~~~~------------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~ 143 (244)
T smart00220 79 KKRG------------RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LL 143 (244)
T ss_pred Hhcc------------CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---cc
Confidence 6531 27888999999999999999999999999999999999999999999999997654332 12
Q ss_pred cCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCC-CChHHHHHHHHcCCCCCCCCC--CCcchhhhcc
Q psy7289 226 SKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG-YSNQEVIEMIRSRQMLPCPED--CPPRMYSLMM 302 (422)
Q Consensus 226 ~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~-~~~~~~~~~i~~~~~~~~p~~--~p~~~~~l~~ 302 (422)
....++..|+|||.+....++.++||||||+++||+++ |..||.. .+...+...+..+.....+.. ++.++.+++.
T Consensus 144 ~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 222 (244)
T smart00220 144 TTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLT-GKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIR 222 (244)
T ss_pred ccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHH
Confidence 23445678999999988889999999999999999998 8899987 555566666655544433332 8899999999
Q ss_pred cccccccchhh
Q psy7289 303 ECWHEVPVAAG 313 (422)
Q Consensus 303 ~cw~~~P~~r~ 313 (422)
+||..+|..|+
T Consensus 223 ~~l~~~p~~Rp 233 (244)
T smart00220 223 KLLVKDPEKRL 233 (244)
T ss_pred HHccCCchhcc
Confidence 99999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=257.93 Aligned_cols=216 Identities=25% Similarity=0.475 Sum_probs=172.7
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEcc-CcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC----
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG---- 126 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~-~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~---- 126 (422)
..+.|+-+.+||+|.||+||+|+...+ ++.||+|++- .+.....-..-++|+++|..|.|+|++.++++|...
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~--~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNT--GKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCc--cchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 345677788999999999999986544 3457877642 222222223457899999999999999999988532
Q ss_pred ----CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC
Q psy7289 127 ----EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG 202 (422)
Q Consensus 127 ----~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~ 202 (422)
..+|+||.+|++ ||.-.|..+. ..++..++.+++.++..||.|+|+..|+|||+||+|+||+.+
T Consensus 93 ~r~r~t~ylVf~~ceh-DLaGlLsn~~-----------vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~d 160 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCEH-DLAGLLSNRK-----------VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKD 160 (376)
T ss_pred ccccceeeeeHHHhhh-hHHHHhcCcc-----------ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCC
Confidence 248999999987 8888886542 358889999999999999999999999999999999999999
Q ss_pred CeEEEecCcccccccCCcceE--eccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHH
Q psy7289 203 LTVKISDFGLSRDVYASDYYR--IQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIE 279 (422)
Q Consensus 203 ~~vKl~DFGla~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~ 279 (422)
+.+||+|||++|....++... .-+....|+.|.+||.+.+. .|+++.|||..|||+.||++ +.+-+.+.++++.+.
T Consensus 161 gilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwt-rspimqgnteqqql~ 239 (376)
T KOG0669|consen 161 GILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWT-RSPIMQGNTEQQQLH 239 (376)
T ss_pred ceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHc-cCccccCChHHHHHH
Confidence 999999999998664333211 11234568899999998864 69999999999999999998 888888888888777
Q ss_pred HHH
Q psy7289 280 MIR 282 (422)
Q Consensus 280 ~i~ 282 (422)
.|.
T Consensus 240 ~Is 242 (376)
T KOG0669|consen 240 LIS 242 (376)
T ss_pred HHH
Confidence 664
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=275.82 Aligned_cols=272 Identities=19% Similarity=0.240 Sum_probs=182.9
Q ss_pred hccccCcccccccccccceeEEEEEEecC--------------CCCeEEEEEEccCcCCHHhHHH--------------H
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTS--------------EGPSLVAIKTLKENANQKTASD--------------F 101 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~--------------~~~~~vavK~~~~~~~~~~~~~--------------~ 101 (422)
.+...+|++.++||+|+||.||+|.+... ..+..||||.++.... ...++ +
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~-~~~~~fl~e~~~~~~~~e~~ 219 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQ-GVRQDFLKTGTLAKGSAETG 219 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccch-hhHHHHHhhhhhhhcccchh
Confidence 34566889999999999999999975321 2345799999864321 11222 3
Q ss_pred HHHHHHHhcCCCCce-----eeEeeEEEc--------CCCeEEEEEecCCCCHHHHHhhcCCCCC------------CCC
Q psy7289 102 RREVDLMSELRHPNI-----VCLLGVCLS--------GEPMCMLFEFMVRGDLHEFLMSRSPRSD------------ISG 156 (422)
Q Consensus 102 ~~E~~il~~l~HpnI-----v~l~g~~~~--------~~~~~lv~E~~~~G~L~~~l~~~~~~~~------------~~~ 156 (422)
..|+..+.+++|.|+ ++++++|.. ....++||||+++|+|.++|........ ...
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 447777777876654 677777653 3468999999999999999975321100 000
Q ss_pred CCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccccCCcceEeccCCCCCccccC
Q psy7289 157 SQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 236 (422)
Q Consensus 157 ~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~a 236 (422)
......+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++........ ......+++.|+|
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 011124567788999999999999999999999999999999999999999999999765432211 1112334789999
Q ss_pred ccccccCC--------------------C--CCchhHHhHHHHHHHHHhCCCCCCCCCChH--HH---------HHHHHc
Q psy7289 237 PESILYGK--------------------F--TTESDVWSYGVVLWEVYSYGLQPYYGYSNQ--EV---------IEMIRS 283 (422)
Q Consensus 237 PE~~~~~~--------------------~--~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~--~~---------~~~i~~ 283 (422)
||.+.... + ..+.||||+||++|||++....||.+.... +. ...+..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99876432 1 134799999999999998444577643211 11 111111
Q ss_pred -CCCCCCCCCCCcchhhhcccccccccc----hhhHHHHhhhhhh
Q psy7289 284 -RQMLPCPEDCPPRMYSLMMECWHEVPV----AAGMAYLCSHHYV 323 (422)
Q Consensus 284 -~~~~~~p~~~p~~~~~l~~~cw~~~P~----~r~~~~lh~~~~i 323 (422)
....+....+++..++|+.+++..+|. +..+..+.+|.++
T Consensus 459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f 503 (507)
T PLN03224 459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFF 503 (507)
T ss_pred cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCc
Confidence 112223345678889999999987763 2244455556554
|
|
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-33 Score=258.22 Aligned_cols=206 Identities=25% Similarity=0.398 Sum_probs=171.5
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC-C-Cc----eeeEeeEE
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR-H-PN----IVCLLGVC 123 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-H-pn----Iv~l~g~~ 123 (422)
.....+|.+++.+|+|.||.|.++.+..+ ...||||+++.-. +..++-+-|+++|.+|. + || +|.+.++|
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~--~~~vAlKIik~V~--kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRET--KEHVALKIIKNVD--KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCC--CceehHHHHHHHH--HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 44567899999999999999999876544 6789999987532 33456677999999994 3 43 88898999
Q ss_pred EcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC--
Q psy7289 124 LSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD-- 201 (422)
Q Consensus 124 ~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~-- 201 (422)
.-.++.|+|+|.+ |-|++++|.++. ..+++..+++.++.|++.+++|||+.+++|-||||+|||+.+
T Consensus 161 dyrghiCivfell-G~S~~dFlk~N~----------y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~ 229 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKENN----------YIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSE 229 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhccCC----------ccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccc
Confidence 9999999999987 449999998753 357899999999999999999999999999999999999842
Q ss_pred ------------------CCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHh
Q psy7289 202 ------------------GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYS 263 (422)
Q Consensus 202 ------------------~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t 263 (422)
+..+||+|||.|+...+.. +....|..|.|||++.+-.++.++||||+||||+|+++
T Consensus 230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Elyt 304 (415)
T KOG0671|consen 230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYT 304 (415)
T ss_pred eEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeec
Confidence 2358999999998654432 33345678999999999999999999999999999998
Q ss_pred CCCCCCCCCChHH
Q psy7289 264 YGLQPYYGYSNQE 276 (422)
Q Consensus 264 ~g~~Pf~~~~~~~ 276 (422)
|..-|+.-++.|
T Consensus 305 -G~~LFqtHen~E 316 (415)
T KOG0671|consen 305 -GETLFQTHENLE 316 (415)
T ss_pred -cceecccCCcHH
Confidence 988888777766
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=240.07 Aligned_cols=220 Identities=32% Similarity=0.489 Sum_probs=180.5
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEe
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEF 135 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~ 135 (422)
|++.+.||+|++|.||++.... .+..+++|...........+.+.+|++.+++++|+||+++++.+......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKG--TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcC--CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 3567889999999999998754 24679999987543332567889999999999999999999999988999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccccc
Q psy7289 136 MVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRD 215 (422)
Q Consensus 136 ~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~ 215 (422)
+++++|.+++.... ..+++..+..++.|++.++.|||+++++|+||+|+||+++.++.++|+|||++..
T Consensus 79 ~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~ 147 (225)
T smart00221 79 CEGGDLFDYLRKKG-----------GKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARF 147 (225)
T ss_pred cCCCCHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeE
Confidence 99999999997532 1178889999999999999999999999999999999999999999999999876
Q ss_pred ccCCcceEeccCCCCCccccCcccc-ccCCCCCchhHHhHHHHHHHHHhCCCCCCCC-CChH-HHHHHHHcCCCCCCC
Q psy7289 216 VYASDYYRIQSKSLLPVRWMPPESI-LYGKFTTESDVWSYGVVLWEVYSYGLQPYYG-YSNQ-EVIEMIRSRQMLPCP 290 (422)
Q Consensus 216 ~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~-~~~~-~~~~~i~~~~~~~~p 290 (422)
...... .......++..|++||.+ ....++.++|+||||+++|||++ |..||.+ .++. ++.+.+..+..++.|
T Consensus 148 ~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 223 (225)
T smart00221 148 IHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLW-GPEPFSGEGEFTSLLSDVWSFGVPLLWE 223 (225)
T ss_pred ecCccc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHH-CCCCccccchhHHHHHHHHhcCCccccc
Confidence 543320 011223345679999988 56678889999999999999999 9999988 4444 777888777655443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=276.81 Aligned_cols=266 Identities=16% Similarity=0.184 Sum_probs=166.8
Q ss_pred ccccCcccccccccccceeEEEEEEecC--CCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeE------
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTS--EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGV------ 122 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~------ 122 (422)
....+|++.+.||+|+||.||+|++..+ ..+..||||++..... .+.+.+| .++...+.+++.++..
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 3456789999999999999999987643 1146799998754321 1112222 1222223333332221
Q ss_pred EEcCCCeEEEEEecCCCCHHHHHhhcCCCCCC--------CCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy7289 123 CLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDI--------SGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAA 194 (422)
Q Consensus 123 ~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~--------~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp 194 (422)
+......++||||+.+|+|.+++......... .............+..++.||+.||+|||+++|+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 23556799999999999999998754210000 0000001123445678999999999999999999999999
Q ss_pred CceeecC-CCeEEEecCcccccccCCcceEeccCCCCCccccCccccccC----------------------CCCCchhH
Q psy7289 195 RNCLVGD-GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG----------------------KFTTESDV 251 (422)
Q Consensus 195 ~NiLl~~-~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----------------------~~~~~~Dv 251 (422)
+|||+++ ++.+||+|||+|+.......+ ......+++.|||||.+... .++.++||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 9999985 579999999999865432221 22345678899999965432 23456799
Q ss_pred HhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC---------CC-----------CCCCCCcchhhhcccccccccch
Q psy7289 252 WSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM---------LP-----------CPEDCPPRMYSLMMECWHEVPVA 311 (422)
Q Consensus 252 wS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~---------~~-----------~p~~~p~~~~~l~~~cw~~~P~~ 311 (422)
|||||++|||++ +..|+... .......+..... .+ .........++|+.+|+..||..
T Consensus 363 wSlGviL~el~~-~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 363 YSAGLIFLQMAF-PNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred HHHHHHHHHHHh-CcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 999999999997 54443211 1111112211100 00 00111223458999999999988
Q ss_pred hh-HHHHhhhhhhh
Q psy7289 312 AG-MAYLCSHHYVH 324 (422)
Q Consensus 312 r~-~~~lh~~~~i~ 324 (422)
|+ +..+.+|.++.
T Consensus 441 R~ta~e~L~Hpff~ 454 (566)
T PLN03225 441 RISAKAALAHPYFD 454 (566)
T ss_pred CCCHHHHhCCcCcC
Confidence 86 33455566653
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=263.22 Aligned_cols=199 Identities=27% Similarity=0.400 Sum_probs=165.3
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC-------HHhHHHHHHHHHHHhcCC---CCceeeEeeEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN-------QKTASDFRREVDLMSELR---HPNIVCLLGVC 123 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~il~~l~---HpnIv~l~g~~ 123 (422)
+.|..++.+|.|+||.|+.|.++.. ...|+||.+.+..- .+..-..-.|++||+.|+ |+||++++++|
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n--~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKEN--NYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccceeeeeccccccceEEEeeeccc--ceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 4578899999999999999987543 67899998864321 111112346999999997 99999999999
Q ss_pred EcCCCeEEEEEe-cCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC
Q psy7289 124 LSGEPMCMLFEF-MVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG 202 (422)
Q Consensus 124 ~~~~~~~lv~E~-~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~ 202 (422)
.+++++|++||- -++-||++++.-+ ..+++.++.-|+.||+.|+++||+.||||||||-+||.++.+
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~k------------p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~ 706 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFK------------PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSN 706 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhcc------------CccchHHHHHHHHHHHhccccccccCceecccccccEEEecC
Confidence 999999999996 4566999999653 358999999999999999999999999999999999999999
Q ss_pred CeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCC-CchhHHhHHHHHHHHHhCCCCCCCC
Q psy7289 203 LTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFT-TESDVWSYGVVLWEVYSYGLQPYYG 271 (422)
Q Consensus 203 ~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwS~Gvil~El~t~g~~Pf~~ 271 (422)
|.+||+|||.|.-...... ....||..|.|||++.+.+|- ..-|||++|++||-++ +..-||+.
T Consensus 707 g~~klidfgsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytiv-ykenpyyn 771 (772)
T KOG1152|consen 707 GFVKLIDFGSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIV-YKENPYYN 771 (772)
T ss_pred CeEEEeeccchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEE-eccCCCcC
Confidence 9999999999865544332 234678999999999988874 5689999999999887 46778874
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=274.56 Aligned_cols=243 Identities=27% Similarity=0.357 Sum_probs=186.2
Q ss_pred ccccccccee-EEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCCeEEEEEecC
Q psy7289 60 QELGEGAFGK-VYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPMCMLFEFMV 137 (422)
Q Consensus 60 ~~LG~G~fg~-Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lv~E~~~ 137 (422)
+.+|.|+-|+ ||+|... ++.||||.+-.. ...-..||+..|+.- +|||||++|+.-.++++.||..|+|.
T Consensus 515 eilG~Gs~Gt~Vf~G~ye----~R~VAVKrll~e----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYE----GREVAVKRLLEE----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred HHcccCCCCcEEEEEeeC----CceehHHHHhhH----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 5789998884 6899873 467999987432 223346899999887 59999999999999999999999996
Q ss_pred CCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC---C--CeEEEecCcc
Q psy7289 138 RGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD---G--LTVKISDFGL 212 (422)
Q Consensus 138 ~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~---~--~~vKl~DFGl 212 (422)
.+|.+++........ ....-..+.+..|+++||++||+.+||||||||.||||+. + ..++|+|||+
T Consensus 587 -~sL~dlie~~~~d~~--------~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgl 657 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVE--------MQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGL 657 (903)
T ss_pred -hhHHHHHhccccchh--------hcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccc
Confidence 499999976411100 0111345778999999999999999999999999999975 2 5799999999
Q ss_pred cccccCCc-ceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC----C
Q psy7289 213 SRDVYASD-YYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM----L 287 (422)
Q Consensus 213 a~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~----~ 287 (422)
++.+..+. .....++..||-.|+|||++....-+.++||+|+||++|..++.|.+||.+.-.++. +|..+.. +
T Consensus 658 sKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L 735 (903)
T KOG1027|consen 658 SKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHL 735 (903)
T ss_pred ccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeee
Confidence 99886543 223356777899999999999888888999999999999999989999986554432 3443321 1
Q ss_pred CCCCCCCcchhhhcccccccccchhhHH-HHhhhhhh
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAGMA-YLCSHHYV 323 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~~~-~lh~~~~i 323 (422)
..-.+| +..+||.++++.+|..|+-+ ....|+++
T Consensus 736 ~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlF 770 (903)
T KOG1027|consen 736 EPLPDC--EAKDLISRMLNPDPQLRPSATDVLNHPLF 770 (903)
T ss_pred ccCchH--HHHHHHHHhcCCCcccCCCHHHHhCCCcc
Confidence 222334 78999999999999998743 23344443
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-33 Score=247.75 Aligned_cols=208 Identities=26% Similarity=0.445 Sum_probs=165.9
Q ss_pred ccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC-----CeE
Q psy7289 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE-----PMC 130 (422)
Q Consensus 57 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-----~~~ 130 (422)
+--+.||-|+||+||-..+ ..+++.||.|++.... +-...+.+.+|+++|...+|.|++..+++..-.. .+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTD--PRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTD--PRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCcccccceeEEEeccC--CCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 3457899999999998654 3446779998875432 2234567889999999999999999998875443 368
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+++|+|. .||+..+.+. .+++.+.+.-+..||++||.|||+.+|+||||||.|.|++++..+|||||
T Consensus 134 V~TELmQ-SDLHKIIVSP------------Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDF 200 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVSP------------QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDF 200 (449)
T ss_pred HHHHHHH-hhhhheeccC------------CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEeccc
Confidence 8888885 4888877542 36889999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHH
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i 281 (422)
||+|....++.. ..+....|-.|.|||.+.+. .|+.+.||||.|||+.|++. .+.-|...++-+.++.|
T Consensus 201 GLARvee~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLg-RrILFQAq~PiqQL~lI 270 (449)
T KOG0664|consen 201 GLARTWDQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQ-RKILFQAAGPIEQLQMI 270 (449)
T ss_pred ccccccchhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHh-hhhhhhccChHHHHHHH
Confidence 999976543322 22334556789999998864 59999999999999999995 55677777776655555
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-30 Score=224.84 Aligned_cols=204 Identities=22% Similarity=0.445 Sum_probs=161.7
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC-CCceeeEeeEEEcCC--Ce
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR-HPNIVCLLGVCLSGE--PM 129 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~--~~ 129 (422)
.++|++.+++|+|.|++||.|....+ .+.++||+++.. ..+.+.||+.||..|+ ||||++|+++..++. ..
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~--~eK~ViKiLKPV----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITN--NEKCVIKILKPV----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCC--CceEEEeeechH----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 36789999999999999999985443 466889988653 3456889999999997 999999999987654 47
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC-CeEEEe
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG-LTVKIS 208 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~-~~vKl~ 208 (422)
.+|+||..+-+...+- ..|+..+++.++.|++.||.||||.||+|||+||.|++||.. -.++|+
T Consensus 111 aLiFE~v~n~Dfk~ly---------------~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlI 175 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY---------------PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLI 175 (338)
T ss_pred hhHhhhhccccHHHHh---------------hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeee
Confidence 8999999998876654 347888999999999999999999999999999999999954 579999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCC-CCChHHHHHHH
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYY-GYSNQEVIEMI 281 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~-~~~~~~~~~~i 281 (422)
|.|||........+... ..+..|--||.+.. ..|+..-|+|||||++.+|+- .+.||. |.++.+.+-+|
T Consensus 176 DWGLAEFYHp~~eYnVR---VASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miF-rkepFFhG~dN~DQLVkI 246 (338)
T KOG0668|consen 176 DWGLAEFYHPGKEYNVR---VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF-RKEPFFHGHDNYDQLVKI 246 (338)
T ss_pred ecchHhhcCCCceeeee---eehhhcCCchheeechhccccHHHHHHHHHHHHHHh-ccCcccCCCCCHHHHHHH
Confidence 99999765444333222 12234678998764 568899999999999999996 556664 55555444333
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=218.76 Aligned_cols=204 Identities=32% Similarity=0.559 Sum_probs=171.7
Q ss_pred cccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEecCCCCH
Q psy7289 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDL 141 (422)
Q Consensus 62 LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~~~G~L 141 (422)
||+|++|.||+++... .+..+++|...........+.+.+|++.++.++|++|+++++++......+++||++.+++|
T Consensus 1 l~~g~~~~v~~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKK--TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecC--CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 6899999999998643 35679999987544332456799999999999999999999999988899999999999999
Q ss_pred HHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC-CCeEEEecCcccccccCCc
Q psy7289 142 HEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD-GLTVKISDFGLSRDVYASD 220 (422)
Q Consensus 142 ~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~-~~~vKl~DFGla~~~~~~~ 220 (422)
.+++.... ..++...+..++.+++.+++|||+.+++|+||+|.||+++. ++.++|+|||.+.......
T Consensus 79 ~~~~~~~~-----------~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~ 147 (215)
T cd00180 79 KDLLKENE-----------GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK 147 (215)
T ss_pred HHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence 99987531 24788999999999999999999999999999999999999 8999999999987554322
Q ss_pred ceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcchhh
Q psy7289 221 YYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYS 299 (422)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~~~~ 299 (422)
. ..........|++||.+... .++.++|+||+|+++++| +.+.+
T Consensus 148 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~ 192 (215)
T cd00180 148 S--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKD 192 (215)
T ss_pred c--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHH
Confidence 1 11223345679999998876 788999999999999998 46778
Q ss_pred hcccccccccchhh
Q psy7289 300 LMMECWHEVPVAAG 313 (422)
Q Consensus 300 l~~~cw~~~P~~r~ 313 (422)
++..|+..+|..|+
T Consensus 193 ~l~~~l~~~p~~R~ 206 (215)
T cd00180 193 LIRKMLQKDPEKRP 206 (215)
T ss_pred HHHHHhhCCcccCc
Confidence 88899988888886
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-30 Score=229.66 Aligned_cols=238 Identities=26% Similarity=0.374 Sum_probs=177.0
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC-CCceeeEeeE-EEcCCCe
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR-HPNIVCLLGV-CLSGEPM 129 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~-~~~~~~~ 129 (422)
.++.|.+.+.||+|.||.+-+++++.++ ..+++|.+... ..+..+|.+|..---.|. |.||+.-|++ |++.+.+
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~--t~ivlKavp~p--~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSK--TRIVLKAVPRP--QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCc--eEEEeeccCcc--hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 3567889999999999999999987654 67999988654 345678999998766674 8999998864 6677788
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec--CCCeEEE
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVG--DGLTVKI 207 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~--~~~~vKl 207 (422)
+++|||++.|||.+-+.. ..+.+....+++.|+++|++|+|++++||||||.+||||- +.-.|||
T Consensus 98 vF~qE~aP~gdL~snv~~-------------~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKl 164 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEA-------------AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKL 164 (378)
T ss_pred EEeeccCccchhhhhcCc-------------ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEe
Confidence 899999999999886643 2477888899999999999999999999999999999994 3458999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCcccccc---CC--CCCchhHHhHHHHHHHHHhCCCCCCCCCChH--HHH--
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY---GK--FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ--EVI-- 278 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~--~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~--~~~-- 278 (422)
||||+.+.......+ ..-+..|.|||.... +. ..+.+|+|.||+++|.++| |..|+...... ...
T Consensus 165 cDFG~t~k~g~tV~~-----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~clt-G~~PWQka~~~d~~Y~~~ 238 (378)
T KOG1345|consen 165 CDFGLTRKVGTTVKY-----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLT-GKFPWQKASIMDKPYWEW 238 (378)
T ss_pred eecccccccCceehh-----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeec-CCCcchhhhccCchHHHH
Confidence 999998764322111 112345889997643 22 4577899999999999998 99999854322 111
Q ss_pred HHHHcCCCCCCCCC---CCcchhhhcccccccccchh
Q psy7289 279 EMIRSRQMLPCPED---CPPRMYSLMMECWHEVPVAA 312 (422)
Q Consensus 279 ~~i~~~~~~~~p~~---~p~~~~~l~~~cw~~~P~~r 312 (422)
.+-..+..+..|.. .++.+..+.++-+..+|..|
T Consensus 239 ~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 239 EQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred HHHhcccCccCchhhcccCHHHHHHHHHhcCCccccc
Confidence 12223444444443 34455566666667777666
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=242.55 Aligned_cols=214 Identities=22% Similarity=0.340 Sum_probs=178.4
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCC------CceeeEeeEE
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRH------PNIVCLLGVC 123 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~H------pnIv~l~g~~ 123 (422)
|+...+|.+....|+|-|+.|.+|.....+ ..||||++..+. ...+.=++|++||++|+. -|+++|+..|
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~--~~vAiKIIRnNE--~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARG--QEVAIKIIRNNE--VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCC--CeeEEEEeecch--HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 677889999999999999999999865443 479999997542 233456789999999952 3799999999
Q ss_pred EcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC-
Q psy7289 124 LSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG- 202 (422)
Q Consensus 124 ~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~- 202 (422)
...+++|||+|-+. -+|.+.|...+.. ..|....+..++.|+..||..|-..||+|.||||.|||++++
T Consensus 504 ~hknHLClVFE~Ls-lNLRevLKKyG~n---------vGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 504 KHKNHLCLVFEPLS-LNLREVLKKYGRN---------VGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESK 573 (752)
T ss_pred hhcceeEEEehhhh-chHHHHHHHhCcc---------cceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCc
Confidence 99999999999774 5999999886543 247778899999999999999999999999999999999865
Q ss_pred CeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q psy7289 203 LTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282 (422)
Q Consensus 203 ~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~ 282 (422)
..+||||||.|.....+... ....+..|.|||.+.+-.|+...|+||.||+|||++| |+.-|.|.++.+++....
T Consensus 574 ~iLKLCDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYt-GkIlFpG~TNN~MLrl~m 648 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYT-GKILFPGRTNNQMLRLFM 648 (752)
T ss_pred ceeeeccCcccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeec-cceecCCCCcHHHHHHHH
Confidence 57999999998765444321 1112346999999999999999999999999999999 999999999988876654
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-29 Score=227.27 Aligned_cols=208 Identities=28% Similarity=0.366 Sum_probs=164.2
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC----
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE---- 127 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~---- 127 (422)
..+|.-++.+|.|.- .|.-+-+. -.++.||+|++.... .....++-.+|..++..++|+||++++.+++-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~--v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQ--VLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchh--hccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 346666788888888 45444332 235679999875432 2233456678999999999999999999986433
Q ss_pred --CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 128 --PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 128 --~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
.+|+|||||. ++|.+.+.. .+.-..+..+..|++.|++|||+.||+||||||+||++..+..+
T Consensus 93 ~~e~y~v~e~m~-~nl~~vi~~--------------elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~l 157 (369)
T KOG0665|consen 93 FQEVYLVMELMD-ANLCQVILM--------------ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTL 157 (369)
T ss_pred HHhHHHHHHhhh-hHHHHHHHH--------------hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhhe
Confidence 5799999996 588888763 36677889999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~ 282 (422)
||.|||+|+....+ -..+....|..|.|||++.+..|.+.+||||.||++.||++ |..-|.|.+.-+-..++.
T Consensus 158 Ki~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~-~~Vlf~g~d~idQ~~ki~ 230 (369)
T KOG0665|consen 158 KILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELIL-GTVLFPGKDHIDQWNKII 230 (369)
T ss_pred eeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhh-ceEEecCchHHHHHHHHH
Confidence 99999999864322 12334455677999999999889999999999999999997 888888877655555544
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-29 Score=267.68 Aligned_cols=199 Identities=19% Similarity=0.194 Sum_probs=140.1
Q ss_pred cCCC-CceeeEeeEE-------EcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHH
Q psy7289 110 ELRH-PNIVCLLGVC-------LSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAY 181 (422)
Q Consensus 110 ~l~H-pnIv~l~g~~-------~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~y 181 (422)
.++| +||++++++| .....++.+|||+ +++|+++|.... ..+++.++..++.||+.||+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~al~~ 95 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-----------RSVDAFECFHVFRQIVEIVNA 95 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-----------ccccHHHHHHHHHHHHHHHHH
Confidence 4556 6888888877 3334678888987 569999996421 358999999999999999999
Q ss_pred HHhCCccccCCCCCceeecC-------------------CCeEEEecCcccccccCCcc--------------eEeccCC
Q psy7289 182 LCSHHYVHRDLAARNCLVGD-------------------GLTVKISDFGLSRDVYASDY--------------YRIQSKS 228 (422)
Q Consensus 182 LH~~~ivHrDlKp~NiLl~~-------------------~~~vKl~DFGla~~~~~~~~--------------~~~~~~~ 228 (422)
||++||+||||||+||||+. ++.+||+|||+++....... .......
T Consensus 96 lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (793)
T PLN00181 96 AHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILA 175 (793)
T ss_pred HHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCccccccc
Confidence 99999999999999999954 34566667777654211000 0001113
Q ss_pred CCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcchhhhcccccccc
Q psy7289 229 LLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEV 308 (422)
Q Consensus 229 ~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~ 308 (422)
.+|+.|||||++....++.++|||||||+||||++ |.+|+... .+.+..+.....++.+....+....++..||+.+
T Consensus 176 ~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~-~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~ 252 (793)
T PLN00181 176 MEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFC-PVSSREEK--SRTMSSLRHRVLPPQILLNWPKEASFCLWLLHPE 252 (793)
T ss_pred CCCcceEChhhhccCCCCchhhhhhHHHHHHHHhh-CCCchhhH--HHHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCC
Confidence 46788999999999999999999999999999998 77776532 2233333333222222223445678899999999
Q ss_pred cchhh-HHHHhhhhhh
Q psy7289 309 PVAAG-MAYLCSHHYV 323 (422)
Q Consensus 309 P~~r~-~~~lh~~~~i 323 (422)
|..|+ +..+..|.++
T Consensus 253 P~~Rps~~eil~h~~~ 268 (793)
T PLN00181 253 PSCRPSMSELLQSEFI 268 (793)
T ss_pred hhhCcChHHHhhchhh
Confidence 98876 3334444444
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=229.01 Aligned_cols=169 Identities=17% Similarity=0.139 Sum_probs=128.0
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC----CHHhHHHHHHHHHHHhcCCCCceee-EeeEEEc
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA----NQKTASDFRREVDLMSELRHPNIVC-LLGVCLS 125 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~il~~l~HpnIv~-l~g~~~~ 125 (422)
.....|++.+.||+|+||+||+|++... ++..||||++.... .......|.+|+++|++++|+||+. +++.
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGD-PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCC-CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 4567899999999999999999987543 24568999865321 2334567999999999999999985 5442
Q ss_pred CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCceeecCCCe
Q psy7289 126 GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDL-AARNCLVGDGLT 204 (422)
Q Consensus 126 ~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDl-Kp~NiLl~~~~~ 204 (422)
...|+||||+++++|.. +.. .. ...++.|++.||.|||++||+|||| ||+|||++.++.
T Consensus 91 -~~~~LVmE~~~G~~L~~-~~~---------------~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ 150 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHL-ARP---------------HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGE 150 (365)
T ss_pred -CCcEEEEEccCCCCHHH-hCc---------------cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCC
Confidence 45799999999999963 210 11 1357889999999999999999999 999999998899
Q ss_pred EEEecCcccccccCCcc-eEe-----ccCCCCCccccCccccccC
Q psy7289 205 VKISDFGLSRDVYASDY-YRI-----QSKSLLPVRWMPPESILYG 243 (422)
Q Consensus 205 vKl~DFGla~~~~~~~~-~~~-----~~~~~~t~~y~aPE~~~~~ 243 (422)
+||+|||+|+....... ... -....+++.|+|||.+...
T Consensus 151 ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 151 AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99999999986543221 111 0233456789999988643
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-29 Score=257.26 Aligned_cols=346 Identities=24% Similarity=0.342 Sum_probs=248.1
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCC-CCceeeEeeEEEcCCCeE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELR-HPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~ 130 (422)
...|++.+.||+|+|+.|-.... .......+|+|.+.... ......+...|..+-..+. |+|++++++.....+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~-~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASN-SRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhh-cCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 45678889999999999977543 22334567777665432 2333445566888888887 999999999999999999
Q ss_pred EEEEecCCCCHHHHHh-hcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCceeecCCC-eEEE
Q psy7289 131 MLFEFMVRGDLHEFLM-SRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLC-SHHYVHRDLAARNCLVGDGL-TVKI 207 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~-~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH-~~~ivHrDlKp~NiLl~~~~-~vKl 207 (422)
+++||..+|++.+.+. ... ...+...+..++.|+..|+.|+| ..++.|||+||+|.+++..+ ..|+
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~-----------~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~ 166 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDS-----------TGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKI 166 (601)
T ss_pred cccCcccccccccccccCCc-----------cCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccC
Confidence 9999999999998773 211 13556677889999999999999 99999999999999999998 9999
Q ss_pred ecCcccccccC-CcceEeccCCCC-CccccCccccccCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCC-----------
Q psy7289 208 SDFGLSRDVYA-SDYYRIQSKSLL-PVRWMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYS----------- 273 (422)
Q Consensus 208 ~DFGla~~~~~-~~~~~~~~~~~~-t~~y~aPE~~~~~~-~~~~~DvwS~Gvil~El~t~g~~Pf~~~~----------- 273 (422)
+|||+|..... +..........+ ++.|+|||...+.. .....|+||.|+++.-+++ |..|+....
T Consensus 167 ~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~-g~~p~~~~~~~~~~~~~~~~ 245 (601)
T KOG0590|consen 167 ADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLT-GELPWDFPSRKDGRYSSWKS 245 (601)
T ss_pred CCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCccccccccccccccc-CCCCccccccccccceeecc
Confidence 99999987655 333334444556 88999999888744 4577899999999999887 655553211
Q ss_pred --------------hH--HHHHHHH-------------------cC----------C---------CC------------
Q psy7289 274 --------------NQ--EVIEMIR-------------------SR----------Q---------ML------------ 287 (422)
Q Consensus 274 --------------~~--~~~~~i~-------------------~~----------~---------~~------------ 287 (422)
.. .+...+. .. . ..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~y~~~~~~ 325 (601)
T KOG0590|consen 246 NKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSSKRNGFSKSNPCADSLTIAKSPIGFSEKYGKPGRV 325 (601)
T ss_pred cccccccCccccCChhhhhcccccccCCchhccccccccccccccccccccccccccccccccccCccccccccCCccce
Confidence 00 0000000 00 0 00
Q ss_pred ----------------C---CC-----------------------------------------------------CCCCc
Q psy7289 288 ----------------P---CP-----------------------------------------------------EDCPP 295 (422)
Q Consensus 288 ----------------~---~p-----------------------------------------------------~~~p~ 295 (422)
+ .| +.||.
T Consensus 326 ~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~ 405 (601)
T KOG0590|consen 326 LGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY 405 (601)
T ss_pred eeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhcccH
Confidence 0 00 00011
Q ss_pred chhhhccc---------ccccccchhhHHHHhhhhhhhhhcccccccccCCcceeeccccccccccc--CcceeeccccC
Q psy7289 296 RMYSLMME---------CWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA--SDYYRIQSKSL 364 (422)
Q Consensus 296 ~~~~l~~~---------cw~~~P~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~--~~~~~~~~~~~ 364 (422)
+++.++.+ |+-.....+++.|+|++++.|||+|++|+++...+.+|++|||.+..... ........+..
T Consensus 406 Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~ 485 (601)
T KOG0590|consen 406 DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIV 485 (601)
T ss_pred HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcc
Confidence 11111111 01111234789999999999999999999999999999999999864322 12223455666
Q ss_pred CCcccCCccccccCCCCc-chhHHHHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 365 LPVRWMPPESILYGKFTT-ESDVWSYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 365 ~~~~y~aPE~~~~~~~~~-~~Dvws~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
++-.|+|||++....|+. .+||||.||++..|.+ |+.||.-....+.
T Consensus 486 gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~-~~~~Wk~a~~~~~ 533 (601)
T KOG0590|consen 486 GSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMIL-GRFPWKVAKKSDN 533 (601)
T ss_pred cCCcCcCcccccccccCcchhhhhhccceEEEEec-CCCcccccccccc
Confidence 777899999999888986 4899999999999985 8999987666554
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=215.01 Aligned_cols=237 Identities=24% Similarity=0.419 Sum_probs=192.6
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccC-cCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKE-NANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
-..+.++.+|.+...|+.|+|+|...+ +++|+++- ..+.+..++|..|.-.|+-+.||||+.++|.|..++++.+
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrwqgnd----ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~ 264 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRWQGND----IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVI 264 (448)
T ss_pred hhhhhhhhhhccCCCcccccccccCcc----hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceE
Confidence 345567788999999999999995432 55566642 3345556789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCC-cc-ccCCCCCceeecCCCeEEEe-
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHH-YV-HRDLAARNCLVGDGLTVKIS- 208 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-iv-HrDlKp~NiLl~~~~~vKl~- 208 (422)
+..||+.|+|+..|+... ...+...++.+++.++|+||+|||+.. ++ ---|.+..+++|++.+++|+
T Consensus 265 isq~mp~gslynvlhe~t----------~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarism 334 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQT----------SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISM 334 (448)
T ss_pred eeeeccchHHHHHHhcCc----------cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheec
Confidence 999999999999998743 234667789999999999999999964 43 44788999999999888774
Q ss_pred -cCcccccccCCcceEeccCCCCCccccCccccccCCCC---CchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH-c
Q psy7289 209 -DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFT---TESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR-S 283 (422)
Q Consensus 209 -DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~---~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~-~ 283 (422)
|--++- ...+....|.||+||.+....-+ .++|+|||.+++||+-| ...||.+.++.|.-..|. .
T Consensus 335 ad~kfsf---------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~t-revpfadlspmecgmkiale 404 (448)
T KOG0195|consen 335 ADTKFSF---------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNT-REVPFADLSPMECGMKIALE 404 (448)
T ss_pred ccceeee---------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhc-cccccccCCchhhhhhhhhc
Confidence 322221 12233446889999999865433 57899999999999998 678999999999876664 6
Q ss_pred CCCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 284 RQMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 284 ~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
|-+..+|+..++.+..||.-|.++||..|+
T Consensus 405 glrv~ippgis~hm~klm~icmnedpgkrp 434 (448)
T KOG0195|consen 405 GLRVHIPPGISRHMNKLMNICMNEDPGKRP 434 (448)
T ss_pred cccccCCCCccHHHHHHHHHHhcCCCCcCC
Confidence 777889999999999999999999999998
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-25 Score=215.24 Aligned_cols=134 Identities=25% Similarity=0.397 Sum_probs=110.1
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC-----CC---ceeeEeeEEE-
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR-----HP---NIVCLLGVCL- 124 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-----Hp---nIv~l~g~~~- 124 (422)
.+|-+.++||=|.|++||+|... ...+.||+|+.+... ...+.-+.||++|++++ |+ .||+|++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDt--q~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDT--QNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred ceEEEEEeccccccceeEEEeec--cCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 78999999999999999999754 456789999986432 23355678999999884 33 5999999886
Q ss_pred ---cCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeec
Q psy7289 125 ---SGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCS-HHYVHRDLAARNCLVG 200 (422)
Q Consensus 125 ---~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlKp~NiLl~ 200 (422)
.+.++|||+|++ |-+|..+|.... ...++...+.+|++||+.||.|||+ .||||-||||+|||+.
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~----------YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSN----------YRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhC----------CCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 345799999988 558989887643 2358899999999999999999998 4899999999999996
Q ss_pred CC
Q psy7289 201 DG 202 (422)
Q Consensus 201 ~~ 202 (422)
.+
T Consensus 223 ~~ 224 (590)
T KOG1290|consen 223 ST 224 (590)
T ss_pred cc
Confidence 54
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-24 Score=207.25 Aligned_cols=243 Identities=30% Similarity=0.502 Sum_probs=192.3
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHH--hHHHHHHHHHHHhcCCCC-ceeeEeeEEEcCCCeEEE
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQK--TASDFRREVDLMSELRHP-NIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~il~~l~Hp-nIv~l~g~~~~~~~~~lv 132 (422)
|++.+.||.|+||.||++... ..+++|.+....... ....|.+|+.++..+.|+ ||+++++.+......+++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 76 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-----KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLV 76 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-----cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEE
Confidence 567789999999999999864 568999887554333 467899999999999988 799999999777778999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC-eEEEecCc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL-TVKISDFG 211 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~-~vKl~DFG 211 (422)
+|++.+++|.+++...... ..++......++.|++.++.|+|+.+++|||+||+||+++... .++++|||
T Consensus 77 ~~~~~~~~l~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg 147 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRK---------GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFG 147 (384)
T ss_pred EecCCCCcHHHHHHhcccc---------cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccC
Confidence 9999999999777653210 2588899999999999999999999999999999999999888 79999999
Q ss_pred ccccccCCcceE----eccCCCCCccccCcccccc---CCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh----HHHHHH
Q psy7289 212 LSRDVYASDYYR----IQSKSLLPVRWMPPESILY---GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN----QEVIEM 280 (422)
Q Consensus 212 la~~~~~~~~~~----~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~----~~~~~~ 280 (422)
+++......... ......++..|+|||.+.. ..++...|+||+|++++++++ |..||..... .+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~-~~~p~~~~~~~~~~~~~~~~ 226 (384)
T COG0515 148 LAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLT-GLPPFEGEKNSSATSQTLKI 226 (384)
T ss_pred cceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccccHHHHHHH
Confidence 997544332111 2345567889999999987 578899999999999999987 8889877763 556555
Q ss_pred HHcCCCC----CCCCCCC----cchhhhcccccccccchhh
Q psy7289 281 IRSRQML----PCPEDCP----PRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 281 i~~~~~~----~~p~~~p----~~~~~l~~~cw~~~P~~r~ 313 (422)
+...... +.....+ ..+.+++..|...+|..|.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~ 267 (384)
T COG0515 227 ILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRL 267 (384)
T ss_pred HHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcC
Confidence 5544322 1111221 3678888999888887764
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=218.39 Aligned_cols=202 Identities=23% Similarity=0.404 Sum_probs=164.1
Q ss_pred ccCcccccccccccceeEEEEEEecC-CCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC-CCceeeEeeEEEcCCCeE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTS-EGPSLVAIKTLKENANQKTASDFRREVDLMSELR-HPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~ 130 (422)
...|+.+.+||.|+|+.||++..... .....||+|.+..... ...+.+|++.|..+. +.||+++.+++..++.+.
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC---chHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 45678899999999999999987541 2457899999865433 346889999999995 899999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC-CeEEEec
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG-LTVKISD 209 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~-~~vKl~D 209 (422)
+||||+++-+..++... ++..++..+++.+..||.++|.+|||||||||+|+|.+.. +.-.|.|
T Consensus 112 ivlp~~~H~~f~~l~~~---------------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvD 176 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS---------------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVD 176 (418)
T ss_pred EEecccCccCHHHHHhc---------------CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEe
Confidence 99999999999998853 7788999999999999999999999999999999999743 4667999
Q ss_pred Cccccccc-----------------C-----------------CcceE--------eccCCCCCccccCcccccc-CCCC
Q psy7289 210 FGLSRDVY-----------------A-----------------SDYYR--------IQSKSLLPVRWMPPESILY-GKFT 246 (422)
Q Consensus 210 FGla~~~~-----------------~-----------------~~~~~--------~~~~~~~t~~y~aPE~~~~-~~~~ 246 (422)
||||.... . ..++. ......||++|.|||++.. ..-+
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt 256 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT 256 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence 99986210 0 00011 1112457899999999875 4578
Q ss_pred CchhHHhHHHHHHHHHhCCCCCCCCCC
Q psy7289 247 TESDVWSYGVVLWEVYSYGLQPYYGYS 273 (422)
Q Consensus 247 ~~~DvwS~Gvil~El~t~g~~Pf~~~~ 273 (422)
+++||||.|||+.-+++ +..||....
T Consensus 257 taiDiws~GVI~Lslls-~~~PFf~a~ 282 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLS-RRYPFFKAK 282 (418)
T ss_pred Cccceeeccceeehhhc-cccccccCc
Confidence 89999999999999998 888987543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.8e-26 Score=199.31 Aligned_cols=148 Identities=20% Similarity=0.271 Sum_probs=117.5
Q ss_pred CCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccccC
Q psy7289 139 GDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA 218 (422)
Q Consensus 139 G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~ 218 (422)
|+|.+++..+. ..+++.++..++.||+.||+|||+++ ||+|||++.++.+|+ ||+++....
T Consensus 1 GsL~~~l~~~~-----------~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~ 61 (176)
T smart00750 1 VSLADILEVRG-----------RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP 61 (176)
T ss_pred CcHHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc
Confidence 78999997642 35899999999999999999999998 999999999999999 999875432
Q ss_pred CcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHcCCCCC------CCC
Q psy7289 219 SDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN-QEVIEMIRSRQMLP------CPE 291 (422)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~-~~~~~~i~~~~~~~------~p~ 291 (422)
. ...+|+.|||||++....++.++|||||||++|||++ |..||..... ...+..+..+.... .+.
T Consensus 62 ~-------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (176)
T smart00750 62 E-------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALD-YELPYNEERELSAILEILLNGMPADDPRDRSNLE 133 (176)
T ss_pred c-------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHh-CCCCccccchhcHHHHHHHHHhccCCccccccHH
Confidence 1 2256789999999999999999999999999999998 8899976543 23333333222211 122
Q ss_pred CCCc--chhhhcccccccccchhh
Q psy7289 292 DCPP--RMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 292 ~~p~--~~~~l~~~cw~~~P~~r~ 313 (422)
..+. ++.+++.+||..+|..|+
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp 157 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRRE 157 (176)
T ss_pred HHHhhhhHHHHHHHHHhccccccc
Confidence 2333 689999999999999997
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-24 Score=211.16 Aligned_cols=206 Identities=21% Similarity=0.271 Sum_probs=164.0
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCC----CceeeEeeEE-EcCCCe
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRH----PNIVCLLGVC-LSGEPM 129 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~H----pnIv~l~g~~-~~~~~~ 129 (422)
+|.+.+.||+|+||.||++...... ...+|+|........... .+..|..++..+.. +++.++++.. ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~-~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK-NKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC-CeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 7889999999999999999865443 457888887543222222 57789999988873 5888888888 467788
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC-----Ce
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG-----LT 204 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~-----~~ 204 (422)
++||+.+ |-+|.++..... ...++..++.+++.|++.+|++||+.|++||||||+|++++.. ..
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~----------~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~ 165 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP----------PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRT 165 (322)
T ss_pred EEEEecc-CccHHHHHHhCC----------CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccce
Confidence 9999976 679999775432 1468999999999999999999999999999999999999864 46
Q ss_pred EEEecCcccc--cccCCcc---e--Ee-ccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh
Q psy7289 205 VKISDFGLSR--DVYASDY---Y--RI-QSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN 274 (422)
Q Consensus 205 vKl~DFGla~--~~~~~~~---~--~~-~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~ 274 (422)
+.|.|||+++ ....... . +. .....||.+|+++.+..+...+.+.|+||++.++.|+.. |..|+.+...
T Consensus 166 ~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~-g~LPW~~~~~ 242 (322)
T KOG1164|consen 166 LYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLK-GSLPWEALEM 242 (322)
T ss_pred EEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhc-CCCCCccccc
Confidence 9999999998 3222211 1 11 123458999999999999999999999999999999997 8799977664
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-25 Score=196.48 Aligned_cols=267 Identities=19% Similarity=0.258 Sum_probs=198.5
Q ss_pred hhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCC-CceeeEeeEEEcC
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRH-PNIVCLLGVCLSG 126 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~g~~~~~ 126 (422)
...+...+|+++++||+|+||.+|.|.... .++.||||.-+..+.. .++..|.++.+.|+| ..|..+..+..+.
T Consensus 9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~--~ge~VAiK~Es~~a~h---pqL~yEskvY~iL~~g~GiP~i~~y~~e~ 83 (341)
T KOG1163|consen 9 EELIVGGKYKLVRKIGSGSFGDIYLGISIT--SGEEVAIKLESSKAKH---PQLLYESKVYRILQGGVGIPHIRHYGTEK 83 (341)
T ss_pred hhheeccceEEEEeecCCchhheeeeeecc--CCceEEEEeecccCCC---cchhHHHHHHHHhccCCCCchhhhhcccc
Confidence 445677899999999999999999998654 3578999986554432 357789999999986 6788888888888
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC---CC
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD---GL 203 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~---~~ 203 (422)
..-.+|||++ |-+|.++..-- ...++-.++..++-|++.-++|+|.+++|||||||+|.|.+- ..
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnfC-----------~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~ 151 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNFC-----------SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCN 151 (341)
T ss_pred ccceeeeecc-CccHHHHHHHH-----------hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccc
Confidence 8999999987 56887776422 135888899999999999999999999999999999999864 34
Q ss_pred eEEEecCcccccccCCc-----ceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChH---
Q psy7289 204 TVKISDFGLSRDVYASD-----YYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ--- 275 (422)
Q Consensus 204 ~vKl~DFGla~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~--- 275 (422)
.+-++|||||+...... .++....-.||.+|.+-....+-.-+...|+=|+|.+|...- +|..||.+....
T Consensus 152 kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfn-rG~LPWQglka~tk~ 230 (341)
T KOG1163|consen 152 KLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFN-RGSLPWQGLKAATKK 230 (341)
T ss_pred eEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeee-cCCCcccccchhhHH
Confidence 68899999998654321 233444556789999988777777889999999999887665 599999987654
Q ss_pred HHHHHHHcCCCCCCC----CCCCcchhhhccccc----ccccchhhHHHHhhhhhhhhhcccccccc
Q psy7289 276 EVIEMIRSRQMLPCP----EDCPPRMYSLMMECW----HEVPVAAGMAYLCSHHYVHRDLAARNCLV 334 (422)
Q Consensus 276 ~~~~~i~~~~~~~~p----~~~p~~~~~l~~~cw----~~~P~~r~~~~lh~~~~i~~dLk~~nil~ 334 (422)
+-.++|.+...-..+ ...|.++...+..|- .+.|.-.-+. .-+.+..+.|+-.+-++
T Consensus 231 QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylr--qlFriLfr~ln~~~d~i 295 (341)
T KOG1163|consen 231 QKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLR--QLFRILFRTLNHQYDYI 295 (341)
T ss_pred HHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHH--HHHHHHHhhccccCCeE
Confidence 455666554432222 467889888888883 3444433211 13445555555444343
|
|
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.3e-26 Score=221.92 Aligned_cols=113 Identities=50% Similarity=0.924 Sum_probs=101.9
Q ss_pred hhhcccccccccchhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCcccccc
Q psy7289 298 YSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY 377 (422)
Q Consensus 298 ~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 377 (422)
.+|+.-|+ .++.||+||.++++|||||.++|||++.+..+||+||||+| ...++.+....+...|+.|+|||.+++
T Consensus 303 ~~Ll~~a~---qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr-~~~d~~Y~~~~~~kfPIkWtAPEa~~~ 378 (468)
T KOG0197|consen 303 PQLLDFAA---QIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLAR-LIGDDEYTASEGGKFPIKWTAPEALNY 378 (468)
T ss_pred HHHHHHHH---HHHHHHHHHHhCCccchhhhhhheeeccCceEEEccccccc-ccCCCceeecCCCCCCceecCHHHHhh
Confidence 34554444 38899999999999999999999999999999999999999 456677888888999999999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHhcCCCCCCCCCchhhhh
Q psy7289 378 GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFL 414 (422)
Q Consensus 378 ~~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~~~~ 414 (422)
+.|+.|||||||||+||||+|+|+.||.++++.|+.-
T Consensus 379 ~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~ 415 (468)
T KOG0197|consen 379 GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLE 415 (468)
T ss_pred CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHH
Confidence 9999999999999999999999999999999988653
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.3e-26 Score=231.30 Aligned_cols=103 Identities=78% Similarity=1.437 Sum_probs=100.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
++.||+||-++.++||||..+|||++.+..+||+||||||+....++|+.......|++|||||.|++|+||++||||||
T Consensus 612 IAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~ 691 (774)
T KOG1026|consen 612 IAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSF 691 (774)
T ss_pred HHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhh
Confidence 78899999999999999999999999999999999999999999999999989999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||+|||+|+||++||+|.+|.|+
T Consensus 692 GVvLWEIFsyG~QPy~glSn~EV 714 (774)
T KOG1026|consen 692 GVVLWEIFSYGKQPYYGLSNQEV 714 (774)
T ss_pred hhhhhhhhccccCcccccchHHH
Confidence 99999999999999999999885
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=188.28 Aligned_cols=139 Identities=24% Similarity=0.247 Sum_probs=105.4
Q ss_pred ccccccccceeEEEEEEecCCCCeEEEEEEccCcCCH-Hh-------HHH-----------------HHHHHHHHhcCCC
Q psy7289 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQ-KT-------ASD-----------------FRREVDLMSELRH 113 (422)
Q Consensus 59 ~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~-~~-------~~~-----------------~~~E~~il~~l~H 113 (422)
...||+|+||.||+|... +++.||||+++..... .. ... ..+|++++.++.|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~---~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 78 (190)
T cd05147 2 NGCISTGKEANVYHATTA---NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVT 78 (190)
T ss_pred CCccccccceEEEEEECC---CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHH
Confidence 467999999999999763 4678999998643210 00 112 2359999999987
Q ss_pred CceeeEeeEEEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCC
Q psy7289 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYL-CSHHYVHRDL 192 (422)
Q Consensus 114 pnIv~l~g~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yL-H~~~ivHrDl 192 (422)
++|.....+.. ...++||||++++++....... ..++..++..++.|++.+|+|+ |+.||+||||
T Consensus 79 ~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~------------~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDl 144 (190)
T cd05147 79 AGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLKD------------APLSESKARELYLQVIQIMRILYQDCRLVHADL 144 (190)
T ss_pred CCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhhc------------CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 77643322222 2238999999998876553221 2578899999999999999999 7999999999
Q ss_pred CCCceeecCCCeEEEecCccccc
Q psy7289 193 AARNCLVGDGLTVKISDFGLSRD 215 (422)
Q Consensus 193 Kp~NiLl~~~~~vKl~DFGla~~ 215 (422)
||+|||+++ +.++|+|||+|..
T Consensus 145 kP~NIli~~-~~v~LiDFG~a~~ 166 (190)
T cd05147 145 SEYNLLYHD-GKLYIIDVSQSVE 166 (190)
T ss_pred CHHHEEEEC-CcEEEEEcccccc
Confidence 999999984 6899999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=191.60 Aligned_cols=174 Identities=14% Similarity=0.156 Sum_probs=132.7
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC--HHhHHH------HHHHHHHHhcCCCCceeeEee
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN--QKTASD------FRREVDLMSELRHPNIVCLLG 121 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~------~~~E~~il~~l~HpnIv~l~g 121 (422)
.+...+|+..+.||.|+||.||.... . ...+|||.+..... +...+. +.+|++.+.+++||+|.....
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~--~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d 102 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT--D--YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLND 102 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec--C--CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceE
Confidence 46678999999999999999998543 2 34699999875432 222233 679999999999999999988
Q ss_pred EEEcC--------CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy7289 122 VCLSG--------EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLA 193 (422)
Q Consensus 122 ~~~~~--------~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlK 193 (422)
++... ...+++|||++|.+|.++.. +++ ....+++.+|..+|+.|++|||+|
T Consensus 103 ~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----------------~~~----~~~~~i~~~l~~lH~~gi~H~Dik 162 (232)
T PRK10359 103 FYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----------------ISE----DVKAKIKASIESLHQHGMVSGDPH 162 (232)
T ss_pred eeeecccccccccCCeEEEEEEECCccHHHhhh----------------ccH----HHHHHHHHHHHHHHHcCCccCCCC
Confidence 86533 35789999999999987631 232 245699999999999999999999
Q ss_pred CCceeecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHH
Q psy7289 194 ARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVY 262 (422)
Q Consensus 194 p~NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~ 262 (422)
|+|++++.++ ++|+|||.++....... ....+....|+.++|+||||+++.-..
T Consensus 163 p~Nili~~~g-i~liDfg~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 163 KGNFIVSKNG-LRIIDLSGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred hHHEEEeCCC-EEEEECCCcccccchhh--------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 9999999888 99999998764321110 011334456778999999999876543
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-22 Score=185.11 Aligned_cols=234 Identities=21% Similarity=0.296 Sum_probs=181.6
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC-CCceeeEeeEEEcCCCe
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR-HPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~ 129 (422)
+....|++.++||+|+||+++.|+..- +++.||||.-.... ...++..|.+..+.|. .+.|...|-+..++-+-
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~--nne~VAIKfEPrkS---~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLY--NNEPVAIKFEPRKS---EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred EecccceeccccccCcceeeecccccc--cCceEEEEeccccC---CcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 556789999999999999999998654 35789999864332 2235667888877775 58999888888888888
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC-----CCe
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD-----GLT 204 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~-----~~~ 204 (422)
.||||++ |-||.|+..-- ...|+..++..+|.|++.-++|+|++.+|.|||||+|.||+. ...
T Consensus 100 iLVidLL-GPSLEDLFD~C-----------gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~ 167 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLC-----------GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANV 167 (449)
T ss_pred hhhhhhh-CcCHHHHHHHh-----------cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCce
Confidence 8999987 55777765322 135999999999999999999999999999999999999974 346
Q ss_pred EEEecCcccccccCCc-----ceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCC---ChHH
Q psy7289 205 VKISDFGLSRDVYASD-----YYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY---SNQE 276 (422)
Q Consensus 205 vKl~DFGla~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~---~~~~ 276 (422)
+.|+|||+|+...... .|+....-.||.+||+-....+..-+...|+=|+|-++...+ +|..||.|. ++.+
T Consensus 168 IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFL-RGsLPWQGLKA~tnK~ 246 (449)
T KOG1165|consen 168 IHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL-RGSLPWQGLKADTNKE 246 (449)
T ss_pred EEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhc-cCCCccccccCcchHH
Confidence 8999999998754332 233344456899999999989999999999999998888777 499999975 4567
Q ss_pred HHHHHHcCCCCCCC----CCCCcchhhhcc
Q psy7289 277 VIEMIRSRQMLPCP----EDCPPRMYSLMM 302 (422)
Q Consensus 277 ~~~~i~~~~~~~~p----~~~p~~~~~l~~ 302 (422)
-++.|-...+...+ ++.|.++...|+
T Consensus 247 kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~ 276 (449)
T KOG1165|consen 247 KYEKIGETKRSTPIEVLCEGFPEEFATYLR 276 (449)
T ss_pred HHHHhccccccCCHHHHHhcCHHHHHHHHH
Confidence 77777655544322 345666655553
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=180.09 Aligned_cols=140 Identities=18% Similarity=0.177 Sum_probs=108.2
Q ss_pred ccccccccceeEEEEEEecCCCCeEEEEEEccCcCCH-----------------------H--hHHHHHHHHHHHhcCCC
Q psy7289 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQ-----------------------K--TASDFRREVDLMSELRH 113 (422)
Q Consensus 59 ~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~-----------------------~--~~~~~~~E~~il~~l~H 113 (422)
.+.||+|+||.||+|+.. ++..||||+++..... . ....+.+|.+.+.+++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~---~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 78 (190)
T cd05145 2 NGCISTGKEANVYHARTG---DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYE 78 (190)
T ss_pred CceeecCCCcEEEEEEcC---CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHh
Confidence 468999999999999864 4678999998653210 0 01234679999999999
Q ss_pred CceeeEeeEEEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCC
Q psy7289 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCS-HHYVHRDL 192 (422)
Q Consensus 114 pnIv~l~g~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDl 192 (422)
++|.....+... ..++||||++++++....... ..++..++..++.|++.+|.++|+ +||+||||
T Consensus 79 ~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~------------~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDl 144 (190)
T cd05145 79 AGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD------------VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDL 144 (190)
T ss_pred CCCCCceEEEec--CCEEEEEEecCCCchhhhhhh------------ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCC
Confidence 987544433322 248999999988654432221 246788899999999999999999 99999999
Q ss_pred CCCceeecCCCeEEEecCcccccc
Q psy7289 193 AARNCLVGDGLTVKISDFGLSRDV 216 (422)
Q Consensus 193 Kp~NiLl~~~~~vKl~DFGla~~~ 216 (422)
||+|||++ ++.++|+|||+++..
T Consensus 145 kP~NIll~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 145 SEYNILYH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred ChhhEEEE-CCCEEEEEcccceec
Confidence 99999998 789999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-23 Score=194.39 Aligned_cols=101 Identities=26% Similarity=0.516 Sum_probs=87.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
++.++.|||++++|||||||+|||++..++++++||||++.....+ ....+-+||+-|||||++....|+..+|+||+
T Consensus 134 i~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsL 211 (357)
T KOG0598|consen 134 IVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSL 211 (357)
T ss_pred HHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC--CccccccCCccccChHHHhcCCCCcccchHhH
Confidence 5679999999999999999999999999999999999999643332 12334578999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||++|||++ |..||.+.+..+..
T Consensus 212 GillYeML~-G~pPF~~~~~~~~~ 234 (357)
T KOG0598|consen 212 GILLYEMLT-GKPPFYAEDVKKMY 234 (357)
T ss_pred HHHHHHHhh-CCCCCcCccHHHHH
Confidence 999999996 99999998766643
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-23 Score=220.26 Aligned_cols=117 Identities=56% Similarity=1.009 Sum_probs=107.7
Q ss_pred cchhhhcccccccccchhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccc
Q psy7289 295 PRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPES 374 (422)
Q Consensus 295 ~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~ 374 (422)
..+.+|+.-|.+ +++|++||+++++|||||.++|||++....+||+|||+|+++...++++.......|++|||||.
T Consensus 799 L~~~dLl~~a~d---vA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEs 875 (1025)
T KOG1095|consen 799 LSMRDLLAFALD---VAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPES 875 (1025)
T ss_pred CCHHHHHHHHHH---HhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHH
Confidence 356777777764 89999999999999999999999999999999999999999988898988777788999999999
Q ss_pred cccCCCCcchhHHHHHHHHHHHHhcCCCCCCCCCchhhhh
Q psy7289 375 ILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFL 414 (422)
Q Consensus 375 ~~~~~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~~~~ 414 (422)
++.+.|++|+|||||||+|||+||.|..||.+.+|.++..
T Consensus 876 l~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~ 915 (1025)
T KOG1095|consen 876 LKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL 915 (1025)
T ss_pred HhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH
Confidence 9999999999999999999999999999999999988665
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.8e-23 Score=212.15 Aligned_cols=241 Identities=22% Similarity=0.239 Sum_probs=175.0
Q ss_pred ccccccccccceeEEEEEEecCCCCeEEEEEEcc----CcCCH-HhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK----ENANQ-KTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 57 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~----~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
...+.+|.|++|.|+........ ...+.|..+ ..... .....+..|.-+-..|+||||+..+..+.+.....-
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~--~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~ 398 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDL--KSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQ 398 (601)
T ss_pred CccceeeecccCceEEEEecCCC--ccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchh
Confidence 35678999999977766543322 222333221 11111 112236678888899999999888877766665555
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
.||||++ ||+.++... ..++..++..++.|++.|++|+|+.||.|||+|++|++++.++.+||+|||
T Consensus 399 ~mE~~~~-Dlf~~~~~~------------~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg 465 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMSN------------GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFG 465 (601)
T ss_pred hhhcccH-HHHHHHhcc------------cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecC
Confidence 6999999 999999763 247778889999999999999999999999999999999999999999999
Q ss_pred ccccccCCcc--eEeccCCCCCccccCccccccCCCCC-chhHHhHHHHHHHHHhCCCCCCCCCChHHH--HHHHHcCCC
Q psy7289 212 LSRDVYASDY--YRIQSKSLLPVRWMPPESILYGKFTT-ESDVWSYGVVLWEVYSYGLQPYYGYSNQEV--IEMIRSRQM 286 (422)
Q Consensus 212 la~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~--~~~i~~~~~ 286 (422)
.+........ .....+..|+-.|+|||++....|++ ..||||.|+++..|.+ |+.||.-....+- .........
T Consensus 466 ~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~-~~~~Wk~a~~~~~~~~~~~~~~~~ 544 (601)
T KOG0590|consen 466 AASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMIL-GRFPWKVAKKSDNSFKTNNYSDQR 544 (601)
T ss_pred cceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEec-CCCccccccccccchhhhcccccc
Confidence 9865432221 13445566778899999999999885 5899999999999997 7889965433322 111111111
Q ss_pred ------CCCCCCCCcchhhhcccccccccchhh
Q psy7289 287 ------LPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 287 ------~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
...-...|.+.+.+|.+.++.+|..|.
T Consensus 545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ 577 (601)
T KOG0590|consen 545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRI 577 (601)
T ss_pred ccccChHHHHHhchhhHHHHHHHHccCChhhee
Confidence 111235677888899999999998886
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-21 Score=175.20 Aligned_cols=135 Identities=19% Similarity=0.191 Sum_probs=103.1
Q ss_pred ccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-----CCCceeeEeeEEEcCC---C-e
Q psy7289 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-----RHPNIVCLLGVCLSGE---P-M 129 (422)
Q Consensus 59 ~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~g~~~~~~---~-~ 129 (422)
.+.||+|+||.||. +.. ... .+||++..... ...+.+.+|+.+++.+ +||||++++|++.++. . +
T Consensus 7 ~~~LG~G~~~~Vy~--hp~--~~~-k~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPE--DAQ-RCIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCC--CcC-eEEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 46799999999995 322 222 35887754322 2346789999999999 5799999999998874 3 3
Q ss_pred EEEEEe--cCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHH-HHHHhCCccccCCCCCceeecC----C
Q psy7289 130 CMLFEF--MVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGM-AYLCSHHYVHRDLAARNCLVGD----G 202 (422)
Q Consensus 130 ~lv~E~--~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL-~yLH~~~ivHrDlKp~NiLl~~----~ 202 (422)
.+|||| +++|+|.+++.+. .+++. ..++.|++.++ +|||+++|+||||||+|||++. +
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-------------~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~ 145 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-------------RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESE 145 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-------------cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCC
Confidence 378999 6689999999642 24444 35678888888 9999999999999999999974 3
Q ss_pred CeEEEecCcccc
Q psy7289 203 LTVKISDFGLSR 214 (422)
Q Consensus 203 ~~vKl~DFGla~ 214 (422)
..++|+||+-++
T Consensus 146 ~~~~LiDg~G~~ 157 (210)
T PRK10345 146 VIPVVCDNIGES 157 (210)
T ss_pred CcEEEEECCCCc
Confidence 479999955443
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.2e-22 Score=195.77 Aligned_cols=204 Identities=24% Similarity=0.453 Sum_probs=156.4
Q ss_pred HhcCCCCceeeEeeEEEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7289 108 MSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHY 187 (422)
Q Consensus 108 l~~l~HpnIv~l~g~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~i 187 (422)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+.... ..++..-...+.++|+.||+|||...|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-----------~~~d~~F~~s~~rdi~~Gl~ylh~s~i 69 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-----------IKLDYFFILSFIRDISKGLAYLHNSPI 69 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-----------cCccHHHHHHHHHHHHHHHHHHhcCcc
Confidence 467899999999999999999999999999999999997632 235555566789999999999999876
Q ss_pred -cccCCCCCceeecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCC-------CCCchhHHhHHHHHH
Q psy7289 188 -VHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK-------FTTESDVWSYGVVLW 259 (422)
Q Consensus 188 -vHrDlKp~NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-------~~~~~DvwS~Gvil~ 259 (422)
.|..|++.|++++....+||+|||+....................-|.|||.+.... .+.+.||||||++++
T Consensus 70 ~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ 149 (484)
T KOG1023|consen 70 GYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMY 149 (484)
T ss_pred eeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHH
Confidence 999999999999999999999999986553211111111111234699999987642 466799999999999
Q ss_pred HHHhCCCCCCCC----CChHHHHHHHHc-CCCCCCCC-----CCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 260 EVYSYGLQPYYG----YSNQEVIEMIRS-RQMLPCPE-----DCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 260 El~t~g~~Pf~~----~~~~~~~~~i~~-~~~~~~p~-----~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
|+++ ...||.. .++.+++..+.. +..+..|. .+++++..++++||.++|..|| ++..+..-++
T Consensus 150 ei~~-r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rP-----s~~~i~~~~~ 222 (484)
T KOG1023|consen 150 EILF-RSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRP-----SIEQIRSKLL 222 (484)
T ss_pred HHHh-ccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCc-----cHHHHHhhhh
Confidence 9998 5578865 334578888877 33222232 4667889999999999999998 6555554443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-21 Score=171.89 Aligned_cols=186 Identities=13% Similarity=0.070 Sum_probs=130.2
Q ss_pred cccccccccceeEEEEEEecCCCCeEEEEEEccCcCC---HHhHHHHHHHHHHHhcCC-CCceeeEeeEEEcCCCeEEEE
Q psy7289 58 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN---QKTASDFRREVDLMSELR-HPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 58 ~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~lv~ 133 (422)
+...|++|+||+||.+.. ....++.+.+....- ......|.+|+++|++|. |++|++++++ +..+++|
T Consensus 6 ~~~~l~~~~f~~v~~~~~----~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG----GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cceeecCCCcceEEEeec----CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 457899999999996532 345566665543321 111235789999999995 5889999886 3469999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCceeecCCCeEEEecCcc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDL-AARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDl-Kp~NiLl~~~~~vKl~DFGl 212 (422)
||+.|.+|.+.+.. . ...++.|++.+|+++|++||+|||| ||+|||++.++.++|+|||+
T Consensus 78 eyI~G~~L~~~~~~------------------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~ 138 (218)
T PRK12274 78 SYLAGAAMYQRPPR------------------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQL 138 (218)
T ss_pred eeecCccHHhhhhh------------------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCC
Confidence 99999998654311 1 1347789999999999999999999 79999999999999999999
Q ss_pred cccccCCcce----E-------eccCCCCCccccCccccccC-CCC-CchhHHhHHHHHHHHHhCCCCCCCC
Q psy7289 213 SRDVYASDYY----R-------IQSKSLLPVRWMPPESILYG-KFT-TESDVWSYGVVLWEVYSYGLQPYYG 271 (422)
Q Consensus 213 a~~~~~~~~~----~-------~~~~~~~t~~y~aPE~~~~~-~~~-~~~DvwS~Gvil~El~t~g~~Pf~~ 271 (422)
|......... . ...-...++.|++|+..... ..+ ...+.++-|.-+|.++|+|. |+.+
T Consensus 139 A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~-~~~~ 209 (218)
T PRK12274 139 AVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRV-LHWE 209 (218)
T ss_pred ceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccC-Cccc
Confidence 9754322100 0 00011235567777644322 233 45688899999999999554 4443
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.8e-22 Score=180.79 Aligned_cols=100 Identities=26% Similarity=0.514 Sum_probs=88.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..+++|||++.+++|||||+|+|++..+++|+.|||+++..... +++ -++|+-|+|||++....|+.++|+|||
T Consensus 153 ivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-T~T----lCGTPeYLAPEii~sk~ynkavDWWal 227 (355)
T KOG0616|consen 153 IVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-TWT----LCGTPEYLAPEIIQSKGYNKAVDWWAL 227 (355)
T ss_pred HHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-EEE----ecCCccccChHHhhcCCCCcchhHHHH
Confidence 556999999999999999999999999999999999999965433 343 457889999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhhhc
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEFLK 415 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~~~ 415 (422)
||++|||++ |..||...+..+++-|
T Consensus 228 GVLIYEMla-G~pPF~~~~~~~iY~K 252 (355)
T KOG0616|consen 228 GVLIYEMLA-GYPPFYDDNPIQIYEK 252 (355)
T ss_pred HHHHHHHHc-CCCCCcCCChHHHHHH
Confidence 999999996 9999999888776654
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.3e-22 Score=199.14 Aligned_cols=101 Identities=30% Similarity=0.500 Sum_probs=88.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||++++|+||||.+|||++..+++||+|||++|.....+ ..+++-+||+-|||||++..+.|+..+|+|||
T Consensus 477 v~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~l 554 (694)
T KOG0694|consen 477 VVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGL 554 (694)
T ss_pred HHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCC--CccccccCChhhcChhhhccCcccchhhHHHH
Confidence 5678999999999999999999999999999999999999754222 23566788999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||+||||+. |..||+|.+..|.|
T Consensus 555 GVLlyeML~-Gq~PF~gddEee~F 577 (694)
T KOG0694|consen 555 GVLLYEMLV-GESPFPGDDEEEVF 577 (694)
T ss_pred HHHHHHHHc-CCCCCCCCCHHHHH
Confidence 999999995 99999996665544
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.2e-22 Score=186.91 Aligned_cols=100 Identities=26% Similarity=0.545 Sum_probs=86.5
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCC------cceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcc
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDG------LTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTE 383 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~------~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 383 (422)
.+.++++||++++|||||||.|||+... ..+||+|||+||.+... ....+-+|++-|||||++..++|+.|
T Consensus 118 LA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAK 194 (429)
T KOG0595|consen 118 LASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAK 194 (429)
T ss_pred HHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch---hHHHHhhCCccccCHHHHHhccccch
Confidence 6889999999999999999999999764 67999999999976432 34566778899999999999999999
Q ss_pred hhHHHHHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 384 SDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 384 ~Dvws~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
+|+||+|+||||+++ |+.||...+-.|-+
T Consensus 195 ADLWSiG~Ilyq~l~-g~~Pf~a~t~~eL~ 223 (429)
T KOG0595|consen 195 ADLWSIGTILYQCLT-GKPPFDAETPKELL 223 (429)
T ss_pred hhHHHHHHHHHHHHh-CCCCccccCHHHHH
Confidence 999999999999996 99999875555533
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.3e-22 Score=185.16 Aligned_cols=93 Identities=35% Similarity=0.541 Sum_probs=84.2
Q ss_pred chhhHHHHhh-hhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHH
Q psy7289 310 VAAGMAYLCS-HHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~-~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 388 (422)
+.+|+.|||. +++||||+||.|+|++..+.+||||||.|+.+..+ ...+..+|..|||||.+.++.|+.++||||
T Consensus 187 VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWS 262 (364)
T KOG0581|consen 187 VLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWS 262 (364)
T ss_pred HHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceec
Confidence 4679999995 99999999999999999999999999999976654 455677888999999999999999999999
Q ss_pred HHHHHHHHHhcCCCCCCCC
Q psy7289 389 YGVVLWEVYSYGLQPYYGY 407 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~ 407 (422)
||+.++|+.+ |+.||...
T Consensus 263 LGLsllE~a~-GrfP~~~~ 280 (364)
T KOG0581|consen 263 LGLSLLELAI-GRFPYPPP 280 (364)
T ss_pred ccHHHHHHhh-CCCCCCCc
Confidence 9999999985 99999874
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-21 Score=189.25 Aligned_cols=99 Identities=40% Similarity=0.667 Sum_probs=85.1
Q ss_pred chhhHHHHhhhh-hhhhhcccccccccCCc-ceeecccccccccccCcceeeccccCCCcccCCccccc--cCCCCcchh
Q psy7289 310 VAAGMAYLCSHH-YVHRDLAARNCLVGDGL-TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL--YGKFTTESD 385 (422)
Q Consensus 310 ~~r~~~~lh~~~-~i~~dLk~~nil~~~~~-~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~D 385 (422)
++|||+|||++. +||||||++|+|++... ++||+|||+|+...... ...+...+|..|||||++. ...|+.|+|
T Consensus 151 iArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~D 228 (362)
T KOG0192|consen 151 IARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSD 228 (362)
T ss_pred HHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccch
Confidence 689999999999 99999999999999986 99999999998643321 2223366789999999999 558999999
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 386 VWSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 386 vws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||||||+||||+| |+.||.+....+
T Consensus 229 vySFgIvlWEl~t-~~~Pf~~~~~~~ 253 (362)
T KOG0192|consen 229 VYSFGIVLWELLT-GEIPFEDLAPVQ 253 (362)
T ss_pred hhhHHHHHHHHHH-CCCCCCCCCHHH
Confidence 9999999999998 999999987633
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-20 Score=196.54 Aligned_cols=209 Identities=26% Similarity=0.408 Sum_probs=151.5
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
-.+..++.++.|..|+||.||..+++.+ .+..|+|+-+++. ++|- ++.....|.+|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~t--rqrfa~kiNkq~l-------ilRn--ilt~a~npfvv------------- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKET--RQRFAMKINKQNL-------ILRN--ILTFAGNPFVV------------- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeecccc--ccchhhcccccch-------hhhc--cccccCCccee-------------
Confidence 3456788899999999999999876544 3557775422211 1111 23333333333
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
||-...++... +++. +.+.+++|||+.||+|||+||+|.||+.-|++|+.||
T Consensus 136 --------gDc~tllk~~g------------~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDf 187 (1205)
T KOG0606|consen 136 --------GDCATLLKNIG------------PLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDF 187 (1205)
T ss_pred --------chhhhhcccCC------------CCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccch
Confidence 66666665432 3443 2378999999999999999999999999999999999
Q ss_pred cccccccCCc------------ceE-eccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHH
Q psy7289 211 GLSRDVYASD------------YYR-IQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEV 277 (422)
Q Consensus 211 Gla~~~~~~~------------~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~ 277 (422)
|+++...... ... ...+..+|+.|.|||++..+.|+..+|+|++|+|+||.+. |..||.+.+++|+
T Consensus 188 gLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLV-gcvpffGdtpeel 266 (1205)
T KOG0606|consen 188 GLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLV-GCVPFFGDTPEEL 266 (1205)
T ss_pred hhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHhe-eeeeccCCCHHHH
Confidence 9987542110 001 1223478999999999999999999999999999999997 9999999999999
Q ss_pred HHHHHcCCCC--CCCCCCCcchhhhcccccccccchh
Q psy7289 278 IEMIRSRQML--PCPEDCPPRMYSLMMECWHEVPVAA 312 (422)
Q Consensus 278 ~~~i~~~~~~--~~p~~~p~~~~~l~~~cw~~~P~~r 312 (422)
+..+.+.... .-.+..|++.++++.+.++.+|..|
T Consensus 267 fg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~R 303 (1205)
T KOG0606|consen 267 FGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCR 303 (1205)
T ss_pred HhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhh
Confidence 9887764321 1123456777888877777777665
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.7e-21 Score=183.19 Aligned_cols=102 Identities=30% Similarity=0.570 Sum_probs=86.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCcccccc-CCCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws 388 (422)
+..|++++|+|+++|||+||+|||+.....+||+|||++|.+...+-++ .-+.|.||.|||+|+. +.|+.++||||
T Consensus 119 ilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYT---eYVSTRWYRAPEvLLrs~~Ys~pvD~wA 195 (538)
T KOG0661|consen 119 ILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYT---EYVSTRWYRAPEVLLRSGYYSSPVDMWA 195 (538)
T ss_pred HHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCcc---hhhhcccccchHHhhhccccCCchHHHH
Confidence 3469999999999999999999999878889999999999876654442 2345789999999884 56999999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhhhhc
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEEFLK 415 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~~~~ 415 (422)
+|||++|+.+ =+.-|+|.+.-|...|
T Consensus 196 ~GcI~aEl~s-LrPLFPG~sE~Dqi~K 221 (538)
T KOG0661|consen 196 VGCIMAELYS-LRPLFPGASEIDQIYK 221 (538)
T ss_pred HHHHHHHHHH-hcccCCCCcHHHHHHH
Confidence 9999999997 5677999888887766
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.8e-22 Score=199.37 Aligned_cols=104 Identities=53% Similarity=0.933 Sum_probs=93.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCc-ceeeccccCCCcccCCccccccCCCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD-YYRIQSKSLLPVRWMPPESILYGKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 388 (422)
++.+|.||-.++.+||||.++|||++.++..|++||||||.+.++. ......+.+.|++|.|||.|.+++|+.+|||||
T Consensus 740 IAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWS 819 (996)
T KOG0196|consen 740 IASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWS 819 (996)
T ss_pred HHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccc
Confidence 6779999999999999999999999999999999999999664432 333455677799999999999999999999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
|||++||.++||..||+.|+|.|+.
T Consensus 820 yGIVmWEVmSyGERPYWdmSNQdVI 844 (996)
T KOG0196|consen 820 YGIVMWEVMSYGERPYWDMSNQDVI 844 (996)
T ss_pred cceEEEEecccCCCcccccchHHHH
Confidence 9999999999999999999998853
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-21 Score=190.50 Aligned_cols=103 Identities=27% Similarity=0.502 Sum_probs=89.4
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..|+.|||++++||||||..|++++.+..+||+|||||.....++ ....+-+||+.|+|||++....+++++||||+
T Consensus 127 Iv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSl 204 (592)
T KOG0575|consen 127 IVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSL 204 (592)
T ss_pred HHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc--cccceecCCCcccChhHhccCCCCCchhhhhh
Confidence 5679999999999999999999999999999999999998654332 12344578999999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhhhc
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEFLK 415 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~~~ 415 (422)
||+||.|+ .|++||...+-.|++-+
T Consensus 205 GcvmYtLL-~G~PPFetk~vkety~~ 229 (592)
T KOG0575|consen 205 GCVMYTLL-VGRPPFETKTVKETYNK 229 (592)
T ss_pred hhHHHhhh-hCCCCcccchHHHHHHH
Confidence 99999999 59999999877777654
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.2e-21 Score=186.66 Aligned_cols=110 Identities=28% Similarity=0.485 Sum_probs=92.1
Q ss_pred chhhhcccccccccchhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCcccc
Q psy7289 296 RMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESI 375 (422)
Q Consensus 296 ~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~ 375 (422)
.+..+|++. ..|+.|||+.+++|||+|..|||+++++.+||+||||++....+. ...-+..++|+||.|||.|
T Consensus 219 qIKc~mkQL------l~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~-~~~~T~rVvTLWYRpPELL 291 (560)
T KOG0600|consen 219 QIKCYMKQL------LEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG-SAPYTSRVVTLWYRPPELL 291 (560)
T ss_pred HHHHHHHHH------HHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC-CcccccceEEeeccChHHh
Confidence 455566553 569999999999999999999999999999999999998543332 2224667889999999988
Q ss_pred ccC-CCCcchhHHHHHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 376 LYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 376 ~~~-~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
++. .|+.++|+||.||||+||++ |+..|+|.+..+..
T Consensus 292 LG~t~Yg~aVDlWS~GCIl~El~~-gkPI~~G~tEveQl 329 (560)
T KOG0600|consen 292 LGATSYGTAVDLWSVGCILAELFL-GKPILQGRTEVEQL 329 (560)
T ss_pred cCCcccccceeehhhhHHHHHHHc-CCCCcCCccHHHHH
Confidence 865 59999999999999999996 99999998777643
|
|
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.6e-21 Score=188.09 Aligned_cols=98 Identities=39% Similarity=0.683 Sum_probs=84.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
++.+|+|||.|.+||||||..|||+.....+||+|||-|+...... ..-.-.+|+.|||||+|.+...+.|+|||||
T Consensus 221 IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---TkMSFaGTVaWMAPEvIrnePcsEKVDIwSf 297 (904)
T KOG4721|consen 221 IAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSF 297 (904)
T ss_pred hhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhh---hhhhhhhhHhhhCHHHhhcCCcccccceehh
Confidence 6889999999999999999999999999999999999998643221 1123456889999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||+||||+| |..||..-+...
T Consensus 298 GVVLWEmLT-~EiPYkdVdssA 318 (904)
T KOG4721|consen 298 GVVLWEMLT-GEIPYKDVDSSA 318 (904)
T ss_pred HHHHHHHHh-cCCCccccchhe
Confidence 999999998 999997755443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.4e-19 Score=163.30 Aligned_cols=135 Identities=20% Similarity=0.272 Sum_probs=110.8
Q ss_pred cccccccceeEEEEEEecCCCCeEEEEEEccCcCC--H-----HhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN--Q-----KTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~--~-----~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
+.||+|++|.||+|++. +..|++|....... . .....+.+|+.++..++|+||.....++.+....+++
T Consensus 2 ~~l~~G~~~~vy~~~~~----~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFL----GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIV 77 (211)
T ss_pred cccccCceEEEEEEeeC----CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEE
Confidence 67999999999999862 34588887543221 1 1234678899999999999988777777777788999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||++|++|.+++... .. ....++.+++.+|.++|+.+++|||++|.|||++ ++.++|+|||+
T Consensus 78 ~e~~~G~~L~~~~~~~---------------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~ 140 (211)
T PRK14879 78 MEYIEGEPLKDLINSN---------------GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGL 140 (211)
T ss_pred EEEeCCcCHHHHHHhc---------------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCc
Confidence 9999999999998542 11 6788999999999999999999999999999999 78899999999
Q ss_pred ccc
Q psy7289 213 SRD 215 (422)
Q Consensus 213 a~~ 215 (422)
++.
T Consensus 141 a~~ 143 (211)
T PRK14879 141 AEF 143 (211)
T ss_pred ccC
Confidence 874
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.3e-20 Score=173.02 Aligned_cols=187 Identities=21% Similarity=0.321 Sum_probs=138.4
Q ss_pred CCCceeeEeeEEEcC---------------------------CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCC
Q psy7289 112 RHPNIVCLLGVCLSG---------------------------EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLS 164 (422)
Q Consensus 112 ~HpnIv~l~g~~~~~---------------------------~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~ 164 (422)
+|||||++.++|.++ ..+|+||.-.+. +|++||..+ ..+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-------------~~s 339 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-------------HRS 339 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-------------CCc
Confidence 699999999987542 246899987764 899999764 356
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec--CCC--eEEEecCcccccccCC----cceEeccCCCCCccccC
Q psy7289 165 QQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVG--DGL--TVKISDFGLSRDVYAS----DYYRIQSKSLLPVRWMP 236 (422)
Q Consensus 165 ~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~--~~~--~vKl~DFGla~~~~~~----~~~~~~~~~~~t~~y~a 236 (422)
.....-++.|+++|+.|||.+||.|||+|++|||+. +++ .+.|+|||-+-..... .+..-.-...|.-.-||
T Consensus 340 ~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmA 419 (598)
T KOG4158|consen 340 YRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMA 419 (598)
T ss_pred hHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecc
Confidence 677888999999999999999999999999999983 443 6789999976322111 01111111223345799
Q ss_pred ccccccCC------CCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHH-HHHHcCCCCCCCCCCCcchhhhccccccccc
Q psy7289 237 PESILYGK------FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVI-EMIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309 (422)
Q Consensus 237 PE~~~~~~------~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~-~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P 309 (422)
||+..... --.|+|.|+.|.+.||++. ..-||++....-+- ..-...+.++.|+.||+.+++|+...+..+|
T Consensus 420 PEi~ta~PGp~avvny~kAD~WA~GalaYEIfg-~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~p 498 (598)
T KOG4158|consen 420 PEIATAVPGPNAVVNYEKADTWAAGALAYEIFG-RSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDP 498 (598)
T ss_pred hhhhhcCCCCceeeccchhhhhhhhhhHHHHhc-cCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCc
Confidence 99876432 1258999999999999997 66799874322111 1134567788999999999999999999999
Q ss_pred chhh
Q psy7289 310 VAAG 313 (422)
Q Consensus 310 ~~r~ 313 (422)
..|.
T Consensus 499 skRv 502 (598)
T KOG4158|consen 499 SKRV 502 (598)
T ss_pred cccC
Confidence 8875
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.6e-21 Score=178.08 Aligned_cols=101 Identities=28% Similarity=0.457 Sum_probs=85.4
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccC-CCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws 388 (422)
+.||+.|+|+.+++||||||.|++++.+...||+|||+++...........+.-..|.||.|||++... .|+..+||||
T Consensus 134 iLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWS 213 (359)
T KOG0660|consen 134 ILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWS 213 (359)
T ss_pred HHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhh
Confidence 457999999999999999999999999999999999999975432222233555668899999988765 5999999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
.||||+||++ |+.-|+|.+.-+
T Consensus 214 vGCI~AEmL~-gkplFpG~d~v~ 235 (359)
T KOG0660|consen 214 VGCILAEMLT-GKPLFPGKDYVH 235 (359)
T ss_pred hhHHHHHHHc-CCCCCCCCchHH
Confidence 9999999996 999999977655
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-20 Score=176.97 Aligned_cols=110 Identities=28% Similarity=0.565 Sum_probs=90.7
Q ss_pred hhhhcccccccccchhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccc
Q psy7289 297 MYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL 376 (422)
Q Consensus 297 ~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 376 (422)
+..+|.+ ..+|+.|||+++++||||||.|+++++.+.+|++|||+|+...-. .+.-+...+|.||.|||++.
T Consensus 122 ik~~m~Q------ll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip--~~~yt~evvTlWYRaPEvLl 193 (323)
T KOG0594|consen 122 IKSFMRQ------LLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIP--MRTYTPEVVTLWYRAPEVLL 193 (323)
T ss_pred HHHHHHH------HHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCC--cccccccEEEeeccCHHHhc
Confidence 4555554 467999999999999999999999999999999999999853211 12245677899999999998
Q ss_pred cC-CCCcchhHHHHHHHHHHHHhcCCCCCCCCCchhhhhc
Q psy7289 377 YG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415 (422)
Q Consensus 377 ~~-~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~~~~~ 415 (422)
+. .|++.+||||+|||++||++ ++.=|+|.++-+...+
T Consensus 194 Gs~~Ys~~vDiWs~GcIfaEm~~-~~~LFpG~se~~ql~~ 232 (323)
T KOG0594|consen 194 GSTSYSTSVDIWSLGCIFAEMFT-RRPLFPGDSEIDQLFR 232 (323)
T ss_pred CCCcCCCCcchHhHHHHHHHHHh-CCCCCCCCcHHHHHHH
Confidence 76 69999999999999999997 8888988777654433
|
|
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.1e-21 Score=190.54 Aligned_cols=104 Identities=28% Similarity=0.400 Sum_probs=82.6
Q ss_pred hhhhcccccccccchhhHHHHhhhhhhhhhcccccccccCC--cceeecccccccccccCcceeeccccCCCcccCCccc
Q psy7289 297 MYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDG--LTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPES 374 (422)
Q Consensus 297 ~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk~~nil~~~~--~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~ 374 (422)
++.+.++| ..++.+||..++||.||||+|||+... ..+|+.|||.|......-+..+|+ ..|.|||+
T Consensus 291 ir~~~~Qi------l~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vytYiQS-----RfYRAPEV 359 (586)
T KOG0667|consen 291 VRKFAQQI------LTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVYTYIQS-----RFYRAPEV 359 (586)
T ss_pred HHHHHHHH------HHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcceeeeec-----cccccchh
Confidence 44455554 458999999999999999999998654 369999999997533322223343 56999999
Q ss_pred cccCCCCcchhHHHHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 375 ILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 375 ~~~~~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
|++..|++++||||||||++||++ |..-|+|.+..+.
T Consensus 360 ILGlpY~~~IDmWSLGCIlAEL~t-G~PLfpG~ne~DQ 396 (586)
T KOG0667|consen 360 ILGLPYDTAIDMWSLGCILAELFT-GEPLFPGDNEYDQ 396 (586)
T ss_pred hccCCCCCccceeehhhhHHhHhc-CccccCCCCHHHH
Confidence 999999999999999999999997 9777888666553
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-20 Score=169.01 Aligned_cols=100 Identities=27% Similarity=0.452 Sum_probs=84.6
Q ss_pred chhhHHHHhh----hhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchh
Q psy7289 310 VAAGMAYLCS----HHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESD 385 (422)
Q Consensus 310 ~~r~~~~lh~----~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 385 (422)
..+++..||+ ..++|||+||.||+++.++.+|+.||||++.+..+. ....+-++|+.||+||.+....|++|||
T Consensus 133 L~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSD 210 (375)
T KOG0591|consen 133 LCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSD 210 (375)
T ss_pred HHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchh
Confidence 3578889998 349999999999999999999999999999654332 3456678899999999999999999999
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 386 VWSYGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 386 vws~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
|||+||++|||.+ =+.||.|. |-..+
T Consensus 211 iWslGCllyEMca-L~~PF~g~-n~~~L 236 (375)
T KOG0591|consen 211 IWSLGCLLYEMCA-LQSPFYGD-NLLSL 236 (375)
T ss_pred HHHHHHHHHHHHh-cCCCcccc-cHHHH
Confidence 9999999999997 67899995 44333
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=4e-21 Score=189.28 Aligned_cols=104 Identities=44% Similarity=0.961 Sum_probs=96.2
Q ss_pred cchhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHH
Q psy7289 309 PVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWS 388 (422)
Q Consensus 309 P~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 388 (422)
.+..+|+||...++|||||.++|||++.+..+|++|||||+.+. .++|+...+.+.++.|.|||.|.+..|+.|+|||+
T Consensus 373 QIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt-gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWA 451 (1157)
T KOG4278|consen 373 QISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWA 451 (1157)
T ss_pred HHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhc-CCceecccCccCcccccCcccccccccccchhhHH
Confidence 36789999999999999999999999999999999999999765 45677888999999999999999999999999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
|||+|||+.|||-.||+|.+-.+++
T Consensus 452 FGVLLWEIATYGMsPYPGidlSqVY 476 (1157)
T KOG4278|consen 452 FGVLLWEIATYGMSPYPGIDLSQVY 476 (1157)
T ss_pred HHHHHHHHHhcCCCCCCCccHHHHH
Confidence 9999999999999999999887754
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-20 Score=184.02 Aligned_cols=105 Identities=26% Similarity=0.438 Sum_probs=86.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcce------ee---c--cccCCCcccCCccccccC
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYY------RI---Q--SKSLLPVRWMPPESILYG 378 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~------~~---~--~~~~~~~~y~aPE~~~~~ 378 (422)
+..+++|||++++|||||||+|||++.++++||+|||-++.+...... .. . ++-+||..|.+||.|.++
T Consensus 183 IldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~ 262 (604)
T KOG0592|consen 183 ILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS 262 (604)
T ss_pred HHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCC
Confidence 356899999999999999999999999999999999999865432111 11 1 335678899999999999
Q ss_pred CCCcchhHHHHHHHHHHHHhcCCCCCCCCCchhhhhc
Q psy7289 379 KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415 (422)
Q Consensus 379 ~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~~~~~ 415 (422)
..+..+|+|+||||||.|++ |..||.+.+.--+|-|
T Consensus 263 ~~~~~sDiWAlGCilyQmla-G~PPFra~NeyliFqk 298 (604)
T KOG0592|consen 263 PAGPSSDLWALGCILYQMLA-GQPPFRAANEYLIFQK 298 (604)
T ss_pred CCCcccchHHHHHHHHHHhc-CCCCCccccHHHHHHH
Confidence 88999999999999999997 9999999655544443
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-20 Score=173.95 Aligned_cols=109 Identities=26% Similarity=0.464 Sum_probs=90.5
Q ss_pred chhhhcccccccccchhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCcccc
Q psy7289 296 RMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESI 375 (422)
Q Consensus 296 ~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~ 375 (422)
+...||.+. .++++|||.+.++|||||++|+|+...+.+||+|||++|..... ..--+.-++|.||.|||.+
T Consensus 178 evK~L~~Ql------L~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp--~k~~T~lVVTLWYRaPELL 249 (419)
T KOG0663|consen 178 EVKTLMLQL------LRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP--LKPYTPLVVTLWYRAPELL 249 (419)
T ss_pred HHHHHHHHH------HHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC--cccCcceEEEeeecCHHHh
Confidence 444555543 57999999999999999999999999999999999999964222 2334556779999999988
Q ss_pred ccC-CCCcchhHHHHHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 376 LYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 376 ~~~-~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
++- .|++++||||+|||++||++ ++.-|+|.+..+..
T Consensus 250 LG~~tyst~iDMWSvGCI~aE~l~-~kPlf~G~sE~dQl 287 (419)
T KOG0663|consen 250 LGAKTYSTAVDMWSVGCIFAELLT-QKPLFPGKSEIDQL 287 (419)
T ss_pred cCCcccCcchhhhhHHHHHHHHHh-cCCCCCCCchHHHH
Confidence 865 49999999999999999997 89999998887743
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-19 Score=166.87 Aligned_cols=143 Identities=16% Similarity=0.118 Sum_probs=108.0
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCH---------------------H--hHHHHHHHHHHHhcC
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQ---------------------K--TASDFRREVDLMSEL 111 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~---------------------~--~~~~~~~E~~il~~l 111 (422)
-|++.+.||+|+||.||+|.... .++..||||+++..... . ....+.+|+.++.++
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~-~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFD-GSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecC-CCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 46788999999999999997211 23578999988643210 0 113456899999999
Q ss_pred CCCc--eeeEeeEEEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCC-cc
Q psy7289 112 RHPN--IVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHH-YV 188 (422)
Q Consensus 112 ~Hpn--Iv~l~g~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-iv 188 (422)
.+.. +.+.++. ...++||||+++++|..+.... ..+...++..++.|++.+|++||++| |+
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~------------~~~~~~~~~~i~~qi~~~l~~LH~~g~ii 171 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD------------VEPEEEEEFELYDDILEEMRKLYKEGELV 171 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCccccccccc------------CCcchHHHHHHHHHHHHHHHHHHhcCCEE
Confidence 7532 3444442 2358999999998887654221 23456667899999999999999999 99
Q ss_pred ccCCCCCceeecCCCeEEEecCccccc
Q psy7289 189 HRDLAARNCLVGDGLTVKISDFGLSRD 215 (422)
Q Consensus 189 HrDlKp~NiLl~~~~~vKl~DFGla~~ 215 (422)
||||||+||+++ ++.++|+|||++..
T Consensus 172 H~Dikp~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 172 HGDLSEYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred eCCCChhhEEEE-CCCEEEEEChhhhc
Confidence 999999999999 78899999999864
|
|
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.8e-21 Score=189.25 Aligned_cols=114 Identities=44% Similarity=0.803 Sum_probs=96.0
Q ss_pred hhhhcccccccccchhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccc
Q psy7289 297 MYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL 376 (422)
Q Consensus 297 ~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 376 (422)
+.+.++.|+. .++||+|||++++||||+.++|||++.+..+||+|||+|+... .+.........|++|+|||.+.
T Consensus 261 ~~ek~~~~~~---AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~--~~~~~~~~~klPirWLAPEtl~ 335 (474)
T KOG0194|consen 261 TLEKLRFCYD---AARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS--QYVMKKFLKKLPIRWLAPETLN 335 (474)
T ss_pred HHHHHHHHHH---HHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCc--ceeeccccccCcceecChhhhc
Confidence 3456666664 7899999999999999999999999998889999999998532 2222222456899999999999
Q ss_pred cCCCCcchhHHHHHHHHHHHHhcCCCCCCCCCchhhhhc
Q psy7289 377 YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415 (422)
Q Consensus 377 ~~~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~~~~~ 415 (422)
.+.||+++|||||||++||+++.|..||+|+++.++..+
T Consensus 336 ~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~k 374 (474)
T KOG0194|consen 336 TGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAK 374 (474)
T ss_pred cCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHH
Confidence 999999999999999999999999999999998775443
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.1e-20 Score=165.95 Aligned_cols=99 Identities=29% Similarity=0.512 Sum_probs=82.2
Q ss_pred hhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccC-CCCcchhHHHH
Q psy7289 311 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSY 389 (422)
Q Consensus 311 ~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws~ 389 (422)
.+|++|||++.++|||+||.|+|+++++.+|++|||+++.....+ +.++..++|.||.|||.+.+. .|++.+||||.
T Consensus 111 LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~--~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWav 188 (318)
T KOG0659|consen 111 LKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN--RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAV 188 (318)
T ss_pred HHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCC--cccccceeeeeccChHHhccchhcCCcchhhhH
Confidence 579999999999999999999999999999999999999754433 334555789999999977643 59999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
|||++||+. |..=|+|.++-|.
T Consensus 189 GCI~AELll-r~P~fpG~sDidQ 210 (318)
T KOG0659|consen 189 GCIFAELLL-RVPFFPGDSDIDQ 210 (318)
T ss_pred HHHHHHHHc-cCCCCCCCchHHH
Confidence 999999994 6555666555553
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.5e-19 Score=183.68 Aligned_cols=136 Identities=23% Similarity=0.269 Sum_probs=107.8
Q ss_pred ccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC-----HHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN-----QKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 57 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
...+.||+|+||.||+|.+... ...++++..+.... ....+.+.+|+++++.++|+||+....++.+....++
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred CccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 3467899999999999986432 22222222221111 1123578899999999999999988877777778899
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
||||+++++|.+++.. ...++.|++.+|.|||+.+++||||||+|||+ +++.++|+|||
T Consensus 414 v~E~~~g~~L~~~l~~--------------------~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 414 VMEYIGGKDLKDVLEG--------------------NPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred EEEecCCCcHHHHHHH--------------------HHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCc
Confidence 9999999999998842 35689999999999999999999999999999 56789999999
Q ss_pred cccc
Q psy7289 212 LSRD 215 (422)
Q Consensus 212 la~~ 215 (422)
+++.
T Consensus 473 la~~ 476 (535)
T PRK09605 473 LGKY 476 (535)
T ss_pred cccc
Confidence 9975
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.4e-20 Score=180.88 Aligned_cols=104 Identities=28% Similarity=0.539 Sum_probs=84.4
Q ss_pred hhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccC----------------------cce-----e-----
Q psy7289 311 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS----------------------DYY-----R----- 358 (422)
Q Consensus 311 ~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~----------------------~~~-----~----- 358 (422)
..+++-+|++++|||||||+|+|++..+++|++|||||+..... +.. .
T Consensus 251 vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (550)
T KOG0605|consen 251 VLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSR 330 (550)
T ss_pred HHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhH
Confidence 45888999999999999999999999999999999998532110 000 0
Q ss_pred -------------eccccCCCcccCCccccccCCCCcchhHHHHHHHHHHHHhcCCCCCCCCCchhhhhc
Q psy7289 359 -------------IQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415 (422)
Q Consensus 359 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~~~~~ 415 (422)
...+..||+.|||||++++..|+..+|+||+|||+|||+. |=+||.+.+.++++-|
T Consensus 331 ~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLv-GyPPF~s~tp~~T~rk 399 (550)
T KOG0605|consen 331 REQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLV-GYPPFCSETPQETYRK 399 (550)
T ss_pred HHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence 0123457888999999999899999999999999999995 9999999777776543
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-20 Score=194.82 Aligned_cols=229 Identities=18% Similarity=0.278 Sum_probs=167.2
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHH---HHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDF---RREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~---~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
.+...+.||++.|=+|.+|++.. ..|.||++-+....-....| ++|++ ...++|||++.+.-+-......||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e----G~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE----GLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC----ceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHH
Confidence 56778999999999999987532 23888887544322223333 44555 566699999999887766777788
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
|=+|..+ +|+|.|..| .-+..-+..-|+.|++.||.-+|..||+|+|||.+||||+.=+.+.|+||.
T Consensus 99 vRqyvkh-nLyDRlSTR------------PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFA 165 (1431)
T KOG1240|consen 99 VRQYVKH-NLYDRLSTR------------PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFA 165 (1431)
T ss_pred HHHHHhh-hhhhhhccc------------hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhccc
Confidence 8888765 899988654 246777888899999999999999999999999999999999999999999
Q ss_pred ccccccCC-----cceEeccCCCCCccccCccccccCC-----------CCCchhHHhHHHHHHHHHhCCCCCCCC----
Q psy7289 212 LSRDVYAS-----DYYRIQSKSLLPVRWMPPESILYGK-----------FTTESDVWSYGVVLWEVYSYGLQPYYG---- 271 (422)
Q Consensus 212 la~~~~~~-----~~~~~~~~~~~t~~y~aPE~~~~~~-----------~~~~~DvwS~Gvil~El~t~g~~Pf~~---- 271 (422)
..+..+-. ++.-.-.+......|+|||.+.... .+++-||+|+||++.|+++.|.+||.-
T Consensus 166 sFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~ 245 (1431)
T KOG1240|consen 166 SFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLL 245 (1431)
T ss_pred ccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHH
Confidence 87765421 1111111122224599999876421 567789999999999999999998841
Q ss_pred -------CChHHHHHHHHcCCCCCCCCCCCcchhhhcccccccccchh
Q psy7289 272 -------YSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAA 312 (422)
Q Consensus 272 -------~~~~~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r 312 (422)
.+.+.+++.|. ...++.|+..+.+.+|..|
T Consensus 246 aYr~~~~~~~e~~Le~Ie-----------d~~~Rnlil~Mi~rdPs~R 282 (1431)
T KOG1240|consen 246 AYRSGNADDPEQLLEKIE-----------DVSLRNLILSMIQRDPSKR 282 (1431)
T ss_pred hHhccCccCHHHHHHhCc-----------CccHHHHHHHHHccCchhc
Confidence 12223333332 1267889999999999776
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.8e-19 Score=185.39 Aligned_cols=150 Identities=21% Similarity=0.245 Sum_probs=107.1
Q ss_pred HHHHHHHHHHhcCCCCceeeEeeEEEcCCCe----EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHH
Q psy7289 99 SDFRREVDLMSELRHPNIVCLLGVCLSGEPM----CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174 (422)
Q Consensus 99 ~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~----~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 174 (422)
+....|...+.++.|+|+++++.+-...... .+..|+|..-++...+..- ...+..+++.+..+
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v------------~~i~~~~~r~~~~~ 294 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV------------GSIPLETLRILHQK 294 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc------------cccCHHHHHHHHHH
Confidence 3444577778899999999999987655433 3446788888888777553 45788899999999
Q ss_pred HHHHHHHHHhCCccccCCCCC---ceeecCCCeEEEe--cCcccccccCCcceEeccCCCCCccccCccccccCCCCC--
Q psy7289 175 VAAGMAYLCSHHYVHRDLAAR---NCLVGDGLTVKIS--DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTT-- 247 (422)
Q Consensus 175 i~~gL~yLH~~~ivHrDlKp~---NiLl~~~~~vKl~--DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-- 247 (422)
+..||.|+|+....|.-|..+ +-..+..+.+.++ ||+.++........ .....+..|.|||......+..
T Consensus 295 ~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r 371 (1351)
T KOG1035|consen 295 LLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSR 371 (1351)
T ss_pred HhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhh
Confidence 999999999997666665555 4444556677777 99888765433221 1222345578888777655444
Q ss_pred chhHHhHHHHHHHHHh
Q psy7289 248 ESDVWSYGVVLWEVYS 263 (422)
Q Consensus 248 ~~DvwS~Gvil~El~t 263 (422)
..|+|.+|.....+..
T Consensus 372 ~~dL~~lgll~~~~~~ 387 (1351)
T KOG1035|consen 372 LTDLWCLGLLLLQLSQ 387 (1351)
T ss_pred hhHHHHHHHHHhhhhh
Confidence 4799999999888765
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.2e-20 Score=170.43 Aligned_cols=100 Identities=24% Similarity=0.499 Sum_probs=84.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeeccccccccccc-CcceeeccccCCCcccCCcccccc-CCCCcchhHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA-SDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVW 387 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~-~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvw 387 (422)
..+++.|||++++||||+||+|||+..++.+|+||||+++.+.. ++.| +.-+-|.||.|||.+.+ -+|...+|||
T Consensus 110 ~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y---TDYVATRWYRaPELLvGDtqYG~pVDiW 186 (396)
T KOG0593|consen 110 LLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY---TDYVATRWYRAPELLVGDTQYGKPVDIW 186 (396)
T ss_pred HHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh---hhhhhhhhccChhhhcccCcCCCcccch
Confidence 46799999999999999999999999999999999999997653 2222 22334689999998876 4799999999
Q ss_pred HHHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 388 SYGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
|+||+++||++ |..-|+|.++-+.+
T Consensus 187 AiGCv~aEl~~-G~pL~PG~SDiDQL 211 (396)
T KOG0593|consen 187 AIGCVFAELLT-GEPLWPGRSDIDQL 211 (396)
T ss_pred hhhHHHHHHhc-CCcCCCCcchHHHH
Confidence 99999999997 98888888776643
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.8e-20 Score=174.24 Aligned_cols=103 Identities=27% Similarity=0.519 Sum_probs=89.4
Q ss_pred cchhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHH
Q psy7289 309 PVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWS 388 (422)
Q Consensus 309 P~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 388 (422)
-++.++-+||+.++|.||||.+|++++..+++||+|||++++...++.. ..+-++|+.|+|||++.+..|+.++|+||
T Consensus 458 EiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~T--TkTFCGTPdYiAPEIi~YqPYgksvDWWa 535 (683)
T KOG0696|consen 458 EIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWA 535 (683)
T ss_pred HHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcc--eeeecCCCcccccceEEecccccchhHHH
Confidence 3677899999999999999999999999999999999999975443321 23456789999999999999999999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhhhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEEFL 414 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~~~ 414 (422)
|||+||||++ |+.||.|.+..|.|.
T Consensus 536 ~GVLLyEmla-GQpPFdGeDE~elF~ 560 (683)
T KOG0696|consen 536 FGVLLYEMLA-GQPPFDGEDEDELFQ 560 (683)
T ss_pred HHHHHHHHHc-CCCCCCCCCHHHHHH
Confidence 9999999996 999999977766554
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=2e-20 Score=182.83 Aligned_cols=243 Identities=18% Similarity=0.238 Sum_probs=160.6
Q ss_pred ccCcccccccccccceeEEEEEEecCC-CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEee-------EEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSE-GPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLG-------VCL 124 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g-------~~~ 124 (422)
....++.+..+..+++.+...+..... ..+.++.+..+.. +........+++-.+....|-|..-+.. ...
T Consensus 243 ~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d-~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~ 321 (516)
T KOG1033|consen 243 SGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVD-SLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSK 321 (516)
T ss_pred cccccccccccccccCCchhhhhcccchhhhhccchhhhcc-chhhhhhhhhhhhheeccccCCcccccCCCCchhhhcc
Confidence 344566677888888887765433221 1223333332221 1112222334554444444433332222 111
Q ss_pred -----cCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceee
Q psy7289 125 -----SGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV 199 (422)
Q Consensus 125 -----~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl 199 (422)
....+|+.|++|...+|.+||..+... ..-+......++.|++.|++| ++.+|||+||.||..
T Consensus 322 ~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~---------e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~ 389 (516)
T KOG1033|consen 322 RNKVGKKVYLYIQMNLCEKETLEDWLRRRRTG---------EERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFF 389 (516)
T ss_pred ccccccccchhhhhhhhhhhhHHHHhhCCCcc---------cccchhHHHHHHHhhccchhh---ccchhhhcccccccc
Confidence 122589999999999999999765432 224555678899999999999 999999999999999
Q ss_pred cCCCeEEEecCcccccccCCc----ceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCC-h
Q psy7289 200 GDGLTVKISDFGLSRDVYASD----YYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS-N 274 (422)
Q Consensus 200 ~~~~~vKl~DFGla~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~-~ 274 (422)
..+..+||.|||+...+.... .....+...+|..||+||.+.+..|+.++||||||++++|++. +|.-.. .
T Consensus 390 ~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~----~f~T~~er 465 (516)
T KOG1033|consen 390 SDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI----QFSTQFER 465 (516)
T ss_pred ccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH----HhccHHHH
Confidence 999999999999987654433 1223455678999999999999999999999999999999997 332211 1
Q ss_pred HHHHHHHHcCCCCCC-CCCCCcchhhhcccccccccchhh
Q psy7289 275 QEVIEMIRSRQMLPC-PEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 275 ~~~~~~i~~~~~~~~-p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.....-++.+..+|. -.+.| .-+.|+.+.++..|..||
T Consensus 466 ~~t~~d~r~g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP 504 (516)
T KOG1033|consen 466 IATLTDIRDGIIPPEFLQDYP-EEYTLLQQLLSPSPEERP 504 (516)
T ss_pred HHhhhhhhcCCCChHHhhcCc-HHHHHHHHhcCCCcccCc
Confidence 123444556655432 22333 346788888899999998
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.4e-20 Score=160.17 Aligned_cols=102 Identities=30% Similarity=0.439 Sum_probs=86.7
Q ss_pred chhhHHHHhh-hhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccC----CCCcch
Q psy7289 310 VAAGMAYLCS-HHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG----KFTTES 384 (422)
Q Consensus 310 ~~r~~~~lh~-~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~ 384 (422)
+..+++|||+ ..+||||+||.|||++..+.+|+||||+|..+.++-..+++++.+ .|||||.+..+ .|+.||
T Consensus 157 vv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCk---pYmaPEri~~e~n~~gY~vks 233 (282)
T KOG0984|consen 157 VVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMDAGCK---PYMAPERINPELNQKGYSVKS 233 (282)
T ss_pred HHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHhcCCC---ccCChhhcCcccCcccceeeh
Confidence 4578999996 589999999999999999999999999998766554334444443 49999988643 599999
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCchhhhhc
Q psy7289 385 DVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415 (422)
Q Consensus 385 Dvws~Gv~l~el~~~g~~p~~~~~~~~~~~~ 415 (422)
||||||+.+.||.+ ++.||+.+-++.++++
T Consensus 234 DvWSLGItmiElA~-lr~PY~~w~tpF~qLk 263 (282)
T KOG0984|consen 234 DVWSLGITMIEMAI-LRFPYESWGTPFQQLK 263 (282)
T ss_pred hhhhhhhhhhhhhh-ccccccccCCHHHHHH
Confidence 99999999999985 9999999999998887
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.79 E-value=7e-19 Score=158.82 Aligned_cols=131 Identities=18% Similarity=0.258 Sum_probs=104.0
Q ss_pred ccccccceeEEEEEEecCCCCeEEEEEEccCcC--C-----HHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 61 ELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--N-----QKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 61 ~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~-----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
.||+|+||.||+|.+. +..|++|...... . ......+.+|++++..++|+++.....++...+..++||
T Consensus 1 ~ig~G~~~~vy~~~~~----~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL----GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVM 76 (199)
T ss_pred CCCCCceEEEEEeecC----CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEE
Confidence 4899999999999852 2458888754321 1 112356788999999999887655444555666789999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||++|++|.+++.... ..++.|++.+|.+||+.+++|+|++|+||+++ ++.+++.|||++
T Consensus 77 e~~~g~~l~~~~~~~~-------------------~~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a 136 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGN-------------------DELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLG 136 (199)
T ss_pred EEECCccHHHHHhhcH-------------------HHHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCC
Confidence 9999999999875320 06899999999999999999999999999999 789999999998
Q ss_pred cc
Q psy7289 214 RD 215 (422)
Q Consensus 214 ~~ 215 (422)
+.
T Consensus 137 ~~ 138 (199)
T TIGR03724 137 KY 138 (199)
T ss_pred cC
Confidence 75
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.4e-20 Score=176.45 Aligned_cols=95 Identities=27% Similarity=0.436 Sum_probs=84.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+.-|+++||+..++.|||||+|||+|+.+++.|+|.||+.++.... ...+..+|++|||||++.++.|+++.|+||+
T Consensus 296 i~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~l 372 (591)
T KOG0986|consen 296 IICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSL 372 (591)
T ss_pred HHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC---ccccccCcccccCHHHHcCCcccCCccHHHH
Confidence 4569999999999999999999999999999999999998765443 2345688999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCC
Q psy7289 390 GVVLWEVYSYGLQPYYGYS 408 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~ 408 (422)
||++|||+. |+.||...-
T Consensus 373 GCllYemi~-G~sPFr~~K 390 (591)
T KOG0986|consen 373 GCLLYEMIA-GHSPFRQRK 390 (591)
T ss_pred HhHHHHHHc-ccCchhhhh
Confidence 999999996 999998753
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-19 Score=178.55 Aligned_cols=103 Identities=28% Similarity=0.410 Sum_probs=86.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCC-cceeecccccccccccCcceeeccccCCCcccCCccccccCC-CC-cchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDG-LTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK-FT-TESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~-~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~Dv 386 (422)
...+++|||+++++||||||+|++++.+ ..+|++|||+|.... .........+|++.|+|||++.+.. |+ .++||
T Consensus 129 lisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDv 206 (370)
T KOG0583|consen 129 LISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADV 206 (370)
T ss_pred HHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhh
Confidence 4679999999999999999999999998 999999999998652 1122345677889999999999877 87 68999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchhhhhc
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~~~~~ 415 (422)
||+||+||.|++ |..||...+.+..+.+
T Consensus 207 WS~GViLy~ml~-G~~PF~d~~~~~l~~k 234 (370)
T KOG0583|consen 207 WSLGVILYVLLC-GRLPFDDSNVPNLYRK 234 (370)
T ss_pred hhhHHHHHHHHh-CCCCCCCccHHHHHHH
Confidence 999999999985 9999999666655544
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-19 Score=173.63 Aligned_cols=109 Identities=30% Similarity=0.589 Sum_probs=91.2
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCc---ceeeccccCCCcccCCccccccC--CCCcch
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD---YYRIQSKSLLPVRWMPPESILYG--KFTTES 384 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~ 384 (422)
..+++.|||.++.||||+|+.|||++.++.+|++|||.+..++.+. ..++ ....++++|||||+++.. .|++|+
T Consensus 135 ~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf-~tfvgtp~wmAPEvl~q~~~GYdfKa 213 (516)
T KOG0582|consen 135 VLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRF-NTFVGTPCWMAPEVLMQQLHGYDFKA 213 (516)
T ss_pred HHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEee-ccccCcccccChHHhhhcccCccchh
Confidence 3579999999999999999999999999999999999998776543 1122 445778999999996543 499999
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCchhhhhc----CCCCC
Q psy7289 385 DVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK----TPPSW 420 (422)
Q Consensus 385 Dvws~Gv~l~el~~~g~~p~~~~~~~~~~~~----~~~~~ 420 (422)
||||||+...||. .|..||..+...++++. .||+.
T Consensus 214 DIwSfGITA~ELA-~G~aPf~k~pPmkvLl~tLqn~pp~~ 252 (516)
T KOG0582|consen 214 DIWSFGITACELA-HGHAPFSKYPPMKVLLLTLQNDPPTL 252 (516)
T ss_pred hhhhhhHHHHHHh-cCCCCcccCChHHHHHHHhcCCCCCc
Confidence 9999999999998 59999999999986554 56654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=156.81 Aligned_cols=136 Identities=16% Similarity=0.165 Sum_probs=105.5
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCH---------------------HhHHHHHHHHHHHhcCCCC
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQ---------------------KTASDFRREVDLMSELRHP 114 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~E~~il~~l~Hp 114 (422)
|.+.+.||+|+||.||++... +++.||||++...... .....+.+|..++..+.|+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 93 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP---DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE 93 (198)
T ss_pred hhcCCccccCcceEEEEEEcC---CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence 667889999999999999753 3578999986532100 0112467899999999887
Q ss_pred c--eeeEeeEEEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy7289 115 N--IVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDL 192 (422)
Q Consensus 115 n--Iv~l~g~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDl 192 (422)
+ +...++ ....++||||+++++|.+.... .....++.+++.++.++|+.+|+||||
T Consensus 94 ~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------------------~~~~~~~~~i~~~l~~lh~~gi~H~Dl 151 (198)
T cd05144 94 GFPVPKPID----WNRHAVVMEYIDGVELYRVRVL------------------EDPEEVLDEILEEIVKAYKHGIIHGDL 151 (198)
T ss_pred CCCCCceee----cCCceEEEEEeCCcchhhcccc------------------ccHHHHHHHHHHHHHHHHHCCCCcCCC
Confidence 4 444443 2456899999999998764310 234578899999999999999999999
Q ss_pred CCCceeecCCCeEEEecCcccccc
Q psy7289 193 AARNCLVGDGLTVKISDFGLSRDV 216 (422)
Q Consensus 193 Kp~NiLl~~~~~vKl~DFGla~~~ 216 (422)
||+||++++++.++|+|||++...
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccC
Confidence 999999999999999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-19 Score=180.28 Aligned_cols=109 Identities=43% Similarity=0.769 Sum_probs=97.4
Q ss_pred ccccccccchhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccc-cCcceeeccccCCCcccCCccccccCCC
Q psy7289 302 MECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVY-ASDYYRIQSKSLLPVRWMPPESILYGKF 380 (422)
Q Consensus 302 ~~cw~~~P~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~-~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 380 (422)
.-|-....++.+|.||.+..+|||||.++|+|+-...++||+||||.+.+. ..++|.++...+++..|.|||.|++++|
T Consensus 213 ~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kF 292 (1039)
T KOG0199|consen 213 RLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKF 292 (1039)
T ss_pred HHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccc
Confidence 445555678999999999999999999999999999999999999999654 4567788888999999999999999999
Q ss_pred CcchhHHHHHHHHHHHHhcCCCCCCCCCch
Q psy7289 381 TTESDVWSYGVVLWEVYSYGLQPYYGYSNQ 410 (422)
Q Consensus 381 ~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~ 410 (422)
+.+||||+|||.+||||+||.-||.|-.--
T Consensus 293 ShaSDvWmyGVTiWEMFtyGEePW~G~~g~ 322 (1039)
T KOG0199|consen 293 SHASDVWMYGVTIWEMFTYGEEPWVGCRGI 322 (1039)
T ss_pred cccchhhhhhhhHHhhhccCCCCCCCCCHH
Confidence 999999999999999999999999994433
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.6e-19 Score=166.80 Aligned_cols=235 Identities=22% Similarity=0.316 Sum_probs=145.4
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCc--CCHHhHHHHHHHHHHHhcCCC---C-------c------ee
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRH---P-------N------IV 117 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~H---p-------n------Iv 117 (422)
+...+.||.|+|+.||.+++.. .++.+|||+.... ......+++.+|.-....+.+ | . ++
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~--t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVE--TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETT--TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred EEEccccccCCceEEEEEEEcc--CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 3456789999999999988654 4578999986432 223356677777655444333 1 1 22
Q ss_pred eEee---EEEcCC--------CeEEEEEecCCCCHHHHHhh---cCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHH
Q psy7289 118 CLLG---VCLSGE--------PMCMLFEFMVRGDLHEFLMS---RSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLC 183 (422)
Q Consensus 118 ~l~g---~~~~~~--------~~~lv~E~~~~G~L~~~l~~---~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH 183 (422)
++-+ +..... +.+++|+-+ .+||.+++.. +... ...+.......+..|+.+.+++||
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~--------~~~l~~~arl~lT~Q~I~lvA~Lh 162 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT--------HSPLAFAARLSLTVQMIRLVANLH 162 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT--------SHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc--------cchhHHHHHHHHHHHHHHHHHHHh
Confidence 2211 111111 346677766 4688877542 2210 012223333566789999999999
Q ss_pred hCCccccCCCCCceeecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccC--------CCCCchhHHhHH
Q psy7289 184 SHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG--------KFTTESDVWSYG 255 (422)
Q Consensus 184 ~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--------~~~~~~DvwS~G 255 (422)
+.|++|+||||+|++++.+|.+.|+||+...... ..+.. ...+..|.+||..... .++.+.|.|++|
T Consensus 163 ~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g--~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG 237 (288)
T PF14531_consen 163 SYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAG--TRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLG 237 (288)
T ss_dssp HTTEEEST-SGGGEEE-TTS-EEE--GGGEEETT--EEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHH
T ss_pred hcceEecccceeeEEEcCCCCEEEcChHHHeecC--ceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHH
Confidence 9999999999999999999999999998765432 22211 2344678999976442 478899999999
Q ss_pred HHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcchhhhcccccccccchh
Q psy7289 256 VVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAA 312 (422)
Q Consensus 256 vil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r 312 (422)
+++|.|++ +..||...+....... ..-.|. +.|..++.|++..++.+|..|
T Consensus 238 ~~ly~lWC-~~lPf~~~~~~~~~~~----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 238 ITLYSLWC-GRLPFGLSSPEADPEW----DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHH-SS-STCCCGGGSTSGG----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHH-ccCCCCCCCccccccc----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999998 8899986543322211 223455 788899999999999988765
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-19 Score=177.44 Aligned_cols=107 Identities=32% Similarity=0.580 Sum_probs=89.3
Q ss_pred hhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHHH
Q psy7289 311 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYG 390 (422)
Q Consensus 311 ~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~G 390 (422)
..++.|||++.++|||+||.|||++.++++|+||||++|.+..+. .+.+.-++|+-|||||.+..+.|+..+|+||+|
T Consensus 110 VsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t--~vltsikGtPlYmAPElv~e~pyd~~sDlWslG 187 (808)
T KOG0597|consen 110 VSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT--SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLG 187 (808)
T ss_pred HHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc--eeeeeccCcccccCHHHHcCCCccchhhHHHHH
Confidence 458999999999999999999999999999999999999765432 345667788999999999988999999999999
Q ss_pred HHHHHHHhcCCCCCCCCCchh---hhhcCCCCC
Q psy7289 391 VVLWEVYSYGLQPYYGYSNQE---EFLKTPPSW 420 (422)
Q Consensus 391 v~l~el~~~g~~p~~~~~~~~---~~~~~~~~~ 420 (422)
||+||+++ |+.||...+--+ ..+++|+-|
T Consensus 188 cilYE~~~-G~PPF~a~si~~Lv~~I~~d~v~~ 219 (808)
T KOG0597|consen 188 CILYELYV-GQPPFYARSITQLVKSILKDPVKP 219 (808)
T ss_pred HHHHHHhc-CCCCchHHHHHHHHHHHhcCCCCC
Confidence 99999996 999998744332 223455544
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-19 Score=179.70 Aligned_cols=102 Identities=27% Similarity=0.468 Sum_probs=86.0
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCC-cchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFT-TESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dvws 388 (422)
+..++.|||.++++||||||+|+|++....+||+|||++.....+ .+..+.+|++.|.|||++.+..|+ .++||||
T Consensus 121 Ii~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g---klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWS 197 (786)
T KOG0588|consen 121 ILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG---KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWS 197 (786)
T ss_pred HHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC---ccccccCCCcccCCchhhcCCCCCCCccccch
Confidence 456999999999999999999999998888999999999754433 344567788999999999999886 6899999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhhhhc
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEEFLK 415 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~~~~ 415 (422)
.||||+.|++ |+.||++-.-...++|
T Consensus 198 CGVILfALLt-G~LPFdDdNir~LLlK 223 (786)
T KOG0588|consen 198 CGVILFALLT-GKLPFDDDNIRVLLLK 223 (786)
T ss_pred hHHHHHHHHh-CCCCCCCccHHHHHHH
Confidence 9999999997 9999997444444444
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-19 Score=162.71 Aligned_cols=101 Identities=28% Similarity=0.589 Sum_probs=85.8
Q ss_pred chhhhcccccccccchhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCcccc
Q psy7289 296 RMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESI 375 (422)
Q Consensus 296 ~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~ 375 (422)
+.+.+|++.+ .++.|||...++||||||+|||++++..+|++|||+|..+...... ..-++|++|+|||.+
T Consensus 124 ~tR~iMrqlf------egVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekL---relCGTPgYLAPEti 194 (411)
T KOG0599|consen 124 ETRRIMRQLF------EGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKL---RELCGTPGYLAPETI 194 (411)
T ss_pred HHHHHHHHHH------HHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCchhH---HHhcCCCcccChhhe
Confidence 4567777654 5999999999999999999999999999999999999876554433 345678999999988
Q ss_pred c------cCCCCcchhHHHHHHHHHHHHhcCCCCCCC
Q psy7289 376 L------YGKFTTESDVWSYGVVLWEVYSYGLQPYYG 406 (422)
Q Consensus 376 ~------~~~~~~~~Dvws~Gv~l~el~~~g~~p~~~ 406 (422)
. +..|+.++|+||.|||+|.|++ |-.||+.
T Consensus 195 kC~m~e~~pGYs~EVD~Wa~GVImyTLLa-GcpPFwH 230 (411)
T KOG0599|consen 195 KCSMYENHPGYSKEVDEWACGVIMYTLLA-GCPPFWH 230 (411)
T ss_pred eeecccCCCCccchhhHHHHHHHHHHHHc-CCCchhH
Confidence 6 2258899999999999999996 9999986
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.3e-19 Score=178.84 Aligned_cols=115 Identities=44% Similarity=0.889 Sum_probs=102.5
Q ss_pred hhhhcccccccccchhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccc
Q psy7289 297 MYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL 376 (422)
Q Consensus 297 ~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 376 (422)
+..|+..|.+ +..++.||++..++|||+.++|||+.++.++|++|||+||.+.++.+|+. +....|+.|||||.++
T Consensus 490 l~tL~ly~~Q---i~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYka-S~~kLPIKWmaPESIN 565 (974)
T KOG4257|consen 490 LRTLTLYCYQ---ICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKA-SRGKLPIKWMAPESIN 565 (974)
T ss_pred HHHHHHHHHH---HHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhc-cccccceeecCccccc
Confidence 4456666653 67899999999999999999999999999999999999998887777764 4667799999999999
Q ss_pred cCCCCcchhHHHHHHHHHHHHhcCCCCCCCCCchhhhhc
Q psy7289 377 YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415 (422)
Q Consensus 377 ~~~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~~~~~ 415 (422)
.+.|+++||||=|||++||+++.|..||.|-.|+++..+
T Consensus 566 fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~ 604 (974)
T KOG4257|consen 566 FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH 604 (974)
T ss_pred hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE
Confidence 999999999999999999999999999999999987654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.3e-19 Score=174.21 Aligned_cols=104 Identities=51% Similarity=0.928 Sum_probs=86.0
Q ss_pred cchhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHH
Q psy7289 309 PVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWS 388 (422)
Q Consensus 309 P~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 388 (422)
.++.++.|||+.+++|+||||+||+++....+|++|||+++...............+++.|+|||++.++.++.++||||
T Consensus 182 qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiws 261 (338)
T cd05102 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWS 261 (338)
T ss_pred HHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHH
Confidence 46789999999999999999999999998999999999998643332222222334467899999998888999999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
|||+||||++.|..||.+....+.
T Consensus 262 lG~il~el~~~g~~pf~~~~~~~~ 285 (338)
T cd05102 262 FGVLLWEIFSLGASPYPGVQINEE 285 (338)
T ss_pred HHHHHHHHHhCCCCCCCCCCccHH
Confidence 999999999889999998765543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.4e-20 Score=174.81 Aligned_cols=97 Identities=26% Similarity=0.458 Sum_probs=81.1
Q ss_pred hhhHHHHhhhhhhhhhcccccccccCC---cceeecccccccccccCcceeeccccCCCcccCCccccccCC---CCcch
Q psy7289 311 AAGMAYLCSHHYVHRDLAARNCLVGDG---LTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK---FTTES 384 (422)
Q Consensus 311 ~r~~~~lh~~~~i~~dLk~~nil~~~~---~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~ 384 (422)
..++.|||+++++||||||+|||+... ..+||+|||+|+.... ..+..+.+||+.|.|||++..+. +..++
T Consensus 286 l~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kV 362 (475)
T KOG0615|consen 286 LTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKV 362 (475)
T ss_pred HHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcccc---ceehhhhcCCccccChhheecCCeecccchh
Confidence 358999999999999999999999766 7899999999996432 23455678899999999998764 33589
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 385 DVWSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 385 Dvws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
|+||+||+||-+++ |-.||.+...+.
T Consensus 363 DiWSlGcvLfvcLs-G~pPFS~~~~~~ 388 (475)
T KOG0615|consen 363 DIWSLGCVLFVCLS-GYPPFSEEYTDP 388 (475)
T ss_pred eeeeccceEEEEec-cCCCcccccCCc
Confidence 99999999999996 999998866554
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.2e-19 Score=186.76 Aligned_cols=106 Identities=53% Similarity=0.989 Sum_probs=92.5
Q ss_pred cchhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeecccc-CCCcccCCccccccCCCCcchhHH
Q psy7289 309 PVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKS-LLPVRWMPPESILYGKFTTESDVW 387 (422)
Q Consensus 309 P~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~Dvw 387 (422)
.+++||+||.+..++||||.++|||+..+..+||+|||++++....+++....+. ..|+.|||||.+....|+.|||||
T Consensus 426 QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVW 505 (609)
T KOG0200|consen 426 QIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVW 505 (609)
T ss_pred HHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhh
Confidence 4789999999999999999999999999999999999999987776766644322 278899999999998899999999
Q ss_pred HHHHHHHHHHhcCCCCCCCCCchhhhh
Q psy7289 388 SYGVVLWEVYSYGLQPYYGYSNQEEFL 414 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~~~~~~~~~ 414 (422)
||||+|||++|.|..||+|....+.++
T Consensus 506 SfGI~L~EifsLG~~PYp~~~~~~~l~ 532 (609)
T KOG0200|consen 506 SFGILLWEIFTLGGTPYPGIPPTEELL 532 (609)
T ss_pred HHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence 999999999999999999976444333
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=99.77 E-value=4e-19 Score=157.88 Aligned_cols=101 Identities=27% Similarity=0.524 Sum_probs=85.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccC---CcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGD---GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~---~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 386 (422)
+..++.|||.++++|||+||+|+++.+ +--+|++|||++.+.... ....+..+++.|||||+++...|+..+||
T Consensus 119 iLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDi 195 (355)
T KOG0033|consen 119 ILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDI 195 (355)
T ss_pred HHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc---cccccccCCCcccCHHHhhcCCCCCcchh
Confidence 356899999999999999999999854 345899999999876532 34567788999999999998899999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchhhhh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQEEFL 414 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~~~~ 414 (422)
||.|||||-|+. |..||+|.+....|-
T Consensus 196 W~cGViLfiLL~-G~~PF~~~~~~rlye 222 (355)
T KOG0033|consen 196 WACGVILYILLV-GYPPFWDEDQHRLYE 222 (355)
T ss_pred hhhhHHHHHHHh-CCCCCCCccHHHHHH
Confidence 999999999985 999999977665443
|
|
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.4e-19 Score=160.64 Aligned_cols=102 Identities=31% Similarity=0.511 Sum_probs=83.2
Q ss_pred chhhHHHHh-hhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCcccccc---CCCCcchh
Q psy7289 310 VAAGMAYLC-SHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY---GKFTTESD 385 (422)
Q Consensus 310 ~~r~~~~lh-~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~D 385 (422)
+..++.||. +|++||||+||+|||++..+.+|+||||+|..+.++.....++ +-+.|||||.+-- .+|+.++|
T Consensus 200 ~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsA---GC~~YMaPERidp~~~~kYDiRaD 276 (391)
T KOG0983|consen 200 IVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSA---GCAAYMAPERIDPPDKPKYDIRAD 276 (391)
T ss_pred HHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccccccccc---CCccccCccccCCCCCCccchhhh
Confidence 345777875 6899999999999999999999999999998766654333233 3356999998863 36999999
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCchhhhhc
Q psy7289 386 VWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415 (422)
Q Consensus 386 vws~Gv~l~el~~~g~~p~~~~~~~~~~~~ 415 (422)
||||||.|+||.| |+.||.+-.+..+.+-
T Consensus 277 VWSlGITlveLaT-g~yPy~~c~tdFe~lt 305 (391)
T KOG0983|consen 277 VWSLGITLVELAT-GQYPYKGCKTDFEVLT 305 (391)
T ss_pred hhhhccchhhhhc-ccCCCCCCCccHHHHH
Confidence 9999999999997 9999999777775553
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=4e-19 Score=174.43 Aligned_cols=103 Identities=57% Similarity=1.087 Sum_probs=95.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
++.+|+||-+.+++|||+.++|||++...++||+|||+|+.+...++++.+.....|++|||||.|+.|+++++||||+|
T Consensus 646 iasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWaf 725 (807)
T KOG1094|consen 646 IASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAF 725 (807)
T ss_pred HHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhh
Confidence 45689999999999999999999999999999999999999888999999999999999999999999999999999999
Q ss_pred HHHHHHHHh-cCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYS-YGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~-~g~~p~~~~~~~~~ 412 (422)
||.+||+++ +-.+||...++.+.
T Consensus 726 gvTlwE~~~~C~e~Py~~lt~e~v 749 (807)
T KOG1094|consen 726 GVTLWEVFMLCREQPYSQLTDEQV 749 (807)
T ss_pred HHHHHHHHHHHhhCchhhhhHHHH
Confidence 999999998 55679988877663
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.3e-19 Score=174.54 Aligned_cols=323 Identities=21% Similarity=0.238 Sum_probs=223.3
Q ss_pred Cccccccccc--ccceeEEEEEEecCCCCeEEEEEEccCcCC-HHhHHHHHHHHHHHhcCC-CCceeeEeeEEEcCCCeE
Q psy7289 55 KPRFLQELGE--GAFGKVYKGEVCTSEGPSLVAIKTLKENAN-QKTASDFRREVDLMSELR-HPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 55 ~~~~~~~LG~--G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~ 130 (422)
...+.+.+|. |.+|.||.+..........+|+|.-+.... ......=.+|+.-.++++ |+|.|+.+..+..++..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3456678999 999999998864445567788887432221 111122246777777774 999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHH----HHHHHHhCCccccCCCCCceeecCC-CeE
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA----GMAYLCSHHYVHRDLAARNCLVGDG-LTV 205 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~----gL~yLH~~~ivHrDlKp~NiLl~~~-~~v 205 (422)
+-+|+|. .+|.++..... ..+++..++....+... ||.++|+.+++|-|+||.||.+..+ ...
T Consensus 195 iqtE~~~-~sl~~~~~~~~-----------~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPC-----------NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred eeecccc-chhHHhhhccc-----------ccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccccee
Confidence 9999986 68888876542 23677788888888888 9999999999999999999999988 899
Q ss_pred EEecCcccccccCCcceE---eccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q psy7289 206 KISDFGLSRDVYASDYYR---IQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~ 282 (422)
+++|||+...+....... ......+-..|++||+.. +.++..+|++|+|.+..|....-..|-.+.... ...++
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--W~~~r 339 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS--WSQLR 339 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC--ccccc
Confidence 999999988765543211 111223456799999764 568899999999999999886333343442211 11111
Q ss_pred cCCCCCCCCCC---Ccchhhhcccccccccch-------hhHHHHhhhhhhhhhcccccccccCC-cceeeccccccccc
Q psy7289 283 SRQMLPCPEDC---PPRMYSLMMECWHEVPVA-------AGMAYLCSHHYVHRDLAARNCLVGDG-LTVKISDFGLSRDV 351 (422)
Q Consensus 283 ~~~~~~~p~~~---p~~~~~l~~~cw~~~P~~-------r~~~~lh~~~~i~~dLk~~nil~~~~-~~~ki~Dfgls~~~ 351 (422)
.+. . ..+.| ..++...+...++.+|.. .++.++|+...+|.|++|.||++..+ +..++.||++...+
T Consensus 340 ~~~-i-p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 340 QGY-I-PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred ccc-C-chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccc
Confidence 111 0 11222 233444566666666644 45677899999999999999998664 77889999987532
Q ss_pred ccCcceeeccccCCCcccCC-cccccc-CCCCcchhHHHHHHHHHHHHhc
Q psy7289 352 YASDYYRIQSKSLLPVRWMP-PESILY-GKFTTESDVWSYGVVLWEVYSY 399 (422)
Q Consensus 352 ~~~~~~~~~~~~~~~~~y~a-PE~~~~-~~~~~~~Dvws~Gv~l~el~~~ 399 (422)
.-.. .......+++| +|++.. ..+-.+.|++|||.-+.|..++
T Consensus 418 ~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~ 462 (524)
T KOG0601|consen 418 AFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITG 462 (524)
T ss_pred ceec-----ccccccccccccchhhccccccccccccccccccccccccC
Confidence 1110 11111234553 555543 3466789999999999998863
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-18 Score=163.74 Aligned_cols=102 Identities=40% Similarity=0.785 Sum_probs=95.0
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
.+.+|.++|++++||.|+.++|+++++...+|++|-.+||+++..++....-.+.-|+.||+||.+.+..|+..+|||||
T Consensus 405 la~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsf 484 (563)
T KOG1024|consen 405 LAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSF 484 (563)
T ss_pred HHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHH
Confidence 56789999999999999999999999999999999999999999888877777778999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||+||||+|.|+.||...+.-|
T Consensus 485 GVllWELmtlg~~PyaeIDPfE 506 (563)
T KOG1024|consen 485 GVLLWELMTLGKLPYAEIDPFE 506 (563)
T ss_pred HHHHHHHHhcCCCCccccCHHH
Confidence 9999999999999998877554
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.5e-19 Score=173.67 Aligned_cols=93 Identities=27% Similarity=0.547 Sum_probs=81.7
Q ss_pred hhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHHH
Q psy7289 311 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYG 390 (422)
Q Consensus 311 ~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~G 390 (422)
..|+.|||.++++|||+|.+|||++.++.+|++|||++..+..... ..++-.+|+.|||||++....|++|+||||||
T Consensus 379 l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLG 456 (550)
T KOG0578|consen 379 LQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLG 456 (550)
T ss_pred HHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhh
Confidence 4689999999999999999999999999999999999976544322 23455678999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCC
Q psy7289 391 VVLWEVYSYGLQPYYG 406 (422)
Q Consensus 391 v~l~el~~~g~~p~~~ 406 (422)
++.+||+. |..||..
T Consensus 457 IMaIEMve-GEPPYln 471 (550)
T KOG0578|consen 457 IMAIEMVE-GEPPYLN 471 (550)
T ss_pred hHHHHHhc-CCCCccC
Confidence 99999995 9999985
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-18 Score=165.00 Aligned_cols=105 Identities=30% Similarity=0.461 Sum_probs=84.2
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcce-------------------------e---e--
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYY-------------------------R---I-- 359 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~-------------------------~---~-- 359 (422)
+.-+++|||.+++|.|||||+|||+..++++-++||-||.......+. + .
T Consensus 188 vl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~ 267 (459)
T KOG0610|consen 188 VLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSK 267 (459)
T ss_pred HHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhcccc
Confidence 345899999999999999999999999999999999887422110000 0 0
Q ss_pred ------------------------ccccCCCcccCCccccccCCCCcchhHHHHHHHHHHHHhcCCCCCCCCCchhhhhc
Q psy7289 360 ------------------------QSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415 (422)
Q Consensus 360 ------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~~~~~ 415 (422)
+.+-++|--|.|||+|.+..++.++|||+|||.+|||+ ||..||.|.++.+++.+
T Consensus 268 ~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmL-yG~TPFKG~~~~~Tl~N 346 (459)
T KOG0610|consen 268 KRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEML-YGTTPFKGSNNKETLRN 346 (459)
T ss_pred ccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHH-hCCCCcCCCCchhhHHH
Confidence 00112344599999999888999999999999999998 89999999999998876
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.9e-19 Score=164.90 Aligned_cols=99 Identities=31% Similarity=0.492 Sum_probs=81.4
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCC-cceeecccccccccccCcceeeccccCCCcccCCccccccC-CCCcchhHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDG-LTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVW 387 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~-~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvw 387 (422)
+-|++.|||+++++|||+||.|+|++.. +.+||||||-|+.+..+.. ..+-..+..|.|||.+.+- .|+.++|||
T Consensus 134 lfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiW 210 (364)
T KOG0658|consen 134 LFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTSIDIW 210 (364)
T ss_pred HHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC---ceeEEEeccccCHHHHcCccccCceeEEh
Confidence 5689999999999999999999999875 7899999999986544321 1122345679999977754 599999999
Q ss_pred HHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 388 SYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
|.||+++||+ .|+.-|+|.+..+.
T Consensus 211 SaGCV~aELl-~g~plFpG~s~~dQ 234 (364)
T KOG0658|consen 211 SAGCVMAELL-KGQPLFPGDSSVDQ 234 (364)
T ss_pred hhhHHHHHHh-cCCcccCCCCHHHH
Confidence 9999999999 59999999776653
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.4e-19 Score=170.16 Aligned_cols=96 Identities=31% Similarity=0.518 Sum_probs=80.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccccC-Ccceeeccccccccccc-CcceeeccccCCCcccCCccccccCCCC-cchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGD-GLTVKISDFGLSRDVYA-SDYYRIQSKSLLPVRWMPPESILYGKFT-TESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~-~~~~ki~Dfgls~~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv 386 (422)
+.+++.|||+++++|+||||+|+|++. +..+|++|||+++.... ...........+|+.|||||++.+|... .++||
T Consensus 126 iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDi 205 (313)
T KOG0198|consen 126 ILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDI 205 (313)
T ss_pred HHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchh
Confidence 567999999999999999999999999 78999999999986543 1222333456678999999999975433 48999
Q ss_pred HHHHHHHHHHHhcCCCCCCC
Q psy7289 387 WSYGVVLWEVYSYGLQPYYG 406 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~ 406 (422)
||+||++.||+| |..||..
T Consensus 206 WSlGCtVvEM~T-g~~PW~~ 224 (313)
T KOG0198|consen 206 WSLGCTVVEMLT-GKPPWSE 224 (313)
T ss_pred hhcCCEEEeccC-CCCcchh
Confidence 999999999997 8999987
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-18 Score=172.00 Aligned_cols=102 Identities=24% Similarity=0.463 Sum_probs=82.7
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcce--------------------------------
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYY-------------------------------- 357 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~-------------------------------- 357 (422)
+..+++|||+++++||||||+||+++....+|++|||+++........
T Consensus 110 i~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (363)
T cd05628 110 TVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNR 189 (363)
T ss_pred HHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhcc
Confidence 456999999999999999999999999999999999998743211000
Q ss_pred -eeccccCCCcccCCccccccCCCCcchhHHHHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 358 -RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 358 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
.......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.
T Consensus 190 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~-G~~Pf~~~~~~~~ 244 (363)
T cd05628 190 RQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI-GYPPFCSETPQET 244 (363)
T ss_pred ccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHh-CCCCCCCCCHHHH
Confidence 00123357889999999988889999999999999999996 9999988665553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=99.74 E-value=9.2e-19 Score=171.15 Aligned_cols=103 Identities=28% Similarity=0.495 Sum_probs=84.4
Q ss_pred hhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCC-----------
Q psy7289 311 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK----------- 379 (422)
Q Consensus 311 ~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----------- 379 (422)
..++.++|.+++||.||||.|+|+-.+ .+|+.|||+++.+..+.+.-....-.||+.||+||.+....
T Consensus 470 L~aV~~IH~~gIVHSDLKPANFLlVkG-~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~K 548 (677)
T KOG0596|consen 470 LLAVKTIHQHGIVHSDLKPANFLLVKG-RLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIK 548 (677)
T ss_pred HHHHHHHHHhceeecCCCcccEEEEee-eEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCccee
Confidence 357889999999999999999998655 58999999999776655444445667899999999887432
Q ss_pred CCcchhHHHHHHHHHHHHhcCCCCCCCCCchhhhhc
Q psy7289 380 FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415 (422)
Q Consensus 380 ~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~~~~~ 415 (422)
.+.+|||||+|||||+|+ ||+.||..+-|--..++
T Consensus 549 i~r~SDvWSLGCILYqMv-YgktPf~~~~n~~aKl~ 583 (677)
T KOG0596|consen 549 ISRKSDVWSLGCILYQMV-YGKTPFGQIINQIAKLH 583 (677)
T ss_pred ecCccchhhhhhHHHHHH-hcCCchHHHHHHHHHHH
Confidence 457899999999999998 99999988776655544
|
|
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-18 Score=172.59 Aligned_cols=100 Identities=34% Similarity=0.587 Sum_probs=79.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccC---CCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG---KFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv 386 (422)
++.||.|||+.+|||||||..||++.++.++||.||||+..........-.....+.+.|||||+++.. .|++.+||
T Consensus 497 iaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDV 576 (678)
T KOG0193|consen 497 IAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDV 576 (678)
T ss_pred HHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccch
Confidence 678999999999999999999999999999999999997532111101111234456789999999855 59999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
|||||++|||++ |..||.. .+.|
T Consensus 577 YaFGiV~YELlt-g~lPysi-~~~d 599 (678)
T KOG0193|consen 577 YAFGIVWYELLT-GELPYSI-QNRD 599 (678)
T ss_pred hhhhHHHHHHHh-CcCCcCC-CChh
Confidence 999999999997 9999984 4444
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.8e-18 Score=168.14 Aligned_cols=99 Identities=27% Similarity=0.534 Sum_probs=83.0
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++|+||||+||+++.+..+|++|||+++....... ......+++.|+|||++..+.++.++|||||
T Consensus 110 i~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 187 (323)
T cd05616 110 IAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF 187 (323)
T ss_pred HHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhch
Confidence 56799999999999999999999999999999999999875322111 1223446788999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||++|||++ |+.||.+.+..+
T Consensus 188 Gvil~ellt-g~~Pf~~~~~~~ 208 (323)
T cd05616 188 GVLLYEMLA-GQAPFEGEDEDE 208 (323)
T ss_pred hHHHHHHHh-CCCCCCCCCHHH
Confidence 999999997 999998865544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.1e-18 Score=164.99 Aligned_cols=99 Identities=23% Similarity=0.484 Sum_probs=87.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccC-cceeeccccCCCcccCCccccccCCCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS-DYYRIQSKSLLPVRWMPPESILYGKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 388 (422)
...+.+|||++++|.|||||+|++++..+++|+-|||+++.+..+ .+|+ -++|+-|.|||+++++.++.++|.||
T Consensus 529 v~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwT----FcGTpEYVAPEIILnKGHD~avDyWa 604 (732)
T KOG0614|consen 529 VLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWT----FCGTPEYVAPEIILNKGHDRAVDYWA 604 (732)
T ss_pred HHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCceee----ecCCcccccchhhhccCcchhhHHHH
Confidence 467999999999999999999999999999999999999865443 3343 45788999999999999999999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
+|+++|||++ |.+||.+.+.+.++
T Consensus 605 LGIli~ELL~-G~pPFs~~dpmktY 628 (732)
T KOG0614|consen 605 LGILIYELLT-GSPPFSGVDPMKTY 628 (732)
T ss_pred HHHHHHHHHc-CCCCCCCCchHHHH
Confidence 9999999996 99999997777654
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.2e-18 Score=167.03 Aligned_cols=100 Identities=27% Similarity=0.509 Sum_probs=83.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++|+||||+||+++.+..+|++|||+++...... .......++..|+|||.+.+..++.++|||||
T Consensus 105 i~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 182 (316)
T cd05592 105 IICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSF 182 (316)
T ss_pred HHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhH
Confidence 5679999999999999999999999999999999999997533222 11233456788999999988889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||++|||++ |+.||.+.+..+.
T Consensus 183 G~il~ell~-G~~Pf~~~~~~~~ 204 (316)
T cd05592 183 GVLLYEMLI-GQSPFHGEDEDEL 204 (316)
T ss_pred HHHHHHHHh-CCCCCCCCCHHHH
Confidence 999999996 9999998665543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.1e-18 Score=162.68 Aligned_cols=103 Identities=84% Similarity=1.526 Sum_probs=87.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
...++.|||+++++|+|++|+|++++.+..++++|||+++.....+..........+..|+|||.+.++.++.++|||||
T Consensus 133 l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~sl 212 (283)
T cd05048 133 IAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSF 212 (283)
T ss_pred HHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHH
Confidence 56799999999999999999999999999999999999986543333333344455678999999988889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||++|||++.|..||.+.+..+.
T Consensus 213 G~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05048 213 GVVLWEIFSYGLQPYYGFSNQEV 235 (283)
T ss_pred HHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999889999998766554
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.9e-18 Score=164.41 Aligned_cols=100 Identities=15% Similarity=0.191 Sum_probs=82.2
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcce-----eeccccCCCcccCCccccccCCCCcch
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYY-----RIQSKSLLPVRWMPPESILYGKFTTES 384 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~ 384 (422)
.+.++.|||+.+++||||||+||+++....++++|||+|+....+... .......+|+.|+|||+..+..++.++
T Consensus 135 i~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~ 214 (294)
T PHA02882 135 MLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRG 214 (294)
T ss_pred HHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHH
Confidence 567999999999999999999999998889999999999754322111 011123467899999999888899999
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCch
Q psy7289 385 DVWSYGVVLWEVYSYGLQPYYGYSNQ 410 (422)
Q Consensus 385 Dvws~Gv~l~el~~~g~~p~~~~~~~ 410 (422)
|||||||+++||++ |..||.+.+..
T Consensus 215 DiwSlG~~l~el~~-g~~P~~~~~~~ 239 (294)
T PHA02882 215 DLESLGYCMLKWAG-IKLPWKGFGHN 239 (294)
T ss_pred HHHHHHHHHHHHHh-CCCCCCccccc
Confidence 99999999999996 99999887543
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.72 E-value=4e-18 Score=165.02 Aligned_cols=102 Identities=46% Similarity=0.786 Sum_probs=84.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
++++++|||+++++|+||||+||+++.+..+|++|||+++................+..|+|||.+..+.++.++|||||
T Consensus 118 i~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 197 (316)
T cd05108 118 IAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 197 (316)
T ss_pred HHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHH
Confidence 57899999999999999999999999999999999999986433222111223334668999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||++|||+++|..||.+.+..+
T Consensus 198 Gv~l~el~t~g~~p~~~~~~~~ 219 (316)
T cd05108 198 GVTVWELMTFGSKPYDGIPASE 219 (316)
T ss_pred HHHHHHHHcCCCCCCCCCCHHH
Confidence 9999999988999998865543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.2e-18 Score=163.33 Aligned_cols=99 Identities=29% Similarity=0.536 Sum_probs=83.5
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++|+|+||+||+++....+|++|||+++..... .......++..|+|||.+..+.++.++|||||
T Consensus 119 i~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 195 (290)
T cd07862 119 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSV 195 (290)
T ss_pred HHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHH
Confidence 578999999999999999999999999999999999998753222 12233456788999999988889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||++|||++ |..||.+.+..+.
T Consensus 196 G~il~el~~-g~~~f~~~~~~~~ 217 (290)
T cd07862 196 GCIFAEMFR-RKPLFRGSSDVDQ 217 (290)
T ss_pred HHHHHHHHc-CCCCcCCCCHHHH
Confidence 999999996 9999988665443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.72 E-value=4e-18 Score=169.14 Aligned_cols=102 Identities=49% Similarity=0.934 Sum_probs=84.7
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++|+||||+||+++....+|++|||+++................+..|+|||++..+.++.++|||||
T Consensus 221 i~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSl 300 (374)
T cd05106 221 VAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSY 300 (374)
T ss_pred HHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHH
Confidence 57899999999999999999999999999999999999976433322222222334567999999988889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||++|||++.|+.||......+
T Consensus 301 Gvil~ellt~G~~Pf~~~~~~~ 322 (374)
T cd05106 301 GILLWEIFSLGKSPYPGILVNS 322 (374)
T ss_pred HHHHHHHHhCCCCCCccccccH
Confidence 9999999988999998876554
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.2e-19 Score=157.60 Aligned_cols=107 Identities=31% Similarity=0.462 Sum_probs=85.9
Q ss_pred chhhHHHHh-hhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccC--CCCcchhH
Q psy7289 310 VAAGMAYLC-SHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG--KFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh-~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv 386 (422)
..+++.||. ++.+||||+||+|||++-.+.+|+||||++..+..+-.. +...+-..|||||.+-.. .|+.+|||
T Consensus 176 tV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAk---T~daGCrpYmAPERi~p~~~gyDiRSDv 252 (361)
T KOG1006|consen 176 TVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAK---TVDAGCRPYMAPERIDPSDKGYDIRSDV 252 (361)
T ss_pred ehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHh---hhccCCccccChhccCCccCCcchhhhh
Confidence 567899986 578999999999999999999999999999866554322 223333569999988743 39999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchhhhh-----cCCCCC
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQEEFL-----KTPPSW 420 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~~~~-----~~~~~~ 420 (422)
||||+.|||+.| |..||+++++-.+.+ .+||-+
T Consensus 253 WSLGITL~EvAt-G~fPyr~w~svfeql~~Vv~gdpp~l 290 (361)
T KOG1006|consen 253 WSLGITLYEVAT-GNFPYRKWDSVFEQLCQVVIGDPPIL 290 (361)
T ss_pred hhhcceEeeeec-CCCCcchHHHHHHHHHHHHcCCCCee
Confidence 999999999986 999999999865444 366644
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.3e-17 Score=176.84 Aligned_cols=197 Identities=19% Similarity=0.192 Sum_probs=146.8
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC---CCceeeEeeEEEcC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR---HPNIVCLLGVCLSG 126 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~g~~~~~ 126 (422)
++-...+.+-+.||+|+||.||+|...+ ++.||+|+-+....- +|.-=.+++.+|+ -+-|..+..+....
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~---~~~~alK~e~P~~~W----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN---GKLVALKVEKPPNPW----EFYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC---CcEEEEEeecCCCce----eeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 3445667788999999999999997533 788999986543211 1111223444554 23455566666667
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC-----
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD----- 201 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~----- 201 (422)
+.-++|+||.+.|+|.++++.. ..+++..+..++.|++.-++.||..+|||+||||+|.||..
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~------------~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~ 834 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTN------------KVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICAD 834 (974)
T ss_pred CcceeeeeccccccHHHhhccC------------CCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCC
Confidence 7789999999999999999732 35888889999999999999999999999999999999953
Q ss_pred --CCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCC
Q psy7289 202 --GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGL 266 (422)
Q Consensus 202 --~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~ 266 (422)
...++|+|||-|-.+.--.....-.....|-.+-.+|...++.++..+|.|.++.+++-|+- |.
T Consensus 835 ~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLF-G~ 900 (974)
T KOG1166|consen 835 SDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLF-GK 900 (974)
T ss_pred CcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHH-HH
Confidence 34699999999865531110011122233455778999999999999999999999999995 63
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.6e-18 Score=162.15 Aligned_cols=96 Identities=28% Similarity=0.483 Sum_probs=81.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
...++.|||+.+++|+|+||+||+++....+|++|||+++....... .....++..|+|||++.++.++.++|||||
T Consensus 111 i~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dvwsl 187 (285)
T cd05631 111 LCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGL 187 (285)
T ss_pred HHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhH
Confidence 46799999999999999999999999988999999999875422211 223456789999999998899999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCc
Q psy7289 390 GVVLWEVYSYGLQPYYGYSN 409 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~ 409 (422)
||++|||++ |+.||.+...
T Consensus 188 Gvil~el~~-g~~pf~~~~~ 206 (285)
T cd05631 188 GCLIYEMIQ-GQSPFRKRKE 206 (285)
T ss_pred HHHHHHHHh-CCCCCCCCCc
Confidence 999999996 9999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.4e-18 Score=160.65 Aligned_cols=102 Identities=70% Similarity=1.282 Sum_probs=85.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
..+++.|+|+++++|+|+||.|++++....+|++|||+++................++.|+|||.+..+.++.++|||||
T Consensus 133 l~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 212 (283)
T cd05091 133 IAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSY 212 (283)
T ss_pred HHHHHHHHHHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHH
Confidence 57899999999999999999999999888999999999886543332222333344678999999988889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||++|||++.|..||.+.+..+
T Consensus 213 G~~l~el~~~g~~p~~~~~~~~ 234 (283)
T cd05091 213 GVVLWEVFSYGLQPYCGYSNQD 234 (283)
T ss_pred HHHHHHHHcCCCCCCCCCCHHH
Confidence 9999999988999998866554
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.4e-18 Score=167.22 Aligned_cols=99 Identities=25% Similarity=0.492 Sum_probs=82.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..+++|||+++++|+||||+||+++....+|++|||+++....... ......+++.|+|||++....++.++||||+
T Consensus 104 i~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 181 (323)
T cd05571 104 IVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181 (323)
T ss_pred HHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cccceecCccccChhhhcCCCCCccccCccc
Confidence 46799999999999999999999999999999999999875322111 1123346788999999988889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||++|||++ |..||.+.+..+
T Consensus 182 G~il~ellt-g~~Pf~~~~~~~ 202 (323)
T cd05571 182 GVVMYEMMC-GRLPFYNQDHEK 202 (323)
T ss_pred chhhhhhhc-CCCCCCCCCHHH
Confidence 999999996 999998755443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.8e-18 Score=157.14 Aligned_cols=99 Identities=26% Similarity=0.500 Sum_probs=86.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+.+++.||||.+|++++.++++||+||||.+.-.... ....+-++|+-|+|||++....|...+|+|.+
T Consensus 277 IvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g--~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~ 354 (516)
T KOG0690|consen 277 IVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG--DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGV 354 (516)
T ss_pred HHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccc--ceeccccCChhhcCchhhccccccceeehhhh
Confidence 5568999999999999999999999999999999999998643321 22445678999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||++|||+ +|+.||+..++.-
T Consensus 355 GVVMYEMm-CGRLPFyn~dh~k 375 (516)
T KOG0690|consen 355 GVVMYEMM-CGRLPFYNKDHEK 375 (516)
T ss_pred hHHHHHHH-hccCcccccchhH
Confidence 99999997 8999999876654
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.7e-18 Score=164.67 Aligned_cols=99 Identities=27% Similarity=0.529 Sum_probs=82.4
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++|+||||+||+++....+|++|||+++....... ......++..|+|||++.++.++.++||||+
T Consensus 110 i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 187 (324)
T cd05587 110 IAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAF 187 (324)
T ss_pred HHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhh
Confidence 56799999999999999999999999999999999999874322111 1123346788999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||++|||++ |+.||.+.+..+
T Consensus 188 Gvil~ellt-G~~pf~~~~~~~ 208 (324)
T cd05587 188 GVLLYEMLA-GQPPFDGEDEDE 208 (324)
T ss_pred HHHHHHHHh-CCCCCCCCCHHH
Confidence 999999997 999998865544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.8e-18 Score=164.08 Aligned_cols=99 Identities=29% Similarity=0.512 Sum_probs=82.7
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
...+++|||+++++|+||||+||+++.+..+|++|||+++....... ......++..|+|||++.+..++.++||||+
T Consensus 105 i~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 182 (316)
T cd05620 105 IVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSF 182 (316)
T ss_pred HHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--ceeccCCCcCccCHHHHcCCCCCcccchhhh
Confidence 56799999999999999999999999999999999999874322111 1223446788999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||++|||++ |+.||.+.+..+
T Consensus 183 Gvil~el~~-g~~Pf~~~~~~~ 203 (316)
T cd05620 183 GVLLYEMLI-GQSPFHGDDEDE 203 (316)
T ss_pred HHHHHHHHh-CCCCCCCCCHHH
Confidence 999999996 999998866544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.2e-17 Score=147.50 Aligned_cols=136 Identities=21% Similarity=0.197 Sum_probs=96.2
Q ss_pred ccccccccceeEEEEEEecCCCCeEEEEEEccCcCCH-HhHHH----------------------HHHHHHHHhcCCCCc
Q psy7289 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQ-KTASD----------------------FRREVDLMSELRHPN 115 (422)
Q Consensus 59 ~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~-~~~~~----------------------~~~E~~il~~l~Hpn 115 (422)
.+.||+|+||.||+|... ++..||||+++..... ..... ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~---~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 78 (187)
T cd05119 2 GGPIGTGKEADVYLALDG---DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAG 78 (187)
T ss_pred CcccccccceeEEEEECC---CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcC
Confidence 567999999999999753 4567999987643211 11111 135666666665432
Q ss_pred --eeeEeeEEEcCCCeEEEEEecCCCCHHHH-HhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccC
Q psy7289 116 --IVCLLGVCLSGEPMCMLFEFMVRGDLHEF-LMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCS-HHYVHRD 191 (422)
Q Consensus 116 --Iv~l~g~~~~~~~~~lv~E~~~~G~L~~~-l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrD 191 (422)
+.+.++. ...++||||+++|++... +... ... .++..++.+++.++.++|+ ++|+|||
T Consensus 79 ~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-------------~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~D 140 (187)
T cd05119 79 VPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-------------RLL-EDPEELYDQILELMRKLYREAGLVHGD 140 (187)
T ss_pred CCCCceEec----CCCEEEEEEeCCCCccChhhhhh-------------hhc-ccHHHHHHHHHHHHHHHhhccCcCcCC
Confidence 4444443 246899999999654321 1110 011 5678899999999999999 9999999
Q ss_pred CCCCceeecCCCeEEEecCcccccc
Q psy7289 192 LAARNCLVGDGLTVKISDFGLSRDV 216 (422)
Q Consensus 192 lKp~NiLl~~~~~vKl~DFGla~~~ 216 (422)
|||+||+++ ++.++|+|||.+...
T Consensus 141 l~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 141 LSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred CChhhEEEE-CCcEEEEECcccccc
Confidence 999999999 889999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.1e-18 Score=173.62 Aligned_cols=101 Identities=26% Similarity=0.382 Sum_probs=83.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
...++.|+|+++++|+||||+||+++.+..+|++|||+++...............+++.|+|||++..+.|+.++|||||
T Consensus 152 ll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSl 231 (496)
T PTZ00283 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSL 231 (496)
T ss_pred HHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHH
Confidence 46799999999999999999999999999999999999975432211111233456788999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||++|||++ |+.||.+.+..+
T Consensus 232 GvilyeLlt-G~~Pf~~~~~~~ 252 (496)
T PTZ00283 232 GVLLYELLT-LKRPFDGENMEE 252 (496)
T ss_pred HHHHHHHHH-CCCCCCCCCHHH
Confidence 999999997 999998865544
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.7e-18 Score=164.14 Aligned_cols=99 Identities=24% Similarity=0.490 Sum_probs=82.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++|+||||+||+++.+..+|++|||+++....... ......+++.|+|||++.++.++.++|||||
T Consensus 104 i~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 181 (323)
T cd05595 104 IVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181 (323)
T ss_pred HHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--ccccccCCcCcCCcccccCCCCCchhchhhh
Confidence 46799999999999999999999999999999999999875322211 1123346788999999988889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||++|||++ |+.||.+.+..+
T Consensus 182 Gvil~ell~-g~~Pf~~~~~~~ 202 (323)
T cd05595 182 GVVMYEMMC-GRLPFYNQDHER 202 (323)
T ss_pred HHHHHHHHh-CCCCCCCCCHHH
Confidence 999999996 999998765443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
Homologous Structure Templates
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 442 bits (1139), Expect = e-155
Identities = 145/317 (45%), Positives = 198/317 (62%), Gaps = 21/317 (6%)
Query: 14 GKVYKGEVCTSEGPSLVAIKTLKENANQKTAS------DFRREVIETKPRFLQELGEGAF 67
G + V + PS + + L N + E +++++GEGAF
Sbjct: 1 GAMESAAVTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAF 60
Query: 68 GKVYKGEV---CTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCL 124
G+V++ E ++VA+K LKE A+ +DF+RE LM+E +PNIV LLGVC
Sbjct: 61 GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120
Query: 125 SGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQA------------PLSQQDFSHIA 172
G+PMC+LFE+M GDL+EFL S SP + S S PLS + IA
Sbjct: 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIA 180
Query: 173 LQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV 232
QVAAGMAYL +VHRDLA RNCLVG+ + VKI+DFGLSR++Y++DYY+ +P+
Sbjct: 181 RQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPI 240
Query: 233 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPED 292
RWMPPESI Y ++TTESDVW+YGVVLWE++SYGLQPYYG +++EVI +R +L CPE+
Sbjct: 241 RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPEN 300
Query: 293 CPPRMYSLMMECWHEVP 309
CP +Y+LM CW ++P
Sbjct: 301 CPLELYNLMRLCWSKLP 317
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 1e-73
Identities = 67/108 (62%), Positives = 89/108 (82%), Gaps = 2/108 (1%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
VAAGMAYL +VHRDLA RNCLVG+ + VKI+DFGLSR++Y++DYY+ +P+RW
Sbjct: 183 VAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRW 242
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE--EFLK 415
MPPESI Y ++TTESDVW+YGVVLWE++SYGLQPYYG +++E +++
Sbjct: 243 MPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR 290
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 439 bits (1132), Expect = e-155
Identities = 151/270 (55%), Positives = 191/270 (70%), Gaps = 11/270 (4%)
Query: 47 FRREVIETKPRFLQELGEGAFGKVYKGEV---CTSEGPSLVAIKTLKENANQKTASDFRR 103
+ RF++ELGE FGKVYKG + E VAIKTLK+ A +FR
Sbjct: 6 ISLSAV----RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH 61
Query: 104 EVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDI----SGSQV 159
E L + L+HPN+VCLLGV +P+ M+F + GDLHEFL+ RSP SD+ V
Sbjct: 62 EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 160 QAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS 219
++ L DF H+ Q+AAGM YL SHH VH+DLA RN LV D L VKISD GL R+VYA+
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181
Query: 220 DYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIE 279
DYY++ SLLP+RWM PE+I+YGKF+ +SD+WSYGVVLWEV+SYGLQPY GYSNQ+V+E
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 241
Query: 280 MIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
MIR+RQ+LPCP+DCP +Y+LM+ECW+E P
Sbjct: 242 MIRNRQVLPCPDDCPAWVYALMIECWNEFP 271
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 2e-74
Identities = 72/102 (70%), Positives = 86/102 (84%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+AAGM YL SHH VH+DLA RN LV D L VKISD GL R+VYA+DYY++ SLLP+RW
Sbjct: 137 IAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRW 196
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
M PE+I+YGKF+ +SD+WSYGVVLWEV+SYGLQPY GYSNQ+
Sbjct: 197 MAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 238
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 434 bits (1117), Expect = e-152
Identities = 141/308 (45%), Positives = 185/308 (60%), Gaps = 16/308 (5%)
Query: 11 GAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASD---FRREVIETKPRFLQELGEGAF 67
GA G + +EG + EN + + +R I ELGEGAF
Sbjct: 1 GAMG--SGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDI----VLKWELGEGAF 54
Query: 68 GKVYKGEV---CTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCL 124
GKV+ E + LVA+K LKE A++ DF+RE +L++ L+H +IV GVC
Sbjct: 55 GKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTMLQHQHIVRFFGVCT 113
Query: 125 SGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGS---QVQAPLSQQDFSHIALQVAAGMAY 181
G P+ M+FE+M GDL+ FL S P + + PL +A QVAAGM Y
Sbjct: 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVY 173
Query: 182 LCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL 241
L H+VHRDLA RNCLVG GL VKI DFG+SRD+Y++DYYR+ +++LP+RWMPPESIL
Sbjct: 174 LAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL 233
Query: 242 YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLM 301
Y KFTTESDVWS+GVVLWE+++YG QP+Y SN E I+ I + L P CPP +Y++M
Sbjct: 234 YRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIM 293
Query: 302 MECWHEVP 309
CW P
Sbjct: 294 RGCWQREP 301
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 4e-73
Identities = 72/102 (70%), Positives = 87/102 (85%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
VAAGM YL H+VHRDLA RNCLVG GL VKI DFG+SRD+Y++DYYR+ +++LP+RW
Sbjct: 167 VAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 226
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
MPPESILY KFTTESDVWS+GVVLWE+++YG QP+Y SN E
Sbjct: 227 MPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 268
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 432 bits (1112), Expect = e-152
Identities = 129/260 (49%), Positives = 174/260 (66%), Gaps = 8/260 (3%)
Query: 57 RFLQELGEGAFGKVYKGE---VCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRH 113
+ELGEGAFGKV+ E + ++ LVA+K LK+ DF+RE +L++ L+H
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PTLAARKDFQREAELLTNLQH 76
Query: 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGS----QVQAPLSQQDFS 169
+IV GVC G+P+ M+FE+M GDL++FL + P + I Q + L
Sbjct: 77 EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 229
HIA Q+A+GM YL S H+VHRDLA RNCLVG L VKI DFG+SRDVY++DYYR+ ++
Sbjct: 137 HIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 230 LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289
LP+RWMPPESI+Y KFTTESDVWS+GV+LWE+++YG QP++ SN EVIE I ++L
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLER 256
Query: 290 PEDCPPRMYSLMMECWHEVP 309
P CP +Y +M+ CW P
Sbjct: 257 PRVCPKEVYDVMLGCWQREP 276
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 230 bits (590), Expect = 2e-73
Identities = 68/102 (66%), Positives = 86/102 (84%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+A+GM YL S H+VHRDLA RNCLVG L VKI DFG+SRDVY++DYYR+ ++LP+RW
Sbjct: 142 IASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 201
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
MPPESI+Y KFTTESDVWS+GV+LWE+++YG QP++ SN E
Sbjct: 202 MPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 243
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 425 bits (1096), Expect = e-149
Identities = 120/263 (45%), Positives = 164/263 (62%), Gaps = 5/263 (1%)
Query: 50 EVIETKPRFLQELGEGAFGKVYKGE---VCTSEGPSLVAIKTLKENANQKTASDFRREVD 106
EV K +ELG+G+FG VY+G V E + VAIKT+ E A+ + +F E
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 107 LMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQ 166
+M E ++V LLGV G+P ++ E M RGDL +L RS R ++ + V AP S
Sbjct: 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPAMANNPVLAPPSLS 138
Query: 167 DFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQS 226
+A ++A GMAYL ++ +VHRDLAARNC+V + TVKI DFG++RD+Y +DYYR
Sbjct: 139 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 227 KSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286
K LLPVRWM PES+ G FTT SDVWS+GVVLWE+ + QPY G SN++V+ + +
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 258
Query: 287 LPCPEDCPPRMYSLMMECWHEVP 309
L P++CP ++ LM CW P
Sbjct: 259 LDKPDNCPDMLFELMRMCWQYNP 281
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 2e-71
Identities = 68/137 (49%), Positives = 88/137 (64%), Gaps = 5/137 (3%)
Query: 282 RSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 341
M P PP + ++ +A GMAYL ++ +VHRDLAARNC+V + TVK
Sbjct: 122 LRPAMANNPVLAPPSLSKMIQMAGE---IADGMAYLNANKFVHRDLAARNCMVAEDFTVK 178
Query: 342 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGL 401
I DFG++RD+Y +DYYR K LLPVRWM PES+ G FTT SDVWS+GVVLWE+ +
Sbjct: 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 238
Query: 402 QPYYGYSNQE--EFLKT 416
QPY G SN++ F+
Sbjct: 239 QPYQGLSNEQVLRFVME 255
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 414 bits (1065), Expect = e-145
Identities = 108/259 (41%), Positives = 154/259 (59%), Gaps = 11/259 (4%)
Query: 57 RFLQELGEGAFGKVYKGEV---CTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRH 113
++ LG GAFG+VY+G+V P VA+KTL E +++ DF E ++S+ H
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92
Query: 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
NIV +GV L P +L E M GDL FL PR L+ D H+A
Sbjct: 93 QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS-----SLAMLDLLHVAR 147
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASDYYRIQSKSLL 230
+A G YL +H++HRD+AARNCL+ G G KI DFG++RD+Y + YYR ++L
Sbjct: 148 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 207
Query: 231 PVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP 290
PV+WMPPE+ + G FT+++D WS+GV+LWE++S G PY SNQEV+E + S + P
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 267
Query: 291 EDCPPRMYSLMMECWHEVP 309
++CP +Y +M +CW P
Sbjct: 268 KNCPGPVYRIMTQCWQHQP 286
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 4e-68
Identities = 54/105 (51%), Positives = 76/105 (72%), Gaps = 3/105 (2%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 366
+A G YL +H++HRD+AARNCL+ G G KI DFG++RD+Y + YYR ++LP
Sbjct: 149 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 208
Query: 367 VRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
V+WMPPE+ + G FT+++D WS+GV+LWE++S G PY SNQE
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 253
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 414 bits (1067), Expect = e-144
Identities = 95/263 (36%), Positives = 151/263 (57%), Gaps = 10/263 (3%)
Query: 57 RFLQELGEGAFGKVYKGEV-----CTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL 111
+ LGEG FG+V E + VA+K LK++A +K SD E+++M +
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 143
Query: 112 -RHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPR----SDISGSQVQAPLSQQ 166
+H NI+ LLG C P+ ++ E+ +G+L E+L +R P S + ++ +
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 167 DFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQS 226
D Q+A GM YL S +HRDLAARN LV + +KI+DFGL+RD+ DYY+ +
Sbjct: 204 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 227 KSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286
LPV+WM PE++ +T +SDVWS+GV++WE+++ G PY G +E+ ++++
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR 323
Query: 287 LPCPEDCPPRMYSLMMECWHEVP 309
+ P +C +Y +M +CWH VP
Sbjct: 324 MDKPANCTNELYMMMRDCWHAVP 346
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 4e-69
Identities = 51/109 (46%), Positives = 73/109 (66%), Gaps = 2/109 (1%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+A GM YL S +HRDLAARN LV + +KI+DFGL+RD+ DYY+ + LPV+W
Sbjct: 212 LARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKW 271
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE--EFLKT 416
M PE++ +T +SDVWS+GV++WE+++ G PY G +E + LK
Sbjct: 272 MAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 320
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 413 bits (1063), Expect = e-144
Identities = 110/270 (40%), Positives = 157/270 (58%), Gaps = 11/270 (4%)
Query: 46 DFRREVIETKPRFLQELGEGAFGKVYKGEV---CTSEGPSLVAIKTLKENANQKTASDFR 102
+EV ++ LG GAFG+VY+G+V P VA+KTL E +++ DF
Sbjct: 63 SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 122
Query: 103 REVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAP 162
E ++S+ H NIV +GV L P +L E M GDL FL PR
Sbjct: 123 MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS-----S 177
Query: 163 LSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYAS 219
L+ D H+A +A G YL +H++HRD+AARNCL+ G G KI DFG++RD+Y +
Sbjct: 178 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 237
Query: 220 DYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIE 279
YYR ++LPV+WMPPE+ + G FT+++D WS+GV+LWE++S G PY SNQEV+E
Sbjct: 238 GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 297
Query: 280 MIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
+ S + P++CP +Y +M +CW P
Sbjct: 298 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQP 327
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 218 bits (556), Expect = 1e-67
Identities = 56/127 (44%), Positives = 80/127 (62%), Gaps = 6/127 (4%)
Query: 288 PCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISD 344
+ M L+ +A G YL +H++HRD+AARNCL+ G G KI D
Sbjct: 171 RPSQPSSLAMLDLLHVARD---IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 227
Query: 345 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPY 404
FG++RD+Y + YYR ++LPV+WMPPE+ + G FT+++D WS+GV+LWE++S G PY
Sbjct: 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 287
Query: 405 YGYSNQE 411
SNQE
Sbjct: 288 PSKSNQE 294
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 411 bits (1058), Expect = e-144
Identities = 97/268 (36%), Positives = 143/268 (53%), Gaps = 15/268 (5%)
Query: 57 RFLQELGEGAFGKVYKGE---VCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRH 113
+ LGEG FGKV K + G + VA+K LKENA+ D E +++ ++ H
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85
Query: 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQA------------ 161
P+++ L G C P+ ++ E+ G L FL +
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 162 PLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDY 221
L+ D A Q++ GM YL VHRDLAARN LV +G +KISDFGLSRDVY D
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 222 YRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281
Y +S+ +PV+WM ES+ +TT+SDVWS+GV+LWE+ + G PY G + + ++
Sbjct: 206 YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL 265
Query: 282 RSRQMLPCPEDCPPRMYSLMMECWHEVP 309
++ + P++C MY LM++CW + P
Sbjct: 266 KTGHRMERPDNCSEEMYRLMLQCWKQEP 293
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 5e-69
Identities = 55/108 (50%), Positives = 71/108 (65%), Gaps = 2/108 (1%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
++ GM YL VHRDLAARN LV +G +KISDFGLSRDVY D Y +S+ +PV+W
Sbjct: 159 ISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKW 218
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE--EFLK 415
M ES+ +TT+SDVWS+GV+LWE+ + G PY G + LK
Sbjct: 219 MAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLK 266
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 407 bits (1049), Expect = e-142
Identities = 96/263 (36%), Positives = 152/263 (57%), Gaps = 10/263 (3%)
Query: 57 RFLQELGEGAFGKVYKGEV-----CTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL 111
+ LGEGAFG+V E + VA+K LK++A +K SD E+++M +
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 112 -RHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPR----SDISGSQVQAPLSQQ 166
+H NI+ LLG C P+ ++ E+ +G+L E+L +R P S + ++ +
Sbjct: 98 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 167 DFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQS 226
D Q+A GM YL S +HRDLAARN LV + +KI+DFGL+RD+ DYY+ +
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 227 KSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286
LPV+WM PE++ +T +SDVWS+GV++WE+++ G PY G +E+ ++++
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR 277
Query: 287 LPCPEDCPPRMYSLMMECWHEVP 309
+ P +C +Y +M +CWH VP
Sbjct: 278 MDKPANCTNELYMMMRDCWHAVP 300
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 2e-68
Identities = 51/109 (46%), Positives = 73/109 (66%), Gaps = 2/109 (1%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+A GM YL S +HRDLAARN LV + +KI+DFGL+RD+ DYY+ + LPV+W
Sbjct: 166 LARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKW 225
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE--EFLKT 416
M PE++ +T +SDVWS+GV++WE+++ G PY G +E + LK
Sbjct: 226 MAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 274
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 401 bits (1033), Expect = e-140
Identities = 104/279 (37%), Positives = 142/279 (50%), Gaps = 12/279 (4%)
Query: 36 KENANQKTASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQ 95
K N + I +F +GEG FG+V K + AIK +KE A++
Sbjct: 11 KNNPDPTIYPVLDWNDI----KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK 66
Query: 96 KTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDI 154
DF E++++ +L HPNI+ LLG C + + E+ G+L +FL
Sbjct: 67 DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 126
Query: 155 SGSQVQ----APLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210
+ + LS Q H A VA GM YL ++HRDLAARN LVG+ KI+DF
Sbjct: 127 PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 186
Query: 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYY 270
GLSR + Y ++ LPVRWM ES+ Y +TT SDVWSYGV+LWE+ S G PY
Sbjct: 187 GLSRG---QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 243
Query: 271 GYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
G + E+ E + L P +C +Y LM +CW E P
Sbjct: 244 GMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKP 282
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 1e-64
Identities = 54/102 (52%), Positives = 66/102 (64%), Gaps = 3/102 (2%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
VA GM YL ++HRDLAARN LVG+ KI+DFGLSR + Y ++ LPVRW
Sbjct: 151 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKKTMGRLPVRW 207
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
M ES+ Y +TT SDVWSYGV+LWE+ S G PY G + E
Sbjct: 208 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 249
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 399 bits (1027), Expect = e-139
Identities = 94/260 (36%), Positives = 148/260 (56%), Gaps = 13/260 (5%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSL-VAIKTLK-ENANQKTASDFRREVDLMSELRHP 114
+ LGEG FG V +G + +G SL VA+KT+K +N++Q+ +F E M + HP
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96
Query: 115 NIVCLLGVCLSGEPMC-----MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFS 169
N++ LLGVC+ ++ FM GDLH +L+ + + Q
Sbjct: 97 NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETG------PKHIPLQTLL 150
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 229
+ +A GM YL + +++HRDLAARNC++ D +TV ++DFGLS+ +Y+ DYYR +
Sbjct: 151 KFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK 210
Query: 230 LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289
+PV+W+ ES+ +T++SDVW++GV +WE+ + G+ PY G N E+ + + L
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQ 270
Query: 290 PEDCPPRMYSLMMECWHEVP 309
PEDC +Y +M CW P
Sbjct: 271 PEDCLDELYEIMYSCWRTDP 290
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 2e-70
Identities = 49/135 (36%), Positives = 81/135 (60%), Gaps = 5/135 (3%)
Query: 284 RQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 343
+ +L+ +A GM YL + +++HRDLAARNC++ D +TV ++
Sbjct: 133 LYSRLETGPKHIPLQTLLKFMVD---IALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVA 189
Query: 344 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQP 403
DFGLS+ +Y+ DYYR + +PV+W+ ES+ +T++SDVW++GV +WE+ + G+ P
Sbjct: 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
Query: 404 YYGYSNQE--EFLKT 416
Y G N E ++L
Sbjct: 250 YPGVQNHEMYDYLLH 264
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 395 bits (1018), Expect = e-138
Identities = 97/273 (35%), Positives = 148/273 (54%), Gaps = 15/273 (5%)
Query: 41 QKTASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSL-VAIKTLKENANQKTAS 99
+ F + +G G FG VY G + ++G + A+K+L + S
Sbjct: 12 VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS 71
Query: 100 DFRREVDLMSELRHPNIVCLLGVCLSGE-PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQ 158
F E +M + HPN++ LLG+CL E ++ +M GDL F+ + +
Sbjct: 72 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------- 124
Query: 159 VQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA 218
+ +D LQVA GM YL S +VHRDLAARNC++ + TVK++DFGL+RD+Y
Sbjct: 125 ----PTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180
Query: 219 SDYYRIQSKS--LLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 276
+YY + +K+ LPV+WM ES+ KFTT+SDVWS+GV+LWE+ + G PY + +
Sbjct: 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240
Query: 277 VIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
+ + + L PE CP +Y +M++CWH
Sbjct: 241 ITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKA 273
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 2e-67
Identities = 54/104 (51%), Positives = 75/104 (72%), Gaps = 2/104 (1%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKS--LLPV 367
VA GM YL S +VHRDLAARNC++ + TVK++DFGL+RD+Y +YY + +K+ LPV
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196
Query: 368 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
+WM ES+ KFTT+SDVWS+GV+LWE+ + G PY + +
Sbjct: 197 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 396 bits (1020), Expect = e-137
Identities = 101/260 (38%), Positives = 146/260 (56%), Gaps = 7/260 (2%)
Query: 57 RFLQELGEGAFGKVYKGE---VCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-R 112
+F + LG GAFGKV + + + VA+K LK A+ E+ +MS L +
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 113 HPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQA--PLSQQDFSH 170
H NIV LLG C G P+ ++ E+ GDL FL +S + + A S +D H
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 171 IALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL 230
+ QVA GMA+L S + +HRD+AARN L+ +G KI DFGL+RD+ Y ++ + L
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 231 PVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY-SNQEVIEMIRSRQMLPC 289
PV+WM PESI +T +SDVWSYG++LWE++S GL PY G N + ++++ +
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQ 288
Query: 290 PEDCPPRMYSLMMECWHEVP 309
P P +YS+M CW P
Sbjct: 289 PAFAPKNIYSIMQACWALEP 308
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-66
Identities = 54/126 (42%), Positives = 75/126 (59%), Gaps = 3/126 (2%)
Query: 290 PEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR 349
+ L+ VA GMA+L S + +HRD+AARN L+ +G KI DFGL+R
Sbjct: 156 IANSTASTRDLLHFSSQ---VAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
Query: 350 DVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN 409
D+ Y ++ + LPV+WM PESI +T +SDVWSYG++LWE++S GL PY G
Sbjct: 213 DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272
Query: 410 QEEFLK 415
+F K
Sbjct: 273 NSKFYK 278
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 397 bits (1022), Expect = e-137
Identities = 100/263 (38%), Positives = 151/263 (57%), Gaps = 10/263 (3%)
Query: 57 RFLQELGEGAFGKVYKGEV-----CTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL 111
+ LGEGAFG+V E + VA+K LK +A +K SD E+++M +
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131
Query: 112 -RHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQ----APLSQQ 166
+H NI+ LLG C P+ ++ E+ +G+L E+L +R P LS +
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 167 DFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQS 226
D A QVA GM YL S +HRDLAARN LV + +KI+DFGL+RD++ DYY+ +
Sbjct: 192 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 227 KSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286
LPV+WM PE++ +T +SDVWS+GV+LWE+++ G PY G +E+ ++++
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 311
Query: 287 LPCPEDCPPRMYSLMMECWHEVP 309
+ P +C +Y +M +CWH VP
Sbjct: 312 MDKPSNCTNELYMMMRDCWHAVP 334
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 5e-66
Identities = 53/109 (48%), Positives = 74/109 (67%), Gaps = 2/109 (1%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
VA GM YL S +HRDLAARN LV + +KI+DFGL+RD++ DYY+ + LPV+W
Sbjct: 200 VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKW 259
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE--EFLKT 416
M PE++ +T +SDVWS+GV+LWE+++ G PY G +E + LK
Sbjct: 260 MAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 308
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 393 bits (1012), Expect = e-137
Identities = 104/274 (37%), Positives = 142/274 (51%), Gaps = 15/274 (5%)
Query: 47 FRREVIETKPRFLQELGEGAFGKVYKGE---VCTSEGPSLVAIKTLKENANQKTASDFRR 103
F R + F + LG GAFGKV + + S+ VA+K LK +A+
Sbjct: 20 FPRNRL----SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75
Query: 104 EVDLMSEL-RHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQ-- 160
E+ ++S L H NIV LLG C G P ++ E+ GDL FL + S +
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 161 ----APLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV 216
L +D + QVA GMA+L S + +HRDLAARN L+ G KI DFGL+RD+
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 217 YASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS-NQ 275
Y ++ + LPV+WM PESI +T ESDVWSYG+ LWE++S G PY G +
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 276 EVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
+ +MI+ + PE P MY +M CW P
Sbjct: 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 289
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 7e-67
Identities = 54/106 (50%), Positives = 69/106 (65%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
VA GMA+L S + +HRDLAARN L+ G KI DFGL+RD+ Y ++ + LPV+W
Sbjct: 154 VAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKW 213
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
M PESI +T ESDVWSYG+ LWE++S G PY G +F K
Sbjct: 214 MAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 393 bits (1012), Expect = e-136
Identities = 92/261 (35%), Positives = 138/261 (52%), Gaps = 14/261 (5%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSL-VAIKTLKENANQKT-ASDFRREVDLMSELRHP 114
+ LG+G FG V + ++ +G + VA+K LK + + +F RE M E HP
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHP 85
Query: 115 NIVCLLGVCLSGEP------MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDF 168
++ L+GV L ++ FM GDLH FL++ + L Q
Sbjct: 86 HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN------PFNLPLQTL 139
Query: 169 SHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKS 228
+ +A GM YL S +++HRDLAARNC++ + +TV ++DFGLSR +Y+ DYYR S
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199
Query: 229 LLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP 288
LPV+W+ ES+ +T SDVW++GV +WE+ + G PY G N E+ + L
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLK 259
Query: 289 CPEDCPPRMYSLMMECWHEVP 309
P +C +Y LM +CW P
Sbjct: 260 QPPECMEEVYDLMYQCWSADP 280
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 2e-69
Identities = 52/135 (38%), Positives = 77/135 (57%), Gaps = 5/135 (3%)
Query: 284 RQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 343
+ +L+ +A GM YL S +++HRDLAARNC++ + +TV ++
Sbjct: 123 LASRIGENPFNLPLQTLVRFMVD---IACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVA 179
Query: 344 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQP 403
DFGLSR +Y+ DYYR S LPV+W+ ES+ +T SDVW++GV +WE+ + G P
Sbjct: 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
Query: 404 YYGYSNQE--EFLKT 416
Y G N E +L
Sbjct: 240 YAGIENAEIYNYLIG 254
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 391 bits (1006), Expect = e-136
Identities = 91/263 (34%), Positives = 139/263 (52%), Gaps = 10/263 (3%)
Query: 57 RFLQELGEGAFGKVYKGE---VCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-R 112
+ + LG GAFG+V + + + + VA+K LKE A E+ ++ +
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 113 HPNIVCLLGVCL-SGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQ----APLSQQD 167
H N+V LLG C G P+ ++ EF G+L +L S+ + L+ +
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 168 FSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSK 227
+ QVA GM +L S +HRDLAARN L+ + VKI DFGL+RD+Y Y +
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 228 SLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS-NQEVIEMIRSRQM 286
+ LP++WM PE+I +T +SDVWS+GV+LWE++S G PY G ++E ++
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 269
Query: 287 LPCPEDCPPRMYSLMMECWHEVP 309
+ P+ P MY M++CWH P
Sbjct: 270 MRAPDYTTPEMYQTMLDCWHGEP 292
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 5e-67
Identities = 52/106 (49%), Positives = 70/106 (66%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
VA GM +L S +HRDLAARN L+ + VKI DFGL+RD+Y Y + + LP++W
Sbjct: 157 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 216
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
M PE+I +T +SDVWS+GV+LWE++S G PY G EEF +
Sbjct: 217 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 391 bits (1006), Expect = e-135
Identities = 100/279 (35%), Positives = 145/279 (51%), Gaps = 20/279 (7%)
Query: 47 FRREVIETKPRFLQELGEGAFGKVYKGE---VCTSEGPSLVAIKTLKENANQKTASDFRR 103
F RE + F + LG GAFGKV + + VA+K LKE A+
Sbjct: 42 FPRENL----EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMS 97
Query: 104 EVDLMSEL-RHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQA- 161
E+ +M++L H NIV LLG C P+ ++FE+ GDL +L S+ + + +
Sbjct: 98 ELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 157
Query: 162 ----------PLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211
L+ +D A QVA GM +L VHRDLAARN LV G VKI DFG
Sbjct: 158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFG 217
Query: 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG 271
L+RD+ + Y ++ + LPV+WM PES+ G +T +SDVWSYG++LWE++S G+ PY G
Sbjct: 218 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277
Query: 272 YS-NQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
+ ++I++ + P +Y +M CW
Sbjct: 278 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDS 316
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 1e-66
Identities = 54/106 (50%), Positives = 70/106 (66%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
VA GM +L VHRDLAARN LV G VKI DFGL+RD+ + Y ++ + LPV+W
Sbjct: 181 VAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKW 240
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
M PES+ G +T +SDVWSYG++LWE++S G+ PY G F K
Sbjct: 241 MAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK 286
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 387 bits (995), Expect = e-133
Identities = 93/272 (34%), Positives = 146/272 (53%), Gaps = 15/272 (5%)
Query: 42 KTASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSL-VAIKTLKENANQKTASD 100
+ F + +G G FG VY G + ++G + A+K+L + S
Sbjct: 77 QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ 136
Query: 101 FRREVDLMSELRHPNIVCLLGVCLSGE-PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQV 159
F E +M + HPN++ LLG+CL E ++ +M GDL F+ + +
Sbjct: 137 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-------- 188
Query: 160 QAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS 219
+ +D LQVA GM +L S +VHRDLAARNC++ + TVK++DFGL+RD+Y
Sbjct: 189 ---PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245
Query: 220 DY--YRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEV 277
++ ++ + LPV+WM ES+ KFTT+SDVWS+GV+LWE+ + G PY + ++
Sbjct: 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 305
Query: 278 IEMIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
+ + L PE CP +Y +M++CWH
Sbjct: 306 TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKA 337
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 2e-64
Identities = 50/104 (48%), Positives = 73/104 (70%), Gaps = 2/104 (1%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDY--YRIQSKSLLPV 367
VA GM +L S +VHRDLAARNC++ + TVK++DFGL+RD+Y ++ ++ + LPV
Sbjct: 201 VAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 260
Query: 368 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
+WM ES+ KFTT+SDVWS+GV+LWE+ + G PY + +
Sbjct: 261 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 382 bits (983), Expect = e-132
Identities = 97/257 (37%), Positives = 142/257 (55%), Gaps = 15/257 (5%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSL-VAIKTLKENANQKTASDFRREVDLMSELRHPN 115
+ +G+G FG VY GE + AIK+L + F RE LM L HPN
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 116 IVCLLGVCLSGEPMCML-FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
++ L+G+ L E + + +M GDL +F+ RSP+ + + +D LQ
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRN---------PTVKDLISFGLQ 132
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQ--SKSLLPV 232
VA GM YL +VHRDLAARNC++ + TVK++DFGL+RD+ +YY +Q + LPV
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192
Query: 233 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPED 292
+W ES+ +FTT+SDVWS+GV+LWE+ + G PY ++ + + LP PE
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEY 252
Query: 293 CPPRMYSLMMECWHEVP 309
CP +Y +M +CW P
Sbjct: 253 CPDSLYQVMQQCWEADP 269
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 8e-65
Identities = 50/104 (48%), Positives = 70/104 (67%), Gaps = 2/104 (1%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQ--SKSLLPV 367
VA GM YL +VHRDLAARNC++ + TVK++DFGL+RD+ +YY +Q + LPV
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192
Query: 368 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
+W ES+ +FTT+SDVWS+GV+LWE+ + G PY +
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 374 bits (962), Expect = e-130
Identities = 102/262 (38%), Positives = 146/262 (55%), Gaps = 14/262 (5%)
Query: 49 REVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSL-VAIKTLKENANQKTASDFRREVDL 107
E+ + + +GEG FG V++G + E P+L VAIKT K + F +E
Sbjct: 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALT 69
Query: 108 MSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQD 167
M + HP+IV L+GV + P+ ++ E G+L FL R L
Sbjct: 70 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS-----------LDLAS 117
Query: 168 FSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSK 227
A Q++ +AYL S +VHRD+AARN LV VK+ DFGLSR + S YY+ SK
Sbjct: 118 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-ASK 176
Query: 228 SLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287
LP++WM PESI + +FT+ SDVW +GV +WE+ +G++P+ G N +VI I + + L
Sbjct: 177 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 236
Query: 288 PCPEDCPPRMYSLMMECWHEVP 309
P P +CPP +YSLM +CW P
Sbjct: 237 PMPPNCPPTLYSLMTKCWAYDP 258
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 3e-63
Identities = 49/102 (48%), Positives = 70/102 (68%), Gaps = 1/102 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
++ +AYL S +VHRD+AARN LV VK+ DFGLSR + S YY+ SK LP++W
Sbjct: 125 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKW 183
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
M PESI + +FT+ SDVW +GV +WE+ +G++P+ G N +
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 225
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 18/48 (37%), Positives = 26/48 (54%), Gaps = 1/48 (2%)
Query: 4 FLQELGEGAFGKVYKGEVCTSEGPSL-VAIKTLKENANQKTASDFRRE 50
+ +GEG FG V++G + E P+L VAIKT K + F +E
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQE 66
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 374 bits (962), Expect = e-129
Identities = 97/261 (37%), Positives = 139/261 (53%), Gaps = 14/261 (5%)
Query: 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSL-VAIKTLKENANQKTASDFRREVDLM 108
+ + LGEG FG+VY+G +G + VA+KT K++ F E +M
Sbjct: 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM 67
Query: 109 SELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDF 168
L HP+IV L+G+ EP ++ E G+L +L L
Sbjct: 68 KNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNS-----------LKVLTL 115
Query: 169 SHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKS 228
+LQ+ MAYL S + VHRD+A RN LV VK+ DFGLSR + DYY+ S +
Sbjct: 116 VLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYK-ASVT 174
Query: 229 LLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP 288
LP++WM PESI + +FTT SDVW + V +WE+ S+G QP++ N++VI ++ LP
Sbjct: 175 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP 234
Query: 289 CPEDCPPRMYSLMMECWHEVP 309
P+ CPP +Y+LM CW P
Sbjct: 235 KPDLCPPVLYTLMTRCWDYDP 255
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 6e-64
Identities = 49/102 (48%), Positives = 68/102 (66%), Gaps = 1/102 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+ MAYL S + VHRD+A RN LV VK+ DFGLSR + DYY+ S + LP++W
Sbjct: 122 ICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYK-ASVTRLPIKW 180
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
M PESI + +FTT SDVW + V +WE+ S+G QP++ N++
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 17/48 (35%), Positives = 25/48 (52%), Gaps = 1/48 (2%)
Query: 4 FLQELGEGAFGKVYKGEVCTSEGPSL-VAIKTLKENANQKTASDFRRE 50
+ LGEG FG+VY+G +G + VA+KT K++ F E
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSE 63
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 373 bits (961), Expect = e-129
Identities = 95/271 (35%), Positives = 139/271 (51%), Gaps = 13/271 (4%)
Query: 41 QKTASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSL-VAIKTLKENANQKTAS 99
+ F RE+ ++ + +G G G+V G + + VAIK LK ++
Sbjct: 36 GRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRR 95
Query: 100 DFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQV 159
DF E +M + HPNI+ L GV G ++ E+M G L FL + +
Sbjct: 96 DFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-------- 147
Query: 160 QAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA- 218
+ + V AGM YL YVHRDLAARN LV L K+SDFGLSR +
Sbjct: 148 ---FTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204
Query: 219 SDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVI 278
D + +P+RW PE+I + F++ SDVWS+GVV+WEV +YG +PY+ +N++VI
Sbjct: 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI 264
Query: 279 EMIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
+ LP P CP ++ LM++CWH+
Sbjct: 265 SSVEEGYRLPAPMGCPHALHQLMLDCWHKDR 295
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 8e-62
Identities = 51/103 (49%), Positives = 68/103 (66%), Gaps = 1/103 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA-SDYYRIQSKSLLPVR 368
V AGM YL YVHRDLAARN LV L K+SDFGLSR + D + +P+R
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR 219
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
W PE+I + F++ SDVWS+GVV+WEV +YG +PY+ +N++
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD 262
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 371 bits (954), Expect = e-127
Identities = 103/271 (38%), Positives = 144/271 (53%), Gaps = 13/271 (4%)
Query: 41 QKTASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSL-VAIKTLKENANQKTAS 99
+T +F +E+ T + +G G FG+V G + + VAIKTLK +K
Sbjct: 32 TQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 100 DFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQV 159
DF E +M + HPNI+ L GV +P+ ++ E+M G L FL +
Sbjct: 92 DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-------- 143
Query: 160 QAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA- 218
+ + +A+GM YL YVHRDLAARN L+ L K+SDFGL R +
Sbjct: 144 ---FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200
Query: 219 SDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVI 278
+ +P+RW PE+I Y KFT+ SDVWSYG+VLWEV SYG +PY+ SNQ+VI
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260
Query: 279 EMIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
+ + LP P DCP +Y LM++CW +
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDR 291
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 6e-60
Identities = 54/103 (52%), Positives = 68/103 (66%), Gaps = 1/103 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA-SDYYRIQSKSLLPVR 368
+A+GM YL YVHRDLAARN L+ L K+SDFGL R + + +P+R
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
W PE+I Y KFT+ SDVWSYG+VLWEV SYG +PY+ SNQ+
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 17/48 (35%), Positives = 23/48 (47%), Gaps = 1/48 (2%)
Query: 4 FLQELGEGAFGKVYKGEVCTSEGPSL-VAIKTLKENANQKTASDFRRE 50
+ +G G FG+V G + + VAIKTLK +K DF E
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 367 bits (943), Expect = e-126
Identities = 109/272 (40%), Positives = 148/272 (54%), Gaps = 14/272 (5%)
Query: 41 QKTASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPS--LVAIKTLKENANQKTA 98
+ F E+ + + +G G FG+VYKG + TS G VAIKTLK +K
Sbjct: 31 NQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR 90
Query: 99 SDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQ 158
DF E +M + H NI+ L GV +PM ++ E+M G L +FL +
Sbjct: 91 VDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE------- 143
Query: 159 VQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA 218
S + +AAGM YL + +YVHRDLAARN LV L K+SDFGLSR +
Sbjct: 144 ----FSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199
Query: 219 -SDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEV 277
+ S +P+RW PE+I Y KFT+ SDVWS+G+V+WEV +YG +PY+ SN EV
Sbjct: 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV 259
Query: 278 IEMIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
++ I LP P DCP +Y LMM+CW +
Sbjct: 260 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQER 291
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 7e-60
Identities = 55/103 (53%), Positives = 71/103 (68%), Gaps = 1/103 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA-SDYYRIQSKSLLPVR 368
+AAGM YL + +YVHRDLAARN LV L K+SDFGLSR + + S +P+R
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 215
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
W PE+I Y KFT+ SDVWS+G+V+WEV +YG +PY+ SN E
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 258
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 22/49 (44%), Positives = 27/49 (55%), Gaps = 2/49 (4%)
Query: 4 FLQELGEGAFGKVYKGEVCTSEGPS--LVAIKTLKENANQKTASDFRRE 50
+ +G G FG+VYKG + TS G VAIKTLK +K DF E
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 96
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 364 bits (936), Expect = e-125
Identities = 96/250 (38%), Positives = 137/250 (54%), Gaps = 13/250 (5%)
Query: 61 ELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLL 120
ELG G FG V +G + VAIK LK+ + + RE +M +L +P IV L+
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 121 GVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMA 180
GVC E + ++ E G LH+FL+ + + + + + QV+ GM
Sbjct: 77 GVC-QAEALMLVMEMAGGGPLHKFLVGKREE-----------IPVSNVAELLHQVSMGMK 124
Query: 181 YLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD-YYRIQSKSLLPVRWMPPES 239
YL ++VHRDLAARN L+ + KISDFGLS+ + A D YY +S P++W PE
Sbjct: 125 YLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 184
Query: 240 ILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYS 299
I + KF++ SDVWSYGV +WE SYG +PY EV+ I + + CP +CPP +Y+
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 244
Query: 300 LMMECWHEVP 309
LM +CW
Sbjct: 245 LMSDCWIYKW 254
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 1e-60
Identities = 51/103 (49%), Positives = 66/103 (64%), Gaps = 1/103 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD-YYRIQSKSLLPVR 368
V+ GM YL ++VHRDLAARN L+ + KISDFGLS+ + A D YY +S P++
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
W PE I + KF++ SDVWSYGV +WE SYG +PY E
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 221
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 16/45 (35%), Positives = 21/45 (46%)
Query: 7 ELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREV 51
ELG G FG V +G + VAIK LK+ + + RE
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 61
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 363 bits (934), Expect = e-125
Identities = 98/253 (38%), Positives = 133/253 (52%), Gaps = 17/253 (6%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
FL+ELG G FG V G+ G VAIK +KE + + +F E +M L H +
Sbjct: 27 TFLKELGTGQFGVVKYGKWR---GQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKL 81
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V L GVC P+ ++ E+M G L +L R Q + V
Sbjct: 82 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-----------FQTQQLLEMCKDVC 130
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 236
M YL S ++HRDLAARNCLV D VK+SDFGLSR V +Y S PVRW P
Sbjct: 131 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSP 189
Query: 237 PESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPR 296
PE ++Y KF+++SD+W++GV++WE+YS G PY ++N E E I L P +
Sbjct: 190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK 249
Query: 297 MYSLMMECWHEVP 309
+Y++M CWHE
Sbjct: 250 VYTIMYSCWHEKA 262
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 4e-62
Identities = 53/102 (51%), Positives = 70/102 (68%), Gaps = 1/102 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
V M YL S ++HRDLAARNCLV D VK+SDFGLSR V +Y S PVRW
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRW 187
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
PPE ++Y KF+++SD+W++GV++WE+YS G PY ++N E
Sbjct: 188 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 361 bits (929), Expect = e-125
Identities = 98/253 (38%), Positives = 141/253 (55%), Gaps = 17/253 (6%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
F+QE+G G FG V+ G VAIKT++E A + DF E ++M +L HP +
Sbjct: 11 TFVQEIGSGQFGLVHLGYWL---NKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKL 65
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V L GVCL P+C++ EFM G L ++L ++ + + + L V
Sbjct: 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL-----------FAAETLLGMCLDVC 114
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 236
GMAYL +HRDLAARNCLVG+ +K+SDFG++R V D Y + + PV+W
Sbjct: 115 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWAS 173
Query: 237 PESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPR 296
PE + +++++SDVWS+GV++WEV+S G PY SN EV+E I + L P
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 233
Query: 297 MYSLMMECWHEVP 309
+Y +M CW E P
Sbjct: 234 VYQIMNHCWRERP 246
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 198 bits (507), Expect = 2e-61
Identities = 49/102 (48%), Positives = 68/102 (66%), Gaps = 1/102 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
V GMAYL +HRDLAARNCLVG+ +K+SDFG++R V D Y + + PV+W
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKW 171
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
PE + +++++SDVWS+GV++WEV+S G PY SN E
Sbjct: 172 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 361 bits (928), Expect = e-124
Identities = 94/252 (37%), Positives = 135/252 (53%), Gaps = 15/252 (5%)
Query: 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTAS-DFRREVDLMSELRHPNIVC 118
+ELG G FG V KG + VA+K LK AN + E ++M +L +P IV
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
++G+C E ++ E G L+++L + ++ + QV+ G
Sbjct: 83 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRH------------VKDKNIIELVHQVSMG 129
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA-SDYYRIQSKSLLPVRWMPP 237
M YL ++VHRDLAARN L+ KISDFGLS+ + A +YY+ Q+ PV+W P
Sbjct: 130 MKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 189
Query: 238 ESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRM 297
E I Y KF+++SDVWS+GV++WE +SYG +PY G EV M+ + + CP CP M
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM 249
Query: 298 YSLMMECWHEVP 309
Y LM CW
Sbjct: 250 YDLMNLCWTYDV 261
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 8e-61
Identities = 52/103 (50%), Positives = 70/103 (67%), Gaps = 1/103 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA-SDYYRIQSKSLLPVR 368
V+ GM YL ++VHRDLAARN L+ KISDFGLS+ + A +YY+ Q+ PV+
Sbjct: 126 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 185
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
W PE I Y KF+++SDVWS+GV++WE +SYG +PY G E
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 361 bits (928), Expect = e-124
Identities = 88/264 (33%), Positives = 137/264 (51%), Gaps = 14/264 (5%)
Query: 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPS--LVAIKTLKENANQKTASDFRREV 105
R + ET+ + ++ LG GAFG VYKG VAIK L+E + K + E
Sbjct: 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 68
Query: 106 DLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQ 165
+M+ + +P++ LLG+CL + ++ + M G L +++ +
Sbjct: 69 YVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN-----------IGS 116
Query: 166 QDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQ 225
Q + +Q+A GM YL VHRDLAARN LV VKI+DFGL++ + A +
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 226 SKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ 285
+P++WM ESIL+ +T +SDVWSYGV +WE+ ++G +PY G E+ ++ +
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236
Query: 286 MLPCPEDCPPRMYSLMMECWHEVP 309
LP P C +Y +M +CW
Sbjct: 237 RLPQPPICTIDVYMIMRKCWMIDA 260
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 2e-61
Identities = 47/102 (46%), Positives = 64/102 (62%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+A GM YL VHRDLAARN LV VKI+DFGL++ + A + +P++W
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
M ESIL+ +T +SDVWSYGV +WE+ ++G +PY G E
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 370 bits (952), Expect = e-123
Identities = 102/266 (38%), Positives = 147/266 (55%), Gaps = 14/266 (5%)
Query: 45 SDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSL-VAIKTLKENANQKTASDFRR 103
S E+ + + +GEG FG V++G + E P++ VAIKT K + F +
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 440
Query: 104 EVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPL 163
E M + HP+IV L+GV + P+ ++ E G+L FL R L
Sbjct: 441 EALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFS-----------L 488
Query: 164 SQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYR 223
A Q++ +AYL S +VHRD+AARN LV VK+ DFGLSR + S YY+
Sbjct: 489 DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 548
Query: 224 IQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS 283
SK LP++WM PESI + +FT+ SDVW +GV +WE+ +G++P+ G N +VI I +
Sbjct: 549 -ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 607
Query: 284 RQMLPCPEDCPPRMYSLMMECWHEVP 309
+ LP P +CPP +YSLM +CW P
Sbjct: 608 GERLPMPPNCPPTLYSLMTKCWAYDP 633
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 1e-57
Identities = 49/102 (48%), Positives = 70/102 (68%), Gaps = 1/102 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
++ +AYL S +VHRD+AARN LV VK+ DFGLSR + S YY+ SK LP++W
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKW 558
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
M PESI + +FT+ SDVW +GV +WE+ +G++P+ G N +
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 600
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 17/48 (35%), Positives = 26/48 (54%), Gaps = 1/48 (2%)
Query: 4 FLQELGEGAFGKVYKGEVCTSEGPSL-VAIKTLKENANQKTASDFRRE 50
+ +GEG FG V++G + E P++ VAIKT K + F +E
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQE 441
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 357 bits (917), Expect = e-122
Identities = 86/280 (30%), Positives = 134/280 (47%), Gaps = 30/280 (10%)
Query: 49 REVIETKPRFLQELGEGAFGKVYKGE--VCTSEGPSLVAIKTLKENANQKTASDFRREVD 106
+ + +++LGEG FGKV VA+K+LK + +D ++E++
Sbjct: 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIE 75
Query: 107 LMSELRHPNIVCLLGVCLS--GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLS 164
++ L H NIV G+C G + ++ EF+ G L E+L + ++
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-----------IN 124
Query: 165 QQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA-SDYYR 223
+ A+Q+ GM YL S YVHRDLAARN LV VKI DFGL++ + +YY
Sbjct: 125 LKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT 184
Query: 224 IQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQ--------------PY 269
++ PV W PE ++ KF SDVWS+GV L E+ +Y +
Sbjct: 185 VKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH 244
Query: 270 YGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
+ ++ ++ + LPCP +CP +Y LM +CW P
Sbjct: 245 GQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQP 284
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 3e-57
Identities = 44/114 (38%), Positives = 60/114 (52%), Gaps = 1/114 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA-SDYYRIQSKSLLPVR 368
+ GM YL S YVHRDLAARN LV VKI DFGL++ + +YY ++ PV
Sbjct: 135 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF 194
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLKTPPSWIT 422
W PE ++ KF SDVWS+GV L E+ +Y + + + +T
Sbjct: 195 WYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT 248
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 355 bits (913), Expect = e-122
Identities = 93/261 (35%), Positives = 136/261 (52%), Gaps = 17/261 (6%)
Query: 49 REVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLM 108
E+ + L+ELG G FG V G+ G VA+K +KE + + +F +E M
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWK---GQYDVAVKMIKEGSMSE--DEFFQEAQTM 57
Query: 109 SELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDF 168
+L HP +V GVC P+ ++ E++ G L +L S L
Sbjct: 58 MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG-----------LEPSQL 106
Query: 169 SHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKS 228
+ V GMA+L SH ++HRDLAARNCLV L VK+SDFG++R V Y +
Sbjct: 107 LEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS-SVGT 165
Query: 229 LLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP 288
PV+W PE Y K++++SDVW++G+++WEV+S G PY Y+N EV+ + L
Sbjct: 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLY 225
Query: 289 CPEDCPPRMYSLMMECWHEVP 309
P +Y +M CWHE+P
Sbjct: 226 RPHLASDTIYQIMYSCWHELP 246
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 5e-61
Identities = 50/102 (49%), Positives = 69/102 (67%), Gaps = 1/102 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
V GMA+L SH ++HRDLAARNCLV L VK+SDFG++R V Y + PV+W
Sbjct: 113 VCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS-SVGTKFPVKW 171
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
PE Y K++++SDVW++G+++WEV+S G PY Y+N E
Sbjct: 172 SAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE 213
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 356 bits (916), Expect = e-122
Identities = 83/280 (29%), Positives = 131/280 (46%), Gaps = 32/280 (11%)
Query: 49 REVIETKPRFLQELGEGAFGKVYKGE--VCTSEGPSLVAIKTLKENANQKTASDFRREVD 106
+ + +++LGEG FGKV +VA+K LK +A + S +++E+D
Sbjct: 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEID 85
Query: 107 LMSELRHPNIVCLLGVCLS--GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLS 164
++ L H +I+ G C + ++ E++ G L ++L S +
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-------------IG 132
Query: 165 QQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA-SDYYR 223
A Q+ GMAYL + HY+HRDLAARN L+ + VKI DFGL++ V +YYR
Sbjct: 133 LAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR 192
Query: 224 IQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQ--------------PY 269
++ PV W PE + KF SDVWS+GV L+E+ ++
Sbjct: 193 VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ 252
Query: 270 YGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
+ + E++ + LP P+ CP +Y LM CW
Sbjct: 253 GQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEA 292
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 2e-57
Identities = 44/109 (40%), Positives = 62/109 (56%), Gaps = 1/109 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA-SDYYRIQSKSLLPVR 368
+ GMAYL + HY+HRDLAARN L+ + VKI DFGL++ V +YYR++ PV
Sbjct: 143 ICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 202
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLKTP 417
W PE + KF SDVWS+GV L+E+ ++ + E +
Sbjct: 203 WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA 251
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 9e-10
Identities = 16/50 (32%), Positives = 27/50 (54%), Gaps = 2/50 (4%)
Query: 4 FLQELGEGAFGKVYKGE--VCTSEGPSLVAIKTLKENANQKTASDFRREV 51
+++LGEG FGKV +VA+K LK +A + S +++E+
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEI 84
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 352 bits (905), Expect = e-121
Identities = 69/267 (25%), Positives = 118/267 (44%), Gaps = 34/267 (12%)
Query: 57 RFLQELGEGAFGKVYKGE-----VCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL 111
F + LG+G F K++KG + V +K L + A++ + F +MS+L
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK-AHRNYSESFFEAASMMSKL 69
Query: 112 RHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHI 171
H ++V GVC+ G+ ++ EF+ G L +L ++ +
Sbjct: 70 SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC-----------INILWKLEV 118
Query: 172 ALQVAAGMAYLCSHHYVHRDLAARNCLV--------GDGLTVKISDFGLSRDVYASDYYR 223
A Q+AA M +L + +H ++ A+N L+ G+ +K+SD G+S V D +
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ 178
Query: 224 IQSKSLLPVRWMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282
+ W+PPE I K +D WS+G LWE+ S G +P +Q ++
Sbjct: 179 E------RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE 232
Query: 283 SRQMLPCPEDCPPRMYSLMMECWHEVP 309
R LP P+ + +L+ C P
Sbjct: 233 DRHQLPAPKAAE--LANLINNCMDYEP 257
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 6e-58
Identities = 33/111 (29%), Positives = 53/111 (47%), Gaps = 15/111 (13%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV--------GDGLTVKISDFGLSRDVYASDYYRIQS 361
+AA M +L + +H ++ A+N L+ G+ +K+SD G+S V D +
Sbjct: 122 LAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQE-- 179
Query: 362 KSLLPVRWMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
+ W+PPE I K +D WS+G LWE+ S G +P +Q
Sbjct: 180 ----RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 353 bits (908), Expect = e-121
Identities = 83/267 (31%), Positives = 138/267 (51%), Gaps = 14/267 (5%)
Query: 45 SDFRREVIETKPRFLQELGEGAFGKVYKGE--VCTSEGPSLVAIKTLKENANQKTASDFR 102
R ET+ R L+ LG G FG V+KG V IK +++ + +++
Sbjct: 4 KVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT 63
Query: 103 REVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAP 162
+ + L H +IV LLG+C G + ++ +++ G L + +
Sbjct: 64 DHMLAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGA----------- 111
Query: 163 LSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYY 222
L Q + +Q+A GM YL H VHR+LAARN L+ V+++DFG++ + D
Sbjct: 112 LGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171
Query: 223 RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282
+ S++ P++WM ESI +GK+T +SDVWSYGV +WE+ ++G +PY G EV +++
Sbjct: 172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
Query: 283 SRQMLPCPEDCPPRMYSLMMECWHEVP 309
+ L P+ C +Y +M++CW
Sbjct: 232 KGERLAQPQICTIDVYMVMVKCWMIDE 258
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 2e-59
Identities = 45/102 (44%), Positives = 67/102 (65%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+A GM YL H VHR+LAARN L+ V+++DFG++ + D + S++ P++W
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
M ESI +GK+T +SDVWSYGV +WE+ ++G +PY G E
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE 225
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 351 bits (904), Expect = e-121
Identities = 96/253 (37%), Positives = 148/253 (58%), Gaps = 15/253 (5%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
+LG G +G+VY+G VA+KTLKE+ + +F +E +M E++HPN+
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLT--VAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNL 71
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V LLGVC P ++ EFM G+L ++L + + +S ++A Q++
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE----------VSAVVLLYMATQIS 121
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 236
+ M YL +++HRDLAARNCLVG+ VK++DFGLSR + D Y + + P++W
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTA 180
Query: 237 PESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPR 296
PES+ Y KF+ +SDVW++GV+LWE+ +YG+ PY G +V E++ + PE CP +
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 240
Query: 297 MYSLMMECWHEVP 309
+Y LM CW P
Sbjct: 241 VYELMRACWQWNP 253
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 8e-60
Identities = 47/102 (46%), Positives = 71/102 (69%), Gaps = 1/102 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+++ M YL +++HRDLAARNCLVG+ VK++DFGLSR + D Y + + P++W
Sbjct: 120 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKW 178
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
PES+ Y KF+ +SDVW++GV+LWE+ +YG+ PY G +
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 220
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 355 bits (913), Expect = e-121
Identities = 93/253 (36%), Positives = 138/253 (54%), Gaps = 13/253 (5%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
+++G G FG+V+ G + VA+K+ +E + F +E ++ + HPNI
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTL--VAVKSCRETLPPDLKAKFLQEARILKQYSHPNI 174
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V L+GVC +P+ ++ E + GD FL + R L + + A
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-----------LRVKTLLQMVGDAA 223
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 236
AGM YL S +HRDLAARNCLV + +KISDFG+SR+ Y +PV+W
Sbjct: 224 AGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTA 283
Query: 237 PESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPR 296
PE++ YG++++ESDVWS+G++LWE +S G PY SNQ+ E + LPCPE CP
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDA 343
Query: 297 MYSLMMECWHEVP 309
++ LM +CW P
Sbjct: 344 VFRLMEQCWAYEP 356
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 6e-60
Identities = 51/102 (50%), Positives = 69/102 (67%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
AAGM YL S +HRDLAARNCLV + +KISDFG+SR+ Y +PV+W
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKW 281
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
PE++ YG++++ESDVWS+G++LWE +S G PY SNQ+
Sbjct: 282 TAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 349 bits (897), Expect = e-119
Identities = 99/276 (35%), Positives = 143/276 (51%), Gaps = 17/276 (6%)
Query: 39 ANQKTASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSL-VAIKTLKENA--NQ 95
A + + E R L++LG+G+FG V +GE G ++ VA+K LK +
Sbjct: 3 AGEGPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP 62
Query: 96 KTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDIS 155
+ DF REV+ M L H N++ L GV L PM M+ E G L + L
Sbjct: 63 EAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGH---- 117
Query: 156 GSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRD 215
S A+QVA GM YL S ++HRDLAARN L+ VKI DFGL R
Sbjct: 118 -------FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170
Query: 216 VYA-SDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN 274
+ D+Y +Q +P W PES+ F+ SD W +GV LWE+++YG +P+ G +
Sbjct: 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 230
Query: 275 QEVIEMI-RSRQMLPCPEDCPPRMYSLMMECWHEVP 309
+++ I + + LP PEDCP +Y++M++CW P
Sbjct: 231 SQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKP 266
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 9e-59
Identities = 45/103 (43%), Positives = 62/103 (60%), Gaps = 1/103 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA-SDYYRIQSKSLLPVR 368
VA GM YL S ++HRDLAARN L+ VKI DFGL R + D+Y +Q +P
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 189
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
W PES+ F+ SD W +GV LWE+++YG +P+ G + +
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 232
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 20/51 (39%), Positives = 30/51 (58%), Gaps = 3/51 (5%)
Query: 4 FLQELGEGAFGKVYKGEVCTSEGPSL-VAIKTLKENA--NQKTASDFRREV 51
L++LG+G+FG V +GE G ++ VA+K LK + + DF REV
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV 72
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 348 bits (895), Expect = e-119
Identities = 86/273 (31%), Positives = 137/273 (50%), Gaps = 32/273 (11%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEG--PSLVAIKTLKENANQKTASDFRREVDLMSELRHP 114
+FLQ+LG+G FG V + +VA+K L+ + ++ DF RE++++ L+H
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHD 102
Query: 115 NIVCLLGVCLS--GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIA 172
NIV GVC S + ++ E++ G L ++L R +
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----------IDHIKLLQYT 151
Query: 173 LQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS-DYYRIQSKSLLP 231
Q+ GM YL + Y+HRDLA RN LV + VKI DFGL++ + +YY+++ P
Sbjct: 152 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 232 VRWMPPESILYGKFTTESDVWSYGVVLWEVYSY---------------GLQPYYGYSNQE 276
+ W PES+ KF+ SDVWS+GVVL+E+++Y G
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271
Query: 277 VIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
+IE++++ LP P+ CP +Y +M ECW+
Sbjct: 272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNV 304
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-55
Identities = 42/118 (35%), Positives = 61/118 (51%), Gaps = 16/118 (13%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS-DYYRIQSKSLLPVR 368
+ GM YL + Y+HRDLA RN LV + VKI DFGL++ + +YY+++ P+
Sbjct: 154 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF 213
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSY---------------GLQPYYGYSNQE 411
W PES+ KF+ SDVWS+GVVL+E+++Y G
Sbjct: 214 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 345 bits (888), Expect = e-118
Identities = 85/281 (30%), Positives = 138/281 (49%), Gaps = 32/281 (11%)
Query: 49 REVIETKPRFLQELGEGAFGKVYKGE--VCTSEGPSLVAIKTLKENANQKTASDFRREVD 106
+ E +FLQ+LG+G FG V +VA+K L+ + ++ DF RE++
Sbjct: 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIE 63
Query: 107 LMSELRHPNIVCLLGVCLS--GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLS 164
++ L+H NIV GVC S + ++ E++ G L ++L R +
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----------ID 112
Query: 165 QQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS-DYYR 223
Q+ GM YL + Y+HRDLA RN LV + VKI DFGL++ + ++++
Sbjct: 113 HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFK 172
Query: 224 IQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY---------------GLQP 268
++ P+ W PES+ KF+ SDVWS+GVVL+E+++Y G
Sbjct: 173 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 232
Query: 269 YYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
+IE++++ LP P+ CP +Y +M ECW+
Sbjct: 233 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNV 273
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 3e-55
Identities = 40/118 (33%), Positives = 61/118 (51%), Gaps = 16/118 (13%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS-DYYRIQSKSLLPVR 368
+ GM YL + Y+HRDLA RN LV + VKI DFGL++ + ++++++ P+
Sbjct: 123 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSY---------------GLQPYYGYSNQE 411
W PES+ KF+ SDVWS+GVVL+E+++Y G
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 346 bits (890), Expect = e-118
Identities = 84/280 (30%), Positives = 130/280 (46%), Gaps = 31/280 (11%)
Query: 49 REVIETKPRFLQELGEGAFGKVYKGE--VCTSEGPSLVAIKTLKENANQKTASDFRREVD 106
E +++ +LG+G FG V +LVA+K L+ + + DF+RE+
Sbjct: 18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR-DFQREIQ 76
Query: 107 LMSELRHPNIVCLLGVCLS--GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLS 164
++ L IV GV + + ++ E++ G L +FL R L
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-----------LD 125
Query: 165 QQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV-YASDYYR 223
+ Q+ GM YL S VHRDLAARN LV VKI+DFGL++ + DYY
Sbjct: 126 ASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV 185
Query: 224 IQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY----------- 272
++ P+ W PES+ F+ +SDVWS+GVVL+E+++Y +
Sbjct: 186 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER 245
Query: 273 ---SNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
+ ++E++ Q LP P CP ++ LM CW P
Sbjct: 246 DVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSP 285
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-57
Identities = 43/114 (37%), Positives = 62/114 (54%), Gaps = 1/114 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV-YASDYYRIQSKSLLPVR 368
+ GM YL S VHRDLAARN LV VKI+DFGL++ + DYY ++ P+
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 195
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLKTPPSWIT 422
W PES+ F+ +SDVWS+GVVL+E+++Y + + +
Sbjct: 196 WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPA 249
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 15/50 (30%), Positives = 26/50 (52%), Gaps = 3/50 (6%)
Query: 4 FLQELGEGAFGKVYKGE--VCTSEGPSLVAIKTLKENANQKTASDFRREV 51
++ +LG+G FG V +LVA+K L+ + + DF+RE+
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR-DFQREI 75
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 345 bits (887), Expect = e-118
Identities = 88/264 (33%), Positives = 138/264 (52%), Gaps = 14/264 (5%)
Query: 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPS--LVAIKTLKENANQKTASDFRREV 105
R + ET+ + ++ LG GAFG VYKG VAIK L+E + K + E
Sbjct: 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 68
Query: 106 DLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQ 165
+M+ + +P++ LLG+CL + ++ + M G L +++ +
Sbjct: 69 YVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN-----------IGS 116
Query: 166 QDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQ 225
Q + +Q+A GM YL VHRDLAARN LV VKI+DFGL++ + A +
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 226 SKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ 285
+P++WM ESIL+ +T +SDVWSYGV +WE+ ++G +PY G E+ ++ +
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236
Query: 286 MLPCPEDCPPRMYSLMMECWHEVP 309
LP P C +Y +M++CW
Sbjct: 237 RLPQPPICTIDVYMIMVKCWMIDA 260
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 1e-58
Identities = 47/102 (46%), Positives = 64/102 (62%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+A GM YL VHRDLAARN LV VKI+DFGL++ + A + +P++W
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
M ESIL+ +T +SDVWSYGV +WE+ ++G +PY G E
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 343 bits (881), Expect = e-117
Identities = 90/254 (35%), Positives = 141/254 (55%), Gaps = 23/254 (9%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
+ LQ +G+G FG V G+ ++ VA+K +K +A TA F E +M++LRH N+
Sbjct: 24 KLLQTIGKGEFGDVMLGDYRGNK----VAVKCIKNDA---TAQAFLAEASVMTQLRHSNL 76
Query: 117 VCLLGVCLSGEP-MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQV 175
V LLGV + + + ++ E+M +G L ++L SR L +L V
Sbjct: 77 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS----------VLGGDCLLKFSLDV 126
Query: 176 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM 235
M YL +++VHRDLAARN LV + K+SDFGL+++ ++ LPV+W
Sbjct: 127 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWT 181
Query: 236 PPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPP 295
PE++ KF+T+SDVWS+G++LWE+YS+G PY ++V+ + + P+ CPP
Sbjct: 182 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP 241
Query: 296 RMYSLMMECWHEVP 309
+Y +M CWH
Sbjct: 242 AVYEVMKNCWHLDA 255
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 6e-58
Identities = 44/102 (43%), Positives = 66/102 (64%), Gaps = 5/102 (4%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
V M YL +++VHRDLAARN LV + K+SDFGL+++ ++ LPV+W
Sbjct: 126 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKW 180
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
PE++ KF+T+SDVWS+G++LWE+YS+G PY ++
Sbjct: 181 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 222
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 350 bits (898), Expect = e-115
Identities = 95/251 (37%), Positives = 137/251 (54%), Gaps = 13/251 (5%)
Query: 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCL 119
ELG G FG V +G + VAIK LK+ + + RE +M +L +P IV L
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 120 LGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGM 179
+GVC E + ++ E G LH+FL+ + + + + + QV+ GM
Sbjct: 402 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREE-----------IPVSNVAELLHQVSMGM 449
Query: 180 AYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD-YYRIQSKSLLPVRWMPPE 238
YL ++VHR+LAARN L+ + KISDFGLS+ + A D YY +S P++W PE
Sbjct: 450 KYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 509
Query: 239 SILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMY 298
I + KF++ SDVWSYGV +WE SYG +PY EV+ I + + CP +CPP +Y
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 569
Query: 299 SLMMECWHEVP 309
+LM +CW
Sbjct: 570 ALMSDCWIYKW 580
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 4e-55
Identities = 50/103 (48%), Positives = 66/103 (64%), Gaps = 1/103 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD-YYRIQSKSLLPVR 368
V+ GM YL ++VHR+LAARN L+ + KISDFGLS+ + A D YY +S P++
Sbjct: 445 VSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 504
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
W PE I + KF++ SDVWSYGV +WE SYG +PY E
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 7e-09
Identities = 16/45 (35%), Positives = 21/45 (46%)
Query: 6 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRRE 50
ELG G FG V +G + VAIK LK+ + + RE
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMRE 386
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 337 bits (867), Expect = e-115
Identities = 92/253 (36%), Positives = 145/253 (57%), Gaps = 17/253 (6%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
+ ++ LG G FG+V+ G G + VA+K+LK+ + F E +LM +L+H +
Sbjct: 16 KLVERLGAGQFGEVWMGYY---NGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRL 70
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V L V + EP+ ++ E+M G L +FL + S L+ +A Q+A
Sbjct: 71 VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIK----------LTINKLLDMAAQIA 119
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 236
GMA++ +Y+HRDL A N LV D L+ KI+DFGL+R + ++Y + + P++W
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFPIKWTA 178
Query: 237 PESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPR 296
PE+I YG FT +SDVWS+G++L E+ ++G PY G +N EVI+ + + P++CP
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 238
Query: 297 MYSLMMECWHEVP 309
+Y LM CW E P
Sbjct: 239 LYQLMRLCWKERP 251
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 2e-58
Identities = 46/102 (45%), Positives = 70/102 (68%), Gaps = 1/102 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+A GMA++ +Y+HRDL A N LV D L+ KI+DFGL+R + ++Y + + P++W
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFPIKW 176
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
PE+I YG FT +SDVWS+G++L E+ ++G PY G +N E
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 333 bits (855), Expect = e-111
Identities = 90/254 (35%), Positives = 141/254 (55%), Gaps = 23/254 (9%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
+ LQ +G+G FG V G+ ++ VA+K +K +A TA F E +M++LRH N+
Sbjct: 196 KLLQTIGKGEFGDVMLGDYRGNK----VAVKCIKNDA---TAQAFLAEASVMTQLRHSNL 248
Query: 117 VCLLGVCLSGEP-MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQV 175
V LLGV + + + ++ E+M +G L ++L SR L +L V
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS----------VLGGDCLLKFSLDV 298
Query: 176 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM 235
M YL +++VHRDLAARN LV + K+SDFGL+++ ++ LPV+W
Sbjct: 299 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWT 353
Query: 236 PPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPP 295
PE++ KF+T+SDVWS+G++LWE+YS+G PY ++V+ + + P+ CPP
Sbjct: 354 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP 413
Query: 296 RMYSLMMECWHEVP 309
+Y +M CWH
Sbjct: 414 AVYDVMKNCWHLDA 427
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 7e-54
Identities = 44/102 (43%), Positives = 66/102 (64%), Gaps = 5/102 (4%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
V M YL +++VHRDLAARN LV + K+SDFGL+++ ++ LPV+W
Sbjct: 298 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKW 352
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
PE++ KF+T+SDVWS+G++LWE+YS+G PY ++
Sbjct: 353 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 394
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 326 bits (838), Expect = e-108
Identities = 93/271 (34%), Positives = 142/271 (52%), Gaps = 17/271 (6%)
Query: 39 ANQKTASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTA 98
QK E+ + ++LG G FG+V+ T + VA+KT+K +
Sbjct: 173 KPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMA---TYNKHTKVAVKTMKPGSMSVE- 228
Query: 99 SDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQ 158
F E ++M L+H +V L V + EP+ ++ EFM +G L +FL S
Sbjct: 229 -AFLAEANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGS------- 279
Query: 159 VQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA 218
+ Q+A GMA++ +Y+HRDL A N LV L KI+DFGL+R +
Sbjct: 280 ---KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336
Query: 219 SDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVI 278
++Y + + P++W PE+I +G FT +SDVWS+G++L E+ +YG PY G SN EVI
Sbjct: 337 NEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 395
Query: 279 EMIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
+ +P PE+CP +Y++MM CW P
Sbjct: 396 RALERGYRMPRPENCPEELYNIMMRCWKNRP 426
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 9e-54
Identities = 46/102 (45%), Positives = 68/102 (66%), Gaps = 1/102 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+A GMA++ +Y+HRDL A N LV L KI+DFGL+R + ++Y + + P++W
Sbjct: 293 IAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA-REGAKFPIKW 351
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
PE+I +G FT +SDVWS+G++L E+ +YG PY G SN E
Sbjct: 352 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE 393
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 325 bits (836), Expect = e-108
Identities = 96/265 (36%), Positives = 149/265 (56%), Gaps = 17/265 (6%)
Query: 45 SDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRRE 104
+ E+ R +LG+G FG+V+ G G + VAIKTLK F +E
Sbjct: 175 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTW---NGTTRVAIKTLKPGTMSPE--AFLQE 229
Query: 105 VDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLS 164
+M +LRH +V L V S EP+ ++ E+M +G L +FL + + L
Sbjct: 230 AQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKY----------LR 278
Query: 165 QQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRI 224
+A Q+A+GMAY+ +YVHRDL A N LVG+ L K++DFGL+R + ++Y
Sbjct: 279 LPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA- 337
Query: 225 QSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR 284
+ + P++W PE+ LYG+FT +SDVWS+G++L E+ + G PY G N+EV++ +
Sbjct: 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 397
Query: 285 QMLPCPEDCPPRMYSLMMECWHEVP 309
+PCP +CP ++ LM +CW + P
Sbjct: 398 YRMPCPPECPESLHDLMCQCWRKEP 422
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-52
Identities = 47/102 (46%), Positives = 71/102 (69%), Gaps = 1/102 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+A+GMAY+ +YVHRDL A N LVG+ L K++DFGL+R + ++Y + + P++W
Sbjct: 289 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKW 347
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
PE+ LYG+FT +SDVWS+G++L E+ + G PY G N+E
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 389
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 327 bits (840), Expect = e-108
Identities = 96/274 (35%), Positives = 150/274 (54%), Gaps = 17/274 (6%)
Query: 36 KENANQKTASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQ 95
+ + E+ R +LG+G FG+V+ G G + VAIKTLK
Sbjct: 249 TSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW---NGTTRVAIKTLKPGTMS 305
Query: 96 KTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDIS 155
F +E +M +LRH +V L V S EP+ ++ E+M +G L +FL + +
Sbjct: 306 PE--AFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKY--- 359
Query: 156 GSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRD 215
L +A Q+A+GMAY+ +YVHRDL A N LVG+ L K++DFGL+R
Sbjct: 360 -------LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 412
Query: 216 VYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ 275
+ ++Y + + P++W PE+ LYG+FT +SDVWS+G++L E+ + G PY G N+
Sbjct: 413 IEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 471
Query: 276 EVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
EV++ + +PCP +CP ++ LM +CW + P
Sbjct: 472 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 505
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-51
Identities = 47/102 (46%), Positives = 71/102 (69%), Gaps = 1/102 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+A+GMAY+ +YVHRDL A N LVG+ L K++DFGL+R + ++Y + + P++W
Sbjct: 372 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKW 430
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
PE+ LYG+FT +SDVWS+G++L E+ + G PY G N+E
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 472
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 325 bits (836), Expect = e-107
Identities = 99/278 (35%), Positives = 156/278 (56%), Gaps = 15/278 (5%)
Query: 32 IKTLKENANQKTASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKE 91
K K + + + E+ T +LG G +G+VY+G VA+KTLKE
Sbjct: 198 PKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLT--VAVKTLKE 255
Query: 92 NANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPR 151
+ + +F +E +M E++HPN+V LLGVC P ++ EFM G+L ++L + +
Sbjct: 256 DTMEVE--EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 313
Query: 152 SDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211
+S ++A Q+++ M YL +++HR+LAARNCLVG+ VK++DFG
Sbjct: 314 ----------EVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFG 363
Query: 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG 271
LSR + D Y + + P++W PES+ Y KF+ +SDVW++GV+LWE+ +YG+ PY G
Sbjct: 364 LSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 422
Query: 272 YSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
+V E++ + PE CP ++Y LM CW P
Sbjct: 423 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 460
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 9e-52
Identities = 46/102 (45%), Positives = 71/102 (69%), Gaps = 1/102 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+++ M YL +++HR+LAARNCLVG+ VK++DFGLSR + D Y + + P++W
Sbjct: 327 ISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKW 385
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
PES+ Y KF+ +SDVW++GV+LWE+ +YG+ PY G +
Sbjct: 386 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 427
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 300 bits (769), Expect = 2e-99
Identities = 93/313 (29%), Positives = 141/313 (45%), Gaps = 60/313 (19%)
Query: 57 RFLQELGEGAFGKVYKGE---VCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-R 112
+ + LG GAFG+V + + + + VA+K LKE A E+ ++ +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84
Query: 113 HPNIVCLLGVCL-SGEPMCMLFEFMVRGDLHEFL-------------------------- 145
H N+V LLG C G P+ ++ EF G+L +L
Sbjct: 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGA 144
Query: 146 --MSRSPRSDISGSQVQA--------------------------PLSQQDFSHIALQVAA 177
+ R D S + L+ + + QVA
Sbjct: 145 IPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAK 204
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 237
GM +L S +HRDLAARN L+ + VKI DFGL+RD+Y Y + + LP++WM P
Sbjct: 205 GMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 264
Query: 238 ESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS-NQEVIEMIRSRQMLPCPEDCPPR 296
E+I +T +SDVWS+GV+LWE++S G PY G ++E ++ + P+ P
Sbjct: 265 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE 324
Query: 297 MYSLMMECWHEVP 309
MY M++CWH P
Sbjct: 325 MYQTMLDCWHGEP 337
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 7e-56
Identities = 69/237 (29%), Positives = 107/237 (45%), Gaps = 8/237 (3%)
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPE 238
+ ++ H V L A C G + I +F ++ Y R + +P
Sbjct: 79 LIHIGHHLNVVNLLGA--CTKPGGPLMVIVEFCKFGNLS--TYLRSKRNEFVPY-KTKGA 133
Query: 239 SILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMY 298
GK + L + S G+ ++ + + + +
Sbjct: 134 RFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLE 193
Query: 299 SLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYR 358
L+ + VA GM +L S +HRDLAARN L+ + VKI DFGL+RD+Y Y
Sbjct: 194 HLICYSFQ---VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250
Query: 359 IQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
+ + LP++WM PE+I +T +SDVWS+GV+LWE++S G PY G EEF +
Sbjct: 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 307
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 1e-88
Identities = 69/265 (26%), Positives = 110/265 (41%), Gaps = 27/265 (10%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIV 117
+ LG+G FG+ K + + +K L +++T F +EV +M L HPN++
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEV--MVMKELI-RFDEETQRTFLKEVKVMRCLEHPNVL 70
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
+GV + + + E++ G L + S A +A+
Sbjct: 71 KFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS-----------QYPWSQRVSFAKDIAS 119
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR---DVYASDYYRIQSKSLLPV-- 232
GMAYL S + +HRDL + NCLV + V ++DFGL+R D K
Sbjct: 120 GMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 233 -------RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGL-QPYYGYSNQEVIEMIRSR 284
WM PE I + + DV+S+G+VL E+ P Y + +R
Sbjct: 180 YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF 239
Query: 285 QMLPCPEDCPPRMYSLMMECWHEVP 309
CP +CPP + + + C P
Sbjct: 240 LDRYCPPNCPPSFFPITVRCCDLDP 264
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-38
Identities = 36/116 (31%), Positives = 52/116 (44%), Gaps = 12/116 (10%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR---DVYASDYYRIQSKSLLP 366
+A+GMAYL S + +HRDL + NCLV + V ++DFGL+R D K
Sbjct: 117 IASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176
Query: 367 V---------RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
WM PE I + + DV+S+G+VL E+ +F
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF 232
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 256 bits (657), Expect = 1e-83
Identities = 72/262 (27%), Positives = 119/262 (45%), Gaps = 27/262 (10%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKE-NANQKTASDFRREVDLMSELRHPN 115
Q +G G+FG VYKG+ VA+K L + F+ EV ++ + RH N
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGD-----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 116 IVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQV 175
I+ +G + + ++ ++ L+ L + + + IA Q
Sbjct: 82 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETK-----------FEMKKLIDIARQT 129
Query: 176 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM 235
A GM YL + +HRDL + N + + TVKI DFGL+ + + + WM
Sbjct: 130 ARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189
Query: 236 PPESILY---GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN-QEVIEMI----RSRQML 287
PE I ++ +SDV+++G+VL+E+ + G PY +N ++IEM+ S +
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRDQIIEMVGRGSLSPDLS 248
Query: 288 PCPEDCPPRMYSLMMECWHEVP 309
+CP RM LM EC +
Sbjct: 249 KVRSNCPKRMKRLMAECLKKKR 270
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-35
Identities = 34/108 (31%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
A GM YL + +HRDL + N + + TVKI DFGL+ + + + W
Sbjct: 129 TARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 188
Query: 370 MPPESILY---GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFL 414
M PE I ++ +SDV+++G+VL+E+ + G PY +N+++ +
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRDQII 235
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 254 bits (652), Expect = 4e-83
Identities = 82/268 (30%), Positives = 125/268 (46%), Gaps = 37/268 (13%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQ---KTASDFRREVDLMSELRH 113
+ +G G FGKVY+ E VA+K + + ++ +T + R+E L + L+H
Sbjct: 10 TLEEIIGIGGFGKVYRAFWIGDE----VAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
PNI+ L GVCL +C++ EF G L+ L + + + A+
Sbjct: 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-------------RIPPDILVNWAV 112
Query: 174 QVAAGMAYLCSHHY---VHRDLAARNCLVG--------DGLTVKISDFGLSRDVYASDYY 222
Q+A GM YL +HRDL + N L+ +KI+DFGL+R+ + +
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK- 171
Query: 223 RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282
+ WM PE I F+ SDVWSYGV+LWE+ + G P+ G V +
Sbjct: 172 ---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLT-GEVPFRGIDGLAVAYGVA 227
Query: 283 SRQM-LPCPEDCPPRMYSLMMECWHEVP 309
++ LP P CP LM +CW+ P
Sbjct: 228 MNKLALPIPSTCPEPFAKLMEDCWNPDP 255
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 38/113 (33%), Positives = 54/113 (47%), Gaps = 16/113 (14%)
Query: 310 VAAGMAYLCSHHY---VHRDLAARNCLVG--------DGLTVKISDFGLSRDVYASDYYR 358
+A GM YL +HRDL + N L+ +KI+DFGL+R+ + +
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK-- 171
Query: 359 IQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
+ WM PE I F+ SDVWSYGV+LWE+ + G P+ G
Sbjct: 172 --MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLT-GEVPFRGIDGLA 221
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 1e-79
Identities = 75/256 (29%), Positives = 127/256 (49%), Gaps = 20/256 (7%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPNI 116
+++G G+FG V++ E S+ VA+K L ++ + + ++F REV +M LRHPNI
Sbjct: 41 IKEKIGAGSFGTVHRAEWHGSD----VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V +G + ++ E++ RG L+ L R + + +A VA
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRR---------LSMAYDVA 147
Query: 177 AGMAYLCSHHY--VHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 234
GM YL + + VHR+L + N LV TVK+ DFGLSR ++ + W
Sbjct: 148 KGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAG--TPEW 205
Query: 235 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM-LPCPEDC 293
M PE + +SDV+S+GV+LWE+ + QP+ + +V+ + + L P +
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKCKRLEIPRNL 264
Query: 294 PPRMYSLMMECWHEVP 309
P++ +++ CW P
Sbjct: 265 NPQVAAIIEGCWTNEP 280
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 37/102 (36%), Positives = 54/102 (52%), Gaps = 5/102 (4%)
Query: 310 VAAGMAYLCSHHY--VHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV 367
VA GM YL + + VHR+L + N LV TVK+ DFGLSR ++ +
Sbjct: 146 VAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAG--TP 203
Query: 368 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN 409
WM PE + +SDV+S+GV+LWE+ + QP+ +
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELAT-LQQPWGNLNP 244
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 4e-76
Identities = 59/267 (22%), Positives = 106/267 (39%), Gaps = 34/267 (12%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPNI 116
+ +G+G FG+VY G E VAI+ + E N+ F+REV + RH N+
Sbjct: 37 IGELIGKGRFGQVYHG-RWHGE----VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENV 91
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V +G C+S + ++ L+ + L IA ++
Sbjct: 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI-----------VLDVNKTRQIAQEIV 140
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV---R 233
GM YL + +H+DL ++N +G V I+DFGL R + K +
Sbjct: 141 KGMGYLHAKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199
Query: 234 WMPPESILYGK---------FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS- 283
+ PE I F+ SDV++ G + +E+++ P+ + +I + +
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA-REWPFKTQPAEAIIWQMGTG 258
Query: 284 -RQMLPCPEDCPPRMYSLMMECWHEVP 309
+ L + +++ CW
Sbjct: 259 MKPNLS-QIGMGKEISDILLFCWAFEQ 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-27
Identities = 27/114 (23%), Positives = 48/114 (42%), Gaps = 14/114 (12%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV-- 367
+ GM YL + +H+DL ++N +G V I+DFGL R + K +
Sbjct: 139 IVKGMGYLHAKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGW 197
Query: 368 -RWMPPESILYGK---------FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
+ PE I F+ SDV++ G + +E+++ P+ +
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA-REWPFKTQPAEA 250
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 8e-75
Identities = 58/261 (22%), Positives = 107/261 (40%), Gaps = 31/261 (11%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPNI 116
FL +L E G+++KG ++ + +K LK + + + + DF E + HPN+
Sbjct: 14 FLTKLNENHSGELWKGRWQGND----IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 117 VCLLGVCLS--GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
+ +LG C S ++ +M G L+ L + + Q AL
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF----------VVDQSQAVKFALD 119
Query: 175 VAAGMAYLCSHHY--VHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV 232
+A GMA+L + L +R+ ++ + +T +IS + +
Sbjct: 120 MARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAP 172
Query: 233 RWMPPESIL---YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM-LP 288
W+ PE++ +D+WS+ V+LWE+ + P+ SN E+ + +
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT-REVPFADLSNMEIGMKVALEGLRPT 231
Query: 289 CPEDCPPRMYSLMMECWHEVP 309
P P + LM C +E P
Sbjct: 232 IPPGISPHVSKLMKICMNEDP 252
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 24/107 (22%), Positives = 46/107 (42%), Gaps = 13/107 (12%)
Query: 310 VAAGMAYLCSHHY--VHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV 367
+A GMA+L + L +R+ ++ + +T +IS + +
Sbjct: 120 MARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAP 172
Query: 368 RWMPPESIL---YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
W+ PE++ +D+WS+ V+LWE+ + P+ SN E
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT-REVPFADLSNME 218
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 1e-73
Identities = 83/271 (30%), Positives = 136/271 (50%), Gaps = 41/271 (15%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK------ENANQKTASDFRREVDLMSEL 111
+ +++G+G FG V+KG + S+VAIK+L E + +F+REV +MS L
Sbjct: 23 YEKQIGKGGFGLVHKGR-LVKDK-SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 112 RHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHI 171
HPNIV L G+ P M+ EF+ GDL+ L+ ++ P+ +
Sbjct: 81 NHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAH-----------PIKWSVKLRL 127
Query: 172 ALQVAAGMAYLCSHHY--VHRDLAARNCLVGDG-----LTVKISDFGLSRDVYASDYYRI 224
L +A G+ Y+ + + VHRDL + N + + K++DFGLS+ S
Sbjct: 128 MLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS----- 182
Query: 225 QSKSLL-PVRWMPPESILY--GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEV--IE 279
LL +WM PE+I +T ++D +S+ ++L+ + + G P+ YS ++ I
Sbjct: 183 -VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT-GEGPFDEYSYGKIKFIN 240
Query: 280 MIRSRQM-LPCPEDCPPRMYSLMMECWHEVP 309
MIR + PEDCPPR+ +++ CW P
Sbjct: 241 MIREEGLRPTIPEDCPPRLRNVIELCWSGDP 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 31/112 (27%), Positives = 56/112 (50%), Gaps = 17/112 (15%)
Query: 310 VAAGMAYLCSHHY--VHRDLAARNCLVGDG-----LTVKISDFGLSRDVYASDYYRIQSK 362
+A G+ Y+ + + VHRDL + N + + K++DFGLS+ S
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS------VS 184
Query: 363 SLL-PVRWMPPESILY--GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
LL +WM PE+I +T ++D +S+ ++L+ + + G P+ YS +
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT-GEGPFDEYSYGK 235
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 5e-73
Identities = 73/258 (28%), Positives = 116/258 (44%), Gaps = 30/258 (11%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIV 117
+ +G GAFG V K + + VAIK ++ + +K F E+ +S + HPNIV
Sbjct: 12 VEEVVGRGAFGVVCKAKWRAKD----VAIKQIESESERK---AFIVELRQLSRVNHPNIV 64
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
L G CL P+C++ E+ G L+ L P + + LQ +
Sbjct: 65 KLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHA---------MSWCLQCSQ 113
Query: 178 GMAYLCSHHY---VHRDLAARNCLV-GDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR 233
G+AYL S +HRDL N L+ G +KI DFG + D+ S
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGS-----AA 168
Query: 234 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN--QEVIEMIRSRQMLPCPE 291
WM PE ++ + DV+S+G++LWEV + +P+ ++ + + P +
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVIT-RRKPFDEIGGPAFRIMWAVHNGTRPPLIK 227
Query: 292 DCPPRMYSLMMECWHEVP 309
+ P + SLM CW + P
Sbjct: 228 NLPKPIESLMTRCWSKDP 245
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 32/104 (30%), Positives = 49/104 (47%), Gaps = 10/104 (9%)
Query: 310 VAAGMAYLCSHHY---VHRDLAARNCLV-GDGLTVKISDFGLSRDVYASDYYRIQSKSLL 365
+ G+AYL S +HRDL N L+ G +KI DFG + D+ S
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGS---- 166
Query: 366 PVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN 409
WM PE ++ + DV+S+G++LWEV + +P+
Sbjct: 167 -AAWMAPEVFEGSNYSEKCDVFSWGIILWEVIT-RRKPFDEIGG 208
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 6e-53
Identities = 70/321 (21%), Positives = 133/321 (41%), Gaps = 68/321 (21%)
Query: 35 LKENANQKTASDFRREVIETKPR---FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKE 91
++++ + + S V T + ++++G+G +G+V+ G+ + VA+K
Sbjct: 15 IEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEK----VAVKVFFT 70
Query: 92 NANQKTASDFR-REVDLMSELRHPNIVCLLGVCLSGEP----MCMLFEFMVRGDLHEFLM 146
+ AS FR E+ +RH NI+ + + G + ++ ++ G L+++L
Sbjct: 71 ---TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK 127
Query: 147 SRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYL--------CSHHYVHRDLAARNCL 198
S L + +A +G+ +L HRDL ++N L
Sbjct: 128 ST-------------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNIL 174
Query: 199 VGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV---RWMPPESILYGKFTTES------ 249
V T I+D GL+ + SD + V R+MPPE +L
Sbjct: 175 VKKNGTCCIADLGLAV-KFISDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIM 232
Query: 250 -DVWSYGVVLWEVYSYGL---------QPYYGY-----SNQEVIEMIRSRQMLP------ 288
D++S+G++LWEV + PY+ S +++ E++ +++ P
Sbjct: 233 ADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRW 292
Query: 289 CPEDCPPRMYSLMMECWHEVP 309
++C +M LM ECW P
Sbjct: 293 SSDECLRQMGKLMTECWAHNP 313
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 8e-19
Identities = 30/107 (28%), Positives = 46/107 (42%), Gaps = 20/107 (18%)
Query: 310 VAAGMAYL--------CSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQS 361
+G+ +L HRDL ++N LV T I+D GL+ + SD +
Sbjct: 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV-KFISDTNEVDI 201
Query: 362 KSLLPV---RWMPPESILYGKFTTES-------DVWSYGVVLWEVYS 398
V R+MPPE +L D++S+G++LWEV
Sbjct: 202 PPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVAR 247
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 7e-53
Identities = 65/295 (22%), Positives = 120/295 (40%), Gaps = 65/295 (22%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFR-REVDLMSELRHPNI 116
L+ +G+G +G+V++G VA+K + S FR E+ LRH NI
Sbjct: 12 LLECVGKGRYGEVWRGSWQGEN----VAVKIFSS---RDEKSWFRETELYNTVMLRHENI 64
Query: 117 VCLLGVCLSGE----PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIA 172
+ + ++ + ++ + G L+++L L I
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-------------TLDTVSCLRIV 111
Query: 173 LQVAAGMAYLCSHHY--------VHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRI 224
L +A+G+A+L + HRDL ++N LV I+D GL+ +++ ++
Sbjct: 112 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV-MHSQSTNQL 170
Query: 225 QSKSLLPV---RWMPPESILYGKFTTE-------SDVWSYGVVLWEVYS----YGL---- 266
+ V R+M PE +L + D+W++G+VLWEV G+
Sbjct: 171 DVGNNPRVGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229
Query: 267 -QPYYGY-----SNQEVIEMIRSRQMLP------CPEDCPPRMYSLMMECWHEVP 309
P+Y S +++ +++ Q P + + LM ECW++ P
Sbjct: 230 KPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNP 284
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-19
Identities = 29/107 (27%), Positives = 51/107 (47%), Gaps = 20/107 (18%)
Query: 310 VAAGMAYLCSHHY--------VHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQS 361
+A+G+A+L + HRDL ++N LV I+D GL+ +++ ++
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV-MHSQSTNQLDV 172
Query: 362 KSLLPV---RWMPPESILYGKFTTE-------SDVWSYGVVLWEVYS 398
+ V R+M PE +L + D+W++G+VLWEV
Sbjct: 173 GNNPRVGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVAR 218
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-49
Identities = 64/295 (21%), Positives = 117/295 (39%), Gaps = 65/295 (22%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFR-REVDLMSELRHPNI 116
+ +G+G FG+V++G+ E VA+K ++ S FR E+ LRH NI
Sbjct: 46 LQESIGKGRFGEVWRGKWRGEE----VAVKIFSS---REERSWFREAEIYQTVMLRHENI 98
Query: 117 VCLLGVCL----SGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIA 172
+ + + + ++ ++ G L ++L ++ + +A
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-------------TVTVEGMIKLA 145
Query: 173 LQVAAGMAYLCSHHY--------VHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRI 224
L A+G+A+L HRDL ++N LV T I+D GL+ + S I
Sbjct: 146 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV-RHDSATDTI 204
Query: 225 QSKSLLPV---RWMPPESILYGKFTTE-------SDVWSYGVVLWEVYSYGL-------- 266
V R+M PE +L + +D+++ G+V WE+
Sbjct: 205 DIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263
Query: 267 -QPYYGY-----SNQEVIEMIRSRQMLP------CPEDCPPRMYSLMMECWHEVP 309
PYY S +E+ +++ +++ P + M +M ECW+
Sbjct: 264 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 318
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 29/107 (27%), Positives = 46/107 (42%), Gaps = 20/107 (18%)
Query: 310 VAAGMAYLCSHHY--------VHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQS 361
A+G+A+L HRDL ++N LV T I+D GL+ + S I
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV-RHDSATDTIDI 206
Query: 362 KSLLPV---RWMPPESILYGKFTTE-------SDVWSYGVVLWEVYS 398
V R+M PE +L + +D+++ G+V WE+
Sbjct: 207 APNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIAR 252
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 8e-49
Identities = 65/305 (21%), Positives = 117/305 (38%), Gaps = 66/305 (21%)
Query: 51 VIETKP-RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMS 109
++ P + L+ G FG V+K ++ VA+K Q EV +
Sbjct: 20 YFQSMPLQLLEVKARGRFGCVWKAQLLNEY----VAVKIFPIQDKQSWQ--NEYEVYSLP 73
Query: 110 ELRHPNIVCLLGVCLSGE----PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQ 165
++H NI+ +G G + ++ F +G L +FL + +S
Sbjct: 74 GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-------------VVSW 120
Query: 166 QDFSHIALQVAAGMAYL----------CSHHYVHRDLAARNCLVGDGLTVKISDFGLSRD 215
+ HIA +A G+AYL HRD+ ++N L+ + LT I+DFGL+
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL- 179
Query: 216 VYASDYYRIQSKSLLP-VRWMPPESILYGKFTTE------SDVWSYGVVLWEVYSYGLQP 268
+ + + + R+M PE +L G + D+++ G+VLWE+ S
Sbjct: 180 KFEAGKSAGDTHGQVGTRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELAS-RCTA 237
Query: 269 YYGY----------------SNQEVIEMIRSRQMLPC-PEDCPP-----RMYSLMMECWH 306
G S +++ E++ ++ P + + + ECW
Sbjct: 238 ADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWD 297
Query: 307 EVPVA 311
A
Sbjct: 298 HDAEA 302
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 31/114 (27%), Positives = 52/114 (45%), Gaps = 20/114 (17%)
Query: 310 VAAGMAYL----------CSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRI 359
+A G+AYL HRD+ ++N L+ + LT I+DFGL+ + +
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL-KFEAGKSAG 188
Query: 360 QSKSLLP-VRWMPPESILYGKFTTE------SDVWSYGVVLWEVYSYGLQPYYG 406
+ + R+M PE +L G + D+++ G+VLWE+ S G
Sbjct: 189 DTHGQVGTRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELAS-RCTAADG 240
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 165 bits (418), Expect = 1e-47
Identities = 62/308 (20%), Positives = 105/308 (34%), Gaps = 76/308 (24%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVD--LMSELRHPN 115
L+ +G G +G VYKG + VA+K Q +F E + + + H N
Sbjct: 17 LLELIGRGRYGAVYKGSLDERP----VAVKVFSFANRQ----NFINEKNIYRVPLMEHDN 68
Query: 116 IVCLLGVCLSGE-----PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSH 170
I + ++ E+ G L ++L +
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-------------SDWVSSCR 115
Query: 171 IALQVAAGMAYL---------CSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDY 221
+A V G+AYL HRDL +RN LV + T ISDFGLS + +
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 222 YRIQSKSLLP------VRWMPPESILYG--------KFTTESDVWSYGVVLWEVYSYG-- 265
R + +R+M PE +L G + D+++ G++ WE++
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 266 ----------LQPYYGY--SNQEVIEMI----RSRQMLPCPEDC------PPRMYSLMME 303
+ ++ +M R +Q PE + + +
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 304 CWHEVPVA 311
CW + A
Sbjct: 295 CWDQDAEA 302
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 32/112 (28%), Positives = 49/112 (43%), Gaps = 24/112 (21%)
Query: 310 VAAGMAYL---------CSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQ 360
V G+AYL HRDL +RN LV + T ISDFGLS + + R
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 361 SKSLLP------VRWMPPESILYG--------KFTTESDVWSYGVVLWEVYS 398
+ +R+M PE +L G + D+++ G++ WE++
Sbjct: 180 EEDNAAISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 9e-41
Identities = 62/303 (20%), Positives = 119/303 (39%), Gaps = 41/303 (13%)
Query: 23 TSEGPSLVAIKTLKENANQKTASDFRREVIETKPR---FLQELGEGAFGKVYKGEVCTSE 79
++ + AS E I K R L+++G G KV++ +
Sbjct: 22 AAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQ 81
Query: 80 GPSLVAIKTL-KENANQKTASDFRREVDLMSELRHPN--IVCLLGVCLSGEPMCMLFEFM 136
+ AIK + E A+ +T +R E+ +++L+ + I+ L ++ + + M+ E
Sbjct: 82 ---IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC- 137
Query: 137 VRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARN 196
DL+ +L + + + + + + H VH DL N
Sbjct: 138 GNIDLNSWLKKKK------------SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPAN 185
Query: 197 CLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL--PVRWMPPESIL-----------YG 243
L+ DG +K+ DFG++ D + S + +MPPE+I
Sbjct: 186 FLIVDG-MLKLIDFGIAN-QMQPDTTSVVKDSQVGAV-NYMPPEAIKDMSSSRENGKSKS 242
Query: 244 KFTTESDVWSYGVVLWEVYSYGLQPYYGYSN--QEVIEMIRSRQMLPCPEDCPPRMYSLM 301
K + +SDVWS G +L+ + YG P+ N ++ +I + P+ + ++
Sbjct: 243 KISPKSDVWSLGCILYYMT-YGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVL 301
Query: 302 MEC 304
C
Sbjct: 302 KCC 304
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 38/157 (24%), Positives = 64/157 (40%), Gaps = 28/157 (17%)
Query: 272 YSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARN 331
N ++ ++ ++ + E + Y W + + + H VH DL N
Sbjct: 137 CGNIDLNSWLKKKKSIDPWE---RKSY------WKNM--LEAVHTIHQHGIVHSDLKPAN 185
Query: 332 CLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL--PVRWMPPESIL-----------YG 378
L+ DG +K+ DFG++ D + S + +MPPE+I
Sbjct: 186 FLIVDG-MLKLIDFGIAN-QMQPDTTSVVKDSQVGAV-NYMPPEAIKDMSSSRENGKSKS 242
Query: 379 KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
K + +SDVWS G +L+ + YG P+ NQ L
Sbjct: 243 KISPKSDVWSLGCILYYMT-YGKTPFQQIINQISKLH 278
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-40
Identities = 57/266 (21%), Positives = 111/266 (41%), Gaps = 38/266 (14%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTL-KENANQKTASDFRREVDLMSELRHPN 115
L+++G G KV++ + + AIK + E A+ +T +R E+ +++L+ +
Sbjct: 31 SILKQIGSGGSSKVFQVLNEKKQ---IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 116 --IVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
I+ L ++ + + M+ E DL+ +L + + +
Sbjct: 88 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK------------SIDPWERKSYWK 134
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL--P 231
+ + + H VH DL N L+ DG +K+ DFG++ D + S +
Sbjct: 135 NMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIAN-QMQPDTTSVVKDSQVGTV 192
Query: 232 VRWMPPESIL-----------YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ--EVI 278
+MPPE+I K + +SDVWS G +L+ + YG P+ NQ ++
Sbjct: 193 -NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT-YGKTPFQQIINQISKLH 250
Query: 279 EMIRSRQMLPCPEDCPPRMYSLMMEC 304
+I + P+ + ++ C
Sbjct: 251 AIIDPNHEIEFPDIPEKDLQDVLKCC 276
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 7e-14
Identities = 38/157 (24%), Positives = 64/157 (40%), Gaps = 28/157 (17%)
Query: 272 YSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARN 331
N ++ ++ ++ + E + Y W + + + H VH DL N
Sbjct: 109 CGNIDLNSWLKKKKSIDPWE---RKSY------WKNM--LEAVHTIHQHGIVHSDLKPAN 157
Query: 332 CLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL--PVRWMPPESIL-----------YG 378
L+ DG +K+ DFG++ D + S + +MPPE+I
Sbjct: 158 FLIVDG-MLKLIDFGIAN-QMQPDTTSVVKDSQVGTV-NYMPPEAIKDMSSSRENGKSKS 214
Query: 379 KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
K + +SDVWS G +L+ + YG P+ NQ L
Sbjct: 215 KISPKSDVWSLGCILYYMT-YGKTPFQQIINQISKLH 250
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-40
Identities = 57/266 (21%), Positives = 111/266 (41%), Gaps = 38/266 (14%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTL-KENANQKTASDFRREVDLMSELRHPN 115
L+++G G KV++ + + AIK + E A+ +T +R E+ +++L+ +
Sbjct: 12 SILKQIGSGGSSKVFQVLNEKKQ---IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 116 --IVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
I+ L ++ + + M+ E DL+ +L + + +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK------------SIDPWERKSYWK 115
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL--P 231
+ + + H VH DL N L+ DG +K+ DFG++ D + S +
Sbjct: 116 NMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIAN-QMQPDTTSVVKDSQVGTV 173
Query: 232 VRWMPPESIL-----------YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ--EVI 278
+MPPE+I K + +SDVWS G +L+ + YG P+ NQ ++
Sbjct: 174 -NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT-YGKTPFQQIINQISKLH 231
Query: 279 EMIRSRQMLPCPEDCPPRMYSLMMEC 304
+I + P+ + ++ C
Sbjct: 232 AIIDPNHEIEFPDIPEKDLQDVLKCC 257
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 38/157 (24%), Positives = 64/157 (40%), Gaps = 28/157 (17%)
Query: 272 YSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARN 331
N ++ ++ ++ + E + Y W + + + H VH DL N
Sbjct: 90 CGNIDLNSWLKKKKSIDPWE---RKSY------WKNM--LEAVHTIHQHGIVHSDLKPAN 138
Query: 332 CLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL--PVRWMPPESIL-----------YG 378
L+ DG +K+ DFG++ D + S + +MPPE+I
Sbjct: 139 FLIVDG-MLKLIDFGIAN-QMQPDTTSVVKDSQVGTV-NYMPPEAIKDMSSSRENGKSKS 195
Query: 379 KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
K + +SDVWS G +L+ + YG P+ NQ L
Sbjct: 196 KISPKSDVWSLGCILYYMT-YGKTPFQQIINQISKLH 231
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 8e-39
Identities = 54/249 (21%), Positives = 109/249 (43%), Gaps = 16/249 (6%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPN 115
LQ++GEG+FGK + T +G IK + + K + RREV +++ ++HPN
Sbjct: 27 VRLQKIGEGSFGKAILVK-STEDG-RQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 116 IVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQV 175
IV + ++ ++ GDL + + ++ + +Q+
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGV----------LFQEDQILDWFVQI 134
Query: 176 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM 235
+ ++ +HRD+ ++N + TV++ DFG++R V S ++ P ++
Sbjct: 135 CLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIAR-VLNSTVELARACIGTPY-YL 192
Query: 236 PPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPP 295
PE + +SD+W+ G VL+E+ + + S + ++ I S P
Sbjct: 193 SPEICENKPYNNKSDIWALGCVLYELCT-LKHAFEAGSMKNLVLKIISGSFPPVSLHYSY 251
Query: 296 RMYSLMMEC 304
+ SL+ +
Sbjct: 252 DLRSLVSQL 260
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 8e-12
Identities = 25/106 (23%), Positives = 51/106 (48%), Gaps = 3/106 (2%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+ + ++ +HRD+ ++N + TV++ DFG++R V S ++ P +
Sbjct: 134 ICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIAR-VLNSTVELARACIGTPY-Y 191
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
+ PE + +SD+W+ G VL+E+ + + S + LK
Sbjct: 192 LSPEICENKPYNNKSDIWALGCVLYELCT-LKHAFEAGSMKNLVLK 236
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-38
Identities = 79/294 (26%), Positives = 129/294 (43%), Gaps = 51/294 (17%)
Query: 46 DFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTA---SDFR 102
+F I + GEG FG VYKG V + VA+K L + T F
Sbjct: 26 NFDERPISVGGNKM---GEGGFGVVYKGYV---NN-TTVAVKKLAAMVDITTEELKQQFD 78
Query: 103 REVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAP 162
+E+ +M++ +H N+V LLG G+ +C+++ +M G L + L S P
Sbjct: 79 QEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL---------SCLDGTPP 129
Query: 163 LSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYY 222
LS IA A G+ +L +H++HRD+ + N L+ + T KISDFGL+R
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA-- 187
Query: 223 RIQSKSLLPVR------WMPPESILY--GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN 274
++++ R +M PE G+ T +SD++S+GVVL E+ + GL +
Sbjct: 188 ----QTVMTSRIVGTTAYMAPE---ALRGEITPKSDIYSFGVVLLEIIT-GLPAVDEHRE 239
Query: 275 QEVI-----EMIRSRQMLPCPEDCPPRM--YSLMMECWHEVPVAAGMAYLCSHH 321
+++ E+ + + D +M V +A C H
Sbjct: 240 PQLLLDIKEEIEDEEKTIEDYID--KKMNDADS-----TSVEAMYSVASQCLHE 286
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 8e-13
Identities = 35/113 (30%), Positives = 59/113 (52%), Gaps = 19/113 (16%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR- 368
A G+ +L +H++HRD+ + N L+ + T KISDFGL+R ++++ R
Sbjct: 142 AANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA------QTVMTSRI 195
Query: 369 -----WMPPESILY--GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFL 414
+M PE G+ T +SD++S+GVVL E+ + GL + + L
Sbjct: 196 VGTTAYMAPE---ALRGEITPKSDIYSFGVVLLEIIT-GLPA-VDEHREPQLL 243
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-37
Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 41/215 (19%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLG 121
LG G FGKVYKG ++G +LVA+K LKE Q F+ EV+++S H N++ L G
Sbjct: 38 LGRGGFGKVYKG--RLADG-TLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94
Query: 122 VCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAY 181
C++ +++ +M G + L R Q PL IAL A G+AY
Sbjct: 95 FCMTPTERLLVYPYMANGSVASCLRERPES--------QPPLDWPKRQRIALGSARGLAY 146
Query: 182 L---CSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR----- 233
L C +HRD+ A N L+ + + DFGL++ L+ +
Sbjct: 147 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK--------------LMDYKDTHVT 192
Query: 234 --------WMPPESILYGKFTTESDVWSYGVVLWE 260
+ PE + GK + ++DV+ YGV+L E
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLE 227
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 28/102 (27%), Positives = 45/102 (44%), Gaps = 30/102 (29%)
Query: 310 VAAGMAYL---CSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 366
A G+AYL C +HRD+ A N L+ + + DFGL++ L+
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK--------------LMD 185
Query: 367 VR-------------WMPPESILYGKFTTESDVWSYGVVLWE 395
+ + PE + GK + ++DV+ YGV+L E
Sbjct: 186 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLE 227
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 7e-07
Identities = 23/52 (44%), Positives = 29/52 (55%), Gaps = 5/52 (9%)
Query: 2 KGFLQE--LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREV 51
F + LG G FGKVYKG ++G +LVA+K LKE Q F+ EV
Sbjct: 30 DNFSNKNILGRGGFGKVYKG--RLADG-TLVAVKRLKEERTQGGELQFQTEV 78
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 9e-37
Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 20/204 (9%)
Query: 62 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLG 121
+G G FGKVYKG + + VA+K ++Q +F E++ +S RHP++V L+G
Sbjct: 47 IGHGVFGKVYKGVL---RDGAKVALKRRTPESSQGIE-EFETEIETLSFCRHPHLVSLIG 102
Query: 122 VCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAY 181
C M +++++M G+L L +S + I + A G+ Y
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLYGSDLP--------TMSMSWEQRLEICIGAARGLHY 154
Query: 182 LCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR----WMPP 237
L + +HRD+ + N L+ + KI+DFG+S+ D + + V+ ++ P
Sbjct: 155 LHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV----VKGTLGYIDP 210
Query: 238 ESILYGKFTTESDVWSYGVVLWEV 261
E + G+ T +SDV+S+GVVL+EV
Sbjct: 211 EYFIKGRLTEKSDVYSFGVVLFEV 234
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 4e-11
Identities = 31/90 (34%), Positives = 52/90 (57%), Gaps = 8/90 (8%)
Query: 311 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR-- 368
A G+ YL + +HRD+ + N L+ + KI+DFG+S+ D + + V+
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV----VKGT 204
Query: 369 --WMPPESILYGKFTTESDVWSYGVVLWEV 396
++ PE + G+ T +SDV+S+GVVL+EV
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEV 234
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 7e-04
Identities = 15/44 (34%), Positives = 23/44 (52%), Gaps = 4/44 (9%)
Query: 8 LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREV 51
+G G FGKVYKG + + VA+K ++Q +F E+
Sbjct: 47 IGHGVFGKVYKGVL---RDGAKVALKRRTPESSQGIE-EFETEI 86
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-35
Identities = 64/285 (22%), Positives = 121/285 (42%), Gaps = 31/285 (10%)
Query: 27 PSLVAIKTLKENANQKTASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAI 86
P K L+ + T ++FR +++G G F +VY+ C +G VA+
Sbjct: 14 PQFQPQKALRPDMGYNTLANFRI---------EKKIGRGQFSEVYRAA-CLLDG-VPVAL 62
Query: 87 KT--LKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEF 144
K + + + K +D +E+DL+ +L HPN++ + + ++ E GDL
Sbjct: 63 KKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRM 122
Query: 145 LMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLT 204
+ + + + ++ +Q+ + + ++ S +HRD+ N +
Sbjct: 123 IKHFK--------KQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV 174
Query: 205 VKISDFGLSRDVYASDYYRIQSKSLL--PVRWMPPESILYGKFTTESDVWSYGVVLWEVY 262
VK+ D GL R + + SL+ P +M PE I + +SD+WS G +L+E+
Sbjct: 175 VKLGDLGLGRFFSSKT---TAAHSLVGTPY-YMSPERIHENGYNFKSDIWSLGCLLYEMA 230
Query: 263 SYGLQPYYGYSN--QEVIEMIRSRQMLPCPEDC-PPRMYSLMMEC 304
+ P+YG + + I P P D + L+ C
Sbjct: 231 A-LQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMC 274
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 25/88 (28%), Positives = 43/88 (48%), Gaps = 6/88 (6%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL--PV 367
+ + + ++ S +HRD+ N + VK+ D GL R + + SL+ P
Sbjct: 145 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT---TAAHSLVGTPY 201
Query: 368 RWMPPESILYGKFTTESDVWSYGVVLWE 395
+M PE I + +SD+WS G +L+E
Sbjct: 202 -YMSPERIHENGYNFKSDIWSLGCLLYE 228
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 5e-35
Identities = 51/252 (20%), Positives = 92/252 (36%), Gaps = 36/252 (14%)
Query: 57 RFLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPN 115
+ LG G FG V + T E VAIK ++ + K + E+ +M +L HPN
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGE---QVAIKQCRQELSPKNRERWCLEIQIMKKLNHPN 73
Query: 116 IVCLLGV------CLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFS 169
+V V + + E+ GDL ++L + L +
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF---------ENCCGLKEGPIR 124
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASDYYRIQS 226
+ +++ + YL + +HRDL N ++ L KI D G +++ +
Sbjct: 125 TLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--------LDQ 176
Query: 227 KSLLPVR-----WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281
L ++ PE + K+T D WS+G + +E + G +P+
Sbjct: 177 GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT-GFRPFLPNWQPVQWHGK 235
Query: 282 RSRQMLPCPEDC 293
+
Sbjct: 236 VREKSNEHIVVY 247
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 24/115 (20%), Positives = 48/115 (41%), Gaps = 17/115 (14%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 366
+++ + YL + +HRDL N ++ L KI D G +++ + L
Sbjct: 130 ISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--------LDQGELCT 181
Query: 367 VR-----WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLKT 416
++ PE + K+T D WS+G + +E + G +P+ ++
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT-GFRPFLPNWQPVQWHGK 235
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-34
Identities = 52/269 (19%), Positives = 95/269 (35%), Gaps = 51/269 (18%)
Query: 57 RFLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPN 115
LG+GA V++G T + L AIK + + RE +++ +L H N
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGD---LFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 116 IVCLLGV--CLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
IV L + + ++ EF G L+ L S L + +F +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY---------GLPESEFLIVLR 119
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDG----LTVKISDFGLSRDVYASD--------- 220
V GM +L + VHR++ N + G K++DFG +R++ +
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTE 179
Query: 221 YYRIQSKSLLPVRWMPPESILYG---------KFTTESDVWSYGVVLWEVYSYGLQPYYG 271
Y + P+ + K+ D+WS GV + + G P+
Sbjct: 180 EY------------LHPD-MYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT-GSLPFRP 225
Query: 272 YSNQEVIEMIRSRQMLPCPEDCPPRMYSL 300
+ + + + + P +
Sbjct: 226 FEGPRRNKEVMYKIITGKPSGAISGVQKA 254
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 24/126 (19%), Positives = 44/126 (34%), Gaps = 36/126 (28%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDG----LTVKISDFGLSRDVYASD---------Y 356
V GM +L + VHR++ N + G K++DFG +R++ +
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180
Query: 357 YRIQSKSLLPVRWMPPESILYG---------KFTTESDVWSYGVVLWEVYSYGLQPYYGY 407
Y + P+ + K+ D+WS GV + + G P+ +
Sbjct: 181 Y------------LHPD-MYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT-GSLPFRPF 226
Query: 408 SNQEEF 413
Sbjct: 227 EGPRRN 232
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-34
Identities = 53/260 (20%), Positives = 95/260 (36%), Gaps = 31/260 (11%)
Query: 33 KTLKENANQKTASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN 92
+L+++ + S I P+ LG GA G + + + VA+K +
Sbjct: 5 PSLEQDDGDEETSVVIVGKISFCPK--DVLGHGAEGTIVYRGMFDNR---DVAVKRILPE 59
Query: 93 ANQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPR 151
REV L+ E HPN++ + + E L E++ +
Sbjct: 60 CFSFA----DREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL-CAATLQEYVEQK--- 111
Query: 152 SDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD-----GLTVK 206
+ + Q +G+A+L S + VHRDL N L+ +
Sbjct: 112 --------DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAM 163
Query: 207 ISDFGLSRDVYASDYYRIQSKSLL-PVRWMPPESI---LYGKFTTESDVWSYGVVLWEVY 262
ISDFGL + + + + + W+ PE + T D++S G V + V
Sbjct: 164 ISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVI 223
Query: 263 SYGLQPYYGYSNQEVIEMIR 282
S G P+ ++ ++
Sbjct: 224 SEGSHPFGKSLQRQANILLG 243
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 29/115 (25%), Positives = 49/115 (42%), Gaps = 9/115 (7%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGD-----GLTVKISDFGLSRDVYASDYYRIQSKSL 364
+G+A+L S + VHRDL N L+ + ISDFGL + + + + +
Sbjct: 127 TTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186
Query: 365 L-PVRWMPPESI---LYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
W+ PE + T D++S G V + V S G P+ ++ +
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL 241
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-33
Identities = 52/270 (19%), Positives = 96/270 (35%), Gaps = 51/270 (18%)
Query: 57 RFLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPN 115
LG+GA V++G T + L AIK + + RE +++ +L H N
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGD---LFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 116 IVCLLGV--CLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
IV L + + ++ EF G L+ L L + +F +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP---------SNAYGLPESEFLIVLR 119
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDG----LTVKISDFGLSRDV---------YASD 220
V GM +L + VHR++ N + G K++DFG +R++ Y ++
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTE 179
Query: 221 YYRIQSKSLLPVRWMPPESILYG---------KFTTESDVWSYGVVLWEVYSYGLQPYYG 271
Y + P+ + K+ D+WS GV + + G P+
Sbjct: 180 EY------------LHPD-MYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT-GSLPFRP 225
Query: 272 YSNQEVIEMIRSRQMLPCPEDCPPRMYSLM 301
+ + + + + P +
Sbjct: 226 FEGPRRNKEVMYKIITGKPSGAISGVQKAE 255
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 25/126 (19%), Positives = 46/126 (36%), Gaps = 36/126 (28%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDG----LTVKISDFGLSRDV---------YASDY 356
V GM +L + VHR++ N + G K++DFG +R++ Y ++
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180
Query: 357 YRIQSKSLLPVRWMPPESILYG---------KFTTESDVWSYGVVLWEVYSYGLQPYYGY 407
Y + P+ + K+ D+WS GV + + G P+ +
Sbjct: 181 Y------------LHPD-MYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT-GSLPFRPF 226
Query: 408 SNQEEF 413
Sbjct: 227 EGPRRN 232
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 57/283 (20%), Positives = 107/283 (37%), Gaps = 46/283 (16%)
Query: 57 RFLQE------LGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSE 110
R+L + LG G FG V++ + + AIK ++ + REV +++
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAK-NKVDD-CNYAIKRIRLPNRELAREKVMREVKALAK 59
Query: 111 LRHPNIVCLLGVCLSGEPM------------CMLFEFMVRGDLHEFLMSRSPRSDISGSQ 158
L HP IV L + + + +L +++ R + S
Sbjct: 60 LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 159 VQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA 218
HI LQ+A + +L S +HRDL N VK+ DFGL +
Sbjct: 120 CL---------HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 170
Query: 219 SDYYRIQSKSLLPVR----------WMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQ 267
+ + + +M PE ++G ++ + D++S G++L+E+ L
Sbjct: 171 DEEEQTVLTPMPAYARHTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFEL----LY 225
Query: 268 PYYGYSNQ-EVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
P+ + + +R+ + P P Y ++ + P
Sbjct: 226 PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSP 268
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 26/117 (22%), Positives = 49/117 (41%), Gaps = 16/117 (13%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR- 368
+A + +L S +HRDL N VK+ DFGL + + + +
Sbjct: 127 IAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 369 ---------WMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
+M PE ++G ++ + D++S G++L+E+ L P+ + L
Sbjct: 187 HTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFEL----LYPFSTQMERVRTLT 238
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 62/232 (26%), Positives = 107/232 (46%), Gaps = 25/232 (10%)
Query: 57 RFLQELGEGAFGKVYKGEVCTS-EGPSLVAIKTL-KENANQKTASDFRREVDLMSELRHP 114
+ +++LG GA+G+V C AIK + K + + + S EV ++ L HP
Sbjct: 40 QRVKKLGSGAYGEVLL---CRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
NI+ L ++ E G+L + ++ R ++ D + I Q
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM------------KFNEVDAAVIIKQ 144
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 231
V +G+ YL H+ VHRDL N L+ +KI DFGLS + + +
Sbjct: 145 VLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAY- 203
Query: 232 VRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS 283
++ PE +L K+ + DVWS GV+L+ + + G P+ G ++QE++ +
Sbjct: 204 --YIAPE-VLRKKYDEKCDVWSIGVILFILLA-GYPPFGGQTDQEILRKVEK 251
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 35/107 (32%), Positives = 55/107 (51%), Gaps = 8/107 (7%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 366
V +G+ YL H+ VHRDL N L+ +KI DFGLS + + +
Sbjct: 145 VLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAY- 203
Query: 367 VRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
++ PE +L K+ + DVWS GV+L+ + + G P+ G ++QE
Sbjct: 204 --YIAPE-VLRKKYDEKCDVWSIGVILFILLA-GYPPFGGQTDQEIL 246
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-33
Identities = 56/256 (21%), Positives = 108/256 (42%), Gaps = 21/256 (8%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTL-KENANQKTASDFRREVDLMSELRHPN 115
L +G G++G+ K S+G ++ K L + + EV+L+ EL+HPN
Sbjct: 9 EVLYTIGTGSYGRCQKIR-RKSDG-KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 116 IVCLLG--VCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
IV + + + ++ E+ GDL + + + + L ++ +
Sbjct: 67 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGT--------KERQYLDEEFVLRVMT 118
Query: 174 QVAAGMAYL-----CSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKS 228
Q+ + H +HRDL N + VK+ DFGL+R + D ++
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKTFV 177
Query: 229 LLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP 288
P +M PE + + +SD+WS G +L+E+ + + P+ +S +E+ IR +
Sbjct: 178 GTPY-YMSPEQMNRMSYNEKSDIWSLGCLLYELCA-LMPPFTAFSQKELAGKIREGKFRR 235
Query: 289 CPEDCPPRMYSLMMEC 304
P + ++
Sbjct: 236 IPYRYSDELNEIITRM 251
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 3/93 (3%)
Query: 323 VHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTT 382
+HRDL N + VK+ DFGL+R + D ++ P +M PE + +
Sbjct: 138 LHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKTFVGTPY-YMSPEQMNRMSYNE 195
Query: 383 ESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
+SD+WS G +L+E+ + + P+ +S +E K
Sbjct: 196 KSDIWSLGCLLYELCA-LMPPFTAFSQKELAGK 227
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-33
Identities = 55/277 (19%), Positives = 98/277 (35%), Gaps = 34/277 (12%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTL-KENANQKTASDFRREVDLMSEL-RHP 114
+ L LG G++G+V+K +G L A+K K + EV ++ +HP
Sbjct: 60 QRLSRLGHGSYGEVFKV-RSKEDG-RLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
V L G + + E L + A L +
Sbjct: 118 CCVRLEQAWEEGGILYLQTEL-CGPSLQQHCE-----------AWGASLPEAQVWGYLRD 165
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV-- 232
+A+L S VH D+ N +G K+ DFGL + + V
Sbjct: 166 TLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLV--------ELGTAGAGEVQE 217
Query: 233 ---RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289
R+M PE +L G + T +DV+S G+ + EV ++ +G + ++ +
Sbjct: 218 GDPRYMAPE-LLQGSYGTAADVFSLGLTILEVAC-NMELPHGGEGWQ--QLRQGYLPPEF 273
Query: 290 PEDCPPRMYSLMMECWHEVPVA-AGMAYLCSHHYVHR 325
+ S+++ P A L + + +
Sbjct: 274 TAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 6e-13
Identities = 28/105 (26%), Positives = 45/105 (42%), Gaps = 15/105 (14%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV-- 367
+A+L S VH D+ N +G K+ DFGL + + V
Sbjct: 166 TLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLV--------ELGTAGAGEVQE 217
Query: 368 ---RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN 409
R+M PE +L G + T +DV+S G+ + EV ++ +G
Sbjct: 218 GDPRYMAPE-LLQGSYGTAADVFSLGLTILEVAC-NMELPHGGEG 260
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-33
Identities = 54/220 (24%), Positives = 83/220 (37%), Gaps = 29/220 (13%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
F+Q+LGEG F V E +G A+K + + Q+ + +RE D+ HPNI
Sbjct: 32 LFIQKLGEGGFSYVDLVE-GLHDG-HFYALKRILCH-EQQDREEAQREADMHRLFNHPNI 88
Query: 117 VCLLGVCLSGEP----MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIA 172
+ L+ CL +L F RG L + L++ +
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLK--------DKGNFLTEDQILWLL 140
Query: 173 LQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV 232
L + G+ + + Y HRDL N L+GD + D G A + ++L
Sbjct: 141 LGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN--QACIHVEGSRQALTLQ 198
Query: 233 RW---------MPPESI---LYGKFTTESDVWSYGVVLWE 260
W PE + +DVWS G VL+
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYA 238
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 27/118 (22%), Positives = 44/118 (37%), Gaps = 15/118 (12%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+ G+ + + Y HRDL N L+GD + D G A + ++L W
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN--QACIHVEGSRQALTLQDW 200
Query: 370 ---------MPPESI---LYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
PE + +DVWS G VL+ + +G PY + + +
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAM-MFGEGPYDMVFQKGDSVA 257
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-33
Identities = 63/292 (21%), Positives = 114/292 (39%), Gaps = 41/292 (14%)
Query: 36 KENANQKTASDFRREVIETKP-----RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK 90
+ N Q + + + +F E+G G+F VYKG + T VA L+
Sbjct: 3 ERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKG-LDTETT-VEVAWCELQ 60
Query: 91 -ENANQKTASDFRREVDLMSELRHPNIV----CLLGVCLSGEPMCMLFEFMVRGDLHEFL 145
+ F+ E +++ L+HPNIV + + ++ E M G L +L
Sbjct: 61 DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL 120
Query: 146 MSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHY--VHRDLAARNCLVGDGL 203
+ + + Q+ G+ +L + +HRDL N + G
Sbjct: 121 ------------KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI-TGP 167
Query: 204 T--VKISDFGLSRDVYASDYYRIQSKSLL--PVRWMPPESILYGKFTTESDVWSYGVVLW 259
T VKI D GL+ AS +K+++ P +M PE + K+ DV+++G+ +
Sbjct: 168 TGSVKIGDLGLATLKRAS-----FAKAVIGTP-EFMAPE-MYEEKYDESVDVYAFGMCML 220
Query: 260 EVYSYGLQPYYGYSNQEVIEMIRSRQMLPC--PEDCPPRMYSLMMECWHEVP 309
E+ + PY N I + + P + P + ++ C +
Sbjct: 221 EMAT-SEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNK 271
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 30/103 (29%), Positives = 50/103 (48%), Gaps = 15/103 (14%)
Query: 313 GMAYLCSHHY--VHRDLAARNCLVGDGLT--VKISDFGLSRDVYASDYYRIQSKSLL--P 366
G+ +L + +HRDL N + G T VKI D GL+ AS +K+++ P
Sbjct: 141 GLQFLHTRTPPIIHRDLKCDNIFI-TGPTGSVKIGDLGLATLKRAS-----FAKAVIGTP 194
Query: 367 VRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN 409
+M PE + K+ DV+++G+ + E+ + PY N
Sbjct: 195 -EFMAPE-MYEEKYDESVDVYAFGMCMLEMAT-SEYPYSECQN 234
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 65/233 (27%), Positives = 111/233 (47%), Gaps = 26/233 (11%)
Query: 57 RFLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTL-KENANQKTA-SDFRREVDLMSELRH 113
+ + LG+G+FG+V + T + A+K + K QKT REV L+ +L H
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQ---ECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
PNI+ L ++ E G+L + ++SR S+ D + I
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK------------RFSEVDAARIIR 133
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASDYYRIQSKSLL 230
QV +G+ Y+ + VHRDL N L+ ++I DFGLS AS + + +
Sbjct: 134 QVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAY 193
Query: 231 PVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS 283
++ PE +L+G + + DVWS GV+L+ + S G P+ G + ++++ +
Sbjct: 194 ---YIAPE-VLHGTYDEKCDVWSTGVILYILLS-GCPPFNGANEYDILKKVEK 241
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 8/107 (7%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 366
V +G+ Y+ + VHRDL N L+ ++I DFGLS AS + + +
Sbjct: 135 VLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAY- 193
Query: 367 VRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
++ PE +L+G + + DVWS GV+L+ + S G P+ G + +
Sbjct: 194 --YIAPE-VLHGTYDEKCDVWSTGVILYILLS-GCPPFNGANEYDIL 236
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-32
Identities = 50/256 (19%), Positives = 90/256 (35%), Gaps = 31/256 (12%)
Query: 57 RFLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHP 114
+G G+FG+V++ + T A+K ++ E E+ + L P
Sbjct: 61 THQPRVGRGSFGEVHRMKDKQTGF---QCAVKKVRLEVFRV-------EELVACAGLSSP 110
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
IV L G G + + E + G L + + + L + + Q
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLI------------KQMGCLPEDRALYYLGQ 158
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVG-DGLTVKISDFGLSRDVYASDYYRIQSKSLLPV- 232
G+ YL + +H D+ A N L+ DG + DFG + + +
Sbjct: 159 ALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 233 --RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ--MLP 288
M PE ++ + D+WS ++ + + G P+ Y + I S +
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN-GCHPWTQYFRGPLCLKIASEPPPIRE 277
Query: 289 CPEDCPPRMYSLMMEC 304
P C P + E
Sbjct: 278 IPPSCAPLTAQAIQEG 293
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 22/99 (22%), Positives = 40/99 (40%), Gaps = 5/99 (5%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVG-DGLTVKISDFGLSRDVYASDYYRIQSKSLLPV---R 368
G+ YL + +H D+ A N L+ DG + DFG + + +
Sbjct: 162 GLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 221
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY 407
M PE ++ + D+WS ++ + + G P+ Y
Sbjct: 222 HMAPEVVMGKPCDAKVDIWSSCCMMLHMLN-GCHPWTQY 259
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-32
Identities = 54/242 (22%), Positives = 102/242 (42%), Gaps = 49/242 (20%)
Query: 58 FLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
++LG G FG V++ E + + K +K + ++E+ +++ RH NI
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKK---TYMAKFVKVKGTDQ--VLVKKEISILNIARHRNI 63
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
+ L S E + M+FEF+ D+ E + + + L++++ QV
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFE-----------LNEREIVSYVHQVC 112
Query: 177 AGMAYLCSHHYVHRDLAARN--CLVGDGLTVKISDFGLSR---------DVYASDYYRIQ 225
+ +L SH+ H D+ N T+KI +FG +R ++ + Y
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEY--- 169
Query: 226 SKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYSNQEVIEMI 281
PE + +T +D+WS G ++ Y G+ P+ +NQ++IE I
Sbjct: 170 ---------YAPEVHQHDVVSTATDMWSLGTLV-----YVLLSGINPFLAETNQQIIENI 215
Query: 282 RS 283
+
Sbjct: 216 MN 217
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 25/118 (21%), Positives = 45/118 (38%), Gaps = 32/118 (27%)
Query: 313 GMAYLCSHHYVHRDLAARN--CLVGDGLTVKISDFGLSR---------DVYASDYYRIQS 361
+ +L SH+ H D+ N T+KI +FG +R ++ + Y
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEY---- 169
Query: 362 KSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYSNQEEFLK 415
PE + +T +D+WS G ++ Y G+ P+ +NQ+
Sbjct: 170 --------YAPEVHQHDVVSTATDMWSLGTLV-----YVLLSGINPFLAETNQQIIEN 214
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-31
Identities = 57/287 (19%), Positives = 107/287 (37%), Gaps = 63/287 (21%)
Query: 40 NQKTASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTAS 99
+++ DF+ ++ +G G FG+V+K + +G IK +K N N+K
Sbjct: 6 DKRFGMDFKE---------IELIGSGGFGQVFKAK-HRIDG-KTYVIKRVKYN-NEKA-- 51
Query: 100 DFRREVDLMSELRHPNIV----------------CLLGVCLSGEPMCMLFEFMVRGDLHE 143
REV +++L H NIV + + + EF +G L +
Sbjct: 52 --EREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQ 109
Query: 144 FLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL 203
++ R L + + Q+ G+ Y+ S ++RDL N + D
Sbjct: 110 WIEKRRGE----------KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK 159
Query: 204 TVKISDFGLSRDVYASDYYRIQSKSLL------PVRWMPPESILYGKFTTESDVWSYGVV 257
VKI DFGL +++ R+M PE I + E D+++ G++
Sbjct: 160 QVKIGDFGLVT--------SLKNDGKRTRSKGTL-RYMSPEQISSQDYGKEVDLYALGLI 210
Query: 258 LWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMEC 304
L E+ + + +R + + +L+ +
Sbjct: 211 LAELLHVCDTAFET---SKFFTDLRDG---IISDIFDKKEKTLLQKL 251
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 7e-11
Identities = 25/92 (27%), Positives = 41/92 (44%), Gaps = 15/92 (16%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL---- 365
+ G+ Y+ S ++RDL N + D VKI DFGL +++
Sbjct: 131 ITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT--------SLKNDGKRTRSK 182
Query: 366 --PVRWMPPESILYGKFTTESDVWSYGVVLWE 395
R+M PE I + E D+++ G++L E
Sbjct: 183 GTL-RYMSPEQISSQDYGKEVDLYALGLILAE 213
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 58/261 (22%), Positives = 106/261 (40%), Gaps = 57/261 (21%)
Query: 47 FRREVIETKPRFLQELGEGAFGKVYKGEVCT--SEGPSLVAIKT-----LKENANQKTAS 99
F+++ +E +ELG G F V K C S G A K + + +
Sbjct: 5 FKQQKVEDFYDIGEELGSGQFAIVKK---CREKSTG-LEYAAKFIKKRQSRASRRGVSRE 60
Query: 100 DFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQV 159
+ REV ++ ++ H N++ L V + + ++ E + G+L +FL +
Sbjct: 61 EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---------- 110
Query: 160 QAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV----GDGLTVKISDFGLSR- 214
LS+++ + Q+ G+ YL + H DL N ++ +K+ DFGL+
Sbjct: 111 --SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 215 --------DVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY-- 264
+++ + + + PE + Y E+D+WS GV+ Y
Sbjct: 169 IEDGVEFKNIFGTPEF------------VAPEIVNYEPLGLEADMWSIGVIT-----YIL 211
Query: 265 --GLQPYYGYSNQEVIEMIRS 283
G P+ G + QE + I S
Sbjct: 212 LSGASPFLGDTKQETLANITS 232
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 7e-11
Identities = 27/120 (22%), Positives = 46/120 (38%), Gaps = 34/120 (28%)
Query: 313 GMAYLCSHHYVHRDLAARNCLV----GDGLTVKISDFGLSR---------DVYASDYYRI 359
G+ YL + H DL N ++ +K+ DFGL+ +++ + +
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF-- 184
Query: 360 QSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYSNQEEFLK 415
+ PE + Y E+D+WS GV+ Y G P+ G + QE
Sbjct: 185 ----------VAPEIVNYEPLGLEADMWSIGVIT-----YILLSGASPFLGDTKQETLAN 229
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 58/260 (22%), Positives = 105/260 (40%), Gaps = 55/260 (21%)
Query: 47 FRREVIETKPRFLQELGEGAFGKVYKG-EVCTSEGPSLVAIKT-----LKENANQKTASD 100
F+++ +E +ELG G F V K E T A K + + +
Sbjct: 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGL---EYAAKFIKKRQSRASRRGVCREE 61
Query: 101 FRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQ 160
REV ++ ++ HPNI+ L V + + ++ E + G+L +FL +
Sbjct: 62 IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE----------- 110
Query: 161 APLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV----GDGLTVKISDFGLSR-- 214
LS+++ + Q+ G+ YL + H DL N ++ +K+ DFGL+
Sbjct: 111 -SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 215 -------DVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY--- 264
+++ + + + PE + Y E+D+WS GV+ Y
Sbjct: 170 EDGVEFKNIFGTPEF------------VAPEIVNYEPLGLEADMWSIGVIT-----YILL 212
Query: 265 -GLQPYYGYSNQEVIEMIRS 283
G P+ G + QE + I +
Sbjct: 213 SGASPFLGDTKQETLANITA 232
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 27/120 (22%), Positives = 46/120 (38%), Gaps = 34/120 (28%)
Query: 313 GMAYLCSHHYVHRDLAARNCLV----GDGLTVKISDFGLSR---------DVYASDYYRI 359
G+ YL + H DL N ++ +K+ DFGL+ +++ + +
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF-- 184
Query: 360 QSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYSNQEEFLK 415
+ PE + Y E+D+WS GV+ Y G P+ G + QE
Sbjct: 185 ----------VAPEIVNYEPLGLEADMWSIGVIT-----YILLSGASPFLGDTKQETLAN 229
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 66/232 (28%), Positives = 114/232 (49%), Gaps = 25/232 (10%)
Query: 57 RFLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTL-KENANQKTASDFRREVDLMSELRHP 114
+ LG+G+FG+V K + T + A+K + K +A K S REV+L+ +L HP
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQ---EYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
NI+ L + ++ E G+L + ++ R S+ D + I Q
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK------------RFSEHDAARIIKQ 129
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 231
V +G+ Y+ H+ VHRDL N L+ +KI DFGLS + + + +
Sbjct: 130 VFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY- 188
Query: 232 VRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS 283
++ PE +L G + + DVWS GV+L+ + S G P+YG + ++++ + +
Sbjct: 189 --YIAPE-VLRGTYDEKCDVWSAGVILYILLS-GTPPFYGKNEYDILKRVET 236
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 34/107 (31%), Positives = 55/107 (51%), Gaps = 8/107 (7%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 366
V +G+ Y+ H+ VHRDL N L+ +KI DFGLS + + + +
Sbjct: 130 VFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY- 188
Query: 367 VRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
++ PE +L G + + DVWS GV+L+ + S G P+YG + +
Sbjct: 189 --YIAPE-VLRGTYDEKCDVWSAGVILYILLS-GTPPFYGKNEYDIL 231
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 52/254 (20%), Positives = 99/254 (38%), Gaps = 48/254 (18%)
Query: 46 DFRREVIETKPRFLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASDFRRE 104
+ ++ + L+ELG GAFG V++ E T + K + + E
Sbjct: 43 EVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGR---VFVAKFINT-PYPLDKYTVKNE 98
Query: 105 VDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLS 164
+ +M++L HP ++ L M ++ EF+ G+L + + + + +S
Sbjct: 99 ISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-----------MS 147
Query: 165 QQDFSHIALQVAAGMAYLCSHHYVHRDLAARN--CLVGDGLTVKISDFGLSR-------- 214
+ + + Q G+ ++ H VH D+ N C +VKI DFGL+
Sbjct: 148 EAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207
Query: 215 -DVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPY 269
A+ + PE + +D+W+ GV+ Y GL P+
Sbjct: 208 KVTTATAEF------------AAPEIVDREPVGFYTDMWAIGVLG-----YVLLSGLSPF 250
Query: 270 YGYSNQEVIEMIRS 283
G + E ++ ++
Sbjct: 251 AGEDDLETLQNVKR 264
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 7e-11
Identities = 27/118 (22%), Positives = 42/118 (35%), Gaps = 32/118 (27%)
Query: 313 GMAYLCSHHYVHRDLAARN--CLVGDGLTVKISDFGLSR---------DVYASDYYRIQS 361
G+ ++ H VH D+ N C +VKI DFGL+ A+ +
Sbjct: 161 GLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEF---- 216
Query: 362 KSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYSNQEEFLK 415
PE + +D+W+ GV+ Y GL P+ G + E
Sbjct: 217 --------AAPEIVDREPVGFYTDMWAIGVLG-----YVLLSGLSPFAGEDDLETLQN 261
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-31
Identities = 54/262 (20%), Positives = 101/262 (38%), Gaps = 47/262 (17%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIV 117
+ LG+GAFG+V K + AIK ++ + S EV L++ L H +V
Sbjct: 10 EIAVLGQGAFGQVVKAR-NALDS-RYYAIKKIRHTEEKL--STILSEVMLLASLNHQYVV 65
Query: 118 CLLGV-------------CLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLS 164
+ + E+ G L++ + S
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-----------NLNQQ 114
Query: 165 QQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRI 224
+ ++ + Q+ ++Y+ S +HRDL N + + VKI DFGL+++V+ S
Sbjct: 115 RDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 225 QSKSLLPVR------------WMPPESILYGK--FTTESDVWSYGVVLWEVYSYGLQPYY 270
LP ++ E +L G + + D++S G++ +E+ Y
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMI-YP--FST 230
Query: 271 GYSNQEVIEMIRSRQMLPCPED 292
G +++ +RS + P D
Sbjct: 231 GMERVNILKKLRSVS-IEFPPD 251
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 29/129 (22%), Positives = 50/129 (38%), Gaps = 24/129 (18%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR---- 368
++Y+ S +HRDL N + + VKI DFGL+++V+ S LP
Sbjct: 128 ALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 369 --------WMPPESILYGK--FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK--- 415
++ E +L G + + D++S G++ +E+ Y G K
Sbjct: 188 TSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMI-YP--FSTGMERVNILKKLRS 243
Query: 416 ---TPPSWI 421
P
Sbjct: 244 VSIEFPPDF 252
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 9e-31
Identities = 60/251 (23%), Positives = 105/251 (41%), Gaps = 26/251 (10%)
Query: 62 LGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLL 120
LG+G +G VY G ++ +AIK + E + + + E+ L L+H NIV L
Sbjct: 30 LGKGTYGIVYAGRDLSNQV---RIAIKEIPER-DSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 121 GVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMA 180
G + + E + G L L S+ + + Q+ G+
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG---------FYTKQILEGLK 136
Query: 181 YLCSHHYVHRDLAARNCLV--GDGLTVKISDFGLSRDVYASDYYRIQSKSLL-PVRWMPP 237
YL + VHRD+ N L+ G +KISDFG S+ + +++ +++M P
Sbjct: 137 YLHDNQIVHRDIKGDNVLINTYSG-VLKISDFGTSKRLAGI---NPCTETFTGTLQYMAP 192
Query: 238 ESILYGK--FTTESDVWSYGVVLWEVYSYGLQPYYGYSN-QEVIEMI-RSRQMLPCPEDC 293
E I G + +D+WS G + E+ + G P+Y Q + + + PE
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMAT-GKPPFYELGEPQAAMFKVGMFKVHPEIPESM 251
Query: 294 PPRMYSLMMEC 304
+ +++C
Sbjct: 252 SAEAKAFILKC 262
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 6e-10
Identities = 30/103 (29%), Positives = 50/103 (48%), Gaps = 10/103 (9%)
Query: 313 GMAYLCSHHYVHRDLAARNCLV--GDGLTVKISDFGLSRDVYASDYYRIQSKSLL-PVRW 369
G+ YL + VHRD+ N L+ G +KISDFG S+ + +++ +++
Sbjct: 134 GLKYLHDNQIVHRDIKGDNVLINTYSG-VLKISDFGTSKRLAGI---NPCTETFTGTLQY 189
Query: 370 MPPESILYGK--FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ 410
M PE I G + +D+WS G + E+ + G P+Y
Sbjct: 190 MAPEIIDKGPRGYGKAADIWSLGCTIIEMAT-GKPPFYELGEP 231
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 62/264 (23%), Positives = 109/264 (41%), Gaps = 57/264 (21%)
Query: 44 ASDFRREVIETKPRFLQELGEGAFGKVYKGEVCT--SEGPSLVAIKT-----LKENANQK 96
+ FR+E ++ +ELG G F V K C S G A K K +
Sbjct: 1 GTVFRQENVDDYYDTGEELGSGQFAVVKK---CREKSTG-LQYAAKFIKKRRTKSSRRGV 56
Query: 97 TASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISG 156
+ D REV ++ E++HPN++ L V + + ++ E + G+L +FL +
Sbjct: 57 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE------- 109
Query: 157 SQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV----GDGLTVKISDFGL 212
L++++ + Q+ G+ YL S H DL N ++ +KI DFGL
Sbjct: 110 -----SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 213 SR---------DVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYS 263
+ +++ + + + PE + Y E+D+WS GV+
Sbjct: 165 AHKIDFGNEFKNIFGTPEF------------VAPEIVNYEPLGLEADMWSIGVIT----- 207
Query: 264 Y----GLQPYYGYSNQEVIEMIRS 283
Y G P+ G + QE + + +
Sbjct: 208 YILLSGASPFLGDTKQETLANVSA 231
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 29/120 (24%), Positives = 46/120 (38%), Gaps = 34/120 (28%)
Query: 313 GMAYLCSHHYVHRDLAARNCLV----GDGLTVKISDFGLSR---------DVYASDYYRI 359
G+ YL S H DL N ++ +KI DFGL+ +++ + +
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF-- 183
Query: 360 QSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYSNQEEFLK 415
+ PE + Y E+D+WS GV+ Y G P+ G + QE
Sbjct: 184 ----------VAPEIVNYEPLGLEADMWSIGVIT-----YILLSGASPFLGDTKQETLAN 228
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 66/248 (26%), Positives = 103/248 (41%), Gaps = 44/248 (17%)
Query: 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL 111
I+ F ++LG GAFG V+ E +S IKT+ ++ +Q E++++ L
Sbjct: 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLE--RVIKTINKDRSQVPMEQIEAEIEVLKSL 77
Query: 112 RHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHI 171
HPNI+ + V M ++ E G+L E ++S R LS+ + +
Sbjct: 78 DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQAR--------GKALSEGYVAEL 129
Query: 172 ALQVAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSR---------DVYAS 219
Q+ +AY S H VH+DL N L +KI DFGL+ + +
Sbjct: 130 MKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGT 189
Query: 220 DYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYSNQ 275
Y M PE + T + D+WS GVV+ Y G P+ G S +
Sbjct: 190 ALY------------MAPE-VFKRDVTFKCDIWSAGVVM-----YFLLTGCLPFTGTSLE 231
Query: 276 EVIEMIRS 283
EV +
Sbjct: 232 EVQQKATY 239
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 34/122 (27%), Positives = 47/122 (38%), Gaps = 34/122 (27%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSR---------DVYASDYY 357
+ +AY S H VH+DL N L +KI DFGL+ + + Y
Sbjct: 133 MMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALY 192
Query: 358 RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYSNQEEF 413
M PE + T + D+WS GVV+ Y G P+ G S +E
Sbjct: 193 ------------MAPE-VFKRDVTFKCDIWSAGVVM-----YFLLTGCLPFTGTSLEEVQ 234
Query: 414 LK 415
K
Sbjct: 235 QK 236
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 62/231 (26%), Positives = 107/231 (46%), Gaps = 32/231 (13%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPNIV 117
L+++GEG +G VYK + E A+K ++ E ++ S RE+ ++ EL+H NIV
Sbjct: 7 LEKIGEGTYGVVYKAQNNYGE---TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
L V + + + ++FE + + DL + L + + LQ+
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQ-DLKKLL--DVCEGGLESVTAK---------SFLLQLLN 111
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV---RW 234
G+AY +HRDL +N L+ +KI+DFGL+R + I + W
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR------AFGIPVRKYTHEIVTLW 165
Query: 235 M-PPESILYG--KFTTESDVWSYGVVLWEVYSYGLQPYY-GYSNQEVIEMI 281
P+ +L G K++T D+WS G + E+ + P + G S + + I
Sbjct: 166 YRAPD-VLMGSKKYSTTIDIWSVGCIFAEMVN--GTPLFPGVSEADQLMRI 213
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 8e-09
Identities = 28/89 (31%), Positives = 43/89 (48%), Gaps = 13/89 (14%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV---RW 369
G+AY +HRDL +N L+ +KI+DFGL+R + I + W
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR------AFGIPVRKYTHEIVTLW 165
Query: 370 M-PPESILYG--KFTTESDVWSYGVVLWE 395
P+ +L G K++T D+WS G + E
Sbjct: 166 YRAPD-VLMGSKKYSTTIDIWSVGCIFAE 193
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 69/257 (26%), Positives = 113/257 (43%), Gaps = 54/257 (21%)
Query: 52 IETKPRFLQELGEGAFGKVYKGEVCTS-EGPSLVAIKTLK------------ENANQKTA 98
I +++LG GA+G+V C G S AIK +K +K
Sbjct: 34 IGESYFKVRKLGSGAYGEVLL---CKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH 90
Query: 99 SDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQ 158
+ E+ L+ L HPNI+ L V + ++ EF G+L E +++R
Sbjct: 91 EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--------- 141
Query: 159 VQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSR- 214
+ D ++I Q+ +G+ YL H+ VHRD+ N L+ L +KI DFGLS
Sbjct: 142 ---KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198
Query: 215 --------DVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGL 266
D + YY + PE +L K+ + DVWS GV+++ + G
Sbjct: 199 FSKDYKLRDRLGTAYY------------IAPE-VLKKKYNEKCDVWSCGVIMYILLC-GY 244
Query: 267 QPYYGYSNQEVIEMIRS 283
P+ G ++Q++I+ +
Sbjct: 245 PPFGGQNDQDIIKKVEK 261
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 35/116 (30%), Positives = 55/116 (47%), Gaps = 26/116 (22%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSR---------DVYASDYY 357
+ +G+ YL H+ VHRD+ N L+ L +KI DFGLS D + YY
Sbjct: 155 ILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYY 214
Query: 358 RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
+ PE +L K+ + DVWS GV+++ + G P+ G ++Q+
Sbjct: 215 ------------IAPE-VLKKKYNEKCDVWSCGVIMYILLC-GYPPFGGQNDQDII 256
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 59/254 (23%), Positives = 99/254 (38%), Gaps = 48/254 (18%)
Query: 46 DFRREVIETKPRFLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASDFRRE 104
+ + + + +ELG GAFG V++ E T A K + ++ R+E
Sbjct: 149 EIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGN---NFAAKFVMT-PHESDKETVRKE 204
Query: 105 VDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLS 164
+ MS LRHP +V L M M++EFM G+L E + + +S
Sbjct: 205 IQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-----------MS 253
Query: 165 QQDFSHIALQVAAGMAYLCSHHYVHRDLAARN--CLVGDGLTVKISDFGLSR-------- 214
+ + QV G+ ++ ++YVH DL N +K+ DFGL+
Sbjct: 254 EDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313
Query: 215 -DVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPY 269
+ + PE +D+WS GV+ Y GL P+
Sbjct: 314 KVTTGTAEF------------AAPEVAEGKPVGYYTDMWSVGVLS-----YILLSGLSPF 356
Query: 270 YGYSNQEVIEMIRS 283
G ++ E + ++S
Sbjct: 357 GGENDDETLRNVKS 370
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 25/118 (21%), Positives = 41/118 (34%), Gaps = 32/118 (27%)
Query: 313 GMAYLCSHHYVHRDLAARN--CLVGDGLTVKISDFGLSR---------DVYASDYYRIQS 361
G+ ++ ++YVH DL N +K+ DFGL+ + +
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEF---- 322
Query: 362 KSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYSNQEEFLK 415
PE +D+WS GV+ Y GL P+ G ++ E
Sbjct: 323 --------AAPEVAEGKPVGYYTDMWSVGVLS-----YILLSGLSPFGGENDDETLRN 367
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-30
Identities = 63/232 (27%), Positives = 117/232 (50%), Gaps = 32/232 (13%)
Query: 59 LQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPNI 116
L+++GEG +G V+K T E +VA+K ++ ++ ++ S RE+ L+ EL+H NI
Sbjct: 7 LEKIGEGTYGTVFKAKNRETHE---IVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V L V S + + ++FEF + DL ++ S D+ V++ Q+
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQ-DLKKYF--DSCNGDLDPEIVKS---------FLFQLL 111
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV---R 233
G+ + S + +HRDL +N L+ +K+++FGL+R + I +
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR------AFGIPVRCYSAEVVTL 165
Query: 234 WM-PPESILYG--KFTTESDVWSYGVVLWEVYSYGLQPYY-GYSNQEVIEMI 281
W PP+ +L+G ++T D+WS G + E+ + G +P + G + ++ I
Sbjct: 166 WYRPPD-VLFGAKLYSTSIDMWSAGCIFAELANAG-RPLFPGNDVDDQLKRI 215
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 5e-09
Identities = 28/110 (25%), Positives = 55/110 (50%), Gaps = 15/110 (13%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV---RW 369
G+ + S + +HRDL +N L+ +K+++FGL+R + I + W
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR------AFGIPVRCYSAEVVTLW 166
Query: 370 M-PPESILYG--KFTTESDVWSYGVVLWEVYSYGLQPYY-GYSNQEEFLK 415
PP+ +L+G ++T D+WS G + E+ + G +P + G ++ +
Sbjct: 167 YRPPD-VLFGAKLYSTSIDMWSAGCIFAELANAG-RPLFPGNDVDDQLKR 214
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-30
Identities = 56/249 (22%), Positives = 106/249 (42%), Gaps = 29/249 (11%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
+ +G GA V C + VAIK + Q + + +E+ MS+ HPNI
Sbjct: 18 ELQEVIGSGATAVVQAA-YCAPKK-EKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V + + + ++ + + G + + + + G L + + I +V
Sbjct: 76 VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAK----GEHKSGVLDESTIATILREVL 131
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR--- 233
G+ YL + +HRD+ A N L+G+ +V+I+DFG+S + R
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV-----RKTF 186
Query: 234 -----WMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287
WM PE + + + ++D+WS+G+ E+ + G PY+ Y +V+ +
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIEL-ATGAAPYHKYPPMKVLMLT------ 239
Query: 288 PCPEDCPPR 296
++ PP
Sbjct: 240 --LQNDPPS 246
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 26/92 (28%), Positives = 45/92 (48%), Gaps = 14/92 (15%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR---- 368
G+ YL + +HRD+ A N L+G+ +V+I+DFG+S + R
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV-----RKTFV 187
Query: 369 ----WMPPESILYGK-FTTESDVWSYGVVLWE 395
WM PE + + + ++D+WS+G+ E
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 57/250 (22%), Positives = 101/250 (40%), Gaps = 57/250 (22%)
Query: 58 FLQELGEGAFGKVYKGEVCT--SEGPSLVAIKT-----LKENANQKTASDFRREVDLMSE 110
+ELG G F V K C G A K L + + + REV+++ E
Sbjct: 9 MGEELGSGQFAIVRK---CRQKGTG-KEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 111 LRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSH 170
+RHPNI+ L + + + ++ E + G+L +FL + L++ + +
Sbjct: 65 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE------------SLTEDEATQ 112
Query: 171 IALQVAAGMAYLCSHHYVHRDLAARNCLV----GDGLTVKISDFGLSR---------DVY 217
Q+ G+ YL S H DL N ++ +K+ DFG++ +++
Sbjct: 113 FLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF 172
Query: 218 ASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYS 273
+ + + PE + Y E+D+WS GV+ Y G P+ G +
Sbjct: 173 GTPEF------------VAPEIVNYEPLGLEADMWSIGVIT-----YILLSGASPFLGET 215
Query: 274 NQEVIEMIRS 283
QE + I +
Sbjct: 216 KQETLTNISA 225
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 4e-10
Identities = 27/120 (22%), Positives = 46/120 (38%), Gaps = 34/120 (28%)
Query: 313 GMAYLCSHHYVHRDLAARNCLV----GDGLTVKISDFGLSR---------DVYASDYYRI 359
G+ YL S H DL N ++ +K+ DFG++ +++ + +
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEF-- 177
Query: 360 QSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYSNQEEFLK 415
+ PE + Y E+D+WS GV+ Y G P+ G + QE
Sbjct: 178 ----------VAPEIVNYEPLGLEADMWSIGVIT-----YILLSGASPFLGETKQETLTN 222
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 69/245 (28%), Positives = 111/245 (45%), Gaps = 51/245 (20%)
Query: 57 RFLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTL-KENANQKTASDFRREVDLMSELRHP 114
+ LG+G+FG+V K + T + A+K + K +A K S REV+L+ +L HP
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQ---EYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
NI+ L + ++ E G+L + ++ R S+ D + I Q
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK------------RFSEHDAARIIKQ 129
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSR---------DVYASDYY 222
V +G+ Y+ H+ VHRDL N L+ +KI DFGLS D + YY
Sbjct: 130 VFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYY 189
Query: 223 RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYSNQEVI 278
+ PE +L G + + DVWS GV+L Y G P+YG + +++
Sbjct: 190 ------------IAPE-VLRGTYDEKCDVWSAGVIL-----YILLSGTPPFYGKNEYDIL 231
Query: 279 EMIRS 283
+ + +
Sbjct: 232 KRVET 236
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 9e-10
Identities = 37/122 (30%), Positives = 53/122 (43%), Gaps = 34/122 (27%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSR---------DVYASDYY 357
V +G+ Y+ H+ VHRDL N L+ +KI DFGLS D + YY
Sbjct: 130 VFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYY 189
Query: 358 RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYSNQEEF 413
+ PE +L G + + DVWS GV+L Y G P+YG + +
Sbjct: 190 ------------IAPE-VLRGTYDEKCDVWSAGVIL-----YILLSGTPPFYGKNEYDIL 231
Query: 414 LK 415
+
Sbjct: 232 KR 233
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 66/231 (28%), Positives = 117/231 (50%), Gaps = 32/231 (13%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPNIV 117
L+++GEG +G VYK + +VA+K ++ + ++ S RE+ L+ EL HPNIV
Sbjct: 26 LEKVGEGTYGVVYKAKDSQGR---IVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
L+ V S + ++FEFM + DL + L ++ + SQ++ Q+
Sbjct: 83 SLIDVIHSERCLTLVFEFMEK-DLKKVL--DENKTGLQDSQIKI---------YLYQLLR 130
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV---RW 234
G+A+ H +HRDL +N L+ +K++DFGL+R + I +S W
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR------AFGIPVRSYTHEVVTLW 184
Query: 235 M-PPESILYG--KFTTESDVWSYGVVLWEVYSYGLQPYY-GYSNQEVIEMI 281
P+ +L G K++T D+WS G + E+ + +P + G ++ + + I
Sbjct: 185 YRAPD-VLMGSKKYSTSVDIWSIGCIFAEMIT--GKPLFPGVTDDDQLPKI 232
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 9e-09
Identities = 28/89 (31%), Positives = 45/89 (50%), Gaps = 13/89 (14%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV---RW 369
G+A+ H +HRDL +N L+ +K++DFGL+R + I +S W
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR------AFGIPVRSYTHEVVTLW 184
Query: 370 M-PPESILYG--KFTTESDVWSYGVVLWE 395
P+ +L G K++T D+WS G + E
Sbjct: 185 YRAPD-VLMGSKKYSTSVDIWSIGCIFAE 212
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 55/264 (20%), Positives = 98/264 (37%), Gaps = 39/264 (14%)
Query: 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVC 118
+ LG G+ G V VA+K + E+ L++E HPN++
Sbjct: 21 KILGYGSSGTVVFQGSFQGR---PVAVKRM----LIDFCDIALMEIKLLTESDDHPNVIR 73
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
+ + + E +L + + S++ + + + + Q+A+G
Sbjct: 74 YYCSETTDRFLYIALEL-CNLNLQDLVESKN-----VSDENLKLQKEYNPISLLRQIASG 127
Query: 179 MAYLCSHHYVHRDLAARNCLV-------------GDGLTVKISDFGLSRDVYASDYYRIQ 225
+A+L S +HRDL +N LV + L + ISDFGL + S +
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK-KLDSGQSSFR 186
Query: 226 SKSLLPV---RWMPPESIL-------YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ 275
+ P W PE + + T D++S G V + + S G P+ ++
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 276 EVIEMIRSRQMLPCPEDCPPRMYS 299
E +IR L + R
Sbjct: 247 ES-NIIRGIFSLDEMKCLHDRSLI 269
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 33/126 (26%), Positives = 53/126 (42%), Gaps = 24/126 (19%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV-------------GDGLTVKISDFGLSRDVYASDY 356
+A+G+A+L S +HRDL +N LV + L + ISDFGL + S
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK-KLDSGQ 182
Query: 357 YRIQSKSLLPV---RWMPPESIL-------YGKFTTESDVWSYGVVLWEVYSYGLQPYYG 406
++ P W PE + + T D++S G V + + S G P+
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242
Query: 407 YSNQEE 412
++E
Sbjct: 243 KYSRES 248
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 43/214 (20%)
Query: 62 LGEGAFGKVYKG-EVCTSEGPSLVAIKTL--KENANQKTASDFRREVDLMSELRHPNIVC 118
LG+G+F VY+ + T VAIK + K + EV + +L+HP+I+
Sbjct: 19 LGKGSFAGVYRAESIHTGL---EVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILE 75
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
L + ++ E G+++ +L +R S+ + H Q+ G
Sbjct: 76 LYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP-----------FSENEARHFMHQIITG 124
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS-----------DYYRIQSK 227
M YL SH +HRDL N L+ + +KI+DFGL+ + +Y
Sbjct: 125 MLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNY------ 178
Query: 228 SLLPVRWMPPESILYGK-FTTESDVWSYGVVLWE 260
+ PE I ESDVWS G + +
Sbjct: 179 -------ISPE-IATRSAHGLESDVWSLGCMFYT 204
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 4e-10
Identities = 29/98 (29%), Positives = 41/98 (41%), Gaps = 26/98 (26%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS-----------DYYR 358
+ GM YL SH +HRDL N L+ + +KI+DFGL+ + +Y
Sbjct: 121 IITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNY-- 178
Query: 359 IQSKSLLPVRWMPPESILYGK-FTTESDVWSYGVVLWE 395
+ PE I ESDVWS G + +
Sbjct: 179 -----------ISPE-IATRSAHGLESDVWSLGCMFYT 204
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-29
Identities = 54/243 (22%), Positives = 94/243 (38%), Gaps = 49/243 (20%)
Query: 60 QELGEGAFGKVYKGEVCTS-EGPSLVAIKTL-KENANQKTASDFRREVDLMSELRH-PNI 116
+ELG G F V + C S A K L K Q ++ E+ ++ + P +
Sbjct: 35 KELGRGKFAVVRQ---CISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
+ L V + + ++ E+ G++ + +S+ D + Q+
Sbjct: 92 INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEM----------VSENDVIRLIKQIL 141
Query: 177 AGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSR---------DVYASDYYRI 224
G+ YL ++ VH DL +N L+ +KI DFG+SR ++ + Y
Sbjct: 142 EGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEY-- 199
Query: 225 QSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYSNQEVIEM 280
+ PE + Y TT +D+W+ G++ Y P+ G NQE
Sbjct: 200 ----------LAPEILNYDPITTATDMWNIGIIA-----YMLLTHTSPFVGEDNQETYLN 244
Query: 281 IRS 283
I
Sbjct: 245 ISQ 247
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 8e-10
Identities = 32/119 (26%), Positives = 51/119 (42%), Gaps = 33/119 (27%)
Query: 313 GMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSR---------DVYASDYYRIQ 360
G+ YL ++ VH DL +N L+ +KI DFG+SR ++ + Y
Sbjct: 143 GVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEY--- 199
Query: 361 SKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYSNQEEFLK 415
+ PE + Y TT +D+W+ G++ Y P+ G NQE +L
Sbjct: 200 ---------LAPEILNYDPITTATDMWNIGIIA-----YMLLTHTSPFVGEDNQETYLN 244
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-29
Identities = 65/231 (28%), Positives = 112/231 (48%), Gaps = 27/231 (11%)
Query: 59 LQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIV 117
L++LG G + VYKG T VA+K +K ++ + T S RE+ LM EL+H NIV
Sbjct: 10 LEKLGNGTYATVYKGLNKTTGV---YVALKEVKLDSEEGTPSTAIREISLMKELKHENIV 66
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
L V + + ++FEFM DL +++ + L + Q+
Sbjct: 67 RLYDVIHTENKLTLVFEFMDN-DLKKYM------DSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV---RW 234
G+A+ + +HRDL +N L+ +K+ DFGL+R + I + W
Sbjct: 120 GLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR------AFGIPVNTFSSEVVTLW 173
Query: 235 M-PPESILYG--KFTTESDVWSYGVVLWEVYSYGLQPYY-GYSNQEVIEMI 281
P+ +L G ++T D+WS G +L E+ + +P + G +++E +++I
Sbjct: 174 YRAPD-VLMGSRTYSTSIDIWSCGCILAEMIT--GKPLFPGTNDEEQLKLI 221
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 3e-08
Identities = 26/89 (29%), Positives = 43/89 (48%), Gaps = 13/89 (14%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV---RW 369
G+A+ + +HRDL +N L+ +K+ DFGL+R + I + W
Sbjct: 120 GLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR------AFGIPVNTFSSEVVTLW 173
Query: 370 M-PPESILYG--KFTTESDVWSYGVVLWE 395
P+ +L G ++T D+WS G +L E
Sbjct: 174 YRAPD-VLMGSRTYSTSIDIWSCGCILAE 201
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-29
Identities = 57/277 (20%), Positives = 98/277 (35%), Gaps = 67/277 (24%)
Query: 58 FLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLK----ENANQKTASDFRREVDLMSELR 112
+G+G++G V E T + AIK + N K + EV LM +L
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRA---IRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 113 HPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSR------------------------ 148
HPNI L V + +C++ E G L + L
Sbjct: 87 HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 149 ----SPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVG--DG 202
+ + ++ S+I Q+ + + YL + HRD+ N L
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206
Query: 203 LTVKISDFGLSRDVYASD--------------YYRIQSKSLLPVRWMPPESILYG--KFT 246
+K+ DFGLS++ Y + Y+ + PE + +
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF------------VAPEVLNTTNESYG 254
Query: 247 TESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS 283
+ D WS GV+L + G P+ G ++ + I + +
Sbjct: 255 PKCDAWSAGVLLHLLLM-GAVPFPGVNDADTISQVLN 290
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 26/124 (20%), Positives = 48/124 (38%), Gaps = 31/124 (25%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVG--DGLTVKISDFGLSRDVYASD------------ 355
+ + + YL + HRD+ N L +K+ DFGLS++ Y +
Sbjct: 177 IFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG 236
Query: 356 --YYRIQSKSLLPVRWMPPESILYG--KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
Y+ + PE + + + D WS GV+L + G P+ G ++ +
Sbjct: 237 TPYF------------VAPEVLNTTNESYGPKCDAWSAGVLLHLLLM-GAVPFPGVNDAD 283
Query: 412 EFLK 415
+
Sbjct: 284 TISQ 287
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 9e-29
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 33/213 (15%)
Query: 59 LQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASDFR----REVDLMSELRH 113
L LGEG F VYK + T++ +VAIK +K + RE+ L+ EL H
Sbjct: 15 LDFLGEGQFATVYKARDKNTNQ---IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
PNI+ LL + ++F+FM DL + + ++ S ++A L
Sbjct: 72 PNIIGLLDAFGHKSNISLVFDFMET-DLEVII--KDNSLVLTPSHIKA---------YML 119
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV- 232
G+ YL H +HRDL N L+ + +K++DFGL++ + +++
Sbjct: 120 MTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK------SFGSPNRAYTHQV 173
Query: 233 --RWM-PPESILYG--KFTTESDVWSYGVVLWE 260
RW PE +L+G + D+W+ G +L E
Sbjct: 174 VTRWYRAPE-LLFGARMYGVGVDMWAVGCILAE 205
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 9e-08
Identities = 26/89 (29%), Positives = 45/89 (50%), Gaps = 13/89 (14%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV---RW 369
G+ YL H +HRDL N L+ + +K++DFGL++ + +++ RW
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK------SFGSPNRAYTHQVVTRW 177
Query: 370 M-PPESILYG--KFTTESDVWSYGVVLWE 395
PE +L+G + D+W+ G +L E
Sbjct: 178 YRAPE-LLFGARMYGVGVDMWAVGCILAE 205
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 59/245 (24%), Positives = 100/245 (40%), Gaps = 50/245 (20%)
Query: 57 RFLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTL-KENANQKTASDFRREVDLMSELRHP 114
+ELG+GAF V + T A K + + + + RE + +L+HP
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGL---EFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
NIV L ++F+ + G+L E +++R S+ D SH Q
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-------EF-----YSEADASHCIQQ 113
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASD---------YY 222
+ +AY S+ VHR+L N L+ G VK++DFGL+ +V S+ Y
Sbjct: 114 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 173
Query: 223 RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYSNQEVI 278
+ PE + ++ D+W+ GV+L Y G P++ +
Sbjct: 174 ------------LSPEVLKKDPYSKPVDIWACGVIL-----YILLVGYPPFWDEDQHRLY 216
Query: 279 EMIRS 283
I++
Sbjct: 217 AQIKA 221
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 3e-08
Identities = 29/120 (24%), Positives = 49/120 (40%), Gaps = 33/120 (27%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASD---------YY 357
+ +AY S+ VHR+L N L+ G VK++DFGL+ +V S+ Y
Sbjct: 114 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 173
Query: 358 RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYSNQEEF 413
+ PE + ++ D+W+ GV+L Y G P++ +
Sbjct: 174 ------------LSPEVLKKDPYSKPVDIWACGVIL-----YILLVGYPPFWDEDQHRLY 216
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 56/240 (23%), Positives = 103/240 (42%), Gaps = 50/240 (20%)
Query: 61 ELGEGAFGKVYKGEVCT--SEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVC 118
LG G FG+V+K C + G +A K +K K + + E+ +M++L H N++
Sbjct: 96 ILGGGRFGQVHK---CEETATG-LKLAAKIIKT-RGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
L S + ++ E++ G+L + ++ S L++ D Q+ G
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYN-----------LTELDTILFMKQICEG 199
Query: 179 MAYLCSHHYVHRDLAARN--CLVGDGLTVKISDFGLSR---------DVYASDYYRIQSK 227
+ ++ + +H DL N C+ D +KI DFGL+R + + +
Sbjct: 200 IRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEF----- 254
Query: 228 SLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYSNQEVIEMIRS 283
+ PE + Y + +D+WS GV+ Y GL P+ G ++ E + I +
Sbjct: 255 -------LAPEVVNYDFVSFPTDMWSVGVIA-----YMLLSGLSPFLGDNDAETLNNILA 302
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 28/118 (23%), Positives = 48/118 (40%), Gaps = 32/118 (27%)
Query: 313 GMAYLCSHHYVHRDLAARN--CLVGDGLTVKISDFGLSR---------DVYASDYYRIQS 361
G+ ++ + +H DL N C+ D +KI DFGL+R + + +
Sbjct: 199 GIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEF---- 254
Query: 362 KSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYSNQEEFLK 415
+ PE + Y + +D+WS GV+ Y GL P+ G ++ E
Sbjct: 255 --------LAPEVVNYDFVSFPTDMWSVGVIA-----YMLLSGLSPFLGDNDAETLNN 299
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 60/249 (24%), Positives = 98/249 (39%), Gaps = 58/249 (23%)
Query: 57 RFLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTL-KENANQKTASDFRREVDLMSELRHP 114
+ELG+GAF V + T A K + + + + RE + +L+HP
Sbjct: 32 DVKEELGKGAFSVVRRCVHKTTGL---EFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
NIV L ++F+ + G+L E +++R S+ D SH Q
Sbjct: 89 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE------------FYSEADASHCIQQ 136
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSR---------DVYASDYY 222
+ +AY S+ VHR+L N L+ G VK++DFGL+ + Y
Sbjct: 137 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 196
Query: 223 RIQSKSLLPVRWMPPESIL----YGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYSN 274
+ PE +L Y K D+W+ GV+L Y G P++
Sbjct: 197 ------------LSPE-VLKKDPYSK---PVDIWACGVIL-----YILLVGYPPFWDEDQ 235
Query: 275 QEVIEMIRS 283
+ I++
Sbjct: 236 HRLYAQIKA 244
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 30/124 (24%), Positives = 47/124 (37%), Gaps = 41/124 (33%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSR---------DVYASDYY 357
+ +AY S+ VHR+L N L+ G VK++DFGL+ + Y
Sbjct: 137 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 196
Query: 358 RIQSKSLLPVRWMPPESIL----YGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYSN 409
+ PE +L Y K D+W+ GV+L Y G P++
Sbjct: 197 ------------LSPE-VLKKDPYSK---PVDIWACGVIL-----YILLVGYPPFWDEDQ 235
Query: 410 QEEF 413
+
Sbjct: 236 HRLY 239
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 50/214 (23%), Positives = 81/214 (37%), Gaps = 44/214 (20%)
Query: 62 LGEGAFGKVYKG-EVCTSEGPSLVAIKTL-KEN-ANQKTASDFRREVDLMSELRHPNIVC 118
LG+G F K ++ + T E + A K + K E+ + L H ++V
Sbjct: 49 LGKGGFAKCFEISDADTKE---VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 105
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
G + + ++ E R L E R L++ + + Q+ G
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKA------------LTEPEARYYLRQIVLG 153
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS-----------DYYRIQSK 227
YL + +HRDL N + + L VKI DFGL+ V +Y
Sbjct: 154 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY------ 207
Query: 228 SLLPVRWMPPESILYGK-FTTESDVWSYGVVLWE 260
+ PE +L K + E DVWS G +++
Sbjct: 208 -------IAPE-VLSKKGHSFEVDVWSIGCIMYT 233
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 9e-11
Identities = 35/135 (25%), Positives = 56/135 (41%), Gaps = 37/135 (27%)
Query: 273 SNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNC 332
+ ++E+ + R+ L PE R Y + + + G YL + +HRDL N
Sbjct: 124 RRRSLLELHKRRKALTEPE---ARYY--LRQ------IVLGCQYLHRNRVIHRDLKLGNL 172
Query: 333 LVGDGLTVKISDFGLSRDVYAS-----------DYYRIQSKSLLPVRWMPPESILYGK-F 380
+ + L VKI DFGL+ V +Y + PE +L K
Sbjct: 173 FLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY-------------IAPE-VLSKKGH 218
Query: 381 TTESDVWSYGVVLWE 395
+ E DVWS G +++
Sbjct: 219 SFEVDVWSIGCIMYT 233
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 63/246 (25%), Positives = 101/246 (41%), Gaps = 42/246 (17%)
Query: 62 LGEGAFGKVYKG-EVCTSEGPSLVAIKTL--KENANQKTASDFRREVDLMSELRHPNIVC 118
LG+G FG VY E + ++A+K L + RREV++ S LRHPNI+
Sbjct: 17 LGKGKFGNVYLAREKQSKF---ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 73
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
L G + ++ E+ G ++ L Q + +Q + ++A
Sbjct: 74 LYGYFHDATRVYLILEYAPLGTVYREL------------QKLSKFDEQRTATYITELANA 121
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS---------DYYRIQSKSL 229
++Y S +HRD+ N L+G +KI+DFG S +S DY
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDY-------- 173
Query: 230 LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289
+PPE I + D+WS GV+ +E G P+ + QE + I +
Sbjct: 174 -----LPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVE-FTF 226
Query: 290 PEDCPP 295
P+
Sbjct: 227 PDFVTE 232
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 28/95 (29%), Positives = 42/95 (44%), Gaps = 22/95 (23%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS---------DYYRIQ 360
+A ++Y S +HRD+ N L+G +KI+DFG S +S DY
Sbjct: 118 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDY---- 173
Query: 361 SKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWE 395
+PPE I + D+WS GV+ +E
Sbjct: 174 ---------LPPEMIEGRMHDEKVDLWSLGVLCYE 199
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-28
Identities = 50/206 (24%), Positives = 80/206 (38%), Gaps = 32/206 (15%)
Query: 62 LGEGAFGKVYKG-EVCTSEGPSLVAIKTL-KEN-ANQKTASDFRREVDLMSELRHPNIVC 118
LG+G F K ++ + T E + A K + K E+ + L H ++V
Sbjct: 23 LGKGGFAKCFEISDADTKE---VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 79
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
G + + ++ E R L E R L++ + + Q+ G
Sbjct: 80 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKA------------LTEPEARYYLRQIVLG 127
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR----- 233
YL + +HRDL N + + L VKI DFGL+ V V
Sbjct: 128 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-------ERKKVLCGTPN 180
Query: 234 WMPPESILYGK-FTTESDVWSYGVVL 258
++ PE +L K + E DVWS G ++
Sbjct: 181 YIAPE-VLSKKGHSFEVDVWSIGCIM 205
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 35/127 (27%), Positives = 55/127 (43%), Gaps = 25/127 (19%)
Query: 273 SNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNC 332
+ ++E+ + R+ L PE R Y + + + G YL + +HRDL N
Sbjct: 98 RRRSLLELHKRRKALTEPE---ARYY--LRQ------IVLGCQYLHRNRVIHRDLKLGNL 146
Query: 333 LVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR-----WMPPESILYGK-FTTESDV 386
+ + L VKI DFGL+ V V ++ PE +L K + E DV
Sbjct: 147 FLNEDLEVKIGDFGLATKVEYDG-------ERKKVLCGTPNYIAPE-VLSKKGHSFEVDV 198
Query: 387 WSYGVVL 393
WS G ++
Sbjct: 199 WSIGCIM 205
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-28
Identities = 58/253 (22%), Positives = 106/253 (41%), Gaps = 49/253 (19%)
Query: 47 FRREVIETKPRFLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASDFRREV 105
+ I F++ LG GAF +V+ + T + L A+K +K+ + S E+
Sbjct: 2 MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGK---LFALKCIKK-SPAFRDSSLENEI 57
Query: 106 DLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQ 165
++ +++H NIV L + S ++ + + G+L + ++ R G ++
Sbjct: 58 AVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER-------GV-----YTE 105
Query: 166 QDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSR-------- 214
+D S + QV + + YL + VHRDL N L + + I+DFGLS+
Sbjct: 106 KDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS 165
Query: 215 DVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPYY 270
+ Y + PE + ++ D WS GV+ Y G P+Y
Sbjct: 166 TACGTPGY------------VAPEVLAQKPYSKAVDCWSIGVIT-----YILLCGYPPFY 208
Query: 271 GYSNQEVIEMIRS 283
+ ++ E I+
Sbjct: 209 EETESKLFEKIKE 221
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 2e-09
Identities = 29/119 (24%), Positives = 45/119 (37%), Gaps = 32/119 (26%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSR--------DVYASDYYR 358
V + + YL + VHRDL N L + + I+DFGLS+ + Y
Sbjct: 115 VLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGY- 173
Query: 359 IQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYSNQEEF 413
+ PE + ++ D WS GV+ Y G P+Y + + F
Sbjct: 174 -----------VAPEVLAQKPYSKAVDCWSIGVIT-----YILLCGYPPFYEETESKLF 216
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-28
Identities = 54/248 (21%), Positives = 94/248 (37%), Gaps = 49/248 (19%)
Query: 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL 111
I +G G++G+V + A K + + + F++E+++M L
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGTR--IRRAAKKIPK-YFVEDVDRFKQEIEIMKSL 63
Query: 112 RHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHI 171
HPNI+ L + ++ E G+L E ++ + + D + I
Sbjct: 64 DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR------------VFRESDAARI 111
Query: 172 ALQVAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSR---------DVYAS 219
V + +AY + HRDL N L +K+ DFGL+ +
Sbjct: 112 MKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGT 171
Query: 220 DYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYSNQ 275
YY + P+ +L G + E D WS GV++ Y G P+ ++
Sbjct: 172 PYY------------VSPQ-VLEGLYGPECDEWSAGVMM-----YVLLCGYPPFSAPTDS 213
Query: 276 EVIEMIRS 283
EV+ IR
Sbjct: 214 EVMLKIRE 221
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 3e-10
Identities = 31/122 (25%), Positives = 47/122 (38%), Gaps = 34/122 (27%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSR---------DVYASDYY 357
V + +AY + HRDL N L +K+ DFGL+ + YY
Sbjct: 115 VLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYY 174
Query: 358 RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYSNQEEF 413
+ P+ +L G + E D WS GV++ Y G P+ ++ E
Sbjct: 175 ------------VSPQ-VLEGLYGPECDEWSAGVMM-----YVLLCGYPPFSAPTDSEVM 216
Query: 414 LK 415
LK
Sbjct: 217 LK 218
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-28
Identities = 33/239 (13%), Positives = 71/239 (29%), Gaps = 35/239 (14%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPS---LVAIKTLKENANQKTASDFRREVDLMSELRHP 114
LGEGAF +VY+ +K K AN + ++ +
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP-ANPWEFYIGTQLMERLKPSMQH 127
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
+ L ++ E G L + + + + Q A++
Sbjct: 128 MFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLY-------KNTPEKVMPQGLVISFAMR 180
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVGDGLT-----------VKISDFGLSRDVYASDYYR 223
+ + + +H D+ N ++G+G + + D G S D+
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL----- 235
Query: 224 IQSKSLLPVRW-----MPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 276
++ + E +L K + + D + ++ + +G E
Sbjct: 236 FPKGTIFTAKCETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCML-FGTYMKVKNEGGE 292
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 23/182 (12%), Positives = 55/182 (30%), Gaps = 34/182 (18%)
Query: 254 YGVVLWEVYSYGLQPYYGYSN-QEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAA 312
Y L++ S + Y Y I + ++ P+ L++ +
Sbjct: 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQG-------LVISFAMRM--LY 183
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLT-----------VKISDFGLSRDVYASDYYRIQS 361
+ + +H D+ N ++G+G + + D G S D+
Sbjct: 184 MIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL-----FPK 238
Query: 362 KSLLPVRW-----MPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
++ + E +L K + + D + ++ + +G E +
Sbjct: 239 GTIFTAKCETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCML-FGTYMKVKNEGGECKPE 296
Query: 416 TP 417
Sbjct: 297 GL 298
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-28
Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 51/220 (23%)
Query: 57 RFLQELGEGAFGKVYKGE-VCTSEGPSLVAIKTL-KENANQKTASDFRREVDLMSELRHP 114
R L+ +G+G F KV + T VAIK + K N + REV +M L HP
Sbjct: 18 RLLKTIGKGNFAKVKLARHILTGR---EVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
NIV L V + + + ++ E+ G++ ++L++ + +++ Q
Sbjct: 75 NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR------------MKEKEARSKFRQ 122
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV--------------YASD 220
+ + + Y VHRDL A N L+ + +KI+DFG S + YA+
Sbjct: 123 IVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAA- 181
Query: 221 YYRIQSKSLLPVRWMPPESILYGKFTT--ESDVWSYGVVL 258
PE + GK E DVWS GV+L
Sbjct: 182 ----------------PE-LFQGKKYDGPEVDVWSLGVIL 204
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 9e-09
Identities = 29/97 (29%), Positives = 38/97 (39%), Gaps = 34/97 (35%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV--------------YASDYYR 358
+ Y VHRDL A N L+ + +KI+DFG S + YA+
Sbjct: 126 AVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAA---- 181
Query: 359 IQSKSLLPVRWMPPESILYGKFTT--ESDVWSYGVVL 393
PE + GK E DVWS GV+L
Sbjct: 182 -------------PE-LFQGKKYDGPEVDVWSLGVIL 204
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-28
Identities = 63/230 (27%), Positives = 116/230 (50%), Gaps = 30/230 (13%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVC 118
L +LGEG + VYKG+ ++ +LVA+K ++ + REV L+ +L+H NIV
Sbjct: 7 LDKLGEGTYATVYKGKSKLTD--NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 64
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
L + + + + ++FE++ + DL ++L + I+ V+ Q+ G
Sbjct: 65 LHDIIHTEKSLTLVFEYLDK-DLKQYL--DDCGNIINMHNVKL---------FLFQLLRG 112
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV---RWM 235
+AY +HRDL +N L+ + +K++DFGL+R I +K+ W
Sbjct: 113 LAYCHRQKVLHRDLKPQNLLINERGELKLADFGLAR------AKSIPTKTYDNEVVTLWY 166
Query: 236 -PPESILYG--KFTTESDVWSYGVVLWEVYSYGLQPYY-GYSNQEVIEMI 281
PP+ IL G ++T+ D+W G + +E+ + +P + G + +E + I
Sbjct: 167 RPPD-ILLGSTDYSTQIDMWGVGCIFYEMAT--GRPLFPGSTVEEQLHFI 213
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 4e-08
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 13/89 (14%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV---RW 369
G+AY +HRDL +N L+ + +K++DFGL+R I +K+ W
Sbjct: 112 GLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLAR------AKSIPTKTYDNEVVTLW 165
Query: 370 M-PPESILYG--KFTTESDVWSYGVVLWE 395
PP+ IL G ++T+ D+W G + +E
Sbjct: 166 YRPPD-ILLGSTDYSTQIDMWGVGCIFYE 193
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-28
Identities = 67/299 (22%), Positives = 111/299 (37%), Gaps = 33/299 (11%)
Query: 28 SLVAIKTLKENANQKTASDFRREVIETKPRFLQELGEGAFGKVYKGE-VCTSEGPSLVAI 86
L A T K+ + DF + + ELG G G V+K + ++A
Sbjct: 16 RLEAFLTQKQKVGELKDDDFEK---------ISELGAGNGGVVFKVSHKPSGL---VMAR 63
Query: 87 KTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLM 146
K + + RE+ ++ E P IV G S + + E M G L + L
Sbjct: 64 KLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL- 122
Query: 147 SRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYL-CSHHYVHRDLAARNCLVGDGLTV 205
+ + +Q +++ V G+ YL H +HRD+ N LV +
Sbjct: 123 -----------KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 171
Query: 206 KISDFGLSRDVYASDYYRIQSKSLLPVR-WMPPESILYGKFTTESDVWSYGVVLWEVYSY 264
K+ DFG+S + S + S + R +M PE + ++ +SD+WS G+ L E+
Sbjct: 172 KLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV- 225
Query: 265 GLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYV 323
G P +E+ M + E P + MA Y+
Sbjct: 226 GRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYI 284
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 33/112 (29%), Positives = 51/112 (45%), Gaps = 8/112 (7%)
Query: 310 VAAGMAYL-CSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR 368
V G+ YL H +HRD+ N LV +K+ DFG+S + S + S + R
Sbjct: 140 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTR 194
Query: 369 -WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLKTPPS 419
+M PE + ++ +SD+WS G+ L E+ G P +E L
Sbjct: 195 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAV-GRYPIPPPDAKELELMFGCQ 245
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-28
Identities = 43/234 (18%), Positives = 88/234 (37%), Gaps = 53/234 (22%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTAS----------------D 100
R ++ L +G F K+ E + A+K +++ +K D
Sbjct: 34 RIIRTLNQGKFNKIILCE----KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 101 FRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQ 160
F+ E+ +++++++ + G+ + + + +++E+M + +F
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK----NYT 145
Query: 161 APLSQQDFSHIALQVAAGMAYLCSHHYV-HRDLAARNCLVGDGLTVKISDFGLSRDVYAS 219
+ Q I V +Y+ + + HRD+ N L+ VK+SDFG S Y
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES--EYMV 203
Query: 220 D----------YYRIQSKSLLPVRWMPPESILYGKFTT---ESDVWSYGVVLWE 260
D + MPPE + + + D+WS G+ L+
Sbjct: 204 DKKIKGSRGTYEF------------MPPE-FFSNESSYNGAKVDIWSLGICLYV 244
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 28/120 (23%), Positives = 47/120 (39%), Gaps = 30/120 (25%)
Query: 310 VAAGMAYLCSHHYV-HRDLAARNCLVGDGLTVKISDFGLSRDVYASD----------YYR 358
V +Y+ + + HRD+ N L+ VK+SDFG S Y D +
Sbjct: 160 VLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES--EYMVDKKIKGSRGTYEF- 216
Query: 359 IQSKSLLPVRWMPPESILYGKFTT---ESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
MPPE + + + D+WS G+ L+ ++ Y + P+ + E
Sbjct: 217 -----------MPPE-FFSNESSYNGAKVDIWSLGICLYVMF-YNVVPFSLKISLVELFN 263
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 54/253 (21%), Positives = 96/253 (37%), Gaps = 53/253 (20%)
Query: 57 RFLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTL-------KENANQKTASDFRREVDLM 108
+ LG GA G+V E T + VAI+ + A + E++++
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCK---KVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 109 SELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDF 168
+L HP I+ + + E ++ E M G+L + ++ L +
Sbjct: 195 KKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNK------------RLKEATC 241
Query: 169 SHIALQVAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASD----- 220
Q+ + YL + +HRDL N L+ + +KI+DFG S+ + +
Sbjct: 242 KLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 301
Query: 221 ----YYRIQSKSLLPVRWMPPE---SILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS 273
Y + PE S+ + D WS GV+L+ S G P+ +
Sbjct: 302 CGTPTY------------LAPEVLVSVGTAGYNRAVDCWSLGVILFICLS-GYPPFSEHR 348
Query: 274 NQEVI-EMIRSRQ 285
Q + + I S +
Sbjct: 349 TQVSLKDQITSGK 361
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 28/118 (23%), Positives = 46/118 (38%), Gaps = 28/118 (23%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASD---------YY 357
+ + YL + +HRDL N L+ + +KI+DFG S+ + + Y
Sbjct: 248 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 307
Query: 358 RIQSKSLLPVRWMPPE---SILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEE 412
+ PE S+ + D WS GV+L+ S G P+ + Q
Sbjct: 308 ------------LAPEVLVSVGTAGYNRAVDCWSLGVILFICLS-GYPPFSEHRTQVS 352
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 63/248 (25%), Positives = 103/248 (41%), Gaps = 46/248 (18%)
Query: 62 LGEGAFGKVYKG-EVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHPNIVC 118
LG+G FG VY E ++A+K L ++ + RRE+++ S LRHPNI+
Sbjct: 22 LGKGKFGNVYLAREKQNKF---IMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILR 78
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
+ + + ++ EF RG+L++ L + R +Q + ++A
Sbjct: 79 MYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGR-----------FDEQRSATFMEELADA 126
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS-----------DYYRIQSK 227
+ Y +HRD+ N L+G +KI+DFG S V+A DY
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRTMCGTLDY------ 178
Query: 228 SLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287
+PPE I + D+W GV+ +E G+ P+ S+ E I + L
Sbjct: 179 -------LPPEMIEGKTHDEKVDLWCAGVLCYEFL-VGMPPFDSPSHTETHRRIVNVD-L 229
Query: 288 PCPEDCPP 295
P
Sbjct: 230 KFPPFLSD 237
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 8e-10
Identities = 32/130 (24%), Positives = 52/130 (40%), Gaps = 33/130 (25%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS-----------DYYR 358
+A + Y +HRD+ N L+G +KI+DFG S V+A DY
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRTMCGTLDY-- 178
Query: 359 IQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK--- 415
+PPE I + D+W GV+ +E G+ P+ S+ E +
Sbjct: 179 -----------LPPEMIEGKTHDEKVDLWCAGVLCYEFL-VGMPPFDSPSHTETHRRIVN 226
Query: 416 ---TPPSWIT 422
P +++
Sbjct: 227 VDLKFPPFLS 236
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 53/279 (18%), Positives = 98/279 (35%), Gaps = 54/279 (19%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSEL-RHPNI 116
L+++G G FG V+K V +G + AIK K A + REV + L +H ++
Sbjct: 16 LEKIGSGEFGSVFKC-VKRLDG-CIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 73
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V + M + E+ G L + + ++ + + + + LQV
Sbjct: 74 VRYFSAWAEDDHMLIQNEYCNGGSLADAISENY--------RIMSYFKEAELKDLLLQVG 125
Query: 177 AGMAYLCSHHYVHRDLAARNCLV-------------------GDGLTVKISDFGLSRDVY 217
G+ Y+ S VH D+ N + + + KI D G
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT--- 182
Query: 218 ASDYYRIQSKSLLPV-----RWMPPESILYGKF--TTESDVWSYGVVLWEVYSYGLQPYY 270
S V R++ E +L + ++D+++ + + G +P
Sbjct: 183 --------RISSPQVEEGDSRFLANE-VLQENYTHLPKADIFALALTVVCA--AGAEPL- 230
Query: 271 GYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
N + IR ++ P+ L+ H P
Sbjct: 231 -PRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDP 268
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 5e-06
Identities = 18/112 (16%), Positives = 35/112 (31%), Gaps = 38/112 (33%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV-------------------GDGLTVKISDFGLSRD 350
V G+ Y+ S VH D+ N + + + KI D G
Sbjct: 124 VGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT- 182
Query: 351 VYASDYYRIQSKSLLPV-----RWMPPESILYGKF--TTESDVWSYGVVLWE 395
S V R++ E +L + ++D+++ + +
Sbjct: 183 ----------RISSPQVEEGDSRFLANE-VLQENYTHLPKADIFALALTVVC 223
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 58/246 (23%), Positives = 109/246 (44%), Gaps = 42/246 (17%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVC 118
L+++G+G+FG+V+KG + +VAIK + + D ++E+ ++S+ P +
Sbjct: 27 LEKIGKGSFGEVFKG-IDNRTQ-KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 84
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
G L + ++ E++ G + L PL + + I ++ G
Sbjct: 85 YYGSYLKDTKLWIIMEYLGGGSALDLLEPG-------------PLDETQIATILREILKG 131
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR----- 233
+ YL S +HRD+ A N L+ + VK++DFG++ Q R
Sbjct: 132 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAG----------QLTDTQIKRNTFVG 181
Query: 234 ---WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP 290
WM PE I + +++D+WS G+ E+ + G P+ +V+ +I P
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIEL-ARGEPPHSELHPMKVLFLI--------P 232
Query: 291 EDCPPR 296
++ PP
Sbjct: 233 KNNPPT 238
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 27/91 (29%), Positives = 42/91 (46%), Gaps = 18/91 (19%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR---- 368
G+ YL S +HRD+ A N L+ + VK++DFG++ Q R
Sbjct: 131 GLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAG----------QLTDTQIKRNTFV 180
Query: 369 ----WMPPESILYGKFTTESDVWSYGVVLWE 395
WM PE I + +++D+WS G+ E
Sbjct: 181 GTPFWMAPEVIKQSAYDSKADIWSLGITAIE 211
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 57/250 (22%), Positives = 98/250 (39%), Gaps = 59/250 (23%)
Query: 57 RFLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTL-KENANQKTASDFRREVDLMSELRHP 114
+ +ELG+GAF V + +V + A + + + + RE + L+HP
Sbjct: 14 QLFEELGKGAFSVVRRCVKVLAGQ---EYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
NIV L ++F+ + G+L E +++R S+ D SH Q
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE------------YYSEADASHCIQQ 118
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSR----------DVYASDY 221
+ + + VHR+L N L+ G VK++DFGL+ +
Sbjct: 119 ILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPG 178
Query: 222 YRIQSKSLLPVRWMPPESIL----YGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYS 273
Y + PE +L YGK D+W+ GV+L Y G P++
Sbjct: 179 Y------------LSPE-VLRKDPYGK---PVDLWACGVIL-----YILLVGYPPFWDED 217
Query: 274 NQEVIEMIRS 283
+ + I++
Sbjct: 218 QHRLYQQIKA 227
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 28/125 (22%), Positives = 45/125 (36%), Gaps = 42/125 (33%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSR----------DVYASDY 356
+ + + VHR+L N L+ G VK++DFGL+ +
Sbjct: 119 ILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPG 178
Query: 357 YRIQSKSLLPVRWMPPESIL----YGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYS 408
Y + PE +L YGK D+W+ GV+L Y G P++
Sbjct: 179 Y------------LSPE-VLRKDPYGK---PVDLWACGVIL-----YILLVGYPPFWDED 217
Query: 409 NQEEF 413
+
Sbjct: 218 QHRLY 222
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 67/250 (26%), Positives = 104/250 (41%), Gaps = 43/250 (17%)
Query: 59 LQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQ----KTASDFRREVDLMSELRH 113
L +GEG++G V K T +VAIK E+ + K A RE+ L+ +LRH
Sbjct: 30 LGLVGEGSYGMVMKCRNKDTGR---IVAIKKFLESDDDKMVKKIAM---REIKLLKQLRH 83
Query: 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
N+V LL VC + ++FEF+ + + L L Q
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFP-----------NGLDYQVVQKYLF 131
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV- 232
Q+ G+ + SH+ +HRD+ N LV VK+ DFG +R +
Sbjct: 132 QIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR------TLAAPGEVYDDEV 185
Query: 233 --RWM-PPESILYG--KFTTESDVWSYGVVLWEVYSYGLQPYY-GYSNQEVIEMIRSRQM 286
RW PE +L G K+ DVW+ G ++ E++ +P + G S+ + + I
Sbjct: 186 ATRWYRAPE-LLVGDVKYGKAVDVWAIGCLVTEMFM--GEPLFPGDSDIDQLYHI--MMC 240
Query: 287 L--PCPEDCP 294
L P
Sbjct: 241 LGNLIPRHQE 250
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 2e-07
Identities = 27/92 (29%), Positives = 42/92 (45%), Gaps = 13/92 (14%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV---RW 369
G+ + SH+ +HRD+ N LV VK+ DFG +R + RW
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR------TLAAPGEVYDDEVATRW 189
Query: 370 M-PPESILYG--KFTTESDVWSYGVVLWEVYS 398
PE +L G K+ DVW+ G ++ E++
Sbjct: 190 YRAPE-LLVGDVKYGKAVDVWAIGCLVTEMFM 220
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 63/257 (24%), Positives = 106/257 (41%), Gaps = 57/257 (22%)
Query: 59 LQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQ----KTASDFRREVDLMSELRH 113
+ ++GEG++G V+K T + +VAIK E+ + K A RE+ ++ +L+H
Sbjct: 8 IGKIGEGSYGVVFKCRNRDTGQ---IVAIKKFLESEDDPVIKKIAL---REIRMLKQLKH 61
Query: 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
PN+V LL V + ++FE+ + L + + I
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQR-----------GVPEHLVKSITW 109
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR------DVYASDY-----Y 222
Q + + H+ +HRD+ N L+ +K+ DFG +R D Y D Y
Sbjct: 110 QTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY-DDEVATRWY 168
Query: 223 RIQSKSLLPVRWMPPESILYG--KFTTESDVWSYGVVLWEVYSYGLQPYY-GYSNQEVIE 279
R PE +L G ++ DVW+ G V E+ S P + G S+ + +
Sbjct: 169 R------------SPE-LLVGDTQYGPPVDVWAIGCVFAELLS--GVPLWPGKSDVDQLY 213
Query: 280 MIRSRQML--PCPEDCP 294
+I R+ L P
Sbjct: 214 LI--RKTLGDLIPRHQQ 228
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 2e-07
Identities = 27/99 (27%), Positives = 41/99 (41%), Gaps = 27/99 (27%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR------DVYASDY-----YRIQS 361
+ + H+ +HRD+ N L+ +K+ DFG +R D Y D YR
Sbjct: 114 AVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY-DDEVATRWYR--- 169
Query: 362 KSLLPVRWMPPESILYG--KFTTESDVWSYGVVLWEVYS 398
PE +L G ++ DVW+ G V E+ S
Sbjct: 170 ---------SPE-LLVGDTQYGPPVDVWAIGCVFAELLS 198
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 58/252 (23%), Positives = 100/252 (39%), Gaps = 59/252 (23%)
Query: 58 FLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLK----ENANQKTASDFRREVDLMSELR 112
+ +G+G F V + T + A+K + ++ + D +RE + L+
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQ---QFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 113 HPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIA 172
HP+IV LL S + M+FEFM DL ++ R + S+ SH
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKR--------ADAGFVYSEAVASHYM 136
Query: 173 LQVAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASD--------- 220
Q+ + Y ++ +HRD+ L+ + VK+ FG++ + S
Sbjct: 137 RQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGT 196
Query: 221 -YYRIQSKSLLPVRWMPPESIL----YGKFTTESDVWSYGVVLWEVYSY----GLQPYYG 271
++ M PE ++ YGK DVW GV+L + G P+YG
Sbjct: 197 PHF------------MAPE-VVKREPYGK---PVDVWGCGVIL-----FILLSGCLPFYG 235
Query: 272 YSNQEVIEMIRS 283
+ + + E I
Sbjct: 236 -TKERLFEGIIK 246
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 27/120 (22%), Positives = 46/120 (38%), Gaps = 43/120 (35%)
Query: 315 AYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASD----------YYRIQS 361
Y ++ +HRD+ L+ + VK+ FG++ + S ++
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF---- 199
Query: 362 KSLLPVRWMPPESIL----YGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYSNQEEF 413
M PE ++ YGK DVW GV+L + G P+YG + + F
Sbjct: 200 --------MAPE-VVKREPYGK---PVDVWGCGVIL-----FILLSGCLPFYG-TKERLF 241
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-27
Identities = 39/250 (15%), Positives = 85/250 (34%), Gaps = 31/250 (12%)
Query: 57 RFLQELGEGA--FGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRH 113
L +G+G V G V ++ + E + + + + E+ + H
Sbjct: 28 ELLTVIGKGFEDLMTVNLA-RYKPTG-EYVTVRRINLEACSNEMVTFLQGELHVSKLFNH 85
Query: 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
PNIV ++ + ++ FM G D+ + +++ ++I
Sbjct: 86 PNIVPYRATFIADNELWVVTSFMAYGSA----------KDLICTHFMDGMNELAIAYILQ 135
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR 233
V + Y+ YVHR + A + L+ V +S + + + +
Sbjct: 136 GVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 234 -----WMPPESI--LYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286
W+ PE + + +SD++S G+ E+ + G P+ +++
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACEL-ANGHVPFKDMPATQMLLEK----- 249
Query: 287 LPCPEDCPPR 296
P
Sbjct: 250 ---LNGTVPC 256
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 19/102 (18%), Positives = 39/102 (38%), Gaps = 8/102 (7%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR---- 368
+ Y+ YVHR + A + L+ V +S + + + +
Sbjct: 140 ALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 369 -WMPPESI--LYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY 407
W+ PE + + +SD++S G+ E+ + G P+
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACEL-ANGHVPFKDM 240
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 58/238 (24%), Positives = 98/238 (41%), Gaps = 29/238 (12%)
Query: 41 QKTASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASD 100
+ S R V + ++G G +G VYK + + A+K ++ +A
Sbjct: 8 KVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC- 66
Query: 101 FRREVDLMSELRHPNIVCLLGVCLSGEPMC--MLFEFMVRGDLHEFLMSRSPRSDISGSQ 158
RE+ L+ EL+HPN++ L V LS +LF++ DL + ++
Sbjct: 67 --REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRAS---KANK 120
Query: 159 VQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL----TVKISDFGLSR 214
L + + Q+ G+ YL ++ +HRDL N LV VKI+D G +R
Sbjct: 121 KPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180
Query: 215 DVYASDYYRIQSKSLLPV------RWM-PPESILYG--KFTTESDVWSYGVVLWEVYS 263
+ K L + W PE +L G +T D+W+ G + E+ +
Sbjct: 181 ------LFNSPLKPLADLDPVVVTFWYRAPE-LLLGARHYTKAIDIWAIGCIFAELLT 231
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 28/99 (28%), Positives = 43/99 (43%), Gaps = 20/99 (20%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGL----TVKISDFGLSRDVYASDYYRIQSKSLLPV- 367
G+ YL ++ +HRDL N LV VKI+D G +R + K L +
Sbjct: 140 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR------LFNSPLKPLADLD 193
Query: 368 -----RWM-PPESILYG--KFTTESDVWSYGVVLWEVYS 398
W PE +L G +T D+W+ G + E+ +
Sbjct: 194 PVVVTFWYRAPE-LLLGARHYTKAIDIWAIGCIFAELLT 231
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 62/235 (26%), Positives = 103/235 (43%), Gaps = 37/235 (15%)
Query: 59 LQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIV 117
++GEG+ G V E + VA+K + Q+ EV +M + +H N+V
Sbjct: 50 YVKIGEGSTGIVCLAREKHSGR---QVAVKMMDLRKQQRR-ELLFNEVVIMRDYQHFNVV 105
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
+ L GE + +L EF+ G L +DI Q L+++ + + V
Sbjct: 106 EMYKSYLVGEELWVLMEFLQGGAL----------TDIV---SQVRLNEEQIATVCEAVLQ 152
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR---- 233
+AYL + +HRD+ + + L+ VK+SDFG Q +P R
Sbjct: 153 ALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFC----------AQISKDVPKRKSLV 202
Query: 234 ----WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR 284
WM PE I + TE D+WS G+++ E+ G PY+ S + ++ +R
Sbjct: 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEM-VDGEPPYFSDSPVQAMKRLRDS 256
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 28/91 (30%), Positives = 42/91 (46%), Gaps = 18/91 (19%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR---- 368
+AYL + +HRD+ + + L+ VK+SDFG Q +P R
Sbjct: 153 ALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFC----------AQISKDVPKRKSLV 202
Query: 369 ----WMPPESILYGKFTTESDVWSYGVVLWE 395
WM PE I + TE D+WS G+++ E
Sbjct: 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIE 233
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 39/216 (18%)
Query: 59 LQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIV 117
+ ELG+GAFGKVYK T L A K ++ + ++ D+ E+++++ HP IV
Sbjct: 24 VGELGDGAFGKVYKAKNKETGA---LAAAKVIETKSEEEL-EDYIVEIEILATCDHPYIV 79
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
LLG + ++ EF G + +M R L++ + Q+
Sbjct: 80 KLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDR----------GLTEPQIQVVCRQMLE 128
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR---- 233
+ +L S +HRDL A N L+ ++++DFG+S ++ L R
Sbjct: 129 ALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA----------KNLKTLQKRDSFI 178
Query: 234 ----WMPPESILYGKFTTES-----DVWSYGVVLWE 260
WM PE ++ D+WS G+ L E
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 214
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 25/96 (26%), Positives = 40/96 (41%), Gaps = 23/96 (23%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR---- 368
+ +L S +HRDL A N L+ ++++DFG+S ++ L R
Sbjct: 129 ALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA----------KNLKTLQKRDSFI 178
Query: 369 ----WMPPESILYGKFTTES-----DVWSYGVVLWE 395
WM PE ++ D+WS G+ L E
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 214
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 53/235 (22%), Positives = 99/235 (42%), Gaps = 37/235 (15%)
Query: 59 LQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIV 117
+++G+GA G VY +V T + VAI+ + K E+ +M E ++PNIV
Sbjct: 25 FEKIGQGASGTVYTAMDVATGQ---EVAIRQMNLQQQPKK-ELIINEILVMRENKNPNIV 80
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
L L G+ + ++ E++ G L + + + + + + +
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTET-------------CMDEGQIAAVCRECLQ 127
Query: 178 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR---- 233
+ +L S+ +HRD+ + N L+G +VK++DFG Q R
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC----------AQITPEQSKRSTMV 177
Query: 234 ----WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR 284
WM PE + + + D+WS G++ E+ G PY + + +I +
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM-IEGEPPYLNENPLRALYLIATN 231
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 24/91 (26%), Positives = 40/91 (43%), Gaps = 18/91 (19%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR---- 368
+ +L S+ +HRD+ + N L+G +VK++DFG Q R
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC----------AQITPEQSKRSTMV 177
Query: 369 ----WMPPESILYGKFTTESDVWSYGVVLWE 395
WM PE + + + D+WS G++ E
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 208
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 63/267 (23%), Positives = 104/267 (38%), Gaps = 39/267 (14%)
Query: 38 NANQKTASDFRREVIE---TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN 94
A+ + SDF + +E + R + L EG F VY+ + G A+K L N
Sbjct: 9 GASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQ-DVGSG-REYALKRLLSNEE 66
Query: 95 QKTASDFRREVDLMSELR-HPNIVCLLGVCLSGEPM-------CMLFEFMVRGDLHEFLM 146
+K +EV M +L HPNIV G+ +L + +G L EFL
Sbjct: 67 EKNR-AIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK 125
Query: 147 SRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHH--YVHRDLAARNCLVGDGLT 204
R +S V I Q + ++ +HRDL N L+ + T
Sbjct: 126 KMESRGPLSCDTVL---------KIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT 176
Query: 205 VKISDFGLSRDVYASDYYRIQSKSLLPVR----------WMPPESI-LYGKF--TTESDV 251
+K+ DFG + + Y ++ V + PE I LY F + D+
Sbjct: 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDI 236
Query: 252 WSYGVVLWEVYSYGLQPYYGYSNQEVI 278
W+ G +L+ + + P+ + ++
Sbjct: 237 WALGCILYLL-CFRQHPFEDGAKLRIV 262
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 24/112 (21%), Positives = 45/112 (40%), Gaps = 16/112 (14%)
Query: 310 VAAGMAYLCSHH--YVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV 367
+ ++ +HRDL N L+ + T+K+ DFG + + Y ++ V
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 368 R----------WMPPESI-LYGKF--TTESDVWSYGVVLWEVYSYGLQPYYG 406
+ PE I LY F + D+W+ G +L+ + + P+
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL-CFRQHPFED 255
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 36/215 (16%)
Query: 59 LQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPNI 116
+ +LGEG +G+VYK + T+E VAIK ++ E+ + REV L+ EL+H NI
Sbjct: 39 ITKLGEGTYGEVYKAIDTVTNE---TVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNI 95
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
+ L V + ++FE+ DL + M ++P +S + Q+
Sbjct: 96 IELKSVIHHNHRLHLIFEYAEN-DLKK-YMDKNP-----------DVSMRVIKSFLYQLI 142
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLT-----VKISDFGLSRDVYASDYYRIQSKSLLP 231
G+ + S +HRDL +N L+ +KI DFGL+R + I +
Sbjct: 143 NGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR------AFGIPIRQFTH 196
Query: 232 V---RWM-PPESILYG--KFTTESDVWSYGVVLWE 260
W PPE IL G ++T D+WS + E
Sbjct: 197 EIITLWYRPPE-ILLGSRHYSTSVDIWSIACIWAE 230
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 8e-07
Identities = 28/94 (29%), Positives = 41/94 (43%), Gaps = 18/94 (19%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLT-----VKISDFGLSRDVYASDYYRIQSKSLLPV 367
G+ + S +HRDL +N L+ +KI DFGL+R + I +
Sbjct: 144 GVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR------AFGIPIRQFTHE 197
Query: 368 ---RWM-PPESILYG--KFTTESDVWSYGVVLWE 395
W PPE IL G ++T D+WS + E
Sbjct: 198 IITLWYRPPE-ILLGSRHYSTSVDIWSIACIWAE 230
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 51/253 (20%), Positives = 93/253 (36%), Gaps = 42/253 (16%)
Query: 23 TSEGPSLVAIKTLKENANQKTASDFRREVIETKPRFLQELGEGAFGKVYKGE-VCTSEGP 81
+ P + + K A +E +E++ + LG G FG VY G V +
Sbjct: 12 SGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-- 69
Query: 82 SLVAIK-----TLKENANQKTASDFRREVDLMSELRH--PNIVCLLGVCLSGEPMCMLFE 134
VAIK + + + EV L+ ++ ++ LL + ++ E
Sbjct: 70 -PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE 128
Query: 135 FMV-RGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLA 193
DL +F+ R L ++ QV + + + +HRD+
Sbjct: 129 RPEPVQDLFDFITERGA------------LQEELARSFFWQVLEAVRHCHNCGVLHRDIK 176
Query: 194 ARNCLV-GDGLTVKISDFGLSRDVYASDYYRIQSKSLL------PVRWMPPESILYGKFT 246
N L+ + +K+ DFG + ++ V + PPE I Y ++
Sbjct: 177 DENILIDLNRGELKLIDFGSG---------ALLKDTVYTDFDGTRV-YSPPEWIRYHRYH 226
Query: 247 -TESDVWSYGVVL 258
+ VWS G++L
Sbjct: 227 GRSAAVWSLGILL 239
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 21/92 (22%), Positives = 39/92 (42%), Gaps = 18/92 (19%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFGLSRDVYASDYYRIQSKSLL--- 365
V + + + +HRD+ N L+ + +K+ DFG + ++
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG---------ALLKDTVYTDF 208
Query: 366 ---PVRWMPPESILYGKFT-TESDVWSYGVVL 393
V + PPE I Y ++ + VWS G++L
Sbjct: 209 DGTRV-YSPPEWIRYHRYHGRSAAVWSLGILL 239
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 35/288 (12%), Positives = 65/288 (22%), Gaps = 55/288 (19%)
Query: 57 RFLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTL--KENANQKTASDFRREVDLMSELRH 113
+ ++ L G V+ +V E A+K ++ + L
Sbjct: 65 KLVEPLRVGDRSVVFLVRDVERLE---DFALKVFTMGAENSRSELERLHEATFAAARLLG 121
Query: 114 PNIVCLLG----------VCLSGEPM----------------CMLFEFMVRGDLHEFLMS 147
+ V + +P +L DL +
Sbjct: 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFST 180
Query: 148 RSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207
G + Q+ A L S VH N + + +
Sbjct: 181 LDFVYVFRG-----DEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLML 235
Query: 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK---FTTESDVWSYGVVLWEVYSY 264
D S + P L FT + W G+ ++ V+
Sbjct: 236 GDVSALW--KVGTRGPASSVPV----TYAPREFLNASTATFTHALNAWQLGLSIYRVWC- 288
Query: 265 GLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAA 312
P+ + R +P + L +P
Sbjct: 289 LFLPFGLVTPGIKGSWKRPSLRVPGTDS-------LAFGSCTPLPDFV 329
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 14/89 (15%), Positives = 23/89 (25%), Gaps = 9/89 (10%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+ A L S VH N + + + D S +
Sbjct: 203 LIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW--KVGTRGPASSVPV----T 256
Query: 370 MPPESILYGK---FTTESDVWSYGVVLWE 395
P L FT + W G+ ++
Sbjct: 257 YAPREFLNASTATFTHALNAWQLGLSIYR 285
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 54/255 (21%), Positives = 94/255 (36%), Gaps = 61/255 (23%)
Query: 57 RFLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTL-------KENANQKTASDFRREVDLM 108
+ LG GA G+V E T + VAIK + A + E++++
Sbjct: 13 IMSKTLGSGACGEVKLAFERKTCK---KVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 109 SELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDF 168
+L HP I+ + + E ++ E M G+L + ++ L +
Sbjct: 70 KKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNK------------RLKEATC 116
Query: 169 SHIALQVAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASD----- 220
Q+ + YL + +HRDL N L+ + +KI+DFG S+ + +
Sbjct: 117 KLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 176
Query: 221 ----YYRIQSKSLLPVRWMPPE---SILYGKFTTESDVWSYGVVLWEVYSY----GLQPY 269
Y + PE S+ + D WS GV+L + G P+
Sbjct: 177 CGTPTY------------LAPEVLVSVGTAGYNRAVDCWSLGVIL-----FICLSGYPPF 219
Query: 270 YGYSNQEVI-EMIRS 283
+ Q + + I S
Sbjct: 220 SEHRTQVSLKDQITS 234
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 27/125 (21%), Positives = 45/125 (36%), Gaps = 36/125 (28%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASD---------YY 357
+ + YL + +HRDL N L+ + +KI+DFG S+ + + Y
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 182
Query: 358 RIQSKSLLPVRWMPPE---SILYGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYSNQ 410
+ PE S+ + D WS GV+L + G P+ + Q
Sbjct: 183 ------------LAPEVLVSVGTAGYNRAVDCWSLGVIL-----FICLSGYPPFSEHRTQ 225
Query: 411 EEFLK 415
Sbjct: 226 VSLKD 230
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 52/224 (23%), Positives = 88/224 (39%), Gaps = 32/224 (14%)
Query: 48 RREVIETKPRFLQELGEGAFGKVYKGE-VCTSEGPSLVAIK-----TLKENANQKTASDF 101
RE E + R LG+G FG V+ G + VAIK + + +
Sbjct: 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRL---QVAIKVIPRNRVLGWSPLSDSVTC 81
Query: 102 RREVDLMSELR----HPNIVCLLGVCLSGEPMCMLFEFMVRG-DLHEFLMSRSPRSDISG 156
EV L+ ++ HP ++ LL + E ++ E + DL +++ + P
Sbjct: 82 PLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP------ 135
Query: 157 SQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFGLSRD 215
L + QV A + + S VHRD+ N L+ K+ DFG
Sbjct: 136 ------LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG-A 188
Query: 216 VYASDYYRIQSKSLLPVRWMPPESILYGKFT-TESDVWSYGVVL 258
+ + Y + + + PPE I ++ + VWS G++L
Sbjct: 189 LLHDEPYTDFDGTRV---YSPPEWISRHQYHALPATVWSLGILL 229
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 5e-10
Identities = 23/86 (26%), Positives = 38/86 (44%), Gaps = 6/86 (6%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR 368
V A + + S VHRD+ N L+ K+ DFG + + Y + +
Sbjct: 148 VVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTDFDGTRV--- 203
Query: 369 WMPPESILYGKFT-TESDVWSYGVVL 393
+ PPE I ++ + VWS G++L
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILL 229
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-26
Identities = 57/247 (23%), Positives = 101/247 (40%), Gaps = 50/247 (20%)
Query: 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDL 107
R+ + ELG GA VY+ + ++ A+K LK+ ++K R E+ +
Sbjct: 47 NRDALSDFFEVESELGRGATSIVYRCKQKGTQ--KPYALKVLKKTVDKK---IVRTEIGV 101
Query: 108 MSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQD 167
+ L HPNI+ L + + + ++ E + G+L + ++ + S++D
Sbjct: 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG------------YYSERD 149
Query: 168 FSHIALQVAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSR---------D 215
+ Q+ +AYL + VHRDL N L +KI+DFGLS+
Sbjct: 150 AADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT 209
Query: 216 VYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPYYG 271
V + Y PE + + E D+WS G++ Y G +P+Y
Sbjct: 210 VCGTPGY------------CAPEILRGCAYGPEVDMWSVGIIT-----YILLCGFEPFYD 252
Query: 272 YSNQEVI 278
+ +
Sbjct: 253 ERGDQFM 259
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 30/119 (25%), Positives = 45/119 (37%), Gaps = 33/119 (27%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSR---------DVYASDYY 357
+ +AYL + VHRDL N L +KI+DFGLS+ V + Y
Sbjct: 157 ILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGY 216
Query: 358 RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYSNQEE 412
PE + + E D+WS G++ Y G +P+Y +
Sbjct: 217 ------------CAPEILRGCAYGPEVDMWSVGIIT-----YILLCGFEPFYDERGDQF 258
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-26
Identities = 51/232 (21%), Positives = 92/232 (39%), Gaps = 41/232 (17%)
Query: 57 RFLQELGEGAFGKVYKGE-VCTSEGPSLVAIKTL-KENANQKTASDFR------REVDLM 108
+ LG GAFG V+ ++ V +K + KE + + E+ ++
Sbjct: 27 STMSPLGSGAFGFVWTAVDKEKNK---EVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 109 SELRHPNIVCLLGVCLSGEPMCMLFEFMVRG-DLHEFLMSRSPRSDISGSQVQAPLSQQD 167
S + H NI+ +L + + ++ E G DL F+ PR L +
Sbjct: 84 SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH-PR-----------LDEPL 131
Query: 168 FSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSK 227
S+I Q+ + + YL +HRD+ N ++ + T+K+ DFG + ++
Sbjct: 132 ASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA--------YLERG 183
Query: 228 SLLPV-----RWMPPESILYGKFTT--ESDVWSYGVVLWEVYSYGLQPYYGY 272
L + PE +L G E ++WS GV L+ + P+
Sbjct: 184 KLFYTFCGTIEYCAPE-VLMGNPYRGPELEMWSLGVTLY-TLVFEENPFCEL 233
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 26/120 (21%), Positives = 48/120 (40%), Gaps = 17/120 (14%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV-- 367
+ + + YL +HRD+ N ++ + T+K+ DFG + ++ L
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA--------YLERGKLFYTFC 190
Query: 368 ---RWMPPESILYGKFTT--ESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLKTPPSWIT 422
+ PE +L G E ++WS GV L+ + P+ E PP ++
Sbjct: 191 GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLY-TLVFEENPFCELEETVEAAIHPPYLVS 248
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 48/225 (21%)
Query: 59 LQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLK-ENANQ---KTASDFRREVDLMSELRH 113
L ++G+G FG+V+K T + VA+K + EN + TA RE+ ++ L+H
Sbjct: 22 LAKIGQGTFGEVFKARHRKTGQ---KVALKKVLMENEKEGFPITAL---REIKILQLLKH 75
Query: 114 PNIVCLLGVCLSGEPMC--------MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQ 165
N+V L+ +C + ++F+F DL L + + S+++
Sbjct: 76 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL--SNVLVKFTLSEIK----- 127
Query: 166 QDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQ 225
+ + G+ Y+ + +HRD+ A N L+ +K++DFGL+R + +
Sbjct: 128 ----RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR------AFSLA 177
Query: 226 SKSLLPV-------RWM-PPESILYG--KFTTESDVWSYGVVLWE 260
S W PPE +L G + D+W G ++ E
Sbjct: 178 KNSQPNRYTNRVVTLWYRPPE-LLLGERDYGPPIDLWGAGCIMAE 221
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 25/93 (26%), Positives = 42/93 (45%), Gaps = 17/93 (18%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV----- 367
G+ Y+ + +HRD+ A N L+ +K++DFGL+R + + S
Sbjct: 136 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR------AFSLAKNSQPNRYTNRV 189
Query: 368 --RWM-PPESILYG--KFTTESDVWSYGVVLWE 395
W PPE +L G + D+W G ++ E
Sbjct: 190 VTLWYRPPE-LLLGERDYGPPIDLWGAGCIMAE 221
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 54/324 (16%), Positives = 112/324 (34%), Gaps = 39/324 (12%)
Query: 5 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVIETKPRFLQELGE 64
+Q +G G FG V++ + + AIK ++ + REV + L +L
Sbjct: 11 IQCMGRGGFGVVFEAK-NKVDD-CNYAIKRIRLPNRELAREKVMREV-----KALAKLEH 63
Query: 65 GAFGKVY--------KGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
+ + + + L T ++ ++ M N
Sbjct: 64 PGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNT 123
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V L + + + + +L +++ R D HI +Q+A
Sbjct: 124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCL---------HIFIQIA 174
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR--- 233
+ +L S +HRDL N VK+ DFGL + + + +
Sbjct: 175 EAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234
Query: 234 -------WMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ 285
+M PE ++G ++ + D++S G++L+E+ Y +I +R+ +
Sbjct: 235 GQVGTKLYMSPE-QIHGNNYSHKVDIFSLGLILFELL-YSFST--QMERVRIITDVRNLK 290
Query: 286 MLPCPEDCPPRMYSLMMECWHEVP 309
P+ + ++ + P
Sbjct: 291 FPLLFTQKYPQEHMMVQDMLSPSP 314
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 8e-11
Identities = 22/94 (23%), Positives = 41/94 (43%), Gaps = 12/94 (12%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR---- 368
+ +L S +HRDL N VK+ DFGL + + + +
Sbjct: 176 AVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG 235
Query: 369 ------WMPPESILYGK-FTTESDVWSYGVVLWE 395
+M PE ++G ++ + D++S G++L+E
Sbjct: 236 QVGTKLYMSPE-QIHGNNYSHKVDIFSLGLILFE 268
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 56/259 (21%), Positives = 104/259 (40%), Gaps = 68/259 (26%)
Query: 57 RFLQELGEGAFGKVYKG-EVCTSEGPSLVAIKT-------LKENANQKTASDFRREVDLM 108
+G G V + T A+K L ++ RRE ++
Sbjct: 97 DPKDVIGRGVSSVVRRCVHRATGH---EFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 109 SELR-HPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQD 167
++ HP+I+ L+ S M ++F+ M +G+L ++L + + LS+++
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK-------VA-----LSEKE 201
Query: 168 FSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR---------DVYA 218
I + +++L +++ VHRDL N L+ D + +++SDFG S ++
Sbjct: 202 TRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCG 261
Query: 219 SDYYRIQSKSLLPVRWMPPESIL----------YGKFTTESDVWSYGVVLWEVYSY---- 264
+ Y + PE IL YGK E D+W+ GV+L +
Sbjct: 262 TPGY------------LAPE-ILKCSMDETHPGYGK---EVDLWACGVIL-----FTLLA 300
Query: 265 GLQPYYGYSNQEVIEMIRS 283
G P++ ++ MI
Sbjct: 301 GSPPFWHRRQILMLRMIME 319
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 30/127 (23%), Positives = 52/127 (40%), Gaps = 44/127 (34%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR---------DVYASDYYRIQ 360
+ +++L +++ VHRDL N L+ D + +++SDFG S ++ + Y
Sbjct: 209 LLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGY--- 265
Query: 361 SKSLLPVRWMPPESIL----------YGKFTTESDVWSYGVVLWEVYSY----GLQPYYG 406
+ PE IL YGK E D+W+ GV+L + G P++
Sbjct: 266 ---------LAPE-ILKCSMDETHPGYGK---EVDLWACGVIL-----FTLLAGSPPFWH 307
Query: 407 YSNQEEF 413
Sbjct: 308 RRQILML 314
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 52/226 (23%)
Query: 59 LQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASDFR----REVDLMSELR- 112
+ E+G GA+G VYK + + VA+K+++ REV L+ L
Sbjct: 14 VAEIGVGAYGTVYKARDPHSGH---FVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 113 --HPNIVCLLGVCLSGEPMC-----MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQ 165
HPN+V L+ VC + ++FE + + DL + ++P + ++
Sbjct: 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRT-YLDKAPPPGLPAETIK----- 123
Query: 166 QDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD----- 220
+ Q G+ +L ++ VHRDL N LV G TVK++DFGL+R +Y+
Sbjct: 124 ----DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALTP 178
Query: 221 -----YYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWE 260
+YR PE +L + T D+WS G + E
Sbjct: 179 VVVTLWYR------------APE-VLLQSTYATPVDMWSVGCIFAE 211
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 7e-08
Identities = 31/94 (32%), Positives = 45/94 (47%), Gaps = 25/94 (26%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD----------YYRIQSK 362
G+ +L ++ VHRDL N LV G TVK++DFGL+R +Y+ +YR
Sbjct: 132 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALTPVVVTLWYR---- 186
Query: 363 SLLPVRWMPPESILYG-KFTTESDVWSYGVVLWE 395
PE +L + T D+WS G + E
Sbjct: 187 --------APE-VLLQSTYATPVDMWSVGCIFAE 211
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 49/233 (21%), Positives = 95/233 (40%), Gaps = 40/233 (17%)
Query: 41 QKTASDFRREVIETKP----RFLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQ 95
++ + + +P L++LGEG++G VYK T + +VAIK + +
Sbjct: 12 RRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQ---IVAIKQVP---VE 65
Query: 96 KTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDIS 155
+ +E+ +M + P++V G + ++ E+ G + + ++ +
Sbjct: 66 SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNK---- 120
Query: 156 GSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRD 215
L++ + + I G+ YL +HRD+ A N L+ K++DFG++
Sbjct: 121 ------TLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAG- 173
Query: 216 VYASDYYRIQSKSLLPVR--------WMPPESILYGKFTTESDVWSYGVVLWE 260
Q + R WM PE I + +D+WS G+ E
Sbjct: 174 ---------QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIE 217
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 25/91 (27%), Positives = 38/91 (41%), Gaps = 18/91 (19%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR---- 368
G+ YL +HRD+ A N L+ K++DFG++ Q + R
Sbjct: 137 GLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAG----------QLTDTMAKRNTVI 186
Query: 369 ----WMPPESILYGKFTTESDVWSYGVVLWE 395
WM PE I + +D+WS G+ E
Sbjct: 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIE 217
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-24
Identities = 58/260 (22%), Positives = 103/260 (39%), Gaps = 69/260 (26%)
Query: 57 RFLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTL-KENANQKTASD-------FRREVDL 107
+ LG G V + T + A+K + +A + +EVD+
Sbjct: 20 EPKEILGRGVSSVVRRCIHKPTCK---EYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 108 MSEL-RHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQ 166
+ ++ HPNI+ L + ++F+ M +G+L ++L + + LS++
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-------VT-----LSEK 124
Query: 167 DFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR---------DVY 217
+ I + + L + VHRDL N L+ D + +K++DFG S +V
Sbjct: 125 ETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC 184
Query: 218 ASDYYRIQSKSLLPVRWMPPESIL----------YGKFTTESDVWSYGVVLWEVYSY--- 264
+ Y + PE I+ YGK E D+WS GV++ Y
Sbjct: 185 GTPSY------------LAPE-IIECSMNDNHPGYGK---EVDMWSTGVIM-----YTLL 223
Query: 265 -GLQPYYGYSNQEVIEMIRS 283
G P++ ++ MI S
Sbjct: 224 AGSPPFWHRKQMLMLRMIMS 243
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 31/127 (24%), Positives = 48/127 (37%), Gaps = 44/127 (34%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR---------DVYASDYYRIQ 360
+ + L + VHRDL N L+ D + +K++DFG S +V + Y
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSY--- 189
Query: 361 SKSLLPVRWMPPESIL----------YGKFTTESDVWSYGVVLWEVYSY----GLQPYYG 406
+ PE I+ YGK E D+WS GV++ Y G P++
Sbjct: 190 ---------LAPE-IIECSMNDNHPGYGK---EVDMWSTGVIM-----YTLLAGSPPFWH 231
Query: 407 YSNQEEF 413
Sbjct: 232 RKQMLML 238
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 46/222 (20%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELR---HP 114
+ E+GEGA+GKV+K + G VA+K ++ + + REV ++ L HP
Sbjct: 16 VAEIGEGAYGKVFKARDLKNGG-RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 74
Query: 115 NIVCLLGVCLSGEP-----MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFS 169
N+V L VC + ++FE + + DL + + P + ++
Sbjct: 75 NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTT-YLDKVPEPGVPTETIK--------- 123
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD--------- 220
+ Q+ G+ +L SH VHRDL +N LV +K++DFGL+R +Y+
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALTSVVVT 182
Query: 221 -YYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWE 260
+YR PE +L + T D+WS G + E
Sbjct: 183 LWYR------------APE-VLLQSSYATPVDLWSVGCIFAE 211
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 30/94 (31%), Positives = 44/94 (46%), Gaps = 25/94 (26%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD----------YYRIQSK 362
G+ +L SH VHRDL +N LV +K++DFGL+R +Y+ +YR
Sbjct: 132 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALTSVVVTLWYR---- 186
Query: 363 SLLPVRWMPPESILYG-KFTTESDVWSYGVVLWE 395
PE +L + T D+WS G + E
Sbjct: 187 --------APE-VLLQSSYATPVDLWSVGCIFAE 211
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 53/211 (25%), Positives = 86/211 (40%), Gaps = 31/211 (14%)
Query: 57 RFLQELGEGAFGKVYKGE-VCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPN 115
+Q LGEGA+G+V T E VA+K + + ++E+ + L H N
Sbjct: 10 DLVQTLGEGAYGEVQLAVNRVTEE---AVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 116 IVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQV 175
+V G G + E+ G+L + + + + D Q+
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG------------MPEPDAQRFFHQL 114
Query: 176 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW- 234
AG+ YL HRD+ N L+ + +KISDFGL+ +R ++ L +
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT------VFRYNNRERLLNKMC 168
Query: 235 -----MPPESILYGK--FTTESDVWSYGVVL 258
+ PE +L + DVWS G+VL
Sbjct: 169 GTLPYVAPE-LLKRREFHAEPVDVWSCGIVL 198
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 8e-08
Identities = 28/90 (31%), Positives = 42/90 (46%), Gaps = 15/90 (16%)
Query: 312 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW-- 369
AG+ YL HRD+ N L+ + +KISDFGL+ +R ++ L +
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT------VFRYNNRERLLNKMCG 169
Query: 370 ----MPPESILYGK--FTTESDVWSYGVVL 393
+ PE +L + DVWS G+VL
Sbjct: 170 TLPYVAPE-LLKRREFHAEPVDVWSCGIVL 198
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 52/254 (20%), Positives = 102/254 (40%), Gaps = 68/254 (26%)
Query: 57 RFLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHP 114
+++G G++ + T+ A+K + K+ D E++++ +HP
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNM---EFAVKIID-----KSKRDPTEEIEILLRYGQHP 76
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
NI+ L V G+ + ++ E M G+L + ++ + S+++ S +
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF------------FSEREASAVLFT 124
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLV----GDGLTVKISDFGLSRDVYASD---------- 220
+ + YL + VHRDL N L G+ +++I DFG ++ + A +
Sbjct: 125 ITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTA 184
Query: 221 YYRIQSKSLLPVRWMPPESIL----YGKFTTESDVWSYGVVLWEVYSY----GLQPYYGY 272
+ + PE +L Y D+WS GV+L Y G P+
Sbjct: 185 NF------------VAPE-VLERQGYDA---ACDIWSLGVLL-----YTMLTGYTPFANG 223
Query: 273 ---SNQEVIEMIRS 283
+ +E++ I S
Sbjct: 224 PDDTPEEILARIGS 237
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 8e-08
Identities = 25/102 (24%), Positives = 41/102 (40%), Gaps = 34/102 (33%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV----GDGLTVKISDFGLSRDVYASD---------- 355
+ + YL + VHRDL N L G+ +++I DFG ++ + A +
Sbjct: 125 ITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTA 184
Query: 356 YYRIQSKSLLPVRWMPPESIL----YGKFTTESDVWSYGVVL 393
+ + PE +L Y D+WS GV+L
Sbjct: 185 NF------------VAPE-VLERQGYDA---ACDIWSLGVLL 210
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 52/248 (20%), Positives = 104/248 (41%), Gaps = 36/248 (14%)
Query: 59 LQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASDFRREVD-LMSELRHPNI 116
L E+G G G+V+K T ++A+K ++ + N++ ++D ++ P I
Sbjct: 30 LGEMGSGTCGQVWKMRFRKTGH---VIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V G ++ + + E M ++ ++Q P+ ++ + + +
Sbjct: 87 VQCFGTFITNTDVFIAMELMGTC------------AEKLKKRMQGPIPERILGKMTVAIV 134
Query: 177 AGMAYL-CSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM 235
+ YL H +HRD+ N L+ + +K+ DFG+S + + + +S +M
Sbjct: 135 KALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD---KAKDRSAGCAAYM 191
Query: 236 PPESILY-----GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ-EVIEMIRSRQMLPC 289
PE I + +DVWS G+ L E+ + G PY EV+ +
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELAT-GQFPYKNCKTDFEVLTKV-------- 242
Query: 290 PEDCPPRM 297
++ PP +
Sbjct: 243 LQEEPPLL 250
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 6e-08
Identities = 32/118 (27%), Positives = 51/118 (43%), Gaps = 15/118 (12%)
Query: 313 GMAYL-CSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 371
+ YL H +HRD+ N L+ + +K+ DFG+S + + + +S +M
Sbjct: 136 ALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD---KAKDRSAGCAAYMA 192
Query: 372 PESILY-----GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFL-----KTPPS 419
PE I + +DVWS G+ L E+ + G PY E L + PP
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELAT-GQFPYKNCKTDFEVLTKVLQEEPPL 249
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 53/211 (25%), Positives = 86/211 (40%), Gaps = 31/211 (14%)
Query: 57 RFLQELGEGAFGKVYKGE-VCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPN 115
+Q LGEGA+G+V T E VA+K + + ++E+ + L H N
Sbjct: 10 DLVQTLGEGAYGEVQLAVNRVTEE---AVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 116 IVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQV 175
+V G G + E+ G+L + + + + D Q+
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG------------MPEPDAQRFFHQL 114
Query: 176 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW- 234
AG+ YL HRD+ N L+ + +KISDFGL+ +R ++ L +
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT------VFRYNNRERLLNKMC 168
Query: 235 -----MPPESILYGKF--TTESDVWSYGVVL 258
+ PE +L + DVWS G+VL
Sbjct: 169 GTLPYVAPE-LLKRREFHAEPVDVWSCGIVL 198
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 28/90 (31%), Positives = 42/90 (46%), Gaps = 15/90 (16%)
Query: 312 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW-- 369
AG+ YL HRD+ N L+ + +KISDFGL+ +R ++ L +
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT------VFRYNNRERLLNKMCG 169
Query: 370 ----MPPESILYGKF--TTESDVWSYGVVL 393
+ PE +L + DVWS G+VL
Sbjct: 170 TLPYVAPE-LLKRREFHAEPVDVWSCGIVL 198
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 37/213 (17%)
Query: 59 LQELGEGAFGKVYKG-EVCTSEGPSLVAIKT--LKENANQKTASDFRREVDLMSELRHPN 115
L+E+G G+FG VY +V SE +VAIK + + D +EV + +LRHPN
Sbjct: 59 LREIGHGSFGAVYFARDVRNSE---VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 116 IVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQV 175
+ G L ++ E+ + L+ + PL + + + +
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKK----------PLQEVEIAAVTHGA 163
Query: 176 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS-----RDVYASDYYRIQSKSLL 230
G+AYL SH+ +HRD+ A N L+ + VK+ DFG + + + Y
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPY-------- 215
Query: 231 PVRWMPPESILYGK---FTTESDVWSYGVVLWE 260
WM PE IL + + DVWS G+ E
Sbjct: 216 ---WMAPEVILAMDEGQYDGKVDVWSLGITCIE 245
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 30/91 (32%), Positives = 43/91 (47%), Gaps = 19/91 (20%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS-----RDVYASDYYRIQSKSLLPV 367
G+AYL SH+ +HRD+ A N L+ + VK+ DFG + + + Y
Sbjct: 166 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPY---------- 215
Query: 368 RWMPPESILYGK---FTTESDVWSYGVVLWE 395
WM PE IL + + DVWS G+ E
Sbjct: 216 -WMAPEVILAMDEGQYDGKVDVWSLGITCIE 245
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-23
Identities = 67/254 (26%), Positives = 107/254 (42%), Gaps = 38/254 (14%)
Query: 62 LGEGAFGKVYKGE-VCTSEGPSLVAIKTLKENANQKTASDF---RREVDLMSELRHPNIV 117
LGEG++GKV + T A+K LK+ ++ + ++E+ L+ LRH N++
Sbjct: 13 LGEGSYGKVKEVLDSETLC---RRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVI 69
Query: 118 CLLGVCLSGEP--MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQV 175
L+ V + E M M+ E+ + E L S + Q+
Sbjct: 70 QLVDVLYNEEKQKMYMVMEY-CVCGMQEML----------DSVPEKRFPVCQAHGYFCQL 118
Query: 176 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL----- 230
G+ YL S VH+D+ N L+ G T+KIS G++ + +
Sbjct: 119 IDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA-----EALHPFAADDTCRTSQG 173
Query: 231 -PVRWMPPESILYGKFT---TESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286
P + PPE I G T + D+WS GV L+ + GL P+ G + ++ E I
Sbjct: 174 SPA-FQPPE-IANGLDTFSGFKVDIWSAGVTLY-NITTGLYPFEGDNIYKLFENIGKGS- 229
Query: 287 LPCPEDCPPRMYSL 300
P DC P + L
Sbjct: 230 YAIPGDCGPPLSDL 243
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 28/92 (30%), Positives = 41/92 (44%), Gaps = 16/92 (17%)
Query: 312 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL------ 365
G+ YL S VH+D+ N L+ G T+KIS G++ + +
Sbjct: 120 DGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA-----EALHPFAADDTCRTSQGS 174
Query: 366 PVRWMPPESILYGKFT---TESDVWSYGVVLW 394
P + PPE I G T + D+WS GV L+
Sbjct: 175 PA-FQPPE-IANGLDTFSGFKVDIWSAGVTLY 204
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-23
Identities = 53/249 (21%), Positives = 100/249 (40%), Gaps = 24/249 (9%)
Query: 59 LQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASDFRREVD-LMSELRHPNI 116
L E+G GA+G V K + + ++A+K ++ ++K ++D +M P I
Sbjct: 27 LGEIGRGAYGSVNKMVHKPSGQ---IMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V G + E M +F S + + ++ I L
Sbjct: 84 VQFYGALFREGDCWICMELM-STSFDKFY-------KYVYSVLDDVIPEEILGKITLATV 135
Query: 177 AGMAYLCS-HHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM 235
+ +L +HRD+ N L+ +K+ DFG+S + S +++ +M
Sbjct: 136 KALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS---IAKTRDAGCRPYM 192
Query: 236 PPESI----LYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ-EVIEMIRSRQMLPCP 290
PE I + SDVWS G+ L+E+ + G PY +++ + + + + P
Sbjct: 193 APERIDPSASRQGYDVRSDVWSLGITLYELAT-GRFPYPKWNSVFDQLTQV-VKGDPPQL 250
Query: 291 EDCPPRMYS 299
+ R +S
Sbjct: 251 SNSEEREFS 259
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 6e-07
Identities = 37/179 (20%), Positives = 69/179 (38%), Gaps = 32/179 (17%)
Query: 242 YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRM-YSL 300
YG E D W + + S + + + S PE+ ++ +
Sbjct: 87 YGALFREGDCW---ICM---------ELMSTSFDKFYKYVYSVLDDVIPEEILGKITLAT 134
Query: 301 MMECWHEVPVAAGMAYLCS-HHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRI 359
+ + +L +HRD+ N L+ +K+ DFG+S + S
Sbjct: 135 VK----------ALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS---IA 181
Query: 360 QSKSLLPVRWMPPESI----LYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFL 414
+++ +M PE I + SDVWS G+ L+E+ + G PY +++ + L
Sbjct: 182 KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELAT-GRFPYPKWNSVFDQL 239
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-23
Identities = 50/249 (20%), Positives = 96/249 (38%), Gaps = 32/249 (12%)
Query: 57 RFLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASDFRREVD-LMSELRHP 114
+ ELG GA+G V K V + + ++A+K ++ N + ++D M + P
Sbjct: 10 EPIMELGRGAYGVVEKMRHVPSGQ---IMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
V G + + E M L +F + + + IA+
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDK--------GQTIPEDILGKIAVS 117
Query: 175 VAAGMAYLCS-HHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR 233
+ + +L S +HRD+ N L+ VK+ DFG+S + +
Sbjct: 118 IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDAGCKP 174
Query: 234 WMPPESIL----YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ-EVIEMIRSRQMLP 288
+M PE I ++ +SD+WS G+ + E+ PY + + ++ +
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAI-LRFPYDSWGTPFQQLKQV------- 226
Query: 289 CPEDCPPRM 297
E+ P++
Sbjct: 227 -VEEPSPQL 234
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 26/107 (24%), Positives = 45/107 (42%), Gaps = 9/107 (8%)
Query: 313 GMAYLCS-HHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 371
+ +L S +HRD+ N L+ VK+ DFG+S + + +M
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDAGCKPYMA 177
Query: 372 PESIL----YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFL 414
PE I ++ +SD+WS G+ + E+ PY + + L
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIELAI-LRFPYDSWGTPFQQL 223
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 52/230 (22%), Positives = 98/230 (42%), Gaps = 50/230 (21%)
Query: 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMS 109
E E + +G G+FG V++ ++ S+ VAIK + ++ K RE+ +M
Sbjct: 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESD---EVAIKKVLQDKRFKN-----RELQIMR 87
Query: 110 ELRHPNIVCLLGVCLSGEPMC------MLFEFMVRGDLHEFLMSRS-PRSDISGSQVQAP 162
++HPN+V L S ++ E++ ++ + + + ++
Sbjct: 88 IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKL- 145
Query: 163 LSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFGLSRDV----- 216
+ + Q+ +AY+ S HRD+ +N L+ +K+ DFG ++ +
Sbjct: 146 -----YMY---QLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP 197
Query: 217 ---Y-ASDYYRIQSKSLLPVRWMPPESILYG--KFTTESDVWSYGVVLWE 260
Y S YYR PE +++G +TT D+WS G V+ E
Sbjct: 198 NVSYICSRYYR------------APE-LIFGATNYTTNIDIWSTGCVMAE 234
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 6e-07
Identities = 28/95 (29%), Positives = 44/95 (46%), Gaps = 25/95 (26%)
Query: 313 GMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFGLSRDV--------Y-ASDYYRIQSK 362
+AY+ S HRD+ +N L+ +K+ DFG ++ + Y S YYR
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR---- 208
Query: 363 SLLPVRWMPPESILYG--KFTTESDVWSYGVVLWE 395
PE +++G +TT D+WS G V+ E
Sbjct: 209 --------APE-LIFGATNYTTNIDIWSTGCVMAE 234
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 4e-23
Identities = 53/237 (22%), Positives = 94/237 (39%), Gaps = 52/237 (21%)
Query: 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTL-KENANQKTASDFR-------- 102
+++ + + G++G V G VAIK + ++ +T +
Sbjct: 20 MQSPYTVQRFISSGSYGAVCAGVDSEGI---PVAIKRVFNTVSDGRTVNILSDSFLCKRV 76
Query: 103 -REVDLMSELRHPNIVCLLGVCLSGEPMC-----MLFEFMVRGDLHEFLMSRSPRSDISG 156
RE+ L++ HPNI+ L + + E ++ E M R DL + + +
Sbjct: 77 LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQ-------- 127
Query: 157 SQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV 216
+ +S Q + + G+ L VHRDL N L+ D + I DF L+R+
Sbjct: 128 ---RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARED 184
Query: 217 YASD---------YYRIQSKSLLPVRWMPPESIL-YGKFTTESDVWSYGVVLWEVYS 263
A +YR PE ++ + FT D+WS G V+ E+++
Sbjct: 185 TADANKTHYVTHRWYR------------APELVMQFKGFTKLVDMWSAGCVMAEMFN 229
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 28/96 (29%), Positives = 42/96 (43%), Gaps = 22/96 (22%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD---------YYRIQSKS 363
G+ L VHRDL N L+ D + I DF L+R+ A +YR
Sbjct: 146 GLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYR----- 200
Query: 364 LLPVRWMPPESIL-YGKFTTESDVWSYGVVLWEVYS 398
PE ++ + FT D+WS G V+ E+++
Sbjct: 201 -------APELVMQFKGFTKLVDMWSAGCVMAEMFN 229
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 6e-23
Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 52/216 (24%)
Query: 62 LGEGAFGKVYKGE-VCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVC 118
LG G FGKV GE T VA+K L + +RE+ + RHP+I+
Sbjct: 19 LGVGTFGKVKIGEHQLTGH---KVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
L V + M+ E++ G+L +++ + + + + Q+ +
Sbjct: 76 LYQVISTPTDFFMVMEYVSGGELFDYICKHGR------------VEEMEARRLFQQILSA 123
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV--------------YASDYYRI 224
+ Y H VHRDL N L+ + KI+DFGLS + YA+
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAA----- 178
Query: 225 QSKSLLPVRWMPPESILYGKF--TTESDVWSYGVVL 258
PE ++ G+ E D+WS GV+L
Sbjct: 179 ------------PE-VISGRLYAGPEVDIWSCGVIL 201
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 9e-08
Identities = 28/98 (28%), Positives = 40/98 (40%), Gaps = 34/98 (34%)
Query: 312 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV--------------YASDYY 357
+ + Y H VHRDL N L+ + KI+DFGLS + YA+
Sbjct: 122 SAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAA--- 178
Query: 358 RIQSKSLLPVRWMPPESILYGKF--TTESDVWSYGVVL 393
PE ++ G+ E D+WS GV+L
Sbjct: 179 --------------PE-VISGRLYAGPEVDIWSCGVIL 201
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 7e-23
Identities = 52/219 (23%), Positives = 98/219 (44%), Gaps = 38/219 (17%)
Query: 59 LQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNI 116
++ +G G +G+VYKG V T + L AIK + + + ++E++++ + H NI
Sbjct: 29 VELVGNGTYGQVYKGRHVKTGQ---LAAIKVM--DVTGDEEEEIKQEINMLKKYSHHRNI 83
Query: 117 VCLLGVCLSGEP--------MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDF 168
G + P + M EF G + +D+ + L ++
Sbjct: 84 ATYYGAFIKKNPPGMDDQLWLVM--EFCGAGSV----------TDLIKNTKGNTLKEEWI 131
Query: 169 SHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKS 228
++I ++ G+++L H +HRD+ +N L+ + VK+ DFG+S + + R +
Sbjct: 132 AYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR---NT 188
Query: 229 LL--PVRWMPPESILYGKFTTES-----DVWSYGVVLWE 260
+ P WM PE I + + D+WS G+ E
Sbjct: 189 FIGTP-YWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 7e-08
Identities = 26/90 (28%), Positives = 44/90 (48%), Gaps = 11/90 (12%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL--PVRWM 370
G+++L H +HRD+ +N L+ + VK+ DFG+S + + R + + P WM
Sbjct: 141 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR---NTFIGTP-YWM 196
Query: 371 PPESILYGKFTTES-----DVWSYGVVLWE 395
PE I + + D+WS G+ E
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIE 226
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 9e-23
Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHP 114
+ + +LG G VY E T VAIK + ++T F REV S+L H
Sbjct: 14 KIVDKLGGGGMSTVYLAE-DTILN-IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQ 71
Query: 115 NIVCLLGVCLSGEPMCMLFEFM--VRG-DLHEFLMSRSPRSDISGSQVQAPLSQQDFSHI 171
NIV ++ V E + M + G L E++ S PLS +
Sbjct: 72 NIVSMIDV---DEEDDCYYLVMEYIEGPTLSEYIESH------------GPLSVDTAINF 116
Query: 172 ALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL- 230
Q+ G+ + VHRD+ +N L+ T+KI DFG+++ + S+ Q+ +L
Sbjct: 117 TNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLG 174
Query: 231 PVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG 271
V++ PE +D++S G+VL+E+ G P+ G
Sbjct: 175 TVQYFSPEQAKGEATDECTDIYSIGIVLYEMLV-GEPPFNG 214
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 2e-09
Identities = 32/129 (24%), Positives = 56/129 (43%), Gaps = 15/129 (11%)
Query: 279 EMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGL 338
E I S L + + G+ + VHRD+ +N L+
Sbjct: 100 EYIESHGPLS-----VDTAINFT------NQILDGIKHAHDMRIVHRDIKPQNILIDSNK 148
Query: 339 TVKISDFGLSRDVYASDYYRIQSKSLL-PVRWMPPESILYGKFTTESDVWSYGVVLWEVY 397
T+KI DFG+++ + S+ Q+ +L V++ PE +D++S G+VL+E+
Sbjct: 149 TLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEML 206
Query: 398 SYGLQPYYG 406
G P+ G
Sbjct: 207 V-GEPPFNG 214
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 9e-23
Identities = 60/231 (25%), Positives = 95/231 (41%), Gaps = 55/231 (23%)
Query: 52 IETKPRFLQELGEGAFGKVYKGEVC-TSEGPSLVAIKTLKENANQKTASDFR---REVDL 107
E + +G G+FG VY+ ++C + E LVAIK K D R RE+ +
Sbjct: 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGE---LVAIK--------KVLQDKRFKNRELQI 100
Query: 108 MSELRHPNIVCLLGVCLSGEP------MCMLFEFMVRGDLHEFLMSRSPRS-DISGSQVQ 160
M +L H NIV L S + ++ +++ ++ S + V+
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVK 159
Query: 161 APLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFGLSRDV--- 216
+ + Q+ +AY+ S HRD+ +N L+ D +K+ DFG ++ +
Sbjct: 160 L------YMY---QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210
Query: 217 -----Y-ASDYYRIQSKSLLPVRWMPPESIL-YGKFTTESDVWSYGVVLWE 260
Y S YYR PE I +T+ DVWS G VL E
Sbjct: 211 EPNVSYICSRYYR------------APELIFGATDYTSSIDVWSAGCVLAE 249
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 30/94 (31%), Positives = 42/94 (44%), Gaps = 23/94 (24%)
Query: 313 GMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFGLSRDV--------Y-ASDYYRIQSK 362
+AY+ S HRD+ +N L+ D +K+ DFG ++ + Y S YYR
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR---- 223
Query: 363 SLLPVRWMPPESIL-YGKFTTESDVWSYGVVLWE 395
PE I +T+ DVWS G VL E
Sbjct: 224 --------APELIFGATDYTSSIDVWSAGCVLAE 249
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 55/246 (22%), Positives = 97/246 (39%), Gaps = 57/246 (23%)
Query: 60 QELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIV 117
Q LG G GKV + T + A+K L + R+EVD + P+IV
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQ---KCALKLLY------DSPKARQEVDHHWQASGGPHIV 85
Query: 118 CLLGVC----LSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
C+L V + ++ E M G+L + R ++ ++++ + I
Sbjct: 86 CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA----------FTEREAAEIMR 135
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSR--------DVYASDYY 222
+ + +L SH+ HRD+ N L +K++DFG ++ + YY
Sbjct: 136 DIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYY 195
Query: 223 RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYSNQEVI 278
+ PE + K+ D+WS GV++ Y G P+Y + Q +
Sbjct: 196 ------------VAPEVLGPEKYDKSCDMWSLGVIM-----YILLCGFPPFYSNTGQAIS 238
Query: 279 EMIRSR 284
++ R
Sbjct: 239 PGMKRR 244
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 27/119 (22%), Positives = 46/119 (38%), Gaps = 32/119 (26%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSR--------DVYASDYYR 358
+ + +L SH+ HRD+ N L +K++DFG ++ + YY
Sbjct: 137 IGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYY- 195
Query: 359 IQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYSNQEEF 413
+ PE + K+ D+WS GV++ Y G P+Y + Q
Sbjct: 196 -----------VAPEVLGPEKYDKSCDMWSLGVIM-----YILLCGFPPFYSNTGQAIS 238
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 59/216 (27%), Positives = 90/216 (41%), Gaps = 53/216 (24%)
Query: 62 LGEGAFGKVYKGE-VCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHPNIVC 118
LGEG+FGKV T + VA+K + RE+ + LRHP+I+
Sbjct: 17 LGEGSFGKVKLATHYKTQQ---KVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
L V + + M+ E+ G+L ++++ + +++ + Q+
Sbjct: 74 LYDVITTPTDIVMVIEY-AGGELFDYIVEKKR------------MTEDEGRRFFQQIICA 120
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV--------------YASDYYRI 224
+ Y H VHRDL N L+ D L VKI+DFGLS + YA+
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAA----- 175
Query: 225 QSKSLLPVRWMPPESILYGKF--TTESDVWSYGVVL 258
PE ++ GK E DVWS G+VL
Sbjct: 176 ------------PE-VINGKLYAGPEVDVWSCGIVL 198
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 33/98 (33%), Positives = 41/98 (41%), Gaps = 34/98 (34%)
Query: 312 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV--------------YASDYY 357
+ Y H VHRDL N L+ D L VKI+DFGLS + YA+
Sbjct: 119 CAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAA--- 175
Query: 358 RIQSKSLLPVRWMPPESILYGKF--TTESDVWSYGVVL 393
PE ++ GK E DVWS G+VL
Sbjct: 176 --------------PE-VINGKLYAGPEVDVWSCGIVL 198
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-22
Identities = 55/239 (23%), Positives = 96/239 (40%), Gaps = 61/239 (25%)
Query: 57 RFLQELGEGAFGKVYKGE-VCTSEGPSLVAIKTL-KENANQKTASDF------------- 101
E+G+G++G V + A+K L K+ ++
Sbjct: 16 TLKDEIGKGSYGVVKLAYNENDNT---YYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 102 -----------RREVDLMSELRHPNIVCLLGV--CLSGEPMCMLFEFMVRGDLHEFLMSR 148
+E+ ++ +L HPN+V L+ V + + + M+FE + +G +
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV--M---- 126
Query: 149 SPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208
++ + PLS+ + G+ YL +HRD+ N LVG+ +KI+
Sbjct: 127 ----EVPTLK---PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIA 179
Query: 209 DFGLSRDVYASDYYRIQSKSLL------PVRWMPPESILYGKFT---TESDVWSYGVVL 258
DFG+S + SD +LL P +M PES+ + DVW+ GV L
Sbjct: 180 DFGVSNEFKGSD-------ALLSNTVGTPA-FMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 31/90 (34%), Positives = 44/90 (48%), Gaps = 17/90 (18%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL------P 366
G+ YL +HRD+ N LVG+ +KI+DFG+S + SD +LL P
Sbjct: 149 GIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD-------ALLSNTVGTP 201
Query: 367 VRWMPPESILYGKFT---TESDVWSYGVVL 393
+M PES+ + DVW+ GV L
Sbjct: 202 A-FMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 9e-22
Identities = 48/222 (21%), Positives = 89/222 (40%), Gaps = 22/222 (9%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHP 114
+ LG G +V+ + VA+K L+ + + FRRE + L HP
Sbjct: 15 ELGEILGFGGMSEVHLAR-DLRDH-RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 115 NIVCLLGV-CLSGEPMCMLFEFM--VRG-DLHEFLMSRSPRSDISGSQVQAPLSQQDFSH 170
IV + + + M V G L + + + P++ +
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE------------GPMTPKRAIE 120
Query: 171 IALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL 230
+ + + + +HRD+ N ++ VK+ DFG++R + S Q+ +++
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 231 -PVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG 271
+++ PE SDV+S G VL+EV + G P+ G
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPFTG 221
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 7e-10
Identities = 26/99 (26%), Positives = 48/99 (48%), Gaps = 2/99 (2%)
Query: 309 PVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL-PV 367
+ + + +HRD+ N ++ VK+ DFG++R + S Q+ +++
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 368 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG 406
+++ PE SDV+S G VL+EV + G P+ G
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPFTG 221
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 1e-21
Identities = 56/297 (18%), Positives = 98/297 (32%), Gaps = 63/297 (21%)
Query: 18 KGEVCTSEGPSLVAIKTLKENANQKTASDFRREVIETKPRFLQELGEGAFGKVYKGEVCT 77
+ V S+ + I + +G G++G V +
Sbjct: 17 QHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEA-YDK 75
Query: 78 SEGPSLVAIKTLKENANQKTASDFR---------REVDLMSELRHPNIVCLLGVCLSGEP 128
E +VAIK K F RE+ +++ L H ++V +L + + +
Sbjct: 76 LEK-RVVAIK--------KILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126
Query: 129 MC-----MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLC 183
++ E D + + L++ + + G+ Y+
Sbjct: 127 EKFDELYVVLEIA-DSDFKKLFRT------------PVYLTELHIKTLLYNLLVGVKYVH 173
Query: 184 SHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV----------- 232
S +HRDL NCLV +VK+ DFGL+R V + Q
Sbjct: 174 SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHT 233
Query: 233 -------------RWM-PPESIL-YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN 274
RW PE IL +T DVWS G + E+ + + +++
Sbjct: 234 KNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 8e-07
Identities = 33/123 (26%), Positives = 48/123 (39%), Gaps = 26/123 (21%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV----- 367
G+ Y+ S +HRDL NCLV +VK+ DFGL+R V + Q
Sbjct: 168 GVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 368 -------------------RWM-PPESIL-YGKFTTESDVWSYGVVLWEVYSYGLQPYYG 406
RW PE IL +T DVWS G + E+ + +
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287
Query: 407 YSN 409
+++
Sbjct: 288 HAD 290
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 1e-21
Identities = 37/227 (16%), Positives = 78/227 (34%), Gaps = 31/227 (13%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
+ G G +Y + V +K L + + + + E ++E+ HP+I
Sbjct: 83 EVKGCIAHGGLGWIYLAL-DRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSI 141
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V + + ++V E++ +S + L + L++
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVM----EYVGGQSLKRSKGQ-----KLPVAEAIAYLLEIL 192
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR------DVYASDYYRIQSKSLL 230
++YL S V+ DL N ++ + +K+ D G +Y + +
Sbjct: 193 PALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLYGTPGF-------- 243
Query: 231 PVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEV 277
PE I+ T +D+++ G L + L G +
Sbjct: 244 ----QAPE-IVRTGPTVATDIYTVGRTLAALTL-DLPTRNGRYVDGL 284
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 8e-09
Identities = 20/104 (19%), Positives = 38/104 (36%), Gaps = 21/104 (20%)
Query: 309 PVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR------DVYASDYYRIQSK 362
+ ++YL S V+ DL N ++ + +K+ D G +Y + +
Sbjct: 190 EILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLYGTPGF----- 243
Query: 363 SLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG 406
PE I+ T +D+++ G L + L G
Sbjct: 244 -------QAPE-IVRTGPTVATDIYTVGRTLAALTL-DLPTRNG 278
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 42/300 (14%), Positives = 80/300 (26%), Gaps = 59/300 (19%)
Query: 8 LGEGAFGKVYKGE-VCTSEGPSLVAIKTL--KENANQKTASDFRREVIETKPRFLQELGE 64
LG+ + T E + E + EV+
Sbjct: 86 LGQEDPYAYLEATDQETGE---SFEVHVPYFTERPPSNAIKQMKEEVL------------ 130
Query: 65 GAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCL 124
++ L+ NQK A R + ++ P ++ V L
Sbjct: 131 --------------------RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRL 170
Query: 125 SGEPMCMLFEFMV----RGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMA 180
M +L F + + +L F S L + LQV +A
Sbjct: 171 DERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK-----SLVHHARLQLTLQVIRLLA 225
Query: 181 YLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESI 240
L + VH L + ++ V ++ F + + P +
Sbjct: 226 SLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD-GASAVSPIGRGFAPPETTAERML 284
Query: 241 LY-----GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPP 295
+ T D W+ G+ ++ ++ P + E I ++ P
Sbjct: 285 PFGQHHPTLMTFAFDTWTLGLAIYWIWC-ADLPNTDDAALGGSEWI-----FRSCKNIPQ 338
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 29/239 (12%), Positives = 62/239 (25%), Gaps = 40/239 (16%)
Query: 178 GMA--YLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYR--IQSKSLLPVR 233
+ V + F A + + LL
Sbjct: 90 DPYAYLEATDQETGESFE-----------VHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 234 WMPPESILYGKFTTESD------------VWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281
++ ++ +F D V +W + + L P + Q E++
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 282 RSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 341
S R+ L ++ V +A L + VH L + ++ V
Sbjct: 199 LSHSSTHKSLVHHARLQ-LTLQ------VIRLLASLHHYGLVHTYLRPVDIVLDQRGGVF 251
Query: 342 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-----GKFTTESDVWSYGVVLWE 395
++ F + + P + + T D W+ G+ ++
Sbjct: 252 LTGFEHLVRD-GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 57/216 (26%), Positives = 90/216 (41%), Gaps = 52/216 (24%)
Query: 62 LGEGAFGKVYKGE-VCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHPNIVC 118
LG G FGKV G+ T VA+K L + RRE+ + RHP+I+
Sbjct: 24 LGVGTFGKVKVGKHELTGH---KVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAG 178
L V + + M+ E++ G+L +++ L +++ + Q+ +G
Sbjct: 81 LYQVISTPSDIFMVMEYVSGGELFDYICKNGR------------LDEKESRRLFQQILSG 128
Query: 179 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV--------------YASDYYRI 224
+ Y H VHRDL N L+ + KI+DFGLS + YA+
Sbjct: 129 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAA----- 183
Query: 225 QSKSLLPVRWMPPESILYGKF--TTESDVWSYGVVL 258
PE ++ G+ E D+WS GV+L
Sbjct: 184 ------------PE-VISGRLYAGPEVDIWSSGVIL 206
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 29/98 (29%), Positives = 41/98 (41%), Gaps = 34/98 (34%)
Query: 312 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV--------------YASDYY 357
+G+ Y H VHRDL N L+ + KI+DFGLS + YA+
Sbjct: 127 SGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAA--- 183
Query: 358 RIQSKSLLPVRWMPPESILYGKF--TTESDVWSYGVVL 393
PE ++ G+ E D+WS GV+L
Sbjct: 184 --------------PE-VISGRLYAGPEVDIWSSGVIL 206
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 49/218 (22%), Positives = 89/218 (40%), Gaps = 54/218 (24%)
Query: 60 QELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR-HPNIV 117
+ LGEG+F K +++ A+K + +++ ++ ++E+ + HPNIV
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQ---AFAVKII----SKRMEANTQKEITALKLCEGHPNIV 69
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
L V ++ E + G+L E + + S+ + S+I ++ +
Sbjct: 70 KLHEVFHDQLHTFLVMELLNGGELFERIKKKKH------------FSETEASYIMRKLVS 117
Query: 178 GMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASD----------YYRI 224
++++ VHRDL N L D L +KI DFG +R + +Y
Sbjct: 118 AVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHY-- 175
Query: 225 QSKSLLPVRWMPPESIL----YGKFTTESDVWSYGVVL 258
PE +L Y + D+WS GV+L
Sbjct: 176 ----------AAPE-LLNQNGYDE---SCDLWSLGVIL 199
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 6e-07
Identities = 26/101 (25%), Positives = 40/101 (39%), Gaps = 33/101 (32%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASD----------Y 356
+ + ++++ VHRDL N L D L +KI DFG +R + +
Sbjct: 115 LVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLH 174
Query: 357 YRIQSKSLLPVRWMPPESIL----YGKFTTESDVWSYGVVL 393
Y PE +L Y + D+WS GV+L
Sbjct: 175 Y------------AAPE-LLNQNGYDE---SCDLWSLGVIL 199
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 60/227 (26%), Positives = 90/227 (39%), Gaps = 49/227 (21%)
Query: 52 IETKPRFLQELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASDFR--REVDLM 108
+ + + L+ +G GA G V + VAIK L Q R RE+ LM
Sbjct: 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKL-SRPFQNQTHAKRAYRELVLM 115
Query: 109 SELRHPNIVCLLGVCLSGEPMC------MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAP 162
+ H NI+ LL V + + ++ E M +L + + Q
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--------------QME 160
Query: 163 LSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD-- 220
L + S++ Q+ G+ +L S +HRDL N +V T+KI DFGL+R S
Sbjct: 161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 220
Query: 221 -------YYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWE 260
YYR PE IL + D+WS G ++ E
Sbjct: 221 TPYVVTRYYR------------APEVILGMGYKENVDIWSVGCIMGE 255
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 30/92 (32%), Positives = 40/92 (43%), Gaps = 21/92 (22%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD---------YYRIQSKS 363
G+ +L S +HRDL N +V T+KI DFGL+R S YYR
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR----- 230
Query: 364 LLPVRWMPPESILYGKFTTESDVWSYGVVLWE 395
PE IL + D+WS G ++ E
Sbjct: 231 -------APEVILGMGYKENVDIWSVGCIMGE 255
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 4e-21
Identities = 57/215 (26%), Positives = 88/215 (40%), Gaps = 42/215 (19%)
Query: 57 RFLQELGEGAFGKVYKGE-VCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPN 115
F++++G G FG T E LVA+K + + +RE+ LRHPN
Sbjct: 23 DFVKDIGSGNFGVARLMRDKLTKE---LVAVKYI--ERGAAIDENVQREIINHRSLRHPN 77
Query: 116 IVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQV 175
IV V L+ + ++ E+ G+L+E + + S+ + Q+
Sbjct: 78 IVRFKEVILTPTHLAIIMEYASGGELYERICNAG------------RFSEDEARFFFQQL 125
Query: 176 AAGMAYLCSHHYVHRDLAARNCLV--GDGLTVKISDFGLSRDVYASDYYRIQSKSLL--- 230
+G++Y S HRDL N L+ +KI DFG S+ S
Sbjct: 126 LSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK--------SSVLHSQPKST 177
Query: 231 ---PVRWMPPESI---LY-GKFTTESDVWSYGVVL 258
P ++ PE + Y GK +DVWS GV L
Sbjct: 178 VGTP-AYIAPEVLLRQEYDGK---IADVWSCGVTL 208
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 29/93 (31%), Positives = 38/93 (40%), Gaps = 24/93 (25%)
Query: 313 GMAYLCSHHYVHRDLAARNCLV--GDGLTVKISDFGLSRDVYASDYYRIQSKSLL----- 365
G++Y S HRDL N L+ +KI DFG S+ S
Sbjct: 128 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK--------SSVLHSQPKSTVG 179
Query: 366 -PVRWMPPESI---LY-GKFTTESDVWSYGVVL 393
P ++ PE + Y GK +DVWS GV L
Sbjct: 180 TP-AYIAPEVLLRQEYDGK---IADVWSCGVTL 208
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 54/247 (21%), Positives = 98/247 (39%), Gaps = 58/247 (23%)
Query: 60 QELGEGAFGKVYKGEVCTS-EGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIV 117
Q LG G GKV + + A+K L++ RREV+L + P+IV
Sbjct: 68 QVLGLGINGKVLQ---IFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIV 118
Query: 118 CLLGVC--LSGEPMC--MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
++ V L C ++ E + G+L + R ++ ++++ S I
Sbjct: 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA----------FTEREASEIMK 168
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASD---------Y 221
+ + YL S + HRD+ N L +K++DFG +++ + + Y
Sbjct: 169 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 228
Query: 222 YRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYSNQEV 277
Y + PE + K+ D+WS GV++ Y G P+Y +
Sbjct: 229 Y------------VAPEVLGPEKYDKSCDMWSLGVIM-----YILLCGYPPFYSNHGLAI 271
Query: 278 IEMIRSR 284
+++R
Sbjct: 272 SPGMKTR 278
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 22/96 (22%), Positives = 40/96 (41%), Gaps = 24/96 (25%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASD---------YY 357
+ + YL S + HRD+ N L +K++DFG +++ + + YY
Sbjct: 170 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYY 229
Query: 358 RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVL 393
+ PE + K+ D+WS GV++
Sbjct: 230 ------------VAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 5e-21
Identities = 51/217 (23%), Positives = 83/217 (38%), Gaps = 37/217 (17%)
Query: 60 QELGEGAFGKVYKG-EVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR-HPNIV 117
LGEGA +V + TS+ A+K + E S REV+++ + + H N++
Sbjct: 19 DVLGEGAHARVQTCINLITSQ---EYAVKII-EKQPGHIRSRVFREVEMLYQCQGHRNVL 74
Query: 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAA 177
L+ + ++FE M G + + R ++ + S + VA+
Sbjct: 75 ELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH------------FNELEASVVVQDVAS 122
Query: 178 GMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASDYYRIQSKSLLP--- 231
+ +L + HRDL N L VKI DF L + + S L
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 232 ----------VRWMPPESILYGKFTTESDVWSYGVVL 258
V E+ +Y K D+WS GV+L
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDK---RCDLWSLGVIL 216
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 27/100 (27%), Positives = 37/100 (37%), Gaps = 19/100 (19%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 366
VA+ + +L + HRDL N L VKI DF L + + S L
Sbjct: 120 VASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179
Query: 367 -------------VRWMPPESILYGKFTTESDVWSYGVVL 393
V E+ +Y K D+WS GV+L
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDK---RCDLWSLGVIL 216
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 5e-21
Identities = 52/221 (23%), Positives = 89/221 (40%), Gaps = 26/221 (11%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHP 114
R + +G G G VY+ E T +VA+K + E ++ + +RE L+ P
Sbjct: 37 RLRRLVGRGGMGDVYEAE-DTVRE-RIVALKLMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 115 NIVCLLGVCLSGEPMCMLFEFM--VRG-DLHEFLMSRSPRSDISGSQVQAPLSQQDFSHI 171
++V + GE L+ M + G DL L + PL+ I
Sbjct: 95 HVV---PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ------------GPLAPPRAVAI 139
Query: 172 ALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL- 230
Q+ + + + HRD+ N LV + DFG++ +D Q + +
Sbjct: 140 VRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVG 197
Query: 231 PVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG 271
+ +M PE T +D+++ VL+E + G PY G
Sbjct: 198 TLYYMAPERFSESHATYRADIYALTCVLYECLT-GSPPYQG 237
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 5e-08
Identities = 29/129 (22%), Positives = 53/129 (41%), Gaps = 15/129 (11%)
Query: 279 EMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGL 338
M+R + L PPR +++ + + + + HRD+ N LV
Sbjct: 123 AMLRRQGPLA-----PPRAVAIVR------QIGSALDAAHAAGATHRDVKPENILVSADD 171
Query: 339 TVKISDFGLSRDVYASDYYRIQSKSLL-PVRWMPPESILYGKFTTESDVWSYGVVLWEVY 397
+ DFG++ +D Q + + + +M PE T +D+++ VL+E
Sbjct: 172 FAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECL 229
Query: 398 SYGLQPYYG 406
+ G PY G
Sbjct: 230 T-GSPPYQG 237
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 7e-21
Identities = 56/228 (24%), Positives = 91/228 (39%), Gaps = 46/228 (20%)
Query: 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFR--REVDLMS 109
+ +G GA+G V + G VAIK L Q R RE+ L+
Sbjct: 22 LPKTYVSPTHVGSGAYGSVCSA-IDKRSG-EKVAIKKL-SRPFQSEIFAKRAYRELLLLK 78
Query: 110 ELRHPNIVCLLGVCLSGEPMC------MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPL 163
++H N++ LL V + ++ FM + DL + +
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--------------GLKF 123
Query: 164 SQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV------Y 217
S++ ++ Q+ G+ Y+ S VHRDL N V + +KI DFGL+R Y
Sbjct: 124 SEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY 183
Query: 218 -ASDYYRIQSKSLLPVRWMPPESIL-YGKFTTESDVWSYGVVLWEVYS 263
+ +YR PE IL + + D+WS G ++ E+ +
Sbjct: 184 VVTRWYR------------APEVILSWMHYNQTVDIWSVGCIMAEMLT 219
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 29/94 (30%), Positives = 43/94 (45%), Gaps = 20/94 (21%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV------Y-ASDYYRIQSKSLL 365
G+ Y+ S VHRDL N V + +KI DFGL+R Y + +YR
Sbjct: 138 GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYR------- 190
Query: 366 PVRWMPPESIL-YGKFTTESDVWSYGVVLWEVYS 398
PE IL + + D+WS G ++ E+ +
Sbjct: 191 -----APEVILSWMHYNQTVDIWSVGCIMAEMLT 219
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 9e-21
Identities = 56/223 (25%), Positives = 86/223 (38%), Gaps = 34/223 (15%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFR--REVDLMSELRHP 114
+ LGEGA+G V G +VAIK K K R RE+ ++ +H
Sbjct: 14 QLKSLLGEGAYGVVCSA-THKPTG-EIVAIK--KIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 115 NIVCLLGVCLSGEPMCM-----LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFS 169
NI+ + + + E M + DLH + +Q LS
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELM-QTDLHR----------VISTQ---MLSDDHIQ 115
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 229
+ Q + L + +HRDL N L+ +K+ DFGL+R + S +
Sbjct: 116 YFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 230 LPV-------RWM-PPESIL-YGKFTTESDVWSYGVVLWEVYS 263
RW PE +L K++ DVWS G +L E++
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 27/95 (28%), Positives = 42/95 (44%), Gaps = 9/95 (9%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV----- 367
+ L + +HRDL N L+ +K+ DFGL+R + S +
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 368 --RWM-PPESIL-YGKFTTESDVWSYGVVLWEVYS 398
RW PE +L K++ DVWS G +L E++
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 51/272 (18%), Positives = 97/272 (35%), Gaps = 47/272 (17%)
Query: 33 KTLKENANQKTASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN 92
+ +EN + + + +G G++G VY + VAIK +
Sbjct: 8 SSGRENLYFQGIKNVH---VPDNYIIKHLIGRGSYGYVYLA-YDKNTE-KNVAIKKV-NR 61
Query: 93 ANQKTASDFR--REVDLMSELRHPNIVCLLGVCLSGEPMC-----MLFEFMVRGDLHEFL 145
+ R RE+ +++ L+ I+ L + + + + ++ E DL +
Sbjct: 62 MFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLF 120
Query: 146 MSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205
+ L+++ I + G ++ +HRDL NCL+ +V
Sbjct: 121 KTP------------IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSV 168
Query: 206 KISDFGLSRDVYASDYYRIQSKSLLPV-------------------RWM-PPESIL-YGK 244
K+ DFGL+R + + I + RW PE IL
Sbjct: 169 KVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQEN 228
Query: 245 FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 276
+T D+WS G + E+ + +N+
Sbjct: 229 YTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 29/120 (24%), Positives = 46/120 (38%), Gaps = 21/120 (17%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV----- 367
G ++ +HRDL NCL+ +VK+ DFGL+R + + I +
Sbjct: 141 GENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 368 --------------RWM-PPESIL-YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
RW PE IL +T D+WS G + E+ + +N+
Sbjct: 201 NKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 50/259 (19%), Positives = 85/259 (32%), Gaps = 75/259 (28%)
Query: 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFR---REVD 106
E K + LG G+FG V + G A+K K D R RE+D
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEV-FDIESG-KRFALK--------KVLQDPRYKNRELD 52
Query: 107 LMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQ 166
+M L H NI+ L+ + E + + ++ ++
Sbjct: 53 IMKVLDHVNIIKLVDYFYT----TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPS 108
Query: 167 DFSHIAL---------------------------------QVAAGMAYLCSHHYVHRDLA 193
++ + Q+ + ++ S HRD+
Sbjct: 109 QNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIK 168
Query: 194 ARNCLVGDGLT--VKISDFGLSRDV--------Y-ASDYYRIQSKSLLPVRWMPPESIL- 241
+N LV + +K+ DFG ++ + Y S +YR PE +L
Sbjct: 169 PQNLLV-NSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR------------APELMLG 215
Query: 242 YGKFTTESDVWSYGVVLWE 260
++T D+WS G V E
Sbjct: 216 ATEYTPSIDLWSIGCVFGE 234
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 25/95 (26%), Positives = 41/95 (43%), Gaps = 25/95 (26%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLT--VKISDFGLSRDV--------Y-ASDYYRIQS 361
+ ++ S HRD+ +N LV + +K+ DFG ++ + Y S +YR
Sbjct: 153 AVGFIHSLGICHRDIKPQNLLV-NSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR--- 208
Query: 362 KSLLPVRWMPPESIL-YGKFTTESDVWSYGVVLWE 395
PE +L ++T D+WS G V E
Sbjct: 209 ---------APELMLGATEYTPSIDLWSIGCVFGE 234
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 60/226 (26%), Positives = 89/226 (39%), Gaps = 47/226 (20%)
Query: 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFR--REVDLMS 109
+ + + L+ +G GA G V VAIK L Q R RE+ LM
Sbjct: 23 VLKRYQNLKPIGSGAQGIVCAA-YDAILE-RNVAIKKL-SRPFQNQTHAKRAYRELVLMK 79
Query: 110 ELRHPNIVCLLGVCLSGEPMC------MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPL 163
+ H NI+ LL V + + ++ E M +L + + Q L
Sbjct: 80 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI--------------QMEL 124
Query: 164 SQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD--- 220
+ S++ Q+ G+ +L S +HRDL N +V T+KI DFGL+R S
Sbjct: 125 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 184
Query: 221 ------YYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWE 260
YYR PE IL + D+WS G ++ E
Sbjct: 185 PYVVTRYYR------------APEVILGMGYKENVDIWSVGCIMGE 218
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 6e-08
Identities = 30/92 (32%), Positives = 40/92 (43%), Gaps = 21/92 (22%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD---------YYRIQSKS 363
G+ +L S +HRDL N +V T+KI DFGL+R S YYR
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR----- 193
Query: 364 LLPVRWMPPESILYGKFTTESDVWSYGVVLWE 395
PE IL + D+WS G ++ E
Sbjct: 194 -------APEVILGMGYKENVDIWSVGCIMGE 218
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 90.8 bits (225), Expect = 3e-20
Identities = 47/308 (15%), Positives = 86/308 (27%), Gaps = 74/308 (24%)
Query: 8 LGEGAFGKVYKG-EVCTSEGPSLVAIKTL--KENANQKTASDFRREVIETKPRFLQELGE 64
LG+ + + T E + E + EV+
Sbjct: 81 LGQEDPYAYLEATDQETGE---SFEVHVPYFTERPPSNAIKQMKEEVL------------ 125
Query: 65 GAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCL 124
++ L+ NQK A R + ++ P ++ V L
Sbjct: 126 --------------------RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRL 165
Query: 125 SGEPMCMLFEFMV----RGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMA 180
M +L F + + +L F S L + LQV +A
Sbjct: 166 DERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK-----SLVHHARLQLTLQVIRLLA 220
Query: 181 YLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV--RWMPPE 238
L + VH L + ++ V ++ F R ++ + V + PPE
Sbjct: 221 SLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--------RDGARVVSSVSRGFEPPE 272
Query: 239 SILY-----------GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287
T D W+ G+V++ ++ P + E I
Sbjct: 273 LEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC-ADLPITKDAALGGSEWI-----F 326
Query: 288 PCPEDCPP 295
++ P
Sbjct: 327 RSCKNIPQ 334
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 35/229 (15%), Positives = 70/229 (30%), Gaps = 42/229 (18%)
Query: 194 ARNCLVGDGLTVKISDFGLSRDVYASDYYR--IQSKSLLPVRWMPPESILYGKFTTESDV 251
A + G+ V + F A + + LL ++ ++ +F D+
Sbjct: 92 ATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151
Query: 252 ------------WSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYS 299
+W + + L P + Q E++ S R+
Sbjct: 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQ- 210
Query: 300 LMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRI 359
L ++ V +A L + VH L + ++ V ++ F R
Sbjct: 211 LTLQ------VIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--------RD 256
Query: 360 QSKSLLPV--RWMPPESILY-----------GKFTTESDVWSYGVVLWE 395
++ + V + PPE T D W+ G+V++
Sbjct: 257 GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 62/228 (27%), Positives = 95/228 (41%), Gaps = 45/228 (19%)
Query: 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFR--REVDLMS 109
+ R LQ +G GA+G V V G + VAIK L Q R RE+ L+
Sbjct: 23 VRAVYRDLQPVGSGAYGAVCSA-VDGRTG-AKVAIKKL-YRPFQSELFAKRAYRELRLLK 79
Query: 110 ELRHPNIVCLLGVCLSGEPMC------MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPL 163
+RH N++ LL V E + ++ FM DL + + L
Sbjct: 80 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE-------------KL 125
Query: 164 SQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR--DVYASDY 221
+ + Q+ G+ Y+ + +HRDL N V + +KI DFGL+R D + Y
Sbjct: 126 GEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY 185
Query: 222 -----YRIQSKSLLPVRWMPPESIL-YGKFTTESDVWSYGVVLWEVYS 263
YR PE IL + ++T D+WS G ++ E+ +
Sbjct: 186 VVTRWYR------------APEVILNWMRYTQTVDIWSVGCIMAEMIT 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 29/94 (30%), Positives = 45/94 (47%), Gaps = 20/94 (21%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR--DVYASDY-----YRIQSKSLL 365
G+ Y+ + +HRDL N V + +KI DFGL+R D + Y YR
Sbjct: 140 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYR------- 192
Query: 366 PVRWMPPESIL-YGKFTTESDVWSYGVVLWEVYS 398
PE IL + ++T D+WS G ++ E+ +
Sbjct: 193 -----APEVILNWMRYTQTVDIWSVGCIMAEMIT 221
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 60/245 (24%), Positives = 94/245 (38%), Gaps = 53/245 (21%)
Query: 40 NQKTASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTAS 99
N A+D R + + + G+G FG V G S G VAIK + ++ +
Sbjct: 9 NAAAAADERSRKEMDRFQVERMAGQGTFGTVQLG-KEKSTG-MSVAIKKVIQDPRFRN-- 64
Query: 100 DFRREVDLMSELR---HPNIVCLLGVCLSGEP-------MCMLFEFMVRGDLHEFLMSRS 149
RE+ +M +L HPNIV L + + ++ E++ LH
Sbjct: 65 ---RELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCC---- 116
Query: 150 PRSDISGSQVQAPLSQQDFSHIALQVAAGMAYL--CSHHYVHRDLAARNCLVGDGLT--V 205
R+ P+ + F Q+ + L S + HRD+ N LV + +
Sbjct: 117 -RNYYRRQVAPPPILIKVFLF---QLIRSIGCLHLPSVNVCHRDIKPHNVLV-NEADGTL 171
Query: 206 KISDFGLSRDV--------Y-ASDYYRIQSKSLLPVRWMPPESIL-YGKFTTESDVWSYG 255
K+ DFG ++ + Y S YYR PE I +TT D+WS G
Sbjct: 172 KLCDFGSAKKLSPSEPNVAYICSRYYR------------APELIFGNQHYTTAVDIWSVG 219
Query: 256 VVLWE 260
+ E
Sbjct: 220 CIFAE 224
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 27/97 (27%), Positives = 39/97 (40%), Gaps = 27/97 (27%)
Query: 313 GMAYL--CSHHYVHRDLAARNCLVGDGLT--VKISDFGLSRDV--------Y-ASDYYRI 359
+ L S + HRD+ N LV + +K+ DFG ++ + Y S YYR
Sbjct: 141 SIGCLHLPSVNVCHRDIKPHNVLV-NEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYR- 198
Query: 360 QSKSLLPVRWMPPESIL-YGKFTTESDVWSYGVVLWE 395
PE I +TT D+WS G + E
Sbjct: 199 -----------APELIFGNQHYTTAVDIWSVGCIFAE 224
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 51/238 (21%), Positives = 89/238 (37%), Gaps = 61/238 (25%)
Query: 60 QELGEGAFGKVYKGEVCTS-EGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIV 117
Q LG G GKV + + A+K L++ RREV+L + P+IV
Sbjct: 24 QVLGLGINGKVLQ---IFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIV 74
Query: 118 CLLGVC--LSGEPMC--MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
++ V L C ++ E + G+L + R ++ ++++ S I
Sbjct: 75 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA----------FTEREASEIMK 124
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASDYYRIQSKSLL 230
+ + YL S + HRD+ N L +K++DFG +
Sbjct: 125 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----------------- 167
Query: 231 PVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY----GLQPYYGYSNQEVIEMIRSR 284
E K+ D+WS GV++ Y G P+Y + +++R
Sbjct: 168 ------KE-TTGEKYDKSCDMWSLGVIM-----YILLCGYPPFYSNHGLAISPGMKTR 213
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 19/87 (21%), Positives = 31/87 (35%), Gaps = 27/87 (31%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 366
+ + YL S + HRD+ N L +K++DFG +
Sbjct: 126 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA------------------ 167
Query: 367 VRWMPPESILYGKFTTESDVWSYGVVL 393
E K+ D+WS GV++
Sbjct: 168 -----KE-TTGEKYDKSCDMWSLGVIM 188
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 53/228 (23%), Positives = 91/228 (39%), Gaps = 45/228 (19%)
Query: 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFR--REVDLMS 109
+ + + L +G GA+G V + VA+K L Q R RE+ L+
Sbjct: 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLR--VAVKKLS-RPFQSIIHAKRTYRELRLLK 83
Query: 110 ELRHPNIVCLLGVCLSGEPMC------MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPL 163
++H N++ LL V + ++ M DL+ + + L
Sbjct: 84 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-------------KL 129
Query: 164 SQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV------Y 217
+ + Q+ G+ Y+ S +HRDL N V + +KI DFGL+R Y
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY 189
Query: 218 -ASDYYRIQSKSLLPVRWMPPESIL-YGKFTTESDVWSYGVVLWEVYS 263
A+ +YR PE +L + + D+WS G ++ E+ +
Sbjct: 190 VATRWYR------------APEIMLNWMHYNQTVDIWSVGCIMAELLT 225
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 28/94 (29%), Positives = 44/94 (46%), Gaps = 20/94 (21%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV------Y-ASDYYRIQSKSLL 365
G+ Y+ S +HRDL N V + +KI DFGL+R Y A+ +YR
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYR------- 196
Query: 366 PVRWMPPESIL-YGKFTTESDVWSYGVVLWEVYS 398
PE +L + + D+WS G ++ E+ +
Sbjct: 197 -----APEIMLNWMHYNQTVDIWSVGCIMAELLT 225
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 27/221 (12%)
Query: 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFR--REVDLMS 109
+ + L +GEGA+G V VAIK K + + R RE+ ++
Sbjct: 25 VGPRYTNLSYIGEGAYGMVCSA-YDNLNK-VRVAIK--KISPFEHQTYCQRTLREIKILL 80
Query: 110 ELRHPNIVCLLGVCLSGEPMCM-----LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLS 164
RH NI+ + + + M + + M DL++ L ++ LS
Sbjct: 81 RFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-------------HLS 126
Query: 165 QQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRI 224
+ Q+ G+ Y+ S + +HRDL N L+ +KI DFGL+R +
Sbjct: 127 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
Query: 225 QSKSLLPVRWM-PPESIL-YGKFTTESDVWSYGVVLWEVYS 263
+ RW PE +L +T D+WS G +L E+ S
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 29/88 (32%), Positives = 43/88 (48%), Gaps = 2/88 (2%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM-P 371
G+ Y+ S + +HRDL N L+ +KI DFGL+R + + RW
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 372 PESIL-YGKFTTESDVWSYGVVLWEVYS 398
PE +L +T D+WS G +L E+ S
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLS 227
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 52/228 (22%), Positives = 86/228 (37%), Gaps = 38/228 (16%)
Query: 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFR--REVDLMS 109
+ ++ L+ LG G G V+ V VAIK + S RE+ ++
Sbjct: 9 LGSRYMDLKPLGCGGNGLVFSA-VDNDCD-KRVAIKKI---VLTDPQSVKHALREIKIIR 63
Query: 110 ELRHPNIVCLLGVCLSGEPMC--------------MLFEFMVRGDLHEFLMSRSPRSDIS 155
L H NIV + + ++ E+M DL L
Sbjct: 64 RLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQG------- 115
Query: 156 GSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFGLSR 214
PL ++ Q+ G+ Y+ S + +HRDL N + + L +KI DFGL+R
Sbjct: 116 ------PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLAR 169
Query: 215 DVYASDYYRIQSKSLLPVRWM-PPESIL-YGKFTTESDVWSYGVVLWE 260
+ ++ L +W P +L +T D+W+ G + E
Sbjct: 170 IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAE 217
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 25/86 (29%), Positives = 42/86 (48%), Gaps = 3/86 (3%)
Query: 313 GMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM- 370
G+ Y+ S + +HRDL N + + L +KI DFGL+R + ++ L +W
Sbjct: 132 GLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYR 191
Query: 371 PPESIL-YGKFTTESDVWSYGVVLWE 395
P +L +T D+W+ G + E
Sbjct: 192 SPRLLLSPNNYTKAIDMWAAGCIFAE 217
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-18
Identities = 44/216 (20%), Positives = 87/216 (40%), Gaps = 47/216 (21%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR-HPNIV 117
+++LG G + +V++ + + V +K LK +K +RE+ ++ LR PNI+
Sbjct: 41 VRKLGRGKYSEVFEA-INITNN-EKVVVKILKPVKKKKI----KREIKILENLRGGPNII 94
Query: 118 CLLGVCLSGEPMC--MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQV 175
L + ++FE + D Q+ L+ D ++
Sbjct: 95 TLADIVKDPVSRTPALVFEHVNNTDFK---------------QLYQTLTDYDIRFYMYEI 139
Query: 176 AAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFGLSR--------DVY-ASDYYRIQ 225
+ Y S +HRD+ N ++ + +++ D+GL+ +V AS Y++
Sbjct: 140 LKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFK-- 197
Query: 226 SKSLLPVRWMPPESIL-YGKFTTESDVWSYGVVLWE 260
PE ++ Y + D+WS G +L
Sbjct: 198 ----------GPELLVDYQMYDYSLDMWSLGCMLAS 223
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 21/94 (22%), Positives = 40/94 (42%), Gaps = 23/94 (24%)
Query: 313 GMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFGLSR--------DVY-ASDYYRIQSK 362
+ Y S +HRD+ N ++ + +++ D+GL+ +V AS Y++
Sbjct: 142 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFK---- 197
Query: 363 SLLPVRWMPPESIL-YGKFTTESDVWSYGVVLWE 395
PE ++ Y + D+WS G +L
Sbjct: 198 --------GPELLVDYQMYDYSLDMWSLGCMLAS 223
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 8e-18
Identities = 62/237 (26%), Positives = 102/237 (43%), Gaps = 42/237 (17%)
Query: 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFR--REVDLMS 109
+ K +++LG+GA+G V+K + G +VA+K + +A Q + R RE+ +++
Sbjct: 7 VLRKYELVKKLGKGAYGIVWKS-IDRRTG-EVVAVKKI-FDAFQNSTDAQRTFREIMILT 63
Query: 110 ELR-HPNIVCLLGVCL--SGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQ 166
EL H NIV LL V + + ++F++M DLH + + L
Sbjct: 64 ELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRAN-------------ILEPV 109
Query: 167 DFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQS 226
++ Q+ + YL S +HRD+ N L+ VK++DFGLSR
Sbjct: 110 HKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 227 KSLLPV------------------RWM-PPESIL-YGKFTTESDVWSYGVVLWEVYS 263
+ RW PE +L K+T D+WS G +L E+
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 29/106 (27%), Positives = 41/106 (38%), Gaps = 20/106 (18%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV----- 367
+ YL S +HRD+ N L+ VK++DFGLSR +
Sbjct: 121 VIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 368 -------------RWM-PPESIL-YGKFTTESDVWSYGVVLWEVYS 398
RW PE +L K+T D+WS G +L E+
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 46/251 (18%), Positives = 94/251 (37%), Gaps = 49/251 (19%)
Query: 59 LQELGEGAFGKVYKGEVCT-SEGPSLVAIKTLKENANQKTASDFRREVDLMSELR----- 112
+++LG G F V+ + VA+K ++ + A+ E+ L+ +
Sbjct: 24 VRKLGWGHFSTVWL---AKDMVNNTHVAMKIVRGDKVYTEAA--EDEIKLLQRVNDADNT 78
Query: 113 ------HPNIVCLLGV----CLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAP 162
+I+ LL +G + M+FE + +L + R I V+
Sbjct: 79 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRG-IPLIYVK-- 134
Query: 163 LSQQDFSHIALQVAAGMAYLCSH-HYVHRDLAARNCLVGDG------LTVKISDFGLSRD 215
I+ Q+ G+ Y+ +H D+ N L+ + +KI+D G +
Sbjct: 135 -------QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187
Query: 216 VYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYS-----YGLQPYY 270
IQ++ R PE +L + +D+WS +++E+ + + +
Sbjct: 188 YDEHYTNSIQTREY---RS--PEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 242
Query: 271 GYSNQEVIEMI 281
+ + I I
Sbjct: 243 YTKDDDHIAQI 253
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 24/127 (18%), Positives = 50/127 (39%), Gaps = 23/127 (18%)
Query: 313 GMAYLCSH-HYVHRDLAARNCLVGDG------LTVKISDFGLSRDVYASDYYRIQSKSLL 365
G+ Y+ +H D+ N L+ + +KI+D G + IQ++
Sbjct: 143 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY- 201
Query: 366 PVRWMPPESILYGKFTTESDVWSYGVVLWEVYS-----YGLQPYYGYSNQE------EFL 414
R PE +L + +D+WS +++E+ + + + + + E L
Sbjct: 202 --RS--PEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 257
Query: 415 KTPPSWI 421
PS++
Sbjct: 258 GELPSYL 264
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 56/262 (21%), Positives = 107/262 (40%), Gaps = 45/262 (17%)
Query: 57 RFLQELGEGAFGKVYKGE-VCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRH 113
L+ +G+G+FGKV + T + + A+K + + + + +E+ +M L H
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKK---MYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFS---- 169
P +V L E M M+ + ++ GDL + + ++ F
Sbjct: 75 PFLVNLWYSFQDEEDMFMVVDLLLGGDLR-YHLQQNVH----------------FKEETV 117
Query: 170 --HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSK 227
I ++ + YL + +HRD+ N L+ + V I+DF ++ + +I +
Sbjct: 118 KLFIC-ELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--QITTM 174
Query: 228 SLLPVRWMPPESIL------YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281
+ +M PE Y D WS GV +E+ G +PY+ S+ E++
Sbjct: 175 AGTK-PYMAPEMFSSRKGAGYSF---AVDWWSLGVTAYELL-RGRRPYHIRSSTSSKEIV 229
Query: 282 RSRQM--LPCPEDCPPRMYSLM 301
+ + + P M SL+
Sbjct: 230 HTFETTVVTYPSAWSQEMVSLL 251
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 28/127 (22%), Positives = 50/127 (39%), Gaps = 23/127 (18%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+ + YL + +HRD+ N L+ + V I+DF ++ + +I + + +
Sbjct: 124 LVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--QITTMAGTK-PY 180
Query: 370 MPPESIL------YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF---------- 413
M PE Y D WS GV +E+ G +PY+ S+
Sbjct: 181 MAPEMFSSRKGAGYSF---AVDWWSLGVTAYELL-RGRRPYHIRSSTSSKEIVHTFETTV 236
Query: 414 LKTPPSW 420
+ P +W
Sbjct: 237 VTYPSAW 243
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 53/245 (21%), Positives = 95/245 (38%), Gaps = 38/245 (15%)
Query: 46 DFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREV 105
+R EV++ +G+G+FG+V K + VA+K ++ + E+
Sbjct: 96 AYRYEVLKV-------IGKGSFGQVVK--AYDHKVHQHVALKMVRNEKRFHRQA--AEEI 144
Query: 106 DLMSELRH------PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQV 159
++ LR N++ +L +CM FE + +L+E + +
Sbjct: 145 RILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQ-------- 195
Query: 160 QAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL--TVKISDFGLSRDVY 217
S A + + L + +H DL N L+ +K+ DFG S +
Sbjct: 196 --GFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253
Query: 218 ASDYYRIQSKSLLPVRW-MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 276
Y IQS R+ PE IL ++ D+WS G +L E+ + G G +
Sbjct: 254 QRVYTYIQS------RFYRAPEVILGARYGMPIDMWSLGCILAELLT-GYPLLPGEDEGD 306
Query: 277 VIEMI 281
+ +
Sbjct: 307 QLACM 311
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 31/118 (26%), Positives = 47/118 (39%), Gaps = 16/118 (13%)
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGL--TVKISDFGLSRDVYASDYYRIQSKSLLPVRW- 369
+ L + +H DL N L+ +K+ DFG S + Y IQS R+
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQS------RFY 265
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE------EFLKTPPSWI 421
PE IL ++ D+WS G +L E+ + G G + E L P +
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLT-GYPLLPGEDEGDQLACMIELLGMPSQKL 322
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 58/300 (19%), Positives = 113/300 (37%), Gaps = 63/300 (21%)
Query: 23 TSEGPSLVAIKTLKENANQK--TASDFRREVIETKPRFLQELGEGAFGKVYKG-EVCTSE 79
P +++ + + DF+ F + LGEG+F V E+ TS
Sbjct: 6 AEPRPGAGSLQHAQPPPQPRKKRPEDFK---------FGKILGEGSFSTVVLARELATSR 56
Query: 80 GPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMV 137
AIK L++ + RE D+MS L HP V L E + +
Sbjct: 57 ---EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 113
Query: 138 RGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHI--------------ALQVAAGMAYLC 183
G+L +I ++ + + YL
Sbjct: 114 NGEL--------------------------LKYIRKIGSFDETCTRFYTAEIVSALEYLH 147
Query: 184 SHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL--PVRWMPPESIL 241
+HRDL N L+ + + ++I+DFG ++ + + + + ++ S + +++ PE +
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANSFVGTA-QYVSPELLT 205
Query: 242 YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLM 301
SD+W+ G +++++ GL P+ + + + I + PE P+ L+
Sbjct: 206 EKSACKSSDLWALGCIIYQLV-AGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLV 263
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 24/108 (22%), Positives = 56/108 (51%), Gaps = 5/108 (4%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL--PV 367
+ + + YL +HRDL N L+ + + ++I+DFG ++ + + + + ++ S +
Sbjct: 139 IVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANSFVGTA- 196
Query: 368 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
+++ PE + SD+W+ G +++++ GL P+ + F K
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLV-AGLPPFRAGNEYLIFQK 243
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 56/257 (21%), Positives = 104/257 (40%), Gaps = 28/257 (10%)
Query: 43 TASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTL-KENANQKTASDF 101
T + FR + LG+G FG+V +V + + A K L K+ ++
Sbjct: 182 TKNTFR---------QYRVLGKGGFGEVCACQVRATG--KMYACKKLEKKRIKKRKGEAM 230
Query: 102 -RREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQ 160
E ++ ++ +V L + + +C++ M GDL F + ++ ++
Sbjct: 231 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK-FHIYHMGQAGFPEARAV 289
Query: 161 APLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD 220
A ++ G+ L V+RDL N L+ D ++ISD GL+ V
Sbjct: 290 ---------FYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340
Query: 221 YYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEM 280
I+ + +M PE + ++T D W+ G +L+E+ G P+ + E
Sbjct: 341 --TIKGRVGTV-GYMAPEVVKNERYTFSPDWWALGCLLYEMI-AGQSPFQQRKKKIKREE 396
Query: 281 IRSRQMLPCPEDCPPRM 297
+ R + PE+ R
Sbjct: 397 V-ERLVKEVPEEYSERF 412
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 6e-07
Identities = 27/97 (27%), Positives = 45/97 (46%), Gaps = 4/97 (4%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+ G+ L V+RDL N L+ D ++ISD GL+ V I+ + +
Sbjct: 295 ICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--TIKGRVGTV-GY 351
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG 406
M PE + ++T D W+ G +L+E+ G P+
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMI-AGQSPFQQ 387
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 5e-16
Identities = 61/309 (19%), Positives = 116/309 (37%), Gaps = 46/309 (14%)
Query: 1 MKGFLQELGEGAFGKVYKGEVCTSEGPSLV--AIKTLKENANQKTASDFRREVIETKP-- 56
+ + A V V P L I+ + +N F T+
Sbjct: 117 LLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQ 176
Query: 57 ---------------RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-----ENANQK 96
+ +G G FG+VY + + A+K L +
Sbjct: 177 WKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTG--KMYAMKCLDKKRIKMKQGET 234
Query: 97 TASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISG 156
A + R + L+S P IVC+ + + + + + M GDLH + +S+
Sbjct: 235 LALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH-YHLSQHGV----- 288
Query: 157 SQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDV 216
S+ D A ++ G+ ++ + V+RDL N L+ + V+ISD GL+ D
Sbjct: 289 ------FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342
Query: 217 YASDYYRIQSKSLL-PVRWMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSN 274
+ + + +M PE + G + + +D +S G +L+++ G P+ +
Sbjct: 343 SKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKT 396
Query: 275 QEVIEMIRS 283
++ E+ R
Sbjct: 397 KDKHEIDRM 405
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 24/105 (22%), Positives = 52/105 (49%), Gaps = 8/105 (7%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL-PVR 368
+ G+ ++ + V+RDL N L+ + V+ISD GL+ D + + +
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHASVGTHG 355
Query: 369 WMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEE 412
+M PE + G + + +D +S G +L+++ G P+ + +++
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDK 399
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 7e-16
Identities = 64/286 (22%), Positives = 110/286 (38%), Gaps = 38/286 (13%)
Query: 27 PSLVAIKTLKENANQKTASDFRREVIETKPR-----FLQELGEGAFGKVYKGEVCTSEGP 81
L K + E A F +V + + L+ +G GAFG+V V
Sbjct: 44 SPLRREKNILEYLEW--AKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAV--VKLKNAD 99
Query: 82 SLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRG 139
+ A+K L + + + FR E D++ I L + ++ ++ V G
Sbjct: 100 KVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGG 159
Query: 140 DLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV 199
DL L+S+ + + P F ++A ++ + + HYVHRD+ N L+
Sbjct: 160 DLL-TLLSK--------FEDRLPEEMARF-YLA-EMVIAIDSVHQLHYVHRDIKPDNILM 208
Query: 200 GDGLTVKISDFGLSRDVYASDYYRIQSKS-------LLP--VRWMPPESILYGKFTTESD 250
++++DFG + +QS + P ++ M YG E D
Sbjct: 209 DMNGHIRLADFGSCLKLMEDG--TVQSSVAVGTPDYISPEILQAMEGGKGRYGP---ECD 263
Query: 251 VWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM-LPCPEDCPP 295
WS GV ++E+ YG P+Y S E I + + P
Sbjct: 264 WWSLGVCMYEML-YGETPFYAESLVETYGKIMNHKERFQFPTQVTD 308
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 8e-06
Identities = 31/115 (26%), Positives = 50/115 (43%), Gaps = 15/115 (13%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKS------ 363
+ + + HYVHRD+ N L+ ++++DFG + +QS
Sbjct: 184 MVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--TVQSSVAVGTPD 241
Query: 364 -LLP--VRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
+ P ++ M YG E D WS GV ++E+ YG P+Y S E + K
Sbjct: 242 YISPEILQAMEGGKGRYGP---ECDWWSLGVCMYEML-YGETPFYAESLVETYGK 292
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 64/273 (23%), Positives = 108/273 (39%), Gaps = 51/273 (18%)
Query: 36 KENANQKTASDFRREVIETKPRFLQELGEGAFGKVYK-GEVCTSEGPSLVAIKTLK--EN 92
K + A D+ EV++ +G GAFG+V T + + A+K L E
Sbjct: 60 KIRDLRMKAEDY--EVVKV-------IGRGAFGEVQLVRHKSTRK---VYAMKLLSKFEM 107
Query: 93 ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRS 152
+ ++ F E D+M+ P +V L + M+ E+M GDL +
Sbjct: 108 IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL--VNL------ 159
Query: 153 DISGSQVQAPLSQQDFS------HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 206
+S D + A +V + + S ++HRD+ N L+ +K
Sbjct: 160 ----------MSNYDVPEKWARFYTA-EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLK 208
Query: 207 ISDFGLSRDVYASDYYRIQSKSLL--PVRWMPPESIL----YGKFTTESDVWSYGVVLWE 260
++DFG + R + + P ++ PE + G + E D WS GV L+E
Sbjct: 209 LADFGTCMKMNKEGMVR--CDTAVGTP-DYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 265
Query: 261 VYSYGLQPYYGYSNQEVIEMIRSRQM-LPCPED 292
+ G P+Y S I + + L P+D
Sbjct: 266 ML-VGDTPFYADSLVGTYSKIMNHKNSLTFPDD 297
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 29/112 (25%), Positives = 49/112 (43%), Gaps = 10/112 (8%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL--PV 367
V + + S ++HRD+ N L+ +K++DFG + R + + P
Sbjct: 177 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR--CDTAVGTP- 233
Query: 368 RWMPPESIL----YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
++ PE + G + E D WS GV L+E+ G P+Y S + K
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML-VGDTPFYADSLVGTYSK 284
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 5e-15
Identities = 61/255 (23%), Positives = 107/255 (41%), Gaps = 39/255 (15%)
Query: 58 FLQELGEGAFGKVY----KGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSEL 111
L+ +G GAF +V K T + + A+K + + + S FR E D++
Sbjct: 65 ILKVIGRGAFSEVAVVKMKQ---TGQ---VYAMKIMNKWDMLKRGEVSCFREERDVLVNG 118
Query: 112 RHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHI 171
I L + ++ E+ V GDL L+S+ G ++ A +++ F ++
Sbjct: 119 DRRWITQLHFAFQDENYLYLVMEYYVGGDLL-TLLSK------FGERIPAEMAR--F-YL 168
Query: 172 ALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 231
A ++ + + YVHRD+ N L+ ++++DFG + A R SL+
Sbjct: 169 A-EIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR----SLVA 223
Query: 232 V---RWMPPESIL-------YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281
V ++ PE + G + E D W+ GV +E++ YG P+Y S E I
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF-YGQTPFYADSTAETYGKI 282
Query: 282 RSRQM-LPCPEDCPP 295
+ L P
Sbjct: 283 VHYKEHLSLPLVDEG 297
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 31/116 (26%), Positives = 52/116 (44%), Gaps = 15/116 (12%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV-- 367
+ + + YVHRD+ N L+ ++++DFG + A R SL+ V
Sbjct: 171 IVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR----SLVAVGT 226
Query: 368 -RWMPPESIL-------YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
++ PE + G + E D W+ GV +E++ YG P+Y S E + K
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF-YGQTPFYADSTAETYGK 281
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 58/268 (21%), Positives = 104/268 (38%), Gaps = 66/268 (24%)
Query: 46 DFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREV 105
R E++ LGEG FGKV + + + G S VA+K ++ + A+ R E+
Sbjct: 18 QERYEIVGN-------LGEGTFGKVVEC-LDHARGKSQVALKIIRNVGKYREAA--RLEI 67
Query: 106 DLMSELRHP------NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQV 159
+++ +++ V + MC+ FE ++ + EFL + + V
Sbjct: 68 NVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKENNFQP-YPLPHV 125
Query: 160 QAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL---------------- 203
+ H+A Q+ + +L + H DL N L +
Sbjct: 126 R---------HMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176
Query: 204 ---TVKISDFG----LSRDVYA---SDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWS 253
+++++DFG + +YR PPE IL + DVWS
Sbjct: 177 KNTSIRVADFGSATFDHEHHTTIVATRHYR------------PPEVILELGWAQPCDVWS 224
Query: 254 YGVVLWEVYSYGLQPYYGYSNQEVIEMI 281
G +L+E Y G + + N+E + M+
Sbjct: 225 IGCILFEYYR-GFTLFQTHENREHLVMM 251
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 56/244 (22%), Positives = 98/244 (40%), Gaps = 35/244 (14%)
Query: 50 EVIETKPRFLQELGEGAFGKVYKGEVCT-SEGPSLVAIKTLKENANQKTASDFRREVDLM 108
E + +G+G+FG+V K VAIK +K + + EV L+
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVK---AYDRVEQEWVAIKIIKNKKAFLNQA--QIEVRLL 104
Query: 109 SELRHP------NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAP 162
+ IV L + +C++FE + +L++ L + + R
Sbjct: 105 ELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFR----------G 153
Query: 163 LSQQDFSHIALQVAAGMAYLCSH--HYVHRDLAARNCLVGDGL--TVKISDFGLSRDVYA 218
+S A Q+ + +L + +H DL N L+ + +KI DFG S +
Sbjct: 154 VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 213
Query: 219 SDYYRIQSKSLLPVRWM-PPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEV 277
Y IQS R+ PE +L + D+WS G +L E+++ G + G + +
Sbjct: 214 RIYQYIQS------RFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT-GEPLFSGANEVDQ 266
Query: 278 IEMI 281
+ I
Sbjct: 267 MNKI 270
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 33/120 (27%), Positives = 53/120 (44%), Gaps = 18/120 (15%)
Query: 313 GMAYLCSH--HYVHRDLAARNCLVGDGL--TVKISDFGLSRDVYASDYYRIQSKSLLPVR 368
+ +L + +H DL N L+ + +KI DFG S + Y IQS R
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQS------R 222
Query: 369 WM-PPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE------EFLKTPPSWI 421
+ PE +L + D+WS G +L E+++ G + G + + E L PP+ I
Sbjct: 223 FYRSPEVLLGMPYDLAIDMWSLGCILVEMHT-GEPLFSGANEVDQMNKIVEVLGIPPAHI 281
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 47/244 (19%), Positives = 94/244 (38%), Gaps = 41/244 (16%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHP 114
+ LG G FG+V+ ++ + L A K L + +K E +++++
Sbjct: 188 LDFRVLGRGGFGEVFACQMKATG--KLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR 245
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
IV L + +C++ M GD+ + + + + Q
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG--------FQEPRAIFYTAQ 297
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS-----------DYYR 223
+ +G+ +L + ++RDL N L+ D V+ISD GL+ ++ A +
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGF-- 355
Query: 224 IQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG----YSNQEVIE 279
M PE +L ++ D ++ GV L+E+ P+ N+E+ +
Sbjct: 356 -----------MAPELLLGEEYDFSVDYFALGVTLYEMI-AARGPFRARGEKVENKELKQ 403
Query: 280 MIRS 283
+
Sbjct: 404 RVLE 407
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 7e-06
Identities = 25/108 (23%), Positives = 46/108 (42%), Gaps = 25/108 (23%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS-----------DYYR 358
+ +G+ +L + ++RDL N L+ D V+ISD GL+ ++ A +
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGF-- 355
Query: 359 IQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG 406
M PE +L ++ D ++ GV L+E+ P+
Sbjct: 356 -----------MAPELLLGEEYDFSVDYFALGVTLYEMI-AARGPFRA 391
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 63/302 (20%), Positives = 117/302 (38%), Gaps = 64/302 (21%)
Query: 20 EVCTSEGPSLVAIKTLKENANQKTASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSE 79
+ + + ++ N ++ +DF FL LG+G+FGKV E ++
Sbjct: 316 KAPEEKTANTISKFDNNGNRDRMKLTDFN---------FLMVLGKGSFGKVMLSERKGTD 366
Query: 80 GPSLVAIKTLKENANQKTASDFRREVD-LMSE-------LRHPNIVCLLGVCLSGEPMCM 131
L A+K LK K +V+ M E + P + L + + +
Sbjct: 367 --ELYAVKILK-----KDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419
Query: 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRD 191
+ E++ GDL + + + R + A ++A G+ +L S ++RD
Sbjct: 420 VMEYVNGGDLM-YHIQQVGR-----------FKEPHAVFYAAEIAIGLFFLQSKGIIYRD 467
Query: 192 LAARNCLV-GDGLTVKISDFGLSR-----DVYAS------DYYRIQSKSLLPVRWMPPES 239
L N ++ +G +KI+DFG+ + V DY + PE
Sbjct: 468 LKLDNVMLDSEG-HIKIADFGMCKENIWDGVTTKTFCGTPDY-------------IAPEI 513
Query: 240 ILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYS 299
I Y + D W++GV+L+E+ G P+ G E+ + I + P+ +
Sbjct: 514 IAYQPYGKSVDWWAFGVLLYEML-AGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVA 571
Query: 300 LM 301
+
Sbjct: 572 IC 573
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 32/116 (27%), Positives = 52/116 (44%), Gaps = 27/116 (23%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFGLSR-----DVYAS------DYY 357
+A G+ +L S ++RDL N ++ +G +KI+DFG+ + V DY
Sbjct: 451 IAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWDGVTTKTFCGTPDY- 508
Query: 358 RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
+ PE I Y + D W++GV+L+E+ G P+ G E F
Sbjct: 509 ------------IAPEIIAYQPYGKSVDWWAFGVLLYEML-AGQAPFEGEDEDELF 551
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 1e-13
Identities = 66/273 (24%), Positives = 117/273 (42%), Gaps = 63/273 (23%)
Query: 30 VAIKTLKENANQK-TASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPS-LVAIK 87
+AI + ++K S F L+ LG+G+FGKV+ + + L A+K
Sbjct: 8 IAITHHVKEGHEKADPSQFE---------LLKVLGQGSFGKVFLVKKISGSDARQLYAMK 58
Query: 88 TL-KENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLM 146
L K + + E D++ E+ HP IV L + + ++ +F+ GDL +
Sbjct: 59 VLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLF-TRL 117
Query: 147 SRSPRSDISGSQVQAPLSQQDFS------HIALQVAAGMAYLCSHHYVHRDLAARNCLV- 199
S+ F+ ++A ++A + +L S ++RDL N L+
Sbjct: 118 SKEVM----------------FTEEDVKFYLA-ELALALDHLHSLGIIYRDLKPENILLD 160
Query: 200 GDGLTVKISDFGLSR-----DVYAS------DYYRIQSKSLLPVRWMPPESILYGKFTTE 248
+G +K++DFGLS+ + A +Y M PE + T
Sbjct: 161 EEG-HIKLTDFGLSKESIDHEKKAYSFCGTVEY-------------MAPEVVNRRGHTQS 206
Query: 249 SDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281
+D WS+GV+++E+ G P+ G +E + MI
Sbjct: 207 ADWWSFGVLMFEML-TGTLPFQGKDRKETMTMI 238
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 2e-05
Identities = 34/131 (25%), Positives = 59/131 (45%), Gaps = 33/131 (25%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFGLSR-----DVYAS------DYY 357
+A + +L S ++RDL N L+ +G +K++DFGLS+ + A +Y
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHEKKAYSFCGTVEY- 192
Query: 358 RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF---L 414
M PE + T +D WS+GV+++E+ G P+ G +E L
Sbjct: 193 ------------MAPEVVNRRGHTQSADWWSFGVLMFEML-TGTLPFQGKDRKETMTMIL 239
Query: 415 KTP---PSWIT 422
K P +++
Sbjct: 240 KAKLGMPQFLS 250
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 55/260 (21%), Positives = 99/260 (38%), Gaps = 49/260 (18%)
Query: 33 KTLKENANQKTASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN 92
K + N F + I+T LG G+FG+V V E + A+K L +
Sbjct: 29 KWETPSQNTAQLDQF--DRIKT-------LGTGSFGRVML--VKHKESGNHYAMKILDKQ 77
Query: 93 A--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSP 150
K E ++ + P +V L + M+ E++ G++ + R
Sbjct: 78 KVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF-SHLRRIG 136
Query: 151 RSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKISD 209
R ++ F A Q+ YL S ++RDL N L+ G ++++D
Sbjct: 137 RFSEPHAR---------F--YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVTD 184
Query: 210 FGLSRDVYAS--------DYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEV 261
FG ++ V + + PE IL + D W+ GV+++E+
Sbjct: 185 FGFAKRVKGRTWTLCGTPEA-------------LAPEIILSKGYNKAVDWWALGVLIYEM 231
Query: 262 YSYGLQPYYGYSNQEVIEMI 281
+ G P++ ++ E I
Sbjct: 232 -AAGYPPFFADQPIQIYEKI 250
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 66/283 (23%), Positives = 108/283 (38%), Gaps = 72/283 (25%)
Query: 43 TASDFRREVIETKPRFLQELGEGAFGKV----YKGEVCTSEGPSLVAIKTLKENANQKTA 98
DF + LG+G+FGKV +K T++ AIK LK K
Sbjct: 15 KIEDFI---------LHKMLGKGSFGKVFLAEFKK---TNQ---FFAIKALK-----KDV 54
Query: 99 SDFRREVD-LMSE-------LRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSP 150
+V+ M E HP + + + E + + E++ GDL + +
Sbjct: 55 VLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLM-YHIQSCH 113
Query: 151 RSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKISD 209
+ + A ++ G+ +L S V+RDL N L+ DG +KI+D
Sbjct: 114 K-----------FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-HIKIAD 161
Query: 210 FGLSR-----DVYAS------DYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVL 258
FG+ + D + DY + PE +L K+ D WS+GV+L
Sbjct: 162 FGMCKENMLGDAKTNTFCGTPDY-------------IAPEILLGQKYNHSVDWWSFGVLL 208
Query: 259 WEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLM 301
+E+ G P++G +E+ IR P L+
Sbjct: 209 YEM-LIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLL 249
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 5e-05
Identities = 35/116 (30%), Positives = 55/116 (47%), Gaps = 27/116 (23%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFGLSR-----DVYAS------DYY 357
+ G+ +L S V+RDL N L+ DG +KI+DFG+ + D + DY
Sbjct: 127 IILGLQFLHSKGIVYRDLKLDNILLDKDG-HIKIADFGMCKENMLGDAKTNTFCGTPDY- 184
Query: 358 RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
+ PE +L K+ D WS+GV+L+E+ G P++G +E F
Sbjct: 185 ------------IAPEILLGQKYNHSVDWWSFGVLLYEM-LIGQSPFHGQDEEELF 227
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 63/288 (21%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 24 SEGPSLVAIKTLKENANQK-TASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPS 82
S+ ++ + T ++F +L+ LG+G FGKV + +
Sbjct: 126 SDNSGAEEMEVSLAKPKHRVTMNEFE---------YLKLLGKGTFGKVILVKEKATG--R 174
Query: 83 LVAIKTLKENANQKTASDFRREVD-LMSE------LRHPNIVCLLGVCLSGEPMCMLFEF 135
A+K LK K + EV ++E RHP + L + + +C + E+
Sbjct: 175 YYAMKILK-----KEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 229
Query: 136 MVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHH-YVHRDLAA 194
G+L F +SR S+ ++ + + YL S V+RDL
Sbjct: 230 ANGGELF-FHLSRERV-----------FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKL 277
Query: 195 RNCLVGDGLTVKISDFGLSR-DVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWS 253
N ++ +KI+DFGL + + +++ P ++ PE + + D W
Sbjct: 278 ENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTP-EYLAPEVLEDNDYGRAVDWWG 334
Query: 254 YGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLM 301
GVV++E+ G P+Y ++++ E+I + + P P SL+
Sbjct: 335 LGVVMYEMM-CGRLPFYNQDHEKLFELILMEE-IRFPRTLGPEAKSLL 380
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 27/106 (25%), Positives = 51/106 (48%), Gaps = 6/106 (5%)
Query: 310 VAAGMAYLCSHH-YVHRDLAARNCLVGDGLTVKISDFGLSR-DVYASDYYRIQSKSLLPV 367
+ + + YL S V+RDL N ++ +KI+DFGL + + +++ P
Sbjct: 257 IVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTP- 313
Query: 368 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
++ PE + + D W GVV++E+ G P+Y +++ F
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMM-CGRLPFYNQDHEKLF 358
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 6e-13
Identities = 62/278 (22%), Positives = 109/278 (39%), Gaps = 63/278 (22%)
Query: 43 TASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFR 102
T +DF +L+ LG+G FGKV + A+K L+ K +
Sbjct: 3 TMNDFD---------YLKLLGKGTFGKVILVREKATG--RYYAMKILR-----KEVIIAK 46
Query: 103 REVD-LMSE------LRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDIS 155
EV ++E RHP + L + + +C + E+ G+L F +SR
Sbjct: 47 DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF-FHLSRERV---- 101
Query: 156 GSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFGLSR 214
+++ ++ + + YL S V+RD+ N ++ DG +KI+DFGL +
Sbjct: 102 -------FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCK 153
Query: 215 -DVYASD----------YYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYS 263
+ Y + PE + + D W GVV++E+
Sbjct: 154 EGISDGATMKTFCGTPEY-------------LAPEVLEDNDYGRAVDWWGLGVVMYEMM- 199
Query: 264 YGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLM 301
G P+Y ++ + E+I + + P P SL+
Sbjct: 200 CGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLL 236
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 4e-05
Identities = 28/116 (24%), Positives = 48/116 (41%), Gaps = 27/116 (23%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFGLSR-DVYASD----------YY 357
+ + + YL S V+RD+ N ++ DG +KI+DFGL + + Y
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFCGTPEY- 171
Query: 358 RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
+ PE + + D W GVV++E+ G P+Y ++ F
Sbjct: 172 ------------LAPEVLEDNDYGRAVDWWGLGVVMYEMM-CGRLPFYNQDHERLF 214
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 6e-13
Identities = 55/272 (20%), Positives = 96/272 (35%), Gaps = 74/272 (27%)
Query: 46 DFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRR-- 103
R E+++T LGEGAFGKV + + G VA+K +K N +
Sbjct: 13 SARYEIVDT-------LGEGAFGKVVEC-IDHKAGGRHVAVKIVK---NVD---RYCEAA 58
Query: 104 --EVDLMSELRHP------NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDIS 155
E+ ++ L V +L +C++FE ++ ++F+
Sbjct: 59 RSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLP-FR 116
Query: 156 GSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDL-------------------AARN 196
++ +A Q+ + +L S+ H DL R+
Sbjct: 117 LDHIR---------KMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167
Query: 197 CLVGDGLTVKISDFG----LSRDVYA---SDYYRIQSKSLLPVRWMPPESILYGKFTTES 249
+K+ DFG + +YR PE IL ++
Sbjct: 168 ERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYR------------APEVILALGWSQPC 215
Query: 250 DVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281
DVWS G +L E Y G + + ++E + M+
Sbjct: 216 DVWSIGCILIEYYL-GFTVFPTHDSKEHLAMM 246
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 1e-12
Identities = 54/249 (21%), Positives = 97/249 (38%), Gaps = 68/249 (27%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPN 115
L+ LG G+FG+V+ + + A+K LK+ K E ++S + HP
Sbjct: 10 ILRTLGTGSFGRVHL--IRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 116 IVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHI---- 171
I+ + G + + M+ +++ G+L FS +
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGEL--------------------------FSLLRKSQ 101
Query: 172 ----------ALQVAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFGLSRDVYAS- 219
A +V + YL S ++RDL N L+ +G +KI+DFG ++ V
Sbjct: 102 RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFAKYVPDVT 160
Query: 220 -------DYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY 272
DY + PE + + D WS+G++++E+ G P+Y
Sbjct: 161 YTLCGTPDY-------------IAPEVVSTKPYNKSIDWWSFGILIYEM-LAGYTPFYDS 206
Query: 273 SNQEVIEMI 281
+ + E I
Sbjct: 207 NTMKTYEKI 215
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 40.2 bits (95), Expect = 7e-04
Identities = 28/106 (26%), Positives = 47/106 (44%), Gaps = 24/106 (22%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFGLSRDVYAS--------DYYRIQ 360
V + YL S ++RDL N L+ +G +KI+DFG ++ V DY
Sbjct: 115 VCLALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFAKYVPDVTYTLCGTPDY---- 169
Query: 361 SKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG 406
+ PE + + D WS+G++++E+ G P+Y
Sbjct: 170 ---------IAPEVVSTKPYNKSIDWWSFGILIYEM-LAGYTPFYD 205
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 48/270 (17%), Positives = 97/270 (35%), Gaps = 67/270 (24%)
Query: 50 EVIETKPRFLQELGEGAFGKVYKGEVCT-SEGPSLVAIKTLKENANQKTASDFRREVDLM 108
++ ++++G+G FG+V C + A+K ++ ++ + E D++
Sbjct: 31 MLLNNAFLVIRKMGDGTFGRVLL---CQHIDNKKYYAVKVVRNIKKYTRSA--KIEADIL 85
Query: 109 SELRH-----PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPL 163
++++ NIV G + + MC++FE + L+E + + ++
Sbjct: 86 KKIQNDDINNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNG-FHIEDIK--- 140
Query: 164 SQQDFSHIALQVAAGMAYLCSHHYVHRDL-------------------------AARNCL 198
+++ + YL H DL
Sbjct: 141 ------LYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY 194
Query: 199 VGDGLTVKISDFG----LSRDVYA---SDYYRIQSKSLLPVRWMPPESILYGKFTTESDV 251
+K+ DFG S + + YR PE IL + SD+
Sbjct: 195 RTKSTGIKLIDFGCATFKSDYHGSIINTRQYR------------APEVILNLGWDVSSDM 242
Query: 252 WSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281
WS+G VL E+Y+ G + + + E + M+
Sbjct: 243 WSFGCVLAELYT-GSLLFRTHEHMEHLAMM 271
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 61/299 (20%), Positives = 112/299 (37%), Gaps = 67/299 (22%)
Query: 26 GPSLVAIKTLKENANQK---TASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPS 82
GP + + N +F F++ LG+G+FGKV V +
Sbjct: 1 GPKESSKEGNGIGVNSSNRLGIDNFE---------FIRVLGKGSFGKVMLARVKETG--D 49
Query: 83 LVAIKTLKENANQKTASDFRREVD-LMSE-------LRHPNIVCLLGVCLSGEPMCMLFE 134
L A+K LK K +V+ M+E HP + L + + + + E
Sbjct: 50 LYAVKVLK-----KDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVME 104
Query: 135 FMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAA 194
F+ GDL F + +S R + A ++ + + +L ++RDL
Sbjct: 105 FVNGGDLM-FHIQKSRR-----------FDEARARFYAAEIISALMFLHDKGIIYRDLKL 152
Query: 195 RNCLV-GDGLTVKISDFGLSR-----DVYAS------DYYRIQSKSLLPVRWMPPESILY 242
N L+ +G K++DFG+ + V + DY + PE +
Sbjct: 153 DNVLLDHEG-HCKLADFGMCKEGICNGVTTATFCGTPDY-------------IAPEILQE 198
Query: 243 GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLM 301
+ D W+ GV+L+E+ G P+ + ++ E I + + + P ++
Sbjct: 199 MLYGPAVDWWAMGVLLYEML-CGHAPFEAENEDDLFEAILNDE-VVYPTWLHEDATGIL 255
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 25/116 (21%), Positives = 48/116 (41%), Gaps = 27/116 (23%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFGLSR-----DVYAS------DYY 357
+ + + +L ++RDL N L+ +G K++DFG+ + V + DY
Sbjct: 133 IISALMFLHDKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGICNGVTTATFCGTPDY- 190
Query: 358 RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
+ PE + + D W+ GV+L+E+ G P+ + + F
Sbjct: 191 ------------IAPEILQEMLYGPAVDWWAMGVLLYEML-CGHAPFEAENEDDLF 233
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.8 bits (162), Expect = 2e-12
Identities = 39/212 (18%), Positives = 63/212 (29%), Gaps = 38/212 (17%)
Query: 40 NQKTASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIK-------TLKEN 92
+QK F + K + +++GEG FG+V++ + VAIK L
Sbjct: 6 SQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQT----IADHTPVAIKIIAIEGPDLVNG 61
Query: 93 ANQKTASDFRREVDLMSEL---------RHPNIVCLLG--VCLSGEPMCMLFEFMVRGDL 141
++QKT + E+ + EL R + L P +L +
Sbjct: 62 SHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNST 121
Query: 142 HEFLMSRSPRSDISG---------------SQVQAPLSQQDFSHIALQVAAGMAYLC-SH 185
R S I Q+ A +A S
Sbjct: 122 KGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL 181
Query: 186 HYVHRDLAARNCLVGDGLTVKISDFGLSRDVY 217
+ HRDL N L+ K+ +
Sbjct: 182 RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSST 213
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 3e-12
Identities = 54/264 (20%), Positives = 110/264 (41%), Gaps = 52/264 (19%)
Query: 34 TLKENANQKTASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPS-LVAIKTLKEN 92
++ + F L+ LG+G +GKV++ T + A+K LK+
Sbjct: 6 SVNRGPEKIRPECFE---------LLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKA 56
Query: 93 ---ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRS 149
N K + + E +++ E++HP IV L+ +G + ++ E++ G+L + R
Sbjct: 57 MIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELF-MQLERE 115
Query: 150 PRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKIS 208
+ F ++A +++ + +L ++RDL N ++ G VK++
Sbjct: 116 GIFMEDTAC---------F-YLA-EISMALGHLHQKGIIYRDLKPENIMLNHQG-HVKLT 163
Query: 209 DFGLSR-DVYASD----------YYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVV 257
DFGL + ++ Y M PE ++ D WS G +
Sbjct: 164 DFGLCKESIHDGTVTHTFCGTIEY-------------MAPEILMRSGHNRAVDWWSLGAL 210
Query: 258 LWEVYSYGLQPYYGYSNQEVIEMI 281
++++ G P+ G + ++ I+ I
Sbjct: 211 MYDML-TGAPPFTGENRKKTIDKI 233
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 3e-05
Identities = 27/131 (20%), Positives = 53/131 (40%), Gaps = 33/131 (25%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFGLSR-DVYASD----------YY 357
++ + +L ++RDL N ++ G VK++DFGL + ++ Y
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQG-HVKLTDFGLCKESIHDGTVTHTFCGTIEY- 187
Query: 358 RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF---L 414
M PE ++ D WS G +++++ G P+ G + ++ L
Sbjct: 188 ------------MAPEILMRSGHNRAVDWWSLGALMYDML-TGAPPFTGENRKKTIDKIL 234
Query: 415 KTP---PSWIT 422
K P ++T
Sbjct: 235 KCKLNLPPYLT 245
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 7e-12
Identities = 65/285 (22%), Positives = 112/285 (39%), Gaps = 66/285 (23%)
Query: 38 NANQKTASDFRREVIETKPRFLQELGEGAFGKVYKGE-VCTSEGPSLVAIKTLKENANQK 96
N ++ +DF FL LG+G+FGKV E T E L A+K LK K
Sbjct: 13 NRDRMKLTDFN---------FLMVLGKGSFGKVMLSERKGTDE---LYAVKILK-----K 55
Query: 97 TASDFRREVD-LMSE-------LRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSR 148
+V+ M E + P + L + + + + E++ GDL + + +
Sbjct: 56 DVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLM-YHIQQ 114
Query: 149 SPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKI 207
R + A ++A G+ +L S ++RDL N ++ +G +KI
Sbjct: 115 VGR-----------FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKI 162
Query: 208 SDFGLSR-----DVYAS------DYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGV 256
+DFG+ + V DY + PE I Y + D W++GV
Sbjct: 163 ADFGMCKENIWDGVTTKTFCGTPDY-------------IAPEIIAYQPYGKSVDWWAFGV 209
Query: 257 VLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLM 301
+L+E+ G P+ G E+ + I + P+ ++
Sbjct: 210 LLYEML-AGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAIC 252
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 9e-05
Identities = 33/131 (25%), Positives = 57/131 (43%), Gaps = 33/131 (25%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFGLSR-----DVYAS------DYY 357
+A G+ +L S ++RDL N ++ +G +KI+DFG+ + V DY
Sbjct: 130 IAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWDGVTTKTFCGTPDY- 187
Query: 358 RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF---L 414
+ PE I Y + D W++GV+L+E+ G P+ G E F +
Sbjct: 188 ------------IAPEIIAYQPYGKSVDWWAFGVLLYEML-AGQAPFEGEDEDELFQSIM 234
Query: 415 KTP---PSWIT 422
+ P ++
Sbjct: 235 EHNVAYPKSMS 245
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 7e-12
Identities = 25/243 (10%), Positives = 50/243 (20%), Gaps = 53/243 (21%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHP 114
R L G + ++ + VA+ + + +S + P
Sbjct: 34 RLLIFHGGVPPLQFWQALDTALDRQ--VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKP 91
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRG-DLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
+ +L V + ++ E+ +RG L E S
Sbjct: 92 GVARVLDVVHTRAGGLVVAEW-IRGGSLQEVA--------------DTSPSPVGAIRAMQ 136
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR 233
+AA V V ++ D
Sbjct: 137 SLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDA----------------- 179
Query: 234 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDC 293
+ D+ G L+ + P + +
Sbjct: 180 ------------NPQDDIRGIGASLYALLV-NRWPLPEAGVRSGLAPAERDTAGQPI--- 223
Query: 294 PPR 296
P
Sbjct: 224 EPA 226
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 64/293 (21%), Positives = 111/293 (37%), Gaps = 92/293 (31%)
Query: 24 SEGPSLVAIKTLKENANQK-TASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPS 82
+ P+ L ++N SDF FL+ +G+G+FGKV E
Sbjct: 16 APPPAPSQQINLGPSSNPHAKPSDFH---------FLKVIGKGSFGKVLLARHKAEE--V 64
Query: 83 LVAIKTLKENANQKTASDFRREVD-LMSE-------LRHPNIVCLLGVCLSGEPMCMLFE 134
A+K L+ K A ++E +MSE ++HP +V L + + + + +
Sbjct: 65 FYAVKVLQ-----KKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD 119
Query: 135 FMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHI--------------ALQVAAGMA 180
++ G+L F H+ A ++A+ +
Sbjct: 120 YINGGEL--------------------------FYHLQRERCFLEPRARFYAAEIASALG 153
Query: 181 YLCSHHYVHRDLAARNCLV-GDGLTVKISDFGLSRDVYAS-----------DYYRIQSKS 228
YL S + V+RDL N L+ G + ++DFGL ++ +Y
Sbjct: 154 YLHSLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEHNSTTSTFCGTPEY------- 205
Query: 229 LLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281
+ PE + + D W G VL+E+ YGL P+Y + E+ + I
Sbjct: 206 ------LAPEVLHKQPYDRTVDWWCLGAVLYEML-YGLPPFYSRNTAEMYDNI 251
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 8e-05
Identities = 34/131 (25%), Positives = 54/131 (41%), Gaps = 33/131 (25%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFGLSRDVYAS-----------DYY 357
+A+ + YL S + V+RDL N L+ G + ++DFGL ++ +Y
Sbjct: 148 IASALGYLHSLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEHNSTTSTFCGTPEY- 205
Query: 358 RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF---L 414
+ PE + + D W G VL+E+ YGL P+Y + E + L
Sbjct: 206 ------------LAPEVLHKQPYDRTVDWWCLGAVLYEML-YGLPPFYSRNTAEMYDNIL 252
Query: 415 KTP---PSWIT 422
P IT
Sbjct: 253 NKPLQLKPNIT 263
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 5e-11
Identities = 52/278 (18%), Positives = 98/278 (35%), Gaps = 86/278 (30%)
Query: 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMS 109
++ + +++LG G F V+ + VA+K +K + + E+ L+
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGK--KFVAMKVVK--SAEHYTETALDEIRLLK 88
Query: 110 ELR-----HPN---IVCLL------GVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDIS 155
+R PN +V LL GV +G +CM+FE + L ++ + +S +
Sbjct: 89 SVRNSDPNDPNREMVVQLLDDFKISGV--NGTHICMVFEVL-GHHLLKW-IIKSNYQGLP 144
Query: 156 GSQVQAPLSQQDFSHIALQVAAGMAYLCSH-HYVHRDLAARNCLVG-------------- 200
V+ I QV G+ YL + +H D+ N L+
Sbjct: 145 LPCVKK---------IIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEAT 195
Query: 201 -----------------------------------DGLTVKISDFGLSRDVYASDYYRIQ 225
+ L VKI+D G + V+ IQ
Sbjct: 196 EWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ 255
Query: 226 SKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYS 263
++ E ++ + T +D+WS + +E+ +
Sbjct: 256 TRQYRS-----LEVLIGSGYNTPADIWSTACMAFELAT 288
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 8e-06
Identities = 18/116 (15%), Positives = 38/116 (32%), Gaps = 8/116 (6%)
Query: 286 MLPCPEDCPPRMYSLMMECWHEVPVAAGMA---YLCSHHYVHRDLAARNCLVGDGLTVKI 342
+L + R + W + + + L VKI
Sbjct: 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKI 237
Query: 343 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYS 398
+D G + V+ IQ++ E ++ + T +D+WS + +E+ +
Sbjct: 238 ADLGNACWVHKHFTEDIQTRQYRS-----LEVLIGSGYNTPADIWSTACMAFELAT 288
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 49/306 (16%), Positives = 111/306 (36%), Gaps = 71/306 (23%)
Query: 24 SEGPSLVAIKTLKENANQKTASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSL 83
E + + + ++ DF L+ +G G++ KV + ++ +
Sbjct: 31 EEEKEAMNTRESGKASSSLGLQDFD---------LLRVIGRGSYAKVLLVRLKKTD--RI 79
Query: 84 VAIKTLKENANQKTASDFRREVD-LMSE-------LRHPNIVCLLGVCLSGEPMCMLFEF 135
A++ +K K + ++D + +E HP +V L + + + E+
Sbjct: 80 YAMRVVK-----KELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 134
Query: 136 MVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAAR 195
+ GDL F M R + L ++ + +++ + YL ++RDL
Sbjct: 135 VNGGDLM-FHMQRQRK-----------LPEEHARFYSAEISLALNYLHERGIIYRDLKLD 182
Query: 196 NCLV-GDGLTVKISDFGLSR-----DVYAS------DYYRIQSKSLLPVRWMPPESILYG 243
N L+ +G +K++D+G+ + S +Y + PE +
Sbjct: 183 NVLLDSEG-HIKLTDYGMCKEGLRPGDTTSTFCGTPNY-------------IAPEILRGE 228
Query: 244 KFTTESDVWSYGVVLWE--------VYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPP 295
+ D W+ GV+++E + + ++I +Q + P
Sbjct: 229 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-IRIPRSLSV 287
Query: 296 RMYSLM 301
+ S++
Sbjct: 288 KAASVL 293
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 2e-09
Identities = 49/292 (16%), Positives = 106/292 (36%), Gaps = 71/292 (24%)
Query: 38 NANQKTASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKT 97
+ DF L+ +G G++ KV + ++ + A+K +K K
Sbjct: 2 AMDPLGLQDFD---------LLRVIGRGSYAKVLLVRLKKTD--RIYAMKVVK-----KE 45
Query: 98 ASDFRREVD-LMSE-------LRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRS 149
+ ++D + +E HP +V L + + + E++ GDL F M R
Sbjct: 46 LVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLM-FHMQRQ 104
Query: 150 PRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKIS 208
+ L ++ + +++ + YL ++RDL N L+ +G +K++
Sbjct: 105 RK-----------LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLT 152
Query: 209 DFGLSR-----DVYAS------DYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVV 257
D+G+ + S +Y + PE + + D W+ GV+
Sbjct: 153 DYGMCKEGLRPGDTTSTFCGTPNY-------------IAPEILRGEDYGFSVDWWALGVL 199
Query: 258 LWE--------VYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLM 301
++E + + ++I +Q + P + S++
Sbjct: 200 MFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-IRIPRSLSVKAASVL 250
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 55/265 (20%), Positives = 107/265 (40%), Gaps = 37/265 (13%)
Query: 30 VAIKTLKENANQKTASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPS-LVAIKT 88
+ L +A + +F L+ LG GA+GKV+ + L A+K
Sbjct: 39 LRTANLTGHAEKVGIENFE---------LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKV 89
Query: 89 LK-----ENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHE 143
LK + A + R+V L + P +V L + + ++ +++ G+L
Sbjct: 90 LKKATIVQKAKTTEHTRTERQV-LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELF- 147
Query: 144 FLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV-GDG 202
+S+ R Q ++ ++ + +L ++RD+ N L+ +G
Sbjct: 148 THLSQRERFTEHEVQ---------I-YVG-EIVLALEHLHKLGIIYRDIKLENILLDSNG 196
Query: 203 LTVKISDFGLSRDVYASDYYRIQSKSLL-PVRWMPPESILYGK--FTTESDVWSYGVVLW 259
V ++DFGLS++ A + R + + +M P+ + G D WS GV+++
Sbjct: 197 -HVVLTDFGLSKEFVADETER--AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMY 253
Query: 260 EVYSYGLQPYYGYSNQE-VIEMIRS 283
E+ G P+ + E+ R
Sbjct: 254 ELL-TGASPFTVDGEKNSQAEISRR 277
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 25/106 (23%), Positives = 49/106 (46%), Gaps = 8/106 (7%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFGLSRDVYASDYYRIQSKSLL-PV 367
+ + +L ++RD+ N L+ +G V ++DFGLS++ A + R + +
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFVADETER--AYDFCGTI 224
Query: 368 RWMPPESILYGK--FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
+M P+ + G D WS GV+++E+ G P+ +
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL-TGASPFTVDGEKN 269
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 6e-07
Identities = 26/169 (15%), Positives = 57/169 (33%), Gaps = 15/169 (8%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSL------VAIKTLKENANQKTASDFRREVDLMSE 110
+ G +Y+ ++ ++K ++ +F + +
Sbjct: 45 KLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQ 104
Query: 111 LRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFL-MSRSPRS--DISGSQVQAPLSQQD 167
+ L L P C F V D + FL + RS + LS++
Sbjct: 105 VNKWKK--LYSTPLLAIPTC--MGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERS 160
Query: 168 FSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI--SDFGLSR 214
+A ++ + +L + YVH ++ A N V ++ + +G +
Sbjct: 161 VLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 35/176 (19%), Positives = 62/176 (35%), Gaps = 29/176 (16%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSL---VAIKTLKENANQKTASDFRREVDLMSELRH 113
+ +G+G FG +Y ++ +SE +K + E+
Sbjct: 38 KVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP-----LFTELKFYQRAAK 92
Query: 114 PNIV----CLLGVCLSGEPMCMLF-EFMVRGDLHEFL-MSRSPRSDISGSQVQAPLSQQD 167
P + + G P G + F+ M D GS +Q
Sbjct: 93 PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIM------DRFGSDLQKIYEANA 146
Query: 168 --FS-----HIALQVAAGMAYLCSHHYVHRDLAARNCLVG--DGLTVKISDFGLSR 214
FS ++L++ + Y+ H YVH D+ A N L+ + V + D+GL+
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 39/163 (23%), Positives = 66/163 (40%), Gaps = 23/163 (14%)
Query: 57 RFLQELGEGAFGKVYKGE-VCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRH-P 114
R +++G G+FG +Y G + E VAIK E + ++
Sbjct: 12 RLGRKIGSGSFGDIYLGTDIAAGE---EVAIKLECVKTKH---PQLHIESKIYKMMQGGV 65
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
I + G+ M+ E + G E L + R S + +A Q
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRK----------FSLKTVLLLADQ 113
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVGDGLT---VKISDFGLSR 214
+ + + Y+ S +++HRD+ N L+G G V I DFGL++
Sbjct: 114 MISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 41/164 (25%), Positives = 69/164 (42%), Gaps = 25/164 (15%)
Query: 57 RFLQELGEGAFGKVYKGE-VCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPN 115
R +++G G+FG++Y G + T+E VAIK E + L+
Sbjct: 10 RLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTKH---PQLLYESKIYRILQ--- 60
Query: 116 IVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRS--DISGSQVQAPLSQQDFSHIAL 173
G + + F V GD + +M S D+ + LS + +A
Sbjct: 61 ---------GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSR-KLSLKTVLMLAD 110
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLT---VKISDFGLSR 214
Q+ + ++ S ++HRD+ N L+G G V I DFGL++
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 2e-05
Identities = 73/501 (14%), Positives = 139/501 (27%), Gaps = 168/501 (33%)
Query: 30 VAIKTLKENANQKTASDFRREVI-------------------------ETKP-----RFL 59
V +N + K D + ++ +K +F+
Sbjct: 24 VFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFV 83
Query: 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKE-----NANQKTASDFRREVDLMSELR-- 112
+E+ + + PS++ +++ N NQ A + +LR
Sbjct: 84 EEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQA 143
Query: 113 ------HPNIV----------CL-LGVCLSGEPMCMLFEFMVRGDLHEFLMS----RSPR 151
N++ + L VCLS + C +F + F ++ SP
Sbjct: 144 LLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCK-MDFKI------FWLNLKNCNSPE 196
Query: 152 SDISG-----SQVQAPLSQQD--FSHIALQVAAGMAYLCSHHYVHRDLAARNCL-----V 199
+ + Q+ + + S+I L++ + A L + NCL V
Sbjct: 197 TVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAEL-RRLLKSKPY--ENCLLVLLNV 253
Query: 200 GDGLTVKISDFG-----LSRDVYASD------YYRI------------QSKSLLPVRWM- 235
+ + +R +D I + KSLL ++++
Sbjct: 254 QNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL-LKYLD 312
Query: 236 ------PPE---------SILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN-QEVIE 279
P E SI+ W W+ + +IE
Sbjct: 313 CRPQDLPREVLTTNPRRLSIIAESIRDGLATWDN----WK--------HVNCDKLTTIIE 360
Query: 280 M---------IRSR-QMLPC-PEDC--PPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRD 326
R L P P + SL+ W +V + M + H
Sbjct: 361 SSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLI---WFDVIKSDVMVVVNKLH--KYS 415
Query: 327 LAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDV 386
L + T+ I L V + Y + +S++ + Y D
Sbjct: 416 LVEKQ---PKESTISIPSIYLELKVKLENEYALH-RSIV-------DH--Y-NIPKTFDS 461
Query: 387 WSYGVVLWEVYSYGLQPYYGY 407
+ Y Y + G+
Sbjct: 462 DDLIPPYLDQYFYS---HIGH 479
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 39/172 (22%), Positives = 66/172 (38%), Gaps = 39/172 (22%)
Query: 57 RFLQELGEGAFGKVYKGE-VCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRH-- 113
R +++G G FG++ G+ + T+E VAIK + E +L
Sbjct: 12 RVGKKIGCGNFGELRLGKNLYTNE---YVAIKLEPMKSRA---PQLHLEYRFYKQLGSGD 65
Query: 114 --PNIVCLLGVCLSGEPMCMLFEFMVRGDLH----EFLMSRSPRSDISGSQVQAPLSQQD 167
P + G C + MV +L E L R+ S +
Sbjct: 66 GIPQVYY------FGP--CGKYNAMV-LELLGPSLEDLFDLCDRT----------FSLKT 106
Query: 168 FSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLT-----VKISDFGLSR 214
IA+Q+ + M Y+ S + ++RD+ N L+G + I DF L++
Sbjct: 107 VLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 37/178 (20%), Positives = 67/178 (37%), Gaps = 39/178 (21%)
Query: 51 VIETKPRFLQELGEGAFGKVYKGE-VCTSEGPSLVAIKTLKENANQKTASDFRREVDLMS 109
V+ + + +GEG+FG +++G + ++ VAIK ++ R E
Sbjct: 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQ---QVAIKFEPRRSDA---PQLRDEYRTYK 60
Query: 110 ELRH----PNIVCLLGVCLSGEPMCMLFEFMVRGDLH----EFLMSRSPRSDISGSQVQA 161
L PN+ G+ L +V DL E L+ R
Sbjct: 61 LLAGCTGIPNVYY------FGQ--EGLHNVLV-IDLLGPSLEDLLDLCGRK--------- 102
Query: 162 PLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLT-----VKISDFGLSR 214
S + + A Q+ A + + V+RD+ N L+G + + + DFG+ +
Sbjct: 103 -FSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 7e-05
Identities = 29/172 (16%), Positives = 61/172 (35%), Gaps = 24/172 (13%)
Query: 57 RFLQELGEGAFGKVYKGE-VCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPN 115
+++G G FG +Y E + +K + E+ + +
Sbjct: 40 VLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP-----LFSELKFYQRVAKKD 94
Query: 116 IVC----LLGVCLSGEPMCMLF-EFMVRGDLHEFL-MSRSPRS-----DISGSQVQAPLS 164
+ + G P+ +G + F+ M R +G+
Sbjct: 95 CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGT-----FK 149
Query: 165 QQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVG--DGLTVKISDFGLSR 214
+ + +++ + Y+ + YVH D+ A N L+G + V ++D+GLS
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 422 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 99.92 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 99.92 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.92 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 99.91 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.91 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 99.91 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.9 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.9 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.89 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 99.89 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.89 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.88 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.86 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.86 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.85 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.85 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.85 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.81 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.79 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.78 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.78 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.78 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.77 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.77 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.77 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.77 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.77 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.77 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.77 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.77 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.77 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.76 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.76 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.76 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.76 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.76 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.76 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.75 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.75 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.75 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.75 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.75 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.75 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.75 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.75 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.74 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.74 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.74 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.74 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.74 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.74 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.74 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.74 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.74 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.74 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.74 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.74 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.74 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.74 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.74 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.74 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.74 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.74 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.73 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.73 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.73 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.73 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.73 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.73 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.73 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.73 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.73 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.73 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.73 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.73 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.73 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.73 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.73 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.73 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.73 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.73 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.73 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.73 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.73 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.73 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.73 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.72 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.72 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.72 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.72 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.72 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.72 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.72 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.72 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.72 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.72 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.72 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.72 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.72 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.72 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.72 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.72 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.72 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.72 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.71 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.71 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.71 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.71 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.71 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.71 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.71 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.71 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.71 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.71 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.71 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.71 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.71 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.71 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.71 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.7 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.7 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.7 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.7 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.7 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.7 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.7 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.7 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.7 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.7 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.7 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.7 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.7 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.7 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.7 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.7 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.7 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.7 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.7 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.69 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.69 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.69 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.69 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.69 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.69 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.69 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.69 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.69 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.69 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.69 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.69 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.69 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.68 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.68 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.68 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.68 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.68 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.68 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.68 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.68 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.68 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.68 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.68 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.68 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.68 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.68 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.68 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.68 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.68 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.68 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.68 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.67 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.67 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.67 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.67 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.67 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.67 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.67 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.67 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.67 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.67 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.67 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.67 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.67 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.67 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.67 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.67 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.67 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.66 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.66 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.66 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.66 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.66 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.66 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.66 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.66 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.66 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.66 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.66 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.66 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.66 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.66 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.66 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.66 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.65 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.65 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.65 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.65 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.65 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.65 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.65 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.65 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.65 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.65 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.65 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.64 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.64 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.64 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.64 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.64 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.63 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.63 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.63 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.63 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.63 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.63 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.62 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.62 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.62 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.62 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.62 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.62 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.62 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.62 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.62 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.62 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.62 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.62 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.61 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.61 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.6 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.6 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.6 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.57 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.56 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.56 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-66 Score=496.07 Aligned_cols=276 Identities=56% Similarity=1.038 Sum_probs=241.1
Q ss_pred hhccccCcccccccccccceeEEEEEEec---CCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc
Q psy7289 49 REVIETKPRFLQELGEGAFGKVYKGEVCT---SEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLS 125 (422)
Q Consensus 49 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 125 (422)
.++..+.+++.++||+|+||+||+|++.. ...++.||||+++........+.|.+|+.+|++|+|||||+++|+|.+
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 35666788999999999999999999753 234678999999866555567889999999999999999999999999
Q ss_pred CCCeEEEEEecCCCCHHHHHhhcCCCCCCCC----CCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC
Q psy7289 126 GEPMCMLFEFMVRGDLHEFLMSRSPRSDISG----SQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD 201 (422)
Q Consensus 126 ~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~----~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~ 201 (422)
++.+++|||||++|||.++|..+.+..+... ......+++.++.+++.|||.||+|||+++||||||||+||||++
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 9999999999999999999987654332111 122356999999999999999999999999999999999999999
Q ss_pred CCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHH
Q psy7289 202 GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281 (422)
Q Consensus 202 ~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i 281 (422)
++.+||+|||+|+.....+.........+|++|||||++..+.|+.++|||||||++|||+|.|..||.+.++.+++..|
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i 260 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 260 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999999998765554445556678999999999999999999999999999999999899999999999999999
Q ss_pred HcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhccc
Q psy7289 282 RSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAA 329 (422)
Q Consensus 282 ~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk~ 329 (422)
.++.++|.|++||+++++||.+||+.+|..|| ++..+...|++
T Consensus 261 ~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RP-----s~~ei~~~L~a 303 (308)
T 4gt4_A 261 RNRQVLPCPDDCPAWVYALMIECWNEFPSRRP-----RFKDIHSRLRA 303 (308)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHHT
T ss_pred HcCCCCCCcccchHHHHHHHHHHcCCChhHCc-----CHHHHHHHHHh
Confidence 99999999999999999999999999999999 88888887765
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-65 Score=485.43 Aligned_cols=276 Identities=49% Similarity=0.933 Sum_probs=236.8
Q ss_pred chhhccccCcccccccccccceeEEEEEEec---CCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEE
Q psy7289 47 FRREVIETKPRFLQELGEGAFGKVYKGEVCT---SEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVC 123 (422)
Q Consensus 47 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~ 123 (422)
+.+++...++.+.++||+|+||+||+|++.. ..++..||||+++.. +....++|.+|+++|++|+|||||+++|+|
T Consensus 6 ~~~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 84 (299)
T 4asz_A 6 FVQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVC 84 (299)
T ss_dssp SCCBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhcccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 4456777789999999999999999999753 234678999999753 455678899999999999999999999999
Q ss_pred EcCCCeEEEEEecCCCCHHHHHhhcCCCCCC-CCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC
Q psy7289 124 LSGEPMCMLFEFMVRGDLHEFLMSRSPRSDI-SGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG 202 (422)
Q Consensus 124 ~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~-~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~ 202 (422)
.+++.+++|||||++|||.++|+...+.... ........+++.++..++.|||+||+|||+++||||||||+||||+++
T Consensus 85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence 9999999999999999999999864311000 000112469999999999999999999999999999999999999999
Q ss_pred CeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q psy7289 203 LTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282 (422)
Q Consensus 203 ~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~ 282 (422)
+.+||+|||+|+.....+.........+|+.|||||++..+.|+.++|||||||++|||+|.|..||.+.++.+++..+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99999999999977666555555556789999999999999999999999999999999998999999999999999999
Q ss_pred cCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 283 SRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 283 ~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
.+.+++.|+.||+++.+||.+||+.+|..|+ ++..++..|+
T Consensus 245 ~~~~~~~p~~~~~~~~~li~~cl~~dP~~RP-----s~~~i~~~L~ 285 (299)
T 4asz_A 245 QGRVLQRPRTCPQEVYELMLGCWQREPHMRK-----NIKGIHTLLQ 285 (299)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHH
T ss_pred cCCCCCCCccchHHHHHHHHHHcCCChhHCc-----CHHHHHHHHH
Confidence 9999999999999999999999999999999 7777776554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-63 Score=482.28 Aligned_cols=274 Identities=49% Similarity=0.925 Sum_probs=226.4
Q ss_pred hhccccCcccccccccccceeEEEEEEec---CCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc
Q psy7289 49 REVIETKPRFLQELGEGAFGKVYKGEVCT---SEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLS 125 (422)
Q Consensus 49 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 125 (422)
.++...++.+.++||+|+||+||+|+++. ..++..||||+++.. +....++|.+|+++|++|+|||||+++|+|.+
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 114 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTE 114 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 34556678888999999999999999853 234678999999753 45567889999999999999999999999999
Q ss_pred CCCeEEEEEecCCCCHHHHHhhcCCCCCCC---CCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC
Q psy7289 126 GEPMCMLFEFMVRGDLHEFLMSRSPRSDIS---GSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG 202 (422)
Q Consensus 126 ~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~---~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~ 202 (422)
++.+++|||||++|+|.++|+...+..... ......++++.++..++.|||.||+|||+++||||||||+||||+++
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG 194 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC
Confidence 999999999999999999998754322110 01123579999999999999999999999999999999999999999
Q ss_pred CeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q psy7289 203 LTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282 (422)
Q Consensus 203 ~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~ 282 (422)
+.+||+|||+|+.....+.........+|+.|||||++....|+.++|||||||++|||+|.|..||.+.++.+++..|.
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 274 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99999999999977655554455566789999999999999999999999999999999998999999999999999999
Q ss_pred cCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 283 SRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 283 ~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
.+.+++.|+.||+++.+||.+||+.+|..|+ ++..++..|+
T Consensus 275 ~g~~~~~p~~~~~~~~~li~~cl~~dP~~RP-----s~~ei~~~L~ 315 (329)
T 4aoj_A 275 QGRELERPRACPPEVYAIMRGCWQREPQQRH-----SIKDVHARLQ 315 (329)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSC-----CHHHHHHHHH
T ss_pred cCCCCCCcccccHHHHHHHHHHcCcChhHCc-----CHHHHHHHHH
Confidence 9999999999999999999999999999999 7777766654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-61 Score=472.71 Aligned_cols=275 Identities=33% Similarity=0.626 Sum_probs=234.9
Q ss_pred hhhccccCcccccccccccceeEEEEEEecCC---CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCC-CceeeEeeEE
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSE---GPSLVAIKTLKENANQKTASDFRREVDLMSELRH-PNIVCLLGVC 123 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~g~~ 123 (422)
+||+..++|++.++||+|+||+||+|++...+ ..+.||||.++........+.|.+|+++|++++| ||||+++|+|
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~ 137 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 137 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence 57888999999999999999999999987543 2367999999877777777889999999999975 9999999999
Q ss_pred EcC-CCeEEEEEecCCCCHHHHHhhcCCCCC----CCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcee
Q psy7289 124 LSG-EPMCMLFEFMVRGDLHEFLMSRSPRSD----ISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCL 198 (422)
Q Consensus 124 ~~~-~~~~lv~E~~~~G~L~~~l~~~~~~~~----~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiL 198 (422)
.+. +.+++|||||++|+|.++|+....... .........+++.++..++.|||.||+|||+++||||||||+|||
T Consensus 138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 217 (353)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence 764 578999999999999999986422100 000111245899999999999999999999999999999999999
Q ss_pred ecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCC-hHHH
Q psy7289 199 VGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS-NQEV 277 (422)
Q Consensus 199 l~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~-~~~~ 277 (422)
+++++.+||+|||+|+....+..+.......+|+.|||||++..+.|+.++|||||||++|||+|.|..||.+.+ .+++
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~ 297 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 297 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999999987665554455566789999999999999999999999999999999998999999876 4567
Q ss_pred HHHHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 278 IEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 278 ~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
...+..+.+++.|+.||++++++|.+||+.+|..|+ ++..+...|
T Consensus 298 ~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RP-----t~~eil~~L 342 (353)
T 4ase_A 298 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP-----TFSELVEHL 342 (353)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHH
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCc-----CHHHHHHHH
Confidence 778888999999999999999999999999999998 666655544
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-61 Score=458.90 Aligned_cols=260 Identities=30% Similarity=0.484 Sum_probs=212.7
Q ss_pred ccchhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEE
Q psy7289 45 SDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVC 123 (422)
Q Consensus 45 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~ 123 (422)
....||+..+++++.++||+|+||+||+|++. ..||||+++.. .+....+.|.+|+.+|++|+|||||+++|++
T Consensus 27 ~~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~-----~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 101 (307)
T 3omv_A 27 SSYYWEIEASEVMLSTRIGSGSFGTVYKGKWH-----GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101 (307)
T ss_dssp --CCCBCCTTSCCEEEECCCCSSSEEEEEESS-----SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CCcCcEEcHHHeEEeeEEeeCCCcEEEEEEEC-----CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34567899999999999999999999999853 24899998743 3456678899999999999999999999998
Q ss_pred EcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC
Q psy7289 124 LSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL 203 (422)
Q Consensus 124 ~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~ 203 (422)
.+ +.+++|||||++|+|.++|.... ..+++.++..++.|||.||+|||+++||||||||+||||++++
T Consensus 102 ~~-~~~~iVmEy~~gGsL~~~l~~~~-----------~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~ 169 (307)
T 3omv_A 102 TK-DNLAIVTQWCEGSSLYKHLHVQE-----------TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGL 169 (307)
T ss_dssp CS-SSCEEEEECCSSCBHHHHHHTSC-----------CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTE
T ss_pred EC-CeEEEEEEcCCCCCHHHHHhhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCC
Confidence 65 56899999999999999997542 3589999999999999999999999999999999999999999
Q ss_pred eEEEecCcccccccCCcceEeccCCCCCccccCcccccc---CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHH-H
Q psy7289 204 TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY---GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVI-E 279 (422)
Q Consensus 204 ~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~-~ 279 (422)
.+||+|||+|+...............||+.|||||++.. +.|+.++|||||||++|||+| |..||.+.++.+.+ .
T Consensus 170 ~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Ellt-g~~Pf~~~~~~~~~~~ 248 (307)
T 3omv_A 170 TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMT-GELPYSHINNRDQIIF 248 (307)
T ss_dssp EEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHH-SSCTTTTCCCHHHHHH
T ss_pred cEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHH-CCCCCCCCChHHHHHH
Confidence 999999999987654333333445678999999999864 358999999999999999999 99999988776544 4
Q ss_pred HHHcCCCCC----CCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 280 MIRSRQMLP----CPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 280 ~i~~~~~~~----~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
.+..+...| .|.+||+++.+||.+||+.+|..|| ++..+...|
T Consensus 249 ~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ei~~~L 295 (307)
T 3omv_A 249 MVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERP-----LFPQILSSI 295 (307)
T ss_dssp HHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSC-----CHHHHHHHH
T ss_pred HHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCc-----CHHHHHHHH
Confidence 455544433 4678999999999999999999998 655555443
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-60 Score=461.21 Aligned_cols=259 Identities=20% Similarity=0.345 Sum_probs=222.4
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
++|+++++||+|+||+||+|+...+ ++.||||+++.. ......+.|.+|+++|++|+|||||++++++.+++.+|+|
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~--~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTED--GRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTT--CCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCC--CCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 5799999999999999999987543 578999998643 3555678899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
||||++|+|.++|..+. ...+++.++..++.||+.||+|||++|||||||||+||||++++.+||+|||+
T Consensus 102 mEy~~gg~L~~~i~~~~----------~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGl 171 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQK----------GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGI 171 (350)
T ss_dssp EECCTTCBHHHHHHHTT----------TCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTE
T ss_pred EeCCCCCcHHHHHHHcC----------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEccccc
Confidence 99999999999997642 13578999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPED 292 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~ 292 (422)
|+....... ......||+.|||||++.+..|+.++|||||||++|||++ |..||.+.+..+++.+|..+..++.|..
T Consensus 172 a~~~~~~~~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~~~ 248 (350)
T 4b9d_A 172 ARVLNSTVE--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT-LKHAFEAGSMKNLVLKIISGSFPPVSLH 248 (350)
T ss_dssp ESCCCHHHH--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred ceeecCCcc--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcCHHHHHHHHHcCCCCCCCcc
Confidence 987543211 1233468999999999999999999999999999999999 9999999999999999999988888999
Q ss_pred CCcchhhhcccccccccchhh-HHHHhhhhhhhhhc
Q psy7289 293 CPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRDL 327 (422)
Q Consensus 293 ~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~dL 327 (422)
+|+++.+|+.+||..||..|+ +..+.+|.++.+.+
T Consensus 249 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 249 YSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence 999999999999999999986 44566777776544
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-59 Score=449.93 Aligned_cols=244 Identities=20% Similarity=0.343 Sum_probs=218.2
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
++|++++.||+|+||+||+|+.+.+ ++.||||++.... .....+.+.+|+++|++|+|||||++++++.+++.+|+
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~--~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELAT--SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTT--CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCC--CCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 5699999999999999999987544 5789999986431 22345679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
|||||++|+|.++|.+. +.+++.++..++.||+.||+|||+++|+||||||+||||++++.+||+|||
T Consensus 110 vmEy~~gG~L~~~i~~~------------~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFG 177 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKI------------GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFG 177 (311)
T ss_dssp EECCCTTEEHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEecCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcC
Confidence 99999999999999865 369999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCC
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPE 291 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~ 291 (422)
+|+............+..||+.|||||++.+..|+.++||||+||++|||++ |.+||.+.+..+++.+|.++. ...|+
T Consensus 178 la~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~-~~~p~ 255 (311)
T 4aw0_A 178 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPFRAGNEGLIFAKIIKLE-YDFPE 255 (311)
T ss_dssp TCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHTC-CCCCT
T ss_pred CceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCc
Confidence 9987654333333455679999999999999999999999999999999999 999999999999999998875 56788
Q ss_pred CCCcchhhhcccccccccchhh
Q psy7289 292 DCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 292 ~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.+++++.+|+.+|+..||..|.
T Consensus 256 ~~s~~~~dli~~lL~~dp~~R~ 277 (311)
T 4aw0_A 256 KFFPKARDLVEKLLVLDATKRL 277 (311)
T ss_dssp TCCHHHHHHHHHHSCSSGGGST
T ss_pred ccCHHHHHHHHHHccCCHhHCc
Confidence 9999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-60 Score=451.28 Aligned_cols=255 Identities=26% Similarity=0.430 Sum_probs=215.2
Q ss_pred ccCcccccccccccceeEEEEEEec-CCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCT-SEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
.++|++++.||+|+||+||+|+... ...++.||||+++... .......+.+|+++|++|+|||||++++++.+++.+|
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 3579999999999999999998754 3346789999986432 2223346889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+|||||++|+|.++|.+. ..+++.++..++.||+.||+|||++||+||||||+|||+++++.+||+||
T Consensus 103 ivmEy~~gg~L~~~l~~~------------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DF 170 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKE------------VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDF 170 (304)
T ss_dssp EEECCCTTCEEHHHHHHH------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESS
T ss_pred EEEEcCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEeccc
Confidence 999999999999999875 35999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP 290 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p 290 (422)
|+|+...... ....+..||+.|||||++....|+.++||||+||++|||++ |..||.+.+..+++..|.++. ++.|
T Consensus 171 Gla~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~-~~~p 246 (304)
T 3ubd_A 171 GLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT-GTLPFQGKDRKETMTMILKAK-LGMP 246 (304)
T ss_dssp EEEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCC-CCCC
T ss_pred ccceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCC-CCCC
Confidence 9998654322 12345678999999999999999999999999999999999 999999999999999998765 5678
Q ss_pred CCCCcchhhhcccccccccchhh------HHHHhhhhhh
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAG------MAYLCSHHYV 323 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~------~~~lh~~~~i 323 (422)
+.+|+++.+|+.+||..||..|+ ++.+.+|.++
T Consensus 247 ~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f 285 (304)
T 3ubd_A 247 QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285 (304)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGG
T ss_pred CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccc
Confidence 89999999999999999999996 3455556554
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-58 Score=449.70 Aligned_cols=258 Identities=23% Similarity=0.383 Sum_probs=221.7
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
...|+++++||+|+||+||+|+++.+ ++.||||+++.... ...+.+.+|+.+|++|+|||||++++++.+++.+|||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~t--g~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSS--GKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTT--CCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCC--CCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 35689999999999999999987544 57899999864322 2335688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
||||++|+|.+++... .+++.++..++.||+.||+|||++|||||||||+||||+.++.+||+|||+
T Consensus 150 mEy~~gg~L~~~l~~~-------------~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGl 216 (346)
T 4fih_A 150 MEFLEGGALTDIVTHT-------------RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGF 216 (346)
T ss_dssp ECCCTTEEHHHHHHHS-------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred EeCCCCCcHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcC
Confidence 9999999999999752 489999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC--CCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML--PCP 290 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~--~~p 290 (422)
|+....... ...+..||+.|||||++....|+.++|||||||++|||++ |.+||.+.+..+++..|..+..+ +.+
T Consensus 217 a~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~~~ 293 (346)
T 4fih_A 217 CAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVD-GEPPYFNEPPLKAMKMIRDNLPPRLKNL 293 (346)
T ss_dssp CEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSSCCCCSCG
T ss_pred ceecCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcCHHHHHHHHHcCCCCCCCcc
Confidence 987654322 2345678999999999999999999999999999999999 99999999999999998876433 334
Q ss_pred CCCCcchhhhcccccccccchhh-HHHHhhhhhhhhhccc
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRDLAA 329 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~dLk~ 329 (422)
..+++++.+|+.+||..||..|+ +..+.+|.++.+.-.|
T Consensus 294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p 333 (346)
T 4fih_A 294 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 333 (346)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence 57899999999999999999886 3456667776554333
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-58 Score=431.32 Aligned_cols=254 Identities=27% Similarity=0.416 Sum_probs=207.9
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
.+|++++.||+|+||+||+|+... .++.||||+++... .......+.+|+++|++++|||||++++++.+++.+|+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTT--TCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECC--CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 479999999999999999998643 45789999986432 23345679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
||||| +|+|.+++.++ ..+++.++..++.||+.||+|||++||+||||||+|||+++++.+||+|||
T Consensus 91 vmEy~-~g~L~~~l~~~------------~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFG 157 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQR------------DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFG 157 (275)
T ss_dssp EEECC-CEEHHHHHHHS------------CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSS
T ss_pred EEeCC-CCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecC
Confidence 99999 68999999764 359999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccccCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYGKF-TTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP 290 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p 290 (422)
+|+...... ...+..||+.|||||++.+..| +.++||||+||++|||++ |..||.+.+..++...+.++. .+.|
T Consensus 158 la~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~llt-g~~PF~~~~~~~~~~~i~~~~-~~~p 232 (275)
T 3hyh_A 158 LSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLC-RRLPFDDESIPVLFKNISNGV-YTLP 232 (275)
T ss_dssp CC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHTC-CCCC
T ss_pred CCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHcCC-CCCC
Confidence 998654322 2334678999999999998876 579999999999999999 999999999999999988765 5678
Q ss_pred CCCCcchhhhcccccccccchhh-HHHHhhhhhhhhhc
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRDL 327 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~dL 327 (422)
..+++++.+|+.+||..||..|+ +..+.+|.++..++
T Consensus 233 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~~ 270 (275)
T 3hyh_A 233 KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDL 270 (275)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTTC
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccCC
Confidence 89999999999999999999986 44566677775544
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-57 Score=430.86 Aligned_cols=248 Identities=23% Similarity=0.367 Sum_probs=207.4
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc----CCCeE
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLS----GEPMC 130 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~~~ 130 (422)
+++.++||+|+||+||+|++.. .+..||||++... ......+.|.+|+++|++|+|||||++++++.+ ++.+|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 105 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTE--TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECC--CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence 4777889999999999998754 3578999998643 355567789999999999999999999999865 34589
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceeecC-CCeEEE
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHH--YVHRDLAARNCLVGD-GLTVKI 207 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--ivHrDlKp~NiLl~~-~~~vKl 207 (422)
+|||||++|+|.++|.+. ..+++..+..++.||+.||+|||+++ ||||||||+||||++ ++.+||
T Consensus 106 lvmEy~~gg~L~~~l~~~------------~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl 173 (290)
T 3fpq_A 106 LVTELMTSGTLKTYLKRF------------KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKI 173 (290)
T ss_dssp EEEECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEE
T ss_pred EEEeCCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEE
Confidence 999999999999999864 35899999999999999999999998 999999999999984 789999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHcCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN-QEVIEMIRSRQM 286 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~-~~~~~~i~~~~~ 286 (422)
+|||+|+...... ..+..||+.|||||++. +.|+.++|||||||++|||+| |..||.+.++ .++...+..+..
T Consensus 174 ~DFGla~~~~~~~----~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~~i~~~~~ 247 (290)
T 3fpq_A 174 GDLGLATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMAT-SEYPYSECQNAAQIYRRVTSGVK 247 (290)
T ss_dssp CCTTGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHH-SSCTTTTCSSHHHHHHHHTTTCC
T ss_pred EeCcCCEeCCCCc----cCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHH-CCCCCCCCCcHHHHHHHHHcCCC
Confidence 9999998543322 23457899999999886 569999999999999999999 9999987654 556667766654
Q ss_pred CC-CCCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 287 LP-CPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 287 ~~-~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
++ .|..+++++.+|+.+||..||..|+ +..+.+|.++
T Consensus 248 ~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~ 286 (290)
T 3fpq_A 248 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286 (290)
T ss_dssp CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 43 4567889999999999999999986 3345555554
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-58 Score=443.41 Aligned_cols=239 Identities=20% Similarity=0.267 Sum_probs=206.6
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
..|++.++||+|+||+||+|+++.+ ++.||||+++.... +.+|+.+|++|+|||||++++++.+++.+||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~--g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm 129 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQT--GFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFM 129 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTT--CCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCC--CCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4567788999999999999987544 57899999875322 247999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC-eEEEecCcc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL-TVKISDFGL 212 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~-~vKl~DFGl 212 (422)
|||++|+|.++|.+. ..+++.++..++.||+.||+|||+++||||||||+||||+.++ .+||+|||+
T Consensus 130 Ey~~gg~L~~~l~~~------------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGl 197 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQM------------GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGH 197 (336)
T ss_dssp CCCTTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTT
T ss_pred eccCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCC
Confidence 999999999999865 3699999999999999999999999999999999999999887 699999999
Q ss_pred cccccCCcce---EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC--
Q psy7289 213 SRDVYASDYY---RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML-- 287 (422)
Q Consensus 213 a~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~-- 287 (422)
|+........ .......||+.|||||++.+..|+.++|||||||++|||++ |.+||.+.+..++...|..+..+
T Consensus 198 a~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemlt-G~~Pf~~~~~~~~~~~i~~~~~~~~ 276 (336)
T 4g3f_A 198 ALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN-GCHPWTQYFRGPLCLKIASEPPPIR 276 (336)
T ss_dssp CEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSSTTTCCSCCHHHHHHSCCGGG
T ss_pred CeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHH-CcCCCCCCCHHHHHHHHHcCCCCch
Confidence 9876543221 12233568999999999999999999999999999999999 99999999888888888776543
Q ss_pred CCCCCCCcchhhhcccccccccchhh
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..|+.+|+.+.+++.+||..||..|+
T Consensus 277 ~~~~~~s~~~~~li~~~L~~dP~~R~ 302 (336)
T 4g3f_A 277 EIPPSCAPLTAQAIQEGLRKEPVHRA 302 (336)
T ss_dssp GSCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred hcCccCCHHHHHHHHHHccCCHhHCc
Confidence 36789999999999999999999997
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-57 Score=451.15 Aligned_cols=255 Identities=24% Similarity=0.400 Sum_probs=221.0
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
...|+++++||+|+||.||+|+++.+ ++.||||++..... ...+.+.+|+.+|++|+|||||++++++.+++.+|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~t--g~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSS--GKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTT--CCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCC--CCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 35699999999999999999987644 57899999864322 2345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
||||++|+|.+++... .+++.++..++.||+.||+|||++|||||||||+||||+.++.+||+|||+
T Consensus 227 mEy~~gG~L~~~i~~~-------------~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGl 293 (423)
T 4fie_A 227 MEFLEGGALTDIVTHT-------------RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGF 293 (423)
T ss_dssp EECCTTEEHHHHHHHS-------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTT
T ss_pred EeCCCCCcHHHHHhcc-------------CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCcc
Confidence 9999999999999653 489999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC--CCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM--LPCP 290 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~--~~~p 290 (422)
|+....... ......||+.|||||++....|+.++|||||||++|||++ |.+||.+.+..+++..|..... .+.+
T Consensus 294 a~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~~~ 370 (423)
T 4fie_A 294 CAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVD-GEPPYFNEPPLKAMKMIRDNLPPRLKNL 370 (423)
T ss_dssp CEECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSCCCCCSCT
T ss_pred ceECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcCHHHHHHHHHcCCCCCCccc
Confidence 987644321 2345678999999999999999999999999999999999 9999999999999999987643 3345
Q ss_pred CCCCcchhhhcccccccccchhh-HHHHhhhhhhhhh
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRD 326 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~d 326 (422)
..+++++.+|+.+||..||..|+ +..+.+|.++.+.
T Consensus 371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 371 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp TSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 67899999999999999999986 4456666666543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-55 Score=421.20 Aligned_cols=244 Identities=22% Similarity=0.354 Sum_probs=192.0
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC-------
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE------- 127 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~------- 127 (422)
+|++++.||+|+||+||+|+++.+ ++.||||+++........+.+.+|+++|++|+|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~--~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVD--DCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTT--CCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hCEEeeEEecCCCeEEEEEEECCC--CCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 578899999999999999987543 57899999976556666778999999999999999999999987544
Q ss_pred -----CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC
Q psy7289 128 -----PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG 202 (422)
Q Consensus 128 -----~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~ 202 (422)
.+|+|||||++|+|.+++..+.. ....++..+..++.||+.||+|||++|||||||||+|||++.+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~---------~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~ 154 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCT---------IEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMD 154 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCS---------GGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCC---------CChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCC
Confidence 37999999999999999976432 1234566788999999999999999999999999999999999
Q ss_pred CeEEEecCcccccccCCcce----------EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Q psy7289 203 LTVKISDFGLSRDVYASDYY----------RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY 272 (422)
Q Consensus 203 ~~vKl~DFGla~~~~~~~~~----------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~ 272 (422)
+.+||+|||+|+........ ...++..||+.|||||++.+..|+.++|||||||++|||++ ||.+.
T Consensus 155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~----Pf~~~ 230 (299)
T 4g31_A 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY----PFSTQ 230 (299)
T ss_dssp CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS----CCSSH
T ss_pred CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc----CCCCc
Confidence 99999999999876433211 11233568999999999999999999999999999999995 88654
Q ss_pred Ch-HHHHHHHHcCCCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 273 SN-QEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 273 ~~-~~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.. ...+..+.....++.+...++...+|+++||..||..|+
T Consensus 231 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rp 272 (299)
T 4g31_A 231 MERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERP 272 (299)
T ss_dssp HHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSC
T ss_pred cHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCc
Confidence 32 234455565555544455566778999999999999997
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-55 Score=417.86 Aligned_cols=250 Identities=23% Similarity=0.365 Sum_probs=193.1
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC----Ce
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE----PM 129 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~----~~ 129 (422)
.+|.+.++||+|+||+||+|++. ++.||||+++... .....+.+|+..+.+++|||||+++|+|.+++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~----g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR----GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET----TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC----CEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 45778899999999999999872 4789999986432 11122334566667899999999999998654 47
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCceeecC
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSH--------HYVHRDLAARNCLVGD 201 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~--------~ivHrDlKp~NiLl~~ 201 (422)
|+|||||++|+|.++|+.. .++++.+.+++.|++.||+|||++ +||||||||+||||++
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~-------------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~ 143 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRY-------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 143 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-------------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred EEEecCCCCCcHHHHHHhC-------------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECC
Confidence 9999999999999999763 488999999999999999999987 8999999999999999
Q ss_pred CCeEEEecCcccccccCCcceE--eccCCCCCccccCccccccC------CCCCchhHHhHHHHHHHHHhCCCCC-----
Q psy7289 202 GLTVKISDFGLSRDVYASDYYR--IQSKSLLPVRWMPPESILYG------KFTTESDVWSYGVVLWEVYSYGLQP----- 268 (422)
Q Consensus 202 ~~~vKl~DFGla~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~------~~~~~~DvwS~Gvil~El~t~g~~P----- 268 (422)
++++||+|||+|+......... ......||+.|||||++... .++.++|||||||++|||+| |.+|
T Consensus 144 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~t-g~~~~~~~~ 222 (303)
T 3hmm_A 144 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHE 222 (303)
T ss_dssp TSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHH-TBCBTTBCC
T ss_pred CCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHH-CCCCCCccc
Confidence 9999999999998765433221 22345689999999998754 36789999999999999999 6544
Q ss_pred -----CCCC-----ChHHHHHHHHcCC-CCCCCCC-----CCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 269 -----YYGY-----SNQEVIEMIRSRQ-MLPCPED-----CPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 269 -----f~~~-----~~~~~~~~i~~~~-~~~~p~~-----~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
|.+. ...++...+..+. +++.|.. +++.+.+||.+||+.||..|+ ++..+.+.|+
T Consensus 223 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ei~~~L~ 293 (303)
T 3hmm_A 223 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL-----TALRIKKTLS 293 (303)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSC-----CHHHHHHHHH
T ss_pred cccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCc-----CHHHHHHHHH
Confidence 4332 2234555554433 3444543 345788999999999999999 7776666553
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=412.53 Aligned_cols=257 Identities=23% Similarity=0.360 Sum_probs=210.0
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc------
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLS------ 125 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------ 125 (422)
..+|++++.||+|+||+||+|+++.+ ++.||||+++... .....+.+.+|+++|+.|+|||||++++++..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t--~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLT--GQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTT--CCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCCeEEEEEEecccCeEEEEEEECCC--CCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 45799999999999999999987544 5789999996543 34456788999999999999999999998764
Q ss_pred CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 126 GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 126 ~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
.+.+|+|||||+ |+|.+++... ..+++.++..++.||+.||+|||++|||||||||+|||++.++.+
T Consensus 131 ~~~~~ivmE~~~-g~L~~~i~~~------------~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~ 197 (398)
T 4b99_A 131 FKSVYVVLDLME-SDLHQIIHSS------------QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCEL 197 (398)
T ss_dssp CCCEEEEEECCS-EEHHHHHTSS------------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCE
T ss_pred CCEEEEEEeCCC-CCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCE
Confidence 357899999996 7899999653 369999999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcce--EeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q psy7289 206 KISDFGLSRDVYASDYY--RIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~ 282 (422)
||+|||+|+........ ....+..||+.|||||++.+. .|+.++||||+||++|||++ |.+||.+.+..+.+..|.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~-G~~pF~g~~~~~~l~~I~ 276 (398)
T 4b99_A 198 KIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA-RRQLFPGKNYVHQLQLIM 276 (398)
T ss_dssp EECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH-TSCSSCCSSHHHHHHHHH
T ss_pred EEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHH-CCCCCCCCCHHHHHHHHH
Confidence 99999999876433211 123456789999999998875 46999999999999999999 999999999988887775
Q ss_pred cCCCCC-------------------------C-----CCCCCcchhhhcccccccccchhh-HHHHhhhhhhhh
Q psy7289 283 SRQMLP-------------------------C-----PEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHR 325 (422)
Q Consensus 283 ~~~~~~-------------------------~-----p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~ 325 (422)
.....| . .+.+++++.+|+.+|+..||..|. +..+.+|.++..
T Consensus 277 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 277 MVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350 (398)
T ss_dssp HHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence 321110 0 124577889999999999999885 445666777654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=424.81 Aligned_cols=252 Identities=22% Similarity=0.337 Sum_probs=211.5
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-----CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-----NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
..+|++++.||+|+||+||+|+.+. .+..||||+++... .........+++.+++.++|||||++++++.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~--tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred hHHeEEEEEEecccCeEEEEEEECC--CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 4578999999999999999998754 45789999985321 1112223334567788899999999999999999
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
.+|+|||||+||+|.++|.+. ..+++..+..++.||+.||+|||++|||||||||+||||+.+|++||
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~------------~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL 333 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQH------------GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRI 333 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHH------------CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEE
T ss_pred EEEEEEecCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEe
Confidence 999999999999999999875 35999999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCC---hHHHHHHHHc
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYS---NQEVIEMIRS 283 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~---~~~~~~~i~~ 283 (422)
+|||+|+...... ..+..||+.|||||++.. ..|+.++||||+||++|||++ |.+||.+.+ ..++...+..
T Consensus 334 ~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLt-G~~PF~~~~~~~~~~i~~~i~~ 408 (689)
T 3v5w_A 334 SDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEIDRMTLT 408 (689)
T ss_dssp CCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHH-SSCTTCGGGCCCHHHHHHHHHH
T ss_pred cccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcC
Confidence 9999998764432 345679999999999975 579999999999999999999 999998643 3455666655
Q ss_pred CCCCCCCCCCCcchhhhcccccccccchhh------HHHHhhhhhhh
Q psy7289 284 RQMLPCPEDCPPRMYSLMMECWHEVPVAAG------MAYLCSHHYVH 324 (422)
Q Consensus 284 ~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~------~~~lh~~~~i~ 324 (422)
.. ++.|..+++++.+|+..|+..||..|. .+.+.+|.++.
T Consensus 409 ~~-~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~ 454 (689)
T 3v5w_A 409 MA-VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454 (689)
T ss_dssp CC-CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGT
T ss_pred CC-CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcccc
Confidence 43 567889999999999999999999884 46677777764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=420.79 Aligned_cols=254 Identities=23% Similarity=0.334 Sum_probs=218.9
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
..+|++++.||+|+||.||+|+.+.+ ++.||+|++... .....+.+.+|+++|+.|+|||||++++++.++..+|+|
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~t--g~~~AiK~i~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERAT--GNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT--CCEEEEEEEECC-SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCC--CCEEEEEEEecc-chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 35799999999999999999987544 578999998653 344567889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC--CeEEEecC
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG--LTVKISDF 210 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~--~~vKl~DF 210 (422)
||||++|+|.++|.... ..+++.++..++.||+.||+|||+++|+||||||+|||++.+ +.+||+||
T Consensus 233 ~E~~~gg~L~~~i~~~~-----------~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DF 301 (573)
T 3uto_A 233 YEFMSGGELFEKVADEH-----------NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDF 301 (573)
T ss_dssp EECCCCCBHHHHHTCTT-----------SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred EeecCCCcHHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeec
Confidence 99999999999996432 358999999999999999999999999999999999999854 79999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC--
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP-- 288 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~-- 288 (422)
|+|+........ ....||+.|||||++.+..|+.++||||+||++|||++ |.+||.+.+..+++..|.......
T Consensus 302 G~a~~~~~~~~~---~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~-G~~Pf~~~~~~~~~~~i~~~~~~~~~ 377 (573)
T 3uto_A 302 GLTAHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS-GLSPFGGENDDETLRNVKSCDWNMDD 377 (573)
T ss_dssp SSCEECCTTSEE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHHHTTCCCCCS
T ss_pred cceeEccCCCce---eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcCHHHHHHHHHhCCCCCCc
Confidence 999977544322 23468999999999999999999999999999999999 999999999999999998765322
Q ss_pred -CCCCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 289 -CPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 289 -~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
.+..+++++.+|+.+||..||..|+ +..+.+|.++.
T Consensus 378 ~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~ 415 (573)
T 3uto_A 378 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 415 (573)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTS
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcC
Confidence 2357889999999999999999885 44555666654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=404.29 Aligned_cols=263 Identities=37% Similarity=0.709 Sum_probs=229.2
Q ss_pred hhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
.+++...+|++.+.||+|+||.||+|++.. ++..||||.++........+.|.+|+++|++++|||||++++++.+.+
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRA--DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETT--TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEec--CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 345667789999999999999999998754 357899999986655666678999999999999999999999999999
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl 254 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEG-----------ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKI 254 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHG-----------GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE
T ss_pred CcEEEEEcCCCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEE
Confidence 9999999999999999997642 35889999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+|||+++...............+|+.|+|||++..+.++.++|||||||++|||++.|..||.+.+..++...+..+.++
T Consensus 255 ~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 334 (377)
T 3cbl_A 255 SDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL 334 (377)
T ss_dssp CCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCC
T ss_pred CcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999986543322211122234678999999998899999999999999999998899999999999999999999999
Q ss_pred CCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
+.|..||+++.+||.+||+.+|..|+ +...+...|+
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~i~~~L~ 370 (377)
T 3cbl_A 335 PCPELCPDAVFRLMEQCWAYEPGQRP-----SFSTIYQELQ 370 (377)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCc-----CHHHHHHHHH
Confidence 99999999999999999999999998 6666655543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=394.48 Aligned_cols=253 Identities=19% Similarity=0.276 Sum_probs=199.6
Q ss_pred cccCcccccccccccceeEEEEEEec-CCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCCe
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCT-SEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~ 129 (422)
...+|++.++||+|+||+||+|+.+. ...++.||||.+..... ...+.+|+++|+.+ +|||||++++++.+.+.+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34679999999999999999998753 33467899999865432 34678999999998 699999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC-CeEEEe
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG-LTVKIS 208 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~-~~vKl~ 208 (422)
|+|||||++|+|.+++. .+++.++..++.||+.||+|||++||+||||||+|||++.+ +.+||+
T Consensus 96 ~lvmE~~~g~~L~~~~~---------------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~ 160 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN---------------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALV 160 (361)
T ss_dssp EEEEECCCCCCHHHHHT---------------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred EEEEeCCCcccHHHHHc---------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEEC
Confidence 99999999999999983 38999999999999999999999999999999999999876 799999
Q ss_pred cCcccccccCCcc--------------------------eEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHH
Q psy7289 209 DFGLSRDVYASDY--------------------------YRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEV 261 (422)
Q Consensus 209 DFGla~~~~~~~~--------------------------~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El 261 (422)
|||+|+....... ........||+.|||||++.+. .|+.++||||+||++|||
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~el 240 (361)
T 4f9c_A 161 DFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSL 240 (361)
T ss_dssp CCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHH
T ss_pred cCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHH
Confidence 9999975432110 0012234689999999999875 589999999999999999
Q ss_pred HhCCCCCCCCCC-hHHHHHHHHc--C------------------------------------C---------------CC
Q psy7289 262 YSYGLQPYYGYS-NQEVIEMIRS--R------------------------------------Q---------------ML 287 (422)
Q Consensus 262 ~t~g~~Pf~~~~-~~~~~~~i~~--~------------------------------------~---------------~~ 287 (422)
++ |..||.+.+ ..+.+..|.. | . ..
T Consensus 241 l~-G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 319 (361)
T 4f9c_A 241 LS-GRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNL 319 (361)
T ss_dssp HH-TCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC--------------------
T ss_pred HH-CCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccc
Confidence 99 999997544 3333333211 0 0 00
Q ss_pred CCCCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
+....+++++.+|+.+|+..||..|. +..+.+|.++
T Consensus 320 ~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f 356 (361)
T 4f9c_A 320 EGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFF 356 (361)
T ss_dssp --CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred cccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence 11235678889999999999999885 3445555554
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=396.11 Aligned_cols=275 Identities=36% Similarity=0.705 Sum_probs=232.6
Q ss_pred hhccccCcccccccccccceeEEEEEEecC-----CCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeE
Q psy7289 49 REVIETKPRFLQELGEGAFGKVYKGEVCTS-----EGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGV 122 (422)
Q Consensus 49 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~ 122 (422)
+++...+|++.+.||+|+||.||+|++... ..+..||||+++........+.+.+|+.+|+.+ +|||||+++++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 455667899999999999999999987532 234679999998766666778899999999999 89999999999
Q ss_pred EEcCCCeEEEEEecCCCCHHHHHhhcCCCCCC----CCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcee
Q psy7289 123 CLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDI----SGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCL 198 (422)
Q Consensus 123 ~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~----~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiL 198 (422)
+.+.+.+|+||||+++|+|.+++....+.... ........+++.++..++.||+.||+|||+++|+||||||+|||
T Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 235 (370)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence 99999999999999999999999875421100 00011235899999999999999999999999999999999999
Q ss_pred ecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHH
Q psy7289 199 VGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVI 278 (422)
Q Consensus 199 l~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~ 278 (422)
++.++.+||+|||+++...............+|+.|+|||++....++.++|||||||++|||++.|..||.+.+..++.
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999999986654333323344456789999999999999999999999999999998899999999999999
Q ss_pred HHHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 279 EMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 279 ~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
..+..+.+++.|..||+++.++|.+||..+|..|+ +...+.+.|.
T Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~L~ 360 (370)
T 2psq_A 316 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRP-----TFKQLVEDLD 360 (370)
T ss_dssp HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHH
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCc-----CHHHHHHHHH
Confidence 99999988889999999999999999999999998 6665555543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=383.79 Aligned_cols=267 Identities=36% Similarity=0.649 Sum_probs=229.9
Q ss_pred cchhhccccCcccccccccccceeEEEEEEecCC-CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEE
Q psy7289 46 DFRREVIETKPRFLQELGEGAFGKVYKGEVCTSE-GPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCL 124 (422)
Q Consensus 46 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~ 124 (422)
.+..++...+|++.+.||+|+||.||+|++..++ ....||||.++........+.|.+|+.++++++||||+++++++.
T Consensus 41 ~~~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 120 (325)
T 3kul_A 41 SFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT 120 (325)
T ss_dssp --CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred hhccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 3456777889999999999999999999986443 346799999987666777788999999999999999999999999
Q ss_pred cCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCe
Q psy7289 125 SGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLT 204 (422)
Q Consensus 125 ~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~ 204 (422)
+++..++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+++|+||||||+|||++.++.
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~ 189 (325)
T 3kul_A 121 RGRLAMIVTEYMENGSLDTFLRTHD-----------GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV 189 (325)
T ss_dssp GGGCCEEEEECCTTCBHHHHHHTTT-----------TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC
T ss_pred eCCccEEEeeCCCCCcHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCC
Confidence 9999999999999999999996532 35899999999999999999999999999999999999999999
Q ss_pred EEEecCcccccccCCcc-eEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc
Q psy7289 205 VKISDFGLSRDVYASDY-YRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS 283 (422)
Q Consensus 205 vKl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~ 283 (422)
+||+|||+++....... ........+|+.|+|||++....++.++|||||||++|||++.|..||.+.+..++...+..
T Consensus 190 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 269 (325)
T 3kul_A 190 CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269 (325)
T ss_dssp EEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT
T ss_pred EEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc
Confidence 99999999986643321 12233344577899999999889999999999999999999889999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 284 RQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 284 ~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
+...+.|..+|+.+.+++..||..+|..|+ +...+...|+
T Consensus 270 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~L~ 309 (325)
T 3kul_A 270 GYRLPAPMGCPHALHQLMLDCWHKDRAQRP-----RFSQIVSVLD 309 (325)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHH
T ss_pred CCCCCCCCCcCHHHHHHHHHHccCChhhCc-----CHHHHHHHHH
Confidence 988899999999999999999999999998 5555555443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-50 Score=393.51 Aligned_cols=269 Identities=40% Similarity=0.777 Sum_probs=229.0
Q ss_pred hhccccCcccccccccccceeEEEEEEec---CCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc
Q psy7289 49 REVIETKPRFLQELGEGAFGKVYKGEVCT---SEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLS 125 (422)
Q Consensus 49 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 125 (422)
.++...+|++.+.||+|+||.||+|++.. ...+..||||+++..........+.+|+.++++++|||||++++++.+
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 35667789999999999999999998653 234578999999876666677789999999999999999999999999
Q ss_pred CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC--
Q psy7289 126 GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL-- 203 (422)
Q Consensus 126 ~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~-- 203 (422)
....++|||||++|+|.+++........ ....+++.++..++.||+.||+|||++||+||||||+|||++.++
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~-----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 220 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPS-----QPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 220 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSS-----SCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccC-----ccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCC
Confidence 9999999999999999999987643211 123589999999999999999999999999999999999998544
Q ss_pred -eEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q psy7289 204 -TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282 (422)
Q Consensus 204 -~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~ 282 (422)
.+||+|||+++...............+|+.|+|||++....++.++|||||||++|||++.|..||.+.+..++...+.
T Consensus 221 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 221 RVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp CCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred ceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 6999999999755332222223334568899999999999999999999999999999988999999999999999999
Q ss_pred cCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 283 SRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 283 ~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
.+..++.|..+|+.+.+|+.+||+.+|..|+ +...+.+.|
T Consensus 301 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~eil~~l 340 (367)
T 3l9p_A 301 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP-----NFAIILERI 340 (367)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHH
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCCCHhHCc-----CHHHHHHHH
Confidence 9988888999999999999999999999998 554444433
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=383.60 Aligned_cols=276 Identities=51% Similarity=0.968 Sum_probs=232.1
Q ss_pred hhhccccCcccccccccccceeEEEEEEecC---CCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEE
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTS---EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCL 124 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~ 124 (422)
..++...+|++.+.||+|+||.||+|++... ..+..||||.++........+.|.+|+.++++++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 4466778899999999999999999998643 2347899999987666666788999999999999999999999999
Q ss_pred cCCCeEEEEEecCCCCHHHHHhhcCCCCCC------------CCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy7289 125 SGEPMCMLFEFMVRGDLHEFLMSRSPRSDI------------SGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDL 192 (422)
Q Consensus 125 ~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~------------~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDl 192 (422)
+.+..++||||+++|+|.+++......... ........+++.++..++.||+.||+|||+++|+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 999999999999999999999875321100 00001146899999999999999999999999999999
Q ss_pred CCCceeecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Q psy7289 193 AARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY 272 (422)
Q Consensus 193 Kp~NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~ 272 (422)
||+|||++.++.+||+|||+++...............+|+.|+|||++....++.++|||||||++|||++.|..||.+.
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999986544333233344556889999999998899999999999999999998899999999
Q ss_pred ChHHHHHHHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 273 SNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 273 ~~~~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
+..++...+..+..++.|..+|+++.+++.+||+.+|..|+ +...+...|+
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~~L~ 331 (343)
T 1luf_A 281 AHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRP-----SFCSIHRILQ 331 (343)
T ss_dssp CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHH
T ss_pred ChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCC-----CHHHHHHHHH
Confidence 99999999999988889999999999999999999999998 6555555443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=385.62 Aligned_cols=281 Identities=37% Similarity=0.706 Sum_probs=239.2
Q ss_pred cccchhhccccCcccccccccccceeEEEEEEecCC-----CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCcee
Q psy7289 44 ASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSE-----GPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIV 117 (422)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv 117 (422)
+....+++...+|++.+.||+|+||.||+|++...+ ....||||+++........+.+.+|+++++++ +|||||
T Consensus 59 ~~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv 138 (382)
T 3tt0_A 59 PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNII 138 (382)
T ss_dssp CCCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhh
Confidence 344566788889999999999999999999875432 23579999998776677778899999999999 899999
Q ss_pred eEeeEEEcCCCeEEEEEecCCCCHHHHHhhcCCCCCC----CCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy7289 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDI----SGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLA 193 (422)
Q Consensus 118 ~l~g~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~----~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlK 193 (422)
++++++.+++..++||||+++|+|.+++....+.... ........+++.++..++.||+.||+|||+++|+|||||
T Consensus 139 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 218 (382)
T 3tt0_A 139 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 218 (382)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred hheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 9999999999999999999999999999875421100 001112469999999999999999999999999999999
Q ss_pred CCceeecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCC
Q psy7289 194 ARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS 273 (422)
Q Consensus 194 p~NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~ 273 (422)
|+|||+++++.+||+|||+++...............+|+.|+|||++....++.++|||||||++|||++.|..||.+.+
T Consensus 219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876544333333445567899999999999999999999999999999987999999999
Q ss_pred hHHHHHHHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhccc
Q psy7289 274 NQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAA 329 (422)
Q Consensus 274 ~~~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk~ 329 (422)
..++...+..+...+.|..+++++.+++.+||..+|..|+ +...+...|+.
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~L~~ 349 (382)
T 3tt0_A 299 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP-----TFKQLVEDLDR 349 (382)
T ss_dssp HHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCc-----CHHHHHHHHHH
Confidence 9999999999988888999999999999999999999998 66666655543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-49 Score=387.75 Aligned_cols=267 Identities=39% Similarity=0.684 Sum_probs=218.7
Q ss_pred ccchhhccccCcccccccccccceeEEEEEEecC-CCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEE
Q psy7289 45 SDFRREVIETKPRFLQELGEGAFGKVYKGEVCTS-EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVC 123 (422)
Q Consensus 45 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~ 123 (422)
..+..++...+|++.+.||+|+||.||+|++... ..+..||||.++........+.|.+|+.+|++++||||+++++++
T Consensus 36 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 115 (373)
T 2qol_A 36 HEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV 115 (373)
T ss_dssp TTTSCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred HHHHhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3455677778999999999999999999986522 345679999998766666778899999999999999999999999
Q ss_pred EcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC
Q psy7289 124 LSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL 203 (422)
Q Consensus 124 ~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~ 203 (422)
.+....++||||+++|+|.+++.... ..+++.++..++.||+.||+|||+++|+||||||+|||++.++
T Consensus 116 ~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 184 (373)
T 2qol_A 116 TKSKPVMIVTEYMENGSLDSFLRKHD-----------AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL 184 (373)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTT-----------TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred eeCCceEEEEeCCCCCcHHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC
Confidence 99999999999999999999997542 3589999999999999999999999999999999999999999
Q ss_pred eEEEecCcccccccCCcce-EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q psy7289 204 TVKISDFGLSRDVYASDYY-RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282 (422)
Q Consensus 204 ~vKl~DFGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~ 282 (422)
.+||+|||+++........ .......+|+.|+|||++....++.++|||||||++|||++.|..||.+.+..++...+.
T Consensus 185 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~ 264 (373)
T 2qol_A 185 VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264 (373)
T ss_dssp CEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH
T ss_pred CEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999999865432211 111222346789999999999999999999999999999988999999999999999999
Q ss_pred cCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 283 SRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 283 ~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
.+.+.+.|..+|+.+.+++.+||+.+|..|+ +...+.+.|
T Consensus 265 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~~i~~~L 304 (373)
T 2qol_A 265 EGYRLPPPMDCPAALYQLMLDCWQKDRNNRP-----KFEQIVSIL 304 (373)
T ss_dssp TTEECCCCTTCBHHHHHHHHHHTCSSGGGSC-----CHHHHHHHH
T ss_pred cCCCCCCCccccHHHHHHHHHHhCcChhhCc-----CHHHHHHHH
Confidence 8888888899999999999999999999998 554444433
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=369.17 Aligned_cols=253 Identities=40% Similarity=0.703 Sum_probs=211.6
Q ss_pred hhhccccCcccccccccccceeEEEEEEecCC-CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSE-GPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG 126 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~ 126 (422)
..++...+|++.+.||+|+||.||+|++..++ ....||+|.++........+.+.+|+.++++++||||+++++++. .
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 87 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence 34677789999999999999999999876533 356799999876666666788999999999999999999999984 5
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEE
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vK 206 (422)
+..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+|
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 156 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRK-----------YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVK 156 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTT-----------TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEE
T ss_pred CccEEEEecCCCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEE
Confidence 67899999999999999997642 2588999999999999999999999999999999999999999999
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~ 286 (422)
|+|||+++........ ......+|+.|+|||++....++.++|||||||++|||++.|..||.+.+..++...+..+..
T Consensus 157 l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~ 235 (281)
T 1mp8_A 157 LGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER 235 (281)
T ss_dssp ECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred ECccccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC
Confidence 9999999866443221 223344577899999999889999999999999999999779999999999999999998888
Q ss_pred CCCCCCCCcchhhhcccccccccchhh
Q psy7289 287 LPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 287 ~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.+.|..+|+.+.+++.+||+.+|..|+
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~Rp 262 (281)
T 1mp8_A 236 LPMPPNCPPTLYSLMTKCWAYDPSRRP 262 (281)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 889999999999999999999999998
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=393.80 Aligned_cols=253 Identities=36% Similarity=0.703 Sum_probs=220.6
Q ss_pred hhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC-
Q psy7289 49 REVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE- 127 (422)
Q Consensus 49 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~- 127 (422)
+++...+|++.+.||+|+||.||+|++. +..||||+++... ..+.|.+|+.+|++++|||||++++++.+..
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~----~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 260 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYR----GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 260 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET----TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEec----CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC
Confidence 3566778999999999999999999863 4679999997543 3467999999999999999999999987765
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
.+++|||||++|+|.+++..... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl 330 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGR----------SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKV 330 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCT----------TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEE
T ss_pred ceEEEEEecCCCcHHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEE
Confidence 79999999999999999987531 24789999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+|||+++..... .....+|+.|+|||++....++.++|||||||++|||++.|..||.+.+..++...+..+.++
T Consensus 331 ~DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 405 (450)
T 1k9a_A 331 SDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 405 (450)
T ss_dssp CCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC
T ss_pred eeCCCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999999854321 122346788999999999999999999999999999998899999999999999999999889
Q ss_pred CCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
+.|..||+++.+||.+||+.+|..|+ ++..+...|+
T Consensus 406 ~~p~~~~~~l~~li~~cl~~dp~~Rp-----t~~~l~~~L~ 441 (450)
T 1k9a_A 406 DAPDGCPPAVYDVMKNCWHLDAATRP-----TFLQLREQLE 441 (450)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCc-----CHHHHHHHHH
Confidence 99999999999999999999999998 6666655443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-49 Score=396.98 Aligned_cols=259 Identities=36% Similarity=0.691 Sum_probs=225.3
Q ss_pred hhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
.+++...+|++.+.||+|+||.||+|++. ++..||||+++... ...+.|.+|+++|++++|||||++++++. .+
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYN---KHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEET---TTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEEC---CccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 34677788999999999999999999874 34679999987543 24578999999999999999999999986 56
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
..++|||||++|+|.+++.... ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl 325 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDE----------GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKI 325 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHH----------HHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEE
T ss_pred ccEEEEeecCCCcHHHHHHhcc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEE
Confidence 7899999999999999997531 124788899999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+|||+++....... .......+|+.|+|||++..+.++.++|||||||++|||++.|..||.+.+..++...+..+.++
T Consensus 326 ~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 404 (454)
T 1qcf_A 326 ADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM 404 (454)
T ss_dssp CSTTGGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC
T ss_pred eeCCCceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999986543221 12233445788999999998999999999999999999999899999999999999999999999
Q ss_pred CCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
+.|..||+++.++|.+||+.+|..|+ ++..+...|.
T Consensus 405 ~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~~i~~~L~ 440 (454)
T 1qcf_A 405 PRPENCPEELYNIMMRCWKNRPEERP-----TFEYIQSVLD 440 (454)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCc-----CHHHHHHHHH
Confidence 99999999999999999999999999 7776666554
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=378.60 Aligned_cols=261 Identities=33% Similarity=0.583 Sum_probs=216.7
Q ss_pred hccccCcccccccccccceeEEEEEEecCCC--CeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEG--PSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
.+...+|++.+.||+|+||.||+|++..++. ...||+|.++........+.|.+|+.++++++||||+++++++.++.
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 3456789999999999999999998754432 23478898865555556678999999999999999999999998754
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
.++|+||+++|+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl 158 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHK-----------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKI 158 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHST-----------TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEE
T ss_pred -eEEEEEecCCCcHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEE
Confidence 789999999999999997642 35899999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+|||+++...............+|+.|+|||++....++.++|||||||++|||++.|..||.+.+..++...+..+...
T Consensus 159 ~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 238 (327)
T 3poz_A 159 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238 (327)
T ss_dssp CCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC
T ss_pred ccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC
Confidence 99999987654433333334456789999999999999999999999999999998899999999999999999988888
Q ss_pred CCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
+.|..++.++.+++.+||..+|..|+ +...+...|
T Consensus 239 ~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ell~~l 273 (327)
T 3poz_A 239 PQPPICTIDVYMIMVKCWMIDADSRP-----KFRELIIEF 273 (327)
T ss_dssp CCCTTBCHHHHHHHHHHTCSCGGGSC-----CHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcCCChhhCC-----CHHHHHHHH
Confidence 88999999999999999999999998 544444433
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=372.38 Aligned_cols=276 Identities=36% Similarity=0.663 Sum_probs=233.3
Q ss_pred chhhccccCcccccccccccceeEEEEEEecC---CCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEE
Q psy7289 47 FRREVIETKPRFLQELGEGAFGKVYKGEVCTS---EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVC 123 (422)
Q Consensus 47 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~ 123 (422)
..+++...+|++.+.||+|+||.||+|+.... ..+..||||+++........+.+.+|++++++++||||+++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 34566778899999999999999999987532 234789999998766667778899999999999999999999999
Q ss_pred EcCCCeEEEEEecCCCCHHHHHhhcCCCCC------------CCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q psy7289 124 LSGEPMCMLFEFMVRGDLHEFLMSRSPRSD------------ISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRD 191 (422)
Q Consensus 124 ~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~------------~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrD 191 (422)
.+.+..++||||+++|+|.+++........ .........+++.++..++.||+.||+|||+++|+|||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 999999999999999999999987532100 00000113488999999999999999999999999999
Q ss_pred CCCCceeecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Q psy7289 192 LAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG 271 (422)
Q Consensus 192 lKp~NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~ 271 (422)
|||+|||+++++.+||+|||+++...............+|+.|+|||.+....++.++|||||||++|||++.|..||.+
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998765544443444555678899999999888999999999999999999879999999
Q ss_pred CChHHHHHHHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 272 YSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 272 ~~~~~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
.+..++...+..+...+.|..+|+++.+++.+||..+|..|+ +...+...|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~l~~~l 306 (314)
T 2ivs_A 256 IPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRP-----VFADISKDL 306 (314)
T ss_dssp CCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHH
T ss_pred CCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCc-----CHHHHHHHH
Confidence 999999999998888888999999999999999999999998 555544443
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=381.57 Aligned_cols=277 Identities=33% Similarity=0.612 Sum_probs=228.0
Q ss_pred cchhhccccCcccccccccccceeEEEEEEec---CCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEee
Q psy7289 46 DFRREVIETKPRFLQELGEGAFGKVYKGEVCT---SEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLG 121 (422)
Q Consensus 46 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g 121 (422)
.-.+++...+|++.+.||+|+||.||+|++.. ...++.||||+++........+.+.+|+++++++ +|||||++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 34567788899999999999999999998753 3345789999998766666678899999999999 7899999999
Q ss_pred EEEcCC-CeEEEEEecCCCCHHHHHhhcCCCCCC----------------------------------------------
Q psy7289 122 VCLSGE-PMCMLFEFMVRGDLHEFLMSRSPRSDI---------------------------------------------- 154 (422)
Q Consensus 122 ~~~~~~-~~~lv~E~~~~G~L~~~l~~~~~~~~~---------------------------------------------- 154 (422)
++.+.+ .+++|||||++|+|.+++.........
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 998765 489999999999999999865321000
Q ss_pred --------CCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccccCCcceEecc
Q psy7289 155 --------SGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQS 226 (422)
Q Consensus 155 --------~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~ 226 (422)
........+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++............
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 253 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcc
Confidence 000011238999999999999999999999999999999999999999999999999998765444333444
Q ss_pred CCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHcCCCCCCCCCCCcchhhhccccc
Q psy7289 227 KSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN-QEVIEMIRSRQMLPCPEDCPPRMYSLMMECW 305 (422)
Q Consensus 227 ~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~-~~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw 305 (422)
...+|+.|+|||++....++.++|||||||++|||++.|..||.+.+. ..+...+..+...+.|..+++++.+++.+||
T Consensus 254 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 333 (359)
T 3vhe_A 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCW 333 (359)
T ss_dssp -CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHT
T ss_pred ccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHc
Confidence 556788999999999999999999999999999999879999988764 4566677777788889999999999999999
Q ss_pred ccccchhhHHHHhhhhhhhhhc
Q psy7289 306 HEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 306 ~~~P~~r~~~~lh~~~~i~~dL 327 (422)
+.+|..|+ +...+.+.|
T Consensus 334 ~~dP~~Rp-----s~~ell~~L 350 (359)
T 3vhe_A 334 HGEPSQRP-----TFSELVEHL 350 (359)
T ss_dssp CSSGGGSC-----CHHHHHHHH
T ss_pred cCChhhCC-----CHHHHHHHH
Confidence 99999998 555444443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=406.14 Aligned_cols=258 Identities=37% Similarity=0.685 Sum_probs=220.1
Q ss_pred cCccccc-ccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 54 TKPRFLQ-ELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 54 ~~~~~~~-~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
..+.+.+ .||+|+||.||+|.+...+++..||||+++........+.|.+|+++|++++|||||++++++.+ +.+++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3444445 79999999999999876666778999999865555567889999999999999999999999976 569999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
||||++|+|.+++.... ..+++.++..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+
T Consensus 414 ~E~~~~g~L~~~l~~~~-----------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGl 482 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKR-----------EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGL 482 (613)
T ss_dssp EECCTTCBHHHHHTTCT-----------TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCST
T ss_pred EEeCCCCcHHHHHhhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccC
Confidence 99999999999996532 3589999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcc-eEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCC
Q psy7289 213 SRDVYASDY-YRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPE 291 (422)
Q Consensus 213 a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~ 291 (422)
++....... ........+|+.|+|||++....++.++|||||||++|||++.|..||.+.+..++...+..+.+++.|.
T Consensus 483 a~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~ 562 (613)
T 2ozo_A 483 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP 562 (613)
T ss_dssp TTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCT
T ss_pred cccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 987643321 2222233456889999999989999999999999999999988999999999999999999999999999
Q ss_pred CCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 292 DCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 292 ~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
.||+++.+||.+||+.+|..|+ ++..+.+.|+
T Consensus 563 ~~~~~l~~li~~cl~~dP~~RP-----s~~~l~~~L~ 594 (613)
T 2ozo_A 563 ECPPELYALMSDCWIYKWEDRP-----DFLTVEQRMR 594 (613)
T ss_dssp TCCHHHHHHHHHTTCSSTTTSC-----CHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCc-----CHHHHHHHHH
Confidence 9999999999999999999998 6666665554
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=376.36 Aligned_cols=254 Identities=21% Similarity=0.377 Sum_probs=219.2
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
..+|++++.||+|+||.||+|+... .++.||+|+++... .......+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKA--TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECC--CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 3578899999999999999998653 35789999986431 1234567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 82 lv~E~~~gg~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DF 149 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRE------------RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp EEEECCTTCBHHHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEeCCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeec
Confidence 999999999999999764 35899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP 290 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p 290 (422)
|+++....... ......+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..++...+..+. ...|
T Consensus 150 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~-~~~p 225 (337)
T 1o6l_A 150 GLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFELILMEE-IRFP 225 (337)
T ss_dssp TTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCC-CCCC
T ss_pred cchhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhc-CCCCCCCCCHHHHHHHHHcCC-CCCC
Confidence 99986432221 1234567899999999999999999999999999999999 999999999999888887654 4567
Q ss_pred CCCCcchhhhcccccccccchhh------HHHHhhhhhhh
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAG------MAYLCSHHYVH 324 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~------~~~lh~~~~i~ 324 (422)
..+++++.+|+.+||..+|..|. +..+.+|.++.
T Consensus 226 ~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~ 265 (337)
T 1o6l_A 226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265 (337)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcC
Confidence 88999999999999999999995 66677776654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=397.75 Aligned_cols=261 Identities=38% Similarity=0.740 Sum_probs=229.6
Q ss_pred hhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
.+++...+|++.+.||+|+||.||+|++..+ +..||||.++.... ..+.|.+|+.+|++++|||||+++++|.+..
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~--~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKY--SLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGG--TEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCC--CeEEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 3466677889999999999999999988643 47899999875432 3568999999999999999999999999999
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
.+++|||||++|+|.+++..... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~----------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl 359 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNR----------QEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKV 359 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCT----------TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEE
T ss_pred cEEEEEEccCCCCHHHHHHhcCc----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEE
Confidence 99999999999999999976421 35889999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+|||+++...... +.......+|+.|+|||++....++.++|||||||++|||++.|..||.+.+..++...+..+.++
T Consensus 360 ~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 438 (495)
T 1opk_A 360 ADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 438 (495)
T ss_dssp CCTTCEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC
T ss_pred eecccceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999998764432 233344556789999999998899999999999999999999899999999999999999998888
Q ss_pred CCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
+.|..||+.+.+||.+||+.+|..|+ +...+.+.|+
T Consensus 439 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~el~~~L~ 474 (495)
T 1opk_A 439 ERPEGCPEKVYELMRACWQWNPSDRP-----SFAEIHQAFE 474 (495)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCcChhHCc-----CHHHHHHHHH
Confidence 99999999999999999999999998 7777666554
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=373.38 Aligned_cols=281 Identities=36% Similarity=0.696 Sum_probs=235.3
Q ss_pred ccccchhhccccCcccccccccccceeEEEEEEecC-----CCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCce
Q psy7289 43 TASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTS-----EGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNI 116 (422)
Q Consensus 43 ~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnI 116 (422)
.+....+++...+|++.+.||+|+||.||+|++... ..+..||||+++........+.+.+|+.+++++ +||||
T Consensus 24 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i 103 (334)
T 2pvf_A 24 LPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 103 (334)
T ss_dssp CCCCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CCCCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCE
Confidence 334455677788999999999999999999987532 235679999998766666778899999999999 89999
Q ss_pred eeEeeEEEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCC----CCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy7289 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDIS----GSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDL 192 (422)
Q Consensus 117 v~l~g~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~----~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDl 192 (422)
+++++++.+.+..++||||+++|+|.+++.......... .......+++.++..++.||+.||+|||+++|+||||
T Consensus 104 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl 183 (334)
T 2pvf_A 104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDL 183 (334)
T ss_dssp CCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred eeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 999999999999999999999999999998653211000 0001235899999999999999999999999999999
Q ss_pred CCCceeecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Q psy7289 193 AARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY 272 (422)
Q Consensus 193 Kp~NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~ 272 (422)
||+|||++.++.+||+|||+++...............+|+.|+|||++....++.++|||||||++|||++.|..||.+.
T Consensus 184 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 184 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 99999999999999999999987655444444445566789999999988889999999999999999998899999999
Q ss_pred ChHHHHHHHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 273 SNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 273 ~~~~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
+..++...+..+...+.|..+|+++.+++..||..+|..|+ +...+...|.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~~L~ 314 (334)
T 2pvf_A 264 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRP-----TFKQLVEDLD 314 (334)
T ss_dssp CHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHH
T ss_pred CHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCc-----CHHHHHHHHH
Confidence 99999999998888888999999999999999999999998 5555555443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=372.01 Aligned_cols=253 Identities=25% Similarity=0.417 Sum_probs=219.3
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
...+|++.+.||+|+||.||+|++..+ +..||||++... ......+.+.+|+++|+.++||||+++++++.+.+.+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILT--GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTT--CCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCC--CCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 346799999999999999999987543 577999998643 34556678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+||||+++|+|.+++... ..+++.++..++.|++.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 91 lv~e~~~~~~L~~~l~~~------------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DF 158 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAH------------GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADF 158 (328)
T ss_dssp EEECCCTTCBHHHHHHHH------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECST
T ss_pred EEEECCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeec
Confidence 999999999999999765 35899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFT-TESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 289 (422)
|+++...... ......+|+.|+|||++.+..++ .++|||||||++|||++ |..||.+.+..++...+..+. .+.
T Consensus 159 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~-~~~ 233 (328)
T 3fe3_A 159 GFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGQNLKELRERVLRGK-YRI 233 (328)
T ss_dssp TCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCC-CCC
T ss_pred cCceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCC
Confidence 9998654332 23445688999999999888775 78999999999999999 999999999999999888765 456
Q ss_pred CCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 290 PEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 290 p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
|..+++++.+|+++||..||..|+ +..+.+|.++
T Consensus 234 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~ 268 (328)
T 3fe3_A 234 PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268 (328)
T ss_dssp CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTT
T ss_pred CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhh
Confidence 788999999999999999999987 3334444444
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=391.97 Aligned_cols=259 Identities=37% Similarity=0.707 Sum_probs=219.5
Q ss_pred hhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
.+++...+|++.+.||+|+||.||+|++.. ...||||+++.... ..+.|.+|+++|++++||||+++++++.+ +
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG---TTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 251 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETT---TEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECC---CceEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence 356777889999999999999999998743 45699999875432 34679999999999999999999999876 6
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
..++||||+++|+|.+++.... ...+++.++..++.||+.||+|||+++|+||||||+|||+++++.+||
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl 321 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGET----------GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKV 321 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHH----------HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred ceEEEehhhcCCCHHHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEE
Confidence 7899999999999999997531 124889999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+|||+++....... .......+|+.|+|||++....++.++|||||||++|||++.|..||.+.+..++...+..+.++
T Consensus 322 ~DfG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 400 (452)
T 1fmk_A 322 ADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM 400 (452)
T ss_dssp CCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CCCccceecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999986543322 22233446788999999998999999999999999999999899999999999999999999899
Q ss_pred CCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
+.|..||+.+.++|.+||..+|..|+ +...+...|+
T Consensus 401 ~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~l~~~L~ 436 (452)
T 1fmk_A 401 PCPPECPESLHDLMCQCWRKEPEERP-----TFEYLQAFLE 436 (452)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCc-----CHHHHHHHHH
Confidence 99999999999999999999999998 6666665554
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=370.84 Aligned_cols=257 Identities=42% Similarity=0.730 Sum_probs=217.8
Q ss_pred cchhhccccCcccccccccccceeEEEEEEecCCC--CeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEE
Q psy7289 46 DFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEG--PSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVC 123 (422)
Q Consensus 46 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~ 123 (422)
.+..++...+|++.+.||+|+||.||+|++..+++ ...||||.++..........+.+|+.++++++||||+++++++
T Consensus 36 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 115 (333)
T 1mqb_A 36 KFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI 115 (333)
T ss_dssp --CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hccccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 45567788899999999999999999998765432 3569999998766666677899999999999999999999999
Q ss_pred EcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC
Q psy7289 124 LSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL 203 (422)
Q Consensus 124 ~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~ 203 (422)
.+.+..++||||+++|+|.+++.... ..+++.++..++.||+.||+|||+++|+||||||+|||++.++
T Consensus 116 ~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~ 184 (333)
T 1mqb_A 116 SKYKPMMIITEYMENGALDKFLREKD-----------GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL 184 (333)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTT-----------TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred ecCCCcEEEEeCCCCCcHHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC
Confidence 99999999999999999999997642 3589999999999999999999999999999999999999999
Q ss_pred eEEEecCcccccccCCcce-EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q psy7289 204 TVKISDFGLSRDVYASDYY-RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282 (422)
Q Consensus 204 ~vKl~DFGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~ 282 (422)
.+||+|||+++........ .......+|+.|+|||++....++.++|||||||++|||++.|..||.+.+..++...+.
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 264 (333)
T 1mqb_A 185 VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264 (333)
T ss_dssp CEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred cEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 9999999999865432211 112233457789999999988999999999999999999988999999999999999999
Q ss_pred cCCCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 283 SRQMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 283 ~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.+.+++.|..+|+.+.+++.+||..+|..|+
T Consensus 265 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 295 (333)
T 1mqb_A 265 DGFRLPTPMDCPSAIYQLMMQCWQQERARRP 295 (333)
T ss_dssp TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSC
T ss_pred CCCcCCCcccCCHHHHHHHHHHcCCChhhCc
Confidence 8888888999999999999999999999998
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=362.61 Aligned_cols=260 Identities=37% Similarity=0.686 Sum_probs=223.3
Q ss_pred ccccCccccc-ccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 51 VIETKPRFLQ-ELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 51 ~~~~~~~~~~-~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
+...+|.+.+ .||+|+||.||+|++.....+..||||.++........+.+.+|++++++++||||+++++++ ..+..
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~ 84 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEAL 84 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSE
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCc
Confidence 4455677776 899999999999987666667889999998766666778899999999999999999999999 45679
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEec
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISD 209 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~D 209 (422)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~D 153 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVGKR-----------EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISD 153 (287)
T ss_dssp EEEEECCTTEEHHHHHTTCT-----------TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECC
T ss_pred EEEEEeCCCCCHHHHHHhCC-----------ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECc
Confidence 99999999999999996432 3589999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCcce-EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC
Q psy7289 210 FGLSRDVYASDYY-RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP 288 (422)
Q Consensus 210 FGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 288 (422)
||+++........ .......+|+.|+|||++....++.++|||||||++|||++.|..||.+.+..++...+..+.+++
T Consensus 154 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~ 233 (287)
T 1u59_A 154 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME 233 (287)
T ss_dssp CTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC
T ss_pred ccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCC
Confidence 9999876433322 222334457899999999888899999999999999999987999999999999999999988888
Q ss_pred CCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 289 CPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 289 ~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
.|..+|+++.+++.+||..+|..|+ +...+...|
T Consensus 234 ~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~~l 267 (287)
T 1u59_A 234 CPPECPPELYALMSDCWIYKWEDRP-----DFLTVEQRM 267 (287)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSC-----CHHHHHHHH
T ss_pred CCCCcCHHHHHHHHHHcCCChhhCc-----CHHHHHHHH
Confidence 9999999999999999999999998 555554443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=375.79 Aligned_cols=262 Identities=31% Similarity=0.569 Sum_probs=220.1
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCC--eEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGP--SLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
.+...+|++.+.||+|+||.||+|++..++.. ..||+|.+.........+.+.+|+.++++++||||+++++++. .+
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 44567899999999999999999987654322 2478888754433333456788999999999999999999986 46
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl 156 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHR-----------GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQV 156 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSG-----------GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEE
T ss_pred ccEEEEEeCCCCCHHHHHHHcc-----------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEE
Confidence 6899999999999999997531 35888999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+|||+++...............+|+.|+|||++....++.++|||||||++|||++.|..||.+.+..++...+..+...
T Consensus 157 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 236 (325)
T 3kex_A 157 ADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERL 236 (325)
T ss_dssp CSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBC
T ss_pred CCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC
Confidence 99999987654433222334456778999999998999999999999999999998899999999999999999998888
Q ss_pred CCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
+.|..+++++.+++.+||..+|..|+ +...+...|+
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~el~~~l~ 272 (325)
T 3kex_A 237 AQPQICTIDVYMVMVKCWMIDENIRP-----TFKELANEFT 272 (325)
T ss_dssp CCCTTBCTTTTHHHHHHTCSCTTTSC-----CHHHHHHHHH
T ss_pred CCCCcCcHHHHHHHHHHcCCChhhCc-----CHHHHHHHHH
Confidence 89999999999999999999999998 5555555443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=368.12 Aligned_cols=274 Identities=43% Similarity=0.765 Sum_probs=232.8
Q ss_pred hhhccccCcccccccccccceeEEEEEEec---CCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEE
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCT---SEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCL 124 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~ 124 (422)
.+++...+|++.+.||+|+||.||+|++.. ...+..||||.+...........+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 346677889999999999999999998753 12356799999987666666778999999999999999999999999
Q ss_pred cCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCe
Q psy7289 125 SGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLT 204 (422)
Q Consensus 125 ~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~ 204 (422)
+.+..++||||+++|+|.+++........ .......+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMA--NNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHH--HCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhc--cCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe
Confidence 99999999999999999999976321000 0001135789999999999999999999999999999999999999999
Q ss_pred EEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC
Q psy7289 205 VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR 284 (422)
Q Consensus 205 vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~ 284 (422)
+||+|||+++...............+|+.|+|||++....++.++|||||||++|||++.|..||.+.+..++...+..+
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 256 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 256 (322)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC
Confidence 99999999987655444444444556788999999998899999999999999999999889999999999999999988
Q ss_pred CCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 285 QMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 285 ~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
...+.|..+|+.+.+++.+||..+|..|+ +...+...|+
T Consensus 257 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~e~l~~L~ 295 (322)
T 1p4o_A 257 GLLDKPDNCPDMLFELMRMCWQYNPKMRP-----SFLEIISSIK 295 (322)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHG
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCc-----CHHHHHHHHH
Confidence 88888999999999999999999999998 6555555444
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=375.93 Aligned_cols=257 Identities=19% Similarity=0.314 Sum_probs=214.9
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSG 126 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~ 126 (422)
.+...+|++++.||+|+||.||+|+... .+..||||+++... .......+.+|..+++.+ +||||+++++++.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 96 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKE--TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP 96 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcC--CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC
Confidence 3445689999999999999999998754 35789999986432 223456788999999988 699999999999999
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEE
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vK 206 (422)
+.+|+|||||++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ik 164 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKS------------RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCK 164 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEE
T ss_pred CEEEEEEeCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEE
Confidence 9999999999999999999764 3589999999999999999999999999999999999999999999
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~ 286 (422)
|+|||+++...... .......+|+.|||||++....++.++|||||||++|||++ |..||.+.+..++...|..+.
T Consensus 165 L~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-G~~Pf~~~~~~~~~~~i~~~~- 240 (353)
T 3txo_A 165 LADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLC-GHAPFEAENEDDLFEAILNDE- 240 (353)
T ss_dssp ECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCC-
T ss_pred EccccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-
Confidence 99999998543222 12334568999999999998889999999999999999999 999999999999999998765
Q ss_pred CCCCCCCCcchhhhcccccccccchhhH-------HHHhhhhhhh
Q psy7289 287 LPCPEDCPPRMYSLMMECWHEVPVAAGM-------AYLCSHHYVH 324 (422)
Q Consensus 287 ~~~p~~~p~~~~~l~~~cw~~~P~~r~~-------~~lh~~~~i~ 324 (422)
...|..+++++.+|+++||..+|..|.- ..+.+|.++.
T Consensus 241 ~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~ 285 (353)
T 3txo_A 241 VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK 285 (353)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGT
T ss_pred CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCccc
Confidence 4567889999999999999999998863 3355555553
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=365.98 Aligned_cols=259 Identities=30% Similarity=0.494 Sum_probs=212.7
Q ss_pred hhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSG 126 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~ 126 (422)
..++...+|++.+.||+|+||.||+|++ .+..||||++.... .....+.|.+|++++++++||||+++++++.+.
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW----HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE----TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE----CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 3456677899999999999999999975 24679999986543 445567899999999999999999999999999
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceeecCCCe
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHH--YVHRDLAARNCLVGDGLT 204 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--ivHrDlKp~NiLl~~~~~ 204 (422)
+.+++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~ 177 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGA---------REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT 177 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTH---------HHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC
T ss_pred CceEEEEecCCCCcHHHHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc
Confidence 999999999999999999975321 124899999999999999999999999 999999999999999999
Q ss_pred EEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH-c
Q psy7289 205 VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR-S 283 (422)
Q Consensus 205 vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~-~ 283 (422)
+||+|||+++...... .......+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..+....+. .
T Consensus 178 ~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~ 254 (309)
T 3p86_A 178 VKVCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFK 254 (309)
T ss_dssp EEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHH-CCCTTTTSCHHHHHHHHHHS
T ss_pred EEECCCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Confidence 9999999997543221 12234567899999999999999999999999999999999 999999999988887775 4
Q ss_pred CCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 284 RQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 284 ~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
....+.|..+|+++.+++.+||..+|..|+ +...+...|
T Consensus 255 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~ll~~L 293 (309)
T 3p86_A 255 CKRLEIPRNLNPQVAAIIEGCWTNEPWKRP-----SFATIMDLL 293 (309)
T ss_dssp CCCCCCCTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHccCChhhCc-----CHHHHHHHH
Confidence 556678899999999999999999999998 555544444
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=369.88 Aligned_cols=268 Identities=35% Similarity=0.681 Sum_probs=209.0
Q ss_pred hccccCcccccccccccceeEEEEEEecCCC-CeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEG-PSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
.+...+|++.+.||+|+||.||+|++..++. ...||||.++... .....+.+.+|++++++++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 4566789999999999999999998754432 2379999986542 3345678999999999999999999999998776
Q ss_pred Ce------EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC
Q psy7289 128 PM------CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD 201 (422)
Q Consensus 128 ~~------~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~ 201 (422)
.. ++||||+++|+|.+++....... ....+++.++..++.|++.||+|||++||+||||||+|||+++
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~------~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGE------NPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAE 172 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccc------cccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcC
Confidence 55 99999999999999997642111 1125899999999999999999999999999999999999999
Q ss_pred CCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHH
Q psy7289 202 GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281 (422)
Q Consensus 202 ~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i 281 (422)
++.+||+|||+++...............+|+.|+|||.+....++.++|||||||++|||++.|..||.+.+..++...+
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~ 252 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 99999999999987654443333344556788999999999999999999999999999998899999999999999999
Q ss_pred HcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 282 RSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 282 ~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
..+...+.|..+|+++.+++.+||..+|..|+ +...+.+.|+
T Consensus 253 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~l~~~l~ 294 (323)
T 3qup_A 253 IGGNRLKQPPECMEEVYDLMYQCWSADPKQRP-----SFTCLRMELE 294 (323)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSC-----CHHHHHHHHH
T ss_pred hcCCCCCCCCccCHHHHHHHHHHccCChhhCc-----CHHHHHHHHH
Confidence 98888888999999999999999999999998 5555544443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=374.05 Aligned_cols=252 Identities=20% Similarity=0.305 Sum_probs=219.9
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
...+|++++.||+|+||.||+|+... .+..||||+++... .....+.+.+|+++|+.++||||+++++++.+...+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKE--SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECC--CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 44678999999999999999998754 35789999985432 122356788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEec
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISD 209 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~D 209 (422)
|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 117 ~lv~e~~~gg~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~D 184 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRI------------GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTD 184 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECC
T ss_pred EEEEcCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcc
Confidence 9999999999999999764 2589999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 289 (422)
||+++..... .....+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..++...+..+. .+.
T Consensus 185 Fg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~-~~~ 257 (350)
T 1rdq_E 185 FGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQPIQIYEKIVSGK-VRF 257 (350)
T ss_dssp CTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCC-CCC
T ss_pred cccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhh-CCCCCCCCCHHHHHHHHHcCC-CCC
Confidence 9999865432 223457899999999999999999999999999999999 999999999999999988775 567
Q ss_pred CCCCCcchhhhcccccccccchhh------HHHHhhhhhhh
Q psy7289 290 PEDCPPRMYSLMMECWHEVPVAAG------MAYLCSHHYVH 324 (422)
Q Consensus 290 p~~~p~~~~~l~~~cw~~~P~~r~------~~~lh~~~~i~ 324 (422)
|..+++++.+++.+||..+|..|. +..+.+|.++.
T Consensus 258 p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~ 298 (350)
T 1rdq_E 258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298 (350)
T ss_dssp CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcC
Confidence 888999999999999999999986 55666666653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=380.01 Aligned_cols=259 Identities=36% Similarity=0.690 Sum_probs=212.7
Q ss_pred CcccccccccccceeEEEEEEecCC-CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc-CCCeEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSE-GPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLS-GEPMCML 132 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~~lv 132 (422)
.|++.+.||+|+||.||+|++...+ ....||||.++........+.|.+|+.++++++||||+++++++.+ .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4567889999999999999986543 2456899998766555667889999999999999999999999764 4578999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++|+|.+++.... ..+++.++..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+
T Consensus 170 ~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~ 238 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET-----------HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGL 238 (373)
T ss_dssp EECCTTCBHHHHHHCTT-----------CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred EECCCCCCHHHHHhhcc-----------cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccc
Confidence 99999999999997542 3478899999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceE--eccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC
Q psy7289 213 SRDVYASDYYR--IQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP 290 (422)
Q Consensus 213 a~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p 290 (422)
++......... ......+|+.|+|||++....++.++|||||||++|||++.|.+||.+.+..++...+..+.+++.|
T Consensus 239 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p 318 (373)
T 3c1x_A 239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 318 (373)
T ss_dssp -------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCC
T ss_pred cccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 98654332211 1233456788999999999999999999999999999999889999998888888888888888889
Q ss_pred CCCCcchhhhcccccccccchhhHHHHhhhhhhhhhccc
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAA 329 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk~ 329 (422)
..||+.+.++|.+||+.+|..|+ +...+...|+.
T Consensus 319 ~~~~~~l~~li~~cl~~dp~~RP-----s~~ell~~L~~ 352 (373)
T 3c1x_A 319 EYCPDPLYEVMLKCWHPKAEMRP-----SFSELVSRISA 352 (373)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCc-----CHHHHHHHHHH
Confidence 99999999999999999999998 66666665543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=358.08 Aligned_cols=248 Identities=40% Similarity=0.740 Sum_probs=218.2
Q ss_pred hhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC
Q psy7289 49 REVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP 128 (422)
Q Consensus 49 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 128 (422)
+.+...+|++.+.||+|+||.||+|++. ++..||+|++..... ..+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWL---NKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET---TTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred EEeChhhceeeheecCCCccEEEEEEec---CCCeEEEEEeccccc--CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence 3456678999999999999999999864 246799999875432 23578999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~ 148 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQR-----------GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVS 148 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTT-----------TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEEC
T ss_pred eEEEEEeCCCCcHHHHHHhcC-----------cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEec
Confidence 999999999999999997542 358999999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP 288 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 288 (422)
|||+++....... .......+|+.|+|||.+....++.++|||||||++|||++.|..||.+.+..++...+..+....
T Consensus 149 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~ 227 (269)
T 4hcu_A 149 DFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY 227 (269)
T ss_dssp CTTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred ccccccccccccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCC
Confidence 9999986543221 122344567789999999989999999999999999999987999999999999999999888888
Q ss_pred CCCCCCcchhhhcccccccccchhh
Q psy7289 289 CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 289 ~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.|..+++.+.+++.+||+.+|..|+
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rp 252 (269)
T 4hcu_A 228 KPRLASTHVYQIMNHCWRERPEDRP 252 (269)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred CCCcCCHHHHHHHHHHccCCcccCc
Confidence 8899999999999999999999998
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=370.34 Aligned_cols=252 Identities=35% Similarity=0.600 Sum_probs=212.3
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCC--eEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGP--SLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
.+...+|++++.||+|+||.||+|++..++.. ..||+|.+.........+.+.+|+.++++++||||+++++++..+.
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 35567899999999999999999987654432 2468888765555556678999999999999999999999998754
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
.++|+||+.+|+|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL 158 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHK-----------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKI 158 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTT-----------TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEE
T ss_pred -ceEEEEecCCCcHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEE
Confidence 889999999999999997642 35899999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+|||+++...............+|+.|+|||++....++.++|||||||++|||++.|..||.+.+..++...+..+...
T Consensus 159 ~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~ 238 (327)
T 3lzb_A 159 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238 (327)
T ss_dssp CCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC
T ss_pred ccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999987644332223334456788999999999999999999999999999998899999999999999999998888
Q ss_pred CCCCCCCcchhhhcccccccccchhh
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+.|..+|+++.+++++||..+|..|+
T Consensus 239 ~~~~~~~~~l~~li~~~l~~dp~~Rp 264 (327)
T 3lzb_A 239 PQPPICTIDVYMIMRKCWMIDADSRP 264 (327)
T ss_dssp CCCTTBCHHHHHHHHHHTCSSGGGSC
T ss_pred CCCccCCHHHHHHHHHHcCCChhHCc
Confidence 89999999999999999999999997
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=363.37 Aligned_cols=260 Identities=32% Similarity=0.623 Sum_probs=212.1
Q ss_pred hccccCcccccccccccceeEEEEEEe--cCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc--
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVC--TSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLS-- 125 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-- 125 (422)
++...+|++++.||+|+||.||+|++. ....+..||||++... .....+.|.+|++++++++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 455678999999999999999999864 3345688999998743 44556789999999999999999999999864
Q ss_pred CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 126 GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 126 ~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
...+++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+++|+||||||+|||++.++.+
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~ 153 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKHK-----------ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 153 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHCG-----------GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEE
T ss_pred CCceEEEEEeCCCCCHHHHHHhcc-----------cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeE
Confidence 356899999999999999997642 248999999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcc-eEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh----------
Q psy7289 206 KISDFGLSRDVYASDY-YRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN---------- 274 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~---------- 274 (422)
||+|||+++....... ........+|+.|+|||.+....++.++|||||||++|||++ |..|+.....
T Consensus 154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~~~~~~~~~~~~~~~~~~ 232 (295)
T 3ugc_A 154 KIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-YIEKSKSPPAEFMRMIGNDK 232 (295)
T ss_dssp EECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHH-TTCTTCSHHHHHHHHHCTTC
T ss_pred EEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHh-cccccCCChHHHHhhhcCcc
Confidence 9999999986643322 122233446778999999999999999999999999999999 8778754321
Q ss_pred ------HHHHHHHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 275 ------QEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 275 ------~~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
..+...+..+.+.+.|..||+++.+++.+||+.+|..|+ +...+...|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~el~~~L 286 (295)
T 3ugc_A 233 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP-----SFRDLALRV 286 (295)
T ss_dssp CTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSC-----CHHHHHHHH
T ss_pred ccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCC-----CHHHHHHHH
Confidence 145556677778888999999999999999999999998 555554444
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=371.69 Aligned_cols=276 Identities=36% Similarity=0.620 Sum_probs=222.6
Q ss_pred chhhccccCcccccccccccceeEEEEEEec---CCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeE
Q psy7289 47 FRREVIETKPRFLQELGEGAFGKVYKGEVCT---SEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGV 122 (422)
Q Consensus 47 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~ 122 (422)
..+++...+|++.+.||+|+||.||+|++.. ...+..||||.++........+.+.+|+.+++++ +||||++++++
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3567778899999999999999999998743 2345689999997654445567899999999999 89999999999
Q ss_pred EEcCCCeEEEEEecCCCCHHHHHhhcCCCCCC-----------CCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q psy7289 123 CLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDI-----------SGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRD 191 (422)
Q Consensus 123 ~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~-----------~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrD 191 (422)
+...+..++||||+++|+|.+++......... ........+++..+..++.||+.||+|||++||+|||
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 99999999999999999999999865321100 0001123589999999999999999999999999999
Q ss_pred CCCCceeecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Q psy7289 192 LAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG 271 (422)
Q Consensus 192 lKp~NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~ 271 (422)
|||+|||++.++.+||+|||+++...............+|+.|+|||++....++.++|||||||++|||++.|..||.+
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 99999999999999999999998765443333344455678899999999899999999999999999999879999988
Q ss_pred CChHH-HHHHHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 272 YSNQE-VIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 272 ~~~~~-~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
.+..+ +...+..+..++.|..+|+++.+|+.+||..+|..|+ +...+...|
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~l~~~l 329 (344)
T 1rjb_A 278 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP-----SFPNLTSFL 329 (344)
T ss_dssp CCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHH
T ss_pred CCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCc-----CHHHHHHHH
Confidence 77554 4555666667778889999999999999999999998 555444433
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=362.47 Aligned_cols=252 Identities=23% Similarity=0.418 Sum_probs=213.6
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
..+|++.+.||+|+||.||+|+.. ..+..||||.+..... ...+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDV--ATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBT--TTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEEC--CCCcEEEEEEeecccc-cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 457899999999999999999754 3457899999864332 2346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++|+|.+++... .+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 96 ~e~~~~~~L~~~~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 162 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET-------------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF 162 (297)
T ss_dssp EECCTTCBHHHHHHHS-------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred EECCCCCCHHHHHhhc-------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCC
Confidence 9999999999999753 488999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC--CCCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ--MLPCP 290 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~--~~~~p 290 (422)
++....... ......+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..+....+.... ..+.|
T Consensus 163 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (297)
T 3fxz_A 163 CAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNENPLRALYLIATNGTPELQNP 239 (297)
T ss_dssp CEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHHCSCCCSCG
T ss_pred ceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCCCCc
Confidence 976543322 2334567899999999999999999999999999999999 999999988877766665433 34457
Q ss_pred CCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
..+++.+.+++.+||..+|..|+ +..+.+|.++
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~ 273 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhhChhh
Confidence 78899999999999999999997 2334444444
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=355.15 Aligned_cols=257 Identities=36% Similarity=0.688 Sum_probs=223.9
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
++...+|++.+.||+|+||.||+|++. ++..||||+++.... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK---GQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET---TTEEEEEEEECBTTB--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEec---CceeEEEEEeccCCC--cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 456678999999999999999999764 346799999875432 335789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEec
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISD 209 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~D 209 (422)
++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+++|+||||||+||+++.++.+||+|
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~D 147 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHG-----------KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSD 147 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHG-----------GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECC
T ss_pred EEEEEccCCCcHHHHHHHcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEcc
Confidence 99999999999999997642 3589999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 289 (422)
||+++....... .......+|+.|+|||.+....++.++||||||+++|||++.|..||...+..+....+..+.....
T Consensus 148 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 226 (268)
T 3sxs_A 148 FGMTRYVLDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR 226 (268)
T ss_dssp TTCEEECCTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred Cccceecchhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCC
Confidence 999986654432 2334455678899999999888999999999999999999879999999999999999998888888
Q ss_pred CCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 290 PEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 290 p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
|..+|+.+.+++..||+.+|..|+ +...+...|+
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~~L~ 260 (268)
T 3sxs_A 227 PHLASDTIYQIMYSCWHELPEKRP-----TFQQLLSSIE 260 (268)
T ss_dssp CTTSCHHHHHHHHHTTCSSGGGSC-----CHHHHHHHHG
T ss_pred CCcChHHHHHHHHHHcCCChhhCc-----CHHHHHHHHH
Confidence 899999999999999999999998 5555544443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=365.86 Aligned_cols=258 Identities=21% Similarity=0.382 Sum_probs=211.5
Q ss_pred hccccCcccccccccccceeEEEEEEec-CCCCeEEEEEEccCcC---CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCT-SEGPSLVAIKTLKENA---NQKTASDFRREVDLMSELRHPNIVCLLGVCLS 125 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 125 (422)
.+...+|++.+.||+|+||.||+++... ...+..||+|+++... .......+.+|+.+|+.++||||+++++++.+
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 4556789999999999999999998742 2356789999987542 22334568899999999999999999999999
Q ss_pred CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 126 GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 126 ~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
.+.+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~ 160 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLERE------------GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHV 160 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCE
T ss_pred CCEEEEEEeCCCCCcHHHHHHhC------------CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcE
Confidence 99999999999999999999764 358899999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ 285 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~ 285 (422)
||+|||+++...... .......+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..+....+....
T Consensus 161 kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~~ 237 (327)
T 3a62_A 161 KLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLT-GAPPFTGENRKKTIDKILKCK 237 (327)
T ss_dssp EECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHTC
T ss_pred EEEeCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHH-CCCCCCCCCHHHHHHHHHhCC
Confidence 999999997543222 12234567899999999998899999999999999999999 999999999988888887654
Q ss_pred CCCCCCCCCcchhhhcccccccccchhh------HHHHhhhhhh
Q psy7289 286 MLPCPEDCPPRMYSLMMECWHEVPVAAG------MAYLCSHHYV 323 (422)
Q Consensus 286 ~~~~p~~~p~~~~~l~~~cw~~~P~~r~------~~~lh~~~~i 323 (422)
...|..+++++.+++.+||..+|..|+ +..+.+|.++
T Consensus 238 -~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f 280 (327)
T 3a62_A 238 -LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280 (327)
T ss_dssp -CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGG
T ss_pred -CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcc
Confidence 456788999999999999999999985 4556666665
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=362.58 Aligned_cols=268 Identities=39% Similarity=0.664 Sum_probs=224.1
Q ss_pred cchhhccccCcccccccccccceeEEEEEEec---CCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEee
Q psy7289 46 DFRREVIETKPRFLQELGEGAFGKVYKGEVCT---SEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLG 121 (422)
Q Consensus 46 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g 121 (422)
...+++...+|++.+.||+|+||.||+|++.. ...+..||||.++........+.+.+|+.+++++ +||||+++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 34467778899999999999999999998643 3456789999998766666678899999999999 8999999999
Q ss_pred EEEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCC------CCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy7289 122 VCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDIS------GSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAAR 195 (422)
Q Consensus 122 ~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~ 195 (422)
++.+++..++||||+++|+|.+++.......... .......+++.++..++.|++.||+|||+++|+||||||+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 174 (313)
T 1t46_A 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (313)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccc
Confidence 9999999999999999999999998753210000 0011235899999999999999999999999999999999
Q ss_pred ceeecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChH
Q psy7289 196 NCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ 275 (422)
Q Consensus 196 NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~ 275 (422)
|||++.++.+||+|||+++...............+|+.|+|||.+....++.++|||||||++|||++.|..||.+.+..
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 99999999999999999987655443334444556788999999998999999999999999999998799999887654
Q ss_pred -HHHHHHHcCCCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 276 -EVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 276 -~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.....+..+...+.|..+|+++.+++.+||..+|..|+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 293 (313)
T 1t46_A 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP 293 (313)
T ss_dssp HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred hHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCc
Confidence 44555566666677888999999999999999999998
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=372.12 Aligned_cols=256 Identities=21% Similarity=0.345 Sum_probs=219.3
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCC
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGE 127 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~ 127 (422)
+...+|++++.||+|+||.||+|+... .++.||||+++... .....+.+.+|..++..+ +||||+++++++.+.+
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKG--TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETT--EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECC--CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence 445689999999999999999998643 35789999986432 122356788999999988 7999999999999999
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
.+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL 162 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQV------------GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKI 162 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEEeCCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEE
Confidence 999999999999999999764 35899999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+|||+++....... ......+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..++...|..+. +
T Consensus 163 ~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-G~~Pf~~~~~~~~~~~i~~~~-~ 238 (353)
T 2i0e_A 163 ADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQAPFEGEDEDELFQSIMEHN-V 238 (353)
T ss_dssp CCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCC-C
T ss_pred EeCCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHc-CCCCCCCCCHHHHHHHHHhCC-C
Confidence 99999986432221 2334568999999999999999999999999999999999 999999999999999888764 4
Q ss_pred CCCCCCCcchhhhcccccccccchhh------HHHHhhhhhhh
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAG------MAYLCSHHYVH 324 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~------~~~lh~~~~i~ 324 (422)
..|..+++++.+|+.+||..+|..|. ...+.+|.++.
T Consensus 239 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~ 281 (353)
T 2i0e_A 239 AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281 (353)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGT
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcccc
Confidence 56788999999999999999999886 45566666653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=367.00 Aligned_cols=251 Identities=22% Similarity=0.350 Sum_probs=217.8
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
..+|++.+.||+|+||.||+|+... +++.||+|+++... .....+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRH--NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 3568899999999999999998654 35789999986432 1123567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 83 lv~e~~~gg~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Df 150 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKS------------QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDF 150 (318)
T ss_dssp EEECCCCSCBHHHHHHHT------------SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred EEEeCCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeec
Confidence 999999999999999764 35899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP 290 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p 290 (422)
|+++..... .....+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..+....+..+. ...|
T Consensus 151 g~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~-~~~p 223 (318)
T 1fot_A 151 GFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA-GYTPFYDSNTMKTYEKILNAE-LRFP 223 (318)
T ss_dssp SSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHCC-CCCC
T ss_pred CcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC-CCCC
Confidence 999865432 234567899999999999999999999999999999999 999999999999888887764 4567
Q ss_pred CCCCcchhhhcccccccccchhh------HHHHhhhhhhh
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAG------MAYLCSHHYVH 324 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~------~~~lh~~~~i~ 324 (422)
..+++++.+++.+||..+|..|. +..+.+|.++.
T Consensus 224 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~ 263 (318)
T 1fot_A 224 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 263 (318)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGS
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcccc
Confidence 88999999999999999999985 45566666653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=377.43 Aligned_cols=257 Identities=17% Similarity=0.309 Sum_probs=213.3
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSG 126 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~ 126 (422)
.+...+|++++.||+|+||.||+|+... ++..||||+++... .....+.+.+|..++.++ +|||||++++++.+.
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~--~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 125 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKK--TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 125 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC
Confidence 3445678999999999999999998754 45789999986432 223345688899999887 899999999999999
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEE
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vK 206 (422)
+.+|+|||||++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+|
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ik 193 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQ------------RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIK 193 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEE
T ss_pred CEEEEEEEcCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEE
Confidence 9999999999999999999764 3589999999999999999999999999999999999999999999
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCC---------hHHH
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS---------NQEV 277 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~---------~~~~ 277 (422)
|+|||+++....... ......+|+.|||||++....++.++|||||||++|||++ |..||.... ...+
T Consensus 194 L~DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~-G~~Pf~~~~~~~~~~~~~~~~~ 270 (396)
T 4dc2_A 194 LTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDIVGSSDNPDQNTEDYL 270 (396)
T ss_dssp ECCCTTCBCCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSTTTTC------CCHHHH
T ss_pred EeecceeeecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHh-CCCCCcccccccccchhhHHHH
Confidence 999999986332221 2345568999999999999999999999999999999999 999996432 2335
Q ss_pred HHHHHcCCCCCCCCCCCcchhhhcccccccccchhh-------HHHHhhhhhhh
Q psy7289 278 IEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG-------MAYLCSHHYVH 324 (422)
Q Consensus 278 ~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~-------~~~lh~~~~i~ 324 (422)
...+... .+..|..+++++.+|+++||..+|..|. +..+.+|.++.
T Consensus 271 ~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~ 323 (396)
T 4dc2_A 271 FQVILEK-QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323 (396)
T ss_dssp HHHHHHC-CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTT
T ss_pred HHHHhcc-ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcccc
Confidence 5555544 4567888999999999999999999985 35666677663
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=370.11 Aligned_cols=245 Identities=24% Similarity=0.365 Sum_probs=212.5
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCC
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGE 127 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~ 127 (422)
+...+|++.+.||+|+||.||+|+... .++.||||+++... .......+.+|..++..+ +||||+++++++.+.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKK--TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETT--TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 445688999999999999999998754 45789999986431 122345678899999876 8999999999999999
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
.+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL 159 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSC------------HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKI 159 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEEeCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEE
Confidence 999999999999999999764 35899999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+..+. +
T Consensus 160 ~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~-~ 235 (345)
T 1xjd_A 160 ADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI-GQSPFHGQDEEELFHSIRMDN-P 235 (345)
T ss_dssp CCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCC-C
T ss_pred eEChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhc-CCCCCCCCCHHHHHHHHHhCC-C
Confidence 99999986432221 2334568999999999999899999999999999999999 999999999999999888764 4
Q ss_pred CCCCCCCcchhhhcccccccccchhh
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..|..+++++.+|+.+||..+|..|+
T Consensus 236 ~~p~~~s~~~~~li~~lL~~dp~~R~ 261 (345)
T 1xjd_A 236 FYPRWLEKEAKDLLVKLFVREPEKRL 261 (345)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSB
T ss_pred CCCcccCHHHHHHHHHHhcCCHhHcC
Confidence 56788999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=367.29 Aligned_cols=259 Identities=42% Similarity=0.812 Sum_probs=218.9
Q ss_pred hccccCcccccccccccceeEEEEEEec---CCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCT---SEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG 126 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~ 126 (422)
++...+|++.+.||+|+||.||+|++.. ...+..||||.+...........+.+|+.++++++||||+++++++.+.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 5667899999999999999999998542 2345689999997666666777899999999999999999999999999
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC---CC
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD---GL 203 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~---~~ 203 (422)
...++||||+++|+|.+++........ ....+++.++..++.||+.||+|||+++|+||||||+|||++. +.
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~-----~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPS-----QPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSS-----STTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred CCcEEEEecCCCCcHHHHHHhhccccc-----ccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcc
Confidence 999999999999999999987543211 1235899999999999999999999999999999999999984 45
Q ss_pred eEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc
Q psy7289 204 TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS 283 (422)
Q Consensus 204 ~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~ 283 (422)
.+||+|||+++...............+|+.|+|||++....++.++|||||||++|||++.|..||.+.+..++...+..
T Consensus 181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 260 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260 (327)
T ss_dssp CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred eEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence 79999999997654433333333445688999999999889999999999999999999889999999999999999998
Q ss_pred CCCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 284 RQMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 284 ~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+...+.|..+|+.+.+++..||..+|..|+
T Consensus 261 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 290 (327)
T 2yfx_A 261 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 290 (327)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred CCCCCCCCCCCHHHHHHHHHHhcCChhhCc
Confidence 888888899999999999999999999998
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=359.51 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=209.6
Q ss_pred hhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc--CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC
Q psy7289 49 REVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG 126 (422)
Q Consensus 49 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~ 126 (422)
.++...+|++.+.||+|+||.||+|+... .+..||+|.+... ......+.|.+|+.++++++||||+++++++.++
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 83 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTI--LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED 83 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETT--TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECC--CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC
Confidence 45667889999999999999999998643 3577999987532 3445567899999999999999999999999999
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEE
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vK 206 (422)
+..++||||+++|+|.+++... .++++.++..++.|++.||+|||+++|+||||||+|||++.++.+|
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~k 151 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIESH------------GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLK 151 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred CeEEEEEeCCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEE
Confidence 9999999999999999999765 3589999999999999999999999999999999999999999999
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~ 286 (422)
|+|||+++....... .......+|+.|+|||.+....++.++|||||||++|||++ |..||.+.+..+..........
T Consensus 152 l~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 229 (294)
T 4eqm_A 152 IFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLV-GEPPFNGETAVSIAIKHIQDSV 229 (294)
T ss_dssp ECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHH-SSCSSCSSCHHHHHHHHHSSCC
T ss_pred EEeCCCccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhccC
Confidence 999999986543321 12233457899999999999999999999999999999999 9999999988777666555544
Q ss_pred CC----CCCCCCcchhhhcccccccccchhh
Q psy7289 287 LP----CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 287 ~~----~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
++ .+.++|+.+.+++.+||+.+|..|+
T Consensus 230 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~ 260 (294)
T 4eqm_A 230 PNVTTDVRKDIPQSLSNVILRATEKDKANRY 260 (294)
T ss_dssp CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred CCcchhcccCCCHHHHHHHHHHhcCCHhHcc
Confidence 33 3567899999999999999999995
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=394.70 Aligned_cols=259 Identities=37% Similarity=0.707 Sum_probs=224.3
Q ss_pred hhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
.+++...+|++.+.||+|+||.||+|++.. ...||||+++.... ..+.|.+|+++|++|+|||||++++++.+ +
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG---TTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETT---TEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECC---CceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 356777889999999999999999998743 46699999875432 34679999999999999999999999876 6
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
..++|||||++|+|.++|.... ...+++.++..++.||+.||+|||+++|+||||||+|||+++++.+||
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl 404 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGET----------GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKV 404 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHH----------HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred cceEeeehhcCCcHHHHHhhcC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEE
Confidence 7899999999999999997531 124889999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+|||+++....... .......+|+.|+|||++....++.++|||||||++|||++.|..||.+.+..+++..+..+.++
T Consensus 405 ~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 483 (535)
T 2h8h_A 405 ADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM 483 (535)
T ss_dssp CCTTSTTTCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC
T ss_pred cccccceecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999986543221 12233446788999999998999999999999999999998899999999999999999999889
Q ss_pred CCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
+.|..||+.+.+||.+||+.+|..|+ ++..+...|+
T Consensus 484 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~l~~~L~ 519 (535)
T 2h8h_A 484 PCPPECPESLHDLMCQCWRKEPEERP-----TFEYLQAFLE 519 (535)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCc-----CHHHHHHHHH
Confidence 99999999999999999999999998 6666655544
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=369.28 Aligned_cols=258 Identities=22% Similarity=0.351 Sum_probs=218.4
Q ss_pred hhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCH-----HhHHHHHHHHHHHhcCCCCceeeEeeEE
Q psy7289 49 REVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQ-----KTASDFRREVDLMSELRHPNIVCLLGVC 123 (422)
Q Consensus 49 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~g~~ 123 (422)
.......|++.+.||+|+||.||+|+... .+..||+|+++..... ...+.+.+|+.+|+.++||||+++++++
T Consensus 7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 84 (361)
T 2yab_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKS--TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY 84 (361)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CCChhhceEEeeEEeeCcCEEEEEEEECC--CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE
Confidence 34456789999999999999999998754 3578999998654321 1356789999999999999999999999
Q ss_pred EcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC
Q psy7289 124 LSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL 203 (422)
Q Consensus 124 ~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~ 203 (422)
.+...+++||||+++|+|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||+++++
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~ 152 (361)
T 2yab_A 85 ENRTDVVLILELVSGGELFDFLAQK------------ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKN 152 (361)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHTTC------------SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTT
T ss_pred EeCCEEEEEEEcCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCC
Confidence 9999999999999999999999653 3589999999999999999999999999999999999998776
Q ss_pred ----eEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHH
Q psy7289 204 ----TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIE 279 (422)
Q Consensus 204 ----~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~ 279 (422)
.+||+|||+++...... ......+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..++..
T Consensus 153 ~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~-g~~Pf~~~~~~~~~~ 228 (361)
T 2yab_A 153 IPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDTKQETLA 228 (361)
T ss_dssp SSSCCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHH
T ss_pred CCccCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Confidence 79999999998664432 1234568899999999998899999999999999999999 999999999999999
Q ss_pred HHHcCCCCCC---CCCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 280 MIRSRQMLPC---PEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 280 ~i~~~~~~~~---p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
.+..+..... +..+++.+.+|+.+||..+|..|+ +..+.+|.++.
T Consensus 229 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 277 (361)
T 2yab_A 229 NITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277 (361)
T ss_dssp HHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred HHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence 9887653322 257889999999999999999886 33455555553
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=356.30 Aligned_cols=251 Identities=38% Similarity=0.692 Sum_probs=216.9
Q ss_pred hccccCcccccccccccceeEEEEEEecCC-CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSE-GPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP 128 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 128 (422)
.+...+|++.+.||+|+||.||+|++.... ....||||.+.........+.|.+|+.++++++||||+++++++.+ +.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 86 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP 86 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence 455678899999999999999999876433 3457999999876666677889999999999999999999999865 45
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 155 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNK-----------NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLG 155 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHT-----------TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEEC
T ss_pred CEEEEecCCCCCHHHHHHhcc-----------ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeC
Confidence 789999999999999997642 358999999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP 288 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 288 (422)
|||+++........ ......+|+.|+|||++....++.++|||||||++|||++.|..||...+..+....+..+...+
T Consensus 156 Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~ 234 (281)
T 3cc6_A 156 DFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP 234 (281)
T ss_dssp CCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC
T ss_pred ccCCCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC
Confidence 99999865443221 22334567889999999888999999999999999999987999999999888888888888888
Q ss_pred CCCCCCcchhhhcccccccccchhh
Q psy7289 289 CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 289 ~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.|..+|+.+.+++.+||..+|..|+
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rp 259 (281)
T 3cc6_A 235 KPDLCPPVLYTLMTRCWDYDPSDRP 259 (281)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred CCCCCCHHHHHHHHHHccCCchhCc
Confidence 8999999999999999999999997
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=356.67 Aligned_cols=249 Identities=39% Similarity=0.713 Sum_probs=216.6
Q ss_pred hhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
.+++...+|++++.||+|+||.||+|++. ++..||||+++.... ..+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWR---GQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 92 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEET---TTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEc---CCCeEEEEEecCCCC--CHHHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence 45677789999999999999999999764 356799999875432 2357899999999999999999999999999
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
..++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+++|+||||||+|||++.++.+||
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl 161 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMR-----------HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKV 161 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGG-----------GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEE
T ss_pred CeEEEEeccCCCcHHHHHHHhc-----------cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEE
Confidence 9999999999999999997631 35899999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+|||+++....... .......+|+.|+|||.+....++.++||||||+++|||++.|..||.+.+..+....+..+...
T Consensus 162 ~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~ 240 (283)
T 3gen_A 162 SDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL 240 (283)
T ss_dssp CSTTGGGGBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC
T ss_pred cccccccccccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC
Confidence 99999986543221 12233445788999999998899999999999999999998799999999999999999988888
Q ss_pred CCCCCCCcchhhhcccccccccchhh
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..|..+++.+.+++.+||+.+|..|+
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rp 266 (283)
T 3gen_A 241 YRPHLASEKVYTIMYSCWHEKADERP 266 (283)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSC
T ss_pred CCCCcCCHHHHHHHHHHccCChhHCc
Confidence 88899999999999999999999998
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=359.26 Aligned_cols=260 Identities=36% Similarity=0.655 Sum_probs=220.7
Q ss_pred hccccCccccc-ccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 50 EVIETKPRFLQ-ELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 50 ~~~~~~~~~~~-~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
.+...+|++.+ .||+|+||.||+|.+.....+..||||+++... .....+.+.+|+++++.++||||+++++++ ..+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 34456788888 999999999999987666667889999987543 233467899999999999999999999999 567
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl 158 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQN------------RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKI 158 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHC------------TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred CcEEEEEeCCCCCHHHHHHhC------------cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEE
Confidence 789999999999999999764 25889999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcce-EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC
Q psy7289 208 SDFGLSRDVYASDYY-RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286 (422)
Q Consensus 208 ~DFGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~ 286 (422)
+|||+++........ .......+|+.|+|||.+....++.++||||||+++|||++.|..||.+.+..++...+..+..
T Consensus 159 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~ 238 (291)
T 1xbb_A 159 SDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER 238 (291)
T ss_dssp CCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC
T ss_pred ccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999876543322 2223344578899999998888999999999999999999879999999999999999999888
Q ss_pred CCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 287 LPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 287 ~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
++.|..+|+.+.+++..||+.+|..|+ +...+.+.|
T Consensus 239 ~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~l~~~L 274 (291)
T 1xbb_A 239 MGCPAGCPREMYDLMNLCWTYDVENRP-----GFAAVELRL 274 (291)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSC-----CHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCc-----CHHHHHHHH
Confidence 888999999999999999999999998 554444433
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=365.50 Aligned_cols=255 Identities=17% Similarity=0.311 Sum_probs=214.6
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCC
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEP 128 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~ 128 (422)
...+|++++.||+|+||.||+|+... .++.||+|+++... .....+.+.+|..+++++ +|||||++++++.+...
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKK--TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred chhheEEEEEEEecCCeEEEEEEECC--CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 34578999999999999999998754 45789999986432 344567788999999988 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~------------~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~ 152 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQ------------RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLT 152 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEEeCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEE
Confidence 99999999999999999764 358999999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCC---------ChHHHHH
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY---------SNQEVIE 279 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~---------~~~~~~~ 279 (422)
|||+++....... ......+|+.|+|||++....++.++|||||||++|||++ |..||... +...+..
T Consensus 153 DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~ 229 (345)
T 3a8x_A 153 DYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDIVGSSDNPDQNTEDYLFQ 229 (345)
T ss_dssp CGGGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTTTTC-------CHHHHHH
T ss_pred eccccccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHh-CCCCcCCcccccccccccHHHHHH
Confidence 9999986432221 2344568999999999999999999999999999999999 99999752 3344555
Q ss_pred HHHcCCCCCCCCCCCcchhhhcccccccccchhh-------HHHHhhhhhhh
Q psy7289 280 MIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG-------MAYLCSHHYVH 324 (422)
Q Consensus 280 ~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~-------~~~lh~~~~i~ 324 (422)
.+..+ ....|..+++++.+|+.+||..+|..|+ +..+.+|.++.
T Consensus 230 ~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~ 280 (345)
T 3a8x_A 230 VILEK-QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280 (345)
T ss_dssp HHHHC-CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGT
T ss_pred HHHcC-CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccC
Confidence 56554 3567888999999999999999999985 34566666653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=397.25 Aligned_cols=250 Identities=38% Similarity=0.692 Sum_probs=214.2
Q ss_pred cccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEecCC
Q psy7289 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVR 138 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~~~ 138 (422)
++||+|+||.||+|.+.....+..||||+++... .....+.|.+|+++|++++|||||++++++.. +..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999988766667889999987543 33456789999999999999999999999964 568999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccccC
Q psy7289 139 GDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA 218 (422)
Q Consensus 139 G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~ 218 (422)
|+|.+++... ..+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 454 g~L~~~l~~~------------~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 454 GPLNKYLQQN------------RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp EEHHHHHHHC------------TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred CCHHHHHhhC------------CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence 9999999754 3589999999999999999999999999999999999999999999999999987644
Q ss_pred Ccc-eEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcch
Q psy7289 219 SDY-YRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRM 297 (422)
Q Consensus 219 ~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~~ 297 (422)
... ........+|+.|+|||++....++.++|||||||++|||++.|..||.+.+..++...+..+.+++.|..||+++
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l 601 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM 601 (635)
T ss_dssp -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 322 2223334467889999999999999999999999999999988999999999999999999999999999999999
Q ss_pred hhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 298 YSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 298 ~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
.+||..||+.+|..|+ +...+...|
T Consensus 602 ~~li~~cl~~dP~~RP-----s~~~l~~~L 626 (635)
T 4fl3_A 602 YDLMNLCWTYDVENRP-----GFAAVELRL 626 (635)
T ss_dssp HHHHHHHTCSSTTTSC-----CHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCc-----CHHHHHHHH
Confidence 9999999999999998 555554443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=377.22 Aligned_cols=259 Identities=20% Similarity=0.312 Sum_probs=216.2
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
++...+|++++.||+|+||.||+|+... .++.||||+++... .....+.+.+|..++..++||||+++++++.+.+
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~--~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQ--TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 3456789999999999999999998754 45789999986421 1223346889999999999999999999999999
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
.+|+||||+++|+|.+++.+.. ..+++..+..++.||+.||+|||+++|+||||||+|||++.++++||
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~-----------~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL 203 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFG-----------ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRL 203 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS-----------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEE
T ss_pred EEEEEEcCCCCCcHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEE
Confidence 9999999999999999997642 25899999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccc-------cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHH
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL-------YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEM 280 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~ 280 (422)
+|||+++........ ......+|+.|||||++. ...++.++|||||||++|||++ |..||.+.+..++...
T Consensus 204 ~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyellt-G~~Pf~~~~~~~~~~~ 281 (412)
T 2vd5_A 204 ADFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY-GQTPFYADSTAETYGK 281 (412)
T ss_dssp CCCTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHH
T ss_pred eechhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence 999999876543322 233457899999999987 3568999999999999999998 9999999999988888
Q ss_pred HHcCC----CCCCCCCCCcchhhhcccccccccchh----hHHHHhhhhhhh
Q psy7289 281 IRSRQ----MLPCPEDCPPRMYSLMMECWHEVPVAA----GMAYLCSHHYVH 324 (422)
Q Consensus 281 i~~~~----~~~~p~~~p~~~~~l~~~cw~~~P~~r----~~~~lh~~~~i~ 324 (422)
|.... .+..+..+|+++.+|+++||. +|..| +++.+.+|.++.
T Consensus 282 i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~ 332 (412)
T 2vd5_A 282 IVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFF 332 (412)
T ss_dssp HHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGT
T ss_pred HHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcC
Confidence 76532 222346899999999999998 88887 567777777764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=362.62 Aligned_cols=256 Identities=21% Similarity=0.328 Sum_probs=218.7
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
..+|++.+.||+|+||.||+|+... .+..||+|.++.. ......+.+|+.+|+.++||||+++++++.+.+.+++|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETS--SKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECC--CCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 4678999999999999999998643 4578999998643 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC--CCeEEEecC
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD--GLTVKISDF 210 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~--~~~vKl~DF 210 (422)
||||++|+|.+++.... ..+++.++..++.||+.||+|||++||+||||||+|||++. ++.+||+||
T Consensus 80 ~e~~~g~~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Df 148 (321)
T 1tki_A 80 FEFISGLDIFERINTSA-----------FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEF 148 (321)
T ss_dssp ECCCCCCBHHHHHTSSS-----------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred EEeCCCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEEC
Confidence 99999999999996531 35899999999999999999999999999999999999987 789999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC-
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC- 289 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~- 289 (422)
|+++........ ....+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..++...+..+.....
T Consensus 149 g~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 224 (321)
T 1tki_A 149 GQARQLKPGDNF---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS-GINPFLAETNQQIIENIMNAEYTFDE 224 (321)
T ss_dssp TTCEECCTTCEE---EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHTCCCCCH
T ss_pred CCCeECCCCCcc---ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHh-CCCCCcCCCHHHHHHHHHcCCCCCCh
Confidence 999876544322 22346889999999998889999999999999999999 9999999999999998887654332
Q ss_pred --CCCCCcchhhhcccccccccchhh-HHHHhhhhhhhhhc
Q psy7289 290 --PEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRDL 327 (422)
Q Consensus 290 --p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~dL 327 (422)
...+|+++.+++.+||..+|..|+ +..+.+|.++....
T Consensus 225 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 247899999999999999999986 34566677776543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=358.14 Aligned_cols=259 Identities=37% Similarity=0.710 Sum_probs=218.8
Q ss_pred cCcccccccccccceeEEEEEEecCC-CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEE-cCCCeEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSE-GPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCL-SGEPMCM 131 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-~~~~~~l 131 (422)
.+|++.+.||+|+||.||+|++.... ....||+|.+.........+.+.+|+.++++++||||+++++++. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 45788999999999999999875433 345689999887666677788999999999999999999999865 4557899
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
||||+++|+|.+++.... ..+++.++..++.|++.||+|||+++|+||||||+|||+++++.+||+|||
T Consensus 105 v~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg 173 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET-----------HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFG 173 (298)
T ss_dssp EEECCTTCBHHHHHHCTT-----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCG
T ss_pred EEeCCCCCCHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccc
Confidence 999999999999997532 357899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcce--EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy7289 212 LSRDVYASDYY--RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289 (422)
Q Consensus 212 la~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 289 (422)
+++........ .......+|+.|+|||.+....++.++|||||||++|||++.+.+||.+.+..+....+..+.....
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (298)
T 3f66_A 174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 253 (298)
T ss_dssp GGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC
T ss_pred ccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCC
Confidence 99866443321 1223345678899999999899999999999999999999978889999988888888888888888
Q ss_pred CCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 290 PEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 290 p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
|..+|+.+.+++.+||+.+|..|+ +...+.+.|+
T Consensus 254 ~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~~L~ 287 (298)
T 3f66_A 254 PEYCPDPLYEVMLKCWHPKAEMRP-----SFSELVSRIS 287 (298)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHH
T ss_pred CccCCHHHHHHHHHHcCCChhhCc-----CHHHHHHHHH
Confidence 999999999999999999999998 5555554443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=364.64 Aligned_cols=266 Identities=38% Similarity=0.668 Sum_probs=221.1
Q ss_pred hhhccccCcccccccccccceeEEEEEEecCCC---CeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEE
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEG---PSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVC 123 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~ 123 (422)
..++...+|++.+.||+|+||.||+|++..++. ...||+|.++........+.+.+|+.+++.+ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 456777899999999999999999998754332 3579999998766666778899999999999 899999999999
Q ss_pred EcCCCeEEEEEecCCCCHHHHHhhcCCCC--CCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC
Q psy7289 124 LSGEPMCMLFEFMVRGDLHEFLMSRSPRS--DISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD 201 (422)
Q Consensus 124 ~~~~~~~lv~E~~~~G~L~~~l~~~~~~~--~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~ 201 (422)
.+++..++||||+++|+|.+++....... ..........+++..+..++.||+.||+|||+++|+||||||+|||++.
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN 199 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC
Confidence 99999999999999999999997642100 0000001235899999999999999999999999999999999999999
Q ss_pred CCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHH-HHHH
Q psy7289 202 GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE-VIEM 280 (422)
Q Consensus 202 ~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~-~~~~ 280 (422)
++.+||+|||+++...............+|+.|+|||++....++.++|||||||++|||++.|..||.+....+ +...
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 279 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence 999999999999866544333334445567889999999988999999999999999999987999998876554 4455
Q ss_pred HHcCCCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 281 IRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 281 i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+..+...+.|..+|+.+.+++..||+.+|..|+
T Consensus 280 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 312 (333)
T 2i1m_A 280 VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRP 312 (333)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHhccChhhCc
Confidence 556666777888999999999999999999998
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=361.35 Aligned_cols=266 Identities=34% Similarity=0.638 Sum_probs=221.3
Q ss_pred hhhccccCcccccccccccceeEEEEEEec---CCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEE
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCT---SEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVC 123 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~ 123 (422)
.+++...+|++.+.||+|+||.||+|++.. ...+..||||.++........+.+.+|+.+++++ +||||+++++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 456677899999999999999999998753 2345789999998766666677899999999999 699999999998
Q ss_pred EcCC-CeEEEEEecCCCCHHHHHhhcCCCCCC----CCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcee
Q psy7289 124 LSGE-PMCMLFEFMVRGDLHEFLMSRSPRSDI----SGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCL 198 (422)
Q Consensus 124 ~~~~-~~~lv~E~~~~G~L~~~l~~~~~~~~~----~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiL 198 (422)
...+ .+++||||+++|+|.+++......... ........+++..+..++.|++.||+|||+++|+||||||+||+
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 180 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 7655 589999999999999999765321000 00001123889999999999999999999999999999999999
Q ss_pred ecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh-HHH
Q psy7289 199 VGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN-QEV 277 (422)
Q Consensus 199 l~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~-~~~ 277 (422)
++.++.+||+|||+++...............+|+.|+|||++....++.++|||||||++|||++.|..||.+.+. .++
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 260 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence 9999999999999998765443333334445678899999999999999999999999999999879999988764 456
Q ss_pred HHHHHcCCCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 278 IEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 278 ~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
...+..+...+.|..+++++.+++.+||+.+|..|+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 296 (316)
T 2xir_A 261 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 296 (316)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCc
Confidence 667777777888889999999999999999999997
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=370.19 Aligned_cols=257 Identities=21% Similarity=0.365 Sum_probs=214.9
Q ss_pred hhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC
Q psy7289 49 REVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSG 126 (422)
Q Consensus 49 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~ 126 (422)
.++...+|++++.||+|+||.||+++... .+..||+|++.... .....+.+.+|+++|+.++|||||++++++.+.
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~--~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 87 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKND--TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE 87 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 34556789999999999999999998654 35789999985422 122356788999999999999999999999999
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEE
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vK 206 (422)
..+|+||||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vk 155 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQN------------VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVH 155 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHTT------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred CEEEEEEecCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEE
Confidence 9999999999999999999753 3589999999999999999999999999999999999999999999
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCcccccc---CCCCCchhHHhHHHHHHHHHhCCCCCCCCCC---hHHHHHH
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY---GKFTTESDVWSYGVVLWEVYSYGLQPYYGYS---NQEVIEM 280 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~---~~~~~~~ 280 (422)
|+|||+++...... ......+|+.|+|||++.. ..++.++|||||||++|||++ |..||...+ ..++...
T Consensus 156 L~DFG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~ 231 (384)
T 4fr4_A 156 ITDFNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR-GRRPYHIRSSTSSKEIVHT 231 (384)
T ss_dssp ECCCTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHH-SSCSSCCCTTSCHHHHHHH
T ss_pred EeccceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHh-CCCCCCCCCCccHHHHHHH
Confidence 99999998654332 2244568999999999874 358999999999999999999 999997543 4455555
Q ss_pred HHcCCCCCCCCCCCcchhhhcccccccccchhh--HHHHhhhhhhh
Q psy7289 281 IRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG--MAYLCSHHYVH 324 (422)
Q Consensus 281 i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~--~~~lh~~~~i~ 324 (422)
+... ..+.|..+++.+.+|+.+||..+|..|+ +..+.+|.++.
T Consensus 232 ~~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~ 276 (384)
T 4fr4_A 232 FETT-VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMN 276 (384)
T ss_dssp HHHC-CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGT
T ss_pred Hhhc-ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhh
Confidence 5443 4567888999999999999999999995 45566666553
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=369.04 Aligned_cols=246 Identities=22% Similarity=0.366 Sum_probs=204.9
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHH-HhcCCCCceeeEeeEEEcC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDL-MSELRHPNIVCLLGVCLSG 126 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~i-l~~l~HpnIv~l~g~~~~~ 126 (422)
.+...+|++++.||+|+||.||+|+... .+..||||+++... .......+.+|..+ ++.++|||||++++++.+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~ 111 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKA--EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA 111 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETT--TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcC--CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC
Confidence 3455789999999999999999998754 35789999986432 23344567778877 5778999999999999999
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEE
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vK 206 (422)
+.+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++++|
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ik 179 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRE------------RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIV 179 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred CEEEEEEeCCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEE
Confidence 9999999999999999999764 3588999999999999999999999999999999999999999999
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~ 286 (422)
|+|||+++...... .......+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..++...|..+.
T Consensus 180 L~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-G~~Pf~~~~~~~~~~~i~~~~- 255 (373)
T 2r5t_A 180 LTDFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY-GLPPFYSRNTAEMYDNILNKP- 255 (373)
T ss_dssp ECCCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCTTCCSBHHHHHHHHHHSC-
T ss_pred EeeCccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcc-
Confidence 99999998643221 12345568999999999999999999999999999999998 999999999999999888764
Q ss_pred CCCCCCCCcchhhhcccccccccchhh
Q psy7289 287 LPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 287 ~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
...|..+++.+.+|+.+||..+|..|.
T Consensus 256 ~~~~~~~~~~~~~li~~lL~~dp~~R~ 282 (373)
T 2r5t_A 256 LQLKPNITNSARHLLEGLLQKDRTKRL 282 (373)
T ss_dssp CCCCSSSCHHHHHHHHHHTCSSGGGST
T ss_pred cCCCCCCCHHHHHHHHHHcccCHHhCC
Confidence 456778999999999999999999886
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=380.16 Aligned_cols=257 Identities=22% Similarity=0.378 Sum_probs=211.4
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc--CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
.+...+|++++.||+|+||.||+|+... .+..||||+++.. ........+.+|+.+++.++||||+++++++.+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKA--TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 221 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcC--CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC
Confidence 3445679999999999999999998654 4578999998643 23334567889999999999999999999999999
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCCeEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCS-HHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlKp~NiLl~~~~~vK 206 (422)
.+++||||+++|+|.+++... ..+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+|
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~k 289 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRE------------RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIK 289 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEE
T ss_pred EEEEEEeeCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEE
Confidence 999999999999999999764 358999999999999999999998 9999999999999999999999
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~ 286 (422)
|+|||+++...... .......+|+.|||||++....++.++|||||||++|||++ |..||.+.+..++...+....
T Consensus 290 l~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~- 365 (446)
T 4ejn_A 290 ITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELILMEE- 365 (446)
T ss_dssp ECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCC-
T ss_pred EccCCCceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCC-
Confidence 99999998643322 12344668999999999999999999999999999999999 999999999999988887654
Q ss_pred CCCCCCCCcchhhhcccccccccchhh------HHHHhhhhhhh
Q psy7289 287 LPCPEDCPPRMYSLMMECWHEVPVAAG------MAYLCSHHYVH 324 (422)
Q Consensus 287 ~~~p~~~p~~~~~l~~~cw~~~P~~r~------~~~lh~~~~i~ 324 (422)
.+.|..+++++.+|+.+||..+|..|+ +..+.+|.++.
T Consensus 366 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~ 409 (446)
T 4ejn_A 366 IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 409 (446)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcccc
Confidence 456788999999999999999999994 66676666654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=377.12 Aligned_cols=259 Identities=21% Similarity=0.323 Sum_probs=217.3
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
++...+|++++.||+|+||.||+|+... .+..||+|+++... .......+.+|+.+++.++|||||++++++.++.
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~--~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKS--TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECC--CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 3456789999999999999999998754 35789999985421 1112235789999999999999999999999999
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
.+|+|||||++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~-------------~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL 209 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNY-------------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKL 209 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHC-------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEE
T ss_pred EEEEEEeCCCCCcHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEE
Confidence 999999999999999999653 4899999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCC----CCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK----FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS 283 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~ 283 (422)
+|||+++....... .......+|+.|||||++.... ++.++|||||||++|||++ |..||.+.+..++...|..
T Consensus 210 ~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~-G~~Pf~~~~~~~~~~~i~~ 287 (410)
T 3v8s_A 210 ADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV-GDTPFYADSLVGTYSKIMN 287 (410)
T ss_dssp CCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHT
T ss_pred eccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHh-CCCCCCCCChhhHHHHHHh
Confidence 99999987654332 2334567899999999998665 7899999999999999999 9999999999999888875
Q ss_pred CC---CCCCCCCCCcchhhhcccccccccch--h-hHHHHhhhhhhhh
Q psy7289 284 RQ---MLPCPEDCPPRMYSLMMECWHEVPVA--A-GMAYLCSHHYVHR 325 (422)
Q Consensus 284 ~~---~~~~p~~~p~~~~~l~~~cw~~~P~~--r-~~~~lh~~~~i~~ 325 (422)
+. ..|.+..+++++.+|+++|+..+|.. | ++..+.+|.++..
T Consensus 288 ~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 288 HKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp HHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred ccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 42 33444578999999999999977765 3 4666777777653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=357.50 Aligned_cols=267 Identities=34% Similarity=0.685 Sum_probs=214.6
Q ss_pred hccccCcccccccccccceeEEEEEEecCC-CCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSE-GPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
.+...+|++.+.||+|+||.||+|++.... .+..||||.++.. ......+.+.+|+.++++++||||+++++++.+..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 445678999999999999999999876432 3568999998644 34555678999999999999999999999998655
Q ss_pred -----CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC
Q psy7289 128 -----PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG 202 (422)
Q Consensus 128 -----~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~ 202 (422)
..++||||+++|+|.+++...... .....+++..+..++.||+.||.|||+++|+||||||+|||++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLE------TGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD 183 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBT------TSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTT
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhh------cCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC
Confidence 359999999999999999653211 112468999999999999999999999999999999999999999
Q ss_pred CeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q psy7289 203 LTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282 (422)
Q Consensus 203 ~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~ 282 (422)
+.+||+|||+++...............+++.|+|||.+....++.++|||||||++|||++.|..||.+.+..++...+.
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 263 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL 263 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH
Confidence 99999999999876544333333344567889999999988999999999999999999987899999999999999999
Q ss_pred cCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 283 SRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 283 ~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
.+..++.|..+|+.+.+++.+||..+|..|+ +...+...|
T Consensus 264 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~l~~~L 303 (313)
T 3brb_A 264 HGHRLKQPEDCLDELYEIMYSCWRTDPLDRP-----TFSVLRLQL 303 (313)
T ss_dssp TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSC-----CHHHHHHHH
T ss_pred cCCCCCCCccccHHHHHHHHHHcCCChhhCc-----CHHHHHHHH
Confidence 8888888999999999999999999999998 555554443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=353.93 Aligned_cols=258 Identities=37% Similarity=0.705 Sum_probs=220.5
Q ss_pred CcccccccccccceeEEEEEEecCC-CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe-EEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSE-GPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM-CML 132 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~-~lv 132 (422)
.|++.+.||+|+||.||+|++..+. ....||+|.+.........+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 3455689999999999999876543 33479999988766666778899999999999999999999999876665 999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+.+|+|.+++.... ..+++.++..++.|++.||+|||++||+||||||+|||+++++.+||+|||+
T Consensus 102 ~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 170 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ-----------RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGL 170 (298)
T ss_dssp ECCCTTCBHHHHHHCTT-----------CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTS
T ss_pred EecccCCCHHHHHhccc-----------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCC
Confidence 99999999999997632 3578999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcce--EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC
Q psy7289 213 SRDVYASDYY--RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP 290 (422)
Q Consensus 213 a~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p 290 (422)
++........ .......+|+.|+|||.+....++.++|||||||++|||++.+.+||.+.+..++...+..+...+.|
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 3pls_A 171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQP 250 (298)
T ss_dssp SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCC
T ss_pred cccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCC
Confidence 9865433221 12233456789999999998899999999999999999999778888888888999999988888889
Q ss_pred CCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
..+|+.+.+++.+||..+|..|+ +...+...|+
T Consensus 251 ~~~~~~l~~li~~~l~~~p~~Rp-----s~~~ll~~l~ 283 (298)
T 3pls_A 251 EYCPDSLYQVMQQCWEADPAVRP-----TFRVLVGEVE 283 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHH
T ss_pred ccchHHHHHHHHHHccCChhhCc-----CHHHHHHHHH
Confidence 99999999999999999999998 5555544443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=365.45 Aligned_cols=260 Identities=23% Similarity=0.340 Sum_probs=209.6
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
..+|++.+.||+|+||.||+|+... .++.||||++.........+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRV--TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECC--CCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 3578999999999999999998654 35789999986544444456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
||||++|+|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 84 ~e~~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 151 (323)
T 3tki_A 84 LEYCSGGELFDRIEPD------------IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGL 151 (323)
T ss_dssp EECCTTEEGGGGSBTT------------TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEcCCCCcHHHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeec
Confidence 9999999999988643 3589999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCChH--HHHHHHHcCCCCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKF-TTESDVWSYGVVLWEVYSYGLQPYYGYSNQ--EVIEMIRSRQMLPC 289 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~--~~~~~i~~~~~~~~ 289 (422)
++...............+|+.|+|||++....+ +.++|||||||++|||++ |..||.+.+.. ............+.
T Consensus 152 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (323)
T 3tki_A 152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPWDQPSDSCQEYSDWKEKKTYLNP 230 (323)
T ss_dssp CEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHH-SSCSCSSSCTTSHHHHHHHTTCTTSTT
T ss_pred cceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhcccccCCc
Confidence 986543332233345678999999999987765 778999999999999999 99999876653 23333333333344
Q ss_pred CCCCCcchhhhcccccccccchhh-HHHHhhhhhhhhhc
Q psy7289 290 PEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRDL 327 (422)
Q Consensus 290 p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~dL 327 (422)
...+++.+.+|+.+||..+|..|+ +..+.+|.++...+
T Consensus 231 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 467899999999999999999986 33455566655433
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=360.45 Aligned_cols=256 Identities=23% Similarity=0.373 Sum_probs=215.5
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCH-----HhHHHHHHHHHHHhcCCCCceeeEeeEEE
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQ-----KTASDFRREVDLMSELRHPNIVCLLGVCL 124 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~g~~~ 124 (422)
+.....|++.+.||+|+||.||+|+... .+..||+|+++..... ...+.+.+|+.+|++++||||+++++++.
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 84 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKS--TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 84 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETT--TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECC--CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 4455678999999999999999998654 3578999998643221 13567999999999999999999999999
Q ss_pred cCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC-
Q psy7289 125 SGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL- 203 (422)
Q Consensus 125 ~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~- 203 (422)
+....++||||+++|+|.+++... ..+++.++..++.||+.||+|||+++|+||||||+|||++.++
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~ 152 (326)
T 2y0a_A 85 NKTDVILILELVAGGELFDFLAEK------------ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNV 152 (326)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTS------------SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSS
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhc------------CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCC
Confidence 999999999999999999999653 3589999999999999999999999999999999999998877
Q ss_pred ---eEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHH
Q psy7289 204 ---TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEM 280 (422)
Q Consensus 204 ---~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~ 280 (422)
.+||+|||+++....... .....+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..+....
T Consensus 153 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 228 (326)
T 2y0a_A 153 PKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDTKQETLAN 228 (326)
T ss_dssp SSCCEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHH
T ss_pred CCCCEEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHH-CcCCCCCCCHHHHHHH
Confidence 899999999986543321 234467899999999998899999999999999999999 9999999999888888
Q ss_pred HHcCCCCCC---CCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 281 IRSRQMLPC---PEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 281 i~~~~~~~~---p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
+........ +..+|+.+.+++.+||..+|..|+ +..+.+|.++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 275 (326)
T 2y0a_A 229 VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275 (326)
T ss_dssp HHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred HHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCc
Confidence 876543221 357889999999999999999987 3344455554
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=376.33 Aligned_cols=260 Identities=21% Similarity=0.336 Sum_probs=215.4
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC--HHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN--QKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
++...+|++++.||+|+||+||+|+... .++.||||+++.... ......+.+|+.++..++|||||++++++.+++
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKN--ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN 147 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcC--CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 3445789999999999999999998754 457899999864211 112234889999999999999999999999999
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
.+|+|||||++|+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~-----------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL 216 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFE-----------DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRL 216 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTT-----------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEE
T ss_pred EEEEEEecCCCCcHHHHHHHcc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEE
Confidence 9999999999999999997631 35899999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccc-----cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL-----YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~ 282 (422)
+|||+|+........ ......+|+.|||||++. ...++.++|||||||++|||++ |..||.+.+..+....|.
T Consensus 217 ~DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~ 294 (437)
T 4aw2_A 217 ADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIM 294 (437)
T ss_dssp CCCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHH
T ss_pred cchhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHh-CCCCCCCCChhHHHHhhh
Confidence 999999866543322 234457899999999987 4578999999999999999999 999999999999888886
Q ss_pred cCC-CCCCC---CCCCcchhhhcccccccccch--h-hHHHHhhhhhhh
Q psy7289 283 SRQ-MLPCP---EDCPPRMYSLMMECWHEVPVA--A-GMAYLCSHHYVH 324 (422)
Q Consensus 283 ~~~-~~~~p---~~~p~~~~~l~~~cw~~~P~~--r-~~~~lh~~~~i~ 324 (422)
... ..+.| ..+++++.+|+++|+..+|.. | ++..+.+|.++.
T Consensus 295 ~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~ 343 (437)
T 4aw2_A 295 NHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFS 343 (437)
T ss_dssp THHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGT
T ss_pred hccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccC
Confidence 432 23333 458999999999999877665 3 355666777764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=374.49 Aligned_cols=256 Identities=22% Similarity=0.355 Sum_probs=216.4
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
...+|++.+.||+|+||.||+|+... .+..||+|++.... .....+.+.+|+.+++.++|||||++++++.+++..+
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~--~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVL--AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETT--TTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECC--CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 34578999999999999999998654 45789999986543 3345678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec---CCCeEEE
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVG---DGLTVKI 207 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~---~~~~vKl 207 (422)
+|||||++|+|.+++..+ ..+++.++..++.||+.||+|||++||+||||||+|||++ +++.+||
T Consensus 87 lv~E~~~gg~L~~~i~~~------------~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL 154 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAR------------EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKL 154 (444)
T ss_dssp EEECCCBCCBHHHHHHHC------------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEE
T ss_pred EEEEeCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEE
Confidence 999999999999999764 3589999999999999999999999999999999999998 4678999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+|||+++....... ......+|+.|+|||++....++.++|||||||++|||++ |.+||.+.+..++...+..+...
T Consensus 155 ~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~-G~~Pf~~~~~~~~~~~i~~~~~~ 231 (444)
T 3soa_A 155 ADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLV-GYPPFWDEDQHRLYQQIKAGAYD 231 (444)
T ss_dssp CCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHTCCC
T ss_pred ccCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCCCC
Confidence 99999986644321 2234568999999999998899999999999999999999 99999999999999998876543
Q ss_pred C-CC--CCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 288 P-CP--EDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 288 ~-~p--~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
. .| ..+++++.+|+.+||..||..|+ +..+.+|.++.
T Consensus 232 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~ 272 (444)
T 3soa_A 232 FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWIS 272 (444)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTH
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence 2 22 46899999999999999999886 33455666653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=364.81 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=215.2
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
..+|++.+.||+|+||.||+|+... .+..||+|++... ......+.+.+|+.+++.++|||||++++++.+.+..|+
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKT--TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECC--CCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 4578999999999999999998654 3578999998643 344556789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC---CeEEEe
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG---LTVKIS 208 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~---~~vKl~ 208 (422)
||||+++|+|.+++..+ ..+++.++..++.||+.||+|||+++|+||||||+|||++.+ +.+||+
T Consensus 106 v~e~~~gg~L~~~l~~~------------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~ 173 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAR------------EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 173 (362)
T ss_dssp EECCCCSCBHHHHHTTC------------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEEC
T ss_pred EEecCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEe
Confidence 99999999999999653 358999999999999999999999999999999999999864 469999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC-
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML- 287 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~- 287 (422)
|||+++....... .....+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..++...+..+...
T Consensus 174 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~i~~~~~~~ 249 (362)
T 2bdw_A 174 DFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDY 249 (362)
T ss_dssp CCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred ecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHhCCCCC
Confidence 9999986653321 234567899999999998899999999999999999999 99999999999999888876543
Q ss_pred CCC--CCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 288 PCP--EDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 288 ~~p--~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
+.+ ..+|+++.+|+.+||..+|..|+ +..+..|.++
T Consensus 250 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 288 (362)
T 2bdw_A 250 PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288 (362)
T ss_dssp CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHH
T ss_pred CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 222 36789999999999999999886 3344555554
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=360.51 Aligned_cols=252 Identities=27% Similarity=0.457 Sum_probs=206.7
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
...+|++.+.||+|+||.||+|++.. ++..||+|.+.. .+....+.|.+|++++++++||||+++++++.++...++
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~--~~~~va~K~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRE--TGEVMVMKELIR-FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETT--TCCEEEEEEESC-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECC--CCcEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence 35678999999999999999998754 357799998754 345567889999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
||||+++|+|.+++.... ..+++.++..++.|++.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 153 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMD-----------SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFG 153 (310)
T ss_dssp EEECCTTCBHHHHHHHCC-----------TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCT
T ss_pred EEEecCCCcHHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecc
Confidence 999999999999997642 358999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceE------------eccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHH---
Q psy7289 212 LSRDVYASDYYR------------IQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE--- 276 (422)
Q Consensus 212 la~~~~~~~~~~------------~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~--- 276 (422)
+++......... ......+|+.|+|||++....++.++|||||||++|||++ |..||.......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~~~~~~~~~~~~~ 232 (310)
T 3s95_A 154 LARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG-RVNADPDYLPRTMDF 232 (310)
T ss_dssp TCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-TCCSSTTTSCBCTTS
T ss_pred cceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhc-CCCCCcchhhhHHHH
Confidence 998654322111 1113467899999999999999999999999999999998 888887543221
Q ss_pred ---HHHHHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 277 ---VIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 277 ---~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
...... ...|..+|+.+.+++.+||+.+|..|+ +...+...|
T Consensus 233 ~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~l~~~L 277 (310)
T 3s95_A 233 GLNVRGFLD----RYCPPNCPPSFFPITVRCCDLDPEKRP-----SFVKLEHWL 277 (310)
T ss_dssp SBCHHHHHH----HTCCTTCCTTHHHHHHHHTCSSGGGSC-----CHHHHHHHH
T ss_pred hhhhhcccc----ccCCCCCCHHHHHHHHHHccCChhhCc-----CHHHHHHHH
Confidence 111111 234778999999999999999999997 554444433
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=348.77 Aligned_cols=247 Identities=39% Similarity=0.732 Sum_probs=216.9
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
.+...+|++.+.||+|+||.||+|++. ++..||+|.+..... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWL---NKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET---TTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred EEchhheeeeeEecCCCceeEEEEEec---CCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence 455678999999999999999999864 346799999875432 236789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEec
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISD 209 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~D 209 (422)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~d 147 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQR-----------GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSD 147 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTT-----------TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECC
T ss_pred EEEEeCCCCCcHHHHHhhCc-----------ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcc
Confidence 99999999999999997642 3588999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 289 (422)
||+++....... .......+|+.|+|||++....++.++||||||+++|||++.|..||.+.+..++...+..+.....
T Consensus 148 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~ 226 (267)
T 3t9t_A 148 FGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 226 (267)
T ss_dssp TTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred cccccccccccc-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC
Confidence 999986543221 1223345677899999999889999999999999999999878999999999999999998888888
Q ss_pred CCCCCcchhhhcccccccccchhh
Q psy7289 290 PEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 290 p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
|..+|+.+.+++.+||+.+|..|+
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rp 250 (267)
T 3t9t_A 227 PRLASTHVYQIMNHCWRERPEDRP 250 (267)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred CccCcHHHHHHHHHHccCChhhCc
Confidence 889999999999999999999998
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=353.58 Aligned_cols=260 Identities=38% Similarity=0.745 Sum_probs=226.4
Q ss_pred hhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
.+++...+|++.+.||+|+||.||+|++..+ +..||+|.+.... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKY--SLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGG--TEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCC--CEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 4567788899999999999999999987543 5789999987543 34578999999999999999999999999999
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
..++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~----------~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l 152 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNR----------QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKV 152 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCT----------TTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEE
T ss_pred CEEEEEEcCCCCcHHHHHHhccc----------CCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEE
Confidence 99999999999999999976421 35899999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+|||+++........ ......+|+.|+|||.+....++.++||||||+++|||++.|..||.+.+..++...+......
T Consensus 153 ~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (288)
T 3kfa_A 153 ADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 231 (288)
T ss_dssp CCCCGGGTSCSSSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC
T ss_pred ccCccceeccCCccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC
Confidence 999999876543322 2333445778999999998999999999999999999998799999999999999999888888
Q ss_pred CCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
+.|..+|+.+.+++.+||..+|..|+ +...+...|
T Consensus 232 ~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~~~~~l 266 (288)
T 3kfa_A 232 ERPEGCPEKVYELMRACWQWNPSDRP-----SFAEIHQAF 266 (288)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHhCCChhhCc-----CHHHHHHHH
Confidence 88999999999999999999999997 555444443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=390.77 Aligned_cols=261 Identities=39% Similarity=0.687 Sum_probs=223.4
Q ss_pred hhccccCcccccccccccceeEEEEEEecCC-CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 49 REVIETKPRFLQELGEGAFGKVYKGEVCTSE-GPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 49 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
.++...+|++.+.||+|+||.||+|++..++ ....||||.++........+.|.+|+.+|++++|||||++++++. .+
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 3555677899999999999999999886543 356899999876666666788999999999999999999999985 46
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
..++||||+++|+|.+++..+. ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL 532 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRK-----------FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKL 532 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTT-----------TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEE
T ss_pred ceEEEEEcCCCCcHHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEE
Confidence 7899999999999999997642 25889999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+|||+++........ ......+|+.|||||++....++.++|||||||++|||++.|..||.+.+..++...+..+.++
T Consensus 533 ~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~ 611 (656)
T 2j0j_A 533 GDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 611 (656)
T ss_dssp CCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC
T ss_pred EecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999999876443322 2233456788999999998899999999999999999998799999999999999999999888
Q ss_pred CCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
+.|..+|+.+.++|.+||+.+|..|+ +...+.+.|
T Consensus 612 ~~~~~~~~~l~~li~~~l~~dP~~RP-----s~~el~~~L 646 (656)
T 2j0j_A 612 PMPPNCPPTLYSLMTKCWAYDPSRRP-----RFTELKAQL 646 (656)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHH
T ss_pred CCCccccHHHHHHHHHHcCCChhHCc-----CHHHHHHHH
Confidence 99999999999999999999999998 555555544
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=361.10 Aligned_cols=260 Identities=38% Similarity=0.655 Sum_probs=214.2
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCCe
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~ 129 (422)
+...+|++.+.||+|+||.||+|+...++....||||.++........+.+.+|+.+++++ +||||+++++++.+.+..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 4456899999999999999999998765433456999987655555567899999999999 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCC----CCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDI----SGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~----~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
++||||+++|+|.+++......... ........+++.++..++.||+.||+|||+++|+||||||+|||++.++.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeE
Confidence 9999999999999999764200000 000012368999999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ 285 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~ 285 (422)
||+|||+++..... .......+++.|+|||++....++.++|||||||++|||++.|..||.+.+..++...+..+.
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~ 258 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 258 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC
Confidence 99999999743211 112233457789999999888899999999999999999987999999999999999998888
Q ss_pred CCCCCCCCCcchhhhcccccccccchhh
Q psy7289 286 MLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 286 ~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..+.|..+|+.+.+++.+||..+|..|+
T Consensus 259 ~~~~~~~~~~~l~~li~~~l~~dp~~Rp 286 (327)
T 1fvr_A 259 RLEKPLNCDDEVYDLMRQCWREKPYERP 286 (327)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSC
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 8888889999999999999999999998
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=349.63 Aligned_cols=258 Identities=37% Similarity=0.697 Sum_probs=221.1
Q ss_pred hhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
.+++...+|++.+.||+|+||.||+|+.. ++..||||.++.... ..+.+.+|++++++++||||+++++++. .+
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 80 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN---GHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVT-QE 80 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET---TTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc---CCcEEEEEEecCCcc--cHHHHHHHHHHHHhCCCcCcceEEEEEc-CC
Confidence 45677789999999999999999999853 346799999865432 3467899999999999999999999986 45
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
..++||||+++|+|.+++.... ...+++.++..++.|++.||+|||++||+||||||+||++++++.+||
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl 150 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPS----------GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKI 150 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHH----------HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEE
T ss_pred CcEEEEecCCCCCHHHHHhcCC----------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEE
Confidence 6899999999999999996431 125899999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+|||+++....... .......+++.|+|||.+....++.++|||||||++|||++.|..||.+.+..++...+..+...
T Consensus 151 ~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 229 (279)
T 1qpc_A 151 ADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM 229 (279)
T ss_dssp CCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CCCcccccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC
Confidence 99999987654332 22334456788999999988889999999999999999998789999999999999999888888
Q ss_pred CCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
..|..+|+++.+++..||..+|..|+ +...+...|
T Consensus 230 ~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~~l 264 (279)
T 1qpc_A 230 VRPDNCPEELYQLMRLCWKERPEDRP-----TFDYLRSVL 264 (279)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHH
T ss_pred CCcccccHHHHHHHHHHhccChhhCC-----CHHHHHHHH
Confidence 88899999999999999999999998 554444433
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=353.86 Aligned_cols=255 Identities=25% Similarity=0.394 Sum_probs=206.1
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC-------------------------HHhHHHHHHHH
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN-------------------------QKTASDFRREV 105 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~-------------------------~~~~~~~~~E~ 105 (422)
+...+|++.+.||+|+||.||+|+... .+..||||++..... ....+.+.+|+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 87 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNEN--DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEI 87 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETT--TTEEEEEEEEECC-------------------------------CHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECC--CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHH
Confidence 344679999999999999999998643 457899999864321 11235689999
Q ss_pred HHHhcCCCCceeeEeeEEEc--CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHH
Q psy7289 106 DLMSELRHPNIVCLLGVCLS--GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLC 183 (422)
Q Consensus 106 ~il~~l~HpnIv~l~g~~~~--~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH 183 (422)
+++++++||||+++++++.+ ...+++||||+++|+|.+++.. ..+++.++..++.||+.||+|||
T Consensus 88 ~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-------------~~~~~~~~~~~~~qi~~~l~~lH 154 (298)
T 2zv2_A 88 AILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-------------KPLSEDQARFYFQDLIKGIEYLH 154 (298)
T ss_dssp HHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-------------SCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999986 5578999999999999875432 35899999999999999999999
Q ss_pred hCCccccCCCCCceeecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCC---CCCchhHHhHHHHHHH
Q psy7289 184 SHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK---FTTESDVWSYGVVLWE 260 (422)
Q Consensus 184 ~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~DvwS~Gvil~E 260 (422)
+++|+||||||+|||++.++.+||+|||+++....... ......+|+.|+|||++.... ++.++|||||||++||
T Consensus 155 ~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~ 232 (298)
T 2zv2_A 155 YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC 232 (298)
T ss_dssp HTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHH
T ss_pred HCCeeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHH
Confidence 99999999999999999999999999999987654332 223456889999999987655 3778999999999999
Q ss_pred HHhCCCCCCCCCChHHHHHHHHcCCC-CCCCCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 261 VYSYGLQPYYGYSNQEVIEMIRSRQM-LPCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 261 l~t~g~~Pf~~~~~~~~~~~i~~~~~-~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
|++ |..||.+.+..++...+..... .+.+..+|+++.+++.+||..+|..|+ +..+.+|.++
T Consensus 233 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~ 296 (298)
T 2zv2_A 233 FVF-GQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296 (298)
T ss_dssp HHH-SSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHH
T ss_pred HHH-CCCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccc
Confidence 999 9999999888888777766543 334467899999999999999999986 3334444443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=357.96 Aligned_cols=249 Identities=20% Similarity=0.329 Sum_probs=204.3
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
.....+|++.+.||+|+||.||+|+... .++.||||+++... .......+.+|+.++++++||||+++++++....
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 85 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLR--DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 85 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECC--CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence 3456789999999999999999998643 46789999987543 3445568999999999999999999999987665
Q ss_pred Ce----EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC
Q psy7289 128 PM----CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL 203 (422)
Q Consensus 128 ~~----~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~ 203 (422)
.. |+||||+++|+|.+++... ..+++.++..++.|++.||+|||+++|+||||||+|||++.++
T Consensus 86 ~~~~~~~lv~e~~~g~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~ 153 (311)
T 3ork_A 86 PAGPLPYIVMEYVDGVTLRDIVHTE------------GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN 153 (311)
T ss_dssp TTEEEEEEEEECCCEEEHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS
T ss_pred CCCcccEEEEecCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC
Confidence 43 9999999999999999764 3589999999999999999999999999999999999999999
Q ss_pred eEEEecCcccccccCCcce-EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q psy7289 204 TVKISDFGLSRDVYASDYY-RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282 (422)
Q Consensus 204 ~vKl~DFGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~ 282 (422)
.+||+|||+++........ .......+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..+....+.
T Consensus 154 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~~~ 232 (311)
T 3ork_A 154 AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPFTGDSPVSVAYQHV 232 (311)
T ss_dssp CEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHH
T ss_pred CEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHh
Confidence 9999999999865433211 12233457899999999999899999999999999999999 999999998888776666
Q ss_pred cCCCCCC---CCCCCcchhhhcccccccccchhh
Q psy7289 283 SRQMLPC---PEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 283 ~~~~~~~---p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.....+. +..+|+++.+++.+||+.+|..|+
T Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~ 266 (311)
T 3ork_A 233 REDPIPPSARHEGLSADLDAVVLKALAKNPENRY 266 (311)
T ss_dssp HCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred cCCCCCcccccCCCCHHHHHHHHHHHhcCHhhCh
Confidence 5544332 357899999999999999999996
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=352.49 Aligned_cols=261 Identities=32% Similarity=0.602 Sum_probs=214.7
Q ss_pred hccccCcccccccccccceeEEEEEEe--cCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC-
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVC--TSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG- 126 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~- 126 (422)
.+....|++.+.||+|+||.||+|++. ....+..||||+++........+.+.+|+.+++.++||||+++++++.+.
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 344567899999999999999999863 23456889999987655445567899999999999999999999999876
Q ss_pred -CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 127 -EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 127 -~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
..+++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+++|+||||||+|||++.++.+
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~ 165 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNK-----------NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQV 165 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHT-----------TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred CceEEEEEEeCCCCcHHHHHHhcc-----------ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCE
Confidence 67899999999999999996542 358999999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcce-EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCC-------------
Q psy7289 206 KISDFGLSRDVYASDYY-RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG------------- 271 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~------------- 271 (422)
||+|||+++........ .......+|..|+|||++....++.++|||||||++|||++ |..|+..
T Consensus 166 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~ 244 (302)
T 4e5w_A 166 KIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT-YCDSDSSPMALFLKMIGPTH 244 (302)
T ss_dssp EECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT-TTCGGGSHHHHHHHHHCSCC
T ss_pred EECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHH-ccCCCcchhhHHhhccCCcc
Confidence 99999999876544322 33445567888999999998899999999999999999998 7766532
Q ss_pred --CChHHHHHHHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 272 --YSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 272 --~~~~~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
.....+...+..+...+.|..+|+.+.+++.+||+.+|..|+ +...+.+.|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~L 297 (302)
T 4e5w_A 245 GQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRT-----SFQNLIEGF 297 (302)
T ss_dssp GGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSC-----CHHHHHHHH
T ss_pred cccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCC-----CHHHHHHHH
Confidence 223355666777888888999999999999999999999997 555444433
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=362.36 Aligned_cols=260 Identities=23% Similarity=0.342 Sum_probs=211.8
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC----CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA----NQKTASDFRREVDLMSELRHPNIVCLLGVCLSG 126 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~ 126 (422)
....+|++.+.||+|+||.||+|+... .++.||||++.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 98 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRE--TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD 98 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECC--CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 345678999999999999999998654 35789999985321 112356799999999999999999999999999
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC---
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL--- 203 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~--- 203 (422)
+.+|+|||||++|+|.+++..+... ...+++..+..++.||+.||+|||+++|+||||||+|||++.++
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~--------~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~ 170 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADA--------GFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSA 170 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHT--------TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTC
T ss_pred CEEEEEEeCCCCCCHHHHHHHhccc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCC
Confidence 9999999999999999988754211 13589999999999999999999999999999999999998654
Q ss_pred eEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc
Q psy7289 204 TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS 283 (422)
Q Consensus 204 ~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~ 283 (422)
.+||+|||+++....... ......+|+.|+|||++....++.++|||||||++|||++ |..||.+. ..++...+..
T Consensus 171 ~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~-~~~~~~~i~~ 246 (351)
T 3c0i_A 171 PVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS-GCLPFYGT-KERLFEGIIK 246 (351)
T ss_dssp CEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCSS-HHHHHHHHHH
T ss_pred cEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHH-CCCCCCCc-HHHHHHHHHc
Confidence 499999999987654322 2234568999999999998899999999999999999999 99999875 4566666666
Q ss_pred CCCCCCC---CCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 284 RQMLPCP---EDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 284 ~~~~~~p---~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
+.....| ..+|+++.+|+.+||..+|..|+ +..+.+|.++.
T Consensus 247 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~ 291 (351)
T 3c0i_A 247 GKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291 (351)
T ss_dssp TCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred CCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhc
Confidence 5543322 57889999999999999999986 33455555553
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=364.03 Aligned_cols=255 Identities=25% Similarity=0.396 Sum_probs=213.2
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC--HHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN--QKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
..+|++.+.||+|+||.||+|++..+ +..||||++..... ......+.+|+.+++.++||||+++++++.++...+
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKT--QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTT--CCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCC--CCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 45789999999999999999987543 57799999864211 112357889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+||||+ +|+|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||+++++.+||+||
T Consensus 86 lv~E~~-~g~l~~~l~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DF 152 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEK------------KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADF 152 (336)
T ss_dssp EEECCC-CEEHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCS
T ss_pred EEEECC-CCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEe
Confidence 999999 78999999765 35899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKF-TTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 289 (422)
|+++...... ......+|+.|+|||++.+..+ +.++|||||||++|||++ |..||.+.+..++...+..+ ....
T Consensus 153 G~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~ 227 (336)
T 3h4j_B 153 GLSNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLV-GRLPFDDEFIPNLFKKVNSC-VYVM 227 (336)
T ss_dssp SCTBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHH-SSCSSBCSSSTTCBCCCCSS-CCCC
T ss_pred ccceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHh-CCCCCCCccHHHHHHHHHcC-CCCC
Confidence 9998654432 2234567899999999987776 689999999999999999 99999887766655544433 3456
Q ss_pred CCCCCcchhhhcccccccccchhh-HHHHhhhhhhhhhc
Q psy7289 290 PEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRDL 327 (422)
Q Consensus 290 p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~dL 327 (422)
|..+|+++.+|+++||..||..|+ +..+.+|.++..++
T Consensus 228 p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 228 PDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCC
Confidence 788999999999999999999986 44566677765543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=355.13 Aligned_cols=248 Identities=33% Similarity=0.607 Sum_probs=210.4
Q ss_pred cccCc-ccccccccccceeEEEEEEec--CCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC--
Q psy7289 52 IETKP-RFLQELGEGAFGKVYKGEVCT--SEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG-- 126 (422)
Q Consensus 52 ~~~~~-~~~~~LG~G~fg~Vy~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-- 126 (422)
...+| ++++.||+|+||.||++.+.. ...+..||||+++........+.+.+|++++++++||||+++++++.+.
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 34455 899999999999999987642 3356889999998766666778899999999999999999999999874
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEE
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vK 206 (422)
..+++||||+++|+|.+++... .+++.++..++.|++.||+|||+++|+||||||+|||++.++.+|
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~k 174 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRH-------------SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVK 174 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGS-------------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred ceEEEEEecccCCcHHHHHhhC-------------CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEE
Confidence 5689999999999999999653 488999999999999999999999999999999999999999999
Q ss_pred EecCcccccccCCcc-eEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh-----------
Q psy7289 207 ISDFGLSRDVYASDY-YRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN----------- 274 (422)
Q Consensus 207 l~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~----------- 274 (422)
|+|||+++....... ........+|+.|+|||++....++.++|||||||++|||++ |..||.....
T Consensus 175 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 253 (318)
T 3lxp_A 175 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIAQG 253 (318)
T ss_dssp ECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT-TTCGGGSHHHHHHHHHCSCCH
T ss_pred ECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHh-CCCcccccchhhhhhhccccc
Confidence 999999987654332 223344556788999999998889999999999999999998 8889875432
Q ss_pred ----HHHHHHHHcCCCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 275 ----QEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 275 ----~~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.++...+..+...+.|..+|+++.+|+++||+.+|..|+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 296 (318)
T 3lxp_A 254 QMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRP 296 (318)
T ss_dssp HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred chhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCc
Confidence 134555667777888999999999999999999999997
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=349.28 Aligned_cols=257 Identities=29% Similarity=0.505 Sum_probs=201.3
Q ss_pred hhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSG 126 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~ 126 (422)
..++...+|++.+.||+|+||.||+|++. ..||||+++... .....+.|.+|+.++++++||||+++++++ ..
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~ 91 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWH-----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA 91 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESS-----SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEc-----CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence 45788899999999999999999999742 249999986543 455667899999999999999999999965 45
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEE
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vK 206 (422)
+..++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+++|+||||||+|||++.++.+|
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~k 160 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASE-----------TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVK 160 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC--------------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEE
T ss_pred CccEEEEEecCCCcHHHHHhhcc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEE
Confidence 67899999999999999996532 3589999999999999999999999999999999999999999999
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCccccc---cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChH-HHHHHHH
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL---YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ-EVIEMIR 282 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~-~~~~~i~ 282 (422)
|+|||+++...............+|+.|+|||.+. ...++.++|||||||++|||++ |..||.+.+.. .+...+.
T Consensus 161 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~ 239 (289)
T 3og7_A 161 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRDQIIEMVG 239 (289)
T ss_dssp ECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHH-SSCTTSSCCCHHHHHHHHH
T ss_pred EccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHH-CCCCccccchHHHHHHHhc
Confidence 99999997554322222223345789999999986 5668889999999999999999 99999886654 4555555
Q ss_pred cCCCCC----CCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 283 SRQMLP----CPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 283 ~~~~~~----~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
.+...+ .+..+|+++.+++.+||+.+|..|+ +...+...|
T Consensus 240 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~~L 283 (289)
T 3og7_A 240 RGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERP-----SFPRILAEI 283 (289)
T ss_dssp HTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHH
T ss_pred ccccCcchhhccccCCHHHHHHHHHHccCChhhCC-----CHHHHHHHH
Confidence 554433 2457899999999999999999998 555554444
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=350.05 Aligned_cols=255 Identities=27% Similarity=0.447 Sum_probs=212.9
Q ss_pred hccccCcccccccccccceeEEEEEEecCCC-----CeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEE
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEG-----PSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCL 124 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~ 124 (422)
++...+|++.+.||+|+||.||+|+...++. ...||+|.+... .....+.+.+|+.++++++||||+++++++.
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG-GGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 4566789999999999999999998865442 256999998643 2345578999999999999999999999999
Q ss_pred cCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCe
Q psy7289 125 SGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLT 204 (422)
Q Consensus 125 ~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~ 204 (422)
+++..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~ 151 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKNK-----------NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREED 151 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHTG-----------GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCB
T ss_pred eCCCCEEEEECCCCCCHHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCc
Confidence 9999999999999999999997642 24899999999999999999999999999999999999988776
Q ss_pred --------EEEecCcccccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChH
Q psy7289 205 --------VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ 275 (422)
Q Consensus 205 --------vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~ 275 (422)
+||+|||+++...... ...+|+.|+|||++.. ..++.++|||||||++|||++.+.+||...+..
T Consensus 152 ~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~ 225 (289)
T 4fvq_A 152 RKTGNPPFIKLSDPGISITVLPKD------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ 225 (289)
T ss_dssp GGGTBCCEEEECCCCSCTTTSCHH------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred ccccccceeeeccCcccccccCcc------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH
Confidence 9999999997553321 1234678999999987 679999999999999999999677777777776
Q ss_pred HHHHHHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhccc
Q psy7289 276 EVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAA 329 (422)
Q Consensus 276 ~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk~ 329 (422)
......... ...|..+++++.+++.+||+.+|..|+ +...+.+.|+.
T Consensus 226 ~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~l~~ 272 (289)
T 4fvq_A 226 RKLQFYEDR--HQLPAPKAAELANLINNCMDYEPDHRP-----SFRAIIRDLNS 272 (289)
T ss_dssp HHHHHHHTT--CCCCCCSSCTTHHHHHHHSCSSGGGSC-----CHHHHHHHHHT
T ss_pred HHHHHhhcc--CCCCCCCCHHHHHHHHHHcCCChhHCc-----CHHHHHHHHHH
Confidence 666655543 345667789999999999999999998 66666665543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=342.93 Aligned_cols=242 Identities=24% Similarity=0.415 Sum_probs=208.6
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC--
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSG-- 126 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-- 126 (422)
++...+|++.+.||+|+||.||+|++. +..||||+++... .....+.|.+|+.++++++||||+++++++.+.
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ----GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET----TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC----CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 455678999999999999999999863 5679999987543 455567899999999999999999999999887
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceeecCCCe
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHH--YVHRDLAARNCLVGDGLT 204 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--ivHrDlKp~NiLl~~~~~ 204 (422)
...++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+++ |+||||||+|||+++++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~ 151 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGT----------NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT 151 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCS----------SCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC
T ss_pred CCeEeeecccCCCcHHHHHhhcc----------cCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc
Confidence 77899999999999999997642 125899999999999999999999999 999999999999999999
Q ss_pred EEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCC---chhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHH
Q psy7289 205 VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTT---ESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281 (422)
Q Consensus 205 vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~---~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i 281 (422)
+||+|||++..... ....+|+.|+|||.+....++. ++|||||||++|||++ |..||.+.+..+....+
T Consensus 152 ~~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~ 223 (271)
T 3kmu_A 152 ARISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT-REVPFADLSNMEIGMKV 223 (271)
T ss_dssp EEEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHH-CSCTTTTSCHHHHHHHH
T ss_pred eeEEeccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHh-CCCCccccChHHHHHHH
Confidence 99999888754322 2345688999999998765544 7999999999999999 99999999888876655
Q ss_pred H-cCCCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 282 R-SRQMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 282 ~-~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
. .+..++.|..+|+++.+++..||+.+|..|+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 256 (271)
T 3kmu_A 224 ALEGLRPTIPPGISPHVSKLMKICMNEDPAKRP 256 (271)
T ss_dssp HHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCc
Confidence 5 5556677889999999999999999999998
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=351.92 Aligned_cols=251 Identities=23% Similarity=0.373 Sum_probs=211.9
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFE 134 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E 134 (422)
.++..+.||+|+||.||+|+... .++.||||++..... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~--~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKH--SGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEETTTC-CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECC--CCcEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 35667799999999999998643 357899999864332 335678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccc
Q psy7289 135 FMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR 214 (422)
Q Consensus 135 ~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~ 214 (422)
|+++|+|.+++.. ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 123 ~~~~~~L~~~l~~-------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~ 189 (321)
T 2c30_A 123 FLQGGALTDIVSQ-------------VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCA 189 (321)
T ss_dssp CCCSCBHHHHHTT-------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cCCCCCHHHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeee
Confidence 9999999999864 248999999999999999999999999999999999999999999999999997
Q ss_pred cccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC--CCCC
Q psy7289 215 DVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP--CPED 292 (422)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~--~p~~ 292 (422)
....... ......+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..+....+.....+. .+..
T Consensus 190 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2c30_A 190 QISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVD-GEPPYFSDSPVQAMKRLRDSPPPKLKNSHK 266 (321)
T ss_dssp ECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSSCCCCTTGGG
T ss_pred ecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCcCcccc
Confidence 6543221 1234567899999999998899999999999999999999 999999999888888887655433 2346
Q ss_pred CCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 293 CPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 293 ~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
+|+.+.+++.+||..+|..|+ +..+.+|.++.
T Consensus 267 ~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~ 299 (321)
T 2c30_A 267 VSPVLRDFLERMLVRDPQERATAQELLDHPFLL 299 (321)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGG
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence 788999999999999999996 33444555543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=347.68 Aligned_cols=257 Identities=23% Similarity=0.429 Sum_probs=221.7
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
....|++++.||+|+||.||+|+... .+..||||++.........+.+.+|+.+++.++||||+++++++.+....++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 97 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNR--TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 97 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETT--TCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECC--CCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 34568899999999999999998643 4578999998765444556789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||
T Consensus 98 v~e~~~~~~L~~~~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg 164 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEP-------------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFG 164 (303)
T ss_dssp EEECCTTEEHHHHHTT-------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEeCCCCcHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecc
Confidence 9999999999999854 258999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCC
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPE 291 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~ 291 (422)
+++....... ......+|+.|+|||++....++.++|||||||++|||++ |..||...+..+....+..+.....+.
T Consensus 165 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T 3a7i_A 165 VAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAR-GEPPHSELHPMKVLFLIPKNNPPTLEG 241 (303)
T ss_dssp TCEECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSCCCCCCS
T ss_pred cceecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHcc-CCCCCCCcCHHHHHHHhhcCCCCCCcc
Confidence 9976543321 1234457889999999998899999999999999999999 999999999888888888777777788
Q ss_pred CCCcchhhhcccccccccchhh-HHHHhhhhhhhhh
Q psy7289 292 DCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRD 326 (422)
Q Consensus 292 ~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~d 326 (422)
.+|+.+.+++.+||+.+|..|+ +..+.++.++.+.
T Consensus 242 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 242 NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 9999999999999999999997 3344555555443
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=358.48 Aligned_cols=253 Identities=25% Similarity=0.386 Sum_probs=202.1
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC-
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP- 128 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~- 128 (422)
.+...+|++.+.||+|+||.||+|++. +..||||+++.. ......+.+|+.++++++|||||++++++.+...
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQLL----NEYVAVKIFPIQ--DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV 93 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEET----TEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred ccchhhchhhheecccCceEEEEEEEC----CCEEEEEEeecC--chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence 455678999999999999999999863 478999998643 2334456779999999999999999999987553
Q ss_pred ---eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhC----------CccccCCCCC
Q psy7289 129 ---MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSH----------HYVHRDLAAR 195 (422)
Q Consensus 129 ---~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~----------~ivHrDlKp~ 195 (422)
+++|||||++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~ 160 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKAN-------------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSK 160 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC-------------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGG
T ss_pred CceEEEEEecCCCCCHHHHHHhc-------------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChH
Confidence 69999999999999999753 488999999999999999999999 9999999999
Q ss_pred ceeecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccC-----CCCCchhHHhHHHHHHHHHhCCCCCCC
Q psy7289 196 NCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-----KFTTESDVWSYGVVLWEVYSYGLQPYY 270 (422)
Q Consensus 196 NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~DvwS~Gvil~El~t~g~~Pf~ 270 (422)
|||++.++.+||+|||+++...............+|+.|+|||++... .++.++|||||||++|||++ |..||.
T Consensus 161 Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~t-g~~pf~ 239 (322)
T 3soc_A 161 NVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS-RCTAAD 239 (322)
T ss_dssp GEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHT-TBTTSS
T ss_pred hEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHh-CCCCCC
Confidence 999999999999999999866544332233345679999999998763 45678899999999999998 989997
Q ss_pred CCC----------------hHHHHHHHHcCCCCCC-CC-----CCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 271 GYS----------------NQEVIEMIRSRQMLPC-PE-----DCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 271 ~~~----------------~~~~~~~i~~~~~~~~-p~-----~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
+.. ..++...+......+. +. .+++++.+|+.+||+.+|..|+ +...+.+.|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~L 313 (322)
T 3soc_A 240 GPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL-----SAGCVGERI 313 (322)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSC-----CHHHHHHHH
T ss_pred CCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCc-----CHHHHHHHH
Confidence 642 2334444444433332 22 2345599999999999999998 555554443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=360.26 Aligned_cols=256 Identities=20% Similarity=0.343 Sum_probs=215.2
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
....|++.+.||+|+||.||+|+... .+..||+|.+.... ......+.+|+.+|+.++|||||++++++.+...+++
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~--~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 125 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKA--TGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 125 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECC--CCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence 34679999999999999999998754 35689999986543 3345678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC--CCeEEEec
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD--GLTVKISD 209 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~--~~~vKl~D 209 (422)
||||+++|+|.+++.... ..+++.++..++.||+.||+|||++||+||||||+|||++. ++.+||+|
T Consensus 126 v~E~~~gg~L~~~l~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~D 194 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAED-----------YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIID 194 (387)
T ss_dssp EEECCCCCBHHHHTTCTT-----------CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECC
T ss_pred EEEcCCCCcHHHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEe
Confidence 999999999999986531 35899999999999999999999999999999999999974 46899999
Q ss_pred CcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC--
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML-- 287 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~-- 287 (422)
||+++......... ...+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..+.+..+......
T Consensus 195 FG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~ 270 (387)
T 1kob_A 195 FGLATKLNPDEIVK---VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS-GLSPFAGEDDLETLQNVKRCDWEFD 270 (387)
T ss_dssp CTTCEECCTTSCEE---EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred cccceecCCCccee---eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 99998765433221 2357899999999998899999999999999999999 99999999988888888765432
Q ss_pred -CCCCCCCcchhhhcccccccccchhh-HHHHhhhhhhhh
Q psy7289 288 -PCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHR 325 (422)
Q Consensus 288 -~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~ 325 (422)
+.+..+|+++.+++.+||..+|..|+ +..+.+|.++..
T Consensus 271 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (387)
T 1kob_A 271 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 310 (387)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccC
Confidence 22357899999999999999999986 334555555543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=356.39 Aligned_cols=253 Identities=26% Similarity=0.463 Sum_probs=212.3
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
...|++++.||+|+||.||+|+... ++..||||++.... .....+.+.+|++++++++|||||++++++.+++..+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 130 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVR--NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 130 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEcc--CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEE
Confidence 4568889999999999999998643 46789999986432 2334568999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+||||+. |+|.+++.... ..+++.++..++.|++.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 131 lv~e~~~-g~l~~~l~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Df 198 (348)
T 1u5q_A 131 LVMEYCL-GSASDLLEVHK-----------KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF 198 (348)
T ss_dssp EEEECCS-EEHHHHHHHHT-----------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCC
T ss_pred EEEecCC-CCHHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeec
Confidence 9999997 68888886542 35899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccc---cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESIL---YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
|+++..... ....+|+.|+|||++. .+.++.++|||||||++|||++ |..||.+.+..+.+..+..+..+
T Consensus 199 G~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~ 271 (348)
T 1u5q_A 199 GSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNESP 271 (348)
T ss_dssp TTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSCCC
T ss_pred cCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCC
Confidence 999765322 2346789999999985 5678999999999999999999 99999998887777666655444
Q ss_pred C-CCCCCCcchhhhcccccccccchhh-HHHHhhhhhhhhh
Q psy7289 288 P-CPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRD 326 (422)
Q Consensus 288 ~-~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~d 326 (422)
+ .+..+|+.+.+++.+||..+|..|+ +..+.+|.++.+.
T Consensus 272 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 272 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 3 3567899999999999999999987 3345556665543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=352.62 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=195.7
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
.+|++++.||+|+||.||+|+... .+..||+|.++........+.+.+|+.++++++||||+++++++.+++.+++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKT--TGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp --------------CEEEEEECSS--SCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECC--CCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 468899999999999999997643 357899999875544444567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||++ |+|.+++....... ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 83 e~~~-~~L~~~l~~~~~~~------~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 155 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGN------TPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA 155 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSS------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred EecC-CCHHHHHHhccccc------cccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccc
Confidence 9998 69999997643111 1235899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC------
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM------ 286 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~------ 286 (422)
+....... ......+|+.|+|||++.. ..++.++|||||||++|||++ |..||.+.+..+.+..+.....
T Consensus 156 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 156 RAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT-GKPLFPGTNDEEQLKLIFDIMGTPNESL 232 (317)
T ss_dssp EETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHHCSCCTTT
T ss_pred eecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhH
Confidence 86543211 1234467899999999876 468999999999999999999 9999999988877766642100
Q ss_pred ---------------------------CCCCCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 287 ---------------------------LPCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 287 ---------------------------~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
...+..+++++.+|+.+||..||..|+ +..+.+|.++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f 297 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhh
Confidence 001235677899999999999999987 2334444444
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=372.30 Aligned_cols=259 Identities=26% Similarity=0.422 Sum_probs=221.5
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
.+...+|++.+.||+|+||.||+|+... .+..||||++.... .......+.+|+.+|+.++||||+++++++.+..
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 89 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHEL--TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETT--TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 3455789999999999999999998754 35789999986432 1123467899999999999999999999999999
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
.+++||||+++|+|.+++... ..+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL 157 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKN------------GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKI 157 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSS------------SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEEEeCCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEE
Confidence 999999999999999999653 35899999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKF-TTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~ 286 (422)
+|||+++...... ......+|+.|+|||++.+..+ +.++|||||||++|||++ |..||.+.+..++...+..+.
T Consensus 158 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~- 232 (476)
T 2y94_A 158 ADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLC-GTLPFDDDHVPTLFKKICDGI- 232 (476)
T ss_dssp CCCSSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHH-SSCSSCCSSSHHHHHHHHTTC-
T ss_pred Eeccchhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhh-CCCCCCCCCHHHHHHHHhcCC-
Confidence 9999998654432 1234567899999999987765 679999999999999999 999999999899988888764
Q ss_pred CCCCCCCCcchhhhcccccccccchhh-HHHHhhhhhhhhhc
Q psy7289 287 LPCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRDL 327 (422)
Q Consensus 287 ~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~dL 327 (422)
...|..+++++.+|+++||..+|..|+ +..+.+|.++..++
T Consensus 233 ~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 274 (476)
T 2y94_A 233 FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDL 274 (476)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence 456788999999999999999999886 45566777776554
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=362.14 Aligned_cols=260 Identities=17% Similarity=0.293 Sum_probs=207.9
Q ss_pred cccCcccccccccc--cceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC
Q psy7289 52 IETKPRFLQELGEG--AFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP 128 (422)
Q Consensus 52 ~~~~~~~~~~LG~G--~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 128 (422)
...+|++.+.||+| +||.||+|+... .+..||||+++.. ......+.+.+|+.+++.++|||||++++++.+++.
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKP--TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETT--TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcC--CCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 35689999999999 999999998754 3578999998644 344556788899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
+++|||||++|+|.+++.... ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~ 170 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHF----------MDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS 170 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTC----------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEEC
T ss_pred EEEEEEccCCCCHHHHHhhhc----------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEc
Confidence 999999999999999997642 1358999999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcce-----EeccCCCCCccccCcccccc--CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHH
Q psy7289 209 DFGLSRDVYASDYY-----RIQSKSLLPVRWMPPESILY--GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281 (422)
Q Consensus 209 DFGla~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i 281 (422)
|||++......... .......+|+.|+|||++.. ..++.++|||||||++|||++ |..||.+.+..+.+..+
T Consensus 171 dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~ 249 (389)
T 3gni_B 171 GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN-GHVPFKDMPATQMLLEK 249 (389)
T ss_dssp CGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHH-SSCTTTTCCSTTHHHHC
T ss_pred ccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHH
Confidence 99998654322111 11223467888999999987 579999999999999999999 99999887765554433
Q ss_pred HcCCC---------------------------------------------CCCCCCCCcchhhhcccccccccchhh-HH
Q psy7289 282 RSRQM---------------------------------------------LPCPEDCPPRMYSLMMECWHEVPVAAG-MA 315 (422)
Q Consensus 282 ~~~~~---------------------------------------------~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~ 315 (422)
..+.. .+.+..+++.+.+|+.+||..||..|+ +.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ 329 (389)
T 3gni_B 250 LNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAS 329 (389)
T ss_dssp --------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred hcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHH
Confidence 22211 123456788899999999999999986 33
Q ss_pred HHhhhhhhh
Q psy7289 316 YLCSHHYVH 324 (422)
Q Consensus 316 ~lh~~~~i~ 324 (422)
.+.+|.++.
T Consensus 330 ell~hp~f~ 338 (389)
T 3gni_B 330 TLLNHSFFK 338 (389)
T ss_dssp HHTTSGGGG
T ss_pred HHhcCHHHH
Confidence 455555553
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=342.79 Aligned_cols=250 Identities=33% Similarity=0.607 Sum_probs=202.5
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC---HHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN---QKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
+...+|++.+.||+|+||.||+|++. +..||||+++.... ....+.+.+|+.+++.++||||+++++++.+++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI----GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP 79 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET----TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc----CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 44568899999999999999999863 46799999864322 233567899999999999999999999999999
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCceeecC---
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHH---YVHRDLAARNCLVGD--- 201 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~---ivHrDlKp~NiLl~~--- 201 (422)
..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~-------------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~ 146 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLSG-------------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVE 146 (271)
T ss_dssp -CEEEEECCTTEEHHHHHTS-------------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCS
T ss_pred ceEEEEEcCCCCCHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccc
Confidence 99999999999999999853 25899999999999999999999999 899999999999986
Q ss_pred -----CCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHH
Q psy7289 202 -----GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 276 (422)
Q Consensus 202 -----~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~ 276 (422)
++.+||+|||+++...... .....+|+.|+|||.+....++.++||||||+++|||++ |..||.+.+..+
T Consensus 147 ~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~ 221 (271)
T 3dtc_A 147 NGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLT-GEVPFRGIDGLA 221 (271)
T ss_dssp SSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHH-CCCTTTTSCHHH
T ss_pred cccccCcceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Confidence 6789999999997654322 223457889999999998899999999999999999999 999999998888
Q ss_pred HHHHHHcC-CCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 277 VIEMIRSR-QMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 277 ~~~~i~~~-~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
....+... ...+.|..+|+.+.+++.+||+.+|..|+ +...+...|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~e~l~~L 268 (271)
T 3dtc_A 222 VAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRP-----SFTNILDQL 268 (271)
T ss_dssp HHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHH
T ss_pred HHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCc-----CHHHHHHHH
Confidence 77766544 44567889999999999999999999998 555444433
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=356.47 Aligned_cols=262 Identities=23% Similarity=0.363 Sum_probs=207.9
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCC--CceeeEeeEEEcCC
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRH--PNIVCLLGVCLSGE 127 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~H--pnIv~l~g~~~~~~ 127 (422)
+...+|++++.||+|+||.||++.. .++..||||++... ......+.+.+|+.+|++++| |||+++++++.++.
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLN---EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEEC---TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred eecCEEEEEEEEecCCCeEEEEEEe---CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 4456799999999999999999875 23578999998643 345556789999999999986 99999999999999
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
..++||| +.+|+|.+++... ..+++.++..++.||+.||+|||+++|+||||||+|||++ ++.+||
T Consensus 83 ~~~lv~e-~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl 148 (343)
T 3dbq_A 83 YIYMVME-CGNIDLNSWLKKK------------KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKL 148 (343)
T ss_dssp EEEEEEC-CCSEEHHHHHHHS------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEE
T ss_pred EEEEEEe-CCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEE
Confidence 9999999 6788999999764 3588999999999999999999999999999999999997 578999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCcccccc-----------CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChH-
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-----------GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ- 275 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~- 275 (422)
+|||+++...............+|+.|+|||++.. ..++.++|||||||++|||++ |..||.+....
T Consensus 149 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~ 227 (343)
T 3dbq_A 149 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQIINQI 227 (343)
T ss_dssp CCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHH-SSCTTTTCCSHH
T ss_pred eecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHh-CCCcchhhhhHH
Confidence 99999987654333223345568999999999864 678999999999999999998 99999875543
Q ss_pred HHH-HHHHcCCCCCCCCCCCcchhhhcccccccccchhh-HHHHhhhhhhhhhcccc
Q psy7289 276 EVI-EMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRDLAAR 330 (422)
Q Consensus 276 ~~~-~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~dLk~~ 330 (422)
..+ ..+........|..+++++.+|+..||..+|..|+ +..+.+|.++.....+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~ 284 (343)
T 3dbq_A 228 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 284 (343)
T ss_dssp HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC--
T ss_pred HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCcc
Confidence 333 33334445567888889999999999999999986 44566777776555443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=343.37 Aligned_cols=255 Identities=21% Similarity=0.345 Sum_probs=215.2
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
..+|++.+.||+|+||.||+|+... .+..||+|.+..... ...+.+.+|++++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKG--TRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCC--CCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 4578899999999999999998654 356799998865332 2356789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceee---cCCCeEEEec
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISD 209 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl---~~~~~vKl~D 209 (422)
|||+++|+|.+++... ..+++.++..++.|++.||+|||+++|+||||||+|||+ +.++.+||+|
T Consensus 85 ~e~~~~~~L~~~~~~~------------~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~D 152 (277)
T 3f3z_A 85 MELCTGGELFERVVHK------------RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLID 152 (277)
T ss_dssp EECCCSCBHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred EeccCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEe
Confidence 9999999999999764 358999999999999999999999999999999999999 7788999999
Q ss_pred CcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 289 (422)
||+++...... ......+|+.|+|||.+.+ .++.++|||||||++|||++ |..||.+.+..+....+..+.....
T Consensus 153 fg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 227 (277)
T 3f3z_A 153 FGLAARFKPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLC-GYPPFSAPTDSEVMLKIREGTFTFP 227 (277)
T ss_dssp CTTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred cccceeccCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHH-CCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 99997654332 1234457889999998764 48999999999999999999 9999999999999888887754432
Q ss_pred C---CCCCcchhhhcccccccccchhh-HHHHhhhhhhhhhc
Q psy7289 290 P---EDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRDL 327 (422)
Q Consensus 290 p---~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~dL 327 (422)
+ ..+|+.+.+++.+||+.+|..|+ +..+.+|.++...+
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 228 EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 2 26899999999999999999986 34455666665543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=350.56 Aligned_cols=256 Identities=27% Similarity=0.404 Sum_probs=204.5
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP 128 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 128 (422)
+....+|++++.||+|+||.||+|+.. ++..||+|+++... .......+.+|++++++++||||+++++++.++..
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 93 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS---QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC 93 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET---TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC---CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence 345678999999999999999999863 35789999986443 22345678999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
+++||||++ |+|.+++.... ..+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+
T Consensus 94 ~~lv~e~~~-~~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~ 161 (311)
T 3niz_A 94 LTLVFEFME-KDLKKVLDENK-----------TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLA 161 (311)
T ss_dssp EEEEEECCS-EEHHHHHHTCT-----------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEcCCC-CCHHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEc
Confidence 999999998 48888886542 358999999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
|||+++....... ......+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+.+..+......
T Consensus 162 Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~ 238 (311)
T 3niz_A 162 DFGLARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT-GKPLFPGVTDDDQLPKIFSILGT 238 (311)
T ss_dssp CCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSTTTHHHHHHHHHCC
T ss_pred cCcCceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHCC
Confidence 9999986543221 2233467899999999876 568999999999999999999 99999988877666555431111
Q ss_pred CC-----------------------------CCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 288 PC-----------------------------PEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 288 ~~-----------------------------p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
+. ++.+++++.+|+.+||..||..|+ +..+.+|.++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 304 (311)
T 3niz_A 239 PNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304 (311)
T ss_dssp CCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred CChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence 11 234567888999999999999987 3334444443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=357.85 Aligned_cols=259 Identities=24% Similarity=0.398 Sum_probs=203.8
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
.....+|++++.||+|+||.||+++... .++.||||++..... ..+.+.+|+.+++.++|||||++++++.++..+
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKL--TKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 91 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETT--TCCEEEEEEEESSTT--SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECC--CCcEEEEEEEecCcc--ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence 3446789999999999999999998654 357899999865332 235688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCe--EEE
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLT--VKI 207 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~--vKl 207 (422)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++. +||
T Consensus 92 ~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl 159 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNA------------GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKI 159 (361)
T ss_dssp EEEEECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEE
T ss_pred EEEEEeCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEE
Confidence 9999999999999999764 35899999999999999999999999999999999999987665 999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCc-hhHHhHHHHHHHHHhCCCCCCCCCCh----HHHHHHHH
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTE-SDVWSYGVVLWEVYSYGLQPYYGYSN----QEVIEMIR 282 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwS~Gvil~El~t~g~~Pf~~~~~----~~~~~~i~ 282 (422)
+|||+++...... ......+|+.|+|||++....++.+ +|||||||++|||++ |..||.+.+. .+.+..+.
T Consensus 160 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~ 235 (361)
T 3uc3_A 160 CDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPRDYRKTIQRIL 235 (361)
T ss_dssp CCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHH-SSCSCC----CCCHHHHHHHHH
T ss_pred eecCccccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHh-CCCCCCCCccHHHHHHHHHHHh
Confidence 9999997533221 2234467899999999988887766 899999999999999 9999987543 34555554
Q ss_pred cCC-CCCCCCCCCcchhhhcccccccccchhh-HHHHhhhhhhhhhcc
Q psy7289 283 SRQ-MLPCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRDLA 328 (422)
Q Consensus 283 ~~~-~~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~dLk 328 (422)
... ..|.+..+++.+.+|+.+||..+|..|+ +..+.+|.++.+.+.
T Consensus 236 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 283 (361)
T 3uc3_A 236 SVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLP 283 (361)
T ss_dssp TTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred cCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence 433 3334446899999999999999999986 445677777765543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=356.35 Aligned_cols=246 Identities=22% Similarity=0.352 Sum_probs=198.3
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC-----
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP----- 128 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~----- 128 (422)
.+|++.+.||+|+||.||+|+...+ +..||||+++........+.+.+|+.+|++++|||||++++++.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~--~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVD--DCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTT--CCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCC--CcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 4688899999999999999987543 578999998755555566789999999999999999999999866543
Q ss_pred ----------------------------------------------------eEEEEEecCCCCHHHHHhhcCCCCCCCC
Q psy7289 129 ----------------------------------------------------MCMLFEFMVRGDLHEFLMSRSPRSDISG 156 (422)
Q Consensus 129 ----------------------------------------------------~~lv~E~~~~G~L~~~l~~~~~~~~~~~ 156 (422)
+++|||||++|+|.+++..+..
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------ 157 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS------ 157 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS------
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC------
Confidence 7999999999999999986532
Q ss_pred CCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccccCCcc----------eEecc
Q psy7289 157 SQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDY----------YRIQS 226 (422)
Q Consensus 157 ~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~~~~----------~~~~~ 226 (422)
....++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 158 ---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T 3qd2_B 158 ---LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234 (332)
T ss_dssp ---GGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCC
T ss_pred ---ccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccc
Confidence 12356677899999999999999999999999999999999999999999999987654321 11223
Q ss_pred CCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcchhhhcccccc
Q psy7289 227 KSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWH 306 (422)
Q Consensus 227 ~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~ 306 (422)
...+|+.|+|||++....++.++|||||||++|||++ |..|+. ...+....+.....+..+..+++.+.+++.+||.
T Consensus 235 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 311 (332)
T 3qd2_B 235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY-SFSTQM--ERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLS 311 (332)
T ss_dssp SCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHS-CCCCHH--HHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHC
T ss_pred ccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHH-cCCChh--HHHHHHHHhhccCCCcccccCChhHHHHHHHHcc
Confidence 4567899999999999999999999999999999998 655542 2234445555554444445667888999999999
Q ss_pred cccchhh
Q psy7289 307 EVPVAAG 313 (422)
Q Consensus 307 ~~P~~r~ 313 (422)
.+|..|+
T Consensus 312 ~~p~~Rp 318 (332)
T 3qd2_B 312 PSPTERP 318 (332)
T ss_dssp SSGGGSC
T ss_pred CCCCcCC
Confidence 9999997
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=374.89 Aligned_cols=260 Identities=20% Similarity=0.294 Sum_probs=217.4
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC--HHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN--QKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP 128 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 128 (422)
+...+|++.+.||+|+||.||+|+... .++.||+|++..... ....+.+.+|+++|++++||||+++++++.+...
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~--tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKA--TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD 259 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECC--CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence 345678899999999999999998754 357899999864321 1234678899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
+|+||||+++|+|.+++...... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~--------~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~ 331 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDED--------NPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRIS 331 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTT--------SCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEEC
T ss_pred EEEEEEeccCCCHHHHHHHhhcc--------cccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEe
Confidence 99999999999999999764211 1358999999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCC----ChHHHHHHHHcC
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY----SNQEVIEMIRSR 284 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~----~~~~~~~~i~~~ 284 (422)
|||+++....... ......+|+.|||||++.+..++.++|||||||++|||++ |..||.+. +..++...+...
T Consensus 332 DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyellt-G~~PF~~~~~~~~~~~~~~~i~~~ 408 (543)
T 3c4z_A 332 DLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA-ARGPFRARGEKVENKELKQRVLEQ 408 (543)
T ss_dssp CCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCTTCCCCHHHHHHHHHHC
T ss_pred ecceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHh-CCCCCCCCccchhHHHHHHHHhhc
Confidence 9999987543321 1233468999999999999999999999999999999999 99999875 345677776654
Q ss_pred CCCCCCCCCCcchhhhcccccccccchhh------HHHHhhhhhhh
Q psy7289 285 QMLPCPEDCPPRMYSLMMECWHEVPVAAG------MAYLCSHHYVH 324 (422)
Q Consensus 285 ~~~~~p~~~p~~~~~l~~~cw~~~P~~r~------~~~lh~~~~i~ 324 (422)
. ...|..+|+.+.+|+.+||..+|..|+ ...+.+|.++.
T Consensus 409 ~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~ 453 (543)
T 3c4z_A 409 A-VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453 (543)
T ss_dssp C-CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGT
T ss_pred c-cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCcccc
Confidence 3 456788999999999999999999986 34556666654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=345.86 Aligned_cols=254 Identities=25% Similarity=0.392 Sum_probs=204.1
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
.+|++++.||+|+||.||+|+... .++.||||+++... .......+.+|+.++++++||||+++++++.++..+++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRE--THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT--TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECC--CCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 468999999999999999998754 35789999986433 334457889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++ +|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 80 ~e~~~~-~l~~~~~~~~-----------~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~ 147 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCN-----------GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp EECCSE-EHHHHHHHTT-----------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EecCCC-CHHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 999985 6666665432 3589999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC----
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML---- 287 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~---- 287 (422)
++...... .......+|+.|+|||++.+.. ++.++|||||||++|||++.+.++|.+.+..+.+..+......
T Consensus 148 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~ 225 (292)
T 3o0g_A 148 ARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225 (292)
T ss_dssp CEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ceecCCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 98654322 1223456789999999987765 8999999999999999998555557777777766665431100
Q ss_pred ------------------------CCCCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 288 ------------------------PCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 288 ------------------------~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
..+..+++++.+|+.+||..||..|+ +..+.+|.++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 286 (292)
T 3o0g_A 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286 (292)
T ss_dssp TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred hhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccc
Confidence 11234677889999999999999986 3345555554
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=346.84 Aligned_cols=251 Identities=37% Similarity=0.710 Sum_probs=210.1
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC-CC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG-EP 128 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~ 128 (422)
.+...+|++.+.||+|+||.||+|++. +..||||.++... ..+.+.+|+.++++++||||+++++++.+. +.
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDYR----GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET----TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred cCChhhceEEeEEecCCCceEEEEEEc----CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence 455678999999999999999999762 5689999986543 346789999999999999999999997654 47
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
.++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~ 159 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRG----------RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVS 159 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHH----------HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred eEEEEecCCCCCHHHHHHhcc----------cccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEe
Confidence 899999999999999997642 1237889999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP 288 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 288 (422)
|||+++..... .....+++.|+|||.+....++.++||||||+++|||++.|..||.+.+..++...+..+...+
T Consensus 160 Dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~ 234 (278)
T 1byg_A 160 DFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD 234 (278)
T ss_dssp CCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCC
T ss_pred ecccccccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 99998754322 1223457789999999988999999999999999999987999999999999999898888888
Q ss_pred CCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 289 CPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 289 ~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
.|..+|+.+.+++.+||+.+|..|+ +...+...|
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~~L 268 (278)
T 1byg_A 235 APDGCPPAVYEVMKNCWHLDAAMRP-----SFLQLREQL 268 (278)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHH
T ss_pred CcccCCHHHHHHHHHHhcCChhhCC-----CHHHHHHHH
Confidence 8899999999999999999999998 555444433
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=376.98 Aligned_cols=258 Identities=23% Similarity=0.350 Sum_probs=217.8
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP 128 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 128 (422)
+...+|++.+.||+|+||.||+|+... .+..||||++.... .......+.+|+++|+.++|||||++++++.+.+.
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~--tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 258 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRA--TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA 258 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECC--CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE
Confidence 455678999999999999999998754 35789999985421 12234578899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
+|+||||+++|+|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~----------~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~ 328 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMG----------QAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRIS 328 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSS----------SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEE
Confidence 999999999999999997542 1248999999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCC----hHHHHHHHHcC
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS----NQEVIEMIRSR 284 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~----~~~~~~~i~~~ 284 (422)
|||+++........ ....+|+.|||||++....++.++|||||||++|||++ |..||.+.+ ..++...+...
T Consensus 329 DFGla~~~~~~~~~---~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLlt-G~~PF~~~~~~~~~~~i~~~i~~~ 404 (576)
T 2acx_A 329 DLGLAVHVPEGQTI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA-GQSPFQQRKKKIKREEVERLVKEV 404 (576)
T ss_dssp CCTTCEECCTTCCE---ECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHH-SSCSSSCSSSCCCHHHHHHHHHHC
T ss_pred ecccceecccCccc---cccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHh-CCCCCcccccchhHHHHHHHhhcc
Confidence 99999876543321 23468999999999998899999999999999999999 999998764 34566666544
Q ss_pred CCCCCCCCCCcchhhhcccccccccchhh------HHHHhhhhhhhh
Q psy7289 285 QMLPCPEDCPPRMYSLMMECWHEVPVAAG------MAYLCSHHYVHR 325 (422)
Q Consensus 285 ~~~~~p~~~p~~~~~l~~~cw~~~P~~r~------~~~lh~~~~i~~ 325 (422)
....|..+++++.+|+.+||..+|..|. +..+.+|.++..
T Consensus 405 -~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 405 -PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred -cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 3456788999999999999999999995 567777777653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=343.68 Aligned_cols=252 Identities=33% Similarity=0.583 Sum_probs=206.4
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHH---h---HHHHHHHHHHHhcCCCCceeeEeeEE
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQK---T---ASDFRREVDLMSELRHPNIVCLLGVC 123 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~---~---~~~~~~E~~il~~l~HpnIv~l~g~~ 123 (422)
.+...+|++.+.||+|+||.||+|++.. ++..||||++....... . .+.+.+|+.++++++||||+++++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVK--DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETT--TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhhccceehhccccCCceeEEEEEEcC--CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence 3456789999999999999999998754 35779999986433211 1 16789999999999999999999998
Q ss_pred EcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceeecC
Q psy7289 124 LSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHH--YVHRDLAARNCLVGD 201 (422)
Q Consensus 124 ~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--ivHrDlKp~NiLl~~ 201 (422)
.+.. ++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.
T Consensus 93 ~~~~--~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~ 159 (287)
T 4f0f_A 93 HNPP--RMVMEFVPCGDLYHRLLDKA-----------HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQS 159 (287)
T ss_dssp TTTT--EEEEECCTTCBHHHHHHCTT-----------SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESC
T ss_pred cCCC--eEEEEecCCCCHHHHHhccc-----------CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEec
Confidence 6554 79999999999999986542 35899999999999999999999999 999999999999987
Q ss_pred CCe-----EEEecCcccccccCCcceEeccCCCCCccccCccccc--cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh
Q psy7289 202 GLT-----VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL--YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN 274 (422)
Q Consensus 202 ~~~-----vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~ 274 (422)
++. +||+|||+++..... .....+|+.|+|||++. ...++.++|||||||++|||++ |..||.+.+.
T Consensus 160 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 233 (287)
T 4f0f_A 160 LDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT-GEGPFDEYSY 233 (287)
T ss_dssp CCTTCSCCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHH-SSCTTTTCCC
T ss_pred cCCCCceeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHc-CCCCCccccc
Confidence 765 999999999854332 23356788999999984 4557899999999999999999 9999987765
Q ss_pred HHH--HHHH-HcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 275 QEV--IEMI-RSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 275 ~~~--~~~i-~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
.+. ...+ ..+..++.|..+|+++.+++.+||..+|..|+ +...+...|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~L 284 (287)
T 4f0f_A 234 GKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRP-----HFSYIVKEL 284 (287)
T ss_dssp CHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHH
T ss_pred cHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCc-----CHHHHHHHH
Confidence 443 3333 34555667889999999999999999999998 555554443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=385.70 Aligned_cols=257 Identities=21% Similarity=0.348 Sum_probs=219.4
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSG 126 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~ 126 (422)
.+...+|++++.||+|+||.||+|+...+ ++.||||+++... .....+.+.+|..++..+ +||||+++++++.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~--~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~ 414 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGT--DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 414 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSS--CCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCC--CcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence 34456799999999999999999987543 5779999986421 122346788999999988 699999999999999
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEE
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vK 206 (422)
+.+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++||||||||+||||+.++.+|
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ik 482 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQV------------GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIK 482 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEE
T ss_pred CEEEEEEeCcCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEE
Confidence 9999999999999999999864 3589999999999999999999999999999999999999999999
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~ 286 (422)
|+|||+++....... ......+|+.|||||++....|+.++|||||||++|||++ |..||.+.+..++...|..+.
T Consensus 483 L~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~- 558 (674)
T 3pfq_A 483 IADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQAPFEGEDEDELFQSIMEHN- 558 (674)
T ss_dssp ECCCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHSSC-
T ss_pred EeecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHc-CCCCCCCCCHHHHHHHHHhCC-
Confidence 999999986432221 2344568999999999999999999999999999999999 999999999999999998765
Q ss_pred CCCCCCCCcchhhhcccccccccchhh------HHHHhhhhhhh
Q psy7289 287 LPCPEDCPPRMYSLMMECWHEVPVAAG------MAYLCSHHYVH 324 (422)
Q Consensus 287 ~~~p~~~p~~~~~l~~~cw~~~P~~r~------~~~lh~~~~i~ 324 (422)
...|..+++++.+|++.||..+|..|. ...+.+|.++.
T Consensus 559 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~ 602 (674)
T 3pfq_A 559 VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 602 (674)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGS
T ss_pred CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCcccc
Confidence 567889999999999999999999885 24555666553
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=350.02 Aligned_cols=255 Identities=22% Similarity=0.342 Sum_probs=214.7
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCH-----HhHHHHHHHHHHHhcCCCCceeeEeeEEEc
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQ-----KTASDFRREVDLMSELRHPNIVCLLGVCLS 125 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 125 (422)
.....|++.+.||+|+||.||+|+... ++..||||.++..... ...+.+.+|+.++++++||||+++++++.+
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKS--TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN 86 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECC--CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 345678999999999999999998754 3577999998643221 135679999999999999999999999999
Q ss_pred CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC--
Q psy7289 126 GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL-- 203 (422)
Q Consensus 126 ~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~-- 203 (422)
....++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~ 154 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQK------------ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIP 154 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTC------------SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSS
T ss_pred CCEEEEEEEcCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCC
Confidence 99999999999999999999753 3588999999999999999999999999999999999999887
Q ss_pred --eEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHH
Q psy7289 204 --TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281 (422)
Q Consensus 204 --~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i 281 (422)
.+||+|||+++....... .....+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..+....+
T Consensus 155 ~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i 230 (321)
T 2a2a_A 155 IPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDTKQETLANI 230 (321)
T ss_dssp SCCEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHH
T ss_pred cCCEEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHH-CCCCCCCCCHHHHHHHH
Confidence 799999999986544321 233457899999999998899999999999999999999 99999999999988888
Q ss_pred HcCCCCCC---CCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 282 RSRQMLPC---PEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 282 ~~~~~~~~---p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
........ +..+|+.+.+++.+||..+|..|+ +..+.+|.++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~ 276 (321)
T 2a2a_A 231 TSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276 (321)
T ss_dssp HTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTT
T ss_pred HhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 76543322 257889999999999999999986 2334444443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=342.48 Aligned_cols=254 Identities=24% Similarity=0.394 Sum_probs=214.0
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
.-.+|++.+.||+|+||.||+|+... .+..||||++.... .......+.+|+.+++.++||||+++++++.+....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEcc--CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 34678999999999999999998653 45679999885422 112346788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEec
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISD 209 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~D 209 (422)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|
T Consensus 85 ~lv~e~~~~~~l~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~D 152 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKL------------SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIAD 152 (279)
T ss_dssp EEEECCCTTEEHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECS
T ss_pred EEEEecCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEe
Confidence 9999999999999999764 3589999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 289 (422)
||++....... .....+|+.|+|||.+....++.++||||||+++|||++ |..||.+.+..+....+.... .+.
T Consensus 153 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~ 226 (279)
T 3fdn_A 153 FGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV-GKPPFEANTYQETYKRISRVE-FTF 226 (279)
T ss_dssp CCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHTC-CCC
T ss_pred ccccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHH-CCCCCCCCcHHHHHHHHHhCC-CCC
Confidence 99986543221 233457889999999998899999999999999999999 999999999888888877654 456
Q ss_pred CCCCCcchhhhcccccccccchhh-HHHHhhhhhhhh
Q psy7289 290 PEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHR 325 (422)
Q Consensus 290 p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~ 325 (422)
|..+++.+.+|+.+||+.+|..|+ +..+.+|.++..
T Consensus 227 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~ 263 (279)
T 3fdn_A 227 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263 (279)
T ss_dssp CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred CCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccC
Confidence 788999999999999999999987 344555665543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=351.66 Aligned_cols=260 Identities=32% Similarity=0.558 Sum_probs=218.4
Q ss_pred ccccCcccccccccccceeEEEEEEe--cCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEE--cC
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVC--TSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCL--SG 126 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~ 126 (422)
+...+|++.+.||+|+||.||+|++. ....+..||||++... .....+.+.+|++++++++||||+++++++. +.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 34568999999999999999999864 2345688999998754 3455678999999999999999999999987 44
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEE
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vK 206 (422)
..+++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+|
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~k 167 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHR-----------ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVK 167 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHG-----------GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred ceEEEEEeecCCCCHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEE
Confidence 56899999999999999997642 3589999999999999999999999999999999999999999999
Q ss_pred EecCcccccccCCcce-EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh-----------
Q psy7289 207 ISDFGLSRDVYASDYY-RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN----------- 274 (422)
Q Consensus 207 l~DFGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~----------- 274 (422)
|+|||+++........ .......+|+.|+|||++....++.++|||||||++|||++ |..||.....
T Consensus 168 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 246 (327)
T 3lxl_A 168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT-YCDKSCSPSAEFLRMMGCERD 246 (327)
T ss_dssp ECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHT-TTCGGGSHHHHHHHHCC----
T ss_pred EcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHh-CCCCCccccchhhhhcccccc
Confidence 9999999876543322 23334556788999999998889999999999999999998 8888865432
Q ss_pred ----HHHHHHHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 275 ----QEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 275 ----~~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
.++...+..+...+.|..+|+.+.+++.+||..+|..|+ +...+...|+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~L~ 299 (327)
T 3lxl_A 247 VPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRP-----SFSALGPQLD 299 (327)
T ss_dssp CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHH
T ss_pred cccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCc-----CHHHHHHHHH
Confidence 345566677778888999999999999999999999998 6666655544
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=360.31 Aligned_cols=255 Identities=28% Similarity=0.403 Sum_probs=198.0
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCC-CCceeeEeeEEEcCC--
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELR-HPNIVCLLGVCLSGE-- 127 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~-- 127 (422)
...+|++++.||+|+||.||+|+...+ +..||||++... ......+.+.+|+.+++.+. ||||+++++++...+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~--~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRT--GEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTT--CCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCC--CCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 346799999999999999999986543 578999988643 34455678889999999997 999999999997554
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
.+|+|||||+ |+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~~-------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl 150 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRAN-------------ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKV 150 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHHT-------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEE
T ss_pred EEEEEecccC-cCHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEe
Confidence 6899999998 6999999753 4889999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCc-------------------ceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCC
Q psy7289 208 SDFGLSRDVYASD-------------------YYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQ 267 (422)
Q Consensus 208 ~DFGla~~~~~~~-------------------~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~ 267 (422)
+|||+|+...... .........+|+.|+|||++.+ ..++.++|||||||++|||++ |.+
T Consensus 151 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~ 229 (388)
T 3oz6_A 151 ADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC-GKP 229 (388)
T ss_dssp CCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-SSC
T ss_pred cCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHh-CCC
Confidence 9999998653210 0112233567899999999876 679999999999999999999 999
Q ss_pred CCCCCChHHHHHHHHcCCCCC----------------------------------------------CCCCCCcchhhhc
Q psy7289 268 PYYGYSNQEVIEMIRSRQMLP----------------------------------------------CPEDCPPRMYSLM 301 (422)
Q Consensus 268 Pf~~~~~~~~~~~i~~~~~~~----------------------------------------------~p~~~p~~~~~l~ 301 (422)
||.+.+..+.+..|......| .+..+++++.+|+
T Consensus 230 pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll 309 (388)
T 3oz6_A 230 IFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLL 309 (388)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHH
Confidence 999998887776664211111 1237788999999
Q ss_pred ccccccccchhh-HHHHhhhhhh
Q psy7289 302 MECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 302 ~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
.+||..||..|+ +..+.+|.++
T Consensus 310 ~~~L~~dP~~R~t~~e~l~Hp~~ 332 (388)
T 3oz6_A 310 DKLLQFNPNKRISANDALKHPFV 332 (388)
T ss_dssp HHHCCSSGGGSCCHHHHTTSTTT
T ss_pred HHhhccCcccCCCHHHHhCCHHH
Confidence 999999999986 3334445543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=354.94 Aligned_cols=253 Identities=23% Similarity=0.341 Sum_probs=196.2
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
+....+|++.+.||+|+||.||+|+... .+..||||+++... ..+.+.+|+.++++++||||+++++++.++...
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 123 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKG--TQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI 123 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECC--CCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeE
Confidence 4456679999999999999999998754 35679999987543 335688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC---CCeEE
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD---GLTVK 206 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~---~~~vK 206 (422)
++||||+++|+|.+++... ..+++.++..++.||+.||+|||+++|+||||||+|||++. ++.+|
T Consensus 124 ~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~k 191 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEK------------GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLK 191 (349)
T ss_dssp EEEECCCCSCBHHHHHTTC------------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEE
T ss_pred EEEEEeCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEE
Confidence 9999999999999999653 35899999999999999999999999999999999999975 78999
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHH-HHHHHHcCC
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE-VIEMIRSRQ 285 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~-~~~~i~~~~ 285 (422)
|+|||+++...... ......+|+.|+|||++....++.++|||||||++|||++ |..||.+....+ +...+....
T Consensus 192 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~i~~~~ 267 (349)
T 2w4o_A 192 IADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLC-GFEPFYDERGDQFMFRRILNCE 267 (349)
T ss_dssp ECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCTTCCTTCHHHHHHHHHTTC
T ss_pred EccCccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHh-CCCCCCCCcccHHHHHHHHhCC
Confidence 99999998654322 1234457899999999998899999999999999999999 999998776654 666666554
Q ss_pred CCC---CCCCCCcchhhhcccccccccchhhH-HHHhhhhhh
Q psy7289 286 MLP---CPEDCPPRMYSLMMECWHEVPVAAGM-AYLCSHHYV 323 (422)
Q Consensus 286 ~~~---~p~~~p~~~~~l~~~cw~~~P~~r~~-~~lh~~~~i 323 (422)
... ....+|+++.+|+.+||..+|..|+- ..+.+|.++
T Consensus 268 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 309 (349)
T 2w4o_A 268 YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV 309 (349)
T ss_dssp CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred CccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 322 23578899999999999999999872 233444443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=341.13 Aligned_cols=256 Identities=21% Similarity=0.320 Sum_probs=217.3
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc--CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP 128 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 128 (422)
....+|++.+.||+|+||.||+|+... .+..||+|.+... ......+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 89 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDAD--TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF 89 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECC--CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCE
Confidence 345678999999999999999998643 3577999988643 234556789999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
.++||||+++++|.+++... ..+++.++..++.|++.||+|||+++|+||||||+|||++.++.+||+
T Consensus 90 ~~lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~ 157 (294)
T 2rku_A 90 VFVVLELCRRRSLLELHKRR------------KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIG 157 (294)
T ss_dssp EEEEEECCTTCBHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEecCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEE
Confidence 99999999999999998764 358999999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP 288 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 288 (422)
|||+++....... ......+|+.|+|||.+....++.++||||||+++|||++ |..||.+.+..+....+.... .+
T Consensus 158 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~ 233 (294)
T 2rku_A 158 DFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV-GKPPFETSCLKETYLRIKKNE-YS 233 (294)
T ss_dssp CCTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHTTC-CC
T ss_pred eccCceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcc-CC
Confidence 9999986543221 1223457889999999998889999999999999999999 999999998888887776654 45
Q ss_pred CCCCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 289 CPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 289 ~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
.|..+++.+.+++.+||+.+|..|+ +..+.++.++.
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~ 270 (294)
T 2rku_A 234 IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFT 270 (294)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred CccccCHHHHHHHHHHcccChhhCcCHHHHhhChhee
Confidence 6788999999999999999999987 22344444443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=356.06 Aligned_cols=248 Identities=23% Similarity=0.352 Sum_probs=204.4
Q ss_pred ccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEecCC
Q psy7289 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVR 138 (422)
Q Consensus 59 ~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~~~ 138 (422)
.+.||+|+||.||+|+... .+..||+|+++... ....+.+.+|+.+|++++|||||++++++.+.+.+++||||+++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~--~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETA--TGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEECC-----CEEEEEETT--TCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred ceEEecCcCEEEEEEEEcC--CCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 5679999999999998654 35789999987533 34567899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceee--cCCCeEEEecCcccccc
Q psy7289 139 GDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV--GDGLTVKISDFGLSRDV 216 (422)
Q Consensus 139 G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl--~~~~~vKl~DFGla~~~ 216 (422)
|+|.+++.... ..+++.++..++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 171 ~~L~~~l~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 171 GELFDRIIDES-----------YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp CEEHHHHHHTG-----------GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred CcHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 99999987532 358999999999999999999999999999999999999 56789999999999865
Q ss_pred cCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC---CCCC
Q psy7289 217 YASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC---PEDC 293 (422)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~ 293 (422)
..... .....+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..+.+..+........ +..+
T Consensus 240 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 315 (373)
T 2x4f_A 240 KPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLS-GLSPFLGDNDAETLNNILACRWDLEDEEFQDI 315 (373)
T ss_dssp CTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTS
T ss_pred CCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCChhhhccC
Confidence 43321 233457899999999998899999999999999999999 9999999999888888876543222 2468
Q ss_pred Ccchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 294 PPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 294 p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
++++.+|+.+||..+|..|+ +..+.+|.++.
T Consensus 316 ~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~ 347 (373)
T 2x4f_A 316 SEEAKEFISKLLIKEKSWRISASEALKHPWLS 347 (373)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhcCcCcC
Confidence 89999999999999999886 33455555543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=359.91 Aligned_cols=257 Identities=22% Similarity=0.354 Sum_probs=206.3
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCC--CCceeeEeeEEEcCCC
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELR--HPNIVCLLGVCLSGEP 128 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~--HpnIv~l~g~~~~~~~ 128 (422)
....|++.+.||+|+||.||+|... .+..||||++... ......+.+.+|+.+|++++ |||||++++++...+.
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~ 130 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNE---KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 130 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT---TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcC---CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence 3456999999999999999999753 2578999998643 34556678999999999996 5999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
+|+||| +.+|+|.+++... ..+++.++..++.||+.||+|||+++|+||||||+|||++ ++.+||+
T Consensus 131 ~~lv~E-~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~ 196 (390)
T 2zmd_A 131 IYMVME-CGNIDLNSWLKKK------------KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLI 196 (390)
T ss_dssp EEEEEE-CCSEEHHHHHHHC------------SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEEC
T ss_pred EEEEEe-cCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEE
Confidence 999999 6789999999764 2578889999999999999999999999999999999996 5789999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCcccccc-----------CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChH-H
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-----------GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ-E 276 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~-~ 276 (422)
|||+++...............+|+.|||||++.. ..++.++|||||||++|||++ |..||.+.... .
T Consensus 197 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~ 275 (390)
T 2zmd_A 197 DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQIINQIS 275 (390)
T ss_dssp CCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHH-SSCTTTTCCCHHH
T ss_pred ecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHH-CCCcchhhhHHHH
Confidence 9999987654332223345568999999999865 368899999999999999998 99999876543 4
Q ss_pred HHHHHHc-CCCCCCCCCCCcchhhhcccccccccchhh-HHHHhhhhhhhhh
Q psy7289 277 VIEMIRS-RQMLPCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRD 326 (422)
Q Consensus 277 ~~~~i~~-~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~d 326 (422)
.+..+.. ....+.|..+++++.+|+.+||..+|..|+ +..+.+|.++...
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 276 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred HHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 4444443 344566778889999999999999999986 3445566666543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=339.98 Aligned_cols=254 Identities=24% Similarity=0.357 Sum_probs=215.0
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
...+|++.+.||+|+||.||+|+... .+..||+|++... ......+.+.+|+.++++++||||+++++++.+++..+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKT--TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcC--CCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence 35678999999999999999998654 3567999998643 34555678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCe---EEE
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLT---VKI 207 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~---vKl 207 (422)
+||||+++|+|.+++..+ ..+++..+..++.|++.||+|||+++|+||||||+||+++.++. +||
T Consensus 82 ~v~e~~~~~~l~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl 149 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAR------------EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKL 149 (284)
T ss_dssp EEECCCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEE
T ss_pred EEEecCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEE
Confidence 999999999999998765 35899999999999999999999999999999999999976554 999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+|||++........ .....+|+.|+|||++....++.++||||||+++|||++ |..||.+.+..+....+..+...
T Consensus 150 ~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 225 (284)
T 3kk8_A 150 ADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYD 225 (284)
T ss_dssp CCCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHTCCC
T ss_pred eeceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHH-CCCCCCCCchhHHHHHHHhcccc
Confidence 99999976543321 233567899999999999899999999999999999999 99999999999988888766532
Q ss_pred -C--CCCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 288 -P--CPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 288 -~--~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
+ ....+|+++.+++.+||..+|..|+ +..+.+|.++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (284)
T 3kk8_A 226 YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265 (284)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHH
T ss_pred CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccc
Confidence 2 2247899999999999999999997 2334444444
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=344.77 Aligned_cols=252 Identities=38% Similarity=0.671 Sum_probs=205.4
Q ss_pred hccccCcccccccccccceeEEEEEEecCC-CCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSE-GPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSG 126 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~ 126 (422)
.+...+|++.+.||+|+||.||+|++.... ....||||+++... .....+.+.+|++++++++||||+++++++.++
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 345678999999999999999999875433 33469999886432 234567899999999999999999999999875
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEE
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vK 206 (422)
. .++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+|
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~k 161 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQ-----------GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVK 161 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHG-----------GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEE
T ss_pred C-ceeeEecccCCCHHHHHHhcc-----------CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEE
Confidence 4 899999999999999997642 3589999999999999999999999999999999999999999999
Q ss_pred EecCcccccccCCcce-EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC-
Q psy7289 207 ISDFGLSRDVYASDYY-RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR- 284 (422)
Q Consensus 207 l~DFGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~- 284 (422)
|+|||+++........ .......+|+.|+|||++....++.++||||||+++|||++.|..||.+.+..++...+...
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~ 241 (291)
T 1u46_A 162 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG 241 (291)
T ss_dssp ECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC
T ss_pred EccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccC
Confidence 9999999876543322 22233456778999999988889999999999999999998799999999998888887653
Q ss_pred CCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 285 QMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 285 ~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
...+.|..+|+++.+++.+||..+|..|+
T Consensus 242 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 270 (291)
T 1u46_A 242 ERLPRPEDCPQDIYNVMVQCWAHKPEDRP 270 (291)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred CCCCCCcCcCHHHHHHHHHHccCCcccCc
Confidence 45567789999999999999999999998
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=348.95 Aligned_cols=258 Identities=21% Similarity=0.317 Sum_probs=218.8
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc--CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP 128 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 128 (422)
....+|++.+.||+|+||.||+++... .+..||+|++... ......+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 115 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDAD--TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF 115 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECC--CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe
Confidence 345678999999999999999998643 3578999998643 234556789999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
.++||||+++++|.+++..+ ..+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+
T Consensus 116 ~~lv~e~~~~~~L~~~~~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~ 183 (335)
T 2owb_A 116 VFVVLELCRRRSLLELHKRR------------KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIG 183 (335)
T ss_dssp EEEEECCCTTCBHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEEC
T ss_pred EEEEEecCCCCCHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEe
Confidence 99999999999999998764 358999999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP 288 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 288 (422)
|||+++....... ......+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..+....+.... ..
T Consensus 184 Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~-~~ 259 (335)
T 2owb_A 184 DFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV-GKPPFETSCLKETYLRIKKNE-YS 259 (335)
T ss_dssp CCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHTC-CC
T ss_pred eccCceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHH-CcCCCCCCCHHHHHHHHhcCC-CC
Confidence 9999986543221 1233457889999999998889999999999999999999 999999988888887776654 45
Q ss_pred CCCCCCcchhhhcccccccccchhh-HHHHhhhhhhhhh
Q psy7289 289 CPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRD 326 (422)
Q Consensus 289 ~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~d 326 (422)
.|..+++.+.+++.+||+.+|..|+ +..+.++.++...
T Consensus 260 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 260 IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 6788999999999999999999987 3334455555443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=343.97 Aligned_cols=252 Identities=25% Similarity=0.376 Sum_probs=200.8
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC-HHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN-QKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
.+|++++.||+|+||.||+|+. ..+..||+|++..... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN---NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE---TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc---CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 4688999999999999999986 2356799999864332 22346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++ +|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 79 ~e~~~~-~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 146 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCE-----------GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGL 146 (288)
T ss_dssp EECCSE-EHHHHHHTST-----------TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred EEecCC-CHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECcc
Confidence 999985 9999986532 3588999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC--CC---
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR--QM--- 286 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~--~~--- 286 (422)
++...... .......+|+.|+|||++.. ..++.++|||||||++|||++ |..||.+.+..+.+..+... ..
T Consensus 147 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 223 (288)
T 1ob3_A 147 ARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN-GTPLFPGVSEADQLMRIFRILGTPNSK 223 (288)
T ss_dssp HHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHHCCCChh
Confidence 97653221 11233456889999999875 458999999999999999999 99999998887766655321 00
Q ss_pred ------------------C-----CCCCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 287 ------------------L-----PCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 287 ------------------~-----~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
. ..+..+++++.+|+.+||..||..|+ +..+.+|.++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 284 (288)
T 1ob3_A 224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284 (288)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred hchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence 0 01234678888999999999999987 2334444443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=343.86 Aligned_cols=248 Identities=27% Similarity=0.381 Sum_probs=203.9
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
.+..+|++.+.||+|+||.||+|+... .+..||+|++.........+.+.+|++++++++||||+++++++.+....+
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 96 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERS--SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY 96 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEcc--CCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence 345678999999999999999998644 357799999876544445678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceee---cCCCeEEE
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKI 207 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl---~~~~~vKl 207 (422)
+||||+++|+|.+++...... ...+++..+..++.|++.||+|||+++|+||||||+|||+ +.++.+||
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl 168 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQAR--------GKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKI 168 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHH--------TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEE
T ss_pred EEEEeCCCCcHHHHHHhhhhc--------ccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEE
Confidence 999999999999998653210 1358999999999999999999999999999999999999 45678999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+|||+++...... ......+|+.|+|||.+. +.++.++|||||||++|||++ |..||.+.+..++...+......
T Consensus 169 ~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 243 (285)
T 3is5_A 169 IDFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLT-GCLPFTGTSLEEVQQKATYKEPN 243 (285)
T ss_dssp CCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCCCC
T ss_pred EeeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHh-CCCCCCCCCHHHHHhhhccCCcc
Confidence 9999997654322 223445789999999875 578999999999999999999 99999999988888777654432
Q ss_pred C--CCCCCCcchhhhcccccccccchhh
Q psy7289 288 P--CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 288 ~--~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
. ....+++++.+++.+||..+|..|+
T Consensus 244 ~~~~~~~~~~~~~~li~~~L~~dP~~Rp 271 (285)
T 3is5_A 244 YAVECRPLTPQAVDLLKQMLTKDPERRP 271 (285)
T ss_dssp CCC--CCCCHHHHHHHHHHTCSCTTTSC
T ss_pred cccccCcCCHHHHHHHHHHccCChhhCc
Confidence 2 2234788999999999999999997
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=361.99 Aligned_cols=260 Identities=14% Similarity=0.164 Sum_probs=201.1
Q ss_pred hccccCcccccccccccceeEEEEEEecCC---CCeEEEEEEccCcCCHH----------hHHHHHHHHHHHhcCCCCce
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSE---GPSLVAIKTLKENANQK----------TASDFRREVDLMSELRHPNI 116 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~---~~~~vavK~~~~~~~~~----------~~~~~~~E~~il~~l~HpnI 116 (422)
++...+|++.+.||+|+||.||+|++..++ .+..||||++....... ....+.+|+..++.++||||
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 445568999999999999999999876543 24679999986543110 01234556777888999999
Q ss_pred eeEeeEEEcC----CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy7289 117 VCLLGVCLSG----EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDL 192 (422)
Q Consensus 117 v~l~g~~~~~----~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDl 192 (422)
+++++++... ...++||||+ +|+|.+++.... ..+++.++..++.||+.||+|||+++|+||||
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-----------~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDl 178 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-----------KRFSRKTVLQLSLRILDILEYIHEHEYVHGDI 178 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-----------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecC
Confidence 9999998765 3489999999 999999997642 35899999999999999999999999999999
Q ss_pred CCCceeec--CCCeEEEecCcccccccCCcceE-----eccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCC
Q psy7289 193 AARNCLVG--DGLTVKISDFGLSRDVYASDYYR-----IQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYG 265 (422)
Q Consensus 193 Kp~NiLl~--~~~~vKl~DFGla~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g 265 (422)
||+|||++ .++.+||+|||+++......... ......+|+.|||||++....++.++|||||||++|||++ |
T Consensus 179 kp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g 257 (364)
T 3op5_A 179 KASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLT-G 257 (364)
T ss_dssp CGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-S
T ss_pred CHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHh-C
Confidence 99999999 88999999999997654322111 1123348899999999999899999999999999999999 9
Q ss_pred CCCCCCCChH-HHHHHHHcCCCC---------CCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 266 LQPYYGYSNQ-EVIEMIRSRQML---------PCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 266 ~~Pf~~~~~~-~~~~~i~~~~~~---------~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
..||.+.... ............ ..+..+|+++.+++..||..+|..|| +...+...|
T Consensus 258 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-----~~~~l~~~l 324 (364)
T 3op5_A 258 HLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKP-----LYENLRDIL 324 (364)
T ss_dssp CCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCC-----CHHHHHHHH
T ss_pred CCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCC-----CHHHHHHHH
Confidence 9999864332 222222111000 01367899999999999999999998 655555443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=355.60 Aligned_cols=258 Identities=25% Similarity=0.411 Sum_probs=205.8
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
...+|++.+.||+|+||.||+|++. ++..||||.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR---DGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT---TCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHhccCccceeecCCCeeEEEEEEC---CCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 4568899999999999999999852 35789999886543 3346789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
||||+++|+|.+++..... ....+++.++..++.|++.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 113 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDL--------PTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp EEECCTTCBTGGGSSSSCC--------CSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCT
T ss_pred EEEcCCCCcHHHHHhccCC--------CccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecc
Confidence 9999999999999865321 11358999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHH-------HHHcC
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIE-------MIRSR 284 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~-------~i~~~ 284 (422)
+++...............+|+.|+|||++....++.++|||||||++|||++ |..||.+..+.+... ....+
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC-ARSAIVQSLPREMVNLAEWAVESHNNG 263 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHH-CCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHh-CCCcccccCcHHHHHHHHHhhhccccc
Confidence 9986543222222233446889999999998999999999999999999999 999998655432211 11111
Q ss_pred CC---------CCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 285 QM---------LPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 285 ~~---------~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
.. ...+..++..+.+++.+||..+|..|+ +...+...|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~L 310 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRP-----SMGDVLWKL 310 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSC-----CHHHHHHHH
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCc-----CHHHHHHHH
Confidence 11 112334567789999999999999998 555554444
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=344.52 Aligned_cols=248 Identities=21% Similarity=0.353 Sum_probs=211.3
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc--CCCe
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLS--GEPM 129 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~~ 129 (422)
..+|++.+.||+|+||.||+|+... +++.||+|.+... ......+.+.+|+.++++++||||+++++++.+ ....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKS--DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT--TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred hhheeeehhccCCCCcEEEEEEECC--CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 3578899999999999999998653 3578999998643 345566789999999999999999999998853 5678
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCCCceeecCCCe
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHH-----YVHRDLAARNCLVGDGLT 204 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-----ivHrDlKp~NiLl~~~~~ 204 (422)
++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~ 154 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKE--------RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN 154 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHT--------TCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC
T ss_pred EEEEeCCCCCCHHHHHHhhccc--------CCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC
Confidence 9999999999999999764211 134899999999999999999999999 999999999999999999
Q ss_pred EEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC
Q psy7289 205 VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR 284 (422)
Q Consensus 205 vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~ 284 (422)
+||+|||+++....... ......+++.|+|||.+....++.++||||||+++|||++ |..||.+.+..++...+..+
T Consensus 155 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~i~~~ 231 (279)
T 2w5a_A 155 VKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA-LMPPFTAFSQKELAGKIREG 231 (279)
T ss_dssp EEECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHT
T ss_pred EEEecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHH-CCCCCcccCHHHHHHHHhhc
Confidence 99999999976533211 1112346788999999998889999999999999999999 99999999999999999988
Q ss_pred CCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 285 QMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 285 ~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
...+.|..+|+++.+++.+||+.+|..|+
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 260 (279)
T 2w5a_A 232 KFRRIPYRYSDELNEIITRMLNLKDYHRP 260 (279)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred ccccCCcccCHHHHHHHHHHcCCCcccCC
Confidence 88888899999999999999999999997
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=353.99 Aligned_cols=269 Identities=23% Similarity=0.350 Sum_probs=208.5
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc----CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN----ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
...+|++.+.||+|+||.||+|+... .+..||+|++... ......+.+.+|++++++++||||+++++++.+.+
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQ--TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhheeecceeeecCCeEEEEEEECC--CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 35678999999999999999998643 4578999988542 13345678999999999999999999999999999
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCC----------------------------CCCCccCCCCHHHHHHHHHHHHHHH
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDI----------------------------SGSQVQAPLSQQDFSHIALQVAAGM 179 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~----------------------------~~~~~~~~l~~~~~~~i~~qi~~gL 179 (422)
..++|||||++|+|.+++......... ........+++..+..++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999999632111000 0000012346778889999999999
Q ss_pred HHHHhCCccccCCCCCceeecCCC--eEEEecCcccccccCCc--ceEeccCCCCCccccCcccccc--CCCCCchhHHh
Q psy7289 180 AYLCSHHYVHRDLAARNCLVGDGL--TVKISDFGLSRDVYASD--YYRIQSKSLLPVRWMPPESILY--GKFTTESDVWS 253 (422)
Q Consensus 180 ~yLH~~~ivHrDlKp~NiLl~~~~--~vKl~DFGla~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwS 253 (422)
+|||+++|+||||||+|||++.++ .+||+|||+++...... .........+|+.|+|||++.. ..++.++||||
T Consensus 182 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 999999999999999999998766 89999999998653211 1112234567899999999875 67899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC-CC--CCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 254 YGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP-CP--EDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 254 ~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~-~p--~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
|||++|||++ |..||.+.+..+....+..+.... .| ..+++.+.+|+.+||..+|..|+ +..+.+|.++
T Consensus 262 lG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~ 334 (345)
T 3hko_A 262 AGVLLHLLLM-GAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWI 334 (345)
T ss_dssp HHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHH
T ss_pred HHHHHHHHHH-CCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhh
Confidence 9999999999 999999999988888877655432 22 24789999999999999999986 2334444444
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=345.31 Aligned_cols=248 Identities=29% Similarity=0.507 Sum_probs=202.7
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
...+|++.+.||+|+||.||+|++. +..||||.+... ...+.|.+|++++++++||||+++++++. +..++
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~l 76 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR----AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCL 76 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET----TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEE
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC----CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEE
Confidence 4467889999999999999999863 467999998643 34568999999999999999999999886 45899
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCCCceeecCCCe-EEE
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCS---HHYVHRDLAARNCLVGDGLT-VKI 207 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~---~~ivHrDlKp~NiLl~~~~~-vKl 207 (422)
||||+++|+|.+++..... ...++...+..++.|++.||+|||+ ++|+||||||+|||++.++. +||
T Consensus 77 v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl 147 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEP---------LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKI 147 (307)
T ss_dssp EEECCTTCBHHHHHHCSSS---------EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEE
T ss_pred EEEcCCCCCHHHHHhccCC---------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEE
Confidence 9999999999999976421 1247888999999999999999999 89999999999999988775 899
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCC--hHHHHHHHHcCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS--NQEVIEMIRSRQ 285 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~--~~~~~~~i~~~~ 285 (422)
+|||+++..... .....+|+.|+|||++....++.++|||||||++|||++ |..||.... ..++...+..+.
T Consensus 148 ~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 221 (307)
T 2eva_A 148 CDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVIT-RRKPFDEIGGPAFRIMWAVHNGT 221 (307)
T ss_dssp CCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHH-TCCTTTTTCSSHHHHHHHHHTTC
T ss_pred cccccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHH-CCCCchhhCccHHHHHHHHhcCC
Confidence 999999754322 123357889999999998899999999999999999999 999998654 344556667777
Q ss_pred CCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 286 MLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 286 ~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
.++.+..+|+.+.+++.+||..+|..|+ +...+...|.
T Consensus 222 ~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~~L~ 259 (307)
T 2eva_A 222 RPPLIKNLPKPIESLMTRCWSKDPSQRP-----SMEEIVKIMT 259 (307)
T ss_dssp CCCCBTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHH
T ss_pred CCCcccccCHHHHHHHHHHhcCChhhCc-----CHHHHHHHHH
Confidence 7888889999999999999999999998 5555554443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=351.24 Aligned_cols=254 Identities=23% Similarity=0.404 Sum_probs=200.4
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
.+|++++.||+|+||.||+|+... .+..||||+++..........+.+|+.++++++||||+++++++.+++..++||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKL--TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECC--CCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 468899999999999999998654 357899999865433332335668999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||++ |+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 e~~~-~~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 147 (324)
T 3mtl_A 80 EYLD-KDLKQYLDDCG-----------NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLA 147 (324)
T ss_dssp ECCS-EEHHHHHHHTT-----------TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEE
T ss_pred cccc-cCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCccc
Confidence 9998 59999987642 35889999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC---
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC--- 289 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~--- 289 (422)
+...... .......+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+......+.
T Consensus 148 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 224 (324)
T 3mtl_A 148 RAKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMAT-GRPLFPGSTVEEQLHFIFRILGTPTEET 224 (324)
T ss_dssp ECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChHh
Confidence 7543222 12233456889999999876 568999999999999999999 9999999998887766653211111
Q ss_pred --------------------------CCCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 290 --------------------------PEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 290 --------------------------p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
+..+++++.+|+.+||..||..|+ +..+.+|.++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 286 (324)
T 3mtl_A 225 WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286 (324)
T ss_dssp STTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred chhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhh
Confidence 224567889999999999999986 33455566654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=348.35 Aligned_cols=251 Identities=33% Similarity=0.647 Sum_probs=209.5
Q ss_pred hccccCcccccccccccceeEEEEEEe--cCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVC--TSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
.+...+|++++.||+|+||.||+|++. ....+..||||++... .....+.+.+|+.++++++||||+++++++...+
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 345667899999999999999999864 2345688999998754 3345678999999999999999999999987654
Q ss_pred --CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 128 --PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 128 --~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
.+++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+++|+||||||+|||++.++.+
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~ 184 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHK-----------ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 184 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHST-----------TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEE
T ss_pred CCceEEEEECCCCCCHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcE
Confidence 7899999999999999997642 258899999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcce-EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCC-----------
Q psy7289 206 KISDFGLSRDVYASDYY-RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS----------- 273 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~----------- 273 (422)
||+|||+++........ .......++..|+|||.+....++.++|||||||++|||++ |..||....
T Consensus 185 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~~~~~~~~~~~~~~~~~~ 263 (326)
T 2w1i_A 185 KIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-YIEKSKSPPAEFMRMIGNDK 263 (326)
T ss_dssp EECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHH-TTCGGGSHHHHHHHHHCTTC
T ss_pred EEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCHHHHHHhhcccc
Confidence 99999999876544322 22333456778999999988889999999999999999999 888875321
Q ss_pred -----hHHHHHHHHcCCCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 274 -----NQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 274 -----~~~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..++...+..+..++.|..+|+++.+++++||..+|..|+
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 308 (326)
T 2w1i_A 264 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 308 (326)
T ss_dssp CTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred chhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCc
Confidence 1134455666777888999999999999999999999998
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=353.15 Aligned_cols=254 Identities=19% Similarity=0.249 Sum_probs=206.1
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCCe
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~ 129 (422)
+...+|++.+.||+|+||.||+|+... .++.||||++..... .+.+.+|+.++++| +||||+++++++..+...
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 80 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLY--TNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN 80 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETT--TTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECC--CCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence 446789999999999999999998643 457899999864332 23578999999999 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCe-----
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLT----- 204 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~----- 204 (422)
++||||+ +|+|.+++.... ..+++.++..++.|++.||+|||+++|+||||||+|||++.++.
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~-----------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~ 148 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLCD-----------RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQV 148 (330)
T ss_dssp EEEEECC-CCBHHHHHHHTT-----------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTS
T ss_pred EEEEEeC-CCCHHHHHHHcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCce
Confidence 9999999 999999997632 35899999999999999999999999999999999999998887
Q ss_pred EEEecCcccccccCCcce-----EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChH---H
Q psy7289 205 VKISDFGLSRDVYASDYY-----RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ---E 276 (422)
Q Consensus 205 vKl~DFGla~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~---~ 276 (422)
+||+|||+++........ .......+|+.|+|||++....++.++|||||||++|||++ |..||.+.+.. +
T Consensus 149 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~-g~~Pf~~~~~~~~~~ 227 (330)
T 2izr_A 149 IHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLR-GSLPWQGLKADTLKE 227 (330)
T ss_dssp EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTTTCCCSSHHH
T ss_pred EEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhc-CCCCccccccccHHH
Confidence 999999999865432211 11234567899999999999999999999999999999999 99999985543 4
Q ss_pred HHHHHHcCCCCCC----CCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 277 VIEMIRSRQMLPC----PEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 277 ~~~~i~~~~~~~~----p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
.+..+........ ...+| ++.+++..||..+|..|+ +...+.+.|+
T Consensus 228 ~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP-----~~~~l~~~l~ 277 (330)
T 2izr_A 228 RYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKP-----DYDYLRKLFT 277 (330)
T ss_dssp HHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCC-----CHHHHHHHHH
T ss_pred HHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCC-----CHHHHHHHHH
Confidence 4444433222111 23467 999999999999999998 5555554443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=338.05 Aligned_cols=258 Identities=25% Similarity=0.417 Sum_probs=211.2
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
.+...+|++.+.||+|+||.||+|+... .+..||||.+.... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQL--TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECC--CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 4456789999999999999999998753 35679999985422 1123467899999999999999999999999999
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
..++||||+++++|.+++... ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+||
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l 152 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKH------------GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKI 152 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEE
T ss_pred eEEEEEeccCCCcHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEE
Confidence 999999999999999999764 25889999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKF-TTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~ 286 (422)
+|||+++....... .....+++.|+|||.+....+ +.++||||||+++|||++ |..||.+.+..++...+..+.
T Consensus 153 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~- 227 (276)
T 2h6d_A 153 ADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLC-GTLPFDDEHVPTLFKKIRGGV- 227 (276)
T ss_dssp CCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCC-
T ss_pred eecccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCc-
Confidence 99999986543321 223456889999999987765 589999999999999999 999999988888888887654
Q ss_pred CCCCCCCCcchhhhcccccccccchhh-HHHHhhhhhhhhh
Q psy7289 287 LPCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRD 326 (422)
Q Consensus 287 ~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~d 326 (422)
.+.|..+++.+.+++.+||+.+|..|+ +..+.+|.++..+
T Consensus 228 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 228 FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 456788999999999999999999987 4445566665544
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=340.23 Aligned_cols=245 Identities=24% Similarity=0.343 Sum_probs=203.9
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
.+|++.+.||+|+||.||+|+... .+..||||.+.........+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRV--TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETT--TCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECC--CCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 468899999999999999998653 356899999865444445678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
||+++|+|.+++... ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||++
T Consensus 85 e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 152 (276)
T 2yex_A 85 EYCSGGELFDRIEPD------------IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA 152 (276)
T ss_dssp ECCTTEEGGGGSBTT------------TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EecCCCcHHHHHhhc------------cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCc
Confidence 999999999988543 35899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcceEeccCCCCCccccCccccccCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCChH-HHHHHHHc-CCCCCCC
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYGKF-TTESDVWSYGVVLWEVYSYGLQPYYGYSNQ-EVIEMIRS-RQMLPCP 290 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~-~~~~~i~~-~~~~~~p 290 (422)
+...............+|+.|+|||.+....+ +.++|||||||++|||++ |..||.+.+.. .....+.. ....+.+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 231 (276)
T 2yex_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPWDQPSDSCQEYSDWKEKKTYLNPW 231 (276)
T ss_dssp EECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHH-SSCCCSCSCTTSHHHHHHHTTCTTSTTG
T ss_pred cccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHhhhcccccCch
Confidence 76543322222344567899999999987665 778999999999999999 99999876543 23333333 2233334
Q ss_pred CCCCcchhhhcccccccccchhh
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..+|+.+.+++.+||..+|..|+
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp 254 (276)
T 2yex_A 232 KKIDSAPLALLHKILVENPSARI 254 (276)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSC
T ss_pred hhcCHHHHHHHHHHCCCCchhCC
Confidence 57889999999999999999997
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=349.49 Aligned_cols=248 Identities=21% Similarity=0.310 Sum_probs=201.0
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC--C
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE--P 128 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~--~ 128 (422)
+...+|++.+.||+|+||.||+|+...+ ++.||||+++........+.+.+|++++++++||||+++++++.... .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKT--GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTT--CCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCC--CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 3456799999999999999999987543 56899999875444445677889999999999999999999998665 7
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceee----cCCCe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV----GDGLT 204 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl----~~~~~ 204 (422)
.++||||+++|+|.+++..... ...+++.++..++.||+.||+|||+++|+||||||+|||+ +.++.
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 154 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSN---------AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSV 154 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGG---------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEE
T ss_pred EEEEEeCCCCCCHHHHHHHhcc---------ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCce
Confidence 8999999999999999976421 1248999999999999999999999999999999999999 77888
Q ss_pred EEEecCcccccccCCcceEeccCCCCCccccCccccc--------cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCC---
Q psy7289 205 VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL--------YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS--- 273 (422)
Q Consensus 205 vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~--------~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~--- 273 (422)
+||+|||+++....... .....+|+.|+|||++. ...++.++|||||||++|||++ |..||....
T Consensus 155 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~ 230 (319)
T 4euu_A 155 YKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT-GSLPFRPFEGPR 230 (319)
T ss_dssp EEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHH-SSCSEECTTCGG
T ss_pred EEEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCccc
Confidence 99999999987644322 22345789999999886 4678999999999999999999 999997543
Q ss_pred -hHHHHHHHHcCCCC--------------------CC----CCCCCcchhhhcccccccccchhh
Q psy7289 274 -NQEVIEMIRSRQML--------------------PC----PEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 274 -~~~~~~~i~~~~~~--------------------~~----p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..+++..+..+... +. +..+++.+.+++++||..||..|+
T Consensus 231 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~ 295 (319)
T 4euu_A 231 RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW 295 (319)
T ss_dssp GCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSC
T ss_pred hhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhc
Confidence 34555555443321 11 112345678899999999999987
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=344.07 Aligned_cols=253 Identities=25% Similarity=0.410 Sum_probs=202.9
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
.+|++++.||+|+||.||+|+... .+..||||++.... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRD--TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCC--CCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 578999999999999999998754 35789999886543 334457788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 81 ~e~~~~~~l~~~~~~~------------~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 148 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQ------------RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGF 148 (311)
T ss_dssp EECCSEEHHHHHHHTS------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEeCCCchHHHHHhhh------------cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCC
Confidence 9999999999988653 3589999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC-------
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR------- 284 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~------- 284 (422)
++....... ......+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
T 4agu_A 149 ARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLS-GVPLWPGKSDVDQLYLIRKTLGDLIPR 225 (311)
T ss_dssp CEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred chhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhcccccc
Confidence 986543221 1234457889999999876 568999999999999999999 99999998887766554321
Q ss_pred -------------CCCCCC----------CCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 285 -------------QMLPCP----------EDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 285 -------------~~~~~p----------~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
...+.| +.+++++.+|+.+||+.+|..|+ +..+.+|.++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 288 (311)
T 4agu_A 226 HQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF 288 (311)
T ss_dssp HHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGG
T ss_pred cccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHH
Confidence 111222 35677899999999999999997 3334444444
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=338.11 Aligned_cols=254 Identities=24% Similarity=0.370 Sum_probs=215.7
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC--HHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN--QKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP 128 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 128 (422)
+...+|++.+.||+|+||.||+|+... .+..||||++..... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQ--NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR 88 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcC--CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence 445678999999999999999998643 457899999854211 1224678999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~ 156 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKH------------GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIA 156 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEEC
T ss_pred EEEEEEeCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEe
Confidence 99999999999999999764 258999999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP 288 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 288 (422)
|||++....... .....+++.|+|||++....++.++||||||+++|||++ |..||...+..+....+.... .+
T Consensus 157 Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~-~~ 230 (284)
T 2vgo_A 157 DFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLV-GMPPFDSPSHTETHRRIVNVD-LK 230 (284)
T ss_dssp CCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHTTC-CC
T ss_pred cccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHH-CCCCCCCCCHhHHHHHHhccc-cC
Confidence 999987543321 233457889999999998889999999999999999998 999999988888888777654 45
Q ss_pred CCCCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 289 CPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 289 ~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
.|..+++.+.+++.+||..+|..|+ +..+.+|.++.
T Consensus 231 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~ 267 (284)
T 2vgo_A 231 FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 267 (284)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHH
T ss_pred CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHH
Confidence 6788999999999999999999987 33344555543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=366.13 Aligned_cols=257 Identities=25% Similarity=0.388 Sum_probs=214.7
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCH------------HhHHHHHHHHHHHhcCCCCceee
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQ------------KTASDFRREVDLMSELRHPNIVC 118 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~------------~~~~~~~~E~~il~~l~HpnIv~ 118 (422)
.+..+|+++++||+|+||.||+|+... .+..||||++...... ...+.+.+|+.+|++++|||||+
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 110 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKN--GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK 110 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETT--TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred CcccceEEEeEecccCCeEEEEEEECC--CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 356789999999999999999998754 3577999998643211 23567899999999999999999
Q ss_pred EeeEEEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcee
Q psy7289 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCL 198 (422)
Q Consensus 119 l~g~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiL 198 (422)
+++++.++..+++|||||++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||
T Consensus 111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil 178 (504)
T 3q5i_A 111 LFDVFEDKKYFYLVTEFYEGGELFEQIINR------------HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENIL 178 (504)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred EEEEEEcCCEEEEEEecCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEE
Confidence 999999999999999999999999999764 35899999999999999999999999999999999999
Q ss_pred ecCCC---eEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChH
Q psy7289 199 VGDGL---TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ 275 (422)
Q Consensus 199 l~~~~---~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~ 275 (422)
++.++ .+||+|||+++...... ......+|+.|+|||++. +.++.++||||+||++|||++ |..||.+.+..
T Consensus 179 ~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 253 (504)
T 3q5i_A 179 LENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLC-GYPPFGGQNDQ 253 (504)
T ss_dssp ESSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHH
T ss_pred EecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHh-CCCCCCCCCHH
Confidence 98765 69999999998654332 123456789999999876 569999999999999999999 99999999999
Q ss_pred HHHHHHHcCCCCCC---CCCCCcchhhhcccccccccchhh-HHHHhhhhhhhhh
Q psy7289 276 EVIEMIRSRQMLPC---PEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRD 326 (422)
Q Consensus 276 ~~~~~i~~~~~~~~---p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~d 326 (422)
+++..+..+..... ...+|+++.+|++.||..+|..|+ +..+.+|.++...
T Consensus 254 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 254 DIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred HHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 99999987764322 257899999999999999999886 3446666766543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=343.67 Aligned_cols=252 Identities=25% Similarity=0.433 Sum_probs=197.6
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhc--CCCCceeeEeeEEEcC-
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSE--LRHPNIVCLLGVCLSG- 126 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~g~~~~~- 126 (422)
++...+|++.+.||+|+||.||+|++ .+..||||++... ....+.+|.+++.. ++||||+++++++...
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~----~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW----QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE----TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE----CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 34567899999999999999999986 3577999998542 34556677777766 7999999999987643
Q ss_pred ---CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHH--------hCCccccCCCCC
Q psy7289 127 ---EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLC--------SHHYVHRDLAAR 195 (422)
Q Consensus 127 ---~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH--------~~~ivHrDlKp~ 195 (422)
..+++||||+++|+|.+++.. ..+++..+..++.|++.||+||| +++|+||||||+
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~-------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~ 142 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQL-------------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSK 142 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTT-------------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGG
T ss_pred CCCceeEEehhhccCCCHHHHHhh-------------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChH
Confidence 458999999999999999954 25899999999999999999999 999999999999
Q ss_pred ceeecCCCeEEEecCcccccccCCcceE--eccCCCCCccccCccccccC------CCCCchhHHhHHHHHHHHHhCC--
Q psy7289 196 NCLVGDGLTVKISDFGLSRDVYASDYYR--IQSKSLLPVRWMPPESILYG------KFTTESDVWSYGVVLWEVYSYG-- 265 (422)
Q Consensus 196 NiLl~~~~~vKl~DFGla~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~------~~~~~~DvwS~Gvil~El~t~g-- 265 (422)
|||++.++.+||+|||+++......... ......+|+.|+|||++... .++.++|||||||++|||++ |
T Consensus 143 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~t-g~~ 221 (301)
T 3q4u_A 143 NILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMV 221 (301)
T ss_dssp GEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT-TBC
T ss_pred hEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHh-hhc
Confidence 9999999999999999997654433221 12234678999999999876 45578999999999999998 7
Q ss_pred --------CCCCCCCCh-----HHHHHHHHc-CCCCCCCC-----CCCcchhhhcccccccccchhhHHHHhhhhhhhhh
Q psy7289 266 --------LQPYYGYSN-----QEVIEMIRS-RQMLPCPE-----DCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRD 326 (422)
Q Consensus 266 --------~~Pf~~~~~-----~~~~~~i~~-~~~~~~p~-----~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~d 326 (422)
..||.+... ..+...+.. ...++.|. .+++++.+|+.+||+.+|..|+ +...+.+.
T Consensus 222 ~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~i~~~ 296 (301)
T 3q4u_A 222 SNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARL-----TALRIKKT 296 (301)
T ss_dssp BTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSC-----CHHHHHHH
T ss_pred CccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCC-----CHHHHHHH
Confidence 788865432 233333332 22333332 3567799999999999999998 66555554
Q ss_pred cc
Q psy7289 327 LA 328 (422)
Q Consensus 327 Lk 328 (422)
|+
T Consensus 297 L~ 298 (301)
T 3q4u_A 297 LT 298 (301)
T ss_dssp HH
T ss_pred Hh
Confidence 43
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=352.47 Aligned_cols=258 Identities=23% Similarity=0.367 Sum_probs=214.5
Q ss_pred hhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC
Q psy7289 49 REVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP 128 (422)
Q Consensus 49 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 128 (422)
.++...+|++.+.||+|+||.||+|++.. .+..||+|++.........+.+.+|+.++++++||||+++++++.+++.
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 105 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKP--SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 105 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECC--CCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence 35667789999999999999999998753 3578999999876666667889999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeecCCCeEEE
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSH-HYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~ivHrDlKp~NiLl~~~~~vKl 207 (422)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl 173 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKA------------GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKL 173 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEE
T ss_pred EEEEEECCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEE
Confidence 99999999999999999764 2588999999999999999999996 9999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHH--------
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIE-------- 279 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~-------- 279 (422)
+|||+++..... ......+|+.|+|||++....++.++|||||||++|||++ |..||...+..++..
T Consensus 174 ~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 248 (360)
T 3eqc_A 174 CDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV-GRYPIPPPDAKELELMFGCQVEG 248 (360)
T ss_dssp CCCCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHH-TSCCSSCCCHHHHHHHHC-----
T ss_pred EECCCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhcccccc
Confidence 999999754321 1223457889999999999899999999999999999999 999998776654432
Q ss_pred ----------------------------------HHHcCCCCCCC-CCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 280 ----------------------------------MIRSRQMLPCP-EDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 280 ----------------------------------~i~~~~~~~~p-~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
.+.....+..| ..+++++.+|+.+||..+|..|+ +..+.+|.++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 328 (360)
T 3eqc_A 249 DAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328 (360)
T ss_dssp -------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred cCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence 22333333333 34788999999999999999986 4456666666
Q ss_pred hh
Q psy7289 324 HR 325 (422)
Q Consensus 324 ~~ 325 (422)
..
T Consensus 329 ~~ 330 (360)
T 3eqc_A 329 KR 330 (360)
T ss_dssp HH
T ss_pred hc
Confidence 54
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=337.10 Aligned_cols=253 Identities=24% Similarity=0.389 Sum_probs=210.1
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC-----HHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN-----QKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
..+|++.+.||+|+||.||+|+... .+..||+|.++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKG--TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT 81 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhhHHhhcccCceEEEEEEEcC--CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence 4568899999999999999998754 356799998864321 123578999999999999999999999999999
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC----
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL---- 203 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~---- 203 (422)
..++||||+++++|.+++... ..+++.++..++.||+.||+|||+++|+||||||+||+++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~ 149 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEK------------ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNP 149 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSC
T ss_pred eEEEEEeecCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCC
Confidence 999999999999999999764 3589999999999999999999999999999999999998876
Q ss_pred eEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc
Q psy7289 204 TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS 283 (422)
Q Consensus 204 ~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~ 283 (422)
.+||+|||+++....... .....+++.|+|||++....++.++||||||+++|||++ |..||.+.+..+....+..
T Consensus 150 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~ 225 (283)
T 3bhy_A 150 RIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGETKQETLTNISA 225 (283)
T ss_dssp CEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHT
T ss_pred ceEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHH-CCCCCCCcchHHHHHHhHh
Confidence 899999999986543221 223457889999999998899999999999999999999 9999999998888888876
Q ss_pred CCCCCC---CCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 284 RQMLPC---PEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 284 ~~~~~~---p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
...... +..+|+.+.+++.+||..+|..|+ +..+.+|.++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 269 (283)
T 3bhy_A 226 VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269 (283)
T ss_dssp TCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHH
T ss_pred cccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHH
Confidence 543222 357888999999999999999997 2234444443
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=366.20 Aligned_cols=255 Identities=25% Similarity=0.393 Sum_probs=211.0
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
+..+|++++.||+|+||.||+|+... .+..||||++.... .......+.+|+.+++.++|||||++++++.+....|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 112 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKV--THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY 112 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETT--TCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECC--CCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 34579999999999999999998654 35779999986432 2233567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC---CCeEEE
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD---GLTVKI 207 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~---~~~vKl 207 (422)
+|||||++|+|.+++..+ ..+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||
T Consensus 113 lv~e~~~~g~L~~~~~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 180 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHR------------MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKI 180 (494)
T ss_dssp EEEECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEE
T ss_pred EEEecCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEE
Confidence 999999999999999765 35899999999999999999999999999999999999975 456999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+|||+++...... ......+|+.|+|||++. +.++.++||||+||++|||++ |.+||.+.+..++...+..+...
T Consensus 181 ~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~ 255 (494)
T 3lij_A 181 VDFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLA-GYPPFGGQTDQEILRKVEKGKYT 255 (494)
T ss_dssp CCCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHTCCC
T ss_pred EECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCC
Confidence 9999998654332 223456889999999876 569999999999999999999 99999999999999999876543
Q ss_pred CC-C--CCCCcchhhhcccccccccchhh-HHHHhhhhhhhh
Q psy7289 288 PC-P--EDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHR 325 (422)
Q Consensus 288 ~~-p--~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~ 325 (422)
.. | ..+|+.+.+|+++||..+|..|+ +..+.+|.++..
T Consensus 256 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 256 FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 32 2 46889999999999999999886 344556666654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=367.42 Aligned_cols=256 Identities=25% Similarity=0.423 Sum_probs=213.6
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
....+|++.+.||+|+||.||+|+... .+..||||++.... .......+.+|+.+|++++|||||++++++.+...+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 96 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRI--TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETT--TCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECC--CCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence 345679999999999999999998654 35789999985321 122356789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec---CCCeEE
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVG---DGLTVK 206 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~---~~~~vK 206 (422)
++|||||++|+|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||++ .++.+|
T Consensus 97 ~lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k 164 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKR------------KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIK 164 (486)
T ss_dssp EEEECCCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEE
T ss_pred EEEEEcCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEE
Confidence 9999999999999999765 3589999999999999999999999999999999999995 456899
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~ 286 (422)
|+|||+++...... ......+|+.|+|||++.+ .++.++|||||||++|||++ |.+||.+.+..+++..+..+..
T Consensus 165 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 239 (486)
T 3mwu_A 165 IIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLS-GTPPFYGKNEYDILKRVETGKY 239 (486)
T ss_dssp ECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHTCC
T ss_pred EEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCC
Confidence 99999998654332 2234568899999998864 69999999999999999999 9999999999999999887654
Q ss_pred CC---CCCCCCcchhhhcccccccccchhh-HHHHhhhhhhhh
Q psy7289 287 LP---CPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHR 325 (422)
Q Consensus 287 ~~---~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~ 325 (422)
.. ....+++++.+|+.+||..+|..|+ ...+..|.++..
T Consensus 240 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 240 AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 32 2246889999999999999999886 334555666543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=352.46 Aligned_cols=250 Identities=21% Similarity=0.372 Sum_probs=207.6
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCCeEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~l 131 (422)
..+|++.+.||+|+||.||+|+... .+..||||+++.... .+.+|++++.++ +||||+++++++.++..+|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKA--TNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECC--CCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 4578999999999999999998654 457899999865432 235688888888 79999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC----CeEEE
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG----LTVKI 207 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~----~~vKl 207 (422)
|||||++|+|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||+.++ +.+||
T Consensus 94 v~E~~~gg~L~~~i~~~------------~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl 161 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQ------------KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRI 161 (342)
T ss_dssp EECCCCSCBHHHHHHTC------------TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEE
T ss_pred EEeCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEE
Confidence 99999999999999753 358999999999999999999999999999999999998543 35999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCC---CChHHHHHHHHcC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYG---YSNQEVIEMIRSR 284 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~---~~~~~~~~~i~~~ 284 (422)
+|||+++....... ......+|+.|+|||++....++.++|||||||++|||++ |..||.+ .+..++...+..+
T Consensus 162 ~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~i~~~ 238 (342)
T 2qr7_A 162 CDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLT-GYTPFANGPDDTPEEILARIGSG 238 (342)
T ss_dssp CCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH-SSCSSCSSTTSCHHHHHHHHHHC
T ss_pred EECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhc-CCCCCCCCCcCCHHHHHHHHccC
Confidence 99999986543321 2234567899999999988889999999999999999999 9999986 4567788888876
Q ss_pred CCCC---CCCCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 285 QMLP---CPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 285 ~~~~---~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
.... .+..+++++.+|+++||..||..|+ +..+.+|.++.
T Consensus 239 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~ 282 (342)
T 2qr7_A 239 KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282 (342)
T ss_dssp CCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred CcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeec
Confidence 5433 2356889999999999999999986 33455566653
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=368.82 Aligned_cols=257 Identities=24% Similarity=0.395 Sum_probs=216.8
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
.+...+|++.+.||+|+||.||+|+... .+..||||++.... .......+.+|+.++++++|||||++++++.+..
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 99 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKI--TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG 99 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECC--CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 3456689999999999999999998654 35789999985432 1234578999999999999999999999999999
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceee---cCCCe
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV---GDGLT 204 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl---~~~~~ 204 (422)
.+++|||||.+|+|.+++..+ ..+++.++..++.||+.||+|||+++|+||||||+|||+ +.++.
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 167 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISR------------KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDAN 167 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTC------------SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCC
T ss_pred EEEEEEecCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCc
Confidence 999999999999999999764 358999999999999999999999999999999999999 46789
Q ss_pred EEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC
Q psy7289 205 VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR 284 (422)
Q Consensus 205 vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~ 284 (422)
+||+|||+++...... ......+|+.|+|||++.+ .++.++|||||||++|||++ |.+||.+.+..+++..+..+
T Consensus 168 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~ 242 (484)
T 3nyv_A 168 IRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLS-GCPPFNGANEYDILKKVEKG 242 (484)
T ss_dssp EEECCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC
T ss_pred EEEEeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHcC
Confidence 9999999998654332 1223457899999998865 79999999999999999999 99999999999999998876
Q ss_pred CCC-CC--CCCCCcchhhhcccccccccchhh-HHHHhhhhhhhh
Q psy7289 285 QML-PC--PEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHR 325 (422)
Q Consensus 285 ~~~-~~--p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~ 325 (422)
... +. +..+|+.+.+|+.+||..+|..|+ +..+.+|.++..
T Consensus 243 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~ 287 (484)
T 3nyv_A 243 KYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287 (484)
T ss_dssp CCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred CCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence 543 22 246889999999999999999986 344666666654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=344.76 Aligned_cols=258 Identities=27% Similarity=0.434 Sum_probs=202.9
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC----CHHhHHHHHHHHHHHhcCC---CCceeeEeeEE
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA----NQKTASDFRREVDLMSELR---HPNIVCLLGVC 123 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~il~~l~---HpnIv~l~g~~ 123 (422)
+...+|++.+.||+|+||.||+|+... .++.||||++.... .......+.+|+.+++.++ ||||+++++++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPH--SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTT--TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECC--CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 445689999999999999999997543 45789999986322 1112345677888777764 99999999999
Q ss_pred EcCC-----CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcee
Q psy7289 124 LSGE-----PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCL 198 (422)
Q Consensus 124 ~~~~-----~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiL 198 (422)
.... .+++||||+. |+|.+++..... ..+++.++..++.||+.||+|||+++|+||||||+|||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~----------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil 152 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVD-QDLRTYLDKAPP----------PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENIL 152 (308)
T ss_dssp EECCSSSEEEEEEEEECCC-CBHHHHHHTCCT----------TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEE
T ss_pred eccCCCCceeEEEEehhhh-cCHHHHHhhccC----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 8765 4799999997 699999976431 24899999999999999999999999999999999999
Q ss_pred ecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHH
Q psy7289 199 VGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVI 278 (422)
Q Consensus 199 l~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~ 278 (422)
++.++.+||+|||+++...... ......+|+.|+|||++....++.++|||||||++|||++ |.+||.+.+..+..
T Consensus 153 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~ 228 (308)
T 3g33_A 153 VTSGGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQL 228 (308)
T ss_dssp ECTTSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTT-SSCSCCCSSHHHHH
T ss_pred EcCCCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Confidence 9999999999999998654322 2234467899999999999999999999999999999998 99999999988877
Q ss_pred HHHHcCCCCC--------------------------CCCCCCcchhhhcccccccccchhh-HHHHhhhhhhhh
Q psy7289 279 EMIRSRQMLP--------------------------CPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHR 325 (422)
Q Consensus 279 ~~i~~~~~~~--------------------------~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~ 325 (422)
..+......+ .++.+++.+.+|+.+||..||..|+ +..+.+|.++..
T Consensus 229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~ 302 (308)
T 3g33_A 229 GKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302 (308)
T ss_dssp HHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred HHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence 7664321111 0135677888999999999999986 334555555543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=341.40 Aligned_cols=245 Identities=19% Similarity=0.263 Sum_probs=198.7
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
-.+|++.+.||+|+||.||+|+... .+..||||++.... .....+.+.+|+.++++++||||+++++++..++..+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTV--RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETT--TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcC--CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 4679999999999999999998643 45789999986432 3344578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+||||+++++|.+++... ..+++.++..++.|++.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 111 lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Df 178 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQ------------GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDF 178 (309)
T ss_dssp EEEECCCCEEHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSC
T ss_pred EEEEecCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecC
Confidence 999999999999999764 25899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC--C
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML--P 288 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~--~ 288 (422)
|+++....... .......+++.|+|||.+....++.++||||||+++|||++ |..||.+.+...+...+...... .
T Consensus 179 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (309)
T 2h34_A 179 GIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLT-GSPPYQGDQLSVMGAHINQAIPRPST 256 (309)
T ss_dssp CC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHH-SSCSSCSCHHHHHHHHHHSCCCCGGG
T ss_pred ccCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHH-CCCCCCCchHHHHHHHhccCCCCccc
Confidence 99976543221 12233457889999999998899999999999999999999 99999988777666655544322 2
Q ss_pred CCCCCCcchhhhcccccccccchhh
Q psy7289 289 CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 289 ~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.+..+|+++.+++.+||..+|..|+
T Consensus 257 ~~~~~~~~l~~li~~~l~~dP~~Rp 281 (309)
T 2h34_A 257 VRPGIPVAFDAVIARGMAKNPEDRY 281 (309)
T ss_dssp TSTTCCTHHHHHHHHHTCSSGGGSC
T ss_pred cCCCCCHHHHHHHHHhccCCHHHHH
Confidence 4678999999999999999999996
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=342.58 Aligned_cols=256 Identities=20% Similarity=0.243 Sum_probs=209.0
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEP 128 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~ 128 (422)
.+...+|++.+.||+|+||.||+|+... .+..||||++..... .+.+.+|+.+++.+ +||||+++++++.+...
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 80 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLL--NNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETT--TTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECC--CCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence 4567789999999999999999998643 467899998864332 23578899999999 79999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCe----
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLT---- 204 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~---- 204 (422)
.++||||+ +|+|.+++.... ..+++.++..++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~ 148 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLCG-----------RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNAN 148 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-----------TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTT
T ss_pred eEEEEEec-CCCHHHHHHHhc-----------cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCC
Confidence 99999999 999999997642 25899999999999999999999999999999999999987765
Q ss_pred -EEEecCcccccccCCcce-----EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCC---hH
Q psy7289 205 -VKISDFGLSRDVYASDYY-----RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS---NQ 275 (422)
Q Consensus 205 -vKl~DFGla~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~---~~ 275 (422)
+||+|||+++........ .......+|+.|+|||++....++.++|||||||++|||++ |..||.+.+ ..
T Consensus 149 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~~~~~~ 227 (298)
T 1csn_A 149 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLR-GSLPWQGLKAATNK 227 (298)
T ss_dssp CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTSSCCSCCHH
T ss_pred eEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHc-CCCCcchhhccccH
Confidence 999999999865433211 12234567899999999999899999999999999999998 999998853 44
Q ss_pred HHHHHHHcCCC-C---CCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 276 EVIEMIRSRQM-L---PCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 276 ~~~~~i~~~~~-~---~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
+.+..+..... . ..+..+|+++.+++.+||+.+|..|+ +...+...|+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP-----~~~~l~~~l~ 279 (298)
T 1csn_A 228 QKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATP-----DYDYLQGLFS 279 (298)
T ss_dssp HHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCC-----CHHHHHHHHH
T ss_pred HHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCC-----CHHHHHHHHH
Confidence 44444433221 1 12457899999999999999999998 5555554443
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=354.27 Aligned_cols=258 Identities=21% Similarity=0.335 Sum_probs=208.7
Q ss_pred ccccCcccccccccccceeEEEEEEec-CCCCeEEEEEEccCcC---CHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEc
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCT-SEGPSLVAIKTLKENA---NQKTASDFRREVDLMSEL-RHPNIVCLLGVCLS 125 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~ 125 (422)
+...+|++.+.||+|+||.||+|+... ...+..||||+++... .....+.+.+|+++++.+ +||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 344689999999999999999998743 2356889999986432 112234577899999999 69999999999999
Q ss_pred CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 126 GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 126 ~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
...+++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 198 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQR------------ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHV 198 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCE
T ss_pred CceEEEEeecCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcE
Confidence 99999999999999999999764 258999999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCcccccc--CCCCCchhHHhHHHHHHHHHhCCCCCCCCCC----hHHHHH
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY--GKFTTESDVWSYGVVLWEVYSYGLQPYYGYS----NQEVIE 279 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~----~~~~~~ 279 (422)
||+|||+++........ ......+|+.|+|||++.. ..++.++|||||||++|||++ |..||...+ ..++..
T Consensus 199 kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~ 276 (355)
T 1vzo_A 199 VLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT-GASPFTVDGEKNSQAEISR 276 (355)
T ss_dssp EESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH-SSCTTSCTTSCCCHHHHHH
T ss_pred EEeeCCCCeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHH-CCCCCccCCccchHHHHHH
Confidence 99999999865332211 1223457899999999885 347899999999999999999 999997543 344555
Q ss_pred HHHcCCCCCCCCCCCcchhhhcccccccccchhh------HHHHhhhhhh
Q psy7289 280 MIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG------MAYLCSHHYV 323 (422)
Q Consensus 280 ~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~------~~~lh~~~~i 323 (422)
.+... .++.|..+++.+.+|+.+||..+|..|+ +..+.+|.++
T Consensus 277 ~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 277 RILKS-EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp HHHHC-CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred HHhcc-CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 55443 4567888999999999999999999995 4555555554
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=346.24 Aligned_cols=233 Identities=22% Similarity=0.336 Sum_probs=180.5
Q ss_pred cccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC-CCceeeEeeEEEcCCCeEEEEEecCC
Q psy7289 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR-HPNIVCLLGVCLSGEPMCMLFEFMVR 138 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~lv~E~~~~ 138 (422)
+.||+|+||.||+|+... .+..||||++... ....+.+|+.+++.++ ||||+++++++.+....|+||||+++
T Consensus 17 ~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKK--SNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp CCSEEETTEEEEEEEETT--TCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CccccCCCeEEEEEEECC--CCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 689999999999998754 3578999998642 3456789999999997 99999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC---eEEEecCccccc
Q psy7289 139 GDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL---TVKISDFGLSRD 215 (422)
Q Consensus 139 G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~---~vKl~DFGla~~ 215 (422)
|+|.+++... ..+++.++..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++.
T Consensus 91 ~~L~~~l~~~------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 91 GELFERIKKK------------KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp CBHHHHHHHC------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred CcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 9999999764 3589999999999999999999999999999999999998665 899999999986
Q ss_pred ccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCC-------hHHHHHHHHcCCCCC
Q psy7289 216 VYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS-------NQEVIEMIRSRQMLP 288 (422)
Q Consensus 216 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~-------~~~~~~~i~~~~~~~ 288 (422)
...... ......+|+.|+|||++....++.++|||||||++|||++ |..||.+.+ ..++...+..+....
T Consensus 159 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~ 235 (325)
T 3kn6_A 159 KPPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLS-GQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF 235 (325)
T ss_dssp CCC------------------------CCCCHHHHHHHHHHHHHHHHH-SSCTTC-------CCCHHHHHHHHTTTCCCC
T ss_pred cCCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHh-CCCCCCCCccccccccHHHHHHHHHcCCCCC
Confidence 543221 2233456889999999998999999999999999999999 999998644 356777777665432
Q ss_pred CC---CCCCcchhhhcccccccccchhh
Q psy7289 289 CP---EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 289 ~p---~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.+ ..+++++.+|+.+||..+|..|+
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rp 263 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRL 263 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCC
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCC
Confidence 22 35889999999999999999997
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=354.34 Aligned_cols=251 Identities=22% Similarity=0.389 Sum_probs=196.8
Q ss_pred cCcccc-cccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHh-cCCCCceeeEeeEEEc----CC
Q psy7289 54 TKPRFL-QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMS-ELRHPNIVCLLGVCLS----GE 127 (422)
Q Consensus 54 ~~~~~~-~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~-~l~HpnIv~l~g~~~~----~~ 127 (422)
..|.+. +.||+|+||.||+|+... .+..||||+++.. ..+.+|+.++. ..+||||+++++++.. ..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~--~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKR--TQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeccceeeeccCeEEEEEEECC--CCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 455565 689999999999998654 3578999998532 35678888874 5589999999999865 55
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC---CCe
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD---GLT 204 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~---~~~ 204 (422)
.+|+|||||++|+|.+++..+. ...+++.++..++.||+.||+|||+++|+||||||+|||++. ++.
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~----------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~ 202 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRG----------DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAI 202 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC-------------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCC
T ss_pred EEEEEEEeCCCCcHHHHHHHhC----------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCcc
Confidence 7899999999999999997642 125899999999999999999999999999999999999997 789
Q ss_pred EEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHH----HHHH
Q psy7289 205 VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE----VIEM 280 (422)
Q Consensus 205 vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~----~~~~ 280 (422)
+||+|||+++...... ......+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..+ +...
T Consensus 203 ~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~ 278 (400)
T 1nxk_A 203 LKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC-GYPPFYSNHGLAISPGMKTR 278 (400)
T ss_dssp EEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHH-SSCSCCCCTTCSSCCSHHHH
T ss_pred EEEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCccccccHHHHHH
Confidence 9999999998654322 1234567899999999999999999999999999999999 999998765432 4455
Q ss_pred HHcCCC-CCCC--CCCCcchhhhcccccccccchhh-HHHHhhhhhhhhh
Q psy7289 281 IRSRQM-LPCP--EDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRD 326 (422)
Q Consensus 281 i~~~~~-~~~p--~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~d 326 (422)
+..+.. .+.| ..+++++.+|+++||..+|..|+ +..+.+|.++...
T Consensus 279 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 279 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp HHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 554432 2222 56899999999999999999986 4456666666543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=346.91 Aligned_cols=245 Identities=22% Similarity=0.359 Sum_probs=204.1
Q ss_pred hhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC-----CCceeeEeeE
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR-----HPNIVCLLGV 122 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-----HpnIv~l~g~ 122 (422)
...+...+|+++++||+|+||.||+|+... .+..||||+++. .......+.+|+.+++.++ |||||+++++
T Consensus 29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHID--NKKYYAVKVVRN--IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEECS--CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred cceEecCEEEEEEEEcccCCeEEEEEEECC--CCeEEEEEEecc--chhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 345677899999999999999999998754 357899999864 2345567888999999996 9999999999
Q ss_pred EEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC-
Q psy7289 123 CLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD- 201 (422)
Q Consensus 123 ~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~- 201 (422)
+...+..++||||+ +|+|.+++..... ..+++.++..++.||+.||+|||+++|+||||||+|||++.
T Consensus 105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 105 FMYYDHMCLIFEPL-GPSLYEIITRNNY----------NGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDP 173 (360)
T ss_dssp EEETTEEEEEECCC-CCBHHHHHHHTTT----------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCT
T ss_pred eeECCeeEEEEcCC-CCCHHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccc
Confidence 99999999999999 9999999976431 24899999999999999999999999999999999999975
Q ss_pred ------------------------CCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHH
Q psy7289 202 ------------------------GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVV 257 (422)
Q Consensus 202 ------------------------~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvi 257 (422)
++.+||+|||+++..... .....+|+.|+|||++....++.++|||||||+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 248 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCV 248 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHH
Confidence 788999999999754322 234567899999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCChHHHHHHHHcCCCCC-------------------------CCCC--------------------
Q psy7289 258 LWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP-------------------------CPED-------------------- 292 (422)
Q Consensus 258 l~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~-------------------------~p~~-------------------- 292 (422)
+|||++ |..||.+.+..+.+..+....... .|..
T Consensus 249 l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 327 (360)
T 3llt_A 249 LAELYT-GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKII 327 (360)
T ss_dssp HHHHHH-SSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHC
T ss_pred HHHHHH-CCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccc
Confidence 999999 999999988887776664321110 1111
Q ss_pred CCcchhhhcccccccccchhh
Q psy7289 293 CPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 293 ~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.++.+.+|+.+||+.||..|+
T Consensus 328 ~~~~l~~li~~~L~~dP~~Rp 348 (360)
T 3llt_A 328 KHELFCDFLYSILQIDPTLRP 348 (360)
T ss_dssp CCHHHHHHHHHHCCSSGGGSC
T ss_pred hHHHHHHHHHHHhcCChhhCC
Confidence 125566999999999999997
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=346.84 Aligned_cols=254 Identities=26% Similarity=0.374 Sum_probs=197.5
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC-HHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN-QKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
...+|++.+.||+|+||.||+|+... .+..||||+++.... ....+.+.+|+.++++++||||+++++++.++..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTV--TNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETT--TTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECC--CCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 44679999999999999999998643 467899999865432 233467889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec-----CCCeE
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVG-----DGLTV 205 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~-----~~~~v 205 (422)
+||||++ |+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+
T Consensus 110 lv~e~~~-~~L~~~~~~~------------~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~ 176 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKN------------PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVL 176 (329)
T ss_dssp EEEECCS-EEHHHHHHHC------------TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEE
T ss_pred EEEecCC-CCHHHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceE
Confidence 9999998 5999999764 2589999999999999999999999999999999999994 45569
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR 284 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~ 284 (422)
||+|||+++...... .......+|+.|+|||++... .++.++|||||||++|||++ |..||.+.+..+.+..+...
T Consensus 177 kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~ 253 (329)
T 3gbz_A 177 KIGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM-KTPLFPGDSEIDQLFKIFEV 253 (329)
T ss_dssp EECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHH
T ss_pred EECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHH-CCCCcCCCCHHHHHHHHHHH
Confidence 999999997653221 122334568899999998864 48999999999999999999 99999998887776666432
Q ss_pred CCCCCC-----------------------------CCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 285 QMLPCP-----------------------------EDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 285 ~~~~~p-----------------------------~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
...+.+ ..+++++.+|+.+||..||..|+ +..+.+|.++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 322 (329)
T 3gbz_A 254 LGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322 (329)
T ss_dssp HCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred hCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCccc
Confidence 111111 11567888999999999999996 3334444443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=365.00 Aligned_cols=255 Identities=25% Similarity=0.325 Sum_probs=201.6
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC----
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE---- 127 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~---- 127 (422)
..+|++++.||+|+||.||+|+... .++.||||++... ......+.+.+|+.+|+.++|||||++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAV--LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETT--TTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred cCCeEEEEEeecCCCeEEEEEEECC--CCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 4679999999999999999998654 3578999998653 24455678899999999999999999999997654
Q ss_pred --CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 128 --PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 128 --~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
.+|+||||+++ +|.+.+.. .+++.++..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~~--------------~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~ 203 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQM--------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 203 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHTS--------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCE
T ss_pred CCeEEEEEeCCCC-CHHHHHhh--------------cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCE
Confidence 46999999986 47676632 38899999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ 285 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~ 285 (422)
||+|||+++...... ......+|+.|+|||++.+..|+.++|||||||++|||++ |..||.+.+..+.+..|....
T Consensus 204 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pF~g~~~~~~~~~i~~~l 279 (464)
T 3ttj_A 204 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKVIEQL 279 (464)
T ss_dssp EECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHHH
T ss_pred EEEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhc
Confidence 999999998654322 1234567899999999999999999999999999999998 999999988877666654311
Q ss_pred CCCC--------------------------CCCC---------------Ccchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 286 MLPC--------------------------PEDC---------------PPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 286 ~~~~--------------------------p~~~---------------p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
..|+ |... ++++.+|+.+||..||..|+ +..+.+|.++
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~ 359 (464)
T 3ttj_A 280 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359 (464)
T ss_dssp CSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred CCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhh
Confidence 1111 0001 34578999999999999885 4556777777
Q ss_pred hhhcc
Q psy7289 324 HRDLA 328 (422)
Q Consensus 324 ~~dLk 328 (422)
.....
T Consensus 360 ~~~~~ 364 (464)
T 3ttj_A 360 NVWYD 364 (464)
T ss_dssp GGGCC
T ss_pred hhccC
Confidence 64333
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=342.42 Aligned_cols=255 Identities=22% Similarity=0.326 Sum_probs=201.3
Q ss_pred cccCcccc-cccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCCe
Q psy7289 52 IETKPRFL-QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 52 ~~~~~~~~-~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~ 129 (422)
....|++. +.||+|+||.||+|+... .+..||||++.... ....+.+.+|+.++.++ +||||+++++++.+++.+
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~ 86 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLI--TSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSS--SCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcC--CCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 34578875 789999999999997543 35789999986543 23456789999999985 799999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCe---EE
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLT---VK 206 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~---vK 206 (422)
++||||+++|+|.+++... ..+++.++..++.||+.||+|||+++|+||||||+|||++.++. +|
T Consensus 87 ~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~k 154 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKR------------RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVK 154 (316)
T ss_dssp EEEEECCTTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEE
T ss_pred EEEEEcCCCCcHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceE
Confidence 9999999999999999764 25899999999999999999999999999999999999987765 99
Q ss_pred EecCcccccccCCcce-----EeccCCCCCccccCcccccc-----CCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh--
Q psy7289 207 ISDFGLSRDVYASDYY-----RIQSKSLLPVRWMPPESILY-----GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN-- 274 (422)
Q Consensus 207 l~DFGla~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~-- 274 (422)
|+|||+++........ .......+|+.|+|||++.. ..++.++|||||||++|||++ |..||.+.+.
T Consensus 155 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~ 233 (316)
T 2ac3_A 155 ICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLS-GYPPFVGRCGSD 233 (316)
T ss_dssp ECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHH-SSCSCCCCCCSC
T ss_pred EEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHH-CCCCCccccccc
Confidence 9999999765322111 11123457899999999875 458899999999999999999 9999987642
Q ss_pred -------------HHHHHHHHcCCCCCCC----CCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 275 -------------QEVIEMIRSRQMLPCP----EDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 275 -------------~~~~~~i~~~~~~~~p----~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
.++...+..+.. ..| ..+|+.+.+|+.+||..||..|+ +..+.+|.++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 299 (316)
T 2ac3_A 234 CGWDRGEACPACQNMLFESIQEGKY-EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299 (316)
T ss_dssp SCC----CCHHHHHHHHHHHHHCCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTC
T ss_pred ccccccccchhHHHHHHHHHhccCc-ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhh
Confidence 345666665543 223 46889999999999999999997 2334444443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=334.46 Aligned_cols=251 Identities=23% Similarity=0.349 Sum_probs=204.9
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc----C
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLS----G 126 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~ 126 (422)
....|++.+.||+|+||.||+|+... .+..||+|.+... ......+.+.+|+.++++++||||+++++++.. .
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTE--TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred CceeEEeeeeccCCCCeEEEEeEecC--CceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence 34567889999999999999998643 4578999988643 345567789999999999999999999999865 3
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceeec-CCC
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHH--YVHRDLAARNCLVG-DGL 203 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--ivHrDlKp~NiLl~-~~~ 203 (422)
..+++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++ +++
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~ 169 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRF------------KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG 169 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS
T ss_pred ceEEEEEEecCCCCHHHHHHHc------------cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCC
Confidence 4589999999999999999764 35889999999999999999999999 99999999999997 788
Q ss_pred eEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh-HHHHHHHH
Q psy7289 204 TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN-QEVIEMIR 282 (422)
Q Consensus 204 ~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~-~~~~~~i~ 282 (422)
.+||+|||+++....... ....+|+.|+|||++. +.++.++|||||||++|||++ |..||.+... .++...+.
T Consensus 170 ~~kl~Dfg~~~~~~~~~~----~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 243 (290)
T 1t4h_A 170 SVKIGDLGLATLKRASFA----KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMAT-SEYPYSECQNAAQIYRRVT 243 (290)
T ss_dssp CEEECCTTGGGGCCTTSB----EESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHH-SSCTTTTCSSHHHHHHHHT
T ss_pred CEEEeeCCCccccccccc----ccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHh-CCCCCCCcCcHHHHHHHHh
Confidence 999999999975443321 2235688999999876 569999999999999999999 9999988554 45555555
Q ss_pred cCCCC-CCCCCCCcchhhhcccccccccchhh-HHHHhhhhh
Q psy7289 283 SRQML-PCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHY 322 (422)
Q Consensus 283 ~~~~~-~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~ 322 (422)
.+..+ ..+..+++++.+++..||..+|..|+ +..+.+|.+
T Consensus 244 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 285 (290)
T 1t4h_A 244 SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp TTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred ccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcc
Confidence 54333 24567788999999999999999997 223444444
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=353.37 Aligned_cols=262 Identities=27% Similarity=0.461 Sum_probs=206.6
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
++...+|++.+.||+|+||.||+|+.. ++..||||++...........+.+|+.+++.++||||+++++++.++...
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLA---DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 102 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCS---SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred HHHhhccccceeEecCCCcEEEEEEec---CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence 456778999999999999999999642 35679999987654333344789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCceeecCCCeEE
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSH---HYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~---~ivHrDlKp~NiLl~~~~~vK 206 (422)
++||||+++|+|.+++..+... ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+|
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPES--------QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTT--------CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEEEEeccCCCHHHHHHhcccc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 9999999999999999765321 23589999999999999999999999 999999999999999999999
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCC-----ChHHHHHHH
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY-----SNQEVIEMI 281 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~-----~~~~~~~~i 281 (422)
|+|||+++........ ......+|+.|+|||++....++.++|||||||++|||++ |..||... ........+
T Consensus 175 l~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp ECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHH-CCCSBCHHHHTTTSCSBHHHHH
T ss_pred eccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHh-CCCcccccccccccchhHHHHH
Confidence 9999999865433222 2234457899999999988889999999999999999999 99999521 111122222
Q ss_pred Hc---CCC----------CCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhccc
Q psy7289 282 RS---RQM----------LPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAA 329 (422)
Q Consensus 282 ~~---~~~----------~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk~ 329 (422)
.. ... ...+..+++.+.+++..||+.+|..|+ +...+.+.|+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~L~~ 308 (326)
T 3uim_A 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERP-----KMSEVVRMLEG 308 (326)
T ss_dssp TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSC-----CHHHHHHHHHT
T ss_pred HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCC-----CHHHHHHHhcC
Confidence 11 110 111223446789999999999999998 66666666654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=338.61 Aligned_cols=243 Identities=24% Similarity=0.393 Sum_probs=183.4
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC--HHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN--QKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
.+|++.+.||+|+||.||+|+... .+..||||.+..... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIH--TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEcc--CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 468899999999999999998643 357799999854221 1224678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
||||+++|+|.+++..+. ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||
T Consensus 89 v~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg 157 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRV-----------KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFG 157 (278)
T ss_dssp EEECCTTEEHHHHHHTCS-----------SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCT
T ss_pred EEecCCCCcHHHHHhhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeec
Confidence 999999999999997542 358999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCC
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPE 291 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~ 291 (422)
+++....... ......+|+.|+|||.+....++.++|||||||++|||++ |..||...+..+....+.... ...|.
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~ 233 (278)
T 3cok_A 158 LATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLI-GRPPFDTDTVKNTLNKVVLAD-YEMPS 233 (278)
T ss_dssp TCEECC------------------------------CTHHHHHHHHHHHHHH-SSCSSCCCSCC-----CCSSC-CCCCT
T ss_pred ceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCChhHHHHHHHHhhcc-cCCcc
Confidence 9976542211 1223456889999999998889999999999999999998 999998877666655544332 34577
Q ss_pred CCCcchhhhcccccccccchhh
Q psy7289 292 DCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 292 ~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.+++++.+++.+||..+|..|+
T Consensus 234 ~~~~~~~~li~~~l~~dp~~Rp 255 (278)
T 3cok_A 234 FLSIEAKDLIHQLLRRNPADRL 255 (278)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSC
T ss_pred ccCHHHHHHHHHHcccCHhhCC
Confidence 8899999999999999999997
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=339.35 Aligned_cols=248 Identities=22% Similarity=0.389 Sum_probs=197.5
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc--CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
..+|++.+.||+|+||.||+|+... ++..||||+++.. ........+.+|+.++++++||||+++++++.+.+..+
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLL--DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETT--TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcC--CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 4578999999999999999998654 3578999998642 34556678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+||||+++|+|.+++...... ...+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+||
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Df 180 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQ--------KRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDL 180 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHT--------TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEecCCCCCHHHHHHHhccc--------ccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEec
Confidence 999999999999999753211 135899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCC--ChHHHHHHHHcCCCCC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY--SNQEVIEMIRSRQMLP 288 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~--~~~~~~~~i~~~~~~~ 288 (422)
|+++....... ......+++.|+|||++....++.++|||||||++|||++ |..||.+. +..++...+.....++
T Consensus 181 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 257 (310)
T 2wqm_A 181 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-LQSPFYGDKMNLYSLCKKIEQCDYPP 257 (310)
T ss_dssp --------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTC---CCHHHHHHHHHTTCSCC
T ss_pred cceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHh-CCCCCcccchhHHHHHHHhhcccCCC
Confidence 99876543221 1223456889999999998899999999999999999999 88999764 3446666777666555
Q ss_pred CC-CCCCcchhhhcccccccccchhh
Q psy7289 289 CP-EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 289 ~p-~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.+ ..+|+++.+++.+||+.+|..|+
T Consensus 258 ~~~~~~~~~l~~li~~~l~~dp~~Rp 283 (310)
T 2wqm_A 258 LPSDHYSEELRQLVNMCINPDPEKRP 283 (310)
T ss_dssp CCTTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred CcccccCHHHHHHHHHHcCCChhhCC
Confidence 44 67899999999999999999998
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=342.09 Aligned_cols=250 Identities=21% Similarity=0.235 Sum_probs=197.0
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCCe
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~ 129 (422)
...+|++.++||+|+||.||+|+... ++..||||++... ........+.+|+..+.++ +||||+++++++.++..+
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKE--DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT--TSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECC--CCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 34678999999999999999998753 3578999987643 2334445566677666555 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEec
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISD 209 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~D 209 (422)
++||||+ +|+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~D 200 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAWG-----------ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGD 200 (311)
T ss_dssp EEEEECC-CCBHHHHHHHHC-----------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECC
T ss_pred EEEEecc-CCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEcc
Confidence 9999999 679999987652 3589999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC-C
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML-P 288 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~-~ 288 (422)
||+++...... ......+|+.|+|||++.+ .++.++|||||||++|||++ |..|+.+. +....+..+..+ .
T Consensus 201 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~-g~~~~~~~---~~~~~~~~~~~~~~ 272 (311)
T 3p1a_A 201 FGLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVAC-NMELPHGG---EGWQQLRQGYLPPE 272 (311)
T ss_dssp CTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHH-TCCCCSSH---HHHHHHTTTCCCHH
T ss_pred ceeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHh-CCCCCCCc---cHHHHHhccCCCcc
Confidence 99997654322 2234457899999998875 79999999999999999999 65555443 233344443322 2
Q ss_pred CCCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 289 CPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 289 ~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
.+..+++++.+++.+||..+|..|+ +..+.+|.++
T Consensus 273 ~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 308 (311)
T 3p1a_A 273 FTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308 (311)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred cccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccc
Confidence 3567899999999999999999987 2334444443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=335.84 Aligned_cols=241 Identities=19% Similarity=0.253 Sum_probs=202.0
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCCeE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~ 130 (422)
..+|++.+.||+|+||.||+|+... .+..||||.++... .......+.+|+..+..+ +||||+++++++.+++..+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRL--DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcC--CCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 3568899999999999999998753 35789999987532 334557888999999999 8999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC---------
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD--------- 201 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~--------- 201 (422)
+||||+++|+|.+++..... ....+++.++..++.||+.||+|||+++|+||||||+|||++.
T Consensus 88 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~ 159 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYR--------IMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASE 159 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHH--------HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------
T ss_pred EEEEecCCCcHHHHHHhhcc--------cccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccc
Confidence 99999999999999976421 0135899999999999999999999999999999999999984
Q ss_pred ----------CCeEEEecCcccccccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCC
Q psy7289 202 ----------GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYY 270 (422)
Q Consensus 202 ----------~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~ 270 (422)
...+||+|||+++..... ....+|+.|+|||++... .++.++|||||||++|||++ |.+|+.
T Consensus 160 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-~~~~~~ 232 (289)
T 1x8b_A 160 EGDEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAG-AEPLPR 232 (289)
T ss_dssp ----------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTT-CCCCCS
T ss_pred ccccccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhc-CCCCCc
Confidence 447999999999865432 223478899999998765 56689999999999999997 766654
Q ss_pred CCChHHHHHHHHcCCCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 271 GYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 271 ~~~~~~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.. +....+..+..+..|..+|+++.+++.+||+.+|..|+
T Consensus 233 ~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 272 (289)
T 1x8b_A 233 NG---DQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRP 272 (289)
T ss_dssp SS---HHHHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSC
T ss_pred ch---hHHHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCC
Confidence 33 34556677777788899999999999999999999997
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=336.18 Aligned_cols=260 Identities=20% Similarity=0.294 Sum_probs=195.0
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHH-HHHHHHHHhcCCCCceeeEeeEEEcCCC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASD-FRREVDLMSELRHPNIVCLLGVCLSGEP 128 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~-~~~E~~il~~l~HpnIv~l~g~~~~~~~ 128 (422)
++...+|++.+.||+|+||.||+|+... .++.||||+++.......... +.++...++.++||||+++++++.+++.
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~ 80 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVP--SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD 80 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecC--CCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC
Confidence 4566789999999999999999998643 457899999876544444334 4455556888999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeecCCCeEEE
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSH-HYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~ivHrDlKp~NiLl~~~~~vKl 207 (422)
.++||||++ |+|.+++...... ...+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||
T Consensus 81 ~~lv~e~~~-~~l~~~l~~~~~~--------~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl 151 (290)
T 3fme_A 81 VWICMELMD-TSLDKFYKQVIDK--------GQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKM 151 (290)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHT--------TCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEB
T ss_pred EEEEEehhc-cchHHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEE
Confidence 999999998 5888887652111 13689999999999999999999998 9999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCcccc----ccCCCCCchhHHhHHHHHHHHHhCCCCCCCCC-ChHHH-HHHH
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESI----LYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY-SNQEV-IEMI 281 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~----~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~-~~~~~-~~~i 281 (422)
+|||+++...... ......+|+.|+|||++ ....++.++|||||||++|||++ |..||... ...+. ...+
T Consensus 152 ~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~ 227 (290)
T 3fme_A 152 CDFGISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAI-LRFPYDSWGTPFQQLKQVV 227 (290)
T ss_dssp CCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHH-TSCSSCCCSCHHHHHHHHH
T ss_pred eecCCcccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHH-CCCCccccCchHHHHHHHh
Confidence 9999997654332 12234578899999996 45678999999999999999999 99999863 33333 3344
Q ss_pred HcCCCCCCCCCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 282 RSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 282 ~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
........+..+|+++.+++.+||..+|..|+ +..+.+|.++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~ 271 (290)
T 3fme_A 228 EEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 271 (290)
T ss_dssp HSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred ccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccc
Confidence 44433334567899999999999999999987 33455555554
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=351.96 Aligned_cols=262 Identities=14% Similarity=0.156 Sum_probs=200.6
Q ss_pred hccccCcccccccccccceeEEEEEEecC-CCCeEEEEEEccCcCCHH----------hHHHHHHHHHHHhcCCCCceee
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTS-EGPSLVAIKTLKENANQK----------TASDFRREVDLMSELRHPNIVC 118 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~-~~~~~vavK~~~~~~~~~----------~~~~~~~E~~il~~l~HpnIv~ 118 (422)
++...+|++.+.||+|+||.||+|+.... .....||||......... ....+.+|+.+++.++||||++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 44567899999999999999999987541 134679999886543221 1134778999999999999999
Q ss_pred EeeEEEc----CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy7289 119 LLGVCLS----GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAA 194 (422)
Q Consensus 119 l~g~~~~----~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp 194 (422)
+++++.+ ....++||||+ +|+|.+++... ..+++.++..++.||+.||+|||+++|+||||||
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 179 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN------------GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKA 179 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG------------GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCH
Confidence 9999987 67899999999 99999999754 2589999999999999999999999999999999
Q ss_pred CceeecCCC--eEEEecCcccccccCCcce-----EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCC
Q psy7289 195 RNCLVGDGL--TVKISDFGLSRDVYASDYY-----RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQ 267 (422)
Q Consensus 195 ~NiLl~~~~--~vKl~DFGla~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~ 267 (422)
+|||++.++ .+||+|||+++........ .......+|+.|+|||++....++.++|||||||++|||++ |..
T Consensus 180 ~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~-g~~ 258 (345)
T 2v62_A 180 ANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLC-GKL 258 (345)
T ss_dssp GGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHH-SSC
T ss_pred HHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh-CCC
Confidence 999999877 9999999999865432111 11134467899999999998889999999999999999999 999
Q ss_pred CCCCCC-hHHHHHHHHcCCCCCC---------CCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcccc
Q psy7289 268 PYYGYS-NQEVIEMIRSRQMLPC---------PEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAAR 330 (422)
Q Consensus 268 Pf~~~~-~~~~~~~i~~~~~~~~---------p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk~~ 330 (422)
||.+.. ................ +..+|+++.+++..||..+|..|+ +...+...|+..
T Consensus 259 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~l~~~L~~~ 326 (345)
T 2v62_A 259 PWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKP-----NYQALKKILNPH 326 (345)
T ss_dssp TTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCC-----CHHHHHHHHCTT
T ss_pred CccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCC-----CHHHHHHHHhcc
Confidence 996532 2222222221111111 227899999999999999999998 777776666553
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=341.96 Aligned_cols=260 Identities=20% Similarity=0.373 Sum_probs=189.7
Q ss_pred chhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC
Q psy7289 47 FRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG 126 (422)
Q Consensus 47 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~ 126 (422)
..+.+...+|++.+.||+|+||.||+|+... .+..||||.+.........+.+.+|+.++++++||||+++++++...
T Consensus 8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 85 (303)
T 2vwi_A 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAP--KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK 85 (303)
T ss_dssp -----CCCCCEEEEECC---CCCEEEEEC------CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS
T ss_pred cccccchhhhhhhheeccccceEEEEEEECC--CCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec
Confidence 4456777899999999999999999997643 34679999986544444567789999999999999999999999999
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEE
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vK 206 (422)
+..++||||+++|+|.+++........ .....+++..+..++.||+.||+|||+++|+||||||+||+++.++.+|
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~----~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k 161 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGE----HKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQ 161 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTT----TTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEE
T ss_pred CCcEEEehhccCCchHHHHHHHhhccc----cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEE
Confidence 999999999999999999975211100 0124589999999999999999999999999999999999999999999
Q ss_pred EecCcccccccCCcc---eEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q psy7289 207 ISDFGLSRDVYASDY---YRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282 (422)
Q Consensus 207 l~DFGla~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~ 282 (422)
|+|||+++....... ........+|+.|+|||++.. ..++.++|||||||++|||++ |..||.+.+..+......
T Consensus 162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~ 240 (303)
T 2vwi_A 162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELAT-GAAPYHKYPPMKVLMLTL 240 (303)
T ss_dssp ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHH-SSCTTTTSCGGGHHHHHH
T ss_pred EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHh-CCCCCccCchhhHHHHHh
Confidence 999999876543211 111233457889999999875 568999999999999999999 999999888776665554
Q ss_pred cCCCCC---------CCCCCCcchhhhcccccccccchhh
Q psy7289 283 SRQMLP---------CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 283 ~~~~~~---------~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
...... .+..+|+++.+++.+||+.+|..|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 280 (303)
T 2vwi_A 241 QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280 (303)
T ss_dssp TSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred ccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCc
Confidence 433221 2356788999999999999999997
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=349.20 Aligned_cols=248 Identities=21% Similarity=0.334 Sum_probs=205.4
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC-------HHhHHHHHHHHHHHhcCCCCceeeEeeEEEc
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN-------QKTASDFRREVDLMSELRHPNIVCLLGVCLS 125 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 125 (422)
..+|++.+.||+|+||.||+|+... .+..||||+++.... ....+.+.+|+.++++++||||+++++++.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKE--KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETT--TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccceEEEeEEEecCCEEEEEEEECC--CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 4578999999999999999998644 457899999865321 1123457789999999999999999999999
Q ss_pred CCCeEEEEEecCCC-CHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCe
Q psy7289 126 GEPMCMLFEFMVRG-DLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLT 204 (422)
Q Consensus 126 ~~~~~lv~E~~~~G-~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~ 204 (422)
.+.+++||||+.+| +|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~ 168 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRH------------PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT 168 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTC------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCc
Confidence 99999999999877 999999764 35899999999999999999999999999999999999999999
Q ss_pred EEEecCcccccccCCcceEeccCCCCCccccCccccccCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc
Q psy7289 205 VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKF-TTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS 283 (422)
Q Consensus 205 vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~ 283 (422)
+||+|||+++....... .....+|+.|+|||++....+ +.++|||||||++|||++ |..||.+.... .
T Consensus 169 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~-------~ 237 (335)
T 3dls_A 169 IKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF-EENPFCELEET-------V 237 (335)
T ss_dssp EEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHH-SSCSCSSGGGG-------T
T ss_pred EEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHh-CCCchhhHHHH-------H
Confidence 99999999986644322 123457899999999988776 789999999999999998 99999763221 1
Q ss_pred CCCCCCCCCCCcchhhhcccccccccchhh-HHHHhhhhhhhh
Q psy7289 284 RQMLPCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHR 325 (422)
Q Consensus 284 ~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~ 325 (422)
......|..+++++.+|+.+||..+|..|+ +..+.+|.++..
T Consensus 238 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 238 EAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp TTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred hhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 223455778999999999999999999986 344556666644
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=340.17 Aligned_cols=252 Identities=24% Similarity=0.394 Sum_probs=210.6
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
...+|++.+.||+|+||.||+|+... .++.||+|.++.... ...+.+.+|+.++++++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRL--TGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECC--CCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence 34578899999999999999998653 357899999875332 234578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceee---cCCCeEEEe
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKIS 208 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl---~~~~~vKl~ 208 (422)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+||++ ++++.+||+
T Consensus 84 v~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~ 151 (304)
T 2jam_A 84 VMQLVSGGELFDRILER------------GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMIT 151 (304)
T ss_dssp EECCCCSCBHHHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBC
T ss_pred EEEcCCCccHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEc
Confidence 99999999999999764 258999999999999999999999999999999999999 778899999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC-
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML- 287 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~- 287 (422)
|||+++...... .....+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..++...+..+...
T Consensus 152 Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~ 226 (304)
T 2jam_A 152 DFGLSKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLC-GYPPFYEETESKLFEKIKEGYYEF 226 (304)
T ss_dssp SCSTTCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHCCCCC
T ss_pred cCCcceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHcCCCCC
Confidence 999997543221 122346789999999998899999999999999999999 99999999999988888876532
Q ss_pred --CCCCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 288 --PCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 288 --~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
+.+..+|+.+.+++.+||..+|..|+ +..+.+|.++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (304)
T 2jam_A 227 ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWI 265 (304)
T ss_dssp CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence 33467899999999999999999986 2334444444
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=336.85 Aligned_cols=258 Identities=26% Similarity=0.373 Sum_probs=210.0
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC---CHHhHHHHHHHHHHHhcCCCCceeeEeeEEE--cCC
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA---NQKTASDFRREVDLMSELRHPNIVCLLGVCL--SGE 127 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~ 127 (422)
..+|++.+.||+|+||.||+|+.. ..+..||+|+++... .......+.+|+.++++++||||+++++++. +..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDS--ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBT--TTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccceeEeeEEecCCCeEEEEEEEC--CCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 457999999999999999999753 345789999986432 1234568999999999999999999999984 455
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
..++||||+++| |.+++.... ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~----------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl 150 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVP----------EKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKI 150 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHST----------TCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE
T ss_pred eEEEEehhccCC-HHHHHHhCc----------ccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEe
Confidence 789999999987 777776532 135899999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCC--CCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK--FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ 285 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~ 285 (422)
+|||+++...............+|+.|+|||++.... ++.++|||||||++|||++ |..||.+.+..++...+..+.
T Consensus 151 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~i~~~~ 229 (305)
T 2wtk_C 151 SALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITT-GLYPFEGDNIYKLFENIGKGS 229 (305)
T ss_dssp CCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHCC
T ss_pred eccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHHHhcCC
Confidence 9999998654322222233455789999999987644 3779999999999999999 999999999888888887764
Q ss_pred CCCCCCCCCcchhhhcccccccccchhh-HHHHhhhhhhhh
Q psy7289 286 MLPCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHR 325 (422)
Q Consensus 286 ~~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~ 325 (422)
.+.|..+++.+.+++.+||..+|..|+ +..+.+|.++..
T Consensus 230 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 269 (305)
T 2wtk_C 230 -YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269 (305)
T ss_dssp -CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred -CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence 466788999999999999999999987 334555555543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=343.14 Aligned_cols=255 Identities=27% Similarity=0.404 Sum_probs=203.4
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
..+|++++.||+|+||.||+|+... .+..||||++.... .....+.+.+|+.++++++||||+++++++.+....++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKD--TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETT--TCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECC--CCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 4578999999999999999998643 35789999886443 34445678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 102 v~e~~~~~~l~~~~~~~------------~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 169 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFP------------NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFG 169 (331)
T ss_dssp EEECCSEEHHHHHHHST------------TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEecCCcchHHHHHhhc------------cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCC
Confidence 99999999999887543 358999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc--C----
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS--R---- 284 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~--~---- 284 (422)
+++....... ......+|+.|+|||++... .++.++|||||||++|||++ |..||.+.+..+....+.. +
T Consensus 170 ~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (331)
T 4aaa_A 170 FARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM-GEPLFPGDSDIDQLYHIMMCLGNLIP 246 (331)
T ss_dssp TC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred CceeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCh
Confidence 9976543221 22344578899999998765 68999999999999999999 9999999887766554431 1
Q ss_pred --------------CCCC----------CCCCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 285 --------------QMLP----------CPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 285 --------------~~~~----------~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
...+ ..+.+++.+.+|+.+||..+|..|+ +..+.+|.++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~ 311 (331)
T 4aaa_A 247 RHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311 (331)
T ss_dssp HHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred hhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhc
Confidence 1111 1135788999999999999999997 33344455443
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=347.22 Aligned_cols=249 Identities=25% Similarity=0.381 Sum_probs=199.5
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC----
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE---- 127 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~---- 127 (422)
..+|++++.||+|+||.||+|+... .+..||||++... ......+.+.+|+++|+.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGR--TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETT--TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cceEEEeEEeeecCCeEEEEEEECC--CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 4679999999999999999998643 3578999998543 34445678999999999999999999999997653
Q ss_pred --CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 128 --PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 128 --~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
.+|+||||+ +++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~~-------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~ 167 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKHE-------------KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCEL 167 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHHC-------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCE
T ss_pred CceEEEEEecC-CCCHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCE
Confidence 469999999 88999998752 48899999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR 284 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~ 284 (422)
||+|||+++..... .....+|+.|+|||++.. ..++.++||||+||++|||++ |..||.+.+..+.+..+...
T Consensus 168 kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~l~~i~~~ 241 (367)
T 1cm8_A 168 KILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT-GKTLFKGSDHLDQLKEIMKV 241 (367)
T ss_dssp EECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHH
T ss_pred EEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Confidence 99999999865322 234467889999999877 679999999999999999999 99999998877666555321
Q ss_pred --C----------------------------CCCCCCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 285 --Q----------------------------MLPCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 285 --~----------------------------~~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
. ....+..+++.+.+|+.+||..||..|+ +..+.+|.++
T Consensus 242 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f 311 (367)
T 1cm8_A 242 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311 (367)
T ss_dssp HCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred cCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHH
Confidence 0 0012346788899999999999999986 3344455554
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=347.28 Aligned_cols=257 Identities=23% Similarity=0.324 Sum_probs=209.4
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC-----C
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG-----E 127 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-----~ 127 (422)
..+|++++.||+|+||.||+|+... ++..||||++.........+.+.+|++++++++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECC--CCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 3689999999999999999998643 45789999997655566668899999999999999999999999755 3
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
..++||||+. |+|.+++... .+++.++..++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~~-------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl 169 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKTQ-------------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKI 169 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHHC-------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEE
T ss_pred eEEEEEcccC-cCHHHHHHhC-------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEE
Confidence 6899999998 5999999653 4899999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcce-EeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC
Q psy7289 208 SDFGLSRDVYASDYY-RIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ 285 (422)
Q Consensus 208 ~DFGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~ 285 (422)
+|||+++........ .......+|+.|+|||++.. ..++.++|||||||++|||++ |..||.+.+..+.+..+....
T Consensus 170 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~ 248 (364)
T 3qyz_A 170 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-NRPIFPGKHYLDQLNHILGIL 248 (364)
T ss_dssp CCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHH-SSCSSCCSSGGGHHHHHHHHH
T ss_pred EeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHH-CCCCCCCCChHHHHHHHHHHh
Confidence 999999865432211 11234467899999998765 458999999999999999999 999999888776665553210
Q ss_pred C---------------------------CC---CCCCCCcchhhhcccccccccchhh-HHHHhhhhhhhhh
Q psy7289 286 M---------------------------LP---CPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRD 326 (422)
Q Consensus 286 ~---------------------------~~---~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~d 326 (422)
. .+ .+..+++++.+|+.+||..+|..|+ +..+.+|.++...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 249 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred CCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 0 00 1245788899999999999999986 3445566666543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=340.72 Aligned_cols=252 Identities=31% Similarity=0.491 Sum_probs=201.9
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcC---CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA---NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
+...+.||+|+||.||+|+. .+..||||.+.... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 108 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV----NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLV 108 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES----SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred cccCCccccCCCeEEEEEEE----CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEE
Confidence 34458899999999999974 24679999886432 234467899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++|+|.+++..... ..++++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+
T Consensus 109 ~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~ 179 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCLDG---------TPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGL 179 (307)
T ss_dssp EECCTTCBHHHHHHTGGG---------CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred EEecCCCcHHHHHHhccC---------CCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 999999999999975321 13589999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHH----HHHHHHcC----
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE----VIEMIRSR---- 284 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~----~~~~i~~~---- 284 (422)
++...............+|+.|+|||.+.+ .++.++|||||||++|||++ |..||.+.+..+ +...+...
T Consensus 180 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 257 (307)
T 2nru_A 180 ARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIIT-GLPAVDEHREPQLLLDIKEEIEDEEKTI 257 (307)
T ss_dssp CEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHH-CCCSBCTTBSSSBTTHHHHHHHTTSCCH
T ss_pred ccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHH-CCCCcccCcchHHHHHHHHHhhhhhhhh
Confidence 986544333333445567899999998764 58999999999999999999 999998765432 22222221
Q ss_pred ------CCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 285 ------QMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 285 ------~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
...+.+..+++.+.+++.+||+.+|..|+ +...+.+.|
T Consensus 258 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~l~~~L 301 (307)
T 2nru_A 258 EDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRP-----DIKKVQQLL 301 (307)
T ss_dssp HHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSC-----CHHHHHHHH
T ss_pred hhhccccccccchHHHHHHHHHHHHHcCCCcccCc-----CHHHHHHHH
Confidence 12223445667899999999999999998 555444433
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=331.93 Aligned_cols=254 Identities=22% Similarity=0.352 Sum_probs=211.6
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC----C----HHhHHHHHHHHHHHhcCC-CCceeeEeeE
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA----N----QKTASDFRREVDLMSELR-HPNIVCLLGV 122 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~----~----~~~~~~~~~E~~il~~l~-HpnIv~l~g~ 122 (422)
...+|++.+.||+|+||.||+|+... .++.||||+++... . ....+.+.+|++++++++ ||||++++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKP--TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcC--cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 34678999999999999999998743 45789999986432 1 123467889999999996 9999999999
Q ss_pred EEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC
Q psy7289 123 CLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG 202 (422)
Q Consensus 123 ~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~ 202 (422)
+.+....++||||+++|+|.+++..+ ..+++..+..++.||+.||+|||++|++||||||+||+++.+
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~ 160 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTEK------------VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD 160 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred eccCCeEEEEEeccCCCcHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCC
Confidence 99999999999999999999999764 358999999999999999999999999999999999999999
Q ss_pred CeEEEecCcccccccCCcceEeccCCCCCccccCccccc------cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHH
Q psy7289 203 LTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL------YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 276 (422)
Q Consensus 203 ~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~------~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~ 276 (422)
+.+||+|||+++...... ......+++.|+|||++. ...++.++||||||+++|||++ |..||.+.+..+
T Consensus 161 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~ 236 (298)
T 1phk_A 161 MNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA-GSPPFWHRKQML 236 (298)
T ss_dssp CCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHH
T ss_pred CcEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHH-CCCCCcCccHHH
Confidence 999999999997654332 123345788999999885 4568899999999999999999 999999999888
Q ss_pred HHHHHHcCCCCC-CC--CCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 277 VIEMIRSRQMLP-CP--EDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 277 ~~~~i~~~~~~~-~p--~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
....+..+.... .| ..+|+.+.+++.+||..+|..|+ +..+.+|.++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (298)
T 1phk_A 237 MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287 (298)
T ss_dssp HHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred HHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHh
Confidence 888887655332 22 46889999999999999999997 2334444443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=344.55 Aligned_cols=253 Identities=22% Similarity=0.375 Sum_probs=211.3
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC---H----HhHHHHHHHHHHHhcC-CCCceeeEeeEEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN---Q----KTASDFRREVDLMSEL-RHPNIVCLLGVCL 124 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~---~----~~~~~~~~E~~il~~l-~HpnIv~l~g~~~ 124 (422)
..+|++.+.||+|+||.||+|+... ++..||||+++.... . ...+.+.+|+.+++++ +||||+++++++.
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRA--TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhcccceEEecCCCEEEEEEEECC--CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 3568888999999999999998753 357899999864321 1 2245788999999999 7999999999999
Q ss_pred cCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCe
Q psy7289 125 SGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLT 204 (422)
Q Consensus 125 ~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~ 204 (422)
.....++||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~------------~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ 238 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEK------------VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ 238 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 999999999999999999999764 35899999999999999999999999999999999999999999
Q ss_pred EEEecCcccccccCCcceEeccCCCCCccccCcccccc------CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHH
Q psy7289 205 VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY------GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVI 278 (422)
Q Consensus 205 vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~ 278 (422)
+||+|||++........ .....+|+.|+|||++.. ..++.++|||||||++|||++ |..||.+.+..+..
T Consensus 239 ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~ 314 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA-GSPPFWHRRQILML 314 (365)
T ss_dssp EEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHH
T ss_pred EEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHH-CCCCCCCCCHHHHH
Confidence 99999999986644321 234567899999998863 358899999999999999999 99999999888888
Q ss_pred HHHHcCCCCCC---CCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 279 EMIRSRQMLPC---PEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 279 ~~i~~~~~~~~---p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
..+..+..... +..+|+.+.+++.+||..+|..|+ +..+.+|.++
T Consensus 315 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f 363 (365)
T 2y7j_A 315 RMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363 (365)
T ss_dssp HHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence 88877654332 257888999999999999999986 2334444443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=347.70 Aligned_cols=251 Identities=26% Similarity=0.340 Sum_probs=197.9
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC----
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE---- 127 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~---- 127 (422)
..+|++++.||+|+||.||+|+... .+..||||++... ......+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAI--LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhheeEeeeeEecCCEEEEEEEECC--CCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 4689999999999999999998643 4578999998653 34455678899999999999999999999997665
Q ss_pred --CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 128 --PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 128 --~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
..++||||++ |+|.+++.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 102 ~~~~~lv~e~~~-~~l~~~~~~--------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~ 166 (371)
T 2xrw_A 102 FQDVYIVMELMD-ANLCQVIQM--------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 166 (371)
T ss_dssp CCEEEEEEECCS-EEHHHHHHS--------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCE
T ss_pred ccceEEEEEcCC-CCHHHHHhh--------------ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCE
Confidence 6799999997 478888852 37899999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ 285 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~ 285 (422)
||+|||+++...... ......+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..+.+..+....
T Consensus 167 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~~ 242 (371)
T 2xrw_A 167 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK-GGVLFPGTDHIDQWNKVIEQL 242 (371)
T ss_dssp EECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHC-C
T ss_pred EEEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHh
Confidence 999999998653321 1233467889999999999899999999999999999999 999999998888777776543
Q ss_pred CCCCCC-----------------------------------------CCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 286 MLPCPE-----------------------------------------DCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 286 ~~~~p~-----------------------------------------~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
..++|+ .+++++.+|+.+||..||..|+ +..+.+|.++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 322 (371)
T 2xrw_A 243 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322 (371)
T ss_dssp CCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred CCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcch
Confidence 222210 0145678999999999999986 3345556665
Q ss_pred h
Q psy7289 324 H 324 (422)
Q Consensus 324 ~ 324 (422)
.
T Consensus 323 ~ 323 (371)
T 2xrw_A 323 N 323 (371)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=338.66 Aligned_cols=245 Identities=23% Similarity=0.388 Sum_probs=203.7
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
...+|++.+.||+|+||.||+|++.. .+..||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKE--TGALAAAKVIETK-SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETT--TCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcC--CCcEEEEEEecCC-CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence 45679999999999999999998753 3578999988643 23345789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
||||+++|+|.+++.... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||
T Consensus 94 v~e~~~~~~l~~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 162 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELD-----------RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFG 162 (302)
T ss_dssp EEECCTTEEHHHHHHHHT-----------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCH
T ss_pred EEEeCCCCcHHHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECC
Confidence 999999999999987642 358999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccc-----cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESIL-----YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~ 286 (422)
++....... .......+|+.|+|||++. ...++.++|||||||++|||++ |..||...+..+....+.....
T Consensus 163 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 239 (302)
T 2j7t_A 163 VSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ-IEPPHHELNPMRVLLKIAKSDP 239 (302)
T ss_dssp HHHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSCC
T ss_pred CCccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhc-CCCCCccCCHHHHHHHHhccCC
Confidence 975432111 0112345788999999883 5678999999999999999998 9999999988887777765543
Q ss_pred C--CCCCCCCcchhhhcccccccccchhh
Q psy7289 287 L--PCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 287 ~--~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+ ..|..+|+.+.+++.+||+.+|..|+
T Consensus 240 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (302)
T 2j7t_A 240 PTLLTPSKWSVEFRDFLKIALDKNPETRP 268 (302)
T ss_dssp CCCSSGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred cccCCccccCHHHHHHHHHHcccChhhCC
Confidence 3 34667889999999999999999997
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=348.97 Aligned_cols=254 Identities=22% Similarity=0.299 Sum_probs=200.3
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC----
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG---- 126 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~---- 126 (422)
....+|++.+.||+|+||.||+|+... .+..||||++..... ...+|+++|+.++|||||++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~--~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIE--SGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETT--TCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECC--CCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 345689999999999999999998654 357899998864322 123799999999999999999998543
Q ss_pred ----------------------------------CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHH
Q psy7289 127 ----------------------------------EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIA 172 (422)
Q Consensus 127 ----------------------------------~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~ 172 (422)
..+++||||++ |+|.+.+...... ...+++..+..++
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--------~~~l~~~~~~~i~ 147 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS--------GRSIPMNLISIYI 147 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT--------TCCCCHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc--------CCCCCHHHHHHHH
Confidence 34889999998 5888887642111 1368999999999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCceeec-CCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccC-CCCCchh
Q psy7289 173 LQVAAGMAYLCSHHYVHRDLAARNCLVG-DGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESD 250 (422)
Q Consensus 173 ~qi~~gL~yLH~~~ivHrDlKp~NiLl~-~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~D 250 (422)
.||+.||+|||++||+||||||+|||++ .++.+||+|||+++...... ......+|+.|+|||++.+. .++.++|
T Consensus 148 ~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~D 224 (383)
T 3eb0_A 148 YQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSID 224 (383)
T ss_dssp HHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHH
T ss_pred HHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchh
Confidence 9999999999999999999999999998 68899999999998654332 12334568889999998765 4899999
Q ss_pred HHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC--C----------------CC----------CCCCCCCcchhhhcc
Q psy7289 251 VWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR--Q----------------ML----------PCPEDCPPRMYSLMM 302 (422)
Q Consensus 251 vwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~--~----------------~~----------~~p~~~p~~~~~l~~ 302 (422)
|||+||++|||++ |..||.+.+..+.+..+... . .. ..|..+|+++.+|+.
T Consensus 225 iwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 303 (383)
T 3eb0_A 225 LWSIGCVFGELIL-GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLE 303 (383)
T ss_dssp HHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHH
T ss_pred hhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHH
Confidence 9999999999999 99999998887766655321 0 00 035668889999999
Q ss_pred cccccccchhh-HHHHhhhhhhh
Q psy7289 303 ECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 303 ~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
+||..+|..|+ +..+.+|.++.
T Consensus 304 ~~L~~dP~~R~t~~e~l~hp~f~ 326 (383)
T 3eb0_A 304 QILRYEPDLRINPYEAMAHPFFD 326 (383)
T ss_dssp HHCCSSGGGSCCHHHHHTSGGGH
T ss_pred HHccCChhhCCCHHHHhcCHHHH
Confidence 99999999985 33455566553
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=342.59 Aligned_cols=259 Identities=22% Similarity=0.368 Sum_probs=205.3
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC-----
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSG----- 126 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~----- 126 (422)
..+|++++.||+|+||.||+|+... .+..||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRK--TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETT--TCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred ccceeEEEEEecCCCcEEEEEEECC--CCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 3679999999999999999998754 35789999885433 222345788999999999999999999999874
Q ss_pred ---CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC
Q psy7289 127 ---EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL 203 (422)
Q Consensus 127 ---~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~ 203 (422)
+.+++||||+++ +|.+.+.... ..+++.++..++.||+.||+|||++||+||||||+|||++.++
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~ 161 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVL-----------VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG 161 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTT-----------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS
T ss_pred cCCceEEEEEeccCC-CHHHHHhhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC
Confidence 458999999985 8888876532 3589999999999999999999999999999999999999999
Q ss_pred eEEEecCcccccccCCc--ceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHH
Q psy7289 204 TVKISDFGLSRDVYASD--YYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEM 280 (422)
Q Consensus 204 ~vKl~DFGla~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~ 280 (422)
.+||+|||+++...... .........+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....
T Consensus 162 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~ 240 (351)
T 3mi9_A 162 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLAL 240 (351)
T ss_dssp CEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHH
T ss_pred CEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Confidence 99999999998654221 1112234567899999999876 458999999999999999999 9999999988887776
Q ss_pred HHcCCCCCCCCC-------------------------------CCcchhhhcccccccccchhh-HHHHhhhhhhhhh
Q psy7289 281 IRSRQMLPCPED-------------------------------CPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRD 326 (422)
Q Consensus 281 i~~~~~~~~p~~-------------------------------~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~d 326 (422)
+......+.+.. .++.+.+|+.+||..||..|+ +..+.+|.++..+
T Consensus 241 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 241 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp HHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred HHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 653211111111 145688999999999999986 3445566666543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=335.44 Aligned_cols=255 Identities=24% Similarity=0.409 Sum_probs=207.6
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
....+|++.+.||+|+||.||+|+... .+..||||.+.... ..+.+.+|+.+++.++||||+++++++.+....+
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKE--TGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETT--TCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECC--CCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 456789999999999999999998643 35789999986533 2357889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+||||+++|+|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+||
T Consensus 101 lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df 169 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRN-----------KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADF 169 (314)
T ss_dssp EEEECCTTEEHHHHHHHHT-----------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCC
T ss_pred EEeecCCCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeec
Confidence 9999999999999997432 35899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC--CC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM--LP 288 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~--~~ 288 (422)
|+++....... ......+++.|+|||.+....++.++|||||||++|||++ |..||.+.+..+....+..... ..
T Consensus 170 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (314)
T 3com_A 170 GVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAE-GKPPYADIHPMRAIFMIPTNPPPTFR 246 (314)
T ss_dssp TTCEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSCCCCCS
T ss_pred ccchhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCcccC
Confidence 99976543221 1233457889999999998889999999999999999999 9999998887777666655433 23
Q ss_pred CCCCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 289 CPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 289 ~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
.|..+|+.+.+++.+||..+|..|+ +..+.+|.++.
T Consensus 247 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~ 283 (314)
T 3com_A 247 KPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283 (314)
T ss_dssp SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred CcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence 4567889999999999999999987 33444555543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=343.48 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=202.0
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCH----HhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQ----KTASDFRREVDLMSELRHPNIVCLLGVCLSGEP 128 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 128 (422)
..+|++.+.||+|+||.||+|+... .+..||||+++..... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKN--TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSS--CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred hcccEEEeEEeecCCEEEEEEEECC--CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 4578999999999999999998643 3578999998643221 122468899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
.++||||+++ +|.+++.... ..+++.++..++.|++.||+|||+++|+||||||+|||++.++.+||+
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~ 154 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS-----------LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLA 154 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC-----------SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred eEEEEEcCCC-CHHHHHHhcC-----------cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEE
Confidence 9999999986 8999886532 358888999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
|||+++....... ......+|+.|+|||++... .++.++|||||||++|||++ |.+||.+.+..+.+..+......
T Consensus 155 Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~~~~~~~~~~~~~~i~~~~~~ 231 (346)
T 1ua2_A 155 DFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRIFETLGT 231 (346)
T ss_dssp CCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHHHCC
T ss_pred ecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHcCC
Confidence 9999986543221 22345678999999998754 58999999999999999999 99999998888777666432111
Q ss_pred C----------------------C-----CCCCCcchhhhcccccccccchhh-HHHHhhhhhhhh
Q psy7289 288 P----------------------C-----PEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHR 325 (422)
Q Consensus 288 ~----------------------~-----p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~ 325 (422)
+ . ...+++++.+|+.+||..+|..|+ +..+.+|.++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~ 297 (346)
T 1ua2_A 232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297 (346)
T ss_dssp CCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred CChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence 1 0 134567899999999999999987 334555666543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=341.57 Aligned_cols=258 Identities=21% Similarity=0.320 Sum_probs=210.2
Q ss_pred hccccCcccc-cccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCC-CCceeeEeeEEEcC
Q psy7289 50 EVIETKPRFL-QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELR-HPNIVCLLGVCLSG 126 (422)
Q Consensus 50 ~~~~~~~~~~-~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~ 126 (422)
+....+|.+. +.||+|+||.||+|+... .+..||||+++... .......+.+|+.+++.++ ||||+++++++.+.
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKS--TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECC--CCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 4455677777 889999999999998754 35789999986533 2334568899999999995 69999999999999
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC---CC
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD---GL 203 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~---~~ 203 (422)
...++||||+++|+|.+++.... ...+++.++..++.|++.||+|||++||+||||||+|||++. ++
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~ 171 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPEL----------AEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLG 171 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC-----------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBC
T ss_pred CeEEEEEEecCCCcHHHHHHHhc----------ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCC
Confidence 99999999999999999885431 235899999999999999999999999999999999999987 78
Q ss_pred eEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc
Q psy7289 204 TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS 283 (422)
Q Consensus 204 ~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~ 283 (422)
.+||+|||+++...... ......+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..+....+..
T Consensus 172 ~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~ 247 (327)
T 3lm5_A 172 DIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT-HTSPFVGEDNQETYLNISQ 247 (327)
T ss_dssp CEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHH
T ss_pred cEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHh
Confidence 99999999998654322 1233467899999999999999999999999999999999 9999999998888877765
Q ss_pred CCCC---CCCCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 284 RQML---PCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 284 ~~~~---~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
.... +.+..+++.+.+++.+||..+|..|+ +..+.+|.++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~ 291 (327)
T 3lm5_A 248 VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291 (327)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGG
T ss_pred cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhh
Confidence 4332 23457899999999999999999997 2234444443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=344.92 Aligned_cols=259 Identities=21% Similarity=0.294 Sum_probs=209.9
Q ss_pred chhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc
Q psy7289 47 FRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLS 125 (422)
Q Consensus 47 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 125 (422)
..+++...+|++.+.||+|+||.||+|++.. .||+|+++... .....+.+.+|+.++++++||||+++++++.+
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 100 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-----EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS-----SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC-----eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 3456778899999999999999999998632 38999886432 22234567889999999999999999999999
Q ss_pred CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 126 GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 126 ~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
.+..++||||+++|+|.+++.... ..+++.++..++.||+.||+|||+++|+||||||+|||++ ++.+
T Consensus 101 ~~~~~iv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~ 168 (319)
T 2y4i_B 101 PPHLAIITSLCKGRTLYSVVRDAK-----------IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKV 168 (319)
T ss_dssp SSCEEEECBCCCSEEHHHHTTSSC-----------CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CC
T ss_pred CCceEEEeecccCCcHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCE
Confidence 999999999999999999996532 3588999999999999999999999999999999999998 6799
Q ss_pred EEecCcccccccCCcce---EeccCCCCCccccCcccccc---------CCCCCchhHHhHHHHHHHHHhCCCCCCCCCC
Q psy7289 206 KISDFGLSRDVYASDYY---RIQSKSLLPVRWMPPESILY---------GKFTTESDVWSYGVVLWEVYSYGLQPYYGYS 273 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~---------~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~ 273 (422)
||+|||+++........ .......+++.|+|||.+.. ..++.++|||||||++|||++ |..||.+.+
T Consensus 169 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~ 247 (319)
T 2y4i_B 169 VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA-REWPFKTQP 247 (319)
T ss_dssp EECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHH-SSCSSSSCC
T ss_pred EEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Confidence 99999998754321111 11223346788999999874 357889999999999999999 999999999
Q ss_pred hHHHHHHHHcCCCCCCC-CCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 274 NQEVIEMIRSRQMLPCP-EDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 274 ~~~~~~~i~~~~~~~~p-~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
..++...+..+..+..+ ..+|+++.+++.+||..+|..|+ +...+...|+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~l~~~l~ 298 (319)
T 2y4i_B 248 AEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERP-----TFTKLMDMLE 298 (319)
T ss_dssp HHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSC-----CHHHHHHHHT
T ss_pred HHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCc-----CHHHHHHHHH
Confidence 99998888877665543 47899999999999999999998 5555554443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=357.89 Aligned_cols=251 Identities=14% Similarity=0.075 Sum_probs=192.1
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc--CCHHhHHHHHHHH---HHHhcCCCCceeeEe-------
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREV---DLMSELRHPNIVCLL------- 120 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~---~il~~l~HpnIv~l~------- 120 (422)
..+|++.+.||+|+||.||+|++.. +++.||||++... ......+.|.+|+ ++|++++|||||+++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQE--TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-C--CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CceEEEcceeecCCCEEEEEEEECC--CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 4678889999999999999998643 3578999998632 2334567899999 555666899999998
Q ss_pred eEEEcCC-----------------CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHH
Q psy7289 121 GVCLSGE-----------------PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLC 183 (422)
Q Consensus 121 g~~~~~~-----------------~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH 183 (422)
+++.+++ ..|+||||+ +|+|.+++....... .....+++..+..++.||+.||+|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~-----~~~~~l~~~~~~~i~~qi~~aL~~LH 223 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS-----STHKSLVHHARLQLTLQVIRLLASLH 223 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTT-----TTTHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccc-----cccccccHHHHHHHHHHHHHHHHHHH
Confidence 6665543 388999999 689999998642110 00123445788889999999999999
Q ss_pred hCCccccCCCCCceeecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccC-----------CCCCchhHH
Q psy7289 184 SHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-----------KFTTESDVW 252 (422)
Q Consensus 184 ~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----------~~~~~~Dvw 252 (422)
+++|+||||||+|||++.++.+||+|||+++.... ......+ +.|+|||++... .++.++|||
T Consensus 224 ~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dvw 297 (377)
T 3byv_A 224 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAW 297 (377)
T ss_dssp HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHH
T ss_pred hCCeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHH
Confidence 99999999999999999999999999999985322 1223345 889999999887 899999999
Q ss_pred hHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 253 SYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 253 S~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
||||++|||++ |..||.+.+..+....+. ..+..+|+++.+|+.+||..+|..|+ +..+.+|.++
T Consensus 298 SlG~il~ellt-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f 363 (377)
T 3byv_A 298 ALGLVIYWIWC-ADLPITKDAALGGSEWIF-----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363 (377)
T ss_dssp HHHHHHHHHHH-SSCCC------CCSGGGG-----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHH
T ss_pred HHHHHHHHHHH-CCCCCcccccccchhhhh-----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHH
Confidence 99999999999 999998776554443332 23467899999999999999999987 3334444444
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=355.79 Aligned_cols=258 Identities=21% Similarity=0.351 Sum_probs=187.5
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC----
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG---- 126 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~---- 126 (422)
...+|++++.||+|+||.||+|+...+ +..||||++... ......+.+.+|+.+|+.++|||||++++++...
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~--~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLE--KRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC----CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCC--CcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 346899999999999999999987543 578999998643 3445567899999999999999999999998543
Q ss_pred -CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 127 -EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 127 -~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
..+|+||||+. |+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+
T Consensus 129 ~~~~~lv~e~~~-~~L~~~~~~~------------~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~ 195 (458)
T 3rp9_A 129 FDELYVVLEIAD-SDFKKLFRTP------------VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSV 195 (458)
T ss_dssp CCCEEEEECCCS-EEHHHHHHSS------------CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCE
T ss_pred CceEEEEEeccc-cchhhhcccC------------CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCE
Confidence 46899999984 7999999653 358999999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcce-------------------------EeccCCCCCccccCccccc-cCCCCCchhHHhHHHHHH
Q psy7289 206 KISDFGLSRDVYASDYY-------------------------RIQSKSLLPVRWMPPESIL-YGKFTTESDVWSYGVVLW 259 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~-------------------------~~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwS~Gvil~ 259 (422)
||+|||+++........ .......+|+.|+|||++. ...++.++|||||||++|
T Consensus 196 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ 275 (458)
T 3rp9_A 196 KVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFA 275 (458)
T ss_dssp EECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred eecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHH
Confidence 99999999875422110 1123346789999999864 567999999999999999
Q ss_pred HHHhC----------CCCCCCCCCh--------------------HHHHHHHHc--CC--------------------C-
Q psy7289 260 EVYSY----------GLQPYYGYSN--------------------QEVIEMIRS--RQ--------------------M- 286 (422)
Q Consensus 260 El~t~----------g~~Pf~~~~~--------------------~~~~~~i~~--~~--------------------~- 286 (422)
||++. |.++|.+.+. .+.+..|.. +. .
T Consensus 276 elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 355 (458)
T 3rp9_A 276 ELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFP 355 (458)
T ss_dssp HHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSC
T ss_pred HHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcC
Confidence 99973 5666665431 111111110 00 0
Q ss_pred -------CCCCCCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 287 -------LPCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 287 -------~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
....+.+++++.+|+.+||..||..|+ +..+.+|.++.
T Consensus 356 ~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~ 401 (458)
T 3rp9_A 356 KREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFK 401 (458)
T ss_dssp CCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred CCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhh
Confidence 001235678899999999999999986 34455566654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=340.91 Aligned_cols=256 Identities=23% Similarity=0.345 Sum_probs=205.5
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC-----
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG----- 126 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~----- 126 (422)
+..+|++.+.||+|+||.||+|+... .+..||||++...........+.+|+.++++++||||+++++++...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKP--TGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECC--CCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 45689999999999999999998643 35789999997655566677889999999999999999999988654
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEE
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vK 206 (422)
...++||||+. |+|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~~-------------~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~k 152 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVISTQ-------------MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLK 152 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHHC-------------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEE
T ss_pred ceEEEEEeccC-ccHHHHHhhc-------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEE
Confidence 67899999997 6999998752 489999999999999999999999999999999999999999999
Q ss_pred EecCcccccccCCcceE--------eccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHH
Q psy7289 207 ISDFGLSRDVYASDYYR--------IQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEV 277 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~ 277 (422)
|+|||+++......... ......+|+.|+|||++.. ..++.++|||||||++|||++ |..||.+.+..+.
T Consensus 153 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~ 231 (353)
T 2b9h_A 153 VCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQ 231 (353)
T ss_dssp ECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHH
T ss_pred EEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHh-CCCCCCCCCcHHH
Confidence 99999998654321110 1123457889999998765 678999999999999999998 9999999887665
Q ss_pred HHHHHc--CC-----------------------CCC------CCCCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 278 IEMIRS--RQ-----------------------MLP------CPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 278 ~~~i~~--~~-----------------------~~~------~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
+..+.. +. ..+ .++.+|+++.+|+.+||..||..|+ +..+.+|.++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 310 (353)
T 2b9h_A 232 LLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310 (353)
T ss_dssp HHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred HHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 544421 00 000 1246788999999999999999997 33455555543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=355.18 Aligned_cols=254 Identities=22% Similarity=0.343 Sum_probs=197.9
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-------CHHhHHHHHHHHHHHhcCCCCceeeEeeEE
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-------NQKTASDFRREVDLMSELRHPNIVCLLGVC 123 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~il~~l~HpnIv~l~g~~ 123 (422)
....+|++.+.||+|+||.||+|+... .+..||||++.... .......+.+|+.+|++++|||||++++++
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~ 209 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERK--TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF 209 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETT--TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECC--CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 345689999999999999999998654 35789999986421 111223588999999999999999999998
Q ss_pred EcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC-
Q psy7289 124 LSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG- 202 (422)
Q Consensus 124 ~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~- 202 (422)
.. +..++||||+++|+|.+++... ..+++.++..++.|++.||+|||+++|+||||||+|||++.+
T Consensus 210 ~~-~~~~lv~e~~~~g~L~~~l~~~------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~ 276 (419)
T 3i6u_A 210 DA-EDYYIVLELMEGGELFDKVVGN------------KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE 276 (419)
T ss_dssp ES-SEEEEEEECCTTCBGGGGTSSS------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS
T ss_pred ec-CceEEEEEcCCCCcHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCC
Confidence 54 5589999999999999988643 358999999999999999999999999999999999999754
Q ss_pred --CeEEEecCcccccccCCcceEeccCCCCCccccCcccccc---CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChH-H
Q psy7289 203 --LTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY---GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ-E 276 (422)
Q Consensus 203 --~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~-~ 276 (422)
..+||+|||+++...... ......+|+.|+|||++.. ..++.++|||||||++|||++ |..||.+.... .
T Consensus 277 ~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~ 352 (419)
T 3i6u_A 277 EDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS-GYPPFSEHRTQVS 352 (419)
T ss_dssp SSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHH-SSCSSCCCSSSCC
T ss_pred CcceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHH-CCCCCCCCcchHH
Confidence 459999999998754322 2234567899999999863 568889999999999999999 99999876543 4
Q ss_pred HHHHHHcCCCCCCC---CCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 277 VIEMIRSRQMLPCP---EDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 277 ~~~~i~~~~~~~~p---~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
+...+..+.....| ..+++.+.+|+.+||..+|..|+ +..+.+|.++
T Consensus 353 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 403 (419)
T 3i6u_A 353 LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403 (419)
T ss_dssp HHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCccc
Confidence 55566665544333 46889999999999999999986 3445555555
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=352.40 Aligned_cols=257 Identities=20% Similarity=0.296 Sum_probs=207.9
Q ss_pred hhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC------CCCceeeEeeE
Q psy7289 49 REVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL------RHPNIVCLLGV 122 (422)
Q Consensus 49 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l------~HpnIv~l~g~ 122 (422)
.+....+|++++.||+|+||.||+|+... .+..||||+++.. ......+.+|+++++.+ +||||++++++
T Consensus 92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~--~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~ 167 (429)
T 3kvw_A 92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHK--VHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN 167 (429)
T ss_dssp TCEETTTEEEEEEEEESSSEEEEEEEETT--TTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred CCcccCcEEEEEEcccCccEEEEEEEECC--CCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence 34556789999999999999999998644 3578999998643 34456788899888877 57799999999
Q ss_pred EEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC
Q psy7289 123 CLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG 202 (422)
Q Consensus 123 ~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~ 202 (422)
+.....+++||||+. |+|.+++..... ..+++..+..++.||+.||+|||+++|+||||||+|||++.+
T Consensus 168 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~ 236 (429)
T 3kvw_A 168 FTFRNHICMTFELLS-MNLYELIKKNKF----------QGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQ 236 (429)
T ss_dssp EEETTEEEEEECCCC-CBHHHHHHHTTT----------CCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESST
T ss_pred cccCCeEEEEEeccC-CCHHHHHHhccC----------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccC
Confidence 999999999999996 699999976431 248999999999999999999999999999999999999988
Q ss_pred Ce--EEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHH
Q psy7289 203 LT--VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEM 280 (422)
Q Consensus 203 ~~--vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~ 280 (422)
+. +||+|||+++..... .....+|+.|+|||++....++.++|||||||++|||++ |.+||.+.+..+.+..
T Consensus 237 ~~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~l~~ 310 (429)
T 3kvw_A 237 GRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLT-GYPLLPGEDEGDQLAC 310 (429)
T ss_dssp TSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHH
T ss_pred CCcceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence 77 999999999754322 234567889999999999999999999999999999999 9999999988776665
Q ss_pred HHcCCCCC----------------------------------------------------------CCCCCCcchhhhcc
Q psy7289 281 IRSRQMLP----------------------------------------------------------CPEDCPPRMYSLMM 302 (422)
Q Consensus 281 i~~~~~~~----------------------------------------------------------~p~~~p~~~~~l~~ 302 (422)
+......| .+...++.+.+|++
T Consensus 311 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~ 390 (429)
T 3kvw_A 311 MIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLK 390 (429)
T ss_dssp HHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHH
T ss_pred HHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHH
Confidence 54210000 01123667889999
Q ss_pred cccccccchhh-HHHHhhhhhhhhh
Q psy7289 303 ECWHEVPVAAG-MAYLCSHHYVHRD 326 (422)
Q Consensus 303 ~cw~~~P~~r~-~~~lh~~~~i~~d 326 (422)
+||..||..|+ +..+.+|.++.+.
T Consensus 391 ~~L~~dP~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 391 QCLEWDPAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp HHTCSSTTTSCCHHHHHTSTTTC--
T ss_pred HHCCCChhhCCCHHHHhCChhhccC
Confidence 99999999986 3456666666543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=355.16 Aligned_cols=248 Identities=21% Similarity=0.304 Sum_probs=200.9
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC--C
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE--P 128 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~--~ 128 (422)
+...+|++.+.||+|+||.||+|++.. .+..||||+++........+.+.+|++++++++||||+++++++.+.. .
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKK--TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECC--CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 345689999999999999999998754 357899999875444445677889999999999999999999998765 6
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceee----cCCCe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV----GDGLT 204 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl----~~~~~ 204 (422)
.++|||||++|+|.+++..... ...+++..+..++.||+.||+|||+++|+||||||+|||+ +.++.
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 154 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSN---------AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSV 154 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGG---------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEE
T ss_pred eEEEEecCCCCCHHHHHHhhhc---------ccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCcee
Confidence 8999999999999999976421 1238999999999999999999999999999999999999 77788
Q ss_pred EEEecCcccccccCCcceEeccCCCCCccccCcccccc--------CCCCCchhHHhHHHHHHHHHhCCCCCCCCC----
Q psy7289 205 VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY--------GKFTTESDVWSYGVVLWEVYSYGLQPYYGY---- 272 (422)
Q Consensus 205 vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~---- 272 (422)
+||+|||+++....... .....+|+.|+|||++.. ..++.++|||||||++|||++ |..||...
T Consensus 155 ~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~t-g~~Pf~~~~~~~ 230 (396)
T 4eut_A 155 YKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT-GSLPFRPFEGPR 230 (396)
T ss_dssp EEECCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHH-SSCSEECTTCTT
T ss_pred EEEecCCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHH-CCCCCCCCCccc
Confidence 99999999986544321 223457899999998865 567889999999999999999 99999753
Q ss_pred ChHHHHHHHHcCCCCCC------------------C------CCCCcchhhhcccccccccchhh
Q psy7289 273 SNQEVIEMIRSRQMLPC------------------P------EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 273 ~~~~~~~~i~~~~~~~~------------------p------~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
...+++..+..+..... | ..+++.+.+++++||..||..|+
T Consensus 231 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~ 295 (396)
T 4eut_A 231 RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW 295 (396)
T ss_dssp TCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSC
T ss_pred chHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhc
Confidence 34456666655432211 1 22345678899999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=335.55 Aligned_cols=257 Identities=21% Similarity=0.409 Sum_probs=205.6
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEc-----
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVCLS----- 125 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~----- 125 (422)
...+|++.+.||+|+||.||+|++.. .+..||||++..... ....+.+|+.+++++ +||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVK--TGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECCSS--TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECC--CCCeEEEEEEecCcc--cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 45678999999999999999998754 357899999864332 345788999999999 79999999999976
Q ss_pred -CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCe
Q psy7289 126 -GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLT 204 (422)
Q Consensus 126 -~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~ 204 (422)
...+++||||+++|+|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTK----------GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSG----------GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcc----------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC
Confidence 457899999999999999997632 135899999999999999999999999999999999999999999
Q ss_pred EEEecCcccccccCCcceEeccCCCCCccccCccccc-----cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHH
Q psy7289 205 VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL-----YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIE 279 (422)
Q Consensus 205 vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~ 279 (422)
+||+|||+++...... .......+|+.|+|||++. ...++.++|||||||++|||++ |..||.+.+..+...
T Consensus 168 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~ 244 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE-GAPPLCDMHPMRALF 244 (326)
T ss_dssp EEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHH
T ss_pred EEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHh-CCCCCCCCcHHHHHH
Confidence 9999999997653221 1123345788999999987 4568999999999999999999 999999988877776
Q ss_pred HHHcCCCCC-CCCCCCcchhhhcccccccccchhh-HHHHhhhhhhhh
Q psy7289 280 MIRSRQMLP-CPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHR 325 (422)
Q Consensus 280 ~i~~~~~~~-~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~ 325 (422)
.+.....+. .+..+|+.+.+++.+||..+|..|+ +..+.+|.++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 292 (326)
T 2x7f_A 245 LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292 (326)
T ss_dssp HHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred HhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence 666544333 3567899999999999999999986 334555555543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=347.80 Aligned_cols=259 Identities=21% Similarity=0.355 Sum_probs=198.0
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC---
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG--- 126 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--- 126 (422)
.+..+|++.+.||+|+||.||+|+... .+..||||+++.. ......+.+.+|+.+|+.++||||+++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 100 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKN--TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLL 100 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETT--TTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECC--CCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCC
Confidence 456789999999999999999998654 4578999998654 3344567899999999999999999999999766
Q ss_pred --CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCe
Q psy7289 127 --EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLT 204 (422)
Q Consensus 127 --~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~ 204 (422)
..+|+||||+. |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 101 ~~~~~~lv~e~~~-~~L~~~~~~~------------~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~ 167 (432)
T 3n9x_A 101 KFDELYIVLEIAD-SDLKKLFKTP------------IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS 167 (432)
T ss_dssp TCCCEEEEEECCS-EEHHHHHHSS------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC
T ss_pred cCCeEEEEEecCC-cCHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCC
Confidence 56899999987 5999999753 35899999999999999999999999999999999999999999
Q ss_pred EEEecCcccccccCCcce--------------------EeccCCCCCccccCcccc-ccCCCCCchhHHhHHHHHHHHHh
Q psy7289 205 VKISDFGLSRDVYASDYY--------------------RIQSKSLLPVRWMPPESI-LYGKFTTESDVWSYGVVLWEVYS 263 (422)
Q Consensus 205 vKl~DFGla~~~~~~~~~--------------------~~~~~~~~t~~y~aPE~~-~~~~~~~~~DvwS~Gvil~El~t 263 (422)
+||+|||+++........ .......+|+.|+|||++ ....++.++|||||||++|||++
T Consensus 168 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~ 247 (432)
T 3n9x_A 168 VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247 (432)
T ss_dssp EEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHT
T ss_pred EEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHh
Confidence 999999999865432211 112445678999999986 45669999999999999999996
Q ss_pred ----------CCCCCCCCCCh-----------------HH------------------------HHHHHHcCCC-CCC--
Q psy7289 264 ----------YGLQPYYGYSN-----------------QE------------------------VIEMIRSRQM-LPC-- 289 (422)
Q Consensus 264 ----------~g~~Pf~~~~~-----------------~~------------------------~~~~i~~~~~-~~~-- 289 (422)
.|.++|.+.+. .+ ....+..... .+.
T Consensus 248 g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (432)
T 3n9x_A 248 MLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINL 327 (432)
T ss_dssp TCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCH
T ss_pred cccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCH
Confidence 24444444321 11 1111211111 111
Q ss_pred ---CCCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 290 ---PEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 290 ---p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
.+.+++++.+|+.+||..||..|+ +..+.+|.++.
T Consensus 328 ~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~ 366 (432)
T 3n9x_A 328 KQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLK 366 (432)
T ss_dssp HHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGT
T ss_pred HHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhh
Confidence 145788999999999999999986 33455555543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=331.12 Aligned_cols=243 Identities=25% Similarity=0.417 Sum_probs=198.2
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEe
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEF 135 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~ 135 (422)
+.....||+|+||.||+|+... ++..||||.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLS--NQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETT--TCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCcEEEeecCcEEEEEEEECC--CCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 3444589999999999998644 35789999986543 33456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC-CCeEEEecCcccc
Q psy7289 136 MVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD-GLTVKISDFGLSR 214 (422)
Q Consensus 136 ~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~-~~~vKl~DFGla~ 214 (422)
+++|+|.+++..... ...+++..+..++.|++.||+|||+++|+||||||+||+++. ++.+||+|||+++
T Consensus 101 ~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~ 171 (295)
T 2clq_A 101 VPGGSLSALLRSKWG---------PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSK 171 (295)
T ss_dssp CSEEEHHHHHHHTTC---------CCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCE
T ss_pred CCCCCHHHHHHhhcc---------CCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccccc
Confidence 999999999976421 124678889999999999999999999999999999999987 8899999999998
Q ss_pred cccCCcceEeccCCCCCccccCccccccCC--CCCchhHHhHHHHHHHHHhCCCCCCCCCChHH--HHHHHHcCCCCCCC
Q psy7289 215 DVYASDYYRIQSKSLLPVRWMPPESILYGK--FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE--VIEMIRSRQMLPCP 290 (422)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~--~~~~i~~~~~~~~p 290 (422)
...... .......+|+.|+|||++.... ++.++|||||||++|||++ |..||.+....+ ..........++.|
T Consensus 172 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (295)
T 2clq_A 172 RLAGIN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMAT-GKPPFYELGEPQAAMFKVGMFKVHPEIP 248 (295)
T ss_dssp ESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHH-TSCTTGGGSSHHHHHHHHHHHCCCCCCC
T ss_pred ccCCCC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHH-CCCCccCCCchhHHHHhhcccccccccc
Confidence 654322 1223446788999999987653 8899999999999999999 999998654432 22222334556678
Q ss_pred CCCCcchhhhcccccccccchhh
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..+|+++.+++.+||..+|..|+
T Consensus 249 ~~~~~~~~~li~~~l~~dp~~Rp 271 (295)
T 2clq_A 249 ESMSAEAKAFILKCFEPDPDKRA 271 (295)
T ss_dssp TTSCHHHHHHHHHTTCSSTTTSC
T ss_pred ccCCHHHHHHHHHHccCChhhCC
Confidence 89999999999999999999997
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=337.01 Aligned_cols=253 Identities=25% Similarity=0.472 Sum_probs=197.6
Q ss_pred hhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC--CCCceeeEeeEEEc
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL--RHPNIVCLLGVCLS 125 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l--~HpnIv~l~g~~~~ 125 (422)
.......+|++.+.||+|+||.||+|++. +..||||++... ....+.+|.+++..+ +||||+++++++..
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR----GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET----TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC----CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 44556678999999999999999999863 578999998532 234456666666655 89999999999987
Q ss_pred C----CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCC
Q psy7289 126 G----EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSH--------HYVHRDLA 193 (422)
Q Consensus 126 ~----~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~--------~ivHrDlK 193 (422)
. ..+++||||+++|+|.+++... .+++..+..++.|++.||+|||++ +|+|||||
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dik 169 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKST-------------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLK 169 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHHC-------------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCC
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhcc-------------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccc
Confidence 7 6789999999999999999653 488999999999999999999999 99999999
Q ss_pred CCceeecCCCeEEEecCcccccccCCcce--EeccCCCCCccccCccccccCCCCCc------hhHHhHHHHHHHHHhCC
Q psy7289 194 ARNCLVGDGLTVKISDFGLSRDVYASDYY--RIQSKSLLPVRWMPPESILYGKFTTE------SDVWSYGVVLWEVYSYG 265 (422)
Q Consensus 194 p~NiLl~~~~~vKl~DFGla~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~------~DvwS~Gvil~El~t~g 265 (422)
|+|||++.++.+||+|||+++........ .......+|+.|+|||++.....+.+ +|||||||++|||++ |
T Consensus 170 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~t-g 248 (337)
T 3mdy_A 170 SKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR-R 248 (337)
T ss_dssp GGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHT-T
T ss_pred hHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHh-c
Confidence 99999999999999999999765433211 11234568899999999987766665 999999999999998 7
Q ss_pred ----------CCCCCCCC-----hHHHHHHHHcCC-CCCCC-----CCCCcchhhhcccccccccchhhHHHHhhhhhhh
Q psy7289 266 ----------LQPYYGYS-----NQEVIEMIRSRQ-MLPCP-----EDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVH 324 (422)
Q Consensus 266 ----------~~Pf~~~~-----~~~~~~~i~~~~-~~~~p-----~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~ 324 (422)
..||.... ..+....+.... .+..| ..|++++.+++.+||+.+|..|+ +...+.
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell 323 (337)
T 3mdy_A 249 CVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRL-----TALRVK 323 (337)
T ss_dssp BCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSC-----CHHHHH
T ss_pred cCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCC-----CHHHHH
Confidence 67776542 233333333322 23333 25777899999999999999998 555554
Q ss_pred hhc
Q psy7289 325 RDL 327 (422)
Q Consensus 325 ~dL 327 (422)
..|
T Consensus 324 ~~L 326 (337)
T 3mdy_A 324 KTL 326 (337)
T ss_dssp HHH
T ss_pred HHH
Confidence 444
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=340.49 Aligned_cols=261 Identities=22% Similarity=0.331 Sum_probs=204.5
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEE----c
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCL----S 125 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~----~ 125 (422)
.+...+|++.+.||+|+||.||+++... .+..||||++... .....+.+.+|+.+++.++||||+++++++. .
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLH--DGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETT--TCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecC--CCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 4556789999999999999999998643 3578999988543 3455678999999999999999999999987 3
Q ss_pred CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 126 GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 126 ~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
....++||||+++|+|.+++...... ...+++.++..++.|++.||+|||+++|+||||||+|||++.++.+
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~ 173 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDK--------GNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQP 173 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTT--------TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCE
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCE
Confidence 34689999999999999999763211 1368999999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcce-------EeccCCCCCccccCccccccCC---CCCchhHHhHHHHHHHHHhCCCCCCCCC--C
Q psy7289 206 KISDFGLSRDVYASDYY-------RIQSKSLLPVRWMPPESILYGK---FTTESDVWSYGVVLWEVYSYGLQPYYGY--S 273 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~---~~~~~DvwS~Gvil~El~t~g~~Pf~~~--~ 273 (422)
||+|||+++........ .......+|+.|+|||.+.... ++.++|||||||++|||++ |..||... .
T Consensus 174 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~ 252 (317)
T 2buj_A 174 VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMF-GEGPYDMVFQK 252 (317)
T ss_dssp EECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHH-SSCTTHHHHHT
T ss_pred EEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHh-CCCChhhhhcc
Confidence 99999998754211000 0001223578899999987543 7899999999999999998 99999642 1
Q ss_pred hHHHHHHHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 274 NQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 274 ~~~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
...+...+......+.+..+|+++.+++.+||..+|..|+ +...+...|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~L 301 (317)
T 2buj_A 253 GDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRP-----HIPLLLSQL 301 (317)
T ss_dssp TSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHH
T ss_pred cchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCC-----CHHHHHHHh
Confidence 2234444555555666778999999999999999999998 555444443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=334.79 Aligned_cols=259 Identities=23% Similarity=0.364 Sum_probs=204.5
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCC--CCceeeEeeEEEcC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELR--HPNIVCLLGVCLSG 126 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~--HpnIv~l~g~~~~~ 126 (422)
.+...+|++.+.||+|+||.||+++.. ++..||||++... ......+.+.+|+.++++++ ||||+++++++.+.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE---KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT---TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC---CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 455677999999999999999999753 3577999998643 34556678999999999997 59999999999999
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEE
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vK 206 (422)
+..++||| +.+|+|.+++... ..+++.++..++.|++.||+|||+++|+||||||+|||+++ +.+|
T Consensus 101 ~~~~lv~e-~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~k 166 (313)
T 3cek_A 101 QYIYMVME-CGNIDLNSWLKKK------------KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLK 166 (313)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHC------------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEE
T ss_pred CEEEEEEe-cCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEE
Confidence 99999999 6788999999764 35889999999999999999999999999999999999975 7999
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCcccccc-----------CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChH
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-----------GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ 275 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~ 275 (422)
|+|||+++...............+|+.|+|||.+.. ..++.++|||||||++|||++ |..||.+....
T Consensus 167 L~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~~~ 245 (313)
T 3cek_A 167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQIINQ 245 (313)
T ss_dssp ECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHH-SSCTTTTCCSH
T ss_pred EeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHh-CCCchhhHHHH
Confidence 999999986643322222334467899999999875 468889999999999999998 99999876443
Q ss_pred -HHHHHH-HcCCCCCCCCCCCcchhhhcccccccccchhh-HHHHhhhhhhhhh
Q psy7289 276 -EVIEMI-RSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRD 326 (422)
Q Consensus 276 -~~~~~i-~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~d 326 (422)
.....+ ......+.|..+++++.+++.+||..+|..|+ +..+.++.++...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 246 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred HHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 333333 33445567788899999999999999999997 3345555555443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=347.06 Aligned_cols=245 Identities=13% Similarity=0.114 Sum_probs=192.4
Q ss_pred ccccCcccccccccccceeEEEEEEe---cCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC---CCceeeEeeEEE
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVC---TSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR---HPNIVCLLGVCL 124 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~g~~~ 124 (422)
+...+|++.+.||+|+||.||+|++. ....+..||||+++.. ....+.+|+++++.++ |+||+++++++.
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 44567899999999999999999532 1234577999998653 2346788888888887 999999999999
Q ss_pred cCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC---
Q psy7289 125 SGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD--- 201 (422)
Q Consensus 125 ~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~--- 201 (422)
..+..++|||||++|+|.+++....... ...+++..+..++.||+.||+|||+++|+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTP-------EKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTST-------TCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGT
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhccc-------ccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEeccccc
Confidence 9999999999999999999997642111 246999999999999999999999999999999999999988
Q ss_pred --------CCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCC
Q psy7289 202 --------GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS 273 (422)
Q Consensus 202 --------~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~ 273 (422)
++.+||+|||+|+...............+|+.|||||++.+..++.++|||||||++|||++ |..||....
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~ 289 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF-GTYMKVKNE 289 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHH-SSCCCEEEE
T ss_pred CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHh-CCCccccCC
Confidence 89999999999976542222233455678999999999999899999999999999999999 989986543
Q ss_pred hHHHHHHHHcCCCCCCCCCCCcchhhhcccccccccchh
Q psy7289 274 NQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAA 312 (422)
Q Consensus 274 ~~~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r 312 (422)
..... .....+ ....++.+.+++..|++.+|..|
T Consensus 290 ~~~~~----~~~~~~-~~~~~~~~~~~~~~~l~~~p~~r 323 (365)
T 3e7e_A 290 GGECK----PEGLFR-RLPHLDMWNEFFHVMLNIPDCHH 323 (365)
T ss_dssp TTEEE----ECSCCT-TCSSHHHHHHHHHHHHCCCCTTC
T ss_pred CCcee----echhcc-ccCcHHHHHHHHHHHcCCCCCCc
Confidence 21100 000011 11235567788888888887665
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=338.44 Aligned_cols=253 Identities=23% Similarity=0.411 Sum_probs=203.0
Q ss_pred hhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhc--CCCCceeeEeeEEEc
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSE--LRHPNIVCLLGVCLS 125 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~g~~~~ 125 (422)
..+.+..+|++.+.||+|+||.||+|++ .+..||||++... ....+.+|++++.. ++||||+++++++..
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKW----RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEE----TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEE----cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 3455667899999999999999999986 2578999998542 34567889999887 799999999999987
Q ss_pred CC----CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHH--------hCCccccCCC
Q psy7289 126 GE----PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLC--------SHHYVHRDLA 193 (422)
Q Consensus 126 ~~----~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH--------~~~ivHrDlK 193 (422)
.. ..++||||+++|+|.+++... .+++.++..++.|++.||+||| +++|+|||||
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlk 174 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY-------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 174 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHHC-------------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCS
T ss_pred cCCccceeEEEEeecCCCcHHHHHhcc-------------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCC
Confidence 76 789999999999999999753 4889999999999999999999 8999999999
Q ss_pred CCceeecCCCeEEEecCcccccccCCcceE--eccCCCCCccccCccccccCC------CCCchhHHhHHHHHHHHHhCC
Q psy7289 194 ARNCLVGDGLTVKISDFGLSRDVYASDYYR--IQSKSLLPVRWMPPESILYGK------FTTESDVWSYGVVLWEVYSYG 265 (422)
Q Consensus 194 p~NiLl~~~~~vKl~DFGla~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~------~~~~~DvwS~Gvil~El~t~g 265 (422)
|+|||++.++.+||+|||+++......... ......+|+.|+|||++.... ++.++|||||||++|||++ |
T Consensus 175 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~t-g 253 (342)
T 1b6c_B 175 SKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-R 253 (342)
T ss_dssp GGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHT-T
T ss_pred HHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHh-c
Confidence 999999999999999999997654433221 234456789999999987652 3368999999999999998 6
Q ss_pred ----------CCCCCCCC-----hHHHHHHHHcCCC-CCCCC-----CCCcchhhhcccccccccchhhHHHHhhhhhhh
Q psy7289 266 ----------LQPYYGYS-----NQEVIEMIRSRQM-LPCPE-----DCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVH 324 (422)
Q Consensus 266 ----------~~Pf~~~~-----~~~~~~~i~~~~~-~~~p~-----~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~ 324 (422)
..||.+.. ..++...+..... +..|. .+++.+.+|+.+||+.+|..|+ +...+.
T Consensus 254 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~i~ 328 (342)
T 1b6c_B 254 CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL-----TALRIK 328 (342)
T ss_dssp BCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSC-----CHHHHH
T ss_pred cCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCC-----CHHHHH
Confidence 77887653 3455555544433 33332 3456789999999999999998 555554
Q ss_pred hhc
Q psy7289 325 RDL 327 (422)
Q Consensus 325 ~dL 327 (422)
..|
T Consensus 329 ~~L 331 (342)
T 1b6c_B 329 KTL 331 (342)
T ss_dssp HHH
T ss_pred HHH
Confidence 444
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=344.33 Aligned_cols=250 Identities=22% Similarity=0.345 Sum_probs=188.2
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC-----
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG----- 126 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~----- 126 (422)
..+|++++.||+|+||.||+|+... .+..||||++... ......+.+.+|+.+|+.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETT--TTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCceEEeeEEeecCCeEEEEEEECC--CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 4689999999999999999998643 4578999998653 3445567889999999999999999999998754
Q ss_pred -CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 127 -EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 127 -~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
...++||||+ +++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~-------------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~ 171 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC-------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 171 (367)
T ss_dssp CCCCEEEEECC-CEECC------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred CCeEEEEeccc-CCCHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCE
Confidence 5679999999 6899988854 248999999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR 284 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~ 284 (422)
||+|||+++..... .....+|+.|+|||++.. ..++.++|||||||++|||++ |..||.+.+..+.+..+...
T Consensus 172 kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~l~~i~~~ 245 (367)
T 2fst_X 172 KILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLILRL 245 (367)
T ss_dssp EECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHH
T ss_pred EEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Confidence 99999999864321 233467889999999876 679999999999999999999 99999998877666555321
Q ss_pred --C--------------------CCCC--------CCCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 285 --Q--------------------MLPC--------PEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 285 --~--------------------~~~~--------p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
. .... ...+++.+.+|+.+||..||..|+ +..+.+|.++.
T Consensus 246 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~ 316 (367)
T 2fst_X 246 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316 (367)
T ss_dssp HCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred hCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhh
Confidence 0 0000 135678899999999999999986 33344555543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=332.68 Aligned_cols=255 Identities=23% Similarity=0.333 Sum_probs=198.3
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEE------
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCL------ 124 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~------ 124 (422)
....+|++.+.||+|+||.||+|+... .++.||||++... +....+.+.+|+.++++++||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDND--CDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETT--TTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECC--CCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 346789999999999999999998643 3578999988643 3455678999999999999999999999874
Q ss_pred --------cCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy7289 125 --------SGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARN 196 (422)
Q Consensus 125 --------~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~N 196 (422)
+....++||||++ |+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 150 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQ-------------GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPAN 150 (320)
T ss_dssp CC----CCSCSEEEEEEECCS-EEHHHHHTT-------------CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGG
T ss_pred ccccccccccCceeEEeeccC-CCHHHHhhc-------------CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 3457899999998 699999854 258899999999999999999999999999999999
Q ss_pred eeec-CCCeEEEecCcccccccCCcc-eEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCC
Q psy7289 197 CLVG-DGLTVKISDFGLSRDVYASDY-YRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYS 273 (422)
Q Consensus 197 iLl~-~~~~vKl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~ 273 (422)
||++ +++.+||+|||+++....... ........+|..|+|||.+.. ..++.++|||||||++|||++ |..||.+.+
T Consensus 151 il~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~ 229 (320)
T 2i6l_A 151 LFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT-GKTLFAGAH 229 (320)
T ss_dssp EEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHH-SSCSSCCSS
T ss_pred EEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHh-CCCCCCCCC
Confidence 9997 567999999999986532211 111223345788999998865 678999999999999999999 999999988
Q ss_pred hHHHHHHHHcCCCC-----------------------------CCCCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 274 NQEVIEMIRSRQML-----------------------------PCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 274 ~~~~~~~i~~~~~~-----------------------------~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
..+....+...... ..+..+|+++.+++.+||..+|..|+ +..+.+|.++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (320)
T 2i6l_A 230 ELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309 (320)
T ss_dssp HHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHH
T ss_pred HHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccc
Confidence 87766655432110 01346889999999999999999987 2334444444
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=345.45 Aligned_cols=253 Identities=12% Similarity=0.137 Sum_probs=199.9
Q ss_pred cccCcccccccccccceeEEEEEEecCC------CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceee-------
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSE------GPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVC------- 118 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~------- 118 (422)
...+|++.+.||+|+||.||+|+...+. .+..||||.+... +.+.+|++++++++||||++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 3578999999999999999999876532 2578999998643 35789999999999999998
Q ss_pred --------EeeEEEc-CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q psy7289 119 --------LLGVCLS-GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVH 189 (422)
Q Consensus 119 --------l~g~~~~-~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivH 189 (422)
+++++.. +...++||||+ +|+|.+++.... ...+++.++..++.||+.||+|||+++|+|
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH 182 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP----------KHVLSERSVLQVACRLLDALEFLHENEYVH 182 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG----------GGCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC----------cCCCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence 5677765 67889999999 999999997631 135899999999999999999999999999
Q ss_pred cCCCCCceeecCCC--eEEEecCcccccccCCcceE-----eccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHH
Q psy7289 190 RDLAARNCLVGDGL--TVKISDFGLSRDVYASDYYR-----IQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVY 262 (422)
Q Consensus 190 rDlKp~NiLl~~~~--~vKl~DFGla~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~ 262 (422)
|||||+|||++.++ .+||+|||+++......... ......+|+.|+|||++....++.++|||||||++|||+
T Consensus 183 ~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 262 (352)
T 2jii_A 183 GNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWL 262 (352)
T ss_dssp SCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 99999999999988 99999999998654322110 112346788999999999889999999999999999999
Q ss_pred hCCCCCCCCCC--hHHHHHHHH--cCCCCCCC------CCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 263 SYGLQPYYGYS--NQEVIEMIR--SRQMLPCP------EDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 263 t~g~~Pf~~~~--~~~~~~~i~--~~~~~~~p------~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
+ |..||.+.. ...+..... .....+.+ ..+|+++.+++..||..+|..|+ +...+...|
T Consensus 263 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~l~~~L 331 (352)
T 2jii_A 263 Y-GFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKP-----PYAMLRNNL 331 (352)
T ss_dssp H-SCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCC-----CHHHHHHHH
T ss_pred h-CCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCC-----CHHHHHHHH
Confidence 9 999998764 333333322 11222222 24689999999999999999998 555544443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=337.16 Aligned_cols=247 Identities=23% Similarity=0.328 Sum_probs=183.1
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC-CCceeeEeeEEE----
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR-HPNIVCLLGVCL---- 124 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~---- 124 (422)
++...+|++.+.||+|+||.||+|++.. .+..||||++... .....+.+.+|+.+++++. ||||+++++++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVG--SGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETT--TCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred eccCceEEEEEEEccCCceEEEEEEECC--CCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence 4556789999999999999999998754 3577999988543 3445678899999999996 999999999984
Q ss_pred ----cCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcee
Q psy7289 125 ----SGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHH--YVHRDLAARNCL 198 (422)
Q Consensus 125 ----~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--ivHrDlKp~NiL 198 (422)
....+++||||+. |+|.+++..... ...+++.++..++.||+.||+|||+++ |+||||||+|||
T Consensus 101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl 170 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELCK-GQLVEFLKKMES---------RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLL 170 (337)
T ss_dssp TSTTSSEEEEEEEECCS-EEHHHHHHHHHT---------TCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCE
T ss_pred ccccCCceEEEEEEecC-CCHHHHHHHhhc---------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEE
Confidence 2334799999996 799999876321 135899999999999999999999999 999999999999
Q ss_pred ecCCCeEEEecCcccccccCCcceE----------eccCCCCCccccCcccc---ccCCCCCchhHHhHHHHHHHHHhCC
Q psy7289 199 VGDGLTVKISDFGLSRDVYASDYYR----------IQSKSLLPVRWMPPESI---LYGKFTTESDVWSYGVVLWEVYSYG 265 (422)
Q Consensus 199 l~~~~~vKl~DFGla~~~~~~~~~~----------~~~~~~~t~~y~aPE~~---~~~~~~~~~DvwS~Gvil~El~t~g 265 (422)
++.++.+||+|||+++......... ......+|+.|+|||++ ....++.++|||||||++|||++ |
T Consensus 171 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~-g 249 (337)
T 3ll6_A 171 LSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCF-R 249 (337)
T ss_dssp ECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHH-S
T ss_pred ECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHh-C
Confidence 9999999999999998654322111 11133478899999998 45678899999999999999998 9
Q ss_pred CCCCCCCChHHHHHHHHcCCCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 266 LQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 266 ~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..||.+....++.. .....+.+..+++.+.+++.+||..+|..|+
T Consensus 250 ~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 294 (337)
T 3ll6_A 250 QHPFEDGAKLRIVN---GKYSIPPHDTQYTVFHSLIRAMLQVNPEERL 294 (337)
T ss_dssp SCCC---------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSC
T ss_pred CCCCcchhHHHhhc---CcccCCcccccchHHHHHHHHHccCChhhCc
Confidence 99998765544332 3334455678889999999999999999998
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=331.72 Aligned_cols=254 Identities=20% Similarity=0.274 Sum_probs=201.8
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEE-EcCCCeE
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVC-LSGEPMC 130 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~-~~~~~~~ 130 (422)
...+|++.+.||+|+||.||+|+... .++.||||++..... .+.+.+|+.+++.++|+|++..+..+ ......+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIA--AGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETT--TTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcC--CCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 35689999999999999999998643 457899998764332 23588999999999998866666555 5667789
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceee---cCCCeEEE
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKI 207 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl---~~~~~vKl 207 (422)
+||||+ +|+|.+++.... ..+++.++..++.|++.||+|||+++|+||||||+|||+ ++++.+||
T Consensus 82 lv~e~~-~~~L~~~~~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl 149 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCS-----------RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYI 149 (296)
T ss_dssp EEEECC-CCBHHHHHHHTT-----------TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEE
T ss_pred EEEEec-CCCHHHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEE
Confidence 999999 999999997432 358999999999999999999999999999999999999 47889999
Q ss_pred ecCcccccccCCcce-----EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh---HHHHH
Q psy7289 208 SDFGLSRDVYASDYY-----RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN---QEVIE 279 (422)
Q Consensus 208 ~DFGla~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~---~~~~~ 279 (422)
+|||+++........ .......+|+.|+|||.+....++.++|||||||++|||++ |..||.+.+. .+.+.
T Consensus 150 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~ 228 (296)
T 3uzp_A 150 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL-GSLPWQGLKAATKRQKYE 228 (296)
T ss_dssp CCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTSSCCCSSSSSHHH
T ss_pred eeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcCchhhhhhhh
Confidence 999999865443221 11234567899999999999899999999999999999999 9999987543 23333
Q ss_pred HHHcCCC----CCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 280 MIRSRQM----LPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 280 ~i~~~~~----~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
.+..... ...+..+|+++.+++.+||+.+|..|+ +...+...|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~l~~~l~ 276 (296)
T 3uzp_A 229 RISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKP-----DYSYLRQLFR 276 (296)
T ss_dssp HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCC-----CHHHHHHHHH
T ss_pred hhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCC-----CHHHHHHHHH
Confidence 3332211 112467899999999999999999998 5555554443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=337.63 Aligned_cols=252 Identities=21% Similarity=0.319 Sum_probs=199.7
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-------CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-------NQKTASDFRREVDLMSELRHPNIVCLLGVCLS 125 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 125 (422)
..+|++.+.||+|+||.||+|+... .+..||||++.... .......+.+|+.++++++||||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERK--TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhceeEeeEEecCCCEEEEEEEEcC--CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 4578999999999999999998653 45789999986432 11223468899999999999999999999876
Q ss_pred CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC--
Q psy7289 126 GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL-- 203 (422)
Q Consensus 126 ~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~-- 203 (422)
+. .++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~ 153 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGN------------KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 153 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTT------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSS
T ss_pred Cc-eEEEEecCCCCcHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCC
Confidence 54 89999999999999998653 3589999999999999999999999999999999999998765
Q ss_pred -eEEEecCcccccccCCcceEeccCCCCCccccCccccc---cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChH-HHH
Q psy7289 204 -TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL---YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ-EVI 278 (422)
Q Consensus 204 -~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~-~~~ 278 (422)
.+||+|||+++....... .....+|+.|+|||++. ...++.++|||||||++|||++ |..||.+.... ++.
T Consensus 154 ~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~ 229 (322)
T 2ycf_A 154 CLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS-GYPPFSEHRTQVSLK 229 (322)
T ss_dssp CCEEECCCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHH-SSCSSCSTTCSSCHH
T ss_pred CeEEEccCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCcccchHHHHH
Confidence 499999999986543221 12234678999999874 4678999999999999999999 99999876543 455
Q ss_pred HHHHcCCCCCC---CCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 279 EMIRSRQMLPC---PEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 279 ~~i~~~~~~~~---p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
..+..+..... +..+++.+.+++.+||..+|..|+ +..+.+|.++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~ 278 (322)
T 2ycf_A 230 DQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278 (322)
T ss_dssp HHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred HHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCc
Confidence 55655544333 257889999999999999999987 2334444444
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=341.11 Aligned_cols=260 Identities=18% Similarity=0.312 Sum_probs=209.7
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCH----------------HhHHHHHHHHHHHhcCCC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQ----------------KTASDFRREVDLMSELRH 113 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~----------------~~~~~~~~E~~il~~l~H 113 (422)
.....+|++.+.||+|+||.||+|+. .+..||||.+...... ...+.+.+|+.++++++|
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 102 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK----DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN 102 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE----TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc----CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC
Confidence 34457899999999999999999986 4678999998532110 112789999999999999
Q ss_pred CceeeEeeEEEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCC
Q psy7289 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCS-HHYVHRDL 192 (422)
Q Consensus 114 pnIv~l~g~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDl 192 (422)
|||+++++++.+.+..++||||+++|+|.+++...... .......+++..+..++.|++.||+|||+ +||+||||
T Consensus 103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l----~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl 178 (348)
T 2pml_X 103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL----DKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDV 178 (348)
T ss_dssp TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESS----CSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCC
T ss_pred CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhh----hhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCC
Confidence 99999999999999999999999999999983211000 00012468999999999999999999999 99999999
Q ss_pred CCCceeecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccC-CCCC-chhHHhHHHHHHHHHhCCCCCCC
Q psy7289 193 AARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTT-ESDVWSYGVVLWEVYSYGLQPYY 270 (422)
Q Consensus 193 Kp~NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~-~~DvwS~Gvil~El~t~g~~Pf~ 270 (422)
||+||+++.++.+||+|||+++..... ......+|+.|+|||++... .++. ++|||||||++|||++ |..||.
T Consensus 179 ~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~ 253 (348)
T 2pml_X 179 KPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY-NVVPFS 253 (348)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHH-SSCSSC
T ss_pred ChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHh-CCCCCC
Confidence 999999999999999999999865433 22345678999999999877 5666 9999999999999999 999999
Q ss_pred CCCh-HHHHHHHHcCCCCCCC-------------------CCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 271 GYSN-QEVIEMIRSRQMLPCP-------------------EDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 271 ~~~~-~~~~~~i~~~~~~~~p-------------------~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
+.+. .++...+..+. .+.| ..+|+++.+|+.+||..+|..|+ +..+.+|.++
T Consensus 254 ~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f 326 (348)
T 2pml_X 254 LKISLVELFNNIRTKN-IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL 326 (348)
T ss_dssp CSSCSHHHHHHHTSCC-CCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred CCCcHHHHHHHHhccC-cCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence 8877 77777776654 3333 56889999999999999999997 2234444443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=349.08 Aligned_cols=251 Identities=14% Similarity=0.071 Sum_probs=183.1
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcC--CCCceeeEe-------eE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSEL--RHPNIVCLL-------GV 122 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l--~HpnIv~l~-------g~ 122 (422)
..|++.+.||+|+||.||+|++.. ++..||||++.... .....+.+.+|+.+++.| +||||++++ ++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVE--RLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECC--CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 458899999999999999998754 35789999987644 234456788885544444 699988755 44
Q ss_pred EEcC-----------------CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHH------HHHHHHHHHHH
Q psy7289 123 CLSG-----------------EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDF------SHIALQVAAGM 179 (422)
Q Consensus 123 ~~~~-----------------~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~------~~i~~qi~~gL 179 (422)
+... ..+|+|||||+ |+|.+++.... ..+++... ..++.||+.||
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----------~~~~~~~~~~~~vk~~i~~qi~~aL 207 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-----------FVYVFRGDEGILALHILTAQLIRLA 207 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-----------HSCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-----------cccchhhhhhhhhHHHHHHHHHHHH
Confidence 4433 23799999999 89999998642 12344444 57779999999
Q ss_pred HHHHhCCccccCCCCCceeecCCCeEEEecCcccccccCCcceEeccCCCCCccccCcccccc--CCCCCchhHHhHHHH
Q psy7289 180 AYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY--GKFTTESDVWSYGVV 257 (422)
Q Consensus 180 ~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwS~Gvi 257 (422)
+|||+++|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.. ..++.++|||||||+
T Consensus 208 ~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~i 282 (371)
T 3q60_A 208 ANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLS 282 (371)
T ss_dssp HHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHH
T ss_pred HHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHH
Confidence 9999999999999999999999999999999999865321 113445689999999987 679999999999999
Q ss_pred HHHHHhCCCCCCCCCChHHHH--HH---H---HcCCCCCCCCCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 258 LWEVYSYGLQPYYGYSNQEVI--EM---I---RSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 258 l~El~t~g~~Pf~~~~~~~~~--~~---i---~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
+|||++ |..||.+.+..... .. . ......+.+..+|+.+.+|+.+||+.+|..|+ ...+.+|.++.
T Consensus 283 l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 357 (371)
T 3q60_A 283 IYRVWC-LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357 (371)
T ss_dssp HHHHHH-SSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHH
T ss_pred HHHHHh-CCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHH
Confidence 999999 99999887543211 00 0 01112233458899999999999999999986 33445555543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=345.89 Aligned_cols=253 Identities=25% Similarity=0.360 Sum_probs=197.0
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC-----
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG----- 126 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~----- 126 (422)
...+|++.+.||+|+||.||+|++..+ +..||||++..... .+.+|+++|+.++|||||++++++...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~--~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDS--GELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTT--CCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCC--CcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 345789999999999999999987543 57899998864321 234799999999999999999988542
Q ss_pred -CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC-CCe
Q psy7289 127 -EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD-GLT 204 (422)
Q Consensus 127 -~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~-~~~ 204 (422)
..+++||||+++ +|.+.+..... ....+++..+..++.||+.||+|||+++|+||||||+|||++. ++.
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~--------~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~ 195 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSR--------AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 195 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHH--------TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTE
T ss_pred ceeEEeehhcccc-cHHHHHHHHhh--------ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCe
Confidence 236799999986 67666653210 0135899999999999999999999999999999999999995 468
Q ss_pred EEEecCcccccccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc
Q psy7289 205 VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS 283 (422)
Q Consensus 205 vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~ 283 (422)
+||+|||+++....... .....+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+.+..+..
T Consensus 196 ~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~l~~i~~ 271 (420)
T 1j1b_A 196 LKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIK 271 (420)
T ss_dssp EEECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHH
T ss_pred EEeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Confidence 99999999986543321 2334678899999998764 79999999999999999999 9999999887665544432
Q ss_pred C------------------CCCC----------CCCCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 284 R------------------QMLP----------CPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 284 ~------------------~~~~----------~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
. ...+ .+..+|+++.+|+.+||..+|..|+ +..+..|.++.
T Consensus 272 ~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~ 341 (420)
T 1j1b_A 272 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341 (420)
T ss_dssp HHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred HhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhc
Confidence 0 0011 2346788999999999999999986 33455666653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=331.45 Aligned_cols=253 Identities=21% Similarity=0.275 Sum_probs=197.5
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEE-EcCCCeE
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVC-LSGEPMC 130 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~-~~~~~~~ 130 (422)
...+|++.+.||+|+||.||+|+... .+..||||++..... .+.+.+|+.+++.++|+|++..++.+ ...+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIA--AGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETT--TTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcC--CCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 34679999999999999999998644 457899998654322 23578899999999988877666655 5677789
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceee---cCCCeEEE
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKI 207 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl---~~~~~vKl 207 (422)
+||||+ +|+|.+++.... ..+++.++..++.||+.||+|||+++|+||||||+|||+ ++++.+||
T Consensus 82 lv~e~~-~~~L~~~~~~~~-----------~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL 149 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCS-----------RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYI 149 (296)
T ss_dssp EEEECC-CCBHHHHHHHTT-----------SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEE
T ss_pred EEEEcc-CCCHHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEE
Confidence 999999 999999997532 358999999999999999999999999999999999999 78899999
Q ss_pred ecCcccccccCCcce-----EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChH---HHHH
Q psy7289 208 SDFGLSRDVYASDYY-----RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ---EVIE 279 (422)
Q Consensus 208 ~DFGla~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~---~~~~ 279 (422)
+|||+++........ .......+|+.|+|||++....++.++|||||||++|||++ |..||.+.+.. +.+.
T Consensus 150 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~ 228 (296)
T 4hgt_A 150 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL-GSLPWQGLKAATKRQKYE 228 (296)
T ss_dssp CCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTSSCCCSSSSSHHH
T ss_pred ecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhc-CCCCCcccchhhhhhhhh
Confidence 999999865433221 12234567899999999999899999999999999999998 99999875432 2333
Q ss_pred HHHcCCC-C---CCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 280 MIRSRQM-L---PCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 280 ~i~~~~~-~---~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
.+..... . ..+..+|+++.+++..||+.+|..|+ +...+...|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~l~~~l 275 (296)
T 4hgt_A 229 RISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKP-----DYSYLRQLF 275 (296)
T ss_dssp HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCC-----CHHHHHHHH
T ss_pred hhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCC-----CHHHHHHHH
Confidence 3222111 1 12367899999999999999999998 555544433
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=328.54 Aligned_cols=255 Identities=25% Similarity=0.420 Sum_probs=210.8
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP 128 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 128 (422)
.....+|++.+.||+|+||.||+|+... .+..||||++... ......+.+.+|++++++++||||+++++++.+...
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~--~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRI--TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcC--CCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence 3445689999999999999999998643 3567999998543 223345789999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC---CeE
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG---LTV 205 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~---~~v 205 (422)
.++||||+++++|.+++... ..+++.++..++.||+.||+|||+++++||||||+||+++.+ +.+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~ 163 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKR------------KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDI 163 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred EEEEEEccCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccE
Confidence 99999999999999998764 258999999999999999999999999999999999999754 479
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ 285 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~ 285 (422)
||+|||+++....... .....+|+.|+|||.+.+ .++.++||||||+++|||++ |..||.+.+..++...+..+.
T Consensus 164 kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 238 (287)
T 2wei_A 164 KIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLS-GTPPFYGKNEYDILKRVETGK 238 (287)
T ss_dssp EECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCC
T ss_pred EEeccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC
Confidence 9999999976543221 112235778999998764 58999999999999999999 999999999999888888765
Q ss_pred CCC-C--CCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 286 MLP-C--PEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 286 ~~~-~--p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
... . ...+|+++.+++.+||..+|..|+ +..+.++.++
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~ 280 (287)
T 2wei_A 239 YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280 (287)
T ss_dssp CCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred CCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHH
Confidence 432 2 257889999999999999999997 2234444444
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=342.99 Aligned_cols=254 Identities=23% Similarity=0.334 Sum_probs=196.7
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC-
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP- 128 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~- 128 (422)
+....+|++.+.||+|+||.||+|+...+ ..||+|++...... ..+|+++|+.++|||||++++++.....
T Consensus 36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~---~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~ 107 (394)
T 4e7w_A 36 EQREIAYTNCKVIGNGSFGVVFQAKLVES---DEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDK 107 (394)
T ss_dssp CEEEEEEEEEEEEEEETTEEEEEEEETTT---EEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred CcccceEEEeEEEeeCCCeEEEEEEECCC---CeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence 45567899999999999999999986432 34888877543221 2369999999999999999999865443
Q ss_pred -----eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec-CC
Q psy7289 129 -----MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVG-DG 202 (422)
Q Consensus 129 -----~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~-~~ 202 (422)
+++||||++++.+........ ....+++..+..++.||+.||+|||++||+||||||+|||++ .+
T Consensus 108 ~~~~~~~lv~e~~~~~l~~~~~~~~~---------~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~ 178 (394)
T 4e7w_A 108 KDEVFLNLVLEYVPETVYRASRHYAK---------LKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPS 178 (394)
T ss_dssp SSCEEEEEEEECCSEEHHHHHHHHHH---------TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT
T ss_pred CCceEEEEEeeccCccHHHHHHHHHh---------hcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCC
Confidence 889999998754443332111 113589999999999999999999999999999999999999 78
Q ss_pred CeEEEecCcccccccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHH
Q psy7289 203 LTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281 (422)
Q Consensus 203 ~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i 281 (422)
+.+||+|||+++...... ......+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+.+..+
T Consensus 179 ~~~kL~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~l~~i 254 (394)
T 4e7w_A 179 GVLKLIDFGSAKILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQ-GQPLFPGESGIDQLVEI 254 (394)
T ss_dssp TEEEECCCTTCEECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred CcEEEeeCCCcccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence 999999999998654332 12344568899999998764 59999999999999999999 99999998877665544
Q ss_pred HcC------------------CCCC----------CCCCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 282 RSR------------------QMLP----------CPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 282 ~~~------------------~~~~----------~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
... ...+ .+..+++++.+|+.+||..+|..|+ +..+.+|.++.
T Consensus 255 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 326 (394)
T 4e7w_A 255 IKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD 326 (394)
T ss_dssp HHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGS
T ss_pred HHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhh
Confidence 321 0000 2345788999999999999999986 33455566553
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=339.48 Aligned_cols=248 Identities=24% Similarity=0.334 Sum_probs=201.7
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe--
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM-- 129 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~-- 129 (422)
..+|++.+.||+|+||.||+|+... .+..||||++.... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKR--SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred cccEEEEeEEecCCCeEEEEEEECC--CCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 4688999999999999999998654 45789999987543 344567889999999999999999999999877655
Q ss_pred ----EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 130 ----CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 130 ----~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
++||||+. |+|.+++.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~~--------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~ 183 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMGM--------------EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCEL 183 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTTS--------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCE
T ss_pred ceeEEEEEcccc-ccHHHHhhc--------------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCE
Confidence 99999998 688887732 48999999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR 284 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~ 284 (422)
||+|||+++..... .....+|+.|+|||++.. ..++.++|||||||++|||++ |..||.+.+..+.+..+...
T Consensus 184 kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~ 257 (371)
T 4exu_A 184 KILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT-GKTLFKGKDYLDQLTQILKV 257 (371)
T ss_dssp EECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHH
T ss_pred EEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Confidence 99999999754321 234567899999999887 679999999999999999999 99999998877766655321
Q ss_pred CCC------------------------------CCCCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 285 QML------------------------------PCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 285 ~~~------------------------------~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
... ..+..+++.+.+|+.+||..+|..|+ +..+.+|.++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 327 (371)
T 4exu_A 258 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 327 (371)
T ss_dssp HCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred hCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccc
Confidence 000 01346788999999999999999986 3344455554
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=327.88 Aligned_cols=236 Identities=23% Similarity=0.358 Sum_probs=196.4
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc------
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLS------ 125 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------ 125 (422)
...+|++.+.||+|+||.||+|++.. ++..||+|.++... ..+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRI--DGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETT--TCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hccccceeeeeccCCceEEEEEEEcC--CCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 34568899999999999999998753 35789999986532 246789999999999999999998854
Q ss_pred ----------CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy7289 126 ----------GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAAR 195 (422)
Q Consensus 126 ----------~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~ 195 (422)
...+++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+++|+||||||+
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~ 151 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR----------GEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPS 151 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGG----------GSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhcc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHH
Confidence 345899999999999999997642 135899999999999999999999999999999999
Q ss_pred ceeecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChH
Q psy7289 196 NCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ 275 (422)
Q Consensus 196 NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~ 275 (422)
|||+++++.+||+|||+++...... ......+|+.|+|||.+....++.++|||||||++|||++ |..|+.. ..
T Consensus 152 Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-~~~~~~~--~~ 225 (284)
T 2a19_B 152 NIFLVDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH-VCDTAFE--TS 225 (284)
T ss_dssp GEEEEETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHS-CCSSHHH--HH
T ss_pred HEEEcCCCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHh-cCCcchh--HH
Confidence 9999999999999999998654332 1233457889999999998899999999999999999998 7777643 23
Q ss_pred HHHHHHHcCCCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 276 EVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 276 ~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
+....+..+. .+..+|+.+.+++.+||+.+|..|+
T Consensus 226 ~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rp 260 (284)
T 2a19_B 226 KFFTDLRDGI---ISDIFDKKEKTLLQKLLSKKPEDRP 260 (284)
T ss_dssp HHHHHHHTTC---CCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHhhccc---ccccCCHHHHHHHHHHccCChhhCc
Confidence 3444444432 4567889999999999999999998
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=332.41 Aligned_cols=255 Identities=27% Similarity=0.443 Sum_probs=203.2
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC-HHhHHHHHHHHHHHhcC---CCCceeeEeeEEE----
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN-QKTASDFRREVDLMSEL---RHPNIVCLLGVCL---- 124 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l---~HpnIv~l~g~~~---- 124 (422)
..+|++.+.||+|+||.||+|+... .++..||||+++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLK-NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT-TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred hhceeeeeeecccccEEEEEEEecC-CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4678999999999999999998642 3457899998864322 11223566788777766 8999999999987
Q ss_pred -cCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC
Q psy7289 125 -SGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL 203 (422)
Q Consensus 125 -~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~ 203 (422)
.....++||||+. |+|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~ 157 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE----------PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG 157 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT----------TCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC
Confidence 4567899999998 699999976421 2489999999999999999999999999999999999999999
Q ss_pred eEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc
Q psy7289 204 TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS 283 (422)
Q Consensus 204 ~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~ 283 (422)
.+||+|||+++...... ......+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..+.+..+..
T Consensus 158 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~ 233 (326)
T 1blx_A 158 QIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGKILD 233 (326)
T ss_dssp CEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHH
T ss_pred CEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHH
Confidence 99999999997653221 1234557889999999998899999999999999999998 9999999888777666643
Q ss_pred CCCC--------------------------CCCCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 284 RQML--------------------------PCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 284 ~~~~--------------------------~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
.... ..+..+|+.+.+|+.+||..+|..|+ +..+.+|.++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 300 (326)
T 1blx_A 234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300 (326)
T ss_dssp HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred HcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccc
Confidence 1100 12346788889999999999999986 2233444443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=345.32 Aligned_cols=266 Identities=21% Similarity=0.346 Sum_probs=188.4
Q ss_pred ccCccc-ccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc--CCCe
Q psy7289 53 ETKPRF-LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLS--GEPM 129 (422)
Q Consensus 53 ~~~~~~-~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~~ 129 (422)
...|++ .++||+|+||.||+|++.....+..||||++..... ...+.+|+.+|++|+|||||++++++.. ...+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 345555 458999999999999987655677899999875432 2467899999999999999999999954 6679
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceee----cCCCeE
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV----GDGLTV 205 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl----~~~~~v 205 (422)
++||||+. |+|.+++........ ......+++..+..++.||+.||+|||+++|+||||||+|||+ +.++.+
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~~---~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASKA---NKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC----------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred EEEEeCCC-CCHHHHHHHhccccc---cccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence 99999997 588888864311000 0011358999999999999999999999999999999999999 677899
Q ss_pred EEecCcccccccCCcc-eEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChH--------
Q psy7289 206 KISDFGLSRDVYASDY-YRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ-------- 275 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~-------- 275 (422)
||+|||+++....... ........+|+.|+|||++... .++.++|||||||++|||++ |.+||.+.+..
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHH-SSCTTCCCC------CCCC
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHh-CCCCCCCccccccccccch
Confidence 9999999986543211 1122345678999999998874 58999999999999999999 99999765542
Q ss_pred -HHHHHHHcCCCCCC-------------------------------------CCCCCcchhhhcccccccccchhh-HHH
Q psy7289 276 -EVIEMIRSRQMLPC-------------------------------------PEDCPPRMYSLMMECWHEVPVAAG-MAY 316 (422)
Q Consensus 276 -~~~~~i~~~~~~~~-------------------------------------p~~~p~~~~~l~~~cw~~~P~~r~-~~~ 316 (422)
+.+..+......|. ....++.+.+|+.+||..||..|+ +..
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 33333321100110 012266788999999999999986 445
Q ss_pred Hhhhhhhhhh
Q psy7289 317 LCSHHYVHRD 326 (422)
Q Consensus 317 lh~~~~i~~d 326 (422)
+.+|.++..+
T Consensus 331 ~L~hp~f~~~ 340 (405)
T 3rgf_A 331 AMQDPYFLED 340 (405)
T ss_dssp HHTSGGGTSS
T ss_pred HhcChhhccC
Confidence 6677777554
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=338.42 Aligned_cols=256 Identities=21% Similarity=0.307 Sum_probs=198.5
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC----------HHhHHHHHHHHHHHhcCCCCceeeEe
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN----------QKTASDFRREVDLMSELRHPNIVCLL 120 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~E~~il~~l~HpnIv~l~ 120 (422)
....+|++.+.||+|+||.||+|+.. .+..||||++..... ....+.+.+|++++++++||||++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 95 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDS---EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLR 95 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECT---TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred HhccceEEeEEeccCCCEEEEEEECC---CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcccee
Confidence 45678999999999999999999752 367899998854221 22347899999999999999999999
Q ss_pred eEEEcC-----CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy7289 121 GVCLSG-----EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAAR 195 (422)
Q Consensus 121 g~~~~~-----~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~ 195 (422)
+++... ..+++||||++ |+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 163 (362)
T 3pg1_A 96 DIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-----------IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPG 163 (362)
T ss_dssp EEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-----------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred eeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChH
Confidence 998543 35799999998 68998887532 35899999999999999999999999999999999
Q ss_pred ceeecCCCeEEEecCcccccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh
Q psy7289 196 NCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN 274 (422)
Q Consensus 196 NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~ 274 (422)
|||++.++.+||+|||+++...... ......+|+.|+|||++.. ..++.++|||||||++|||++ |..||.+.+.
T Consensus 164 NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~ 239 (362)
T 3pg1_A 164 NILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN-RKALFRGSTF 239 (362)
T ss_dssp GEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHH-SSCSCCCSSH
T ss_pred HEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHh-CCCCCCCCCH
Confidence 9999999999999999997543322 2233456888999999876 679999999999999999999 9999999887
Q ss_pred HHHHHHHHcCC-----------------------CCC--------CCCCCCcchhhhcccccccccchhh-HHHHhhhhh
Q psy7289 275 QEVIEMIRSRQ-----------------------MLP--------CPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHY 322 (422)
Q Consensus 275 ~~~~~~i~~~~-----------------------~~~--------~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~ 322 (422)
.+....+.... ... .++.+++.+.+|+.+||..+|..|+ +..+.+|.+
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 319 (362)
T 3pg1_A 240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY 319 (362)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence 77666553210 000 1345678899999999999999986 334555555
Q ss_pred hhh
Q psy7289 323 VHR 325 (422)
Q Consensus 323 i~~ 325 (422)
+..
T Consensus 320 f~~ 322 (362)
T 3pg1_A 320 FES 322 (362)
T ss_dssp GTT
T ss_pred hhh
Confidence 543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=334.77 Aligned_cols=263 Identities=20% Similarity=0.352 Sum_probs=187.7
Q ss_pred chhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHH-HHhcCCCCceeeEeeEEEc
Q psy7289 47 FRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVD-LMSELRHPNIVCLLGVCLS 125 (422)
Q Consensus 47 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~g~~~~ 125 (422)
..+++...+|++.+.||+|+||.||+|+... .+..||||+++..........+.+|+. +++.++||||+++++++.+
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKP--SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETT--TTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcC--CCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 3456677889999999999999999998643 457899999976655555566777776 7788899999999999999
Q ss_pred CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeecCCCe
Q psy7289 126 GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSH-HYVHRDLAARNCLVGDGLT 204 (422)
Q Consensus 126 ~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~ivHrDlKp~NiLl~~~~~ 204 (422)
++..++||||+++ +|.+++...... ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~~~~-------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~ 164 (327)
T 3aln_A 93 EGDCWICMELMST-SFDKFYKYVYSV-------LDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN 164 (327)
T ss_dssp SSEEEEEECCCSE-EHHHHHHHHHHT-------TCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE
T ss_pred CCceEEEEeecCC-ChHHHHHHHHhh-------hcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC
Confidence 9999999999985 888877642100 023689999999999999999999999 9999999999999999999
Q ss_pred EEEecCcccccccCCcceEeccCCCCCccccCcccc----ccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChH-HHHH
Q psy7289 205 VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESI----LYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ-EVIE 279 (422)
Q Consensus 205 vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~----~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~-~~~~ 279 (422)
+||+|||+++...... ......+|+.|+|||++ ....++.++|||||||++|||++ |..||.+.+.. +.+.
T Consensus 165 ~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~ 240 (327)
T 3aln_A 165 IKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELAT-GRFPYPKWNSVFDQLT 240 (327)
T ss_dssp EEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHH-SCCCSSCC-------C
T ss_pred EEEccCCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHH-CCCCCCCcchHHHHHH
Confidence 9999999998654322 12233578899999998 45678999999999999999999 99999875432 3333
Q ss_pred HHHcCCCCCCC----CCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 280 MIRSRQMLPCP----EDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 280 ~i~~~~~~~~p----~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
.+..+..+..+ ..+++.+.+|+..||..+|..|+ +..+.+|.++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~ 289 (327)
T 3aln_A 241 QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289 (327)
T ss_dssp CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHH
Confidence 33333333222 46889999999999999999987 2234444444
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=331.61 Aligned_cols=254 Identities=23% Similarity=0.367 Sum_probs=205.4
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCc------eeeEeeEE
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPN------IVCLLGVC 123 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~Hpn------Iv~l~g~~ 123 (422)
++...+|++.+.||+|+||.||+|+... .++..||||+++.. ....+.+.+|+.+++.++|+| |+++++++
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHK-AGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETT-TTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecC-CCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 4567799999999999999999997632 34678999998642 345577889999999887664 99999999
Q ss_pred EcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC--
Q psy7289 124 LSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD-- 201 (422)
Q Consensus 124 ~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~-- 201 (422)
.+.+..++||||+ +|+|.+++..... .++++.++..++.||+.||+|||+++|+||||||+|||++.
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~ 155 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKENGF----------LPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSD 155 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTT----------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCC
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHhcCC----------CCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccc
Confidence 9999999999999 8999999976431 35889999999999999999999999999999999999987
Q ss_pred -----------------CCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhC
Q psy7289 202 -----------------GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY 264 (422)
Q Consensus 202 -----------------~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~ 264 (422)
++.+||+|||+++..... .....+|+.|+|||++....++.++|||||||++|||++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~- 229 (339)
T 1z57_A 156 YTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL- 229 (339)
T ss_dssp EEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHH-
T ss_pred cccccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHh-
Confidence 567999999999764322 234467899999999998899999999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHcCCC-------------------------------------------CCCCCCCCcchhhhc
Q psy7289 265 GLQPYYGYSNQEVIEMIRSRQM-------------------------------------------LPCPEDCPPRMYSLM 301 (422)
Q Consensus 265 g~~Pf~~~~~~~~~~~i~~~~~-------------------------------------------~~~p~~~p~~~~~l~ 301 (422)
|..||.+.+..+....+..... ...+..+++++.+|+
T Consensus 230 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 309 (339)
T 1z57_A 230 GFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLI 309 (339)
T ss_dssp SSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHH
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHH
Confidence 9999999888776555432110 011223456788999
Q ss_pred ccccccccchhh-HHHHhhhhhh
Q psy7289 302 MECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 302 ~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
.+||..||..|+ +..+.+|.++
T Consensus 310 ~~~L~~dP~~Rpt~~ell~hp~f 332 (339)
T 1z57_A 310 QKMLEYDPAKRITLREALKHPFF 332 (339)
T ss_dssp HHHTCSSTTTSCCHHHHTTSGGG
T ss_pred HHHhCcCcccccCHHHHhcCHHH
Confidence 999999999997 2234444443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=331.09 Aligned_cols=246 Identities=18% Similarity=0.322 Sum_probs=196.6
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC-CCceeeEeeEEEc--CCCe
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR-HPNIVCLLGVCLS--GEPM 129 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~--~~~~ 129 (422)
..+|++.+.||+|+||.||+|+... .+..||||+++.. ..+.+.+|+.++++++ ||||+++++++.+ ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINIT--NNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECC--CCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 4679999999999999999998654 3578999998643 2357889999999997 9999999999987 5678
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC-eEEEe
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL-TVKIS 208 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~-~vKl~ 208 (422)
++||||+++++|.+++. .+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+
T Consensus 109 ~lv~e~~~~~~l~~~~~---------------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~ 173 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ---------------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 173 (330)
T ss_dssp EEEEECCCCCCHHHHGG---------------GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEEEeccCchhHHHHHH---------------hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEE
Confidence 99999999999999884 378899999999999999999999999999999999999766 89999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCC-ChHHHHHHH-----
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGY-SNQEVIEMI----- 281 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~-~~~~~~~~i----- 281 (422)
|||+++....... .....+|+.|+|||.+.. ..++.++|||||||++|||++ |..||... +..+.+..+
T Consensus 174 Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~l~~~~~~~~ 249 (330)
T 3nsz_A 174 DWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF-RKEPFFHGHDNYDQLVRIAKVLG 249 (330)
T ss_dssp CCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-TCSSSSCCSSHHHHHHHHHHHHC
T ss_pred eCCCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHh-CCCCcccCCchHHHHHHHHHhcC
Confidence 9999986543321 233457888999999876 679999999999999999999 88898543 332222221
Q ss_pred --------HcCCC-----------------------CCCCCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 282 --------RSRQM-----------------------LPCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 282 --------~~~~~-----------------------~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
..... ...+..+++++.+|+.+||..+|..|+ +..+.+|.++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f 323 (330)
T 3nsz_A 250 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323 (330)
T ss_dssp HHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGG
T ss_pred CchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccH
Confidence 11110 011223788999999999999999987 3344455554
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=336.19 Aligned_cols=253 Identities=23% Similarity=0.390 Sum_probs=189.9
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHH--HhcCCCCceeeEeeEEEc--
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDL--MSELRHPNIVCLLGVCLS-- 125 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~i--l~~l~HpnIv~l~g~~~~-- 125 (422)
.+...+|++.+.||+|+||.||+|+. .+..||||++... ....+..|.++ +..++||||+++++.+..
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 80 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL----DERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVT 80 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE----TTEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred CcChHHhheeeecccCCCeEEEEEEE----CCeEEEEEEeecc----chhhHHHHHHHHHHHhccCcchhhheecccccc
Confidence 34567899999999999999999975 3578999998642 23445555555 445899999999986542
Q ss_pred ---CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhC---------CccccCCC
Q psy7289 126 ---GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSH---------HYVHRDLA 193 (422)
Q Consensus 126 ---~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~---------~ivHrDlK 193 (422)
...+++|||||++|+|.+++... ..++..+..++.||+.||+|||++ +|+|||||
T Consensus 81 ~~~~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dik 147 (336)
T 3g2f_A 81 ADGRMEYLLVMEYYPNGSLXKYLSLH-------------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLN 147 (336)
T ss_dssp TTSCEEEEEEECCCTTCBHHHHHHHC-------------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCS
T ss_pred cCCCceEEEEEecCCCCcHHHHHhhc-------------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccc
Confidence 22578999999999999999764 357888999999999999999999 99999999
Q ss_pred CCceeecCCCeEEEecCcccccccCCcc------eEeccCCCCCccccCcccccc-------CCCCCchhHHhHHHHHHH
Q psy7289 194 ARNCLVGDGLTVKISDFGLSRDVYASDY------YRIQSKSLLPVRWMPPESILY-------GKFTTESDVWSYGVVLWE 260 (422)
Q Consensus 194 p~NiLl~~~~~vKl~DFGla~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DvwS~Gvil~E 260 (422)
|+|||++.++.+||+|||+++....... ........+|+.|+|||++.+ ..++.++|||||||++||
T Consensus 148 p~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~e 227 (336)
T 3g2f_A 148 SRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227 (336)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHH
T ss_pred cceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHH
Confidence 9999999999999999999986643321 112224467899999999876 356678999999999999
Q ss_pred HHhCCCCCCCCCCh-----------------HHHHHHHH-cCCCCCCCCCCC------cchhhhcccccccccchhhHHH
Q psy7289 261 VYSYGLQPYYGYSN-----------------QEVIEMIR-SRQMLPCPEDCP------PRMYSLMMECWHEVPVAAGMAY 316 (422)
Q Consensus 261 l~t~g~~Pf~~~~~-----------------~~~~~~i~-~~~~~~~p~~~p------~~~~~l~~~cw~~~P~~r~~~~ 316 (422)
|++.+.+||.+.+. .++...+. ...++..|..++ +++.+|+.+||..+|..|+
T Consensus 228 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp--- 304 (336)
T 3g2f_A 228 IFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARL--- 304 (336)
T ss_dssp HHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSC---
T ss_pred HHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCc---
Confidence 99833444433221 12222222 233444555443 4799999999999999998
Q ss_pred Hhhhhhhhhhcc
Q psy7289 317 LCSHHYVHRDLA 328 (422)
Q Consensus 317 lh~~~~i~~dLk 328 (422)
+...+...|+
T Consensus 305 --s~~e~l~~L~ 314 (336)
T 3g2f_A 305 --TAQXAEERMA 314 (336)
T ss_dssp --CHHHHHHHHH
T ss_pred --chHHHHHHHH
Confidence 6555555544
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=333.26 Aligned_cols=248 Identities=24% Similarity=0.337 Sum_probs=200.0
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC---
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP--- 128 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~--- 128 (422)
..+|++.+.||+|+||.||+|+... .+..||||++.... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKR--SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CceEEEeeeEecCCCeEEEEEEECC--CCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence 4678999999999999999998643 45789999986543 34456788999999999999999999999987654
Q ss_pred ---eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 129 ---MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 129 ---~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
+++||||+. |+|.+++. ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~--------------~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~ 165 (353)
T 3coi_A 101 FYDFYLVMPFMQ-TDLQKIMG--------------LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCEL 165 (353)
T ss_dssp CCCCEEEEECCS-EEGGGTTT--------------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCE
T ss_pred ceeEEEEecccc-CCHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcE
Confidence 499999998 68877663 248999999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR 284 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~ 284 (422)
||+|||+++..... .....+|+.|+|||++.. ..++.++|||||||++|||++ |..||.+.+..+.+..+...
T Consensus 166 kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~~~~~~~~i~~~ 239 (353)
T 3coi_A 166 KILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT-GKTLFKGKDYLDQLTQILKV 239 (353)
T ss_dssp EECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHH-SSCSSBSSCHHHHHHHHHHH
T ss_pred EEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Confidence 99999999764321 223456889999999876 678999999999999999999 99999998877665554321
Q ss_pred ------------------------------CCCCCCCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 285 ------------------------------QMLPCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 285 ------------------------------~~~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
.....+..+++++.+|+.+||..+|..|+ +..+.+|.++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f 309 (353)
T 3coi_A 240 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309 (353)
T ss_dssp HCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred hCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence 01122346788999999999999999987 2234444444
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=339.69 Aligned_cols=203 Identities=23% Similarity=0.380 Sum_probs=172.5
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC--------CCceeeEee
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR--------HPNIVCLLG 121 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~--------HpnIv~l~g 121 (422)
++...+|++.+.||+|+||.||+|+... ++..||||+++. .....+.+.+|+.+++.++ ||||+++++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~ 108 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQ--GKKFVAMKVVKS--AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD 108 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecC--CCeEEEEEEEec--CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence 4566889999999999999999997643 467899999864 2445678899999999985 788999999
Q ss_pred EEE----cCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCc
Q psy7289 122 VCL----SGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSH-HYVHRDLAARN 196 (422)
Q Consensus 122 ~~~----~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~ivHrDlKp~N 196 (422)
++. ....+++||||+ +|+|.+++.... ...+++..+..++.||+.||+|||++ ||+||||||+|
T Consensus 109 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~----------~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~N 177 (397)
T 1wak_A 109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKSN----------YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPEN 177 (397)
T ss_dssp EEEEEETTEEEEEEEECCC-CCBHHHHHHHTT----------TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGG
T ss_pred ceeecCCCCceEEEEEecc-CccHHHHHHhcc----------cCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 987 556799999999 667777776532 13589999999999999999999998 99999999999
Q ss_pred eeecCCC-------------------------------------------------eEEEecCcccccccCCcceEeccC
Q psy7289 197 CLVGDGL-------------------------------------------------TVKISDFGLSRDVYASDYYRIQSK 227 (422)
Q Consensus 197 iLl~~~~-------------------------------------------------~vKl~DFGla~~~~~~~~~~~~~~ 227 (422)
||++.++ .+||+|||+++..... ...
T Consensus 178 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~ 252 (397)
T 1wak_A 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTE 252 (397)
T ss_dssp EEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCS
T ss_pred eeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----Ccc
Confidence 9998775 7999999999865432 234
Q ss_pred CCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCC
Q psy7289 228 SLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS 273 (422)
Q Consensus 228 ~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~ 273 (422)
..+|+.|+|||++....++.++|||||||++|||++ |..||.+.+
T Consensus 253 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~ 297 (397)
T 1wak_A 253 DIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELAT-GDYLFEPHS 297 (397)
T ss_dssp CCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHH-SSCSCCCCC
T ss_pred CCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhh-CCCCCCCCc
Confidence 467899999999999999999999999999999999 999998655
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=350.01 Aligned_cols=245 Identities=21% Similarity=0.274 Sum_probs=199.4
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCC-CceeeEeeEEEcCCCe
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRH-PNIVCLLGVCLSGEPM 129 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~g~~~~~~~~ 129 (422)
....+|++.+.||+|+||.||+|++.. .+..||||++...... ..+.+|+++++.|+| ++|..+..++......
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~--~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ--TNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETT--TCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECC--CCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 346789999999999999999998654 3578999987643322 347889999999987 5666777777788889
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceee---cCCCeEE
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVK 206 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl---~~~~~vK 206 (422)
++||||+ +|+|.+++.... ..+++.++..++.||+.||+|||+++|+||||||+|||| +.++.+|
T Consensus 79 ~lvme~~-g~sL~~ll~~~~-----------~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vk 146 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCS-----------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 146 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTT-----------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEE
T ss_pred EEEEECC-CCCHHHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEE
Confidence 9999999 999999997532 358999999999999999999999999999999999999 5788999
Q ss_pred EecCcccccccCCcc-----eEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh---HHHH
Q psy7289 207 ISDFGLSRDVYASDY-----YRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN---QEVI 278 (422)
Q Consensus 207 l~DFGla~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~---~~~~ 278 (422)
|+|||+++....... +.......+|+.|+|||++....++.++|||||||++|||++ |..||.+... .+.+
T Consensus 147 L~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~ 225 (483)
T 3sv0_A 147 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKY 225 (483)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTSSCCCSSHHHHH
T ss_pred EEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHh-CCCCCccccchhHHHHH
Confidence 999999986644322 112234567899999999999999999999999999999999 9999988654 3333
Q ss_pred HHHHcC----CCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 279 EMIRSR----QMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 279 ~~i~~~----~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..+... .....+..+|+++.+++..||..+|..|+
T Consensus 226 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RP 264 (483)
T 3sv0_A 226 EKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKP 264 (483)
T ss_dssp HHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCC
T ss_pred HHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCc
Confidence 333322 12223467899999999999999999997
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=324.14 Aligned_cols=251 Identities=20% Similarity=0.331 Sum_probs=194.4
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc--------
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLS-------- 125 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------- 125 (422)
.+|++.+.||+|+||.||+|+... ++..||||.+.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNAL--DSRYYAIKKIRH--TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEE--EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcC--CCeEEEEEEEec--cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 468899999999999999998643 357899999854 23456789999999999999999999998865
Q ss_pred -----CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec
Q psy7289 126 -----GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVG 200 (422)
Q Consensus 126 -----~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~ 200 (422)
....++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+|||++
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~ 150 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSEN-----------LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID 150 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSC-----------GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccc-----------cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEc
Confidence 346799999999999999997642 2478889999999999999999999999999999999999
Q ss_pred CCCeEEEecCcccccccCCcc------------eEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCC
Q psy7289 201 DGLTVKISDFGLSRDVYASDY------------YRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQ 267 (422)
Q Consensus 201 ~~~~vKl~DFGla~~~~~~~~------------~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~ 267 (422)
.++.+||+|||+++....... ........+|+.|+|||++... .++.++|||||||++|||++
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---- 226 (303)
T 1zy4_A 151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---- 226 (303)
T ss_dssp TTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS----
T ss_pred CCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh----
Confidence 999999999999986542210 0112234568899999998754 68999999999999999997
Q ss_pred CCCC-CChHHHHHHHHcCCC---CCCCCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 268 PYYG-YSNQEVIEMIRSRQM---LPCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 268 Pf~~-~~~~~~~~~i~~~~~---~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
||.. .+..++...+..... ...+..+|+.+.+++++||..+|..|+ +..+.+|.++
T Consensus 227 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (303)
T 1zy4_A 227 PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287 (303)
T ss_dssp CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCS
T ss_pred ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCc
Confidence 5543 334455666654332 123456677799999999999999997 2334444433
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=324.42 Aligned_cols=256 Identities=20% Similarity=0.344 Sum_probs=189.6
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHH-HHHHHHHHHhcCCCCceeeEeeEEEcCCC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTAS-DFRREVDLMSELRHPNIVCLLGVCLSGEP 128 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 128 (422)
.....+|++.+.||+|+||.||+|+... .+..||||++.......... .+.++..+++.++||||+++++++.+++.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~ 98 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRK--TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD 98 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETT--TCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhhhccccccceeeecCCeeEEEEEEec--CCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Confidence 3445678999999999999999998754 35689999987655444433 44455567888899999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeecCCCeEEE
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSH-HYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~ivHrDlKp~NiLl~~~~~vKl 207 (422)
.++||||+ ++.+..+..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl 166 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRMQ-----------GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKL 166 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHHT-----------SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEecc-CCcHHHHHHHhc-----------cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEE
Confidence 99999999 455555544321 3589999999999999999999995 9999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccc-----cCCCCCchhHHhHHHHHHHHHhCCCCCCCCC-ChHHHHHHH
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL-----YGKFTTESDVWSYGVVLWEVYSYGLQPYYGY-SNQEVIEMI 281 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~-~~~~~~~~i 281 (422)
+|||+++...... ......+|+.|+|||++. ...++.++|||||||++|||++ |..||... +..+.+..+
T Consensus 167 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~ 242 (318)
T 2dyl_A 167 CDFGISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELAT-GQFPYKNCKTDFEVLTKV 242 (318)
T ss_dssp CCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHH-SSCTTTTCCSHHHHHHHH
T ss_pred EECCCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccHHHHHHH
Confidence 9999997654322 122345788999999984 4568899999999999999999 99999874 455666666
Q ss_pred HcCCCCCCC--CCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 282 RSRQMLPCP--EDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 282 ~~~~~~~~p--~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
..+.....| ..+|+++.+++.+||..+|..|+ +..+..|.++
T Consensus 243 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (318)
T 2dyl_A 243 LQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFI 287 (318)
T ss_dssp HHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred hccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHH
Confidence 665544444 46899999999999999999997 3334445544
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=329.61 Aligned_cols=254 Identities=24% Similarity=0.379 Sum_probs=203.4
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCc------eeeEeeEE
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPN------IVCLLGVC 123 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~Hpn------Iv~l~g~~ 123 (422)
+....+|++.+.||+|+||.||+|+...+ ++..||||+++.. ....+.+.+|+.+++.++|+| |+.+++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHAR-GKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTT-TTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCC-CceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 45677899999999999999999986443 3478999998642 345577889999999998766 99999999
Q ss_pred EcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceee----
Q psy7289 124 LSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV---- 199 (422)
Q Consensus 124 ~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl---- 199 (422)
...+..++||||+ +|+|.+++..... ..+++.++..++.||+.||+|||+++|+||||||+|||+
T Consensus 92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~----------~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~ 160 (355)
T 2eu9_A 92 NFHGHMCIAFELL-GKNTFEFLKENNF----------QPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSE 160 (355)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTT----------CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCC
T ss_pred eeCCeEEEEEecc-CCChHHHHHhccC----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccc
Confidence 9999999999999 6788888866421 358999999999999999999999999999999999999
Q ss_pred ---------------cCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhC
Q psy7289 200 ---------------GDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSY 264 (422)
Q Consensus 200 ---------------~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~ 264 (422)
+.++.+||+|||+++..... .....+|+.|+|||++....++.++|||||||++|||++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~- 234 (355)
T 2eu9_A 161 FETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR- 234 (355)
T ss_dssp EEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-
T ss_pred ccccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHh-
Confidence 56789999999999754322 234567899999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHcCCCC-C------------------------------------------CCCCCCcchhhhc
Q psy7289 265 GLQPYYGYSNQEVIEMIRSRQML-P------------------------------------------CPEDCPPRMYSLM 301 (422)
Q Consensus 265 g~~Pf~~~~~~~~~~~i~~~~~~-~------------------------------------------~p~~~p~~~~~l~ 301 (422)
|..||.+.+..+.+..+...... | .....++++.+|+
T Consensus 235 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 314 (355)
T 2eu9_A 235 GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLM 314 (355)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHH
Confidence 99999998877765554321100 0 0111234678999
Q ss_pred ccccccccchhh-HHHHhhhhhh
Q psy7289 302 MECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 302 ~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
.+||..||..|+ +..+.+|.++
T Consensus 315 ~~~L~~dP~~Rpt~~e~l~hp~f 337 (355)
T 2eu9_A 315 RRMLEFDPAQRITLAEALLHPFF 337 (355)
T ss_dssp HHHTCSSTTTSCCHHHHTTSGGG
T ss_pred HHHhcCChhhCcCHHHHhcChhh
Confidence 999999999997 2334444443
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=332.49 Aligned_cols=249 Identities=22% Similarity=0.323 Sum_probs=202.1
Q ss_pred hhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCH-----HhHHHHHHHHHHHhcCC--CCceeeEee
Q psy7289 49 REVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQ-----KTASDFRREVDLMSELR--HPNIVCLLG 121 (422)
Q Consensus 49 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~il~~l~--HpnIv~l~g 121 (422)
.+....+|++.+.||+|+||.||+|+... ++..||||.++..... ...+.+.+|+.++++++ ||||+++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVS--DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETT--TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECC--CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 35567889999999999999999998643 4588999998643211 12245678999999996 599999999
Q ss_pred EEEcCCCeEEEEEecCC-CCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec
Q psy7289 122 VCLSGEPMCMLFEFMVR-GDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVG 200 (422)
Q Consensus 122 ~~~~~~~~~lv~E~~~~-G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~ 200 (422)
++..++..++|||++.+ ++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~ 183 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITER------------GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 183 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe
Confidence 99999999999999986 8999999764 3589999999999999999999999999999999999999
Q ss_pred -CCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCChHHHH
Q psy7289 201 -DGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKF-TTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVI 278 (422)
Q Consensus 201 -~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~ 278 (422)
+++.+||+|||+++...... .....+|+.|+|||++....+ +.++|||||||++|||++ |..||...+ +
T Consensus 184 ~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~--~-- 254 (320)
T 3a99_A 184 LNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC-GDIPFEHDE--E-- 254 (320)
T ss_dssp TTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH-SSCSCCSHH--H--
T ss_pred CCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHH-CCCCCCChh--h--
Confidence 78899999999998654332 223457889999999887665 678999999999999999 999997532 2
Q ss_pred HHHHcCCCCCCCCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 279 EMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 279 ~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
+..+ ....+..+|+++.+++.+||..+|..|+ +..+.++.++
T Consensus 255 --~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~ 297 (320)
T 3a99_A 255 --IIRG-QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297 (320)
T ss_dssp --HHHC-CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred --hhcc-cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhh
Confidence 2222 2445678999999999999999999997 2334444444
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=331.05 Aligned_cols=257 Identities=21% Similarity=0.271 Sum_probs=190.3
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC---
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP--- 128 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~--- 128 (422)
...+|++.+.||+|+||.||+|+...+ +..||||++.... .....+.+|++.++.++||||+++++++.....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKST--GMSVAIKKVIQDP--RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHTTEEEC----------CEEEEETTT--CCEEEEEEEECCT--TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hccceEEEEEEecCCCeEEEEEEECCC--CCEEEEEEEecCc--cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 346799999999999999999987543 5689999885432 222456778888999999999999999875443
Q ss_pred ----eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCceeecC-
Q psy7289 129 ----MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLC--SHHYVHRDLAARNCLVGD- 201 (422)
Q Consensus 129 ----~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH--~~~ivHrDlKp~NiLl~~- 201 (422)
+++||||+++ +|.+.+...... ...+++..+..++.|++.||.||| +++|+||||||+|||++.
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~--------~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~ 167 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYYRR--------QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA 167 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHHTT--------TCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETT
T ss_pred cceeEEEEeecccc-cHHHHHHHHhhc--------ccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCC
Confidence 8899999986 555554432110 235889999999999999999999 999999999999999996
Q ss_pred CCeEEEecCcccccccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHH
Q psy7289 202 GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEM 280 (422)
Q Consensus 202 ~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~ 280 (422)
++.+||+|||+++....... .....+|+.|+|||++... .++.++|||||||++|||++ |..||.+.+..+.+..
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~ 243 (360)
T 3e3p_A 168 DGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML-GEPIFRGDNSAGQLHE 243 (360)
T ss_dssp TTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHH
T ss_pred CCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHh-CCCCcCCCChHHHHHH
Confidence 89999999999986644321 2344578899999998655 48999999999999999999 9999999888777666
Q ss_pred HHcCCC-------------------------------CCCCCCCCcchhhhcccccccccchhh-HHHHhhhhhhhh
Q psy7289 281 IRSRQM-------------------------------LPCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHR 325 (422)
Q Consensus 281 i~~~~~-------------------------------~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~ 325 (422)
+..... ...+..+++++.+|+.+||..+|..|+ +..+.+|.++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 320 (360)
T 3e3p_A 244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE 320 (360)
T ss_dssp HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGG
T ss_pred HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccc
Confidence 543110 111223567899999999999999996 334556666544
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=334.07 Aligned_cols=259 Identities=17% Similarity=0.281 Sum_probs=201.5
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC-----------CCceeeE
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR-----------HPNIVCL 119 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-----------HpnIv~l 119 (422)
+...+|++.+.||+|+||.||+|+... .+..||||++.. .......+.+|+.++++++ ||||+++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMV--NNTHVAMKIVRG--DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecC--CCcEEEEEEecC--CccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 445689999999999999999998643 457899999864 3344567889999999886 8999999
Q ss_pred eeEEEcCC----CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCC
Q psy7289 120 LGVCLSGE----PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSH-HYVHRDLAA 194 (422)
Q Consensus 120 ~g~~~~~~----~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~ivHrDlKp 194 (422)
++++.... .+++||||+ +|+|.+++..... ..+++..+..++.||+.||+|||++ ||+||||||
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~----------~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp 160 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH----------RGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKP 160 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTT----------SCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSG
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhc----------cCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCCh
Confidence 99987654 689999999 8999999976421 3489999999999999999999998 999999999
Q ss_pred Cceeec------CCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCC
Q psy7289 195 RNCLVG------DGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQP 268 (422)
Q Consensus 195 ~NiLl~------~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~P 268 (422)
+|||++ ..+.+||+|||+++..... .....+|+.|+|||++....++.++|||||||++|||++ |..|
T Consensus 161 ~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p 234 (373)
T 1q8y_A 161 ENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT-GDFL 234 (373)
T ss_dssp GGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHH-SSCC
T ss_pred HHeEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHh-CCCC
Confidence 999994 4458999999999765332 234467899999999999999999999999999999999 9999
Q ss_pred CCCCCh------HHHHHHHHc--CC---------------------------------------CCCCCCCCCcchhhhc
Q psy7289 269 YYGYSN------QEVIEMIRS--RQ---------------------------------------MLPCPEDCPPRMYSLM 301 (422)
Q Consensus 269 f~~~~~------~~~~~~i~~--~~---------------------------------------~~~~p~~~p~~~~~l~ 301 (422)
|.+.+. .+.+..+.. +. ....|..+++++.+|+
T Consensus 235 f~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 314 (373)
T 1q8y_A 235 FEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 314 (373)
T ss_dssp C---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHH
T ss_pred CCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHH
Confidence 986542 222222211 00 1123345567888999
Q ss_pred ccccccccchhh-HHHHhhhhhhhhhcccc
Q psy7289 302 MECWHEVPVAAG-MAYLCSHHYVHRDLAAR 330 (422)
Q Consensus 302 ~~cw~~~P~~r~-~~~lh~~~~i~~dLk~~ 330 (422)
.+||..||..|+ +..+.+|.++...+..+
T Consensus 315 ~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 344 (373)
T 1q8y_A 315 SPMLQLDPRKRADAGGLVNHPWLKDTLGME 344 (373)
T ss_dssp GGGGCSSTTTCBCHHHHHTCGGGTTCTTCT
T ss_pred HHHhccCccccCCHHHHhhChhhhcccCcc
Confidence 999999999986 44566677766544443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=332.40 Aligned_cols=213 Identities=24% Similarity=0.335 Sum_probs=179.7
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC-CC-----ceeeEeeEE
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR-HP-----NIVCLLGVC 123 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-Hp-----nIv~l~g~~ 123 (422)
+....+|++.+.||+|+||.||+|+... .+..||||+++.. ......+.+|+.+++.++ |+ +|+++++++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRV--EQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETT--TTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcC--CCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 3446789999999999999999998643 4578999998642 344567888999988885 55 499999999
Q ss_pred EcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCCCCceeec-
Q psy7289 124 LSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCS--HHYVHRDLAARNCLVG- 200 (422)
Q Consensus 124 ~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~--~~ivHrDlKp~NiLl~- 200 (422)
...+..++||||+. |+|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++
T Consensus 126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~----------~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~ 194 (382)
T 2vx3_A 126 MFRNHLCLVFEMLS-YNLYDLLRNTNF----------RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN 194 (382)
T ss_dssp EETTEEEEEEECCC-CBHHHHHHHTTT----------SCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS
T ss_pred ccCCceEEEEecCC-CCHHHHHhhcCc----------CCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec
Confidence 99999999999996 599999976421 358999999999999999999994 6899999999999995
Q ss_pred -CCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHH
Q psy7289 201 -DGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIE 279 (422)
Q Consensus 201 -~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~ 279 (422)
.++.+||+|||+++..... .....+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..+.+.
T Consensus 195 ~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~ 268 (382)
T 2vx3_A 195 PKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT-GEPLFSGANEVDQMN 268 (382)
T ss_dssp TTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHH
T ss_pred CCCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Confidence 4778999999999865322 234567889999999999999999999999999999999 999999998888776
Q ss_pred HHHc
Q psy7289 280 MIRS 283 (422)
Q Consensus 280 ~i~~ 283 (422)
.+..
T Consensus 269 ~i~~ 272 (382)
T 2vx3_A 269 KIVE 272 (382)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6653
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=326.59 Aligned_cols=253 Identities=21% Similarity=0.369 Sum_probs=174.7
Q ss_pred ccccCccccc-ccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc----
Q psy7289 51 VIETKPRFLQ-ELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLS---- 125 (422)
Q Consensus 51 ~~~~~~~~~~-~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---- 125 (422)
....+|++.+ .||+|+||.||+|+...+ ++.||||++... .... .+....++.++||||+++++++..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~--~~~vavK~~~~~--~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 97 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRT--GQKCALKLLYDS--PKAR---QEVDHHWQASGGPHIVCILDVYENMHHG 97 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTT--CCEEEEEEEESS--HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCC--CCEEEEEEecCc--HHHH---HHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence 4556788865 599999999999987543 578999998642 2211 222334667799999999999876
Q ss_pred CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC---C
Q psy7289 126 GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD---G 202 (422)
Q Consensus 126 ~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~---~ 202 (422)
...+++||||+++|+|.+++..+.. ..+++.++..++.||+.||+|||+++|+||||||+|||++. +
T Consensus 98 ~~~~~lv~e~~~gg~L~~~l~~~~~----------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~ 167 (336)
T 3fhr_A 98 KRCLLIIMECMEGGELFSRIQERGD----------QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKD 167 (336)
T ss_dssp EEEEEEEEECCTTEEHHHHHHTC-C----------CCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTT
T ss_pred CceEEEEEeccCCCCHHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCC
Confidence 4458999999999999999976421 35899999999999999999999999999999999999975 4
Q ss_pred CeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHH---
Q psy7289 203 LTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIE--- 279 (422)
Q Consensus 203 ~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~--- 279 (422)
+.+||+|||+++...... .....+|+.|+|||++....++.++|||||||++|||++ |..||.+.+...+..
T Consensus 168 ~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~ 242 (336)
T 3fhr_A 168 AVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC-GFPPFYSNTGQAISPGMK 242 (336)
T ss_dssp CCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHH-SSCCC-------------
T ss_pred ceEEEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHH-CCCCCCCccchhhhhhHH
Confidence 569999999997654321 223456889999999988889999999999999999999 999998776655422
Q ss_pred -HHHcCC---CCCCCCCCCcchhhhcccccccccchhh-HHHHhhhhhhhh
Q psy7289 280 -MIRSRQ---MLPCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHR 325 (422)
Q Consensus 280 -~i~~~~---~~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~ 325 (422)
.+..+. ..+....+|+++.+|+.+||..+|..|+ +..+.+|.++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 243 RRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp --------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 222211 1122357899999999999999999986 334555666544
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=325.58 Aligned_cols=240 Identities=26% Similarity=0.390 Sum_probs=189.3
Q ss_pred hhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCH-----HhHHHHHHHHHHHhcC----CCCceee
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQ-----KTASDFRREVDLMSEL----RHPNIVC 118 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~il~~l----~HpnIv~ 118 (422)
..+....+|++.+.||+|+||.||+|+... ++..||||++...... .....+.+|+.+++++ +||||++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~ 102 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLT--DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIR 102 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTT--TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCC
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEcc--CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeee
Confidence 345667889999999999999999997543 4578999998643221 1233466799999998 8999999
Q ss_pred EeeEEEcCCCeEEEEEe-cCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q psy7289 119 LLGVCLSGEPMCMLFEF-MVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNC 197 (422)
Q Consensus 119 l~g~~~~~~~~~lv~E~-~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~Ni 197 (422)
+++++.+.+..++|||| +.+++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+||
T Consensus 103 ~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 170 (312)
T 2iwi_A 103 LLDWFETQEGFMLVLERPLPAQDLFDYITEK------------GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENI 170 (312)
T ss_dssp EEEEC-----CEEEEECCSSEEEHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGE
T ss_pred EEEEEecCCeEEEEEEecCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhE
Confidence 99999999999999999 7899999999764 2589999999999999999999999999999999999
Q ss_pred eec-CCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCChH
Q psy7289 198 LVG-DGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFT-TESDVWSYGVVLWEVYSYGLQPYYGYSNQ 275 (422)
Q Consensus 198 Ll~-~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwS~Gvil~El~t~g~~Pf~~~~~~ 275 (422)
+++ +++.+||+|||+++...... .....+++.|+|||++....+. .++|||||||++|||++ |..||... .
T Consensus 171 l~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~--~ 243 (312)
T 2iwi_A 171 LIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVC-GDIPFERD--Q 243 (312)
T ss_dssp EEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH-SSCSCCSH--H
T ss_pred EEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHH-CCCCCCCh--H
Confidence 999 88999999999998654432 2234578899999998877664 58999999999999999 99999753 2
Q ss_pred HHHHHHHcCCCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 276 EVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 276 ~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
++. . .....|..+++.+.+++.+||..+|..|+
T Consensus 244 ~~~----~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 276 (312)
T 2iwi_A 244 EIL----E-AELHFPAHVSPDCCALIRRCLAPKPSSRP 276 (312)
T ss_dssp HHH----H-TCCCCCTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred HHh----h-hccCCcccCCHHHHHHHHHHccCChhhCc
Confidence 221 1 23456788999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=331.78 Aligned_cols=258 Identities=21% Similarity=0.253 Sum_probs=187.0
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCCeEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~l 131 (422)
...+...+.||+|+||+||.+.. ..+..||||++... ..+.+.+|+.+|+++ +|||||++++++.++..+++
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~~---~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l 86 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQGS---FQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEEE---SSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred hheeeccCeEeeCCCeEEEEEEE---ECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence 44556678899999999976432 23578999988542 234678999999876 89999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC---------
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG--------- 202 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~--------- 202 (422)
|||||. |+|.+++........ .....++..+..++.||+.||+|||+++|+||||||+|||++.+
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~-----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~ 160 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDE-----NLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQT 160 (434)
T ss_dssp EECCCS-EEHHHHHHTC-----------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTT
T ss_pred EEecCC-CCHHHHHhccCCCch-----hhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccccc
Confidence 999996 699999976432110 00112445667899999999999999999999999999999754
Q ss_pred ----CeEEEecCcccccccCCcce--EeccCCCCCccccCcccccc-------CCCCCchhHHhHHHHHHHHHhCCCCCC
Q psy7289 203 ----LTVKISDFGLSRDVYASDYY--RIQSKSLLPVRWMPPESILY-------GKFTTESDVWSYGVVLWEVYSYGLQPY 269 (422)
Q Consensus 203 ----~~vKl~DFGla~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DvwS~Gvil~El~t~g~~Pf 269 (422)
..+||+|||+++........ .......+|+.|+|||++.. ..++.++|||||||++|||++.|..||
T Consensus 161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf 240 (434)
T 2rio_A 161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240 (434)
T ss_dssp CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence 48999999999876443211 11234467899999999865 568999999999999999998789999
Q ss_pred CCCChHHHHHHHHcCCCCCC-----CCCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 270 YGYSNQEVIEMIRSRQMLPC-----PEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 270 ~~~~~~~~~~~i~~~~~~~~-----p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
.+....+. ..+......+. +..+++++.+|+.+||..+|..|+ +..+.+|.++.
T Consensus 241 ~~~~~~~~-~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~ 300 (434)
T 2rio_A 241 GDKYSRES-NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW 300 (434)
T ss_dssp CSTTTHHH-HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred CCchhhHH-HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccC
Confidence 87655442 22222222221 123457889999999999999986 33455565553
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=333.98 Aligned_cols=236 Identities=20% Similarity=0.195 Sum_probs=182.2
Q ss_pred chhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-------CHHhHHHHHHHHHHHhcCC-------
Q psy7289 47 FRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-------NQKTASDFRREVDLMSELR------- 112 (422)
Q Consensus 47 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~il~~l~------- 112 (422)
+...+...+|++.+.||+|+||.||+|++ .+..||||+++... .....+.+.+|+.+|+.++
T Consensus 13 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~ 88 (336)
T 2vuw_A 13 FSHCLPTEKLQRCEKIGEGVFGEVFQTIA----DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVC 88 (336)
T ss_dssp HHHHSCHHHHHTCEEEEEETTEEEEEEEE----TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSS
T ss_pred hhhhcccccchheeeecccCceEEEEEEe----CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhcccc
Confidence 34445567899999999999999999986 34789999986432 2233467889999998886
Q ss_pred --CCceeeEeeEEE-----------------c-------------CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCcc
Q psy7289 113 --HPNIVCLLGVCL-----------------S-------------GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQ 160 (422)
Q Consensus 113 --HpnIv~l~g~~~-----------------~-------------~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~ 160 (422)
|||||++.+++. + ...+|+|||||++|++.+.+.+
T Consensus 89 ~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------------- 155 (336)
T 2vuw_A 89 NRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------------- 155 (336)
T ss_dssp SBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-------------
T ss_pred ccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-------------
Confidence 777777766543 2 6789999999999987776643
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCceeecCCC--------------------eEEEecCcccccccCC
Q psy7289 161 APLSQQDFSHIALQVAAGMAYLC-SHHYVHRDLAARNCLVGDGL--------------------TVKISDFGLSRDVYAS 219 (422)
Q Consensus 161 ~~l~~~~~~~i~~qi~~gL~yLH-~~~ivHrDlKp~NiLl~~~~--------------------~vKl~DFGla~~~~~~ 219 (422)
..+++.++..++.||+.||+||| +++|+||||||+|||++.++ .+||+|||+|+.....
T Consensus 156 ~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~ 235 (336)
T 2vuw_A 156 KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG 235 (336)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC
Confidence 24799999999999999999999 99999999999999999876 9999999999865322
Q ss_pred cceEeccCCCCCccccCccccccCCCCCchhHHhHHHH-HHHHHhCCCCCCCCCCh-HHHHHHHHcCCCCC------CCC
Q psy7289 220 DYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVV-LWEVYSYGLQPYYGYSN-QEVIEMIRSRQMLP------CPE 291 (422)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvi-l~El~t~g~~Pf~~~~~-~~~~~~i~~~~~~~------~p~ 291 (422)
...+|+.|||||++.+.. +.++||||++++ .+++++ |..||.+... ..+...+......+ .+.
T Consensus 236 -------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (336)
T 2vuw_A 236 -------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWG-EYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMK 306 (336)
T ss_dssp -------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTT-SCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHH
T ss_pred -------cEEEeecccChhhhcCCC-ccceehhhhhCCCCccccc-ccCCCcchhhhhHHHHhhhhhhccCcccchhhhh
Confidence 235788999999998665 889999998877 677776 8889854321 22333333221111 123
Q ss_pred CCCcchhhhcccccccc
Q psy7289 292 DCPPRMYSLMMECWHEV 308 (422)
Q Consensus 292 ~~p~~~~~l~~~cw~~~ 308 (422)
.+++++.+|+++||..+
T Consensus 307 ~~s~~~~dli~~~L~~d 323 (336)
T 2vuw_A 307 QIKRKIQEFHRTMLNFS 323 (336)
T ss_dssp HHHHHHHHHHHHGGGSS
T ss_pred hcCHHHHHHHHHHhccC
Confidence 57788999999999988
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=332.28 Aligned_cols=253 Identities=21% Similarity=0.229 Sum_probs=187.2
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCCeE
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~ 130 (422)
...+|++.+.||+|+||.|+.... ..++.||||++..... ..+.+|+++|+++ +|||||++++++.+....|
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~---~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~ 94 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGM---FDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQY 94 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEE---SSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEE---eCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEE
Confidence 345688889999999999653222 2357799999864322 2356899999999 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC-----CCeE
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD-----GLTV 205 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~-----~~~v 205 (422)
+|||||. |+|.+++.... ..+++.++..++.||+.||+|||+++|+||||||+|||++. ...+
T Consensus 95 lv~E~~~-g~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~ 162 (432)
T 3p23_A 95 IAIELCA-ATLQEYVEQKD-----------FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKA 162 (432)
T ss_dssp EEEECCS-EEHHHHHHSSS-----------CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCE
T ss_pred EEEECCC-CCHHHHHHhcC-----------CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeE
Confidence 9999997 69999997642 12444567789999999999999999999999999999953 2368
Q ss_pred EEecCcccccccCCcc-eEeccCCCCCccccCccccc---cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHH
Q psy7289 206 KISDFGLSRDVYASDY-YRIQSKSLLPVRWMPPESIL---YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i 281 (422)
||+|||+++....... ........+|+.|+|||++. ...++.++|||||||++|||++.|..||......+....+
T Consensus 163 kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~ 242 (432)
T 3p23_A 163 MISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL 242 (432)
T ss_dssp EECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHT
T ss_pred EEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHh
Confidence 8999999987643221 12234456899999999987 4567889999999999999998889999766555544333
Q ss_pred HcCCCCC--CCCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 282 RSRQMLP--CPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 282 ~~~~~~~--~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
....... .+...++.+.+|+.+||..+|..|+ +..+.+|.++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f 287 (432)
T 3p23_A 243 GACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287 (432)
T ss_dssp TCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTT
T ss_pred ccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccc
Confidence 2222111 1223345678999999999999986 4445555554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=315.50 Aligned_cols=217 Identities=12% Similarity=0.047 Sum_probs=180.8
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP 128 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 128 (422)
+...+|++.+.||+|+||.||+|+... .++.||||++.... .....+.|.+|+.++++++||||+++++++.+.+.
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 105 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTA--LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAG 105 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETT--TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecC--CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCc
Confidence 567889999999999999999998643 35789999997543 24456789999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
.|+||||+++|+|.+++... ....++.+++.|++.||+|||++||+||||||+|||+++++.+||+
T Consensus 106 ~~lv~e~~~g~~L~~~l~~~--------------~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~ 171 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADTS--------------PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLA 171 (286)
T ss_dssp EEEEEECCCEEEHHHHHTTC--------------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEEC
T ss_pred EEEEEEecCCCCHHHHHhcC--------------CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEE
Confidence 99999999999999999531 3455788999999999999999999999999999999999999998
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHH---HHHcCC
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIE---MIRSRQ 285 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~---~i~~~~ 285 (422)
++| |++| ++.++|||||||++|||++ |..||.+.+..+.+. ....+.
T Consensus 172 ~~~----------------------~~~~-------~~~~~Di~slG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~ 221 (286)
T 3uqc_A 172 YPA----------------------TMPD-------ANPQDDIRGIGASLYALLV-NRWPLPEAGVRSGLAPAERDTAGQ 221 (286)
T ss_dssp SCC----------------------CCTT-------CCHHHHHHHHHHHHHHHHH-SEECSCCCSBCCCSEECCBCTTSC
T ss_pred ecc----------------------ccCC-------CCchhHHHHHHHHHHHHHH-CCCCCCcCCcchhhHHHHHHhccC
Confidence 543 3443 6889999999999999999 999999876544221 111111
Q ss_pred CCC---CCCCCCcchhhhcccccccccchhh
Q psy7289 286 MLP---CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 286 ~~~---~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..+ .+.++|+++.+++.+||+.||..|.
T Consensus 222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rs 252 (286)
T 3uqc_A 222 PIEPADIDRDIPFQISAVAARSVQGDGGIRS 252 (286)
T ss_dssp BCCHHHHCTTSCHHHHHHHHHHHCTTSSCCC
T ss_pred CCChhhcccCCCHHHHHHHHHHcccCCccCC
Confidence 111 2367899999999999999999984
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=354.62 Aligned_cols=233 Identities=16% Similarity=0.173 Sum_probs=189.4
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC-
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP- 128 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~- 128 (422)
++...+|++.+.||+|+||.||+|++... +++.||||++...........+.+|+.++++++|||||++++++...+.
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGG-TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCC-CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 45567899999999999999999987542 3578999998765566667789999999999999999999999987665
Q ss_pred ----eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCe
Q psy7289 129 ----MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLT 204 (422)
Q Consensus 129 ----~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~ 204 (422)
.|+||||+++|+|.+++.. .+++.++..++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~--------------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~ 219 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ--------------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-Q 219 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C--------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-C
T ss_pred CCceeEEEEEeCCCCcHHHHHhC--------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-c
Confidence 7999999999999887642 48999999999999999999999999999999999999986 8
Q ss_pred EEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC
Q psy7289 205 VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR 284 (422)
Q Consensus 205 vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~ 284 (422)
+||+|||+++..... ....+|+.|||||++..+ ++.++|||||||++|||++ |.+||.+.....+
T Consensus 220 ~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~-g~~~~~~~~~~~~------- 284 (681)
T 2pzi_A 220 LKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTL-DLPTRNGRYVDGL------- 284 (681)
T ss_dssp EEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHS-CCCEETTEECSSC-------
T ss_pred EEEEecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHh-CCCCCcccccccc-------
Confidence 999999999865432 344678999999988765 4889999999999999997 8888865321100
Q ss_pred CCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 285 QMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 285 ~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
........+++.+.+++.+||+.+|..|+
T Consensus 285 ~~~~~~~~~~~~l~~li~~~l~~dP~~R~ 313 (681)
T 2pzi_A 285 PEDDPVLKTYDSYGRLLRRAIDPDPRQRF 313 (681)
T ss_dssp CTTCHHHHHCHHHHHHHHHHTCSSGGGSC
T ss_pred cccccccccCHHHHHHHhhhccCChhhCC
Confidence 00000112356789999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=344.35 Aligned_cols=245 Identities=22% Similarity=0.362 Sum_probs=194.0
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc------CC
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLS------GE 127 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~~ 127 (422)
.+|++.+.||+|+||.||+|+... .+..||||+++........+.+.+|++++++++||||+++++++.. ++
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~--tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQD--TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTT--TTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECC--CCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 579999999999999999987543 4567999998876666777889999999999999999999998765 66
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC---e
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL---T 204 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~---~ 204 (422)
..++|||||++|+|.+++..... ...+++..+..++.|++.||+|||++||+||||||+|||++.++ .
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~---------~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~ 162 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFEN---------CCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLI 162 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSC---------TTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCE
T ss_pred eEEEEEEeCCCCCHHHHHHhccc---------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCcee
Confidence 78999999999999999976421 12588899999999999999999999999999999999999665 4
Q ss_pred EEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHH------
Q psy7289 205 VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVI------ 278 (422)
Q Consensus 205 vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~------ 278 (422)
+||+|||+++...... ......+|+.|+|||.+....++.++|||||||++|||++ |..||.+.....-.
T Consensus 163 vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLlt-G~~Pf~~~~~~~~~~~~i~~ 238 (676)
T 3qa8_A 163 HKIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT-GFRPFLPNWQPVQWHGKVRE 238 (676)
T ss_dssp EEECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHS-SCSSCCSSCHHHHSSTTCC-
T ss_pred EEEccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHH-CCCCCCcccchhhhhhhhhc
Confidence 9999999998764432 2234567899999999999999999999999999999998 99999765332110
Q ss_pred ---HHHH-----c-----CCCCCCCC----CCCcchhhhcccccccccchhh
Q psy7289 279 ---EMIR-----S-----RQMLPCPE----DCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 279 ---~~i~-----~-----~~~~~~p~----~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..+. . ....+.|. .+|+.+.+++..||..||..|+
T Consensus 239 ~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRP 290 (676)
T 3qa8_A 239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRG 290 (676)
T ss_dssp -----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---
T ss_pred ccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCc
Confidence 0000 0 01122232 3456789999999999999987
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=306.34 Aligned_cols=232 Identities=22% Similarity=0.394 Sum_probs=181.4
Q ss_pred cccCcccc-cccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHH-hcCCCCceeeEeeEEEc----
Q psy7289 52 IETKPRFL-QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLM-SELRHPNIVCLLGVCLS---- 125 (422)
Q Consensus 52 ~~~~~~~~-~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il-~~l~HpnIv~l~g~~~~---- 125 (422)
...+|.+. +.||+|+||.||+|+... .+..||+|+++.. ..+.+|+.++ +.++||||+++++++..
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKR--TQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccchhhcCcccccCCCeEEEEEEEcC--CCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 34556666 789999999999998654 3578999998532 3567899888 66699999999999876
Q ss_pred CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC---C
Q psy7289 126 GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD---G 202 (422)
Q Consensus 126 ~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~---~ 202 (422)
...+++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+++|+||||||+|||++. +
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 156 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGD----------QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPN 156 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTT----------CCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTT
T ss_pred CceEEEEEeecCCCcHHHHHHhccC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCC
Confidence 6678999999999999999987421 35899999999999999999999999999999999999997 7
Q ss_pred CeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q psy7289 203 LTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282 (422)
Q Consensus 203 ~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~ 282 (422)
+.+||+|||+++... ...++.++|||||||++|||++ |..||.+.+..+....+.
T Consensus 157 ~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~ 211 (299)
T 3m2w_A 157 AILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLC-GYPPFYSNHGLAISPGMK 211 (299)
T ss_dssp CCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHH-SSCSCCC-------CCSC
T ss_pred CcEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHH-CCCCCCCCcchhhhHHHH
Confidence 899999999986421 1346789999999999999999 999998776555432222
Q ss_pred cC---CCCCCC----CCCCcchhhhcccccccccchhh-HHHHhhhhhhhhh
Q psy7289 283 SR---QMLPCP----EDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRD 326 (422)
Q Consensus 283 ~~---~~~~~p----~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~d 326 (422)
.. ...+.| ..+|+++.+++.+||..+|..|+ +..+.+|.++...
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 212 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred HHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 11 112223 57899999999999999999987 3345566665543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=321.38 Aligned_cols=239 Identities=16% Similarity=0.091 Sum_probs=179.2
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC--HHhHHHHHHHHHHHhcCCC-Ccee--------------
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN--QKTASDFRREVDLMSELRH-PNIV-------------- 117 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~H-pnIv-------------- 117 (422)
.++..+.||+|+||.||+|++..+ ++.||||+++.... ....+.|.+|+.+++.++| +|+.
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~--g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQET--GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTT--CCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred eEEEecccccCCCEEEEEEEecCC--CCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 466778999999999999987543 46899999874332 2335779999999999987 3221
Q ss_pred -eE------eeEEEc-----CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7289 118 -CL------LGVCLS-----GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSH 185 (422)
Q Consensus 118 -~l------~g~~~~-----~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~ 185 (422)
.+ ..++.. ....+++|+++ +|+|.+++....... .....+++..+..++.||+.||+|||++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~-----~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 230 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS-----STHKSLVHHARLQLTLQVIRLLASLHHY 230 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHT-----TTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhccc-----ccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 11 111111 22456777754 689999885210000 0123578888999999999999999999
Q ss_pred CccccCCCCCceeecCCCeEEEecCcccccccCCcceEeccCCCCCccccCcccc----------ccCCCCCchhHHhHH
Q psy7289 186 HYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESI----------LYGKFTTESDVWSYG 255 (422)
Q Consensus 186 ~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~----------~~~~~~~~~DvwS~G 255 (422)
+|+||||||+|||++.++.+||+|||+++..... .....+ +.|||||++ ....++.++||||||
T Consensus 231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG 304 (413)
T 3dzo_A 231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304 (413)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred CcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence 9999999999999999999999999998764322 233455 899999999 555688899999999
Q ss_pred HHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 256 VVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 256 vil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
|++|||++ |..||.+.+..+....+.. ....+|+.+.+||.+||..+|..|+
T Consensus 305 vil~ellt-g~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dP~~Rp 356 (413)
T 3dzo_A 305 LAIYWIWC-ADLPNTDDAALGGSEWIFR-----SCKNIPQPVRALLEGFLRYPKEDRL 356 (413)
T ss_dssp HHHHHHHH-SSCCCCTTGGGSCSGGGGS-----SCCCCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHH-CCCCCCCcchhhhHHHHHh-----hcccCCHHHHHHHHHHccCChhhCc
Confidence 99999999 9999988776555444332 2246789999999999999999996
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=298.89 Aligned_cols=183 Identities=12% Similarity=0.047 Sum_probs=125.9
Q ss_pred ccccccceeEEEEEEecCCCCeEEEEEEccCcC---------CHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCCeE
Q psy7289 61 ELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA---------NQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 61 ~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~ 130 (422)
..+.|++|.+..++..-. ++.++||++.... .....++|.+|+++|+++ .|+||+++++++.++..+|
T Consensus 241 ~~~~~~~~~h~~~rr~~f--g~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~y 318 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFF--GEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGW 318 (569)
T ss_dssp C-C--------CCEEEEE--CSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEE
T ss_pred ccccCCcccccccccccc--cceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEE
Confidence 456666666655544322 3558999886431 123456799999999999 6999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
|||||++||+|.++|.... ++++. +|+.||+.||+|||++|||||||||+||||++++.+||+||
T Consensus 319 LVMEyv~G~~L~d~i~~~~------------~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DF 383 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAGE------------EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDF 383 (569)
T ss_dssp EEEECCCSEEHHHHHHTTC------------CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCC
T ss_pred EEEecCCCCcHHHHHHhCC------------CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeec
Confidence 9999999999999997642 45554 58899999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHh
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYS 263 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t 263 (422)
|+|+....+.. ...+..||+.|||||++.+ .+..++|+||+|++++++.+
T Consensus 384 GlAr~~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~ 433 (569)
T 4azs_A 384 GSIVTTPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQ 433 (569)
T ss_dssp TTEESCC---C--CSHHHHHHHHHHHHHHC------------------CCCCT
T ss_pred ccCeeCCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhcc
Confidence 99987643321 1233457899999998864 56788999999999887754
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-30 Score=266.68 Aligned_cols=185 Identities=15% Similarity=0.138 Sum_probs=140.2
Q ss_pred ccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CH-----HhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQ-----KTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 59 ~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~-----~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
.+.||+|+||.||+|+.. +..+++|...... .. ...+.|.+|+++|++++||||+++..++...+..|+
T Consensus 341 ~~~LG~G~fg~Vy~~~~~----~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYL----DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp -------CCEEEEEEECS----SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCEEeeCCCEEEEEEEEC----CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 458999999999999532 3557888753321 11 124568999999999999999966666667778899
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
|||||++|+|.+++.. +..++.|++.||+|||+++|+||||||+|||+++ .+||+|||
T Consensus 417 VmE~~~ggsL~~~l~~--------------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFG 474 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFG 474 (540)
T ss_dssp EEECCCSEEHHHHSTT--------------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCT
T ss_pred EEECCCCCCHHHHHHH--------------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECc
Confidence 9999999999999853 3479999999999999999999999999999998 99999999
Q ss_pred ccccccCCcceE-----eccCCCCCccccCcccccc--CCCCCchhHHhHHHHHHHHHhCCCCCCC
Q psy7289 212 LSRDVYASDYYR-----IQSKSLLPVRWMPPESILY--GKFTTESDVWSYGVVLWEVYSYGLQPYY 270 (422)
Q Consensus 212 la~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwS~Gvil~El~t~g~~Pf~ 270 (422)
+++......... ......+|+.|||||++.. ..|+..+|+||..+-..+.+. .+.+|.
T Consensus 475 la~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~-~r~rY~ 539 (540)
T 3en9_A 475 LGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVE-RRARYV 539 (540)
T ss_dssp TCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHH-TCSCCC
T ss_pred cCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHH-hccccC
Confidence 998764322110 1123457899999999986 568888999999888877775 555553
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=219.74 Aligned_cols=144 Identities=20% Similarity=0.154 Sum_probs=114.6
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCH-----------------HhHHHHHHHHHHHhcCCCCceee
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQ-----------------KTASDFRREVDLMSELRHPNIVC 118 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~E~~il~~l~HpnIv~ 118 (422)
|++.+.||+|+||.||+|++ .++..||||.++..... .....+.+|+.+|++++ | ++
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~---~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS---EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE---TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred EEecCEeccCCCceEEEEEe---CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 34559999999999999987 34678999998643211 13567899999999999 4 66
Q ss_pred EeeEEEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcee
Q psy7289 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCL 198 (422)
Q Consensus 119 l~g~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiL 198 (422)
+.+++.. +..++||||+++|+|.+ +.. .+...++.|++.||+|||++||+||||||+|||
T Consensus 166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~~------------------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NIL 225 (282)
T 1zar_A 166 VPKVYAW-EGNAVLMELIDAKELYR-VRV------------------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVL 225 (282)
T ss_dssp SCCEEEE-ETTEEEEECCCCEEGGG-CCC------------------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEE
T ss_pred cCeEEec-cceEEEEEecCCCcHHH-cch------------------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEE
Confidence 6665543 56799999999999987 421 224579999999999999999999999999999
Q ss_pred ecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccc
Q psy7289 199 VGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL 241 (422)
Q Consensus 199 l~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 241 (422)
++ ++.+||+|||+|+.. ..++|||.+.
T Consensus 226 l~-~~~vkl~DFG~a~~~---------------~~~~a~e~l~ 252 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVEV---------------GEEGWREILE 252 (282)
T ss_dssp EE-TTEEEECCCTTCEET---------------TSTTHHHHHH
T ss_pred EE-CCcEEEEECCCCeEC---------------CCCCHHHHHH
Confidence 99 999999999998632 2478999874
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.9e-26 Score=219.61 Aligned_cols=104 Identities=69% Similarity=1.262 Sum_probs=93.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+++||+|||+++++||||||+|||++.+..+||+|||+|+.....+.....+...+|+.|||||++.++.|+.++|||||
T Consensus 154 ia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSf 233 (308)
T 4gt4_A 154 IAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSY 233 (308)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhH
Confidence 68899999999999999999999999999999999999997655554544556678899999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||+||||+|.|+.||.+.++.+..
T Consensus 234 Gvvl~El~t~g~~Pf~~~~~~~~~ 257 (308)
T 4gt4_A 234 GVVLWEVFSYGLQPYCGYSNQDVV 257 (308)
T ss_dssp HHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999899999998876643
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.9e-26 Score=218.64 Aligned_cols=104 Identities=68% Similarity=1.303 Sum_probs=92.5
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+++|+.|||+++++||||||+|||++.+..+||+|||+|+.....+.........+|+.|||||++.++.|+.++|||||
T Consensus 137 ia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~ 216 (299)
T 4asz_A 137 IAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSL 216 (299)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHH
Confidence 57899999999999999999999999999999999999987655554554555567899999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||+||||+|.|+.||.+.++.+..
T Consensus 217 Gvvl~Ellt~G~~Pf~~~~~~~~~ 240 (299)
T 4asz_A 217 GVVLWEIFTYGKQPWYQLSNNEVI 240 (299)
T ss_dssp HHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHH
Confidence 999999998899999998877644
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.8e-26 Score=222.68 Aligned_cols=106 Identities=49% Similarity=0.923 Sum_probs=93.7
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+++||+|||++++|||||||+|||++.+..+||+|||+|+....+......+...+|+.|||||++.++.|+.++|||||
T Consensus 194 ia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~ 273 (353)
T 4ase_A 194 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 273 (353)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeeh
Confidence 68899999999999999999999999999999999999997655544444555667899999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhhhc
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEFLK 415 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~~~ 415 (422)
||+||||+|.|+.||.+.+..+.+.+
T Consensus 274 Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 274 GVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp HHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999889999999887765543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-25 Score=216.86 Aligned_cols=104 Identities=69% Similarity=1.336 Sum_probs=82.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+++++.|||+++++||||||+|||++.+..+||+|||+|+.....+.....+...+|+.|||||++.++.|+.++|||||
T Consensus 167 ia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~ 246 (329)
T 4aoj_A 167 VAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSF 246 (329)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHH
T ss_pred HHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccch
Confidence 68899999999999999999999999999999999999997655544444556678999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||+||||+|.|+.||.+.++.+..
T Consensus 247 Gvvl~Ellt~G~~Pf~~~~~~~~~ 270 (329)
T 4aoj_A 247 GVVLWEIFTYGKQPWYQLSNTEAI 270 (329)
T ss_dssp HHHHHHHHTTSCCTTCSSCHHHHH
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHH
Confidence 999999998899999998877643
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-25 Score=213.39 Aligned_cols=103 Identities=38% Similarity=0.645 Sum_probs=82.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCcccccc---CCCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY---GKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv 386 (422)
+++|+.|||+++++||||||+|||++.+..+||+|||+|+...............+|+.|||||++.. +.|+.++||
T Consensus 141 ia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDV 220 (307)
T 3omv_A 141 TAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDV 220 (307)
T ss_dssp HHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHH
T ss_pred HHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHh
Confidence 67899999999999999999999999999999999999986433222223345678999999999863 469999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
|||||+||||++ |+.||.+.++.+..
T Consensus 221 wS~Gvvl~Ellt-g~~Pf~~~~~~~~~ 246 (307)
T 3omv_A 221 YSYGIVLYELMT-GELPYSHINNRDQI 246 (307)
T ss_dssp HHHHHHHHHHHH-SSCTTTTCCCHHHH
T ss_pred HhHHHHHHHHHH-CCCCCCCCChHHHH
Confidence 999999999998 99999998776543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=4e-25 Score=210.95 Aligned_cols=103 Identities=21% Similarity=0.480 Sum_probs=88.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..+++|||+++++||||||+|||++.+..+|++|||+|+............+.+||+.|||||++.+..|+.++||||+
T Consensus 141 i~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSl 220 (311)
T 4aw0_A 141 IVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWAL 220 (311)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHH
T ss_pred HHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHH
Confidence 46799999999999999999999999999999999999986543333333445678999999999998899999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||+||||++ |+.||.+.+..+.+
T Consensus 221 Gvilyeml~-G~~PF~~~~~~~~~ 243 (311)
T 4aw0_A 221 GCIIYQLVA-GLPPFRAGNEGLIF 243 (311)
T ss_dssp HHHHHHHHH-SSCSSCCSSHHHHH
T ss_pred HHHHHHHHh-CCCCCCCCCHHHHH
Confidence 999999997 99999987666544
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-24 Score=207.65 Aligned_cols=102 Identities=28% Similarity=0.499 Sum_probs=86.4
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++||||||+|||++.++.+|++|||+|+...... ....+.++|+.|||||++.+..|+.++||||+
T Consensus 135 i~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSl 212 (304)
T 3ubd_A 135 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSF 212 (304)
T ss_dssp HHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHH
T ss_pred HHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccch
Confidence 4679999999999999999999999999999999999998543322 22345678999999999998899999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEFL 414 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~~ 414 (422)
||+||||++ |+.||.+.+..+.+.
T Consensus 213 Gvilyemlt-G~~PF~~~~~~~~~~ 236 (304)
T 3ubd_A 213 GVLMFEMLT-GTLPFQGKDRKETMT 236 (304)
T ss_dssp HHHHHHHHH-SSCSSCCSSHHHHHH
T ss_pred HHHHHHHHh-CCCCCCCcCHHHHHH
Confidence 999999997 999999977666543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-24 Score=209.71 Aligned_cols=101 Identities=27% Similarity=0.473 Sum_probs=87.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++||||||+|||++.++.+||+|||+|+...... ....+.++|+.|||||++....|+.++||||+
T Consensus 179 i~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSl 256 (346)
T 4fih_A 179 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSL 256 (346)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred HHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHH
Confidence 5679999999999999999999999999999999999998653322 12345678999999999998899999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||+||||++ |+.||.+.+..+.+
T Consensus 257 Gvilyeml~-G~~PF~~~~~~~~~ 279 (346)
T 4fih_A 257 GIMVIEMVD-GEPPYFNEPPLKAM 279 (346)
T ss_dssp HHHHHHHHH-SSCTTTTSCHHHHH
T ss_pred HHHHHHHHH-CCCCCCCcCHHHHH
Confidence 999999996 99999997665543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-24 Score=207.83 Aligned_cols=104 Identities=20% Similarity=0.331 Sum_probs=84.2
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCc-ceeecccccccccccCccee---eccccCCCcccCCccccccCCCCcchh
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGL-TVKISDFGLSRDVYASDYYR---IQSKSLLPVRWMPPESILYGKFTTESD 385 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~-~~ki~Dfgls~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~D 385 (422)
+..++.|||+++++||||||+|||++.++ .+||+|||+|+....+.... .....++|+.|||||++.+..|+.++|
T Consensus 159 i~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~D 238 (336)
T 4g3f_A 159 ALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVD 238 (336)
T ss_dssp HHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHH
T ss_pred HHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHH
Confidence 56799999999999999999999998775 69999999998654322111 112345899999999999889999999
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCchhhhh
Q psy7289 386 VWSYGVVLWEVYSYGLQPYYGYSNQEEFL 414 (422)
Q Consensus 386 vws~Gv~l~el~~~g~~p~~~~~~~~~~~ 414 (422)
|||+||+||||++ |+.||.+.+..+.+.
T Consensus 239 iwSlGvilyemlt-G~~Pf~~~~~~~~~~ 266 (336)
T 4g3f_A 239 IWSSCCMMLHMLN-GCHPWTQYFRGPLCL 266 (336)
T ss_dssp HHHHHHHHHHHHH-SSCSSTTTCCSCCHH
T ss_pred HHHHHHHHHHHHH-CcCCCCCCCHHHHHH
Confidence 9999999999997 999999877666443
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-24 Score=210.14 Aligned_cols=103 Identities=21% Similarity=0.416 Sum_probs=88.0
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++||||||+|||++.++.+||+|||+|+...... ......++|+.|||||++.+..|+.++||||+
T Consensus 134 i~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSl 211 (350)
T 4b9d_A 134 ICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWAL 211 (350)
T ss_dssp HHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHH
T ss_pred HHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHH
Confidence 5679999999999999999999999999999999999998643221 12234568999999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhhhc
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEFLK 415 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~~~ 415 (422)
||+||||++ |+.||.+.+..+.+.+
T Consensus 212 Gvilyemlt-G~~PF~~~~~~~~~~~ 236 (350)
T 4b9d_A 212 GCVLYELCT-LKHAFEAGSMKNLVLK 236 (350)
T ss_dssp HHHHHHHHH-SSCSCCCSSHHHHHHH
T ss_pred HHHHHHHHH-CCCCCCCcCHHHHHHH
Confidence 999999997 9999999777665543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.89 E-value=7.6e-24 Score=200.77 Aligned_cols=99 Identities=26% Similarity=0.461 Sum_probs=83.1
Q ss_pred chhhHHHHhhhh--hhhhhcccccccccC-CcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhH
Q psy7289 310 VAAGMAYLCSHH--YVHRDLAARNCLVGD-GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~--~i~~dLk~~nil~~~-~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 386 (422)
++.+++|||+++ ++||||||+|||++. ++.+||+|||+|+....+ ...+.++|+.|||||++. +.|+.++||
T Consensus 138 i~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~----~~~~~~GTp~YmAPE~~~-~~y~~~~Di 212 (290)
T 3fpq_A 138 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDV 212 (290)
T ss_dssp HHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHH
T ss_pred HHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC----ccCCcccCccccCHHHcC-CCCCcHHHH
Confidence 578999999998 999999999999974 678999999999853222 123456899999999876 579999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchhhhh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQEEFL 414 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~~~~ 414 (422)
|||||+||||++ |+.||.+.++....+
T Consensus 213 wSlGvilyellt-g~~Pf~~~~~~~~~~ 239 (290)
T 3fpq_A 213 YAFGMCMLEMAT-SEYPYSECQNAAQIY 239 (290)
T ss_dssp HHHHHHHHHHHH-SSCTTTTCSSHHHHH
T ss_pred HHHHHHHHHHHH-CCCCCCCCCcHHHHH
Confidence 999999999997 999999877766543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=8.8e-24 Score=209.65 Aligned_cols=101 Identities=27% Similarity=0.473 Sum_probs=86.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++||||||+|||++.++.+||+|||+|+...... ......++|+.|||||++....|+.++|||||
T Consensus 256 il~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSl 333 (423)
T 4fie_A 256 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSL 333 (423)
T ss_dssp HHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHH
T ss_pred HHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHH
Confidence 4679999999999999999999999999999999999998653322 12344568899999999998899999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||++|||++ |+.||.+.+..+.+
T Consensus 334 Gvilyeml~-G~~PF~~~~~~~~~ 356 (423)
T 4fie_A 334 GIMVIEMVD-GEPPYFNEPPLKAM 356 (423)
T ss_dssp HHHHHHHHH-SSCTTTTSCHHHHH
T ss_pred HHHHHHHHH-CCCCCCCcCHHHHH
Confidence 999999996 99999987665543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-23 Score=197.24 Aligned_cols=99 Identities=32% Similarity=0.473 Sum_probs=76.7
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCC-CcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKF-TTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dvws 388 (422)
+..+++|||+++++||||||+|||++.+..+|++|||+|+...... ...+..+|+.|||||++.+..| +.++||||
T Consensus 121 i~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwS 197 (275)
T 3hyh_A 121 IISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWS 197 (275)
T ss_dssp HHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHH
T ss_pred HHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHH
Confidence 5679999999999999999999999999999999999998543222 2334568999999999987776 57999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
+||++|||++ |+.||.+.+..+.
T Consensus 198 lGvily~llt-g~~PF~~~~~~~~ 220 (275)
T 3hyh_A 198 CGVILYVMLC-RRLPFDDESIPVL 220 (275)
T ss_dssp HHHHHHHHHH-SSCSSCCSSHHHH
T ss_pred HHHHHHHHHH-CCCCCCCCCHHHH
Confidence 9999999997 9999998655543
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.9e-22 Score=187.25 Aligned_cols=137 Identities=18% Similarity=0.177 Sum_probs=105.6
Q ss_pred cccccccccccceeEEEEEEecCCCCeE--EEEEEccCcCCH-----------------------HhHHHHHHHHHHHhc
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSL--VAIKTLKENANQ-----------------------KTASDFRREVDLMSE 110 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~--vavK~~~~~~~~-----------------------~~~~~~~~E~~il~~ 110 (422)
|++.+.||+|+||.||+|++..+ +.. ||||+++..... .....+.+|+.+|..
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~--g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFD--GKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEET--TEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCC--CcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 56788999999999999987433 466 999986532110 112368899999999
Q ss_pred CCCCce--eeEeeEEEcCCCeEEEEEecCC-C----CHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHH
Q psy7289 111 LRHPNI--VCLLGVCLSGEPMCMLFEFMVR-G----DLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLC 183 (422)
Q Consensus 111 l~HpnI--v~l~g~~~~~~~~~lv~E~~~~-G----~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH 183 (422)
++|+|| ...++. ...++||||+.+ | +|.++... .++.++..++.|++.||.|||
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---------------~~~~~~~~i~~qi~~~l~~lH 187 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---------------LKELDVEGIFNDVVENVKRLY 187 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---------------GGGSCHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---------------cChHHHHHHHHHHHHHHHHHH
Confidence 988754 344432 357899999943 4 67766432 234567889999999999999
Q ss_pred -hCCccccCCCCCceeecCCCeEEEecCccccc
Q psy7289 184 -SHHYVHRDLAARNCLVGDGLTVKISDFGLSRD 215 (422)
Q Consensus 184 -~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~ 215 (422)
++||+||||||+|||+++ .++|+|||+|..
T Consensus 188 ~~~givHrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 188 QEAELVHADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp HTSCEECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred HHCCEEeCCCCHHHEEEcC--cEEEEECccccc
Confidence 999999999999999998 899999999964
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.1e-22 Score=199.39 Aligned_cols=103 Identities=27% Similarity=0.474 Sum_probs=84.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcc--eeeccccCCCcccCCccccccC-CCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDY--YRIQSKSLLPVRWMPPESILYG-KFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv 386 (422)
+..++.|||+++++||||||+|||++....+|++|||+|+....+.. .....+.++|+.|||||++.+. .|+.++||
T Consensus 167 il~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~Di 246 (398)
T 4b99_A 167 LLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDL 246 (398)
T ss_dssp HHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHH
T ss_pred HHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhhe
Confidence 46799999999999999999999999999999999999986533221 1223456789999999998765 46899999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||+||++|||++ |+.||.|.+..+.+
T Consensus 247 WSlG~il~ell~-G~~pF~g~~~~~~l 272 (398)
T 4b99_A 247 WSVGCIFGEMLA-RRQLFPGKNYVHQL 272 (398)
T ss_dssp HHHHHHHHHHHH-TSCSSCCSSHHHHH
T ss_pred ehhHHHHHHHHH-CCCCCCCCCHHHHH
Confidence 999999999997 99999997766644
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.6e-22 Score=196.46 Aligned_cols=104 Identities=24% Similarity=0.353 Sum_probs=81.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCC-cceeecccccccccccCcc--------------------------eeeccc
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDG-LTVKISDFGLSRDVYASDY--------------------------YRIQSK 362 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~-~~~ki~Dfgls~~~~~~~~--------------------------~~~~~~ 362 (422)
...++.|||+++++||||||+|||++.. ..+|++|||+|+....... ....+.
T Consensus 126 ll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (361)
T 4f9c_A 126 LFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAP 205 (361)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------
T ss_pred HHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccc
Confidence 4679999999999999999999999866 6899999999974322110 001123
Q ss_pred cCCCcccCCccccccC-CCCcchhHHHHHHHHHHHHhcCCCCCCCCCchhhhh
Q psy7289 363 SLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFL 414 (422)
Q Consensus 363 ~~~~~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~~~~ 414 (422)
.++|++|||||++.+. .|+.++||||+||++|||++ |+.||++.+++...+
T Consensus 206 ~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~-G~~Pf~~~~~~~~~l 257 (361)
T 4f9c_A 206 RAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS-GRYPFYKASDDLTAL 257 (361)
T ss_dssp CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH-TCSSSSCCSSHHHHH
T ss_pred cccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH-CCCCCCCCCCHHHHH
Confidence 4689999999999865 48999999999999999997 999998876655443
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.6e-22 Score=192.89 Aligned_cols=95 Identities=25% Similarity=0.429 Sum_probs=73.7
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcce----------eeccccCCCcccCCccccccCC
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYY----------RIQSKSLLPVRWMPPESILYGK 379 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~ 379 (422)
++.++.|||+++++||||||+|||++.+..+|++|||+|+....+... ...++.+||+.|||||++.+..
T Consensus 127 i~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~ 206 (299)
T 4g31_A 127 IAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS 206 (299)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCC
T ss_pred HHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCC
Confidence 578999999999999999999999999999999999999864332111 1123456899999999999889
Q ss_pred CCcchhHHHHHHHHHHHHhcCCCCCCCCC
Q psy7289 380 FTTESDVWSYGVVLWEVYSYGLQPYYGYS 408 (422)
Q Consensus 380 ~~~~~Dvws~Gv~l~el~~~g~~p~~~~~ 408 (422)
|+.++|||||||+||||++ ||.+..
T Consensus 207 y~~~~DiwSlGvilyell~----Pf~~~~ 231 (299)
T 4g31_A 207 YSHKVDIFSLGLILFELLY----PFSTQM 231 (299)
T ss_dssp CCTHHHHHHHHHHHHHHHS----CCSSHH
T ss_pred CCCHHHHHHHHHHHHHHcc----CCCCcc
Confidence 9999999999999999983 887643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.3e-22 Score=194.08 Aligned_cols=95 Identities=26% Similarity=0.356 Sum_probs=74.7
Q ss_pred chhhHHHHhhh--------hhhhhhcccccccccCCcceeecccccccccccCcce-e-eccccCCCcccCCccccccC-
Q psy7289 310 VAAGMAYLCSH--------HYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYY-R-IQSKSLLPVRWMPPESILYG- 378 (422)
Q Consensus 310 ~~r~~~~lh~~--------~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~-~-~~~~~~~~~~y~aPE~~~~~- 378 (422)
++++++|||++ +++||||||+|||++.+..+||+|||+|+........ . ......+|++|||||++.+.
T Consensus 109 ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~ 188 (303)
T 3hmm_A 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 188 (303)
T ss_dssp HHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCS
T ss_pred HHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccc
Confidence 67899999987 8999999999999999999999999999864332211 1 12345689999999998753
Q ss_pred -----CCCcchhHHHHHHHHHHHHhcCCCCCC
Q psy7289 379 -----KFTTESDVWSYGVVLWEVYSYGLQPYY 405 (422)
Q Consensus 379 -----~~~~~~Dvws~Gv~l~el~~~g~~p~~ 405 (422)
.|+.++|||||||+||||+| |..||.
T Consensus 189 ~~~~~~~~~k~DVwS~Gvvl~El~t-g~~~~~ 219 (303)
T 3hmm_A 189 NMKHFESFKRADIYAMGLVFWEIAR-RCSIGG 219 (303)
T ss_dssp CTTCHHHHHHHHHHHHHHHHHHHHH-TBCBTT
T ss_pred cccCCccChhHhhhhHHHHHHHHHH-CCCCCC
Confidence 36789999999999999997 765553
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.85 E-value=3.5e-22 Score=207.36 Aligned_cols=96 Identities=26% Similarity=0.452 Sum_probs=83.2
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccC-CCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws 388 (422)
+..+++|||+++++||||||+|||++.++++||+|||+|+...... ..+.+||+.|||||++..+ .|+.++||||
T Consensus 301 Il~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWS 376 (689)
T 3v5w_A 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFS 376 (689)
T ss_dssp HHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHH
T ss_pred HHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHH
Confidence 5679999999999999999999999999999999999998653322 2345789999999999765 6999999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCch
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQ 410 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~ 410 (422)
+||+||||++ |..||.+.+..
T Consensus 377 LGvilYEmLt-G~~PF~~~~~~ 397 (689)
T 3v5w_A 377 LGCMLFKLLR-GHSPFRQHKTK 397 (689)
T ss_dssp HHHHHHHHHH-SSCTTCGGGCC
T ss_pred HHHHHHHHHh-CCCCCCCCChH
Confidence 9999999996 99999875443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.81 E-value=8.8e-21 Score=196.53 Aligned_cols=101 Identities=26% Similarity=0.426 Sum_probs=86.0
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCC--cceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDG--LTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVW 387 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~--~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 387 (422)
+..++.|||+++++||||||+|||++.. ..+|++|||+|+........ ...++|+.|||||++.+..|+.++|||
T Consensus 264 i~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~---~~~~GT~~y~APEv~~~~~y~~~~DiW 340 (573)
T 3uto_A 264 VCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMW 340 (573)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE---EEECSSGGGCCHHHHTTCCBCHHHHHH
T ss_pred HHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCce---eeeEECccccCHHHhCCCCCCcHHHHH
Confidence 4679999999999999999999999754 68999999999865443322 234678999999999988999999999
Q ss_pred HHHHHHHHHHhcCCCCCCCCCchhhhh
Q psy7289 388 SYGVVLWEVYSYGLQPYYGYSNQEEFL 414 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~~~~~~~~~ 414 (422)
|+||++|||++ |..||.+.+..+++.
T Consensus 341 SlGvilyeml~-G~~Pf~~~~~~~~~~ 366 (573)
T 3uto_A 341 SVGVLSYILLS-GLSPFGGENDDETLR 366 (573)
T ss_dssp HHHHHHHHHHH-SCCSSCCSSHHHHHH
T ss_pred HHHHHHHHHHH-CCCCCCCcCHHHHHH
Confidence 99999999996 999999977766543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=4e-20 Score=181.18 Aligned_cols=99 Identities=12% Similarity=0.112 Sum_probs=83.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccC-----------CcceeecccccccccccCcceeeccccCCCcccCCccccccC
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGD-----------GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG 378 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~-----------~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 378 (422)
+++++.|||+++++|+||||+||+++. ...+|++|||+++...............+|..|+|||++.++
T Consensus 181 i~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 260 (365)
T 3e7e_A 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK 260 (365)
T ss_dssp HHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC
T ss_pred HHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC
Confidence 578999999999999999999999988 788999999999754322222234456678999999999988
Q ss_pred CCCcchhHHHHHHHHHHHHhcCCCCCCCCCc
Q psy7289 379 KFTTESDVWSYGVVLWEVYSYGLQPYYGYSN 409 (422)
Q Consensus 379 ~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~ 409 (422)
.|+.++|||||||++|||++ |+.||.....
T Consensus 261 ~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 290 (365)
T 3e7e_A 261 PWNYQIDYFGVAATVYCMLF-GTYMKVKNEG 290 (365)
T ss_dssp CBSTHHHHHHHHHHHHHHHH-SSCCCEEEET
T ss_pred CCCccccHHHHHHHHHHHHh-CCCccccCCC
Confidence 89999999999999999997 9999976544
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.78 E-value=9.5e-20 Score=179.08 Aligned_cols=104 Identities=48% Similarity=0.946 Sum_probs=87.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+++++.|||+++++|+||||+||+++.+..+|++|||+++...............+|+.|+|||++.++.|+.++|||||
T Consensus 212 i~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvwsl 291 (370)
T 2psq_A 212 LARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 291 (370)
T ss_dssp HHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHH
T ss_pred HHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHH
Confidence 57899999999999999999999999999999999999986543332222334455778999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||++|||++.|..||.+.+..+.+
T Consensus 292 G~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 292 GVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp HHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHH
Confidence 999999998899999987765543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=8.1e-20 Score=183.34 Aligned_cols=102 Identities=26% Similarity=0.508 Sum_probs=85.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccc-----cCCCCcch
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL-----YGKFTTES 384 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~ 384 (422)
+..++.|||+++++||||||+|||++.+..+|++|||+++........ ..+...+|+.|+|||++. .+.|+.++
T Consensus 184 i~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~ 262 (437)
T 4aw2_A 184 MVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPEC 262 (437)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHH
T ss_pred HHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcC
Confidence 467999999999999999999999999999999999999765433322 233456789999999987 45689999
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 385 DVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 385 Dvws~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
|||||||++|||++ |+.||.+.+..+.+
T Consensus 263 DvwSlGvil~ellt-G~~Pf~~~~~~~~~ 290 (437)
T 4aw2_A 263 DWWSLGVCMYEMLY-GETPFYAESLVETY 290 (437)
T ss_dssp HHHHHHHHHHHHHH-SSCTTCCSSHHHHH
T ss_pred eeHHHHHHHHHHHh-CCCCCCCCChhHHH
Confidence 99999999999996 99999987766544
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.3e-19 Score=179.00 Aligned_cols=103 Identities=30% Similarity=0.461 Sum_probs=82.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCc-------------------ceeeccccCCCcccC
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD-------------------YYRIQSKSLLPVRWM 370 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~-------------------~~~~~~~~~~~~~y~ 370 (422)
+.+++.|||+++++|+||||+||+++.+..+|++|||+++...... .....+...+|++|+
T Consensus 118 i~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 197 (388)
T 3oz6_A 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYR 197 (388)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGC
T ss_pred HHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcC
Confidence 4679999999999999999999999999999999999997542210 011123446788999
Q ss_pred Ccccccc-CCCCcchhHHHHHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 371 PPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 371 aPE~~~~-~~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
|||++.+ ..|+.++||||+||++|||++ |+.||.+.+..+.+
T Consensus 198 aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~ 240 (388)
T 3oz6_A 198 APEILLGSTKYTKGIDMWSLGCILGEILC-GKPIFPGSSTMNQL 240 (388)
T ss_dssp CHHHHTTCCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHH
T ss_pred CHHHhcCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Confidence 9999876 568999999999999999997 99999997766543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=7.9e-20 Score=178.54 Aligned_cols=101 Identities=21% Similarity=0.415 Sum_probs=82.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++||||||+||+++....+|++|||+++...... .......+|+.|+|||++....|+.++||||+
T Consensus 133 i~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 210 (353)
T 3txo_A 133 IISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAM 210 (353)
T ss_dssp HHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHH
T ss_pred HHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcc
Confidence 4679999999999999999999999999999999999998533221 12334567889999999988889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||++|||++ |..||.+.+..+.+
T Consensus 211 G~il~ell~-G~~Pf~~~~~~~~~ 233 (353)
T 3txo_A 211 GVLLYEMLC-GHAPFEAENEDDLF 233 (353)
T ss_dssp HHHHHHHHH-SSCSSCCSSHHHHH
T ss_pred hHHHHHHHh-CCCCCCCCCHHHHH
Confidence 999999997 99999987666543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.4e-19 Score=180.23 Aligned_cols=102 Identities=25% Similarity=0.489 Sum_probs=85.4
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccc-------cCCCCc
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL-------YGKFTT 382 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~ 382 (422)
+..++.|||+++++||||||+||+++....+|++|||+++........ ......+|+.|+|||++. .+.|+.
T Consensus 171 i~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~ 249 (412)
T 2vd5_A 171 IVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGP 249 (412)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECT
T ss_pred HHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCCh
Confidence 467999999999999999999999999999999999999865433221 123456789999999987 356899
Q ss_pred chhHHHHHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 383 ESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 383 ~~Dvws~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
++|||||||++|||++ |+.||.+.+..+.+
T Consensus 250 ~~DiwSlGvilyellt-G~~Pf~~~~~~~~~ 279 (412)
T 2vd5_A 250 ECDWWALGVFAYEMFY-GQTPFYADSTAETY 279 (412)
T ss_dssp HHHHHHHHHHHHHHHH-SSCTTCCSSHHHHH
T ss_pred HHhhhHHhHHHHHHHh-CCCCCCCCCHHHHH
Confidence 9999999999999996 99999997766643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.77 E-value=1.2e-19 Score=175.08 Aligned_cols=102 Identities=46% Similarity=0.786 Sum_probs=84.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
++.++.|||+++++|+||||+||+++.+..+|++|||+++...............+|..|+|||.+.++.++.++|||||
T Consensus 126 i~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 205 (327)
T 3poz_A 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 205 (327)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhh
Confidence 57899999999999999999999999999999999999986543332223334455778999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||++|||++.|+.||.+.+..+
T Consensus 206 G~il~ellt~g~~p~~~~~~~~ 227 (327)
T 3poz_A 206 GVTVWELMTFGSKPYDGIPASE 227 (327)
T ss_dssp HHHHHHHHTTSCCTTTTCCGGG
T ss_pred HHHHHHHHhcCCCCccCCCHHH
Confidence 9999999987999999876655
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.77 E-value=2.6e-19 Score=173.69 Aligned_cols=100 Identities=24% Similarity=0.476 Sum_probs=84.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++|+||||+||+++..+.+|++|||+++....... ......+|+.|+|||++.++.|+.++|||||
T Consensus 114 i~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 191 (337)
T 1o6l_A 114 IVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 191 (337)
T ss_dssp HHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHH
T ss_pred HHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccc
Confidence 46799999999999999999999999999999999999985332211 1233456789999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||++|||++ |+.||.+.+..+.
T Consensus 192 G~il~ell~-g~~Pf~~~~~~~~ 213 (337)
T 1o6l_A 192 GVVMYEMMC-GRLPFYNQDHERL 213 (337)
T ss_dssp HHHHHHHHH-SSCSSCCSSHHHH
T ss_pred hhHHHHHhc-CCCCCCCCCHHHH
Confidence 999999997 9999988665543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=1.7e-19 Score=179.66 Aligned_cols=102 Identities=25% Similarity=0.436 Sum_probs=85.4
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCC----CCcchh
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK----FTTESD 385 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~D 385 (422)
+..++.|||+++++||||||+||+++..+.+|++|||+++...... ........+|+.|+|||++.... |+.++|
T Consensus 177 i~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~D 255 (410)
T 3v8s_A 177 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 255 (410)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHH
T ss_pred HHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcce
Confidence 4679999999999999999999999999999999999998644332 22233556889999999998654 788999
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 386 VWSYGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 386 vws~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||||||++|||++ |..||.+.+..+.+
T Consensus 256 iwSlGvilyell~-G~~Pf~~~~~~~~~ 282 (410)
T 3v8s_A 256 WWSVGVFLYEMLV-GDTPFYADSLVGTY 282 (410)
T ss_dssp HHHHHHHHHHHHH-SSCTTCCSSHHHHH
T ss_pred EecchHHHHHHHh-CCCCCCCCChhhHH
Confidence 9999999999997 99999987665543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=2.5e-19 Score=174.99 Aligned_cols=101 Identities=28% Similarity=0.529 Sum_probs=85.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++||||||+||+++..+.+|++|||+++...... .......+|+.|+|||++.++.|+.++|||||
T Consensus 130 i~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 207 (353)
T 2i0e_A 130 IAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF 207 (353)
T ss_dssp HHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHH
T ss_pred HHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccch
Confidence 4679999999999999999999999999999999999998533221 11234557889999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||++|||++ |+.||.+.+..+.+
T Consensus 208 G~il~ell~-G~~Pf~~~~~~~~~ 230 (353)
T 2i0e_A 208 GVLLYEMLA-GQAPFEGEDEDELF 230 (353)
T ss_dssp HHHHHHHHH-SSCSSCCSSHHHHH
T ss_pred HHHHHHHHc-CCCCCCCCCHHHHH
Confidence 999999997 99999986655543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=2.7e-19 Score=174.21 Aligned_cols=101 Identities=31% Similarity=0.547 Sum_probs=85.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++|+||||+||+++..+.+|++|||+++....... ......+|+.|+|||++.+..|+.++||||+
T Consensus 127 i~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 204 (345)
T 1xjd_A 127 IILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSF 204 (345)
T ss_dssp HHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred HHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHH
Confidence 46799999999999999999999999999999999999985332211 1234567889999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||++|||++ |..||.+.+..+.+
T Consensus 205 G~il~ell~-g~~Pf~~~~~~~~~ 227 (345)
T 1xjd_A 205 GVLLYEMLI-GQSPFHGQDEEELF 227 (345)
T ss_dssp HHHHHHHHH-SSCSSCCSSHHHHH
T ss_pred HHHHHHHhc-CCCCCCCCCHHHHH
Confidence 999999997 99999987665543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=3.2e-19 Score=175.44 Aligned_cols=101 Identities=28% Similarity=0.522 Sum_probs=85.7
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++||||||+||+++..+.+|++|||+++...... .......+|+.|+|||++.+..|+.++|||||
T Consensus 148 i~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 225 (373)
T 2r5t_A 148 IASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCL 225 (373)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHH
T ss_pred HHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHH
Confidence 4679999999999999999999999999999999999998533221 12334567889999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||++|||++ |..||.+.+..+.+
T Consensus 226 G~il~ell~-G~~Pf~~~~~~~~~ 248 (373)
T 2r5t_A 226 GAVLYEMLY-GLPPFYSRNTAEMY 248 (373)
T ss_dssp HHHHHHHHH-SSCTTCCSBHHHHH
T ss_pred HHHHHHHHc-CCCCCCCCCHHHHH
Confidence 999999996 99999987665543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=2.7e-19 Score=172.40 Aligned_cols=102 Identities=44% Similarity=0.816 Sum_probs=84.7
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++|+||||+||+++.+..+|++|||+++...............++..|+|||.+..+.++.++|||||
T Consensus 124 i~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 203 (325)
T 3kex_A 124 IAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSY 203 (325)
T ss_dssp HHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHh
Confidence 46799999999999999999999999999999999999986544332223344556778999999998999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||++|||++.|+.||.+.+..+
T Consensus 204 G~~l~el~~~g~~p~~~~~~~~ 225 (325)
T 3kex_A 204 GVTVWELMTFGAEPYAGLRLAE 225 (325)
T ss_dssp HHHHHHHHTTSCCTTTTSCTTH
T ss_pred HHHHHHHHhCCCCCccccCHHH
Confidence 9999999977999999876555
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.76 E-value=3.1e-19 Score=176.78 Aligned_cols=96 Identities=21% Similarity=0.418 Sum_probs=82.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++||||||+|||++....+|++|||+++...... .......+|+.|+|||++.+..|+.++|||||
T Consensus 162 i~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~Diwsl 239 (396)
T 4dc2_A 162 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 239 (396)
T ss_dssp HHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred HHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHH
Confidence 4679999999999999999999999999999999999998533221 12334567889999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCC
Q psy7289 390 GVVLWEVYSYGLQPYYGYS 408 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~ 408 (422)
||++|||++ |+.||.+..
T Consensus 240 Gvllyell~-G~~Pf~~~~ 257 (396)
T 4dc2_A 240 GVLMFEMMA-GRSPFDIVG 257 (396)
T ss_dssp HHHHHHHHH-SSCSSTTTT
T ss_pred HHHHHHHHh-CCCCCcccc
Confidence 999999997 999997643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.76 E-value=2.2e-19 Score=181.25 Aligned_cols=102 Identities=45% Similarity=0.864 Sum_probs=87.5
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
++.++.|||+++++|+||||+||+++.+..+|++|||+++..... .........+|+.|+|||++..+.++.++|||||
T Consensus 293 i~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 371 (454)
T 1qcf_A 293 IAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN-EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 371 (454)
T ss_dssp HHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH-HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC-ceeccCCCcccccccCHHHhccCCCCcHHHHHhH
Confidence 578999999999999999999999999999999999999864332 2222334456788999999998999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||++|||+++|+.||.+.++.+.
T Consensus 372 G~~l~el~t~g~~P~~~~~~~~~ 394 (454)
T 1qcf_A 372 GILLMEIVTYGRIPYPGMSNPEV 394 (454)
T ss_dssp HHHHHHHHTTSCCSSTTCCHHHH
T ss_pred HHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999889999999877664
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.3e-19 Score=178.59 Aligned_cols=103 Identities=50% Similarity=0.915 Sum_probs=85.4
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
++.++.|||+++++|+||+|+||+++.+..+|++|||+++...............+|+.|+|||.+..+.++.++|||||
T Consensus 222 i~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 301 (377)
T 3cbl_A 222 AAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSF 301 (377)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHH
T ss_pred HHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHH
Confidence 56799999999999999999999999999999999999985433221111122234678999999998899999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||++|||++.|..||.+.++.+.
T Consensus 302 G~il~el~t~g~~p~~~~~~~~~ 324 (377)
T 3cbl_A 302 GILLWETFSLGASPYPNLSNQQT 324 (377)
T ss_dssp HHHHHHHHTTSCCSSTTSCHHHH
T ss_pred HHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999889999999776653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.76 E-value=3.4e-19 Score=174.53 Aligned_cols=101 Identities=17% Similarity=0.218 Sum_probs=83.1
Q ss_pred chhhHHHHhhhhhhhhhccccccccc--CCcceeecccccccccccCccee-----eccccCCCcccCCccccccCCCCc
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVG--DGLTVKISDFGLSRDVYASDYYR-----IQSKSLLPVRWMPPESILYGKFTT 382 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~--~~~~~ki~Dfgls~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~ 382 (422)
++.++.|||+++++|+||||+||+++ ....+|++|||+++......... ......+|+.|+|||++.+..++.
T Consensus 161 i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 240 (364)
T 3op5_A 161 ILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSR 240 (364)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCH
T ss_pred HHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCc
Confidence 46799999999999999999999998 77899999999997543322111 112334788999999999888999
Q ss_pred chhHHHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 383 ESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 383 ~~Dvws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
++|||||||++|||++ |+.||.+.....
T Consensus 241 ~~Di~slG~~l~el~~-g~~Pf~~~~~~~ 268 (364)
T 3op5_A 241 RGDLEILGYCMIQWLT-GHLPWEDNLKDP 268 (364)
T ss_dssp HHHHHHHHHHHHHHHH-SCCTTGGGTTCH
T ss_pred hhhHHHHHHHHHHHHh-CCCCccccccCH
Confidence 9999999999999997 999999755444
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=4.3e-19 Score=179.62 Aligned_cols=99 Identities=28% Similarity=0.416 Sum_probs=80.7
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+.+++.|||+++++||||||+||+++.+..+|++|||+++...... ..+...+|++|+|||++.+..|+.++||||+
T Consensus 173 il~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 249 (464)
T 3ttj_A 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSV 249 (464)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHH
T ss_pred HHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHH
Confidence 4679999999999999999999999999999999999998543221 2234567889999999998899999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||++|||++ |+.||.+.+..+.
T Consensus 250 G~il~ell~-g~~pF~g~~~~~~ 271 (464)
T 3ttj_A 250 GCIMGEMVR-HKILFPGRDYIDQ 271 (464)
T ss_dssp HHHHHHHHH-SSCSSCCSSHHHH
T ss_pred HHHHHHHHh-CCCCCCCCCHHHH
Confidence 999999996 9999999765543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.9e-19 Score=175.83 Aligned_cols=138 Identities=14% Similarity=0.121 Sum_probs=95.3
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-------------CHHhHHHH--------HHHHHHHhcCCC
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-------------NQKTASDF--------RREVDLMSELRH 113 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~--------~~E~~il~~l~H 113 (422)
-|++.+.||+|+||.||+|.. ..+..||||+++... ........ .+|...|.+|.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d---~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~ 172 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVAD---EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE 172 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEEC---TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCEeeeCCceEEEEEEC---CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence 378899999999999999974 246789999875321 00011122 345566666644
Q ss_pred CceeeEeeEEEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy7289 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLA 193 (422)
Q Consensus 114 pnIv~l~g~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlK 193 (422)
.++....-+.. ...++||||+++++|.++. ..+....++.|++.+|.|||++||||||||
T Consensus 173 ~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~------------------~~~~~~~l~~qll~~l~~lH~~gIVHrDLK 232 (397)
T 4gyi_A 173 EGFPVPEPIAQ--SRHTIVMSLVDALPMRQVS------------------SVPDPASLYADLIALILRLAKHGLIHGDFN 232 (397)
T ss_dssp TTCSCCCEEEE--ETTEEEEECCSCEEGGGCC------------------CCSCHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred cCCCCCeeeec--cCceEEEEecCCccHhhhc------------------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCC
Confidence 33321111111 1237999999998885432 112346788999999999999999999999
Q ss_pred CCceeecCCC----------eEEEecCccccc
Q psy7289 194 ARNCLVGDGL----------TVKISDFGLSRD 215 (422)
Q Consensus 194 p~NiLl~~~~----------~vKl~DFGla~~ 215 (422)
|.|||+++++ .+.|+||+-+..
T Consensus 233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp TTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred HHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 9999998766 488999997653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.75 E-value=5.9e-19 Score=169.85 Aligned_cols=98 Identities=26% Similarity=0.536 Sum_probs=84.2
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++|+||||+||+++.++.+|++|||+++..... .....+|+.|+|||++....|+.++|||||
T Consensus 115 i~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 189 (318)
T 1fot_A 115 VCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSF 189 (318)
T ss_dssp HHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHH
T ss_pred HHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhh
Confidence 467999999999999999999999999999999999999854221 223456889999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||++|||++ |..||.+.+..+.+
T Consensus 190 G~il~ell~-g~~pf~~~~~~~~~ 212 (318)
T 1fot_A 190 GILIYEMLA-GYTPFYDSNTMKTY 212 (318)
T ss_dssp HHHHHHHHH-SSCTTCCSSHHHHH
T ss_pred HHHHHHHHh-CCCCCCCCCHHHHH
Confidence 999999997 99999886655543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.75 E-value=4.6e-19 Score=187.26 Aligned_cols=101 Identities=28% Similarity=0.532 Sum_probs=86.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++||||||+|||++....+||+|||+++....... ......+|+.|+|||++..+.|+.++|||||
T Consensus 451 i~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSl 528 (674)
T 3pfq_A 451 IAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF 528 (674)
T ss_dssp HHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHH
T ss_pred HHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEech
Confidence 56799999999999999999999999999999999999985332221 1334567899999999998899999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||++|||++ |+.||.+.+..+.+
T Consensus 529 Gvilyellt-G~~Pf~~~~~~~~~ 551 (674)
T 3pfq_A 529 GVLLYEMLA-GQAPFEGEDEDELF 551 (674)
T ss_dssp HHHHHHHHH-SSCSSCCSSHHHHH
T ss_pred HHHHHHHHc-CCCCCCCCCHHHHH
Confidence 999999997 99999997666543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=3.9e-19 Score=173.27 Aligned_cols=104 Identities=50% Similarity=0.937 Sum_probs=87.4
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
.+.++.|||+++++|+||||+||+++.+..+|++|||+++...............+|..|+|||++.++.++.++|||||
T Consensus 202 l~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 281 (359)
T 3vhe_A 202 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 281 (359)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhH
Confidence 57899999999999999999999999999999999999986544333333344556778999999998899999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||++|||++.|..||.+....+..
T Consensus 282 G~il~ellt~g~~p~~~~~~~~~~ 305 (359)
T 3vhe_A 282 GVLLWEIFSLGASPYPGVKIDEEF 305 (359)
T ss_dssp HHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred HHHHHHHHhcCCCCCCccchhHHH
Confidence 999999997799999997766543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=6.1e-19 Score=170.28 Aligned_cols=102 Identities=46% Similarity=0.786 Sum_probs=79.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
...++.|||+++++|+|+||+||+++....+|++|||+++...............+|..|+|||.+.+..++.++|||||
T Consensus 126 i~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 205 (327)
T 3lzb_A 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 205 (327)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHH
Confidence 56799999999999999999999999988999999999986433322222334455778999999998899999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||++|||++.|..||.+.+..+
T Consensus 206 G~il~ell~~g~~p~~~~~~~~ 227 (327)
T 3lzb_A 206 GVTVWELMTFGSKPYDGIPASE 227 (327)
T ss_dssp HHHHHHHHTTSCCTTTTCCGGG
T ss_pred HHHHHHHHHCCCCCCCCCCHHH
Confidence 9999999977999999876655
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.9e-19 Score=175.35 Aligned_cols=103 Identities=51% Similarity=1.056 Sum_probs=84.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccC---CcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGD---GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~---~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 386 (422)
++.++.|||+++++|+||||+||+++. +..+|++|||+++...............+|+.|+|||++..+.++.++||
T Consensus 190 i~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv 269 (367)
T 3l9p_A 190 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 269 (367)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHH
Confidence 567999999999999999999999984 44699999999975433322222334456788999999998999999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
|||||++|||++.|..||.+.+..+.
T Consensus 270 wslG~il~ellt~g~~pf~~~~~~~~ 295 (367)
T 3l9p_A 270 WSFGVLLWEIFSLGYMPYPSKSNQEV 295 (367)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999779999998766553
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.1e-18 Score=170.00 Aligned_cols=95 Identities=21% Similarity=0.421 Sum_probs=81.5
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++|+||||+||+++....+|++|||+++...... .......+|+.|+|||++....|+.++||||+
T Consensus 119 i~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 196 (345)
T 3a8x_A 119 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 196 (345)
T ss_dssp HHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred HHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHH
Confidence 4679999999999999999999999999999999999998533221 12334567889999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCC
Q psy7289 390 GVVLWEVYSYGLQPYYGY 407 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~ 407 (422)
||++|||++ |+.||.+.
T Consensus 197 G~il~ell~-g~~pf~~~ 213 (345)
T 3a8x_A 197 GVLMFEMMA-GRSPFDIV 213 (345)
T ss_dssp HHHHHHHHH-SSCTTTTT
T ss_pred HHHHHHHHh-CCCCcCCc
Confidence 999999997 99999763
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.75 E-value=9.6e-19 Score=169.10 Aligned_cols=99 Identities=31% Similarity=0.519 Sum_probs=83.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCC-cchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFT-TESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dvws 388 (422)
+.+++.|||+++++|+||||+||+++.+..+|++|||+++...... ......+++.|+|||++.+..++ .++||||
T Consensus 123 i~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws 199 (328)
T 3fe3_A 123 IVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWS 199 (328)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHH
T ss_pred HHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhh
Confidence 4679999999999999999999999999999999999997543322 12345678899999999888775 7899999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
+||++|||++ |+.||.+.+..+.
T Consensus 200 lG~il~ell~-g~~pf~~~~~~~~ 222 (328)
T 3fe3_A 200 LGVILYTLVS-GSLPFDGQNLKEL 222 (328)
T ss_dssp HHHHHHHHHH-SSCSSCCSSHHHH
T ss_pred hHHHHHHHHh-CCCCCCCCCHHHH
Confidence 9999999997 9999998765543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.74 E-value=9.3e-19 Score=174.92 Aligned_cols=99 Identities=27% Similarity=0.456 Sum_probs=81.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccC-CcceeecccccccccccCcceeeccccCCCcccCCccccccC-CCCcchhHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGD-GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVW 387 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~-~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvw 387 (422)
+.+++.|||+++++|+||||+|||++. ...+|++|||+++....... .....++..|+|||++.+. .|+.++|||
T Consensus 165 i~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 241 (420)
T 1j1b_A 165 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVW 241 (420)
T ss_dssp HHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHH
T ss_pred HHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhH
Confidence 467999999999999999999999985 46789999999986433221 2234567889999998765 689999999
Q ss_pred HHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 388 SYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||||++|||++ |+.||.+.+..+.
T Consensus 242 SlG~il~ell~-G~~pf~~~~~~~~ 265 (420)
T 1j1b_A 242 SAGCVLAELLL-GQPIFPGDSGVDQ 265 (420)
T ss_dssp HHHHHHHHHHH-SSCSSCCSSHHHH
T ss_pred HHHHHHHHHHh-CCCCCCCCCHHHH
Confidence 99999999997 9999999765543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=1e-18 Score=166.36 Aligned_cols=99 Identities=26% Similarity=0.529 Sum_probs=84.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
...++.|||+++++|+|+||+||+++.+..+|++|||+++...... .......+++.|+|||.+.++.++.++||||+
T Consensus 125 i~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 202 (297)
T 3fxz_A 125 CLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 202 (297)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHH
T ss_pred HHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc--cccCCccCCcCccChhhhcCCCCCcHHHHHHH
Confidence 3579999999999999999999999999999999999987543322 12234457889999999998899999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||++|||++ |..||.+.+..+
T Consensus 203 G~il~ell~-g~~pf~~~~~~~ 223 (297)
T 3fxz_A 203 GIMAIEMIE-GEPPYLNENPLR 223 (297)
T ss_dssp HHHHHHHHH-SSCTTTTSCHHH
T ss_pred HHHHHHHHh-CCCCCCCCCHHH
Confidence 999999997 999998866544
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.74 E-value=8.5e-19 Score=168.44 Aligned_cols=103 Identities=49% Similarity=0.981 Sum_probs=79.5
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
...++.|||+++++|+|+||+||+++.+..+|++|||+++...............+++.|+|||.+..+.++.++|||||
T Consensus 146 i~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 225 (323)
T 3qup_A 146 IACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAF 225 (323)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhH
Confidence 46799999999999999999999999999999999999986544333333344455778999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||++|||++.|..||.+.+..+.
T Consensus 226 G~il~ell~~g~~p~~~~~~~~~ 248 (323)
T 3qup_A 226 GVTMWEIMTRGQTPYAGIENAEI 248 (323)
T ss_dssp HHHHHHHHTTSCCTTTTCCGGGH
T ss_pred HHHHHHHHhCCCCCccccChHHH
Confidence 99999999779999998776664
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=5.5e-19 Score=173.48 Aligned_cols=94 Identities=20% Similarity=0.286 Sum_probs=80.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCcccccc--CCCCcchhHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY--GKFTTESDVW 387 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dvw 387 (422)
+..++.|||+++++|+||||+||+++.+..+|++|||+++..... .....+++.|+|||++.+ ..|+.++|||
T Consensus 203 i~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~Diw 277 (371)
T 3q60_A 203 LIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAW 277 (371)
T ss_dssp HHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHH
T ss_pred HHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHH
Confidence 578999999999999999999999999999999999999853221 112334588999999987 5699999999
Q ss_pred HHHHHHHHHHhcCCCCCCCCCc
Q psy7289 388 SYGVVLWEVYSYGLQPYYGYSN 409 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~~~~ 409 (422)
||||++|||++ |+.||.+.+.
T Consensus 278 SlG~il~ellt-g~~Pf~~~~~ 298 (371)
T 3q60_A 278 QLGLSIYRVWC-LFLPFGLVTP 298 (371)
T ss_dssp HHHHHHHHHHH-SSCSTTBCCT
T ss_pred HHHHHHHHHHh-CCCCCCCcCc
Confidence 99999999997 9999988744
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=1.2e-18 Score=168.04 Aligned_cols=100 Identities=21% Similarity=0.338 Sum_probs=83.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcc-----eeecccccccccccCcce-----eeccccCCCcccCCccccccCC
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLT-----VKISDFGLSRDVYASDYY-----RIQSKSLLPVRWMPPESILYGK 379 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~-----~ki~Dfgls~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~ 379 (422)
++.++.|||+++++|+||||+||+++.... +|++|||+++........ .......+|+.|+|||++.+..
T Consensus 114 i~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 193 (330)
T 2izr_A 114 LISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKE 193 (330)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC
T ss_pred HHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCC
Confidence 467999999999999999999999988776 999999999854332211 1123456788999999999888
Q ss_pred CCcchhHHHHHHHHHHHHhcCCCCCCCCCch
Q psy7289 380 FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ 410 (422)
Q Consensus 380 ~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~ 410 (422)
++.++|||||||++|||++ |+.||.+.+..
T Consensus 194 ~~~~~Di~slG~il~ell~-g~~Pf~~~~~~ 223 (330)
T 2izr_A 194 QSRRDDLEALGHMFMYFLR-GSLPWQGLKAD 223 (330)
T ss_dssp CCHHHHHHHHHHHHHHHHH-SSCTTTTCCCS
T ss_pred CCchhHHHHHHHHHHHHhc-CCCCccccccc
Confidence 9999999999999999997 99999986544
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=8.8e-19 Score=167.27 Aligned_cols=100 Identities=30% Similarity=0.532 Sum_probs=85.0
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++|+|+||+||+++.+..+|++|||+++...... ......+|+.|+|||++.++.++.++|||||
T Consensus 129 i~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 205 (308)
T 3g33_A 129 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSV 205 (308)
T ss_dssp HHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHH
T ss_pred HHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHH
Confidence 4679999999999999999999999999999999999997543221 1234456889999999998899999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||++|||++ |+.||.+.+..+..
T Consensus 206 G~il~~l~~-g~~pf~~~~~~~~~ 228 (308)
T 3g33_A 206 GCIFAEMFR-RKPLFCGNSEADQL 228 (308)
T ss_dssp HHHHHHTTT-SSCSCCCSSHHHHH
T ss_pred HHHHHHHHh-CCCCCCCCCHHHHH
Confidence 999999996 99999987766543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.74 E-value=8e-19 Score=179.09 Aligned_cols=102 Identities=44% Similarity=0.950 Sum_probs=88.2
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
++.++.|||+++++|+||||+||+++.+..+|++|||+++..... .........+++.|+|||++..+.++.++|||||
T Consensus 327 i~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSl 405 (495)
T 1opk_A 327 ISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 405 (495)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC-CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred HHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCC-ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhH
Confidence 568999999999999999999999999999999999999865332 2333445556788999999998899999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||++|||+++|..||.+.+..+.
T Consensus 406 G~~l~el~t~g~~p~~~~~~~~~ 428 (495)
T 1opk_A 406 GVLLWEIATYGMSPYPGIDLSQV 428 (495)
T ss_dssp HHHHHHHHTTSCCSSTTCCGGGH
T ss_pred HHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999889999999876653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=1.1e-18 Score=175.58 Aligned_cols=100 Identities=25% Similarity=0.484 Sum_probs=83.8
Q ss_pred chhhHHHHhh-hhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHH
Q psy7289 310 VAAGMAYLCS-HHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~-~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 388 (422)
+..++.|||+ ++++|+||||+||+++.+..+|++|||+++...... .......+|+.|+|||++.++.|+.++||||
T Consensus 257 i~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 334 (446)
T 4ejn_A 257 IVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 334 (446)
T ss_dssp HHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHH
T ss_pred HHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhh
Confidence 5679999998 899999999999999999999999999997533221 1223456788999999999889999999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
|||++|||++ |+.||.+.+..+.
T Consensus 335 lG~il~ell~-g~~Pf~~~~~~~~ 357 (446)
T 4ejn_A 335 LGVVMYEMMC-GRLPFYNQDHEKL 357 (446)
T ss_dssp HHHHHHHHHH-SSCSSCCSSHHHH
T ss_pred hHHHHHHHhh-CCCCCCCCCHHHH
Confidence 9999999997 9999988665543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.74 E-value=8.2e-19 Score=170.07 Aligned_cols=104 Identities=51% Similarity=0.966 Sum_probs=87.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++|+||+|+||+++.+..+|++|||+++...............+|+.|+|||.+..+.++.++|||||
T Consensus 181 i~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 260 (344)
T 1rjb_A 181 VAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 260 (344)
T ss_dssp HHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHH
Confidence 57899999999999999999999999999999999999986544333333344445678999999998899999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||++|||++.|..||.+.+..+.+
T Consensus 261 G~il~el~t~g~~p~~~~~~~~~~ 284 (344)
T 1rjb_A 261 GILLWEIFSLGVNPYPGIPVDANF 284 (344)
T ss_dssp HHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred HHHHHHHHcCCCCCcccCCcHHHH
Confidence 999999997799999997766543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.2e-18 Score=165.53 Aligned_cols=101 Identities=26% Similarity=0.447 Sum_probs=80.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
...++.|||+++++|+|+||+||+++.+..+|++|||+++...... ........+++.|+|||.+.+..++.++||||+
T Consensus 120 i~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 198 (294)
T 4eqm_A 120 ILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSI 198 (294)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHH
T ss_pred HHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc-ccccCccccCccccCHhHhcCCCCCchHhHHHH
Confidence 4679999999999999999999999999999999999997543221 111223456889999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||++|||++ |+.||.+.+..+.
T Consensus 199 G~~l~~ll~-g~~pf~~~~~~~~ 220 (294)
T 4eqm_A 199 GIVLYEMLV-GEPPFNGETAVSI 220 (294)
T ss_dssp HHHHHHHHH-SSCSSCSSCHHHH
T ss_pred HHHHHHHHh-CCCCCCCCChHHH
Confidence 999999997 9999998776554
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.74 E-value=1e-18 Score=170.41 Aligned_cols=97 Identities=24% Similarity=0.446 Sum_probs=83.5
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++|+||||+||+++....+|++|||+++..... .....+|+.|+|||++.+..|+.++|||||
T Consensus 150 i~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 224 (350)
T 1rdq_E 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWAL 224 (350)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred HHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecc
Confidence 467999999999999999999999999999999999999854322 123346788999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||++|||++ |..||.+.+..+.
T Consensus 225 G~il~ell~-g~~Pf~~~~~~~~ 246 (350)
T 1rdq_E 225 GVLIYEMAA-GYPPFFADQPIQI 246 (350)
T ss_dssp HHHHHHHHH-SSCSSCCSSHHHH
T ss_pred cHhHhHHhh-CCCCCCCCCHHHH
Confidence 999999997 9999998665554
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.74 E-value=1.1e-18 Score=175.90 Aligned_cols=99 Identities=45% Similarity=0.882 Sum_probs=84.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+++++.|||+++++|+||+|+||+++.+..+|++|||+++..... .....+++.|+|||.+.++.++.++|||||
T Consensus 298 i~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwsl 372 (450)
T 1k9a_A 298 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSF 372 (450)
T ss_dssp HHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHH
T ss_pred HHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHH
Confidence 568999999999999999999999999999999999999853221 122345788999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||++|||+++|+.||.+.+..+..
T Consensus 373 G~~l~el~t~g~~P~~~~~~~~~~ 396 (450)
T 1k9a_A 373 GILLWEIYSFGRVPYPRIPLKDVV 396 (450)
T ss_dssp HHHHHHHHTTTCCSSTTSCTTTHH
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999998899999998776643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.74 E-value=7.6e-19 Score=170.04 Aligned_cols=103 Identities=65% Similarity=1.322 Sum_probs=85.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++|+||||+||+++.+..+|++|||+++...............+++.|+|||.+..+.++.++|||||
T Consensus 183 i~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 262 (343)
T 1luf_A 183 VAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAY 262 (343)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHH
Confidence 57899999999999999999999999999999999999975443332233334456788999999998899999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||++|||+++|..||.+.+..+.
T Consensus 263 G~il~el~t~g~~p~~~~~~~~~ 285 (343)
T 1luf_A 263 GVVLWEIFSYGLQPYYGMAHEEV 285 (343)
T ss_dssp HHHHHHHHTTTCCTTTTSCHHHH
T ss_pred HHHHHHHHhcCCCcCCCCChHHH
Confidence 99999999879999998776554
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=1.2e-18 Score=172.34 Aligned_cols=100 Identities=30% Similarity=0.502 Sum_probs=78.0
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCcccccc-----------C
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-----------G 378 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~ 378 (422)
+..++.|||+++++|+||||+||+++. ..+|++|||+++...............+|+.|+|||++.. +
T Consensus 164 i~~aL~~lH~~~ivHrDlkp~NIll~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 242 (390)
T 2zmd_A 164 MLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKS 242 (390)
T ss_dssp HHHHHHHHHTTTCCCCCCCGGGEEESS-SCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC-----------
T ss_pred HHHHHHHHHHCCeeecCCCHHHEEEEC-CeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhcccccccccccc
Confidence 467999999999999999999999964 5799999999986533322222344567899999999864 3
Q ss_pred CCCcchhHHHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 379 KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 379 ~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
.|+.++|||||||++|||++ |..||.+..+..
T Consensus 243 ~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~ 274 (390)
T 2zmd_A 243 KISPKSDVWSLGCILYYMTY-GKTPFQQIINQI 274 (390)
T ss_dssp -CCHHHHHHHHHHHHHHHHH-SSCTTTTCCCHH
T ss_pred CCCChhhHHHHHHHHHHHHH-CCCcchhhhHHH
Confidence 68999999999999999996 999998866543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.5e-18 Score=171.23 Aligned_cols=102 Identities=50% Similarity=0.951 Sum_probs=86.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
++.++.|||+++++|+||||+||+++.+..+|++|||+++...............+|+.|+|||++.++.++.++|||||
T Consensus 200 i~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diwsl 279 (382)
T 3tt0_A 200 VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 279 (382)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHH
T ss_pred HHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHH
Confidence 57899999999999999999999999999999999999986543332333344556788999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||++|||++.|..||.+.+..+
T Consensus 280 G~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 280 GVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp HHHHHHHHTTSCCSSTTCCHHH
T ss_pred HHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999977999999866554
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=1.8e-18 Score=165.69 Aligned_cols=101 Identities=26% Similarity=0.528 Sum_probs=83.4
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCcccccc-CCCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws 388 (422)
...++.|||+++++|+|+||+||+++.+..+|++|||+++...... .......++..|+|||++.+ ..++.++||||
T Consensus 128 i~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 205 (311)
T 3niz_A 128 LLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWS 205 (311)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHH
T ss_pred HHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHH
Confidence 4679999999999999999999999999999999999997543221 12234456889999999876 45899999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
+||++|||++ |+.||.+.+..+..
T Consensus 206 lG~il~~ll~-g~~pf~~~~~~~~~ 229 (311)
T 3niz_A 206 IGCIFAEMIT-GKPLFPGVTDDDQL 229 (311)
T ss_dssp HHHHHHHHHH-SSCSCCCSSTTTHH
T ss_pred HHHHHHHHHh-CCCCCCCCChHHHH
Confidence 9999999997 99999997776643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.74 E-value=1.6e-18 Score=172.06 Aligned_cols=96 Identities=24% Similarity=0.544 Sum_probs=77.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccC---CcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGD---GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~---~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 386 (422)
+..++.|||+++++|+||||+||+++. +..+|++|||+++...... ......+|..|+|||++..+.|+.++||
T Consensus 170 i~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di 246 (400)
T 1nxk_A 170 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDM 246 (400)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHH
T ss_pred HHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccH
Confidence 467999999999999999999999987 6789999999998543221 1234456889999999988899999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCc
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSN 409 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~ 409 (422)
|||||++|||++ |..||.+...
T Consensus 247 wslG~il~ell~-g~~pf~~~~~ 268 (400)
T 1nxk_A 247 WSLGVIMYILLC-GYPPFYSNHG 268 (400)
T ss_dssp HHHHHHHHHHHH-SSCSCCCCTT
T ss_pred HHHHHHHHHHHh-CCCCCCCCcc
Confidence 999999999997 9999987654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.74 E-value=9.6e-19 Score=176.50 Aligned_cols=103 Identities=46% Similarity=0.861 Sum_probs=82.5
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
++.++.|||+++++|+||+|+||+++.+..+|++|||+++..... .........+|+.|+|||.+..+.++.++|||||
T Consensus 289 i~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwsl 367 (452)
T 1fmk_A 289 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 367 (452)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCC-ceecccCCcccccccCHhHHhcCCCCccccHHhH
Confidence 567999999999999999999999999999999999999854332 2222334456788999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||++|||++.|+.||.+.++.+..
T Consensus 368 G~~l~el~t~g~~P~~~~~~~~~~ 391 (452)
T 1fmk_A 368 GILLTELTTKGRVPYPGMVNREVL 391 (452)
T ss_dssp HHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999998899999998776643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.6e-18 Score=167.37 Aligned_cols=100 Identities=21% Similarity=0.474 Sum_probs=81.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++|+||||+||+++....+|++|||+++...... .......+++.|+|||++..+.++.++|||||
T Consensus 130 i~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 207 (327)
T 3a62_A 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSL 207 (327)
T ss_dssp HHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHH
T ss_pred HHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhH
Confidence 5679999999999999999999999999999999999987533221 12234457889999999988889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||++|||++ |+.||.+.+..+.
T Consensus 208 G~il~el~~-g~~pf~~~~~~~~ 229 (327)
T 3a62_A 208 GALMYDMLT-GAPPFTGENRKKT 229 (327)
T ss_dssp HHHHHHHHH-SSCSCCCSSHHHH
T ss_pred HHHHHHHHH-CCCCCCCCCHHHH
Confidence 999999997 9999998665543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=9.5e-19 Score=168.83 Aligned_cols=104 Identities=50% Similarity=0.965 Sum_probs=87.4
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
++.++.|||+++++|+||+|+||+++.+..+|++|||+++...............+++.|+|||.+.++.++.++|||||
T Consensus 173 i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 252 (333)
T 2i1m_A 173 VAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSY 252 (333)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHhcCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHH
Confidence 57899999999999999999999999999999999999986543333333334445678999999998899999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||++|||++.|..||.+....+.+
T Consensus 253 G~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 253 GILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp HHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred HHHHHHHHcCCCCCCcccchhHHH
Confidence 999999998799999987766543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.7e-18 Score=174.74 Aligned_cols=99 Identities=33% Similarity=0.536 Sum_probs=75.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcce-------------------------eeccccC
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYY-------------------------RIQSKSL 364 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~-------------------------~~~~~~~ 364 (422)
+.+++.|||+++++||||||+|||++.+..+|++|||+++........ ...+...
T Consensus 165 i~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (458)
T 3rp9_A 165 LLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHV 244 (458)
T ss_dssp HHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------
T ss_pred HHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCc
Confidence 467999999999999999999999999999999999999854321100 1123445
Q ss_pred CCcccCCccccc-cCCCCcchhHHHHHHHHHHHHhc----------CCCCCCCCC
Q psy7289 365 LPVRWMPPESIL-YGKFTTESDVWSYGVVLWEVYSY----------GLQPYYGYS 408 (422)
Q Consensus 365 ~~~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~el~~~----------g~~p~~~~~ 408 (422)
+|++|+|||++. .+.|+.++|||||||+||||++. |+.||+|.+
T Consensus 245 gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 245 VTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSS 299 (458)
T ss_dssp CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC---
T ss_pred ccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCc
Confidence 688999999864 55699999999999999999962 677887754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.6e-18 Score=165.40 Aligned_cols=104 Identities=51% Similarity=0.936 Sum_probs=87.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++|+|+||+||+++.+..+|++|||+++...............+++.|+|||.+..+.++.++|||||
T Consensus 154 i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 233 (313)
T 1t46_A 154 VAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 233 (313)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHH
Confidence 57799999999999999999999999999999999999986544333333334445678999999998899999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||++|||++.|..||.+.+..+..
T Consensus 234 G~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 234 GIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp HHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred HHHHHHHHhCCCCCCCcccchhHH
Confidence 999999997799999987765533
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.7e-18 Score=173.57 Aligned_cols=97 Identities=24% Similarity=0.348 Sum_probs=82.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcc--eeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLT--VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVW 387 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~--~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 387 (422)
+..++.|||+++++|+||||+||+++.... +|++|||+++..... .....+|+.|+|||++.+..|+.++|||
T Consensus 209 i~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Diw 283 (429)
T 3kvw_A 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMW 283 (429)
T ss_dssp HHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHH
T ss_pred HHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHH
Confidence 467999999999999999999999988766 999999999753221 2234567889999999988999999999
Q ss_pred HHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 388 SYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||||++|||++ |..||.+.+..+.
T Consensus 284 SlG~il~ellt-G~~pf~~~~~~~~ 307 (429)
T 3kvw_A 284 SLGCILAELLT-GYPLLPGEDEGDQ 307 (429)
T ss_dssp HHHHHHHHHHH-SSCSSCCSSHHHH
T ss_pred hHHHHHHHHHh-CCCCCCCCCHHHH
Confidence 99999999997 9999999776554
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=2.1e-18 Score=168.88 Aligned_cols=100 Identities=28% Similarity=0.522 Sum_probs=83.5
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCc----ceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchh
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGL----TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESD 385 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~----~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 385 (422)
+..++.|||+++++|+||||+||+++... .+|++|||+++...... ......+|+.|+|||++....|+.++|
T Consensus 124 i~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~D 200 (361)
T 2yab_A 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEAD 200 (361)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHH
T ss_pred HHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCcccc
Confidence 46799999999999999999999997655 79999999998643322 123345788999999999888999999
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 386 VWSYGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 386 vws~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
|||+||++|||++ |..||.+.+..+.+
T Consensus 201 iwslGvil~~ll~-g~~Pf~~~~~~~~~ 227 (361)
T 2yab_A 201 MWSIGVITYILLS-GASPFLGDTKQETL 227 (361)
T ss_dssp HHHHHHHHHHHHH-SCCSSCCSSHHHHH
T ss_pred HHHHHHHHHHHHh-CCCCCCCCCHHHHH
Confidence 9999999999997 99999987665543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.9e-18 Score=171.18 Aligned_cols=99 Identities=27% Similarity=0.447 Sum_probs=82.5
Q ss_pred chhhHHHHhhhhhhhhhccccccccc-CCcceeecccccccccccCcceeeccccCCCcccCCccccccC-CCCcchhHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVG-DGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVW 387 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~-~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvw 387 (422)
+.+++.|||+++++|+||||+||+++ ....+|++|||+++...... ......++..|+|||.+.+. .|+.++|||
T Consensus 150 i~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 226 (394)
T 4e7w_A 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIW 226 (394)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHH
T ss_pred HHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHH
Confidence 46899999999999999999999998 68899999999998643322 12234557889999988754 589999999
Q ss_pred HHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 388 SYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
|+||++|||++ |+.||.+.+..+.
T Consensus 227 SlG~il~ell~-g~~pf~~~~~~~~ 250 (394)
T 4e7w_A 227 STGCVMAELMQ-GQPLFPGESGIDQ 250 (394)
T ss_dssp HHHHHHHHHHH-SSCSSCCSSHHHH
T ss_pred HHHHHHHHHHh-CCCCCCCCCHHHH
Confidence 99999999996 9999999776553
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.9e-18 Score=169.17 Aligned_cols=96 Identities=25% Similarity=0.421 Sum_probs=80.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCcccccc---CCCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY---GKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv 386 (422)
+..++.|||+++++|+||||+||+++..+.+|++|||+++...... ......+|+.|+|||++.. ..|+.++||
T Consensus 124 i~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~Di 200 (384)
T 4fr4_A 124 LVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDW 200 (384)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHH
T ss_pred HHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCcccee
Confidence 4679999999999999999999999999999999999998543322 1234567889999999874 348999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCc
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSN 409 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~ 409 (422)
|||||++|||++ |..||.+.+.
T Consensus 201 wSlG~il~ellt-G~~Pf~~~~~ 222 (384)
T 4fr4_A 201 WSLGVTAYELLR-GRRPYHIRSS 222 (384)
T ss_dssp HHHHHHHHHHHH-SSCSSCCCTT
T ss_pred echHHHHHHHHh-CCCCCCCCCC
Confidence 999999999997 9999986543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.73 E-value=1.5e-18 Score=165.84 Aligned_cols=104 Identities=50% Similarity=0.937 Sum_probs=87.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
...++.|||+++++|+|++|+||+++....+|++|||+++...............++..|+|||++..+.++.++|||||
T Consensus 157 i~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 236 (316)
T 2xir_A 157 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236 (316)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHH
Confidence 57899999999999999999999999889999999999986543332222333445678999999998899999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||++|||++.|..||.+.+..+.+
T Consensus 237 G~il~~l~t~g~~p~~~~~~~~~~ 260 (316)
T 2xir_A 237 GVLLWEIFSLGASPYPGVKIDEEF 260 (316)
T ss_dssp HHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred HHHHHHHHhCCCCCCcccchhHHH
Confidence 999999997799999987766544
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.73 E-value=2.2e-18 Score=163.01 Aligned_cols=100 Identities=25% Similarity=0.346 Sum_probs=83.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccc---cCCcceeecccccccccccCcce-----eeccccCCCcccCCccccccCCCC
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASDYY-----RIQSKSLLPVRWMPPESILYGKFT 381 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~---~~~~~~ki~Dfgls~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~ 381 (422)
++.++.|||+++++|+||||+||++ +....+|++|||+++........ .......++..|+|||.+.+..++
T Consensus 114 i~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 193 (296)
T 4hgt_A 114 MISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS 193 (296)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCC
T ss_pred HHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCC
Confidence 4679999999999999999999999 67788999999999754332211 122344568899999999988899
Q ss_pred cchhHHHHHHHHHHHHhcCCCCCCCCCch
Q psy7289 382 TESDVWSYGVVLWEVYSYGLQPYYGYSNQ 410 (422)
Q Consensus 382 ~~~Dvws~Gv~l~el~~~g~~p~~~~~~~ 410 (422)
.++|||||||++|||++ |+.||.+.+..
T Consensus 194 ~~~Di~slG~il~~l~~-g~~pf~~~~~~ 221 (296)
T 4hgt_A 194 RRDDLESLGYVLMYFNL-GSLPWQGLKAA 221 (296)
T ss_dssp HHHHHHHHHHHHHHHHH-SSCTTSSCCCS
T ss_pred chhHHHHHHHHHHHHhc-CCCCCcccchh
Confidence 99999999999999996 99999886544
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.7e-18 Score=165.41 Aligned_cols=102 Identities=52% Similarity=0.925 Sum_probs=86.4
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++|+||||+||+++.+..+|++|||+++...............+++.|+|||.+.++.++.++|||||
T Consensus 159 i~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 238 (314)
T 2ivs_A 159 ISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSF 238 (314)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred HHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHH
Confidence 57899999999999999999999999999999999999986544333333334455778999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||++|||++.|..||.+.+..+
T Consensus 239 G~il~el~t~g~~p~~~~~~~~ 260 (314)
T 2ivs_A 239 GVLLWEIVTLGGNPYPGIPPER 260 (314)
T ss_dssp HHHHHHHHTTSCCSSTTCCGGG
T ss_pred HHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999977999999876554
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.4e-18 Score=163.71 Aligned_cols=102 Identities=48% Similarity=0.908 Sum_probs=76.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
...++.|||+++++|+|+||+||+++.+..+|++|||+++........ ......+++.|+|||.+..+.++.++|||||
T Consensus 125 i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 203 (281)
T 1mp8_A 125 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMF 203 (281)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHH
T ss_pred HHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHH
Confidence 467999999999999999999999998889999999999764332211 2233445678999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||++|||++.|..||.+.+..+.
T Consensus 204 G~~l~ell~~g~~pf~~~~~~~~ 226 (281)
T 1mp8_A 204 GVCMWEILMHGVKPFQGVKNNDV 226 (281)
T ss_dssp HHHHHHHHTTSCCTTTTCCGGGH
T ss_pred HHHHHHHHhcCCCCCCcCCHHHH
Confidence 99999999779999998776654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.3e-18 Score=181.95 Aligned_cols=104 Identities=48% Similarity=0.880 Sum_probs=83.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCc-ceeeccccCCCcccCCccccccCCCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD-YYRIQSKSLLPVRWMPPESILYGKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 388 (422)
++.++.|||+++++|+||||+||+++.+..+|++|||+++...... .........+|+.|+|||++..+.++.++||||
T Consensus 445 i~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwS 524 (613)
T 2ozo_A 445 VSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWS 524 (613)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHH
T ss_pred HHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHH
Confidence 5689999999999999999999999999999999999998643322 122223344567899999999899999999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
|||++|||+++|+.||.+.+..+..
T Consensus 525 lGv~l~ellt~G~~Pf~~~~~~~~~ 549 (613)
T 2ozo_A 525 YGVTMWEALSYGQKPYKKMKGPEVM 549 (613)
T ss_dssp HHHHHHHHHTTSCCTTTTCCSHHHH
T ss_pred HHHHHHHHHHCCCCCCCCCCHHHHH
Confidence 9999999998899999998877643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.73 E-value=1.6e-18 Score=164.00 Aligned_cols=101 Identities=28% Similarity=0.539 Sum_probs=80.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccC-CCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws 388 (422)
+..++.|||+++++|+||||+||+++.+..+|++|||+++...... .......++..|+|||++... .++.++||||
T Consensus 109 i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 186 (288)
T 1ob3_A 109 LLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWS 186 (288)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHH
T ss_pred HHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--cccccccccccccCchheeCCCCCCcHHHHHH
Confidence 5679999999999999999999999999999999999997532211 112334567889999998754 5899999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
+||++|||++ |+.||.+.+..+..
T Consensus 187 lG~il~~l~~-g~~pf~~~~~~~~~ 210 (288)
T 1ob3_A 187 VGCIFAEMVN-GTPLFPGVSEADQL 210 (288)
T ss_dssp HHHHHHHHHH-SSCSCCCSSHHHHH
T ss_pred HHHHHHHHHh-CCCCCCCCCHHHHH
Confidence 9999999997 99999987765543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.6e-18 Score=168.35 Aligned_cols=99 Identities=30% Similarity=0.516 Sum_probs=76.0
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCcccccc-----------C
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-----------G 378 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~ 378 (422)
+..++.|||+++++|+||||+||+++. ..+|++|||+++...............+|+.|+|||++.. +
T Consensus 117 i~~al~~lH~~~iiHrDikp~NIll~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 195 (343)
T 3dbq_A 117 MLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKS 195 (343)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC----------
T ss_pred HHHHHHHHHhCCeecCCCCcceEEEEC-CcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhcccccccccccc
Confidence 467999999999999999999999975 5699999999986543332223344567899999999865 6
Q ss_pred CCCcchhHHHHHHHHHHHHhcCCCCCCCCCch
Q psy7289 379 KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ 410 (422)
Q Consensus 379 ~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~ 410 (422)
.++.++|||||||++|||++ |+.||.+..+.
T Consensus 196 ~~~~~~DiwslG~il~ell~-g~~pf~~~~~~ 226 (343)
T 3dbq_A 196 KISPKSDVWSLGCILYYMTY-GKTPFQQIINQ 226 (343)
T ss_dssp -CCHHHHHHHHHHHHHHHHH-SSCTTTTCCSH
T ss_pred CCCchhhHHHHHHHHHHHHh-CCCcchhhhhH
Confidence 78999999999999999996 99999886554
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=2.7e-18 Score=164.88 Aligned_cols=99 Identities=26% Similarity=0.520 Sum_probs=82.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccC-CCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws 388 (422)
+..++.|||+++++|+||||+||+++....+|++|||+++...... .......++..|+|||++... .++.++||||
T Consensus 117 i~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 194 (317)
T 2pmi_A 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWS 194 (317)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHH
T ss_pred HHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHH
Confidence 5679999999999999999999999999999999999997543211 112344567899999998764 5899999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
|||++|||++ |+.||.+.+..+
T Consensus 195 lG~il~el~~-g~~pf~~~~~~~ 216 (317)
T 2pmi_A 195 CGCILAEMIT-GKPLFPGTNDEE 216 (317)
T ss_dssp HHHHHHHHHH-SSCSCCCSSHHH
T ss_pred HHHHHHHHHh-CCCCCCCCChHH
Confidence 9999999997 999999876554
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.73 E-value=2.4e-18 Score=176.77 Aligned_cols=96 Identities=26% Similarity=0.425 Sum_probs=82.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++||||||+||+++..+.+|++|||+++....... ......+|+.|+|||++.+..|+.++|||||
T Consensus 298 i~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSl 375 (543)
T 3c4z_A 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFAL 375 (543)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHH
T ss_pred HHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcc
Confidence 56799999999999999999999999999999999999986433221 1233467899999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCC
Q psy7289 390 GVVLWEVYSYGLQPYYGYS 408 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~ 408 (422)
||++|||++ |..||.+.+
T Consensus 376 Gvilyellt-G~~PF~~~~ 393 (543)
T 3c4z_A 376 GVTLYEMIA-ARGPFRARG 393 (543)
T ss_dssp HHHHHHHHH-SSCSSCCTT
T ss_pred hHHHHHHHh-CCCCCCCCc
Confidence 999999997 999998864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.5e-18 Score=167.36 Aligned_cols=104 Identities=48% Similarity=0.898 Sum_probs=84.5
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCc-ceeeccccCCCcccCCccccccCCCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD-YYRIQSKSLLPVRWMPPESILYGKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 388 (422)
...++.|||+++++|+||||+||+++.+..+|++|||+++...... .........+|+.|+|||++.++.++.++||||
T Consensus 160 i~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~s 239 (325)
T 3kul_A 160 VGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWS 239 (325)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHH
T ss_pred HHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHH
Confidence 4679999999999999999999999999999999999998543321 112223344567899999999888999999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
|||++|||+++|..||.+.+..+..
T Consensus 240 lG~il~ell~~g~~p~~~~~~~~~~ 264 (325)
T 3kul_A 240 FGVVMWEVLAYGERPYWNMTNRDVI 264 (325)
T ss_dssp HHHHHHHHHTTSCCTTTTSCHHHHH
T ss_pred HHHHHHHHHcCCCCCcccCCHHHHH
Confidence 9999999998899999987776643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.73 E-value=1.1e-18 Score=171.77 Aligned_cols=95 Identities=20% Similarity=0.164 Sum_probs=77.2
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccC-----------
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG----------- 378 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------- 378 (422)
++.++.|||+++++|+||||+||+++.+..+|++|||+++.... ......+ ..|+|||++...
T Consensus 215 i~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~ 288 (377)
T 3byv_A 215 VIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRT 288 (377)
T ss_dssp HHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEE
T ss_pred HHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccc
Confidence 57899999999999999999999999999999999999985221 1223344 789999999887
Q ss_pred CCCcchhHHHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 379 KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 379 ~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
.|+.++|||||||++|||++ |+.||.+.+..+
T Consensus 289 ~~~~~~DvwSlG~il~ellt-g~~Pf~~~~~~~ 320 (377)
T 3byv_A 289 LMTFSFDAWALGLVIYWIWC-ADLPITKDAALG 320 (377)
T ss_dssp ECCHHHHHHHHHHHHHHHHH-SSCCC------C
T ss_pred cCChhhhHHHHHHHHHHHHH-CCCCCccccccc
Confidence 79999999999999999997 999998866544
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.7e-18 Score=167.50 Aligned_cols=97 Identities=28% Similarity=0.450 Sum_probs=82.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccC-------------------------CcceeecccccccccccCcceeeccccC
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGD-------------------------GLTVKISDFGLSRDVYASDYYRIQSKSL 364 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~-------------------------~~~~ki~Dfgls~~~~~~~~~~~~~~~~ 364 (422)
+..++.|||+++++|+||||+||+++. ...+|++|||+++..... .....
T Consensus 146 i~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~ 220 (360)
T 3llt_A 146 ILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSII 220 (360)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCC
T ss_pred HHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCcc
Confidence 567999999999999999999999974 678999999999753221 23345
Q ss_pred CCcccCCccccccCCCCcchhHHHHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 365 LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 365 ~~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+.
T Consensus 221 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~ 267 (360)
T 3llt_A 221 NTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT-GSLLFRTHEHMEH 267 (360)
T ss_dssp SCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCSCCCSSHHHH
T ss_pred CcccccCcHHHcCCCCCCccchHHHHHHHHHHHH-CCCCCCCCcHHHH
Confidence 6789999999998899999999999999999997 9999988665543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=2.7e-18 Score=168.50 Aligned_cols=96 Identities=28% Similarity=0.528 Sum_probs=82.5
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCcccccc-CCCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws 388 (422)
+.+++.|||+++++|+||||+||+++.+..+|++|||+++..... .+...+|.+|+|||++.+ ..|+.++||||
T Consensus 137 i~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 211 (367)
T 1cm8_A 137 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWS 211 (367)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHH
T ss_pred HHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHH
Confidence 467999999999999999999999999999999999999853221 233456889999999886 57999999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
+||++|||++ |+.||.+.+..+
T Consensus 212 lG~il~ell~-g~~pf~~~~~~~ 233 (367)
T 1cm8_A 212 VGCIMAEMIT-GKTLFKGSDHLD 233 (367)
T ss_dssp HHHHHHHHHH-SSCSSCCSSHHH
T ss_pred HHHHHHHHHh-CCCCCCCCCHHH
Confidence 9999999997 999999876544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.2e-18 Score=173.64 Aligned_cols=95 Identities=19% Similarity=0.181 Sum_probs=79.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCcccc----------ccCC
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESI----------LYGK 379 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~ 379 (422)
+++++.|||+++++||||||+|||++.+..+|++|||+++..... .....+ +.|+|||++ ....
T Consensus 220 i~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~ 293 (413)
T 3dzo_A 220 VIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTL 293 (413)
T ss_dssp HHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEE
T ss_pred HHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcC
Confidence 578999999999999999999999999999999999998753221 223344 889999999 4445
Q ss_pred CCcchhHHHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 380 FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 380 ~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
|+.++|||||||++|||++ |+.||.+.+..+
T Consensus 294 ~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~ 324 (413)
T 3dzo_A 294 MTFAFDTWTLGLAIYWIWC-ADLPNTDDAALG 324 (413)
T ss_dssp ECHHHHHHHHHHHHHHHHH-SSCCCCTTGGGS
T ss_pred CCchhhHHHHHHHHHHHHH-CCCCCCCcchhh
Confidence 8899999999999999997 999998865544
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=3.2e-18 Score=162.21 Aligned_cols=99 Identities=20% Similarity=0.261 Sum_probs=81.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcc-----eeecccccccccccCcce-----eeccccCCCcccCCccccccCC
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLT-----VKISDFGLSRDVYASDYY-----RIQSKSLLPVRWMPPESILYGK 379 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~-----~ki~Dfgls~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~ 379 (422)
++.++.|||+++++|+||||+||+++.... +|++|||+++........ .......++..|+|||.+.++.
T Consensus 115 i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 194 (298)
T 1csn_A 115 MLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE 194 (298)
T ss_dssp HHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC
T ss_pred HHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCC
Confidence 467999999999999999999999976554 999999999754332211 1123445678999999999888
Q ss_pred CCcchhHHHHHHHHHHHHhcCCCCCCCCCc
Q psy7289 380 FTTESDVWSYGVVLWEVYSYGLQPYYGYSN 409 (422)
Q Consensus 380 ~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~ 409 (422)
++.++|||||||++|||++ |+.||.+.+.
T Consensus 195 ~~~~~Di~slG~il~el~~-g~~pf~~~~~ 223 (298)
T 1csn_A 195 QSRRDDLEALGHVFMYFLR-GSLPWQGLKA 223 (298)
T ss_dssp CCHHHHHHHHHHHHHHHHH-SSCTTSSCCS
T ss_pred CChHHHHHHHHHHHHHHHc-CCCCcchhhc
Confidence 9999999999999999996 9999998543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.72 E-value=3e-18 Score=166.15 Aligned_cols=99 Identities=33% Similarity=0.498 Sum_probs=83.2
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCC-CcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKF-TTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dvws 388 (422)
+..++.|||+++++|+||||+||+++....+|++|||+++...... ......+++.|+|||++.+..+ +.++||||
T Consensus 117 i~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws 193 (336)
T 3h4j_B 117 IICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWS 193 (336)
T ss_dssp HHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHH
T ss_pred HHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhH
Confidence 4679999999999999999999999999999999999997543322 1234457889999999987765 67999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
+||++|||++ |+.||.+....+.
T Consensus 194 lG~il~~ll~-g~~Pf~~~~~~~~ 216 (336)
T 3h4j_B 194 CGIVLYVMLV-GRLPFDDEFIPNL 216 (336)
T ss_dssp HHHHHHHHHH-SSCSSBCSSSTTC
T ss_pred HHHHHHHHHh-CCCCCCCccHHHH
Confidence 9999999996 9999988655543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=2e-18 Score=166.36 Aligned_cols=100 Identities=31% Similarity=0.485 Sum_probs=83.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCC-CcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKF-TTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dvws 388 (422)
+..++.|||+++++|+||||+||+++....+|++|||+++...............+++.|+|||++....+ +.++||||
T Consensus 114 i~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws 193 (323)
T 3tki_A 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 193 (323)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHH
T ss_pred HHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHH
Confidence 46799999999999999999999999999999999999975433332333345567889999999987765 67899999
Q ss_pred HHHHHHHHHhcCCCCCCCCCch
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQ 410 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~ 410 (422)
|||++|||++ |+.||.+.+..
T Consensus 194 lG~il~~ll~-g~~pf~~~~~~ 214 (323)
T 3tki_A 194 CGIVLTAMLA-GELPWDQPSDS 214 (323)
T ss_dssp HHHHHHHHHH-SSCSCSSSCTT
T ss_pred HHHHHHHHHh-CCCCCCCCchH
Confidence 9999999997 99999886654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.72 E-value=2.5e-18 Score=164.97 Aligned_cols=102 Identities=62% Similarity=1.133 Sum_probs=86.4
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
++.++.+||+++++|+|+||+||+++.+..+|++|||+++...............+++.|+|||++.++.++.++|||||
T Consensus 147 i~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 226 (322)
T 1p4o_A 147 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 226 (322)
T ss_dssp HHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHH
Confidence 56799999999999999999999999999999999999986544333333334445778999999998899999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||++|||++.|..||.+.+..+
T Consensus 227 G~il~el~~~g~~p~~~~~~~~ 248 (322)
T 1p4o_A 227 GVVLWEIATLAEQPYQGLSNEQ 248 (322)
T ss_dssp HHHHHHHHHTSCCTTTTSCHHH
T ss_pred HHHHHHHHhcCCCccccCCHHH
Confidence 9999999987899998876554
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=3.1e-18 Score=172.25 Aligned_cols=100 Identities=23% Similarity=0.430 Sum_probs=83.5
Q ss_pred chhhHHHHhhhhhhhhhccccccccc---CCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVG---DGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~---~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 386 (422)
+..++.|||+++++|+||||+||+++ .+..+|++|||+++...... .......+|+.|+|||++....|+.++||
T Consensus 119 il~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DI 196 (444)
T 3soa_A 119 ILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDL 196 (444)
T ss_dssp HHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHH
T ss_pred HHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC--ceeecccCCcccCCHHHhcCCCCCCcccc
Confidence 46799999999999999999999997 35679999999997543322 12234567889999999988889999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||+||++|||++ |..||.+.+..+.
T Consensus 197 wSlGvilyell~-G~~Pf~~~~~~~~ 221 (444)
T 3soa_A 197 WACGVILYILLV-GYPPFWDEDQHRL 221 (444)
T ss_dssp HHHHHHHHHHHH-SSCSCCCSSHHHH
T ss_pred HHHHHHHHHHHh-CCCCCCCccHHHH
Confidence 999999999996 9999988765553
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.72 E-value=3.8e-18 Score=167.14 Aligned_cols=99 Identities=26% Similarity=0.500 Sum_probs=82.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCC---cceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDG---LTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~---~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 386 (422)
+..++.|||+++++|+||||+||+++.. ..+|++|||+++....... .....+++.|+|||++..+.|+.++||
T Consensus 137 i~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di 213 (362)
T 2bdw_A 137 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDI 213 (362)
T ss_dssp HHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHH
T ss_pred HHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhH
Confidence 4679999999999999999999999754 4599999999976433221 233457889999999988889999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
|||||++|||++ |..||.+.+..+.
T Consensus 214 wslG~il~~ll~-g~~Pf~~~~~~~~ 238 (362)
T 2bdw_A 214 WACGVILYILLV-GYPPFWDEDQHRL 238 (362)
T ss_dssp HHHHHHHHHHHH-SSCSSCCSSHHHH
T ss_pred HHHHHHHHHHHH-CCCCCCCCCHHHH
Confidence 999999999997 9999998665543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=3e-18 Score=164.15 Aligned_cols=100 Identities=37% Similarity=0.587 Sum_probs=77.0
Q ss_pred chhhHHHHhhhh--hhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHH
Q psy7289 310 VAAGMAYLCSHH--YVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVW 387 (422)
Q Consensus 310 ~~r~~~~lh~~~--~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 387 (422)
++.++.|||+++ ++|+||||+||+++.+..+|++|||+++..... ........++..|+|||++....++.++|||
T Consensus 146 i~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 223 (309)
T 3p86_A 146 VAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVY 223 (309)
T ss_dssp HHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHH
T ss_pred HHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc--ccccccCCCCccccChhhhcCCCCCchhhHH
Confidence 567999999999 999999999999999999999999999743221 1122344567899999999988899999999
Q ss_pred HHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 388 SYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||||++|||++ |+.||.+.+..+.
T Consensus 224 slG~il~ellt-g~~Pf~~~~~~~~ 247 (309)
T 3p86_A 224 SFGVILWELAT-LQQPWGNLNPAQV 247 (309)
T ss_dssp HHHHHHHHHHH-CCCTTTTSCHHHH
T ss_pred HHHHHHHHHHh-CCCCCCCCCHHHH
Confidence 99999999997 9999998766554
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=1e-18 Score=168.24 Aligned_cols=99 Identities=30% Similarity=0.442 Sum_probs=81.2
Q ss_pred chhhHHHHhhh----------hhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccC-
Q psy7289 310 VAAGMAYLCSH----------HYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG- 378 (422)
Q Consensus 310 ~~r~~~~lh~~----------~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~- 378 (422)
+++++.|||+. +++|+||||+||+++....+|++|||+++...............+|+.|+|||++...
T Consensus 130 i~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 209 (322)
T 3soc_A 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAI 209 (322)
T ss_dssp HHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCC
T ss_pred HHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhccccc
Confidence 56799999999 9999999999999999999999999999754433322223345678899999998763
Q ss_pred ----CCCcchhHHHHHHHHHHHHhcCCCCCCCCCc
Q psy7289 379 ----KFTTESDVWSYGVVLWEVYSYGLQPYYGYSN 409 (422)
Q Consensus 379 ----~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~ 409 (422)
.++.++|||||||++|||++ |+.||.+..+
T Consensus 210 ~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~ 243 (322)
T 3soc_A 210 NFQRDAFLRIDMYAMGLVLWELAS-RCTAADGPVD 243 (322)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHT-TBTTSSSCCC
T ss_pred ccCcCCCccchhHHHHHHHHHHHh-CCCCCCCCcc
Confidence 45678899999999999996 9999987544
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.72 E-value=2.8e-18 Score=168.45 Aligned_cols=96 Identities=27% Similarity=0.507 Sum_probs=74.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCcccccc-CCCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws 388 (422)
+.+++.|||+++++|+||||+||+++.+..+|++|||+++..... .+...+|.+|+|||++.+ ..++.++||||
T Consensus 141 i~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 215 (367)
T 2fst_X 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWS 215 (367)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHH
T ss_pred HHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHH
Confidence 567999999999999999999999999999999999999753221 233456789999999876 57899999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
+||++|||++ |+.||.+.+..+
T Consensus 216 lG~il~ell~-g~~pf~~~~~~~ 237 (367)
T 2fst_X 216 VGCIMAELLT-GRTLFPGTDHID 237 (367)
T ss_dssp HHHHHHHHHH-SSCSCCCSSHHH
T ss_pred HHHHHHHHHh-CCCCCCCCCHHH
Confidence 9999999997 999999876544
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=1.5e-18 Score=182.09 Aligned_cols=103 Identities=50% Similarity=0.944 Sum_probs=83.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCc-ceeeccccCCCcccCCccccccCCCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD-YYRIQSKSLLPVRWMPPESILYGKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 388 (422)
++.++.|||+++++|+||||+||+++....+|++|||+++...... .........+|+.|+|||++..+.|+.++||||
T Consensus 478 i~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwS 557 (635)
T 4fl3_A 478 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWS 557 (635)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHH
T ss_pred HHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHH
Confidence 5679999999999999999999999999999999999998653322 222334445678899999999989999999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
|||++|||+++|+.||.+.+..+.
T Consensus 558 lGv~l~ellt~G~~Pf~~~~~~~~ 581 (635)
T 4fl3_A 558 FGVLMWEAFSYGQKPYRGMKGSEV 581 (635)
T ss_dssp HHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999889999999877664
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=2.5e-18 Score=165.15 Aligned_cols=100 Identities=30% Similarity=0.508 Sum_probs=82.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
++.++.|||+++++|+|+||+||+++.+..+|++|||+++...............++..|+|||.+..+.++.++|||||
T Consensus 148 i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 227 (321)
T 2qkw_B 148 AARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSF 227 (321)
T ss_dssp HHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHH
T ss_pred HHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhH
Confidence 56799999999999999999999999999999999999975332222222233345788999999998899999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCch
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQ 410 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~ 410 (422)
||++|||++ |+.||.+....
T Consensus 228 G~il~ell~-g~~p~~~~~~~ 247 (321)
T 2qkw_B 228 GVVLFEVLC-ARSAIVQSLPR 247 (321)
T ss_dssp HHHHHHHHH-CCTTCSCSSSS
T ss_pred HHHHHHHHh-CCCcccccCcH
Confidence 999999997 99999875543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.72 E-value=3.9e-18 Score=161.54 Aligned_cols=99 Identities=25% Similarity=0.510 Sum_probs=79.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCC-CCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK-FTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dvws 388 (422)
...++.|||+++++|+|+||+||+++.+..+|++|||+++...... .......+|..|+|||++.+.. ++.++||||
T Consensus 110 l~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 187 (292)
T 3o0g_A 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS 187 (292)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHH
T ss_pred HHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHH
Confidence 4679999999999999999999999999999999999997543221 2233455688999999987765 899999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
+||++|||++ |..||+...+.+
T Consensus 188 lG~il~~l~~-~~~p~~~~~~~~ 209 (292)
T 3o0g_A 188 AGCIFAELAN-AGRPLFPGNDVD 209 (292)
T ss_dssp HHHHHHHHTT-TSCCSCCCSSHH
T ss_pred HHHHHHHHHH-cCCCCcCCCCHH
Confidence 9999999997 666654434433
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=2.7e-18 Score=164.31 Aligned_cols=102 Identities=25% Similarity=0.441 Sum_probs=78.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcc-eeeccccCCCcccCCccccccCCCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDY-YRIQSKSLLPVRWMPPESILYGKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 388 (422)
...++.|||+++++|+||||+||+++.+..+|++|||+++....... ........++..|+|||++.+..++.++||||
T Consensus 125 i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 204 (311)
T 3ork_A 125 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYS 204 (311)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHH
T ss_pred HHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHH
Confidence 46799999999999999999999999999999999999975433211 11122344688999999999888999999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
|||++|||++ |+.||.+.+..+.
T Consensus 205 lG~~l~~ll~-g~~pf~~~~~~~~ 227 (311)
T 3ork_A 205 LGCVLYEVLT-GEPPFTGDSPVSV 227 (311)
T ss_dssp HHHHHHHHHH-SSCSCCCSSHHHH
T ss_pred HHHHHHHHHh-CCCCCCCCChHHH
Confidence 9999999997 9999998766554
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.72 E-value=3.2e-18 Score=168.14 Aligned_cols=99 Identities=29% Similarity=0.447 Sum_probs=76.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++|+||||+||+++.+..+|++|||+++...... ......++..|+|||++.+..|+.++||||+
T Consensus 136 i~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 212 (371)
T 2xrw_A 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSV 212 (371)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHH
T ss_pred HHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHH
Confidence 4679999999999999999999999999999999999997543221 1233456788999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||++|||++ |+.||.+.+..+.
T Consensus 213 G~il~el~~-g~~pf~~~~~~~~ 234 (371)
T 2xrw_A 213 GCIMGEMIK-GGVLFPGTDHIDQ 234 (371)
T ss_dssp HHHHHHHHH-SSCSSCCSSHHHH
T ss_pred HHHHHHHHh-CCCCCCCCCHHHH
Confidence 999999997 9999998765543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.72 E-value=1.9e-18 Score=177.93 Aligned_cols=103 Identities=46% Similarity=0.861 Sum_probs=87.4
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
++.+|.|||+++++|+||||+|||++.+..+||+|||+++..... .........++..|+|||.+..+.++.++|||||
T Consensus 372 i~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSl 450 (535)
T 2h8h_A 372 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 450 (535)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH-HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC-ceecccCCcCcccccCHHHhccCCCCchhhHHHH
Confidence 567999999999999999999999999999999999999854322 2222334456788999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||+||||++.|+.||.+.++.+..
T Consensus 451 Gv~l~el~t~g~~P~~~~~~~~~~ 474 (535)
T 2h8h_A 451 GILLTELTTKGRVPYPGMVNREVL 474 (535)
T ss_dssp HHHHHHHTTTTCCSSTTCCHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999998899999998776643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.72 E-value=2.8e-18 Score=168.72 Aligned_cols=102 Identities=49% Similarity=0.939 Sum_probs=76.4
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCccee--eccccCCCcccCCccccccCCCCcchhHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYR--IQSKSLLPVRWMPPESILYGKFTTESDVW 387 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 387 (422)
+++++.|||+++++|+||||+||+++.+..+|++|||+++......... ......+|+.|+|||.+..+.++.++|||
T Consensus 201 i~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 280 (373)
T 3c1x_A 201 VAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 280 (373)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHH
Confidence 5789999999999999999999999999999999999998543322111 12334457789999999989999999999
Q ss_pred HHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 388 SYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||||++|||++.|..||.+.+..+
T Consensus 281 SlG~il~ellt~~~~p~~~~~~~~ 304 (373)
T 3c1x_A 281 SFGVLLWELMTRGAPPYPDVNTFD 304 (373)
T ss_dssp HHHHHHHHHHTTSCCSCTTSCSSC
T ss_pred HHHHHHHHHHhCcCCCCCCCCHHH
Confidence 999999999987888998866554
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.72 E-value=3.2e-18 Score=165.44 Aligned_cols=102 Identities=48% Similarity=0.951 Sum_probs=86.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
++.++.|||+++++|+||||+||+++....+|++|||+++...............+++.|+|||++.++.++.++|||||
T Consensus 166 i~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 245 (334)
T 2pvf_A 166 LARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 245 (334)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred HHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHH
Confidence 56799999999999999999999999999999999999986544333333344456778999999988889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||++|||++.|..||.+.+..+
T Consensus 246 G~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 246 GVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp HHHHHHHHTTSCCSSTTCCHHH
T ss_pred HHHHHHHHhCCCCCcCcCCHHH
Confidence 9999999987999999876554
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.72 E-value=2.7e-18 Score=168.91 Aligned_cols=103 Identities=52% Similarity=0.930 Sum_probs=75.4
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcce-eeccccCCCcccCCccccccCCCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYY-RIQSKSLLPVRWMPPESILYGKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 388 (422)
+++++.|||+++++|+||||+||+++.+..+|++|||+++........ .......+++.|+|||++..+.++.++||||
T Consensus 156 i~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~S 235 (373)
T 2qol_A 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWS 235 (373)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHH
T ss_pred HHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHH
Confidence 578999999999999999999999999999999999999854332211 1112233467899999999899999999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
|||++|||+++|+.||.+.+..+.
T Consensus 236 lG~il~ellt~g~~P~~~~~~~~~ 259 (373)
T 2qol_A 236 YGIVLWEVMSYGERPYWEMSNQDV 259 (373)
T ss_dssp HHHHHHHHHTTC-CTTTTCCHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999889999998776553
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.71 E-value=5e-18 Score=160.70 Aligned_cols=99 Identities=25% Similarity=0.350 Sum_probs=81.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccc---cCCcceeecccccccccccCcce-----eeccccCCCcccCCccccccCCCC
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASDYY-----RIQSKSLLPVRWMPPESILYGKFT 381 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~---~~~~~~ki~Dfgls~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~ 381 (422)
+..++.|||+++++|+||||+||++ +.+..+|++|||+++........ .......++..|+|||.+.++.++
T Consensus 114 i~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 193 (296)
T 3uzp_A 114 MISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS 193 (296)
T ss_dssp HHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCC
T ss_pred HHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCC
Confidence 4679999999999999999999999 46778999999999754332211 112344567889999999988899
Q ss_pred cchhHHHHHHHHHHHHhcCCCCCCCCCc
Q psy7289 382 TESDVWSYGVVLWEVYSYGLQPYYGYSN 409 (422)
Q Consensus 382 ~~~Dvws~Gv~l~el~~~g~~p~~~~~~ 409 (422)
.++|||||||++|||++ |+.||.+.+.
T Consensus 194 ~~~Di~slG~il~~l~~-g~~pf~~~~~ 220 (296)
T 3uzp_A 194 RRDDLESLGYVLMYFNL-GSLPWQGLKA 220 (296)
T ss_dssp HHHHHHHHHHHHHHHHH-SSCTTSSCCC
T ss_pred cchhhHHHHHHHHHHHh-CCCCCCCcCc
Confidence 99999999999999997 9999988543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=3.5e-18 Score=176.19 Aligned_cols=95 Identities=28% Similarity=0.493 Sum_probs=82.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++|+||||+||+++..+.+|++|||+++....... .....+|+.|+|||++.++.|+.++|||||
T Consensus 295 Il~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSL 371 (576)
T 2acx_A 295 ICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWAL 371 (576)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHH
T ss_pred HHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHH
Confidence 56799999999999999999999999999999999999986533321 223467899999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCC
Q psy7289 390 GVVLWEVYSYGLQPYYGYS 408 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~ 408 (422)
||++|||++ |..||.+.+
T Consensus 372 GvilyeLlt-G~~PF~~~~ 389 (576)
T 2acx_A 372 GCLLYEMIA-GQSPFQQRK 389 (576)
T ss_dssp HHHHHHHHH-SSCSSSCSS
T ss_pred HHHHHHHHh-CCCCCcccc
Confidence 999999997 999998864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=4.4e-18 Score=162.70 Aligned_cols=103 Identities=46% Similarity=0.961 Sum_probs=79.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++|+|++|+||+++.+..+|++|||+++...............+++.|+|||.+....++.++|||||
T Consensus 156 i~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 235 (313)
T 3brb_A 156 IALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAF 235 (313)
T ss_dssp HHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHH
T ss_pred HHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHH
Confidence 56799999999999999999999999999999999999976543332222333445778999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||++|||++.|..||.+.+..+.
T Consensus 236 G~il~el~~~g~~p~~~~~~~~~ 258 (313)
T 3brb_A 236 GVTMWEIATRGMTPYPGVQNHEM 258 (313)
T ss_dssp HHHHHHHHTTSCCSSTTCCGGGH
T ss_pred HHHHHHHHhcCCCCCccCCHHHH
Confidence 99999999778999988776653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=5.4e-18 Score=163.51 Aligned_cols=99 Identities=30% Similarity=0.517 Sum_probs=82.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCc----ceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchh
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGL----TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESD 385 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~----~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 385 (422)
+..++.|||+++++|+||+|+||+++... .+|++|||+++....... .....+++.|+|||++..+.++.++|
T Consensus 123 i~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~D 199 (326)
T 2y0a_A 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEAD 199 (326)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHH
T ss_pred HHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHH
Confidence 46799999999999999999999997765 799999999975432221 22345678999999998888999999
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 386 VWSYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 386 vws~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||||||++|||++ |..||.+.+..+.
T Consensus 200 iwslG~il~~ll~-g~~pf~~~~~~~~ 225 (326)
T 2y0a_A 200 MWSIGVITYILLS-GASPFLGDTKQET 225 (326)
T ss_dssp HHHHHHHHHHHHH-SCCSSCCSSHHHH
T ss_pred HHHHHHHHHHHHH-CcCCCCCCCHHHH
Confidence 9999999999997 9999988665553
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=5.3e-18 Score=163.20 Aligned_cols=99 Identities=30% Similarity=0.534 Sum_probs=83.7
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++|+|++|+||+++.+..+|++|||+++...... .......++..|+|||++..+.++.++|||||
T Consensus 150 i~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~sl 227 (321)
T 2c30_A 150 VLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSL 227 (321)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred HHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHH
Confidence 4679999999999999999999999999999999999987543321 11233457889999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||++|||++ |+.||.+.+..+
T Consensus 228 G~il~el~~-g~~pf~~~~~~~ 248 (321)
T 2c30_A 228 GIMVIEMVD-GEPPYFSDSPVQ 248 (321)
T ss_dssp HHHHHHHHH-SSCTTTTSCHHH
T ss_pred HHHHHHHHh-CCCCCCCCCHHH
Confidence 999999997 999998865544
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=3.6e-18 Score=165.93 Aligned_cols=99 Identities=20% Similarity=0.251 Sum_probs=81.2
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCc--ceeecccccccccccCcce-----eeccccCCCcccCCccccccCCCCc
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGL--TVKISDFGLSRDVYASDYY-----RIQSKSLLPVRWMPPESILYGKFTT 382 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~--~~ki~Dfgls~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~ 382 (422)
++.++.|||+++++|+||||+||+++.+. .+|++|||+++........ .......++..|+|||++.+..++.
T Consensus 160 i~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 239 (345)
T 2v62_A 160 MLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSR 239 (345)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCH
T ss_pred HHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCc
Confidence 46799999999999999999999998766 8999999999754322111 1113345688999999999888999
Q ss_pred chhHHHHHHHHHHHHhcCCCCCCCCCc
Q psy7289 383 ESDVWSYGVVLWEVYSYGLQPYYGYSN 409 (422)
Q Consensus 383 ~~Dvws~Gv~l~el~~~g~~p~~~~~~ 409 (422)
++|||||||++|||++ |+.||.+...
T Consensus 240 ~~Di~slG~il~ell~-g~~pf~~~~~ 265 (345)
T 2v62_A 240 RSDVEILGYCMLRWLC-GKLPWEQNLK 265 (345)
T ss_dssp HHHHHHHHHHHHHHHH-SSCTTGGGTT
T ss_pred hhhHHHHHHHHHHHHh-CCCCcccccc
Confidence 9999999999999997 9999976433
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.71 E-value=4.3e-18 Score=161.04 Aligned_cols=104 Identities=33% Similarity=0.588 Sum_probs=76.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccc---cCCCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL---YGKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv 386 (422)
...++.|||+++++|+|+||+||+++.+..+|++|||+++...............++..|+|||.+. .+.++.++||
T Consensus 129 i~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di 208 (289)
T 3og7_A 129 TARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDV 208 (289)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHH
T ss_pred HHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccch
Confidence 4679999999999999999999999999999999999987533211111123345678899999886 5568889999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchhhhh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQEEFL 414 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~~~~ 414 (422)
|||||++|||++ |+.||.+..+.+...
T Consensus 209 ~slG~il~el~~-g~~p~~~~~~~~~~~ 235 (289)
T 3og7_A 209 YAFGIVLYELMT-GQLPYSNINNRDQII 235 (289)
T ss_dssp HHHHHHHHHHHH-SSCTTSSCCCHHHHH
T ss_pred HHHHHHHHHHHH-CCCCccccchHHHHH
Confidence 999999999997 999999877766443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=4.6e-18 Score=159.99 Aligned_cols=102 Identities=48% Similarity=0.879 Sum_probs=82.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
...++.+||+++++|+|++|+||+++.+..+|++|||+++........ ......++..|+|||.+..+.++.++|||||
T Consensus 122 i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 200 (281)
T 3cc6_A 122 ICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMF 200 (281)
T ss_dssp HHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHH
Confidence 567999999999999999999999998889999999999754332211 1233445678999999988889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||++|||+++|+.||.+.++.+.
T Consensus 201 G~il~~llt~g~~p~~~~~~~~~ 223 (281)
T 3cc6_A 201 AVCMWEILSFGKQPFFWLENKDV 223 (281)
T ss_dssp HHHHHHHHTTTCCTTTTSCGGGH
T ss_pred HHHHHHHHhCCCCCcccCChHHH
Confidence 99999999779999987666553
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=4.4e-18 Score=163.83 Aligned_cols=98 Identities=27% Similarity=0.513 Sum_probs=82.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccC--CcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGD--GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVW 387 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~--~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 387 (422)
+..++.|||+++++|+||||+||+++. ...+|++|||+++........ ....+++.|+|||++....++.++|||
T Consensus 111 i~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Diw 187 (321)
T 1tki_A 111 VCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQHDVVSTATDMW 187 (321)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE---EEEESCGGGSCHHHHTTCEECHHHHHH
T ss_pred HHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc---ccccCChhhcCcHHhcCCCCCchhhHH
Confidence 467999999999999999999999986 678999999999865433222 223457889999999887789999999
Q ss_pred HHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 388 SYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
|+||++|||++ |..||.+.+..+
T Consensus 188 slG~il~~ll~-g~~pf~~~~~~~ 210 (321)
T 1tki_A 188 SLGTLVYVLLS-GINPFLAETNQQ 210 (321)
T ss_dssp HHHHHHHHHHH-SSCTTCCSSHHH
T ss_pred HHHHHHHHHHh-CCCCCcCCCHHH
Confidence 99999999997 999999866654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=8.8e-18 Score=159.54 Aligned_cols=99 Identities=31% Similarity=0.509 Sum_probs=81.7
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCC---CCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK---FTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv 386 (422)
+..++.|||+++++|+||||+||+++.+..+|++|||+++....... ......+++.|+|||.+.... ++.++||
T Consensus 146 i~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di 223 (298)
T 2zv2_A 146 LIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDV 223 (298)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHH
T ss_pred HHHHHHHHHHCCeeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhh
Confidence 46799999999999999999999999999999999999986433221 223456788999999987654 3678999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
|||||++|||++ |+.||.+....+
T Consensus 224 ~slG~~l~~l~~-g~~pf~~~~~~~ 247 (298)
T 2zv2_A 224 WAMGVTLYCFVF-GQCPFMDERIMC 247 (298)
T ss_dssp HHHHHHHHHHHH-SSCSSCCSSHHH
T ss_pred HhHHHHHHHHHH-CCCCCCCccHHH
Confidence 999999999997 999998765443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.71 E-value=6.6e-18 Score=166.77 Aligned_cols=105 Identities=21% Similarity=0.381 Sum_probs=85.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcce-----eeccccCCCcccCCcccccc--CCCCc
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYY-----RIQSKSLLPVRWMPPESILY--GKFTT 382 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~--~~~~~ 382 (422)
+..++.|||+++++|+||||+||+++....+|++|||++......... .......+++.|+|||++.. ..|+.
T Consensus 137 i~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 216 (389)
T 3gni_B 137 VLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDA 216 (389)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCT
T ss_pred HHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCc
Confidence 467999999999999999999999999999999999998643221111 11223356788999999987 56899
Q ss_pred chhHHHHHHHHHHHHhcCCCCCCCCCchhhhhc
Q psy7289 383 ESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415 (422)
Q Consensus 383 ~~Dvws~Gv~l~el~~~g~~p~~~~~~~~~~~~ 415 (422)
++|||||||++|||++ |+.||.+.+..+...+
T Consensus 217 ~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~ 248 (389)
T 3gni_B 217 KSDIYSVGITACELAN-GHVPFKDMPATQMLLE 248 (389)
T ss_dssp HHHHHHHHHHHHHHHH-SSCTTTTCCSTTHHHH
T ss_pred HhHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHH
Confidence 9999999999999997 9999999877765543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.71 E-value=6.5e-18 Score=164.68 Aligned_cols=95 Identities=25% Similarity=0.515 Sum_probs=79.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCc---ceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGL---TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~---~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 386 (422)
+..++.|||+++++|+||||+||+++... .+|++|||+++...... .......+|+.|+|||++....|+.++||
T Consensus 139 i~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 216 (351)
T 3c0i_A 139 ILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDV 216 (351)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHH
T ss_pred HHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhh
Confidence 46799999999999999999999997544 49999999997643322 12334567889999999998889999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCC
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGY 407 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~ 407 (422)
||+||++|||++ |..||.+.
T Consensus 217 wslG~il~~ll~-g~~pf~~~ 236 (351)
T 3c0i_A 217 WGCGVILFILLS-GCLPFYGT 236 (351)
T ss_dssp HHHHHHHHHHHH-SSCSSCSS
T ss_pred HHHHHHHHHHHH-CCCCCCCc
Confidence 999999999997 99999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=5e-18 Score=158.56 Aligned_cols=104 Identities=49% Similarity=0.947 Sum_probs=87.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
...++.+||+++++|+|++|+||+++.+..+|++|||+++...... ........+++.|+|||.+....++.++||||+
T Consensus 113 i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 191 (268)
T 3sxs_A 113 VCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAF 191 (268)
T ss_dssp HHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHH
T ss_pred HHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh-hhcccCCCcCcccCCHHHHhccCCchhhhhHHH
Confidence 4679999999999999999999999999999999999997543332 222344555678999999988889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEFL 414 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~~ 414 (422)
||++|||++.|..||.+.+..+...
T Consensus 192 G~il~~l~~~g~~p~~~~~~~~~~~ 216 (268)
T 3sxs_A 192 GILMWEVFSLGKMPYDLYTNSEVVL 216 (268)
T ss_dssp HHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred HHHHHHHHcCCCCCccccChHHHHH
Confidence 9999999977999999877766543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=5.8e-18 Score=163.05 Aligned_cols=100 Identities=26% Similarity=0.568 Sum_probs=79.0
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCcccccc-CCCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws 388 (422)
+..++.|||+++++|+|+||+||+++....+|++|||+++...... .......++..|+|||++.+ ..++.++||||
T Consensus 109 i~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 186 (324)
T 3mtl_A 109 LLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWG 186 (324)
T ss_dssp HHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHH
T ss_pred HHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHH
Confidence 4679999999999999999999999999999999999997532221 11233456789999999876 45899999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
+||++|||++ |+.||.+.+..+.
T Consensus 187 lG~il~~l~~-g~~pf~~~~~~~~ 209 (324)
T 3mtl_A 187 VGCIFYEMAT-GRPLFPGSTVEEQ 209 (324)
T ss_dssp HHHHHHHHHH-SSCSCCCSSHHHH
T ss_pred HHHHHHHHHh-CCCCCCCCCHHHH
Confidence 9999999997 9999998765553
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=5e-18 Score=158.70 Aligned_cols=102 Identities=47% Similarity=0.917 Sum_probs=85.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
...++.+||+++++|+|++|+||+++.+..+|++|||+++...... ........+++.|+|||.+..+.++.++||||+
T Consensus 115 i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 193 (269)
T 4hcu_A 115 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 193 (269)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHH
Confidence 4679999999999999999999999999999999999997543322 222334445678999999998899999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||++|||++.|..||.+.+..+.
T Consensus 194 G~~l~~ll~~g~~p~~~~~~~~~ 216 (269)
T 4hcu_A 194 GVLMWEVFSEGKIPYENRSNSEV 216 (269)
T ss_dssp HHHHHHHHTTSCCTTTTCCHHHH
T ss_pred HHHHHHHhcCCCCCCCCCCHHHH
Confidence 99999999779999988766553
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=7.2e-18 Score=165.84 Aligned_cols=99 Identities=28% Similarity=0.519 Sum_probs=82.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccc--cCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLV--GDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVW 387 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~--~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 387 (422)
+.+++.|||+++++|+||||+||++ +....+|++|||+++....... .....+++.|+|||++..+.++.++|||
T Consensus 196 i~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Diw 272 (373)
T 2x4f_A 196 ICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMW 272 (373)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHH
T ss_pred HHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cccccCCCcEeChhhccCCCCCcHHhHH
Confidence 5679999999999999999999998 5567899999999986433221 2234568899999999888899999999
Q ss_pred HHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 388 SYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||||++|||++ |+.||.+.+..+.
T Consensus 273 slG~il~ellt-g~~pf~~~~~~~~ 296 (373)
T 2x4f_A 273 SVGVIAYMLLS-GLSPFLGDNDAET 296 (373)
T ss_dssp HHHHHHHHHHH-SSCTTCCSSHHHH
T ss_pred HHHHHHHHHHh-CCCCCCCCCHHHH
Confidence 99999999997 9999998766543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=8.9e-18 Score=163.36 Aligned_cols=101 Identities=24% Similarity=0.469 Sum_probs=82.5
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCc--ceeeccccCCCcccCCccccccC-CCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD--YYRIQSKSLLPVRWMPPESILYG-KFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv 386 (422)
+..++.|||+++++|+||||+||+++.+..+|++|||+++...... .........+++.|+|||++.+. .++.++||
T Consensus 133 i~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 212 (351)
T 3mi9_A 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDL 212 (351)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHH
T ss_pred HHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHH
Confidence 4679999999999999999999999999999999999997543211 11122344568899999988754 58999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
|||||++|||++ |..||.+.+..+
T Consensus 213 wslG~il~ell~-g~~pf~~~~~~~ 236 (351)
T 3mi9_A 213 WGAGCIMAEMWT-RSPIMQGNTEQH 236 (351)
T ss_dssp HHHHHHHHHHHH-SSCSCCCSSHHH
T ss_pred HHHHHHHHHHHh-CCCCCCCCChHH
Confidence 999999999997 999999866554
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=8.3e-18 Score=163.82 Aligned_cols=96 Identities=32% Similarity=0.563 Sum_probs=81.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccc---cCCCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL---YGKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv 386 (422)
+.+++.|||+++++|+||||+||+++.+..+|++|||+++..... ....+++.|+|||++. .+.++.++||
T Consensus 163 i~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~Di 236 (348)
T 1u5q_A 163 ALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDV 236 (348)
T ss_dssp HHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHH
T ss_pred HHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHH
Confidence 467999999999999999999999999999999999999754221 2345678999999885 5678999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
|||||++|||++ |+.||.+.+..+.
T Consensus 237 wslG~il~ell~-g~~p~~~~~~~~~ 261 (348)
T 1u5q_A 237 WSLGITCIELAE-RKPPLFNMNAMSA 261 (348)
T ss_dssp HHHHHHHHHHHH-SSCTTTTSCHHHH
T ss_pred HHHHHHHHHHHh-CCCCCCCCChHHH
Confidence 999999999997 9999988766553
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=6.5e-18 Score=167.81 Aligned_cols=99 Identities=24% Similarity=0.397 Sum_probs=75.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccc----cCCcceeecccccccccccCc-ceeeccccCCCcccCCccccccC-CCCcc
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLV----GDGLTVKISDFGLSRDVYASD-YYRIQSKSLLPVRWMPPESILYG-KFTTE 383 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~----~~~~~~ki~Dfgls~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~-~~~~~ 383 (422)
+..++.|||+++++|+||||+||++ +....+|++|||+++...... .........+|+.|+|||++.+. .|+.+
T Consensus 137 i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 216 (405)
T 3rgf_A 137 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKA 216 (405)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHH
T ss_pred HHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccch
Confidence 4679999999999999999999999 666789999999997543211 11122345568899999998874 58999
Q ss_pred hhHHHHHHHHHHHHhcCCCCCCCCCc
Q psy7289 384 SDVWSYGVVLWEVYSYGLQPYYGYSN 409 (422)
Q Consensus 384 ~Dvws~Gv~l~el~~~g~~p~~~~~~ 409 (422)
+|||||||++|||++ |+.||.+.+.
T Consensus 217 ~DiwSlG~il~ell~-g~~pf~~~~~ 241 (405)
T 3rgf_A 217 IDIWAIGCIFAELLT-SEPIFHCRQE 241 (405)
T ss_dssp HHHHHHHHHHHHHHH-SSCTTCCCC-
T ss_pred hhhHHHHHHHHHHHh-CCCCCCCccc
Confidence 999999999999997 9999987654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=8.6e-18 Score=163.04 Aligned_cols=96 Identities=26% Similarity=0.494 Sum_probs=82.0
Q ss_pred chhhHHHHhhhhhhhhhcccccccc-------------------cCCcceeecccccccccccCcceeeccccCCCcccC
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLV-------------------GDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM 370 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~-------------------~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~ 370 (422)
+..++.|||+++++|+||||+||++ +....+|++|||+++..... .....+|..|+
T Consensus 132 i~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~ 206 (355)
T 2eu9_A 132 LCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYR 206 (355)
T ss_dssp HHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGC
T ss_pred HHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCccc
Confidence 5679999999999999999999999 55678999999999753221 23345678999
Q ss_pred CccccccCCCCcchhHHHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 371 PPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 371 aPE~~~~~~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
|||++.++.++.++|||||||++|||++ |..||.+.+..+
T Consensus 207 aPE~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~~~~ 246 (355)
T 2eu9_A 207 PPEVILELGWAQPCDVWSIGCILFEYYR-GFTLFQTHENRE 246 (355)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHH
T ss_pred CCeeeecCCCCCccchHHHHHHHHHHHh-CCCCCCCCCHHH
Confidence 9999998899999999999999999997 999999876655
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=8.8e-18 Score=162.72 Aligned_cols=96 Identities=21% Similarity=0.445 Sum_probs=80.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCC-CcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKF-TTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dvws 388 (422)
+..++.|||+++++|+||||+||+++.+..+|++|||+++....... .....+|+.|+|||++....+ +.++||||
T Consensus 139 i~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Diws 215 (335)
T 3dls_A 139 LVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWS 215 (335)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHH
T ss_pred HHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchh
Confidence 46799999999999999999999999999999999999975433221 223456789999999987776 78899999
Q ss_pred HHHHHHHHHhcCCCCCCCCCc
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSN 409 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~ 409 (422)
|||++|||++ |..||.+...
T Consensus 216 lG~il~el~~-g~~pf~~~~~ 235 (335)
T 3dls_A 216 LGVTLYTLVF-EENPFCELEE 235 (335)
T ss_dssp HHHHHHHHHH-SSCSCSSGGG
T ss_pred HHHHHHHHHh-CCCchhhHHH
Confidence 9999999996 9999987444
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.70 E-value=8.6e-18 Score=166.08 Aligned_cols=99 Identities=25% Similarity=0.455 Sum_probs=82.5
Q ss_pred chhhHHHHhhhhhhhhhcccccccccC--CcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGD--GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVW 387 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~--~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 387 (422)
+..++.|||+++++|+||||+||+++. ...+|++|||+++........ ....+|+.|+|||++..+.++.++|||
T Consensus 158 i~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Diw 234 (387)
T 1kob_A 158 ACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDREPVGFYTDMW 234 (387)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE---EEECSSGGGCCHHHHTTCCBCHHHHHH
T ss_pred HHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcce---eeeccCCCccCchhccCCCCCCcccEe
Confidence 467999999999999999999999974 467999999999865433222 223567899999999988899999999
Q ss_pred HHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 388 SYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||||++|||++ |..||.+.+..+.
T Consensus 235 SlG~il~ellt-g~~Pf~~~~~~~~ 258 (387)
T 1kob_A 235 AIGVLGYVLLS-GLSPFAGEDDLET 258 (387)
T ss_dssp HHHHHHHHHHH-SCCSSCCSSHHHH
T ss_pred eHhHHHHHHHh-CCCCCCCCCHHHH
Confidence 99999999997 9999998665443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.70 E-value=9.6e-18 Score=163.03 Aligned_cols=100 Identities=25% Similarity=0.481 Sum_probs=82.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccC-CCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws 388 (422)
+..++.|||+++++|+||||+||+++.+..+|++|||+++...... .......+|..|+|||++.+. .++.++||||
T Consensus 121 i~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 198 (346)
T 1ua2_A 121 TLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWA 198 (346)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHH
T ss_pred HHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHh
Confidence 4679999999999999999999999999999999999997543222 123345568899999998754 4889999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
|||++|||++ |..||.+.+..+.
T Consensus 199 lG~il~ell~-g~~~~~~~~~~~~ 221 (346)
T 1ua2_A 199 VGCILAELLL-RVPFLPGDSDLDQ 221 (346)
T ss_dssp HHHHHHHHHH-SSCSSCCSSHHHH
T ss_pred HHHHHHHHHH-CCCCCCCCCHHHH
Confidence 9999999997 9999988765543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.70 E-value=9.2e-18 Score=165.50 Aligned_cols=99 Identities=25% Similarity=0.440 Sum_probs=82.2
Q ss_pred chhhHHHHhhhhhhhhhccccccccc-CCcceeecccccccccccCcceeeccccCCCcccCCccccccC-CCCcchhHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVG-DGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVW 387 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~-~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvw 387 (422)
+.+++.|||+++++|+||||+||+++ ....+|++|||+++...... ......++..|+|||.+.+. .++.++|||
T Consensus 150 i~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 226 (383)
T 3eb0_A 150 LFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLW 226 (383)
T ss_dssp HHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred HHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence 46799999999999999999999997 57789999999998543322 12234457889999988765 489999999
Q ss_pred HHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 388 SYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
|+||++|||++ |+.||.+.+..+.
T Consensus 227 slG~il~ell~-g~~pf~~~~~~~~ 250 (383)
T 3eb0_A 227 SIGCVFGELIL-GKPLFSGETSIDQ 250 (383)
T ss_dssp HHHHHHHHHHH-SSCSSCCSSHHHH
T ss_pred hHHHHHHHHHh-CCCCCCCCChHHH
Confidence 99999999997 9999999776554
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=9e-18 Score=165.51 Aligned_cols=97 Identities=24% Similarity=0.397 Sum_probs=80.8
Q ss_pred chhhHHHHhh--hhhhhhhccccccccc--CCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchh
Q psy7289 310 VAAGMAYLCS--HHYVHRDLAARNCLVG--DGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESD 385 (422)
Q Consensus 310 ~~r~~~~lh~--~~~i~~dLk~~nil~~--~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 385 (422)
+..++.|||+ .+++|+||||+||+++ ....+|++|||+++..... .....+|+.|+|||++.+..++.++|
T Consensus 166 i~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~D 240 (382)
T 2vx3_A 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAID 240 (382)
T ss_dssp HHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHH
T ss_pred HHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHH
Confidence 4679999994 6899999999999995 4677999999999754221 22345678899999999888999999
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 386 VWSYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 386 vws~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||||||++|||++ |+.||.+.+..+.
T Consensus 241 iwSlG~il~ellt-g~~pf~~~~~~~~ 266 (382)
T 2vx3_A 241 MWSLGCILVEMHT-GEPLFSGANEVDQ 266 (382)
T ss_dssp HHHHHHHHHHHHH-SSCSSCCSSHHHH
T ss_pred HHHHHHHHHHHHh-CCCCCCCCCHHHH
Confidence 9999999999997 9999998766553
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.70 E-value=9.2e-18 Score=170.43 Aligned_cols=99 Identities=24% Similarity=0.357 Sum_probs=83.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccc---cCCcceeecccccccccccCcc-----eeeccccCCCcccCCccccccCCCC
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASDY-----YRIQSKSLLPVRWMPPESILYGKFT 381 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~---~~~~~~ki~Dfgls~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~ 381 (422)
+..++.|||+++++|+||||+|||+ +....+||+|||+++....... +.......++..|+|||.+.+..++
T Consensus 112 i~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s 191 (483)
T 3sv0_A 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQS 191 (483)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC
T ss_pred HHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCC
Confidence 5679999999999999999999999 5778899999999986433221 1112245578899999999988999
Q ss_pred cchhHHHHHHHHHHHHhcCCCCCCCCCc
Q psy7289 382 TESDVWSYGVVLWEVYSYGLQPYYGYSN 409 (422)
Q Consensus 382 ~~~Dvws~Gv~l~el~~~g~~p~~~~~~ 409 (422)
.++|||||||+||||++ |+.||.+...
T Consensus 192 ~~sDvwSlGvil~ellt-G~~Pf~~~~~ 218 (483)
T 3sv0_A 192 RRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (483)
T ss_dssp HHHHHHHHHHHHHHHHH-SSCTTSSCCC
T ss_pred hHHHHHHHHHHHHHHHh-CCCCCccccc
Confidence 99999999999999997 9999998665
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=8.5e-18 Score=165.72 Aligned_cols=95 Identities=23% Similarity=0.378 Sum_probs=80.9
Q ss_pred chhhHHHHhhh-hhhhhhcccccccccCCc-------------------------------------------------c
Q psy7289 310 VAAGMAYLCSH-HYVHRDLAARNCLVGDGL-------------------------------------------------T 339 (422)
Q Consensus 310 ~~r~~~~lh~~-~~i~~dLk~~nil~~~~~-------------------------------------------------~ 339 (422)
++.++.|||++ +++|+||||+||+++.+. .
T Consensus 155 i~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (397)
T 1wak_A 155 VLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLK 234 (397)
T ss_dssp HHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCC
T ss_pred HHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccc
Confidence 56799999998 999999999999998654 7
Q ss_pred eeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHHHHHHHHHHhcCCCCCCCCCch
Q psy7289 340 VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ 410 (422)
Q Consensus 340 ~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~ 410 (422)
+|++|||+++..... .....+|..|+|||++.+..|+.++|||||||++|||++ |+.||.+.+..
T Consensus 235 ~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 299 (397)
T 1wak_A 235 VKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELAT-GDYLFEPHSGE 299 (397)
T ss_dssp EEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHH-SSCSCCCCCCS
T ss_pred eEecccccccccccc-----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhh-CCCCCCCCccc
Confidence 999999999754321 233456889999999998889999999999999999997 99999886643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.70 E-value=1e-17 Score=163.97 Aligned_cols=102 Identities=27% Similarity=0.453 Sum_probs=83.5
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcce-eeccccCCCcccCCccccccC-CCCcchhHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYY-RIQSKSLLPVRWMPPESILYG-KFTTESDVW 387 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvw 387 (422)
+..++.|||+++++|+||||+||+++.+..+|++|||+++........ .......+|..|+|||++..+ .++.++|||
T Consensus 137 i~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw 216 (364)
T 3qyz_A 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 216 (364)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHH
T ss_pred HHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHH
Confidence 467999999999999999999999999999999999999754332211 112334678899999987654 489999999
Q ss_pred HHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 388 SYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
|+||++|||++ |+.||.+.+..+.
T Consensus 217 slG~il~ell~-g~~pf~~~~~~~~ 240 (364)
T 3qyz_A 217 SVGCILAEMLS-NRPIFPGKHYLDQ 240 (364)
T ss_dssp HHHHHHHHHHH-SSCSSCCSSGGGH
T ss_pred HHHHHHHHHHH-CCCCCCCCChHHH
Confidence 99999999997 9999998766554
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.70 E-value=7.4e-18 Score=158.65 Aligned_cols=102 Identities=52% Similarity=1.012 Sum_probs=85.5
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
...++.+||+++++|+|++|+||+++....+|++|||+++...... ........+++.|+|||.+..+.++.++||||+
T Consensus 129 i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 207 (283)
T 3gen_A 129 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 207 (283)
T ss_dssp HHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHH
T ss_pred HHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHH
Confidence 4679999999999999999999999999999999999997543322 222334445678999999998899999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||++|||++.|+.||.+.+..+.
T Consensus 208 G~~l~~l~t~g~~p~~~~~~~~~ 230 (283)
T 3gen_A 208 GVLMWEIYSLGKMPYERFTNSET 230 (283)
T ss_dssp HHHHHHHHTTTCCTTTTSCHHHH
T ss_pred HHHHHHHHhCCCCCccccChhHH
Confidence 99999999779999988776553
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=9.8e-18 Score=163.32 Aligned_cols=98 Identities=29% Similarity=0.505 Sum_probs=75.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccC---CcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGD---GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~---~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 386 (422)
+..++.|||+++++|+|+||+||+++. ...+|++|||+++...... ......+++.|+|||++.+..++.++||
T Consensus 157 i~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di 233 (349)
T 2w4o_A 157 ILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDM 233 (349)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHH
T ss_pred HHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc---ccccccCCCCccCHHHhcCCCCCcccch
Confidence 467999999999999999999999975 7789999999997543221 1233456789999999998889999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
|||||++|||++ |..||.+....+
T Consensus 234 wslG~il~ell~-g~~pf~~~~~~~ 257 (349)
T 2w4o_A 234 WSVGIITYILLC-GFEPFYDERGDQ 257 (349)
T ss_dssp HHHHHHHHHHHH-SSCTTCCTTCHH
T ss_pred HHHHHHHHHHHh-CCCCCCCCcccH
Confidence 999999999996 999998877665
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=9.5e-18 Score=160.59 Aligned_cols=95 Identities=27% Similarity=0.378 Sum_probs=76.7
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
++.++.|||+++++|+|+||+||+++.+..+|++|||+++...... ......+|+.|+|||++. +.++.++|||||
T Consensus 166 i~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Diwsl 241 (311)
T 3p1a_A 166 TLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG---AGEVQEGDPRYMAPELLQ-GSYGTAADVFSL 241 (311)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGG-TCCSTHHHHHHH
T ss_pred HHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC---CCcccCCCccccCHhHhc-CCCCchhhHHHH
Confidence 4679999999999999999999999999999999999987543221 123344688999999876 579999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCc
Q psy7289 390 GVVLWEVYSYGLQPYYGYSN 409 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~ 409 (422)
||++|||++ |..||++...
T Consensus 242 G~il~el~~-g~~~~~~~~~ 260 (311)
T 3p1a_A 242 GLTILEVAC-NMELPHGGEG 260 (311)
T ss_dssp HHHHHHHHH-TCCCCSSHHH
T ss_pred HHHHHHHHh-CCCCCCCccH
Confidence 999999997 7666665433
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.70 E-value=1e-17 Score=163.58 Aligned_cols=98 Identities=23% Similarity=0.419 Sum_probs=79.5
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccC--CCCcchhHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG--KFTTESDVW 387 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dvw 387 (422)
+.+++.|||+++++|+||||+||+++.+..+|++|||+++....... .......+|+.|+|||++..+ .++.++|||
T Consensus 168 i~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dvw 246 (355)
T 1vzo_A 168 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWW 246 (355)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHH
T ss_pred HHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHH
Confidence 56799999999999999999999999999999999999975433221 112234578899999999854 478899999
Q ss_pred HHHHHHHHHHhcCCCCCCCCCc
Q psy7289 388 SYGVVLWEVYSYGLQPYYGYSN 409 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~~~~ 409 (422)
||||++|||++ |+.||.....
T Consensus 247 slG~il~ell~-g~~pf~~~~~ 267 (355)
T 1vzo_A 247 SLGVLMYELLT-GASPFTVDGE 267 (355)
T ss_dssp HHHHHHHHHHH-SSCTTSCTTS
T ss_pred HHHHHHHHHHH-CCCCCccCCc
Confidence 99999999997 9999986543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=1.1e-17 Score=167.75 Aligned_cols=89 Identities=28% Similarity=0.565 Sum_probs=70.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcce--------------------eeccccCCCccc
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYY--------------------RIQSKSLLPVRW 369 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~--------------------~~~~~~~~~~~y 369 (422)
+.+++.|||+++++|+||||+||+++.+..+|++|||+++........ ...+...+|.+|
T Consensus 138 il~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 217 (432)
T 3n9x_A 138 LLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWY 217 (432)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTT
T ss_pred HHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccc
Confidence 467999999999999999999999999999999999999854322111 112445678899
Q ss_pred CCccccc-cCCCCcchhHHHHHHHHHHHHh
Q psy7289 370 MPPESIL-YGKFTTESDVWSYGVVLWEVYS 398 (422)
Q Consensus 370 ~aPE~~~-~~~~~~~~Dvws~Gv~l~el~~ 398 (422)
+|||++. ...|+.++||||+||++|||++
T Consensus 218 ~APE~~~~~~~~~~~~DiwSlG~il~ell~ 247 (432)
T 3n9x_A 218 RAPELILLQENYTKSIDIWSTGCIFAELLN 247 (432)
T ss_dssp CCHHHHTTCSCCCTHHHHHHHHHHHHHHHT
T ss_pred cCHHHHhcCCCCCcccccchHHHHHHHHHh
Confidence 9999864 4569999999999999999995
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=1.3e-17 Score=160.50 Aligned_cols=96 Identities=27% Similarity=0.433 Sum_probs=81.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccC-------------------CcceeecccccccccccCcceeeccccCCCcccC
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGD-------------------GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM 370 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~-------------------~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~ 370 (422)
+..++.|||+++++|+||||+||+++. ...+|++|||+++..... .....+|..|+
T Consensus 127 i~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~ 201 (339)
T 1z57_A 127 ICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYR 201 (339)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGC
T ss_pred HHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc-----cccccCCcccc
Confidence 467999999999999999999999976 557999999999753221 23345678999
Q ss_pred CccccccCCCCcchhHHHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 371 PPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 371 aPE~~~~~~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
|||++....++.++|||||||++|||++ |..||.+.+..+
T Consensus 202 aPE~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~~~~ 241 (339)
T 1z57_A 202 APEVILALGWSQPCDVWSIGCILIEYYL-GFTVFPTHDSKE 241 (339)
T ss_dssp CHHHHTTSCCCTHHHHHHHHHHHHHHHH-SSCSCCCSCHHH
T ss_pred ChHHhhCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHH
Confidence 9999998889999999999999999996 999999876655
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.69 E-value=9.6e-18 Score=157.55 Aligned_cols=102 Identities=45% Similarity=0.860 Sum_probs=85.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
...++.+||+++++|+|++|+||+++....+|++|||+++...... ........++..|+|||.+..+.++.++|||||
T Consensus 118 i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 196 (279)
T 1qpc_A 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 196 (279)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHH
T ss_pred HHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-cccccCCCCccCccChhhhccCCCCchhhhHHH
Confidence 4679999999999999999999999999999999999997543322 222334445678999999988889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||+++||++.|+.||.+.+..+.
T Consensus 197 G~il~el~~~g~~p~~~~~~~~~ 219 (279)
T 1qpc_A 197 GILLTEIVTHGRIPYPGMTNPEV 219 (279)
T ss_dssp HHHHHHHHTTTCCSSTTCCHHHH
T ss_pred HHHHHHHHhCCCCCCcccCHHHH
Confidence 99999999779999998766553
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.3e-17 Score=161.58 Aligned_cols=103 Identities=25% Similarity=0.481 Sum_probs=80.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCc--ceeecccccccccccC--cceeeccccCCCcccCCcccccc--CCCCcc
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGL--TVKISDFGLSRDVYAS--DYYRIQSKSLLPVRWMPPESILY--GKFTTE 383 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~--~~ki~Dfgls~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~ 383 (422)
++.++.|||+++++|+||+|+||+++.+. .+|++|||+++..... ..........+++.|+|||.+.. +.++.+
T Consensus 177 i~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 177 IFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 56799999999999999999999997655 7999999999754321 11112234557889999999875 578999
Q ss_pred hhHHHHHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 384 SDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 384 ~Dvws~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
+|||||||++|||++ |+.||.+.+..+..
T Consensus 257 ~DiwslG~il~el~~-g~~pf~~~~~~~~~ 285 (345)
T 3hko_A 257 CDAWSAGVLLHLLLM-GAVPFPGVNDADTI 285 (345)
T ss_dssp HHHHHHHHHHHHHHH-SSCSSCCSSHHHHH
T ss_pred HHHHHHHHHHHHHHH-CCCCCCCCChHHHH
Confidence 999999999999996 99999987766543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.1e-17 Score=162.91 Aligned_cols=98 Identities=17% Similarity=0.229 Sum_probs=82.0
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCc--ceeecccccccccccCccee-----eccccCCCcccCCccccccCCCCc
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGL--TVKISDFGLSRDVYASDYYR-----IQSKSLLPVRWMPPESILYGKFTT 382 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~--~~ki~Dfgls~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~ 382 (422)
++.++.|||+++++|+||||+||+++.+. .+|++|||+++......... ......+++.|+|||.+.+..++.
T Consensus 168 i~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 247 (352)
T 2jii_A 168 LLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSR 247 (352)
T ss_dssp HHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCH
T ss_pred HHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCc
Confidence 46799999999999999999999999887 89999999997543322110 112335678999999999888999
Q ss_pred chhHHHHHHHHHHHHhcCCCCCCCCC
Q psy7289 383 ESDVWSYGVVLWEVYSYGLQPYYGYS 408 (422)
Q Consensus 383 ~~Dvws~Gv~l~el~~~g~~p~~~~~ 408 (422)
++|||||||++|||++ |+.||.+..
T Consensus 248 ~~Di~slG~il~el~~-g~~pf~~~~ 272 (352)
T 2jii_A 248 RSDLQSLGYCMLKWLY-GFLPWTNCL 272 (352)
T ss_dssp HHHHHHHHHHHHHHHH-SCCTTGGGT
T ss_pred hhhHHHHHHHHHHHHh-CCCCcccCC
Confidence 9999999999999997 999999865
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.2e-17 Score=160.18 Aligned_cols=98 Identities=22% Similarity=0.424 Sum_probs=81.0
Q ss_pred chhhHHHHhhhhhhhhhcccccccc----cCCcceeecccccccccccCcceeeccccCCCcccCCccccc--------c
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLV----GDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL--------Y 377 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~----~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~ 377 (422)
+..++.|||+++++|+||||+||++ +....+|++|||+++....... .....++..|+|||++. .
T Consensus 121 i~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~ 197 (319)
T 4euu_A 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQ 197 (319)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCC
T ss_pred HHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc---eeecccCCCccCHHHhhhcccccccc
Confidence 4679999999999999999999998 7777899999999986433321 22345678999999886 4
Q ss_pred CCCCcchhHHHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 378 GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 378 ~~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
+.++.++|||||||++|||++ |..||......+
T Consensus 198 ~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~ 230 (319)
T 4euu_A 198 KKYGATVDLWSIGVTFYHAAT-GSLPFRPFEGPR 230 (319)
T ss_dssp CCBCTTHHHHHHHHHHHHHHH-SSCSEECTTCGG
T ss_pred CCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCccc
Confidence 678999999999999999997 999998765543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=7.3e-18 Score=159.95 Aligned_cols=100 Identities=30% Similarity=0.458 Sum_probs=80.2
Q ss_pred chhhHHHHh--------hhhhhhhhcccccccccCCcceeecccccccccccCccee--eccccCCCcccCCccccccC-
Q psy7289 310 VAAGMAYLC--------SHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYR--IQSKSLLPVRWMPPESILYG- 378 (422)
Q Consensus 310 ~~r~~~~lh--------~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~- 378 (422)
++.++.||| +++++|+||||+||+++.+..+|++|||+++......... ......+|+.|+|||++..+
T Consensus 114 i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 193 (301)
T 3q4u_A 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETI 193 (301)
T ss_dssp HHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCC
T ss_pred HHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcC
Confidence 567999999 9999999999999999999999999999997543322111 12234678899999999876
Q ss_pred -----CCCcchhHHHHHHHHHHHHhcC----------CCCCCCCCch
Q psy7289 379 -----KFTTESDVWSYGVVLWEVYSYG----------LQPYYGYSNQ 410 (422)
Q Consensus 379 -----~~~~~~Dvws~Gv~l~el~~~g----------~~p~~~~~~~ 410 (422)
.++.++|||||||++|||++ | ..||.+....
T Consensus 194 ~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 194 QVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CTTCHHHHHHHHHHHHHHHHHHHHT-TBCBTTBCCCCCCTTTTTSCS
T ss_pred CCCcccCCchhhHHHHHHHHHHHHh-hhcCccccccccccccccCCC
Confidence 34578999999999999996 7 8899775443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.69 E-value=9.8e-18 Score=158.35 Aligned_cols=102 Identities=49% Similarity=0.875 Sum_probs=85.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcc-eeeccccCCCcccCCccccccCCCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDY-YRIQSKSLLPVRWMPPESILYGKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 388 (422)
...++.+||+++++|+|++|+||+++....+|++|||+++....... ........+++.|+|||.+..+.++.++||||
T Consensus 119 i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 198 (287)
T 1u59_A 119 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWS 198 (287)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHH
T ss_pred HHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHH
Confidence 46799999999999999999999999888999999999986433221 12223344578899999998888999999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
|||++|||+++|+.||.+.+..+
T Consensus 199 lG~il~ellt~g~~p~~~~~~~~ 221 (287)
T 1u59_A 199 YGVTMWEALSYGQKPYKKMKGPE 221 (287)
T ss_dssp HHHHHHHHHTTSCCTTTTCCTHH
T ss_pred HHHHHHHHHcCCCCCcccCCHHH
Confidence 99999999977999998877655
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.6e-17 Score=161.90 Aligned_cols=99 Identities=26% Similarity=0.449 Sum_probs=81.5
Q ss_pred chhhHHHHh--hhhhhhhhcccccccccC-CcceeecccccccccccCcceeeccccCCCcccCCccccccCC-CCcchh
Q psy7289 310 VAAGMAYLC--SHHYVHRDLAARNCLVGD-GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK-FTTESD 385 (422)
Q Consensus 310 ~~r~~~~lh--~~~~i~~dLk~~nil~~~-~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~D 385 (422)
...++.||| +++++|+||||+||+++. +..+|++|||+++...... ......++..|+|||++.... ++.++|
T Consensus 138 i~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~D 214 (360)
T 3e3p_A 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVD 214 (360)
T ss_dssp HHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHH
T ss_pred HHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHH
Confidence 467899999 999999999999999986 7899999999998543322 122345678899999886554 899999
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 386 VWSYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 386 vws~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||||||++|||++ |+.||.+.+..+.
T Consensus 215 i~slG~il~ell~-g~~pf~~~~~~~~ 240 (360)
T 3e3p_A 215 IWSVGCIFAEMML-GEPIFRGDNSAGQ 240 (360)
T ss_dssp HHHHHHHHHHHHH-SSCSSCCSSHHHH
T ss_pred HHHHHHHHHHHHh-CCCCcCCCChHHH
Confidence 9999999999997 9999998665543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.6e-17 Score=158.58 Aligned_cols=100 Identities=34% Similarity=0.562 Sum_probs=81.0
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCccee------------eccccCCCcccCCcccccc
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYR------------IQSKSLLPVRWMPPESILY 377 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~ 377 (422)
.+.++.|||+++++|+||||+||+++.+..+|++|||+++......... ......+|+.|+|||.+.+
T Consensus 117 i~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 196 (310)
T 3s95_A 117 IASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING 196 (310)
T ss_dssp HHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcC
Confidence 5679999999999999999999999999999999999997543221110 0113456888999999998
Q ss_pred CCCCcchhHHHHHHHHHHHHhcCCCCCCCCCch
Q psy7289 378 GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ 410 (422)
Q Consensus 378 ~~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~ 410 (422)
..++.++|||||||++|||++ |..||......
T Consensus 197 ~~~~~~~Di~slG~~l~el~~-g~~~~~~~~~~ 228 (310)
T 3s95_A 197 RSYDEKVDVFSFGIVLCEIIG-RVNADPDYLPR 228 (310)
T ss_dssp CCCCTHHHHHHHHHHHHHHHH-TCCSSTTTSCB
T ss_pred CCCCcHHHHHHHHHHHHHHhc-CCCCCcchhhh
Confidence 889999999999999999996 88998775443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1e-17 Score=161.51 Aligned_cols=97 Identities=26% Similarity=0.472 Sum_probs=62.7
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCc---ceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGL---TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~---~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 386 (422)
+..++.|||+++++|+||||+||+++... .+|++|||+++...... .......+|..|+|||++....|+.++||
T Consensus 115 i~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 192 (325)
T 3kn6_A 115 LVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCFTLHYAAPELLNQNGYDESCDL 192 (325)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------------------------CCCCHHHHH
T ss_pred HHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--CcccccCCCcCccCHHHhcCCCCCCccch
Confidence 46799999999999999999999996544 79999999997533221 11233456789999999998889999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCc
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSN 409 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~ 409 (422)
||+||++|||++ |..||.+.+.
T Consensus 193 wslG~il~~ll~-g~~pf~~~~~ 214 (325)
T 3kn6_A 193 WSLGVILYTMLS-GQVPFQSHDR 214 (325)
T ss_dssp HHHHHHHHHHHH-SSCTTC----
T ss_pred HHHHHHHHHHHh-CCCCCCCCcc
Confidence 999999999997 9999987543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.69 E-value=1.5e-17 Score=160.81 Aligned_cols=103 Identities=53% Similarity=0.940 Sum_probs=79.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcce-eeccccCCCcccCCccccccCCCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYY-RIQSKSLLPVRWMPPESILYGKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 388 (422)
++.++.+||+++++|+||+|+||+++.+..+|++|||+++........ .......++..|+|||.+..+.++.++||||
T Consensus 156 i~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 235 (333)
T 1mqb_A 156 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWS 235 (333)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHH
T ss_pred HHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHH
Confidence 567999999999999999999999999999999999999754332111 1122334467899999999888999999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
|||++|||++.|+.||.+.+..+.
T Consensus 236 lG~il~ellt~g~~pf~~~~~~~~ 259 (333)
T 1mqb_A 236 FGIVMWEVMTYGERPYWELSNHEV 259 (333)
T ss_dssp HHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred HHHHHHHHHcCCCCCcccCCHHHH
Confidence 999999999889999988766553
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.8e-17 Score=162.68 Aligned_cols=97 Identities=30% Similarity=0.512 Sum_probs=79.7
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCcccccc-CCCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws 388 (422)
+..++.|||+++++|+|+||+||+++.+..+|++|||+++..... .....++..|+|||.+.. ..++.++||||
T Consensus 153 i~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 227 (371)
T 4exu_A 153 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWS 227 (371)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHH
T ss_pred HHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHH
Confidence 467999999999999999999999999999999999999753221 233456788999999886 57899999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
|||++|||++ |+.||.+.+..+.
T Consensus 228 lG~il~el~~-g~~pf~~~~~~~~ 250 (371)
T 4exu_A 228 VGCIMAEMLT-GKTLFKGKDYLDQ 250 (371)
T ss_dssp HHHHHHHHHH-SSCSCCCSSHHHH
T ss_pred HHHHHHHHHh-CCCCCCCCChHHH
Confidence 9999999997 9999998765543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.1e-17 Score=163.79 Aligned_cols=98 Identities=28% Similarity=0.509 Sum_probs=71.4
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcc--eeecccccccccccCcceeeccccCCCcccCCccccccCCCCcc-hhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLT--VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTE-SDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~--~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv 386 (422)
..+++.|||+++++|+||||+||+++.... +|++|||+++...... ......+|+.|+|||++.++.++.+ +||
T Consensus 125 l~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 201 (361)
T 3uc3_A 125 LLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADV 201 (361)
T ss_dssp HHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHH
T ss_pred HHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeee
Confidence 467999999999999999999999976654 9999999997432211 1233457889999999988887765 899
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||+||++|||++ |+.||.+.+..+
T Consensus 202 wslG~il~ell~-g~~Pf~~~~~~~ 225 (361)
T 3uc3_A 202 WSCGVTLYVMLV-GAYPFEDPEEPR 225 (361)
T ss_dssp HHHHHHHHHHHH-SSCSCC----CC
T ss_pred ehhHHHHHHHHh-CCCCCCCCccHH
Confidence 999999999997 999998866544
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.69 E-value=2.3e-17 Score=158.43 Aligned_cols=98 Identities=30% Similarity=0.531 Sum_probs=83.5
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++|+|++|+||+++....+|++|||+++...... ......++..|+|||.+..+.++.++|||||
T Consensus 129 i~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 205 (326)
T 1blx_A 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSV 205 (326)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHH
T ss_pred HHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHH
Confidence 5679999999999999999999999999999999999997543221 1233456788999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||++|||++ |+.||.+.+..+
T Consensus 206 G~il~~l~~-g~~pf~~~~~~~ 226 (326)
T 1blx_A 206 GCIFAEMFR-RKPLFRGSSDVD 226 (326)
T ss_dssp HHHHHHHHH-SSCSCCCSSHHH
T ss_pred HHHHHHHHc-CCCCCCCCCHHH
Confidence 999999996 999998866554
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.68 E-value=2.1e-17 Score=154.78 Aligned_cols=100 Identities=31% Similarity=0.485 Sum_probs=82.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCC-CcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKF-TTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dvws 388 (422)
...++.+||+++++|+|++|+||+++.+..+|++|||++................++..|+|||.+....+ +.++||||
T Consensus 114 i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 193 (276)
T 2yex_A 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 193 (276)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHH
T ss_pred HHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHH
Confidence 46799999999999999999999999989999999999975433222222334556788999999987665 67899999
Q ss_pred HHHHHHHHHhcCCCCCCCCCch
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQ 410 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~ 410 (422)
|||++|||++ |..||.+.+..
T Consensus 194 lG~il~~l~~-g~~p~~~~~~~ 214 (276)
T 2yex_A 194 CGIVLTAMLA-GELPWDQPSDS 214 (276)
T ss_dssp HHHHHHHHHH-SSCCCSCSCTT
T ss_pred HHHHHHHHHh-CCCCCCCCchH
Confidence 9999999997 99999886654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.68 E-value=6.6e-18 Score=164.12 Aligned_cols=95 Identities=26% Similarity=0.551 Sum_probs=78.2
Q ss_pred chhhHHHHhhhhhhhhhcccccccccC----CcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchh
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGD----GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESD 385 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~----~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 385 (422)
+..++.|||+++++|+||||+||++.. ...+|++|||+++...... .......+++.|+|||++....|+.++|
T Consensus 125 i~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~D 202 (342)
T 2qr7_A 125 ITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACD 202 (342)
T ss_dssp HHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC--CceeccCCCccccCHHHhcCCCCCCccC
Confidence 467999999999999999999999733 2469999999998543322 1223455688999999998777899999
Q ss_pred HHHHHHHHHHHHhcCCCCCCCC
Q psy7289 386 VWSYGVVLWEVYSYGLQPYYGY 407 (422)
Q Consensus 386 vws~Gv~l~el~~~g~~p~~~~ 407 (422)
||||||++|||++ |..||.+.
T Consensus 203 iwslG~il~ell~-g~~Pf~~~ 223 (342)
T 2qr7_A 203 IWSLGVLLYTMLT-GYTPFANG 223 (342)
T ss_dssp HHHHHHHHHHHHH-SSCSSCSS
T ss_pred eeeHhHHHHHHhc-CCCCCCCC
Confidence 9999999999997 99999874
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=1.1e-17 Score=161.43 Aligned_cols=101 Identities=27% Similarity=0.490 Sum_probs=77.4
Q ss_pred chhhHHHHhhhhhhhhhccccccccc-----CCcceeecccccccccccCcceeeccccCCCcccCCccccccC-CCCcc
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVG-----DGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTE 383 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~-----~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~ 383 (422)
+..++.|||+++++|+||||+||+++ ....+|++|||+++...... .......++..|+|||++... .++.+
T Consensus 141 l~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~ 218 (329)
T 3gbz_A 141 LINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTS 218 (329)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTH
T ss_pred HHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcH
Confidence 46799999999999999999999994 44569999999997542211 112334557889999998865 48999
Q ss_pred hhHHHHHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 384 SDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 384 ~Dvws~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
+|||||||++|||++ |..||.+.+..+..
T Consensus 219 ~DiwslG~il~ell~-g~~pf~~~~~~~~~ 247 (329)
T 3gbz_A 219 VDIWSIACIWAEMLM-KTPLFPGDSEIDQL 247 (329)
T ss_dssp HHHHHHHHHHHHHHH-SSCSSCCSSHHHHH
T ss_pred HHHHHHHHHHHHHHH-CCCCcCCCCHHHHH
Confidence 999999999999997 99999987766544
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.68 E-value=1.8e-17 Score=157.19 Aligned_cols=102 Identities=52% Similarity=0.994 Sum_probs=82.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcce--eeccccCCCcccCCccccccCCCCcchhHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYY--RIQSKSLLPVRWMPPESILYGKFTTESDVW 387 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 387 (422)
...++.+||+++++|+|+||+||+++.+..+|++|||+++........ .......+|+.|+|||.+....++.++|||
T Consensus 137 l~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 216 (298)
T 3f66_A 137 VAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 216 (298)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHH
Confidence 567999999999999999999999999999999999999854332221 122334456789999999988999999999
Q ss_pred HHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 388 SYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
|+||++|||++.|..||.+.+..+
T Consensus 217 slG~il~~l~~~~~~~~~~~~~~~ 240 (298)
T 3f66_A 217 SFGVLLWELMTRGAPPYPDVNTFD 240 (298)
T ss_dssp HHHHHHHHHHTTSCCSSTTSCTTT
T ss_pred HHHHHHHHHHhCCCCCCccCCHHH
Confidence 999999999986777887765554
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.68 E-value=1.8e-17 Score=156.32 Aligned_cols=101 Identities=46% Similarity=0.980 Sum_probs=85.0
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
...++.+||+++++|+|++|+||+++.+..+|++|||+++...... ........++..|+|||.+..+.++.++||||+
T Consensus 120 i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 198 (288)
T 3kfa_A 120 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 198 (288)
T ss_dssp HHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHH
Confidence 4679999999999999999999999999999999999997543322 222333445678999999998899999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||++|||++.|..||.+.+..+
T Consensus 199 G~il~~ll~~g~~p~~~~~~~~ 220 (288)
T 3kfa_A 199 GVLLWEIATYGMSPYPGIDLSQ 220 (288)
T ss_dssp HHHHHHHHTTSCCSSTTCCGGG
T ss_pred HHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999977999998866554
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=1e-17 Score=161.32 Aligned_cols=102 Identities=52% Similarity=1.081 Sum_probs=82.1
Q ss_pred chhhHHHHhhhhhhhhhccccccccc---CCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVG---DGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~---~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 386 (422)
+..++.|||+++++|+||+|+||+++ .+..+|++|||+++...............+++.|+|||.+..+.++.++||
T Consensus 149 i~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 228 (327)
T 2yfx_A 149 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 228 (327)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhH
Confidence 56799999999999999999999997 455699999999975433332222334455788999999998899999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
|||||++|||++.|..||.+.+..+
T Consensus 229 ~slG~il~ellt~g~~p~~~~~~~~ 253 (327)
T 2yfx_A 229 WSFGVLLWEIFSLGYMPYPSKSNQE 253 (327)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred HHHHHHHHHHHcCCCCCCCCcCHHH
Confidence 9999999999977999998866554
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.68 E-value=2.1e-17 Score=167.53 Aligned_cols=99 Identities=30% Similarity=0.496 Sum_probs=83.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCC-CcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKF-TTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dvws 388 (422)
+..++.|||+++++|+||||+||+++.+..+|++|||+++...... ......+++.|+|||++.+..+ +.++||||
T Consensus 125 i~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS 201 (476)
T 2y94_A 125 ILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWS 201 (476)
T ss_dssp HHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHH
T ss_pred HHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehh
Confidence 5679999999999999999999999999999999999998643322 1234457889999999987765 67999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
+||++|||++ |..||.+.+..+.
T Consensus 202 lGvil~ellt-G~~Pf~~~~~~~~ 224 (476)
T 2y94_A 202 SGVILYALLC-GTLPFDDDHVPTL 224 (476)
T ss_dssp HHHHHHHHHH-SSCSSCCSSSHHH
T ss_pred hHHHHHHHhh-CCCCCCCCCHHHH
Confidence 9999999997 9999988665543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.7e-17 Score=158.28 Aligned_cols=100 Identities=23% Similarity=0.457 Sum_probs=78.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCcccccc-CCCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws 388 (422)
...++.|||+++++|+|++|+||+++....+|++|||+++...... .......++..|+|||.+.+ ..++.++||||
T Consensus 111 l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 188 (311)
T 4agu_A 111 TLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWA 188 (311)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHH
T ss_pred HHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc--cccCCCcCCccccChHHHhcCCCCCcchhhHH
Confidence 4679999999999999999999999999999999999997543221 11233456788999999875 56899999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
+||++|||++ |..||.+.+..+.
T Consensus 189 lG~il~~l~~-g~~p~~~~~~~~~ 211 (311)
T 4agu_A 189 IGCVFAELLS-GVPLWPGKSDVDQ 211 (311)
T ss_dssp HHHHHHHHHH-SSCSCCCSSHHHH
T ss_pred HHHHHHHHHh-CCCCCCCCCHHHH
Confidence 9999999997 9999998776554
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=2.2e-17 Score=159.35 Aligned_cols=100 Identities=27% Similarity=0.537 Sum_probs=79.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccC-CCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws 388 (422)
...++.+||+++++|+||+|+||+++.+..+|++|||+++...... .......++..|+|||.+.+. .++.++||||
T Consensus 133 i~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~s 210 (331)
T 4aaa_A 133 IINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWA 210 (331)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHH
T ss_pred HHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc--cccCCCcCCccccCcccccCCCCcchHHHHHH
Confidence 4679999999999999999999999999999999999997543221 122334567889999998765 6899999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
+||++|||++ |+.||.+.+..+.
T Consensus 211 lG~il~~l~~-g~~pf~~~~~~~~ 233 (331)
T 4aaa_A 211 IGCLVTEMFM-GEPLFPGDSDIDQ 233 (331)
T ss_dssp HHHHHHHHHH-SSCSCCCSSHHHH
T ss_pred HHHHHHHHHh-CCCCCCCCCcHHH
Confidence 9999999997 9999998776553
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=2e-17 Score=159.50 Aligned_cols=100 Identities=29% Similarity=0.540 Sum_probs=81.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccC---CcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGD---GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~---~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 386 (422)
...++.|||+++++|+|++|+||+++. ...+|++|||+++...... ......+++.|+|||++..+.++.++||
T Consensus 140 l~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di 216 (327)
T 3lm5_A 140 ILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDM 216 (327)
T ss_dssp HHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHH
T ss_pred HHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhH
Confidence 467999999999999999999999987 6789999999998543221 1223456789999999998889999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
|||||++|||++ |..||.+.+..+.+
T Consensus 217 wslG~il~~ll~-g~~pf~~~~~~~~~ 242 (327)
T 3lm5_A 217 WNIGIIAYMLLT-HTSPFVGEDNQETY 242 (327)
T ss_dssp HHHHHHHHHHHH-SSCSSCCSSHHHHH
T ss_pred HHHHHHHHHHHh-CCCCCCCCCchHHH
Confidence 999999999997 99999997776644
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.68 E-value=2.7e-17 Score=158.00 Aligned_cols=99 Identities=28% Similarity=0.520 Sum_probs=82.7
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCc----ceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchh
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGL----TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESD 385 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~----~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 385 (422)
...++.|||+++++|+|++|+||+++... .+|++|||+++....... .....+++.|+|||.+..+.++.++|
T Consensus 124 i~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~D 200 (321)
T 2a2a_A 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEAD 200 (321)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHH
T ss_pred HHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccc
Confidence 46799999999999999999999998766 799999999975433211 22344678999999998888999999
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 386 VWSYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 386 vws~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||||||++|||++ |..||.+.+..+.
T Consensus 201 i~slG~il~~l~~-g~~pf~~~~~~~~ 226 (321)
T 2a2a_A 201 MWSIGVITYILLS-GASPFLGDTKQET 226 (321)
T ss_dssp HHHHHHHHHHHHH-SCCSSCCSSHHHH
T ss_pred cHHHHHHHHHHHH-CCCCCCCCCHHHH
Confidence 9999999999997 9999988665543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=1.1e-17 Score=158.19 Aligned_cols=102 Identities=50% Similarity=0.929 Sum_probs=83.5
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcc-eeeccccCCCcccCCccccccCCCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDY-YRIQSKSLLPVRWMPPESILYGKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 388 (422)
.+.++.+||+++++|+|++|+||+++.+..+|++|||+++....... ........+++.|+|||.+....++.++||||
T Consensus 126 i~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 205 (291)
T 1xbb_A 126 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWS 205 (291)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHH
T ss_pred HHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHH
Confidence 46799999999999999999999999889999999999975433222 22223344567899999998888999999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
|||++|||++.|..||.+.+..+
T Consensus 206 lG~il~~l~~~g~~p~~~~~~~~ 228 (291)
T 1xbb_A 206 FGVLMWEAFSYGQKPYRGMKGSE 228 (291)
T ss_dssp HHHHHHHHHTTTCCSSTTCCHHH
T ss_pred HHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999977999999876654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=2.3e-17 Score=165.55 Aligned_cols=102 Identities=30% Similarity=0.478 Sum_probs=77.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCC-------------cceeecccccccccccCcce--eeccccCCCcccCCccc
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDG-------------LTVKISDFGLSRDVYASDYY--RIQSKSLLPVRWMPPES 374 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~-------------~~~ki~Dfgls~~~~~~~~~--~~~~~~~~~~~y~aPE~ 374 (422)
++.++.|||+++++|+||||+||+++.. ..+|++|||+++........ .......+|+.|+|||+
T Consensus 124 i~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 203 (434)
T 2rio_A 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPEL 203 (434)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHH
T ss_pred HHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHH
Confidence 5679999999999999999999999643 47999999999864332111 11223457889999999
Q ss_pred ccc-------CCCCcchhHHHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 375 ILY-------GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 375 ~~~-------~~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
+.. +.++.++|||||||++|||++.|..||.+....+
T Consensus 204 ~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 204 LEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp HSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred hccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 875 5689999999999999999977999997755443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=2.1e-17 Score=160.62 Aligned_cols=101 Identities=26% Similarity=0.406 Sum_probs=80.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCccee--------eccccCCCcccCCcccccc-CCC
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYR--------IQSKSLLPVRWMPPESILY-GKF 380 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~ 380 (422)
+..++.|||+++++|+||+|+||+++.+..+|++|||+++......... ......++..|+|||++.. +.+
T Consensus 121 i~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 200 (353)
T 2b9h_A 121 TLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKY 200 (353)
T ss_dssp HHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCC
T ss_pred HHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCc
Confidence 4679999999999999999999999999999999999997543211110 1122356788999998765 568
Q ss_pred CcchhHHHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 381 TTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 381 ~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
+.++|||||||++|||++ |+.||.+.+..+
T Consensus 201 ~~~~Di~slG~il~~l~~-g~~pf~~~~~~~ 230 (353)
T 2b9h_A 201 SRAMDVWSCGCILAELFL-RRPIFPGRDYRH 230 (353)
T ss_dssp CHHHHHHHHHHHHHHHHH-SSCSCCCSSHHH
T ss_pred cchhhHHHHHHHHHHHHh-CCCCCCCCCcHH
Confidence 999999999999999996 999999876544
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.68 E-value=3.7e-17 Score=154.85 Aligned_cols=101 Identities=49% Similarity=0.946 Sum_probs=80.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcce--eeccccCCCcccCCccccccCCCCcchhHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYY--RIQSKSLLPVRWMPPESILYGKFTTESDVW 387 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 387 (422)
...++.|||+++++|+|+||+||+++.+..+|++|||+++........ .......++..|+|||.+....++.++|||
T Consensus 133 i~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 212 (298)
T 3pls_A 133 VARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVW 212 (298)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHH
T ss_pred HHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchh
Confidence 567999999999999999999999999999999999999754332211 112334457789999999988899999999
Q ss_pred HHHHHHHHHHhcCCCCCCCCCch
Q psy7289 388 SYGVVLWEVYSYGLQPYYGYSNQ 410 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~~~~~ 410 (422)
||||++|||++.|..||.+.+..
T Consensus 213 slG~il~~l~~g~~~~~~~~~~~ 235 (298)
T 3pls_A 213 SFGVLLWELLTRGAPPYRHIDPF 235 (298)
T ss_dssp HHHHHHHHHHHTSCCTTTTSCGG
T ss_pred hHHHHHHHHhhCCCCCCccCCHH
Confidence 99999999998555555554433
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=1.5e-17 Score=175.07 Aligned_cols=102 Identities=48% Similarity=0.908 Sum_probs=83.2
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
++.++.|||+++++|+||||+||+++.+..+|++|||+++........ ......+|+.|+|||.+..+.++.++|||||
T Consensus 500 i~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 578 (656)
T 2j0j_A 500 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMF 578 (656)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHH
Confidence 567999999999999999999999999999999999999865333222 2233445678999999998899999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||++|||++.|..||.+.+..+.
T Consensus 579 G~il~ellt~g~~Pf~~~~~~~~ 601 (656)
T 2j0j_A 579 GVCMWEILMHGVKPFQGVKNNDV 601 (656)
T ss_dssp HHHHHHHHTTSCCTTTTCCHHHH
T ss_pred HHHHHHHHHcCCCCCCCCCHHHH
Confidence 99999999779999998776654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=1.9e-17 Score=154.31 Aligned_cols=101 Identities=48% Similarity=0.932 Sum_probs=84.2
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
...++.+||+++++|+|++|+||+++.+..+|++|||+++...... ........++..|+|||.+..+.++.++||||+
T Consensus 113 i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 191 (267)
T 3t9t_A 113 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 191 (267)
T ss_dssp HHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc-ccccccccccccccChhhhcCCCccchhchhhh
Confidence 4679999999999999999999999999999999999997543221 222234445678999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||++|||++.|..||.+.+..+
T Consensus 192 G~il~~l~~~g~~p~~~~~~~~ 213 (267)
T 3t9t_A 192 GVLMWEVFSEGKIPYENRSNSE 213 (267)
T ss_dssp HHHHHHHHTTSCCTTTTCCHHH
T ss_pred HHHHHHHhccCCCCCCCCCHHH
Confidence 9999999976899998866554
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=1.4e-17 Score=160.28 Aligned_cols=100 Identities=54% Similarity=0.929 Sum_probs=82.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.+||+++++|+||+|+||+++.+..+|++|||+++.... ........++..|+|||.+....++.++|||||
T Consensus 151 i~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 227 (327)
T 1fvr_A 151 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 227 (327)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHH
T ss_pred HHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHH
Confidence 46799999999999999999999999999999999999874221 111223345678999999988889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||++|||++.|+.||.+.+..+.
T Consensus 228 G~il~ellt~g~~pf~~~~~~~~ 250 (327)
T 1fvr_A 228 GVLLWEIVSLGGTPYCGMTCAEL 250 (327)
T ss_dssp HHHHHHHHTTSCCTTTTCCHHHH
T ss_pred HHHHHHHHcCCCCCCCCCcHHHH
Confidence 99999999779999998766553
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=2.3e-17 Score=157.09 Aligned_cols=100 Identities=34% Similarity=0.582 Sum_probs=82.2
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
.+.++.|||+++++|+||+|+||+++.+..+|++|||+++...............++..|+|||.+. +.++.++|||||
T Consensus 142 i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~Dv~sl 220 (307)
T 2nru_A 142 AANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSF 220 (307)
T ss_dssp HHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT-TEECTHHHHHHH
T ss_pred HHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhc-CCCCccchhHHH
Confidence 4679999999999999999999999999999999999987543322222233445688999999775 568999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||++|||++ |..||.+....+
T Consensus 221 G~il~~l~~-g~~p~~~~~~~~ 241 (307)
T 2nru_A 221 GVVLLEIIT-GLPAVDEHREPQ 241 (307)
T ss_dssp HHHHHHHHH-CCCSBCTTBSSS
T ss_pred HHHHHHHHH-CCCCcccCcchH
Confidence 999999997 999998865543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=2.7e-17 Score=154.53 Aligned_cols=97 Identities=46% Similarity=0.906 Sum_probs=78.2
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
.+.++.+||+++++|+|++|+||+++.+..+|++|||+++..... .....++..|+|||.+..+.++.++|||||
T Consensus 126 i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 200 (278)
T 1byg_A 126 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSF 200 (278)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHH
Confidence 467999999999999999999999999899999999998753221 122345678999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||++|||++.|+.||.+.+..+
T Consensus 201 G~il~~l~t~g~~p~~~~~~~~ 222 (278)
T 1byg_A 201 GILLWEIYSFGRVPYPRIPLKD 222 (278)
T ss_dssp HHHHHHHHTTSCCSCTTSCGGG
T ss_pred HHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999987999998866554
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.67 E-value=3.7e-17 Score=157.38 Aligned_cols=97 Identities=18% Similarity=0.346 Sum_probs=79.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCc-ceeecccccccccccCcceeeccccCCCcccCCcccccc-CCCCcchhHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGL-TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVW 387 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~-~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvw 387 (422)
+..++.|||+++++|+||||+||+++... .+|++|||+++....... .....++..|+|||.+.. +.++.++|||
T Consensus 139 i~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Diw 215 (330)
T 3nsz_A 139 ILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMW 215 (330)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHH
T ss_pred HHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHH
Confidence 46799999999999999999999998655 899999999975433221 233456788999999876 5689999999
Q ss_pred HHHHHHHHHHhcCCCCCCCCCch
Q psy7289 388 SYGVVLWEVYSYGLQPYYGYSNQ 410 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~~~~~ 410 (422)
||||++|||++ |+.||....+.
T Consensus 216 slG~il~~ll~-g~~p~~~~~~~ 237 (330)
T 3nsz_A 216 SLGCMLASMIF-RKEPFFHGHDN 237 (330)
T ss_dssp HHHHHHHHHHH-TCSSSSCCSSH
T ss_pred HHHHHHHHHHh-CCCCcccCCch
Confidence 99999999997 99999665444
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.67 E-value=1.4e-17 Score=157.27 Aligned_cols=103 Identities=44% Similarity=0.826 Sum_probs=83.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcc-eeeccccCCCcccCCccccccCCCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDY-YRIQSKSLLPVRWMPPESILYGKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 388 (422)
...++.+||+++++|+|++|+||+++.+..+|++|||+++....... ........++..|+|||.+....++.++||||
T Consensus 130 i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 209 (291)
T 1u46_A 130 VAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWM 209 (291)
T ss_dssp HHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHH
T ss_pred HHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHH
Confidence 56799999999999999999999999888999999999976533222 22233445567899999998888999999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
|||++|||++.|+.||.+.+..+.
T Consensus 210 lG~il~~l~~~g~~p~~~~~~~~~ 233 (291)
T 1u46_A 210 FGVTLWEMFTYGQEPWIGLNGSQI 233 (291)
T ss_dssp HHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred HHHHHHHHHhCCCCCcccCCHHHH
Confidence 999999999779999998766553
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=3.3e-17 Score=164.23 Aligned_cols=102 Identities=29% Similarity=0.441 Sum_probs=76.0
Q ss_pred chhhHHHHhhhhhhhhhccccccccc-----CCcceeecccccccccccCc-ceeeccccCCCcccCCccccc---cCCC
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVG-----DGLTVKISDFGLSRDVYASD-YYRIQSKSLLPVRWMPPESIL---YGKF 380 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~-----~~~~~ki~Dfgls~~~~~~~-~~~~~~~~~~~~~y~aPE~~~---~~~~ 380 (422)
+..++.|||+++++|+||||+||+++ ....+|++|||+++...... .........+|+.|+|||++. ...+
T Consensus 127 i~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~ 206 (432)
T 3p23_A 127 TTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENP 206 (432)
T ss_dssp HHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CC
T ss_pred HHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCC
Confidence 56799999999999999999999994 23457899999998643221 112233456789999999997 3567
Q ss_pred CcchhHHHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 381 TTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 381 ~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
+.++|||||||++|||++.|..||......+
T Consensus 207 t~~~DiwSlG~il~ellt~g~~pf~~~~~~~ 237 (432)
T 3p23_A 207 TYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ 237 (432)
T ss_dssp CTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH
T ss_pred CcHHHHHHHHHHHHHHHcCCCCCcchhhHHH
Confidence 8899999999999999977999996654443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.67 E-value=3.5e-17 Score=153.80 Aligned_cols=98 Identities=31% Similarity=0.520 Sum_probs=80.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
...++.|||+++++|+|++|+||+++.+..+|++|||++....... .....++..|+|||.+.+..++.++||||+
T Consensus 118 i~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 193 (279)
T 3fdn_A 118 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSL 193 (279)
T ss_dssp HHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHH
T ss_pred HHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhH
Confidence 4679999999999999999999999999999999999986432221 223456788999999988889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||++|||++ |..||.+.+..+.
T Consensus 194 G~il~~l~~-g~~p~~~~~~~~~ 215 (279)
T 3fdn_A 194 GVLCYEFLV-GKPPFEANTYQET 215 (279)
T ss_dssp HHHHHHHHH-SSCTTCCSSHHHH
T ss_pred HHHHHHHHH-CCCCCCCCcHHHH
Confidence 999999997 9999988665554
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=3.5e-17 Score=159.36 Aligned_cols=96 Identities=30% Similarity=0.512 Sum_probs=79.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCcccccc-CCCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws 388 (422)
+..++.|||+++++|+||+|+||+++.+..+|++|||+++..... .....++..|+|||.+.. ..++.++||||
T Consensus 135 i~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~s 209 (353)
T 3coi_A 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWS 209 (353)
T ss_dssp HHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHH
T ss_pred HHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHH
Confidence 467999999999999999999999999999999999999753221 223456788999998876 57899999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
|||++|||++ |+.||.+.+..+
T Consensus 210 lG~il~el~~-g~~pf~~~~~~~ 231 (353)
T 3coi_A 210 VGCIMAEMLT-GKTLFKGKDYLD 231 (353)
T ss_dssp HHHHHHHHHH-SSCSSBSSCHHH
T ss_pred HHHHHHHHHh-CCCCCCCCCHHH
Confidence 9999999997 999999866543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=1.9e-17 Score=159.27 Aligned_cols=94 Identities=31% Similarity=0.560 Sum_probs=80.3
Q ss_pred chhhHHHHhhh---hhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhH
Q psy7289 310 VAAGMAYLCSH---HYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~---~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 386 (422)
.+.++.|||++ +++|+||||+||+++.+..+|++|||+++....... .......++..|+|||.+..+.++.++||
T Consensus 140 i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 218 (326)
T 3uim_A 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDV 218 (326)
T ss_dssp HHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHH
T ss_pred HHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccc
Confidence 46799999999 999999999999999999999999999975432221 22333447889999999988889999999
Q ss_pred HHHHHHHHHHHhcCCCCCC
Q psy7289 387 WSYGVVLWEVYSYGLQPYY 405 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~ 405 (422)
|||||++|||++ |+.||.
T Consensus 219 ~slG~il~~l~~-g~~pf~ 236 (326)
T 3uim_A 219 FGYGVMLLELIT-GQRAFD 236 (326)
T ss_dssp HHHHHHHHHHHH-CCCSBC
T ss_pred hhHHHHHHHHHh-CCCccc
Confidence 999999999997 999995
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=4.6e-17 Score=153.54 Aligned_cols=97 Identities=32% Similarity=0.568 Sum_probs=79.3
Q ss_pred chhhHHHHhhhh--hhhhhcccccccccCCcc-----eeecccccccccccCcceeeccccCCCcccCCccccc--cCCC
Q psy7289 310 VAAGMAYLCSHH--YVHRDLAARNCLVGDGLT-----VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL--YGKF 380 (422)
Q Consensus 310 ~~r~~~~lh~~~--~i~~dLk~~nil~~~~~~-----~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~ 380 (422)
...++.|||+++ ++|+|+||+||+++.... +|++|||+++..... .....++..|+|||.+. ...+
T Consensus 131 l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~ 205 (287)
T 4f0f_A 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESY 205 (287)
T ss_dssp HHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEE
T ss_pred HHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCc
Confidence 467999999999 999999999999976554 999999999743221 23345678899999984 4457
Q ss_pred CcchhHHHHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 381 TTESDVWSYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 381 ~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
+.++||||+||++|||++ |+.||.+.+..+.
T Consensus 206 ~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 236 (287)
T 4f0f_A 206 TEKADTYSFAMILYTILT-GEGPFDEYSYGKI 236 (287)
T ss_dssp CHHHHHHHHHHHHHHHHH-SSCTTTTCCCCHH
T ss_pred CchhhHHHHHHHHHHHHc-CCCCCccccccHH
Confidence 889999999999999997 9999988766553
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.67 E-value=2.3e-17 Score=156.27 Aligned_cols=96 Identities=40% Similarity=0.759 Sum_probs=76.7
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcc-eeeccccCCCcccCCccccccCCCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDY-YRIQSKSLLPVRWMPPESILYGKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 388 (422)
.+.++.|||+++++|+|+||+||+++....+|++|||+++....... ........++..|+|||.+..+.++.++||||
T Consensus 123 i~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 202 (295)
T 3ugc_A 123 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWS 202 (295)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHH
T ss_pred HHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHH
Confidence 56799999999999999999999999999999999999985433221 12233344567799999999899999999999
Q ss_pred HHHHHHHHHhcCCCCCCC
Q psy7289 389 YGVVLWEVYSYGLQPYYG 406 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~ 406 (422)
|||++|||++ |..||..
T Consensus 203 lG~~l~~l~~-g~~~~~~ 219 (295)
T 3ugc_A 203 FGVVLYELFT-YIEKSKS 219 (295)
T ss_dssp HHHHHHHHHH-TTCTTCS
T ss_pred HHHHHHHHHh-cccccCC
Confidence 9999999997 8888865
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.67 E-value=2.9e-17 Score=160.70 Aligned_cols=93 Identities=20% Similarity=0.384 Sum_probs=76.2
Q ss_pred chhhHHHHhhh-hhhhhhccccccccc------CCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCc
Q psy7289 310 VAAGMAYLCSH-HYVHRDLAARNCLVG------DGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTT 382 (422)
Q Consensus 310 ~~r~~~~lh~~-~~i~~dLk~~nil~~------~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 382 (422)
++.++.|||++ +++|+||||+||+++ ....+|++|||+++..... .....+|+.|+|||++.+..++.
T Consensus 140 i~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~ 214 (373)
T 1q8y_A 140 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGC 214 (373)
T ss_dssp HHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCT
T ss_pred HHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCc
Confidence 46799999998 999999999999994 4457999999999754221 23345678999999999888999
Q ss_pred chhHHHHHHHHHHHHhcCCCCCCCCC
Q psy7289 383 ESDVWSYGVVLWEVYSYGLQPYYGYS 408 (422)
Q Consensus 383 ~~Dvws~Gv~l~el~~~g~~p~~~~~ 408 (422)
++|||||||++|||++ |..||.+.+
T Consensus 215 ~~Di~slG~il~el~~-g~~pf~~~~ 239 (373)
T 1q8y_A 215 GADIWSTACLIFELIT-GDFLFEPDE 239 (373)
T ss_dssp HHHHHHHHHHHHHHHH-SSCCC----
T ss_pred hHhHHHHHHHHHHHHh-CCCCCCCCc
Confidence 9999999999999997 999998754
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=3.6e-17 Score=157.44 Aligned_cols=101 Identities=20% Similarity=0.333 Sum_probs=65.4
Q ss_pred chhhHHHHhhhh--hhhhhcccccccccCCcceeecccccccccccCccee----------eccccCCCcccCCcccc--
Q psy7289 310 VAAGMAYLCSHH--YVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYR----------IQSKSLLPVRWMPPESI-- 375 (422)
Q Consensus 310 ~~r~~~~lh~~~--~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~----------~~~~~~~~~~y~aPE~~-- 375 (422)
+..++.|||+++ ++|+||||+||+++....+|++|||+++......... ......++..|+|||++
T Consensus 145 i~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 224 (337)
T 3ll6_A 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDL 224 (337)
T ss_dssp HHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------C
T ss_pred HHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhc
Confidence 567999999999 9999999999999999999999999997543321111 01133467889999988
Q ss_pred -ccCCCCcchhHHHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 376 -LYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 376 -~~~~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
.+..++.++|||||||++|||++ |+.||.+....+
T Consensus 225 ~~~~~~~~~~Dv~slG~il~el~~-g~~p~~~~~~~~ 260 (337)
T 3ll6_A 225 YSNFPIGEKQDIWALGCILYLLCF-RQHPFEDGAKLR 260 (337)
T ss_dssp CTTSCSSHHHHHHHHHHHHHHHHH-SSCCC-------
T ss_pred cccCCCChHHhHHHHHHHHHHHHh-CCCCCcchhHHH
Confidence 45568899999999999999996 999998755443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=5.1e-17 Score=152.85 Aligned_cols=99 Identities=26% Similarity=0.500 Sum_probs=81.7
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCc---ceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGL---TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~---~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 386 (422)
...++.|||+++++|+|++|+||+++... .+|++|||++........ .....++..|+|||.+....++.++||
T Consensus 114 i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di 190 (284)
T 3kk8_A 114 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDI 190 (284)
T ss_dssp HHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHH
T ss_pred HHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccch
Confidence 46799999999999999999999996544 499999999975433221 223456788999999998889999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||+||++|||++ |..||.+.+..+.
T Consensus 191 ~slG~~l~~l~~-g~~pf~~~~~~~~ 215 (284)
T 3kk8_A 191 WACGVILYILLV-GYPPFWDEDQHRL 215 (284)
T ss_dssp HHHHHHHHHHHH-SSCSSCCSSHHHH
T ss_pred HHHHHHHHHHHH-CCCCCCCCchhHH
Confidence 999999999997 9999988665543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.67 E-value=3.8e-17 Score=154.10 Aligned_cols=99 Identities=25% Similarity=0.388 Sum_probs=73.1
Q ss_pred chhhHHHHhhh-hhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCcccc----ccCCCCcch
Q psy7289 310 VAAGMAYLCSH-HYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESI----LYGKFTTES 384 (422)
Q Consensus 310 ~~r~~~~lh~~-~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~ 384 (422)
...++.|||++ +++|+|+||+||+++....+|++|||+++...... ......++..|+|||.+ ..+.++.++
T Consensus 118 i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~ 194 (290)
T 3fme_A 118 IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKS 194 (290)
T ss_dssp HHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHH
T ss_pred HHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccc---cccccCCCccccChhhcChhhcCcCCCcHH
Confidence 46799999998 99999999999999998999999999997543321 12223467889999996 455689999
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 385 DVWSYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 385 Dvws~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||||+||++|||++ |+.||.+..++..
T Consensus 195 Di~slG~il~~l~~-g~~p~~~~~~~~~ 221 (290)
T 3fme_A 195 DIWSLGITMIELAI-LRFPYDSWGTPFQ 221 (290)
T ss_dssp HHHHHHHHHHHHHH-TSCSSCCCSCHHH
T ss_pred HHHHHHHHHHHHHH-CCCCccccCchHH
Confidence 99999999999997 9999987655543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=3.7e-17 Score=159.61 Aligned_cols=98 Identities=28% Similarity=0.427 Sum_probs=75.7
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCcccccc-CCCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws 388 (422)
+..++.|||+++++|+||+|+||+++.+..+|++|||+++...... ......++..|+|||.+.. +.++.++||||
T Consensus 143 i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 219 (362)
T 3pg1_A 143 ILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWS 219 (362)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHH
T ss_pred HHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHh
Confidence 4679999999999999999999999999999999999997433221 1233456788999998876 56899999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
+||++|||++ |+.||.+.+..+
T Consensus 220 lG~il~~l~~-g~~pf~~~~~~~ 241 (362)
T 3pg1_A 220 AGCVMAEMFN-RKALFRGSTFYN 241 (362)
T ss_dssp HHHHHHHHHH-SSCSCCCSSHHH
T ss_pred HHHHHHHHHh-CCCCCCCCCHHH
Confidence 9999999997 999999866444
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.67 E-value=3.1e-17 Score=157.56 Aligned_cols=94 Identities=26% Similarity=0.460 Sum_probs=77.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcc----------eeeccccCCCcccCCccccccCC
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDY----------YRIQSKSLLPVRWMPPESILYGK 379 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~ 379 (422)
+..++.|||+++++|+||||+||+++.+..+|++|||+++....... ........+|+.|+|||.+.+..
T Consensus 173 i~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 252 (332)
T 3qd2_B 173 IAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN 252 (332)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCC
T ss_pred HHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCC
Confidence 56899999999999999999999999999999999999986433211 11223445788999999999888
Q ss_pred CCcchhHHHHHHHHHHHHhcCCCCC
Q psy7289 380 FTTESDVWSYGVVLWEVYSYGLQPY 404 (422)
Q Consensus 380 ~~~~~Dvws~Gv~l~el~~~g~~p~ 404 (422)
++.++|||||||++|||++ |..|+
T Consensus 253 ~~~~~Di~slG~il~el~~-~~~~~ 276 (332)
T 3qd2_B 253 YSHKVDIFSLGLILFELLY-SFSTQ 276 (332)
T ss_dssp CCTHHHHHHHHHHHHHHHS-CCCCH
T ss_pred CcchhhHHHHHHHHHHHHH-cCCCh
Confidence 9999999999999999995 76665
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=5.4e-17 Score=165.12 Aligned_cols=98 Identities=34% Similarity=0.634 Sum_probs=79.8
Q ss_pred chhhHHHHhhhhhhhhhccccccccc---CCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVG---DGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~---~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 386 (422)
+..++.|||+++++|+||||+||+++ ....+|++|||+++...... ......+|+.|+|||++. +.|+.++||
T Consensus 130 i~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di 205 (486)
T 3mwu_A 130 VFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLR-GTYDEKCDV 205 (486)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGG-SCCCHHHHH
T ss_pred HHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC---ccCCCcCCCCCCCHHHhC-CCCCchhhH
Confidence 46799999999999999999999994 44579999999997543322 123445788999999886 569999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||+||++|||++ |..||.+.+..+.
T Consensus 206 wslG~il~~ll~-g~~pf~~~~~~~~ 230 (486)
T 3mwu_A 206 WSAGVILYILLS-GTPPFYGKNEYDI 230 (486)
T ss_dssp HHHHHHHHHHHH-SSCSSCCSSHHHH
T ss_pred HHHHHHHHHHHh-CCCCCCCCCHHHH
Confidence 999999999996 9999998766553
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.66 E-value=6e-17 Score=152.59 Aligned_cols=97 Identities=28% Similarity=0.478 Sum_probs=82.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
...++.+||+++++|+||+|+||+++....+|++|||++....... .....++..|+|||.+.+..++.++|||||
T Consensus 123 i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 198 (284)
T 2vgo_A 123 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCA 198 (284)
T ss_dssp HHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHH
T ss_pred HHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhH
Confidence 5679999999999999999999999988899999999986532211 223446788999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||++|||++ |..||.+.+..+
T Consensus 199 G~il~~l~~-g~~pf~~~~~~~ 219 (284)
T 2vgo_A 199 GVLCYEFLV-GMPPFDSPSHTE 219 (284)
T ss_dssp HHHHHHHHH-SSCTTCCSSHHH
T ss_pred HHHHHHHHH-CCCCCCCCCHhH
Confidence 999999997 999998866554
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.2e-17 Score=161.26 Aligned_cols=96 Identities=30% Similarity=0.515 Sum_probs=75.4
Q ss_pred chhhHHHHhhh---------hhhhhhcccccccccCCcceeecccccccccccCcc------eeeccccCCCcccCCccc
Q psy7289 310 VAAGMAYLCSH---------HYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDY------YRIQSKSLLPVRWMPPES 374 (422)
Q Consensus 310 ~~r~~~~lh~~---------~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~------~~~~~~~~~~~~y~aPE~ 374 (422)
++.++.|||+. +++|+||||+||+++....+|++|||+++....... ........+|+.|+|||+
T Consensus 120 i~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 199 (336)
T 3g2f_A 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEV 199 (336)
T ss_dssp HHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHH
T ss_pred HHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchh
Confidence 56799999999 999999999999999999999999999975433211 111223457889999999
Q ss_pred ccc-------CCCCcchhHHHHHHHHHHHHhcCCCCCCC
Q psy7289 375 ILY-------GKFTTESDVWSYGVVLWEVYSYGLQPYYG 406 (422)
Q Consensus 375 ~~~-------~~~~~~~Dvws~Gv~l~el~~~g~~p~~~ 406 (422)
+.+ ..++.++|||||||++|||++ |..||+.
T Consensus 200 ~~~~~~~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~ 237 (336)
T 3g2f_A 200 LEGAVNLRDXESALKQVDMYALGLIYWEIFM-RCTDLFP 237 (336)
T ss_dssp HTTCCCGGGHHHHHHHHHHHHHHHHHHHHHT-TBGGGST
T ss_pred hcCCcccccccccccccchHHHHHHHHHHHh-cCCcCCC
Confidence 876 346678999999999999997 6555443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=4.3e-17 Score=155.84 Aligned_cols=100 Identities=30% Similarity=0.501 Sum_probs=75.7
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCcccccc-----------C
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-----------G 378 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~ 378 (422)
..+++.|||+++++|+||+|+||+++. ..+|++|||+++...............++..|+|||.+.. +
T Consensus 136 i~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 214 (313)
T 3cek_A 136 MLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKS 214 (313)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------
T ss_pred HHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccc
Confidence 467999999999999999999999975 6799999999976433222222234456889999998875 4
Q ss_pred CCCcchhHHHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 379 KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 379 ~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
.++.++|||||||++|||++ |+.||.+..+..
T Consensus 215 ~~~~~~Di~slG~il~el~~-g~~pf~~~~~~~ 246 (313)
T 3cek_A 215 KISPKSDVWSLGCILYYMTY-GKTPFQQIINQI 246 (313)
T ss_dssp CCCHHHHHHHHHHHHHHHHH-SSCTTTTCCSHH
T ss_pred cCCchHHHHHHHHHHHHHHh-CCCchhhHHHHH
Confidence 68889999999999999996 999998865543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.66 E-value=5.3e-17 Score=159.11 Aligned_cols=98 Identities=24% Similarity=0.524 Sum_probs=81.2
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCcccccc------CCCCcc
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY------GKFTTE 383 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~ 383 (422)
+..++.|||+++++|+|++|+||+++.+..+|++|||++........ .....+++.|+|||++.. ..++.+
T Consensus 209 i~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 285 (365)
T 2y7j_A 209 LLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKE 285 (365)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTT
T ss_pred HHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCch
Confidence 46799999999999999999999999999999999999875433221 233456789999998863 358889
Q ss_pred hhHHHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 384 SDVWSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 384 ~Dvws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
+|||||||++|||++ |..||.+.+..+
T Consensus 286 ~Di~slG~il~ell~-g~~pf~~~~~~~ 312 (365)
T 2y7j_A 286 VDLWACGVILFTLLA-GSPPFWHRRQIL 312 (365)
T ss_dssp HHHHHHHHHHHHHHH-SSCSSCCSSHHH
T ss_pred hhHHhHHHHHHHHHH-CCCCCCCCCHHH
Confidence 999999999999997 999998855443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.66 E-value=3.9e-17 Score=163.09 Aligned_cols=98 Identities=27% Similarity=0.487 Sum_probs=74.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccC---CcceeecccccccccccCcceeeccccCCCcccCCcccccc---CCCCcc
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGD---GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY---GKFTTE 383 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~---~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~ 383 (422)
...++.|||+++++|+||||+||+++. ...+|++|||+++...... ......+|+.|+|||++.. +.|+.+
T Consensus 248 i~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 324 (419)
T 3i6u_A 248 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRA 324 (419)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHH
T ss_pred HHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCch
Confidence 467999999999999999999999964 3459999999998643221 1233456789999998863 568899
Q ss_pred hhHHHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 384 SDVWSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 384 ~Dvws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
+|||||||++|||++ |..||.+..+..
T Consensus 325 ~DiwslG~il~~llt-g~~pf~~~~~~~ 351 (419)
T 3i6u_A 325 VDCWSLGVILFICLS-GYPPFSEHRTQV 351 (419)
T ss_dssp HHHHHHHHHHHHHHH-SSCSSCCCSSSC
T ss_pred hhhHhHHHHHHHHHH-CCCCCCCCcchH
Confidence 999999999999997 999998765543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=5.3e-17 Score=157.02 Aligned_cols=100 Identities=28% Similarity=0.470 Sum_probs=83.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++|+||+|+||+++.+..+|++|||+++....... ......++..|+|||++.+..++.++|||||
T Consensus 150 i~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 227 (335)
T 2owb_A 150 IVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSI 227 (335)
T ss_dssp HHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHH
T ss_pred HHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHH
Confidence 46799999999999999999999999999999999999975432211 1223446788999999988889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||++|||++ |+.||.+.+..+.
T Consensus 228 G~il~~l~~-g~~pf~~~~~~~~ 249 (335)
T 2owb_A 228 GCIMYTLLV-GKPPFETSCLKET 249 (335)
T ss_dssp HHHHHHHHH-SSCTTCCSSHHHH
T ss_pred HHHHHHHHH-CcCCCCCCCHHHH
Confidence 999999997 9999988665553
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.66 E-value=3.9e-17 Score=152.61 Aligned_cols=98 Identities=39% Similarity=0.706 Sum_probs=76.7
Q ss_pred chhhHHHHhhhh---hhhhhcccccccccC--------CcceeecccccccccccCcceeeccccCCCcccCCccccccC
Q psy7289 310 VAAGMAYLCSHH---YVHRDLAARNCLVGD--------GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG 378 (422)
Q Consensus 310 ~~r~~~~lh~~~---~i~~dLk~~nil~~~--------~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 378 (422)
...++.|||+++ ++|+|++|+||+++. ...+|++|||+++...... .....++..|+|||.+...
T Consensus 114 l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~ 189 (271)
T 3dtc_A 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRAS 189 (271)
T ss_dssp HHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHC
T ss_pred HHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc----ccCCCCccceeCHHHhccC
Confidence 467999999999 889999999999975 6679999999997543221 1234567889999999988
Q ss_pred CCCcchhHHHHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 379 KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 379 ~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
.++.++|||||||+++||++ |+.||.+.+..+.
T Consensus 190 ~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~ 222 (271)
T 3dtc_A 190 MFSKGSDVWSYGVLLWELLT-GEVPFRGIDGLAV 222 (271)
T ss_dssp CCSHHHHHHHHHHHHHHHHH-CCCTTTTSCHHHH
T ss_pred CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Confidence 89999999999999999997 9999998776553
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=5.5e-17 Score=154.97 Aligned_cols=95 Identities=34% Similarity=0.625 Sum_probs=74.8
Q ss_pred chhhHHHHhh---hhhhhhhcccccccccCCcc-eeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchh
Q psy7289 310 VAAGMAYLCS---HHYVHRDLAARNCLVGDGLT-VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESD 385 (422)
Q Consensus 310 ~~r~~~~lh~---~~~i~~dLk~~nil~~~~~~-~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 385 (422)
.++++.|||+ ++++|+||||+||+++.+.. +|++|||+++..... .....++..|+|||++..+.++.++|
T Consensus 111 i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~D 185 (307)
T 2eva_A 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCD 185 (307)
T ss_dssp HHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSCHHHHTCCCCCTHHH
T ss_pred HHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-----cccCCCCCceEChhhhCCCCCCcHHH
Confidence 4679999999 88999999999999977665 799999998753221 12334678899999999888999999
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCch
Q psy7289 386 VWSYGVVLWEVYSYGLQPYYGYSNQ 410 (422)
Q Consensus 386 vws~Gv~l~el~~~g~~p~~~~~~~ 410 (422)
||||||++|||++ |+.||......
T Consensus 186 i~slG~il~el~~-g~~p~~~~~~~ 209 (307)
T 2eva_A 186 VFSWGIILWEVIT-RRKPFDEIGGP 209 (307)
T ss_dssp HHHHHHHHHHHHH-TCCTTTTTCSS
T ss_pred HHHHHHHHHHHHH-CCCCchhhCcc
Confidence 9999999999997 99999875544
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=6.4e-17 Score=151.73 Aligned_cols=99 Identities=25% Similarity=0.482 Sum_probs=81.7
Q ss_pred chhhHHHHhhhhhhhhhcccccccc---cCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~---~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 386 (422)
...++.|||+++++|+|++|+||++ +....+|++|||++....... ......++..|+|||.+. +.++.++||
T Consensus 115 i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di 190 (277)
T 3f3z_A 115 VLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLE-GLYGPECDE 190 (277)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTTHHH
T ss_pred HHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc---chhccCCCCCccChHHhc-ccCCchhhe
Confidence 4679999999999999999999999 777889999999997543322 123345678899999875 558999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
|||||++|||++ |..||.+.+..+..
T Consensus 191 ~slG~~l~~l~~-g~~p~~~~~~~~~~ 216 (277)
T 3f3z_A 191 WSAGVMMYVLLC-GYPPFSAPTDSEVM 216 (277)
T ss_dssp HHHHHHHHHHHH-SSCSSCCSSHHHHH
T ss_pred hhHHHHHHHHHH-CCCCCCCCCHHHHH
Confidence 999999999997 99999987765543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=6.9e-17 Score=152.93 Aligned_cols=100 Identities=28% Similarity=0.470 Sum_probs=83.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
...++.|||+++++|+|++|+||+++.+..+|++|||+++....... ......++..|+|||.+....++.++|||||
T Consensus 124 i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 201 (294)
T 2rku_A 124 IVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSI 201 (294)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHH
T ss_pred HHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHH
Confidence 46799999999999999999999999999999999999975432211 1223446788999999988889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||++|||++ |+.||.+.+..+.
T Consensus 202 G~~l~~l~~-g~~p~~~~~~~~~ 223 (294)
T 2rku_A 202 GCIMYTLLV-GKPPFETSCLKET 223 (294)
T ss_dssp HHHHHHHHH-SSCTTCCSSHHHH
T ss_pred HHHHHHHHh-CCCCCCCCCHHHH
Confidence 999999997 9999988765553
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.66 E-value=6e-17 Score=154.23 Aligned_cols=97 Identities=29% Similarity=0.523 Sum_probs=81.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccc---cCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~---~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 386 (422)
...++.|||+++++|+|++|+||++ +.+..+|++|||+++..... ......++..|+|||.+..+.++.++||
T Consensus 115 i~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di 190 (304)
T 2jam_A 115 VLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDC 190 (304)
T ss_dssp HHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHH
T ss_pred HHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC----ccccccCCCCccChHHhccCCCCchhhH
Confidence 4679999999999999999999998 67788999999998743221 1122346788999999998889999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||+||++|||++ |..||.+.+..+
T Consensus 191 ~slG~il~~l~~-g~~pf~~~~~~~ 214 (304)
T 2jam_A 191 WSIGVITYILLC-GYPPFYEETESK 214 (304)
T ss_dssp HHHHHHHHHHHH-SSCTTTTSCHHH
T ss_pred HHHHHHHHHHHH-CCCCCCCCCHHH
Confidence 999999999997 999998866544
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.66 E-value=5.8e-17 Score=153.01 Aligned_cols=98 Identities=32% Similarity=0.525 Sum_probs=77.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccc---cCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~---~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 386 (422)
...++.|||+.+++|+||+|+||++ +....+|++|||+++...... ......++..|+|||.+. +.++.++||
T Consensus 133 i~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di 208 (285)
T 3is5_A 133 MMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDI 208 (285)
T ss_dssp HHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHH
T ss_pred HHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCe
Confidence 4679999999999999999999999 445679999999997543221 123345678899999875 678999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
|||||++|||++ |..||.+.+..+.
T Consensus 209 ~slG~il~~ll~-g~~pf~~~~~~~~ 233 (285)
T 3is5_A 209 WSAGVVMYFLLT-GCLPFTGTSLEEV 233 (285)
T ss_dssp HHHHHHHHHHHH-SSCSSCCSSHHHH
T ss_pred ehHHHHHHHHHh-CCCCCCCCCHHHH
Confidence 999999999997 9999998766554
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=3.3e-17 Score=166.57 Aligned_cols=98 Identities=33% Similarity=0.617 Sum_probs=81.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccc---cCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~---~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 386 (422)
+..++.|||+++++|+||||+||++ +....+|++|||+++...... ......+|+.|+|||++. +.|+.++||
T Consensus 135 i~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di 210 (484)
T 3nyv_A 135 VLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLH-GTYDEKCDV 210 (484)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHH-TCCCTHHHH
T ss_pred HHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc---ccccCCCCccccCceeec-CCCCCccee
Confidence 4679999999999999999999999 456789999999997543322 123345788999999876 579999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||+||++|||++ |..||.+.+..+.
T Consensus 211 wslG~il~~ll~-g~~pf~~~~~~~~ 235 (484)
T 3nyv_A 211 WSTGVILYILLS-GCPPFNGANEYDI 235 (484)
T ss_dssp HHHHHHHHHHHH-SSCSSCCSSHHHH
T ss_pred HHHHHHHHHHHH-CCCCCCCCCHHHH
Confidence 999999999997 9999998766553
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.66 E-value=2.9e-17 Score=157.14 Aligned_cols=99 Identities=28% Similarity=0.475 Sum_probs=75.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcc---eeecccccccccccCcce-----eeccccCCCcccCCcccccc----
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLT---VKISDFGLSRDVYASDYY-----RIQSKSLLPVRWMPPESILY---- 377 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~---~ki~Dfgls~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~---- 377 (422)
+..++.|||+++++|+||||+||+++.... +|++|||+++........ .......++..|+|||++..
T Consensus 120 i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 199 (316)
T 2ac3_A 120 VASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEE 199 (316)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHH
T ss_pred HHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhccccc
Confidence 567999999999999999999999976554 899999998754321110 01123346789999999875
Q ss_pred -CCCCcchhHHHHHHHHHHHHhcCCCCCCCCCc
Q psy7289 378 -GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN 409 (422)
Q Consensus 378 -~~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~ 409 (422)
+.++.++|||||||++|||++ |+.||.+.+.
T Consensus 200 ~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~ 231 (316)
T 2ac3_A 200 ASIYDKRCDLWSLGVILYILLS-GYPPFVGRCG 231 (316)
T ss_dssp HHHHTTTHHHHHHHHHHHHHHH-SSCSCCCCCC
T ss_pred ccCCCcccccHhHHHHHHHHHH-CCCCCccccc
Confidence 458899999999999999997 9999988654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=6.5e-17 Score=164.86 Aligned_cols=98 Identities=36% Similarity=0.612 Sum_probs=80.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccC---CcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGD---GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~---~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 386 (422)
+..++.|||+++++|+||||+||+++. ...+|++|||+++...... ......+|+.|+|||++. +.|+.++||
T Consensus 145 i~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~Di 220 (494)
T 3lij_A 145 VLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDV 220 (494)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHH
T ss_pred HHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhH
Confidence 467999999999999999999999965 3459999999997543322 123455788999999875 679999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||+||++|||++ |..||.+.+..+.
T Consensus 221 wslG~il~~ll~-g~~pf~~~~~~~~ 245 (494)
T 3lij_A 221 WSIGVILFILLA-GYPPFGGQTDQEI 245 (494)
T ss_dssp HHHHHHHHHHHH-SSCSSCCSSHHHH
T ss_pred HHHHHHHHHHHh-CCCCCCCCCHHHH
Confidence 999999999997 9999998766554
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=7.9e-17 Score=153.18 Aligned_cols=101 Identities=29% Similarity=0.408 Sum_probs=81.5
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCC--CCcchhHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK--FTTESDVW 387 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dvw 387 (422)
+..++.|||+++++|+||+|+||+++.+..+|++|||+++...............++..|+|||++.... ++.++|||
T Consensus 118 i~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~ 197 (305)
T 2wtk_C 118 LIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIW 197 (305)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHH
T ss_pred HHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHH
Confidence 5679999999999999999999999999999999999997543221112223445678999999887543 37799999
Q ss_pred HHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 388 SYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||||++|||++ |..||.+.+..+
T Consensus 198 slG~il~~l~~-g~~p~~~~~~~~ 220 (305)
T 2wtk_C 198 SAGVTLYNITT-GLYPFEGDNIYK 220 (305)
T ss_dssp HHHHHHHHHHH-SSCSCCCSSHHH
T ss_pred HHHHHHHHHHh-CCCCCCCchHHH
Confidence 99999999997 999998865444
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=5.9e-17 Score=154.77 Aligned_cols=101 Identities=28% Similarity=0.494 Sum_probs=79.7
Q ss_pred chhhHHHHhhhhhhhhhccccccccc-CCcceeecccccccccccCcc-eeeccccCCCcccCCcccccc-CCCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVG-DGLTVKISDFGLSRDVYASDY-YRIQSKSLLPVRWMPPESILY-GKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~-~~~~~ki~Dfgls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv 386 (422)
+..++.|||+++++|+||+|+||+++ .+..+|++|||+++....... ........++..|+|||.+.. +.++.++||
T Consensus 129 i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 208 (320)
T 2i6l_A 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDM 208 (320)
T ss_dssp HHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHH
T ss_pred HHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhh
Confidence 56799999999999999999999997 567899999999975432111 111223345778999998875 568999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
|||||++|||++ |+.||.+.+..+
T Consensus 209 ~slG~il~el~~-g~~pf~~~~~~~ 232 (320)
T 2i6l_A 209 WAAGCIFAEMLT-GKTLFAGAHELE 232 (320)
T ss_dssp HHHHHHHHHHHH-SSCSSCCSSHHH
T ss_pred HhHHHHHHHHHh-CCCCCCCCCHHH
Confidence 999999999997 999999876544
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=5.6e-17 Score=152.22 Aligned_cols=99 Identities=29% Similarity=0.506 Sum_probs=63.4
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
...++.|||+++++|+|++|+||+++.+..+|++|||++....... .......++..|+|||.+....++.++|||||
T Consensus 121 i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 198 (278)
T 3cok_A 121 IITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSL 198 (278)
T ss_dssp HHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------------------------------CTHHHHH
T ss_pred HHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC--CcceeccCCCCcCCcchhcCCCCCchhhHHHH
Confidence 5679999999999999999999999999999999999987543211 11122345778999999988889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||++|||++ |+.||.+.+..+
T Consensus 199 G~il~~l~~-g~~p~~~~~~~~ 219 (278)
T 3cok_A 199 GCMFYTLLI-GRPPFDTDTVKN 219 (278)
T ss_dssp HHHHHHHHH-SSCSSCCCSCC-
T ss_pred HHHHHHHHh-CCCCCCChhHHH
Confidence 999999997 999998765444
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.65 E-value=6e-17 Score=154.83 Aligned_cols=99 Identities=21% Similarity=0.345 Sum_probs=72.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
...++.|||+++++|+||+|+||+++.+..+|++|||+++...... ........++..|+|||.+..+.++.++|||||
T Consensus 143 i~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 221 (309)
T 2h34_A 143 IGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYAL 221 (309)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHH
T ss_pred HHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHH
Confidence 4679999999999999999999999999999999999987543322 112233456788999999988889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCch
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQ 410 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~ 410 (422)
||++|||++ |+.||.+.+..
T Consensus 222 G~il~~l~~-g~~pf~~~~~~ 241 (309)
T 2h34_A 222 TCVLYECLT-GSPPYQGDQLS 241 (309)
T ss_dssp HHHHHHHHH-SSCSSCSCHHH
T ss_pred HHHHHHHHH-CCCCCCCchHH
Confidence 999999997 99999875543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1.3e-16 Score=150.76 Aligned_cols=98 Identities=27% Similarity=0.444 Sum_probs=80.6
Q ss_pred chhhHHHHhhhh--hhhhhccccccccc-CCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhH
Q psy7289 310 VAAGMAYLCSHH--YVHRDLAARNCLVG-DGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~--~i~~dLk~~nil~~-~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 386 (422)
...++.|||+++ ++|+|++|+||+++ ....+|++|||++....... .....++..|+|||.+. +.++.++||
T Consensus 138 i~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di 212 (290)
T 1t4h_A 138 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDV 212 (290)
T ss_dssp HHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHH
T ss_pred HHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc----cccccCCcCcCCHHHHh-ccCCCcchH
Confidence 467999999999 99999999999997 67889999999997432221 12234678899999776 669999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||+||++|||++ |+.||.+..+.+..
T Consensus 213 ~slG~~l~~l~~-g~~pf~~~~~~~~~ 238 (290)
T 1t4h_A 213 YAFGMCMLEMAT-SEYPYSECQNAAQI 238 (290)
T ss_dssp HHHHHHHHHHHH-SSCTTTTCSSHHHH
T ss_pred HHHHHHHHHHHh-CCCCCCCcCcHHHH
Confidence 999999999997 99999886665543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=9.6e-17 Score=152.20 Aligned_cols=102 Identities=29% Similarity=0.563 Sum_probs=79.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcc---eeeccccCCCcccCCcccccc-CCCCcchh
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDY---YRIQSKSLLPVRWMPPESILY-GKFTTESD 385 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D 385 (422)
+..++.|||+++++|+||+|+||+++.+..+|++|||+++....... ........++..|+|||.+.. ..++.++|
T Consensus 130 i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 209 (303)
T 2vwi_A 130 VLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKAD 209 (303)
T ss_dssp HHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHH
T ss_pred HHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhh
Confidence 56799999999999999999999999999999999999875432211 111223456788999998875 46899999
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 386 VWSYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 386 vws~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||||||++|||++ |+.||.+.+..+.
T Consensus 210 i~slG~il~~l~~-g~~pf~~~~~~~~ 235 (303)
T 2vwi_A 210 IWSFGITAIELAT-GAAPYHKYPPMKV 235 (303)
T ss_dssp HHHHHHHHHHHHH-SSCTTTTSCGGGH
T ss_pred HHHHHHHHHHHHh-CCCCCccCchhhH
Confidence 9999999999997 9999998766553
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=8.3e-17 Score=154.60 Aligned_cols=100 Identities=27% Similarity=0.500 Sum_probs=76.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccc-----cCCCCcch
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL-----YGKFTTES 384 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~ 384 (422)
+..++.|||+++++|+||+|+||+++.+..+|++|||++....... .......++..|+|||.+. .+.++.++
T Consensus 138 i~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~ 215 (326)
T 2x7f_A 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKS 215 (326)
T ss_dssp HHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTH
T ss_pred HHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccc
Confidence 4679999999999999999999999999999999999987532211 1122345678899999987 45689999
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 385 DVWSYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 385 Dvws~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
|||||||++|||++ |..||.+....+.
T Consensus 216 Di~slG~il~~l~~-g~~p~~~~~~~~~ 242 (326)
T 2x7f_A 216 DLWSLGITAIEMAE-GAPPLCDMHPMRA 242 (326)
T ss_dssp HHHHHHHHHHHHHH-SSCTTTTSCHHHH
T ss_pred hHHHHHHHHHHHHh-CCCCCCCCcHHHH
Confidence 99999999999997 9999988665543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.1e-16 Score=152.16 Aligned_cols=100 Identities=27% Similarity=0.496 Sum_probs=83.5
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
...++.+||+++++|+||+|+||+++.+..+|++|||++....... .......++..|+|||.+.++.++.++|||||
T Consensus 128 i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 205 (303)
T 3a7i_A 128 ILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 205 (303)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred HHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHH
Confidence 4679999999999999999999999999999999999997543322 11233456788999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||++|||++ |..||.+....+.
T Consensus 206 G~il~~l~~-g~~p~~~~~~~~~ 227 (303)
T 3a7i_A 206 GITAIELAR-GEPPHSELHPMKV 227 (303)
T ss_dssp HHHHHHHHH-SSCTTTTSCHHHH
T ss_pred HHHHHHHcc-CCCCCCCcCHHHH
Confidence 999999997 9999987655543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=8e-17 Score=154.96 Aligned_cols=97 Identities=28% Similarity=0.494 Sum_probs=63.8
Q ss_pred chhhHHHHhhh-hhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCcccc----ccCCCCcch
Q psy7289 310 VAAGMAYLCSH-HYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESI----LYGKFTTES 384 (422)
Q Consensus 310 ~~r~~~~lh~~-~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~ 384 (422)
...++.+||+. +++|+||+|+||+++.+..+|++|||+++...... ......++..|+|||.+ ..+.++.++
T Consensus 134 i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 210 (327)
T 3aln_A 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRS 210 (327)
T ss_dssp HHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC---------------------------------CCSHH
T ss_pred HHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchh
Confidence 46799999998 99999999999999999999999999997543321 12223567889999998 455689999
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCch
Q psy7289 385 DVWSYGVVLWEVYSYGLQPYYGYSNQ 410 (422)
Q Consensus 385 Dvws~Gv~l~el~~~g~~p~~~~~~~ 410 (422)
|||||||++|||++ |+.||.+....
T Consensus 211 Di~slG~il~~l~~-g~~pf~~~~~~ 235 (327)
T 3aln_A 211 DVWSLGITLYELAT-GRFPYPKWNSV 235 (327)
T ss_dssp HHHHHHHHHHHHHH-SCCCSSCC---
T ss_pred hHHHHHHHHHHHHH-CCCCCCCcchH
Confidence 99999999999997 99999886543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.65 E-value=1.1e-16 Score=150.56 Aligned_cols=98 Identities=30% Similarity=0.542 Sum_probs=79.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCc----ceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchh
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGL----TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESD 385 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~----~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 385 (422)
+..++.+||+++++|+|++|+||+++... .+|++|||+++....... .....++..|+|||.+..+.++.++|
T Consensus 117 i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~D 193 (283)
T 3bhy_A 117 ILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEAD 193 (283)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHH
T ss_pred HHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchh
Confidence 46799999999999999999999997665 799999999975433221 12334678899999998888999999
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 386 VWSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 386 vws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||||||++|||++ |..||.+.+..+
T Consensus 194 i~slG~il~~l~~-g~~p~~~~~~~~ 218 (283)
T 3bhy_A 194 MWSIGVITYILLS-GASPFLGETKQE 218 (283)
T ss_dssp HHHHHHHHHHHHH-SSCTTCCSSHHH
T ss_pred hhhHHHHHHHHHH-CCCCCCCcchHH
Confidence 9999999999997 999998866554
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.64 E-value=6.3e-17 Score=157.88 Aligned_cols=97 Identities=30% Similarity=0.501 Sum_probs=80.9
Q ss_pred chhhHHHHhhh-hhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHH
Q psy7289 310 VAAGMAYLCSH-HYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~-~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 388 (422)
...++.|||+. +++|+|++|+||+++.+..+|++|||+++..... ......++..|+|||++.+..++.++||||
T Consensus 140 i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 215 (360)
T 3eqc_A 140 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWS 215 (360)
T ss_dssp HHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHH
T ss_pred HHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHH
Confidence 46799999985 8999999999999999999999999998753221 122345678899999999888999999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
|||++|||++ |+.||.+.+..+
T Consensus 216 lG~il~~l~~-g~~pf~~~~~~~ 237 (360)
T 3eqc_A 216 MGLSLVEMAV-GRYPIPPPDAKE 237 (360)
T ss_dssp HHHHHHHHHH-TSCCSSCCCHHH
T ss_pred HHHHHHHHHh-CCCCCCCCCHHH
Confidence 9999999997 999998866554
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.4e-16 Score=152.16 Aligned_cols=99 Identities=26% Similarity=0.452 Sum_probs=83.0
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.+||+++++|+|++|+||+++.+..+|++|||+++...... .......++..|+|||.+....++.++|||||
T Consensus 134 i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 211 (314)
T 3com_A 134 TLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSL 211 (314)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHH
T ss_pred HHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--cccCccCCCCCccChhhcCCCCCCccccHHHH
Confidence 4679999999999999999999999998999999999997543221 11233456788999999988889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||++|||++ |..||.+....+
T Consensus 212 G~il~~l~~-g~~p~~~~~~~~ 232 (314)
T 3com_A 212 GITAIEMAE-GKPPYADIHPMR 232 (314)
T ss_dssp HHHHHHHHH-SSCTTTTSCHHH
T ss_pred HHHHHHHHh-CCCCCCCCChHH
Confidence 999999997 999998866544
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.64 E-value=1.2e-16 Score=153.90 Aligned_cols=98 Identities=29% Similarity=0.456 Sum_probs=76.6
Q ss_pred chhhHHHHhhh--------hhhhhhcccccccccCCcceeecccccccccccCccee--eccccCCCcccCCccccccCC
Q psy7289 310 VAAGMAYLCSH--------HYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYR--IQSKSLLPVRWMPPESILYGK 379 (422)
Q Consensus 310 ~~r~~~~lh~~--------~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~ 379 (422)
.+.++.|||++ +++|+||||+||+++.+..+|++|||+++......... ......+|..|+|||++....
T Consensus 143 i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 222 (337)
T 3mdy_A 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL 222 (337)
T ss_dssp HHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCC
T ss_pred HHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccccc
Confidence 46799999998 99999999999999999999999999997543322111 112345788999999998766
Q ss_pred CCcc------hhHHHHHHHHHHHHhcC----------CCCCCCCC
Q psy7289 380 FTTE------SDVWSYGVVLWEVYSYG----------LQPYYGYS 408 (422)
Q Consensus 380 ~~~~------~Dvws~Gv~l~el~~~g----------~~p~~~~~ 408 (422)
++.+ +|||||||++|||++ | ..||....
T Consensus 223 ~~~~~~~~~~~DiwslG~il~el~t-g~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 223 NRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp CTTCTHHHHHHHHHHHHHHHHHHHT-TBCBTTBCCCCCCTTTTTS
T ss_pred CCccccCccccchHHHHHHHHHHHh-ccCcccccccccccHhhhc
Confidence 6554 999999999999996 8 67776643
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.3e-16 Score=163.02 Aligned_cols=98 Identities=32% Similarity=0.588 Sum_probs=81.0
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCc---ceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGL---TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~---~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 386 (422)
+..++.|||+++++|+||||+||+++... .+|++|||+++...... ......+|+.|+|||++. +.|+.++||
T Consensus 155 i~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di 230 (504)
T 3q5i_A 155 ILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDV 230 (504)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHH
T ss_pred HHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHH
Confidence 46799999999999999999999997654 69999999997543321 123345788999999876 679999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||+||++|||++ |..||.+.+..+.
T Consensus 231 wslG~il~~ll~-g~~pf~~~~~~~~ 255 (504)
T 3q5i_A 231 WSCGVIMYILLC-GYPPFGGQNDQDI 255 (504)
T ss_dssp HHHHHHHHHHHH-SSCSSCCSSHHHH
T ss_pred HHHHHHHHHHHh-CCCCCCCCCHHHH
Confidence 999999999996 9999998766553
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=3.6e-17 Score=162.02 Aligned_cols=96 Identities=23% Similarity=0.432 Sum_probs=79.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccc----cCCcceeecccccccccccCcceeeccccCCCcccCCcccccc--------
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLV----GDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-------- 377 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~----~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------- 377 (422)
+..++.|||+++++|+||||+||++ +....+|++|||+++....... .....++..|+|||++..
T Consensus 121 i~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~ 197 (396)
T 4eut_A 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQ 197 (396)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHH
T ss_pred HHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCc---cccccCCccccCHHHhhccccccccc
Confidence 4679999999999999999999998 6777899999999986433221 223456789999998864
Q ss_pred CCCCcchhHHHHHHHHHHHHhcCCCCCCCCCc
Q psy7289 378 GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN 409 (422)
Q Consensus 378 ~~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~ 409 (422)
+.++.++|||||||++|||++ |+.||.+...
T Consensus 198 ~~~~~~~DiwSlG~il~el~t-g~~Pf~~~~~ 228 (396)
T 4eut_A 198 KKYGATVDLWSIGVTFYHAAT-GSLPFRPFEG 228 (396)
T ss_dssp HHHHHHHHHHHHHHHHHHHHH-SSCSEECTTC
T ss_pred cCCCcHHHHHHHHHHHHHHHH-CCCCCCCCCc
Confidence 467889999999999999997 9999986554
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.63 E-value=9e-17 Score=154.40 Aligned_cols=92 Identities=24% Similarity=0.397 Sum_probs=77.6
Q ss_pred chhhHHHHhhhhhhhhhccccccccc-CCcceeecccccccccccCcceeeccccCCCcccCCccccccCCC-CcchhHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVG-DGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKF-TTESDVW 387 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~-~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dvw 387 (422)
+..++.|||+++++|+||+|+||+++ ....+|++|||+++...... .....++..|+|||++..+.+ +.++|||
T Consensus 158 i~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~ 233 (320)
T 3a99_A 158 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVW 233 (320)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHH
T ss_pred HHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHH
Confidence 56799999999999999999999998 67889999999997543221 223446788999999987765 6789999
Q ss_pred HHHHHHHHHHhcCCCCCCC
Q psy7289 388 SYGVVLWEVYSYGLQPYYG 406 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~ 406 (422)
||||++|||++ |+.||.+
T Consensus 234 slG~il~el~~-g~~pf~~ 251 (320)
T 3a99_A 234 SLGILLYDMVC-GDIPFEH 251 (320)
T ss_dssp HHHHHHHHHHH-SSCSCCS
T ss_pred hHHHHHHHHHH-CCCCCCC
Confidence 99999999997 9999975
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=4.7e-17 Score=154.53 Aligned_cols=95 Identities=43% Similarity=0.729 Sum_probs=79.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcc-eeeccccCCCcccCCccccccCCCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDY-YRIQSKSLLPVRWMPPESILYGKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 388 (422)
...++.+||+++++|+|++|+||+++....+|++|||+++....... ........+|..|+|||.+.+..++.++||||
T Consensus 135 i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 214 (302)
T 4e5w_A 135 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWS 214 (302)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHH
T ss_pred HHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHH
Confidence 46799999999999999999999999889999999999986543322 23334455677899999999888999999999
Q ss_pred HHHHHHHHHhcCCCCCC
Q psy7289 389 YGVVLWEVYSYGLQPYY 405 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~ 405 (422)
+||++|||++ |..|+.
T Consensus 215 lG~il~~l~~-g~~p~~ 230 (302)
T 4e5w_A 215 FGVTLHELLT-YCDSDS 230 (302)
T ss_dssp HHHHHHHHHT-TTCGGG
T ss_pred HHHHHHHHHH-ccCCCc
Confidence 9999999996 878764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=6e-17 Score=152.78 Aligned_cols=94 Identities=32% Similarity=0.570 Sum_probs=75.2
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcc--------eeecccccccccccCcceeeccccCCCcccCCcccccc-CCC
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLT--------VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKF 380 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~--------~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~ 380 (422)
+..++.|||+++++|+||||+||+++.+.. +|++|||+++...... ...++..|+|||.+.. +.+
T Consensus 122 i~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~ 195 (289)
T 4fvq_A 122 LAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------ILQERIPWVPPECIENPKNL 195 (289)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCHH------HHHHTTTTSCHHHHHCGGGC
T ss_pred HHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccCcc------ccCCcCcccCHHHhCCCCCC
Confidence 567999999999999999999999977665 9999999987543221 1224567999999987 568
Q ss_pred CcchhHHHHHHHHHHHHhcCCCCCCCCCc
Q psy7289 381 TTESDVWSYGVVLWEVYSYGLQPYYGYSN 409 (422)
Q Consensus 381 ~~~~Dvws~Gv~l~el~~~g~~p~~~~~~ 409 (422)
+.++|||||||++|||++.|..||...+.
T Consensus 196 ~~~~DiwslG~il~el~~g~~~~~~~~~~ 224 (289)
T 4fvq_A 196 NLATDKWSFGTTLWEICSGGDKPLSALDS 224 (289)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred CchhHHHHHHHHHHHHHcCCCCCccccch
Confidence 99999999999999999755556655433
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.7e-16 Score=151.64 Aligned_cols=98 Identities=29% Similarity=0.501 Sum_probs=73.5
Q ss_pred chhhHHHHhh-hhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccc-----cCCCCcc
Q psy7289 310 VAAGMAYLCS-HHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL-----YGKFTTE 383 (422)
Q Consensus 310 ~~r~~~~lh~-~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~ 383 (422)
+..++.|||+ ++++|+||+|+||+++....+|++|||+++...... ......++..|+|||.+. .+.++.+
T Consensus 133 i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 209 (318)
T 2dyl_A 133 IVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIR 209 (318)
T ss_dssp HHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC--------CCTH
T ss_pred HHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc---cccccCCCccccChhhcccccccccCCccc
Confidence 4679999998 599999999999999999999999999987543321 122334678899999984 4568899
Q ss_pred hhHHHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 384 SDVWSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 384 ~Dvws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
+|||||||++|||++ |+.||.+..+..
T Consensus 210 ~Di~slG~il~~l~~-g~~pf~~~~~~~ 236 (318)
T 2dyl_A 210 ADVWSLGISLVELAT-GQFPYKNCKTDF 236 (318)
T ss_dssp HHHHHHHHHHHHHHH-SSCTTTTCCSHH
T ss_pred cchhhHHHHHHHHHh-CCCCCCCCCccH
Confidence 999999999999997 999998855544
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=7.4e-17 Score=151.34 Aligned_cols=99 Identities=25% Similarity=0.475 Sum_probs=79.6
Q ss_pred chhhHHHHhhhh-----hhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcch
Q psy7289 310 VAAGMAYLCSHH-----YVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTES 384 (422)
Q Consensus 310 ~~r~~~~lh~~~-----~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 384 (422)
...++.+||+.+ ++|+||+|+||+++....+|++|||+++....... ......++..|+|||.+....++.++
T Consensus 120 i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~ 197 (279)
T 2w5a_A 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKS 197 (279)
T ss_dssp HHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHH
T ss_pred HHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccc--cccccCCCccccChHHhccCCCCchh
Confidence 467999999999 99999999999999999999999999875432211 11223457789999999888899999
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 385 DVWSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 385 Dvws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
|||||||++|||++ |..||.+.+..+
T Consensus 198 Di~slG~il~~l~~-g~~p~~~~~~~~ 223 (279)
T 2w5a_A 198 DIWSLGCLLYELCA-LMPPFTAFSQKE 223 (279)
T ss_dssp HHHHHHHHHHHHHH-SSCSSCCSSHHH
T ss_pred hHHHHHHHHHHHHH-CCCCCcccCHHH
Confidence 99999999999997 999998866543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.3e-16 Score=150.89 Aligned_cols=99 Identities=29% Similarity=0.570 Sum_probs=80.0
Q ss_pred chhhHHHHhhhhhhhhhcccccccccC-CcceeecccccccccccCcceeeccccCCCcccCCccccccCC--CCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGD-GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK--FTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~-~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv 386 (422)
.+.++.+||+++++|+||+|+||+++. ...+|++|||+++...... .......++..|+|||++..+. ++.++||
T Consensus 131 i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di 208 (295)
T 2clq_A 131 ILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADI 208 (295)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHH
T ss_pred HHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC--CcccccCCCccccChhhhcCCCCCCCcHHHH
Confidence 567999999999999999999999987 7889999999997543221 1123345678899999987653 8899999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
|||||++|||++ |+.||.+....+
T Consensus 209 ~slG~il~~l~~-g~~pf~~~~~~~ 232 (295)
T 2clq_A 209 WSLGCTIIEMAT-GKPPFYELGEPQ 232 (295)
T ss_dssp HHHHHHHHHHHH-TSCTTGGGSSHH
T ss_pred HHHHHHHHHHHH-CCCCccCCCchh
Confidence 999999999997 999998765544
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=1.2e-16 Score=153.39 Aligned_cols=97 Identities=27% Similarity=0.490 Sum_probs=78.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCc---ceeecccccccccccCcceeeccccCCCcccCCccccc---cCCCCcc
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGL---TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL---YGKFTTE 383 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~---~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~ 383 (422)
+..++.|||+++++|+||+|+||+++... .+|++|||+++...... ......++..|+|||++. ...++.+
T Consensus 123 i~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 199 (322)
T 2ycf_A 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRA 199 (322)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTH
T ss_pred HHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCch
Confidence 46799999999999999999999997644 49999999997543221 112234578899999874 4568899
Q ss_pred hhHHHHHHHHHHHHhcCCCCCCCCCch
Q psy7289 384 SDVWSYGVVLWEVYSYGLQPYYGYSNQ 410 (422)
Q Consensus 384 ~Dvws~Gv~l~el~~~g~~p~~~~~~~ 410 (422)
+|||||||++|||++ |..||.+....
T Consensus 200 ~Di~slG~il~~l~~-g~~pf~~~~~~ 225 (322)
T 2ycf_A 200 VDCWSLGVILFICLS-GYPPFSEHRTQ 225 (322)
T ss_dssp HHHHHHHHHHHHHHH-SSCSSCSTTCS
T ss_pred hhHHHHHHHHHHHHh-CCCCCcccchH
Confidence 999999999999997 99999876554
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=1.6e-16 Score=148.01 Aligned_cols=95 Identities=25% Similarity=0.497 Sum_probs=78.7
Q ss_pred chhhHHHHhhhh--hhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCC---cch
Q psy7289 310 VAAGMAYLCSHH--YVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFT---TES 384 (422)
Q Consensus 310 ~~r~~~~lh~~~--~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~ 384 (422)
.+.++.|||+++ ++|+|++|+||+++.+..++++||+++..... ....+++.|+|||.+....++ .++
T Consensus 120 i~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~ 192 (271)
T 3kmu_A 120 MARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSA 192 (271)
T ss_dssp HHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHH
T ss_pred HHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc-------cCccCCccccChhhhccCCCCCCCchh
Confidence 467999999999 99999999999999988899998888653211 223457889999999866544 379
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 385 DVWSYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 385 Dvws~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
|||||||++|||++ |+.||.+.+..+.
T Consensus 193 Di~slG~il~el~~-g~~p~~~~~~~~~ 219 (271)
T 3kmu_A 193 DMWSFAVLLWELVT-REVPFADLSNMEI 219 (271)
T ss_dssp HHHHHHHHHHHHHH-CSCTTTTSCHHHH
T ss_pred hHHHHHHHHHHHHh-CCCCccccChHHH
Confidence 99999999999997 9999998776664
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=1.9e-16 Score=151.03 Aligned_cols=97 Identities=26% Similarity=0.460 Sum_probs=71.5
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.+||+++++|+||+|+||+++.+..+|++|||+++...... .......++..|+|||.+..+.++.++|||||
T Consensus 145 i~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 222 (310)
T 2wqm_A 145 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSL 222 (310)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHH
T ss_pred HHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHH
Confidence 5679999999999999999999999999999999999987533221 11223345778999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCc
Q psy7289 390 GVVLWEVYSYGLQPYYGYSN 409 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~ 409 (422)
||++|||++ |..||.+...
T Consensus 223 G~il~~l~~-g~~p~~~~~~ 241 (310)
T 2wqm_A 223 GCLLYEMAA-LQSPFYGDKM 241 (310)
T ss_dssp HHHHHHHHH-SSCTTC---C
T ss_pred HHHHHHHHh-CCCCCcccch
Confidence 999999997 9999987544
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.62 E-value=1.5e-16 Score=149.33 Aligned_cols=93 Identities=28% Similarity=0.495 Sum_probs=79.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.+||+++++|+|++|+||+++.+..+|++|||+++...... ......++..|+|||.+....++.++|||||
T Consensus 131 i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 207 (284)
T 2a19_B 131 ITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYAL 207 (284)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHH
T ss_pred HHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHH
Confidence 5679999999999999999999999998999999999987543322 1233456788999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCC
Q psy7289 390 GVVLWEVYSYGLQPYYG 406 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~ 406 (422)
||++|||++ |..||..
T Consensus 208 G~il~~l~~-~~~~~~~ 223 (284)
T 2a19_B 208 GLILAELLH-VCDTAFE 223 (284)
T ss_dssp HHHHHHHHS-CCSSHHH
T ss_pred HHHHHHHHh-cCCcchh
Confidence 999999996 8888754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=8.5e-17 Score=155.77 Aligned_cols=97 Identities=25% Similarity=0.575 Sum_probs=61.7
Q ss_pred chhhHHHHhhhhhhhhhcccccccccC---CcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGD---GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~---~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 386 (422)
...++.|||+++++|+||+|+||+++. ...+|++|||+++...... .....+++.|+|||.+..+.++.++||
T Consensus 137 l~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di 212 (336)
T 3fhr_A 137 IGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDM 212 (336)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--------------------------CHHHHHHHH
T ss_pred HHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhH
Confidence 467999999999999999999999975 4459999999997543221 223445788999999988889999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
|||||++|||++ |..||.+.+..+
T Consensus 213 ~slG~il~~l~~-g~~pf~~~~~~~ 236 (336)
T 3fhr_A 213 WSLGVIMYILLC-GFPPFYSNTGQA 236 (336)
T ss_dssp HHHHHHHHHHHH-SSCCC-------
T ss_pred HHHHHHHHHHHH-CCCCCCCccchh
Confidence 999999999997 999998765443
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.62 E-value=2.7e-16 Score=152.41 Aligned_cols=97 Identities=26% Similarity=0.434 Sum_probs=82.0
Q ss_pred chhhHHHHhh-hhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccC-CCCc-chhH
Q psy7289 310 VAAGMAYLCS-HHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTT-ESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~-~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~Dv 386 (422)
...++.|||+ ++++|+|++|+||+++.+..+|++|||+++..... ......++..|+|||.+..+ .++. ++||
T Consensus 160 i~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di 235 (348)
T 2pml_X 160 VLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDI 235 (348)
T ss_dssp HHHHHHHHHHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHH
T ss_pred HHHHHHHHhccCCEeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhH
Confidence 4679999999 99999999999999999999999999999754322 12344567889999999877 5666 9999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
|||||++|||++ |..||.+.+..+
T Consensus 236 ~slG~il~~l~~-g~~pf~~~~~~~ 259 (348)
T 2pml_X 236 WSLGICLYVMFY-NVVPFSLKISLV 259 (348)
T ss_dssp HHHHHHHHHHHH-SSCSSCCSSCSH
T ss_pred HHHHHHHHHHHh-CCCCCCCCCcHH
Confidence 999999999997 999999877633
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=1.1e-16 Score=152.00 Aligned_cols=100 Identities=24% Similarity=0.416 Sum_probs=79.2
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccc-----cCCCCcch
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL-----YGKFTTES 384 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~ 384 (422)
+..++.|||+++++|+||+|+||+++.+..+|++|||++....... .......++..|+|||.+. .+.++.++
T Consensus 126 i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~ 203 (302)
T 2j7t_A 126 MLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKA 203 (302)
T ss_dssp HHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHH
T ss_pred HHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc--cccccccCChhhcCCeeeccccCCCCCCchhh
Confidence 4679999999999999999999999988899999999976322111 1112334678899999884 56788999
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 385 DVWSYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 385 Dvws~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
|||||||++|||++ |..||.+.+..+.
T Consensus 204 Di~slG~il~~l~~-g~~p~~~~~~~~~ 230 (302)
T 2j7t_A 204 DIWSLGITLIEMAQ-IEPPHHELNPMRV 230 (302)
T ss_dssp HHHHHHHHHHHHHH-SSCTTTTSCHHHH
T ss_pred hHHHHHHHHHHHhc-CCCCCccCCHHHH
Confidence 99999999999997 9999988765543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=9.7e-17 Score=154.45 Aligned_cols=98 Identities=42% Similarity=0.685 Sum_probs=81.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcc-eeeccccCCCcccCCccccccCCCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDY-YRIQSKSLLPVRWMPPESILYGKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 388 (422)
...++.|||+++++|+|+||+||+++.+..+|++|||+++....... ........++..|+|||.+.+..++.++||||
T Consensus 136 i~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 215 (327)
T 3lxl_A 136 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWS 215 (327)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHH
T ss_pred HHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHH
Confidence 46799999999999999999999999999999999999985433222 22233445677899999998888999999999
Q ss_pred HHHHHHHHHhcCCCCCCCCC
Q psy7289 389 YGVVLWEVYSYGLQPYYGYS 408 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~ 408 (422)
|||++|||++ |..||.+..
T Consensus 216 lG~il~~ll~-g~~p~~~~~ 234 (327)
T 3lxl_A 216 FGVVLYELFT-YCDKSCSPS 234 (327)
T ss_dssp HHHHHHHHHT-TTCGGGSHH
T ss_pred HHHHHHHHHh-CCCCCcccc
Confidence 9999999996 889987643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=1.1e-16 Score=153.51 Aligned_cols=97 Identities=43% Similarity=0.735 Sum_probs=80.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcc-eeeccccCCCcccCCccccccCCCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDY-YRIQSKSLLPVRWMPPESILYGKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 388 (422)
...++.+||+.+++|+|++|+||+++.+..+|++|||+++....... ........++..|+|||.+.+..++.++||||
T Consensus 143 l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 222 (318)
T 3lxp_A 143 ICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWS 222 (318)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHH
T ss_pred HHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHH
Confidence 46799999999999999999999999999999999999986543222 22334455677899999999888999999999
Q ss_pred HHHHHHHHHhcCCCCCCCC
Q psy7289 389 YGVVLWEVYSYGLQPYYGY 407 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~ 407 (422)
|||++|||++ |..||...
T Consensus 223 lG~il~~ll~-g~~p~~~~ 240 (318)
T 3lxp_A 223 FGVTLYELLT-HCDSSQSP 240 (318)
T ss_dssp HHHHHHHHHT-TTCGGGSH
T ss_pred HHHHHHHHHh-CCCccccc
Confidence 9999999996 99999764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=2.3e-16 Score=150.96 Aligned_cols=101 Identities=24% Similarity=0.297 Sum_probs=76.5
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCc---ceeeccccCCCcccCCcccccc---------
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD---YYRIQSKSLLPVRWMPPESILY--------- 377 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~--------- 377 (422)
++.++.+||+++++|+|++|+||+++ +..+|++|||+++...... .........++..|+|||.+..
T Consensus 139 i~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~ 217 (319)
T 2y4i_B 139 IVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDK 217 (319)
T ss_dssp HHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCC
T ss_pred HHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccc
Confidence 56799999999999999999999998 4589999999986432111 1111223345678999998874
Q ss_pred CCCCcchhHHHHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 378 GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 378 ~~~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
..++.++|||||||++|||++ |+.||.+.+..+.
T Consensus 218 ~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~ 251 (319)
T 2y4i_B 218 LPFSKHSDVFALGTIWYELHA-REWPFKTQPAEAI 251 (319)
T ss_dssp SCCCHHHHHHHHHHHHHHHHH-SSCSSSSCCHHHH
T ss_pred cCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Confidence 357889999999999999997 9999988765543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=2.9e-16 Score=147.05 Aligned_cols=98 Identities=30% Similarity=0.495 Sum_probs=74.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCC-CcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKF-TTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dvws 388 (422)
...++.+||+++++|+|++|+||+++....+|++|||++....... ......++..|+|||.+....+ +.++||||
T Consensus 120 i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 196 (276)
T 2h6d_A 120 ILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWS 196 (276)
T ss_dssp HHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHH
T ss_pred HHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHH
Confidence 4679999999999999999999999999999999999997543322 1223346778999999887665 57899999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
|||++|||++ |..||.+.+..+
T Consensus 197 lG~~l~~l~~-g~~p~~~~~~~~ 218 (276)
T 2h6d_A 197 CGVILYALLC-GTLPFDDEHVPT 218 (276)
T ss_dssp HHHHHHHHHH-SSCSSCCSSHHH
T ss_pred HHHHHHHHHh-CCCCCCCCcHHH
Confidence 9999999997 999998765444
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=1.7e-16 Score=153.39 Aligned_cols=99 Identities=28% Similarity=0.432 Sum_probs=78.9
Q ss_pred chhhHHHHh--------hhhhhhhhcccccccccCCcceeecccccccccccCcce-e-eccccCCCcccCCccccccCC
Q psy7289 310 VAAGMAYLC--------SHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYY-R-IQSKSLLPVRWMPPESILYGK 379 (422)
Q Consensus 310 ~~r~~~~lh--------~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~-~-~~~~~~~~~~y~aPE~~~~~~ 379 (422)
++.++.||| +++++|+||||+||+++.+..+|++|||+++........ . ......++..|+|||.+....
T Consensus 148 i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 227 (342)
T 1b6c_B 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 227 (342)
T ss_dssp HHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCC
T ss_pred HHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccc
Confidence 567999999 899999999999999999999999999999754332211 1 223445788999999987652
Q ss_pred ------CCcchhHHHHHHHHHHHHhcC----------CCCCCCCCc
Q psy7289 380 ------FTTESDVWSYGVVLWEVYSYG----------LQPYYGYSN 409 (422)
Q Consensus 380 ------~~~~~Dvws~Gv~l~el~~~g----------~~p~~~~~~ 409 (422)
++.++|||||||++|||++ | ..||.+...
T Consensus 228 ~~~~~~~~~~~Di~slG~il~el~t-g~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 228 NMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp CTTCHHHHHHHHHHHHHHHHHHHHT-TBCBTTBCCCCCCTTTTTSC
T ss_pred cccccccCCcccHHHHHHHHHHHHh-ccCcCCcccccccCccccCc
Confidence 3368999999999999997 7 789987543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=3.9e-16 Score=147.83 Aligned_cols=98 Identities=26% Similarity=0.477 Sum_probs=81.2
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccc------cCCCCcc
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL------YGKFTTE 383 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~ 383 (422)
+..++.+||+++++|+|++|+||+++.+..+|++|||++....... ......++..|+|||.+. ...++.+
T Consensus 133 i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~ 209 (298)
T 1phk_A 133 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKE 209 (298)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTH
T ss_pred HHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcc
Confidence 4679999999999999999999999999999999999997543322 122344678899999885 4568899
Q ss_pred hhHHHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 384 SDVWSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 384 ~Dvws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
+|||||||++|||++ |..||.+.+..+
T Consensus 210 ~Di~slG~~l~~l~~-g~~p~~~~~~~~ 236 (298)
T 1phk_A 210 VDMWSTGVIMYTLLA-GSPPFWHRKQML 236 (298)
T ss_dssp HHHHHHHHHHHHHHH-SSCSSCCSSHHH
T ss_pred cccHhHHHHHHHHHH-CCCCCcCccHHH
Confidence 999999999999997 999998865544
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=4.9e-16 Score=148.32 Aligned_cols=92 Identities=26% Similarity=0.379 Sum_probs=77.3
Q ss_pred chhhHHHHhhhhhhhhhccccccccc-CCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCC-cchhHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVG-DGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFT-TESDVW 387 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~-~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dvw 387 (422)
+..++.|||+++++|+|++|+||+++ .+..+|++|||+++...... .....++..|+|||++..+.+. .++|||
T Consensus 148 i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~ 223 (312)
T 2iwi_A 148 VVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVW 223 (312)
T ss_dssp HHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHH
T ss_pred HHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHH
Confidence 46799999999999999999999998 77889999999997543322 2234467889999998877764 589999
Q ss_pred HHHHHHHHHHhcCCCCCCC
Q psy7289 388 SYGVVLWEVYSYGLQPYYG 406 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~ 406 (422)
||||++|||++ |+.||.+
T Consensus 224 slG~il~~l~~-g~~pf~~ 241 (312)
T 2iwi_A 224 SLGILLYDMVC-GDIPFER 241 (312)
T ss_dssp HHHHHHHHHHH-SSCSCCS
T ss_pred HHHHHHHHHHH-CCCCCCC
Confidence 99999999997 9999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=2.4e-16 Score=151.67 Aligned_cols=96 Identities=41% Similarity=0.769 Sum_probs=80.2
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcc-eeeccccCCCcccCCccccccCCCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDY-YRIQSKSLLPVRWMPPESILYGKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 388 (422)
.+.++.+||+++++|+||+|+||+++.+..+|++|||+++....... ........++..|+|||.+....++.++||||
T Consensus 154 i~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 233 (326)
T 2w1i_A 154 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWS 233 (326)
T ss_dssp HHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHH
T ss_pred HHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHH
Confidence 56799999999999999999999999888999999999986433322 22233345567899999998888999999999
Q ss_pred HHHHHHHHHhcCCCCCCC
Q psy7289 389 YGVVLWEVYSYGLQPYYG 406 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~ 406 (422)
|||++|||++ |..||..
T Consensus 234 lG~il~el~t-g~~~~~~ 250 (326)
T 2w1i_A 234 FGVVLYELFT-YIEKSKS 250 (326)
T ss_dssp HHHHHHHHHH-TTCGGGS
T ss_pred HHHHHHHHHh-cCCCCCC
Confidence 9999999997 8888864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=3.6e-16 Score=146.83 Aligned_cols=91 Identities=16% Similarity=0.246 Sum_probs=72.9
Q ss_pred chhhHHHHhhhhhhhhhccccccccc-------------------CCcceeecccccccccccCcceeeccccCCCcccC
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVG-------------------DGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM 370 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~-------------------~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~ 370 (422)
++.++.|||+++++|+||||+||+++ ....+|++|||+++..... ....++..|+
T Consensus 124 i~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~ 197 (289)
T 1x8b_A 124 VGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFL 197 (289)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS------CCCCCCGGGC
T ss_pred HHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc------cccCCCcccc
Confidence 56799999999999999999999997 4447899999998754322 1234678899
Q ss_pred CccccccC-CCCcchhHHHHHHHHHHHHhcCCCCCCCC
Q psy7289 371 PPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGY 407 (422)
Q Consensus 371 aPE~~~~~-~~~~~~Dvws~Gv~l~el~~~g~~p~~~~ 407 (422)
|||.+... .++.++|||||||+++||++ |..|+...
T Consensus 198 aPE~~~~~~~~~~~~Di~slG~il~~l~~-~~~~~~~~ 234 (289)
T 1x8b_A 198 ANEVLQENYTHLPKADIFALALTVVCAAG-AEPLPRNG 234 (289)
T ss_dssp CHHHHTTCCTTHHHHHHHHHHHHHHHHTT-CCCCCSSS
T ss_pred ChhHhcCCCCCCchhhHHHHHHHHHHHhc-CCCCCcch
Confidence 99998766 46689999999999999985 76665443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=6.7e-16 Score=147.62 Aligned_cols=96 Identities=25% Similarity=0.388 Sum_probs=76.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcce-------eeccccCCCcccCCccccccCC---
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYY-------RIQSKSLLPVRWMPPESILYGK--- 379 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~--- 379 (422)
.+.++.|||+++++|+||+|+||+++....+|++|||+++........ .......++..|+|||.+....
T Consensus 143 i~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 222 (317)
T 2buj_A 143 ICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV 222 (317)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEE
T ss_pred HHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcC
Confidence 567999999999999999999999999999999999998643211000 0011233478899999887543
Q ss_pred CCcchhHHHHHHHHHHHHhcCCCCCCC
Q psy7289 380 FTTESDVWSYGVVLWEVYSYGLQPYYG 406 (422)
Q Consensus 380 ~~~~~Dvws~Gv~l~el~~~g~~p~~~ 406 (422)
++.++|||||||++|||++ |+.||.+
T Consensus 223 ~~~~~Di~slG~il~el~~-g~~p~~~ 248 (317)
T 2buj_A 223 IDERTDVWSLGCVLYAMMF-GEGPYDM 248 (317)
T ss_dssp ECTHHHHHHHHHHHHHHHH-SSCTTHH
T ss_pred CCchhhHHHHHHHHHHHHh-CCCChhh
Confidence 6889999999999999996 9999965
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=1.3e-15 Score=143.60 Aligned_cols=97 Identities=34% Similarity=0.649 Sum_probs=77.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccC---CcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGD---GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~---~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 386 (422)
+..++.+||+++++|+|++|+||+++. ...+|++|||+++....... .....++..|+|||.+. +.++.++||
T Consensus 130 i~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di 205 (287)
T 2wei_A 130 VFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLR-GTYDEKCDV 205 (287)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHT-TCCCTHHHH
T ss_pred HHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc---cccccCcccccChHHhc-CCCCCchhh
Confidence 467999999999999999999999965 34699999999875432211 12223467899999876 568999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
|||||++|||++ |..||.+.+..+
T Consensus 206 ~slG~~l~~l~~-g~~p~~~~~~~~ 229 (287)
T 2wei_A 206 WSAGVILYILLS-GTPPFYGKNEYD 229 (287)
T ss_dssp HHHHHHHHHHHH-SSCSSCCSSHHH
T ss_pred HhHHHHHHHHHh-CCCCCCCCCHHH
Confidence 999999999997 999998865544
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.56 E-value=1.2e-15 Score=144.32 Aligned_cols=93 Identities=24% Similarity=0.454 Sum_probs=70.7
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcc------------eeeccccCCCcccCCcccccc
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDY------------YRIQSKSLLPVRWMPPESILY 377 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~ 377 (422)
...++.+||+++++|+|++|+||+++.+..+|++|||+++....... ........++..|+|||.+.+
T Consensus 125 i~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 204 (303)
T 1zy4_A 125 ILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG 204 (303)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTS
T ss_pred HHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccC
Confidence 56799999999999999999999999999999999999875432110 011123446778999999875
Q ss_pred C-CCCcchhHHHHHHHHHHHHhcCCCCCCC
Q psy7289 378 G-KFTTESDVWSYGVVLWEVYSYGLQPYYG 406 (422)
Q Consensus 378 ~-~~~~~~Dvws~Gv~l~el~~~g~~p~~~ 406 (422)
. .++.++|||||||++|||++ ||..
T Consensus 205 ~~~~~~~~Di~slG~il~~l~~----p~~~ 230 (303)
T 1zy4_A 205 TGHYNEKIDMYSLGIIFFEMIY----PFST 230 (303)
T ss_dssp CSCCCTHHHHHHHHHHHHHHHS----CCSS
T ss_pred CCCCcchhhHHHHHHHHHHHHh----ccCC
Confidence 4 68999999999999999995 6654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 422 | ||||
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-75 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-27 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-72 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-25 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-06 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-71 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-25 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-07 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-71 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-23 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-70 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-26 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-69 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-23 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-69 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-24 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-68 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-23 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-68 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-24 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-68 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-24 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-07 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-68 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-27 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-68 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-24 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-67 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-27 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-66 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-23 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-66 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-21 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-66 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-21 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-66 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-22 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-65 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-22 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-65 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-23 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-64 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-21 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-64 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-25 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-61 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-21 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-21 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-20 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-58 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-23 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-22 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-21 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-21 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-20 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-55 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-18 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-54 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-18 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-54 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-19 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-54 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-19 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-53 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-14 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-51 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-18 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-51 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-18 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-17 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-49 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-19 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-48 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-16 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-18 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-15 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-45 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-14 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-15 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-15 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-16 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-43 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-15 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-16 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-42 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-15 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-42 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-17 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-42 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-13 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-15 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-41 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-13 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-14 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-15 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-15 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-15 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-14 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-10 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-11 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-10 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-10 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-24 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-10 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-08 |
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 235 bits (600), Expect = 1e-75
Identities = 138/268 (51%), Positives = 187/268 (69%), Gaps = 15/268 (5%)
Query: 57 RFLQELGEGAFGKVYKGE---VCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRH 113
+++++GEGAFG+V++ + E ++VA+K LKE A+ +DF+RE LM+E +
Sbjct: 16 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 75
Query: 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQ------------A 161
PNIV LLGVC G+PMC+LFE+M GDL+EFL S SP + S S
Sbjct: 76 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 135
Query: 162 PLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDY 221
PLS + IA QVAAGMAYL +VHRDLA RNCLVG+ + VKI+DFGLSR++Y++DY
Sbjct: 136 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 195
Query: 222 YRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI 281
Y+ +P+RWMPPESI Y ++TTESDVW+YGVVLWE++SYGLQPYYG +++EVI +
Sbjct: 196 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV 255
Query: 282 RSRQMLPCPEDCPPRMYSLMMECWHEVP 309
R +L CPE+CP +Y+LM CW ++P
Sbjct: 256 RDGNILACPENCPLELYNLMRLCWSKLP 283
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 109 bits (272), Expect = 1e-27
Identities = 67/102 (65%), Positives = 86/102 (84%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
VAAGMAYL +VHRDLA RNCLVG+ + VKI+DFGLSR++Y++DYY+ +P+RW
Sbjct: 149 VAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRW 208
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
MPPESI Y ++TTESDVW+YGVVLWE++SYGLQPYYG +++E
Sbjct: 209 MPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 8e-72
Identities = 97/253 (38%), Positives = 132/253 (52%), Gaps = 17/253 (6%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
FL+ELG G FG V G+ VAIK +KE + + +F E +M L H +
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQY---DVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKL 61
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V L GVC P+ ++ E+M G L +L R Q + V
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-----------FQTQQLLEMCKDVC 110
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 236
M YL S ++HRDLAARNCLV D VK+SDFGLSR V +Y S PVRW P
Sbjct: 111 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSP 169
Query: 237 PESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPR 296
PE ++Y KF+++SD+W++GV++WE+YS G PY ++N E E I L P +
Sbjct: 170 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK 229
Query: 297 MYSLMMECWHEVP 309
+Y++M CWHE
Sbjct: 230 VYTIMYSCWHEKA 242
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 6e-25
Identities = 53/102 (51%), Positives = 70/102 (68%), Gaps = 1/102 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
V M YL S ++HRDLAARNCLV D VK+SDFGLSR V +Y S PVRW
Sbjct: 109 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRW 167
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
PPE ++Y KF+++SD+W++GV++WE+YS G PY ++N E
Sbjct: 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 209
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.6 bits (110), Expect = 2e-06
Identities = 18/48 (37%), Positives = 24/48 (50%), Gaps = 5/48 (10%)
Query: 4 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREV 51
FL+ELG G FG V G+ VAIK +KE + + +F E
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQY---DVAIKMIKEGSMSE--DEFIEEA 50
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 223 bits (570), Expect = 5e-71
Identities = 104/273 (38%), Positives = 145/273 (53%), Gaps = 15/273 (5%)
Query: 41 QKTASDFRREVIETKPRFLQELGEGAFGKVYKGE-VCTSEGPSLVAIKTLKENANQKTAS 99
+ +F +E+ + + Q +G G FG+V G + VAIKTLK +K
Sbjct: 13 NEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRR 72
Query: 100 DFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQV 159
DF E +M + HPN++ L GV P+ ++ EFM G L FL + +
Sbjct: 73 DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV----- 127
Query: 160 QAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS 219
+ +AAGM YL +YVHRDLAARN LV L K+SDFGLSR +
Sbjct: 128 ------IQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 220 DYYRIQSKSL---LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 276
+ +L +P+RW PE+I Y KFT+ SDVWSYG+V+WEV SYG +PY+ +NQ+
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241
Query: 277 VIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
VI I LP P DCP ++ LM++CW +
Sbjct: 242 VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDR 274
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 100 bits (251), Expect = 9e-25
Identities = 56/105 (53%), Positives = 72/105 (68%), Gaps = 3/105 (2%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL---LP 366
+AAGM YL +YVHRDLAARN LV L K+SDFGLSR + + +L +P
Sbjct: 137 IAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 196
Query: 367 VRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
+RW PE+I Y KFT+ SDVWSYG+V+WEV SYG +PY+ +NQ+
Sbjct: 197 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 50.1 bits (119), Expect = 2e-07
Identities = 18/49 (36%), Positives = 22/49 (44%), Gaps = 1/49 (2%)
Query: 4 FLQELGEGAFGKVYKGE-VCTSEGPSLVAIKTLKENANQKTASDFRREV 51
Q +G G FG+V G + VAIKTLK +K DF E
Sbjct: 30 IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEA 78
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 9e-71
Identities = 94/250 (37%), Positives = 135/250 (54%), Gaps = 13/250 (5%)
Query: 61 ELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLL 120
ELG G FG V +G + VAIK LK+ + + RE +M +L +P IV L+
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75
Query: 121 GVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMA 180
GVC E + ++ E G LH+FL+ + + + + + QV+ GM
Sbjct: 76 GVC-QAEALMLVMEMAGGGPLHKFLVGKRE-----------EIPVSNVAELLHQVSMGMK 123
Query: 181 YLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL-LPVRWMPPES 239
YL ++VHRDLAARN L+ + KISDFGLS+ + A D Y + P++W PE
Sbjct: 124 YLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183
Query: 240 ILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYS 299
I + KF++ SDVWSYGV +WE SYG +PY EV+ I + + CP +CPP +Y+
Sbjct: 184 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 243
Query: 300 LMMECWHEVP 309
LM +CW
Sbjct: 244 LMSDCWIYKW 253
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.6 bits (237), Expect = 6e-23
Identities = 49/103 (47%), Positives = 64/103 (62%), Gaps = 1/103 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL-LPVR 368
V+ GM YL ++VHRDLAARN L+ + KISDFGLS+ + A D Y + P++
Sbjct: 118 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
W PE I + KF++ SDVWSYGV +WE SYG +PY E
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 220
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 6e-70
Identities = 104/301 (34%), Positives = 150/301 (49%), Gaps = 23/301 (7%)
Query: 32 IKTLKENANQKTASDFRREVIETK---PR----FLQELGEGAFGKVYKGEVCTSEGPS-- 82
++ + N+ DFR + K PR F + LG GAFGKV
Sbjct: 8 VQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVS 67
Query: 83 -LVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPMCMLFEFMVRGD 140
VA+K LKE A+ E+ +M++L H NIV LLG C P+ ++FE+ GD
Sbjct: 68 IQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGD 127
Query: 141 LHEFLMSRSPR-----------SDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVH 189
L +L S+ + + + L+ +D A QVA GM +L VH
Sbjct: 128 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 187
Query: 190 RDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTES 249
RDLAARN LV G VKI DFGL+RD+ + Y ++ + LPV+WM PES+ G +T +S
Sbjct: 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKS 247
Query: 250 DVWSYGVVLWEVYSYGLQPYYGYSNQEVI-EMIRSRQMLPCPEDCPPRMYSLMMECWHEV 308
DVWSYG++LWE++S G+ PY G ++I++ + P +Y +M CW
Sbjct: 248 DVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFD 307
Query: 309 P 309
Sbjct: 308 S 308
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 1e-26
Identities = 54/106 (50%), Positives = 70/106 (66%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
VA GM +L VHRDLAARN LV G VKI DFGL+RD+ + Y ++ + LPV+W
Sbjct: 173 VAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKW 232
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
M PES+ G +T +SDVWSYG++LWE++S G+ PY G F K
Sbjct: 233 MAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK 278
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 5e-69
Identities = 91/254 (35%), Positives = 140/254 (55%), Gaps = 23/254 (9%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
+ LQ +G+G FG V G+ ++ VA+K +K N TA F E +M++LRH N+
Sbjct: 10 KLLQTIGKGEFGDVMLGDYRGNK----VAVKCIK---NDATAQAFLAEASVMTQLRHSNL 62
Query: 117 VCLLGVCL-SGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQV 175
V LLGV + + ++ E+M +G L ++L SR L +L V
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS----------VLGGDCLLKFSLDV 112
Query: 176 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM 235
M YL +++VHRDLAARN LV + K+SDFGL+++ ++ Q LPV+W
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWT 167
Query: 236 PPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPP 295
PE++ KF+T+SDVWS+G++LWE+YS+G PY ++V+ + + P+ CPP
Sbjct: 168 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP 227
Query: 296 RMYSLMMECWHEVP 309
+Y +M CWH
Sbjct: 228 AVYEVMKNCWHLDA 241
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.0 bits (241), Expect = 2e-23
Identities = 45/106 (42%), Positives = 68/106 (64%), Gaps = 5/106 (4%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
V M YL +++VHRDLAARN LV + K+SDFGL+++ ++ Q LPV+W
Sbjct: 112 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKW 166
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
PE++ KF+T+SDVWS+G++LWE+YS+G PY ++ +
Sbjct: 167 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 212
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 5e-69
Identities = 98/266 (36%), Positives = 139/266 (52%), Gaps = 20/266 (7%)
Query: 46 DFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASD-FRRE 104
D + +E K ELG G FG V KG + VA+K LK AN D E
Sbjct: 4 DRKLLTLEDK-----ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE 58
Query: 105 VDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLS 164
++M +L +P IV ++G+C E ++ E G L+++L +
Sbjct: 59 ANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH------------VK 105
Query: 165 QQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS-DYYR 223
++ + QV+ GM YL ++VHRDLAARN L+ KISDFGLS+ + A +YY+
Sbjct: 106 DKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165
Query: 224 IQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS 283
Q+ PV+W PE I Y KF+++SDVWS+GV++WE +SYG +PY G EV M+
Sbjct: 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 225
Query: 284 RQMLPCPEDCPPRMYSLMMECWHEVP 309
+ + CP CP MY LM CW
Sbjct: 226 GERMGCPAGCPREMYDLMNLCWTYDV 251
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.0 bits (246), Expect = 3e-24
Identities = 52/103 (50%), Positives = 70/103 (67%), Gaps = 1/103 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS-DYYRIQSKSLLPVR 368
V+ GM YL ++VHRDLAARN L+ KISDFGLS+ + A +YY+ Q+ PV+
Sbjct: 116 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
W PE I Y KF+++SDVWS+GV++WE +SYG +PY G E
Sbjct: 176 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (555), Expect = 1e-68
Identities = 117/256 (45%), Positives = 161/256 (62%), Gaps = 5/256 (1%)
Query: 57 RFLQELGEGAFGKVYKGE---VCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRH 113
+ELG+G+FG VY+G V E + VAIKT+ E A+ + +F E +M E
Sbjct: 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 82
Query: 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
++V LLGV G+P ++ E M RGDL +L RS R ++ + V AP S +A
Sbjct: 83 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR 233
++A GMAYL ++ +VHRDLAARNC+V + TVKI DFG++RD+Y +DYYR K LLPVR
Sbjct: 141 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 234 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDC 293
WM PES+ G FTT SDVWS+GVVLWE+ + QPY G SN++V+ + +L P++C
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 260
Query: 294 PPRMYSLMMECWHEVP 309
P ++ LM CW P
Sbjct: 261 PDMLFELMRMCWQYNP 276
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.0 bits (243), Expect = 1e-23
Identities = 70/162 (43%), Positives = 93/162 (57%), Gaps = 3/162 (1%)
Query: 254 YGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAG 313
GVV + + + + M P PP + ++ +A G
Sbjct: 89 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE---IADG 145
Query: 314 MAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPE 373
MAYL ++ +VHRDLAARNC+V + TVKI DFG++RD+Y +DYYR K LLPVRWM PE
Sbjct: 146 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 205
Query: 374 SILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
S+ G FTT SDVWS+GVVLWE+ + QPY G SN++
Sbjct: 206 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 247
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 2e-68
Identities = 92/253 (36%), Positives = 145/253 (57%), Gaps = 17/253 (6%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
+ ++ LG G FG+V+ G G + VA+K+LK+ + F E +LM +L+H +
Sbjct: 16 KLVERLGAGQFGEVWMG---YYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRL 70
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V L V + EP+ ++ E+M G L +FL + S L+ +A Q+A
Sbjct: 71 VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGI----------KLTINKLLDMAAQIA 119
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 236
GMA++ +Y+HRDL A N LV D L+ KI+DFGL+R + ++Y + + P++W
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTA 178
Query: 237 PESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPR 296
PE+I YG FT +SDVWS+G++L E+ ++G PY G +N EVI+ + + P++CP
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 238
Query: 297 MYSLMMECWHEVP 309
+Y LM CW E P
Sbjct: 239 LYQLMRLCWKERP 251
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 1e-24
Identities = 50/151 (33%), Positives = 82/151 (54%), Gaps = 5/151 (3%)
Query: 269 YYGYSNQE----VIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVH 324
Y QE + E + + ++ + ++ +A GMA++ +Y+H
Sbjct: 73 LYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132
Query: 325 RDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTES 384
RDL A N LV D L+ KI+DFGL+R + ++Y + + P++W PE+I YG FT +S
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAINYGTFTIKS 191
Query: 385 DVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
DVWS+G++L E+ ++G PY G +N E
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQN 222
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 3e-68
Identities = 99/253 (39%), Positives = 142/253 (56%), Gaps = 17/253 (6%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
F+QE+G G FG V+ G + VAIKT++E A + DF E ++M +L HP +
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKD---KVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKL 62
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V L GVCL P+C++FEFM G L ++L ++ + + L V
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA-----------AETLLGMCLDVC 111
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 236
GMAYL +HRDLAARNCLVG+ +K+SDFG++R V D Y + + PV+W
Sbjct: 112 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWAS 170
Query: 237 PESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPR 296
PE + +++++SDVWS+GV++WEV+S G PY SN EV+E I + L P
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 230
Query: 297 MYSLMMECWHEVP 309
+Y +M CW E P
Sbjct: 231 VYQIMNHCWKERP 243
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.6 bits (245), Expect = 3e-24
Identities = 49/103 (47%), Positives = 68/103 (66%), Gaps = 1/103 (0%)
Query: 309 PVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR 368
V GMAYL +HRDLAARNCLVG+ +K+SDFG++R V D Y + + PV+
Sbjct: 109 DVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVK 167
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
W PE + +++++SDVWS+GV++WEV+S G PY SN E
Sbjct: 168 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.9 bits (116), Expect = 4e-07
Identities = 19/48 (39%), Positives = 26/48 (54%), Gaps = 5/48 (10%)
Query: 4 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREV 51
F+QE+G G FG V+ G + VAIKT++E A + DF E
Sbjct: 9 FVQEIGSGQFGLVHLGYWLNKD---KVAIKTIREGAMSE--EDFIEEA 51
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 3e-68
Identities = 85/255 (33%), Positives = 134/255 (52%), Gaps = 14/255 (5%)
Query: 57 RFLQELGEGAFGKVYKGEVCTS--EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHP 114
+ ++ LG GAFG VYKG + VAIK L+E + K + E +M+ + +P
Sbjct: 12 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 71
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
++ LLG+CL+ + ++ + M G L +++ Q + +Q
Sbjct: 72 HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNI-----------GSQYLLNWCVQ 119
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 234
+A GM YL VHRDLAARN LV VKI+DFGL++ + A + +P++W
Sbjct: 120 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 235 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCP 294
M ESIL+ +T +SDVWSYGV +WE+ ++G +PY G E+ ++ + LP P C
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 239
Query: 295 PRMYSLMMECWHEVP 309
+Y +M++CW
Sbjct: 240 IDVYMIMVKCWMIDA 254
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 4e-27
Identities = 47/102 (46%), Positives = 64/102 (62%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+A GM YL VHRDLAARN LV VKI+DFGL++ + A + +P++W
Sbjct: 120 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
M ESIL+ +T +SDVWSYGV +WE+ ++G +PY G E
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 4e-68
Identities = 101/258 (39%), Positives = 141/258 (54%), Gaps = 8/258 (3%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPN 115
+F +GEG FG+V K + AIK +KE A++ DF E++++ +L HPN
Sbjct: 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72
Query: 116 IVCLLGVCLSGEPMCMLFEFMVRGDLHEFL----MSRSPRSDISGSQVQAPLSQQDFSHI 171
I+ LLG C + + E+ G+L +FL + + + + + LS Q H
Sbjct: 73 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132
Query: 172 ALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 231
A VA GM YL ++HRDLAARN LVG+ KI+DFGLSR + Y ++ LP
Sbjct: 133 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKKTMGRLP 189
Query: 232 VRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPE 291
VRWM ES+ Y +TT SDVWSYGV+LWE+ S G PY G + E+ E + L P
Sbjct: 190 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 249
Query: 292 DCPPRMYSLMMECWHEVP 309
+C +Y LM +CW E P
Sbjct: 250 NCDDEVYDLMRQCWREKP 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.1 bits (246), Expect = 6e-24
Identities = 61/170 (35%), Positives = 85/170 (50%), Gaps = 10/170 (5%)
Query: 251 VWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEV-- 308
+ G Y Y Y + +++ +R ++L + ++
Sbjct: 74 INLLGACEHRGYLYLAIEYA--PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 309 ---PVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL 365
VA GM YL ++HRDLAARN LVG+ KI+DFGLSR + Y ++ L
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKKTMGRL 188
Query: 366 PVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
PVRWM ES+ Y +TT SDVWSYGV+LWE+ S G PY G + E + K
Sbjct: 189 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 238
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 2e-67
Identities = 71/262 (27%), Positives = 114/262 (43%), Gaps = 27/262 (10%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPN 115
Q +G G+FG VYKG+ VA+K L + F+ EV ++ + RH N
Sbjct: 11 TVGQRIGSGSFGTVYKGKW-----HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 116 IVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQV 175
I+ +G + + ++ ++ L+ L + IA Q
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHII-----------ETKFEMIKLIDIARQT 113
Query: 176 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM 235
A GM YL + +HRDL + N + + LTVKI DFGL+ + + WM
Sbjct: 114 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 236 PPESILY---GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP---- 288
PE I ++ +SDV+++G+VL+E+ + G PY +N++ I + R L
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRDQIIFMVGRGYLSPDLS 232
Query: 289 -CPEDCPPRMYSLMMECWHEVP 309
+CP M LM EC +
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKR 254
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 1e-27
Identities = 35/109 (32%), Positives = 58/109 (53%), Gaps = 4/109 (3%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
A GM YL + +HRDL + N + + LTVKI DFGL+ + + W
Sbjct: 113 TAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172
Query: 370 MPPESILY---GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
M PE I ++ +SDV+++G+VL+E+ + G PY +N+++ +
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRDQIIF 220
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 1e-66
Identities = 94/257 (36%), Positives = 145/257 (56%), Gaps = 15/257 (5%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPS-LVAIKTLKENANQKTASDFRREVDLMSELRHPN 115
F + +G G FG VY G + ++G A+K+L + S F E +M + HPN
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 116 IVCLLGVCLSGE-PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
++ LLG+CL E ++ +M GDL F+ + + + +D LQ
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----------NPTVKDLIGFGLQ 138
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKS--LLPV 232
VA GM +L S +VHRDLAARNC++ + TVK++DFGL+RD+Y ++ + +K+ LPV
Sbjct: 139 VAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 198
Query: 233 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPED 292
+WM ES+ KFTT+SDVWS+GV+LWE+ + G PY + ++ + + L PE
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 258
Query: 293 CPPRMYSLMMECWHEVP 309
CP +Y +M++CWH
Sbjct: 259 CPDPLYEVMLKCWHPKA 275
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.9 bits (243), Expect = 1e-23
Identities = 53/135 (39%), Positives = 80/135 (59%), Gaps = 5/135 (3%)
Query: 283 SRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 342
+ E P + L+ A GM +L S +VHRDLAARNC++ + TVK+
Sbjct: 115 DLRNFIRNETHNPTVKDLIGFGLQV---AKGMKFLASKKFVHRDLAARNCMLDEKFTVKV 171
Query: 343 SDFGLSRDVYASDYYRIQSKS--LLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYG 400
+DFGL+RD+Y ++ + +K+ LPV+WM ES+ KFTT+SDVWS+GV+LWE+ + G
Sbjct: 172 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 231
Query: 401 LQPYYGYSNQEEFLK 415
PY + + +
Sbjct: 232 APPYPDVNTFDITVY 246
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 210 bits (536), Expect = 4e-66
Identities = 96/253 (37%), Positives = 149/253 (58%), Gaps = 15/253 (5%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
+LG G +G+VY+G + VA+KTLKE+ + +F +E +M E++HPN+
Sbjct: 20 TMKHKLGGGQYGEVYEGVW--KKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNL 75
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V LLGVC P ++ EFM G+L ++L + + +S ++A Q++
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ----------EVSAVVLLYMATQIS 125
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 236
+ M YL +++HRDLAARNCLVG+ VK++DFGLSR + D Y + + P++W
Sbjct: 126 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTA 184
Query: 237 PESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPR 296
PES+ Y KF+ +SDVW++GV+LWE+ +YG+ PY G +V E++ + PE CP +
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 244
Query: 297 MYSLMMECWHEVP 309
+Y LM CW P
Sbjct: 245 VYELMRACWQWNP 257
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 92.1 bits (228), Expect = 1e-21
Identities = 47/102 (46%), Positives = 71/102 (69%), Gaps = 1/102 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+++ M YL +++HRDLAARNCLVG+ VK++DFGLSR + D Y + + P++W
Sbjct: 124 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKW 182
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
PES+ Y KF+ +SDVW++GV+LWE+ +YG+ PY G +
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 224
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 5e-66
Identities = 105/275 (38%), Positives = 142/275 (51%), Gaps = 11/275 (4%)
Query: 46 DFRREVIETKPRFLQELGEGAFGKVYKGE---VCTSEGPSLVAIKTLKENANQKTASDFR 102
D + E + F + LG GAFGKV + + S+ VA+K LK +A+
Sbjct: 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM 74
Query: 103 REVDLMSEL-RHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSR------SPRSDIS 155
E+ ++S L H NIV LLG C G P ++ E+ GDL FL + S S
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 156 GSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRD 215
+ L +D + QVA GMA+L S + +HRDLAARN L+ G KI DFGL+RD
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 216 VYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ 275
+ Y ++ + LPV+WM PESI +T ESDVWSYG+ LWE++S G PY G
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254
Query: 276 EVI-EMIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
+MI+ + PE P MY +M CW P
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 289
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.6 bits (229), Expect = 1e-21
Identities = 54/106 (50%), Positives = 69/106 (65%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
VA GMA+L S + +HRDLAARN L+ G KI DFGL+RD+ Y ++ + LPV+W
Sbjct: 154 VAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKW 213
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
M PESI +T ESDVWSYG+ LWE++S G PY G +F K
Sbjct: 214 MAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 8e-66
Identities = 100/254 (39%), Positives = 143/254 (56%), Gaps = 14/254 (5%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPS-LVAIKTLKENANQKTASDFRREVDLMSELRHPN 115
+ +GEG FG V++G + E P+ VAIKT K + F +E M + HP+
Sbjct: 10 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 69
Query: 116 IVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQV 175
IV L+GV + P+ ++ E G+L FL R + L A Q+
Sbjct: 70 IVKLIGVI-TENPVWIIMELCTLGELRSFLQVR-----------KYSLDLASLILYAYQL 117
Query: 176 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM 235
+ +AYL S +VHRD+AARN LV VK+ DFGLSR + S YY+ SK LP++WM
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKWM 176
Query: 236 PPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPP 295
PESI + +FT+ SDVW +GV +WE+ +G++P+ G N +VI I + + LP P +CPP
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 236
Query: 296 RMYSLMMECWHEVP 309
+YSLM +CW P
Sbjct: 237 TLYSLMTKCWAYDP 250
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.3 bits (231), Expect = 3e-22
Identities = 49/106 (46%), Positives = 71/106 (66%), Gaps = 1/106 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
++ +AYL S +VHRD+AARN LV VK+ DFGLSR + S YY+ SK LP++W
Sbjct: 117 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKW 175
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
M PESI + +FT+ SDVW +GV +WE+ +G++P+ G N + +
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 221
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 1e-65
Identities = 101/263 (38%), Positives = 153/263 (58%), Gaps = 10/263 (3%)
Query: 57 RFLQELGEGAFGKVYKGEVC-----TSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL 111
+ LGEGAFG+V E + VA+K LK +A +K SD E+++M +
Sbjct: 16 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 75
Query: 112 -RHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPR----SDISGSQVQAPLSQQ 166
+H NI+ LLG C P+ ++ E+ +G+L E+L +R P S + LS +
Sbjct: 76 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 135
Query: 167 DFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQS 226
D A QVA GM YL S +HRDLAARN LV + +KI+DFGL+RD++ DYY+ +
Sbjct: 136 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 227 KSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286
LPV+WM PE++ +T +SDVWS+GV+LWE+++ G PY G +E+ ++++
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 255
Query: 287 LPCPEDCPPRMYSLMMECWHEVP 309
+ P +C +Y +M +CWH VP
Sbjct: 256 MDKPSNCTNELYMMMRDCWHAVP 278
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.2 bits (233), Expect = 3e-22
Identities = 52/104 (50%), Positives = 72/104 (69%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
VA GM YL S +HRDLAARN LV + +KI+DFGL+RD++ DYY+ + LPV+W
Sbjct: 144 VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKW 203
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
M PE++ +T +SDVWS+GV+LWE+++ G PY G +E F
Sbjct: 204 MAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 2e-65
Identities = 106/251 (42%), Positives = 141/251 (56%), Gaps = 14/251 (5%)
Query: 62 LGEGAFGKVYKGEVCTSEGPS--LVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCL 119
+G G FG+VYKG + TS G VAIKTLK +K DF E +M + H NI+ L
Sbjct: 15 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 74
Query: 120 LGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGM 179
GV +PM ++ E+M G L +FL + S + +AAGM
Sbjct: 75 EGVISKYKPMMIITEYMENGALDKFLREKDG-----------EFSVLQLVGMLRGIAAGM 123
Query: 180 AYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL-LPVRWMPPE 238
YL + +YVHRDLAARN LV L K+SDFGLSR + + +P+RW PE
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 239 SILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMY 298
+I Y KFT+ SDVWS+G+V+WEV +YG +PY+ SN EV++ I LP P DCP +Y
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY 243
Query: 299 SLMMECWHEVP 309
LMM+CW +
Sbjct: 244 QLMMQCWQQER 254
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.1 bits (238), Expect = 4e-23
Identities = 54/103 (52%), Positives = 70/103 (67%), Gaps = 1/103 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL-LPVR 368
+AAGM YL + +YVHRDLAARN LV L K+SDFGLSR + + +P+R
Sbjct: 119 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
W PE+I Y KFT+ SDVWS+G+V+WEV +YG +PY+ SN E
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 221
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 2e-64
Identities = 98/258 (37%), Positives = 143/258 (55%), Gaps = 17/258 (6%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSL-VAIKTLKEN--ANQKTASDFRREVDLMSELRH 113
R L++LG+G+FG V +GE G ++ VA+K LK + + + DF REV+ M L H
Sbjct: 11 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 70
Query: 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
N++ L GV L+ PM M+ E G L + L Q S A+
Sbjct: 71 RNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKH-----------QGHFLLGTLSRYAV 118
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS-DYYRIQSKSLLPV 232
QVA GM YL S ++HRDLAARN L+ VKI DFGL R + + D+Y +Q +P
Sbjct: 119 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178
Query: 233 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMI-RSRQMLPCPE 291
W PES+ F+ SD W +GV LWE+++YG +P+ G + +++ I + + LP PE
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE 238
Query: 292 DCPPRMYSLMMECWHEVP 309
DCP +Y++M++CW P
Sbjct: 239 DCPQDIYNVMVQCWAHKP 256
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.1 bits (228), Expect = 1e-21
Identities = 46/107 (42%), Positives = 64/107 (59%), Gaps = 1/107 (0%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS-DYYRIQSKSLLPVR 368
VA GM YL S ++HRDLAARN L+ VKI DFGL R + + D+Y +Q +P
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
W PES+ F+ SD W +GV LWE+++YG +P+ G + + K
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 226
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 2e-64
Identities = 97/253 (38%), Positives = 147/253 (58%), Gaps = 17/253 (6%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
R +LG+G FG+V+ G T G + VAIKTLK F +E +M +LRH +
Sbjct: 20 RLEVKLGQGCFGEVWMG---TWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKL 74
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V L V S EP+ ++ E+M +G L +FL + + L +A Q+A
Sbjct: 75 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGK----------YLRLPQLVDMAAQIA 123
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 236
+GMAY+ +YVHRDL A N LVG+ L K++DFGL+R + ++Y Q + P++W
Sbjct: 124 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTA 182
Query: 237 PESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPR 296
PE+ LYG+FT +SDVWS+G++L E+ + G PY G N+EV++ + +PCP +CP
Sbjct: 183 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 242
Query: 297 MYSLMMECWHEVP 309
++ LM +CW + P
Sbjct: 243 LHDLMCQCWRKEP 255
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 1e-25
Identities = 56/159 (35%), Positives = 88/159 (55%), Gaps = 5/159 (3%)
Query: 257 VLWEVYSYGLQPYYGYSNQE----VIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAA 312
V+ ++ L Y ++E V E + +L + + L +A+
Sbjct: 65 VMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124
Query: 313 GMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP 372
GMAY+ +YVHRDL A N LVG+ L K++DFGL+R + ++Y Q + P++W P
Sbjct: 125 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAP 183
Query: 373 ESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
E+ LYG+FT +SDVWS+G++L E+ + G PY G N+E
Sbjct: 184 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 222
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 9e-61
Identities = 69/278 (24%), Positives = 115/278 (41%), Gaps = 25/278 (8%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
+ ELG+GAFGKVYK + E L A K + +++ D+ E+D+++ HPNI
Sbjct: 15 EIIGELGDGAFGKVYKAQ--NKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNI 71
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V LL + +L EF G + ++ + PL++ + Q
Sbjct: 72 VKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-----------ERPLTESQIQVVCKQTL 120
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 236
+ YL + +HRDL A N L +K++DFG+S + R WM
Sbjct: 121 DALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG--TPYWMA 178
Query: 237 PESILY-----GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ--MLPC 289
PE ++ + ++DVWS G+ L E+ P++ + V+ I + L
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAE-IEPPHHELNPMRVLLKIAKSEPPTLAQ 237
Query: 290 PEDCPPRMYSLMMECWHEVPVA-AGMAYLCSHHYVHRD 326
P + +C + A + L H +V D
Sbjct: 238 PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.0 bits (228), Expect = 1e-21
Identities = 29/111 (26%), Positives = 47/111 (42%), Gaps = 8/111 (7%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+ YL + +HRDL A N L +K++DFG+S + R W
Sbjct: 119 TLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG--TPYW 176
Query: 370 MPPESILY-----GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
M PE ++ + ++DVWS G+ L E+ P++ + LK
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE-IEPPHHELNPMRVLLK 226
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 5e-60
Identities = 52/261 (19%), Positives = 103/261 (39%), Gaps = 21/261 (8%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTL-KENANQKTASDFRREVDLMSELRHPN 115
L +G G++G+ K + ++ K L + + EV+L+ EL+HPN
Sbjct: 7 EVLYTIGTGSYGRCQKIRRKSDG--KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 116 IVCLLGVCL--SGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
IV + + + ++ E+ GDL + + + L ++ +
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE--------RQYLDEEFVLRVMT 116
Query: 174 QVAAGMAYL-----CSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKS 228
Q+ + H +HRDL N + VK+ DFGL+R + +
Sbjct: 117 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KAF 174
Query: 229 LLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP 288
+ +M PE + + +SD+WS G +L+E+ + P+ +S +E+ IR +
Sbjct: 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC-ALMPPFTAFSQKELAGKIREGKFRR 233
Query: 289 CPEDCPPRMYSLMMECWHEVP 309
P + ++ +
Sbjct: 234 IPYRYSDELNEIITRMLNLKD 254
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.3 bits (221), Expect = 8e-21
Identities = 27/111 (24%), Positives = 48/111 (43%), Gaps = 8/111 (7%)
Query: 310 VAAGMAYL-----CSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 364
+ + H +HRDL N + VK+ DFGL+R + + +
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KAFV 175
Query: 365 LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
+M PE + + +SD+WS G +L+E+ + P+ +S +E K
Sbjct: 176 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC-ALMPPFTAFSQKELAGK 225
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (488), Expect = 1e-58
Identities = 67/291 (23%), Positives = 118/291 (40%), Gaps = 28/291 (9%)
Query: 43 TASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTAS--D 100
A F ++ E L+E+G G+FG VY + +VAIK + + Q D
Sbjct: 4 VAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNS--EVVAIKKMSYSGKQSNEKWQD 61
Query: 101 FRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQ 160
+EV + +LRHPN + G L ++ E+ + + + P
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---------- 111
Query: 161 APLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD 220
L + + + + G+AYL SH+ +HRD+ A N L+ + VK+ DFG + + ++
Sbjct: 112 --LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN 169
Query: 221 YYRIQSKSLLPVRWMPPESIL---YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEV 277
+ WM PE IL G++ + DVWS G+ E+ P + +
Sbjct: 170 SFVG------TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSA 222
Query: 278 IEMI-RSRQMLPCPEDCPPRMYSLMMECWHEVPVA-AGMAYLCSHHYVHRD 326
+ I ++ + + C ++P L H +V R+
Sbjct: 223 LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 87.7 bits (217), Expect = 5e-20
Identities = 31/109 (28%), Positives = 50/109 (45%), Gaps = 10/109 (9%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
G+AYL SH+ +HRD+ A N L+ + VK+ DFG + + ++ + W
Sbjct: 124 ALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVG------TPYW 177
Query: 370 MPPESIL---YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
M PE IL G++ + DVWS G+ E+ P + +
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYH 225
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 2e-58
Identities = 93/263 (35%), Positives = 139/263 (52%), Gaps = 10/263 (3%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPS---LVAIKTLKENANQKTASDFRREVD-LMSELR 112
+ + LG GAFG+V + + + + VA+K LKE A E+ L+
Sbjct: 16 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 75
Query: 113 HPNIVCLLGVCLS-GEPMCMLFEFMVRGDLHEFLMSR----SPRSDISGSQVQAPLSQQD 167
H N+V LLG C G P+ ++ EF G+L +L S+ P + L+ +
Sbjct: 76 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135
Query: 168 FSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSK 227
+ QVA GM +L S +HRDLAARN L+ + VKI DFGL+RD+Y Y +
Sbjct: 136 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 228 SLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS-NQEVIEMIRSRQM 286
+ LP++WM PE+I +T +SDVWS+GV+LWE++S G PY G ++E ++
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 255
Query: 287 LPCPEDCPPRMYSLMMECWHEVP 309
+ P+ P MY M++CWH P
Sbjct: 256 MRAPDYTTPEMYQTMLDCWHGEP 278
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.0 bits (243), Expect = 1e-23
Identities = 56/152 (36%), Positives = 79/152 (51%), Gaps = 5/152 (3%)
Query: 269 YYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEV-----PVAAGMAYLCSHHYV 323
+ +RS++ P P + VA GM +L S +
Sbjct: 97 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI 156
Query: 324 HRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTE 383
HRDLAARN L+ + VKI DFGL+RD+Y Y + + LP++WM PE+I +T +
Sbjct: 157 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ 216
Query: 384 SDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
SDVWS+GV+LWE++S G PY G EEF +
Sbjct: 217 SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 4e-57
Identities = 66/270 (24%), Positives = 112/270 (41%), Gaps = 23/270 (8%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTA--SDFRREVDLMSELRHP 114
+ LG+G FG VY + ++A+K L + +K RREV++ S LRHP
Sbjct: 9 EIGRPLGKGKFGNVYLAR--EKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
NI+ L G + ++ E+ G ++ L S +Q + +
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK------------FDEQRTATYITE 114
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 234
+A ++Y S +HRD+ N L+G +KI+DFG S +S + + +
Sbjct: 115 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG----TLDY 170
Query: 235 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCP 294
+PPE I + D+WS GV+ +E G P+ + QE + I SR P+
Sbjct: 171 LPPEMIEGRMHDEKVDLWSLGVLCYEFLV-GKPPFEANTYQETYKRI-SRVEFTFPDFVT 228
Query: 295 PRMYSLMMECWHEVPVA-AGMAYLCSHHYV 323
L+ P + + H ++
Sbjct: 229 EGARDLISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.1 bits (231), Expect = 4e-22
Identities = 33/119 (27%), Positives = 56/119 (47%), Gaps = 11/119 (9%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+A ++Y S +HRD+ N L+G +KI+DFG S +S + + +
Sbjct: 115 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG----TLDY 170
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK------TPPSWIT 422
+PPE I + D+WS GV+ +E G P+ + QE + + T P ++T
Sbjct: 171 LPPEMIEGRMHDEKVDLWSLGVLCYEFLV-GKPPFEANTYQETYKRISRVEFTFPDFVT 228
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 4e-57
Identities = 56/255 (21%), Positives = 105/255 (41%), Gaps = 21/255 (8%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
+++G+GA G VY + + G VAI+ + Q E+ +M E ++PNI
Sbjct: 23 TRFEKIGQGASGTVYTA-MDVATG-QEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNI 79
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V L L G+ + ++ E++ G L + + + + + + +
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-------------CMDEGQIAAVCRECL 126
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 236
+ +L S+ +HRD+ + N L+G +VK++DFG + R S + WM
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMA 184
Query: 237 PESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM--LPCPEDCP 294
PE + + + D+WS G++ E+ G PY + + +I + L PE
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNENPLRALYLIATNGTPELQNPEKLS 243
Query: 295 PRMYSLMMECWHEVP 309
+ C
Sbjct: 244 AIFRDFLNRCLDMDV 258
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.4 bits (224), Expect = 5e-21
Identities = 27/106 (25%), Positives = 47/106 (44%), Gaps = 3/106 (2%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+ +L S+ +HRD+ + N L+G +VK++DFG + R S + W
Sbjct: 125 CLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYW 182
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
M PE + + + D+WS G++ E+ G PY +
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNENPLRALYL 227
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 4e-57
Identities = 59/251 (23%), Positives = 96/251 (38%), Gaps = 21/251 (8%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
+ ELG G G V+K S ++A K + + RE+ ++ E P I
Sbjct: 9 EKISELGAGNGGVVFKVSHKPSG--LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V G S + + E M G L + L + +Q +++ V
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG------------RIPEQILGKVSIAVI 114
Query: 177 AGMAYLCSHHY-VHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM 235
G+ YL H +HRD+ N LV +K+ DFG+S + S +M
Sbjct: 115 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG----TRSYM 170
Query: 236 PPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPP 295
PE + ++ +SD+WS G+ L E+ G P +E+ M Q+ + PP
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAV-GRYPIPPPDAKELELMFG-CQVEGDAAETPP 228
Query: 296 RMYSLMMECWH 306
R +
Sbjct: 229 RPRTPGRPLSS 239
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.8 bits (230), Expect = 1e-21
Identities = 31/106 (29%), Positives = 47/106 (44%), Gaps = 6/106 (5%)
Query: 310 VAAGMAYLCSHHY-VHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR 368
V G+ YL H +HRD+ N LV +K+ DFG+S + S
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG----TRS 168
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFL 414
+M PE + ++ +SD+WS G+ L E+ G P +E L
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAV-GRYPIPPPDAKELEL 213
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 3e-56
Identities = 63/275 (22%), Positives = 114/275 (41%), Gaps = 19/275 (6%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
+Q LGEGA+G+V +E VA+K + + ++E+ + L H N+
Sbjct: 8 DLVQTLGEGAYGEVQLAVNRVTE--EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
V G G + E+ G+L + + + + D Q+
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG------------MPEPDAQRFFHQLM 113
Query: 177 AGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 236
AG+ YL HRD+ N L+ + +KISDFGL+ ++ R+ +K + ++
Sbjct: 114 AGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 173
Query: 237 PESILYGKF-TTESDVWSYGVVLWEVYSYGLQPYYGYSN--QEVIEMIRSRQMLPCPEDC 293
PE + +F DVWS G+VL + + G P+ S+ QE + + L +
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLA-GELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 232
Query: 294 PPRMYSLMMECWHEVPVA-AGMAYLCSHHYVHRDL 327
+L+ + E P A + + + ++ L
Sbjct: 233 DSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 267
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.9 bits (220), Expect = 1e-20
Identities = 31/107 (28%), Positives = 53/107 (49%), Gaps = 2/107 (1%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+ AG+ YL HRD+ N L+ + +KISDFGL+ ++ R+ +K + +
Sbjct: 112 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171
Query: 370 MPPESILYGKF-TTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
+ PE + +F DVWS G+VL + + G P+ S+ +
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPWDQPSDSCQEYS 217
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 184 bits (468), Expect = 3e-55
Identities = 53/276 (19%), Positives = 109/276 (39%), Gaps = 24/276 (8%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
L+ELG GAFG V++ V + G + K + + E+ +M++L HP +
Sbjct: 32 DILEELGSGAFGVVHRC-VEKATG-RVFVAKFIN-TPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
+ L M ++ EF+ G+L + + + +S+ + + Q
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAE-----------DYKMSEAEVINYMRQAC 137
Query: 177 AGMAYLCSHHYVHRDLAARNCLV--GDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 234
G+ ++ H VH D+ N + +VKI DFGL+ + + ++ + + +
Sbjct: 138 EGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATA---EF 194
Query: 235 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM---LPCPE 291
PE + +D+W+ GV+ + + GL P+ G + E ++ ++
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLL-SGLSPFAGEDDLETLQNVKRCDWEFDEDAFS 253
Query: 292 DCPPRMYSLMMECWHEVPVA-AGMAYLCSHHYVHRD 326
P + + P + H ++ D
Sbjct: 254 SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 83.2 bits (205), Expect = 3e-18
Identities = 24/108 (22%), Positives = 47/108 (43%), Gaps = 6/108 (5%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV--GDGLTVKISDFGLSRDVYASDYYRIQSKSLLPV 367
G+ ++ H VH D+ N + +VKI DFGL+ + + ++ + +
Sbjct: 136 ACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATA--- 192
Query: 368 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
+ PE + +D+W+ GV+ + + GL P+ G + E
Sbjct: 193 EFAAPEIVDREPVGFYTDMWAIGVLGYVLL-SGLSPFAGEDDLETLQN 239
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 182 bits (464), Expect = 1e-54
Identities = 58/270 (21%), Positives = 107/270 (39%), Gaps = 23/270 (8%)
Query: 45 SDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRRE 104
+ + + + +ELG GAFG V++ + + A K + ++ R+E
Sbjct: 17 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATG--NNFAAKFVM-TPHESDKETVRKE 73
Query: 105 VDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLS 164
+ MS LRHP +V L M M++EFM G+L E + +S
Sbjct: 74 IQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-----------HNKMS 122
Query: 165 QQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVG--DGLTVKISDFGLSRDVYASDYY 222
+ + QV G+ ++ ++YVH DL N + +K+ DFGL+ +
Sbjct: 123 EDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182
Query: 223 RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282
++ + + PE +D+WS GV+ + + S GL P+ G ++ E + ++
Sbjct: 183 KVTTG---TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS-GLSPFGGENDDETLRNVK 238
Query: 283 SRQM---LPCPEDCPPRMYSLMMECWHEVP 309
S + + P
Sbjct: 239 SCDWNMDDSAFSGISEDGKDFIRKLLLADP 268
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 82.4 bits (203), Expect = 5e-18
Identities = 26/108 (24%), Positives = 48/108 (44%), Gaps = 6/108 (5%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVG--DGLTVKISDFGLSRDVYASDYYRIQSKSLLPV 367
V G+ ++ ++YVH DL N + +K+ DFGL+ + ++ +
Sbjct: 133 VCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG---TA 189
Query: 368 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
+ PE +D+WS GV+ + + S GL P+ G ++ E
Sbjct: 190 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLS-GLSPFGGENDDETLRN 236
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 3e-54
Identities = 55/277 (19%), Positives = 119/277 (42%), Gaps = 25/277 (9%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
++LG G FG V++ +S+ K +K + ++E+ +++ RH NI
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSK--KTYMAKFVKVKGTDQVL--VKKEISILNIARHRNI 63
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
+ L S E + M+FEF+ D+ E + + + L++++ QV
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAF-----------ELNEREIVSYVHQVC 112
Query: 177 AGMAYLCSHHYVHRDLAARNCLVG--DGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 234
+ +L SH+ H D+ N + T+KI +FG +R + D +R+ + +
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP---EY 169
Query: 235 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP---CPE 291
PE + +T +D+WS G +++ + G+ P+ +NQ++IE I + + +
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLL-SGINPFLAETNQQIIENIMNAEYTFDEEAFK 228
Query: 292 DCPPRMYSLMMECWHEVPVA-AGMAYLCSHHYVHRDL 327
+ + + + + H ++ + +
Sbjct: 229 EISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.7 bits (209), Expect = 6e-19
Identities = 26/109 (23%), Positives = 51/109 (46%), Gaps = 6/109 (5%)
Query: 309 PVAAGMAYLCSHHYVHRDLAARNCLVG--DGLTVKISDFGLSRDVYASDYYRIQSKSLLP 366
V + +L SH+ H D+ N + T+KI +FG +R + D +R+ +
Sbjct: 110 QVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP-- 167
Query: 367 VRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
+ PE + +T +D+WS G +++ + G+ P+ +NQ+
Sbjct: 168 -EYYAPEVHQHDVVSTATDMWSLGTLVYVLL-SGINPFLAETNQQIIEN 214
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 6e-54
Identities = 50/255 (19%), Positives = 101/255 (39%), Gaps = 18/255 (7%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHP 114
+F + LGEG+F V + AIK L++ + RE D+MS L HP
Sbjct: 11 KFGKILGEGSFSTVVLARELATS--REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
V L E + + G+L +++ + +
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS------------FDETCTRFYTAE 116
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 234
+ + + YL +HRDL N L+ + + ++I+DFG ++ + + + ++
Sbjct: 117 IVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176
Query: 235 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCP 294
+ PE + SD+W+ G +++++ + GL P+ + + + I + PE
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPFRAGNEYLIFQKIIKLE-YDFPEKFF 234
Query: 295 PRMYSLMMECWHEVP 309
P+ L+ +
Sbjct: 235 PKARDLVEKLLVLDA 249
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.1 bits (210), Expect = 3e-19
Identities = 24/119 (20%), Positives = 53/119 (44%), Gaps = 7/119 (5%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+ + + YL +HRDL N L+ + + ++I+DFG ++ + + + ++
Sbjct: 117 IVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK------TPPSWIT 422
+ PE + SD+W+ G +++++ + GL P+ + F K P
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPFRAGNEYLIFQKIIKLEYDFPEKFF 234
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (454), Expect = 1e-53
Identities = 65/288 (22%), Positives = 117/288 (40%), Gaps = 25/288 (8%)
Query: 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDL 107
+ E I F LG GAF +V E ++ LVAIK + + A + E+ +
Sbjct: 3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQ--KLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 108 MSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQD 167
+ +++HPNIV L + SG + ++ + + G+L + ++ + +++D
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG------------FYTERD 108
Query: 168 FSHIALQVAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASDYYRI 224
S + QV + YL VHRDL N L + + ISDFGLS+
Sbjct: 109 ASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST 168
Query: 225 QSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR 284
+ ++ PE + ++ D WS GV+ + + G P+Y ++ ++ E I
Sbjct: 169 ACGTP---GYVAPEVLAQKPYSKAVDCWSIGVIAYILL-CGYPPFYDENDAKLFEQILKA 224
Query: 285 QM---LPCPEDCPPRMYSLMMECWHEVPVA-AGMAYLCSHHYVHRDLA 328
+ P +D + + P H ++ D A
Sbjct: 225 EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTA 272
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 69.7 bits (170), Expect = 7e-14
Identities = 28/109 (25%), Positives = 46/109 (42%), Gaps = 7/109 (6%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 366
V + YL VHRDL N L + + ISDFGLS+ +
Sbjct: 116 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTP-- 173
Query: 367 VRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
++ PE + ++ D WS GV+ + + G P+Y ++ + F +
Sbjct: 174 -GYVAPEVLAQKPYSKAVDCWSIGVIAYILL-CGYPPFYDENDAKLFEQ 220
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 3e-51
Identities = 59/256 (23%), Positives = 104/256 (40%), Gaps = 21/256 (8%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMS-ELRH 113
+ LG+G+FGKV+ E + AIK LK++ E ++S H
Sbjct: 5 ILHKMLGKGSFGKVFLAEFKKTN--QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 114 PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
P + + + E + + E++ GDL + S + A
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK------------FDLSRATFYAA 110
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR 233
++ G+ +L S V+RDL N L+ +KI+DFG+ ++ D
Sbjct: 111 EIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCG--TPD 168
Query: 234 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDC 293
++ PE +L K+ D WS+GV+L+E+ G P++G +E+ IR P
Sbjct: 169 YIAPEILLGQKYNHSVDWWSFGVLLYEML-IGQSPFHGQDEEELFHSIR-MDNPFYPRWL 226
Query: 294 PPRMYSLMMECWHEVP 309
L+++ + P
Sbjct: 227 EKEAKDLLVKLFVREP 242
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.1 bits (202), Expect = 5e-18
Identities = 31/104 (29%), Positives = 52/104 (50%), Gaps = 3/104 (2%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+ G+ +L S V+RDL N L+ +KI+DFG+ ++ D +
Sbjct: 112 IILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCG--TPDY 169
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
+ PE +L K+ D WS+GV+L+E+ G P++G +E F
Sbjct: 170 IAPEILLGQKYNHSVDWWSFGVLLYEML-IGQSPFHGQDEEELF 212
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 8e-51
Identities = 59/263 (22%), Positives = 102/263 (38%), Gaps = 30/263 (11%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTL-KENANQKTASDFRREVDLMSELRHPN 115
+F E+G G+F VYKG +E VA L + F+ E +++ L+HPN
Sbjct: 12 KFDIEIGRGSFKTVYKGL--DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 116 IVCLLGVCLS----GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHI 171
IV S + + ++ E M G L +L + +
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK------------VMKIKVLRSW 117
Query: 172 ALQVAAGMAYLCSHHY--VHRDLAARNCLV-GDGLTVKISDFGLSRDVYASDYYRIQSKS 228
Q+ G+ +L + +HRDL N + G +VKI D GL+ AS +
Sbjct: 118 CRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIG-- 175
Query: 229 LLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP 288
+M PE + K+ DV+++G+ + E+ + PY N I + + P
Sbjct: 176 --TPEFMAPE-MYEEKYDESVDVYAFGMCMLEMAT-SEYPYSECQNAAQIYRRVTSGVKP 231
Query: 289 --CPEDCPPRMYSLMMECWHEVP 309
+ P + ++ C +
Sbjct: 232 ASFDKVAIPEVKEIIEGCIRQNK 254
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.7 bits (204), Expect = 2e-18
Identities = 27/109 (24%), Positives = 48/109 (44%), Gaps = 9/109 (8%)
Query: 310 VAAGMAYLCSHHY--VHRDLAARNCLV-GDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 366
+ G+ +L + +HRDL N + G +VKI D GL+ AS +
Sbjct: 121 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIG----T 176
Query: 367 VRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
+M PE + K+ DV+++G+ + E+ + PY N + +
Sbjct: 177 PEFMAPE-MYEEKYDESVDVYAFGMCMLEMAT-SEYPYSECQNAAQIYR 223
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 166 bits (420), Expect = 4e-49
Identities = 52/263 (19%), Positives = 102/263 (38%), Gaps = 25/263 (9%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHP 114
+ LG G +V+ VA+K L+ + + FRRE + L HP
Sbjct: 10 ELGEILGFGGMSEVHLARDLRLH--RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 115 NIVCLLGVCLS----GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSH 170
IV + + G ++ E++ L + + + P ++ +
Sbjct: 68 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP------------MTPKRAIE 115
Query: 171 IALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL 230
+ + + + +HRD+ N ++ VK+ DFG++R + S Q+ +++
Sbjct: 116 VIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175
Query: 231 -PVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP- 288
+++ PE SDV+S G VL+EV G P+ G S V +P
Sbjct: 176 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL-TGEPPFTGDSPVSVAYQHVREDPIPP 234
Query: 289 --CPEDCPPRMYSLMMECWHEVP 309
E + +++++ + P
Sbjct: 235 SARHEGLSADLDAVVLKALAKNP 257
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 77.9 bits (191), Expect = 9e-17
Identities = 27/107 (25%), Positives = 49/107 (45%), Gaps = 2/107 (1%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLL-PVR 368
+ + + +HRD+ N ++ VK+ DFG++R + S Q+ +++ +
Sbjct: 120 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
++ PE SDV+S G VL+EV G P+ G S +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVL-TGEPPFTGDSPVSVAYQ 225
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 167 bits (423), Expect = 5e-49
Identities = 54/255 (21%), Positives = 101/255 (39%), Gaps = 23/255 (9%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHP 114
+ L+ LG G+FG+V+ + A+K LK+ K E ++S + HP
Sbjct: 7 QILRTLGTGSFGRVHLIRSRHNG--RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
I+ + G + + M+ +++ G+L L + A +
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPN------------PVAKFYAAE 112
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 234
V + YL S ++RDL N L+ +KI+DFG ++ V Y +
Sbjct: 113 VCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG-----TPDY 167
Query: 235 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCP 294
+ PE + + D WS+G++++E+ G P+Y + + E I + + L P
Sbjct: 168 IAPEVVSTKPYNKSIDWWSFGILIYEML-AGYTPFYDSNTMKTYEKILNAE-LRFPPFFN 225
Query: 295 PRMYSLMMECWHEVP 309
+ L+
Sbjct: 226 EDVKDLLSRLITRDL 240
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 85.9 bits (212), Expect = 2e-19
Identities = 32/169 (18%), Positives = 62/169 (36%), Gaps = 17/169 (10%)
Query: 260 EVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCS 319
++ + + IE +L + P + V + YL S
Sbjct: 68 RMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE-----VCLALEYLHS 122
Query: 320 HHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK 379
++RDL N L+ +KI+DFG ++ V Y ++ PE +
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG-----TPDYIAPEVVSTKP 177
Query: 380 FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK------TPPSWIT 422
+ D WS+G++++E+ G P+Y + + + K P +
Sbjct: 178 YNKSIDWWSFGILIYEML-AGYTPFYDSNTMKTYEKILNAELRFPPFFN 225
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-48
Identities = 61/275 (22%), Positives = 116/275 (42%), Gaps = 30/275 (10%)
Query: 47 FRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-----ENANQKTASDF 101
FR+E ++ +ELG G F V K ++ A K +K + + D
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTG--LQYAAKFIKKRRTKSSRRGVSREDI 60
Query: 102 RREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQA 161
REV ++ E++HPN++ L V + + ++ E + G+L +FL +
Sbjct: 61 EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE------------ 108
Query: 162 PLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD----GLTVKISDFGLSRDVY 217
L++++ + Q+ G+ YL S H DL N ++ D +KI DFGL+ +
Sbjct: 109 SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168
Query: 218 ASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEV 277
+ ++ + ++ PE + Y E+D+WS GV+ + + S G P+ G + QE
Sbjct: 169 FGNEFKNIFGT---PEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDTKQET 224
Query: 278 IEMIRSRQM---LPCPEDCPPRMYSLMMECWHEVP 309
+ + + + + + P
Sbjct: 225 LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDP 259
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.2 bits (184), Expect = 9e-16
Identities = 36/164 (21%), Positives = 65/164 (39%), Gaps = 16/164 (9%)
Query: 256 VVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMA 315
+ L EVY ++E++ ++ + E + G+
Sbjct: 76 ITLHEVYENKTDVIL------ILELVAGGELFDFLAEKESLTEEEATEFLK--QILNGVY 127
Query: 316 YLCSHHYVHRDLAARNCLVGD----GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMP 371
YL S H DL N ++ D +KI DFGL+ + + ++ + ++
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT---PEFVA 184
Query: 372 PESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
PE + Y E+D+WS GV+ + + S G P+ G + QE
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDTKQETLAN 227
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 161 bits (408), Expect = 3e-47
Identities = 55/268 (20%), Positives = 105/268 (39%), Gaps = 30/268 (11%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK--------ENANQKTASDFRREVDLM 108
+ LG G V + + A+K + Q+ +EVD++
Sbjct: 6 EPKEILGRGVSSVVRRCIHKPTC--KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 109 SELR-HPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQD 167
++ HPNI+ L + ++F+ M +G+L ++L + LS+++
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT------------LSEKE 111
Query: 168 FSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSK 227
I + + L + VHRDL N L+ D + +K++DFG S + + R
Sbjct: 112 TRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCG 171
Query: 228 S---LLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR 284
+ L P + + + E D+WS GV+++ + G P++ ++ MI S
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL-AGSPPFWHRKQMLMLRMIMSG 230
Query: 285 QM---LPCPEDCPPRMYSLMMECWHEVP 309
P +D + L+ P
Sbjct: 231 NYQFGSPEWDDYSDTVKDLVSRFLVVQP 258
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 81.3 bits (200), Expect = 5e-18
Identities = 25/109 (22%), Positives = 46/109 (42%), Gaps = 4/109 (3%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKS---LLP 366
+ + L + VHRDL N L+ D + +K++DFG S + + R + L P
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178
Query: 367 VRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
+ + + E D+WS GV+++ + G P++
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLL-AGSPPFWHRKQMLMLRM 226
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 159 bits (402), Expect = 2e-45
Identities = 57/261 (21%), Positives = 104/261 (39%), Gaps = 27/261 (10%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-----ENANQKTASDFRREVDLMSEL 111
+ +G G FG+VY G + A+K L + A + R + L+S
Sbjct: 7 SVHRIIGRGGFGEVYGCR-KADTG-KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 112 RHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHI 171
P IVC+ + + + + + M GDLH L S+ D
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE------------ADMRFY 112
Query: 172 ALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 231
A ++ G+ ++ + V+RDL N L+ + V+ISD GL+ D +
Sbjct: 113 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG----T 168
Query: 232 VRWMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM--LP 288
+M PE + G + + +D +S G +L+++ G P+ + ++ E+ R +
Sbjct: 169 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEIDRMTLTMAVE 227
Query: 289 CPEDCPPRMYSLMMECWHEVP 309
P+ P + SL+
Sbjct: 228 LPDSFSPELRSLLEGLLQRDV 248
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 75.2 bits (184), Expect = 1e-15
Identities = 24/111 (21%), Positives = 52/111 (46%), Gaps = 6/111 (5%)
Query: 304 CWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKS 363
++ + G+ ++ + V+RDL N L+ + V+ISD GL+ D +
Sbjct: 110 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG-- 167
Query: 364 LLPVRWMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
+M PE + G + + +D +S G +L+++ G P+ + +++
Sbjct: 168 --THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKH 215
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 3e-45
Identities = 53/255 (20%), Positives = 103/255 (40%), Gaps = 20/255 (7%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHP 114
+L+ LG+G FGKV + G A+K L++ + + E ++ RHP
Sbjct: 8 DYLKLLGKGTFGKVILVR-EKATG-RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
+ L + + +C + E+ G+L L +++ +
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV------------FTEERARFYGAE 113
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 234
+ + + YL S V+RD+ N ++ +KI+DFGL ++ + +
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG--TPEY 171
Query: 235 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCP 294
+ PE + + D W GVV++E+ G P+Y ++ + E+I + + P
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMM-CGRLPFYNQDHERLFELILMEE-IRFPRTLS 229
Query: 295 PRMYSLMMECWHEVP 309
P SL+ + P
Sbjct: 230 PEAKSLLAGLLKKDP 244
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.7 bits (175), Expect = 2e-14
Identities = 25/106 (23%), Positives = 47/106 (44%), Gaps = 3/106 (2%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+ + + YL S V+RD+ N ++ +KI+DFGL ++ + +
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG--TPEY 171
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
+ PE + + D W GVV++E+ G P+Y ++ F
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMM-CGRLPFYNQDHERLFEL 216
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 1e-44
Identities = 52/265 (19%), Positives = 106/265 (40%), Gaps = 37/265 (13%)
Query: 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVC 118
Q LG G GKV + ++ A+K L++ RREV+L + P+IV
Sbjct: 18 QVLGLGINGKVLQIFNKRTQ--EKFALKMLQD------CPKARREVELHWRASQCPHIVR 69
Query: 119 LLGVC----LSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
++ V + + ++ E + G+L + R + ++++ S I
Sbjct: 70 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ----------AFTEREASEIMKS 119
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 231
+ + YL S + HRD+ N L +K++DFG +++ + + +
Sbjct: 120 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP-- 177
Query: 232 VRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML---- 287
++ PE + K+ D+WS GV+++ + G P+Y + +++R +
Sbjct: 178 -YYVAPEVLGPEKYDKSCDMWSLGVIMYILL-CGYPPFYSNHGLAISPGMKTRIRMGQYE 235
Query: 288 ---PCPEDCPPRMYSLMMECWHEVP 309
P + + L+ P
Sbjct: 236 FPNPEWSEVSEEVKMLIRNLLKTEP 260
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.2 bits (179), Expect = 6e-15
Identities = 23/105 (21%), Positives = 46/105 (43%), Gaps = 7/105 (6%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 366
+ + YL S + HRD+ N L +K++DFG +++ + + +
Sbjct: 120 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP-- 177
Query: 367 VRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411
++ PE + K+ D+WS GV+++ + G P+Y
Sbjct: 178 -YYVAPEVLGPEKYDKSCDMWSLGVIMYILL-CGYPPFYSNHGLA 220
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 4e-44
Identities = 64/264 (24%), Positives = 102/264 (38%), Gaps = 16/264 (6%)
Query: 50 EVIETKPRF--LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDL 107
+V + PR+ L +GEGA+G V VAIK + +Q RE+ +
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSA-YDNVNK-VRVAIKKISPFEHQTYCQRTLREIKI 59
Query: 108 MSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQD 167
+ RH NI+ + + + M ++V LM + LS
Sbjct: 60 LLRFRHENIIGINDIIRAPTIEQMKDVYLV-----THLMGADLYKLLK----TQHLSNDH 110
Query: 168 FSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSK 227
+ Q+ G+ Y+ S + +HRDL N L+ +KI DFGL+R +
Sbjct: 111 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 170
Query: 228 SLLPVRW-MPPESILYGKFTTES-DVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ 285
+ RW PE +L K T+S D+WS G +L E+ + G + + I
Sbjct: 171 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLDQLNHILGIL 229
Query: 286 MLPCPEDCPPRMYSLMMECWHEVP 309
P ED + +P
Sbjct: 230 GSPSQEDLNCIINLKARNYLLSLP 253
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.3 bits (179), Expect = 6e-15
Identities = 33/122 (27%), Positives = 53/122 (43%), Gaps = 3/122 (2%)
Query: 296 RMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD 355
+ S C+ + G+ Y+ S + +HRDL N L+ +KI DFGL+R
Sbjct: 104 QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163
Query: 356 YYRIQSKSLLPVRW-MPPESILYGKFTTES-DVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
+ + RW PE +L K T+S D+WS G +L E+ + G ++
Sbjct: 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLDQL 222
Query: 414 LK 415
Sbjct: 223 NH 224
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 4e-43
Identities = 70/289 (24%), Positives = 123/289 (42%), Gaps = 27/289 (9%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSEL---R 112
+ E+GEGA+GKV+K G VA+K ++ + + REV ++ L
Sbjct: 10 ECVAEIGEGAYGKVFKA-RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 113 HPNIVCLLGVCLSGEP-----MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQD 167
HPN+V L VC + ++FE + + P + +
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-----------VPTET 117
Query: 168 FSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSK 227
+ Q+ G+ +L SH VHRDL +N LV +K++DFGL+R + +
Sbjct: 118 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTS 174
Query: 228 SLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287
++ + + PE +L + T D+WS G + E++ + G S+ + + I L
Sbjct: 175 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGKILDVIGL 233
Query: 288 PCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGD 336
P ED PR +L + +H ++ + +DL + CL +
Sbjct: 234 PGEEDW-PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLK-CLTFN 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.1 bits (186), Expect = 5e-16
Identities = 31/156 (19%), Positives = 62/156 (39%), Gaps = 5/156 (3%)
Query: 261 VYSYGLQPYYGYSNQEVIEMIR-SRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCS 319
++ + + + + + P + G+ +L S
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134
Query: 320 HHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK 379
H VHRDL +N LV +K++DFGL+R + + ++ + + PE +L
Sbjct: 135 HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWYRAPEVLLQSS 191
Query: 380 FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
+ T D+WS G + E++ + G S+ ++ K
Sbjct: 192 YATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGK 226
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 8e-43
Identities = 60/292 (20%), Positives = 114/292 (39%), Gaps = 59/292 (20%)
Query: 58 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIV 117
+ +G+G FG+V++G+ E VA+K + E+ LRH NI+
Sbjct: 7 LQESIGKGRFGEVWRGKWRGEE----VAVKIFSSREERSW--FREAEIYQTVMLRHENIL 60
Query: 118 CLLGVC----LSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
+ + + ++ ++ G L ++L ++ + +AL
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-------------TVTVEGMIKLAL 107
Query: 174 QVAAGMAYLCSH--------HYVHRDLAARNCLVGDGLTVKISDFGLSRDV-YASDYYRI 224
A+G+A+L HRDL ++N LV T I+D GL+ A+D I
Sbjct: 108 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 167
Query: 225 QSKSLL-PVRWMPPESIL------YGKFTTESDVWSYGVVLWEVYSYGL---------QP 268
+ R+M PE + + + +D+++ G+V WE+ P
Sbjct: 168 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227
Query: 269 YYG-----YSNQEVIEMIRSRQMLP------CPEDCPPRMYSLMMECWHEVP 309
YY S +E+ +++ +++ P + M +M ECW+
Sbjct: 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 279
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.0 bits (178), Expect = 6e-15
Identities = 31/129 (24%), Positives = 52/129 (40%), Gaps = 16/129 (12%)
Query: 310 VAAGMAYLCSH--------HYVHRDLAARNCLVGDGLTVKISDFGLSRDV-YASDYYRIQ 360
A+G+A+L HRDL ++N LV T I+D GL+ A+D I
Sbjct: 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 168
Query: 361 SKSLL-PVRWMPPESIL------YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
+ R+M PE + + + +D+++ G+V WE+ Q +
Sbjct: 169 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228
Query: 414 LKTPPSWIT 422
PS +
Sbjct: 229 YDLVPSDPS 237
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 148 bits (375), Expect = 2e-42
Identities = 58/240 (24%), Positives = 105/240 (43%), Gaps = 20/240 (8%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPN 115
L+++GEG +G VYK + E A+K ++ E ++ S RE+ ++ EL+H N
Sbjct: 5 HGLEKIGEGTYGVVYKAQNNYGE---TFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 116 IVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQV 175
IV L V + + + ++FE + + + L LQ+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG------------LESVTAKSFLLQL 109
Query: 176 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM 235
G+AY +HRDL +N L+ +KI+DFGL+R ++ + +
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYR 167
Query: 236 PPESIL-YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCP 294
P+ ++ K++T D+WS G + E+ G + G S + + I P ++ P
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMV-NGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 75.7 bits (185), Expect = 5e-16
Identities = 31/148 (20%), Positives = 60/148 (40%), Gaps = 4/148 (2%)
Query: 269 YYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328
+ V+ Q L D + + + G+AY +HRDL
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 329 ARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL-YGKFTTESDVW 387
+N L+ +KI+DFGL+R ++ + + P+ ++ K++T D+W
Sbjct: 128 PQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLMGSKKYSTTIDIW 185
Query: 388 SYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
S G + E+ G + G S ++ ++
Sbjct: 186 SVGCIFAEMV-NGTPLFPGVSEADQLMR 212
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-42
Identities = 50/277 (18%), Positives = 97/277 (35%), Gaps = 35/277 (12%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-----ENANQKTASDFRREVDLMSEL 111
+ LG G FG VY G + S+ VAIK ++ + + EV L+ ++
Sbjct: 7 QVGPLLGSGGFGSVYSG-IRVSDN-LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 112 R--HPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFS 169
++ LL + ++ E ++ + L ++
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-----------RGALQEELAR 113
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFGLSRDVYASDYYRIQSKS 228
QV + + + +HRD+ N L+ + +K+ DFG + + Y
Sbjct: 114 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGT- 172
Query: 229 LLPVRWMPPESILYGKFTTES-DVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287
+ PPE I Y ++ S VWS G++L+++ G P+ R +
Sbjct: 173 ---RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV-CGDIPFEHDEEI-------IRGQV 221
Query: 288 PCPEDCPPRMYSLMMECWHEVPVA-AGMAYLCSHHYV 323
+ L+ C P + +H ++
Sbjct: 222 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.0 bits (181), Expect = 1e-15
Identities = 24/115 (20%), Positives = 46/115 (40%), Gaps = 7/115 (6%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLV-GDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR 368
V + + + +HRD+ N L+ + +K+ DFG + + Y
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGT----RV 174
Query: 369 WMPPESILYGKFTTES-DVWSYGVVLWEVYSYGLQPYYGYSNQEEFLKTPPSWIT 422
+ PPE I Y ++ S VWS G++L+++ G P+ ++
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMV-CGDIPFEHDEEIIRGQVFFRQRVS 228
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 3e-42
Identities = 50/250 (20%), Positives = 104/250 (41%), Gaps = 27/250 (10%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTL-KENANQKTASDFRREVDLMSELRHPN 115
L ++G+G FG+V+K + VA+K + EN + RE+ ++ L+H N
Sbjct: 13 EKLAKIGQGTFGEVFKARHRKTG--QKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 116 IVCLLGVCLSGEP--------MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQD 167
+V L+ +C + + ++F+F + +
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK------------FTLSE 118
Query: 168 FSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR--DVYASDYYRIQ 225
+ + G+ Y+ + +HRD+ A N L+ +K++DFGL+R + +
Sbjct: 119 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 226 SKSLLPVRWMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR 284
+ ++ + + PPE +L + + D+W G ++ E+++ G + Q + +I
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQL 237
Query: 285 QMLPCPEDCP 294
PE P
Sbjct: 238 CGSITPEVWP 247
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.8 bits (193), Expect = 7e-17
Identities = 29/168 (17%), Positives = 65/168 (38%), Gaps = 9/168 (5%)
Query: 251 VWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPV 310
V + + Y Y + E + + +M+ +
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM-----L 126
Query: 311 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR--DVYASDYYRIQSKSLLPVR 368
G+ Y+ + +HRD+ A N L+ +K++DFGL+R + + + ++ +
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 369 WMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
+ PPE +L + + D+W G ++ E+++ G + Q +
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLAL 233
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 5e-42
Identities = 55/263 (20%), Positives = 103/263 (39%), Gaps = 24/263 (9%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPS-LVAIKTLKE---NANQKTASDFRREVDLMSELR 112
L+ LG GA+GKV+ + L A+K LK+ KT R E ++ +R
Sbjct: 27 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 86
Query: 113 H-PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHI 171
P +V L + + ++ +++ G+L L R ++ +
Sbjct: 87 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER------------FTEHEVQIY 134
Query: 172 ALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLP 231
++ + +L ++RD+ N L+ V ++DFGLS++ A + R
Sbjct: 135 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 194
Query: 232 VRWMPPESILYGK--FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM--- 286
+M P+ + G D WS GV+++E+ G P+ + I R +
Sbjct: 195 -EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL-TGASPFTVDGEKNSQAEISRRILKSE 252
Query: 287 LPCPEDCPPRMYSLMMECWHEVP 309
P P++ L+ + P
Sbjct: 253 PPYPQEMSALAKDLIQRLLMKDP 275
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.8 bits (162), Expect = 8e-13
Identities = 24/108 (22%), Positives = 46/108 (42%), Gaps = 4/108 (3%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+ + +L ++RD+ N L+ V ++DFGLS++ A + R +
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI-EY 196
Query: 370 MPPESILYGK--FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
M P+ + G D WS GV+++E+ G P+ + +
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELL-TGASPFTVDGEKNSQAE 243
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (373), Expect = 6e-42
Identities = 45/267 (16%), Positives = 88/267 (32%), Gaps = 30/267 (11%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
R +++G G+FG +Y G + VAIK E + ++
Sbjct: 10 RLGRKIGSGSFGDIYLGTDIAAG--EEVAIKLECVKTKHP---QLHIESKIYKMMQGGVG 64
Query: 117 VCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVA 176
+ + C + ++ ++ L + S S + +A Q+
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR-----------KFSLKTVLLLADQMI 113
Query: 177 AGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSR-----DVYASDYYRIQSKS 228
+ + Y+ S +++HRD+ N L+ G V I DFGL++ + YR
Sbjct: 114 SRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173
Query: 229 LLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP 288
R+ + L + + D+ S G VL L + + + R +
Sbjct: 174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233
Query: 289 ------CPEDCPPRMYSLMMECWHEVP 309
+ P + + C
Sbjct: 234 STPIEVLCKGYPSEFATYLNFCRSLRF 260
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 74.1 bits (181), Expect = 2e-15
Identities = 27/127 (21%), Positives = 47/127 (37%), Gaps = 8/127 (6%)
Query: 296 RMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLV---GDGLTVKISDFGLSR--- 349
R +SL + + + Y+ S +++HRD+ N L+ G V I DFGL++
Sbjct: 98 RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157
Query: 350 --DVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY 407
+ YR R+ + L + + D+ S G VL L
Sbjct: 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217
Query: 408 SNQEEFL 414
+ +
Sbjct: 218 AATKRQK 224
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 147 bits (371), Expect = 3e-41
Identities = 49/255 (19%), Positives = 93/255 (36%), Gaps = 23/255 (9%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN--ANQKTASDFRREVDLMSELRHP 114
++ LG G+FG+V + S + A+K L + K E ++ + P
Sbjct: 44 DRIKTLGTGSFGRVMLVKHKESG--NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
+V L + M+ E++ G++ L S+ A Q
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR------------FSEPHARFYAAQ 149
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 234
+ YL S ++RDL N L+ ++++DFG ++ V +
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG-----TPEA 204
Query: 235 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCP 294
+ PE IL + D W+ GV+++E+ G P++ ++ E I + P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMA-AGYPPFFADQPIQIYEKIV-SGKVRFPSHFS 262
Query: 295 PRMYSLMMECWHEVP 309
+ L+
Sbjct: 263 SDLKDLLRNLLQVDL 277
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 66.8 bits (162), Expect = 9e-13
Identities = 23/104 (22%), Positives = 45/104 (43%), Gaps = 6/104 (5%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+ YL S ++RDL N L+ ++++DFG ++ V +
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG-----TPEA 204
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413
+ PE IL + D W+ GV+++E+ G P++ + +
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMA-AGYPPFFADQPIQIY 247
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 4e-41
Identities = 65/282 (23%), Positives = 102/282 (36%), Gaps = 21/282 (7%)
Query: 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK----ENANQKTASDFRREVDLMSELRHP 114
L LGEG F VYK + +VAIK +K A RE+ L+ EL HP
Sbjct: 3 LDFLGEGQFATVYKARDKNTN--QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 115 NIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQ 174
NI+ LL + ++F+FM DL + S L+ L
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSL-----------VLTPSHIKAYMLM 108
Query: 175 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 234
G+ YL H +HRDL N L+ + +K++DFGL++ + S + +
Sbjct: 109 TLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS-FGSPNRAYTHQVVTRWYR 167
Query: 235 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCP 294
P + D+W+ G +L E+ + G S+ + + I P E P
Sbjct: 168 APELLFGARMYGVGVDMWAVGCILAELL-LRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 226
Query: 295 PRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGD 336
+ P + DL + +
Sbjct: 227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQG-LFLFN 267
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.3 bits (171), Expect = 4e-14
Identities = 24/106 (22%), Positives = 46/106 (43%), Gaps = 2/106 (1%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
G+ YL H +HRDL N L+ + +K++DFGL++ + S + +
Sbjct: 109 TLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS-FGSPNRAYTHQVVTRWYR 167
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
P + D+W+ G +L E+ + G S+ ++ +
Sbjct: 168 APELLFGARMYGVGVDMWAVGCILAELL-LRVPFLPGDSDLDQLTR 212
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 4e-41
Identities = 59/239 (24%), Positives = 108/239 (45%), Gaps = 16/239 (6%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPN 115
+ ++++GEG +G VYK + +VA+K ++ + + S RE+ L+ EL HPN
Sbjct: 5 QKVEKIGEGTYGVVYKARNKLTG--EVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 116 IVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQV 175
IV LL V + + ++FEF+ + DL +F+ + + + Q+
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT----------GIPLPLIKSYLFQL 111
Query: 176 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM 235
G+A+ SH +HRDL +N L+ +K++DFGL+R + + +
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRA 170
Query: 236 PPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCP 294
P + ++T D+WS G + E+ + + G S + + I P P
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.5 bits (182), Expect = 2e-15
Identities = 32/165 (19%), Positives = 67/165 (40%), Gaps = 14/165 (8%)
Query: 251 VWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPV 310
V V+ E Y + + ++ ++ + +P P + S + +
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKKFMD-ASALTGIPLPL-----IKSYLFQL------ 111
Query: 311 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM 370
G+A+ SH +HRDL +N L+ +K++DFGL+R + + +
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRA 170
Query: 371 PPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
P + ++T D+WS G + E+ + + G S ++ +
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFR 214
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 3e-40
Identities = 58/240 (24%), Positives = 110/240 (45%), Gaps = 18/240 (7%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLK-ENANQKTASDFRREVDLMSELRHPN 115
L+++GEG +G V+K + + +VA+K ++ ++ ++ S RE+ L+ EL+H N
Sbjct: 5 EKLEKIGEGTYGTVFKAKNRETH--EIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 116 IVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQV 175
IV L V S + + ++FEF + F + Q+
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP------------EIVKSFLFQL 110
Query: 176 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM 235
G+ + S + +HRDL +N L+ +K+++FGL+R R S ++ + +
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCYSAEVVTLWYR 168
Query: 236 PPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCP 294
PP+ + K ++T D+WS G + E+ + G + G + ++ I P E P
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.6 bits (182), Expect = 1e-15
Identities = 26/151 (17%), Positives = 61/151 (40%), Gaps = 6/151 (3%)
Query: 269 YYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHE---VPVAAGMAYLCSHHYVHR 325
+ + + + + + + + G+ + S + +HR
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHR 125
Query: 326 DLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK-FTTES 384
DL +N L+ +K+++FGL+R R S ++ + + PP+ + K ++T
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 385 DVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
D+WS G + E+ + G + G ++ +
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKR 214
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 142 bits (359), Expect = 5e-40
Identities = 49/276 (17%), Positives = 92/276 (33%), Gaps = 34/276 (12%)
Query: 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSE 110
V+ + + +GEG+FG +++G + VAIK ++ R E
Sbjct: 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNN--QQVAIKFEPRRSDAP---QLRDEYRTYKL 56
Query: 111 LRH-PNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFS 169
L I + G ++ + + G E L+ R S + +
Sbjct: 57 LAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGR----------KFSVKTVA 104
Query: 170 HIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL-----TVKISDFGLSR----DVYASD 220
A Q+ A + + V+RD+ N L+G + + DFG+ + V
Sbjct: 105 MAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH 164
Query: 221 YYRIQSKSLL-PVRWMPPESILYGKFTTESDVWSYGVVLWEVYS--YGLQPYYGYSNQEV 277
+ K+L R+M + L + + D+ + G V Q +N++
Sbjct: 165 IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224
Query: 278 IEMIRSRQMLPCPE----DCPPRMYSLMMECWHEVP 309
E I ++ P Y M +
Sbjct: 225 YERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAF 260
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 74.5 bits (182), Expect = 1e-15
Identities = 27/165 (16%), Positives = 57/165 (34%), Gaps = 16/165 (9%)
Query: 261 VYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSH 320
VY +G + + +++ + C + ++ + A + +
Sbjct: 66 VYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQML-----ARVQSIHEK 120
Query: 321 HYVHRDLAARNCLVGDGLT-----VKISDFGLSR----DVYASDYYRIQSKSLL-PVRWM 370
V+RD+ N L+G + + + DFG+ + V + K+L R+M
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 371 PPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
+ L + + D+ + G V G P+ G K
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFL-RGSLPWQGLKAATNKQK 224
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 7e-40
Identities = 55/260 (21%), Positives = 94/260 (36%), Gaps = 26/260 (10%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
+ +G G+FG VY+ ++C S LVAIK + + RE+ +M +L H NI
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSG--ELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 75
Query: 117 VCLLGVCLSGEP------MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSH 170
V L S + ++ +++ S+ + L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR---------HYSRAKQTLPVIYVKL 126
Query: 171 IALQVAAGMAYLCSHHYVHRDL-AARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSL 229
Q+ +AY+ S HRD+ L D +K+ DFG ++ + + S
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYIC 184
Query: 230 LPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289
P +T+ DVWS G VL E+ G + G S + + I P
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 290 PEDCPPRMYSLMMECWHEVP 309
E + + ++
Sbjct: 244 REQIREMNPNYTEFKFPQIK 263
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.7 bits (175), Expect = 2e-14
Identities = 26/107 (24%), Positives = 44/107 (41%), Gaps = 4/107 (3%)
Query: 310 VAAGMAYLCSHHYVHRDL-AARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR 368
+ +AY+ S HRD+ L D +K+ DFG ++ + + S
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRYY 188
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
P +T+ DVWS G VL E+ G + G S ++ ++
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVE 234
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 3e-38
Identities = 61/270 (22%), Positives = 109/270 (40%), Gaps = 22/270 (8%)
Query: 47 FRREVIETKP------RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTL-KENANQKTAS 99
+R+EV +T R LQ +G GA+G V V G + VAIK L + ++ A
Sbjct: 5 YRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSA-VDGRTG-AKVAIKKLYRPFQSELFAK 62
Query: 100 DFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQV 159
RE+ L+ +RH N++ LL V E + +F + + + + +
Sbjct: 63 RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE------ 116
Query: 160 QAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS 219
L + + Q+ G+ Y+ + +HRDL N V + +KI DFGL+R +
Sbjct: 117 --KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174
Query: 220 DYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIE 279
+ + P + + ++T D+WS G ++ E+ G + G + + ++
Sbjct: 175 MTGYVVT----RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI-TGKTLFKGSDHLDQLK 229
Query: 280 MIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
I P E +P
Sbjct: 230 EIMKVTGTPPAEFVQRLQSDEAKNYMKGLP 259
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.8 bits (144), Expect = 1e-10
Identities = 27/118 (22%), Positives = 52/118 (44%), Gaps = 11/118 (9%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+ G+ Y+ + +HRDL N V + +KI DFGL+R + + +
Sbjct: 130 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVT----RWYR 185
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK------TPPSWI 421
P + + ++T D+WS G ++ E+ G + G + ++ + TPP+
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMI-TGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 132 bits (332), Expect = 9e-36
Identities = 45/257 (17%), Positives = 99/257 (38%), Gaps = 27/257 (10%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR-HPN 115
+ +++LG G + +V++ T+ V +K LK +K +RE+ ++ LR PN
Sbjct: 38 QLVRKLGRGKYSEVFEAINITNN--EKVVVKILKPVKKKK----IKREIKILENLRGGPN 91
Query: 116 IVCLLGVCLS--GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIAL 173
I+ L + ++FE + D + L+ D
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---------------TLTDYDIRFYMY 136
Query: 174 QVAAGMAYLCSHHYVHRDLAARNCLVG-DGLTVKISDFGLSRDVYASDYYRIQSKSLLPV 232
++ + Y S +HRD+ N ++ + +++ D+GL+ + Y ++ S
Sbjct: 137 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS--RY 194
Query: 233 RWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPED 292
P + Y + D+WS G +L + ++G+ N + + I D
Sbjct: 195 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 254
Query: 293 CPPRMYSLMMECWHEVP 309
+ + ++++
Sbjct: 255 YIDKYNIELDPRFNDIL 271
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 61.0 bits (147), Expect = 6e-11
Identities = 20/107 (18%), Positives = 46/107 (42%), Gaps = 4/107 (3%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVG-DGLTVKISDFGLSRDVYASDYYRIQSKSLLPVR 368
+ + Y S +HRD+ N ++ + +++ D+GL+ + Y ++ S
Sbjct: 138 ILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS--RYF 195
Query: 369 WMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
P + Y + D+WS G +L + + +P++ + + L
Sbjct: 196 KGPELLVDYQMYDYSLDMWSLGCMLASMI-FRKEPFFHGHDNYDQLV 241
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-34
Identities = 54/270 (20%), Positives = 102/270 (37%), Gaps = 22/270 (8%)
Query: 47 FRREVIETKP------RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTL-KENANQKTAS 99
+R+E+ +T + L +G GA+G V T G VA+K L + + A
Sbjct: 5 YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTG-LRVAVKKLSRPFQSIIHAK 62
Query: 100 DFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQV 159
RE+ L+ ++H N++ LL V + + + L ++ +
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ------ 116
Query: 160 QAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYAS 219
L+ + Q+ G+ Y+ S +HRDL N V + +KI DFGL+R
Sbjct: 117 --KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174
Query: 220 DYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIE 279
+ + P + + + D+WS G ++ E+ + G + G + + ++
Sbjct: 175 MTGYVAT----RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLK 229
Query: 280 MIRSRQMLPCPEDCPPRMYSLMMECWHEVP 309
+I P E +
Sbjct: 230 LILRLVGTPGAELLKKISSESARNYIQSLT 259
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.0 bits (139), Expect = 7e-10
Identities = 30/175 (17%), Positives = 58/175 (33%), Gaps = 26/175 (14%)
Query: 241 LYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSL 300
L FT + + V + G Q++ + +
Sbjct: 82 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ------------ 129
Query: 301 MMECWHEVPVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQ 360
+ G+ Y+ S +HRDL N V + +KI DFGL+R +
Sbjct: 130 ---------ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA 180
Query: 361 SKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
+ P + + + D+WS G ++ E+ + G + G + ++
Sbjct: 181 T----RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKL 230
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 6e-34
Identities = 58/246 (23%), Positives = 101/246 (41%), Gaps = 16/246 (6%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTL-KENANQKTASDFRREVDLMSELRHPN 115
+ L+ +G GA G V + VAIK L + NQ A RE+ LM + H N
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 116 IVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQV 175
I+ LL V + + + + +L + + + + ++ ++ ++ Q+
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS---------YLLYQM 128
Query: 176 AAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWM 235
G+ +L S +HRDL N +V T+KI DFGL+R S + +
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---YYR 185
Query: 236 PPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPP 295
PE IL + D+WS G ++ E+ + G + + + PCPE
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 296 RMYSLM 301
++
Sbjct: 245 LQPTVR 250
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.3 bits (145), Expect = 1e-10
Identities = 29/106 (27%), Positives = 47/106 (44%), Gaps = 4/106 (3%)
Query: 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRW 369
+ G+ +L S +HRDL N +V T+KI DFGL+R S + +
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---YY 184
Query: 370 MPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415
PE IL + D+WS G ++ E+ + G +++ K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNK 229
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (253), Expect = 1e-24
Identities = 32/245 (13%), Positives = 82/245 (33%), Gaps = 11/245 (4%)
Query: 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI 116
+++LG G F V+ + + + VA+K ++ ++ E+ L+ + +
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNN--THVAMKIVR--GDKVYTEAAEDEIKLLQRVNDADN 71
Query: 117 VCLLGVCLSGE-PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSH---IA 172
+ + + F +H ++ ++ + + I+
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 173 LQVAAGMAYLCSHH-YVHRDLAARNCLV-GDGLTVKISDFGLSRDVYASDYYRIQSKSLL 230
Q+ G+ Y+ +H D+ N L+ + ++ A Y + S+
Sbjct: 132 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 231 PVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP 290
+ PE +L + +D+WS +++E+ G + + +
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELI-TGDFLFEPDEGHSYTKDDDHIAQIIEL 250
Query: 291 EDCPP 295
P
Sbjct: 251 LGELP 255
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 58.1 bits (139), Expect = 6e-10
Identities = 20/157 (12%), Positives = 52/157 (33%), Gaps = 3/157 (1%)
Query: 258 LWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYL 317
+ ++ + + ++ + +L + R L+ + G+ Y+
Sbjct: 82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYM 141
Query: 318 CSHH-YVHRDLAARNCLV-GDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESI 375
+H D+ N L+ + ++ A Y + S+ + PE +
Sbjct: 142 HRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVL 201
Query: 376 LYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEE 412
L + +D+WS +++E+ G +
Sbjct: 202 LGAPWGCGADIWSTACLIFELI-TGDFLFEPDEGHSY 237
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 78.3 bits (192), Expect = 1e-17
Identities = 30/206 (14%), Positives = 61/206 (29%), Gaps = 39/206 (18%)
Query: 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN---------QKTASDFRREVDLMSE 110
+ +GEG V+ SE +K K F +
Sbjct: 6 KLMGEGKESAVFNC---YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 111 LRHPNIVCLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSH 170
+ L G+ + ++ + L E + ++ ++
Sbjct: 63 NEFRALQKLQGLA-----VPKVYAWEGNAVLMELIDAKELYRVR----------VENPDE 107
Query: 171 IALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVY---ASDYYRIQSK 227
+ + +A VH DL+ N LV + + I DF S +V + +
Sbjct: 108 VLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVR 166
Query: 228 SLLPVRWMPPESILYGKFTTESDVWS 253
+++ + + TE D+ S
Sbjct: 167 NII--TY------FSRTYRTEKDINS 184
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 50.9 bits (121), Expect = 3e-08
Identities = 19/118 (16%), Positives = 38/118 (32%), Gaps = 15/118 (12%)
Query: 277 VIEMIRSRQMLPCPEDCPPRMYSLMMECWHE---VPVAAGMAYLCSHHYVHRDLAARNCL 333
V ++ E + + + + +A VH DL+ N L
Sbjct: 76 VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVL 135
Query: 334 VGDGLTVKISDFGLSRDVY---ASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWS 388
V + + I DF S +V + ++++ + + TE D+ S
Sbjct: 136 VSEE-GIWIIDFPQSVEVGEEGWREILERDVRNII--TY------FSRTYRTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 422 | |||
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.89 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.89 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.88 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.87 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.87 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.87 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.87 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.87 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.87 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.87 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.87 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.86 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.86 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.86 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.86 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.86 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.86 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.86 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.85 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.85 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.85 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.85 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.85 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.85 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.85 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.85 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.84 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.84 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.84 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.84 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.84 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.83 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.83 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.83 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.82 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.82 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.82 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.82 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.82 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.82 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.81 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.8 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.8 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.8 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.79 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.79 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.79 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.78 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.78 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.78 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.77 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.77 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.77 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.77 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.76 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.76 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.75 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.72 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.72 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.7 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.69 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.65 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 98.36 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.22 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.66 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.4 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.78 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.07 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 90.98 |
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-60 Score=448.78 Aligned_cols=258 Identities=37% Similarity=0.689 Sum_probs=226.7
Q ss_pred cCccccc-ccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 54 TKPRFLQ-ELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 54 ~~~~~~~-~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
.++.+.+ +||+|+||+||+|.++..+++..||||+++........+.|.+|+++|++++|||||+++|++.+ +.+|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4566666 49999999999998876666778999999877677777899999999999999999999999865 568999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
||||++|+|.+++.... ..+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 87 mE~~~~g~L~~~l~~~~-----------~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGl 155 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR-----------EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGL 155 (285)
T ss_dssp EECCTTEEHHHHHTTCT-----------TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred EEeCCCCcHHHHhhccc-----------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchh
Confidence 99999999999986532 3589999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcce-EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCC
Q psy7289 213 SRDVYASDYY-RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPE 291 (422)
Q Consensus 213 a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~ 291 (422)
|+........ .......+|+.|||||++..+.++.++|||||||++|||+|.|..||.+.+..++...|.++.+++.|+
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~ 235 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP 235 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT
T ss_pred hhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 9977654433 223345678999999999999999999999999999999998999999999999999999999999999
Q ss_pred CCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 292 DCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 292 ~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
+||+++.+||.+||+.+|..|| ++..+.+.|+
T Consensus 236 ~~~~~l~~li~~cl~~~p~~RP-----s~~~i~~~L~ 267 (285)
T d1u59a_ 236 ECPPELYALMSDCWIYKWEDRP-----DFLTVEQRMR 267 (285)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSC-----CHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCCHhHCc-----CHHHHHHHHH
Confidence 9999999999999999999998 7766666654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.4e-60 Score=450.96 Aligned_cols=265 Identities=39% Similarity=0.688 Sum_probs=222.3
Q ss_pred chhhccccCcccccccccccceeEEEEEEecCC-CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc
Q psy7289 47 FRREVIETKPRFLQELGEGAFGKVYKGEVCTSE-GPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLS 125 (422)
Q Consensus 47 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 125 (422)
+..++..++|++.+.||+|+||+||+|++..++ ....||||.+.........+.|.+|+++|++++|||||+++|++.+
T Consensus 19 f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~ 98 (299)
T d1jpaa_ 19 FAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK 98 (299)
T ss_dssp HSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 445666778999999999999999999986543 3457999998877777777899999999999999999999999999
Q ss_pred CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 126 GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 126 ~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
++.+++|||||++|+|.+++.... ..+++.++..++.||+.||+|||+++|+||||||+||||++++++
T Consensus 99 ~~~~~iv~Ey~~~g~L~~~~~~~~-----------~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~ 167 (299)
T d1jpaa_ 99 STPVMIITEFMENGSLDSFLRQND-----------GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVC 167 (299)
T ss_dssp SSSCEEEEECCTTEEHHHHHHTTT-----------TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCE
T ss_pred CCEEEEEEEecCCCcceeeecccc-----------CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcE
Confidence 999999999999999999987542 358999999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceE---eccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q psy7289 206 KISDFGLSRDVYASDYYR---IQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~ 282 (422)
||+|||+|+......... ......+|+.|||||.+..+.++.++|||||||++|||+|.|.+||.+.+..++...+.
T Consensus 168 Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~ 247 (299)
T d1jpaa_ 168 KVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE 247 (299)
T ss_dssp EECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred EECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999998765432211 12223468899999999999999999999999999999998999999999999999999
Q ss_pred cCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 283 SRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 283 ~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
.+.+++.|.+||+++.+||.+||+.+|..|+ +...+...|
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ei~~~L 287 (299)
T d1jpaa_ 248 QDYRLPPPMDCPSALHQLMLDCWQKDRNHRP-----KFGQIVNTL 287 (299)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSC-----CHHHHHHHH
T ss_pred cCCCCCCCccchHHHHHHHHHHcCCCHhHCc-----CHHHHHHHH
Confidence 9999999999999999999999999999998 665555544
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-59 Score=440.11 Aligned_cols=249 Identities=37% Similarity=0.689 Sum_probs=216.4
Q ss_pred cccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEEEecCC
Q psy7289 60 QELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLFEFMVR 138 (422)
Q Consensus 60 ~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~E~~~~ 138 (422)
++||+|+||+||+|.+...+..+.||||+++... +....+.|.+|+++|++++|||||+++|+|.+ +..++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 4799999999999998766667889999986543 33446789999999999999999999999965 567999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccccccC
Q psy7289 139 GDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYA 218 (422)
Q Consensus 139 G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~~~~~ 218 (422)
|+|.+++... ..+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+....
T Consensus 92 g~L~~~l~~~------------~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~ 159 (277)
T d1xbba_ 92 GPLNKYLQQN------------RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 159 (277)
T ss_dssp EEHHHHHHHC------------TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred CcHHHHHhhc------------cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccc
Confidence 9999999764 3589999999999999999999999999999999999999999999999999987654
Q ss_pred Ccce-EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCcch
Q psy7289 219 SDYY-RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPEDCPPRM 297 (422)
Q Consensus 219 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~p~~~ 297 (422)
.... .......+|+.|||||++....++.++|||||||++|||+|.|..||.+.+..++...+..+.+++.|..||+++
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~ 239 (277)
T d1xbba_ 160 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM 239 (277)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred cccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHH
Confidence 4332 233345678999999999999999999999999999999988999999999999999999999999999999999
Q ss_pred hhhcccccccccchhhHHHHhhhhhhhhh
Q psy7289 298 YSLMMECWHEVPVAAGMAYLCSHHYVHRD 326 (422)
Q Consensus 298 ~~l~~~cw~~~P~~r~~~~lh~~~~i~~d 326 (422)
.+||.+||+.+|..|| ++..+...
T Consensus 240 ~~li~~cl~~dp~~RP-----s~~~i~~~ 263 (277)
T d1xbba_ 240 YDLMNLCWTYDVENRP-----GFAAVELR 263 (277)
T ss_dssp HHHHHHHTCSSTTTSC-----CHHHHHHH
T ss_pred HHHHHHHcCCCHhHCc-----CHHHHHHH
Confidence 9999999999999998 55544433
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-58 Score=437.83 Aligned_cols=262 Identities=42% Similarity=0.704 Sum_probs=221.2
Q ss_pred hccccCcccccccccccceeEEEEEEecCCC--CeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEG--PSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
|+..+.|++.+.||+|+||.||+|+++.+.. ...||||+++..........|.+|+++|++++|||||+++|++.+.+
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 82 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence 4555678889999999999999999875432 25799999987777777778999999999999999999999999999
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
..++|||||.+|+|.+++.... ..+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~-----------~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl 151 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKD-----------GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKV 151 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTT-----------TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEE
T ss_pred ceEEEEEecccCcchhhhhccc-----------ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEE
Confidence 9999999999999999887642 35899999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcce-EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC
Q psy7289 208 SDFGLSRDVYASDYY-RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286 (422)
Q Consensus 208 ~DFGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~ 286 (422)
+|||+|+........ .......+|+.|||||++..+.++.++|||||||++|||++.|.+|+.+.+..++...+..+.+
T Consensus 152 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~ 231 (283)
T d1mqba_ 152 SDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR 231 (283)
T ss_dssp CCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred cccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC
Confidence 999999876543221 1233456789999999999999999999999999999999978888888899999999999999
Q ss_pred CCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 287 LPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 287 ~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
++.|.+||+++.+|+.+||+.+|..|| ++..+...|
T Consensus 232 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~eil~~L 267 (283)
T d1mqba_ 232 LPTPMDCPSAIYQLMMQCWQQERARRP-----KFADIVSIL 267 (283)
T ss_dssp CCCCTTCBHHHHHHHHHHTCSSTTTSC-----CHHHHHHHH
T ss_pred CCCchhhHHHHHHHHHHHCcCCHhHCc-----CHHHHHHHH
Confidence 999999999999999999999999998 555554433
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-58 Score=439.54 Aligned_cols=264 Identities=38% Similarity=0.725 Sum_probs=231.4
Q ss_pred ccchhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEE
Q psy7289 45 SDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCL 124 (422)
Q Consensus 45 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~ 124 (422)
+.-.+|+..++|++.++||+|+||+||+|++..+ +..||||+++.... ..++|.+|+++|++++|||||+++|+|.
T Consensus 8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~--~~~vAvK~i~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~ 83 (287)
T d1opja_ 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKY--SLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCT 83 (287)
T ss_dssp TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGG--TEEEEEEECCTTCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCC--CeEEEEEEECCccc--hHHHHHHHHHHHHhCCCCCEecCCccEe
Confidence 3345788889999999999999999999998644 47899999875432 3567999999999999999999999999
Q ss_pred cCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCe
Q psy7289 125 SGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLT 204 (422)
Q Consensus 125 ~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~ 204 (422)
+++.+++|||||++|+|.+++..... ..+++..+..++.||+.||+|||+++|+||||||+||||++++.
T Consensus 84 ~~~~~~iv~E~~~~g~l~~~l~~~~~----------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~ 153 (287)
T d1opja_ 84 REPPFYIITEFMTYGNLLDYLRECNR----------QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL 153 (287)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHSCT----------TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred eCCeeEEEeecccCcchHHHhhhccc----------cchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc
Confidence 99999999999999999999976421 36899999999999999999999999999999999999999999
Q ss_pred EEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC
Q psy7289 205 VKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR 284 (422)
Q Consensus 205 vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~ 284 (422)
+||+|||+|+....+... ......+++.|||||++..+.|+.++|||||||++|||++.|.+||.+.+..++.+.+..+
T Consensus 154 ~Kl~DFG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~ 232 (287)
T d1opja_ 154 VKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 232 (287)
T ss_dssp EEECCCCCTTTCCSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred EEEccccceeecCCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC
Confidence 999999999876554332 2334456889999999999999999999999999999999777778888888898999888
Q ss_pred CCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 285 QMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 285 ~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
.+++.|+.+|+++.+|+.+||+.+|..|+ +...+++.|+
T Consensus 233 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ei~~~L~ 271 (287)
T d1opja_ 233 YRMERPEGCPEKVYELMRACWQWNPSDRP-----SFAEIHQAFE 271 (287)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHH
T ss_pred CCCCCCccchHHHHHHHHHHcCCCHhHCc-----CHHHHHHHHH
Confidence 88999999999999999999999999999 6666666554
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-58 Score=446.92 Aligned_cols=278 Identities=36% Similarity=0.626 Sum_probs=228.6
Q ss_pred ccchhhccccCcccccccccccceeEEEEEEecCCC---CeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEe
Q psy7289 45 SDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSEG---PSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLL 120 (422)
Q Consensus 45 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~ 120 (422)
.+.++|+..++|++.+.||+|+||+||+|++..... ...||||.+...........|.+|+.+|+++ +|||||+++
T Consensus 28 ~~~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~ 107 (325)
T d1rjba_ 28 YDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLL 107 (325)
T ss_dssp CCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEE
Confidence 345678888999999999999999999999875432 3469999987655555667899999999998 899999999
Q ss_pred eEEEcCCCeEEEEEecCCCCHHHHHhhcCCCCC-----------CCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q psy7289 121 GVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSD-----------ISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVH 189 (422)
Q Consensus 121 g~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~-----------~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivH 189 (422)
+++.+.+.+++|||||++|+|.++|..+..... .........+++.++..++.||+.||+|||+++|||
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiH 187 (325)
T d1rjba_ 108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 187 (325)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 999999999999999999999999986532210 000112246899999999999999999999999999
Q ss_pred cCCCCCceeecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCC
Q psy7289 190 RDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPY 269 (422)
Q Consensus 190 rDlKp~NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf 269 (422)
|||||+|||++.++.+||+|||+|+...............+|+.|||||++..+.++.++|||||||++|||+|.|.+||
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 99999999999999999999999987665544444445567899999999999999999999999999999998899999
Q ss_pred CCCChHH-HHHHHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 270 YGYSNQE-VIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 270 ~~~~~~~-~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
.+.+..+ +...+..+.+++.|..||+++.+||.+||+.+|..|| +...+...|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RP-----t~~ei~~~L 321 (325)
T d1rjba_ 268 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP-----SFPNLTSFL 321 (325)
T ss_dssp TTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHH
T ss_pred CCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCc-----CHHHHHHHH
Confidence 9877654 5556677778889999999999999999999999998 666655544
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-58 Score=431.31 Aligned_cols=254 Identities=40% Similarity=0.740 Sum_probs=214.4
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
.++|+++++||+|+||.||+|++. ++..||||+++.... ..++|.+|++++++++|||||+++|+|.+++.+++|
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~---~~~~vAvK~i~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL---NKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET---TTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC---CCCEEEEEEECCCcC--cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 467899999999999999999874 246799999875432 346799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
||||++|+|.+++.... ..+++..+..++.|||.||+|||+++|+||||||+|||+++++.+||+|||+
T Consensus 79 ~E~~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGl 147 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQR-----------GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM 147 (263)
T ss_dssp EECCTTCBHHHHHHTTT-----------TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-
T ss_pred EEecCCCcHHHHhhccc-----------cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccch
Confidence 99999999999987542 3588999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPED 292 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~ 292 (422)
|+........ ......+|+.|||||++....|+.++|||||||++|||+|.|.+||.+.+..++...+..+.+++.|..
T Consensus 148 a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~ 226 (263)
T d1sm2a_ 148 TRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRL 226 (263)
T ss_dssp ------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTT
T ss_pred heeccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccc
Confidence 9876543322 223456789999999999999999999999999999999988899999999999999999999999999
Q ss_pred CCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 293 CPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 293 ~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
||+++.+||.+||+.+|..|+ ++..+.+.|+
T Consensus 227 ~~~~l~~li~~cl~~~p~~Rp-----s~~~il~~L~ 257 (263)
T d1sm2a_ 227 ASTHVYQIMNHCWKERPEDRP-----AFSRLLRQLA 257 (263)
T ss_dssp SCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHH
T ss_pred cCHHHHHHHHHHccCCHhHCc-----CHHHHHHHHH
Confidence 999999999999999999998 6666655443
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-58 Score=433.67 Aligned_cols=257 Identities=28% Similarity=0.467 Sum_probs=210.6
Q ss_pred hhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 49 REVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 49 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
||+...+|++.+.||+|+||+||+|++. ..||||+++.. .+....+.|.+|+.+|++++|||||+++|++.+ +
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~ 76 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH-----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-P 76 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS-----SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC-----CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-c
Confidence 5778889999999999999999999752 24999998643 344567789999999999999999999998764 5
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
.+++|||||++|+|.+++.... ..+++.++..++.|||.||+|||+++||||||||+||||++++.+||
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl 145 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHIIE-----------TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKI 145 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTSC-----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEE
T ss_pred EEEEEEecCCCCCHHHHHhhcc-----------CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEE
Confidence 6899999999999999997542 35899999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCcccccc---CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHH-HHHHHHc
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY---GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQE-VIEMIRS 283 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~-~~~~i~~ 283 (422)
+|||+|+...............+|+.|||||++.. ..|+.++|||||||++|||+| |..||.+.++.+ +...+..
T Consensus 146 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~t-g~~Pf~~~~~~~~~~~~~~~ 224 (276)
T d1uwha_ 146 GDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRDQIIFMVGR 224 (276)
T ss_dssp CCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHH-SSCTTTTCCCHHHHHHHHHH
T ss_pred ccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHH-CCCCCCCCChHHHHHHHHhc
Confidence 99999987654333333345678999999999864 358999999999999999999 999999887664 4455555
Q ss_pred CCCCC----CCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 284 RQMLP----CPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 284 ~~~~~----~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
+...| .+.+||+++.+||.+||+.+|..|+ ++..+...|+
T Consensus 225 ~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~~il~~Le 268 (276)
T d1uwha_ 225 GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERP-----LFPQILASIE 268 (276)
T ss_dssp TSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHH
T ss_pred CCCCCcchhccccchHHHHHHHHHHcCCCHhHCc-----CHHHHHHHHH
Confidence 54443 4678999999999999999999998 6665555543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-58 Score=431.86 Aligned_cols=258 Identities=37% Similarity=0.700 Sum_probs=225.0
Q ss_pred hhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
.+|+...+|++.++||+|+||.||+|++. ++..||||+++... ...+.|.+|+.+|++++|||||+++|++.+ +
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~---~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN---GHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET---TTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEEC---CCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence 46788889999999999999999999863 34679999987543 234679999999999999999999998864 5
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
.+++|||||++|+|.+++.... ...+++.++.+++.||+.||+|||+++|+||||||+||||++++.+||
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~----------~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl 150 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPS----------GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKI 150 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHH----------HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEE
T ss_pred CeEEEEEeCCCCcHHHHHhhcC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceee
Confidence 6799999999999999876532 135899999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+|||+|+....... .......+|+.|||||++..+.++.++|||||||++|||+|.|.+||...+..+++..+..+.++
T Consensus 151 ~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~ 229 (272)
T d1qpca_ 151 ADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM 229 (272)
T ss_dssp CCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC
T ss_pred ccccceEEccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC
Confidence 99999987654432 33445567899999999998999999999999999999999788888888999999999999999
Q ss_pred CCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
+.|..+|+++.+|+.+||+.+|..|+ ++..+.+.|
T Consensus 230 ~~p~~~~~~l~~li~~cl~~~P~~Rp-----t~~ei~~~L 264 (272)
T d1qpca_ 230 VRPDNCPEELYQLMRLCWKERPEDRP-----TFDYLRSVL 264 (272)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHH
T ss_pred CCcccChHHHHHHHHHHcCCCHhHCc-----CHHHHHHHh
Confidence 99999999999999999999999998 655555443
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.2e-58 Score=436.16 Aligned_cols=276 Identities=52% Similarity=0.972 Sum_probs=235.6
Q ss_pred hhhccccCcccccccccccceeEEEEEEecC---CCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEE
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTS---EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCL 124 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~ 124 (422)
..|++.++|+++++||+|+||+||+|++... .++..||||+++........++|.+|+++|++++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 3566777899999999999999999998642 3457899999987666667788999999999999999999999999
Q ss_pred cCCCeEEEEEecCCCCHHHHHhhcCCCCCCC------------CCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy7289 125 SGEPMCMLFEFMVRGDLHEFLMSRSPRSDIS------------GSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDL 192 (422)
Q Consensus 125 ~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~------------~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDl 192 (422)
+.+..+++|||+++|+|.++|.......... .......+++.++..++.|++.||+|||+++||||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence 9999999999999999999997654321100 0111235899999999999999999999999999999
Q ss_pred CCCceeecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Q psy7289 193 AARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY 272 (422)
Q Consensus 193 Kp~NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~ 272 (422)
||+|||++.++.+||+|||+|+...........+...+|+.|||||.+....|+.++|||||||++|||++.+.+||.+.
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence 99999999999999999999987654443334445667889999999999999999999999999999999667899999
Q ss_pred ChHHHHHHHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 273 SNQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 273 ~~~~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
+..++...+..+.+++.|.++|+++.+||.+||+.+|..|| ++..+++.|+
T Consensus 247 ~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RP-----t~~ev~~~L~ 297 (301)
T d1lufa_ 247 AHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRP-----SFCSIHRILQ 297 (301)
T ss_dssp CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHH
T ss_pred CHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCc-----CHHHHHHHHH
Confidence 99999999999999999999999999999999999999999 7777777664
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-58 Score=429.95 Aligned_cols=262 Identities=39% Similarity=0.685 Sum_probs=220.0
Q ss_pred hhccccCcccccccccccceeEEEEEEecCC-CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 49 REVIETKPRFLQELGEGAFGKVYKGEVCTSE-GPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 49 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
+|+..++|++.+.||+|+||.||+|++...+ ....||||.++........+.|.+|+.+|++++|||||+++|++. .+
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 80 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 80 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 5677789999999999999999999886543 346799999876666667788999999999999999999999986 46
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
.+++|||||++|+|.+++.... ..+++.++..++.||+.||+|||+++|+||||||+||++++++.+||
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~-----------~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl 149 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRK-----------YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKL 149 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTT-----------TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEE
T ss_pred eEEEEEEeccCCcHHhhhhccC-----------CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEE
Confidence 7899999999999999987542 35899999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+|||+|+........ ......+|+.|||||++....++.++|||||||++|||++.|.+||.+.+..++...+.++.++
T Consensus 150 ~DfG~a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~ 228 (273)
T d1mp8a_ 150 GDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 228 (273)
T ss_dssp CC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC
T ss_pred ccchhheeccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999999876443322 2334567899999999999999999999999999999999899999999999999999999999
Q ss_pred CCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
+.|++||+++.+||.+||+.+|..|+ +...+...|+
T Consensus 229 ~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ei~~~L~ 264 (273)
T d1mp8a_ 229 PMPPNCPPTLYSLMTKCWAYDPSRRP-----RFTELKAQLS 264 (273)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCc-----CHHHHHHHHH
Confidence 99999999999999999999999998 6665555543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-57 Score=421.90 Aligned_cols=253 Identities=38% Similarity=0.706 Sum_probs=224.9
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
.+.|++.++||+|+||+||+|+++ ++..||||+++.... ..++|.+|+.++++++|||||+++|+|.+++.+++|
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~---~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR---GQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET---TTEEEEEEEEESSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC---CCCEEEEEEECcCcC--CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 356889999999999999999973 357899999875432 346799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+++|+|.+++.... ..+++..+.+++.||++||+|||++||+||||||+|||+++++.+||+|||+
T Consensus 78 ~Ey~~~g~l~~~~~~~~-----------~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~ 146 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMR-----------HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGL 146 (258)
T ss_dssp EECCTTEEHHHHHHSGG-----------GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSS
T ss_pred EEccCCCcHHHhhhccc-----------cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchh
Confidence 99999999999986542 3588999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPED 292 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~ 292 (422)
++........ ......+|+.|||||.+....++.++|||||||++|||+|.|..||.+.+..++...+.++.+++.|..
T Consensus 147 a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~ 225 (258)
T d1k2pa_ 147 SRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHL 225 (258)
T ss_dssp CCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTT
T ss_pred heeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCccc
Confidence 9876544332 233456789999999999999999999999999999999989999999999999999999999999999
Q ss_pred CCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 293 CPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 293 ~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
+|+++.+||.+||..+|..|+ ++..+..+|
T Consensus 226 ~~~~l~~li~~cl~~dP~~RP-----t~~eil~~L 255 (258)
T d1k2pa_ 226 ASEKVYTIMYSCWHEKADERP-----TFKILLSNI 255 (258)
T ss_dssp CCHHHHHHHHHTTCSSGGGSC-----CHHHHHHHH
T ss_pred ccHHHHHHHHHHccCCHhHCc-----CHHHHHHHh
Confidence 999999999999999999999 666665544
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-57 Score=428.02 Aligned_cols=247 Identities=21% Similarity=0.354 Sum_probs=207.0
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc--CCCeE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLS--GEPMC 130 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~~~ 130 (422)
++|++++.||+|+||+||+|+.+.+ ++.||||.++.. .++...+.|.+|+++|++++|||||++++++.+ ++.+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSD--GKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTT--CCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCC--CCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 4689999999999999999987544 478999998654 355567789999999999999999999999865 45689
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCCCceeecCCCeE
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHH-----YVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-----ivHrDlKp~NiLl~~~~~v 205 (422)
+|||||++|+|.+++.+.... ...+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~--------~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~v 153 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKE--------RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV 153 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHH--------TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCE
T ss_pred EEEecCCCCcHHHHHHhcccc--------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcE
Confidence 999999999999998753211 136999999999999999999999976 9999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ 285 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~ 285 (422)
||+|||+|+....... ......+|+.|||||++....|+.++|||||||++|||++ |..||.+.+..++...|.++.
T Consensus 154 kl~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~t-g~~Pf~~~~~~~~~~~i~~~~ 230 (269)
T d2java1 154 KLGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA-LMPPFTAFSQKELAGKIREGK 230 (269)
T ss_dssp EECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHTC
T ss_pred EEeeccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhh-CCCCCCCCCHHHHHHHHHcCC
Confidence 9999999987643321 2334568999999999999999999999999999999999 999999999999999999998
Q ss_pred CCCCCCCCCcchhhhcccccccccchhh
Q psy7289 286 MLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 286 ~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
..+.|..+|+++.+|+.+||..||..|+
T Consensus 231 ~~~~~~~~s~~l~~li~~~L~~dp~~Rp 258 (269)
T d2java1 231 FRRIPYRYSDELNEIITRMLNLKDYHRP 258 (269)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred CCCCCcccCHHHHHHHHHHcCCChhHCc
Confidence 8888999999999999999999999997
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-57 Score=422.36 Aligned_cols=250 Identities=25% Similarity=0.404 Sum_probs=218.1
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
++|++.+.||+|+||+||+|+...+ ++.||||++.... .....+.+.+|+++|++++|||||++++++.+++.+|+
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~--~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQS--KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTT--CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCC--CcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 4689999999999999999987543 5789999985321 12235678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
|||||++|+|.+++... ..+++.++..++.||+.||+|||+++|+||||||+|||+++++.+||+|||
T Consensus 84 vmEy~~~g~L~~~l~~~------------~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG 151 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKL------------SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 151 (263)
T ss_dssp EEECCTTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred EEeecCCCcHHHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccc
Confidence 99999999999999764 358999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCC
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPE 291 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~ 291 (422)
+|+....... ....||+.|||||++.+..|+.++|||||||++|||++ |..||.+.+..++...+.... ++.|+
T Consensus 152 ~a~~~~~~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~ 225 (263)
T d2j4za1 152 WSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV-GKPPFEANTYQETYKRISRVE-FTFPD 225 (263)
T ss_dssp SCSCCCCCCC----EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHTTC-CCCCT
T ss_pred eeeecCCCcc----cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhc-CCCCCCCCCHHHHHHHHHcCC-CCCCc
Confidence 9987654322 23467899999999999999999999999999999999 999999999999999887765 56788
Q ss_pred CCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 292 DCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 292 ~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
.+|+++.+|+.+||..||..|+ +..+.+|.++
T Consensus 226 ~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~ 258 (263)
T d2j4za1 226 FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHH
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCc
Confidence 9999999999999999999986 3334555554
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-57 Score=428.12 Aligned_cols=260 Identities=23% Similarity=0.341 Sum_probs=213.1
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
++|++++.||+|+||+||+|+++.+ ++.||||+++........+.+.+|+++|++++|||||++++++.+++.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~--~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVT--EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTT--CCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCC--CCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 4689999999999999999987544 57899999875544444567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
|||++|+|.++|..+ ..+++.++..++.||++||+|||++||+||||||+|||+++++.+||+|||+|
T Consensus 83 Ey~~gg~L~~~l~~~------------~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a 150 (271)
T d1nvra_ 83 EYCSGGELFDRIEPD------------IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA 150 (271)
T ss_dssp ECCTTEEGGGGSBTT------------TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred eccCCCcHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhh
Confidence 999999999998653 36999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcceEeccCCCCCccccCccccccCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCChH-HHHHHHHcC-CCCCCC
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYGKF-TTESDVWSYGVVLWEVYSYGLQPYYGYSNQ-EVIEMIRSR-QMLPCP 290 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~-~~~~~i~~~-~~~~~p 290 (422)
+...............||+.|||||++....+ +.++|||||||++|||++ |.+||.+.+.. .....+... ...+.+
T Consensus 151 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 229 (271)
T d1nvra_ 151 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPWDQPSDSCQEYSDWKEKKTYLNPW 229 (271)
T ss_dssp EECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHH-SSCSCSSSSTTSHHHHHHHTTCTTSTTG
T ss_pred eeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCcc
Confidence 87654443334455678999999999988776 578999999999999999 99999876543 333333333 333334
Q ss_pred CCCCcchhhhcccccccccchhh-HHHHhhhhhhhhhcc
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRDLA 328 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~dLk 328 (422)
..+++++.+|+.+||+.+|..|+ +..+.+|.++.+.++
T Consensus 230 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l~ 268 (271)
T d1nvra_ 230 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 268 (271)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCCC
Confidence 67899999999999999999985 445667777665543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-57 Score=433.27 Aligned_cols=250 Identities=35% Similarity=0.611 Sum_probs=215.3
Q ss_pred cccCcccccccccccceeEEEEEEecCCC--CeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEG--PSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
..++|++++.||+|+||+||+|++..++. ...||||.++...+....+.|.+|+.+|++++|||||+++|+|.++ ..
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 34579999999999999999999865432 2368999987655556678899999999999999999999999864 57
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEec
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISD 209 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~D 209 (422)
+++|||+.+|+|.+++.... ..+++..+.+++.|||.||+|||+++||||||||+|||++.++.+||+|
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~-----------~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~D 154 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHK-----------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITD 154 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTS-----------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECC
T ss_pred eEEEEeccCCcccccccccc-----------cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeec
Confidence 88999999999999987642 3689999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 289 (422)
||+|+...............+|+.|||||++..+.|+.++|||||||++|||+|.|.+||.+.+..++...+..+.+++.
T Consensus 155 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~ 234 (317)
T d1xkka_ 155 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 234 (317)
T ss_dssp CSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCC
T ss_pred cccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99998765544433344456789999999999999999999999999999999989999999999999999999999999
Q ss_pred CCCCCcchhhhcccccccccchhh
Q psy7289 290 PEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 290 p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
|+.||+++.+|+.+||..+|..||
T Consensus 235 p~~~~~~~~~li~~cl~~dP~~RP 258 (317)
T d1xkka_ 235 PPICTIDVYMIMVKCWMIDADSRP 258 (317)
T ss_dssp CTTBCHHHHHHHHHHTCSSGGGSC
T ss_pred CcccCHHHHHHHHHhCCCChhhCc
Confidence 999999999999999999999998
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-57 Score=425.91 Aligned_cols=254 Identities=26% Similarity=0.431 Sum_probs=216.5
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
++.|+++++||+|+||.||+|++..+ +..||||+++... ....+.|.+|+++|++++|||||++++++.+++.+++|
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~--~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 87 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKET--SVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 87 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT--CCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCC--CeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEE
Confidence 45689999999999999999987544 5789999986543 34456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
||||++|+|.+++.+.. .++++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 88 mEy~~~g~L~~~~~~~~-----------~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~ 156 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELE-----------RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGV 156 (288)
T ss_dssp EECCTTEEHHHHHHHHT-----------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EecCCCCcHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechh
Confidence 99999999999987642 3599999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccc-----cCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC-
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESIL-----YGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM- 286 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~- 286 (422)
|+...... .......||+.|||||++. ...|+.++|||||||++|||++ |..||.+.+..+++..+..+..
T Consensus 157 a~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemlt-g~~Pf~~~~~~~~~~~i~~~~~~ 233 (288)
T d2jfla1 157 SAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE-IEPPHHELNPMRVLLKIAKSEPP 233 (288)
T ss_dssp CEECHHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHH-SSCTTTTSCGGGHHHHHHHSCCC
T ss_pred hhccCCCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCCC
Confidence 97543221 1233567899999999984 4568999999999999999999 9999999999999888887654
Q ss_pred -CCCCCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 287 -LPCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 287 -~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
.+.|..+|+++.+|+.+||..||..|+ +..+.+|.++
T Consensus 234 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~ 272 (288)
T d2jfla1 234 TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272 (288)
T ss_dssp CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 344678999999999999999999996 3344455544
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-56 Score=422.76 Aligned_cols=252 Identities=23% Similarity=0.421 Sum_probs=216.4
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
..+|+++++||+|+||+||+|+... +++.||||+++.... ...+.+.+|+++|++++|||||++++++.+++.+|+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~--~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVA--TGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTT--TCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECC--CCCEEEEEEEecccC-hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 3479999999999999999998644 357899999864332 2346799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
||||++|+|.+++.++ .+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 96 mEy~~gg~L~~~~~~~-------------~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~ 162 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTET-------------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF 162 (293)
T ss_dssp EECCTTCBHHHHHHHS-------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred EEecCCCcHHHHhhcc-------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchh
Confidence 9999999999988653 589999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC--CCCC
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM--LPCP 290 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~--~~~p 290 (422)
|+....... ......||+.|||||++.++.|+.++|||||||++|||++ |..||.+.+..+.+..+..... ++.|
T Consensus 163 a~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T d1yhwa1 163 CAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNENPLRALYLIATNGTPELQNP 239 (293)
T ss_dssp CEECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHHCSCCCSSG
T ss_pred heeeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCc
Confidence 987644322 2345568999999999999999999999999999999999 9999999988877776654433 3456
Q ss_pred CCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
..+|+++.+|+.+||..||..|+ +..+.+|.++
T Consensus 240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~ 273 (293)
T d1yhwa1 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273 (293)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGG
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 78999999999999999999996 3445555555
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-56 Score=424.23 Aligned_cols=244 Identities=20% Similarity=0.344 Sum_probs=212.5
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
++|++++.||+|+||+||+|+...+ ++.||||+++... .....+.+.+|+++|++++|||||++++++.+++.+|+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELAT--SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT--CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCC--CCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 4689999999999999999987544 5779999986421 12345679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
|||||++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|||
T Consensus 86 vmEy~~gg~L~~~~~~~------------~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG 153 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKI------------GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFG 153 (288)
T ss_dssp EECCCTTEEHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEccCCCCHHHhhhcc------------CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccc
Confidence 99999999999998765 369999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCC
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPE 291 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~ 291 (422)
+|+...............||+.|||||++.+..|+.++|||||||++|||++ |..||.+.+..++...|.++. ...|+
T Consensus 154 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~-g~~Pf~~~~~~~~~~~i~~~~-~~~p~ 231 (288)
T d1uu3a_ 154 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPFRAGNEYLIFQKIIKLE-YDFPE 231 (288)
T ss_dssp TCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHTTC-CCCCT
T ss_pred cceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhh-CCCCCCCcCHHHHHHHHHcCC-CCCCc
Confidence 9987654333333345578999999999999999999999999999999999 999999999999999988765 56788
Q ss_pred CCCcchhhhcccccccccchhh
Q psy7289 292 DCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 292 ~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
.+++++.+|+++||..||..|+
T Consensus 232 ~~s~~~~~li~~~L~~dP~~R~ 253 (288)
T d1uu3a_ 232 KFFPKARDLVEKLLVLDATKRL 253 (288)
T ss_dssp TCCHHHHHHHHTTSCSSGGGST
T ss_pred cCCHHHHHHHHHHccCCHhHCc
Confidence 9999999999999999999997
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=420.59 Aligned_cols=279 Identities=38% Similarity=0.712 Sum_probs=234.5
Q ss_pred cccchhhccccCcccccccccccceeEEEEEEecCC-----CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCcee
Q psy7289 44 ASDFRREVIETKPRFLQELGEGAFGKVYKGEVCTSE-----GPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIV 117 (422)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv 117 (422)
+.+.++++..++|++.+.||+|+||.||+|+....+ ....||||+++..........+.+|...+.++ +|||||
T Consensus 3 ~~~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv 82 (299)
T d1fgka_ 3 PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNII 82 (299)
T ss_dssp CCCTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CcCCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEE
Confidence 345568888899999999999999999999876543 23579999998777777778899999999888 799999
Q ss_pred eEeeEEEcCCCeEEEEEecCCCCHHHHHhhcCCCCCC----CCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy7289 118 CLLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDI----SGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLA 193 (422)
Q Consensus 118 ~l~g~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~----~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlK 193 (422)
+++++|.+++.+++|||||++|+|.++|..+...... ........+++.++.+++.||+.||+|||+++|||||||
T Consensus 83 ~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiK 162 (299)
T d1fgka_ 83 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 162 (299)
T ss_dssp CEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred ecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeec
Confidence 9999999999999999999999999999875422100 001112468999999999999999999999999999999
Q ss_pred CCceeecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCC
Q psy7289 194 ARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYS 273 (422)
Q Consensus 194 p~NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~ 273 (422)
|+|||++.++.+||+|||+++...............+|+.|||||.+..+.|+.++|||||||++|||++.|.+||.+.+
T Consensus 163 p~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 163 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp GGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 99999999999999999999877554333333445678899999999999999999999999999999998899999999
Q ss_pred hHHHHHHHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 274 NQEVIEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 274 ~~~~~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
..++...+.++.+++.|..+|+++.+|+.+||+.+|..|+ +...+.++|
T Consensus 243 ~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rp-----s~~eil~~L 291 (299)
T d1fgka_ 243 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP-----TFKQLVEDL 291 (299)
T ss_dssp HHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCc-----CHHHHHHHH
Confidence 9999999999999999999999999999999999999999 777666655
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-55 Score=422.15 Aligned_cols=256 Identities=25% Similarity=0.438 Sum_probs=218.6
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 130 (422)
+..|+.+++||+|+||+||+|+... ++..||||+++... .....+.|.+|+++|++++|||||++++++.+++.+|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 91 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVR--NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETT--TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECC--CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEE
Confidence 3468889999999999999998754 35789999986543 2344567999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+|||||++|+|..++..+ .++++.++..++.||+.||+|||++|||||||||+|||+++++.+||+||
T Consensus 92 iv~E~~~~g~l~~~~~~~------------~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DF 159 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHK------------KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF 159 (309)
T ss_dssp EEEECCSEEHHHHHHHHT------------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCC
T ss_pred EEEEecCCCchHHHHHhC------------CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeec
Confidence 999999999998777653 36899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCcccccc---CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILY---GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
|+|+..... ....||+.|||||++.. ..|+.++|||||||++|||++ |..||.+.+..+.+..+..+..+
T Consensus 160 G~a~~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~-g~~Pf~~~~~~~~~~~i~~~~~~ 232 (309)
T d1u5ra_ 160 GSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNESP 232 (309)
T ss_dssp TTCBSSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSCCC
T ss_pred ccccccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHH-CCCCCCCCCHHHHHHHHHhCCCC
Confidence 999865432 34568999999999864 458999999999999999999 99999999988888887766654
Q ss_pred C-CCCCCCcchhhhcccccccccchhh-HHHHhhhhhhhhhccc
Q psy7289 288 P-CPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRDLAA 329 (422)
Q Consensus 288 ~-~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~dLk~ 329 (422)
+ .+..+|+++.+|+.+||..||..|+ +..+.+|.++.+...+
T Consensus 233 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~~ 276 (309)
T d1u5ra_ 233 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276 (309)
T ss_dssp CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCCCc
Confidence 4 3557899999999999999999996 4456677777654433
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=417.00 Aligned_cols=259 Identities=37% Similarity=0.707 Sum_probs=218.7
Q ss_pred hhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE 127 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 127 (422)
.+|+..++|++.+.||+|+||+||+|++.. +..||||+++.... ..+.|.+|+.+|++++|||||+++|+|.+ +
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~---~~~vAiK~l~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~ 84 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG---TTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 84 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETT---TEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ceEcCHHHEEEeeEEeeCCCeEEEEEEECC---CCEEEEEEECcccC--CHHHHHHHHHHHHhcccCCEeEEEEEEec-C
Confidence 457777889999999999999999998743 35699999875432 34679999999999999999999999854 5
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
..++|||||++|+|.+++.... ...+++.++..++.||+.||+|||+++|+||||||+||||++++.+||
T Consensus 85 ~~~lv~Ey~~~g~l~~~~~~~~----------~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl 154 (285)
T d1fmka3 85 PIYIVTEYMSKGSLLDFLKGET----------GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKV 154 (285)
T ss_dssp SCEEEECCCTTCBHHHHHSHHH----------HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred CeEEEEEecCCCchhhhhhhcc----------cccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEE
Confidence 6899999999999999987532 135899999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+|||+|+....+.. .......+|+.|||||++..+.++.++|||||||++|||++.|.+|+.+.+..+++..+..+.++
T Consensus 155 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~ 233 (285)
T d1fmka3 155 ADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM 233 (285)
T ss_dssp CCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC
T ss_pred cccchhhhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC
Confidence 99999986643332 22334567899999999999999999999999999999999788888889999999999999999
Q ss_pred CCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
+.|..||+++.+++.+||+.+|..|+ +...++..|.
T Consensus 234 ~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~i~~~L~ 269 (285)
T d1fmka3 234 PCPPECPESLHDLMCQCWRKEPEERP-----TFEYLQAFLE 269 (285)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHcccCHhHCc-----CHHHHHHHHh
Confidence 99999999999999999999999998 6665554433
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-56 Score=416.42 Aligned_cols=259 Identities=37% Similarity=0.661 Sum_probs=213.0
Q ss_pred cccCcccccccccccceeEEEEEEecCC-CCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSE-GPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP 128 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 128 (422)
...+|++++.||+|+||.||+|++.... ....||||+++... .....+.|.+|+.+|++++|||||+++|++.+ +.
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~ 84 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP 84 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence 3456899999999999999999876443 34579999986532 23445789999999999999999999999975 56
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
+++|||||++|+|.+++..+. ..+++..+.+++.|||.||+|||+++|+||||||+|||++.++.+||+
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~-----------~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~ 153 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQ-----------GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIG 153 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHG-----------GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEEC
T ss_pred hheeeeeecCcchhhhhhccc-----------CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeec
Confidence 899999999999999887652 368999999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcce-EeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc-CCC
Q psy7289 209 DFGLSRDVYASDYY-RIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS-RQM 286 (422)
Q Consensus 209 DFGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~-~~~ 286 (422)
|||+++........ .......+|+.|||||++....++.++|||||||++|||+|+|..||.+.+..++...+.. +.+
T Consensus 154 DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~ 233 (273)
T d1u46a_ 154 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER 233 (273)
T ss_dssp CCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC
T ss_pred cchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCC
Confidence 99999977554332 2333445688999999999999999999999999999999989999999999999888864 556
Q ss_pred CCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 287 LPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 287 ~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
++.|+.+|+++.+|+.+||+.+|..|| ++..++..|
T Consensus 234 ~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~ei~~~L 269 (273)
T d1u46a_ 234 LPRPEDCPQDIYNVMVQCWAHKPEDRP-----TFVALRDFL 269 (273)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHH
T ss_pred CCCcccccHHHHHHHHHHcCCChhHCc-----CHHHHHHHH
Confidence 778899999999999999999999999 666665544
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-55 Score=420.45 Aligned_cols=255 Identities=25% Similarity=0.409 Sum_probs=202.6
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
+.+.|++.+.||+|+||+||+|+.+.+ ++.||||++...........+.+|+.+|++++|||||++++++.+++.+|+
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~--~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRT--QKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTT--CCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCC--CCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 356799999999999999999987543 578999998755444445678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec---CCCeEEEe
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVG---DGLTVKIS 208 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~---~~~~vKl~ 208 (422)
|||||++|+|.++|..+ ..+++.++..++.||+.||+|||+++|+||||||+|||+. +++.+||+
T Consensus 85 vmE~~~gg~L~~~l~~~------------~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~ 152 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEK------------GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMIS 152 (307)
T ss_dssp EECCCCSCBHHHHHHTC------------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred EEeccCCCcHHHhhhcc------------cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEe
Confidence 99999999999999764 3599999999999999999999999999999999999995 47899999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC-
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML- 287 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~- 287 (422)
|||+|+...... ......||+.|||||++.+..|+.++|||||||++|||++ |..||.+.+..++...+..+...
T Consensus 153 DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~-g~~Pf~~~~~~~~~~~i~~~~~~~ 228 (307)
T d1a06a_ 153 DFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC-GYPPFYDENDAKLFEQILKAEYEF 228 (307)
T ss_dssp CC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHTTCCCC
T ss_pred ccceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCC
Confidence 999998654332 2234568999999999999999999999999999999999 99999999999999988876543
Q ss_pred --CCCCCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 288 --PCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 288 --~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
+.++.+|+++.+|+.+||..||..|+ +..+.+|.++.
T Consensus 229 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 268 (307)
T d1a06a_ 229 DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 268 (307)
T ss_dssp CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTT
T ss_pred CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhC
Confidence 23467899999999999999999996 33444555543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-55 Score=422.47 Aligned_cols=272 Identities=44% Similarity=0.770 Sum_probs=235.8
Q ss_pred hhccccCcccccccccccceeEEEEEEecC---CCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc
Q psy7289 49 REVIETKPRFLQELGEGAFGKVYKGEVCTS---EGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLS 125 (422)
Q Consensus 49 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 125 (422)
+|+...++++.++||+|+||.||+|++... .....||||+++..........|.+|++++++++|||||+++|+|..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 678888999999999999999999988532 22467999999876666677789999999999999999999999999
Q ss_pred CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 126 GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 126 ~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
.+..++|||||++|+|.+++....... ........+++..+.+++.|+|+||.|||+++|+||||||+|||+++++++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAM--ANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHH--HHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred CCceeEEEeecCCCCHHHHHHhccccc--ccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence 999999999999999999987532100 000112357889999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ 285 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~ 285 (422)
||+|||+|+...............+|+.|||||.+..+.++.++|||||||++|||+|.+.+||.+.+..+++..+.++.
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~ 252 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC
Confidence 99999999877655554445556678999999999999999999999999999999996689999999999999999999
Q ss_pred CCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 286 MLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 286 ~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
+++.|..||+.+.+||.+||+.+|..|| ++..+...|
T Consensus 253 ~~~~p~~~~~~l~~li~~cl~~~P~~RP-----s~~~il~~L 289 (308)
T d1p4oa_ 253 LLDKPDNCPDMLFELMRMCWQYNPKMRP-----SFLEIISSI 289 (308)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHH
T ss_pred CCCCcccchHHHHHHHHHHcCCChhHCc-----CHHHHHHHH
Confidence 9999999999999999999999999998 665555444
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-55 Score=419.14 Aligned_cols=274 Identities=33% Similarity=0.620 Sum_probs=218.0
Q ss_pred hhhccccCcccccccccccceeEEEEEEecCC---CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEE
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSE---GPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVC 123 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~ 123 (422)
++|+..++|++.++||+|+||.||+|++.... ..+.||||+++........+.+.+|..++.++ +|||||.+++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 46788889999999999999999999986543 34689999998766666778899999988877 689999999998
Q ss_pred EcC-CCeEEEEEecCCCCHHHHHhhcCCCCC----CCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcee
Q psy7289 124 LSG-EPMCMLFEFMVRGDLHEFLMSRSPRSD----ISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCL 198 (422)
Q Consensus 124 ~~~-~~~~lv~E~~~~G~L~~~l~~~~~~~~----~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiL 198 (422)
.+. ..+++|||||++|+|.++|........ .........+++.++..++.||++||+|||+++||||||||+|||
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL 166 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 166 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence 765 468999999999999999976432100 000011235899999999999999999999999999999999999
Q ss_pred ecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh-HHH
Q psy7289 199 VGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN-QEV 277 (422)
Q Consensus 199 l~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~-~~~ 277 (422)
|++++.+||+|||+|+...........+...+|+.|||||++..+.++.++|||||||++|||+|.+.+||.+.+. .++
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~ 246 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999998765444333445567899999999999999999999999999999999967789987764 456
Q ss_pred HHHHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhh
Q psy7289 278 IEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRD 326 (422)
Q Consensus 278 ~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~d 326 (422)
...+..+.+++.|+.+|+++.++|.+||+.+|..|+ +...+.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~eil~~ 290 (299)
T d1ywna1 247 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP-----TFSELVEH 290 (299)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred HHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCc-----CHHHHHHH
Confidence 677788888999999999999999999999999998 55554443
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-55 Score=423.71 Aligned_cols=253 Identities=21% Similarity=0.384 Sum_probs=223.0
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
++|++++.||+|+||.||+|+.+.+ ++.||||+++... .....+.+.+|+.+|++++|||||++++++.+.+.+|+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~--~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKAT--GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTT--CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCC--CCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 4689999999999999999987543 5789999986432 12345678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
|||||++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+++++.+||+|||
T Consensus 83 v~ey~~gg~L~~~~~~~------------~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG 150 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRE------------RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp EEECCTTCBHHHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred ceeccCCCchhhhhhcc------------cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecc
Confidence 99999999999999875 358999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCC
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPE 291 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~ 291 (422)
+|+....... ......||+.|||||++.+..|+.++||||+||++|||++ |.+||.+.+..++...+..+. +++|.
T Consensus 151 ~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~-G~~pf~~~~~~~~~~~i~~~~-~~~p~ 226 (337)
T d1o6la_ 151 LCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFELILMEE-IRFPR 226 (337)
T ss_dssp TCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCC-CCCCT
T ss_pred cccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHH-CCCCCCCcCHHHHHHHHhcCC-CCCCc
Confidence 9986543322 2234568999999999999999999999999999999999 999999999999999888775 66788
Q ss_pred CCCcchhhhcccccccccchhh------HHHHhhhhhhh
Q psy7289 292 DCPPRMYSLMMECWHEVPVAAG------MAYLCSHHYVH 324 (422)
Q Consensus 292 ~~p~~~~~l~~~cw~~~P~~r~------~~~lh~~~~i~ 324 (422)
.+++++.+|+++||..||..|. ++.+.+|.++.
T Consensus 227 ~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~ 265 (337)
T d1o6la_ 227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265 (337)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred cCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccc
Confidence 9999999999999999999996 56677777764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=412.67 Aligned_cols=252 Identities=37% Similarity=0.705 Sum_probs=215.1
Q ss_pred hhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC-C
Q psy7289 49 REVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG-E 127 (422)
Q Consensus 49 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~ 127 (422)
|++...++++++.||+|+||.||+|++. +..||||+++... ..+.|.+|++++++++|||||+++|+|.++ +
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR----GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET----TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC----CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 4666778999999999999999999873 4579999996543 346799999999999999999999999654 5
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
.+++||||+++|+|.++|..+. ...+++..+.+++.||+.||+|||+++|+||||||+|||++.++.+||
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~----------~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl 144 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRG----------RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKV 144 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHH----------HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEE
T ss_pred cEEEEEeccCCCCHHHHHHhcC----------CCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEee
Confidence 6899999999999999997642 125899999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML 287 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~ 287 (422)
+|||+++..... .....+|+.|||||++..+.++.++|||||||++|||+|.|.+||...+..++...|.++.++
T Consensus 145 ~dfg~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~ 219 (262)
T d1byga_ 145 SDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 219 (262)
T ss_dssp CCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC
T ss_pred cccccceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999999865332 223456789999999999999999999999999999999889999999999999999999999
Q ss_pred CCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 288 PCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 288 ~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
+.|..+|+++.+|+++||+.||..|+ ++..+.+.|
T Consensus 220 ~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~L 254 (262)
T d1byga_ 220 DAPDGCPPAVYEVMKNCWHLDAAMRP-----SFLQLREQL 254 (262)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcccCHhHCc-----CHHHHHHHH
Confidence 99999999999999999999999998 666665544
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=406.84 Aligned_cols=247 Identities=23% Similarity=0.368 Sum_probs=205.1
Q ss_pred cccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc----CCCeE
Q psy7289 56 PRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLS----GEPMC 130 (422)
Q Consensus 56 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~~~ 130 (422)
|++.++||+|+||+||+|++.. ++..||+|.+... ......+.|.+|+++|++++|||||++++++.+ ...+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~--~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTE--TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECC--CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 4677889999999999998754 3578999998643 355567789999999999999999999999865 34589
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceeec-CCCeEEE
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHH--YVHRDLAARNCLVG-DGLTVKI 207 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--ivHrDlKp~NiLl~-~~~~vKl 207 (422)
+|||||++|+|.+++.+. ..+++.++..++.||+.||+|||+++ |+||||||+|||++ +++.+||
T Consensus 89 ivmE~~~~g~L~~~l~~~------------~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl 156 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRF------------KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKI 156 (270)
T ss_dssp EEEECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEE
T ss_pred EEEeCCCCCcHHHHHhcc------------ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEE
Confidence 999999999999999765 35899999999999999999999998 99999999999997 4789999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHcCCC
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN-QEVIEMIRSRQM 286 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~-~~~~~~i~~~~~ 286 (422)
+|||+|+...... .....||+.|||||++. +.++.++|||||||++|||++ |..||.+.++ .++...+..+..
T Consensus 157 ~DFGla~~~~~~~----~~~~~GT~~Y~aPE~~~-~~~~~~~DIwSlGvilyel~~-g~~Pf~~~~~~~~~~~~i~~~~~ 230 (270)
T d1t4ha_ 157 GDLGLATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMAT-SEYPYSECQNAAQIYRRVTSGVK 230 (270)
T ss_dssp CCTTGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHH-SSCTTTTCSSHHHHHHHHTTTCC
T ss_pred eecCcceeccCCc----cCCcccCccccCHHHhC-CCCCCcCchhhHHHHHHHHHH-CCCCCCCcccHHHHHHHHHcCCC
Confidence 9999998644332 22456899999999886 469999999999999999999 9999987654 456667766654
Q ss_pred CC-CCCCCCcchhhhcccccccccchhh-HHHHhhhhh
Q psy7289 287 LP-CPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHY 322 (422)
Q Consensus 287 ~~-~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~ 322 (422)
++ .+..+++++.+|+.+||..+|..|+ +..+.+|.+
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~ 268 (270)
T d1t4ha_ 231 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 268 (270)
T ss_dssp CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcc
Confidence 33 4567889999999999999999997 223444443
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=412.02 Aligned_cols=258 Identities=24% Similarity=0.381 Sum_probs=219.2
Q ss_pred hhhccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-----CHHhHHHHHHHHHHHhcCCCCceeeEeeE
Q psy7289 48 RREVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-----NQKTASDFRREVDLMSELRHPNIVCLLGV 122 (422)
Q Consensus 48 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~g~ 122 (422)
+.+.+.++|++.+.||+|+||+||+|+.+.+ ++.||||+++... .....+.|.+|+.+|++++|||||+++++
T Consensus 4 ~~~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~--~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~ 81 (293)
T d1jksa_ 4 RQENVDDYYDTGEELGSGQFAVVKKCREKST--GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV 81 (293)
T ss_dssp BCSCGGGTEEEEEEEEECSSEEEEEEEETTT--CCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCCCcccCEEEeEEEecCCCeEEEEEEECCC--CCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 3444567899999999999999999987543 5789999985432 12235789999999999999999999999
Q ss_pred EEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC
Q psy7289 123 CLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG 202 (422)
Q Consensus 123 ~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~ 202 (422)
+.+++.+|+|||||++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.+
T Consensus 82 ~~~~~~~~iv~E~~~gg~L~~~i~~~------------~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~ 149 (293)
T d1jksa_ 82 YENKTDVILILELVAGGELFDFLAEK------------ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDR 149 (293)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCS
T ss_pred EEECCEEEEEEEcCCCccccchhccc------------cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecC
Confidence 99999999999999999999999765 358999999999999999999999999999999999999876
Q ss_pred C----eEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHH
Q psy7289 203 L----TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVI 278 (422)
Q Consensus 203 ~----~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~ 278 (422)
+ .+||+|||+|+...... ......+|+.|||||++....++.++|||||||++|||++ |..||.+.+..+++
T Consensus 150 ~~~~~~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~-g~~Pf~~~~~~~~~ 225 (293)
T d1jksa_ 150 NVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDTKQETL 225 (293)
T ss_dssp SSSSCCEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHH
T ss_pred CCcccceEecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHc-CCCCCCCCCHHHHH
Confidence 6 59999999998764432 2334567899999999999999999999999999999999 99999999999999
Q ss_pred HHHHcCCCCC---CCCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 279 EMIRSRQMLP---CPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 279 ~~i~~~~~~~---~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
..+..+.... .+..+|+++.+|+++||..||..|+ ++.+.+|.++
T Consensus 226 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 274 (293)
T d1jksa_ 226 ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274 (293)
T ss_dssp HHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred HHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 9988765432 2467899999999999999999996 2233344433
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=415.31 Aligned_cols=280 Identities=37% Similarity=0.626 Sum_probs=236.3
Q ss_pred ccccchhhccccCcccccccccccceeEEEEEEec---CCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceee
Q psy7289 43 TASDFRREVIETKPRFLQELGEGAFGKVYKGEVCT---SEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVC 118 (422)
Q Consensus 43 ~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~ 118 (422)
-+.+..|++...+|++.+.||+|+||.||+|++.. ......||||+++..........|.+|+.+++++ +|||||+
T Consensus 12 ~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~ 91 (311)
T d1t46a_ 12 LPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVN 91 (311)
T ss_dssp SCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEE
Confidence 34456788888999999999999999999999854 2456789999998766667778899999999999 6999999
Q ss_pred EeeEEEcCCCeEEEEEecCCCCHHHHHhhcCCCCCC------CCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy7289 119 LLGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDI------SGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDL 192 (422)
Q Consensus 119 l~g~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~------~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDl 192 (422)
++|+|.+++.+++|||||++|+|.+++......... ........+++..+..++.||+.||+|||++++|||||
T Consensus 92 ~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDL 171 (311)
T d1t46a_ 92 LLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDL 171 (311)
T ss_dssp EEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred EEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccc
Confidence 999999999999999999999999999875321110 00112346899999999999999999999999999999
Q ss_pred CCCceeecCCCeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Q psy7289 193 AARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY 272 (422)
Q Consensus 193 Kp~NiLl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~ 272 (422)
||+|||++.++.+||+|||+++...............+|+.|||||++..+.++.++|||||||++|||+|.|.+||.+.
T Consensus 172 Kp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999998765554445556678999999999999999999999999999999999888888887
Q ss_pred ChHHH-HHHHHcCCCCCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 273 SNQEV-IEMIRSRQMLPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 273 ~~~~~-~~~i~~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
+..+. .+.+..+.+++.|..+|+++.+||..||+.+|..|+ ++..+.+.|
T Consensus 252 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~~il~~L 302 (311)
T d1t46a_ 252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP-----TFKQIVQLI 302 (311)
T ss_dssp CSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCc-----CHHHHHHHH
Confidence 76554 456677778888899999999999999999999998 666555443
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-55 Score=422.01 Aligned_cols=257 Identities=24% Similarity=0.378 Sum_probs=212.5
Q ss_pred hccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCe
Q psy7289 50 EVIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPM 129 (422)
Q Consensus 50 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 129 (422)
|+..++|+++++||+|+||+||+|+... +++.||||+++........+.+.+|+.+|++++|||||+++++|.+++.+
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~--~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 79 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKP--SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 79 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETT--TTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECC--CCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 4567789999999999999999998754 45889999997655555667899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeecCCCeEEEe
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCS-HHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
|+|||||++|+|.+++.+. ..+++..+..++.|++.||+|||+ +||+||||||+|||+++++.+||+
T Consensus 80 ~iVmEy~~gg~L~~~l~~~------------~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~ 147 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKA------------GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC 147 (322)
T ss_dssp EEEEECCTTEEHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEcCCCCcHHHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEe
Confidence 9999999999999999765 358999999999999999999997 599999999999999999999999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHH----------
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVI---------- 278 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~---------- 278 (422)
|||+|+...... ..+..||+.|||||++.+..|+.++||||+||++|||++ |..||.+.+..+..
T Consensus 148 DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~-G~~Pf~~~~~~~~~~~~~~~~~~~ 222 (322)
T d1s9ja_ 148 DFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV-GRYPIPPPDAKELELMFGCQVEGD 222 (322)
T ss_dssp CCCCCHHHHHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHH-SSCCSSCCCTTHHHHHC-------
T ss_pred eCCCccccCCCc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHhcCC
Confidence 999998654321 234578999999999999999999999999999999999 99999876543321
Q ss_pred --------------------------------HHHHcCCCCCCCC-CCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 279 --------------------------------EMIRSRQMLPCPE-DCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 279 --------------------------------~~i~~~~~~~~p~-~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
..+.....+..|. ..++++.+|+.+||..||..|+ +..+.+|.++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~ 302 (322)
T d1s9ja_ 223 AAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302 (322)
T ss_dssp -----------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred cccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhC
Confidence 1111111122222 2466789999999999999986 55677777775
Q ss_pred h
Q psy7289 325 R 325 (422)
Q Consensus 325 ~ 325 (422)
+
T Consensus 303 ~ 303 (322)
T d1s9ja_ 303 R 303 (322)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-55 Score=419.60 Aligned_cols=268 Identities=38% Similarity=0.640 Sum_probs=222.4
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcC-CCCceeeEeeEEEcCCCeE
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSEL-RHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~ 130 (422)
.-+++++.++||+|+||+||+|+++.++....||||.++........+.|.+|+++|+++ +|||||+++|+|.+.+.++
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 346788899999999999999999876555678999987655555667899999999999 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCC----CCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEE
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSD----ISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~----~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vK 206 (422)
+|||||++|+|.++|+.+..... .........+++.++..++.||+.||.|||+++|+||||||+|||++.++.+|
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~k 167 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 167 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceE
Confidence 99999999999999975421000 00001124689999999999999999999999999999999999999999999
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~ 286 (422)
|+|||+|+...... ......+|+.|+|||.+..+.++.++|||||||++|||++.+.+||.+.+..++...+.++.+
T Consensus 168 l~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~ 244 (309)
T d1fvra_ 168 IADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244 (309)
T ss_dssp ECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred Eccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Confidence 99999997543221 122345788999999999999999999999999999999967789999999999999999999
Q ss_pred CCCCCCCCcchhhhcccccccccchhhHHHHhhhhhhhhhc
Q psy7289 287 LPCPEDCPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDL 327 (422)
Q Consensus 287 ~~~p~~~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dL 327 (422)
++.|..+|+++.+||.+||+.+|..|+ +...+...|
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~eil~~L 280 (309)
T d1fvra_ 245 LEKPLNCDDEVYDLMRQCWREKPYERP-----SFAQILVSL 280 (309)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcCCChhHCc-----CHHHHHHHH
Confidence 999999999999999999999999999 666665543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-54 Score=415.82 Aligned_cols=249 Identities=22% Similarity=0.371 Sum_probs=219.7
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
.+|++++.||+|+||+||+|+.+.+ ++.||||+++... .....+.+.+|+.+|+.++|||||++++++.+++.+|+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~--g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHN--GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT--CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCC--CCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 4689999999999999999987543 5789999986432 12345689999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
|||||++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 82 vmE~~~gg~l~~~~~~~------------~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG 149 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKS------------QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFG 149 (316)
T ss_dssp EECCCCSCBHHHHHHHT------------SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred EeeecCCcccccccccc------------ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCc
Confidence 99999999999998764 357889999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCC
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPE 291 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~ 291 (422)
+|+..... .....||+.|||||++.+..|+.++|||||||++|||++ |..||.+.+..++...+.++. .+.|+
T Consensus 150 ~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemlt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~ 222 (316)
T d1fota_ 150 FAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA-GYTPFYDSNTMKTYEKILNAE-LRFPP 222 (316)
T ss_dssp SCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHCC-CCCCT
T ss_pred cceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHh-CCCCCCCcCHHHHHHHHHcCC-CCCCC
Confidence 99876432 234568999999999999999999999999999999999 999999999999999998775 45678
Q ss_pred CCCcchhhhcccccccccchh------hHHHHhhhhhh
Q psy7289 292 DCPPRMYSLMMECWHEVPVAA------GMAYLCSHHYV 323 (422)
Q Consensus 292 ~~p~~~~~l~~~cw~~~P~~r------~~~~lh~~~~i 323 (422)
.+|+++.+++.+||..+|..| .++.+.+|.++
T Consensus 223 ~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f 260 (316)
T d1fota_ 223 FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260 (316)
T ss_dssp TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccc
Confidence 899999999999999999988 46667777776
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-54 Score=410.96 Aligned_cols=256 Identities=36% Similarity=0.701 Sum_probs=214.0
Q ss_pred ccccccccccceeEEEEEEecCC-CCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC-CCeEEEEE
Q psy7289 57 RFLQELGEGAFGKVYKGEVCTSE-GPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG-EPMCMLFE 134 (422)
Q Consensus 57 ~~~~~LG~G~fg~Vy~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~~lv~E 134 (422)
.+.++||+|+||+||+|++..++ ....||||+++...+....++|.+|+++|++++|||||+++|++.+. ...++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 44678999999999999986543 24579999997666677778999999999999999999999998764 57899999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcccc
Q psy7289 135 FMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSR 214 (422)
Q Consensus 135 ~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla~ 214 (422)
||++|+|.+++.... ..+++..+.+++.|++.||.|||+.+|+||||||+||||++++.+||+|||+++
T Consensus 110 ~~~~g~l~~~~~~~~-----------~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~ 178 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNET-----------HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178 (311)
T ss_dssp CCTTCBHHHHHHCTT-----------CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGC
T ss_pred EeecCchhhhhcccc-----------ccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchh
Confidence 999999999987642 346788889999999999999999999999999999999999999999999998
Q ss_pred cccCCcceE--eccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q psy7289 215 DVYASDYYR--IQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPED 292 (422)
Q Consensus 215 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~ 292 (422)
......... ......+|+.|+|||.+..+.++.++|||||||++|||+|.+.+|+...+..++...+..+.+++.|+.
T Consensus 179 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~ 258 (311)
T d1r0pa_ 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 258 (311)
T ss_dssp CTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTT
T ss_pred hccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence 765433221 223345789999999999999999999999999999999977767777777788888999999999999
Q ss_pred CCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 293 CPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 293 ~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
||+++.+||.+||+.+|..|| +...+...|+
T Consensus 259 ~~~~l~~li~~cl~~dP~~RP-----s~~ei~~~L~ 289 (311)
T d1r0pa_ 259 CPDPLYEVMLKCWHPKAEMRP-----SFSELVSRIS 289 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHH
T ss_pred CcHHHHHHHHHHcCCCHhHCc-----CHHHHHHHHH
Confidence 999999999999999999999 6666655543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.1e-54 Score=416.33 Aligned_cols=255 Identities=23% Similarity=0.330 Sum_probs=218.2
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
+..+|++++.||+|+||.||+|+.+. .+..||||++... .....+.+.+|+++|++|+|||||++++++.+++.+|+
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~--~g~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERA--TGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT--TTEEEEEEEECCC-SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECC--CCCEEEEEEEccc-chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34689999999999999999998754 3578999998654 33456789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC--CCeEEEec
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD--GLTVKISD 209 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~--~~~vKl~D 209 (422)
|||||++|+|.+++.... ..+++.++..++.||+.||+|||++|||||||||+|||++. ++.+||+|
T Consensus 101 vmE~~~gg~L~~~l~~~~-----------~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~D 169 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEH-----------NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLID 169 (350)
T ss_dssp EECCCCSCBHHHHHTCTT-----------SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECC
T ss_pred EEEcCCCCCHHHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEee
Confidence 999999999999996431 35899999999999999999999999999999999999964 57899999
Q ss_pred CcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC 289 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 289 (422)
||+|+........ ....+|+.|||||++.+..|+.++|||||||++|||++ |..||.+.+..+++..|.++.....
T Consensus 170 FG~a~~~~~~~~~---~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~-G~~Pf~~~~~~~~~~~i~~~~~~~~ 245 (350)
T d1koaa2 170 FGLTAHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS-GLSPFGGENDDETLRNVKSCDWNMD 245 (350)
T ss_dssp CTTCEECCTTSCE---EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHTCCCSC
T ss_pred cchheeccccccc---ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 9999876544322 23457899999999999999999999999999999999 9999999999999999887654322
Q ss_pred ---CCCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 290 ---PEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 290 ---p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
+..+++++.+|+.+||..||..|+ ++.+.+|.++.
T Consensus 246 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~ 284 (350)
T d1koaa2 246 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 284 (350)
T ss_dssp CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTS
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 246888999999999999999985 44455666554
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.4e-54 Score=417.25 Aligned_cols=250 Identities=21% Similarity=0.332 Sum_probs=220.4
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCM 131 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 131 (422)
++|++++.||+|+||.||+|+++.+ ++.||||++.... .....+.+.+|+++|+.++|||||++++++.+...+++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~--g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKES--GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT--CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCC--CCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 5799999999999999999987543 5789999985321 12345678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCc
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFG 211 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFG 211 (422)
||||+.+|+|.+++... ..+++.++..++.||+.||+|||+++||||||||+|||++.++.+||+|||
T Consensus 119 v~e~~~~g~l~~~l~~~------------~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG 186 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRI------------GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186 (350)
T ss_dssp EEECCTTCBHHHHHHHH------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ccccccccchhhhHhhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeece
Confidence 99999999999999775 358999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCC
Q psy7289 212 LSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCPE 291 (422)
Q Consensus 212 la~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~ 291 (422)
+|+..... .....||+.|||||++.+..++.++|||||||++|||++ |..||.+.+..+++..|..+. ++.|.
T Consensus 187 ~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemlt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~ 259 (350)
T d1rdqe_ 187 FAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQPIQIYEKIVSGK-VRFPS 259 (350)
T ss_dssp TCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCC-CCCCT
T ss_pred eeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHh-CCCCCCCcCHHHHHHHHhcCC-CCCCc
Confidence 99876432 234567899999999999999999999999999999999 999999999999999998775 45678
Q ss_pred CCCcchhhhcccccccccchh------hHHHHhhhhhhh
Q psy7289 292 DCPPRMYSLMMECWHEVPVAA------GMAYLCSHHYVH 324 (422)
Q Consensus 292 ~~p~~~~~l~~~cw~~~P~~r------~~~~lh~~~~i~ 324 (422)
.+|+++.+|+++||..||..| .++.+.+|.++.
T Consensus 260 ~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~ 298 (350)
T d1rdqe_ 260 HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298 (350)
T ss_dssp TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred cCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCcccc
Confidence 899999999999999999888 366677777764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.7e-53 Score=414.39 Aligned_cols=256 Identities=20% Similarity=0.342 Sum_probs=219.2
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
.+.|++++.||+|+||.||+|+...+ ++.||||+++... ......+.+|+.+|++|+|||||++++++.+++.+|+|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~--~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKAT--GRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT--CCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCC--CCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 45799999999999999999987543 5789999986543 34456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec--CCCeEEEecC
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVG--DGLTVKISDF 210 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~--~~~~vKl~DF 210 (422)
||||++|+|.+++.... .++++.++..++.||+.||+|||++||+||||||+||||+ .++.+||+||
T Consensus 105 mE~~~gg~L~~~~~~~~-----------~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DF 173 (352)
T d1koba_ 105 LEFLSGGELFDRIAAED-----------YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDF 173 (352)
T ss_dssp EECCCCCBHHHHTTCTT-----------CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCC
T ss_pred EEcCCCChHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeec
Confidence 99999999999876532 3589999999999999999999999999999999999998 5689999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC--
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLP-- 288 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~-- 288 (422)
|+|+........ ....+|+.|||||++.+..|+.++|||||||++|||++ |..||.+.+..+++..+..+....
T Consensus 174 Gla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~ 249 (352)
T d1koba_ 174 GLATKLNPDEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS-GLSPFAGEDDLETLQNVKRCDWEFDE 249 (352)
T ss_dssp TTCEECCTTSCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHHHHCCCCCCS
T ss_pred ccceecCCCCce---eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence 999876544322 23456889999999999999999999999999999999 999999999999999888765432
Q ss_pred -CCCCCCcchhhhcccccccccchhh-HHHHhhhhhhhhh
Q psy7289 289 -CPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRD 326 (422)
Q Consensus 289 -~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~d 326 (422)
.+..+|+++.+|+.+||..+|..|+ +..+.+|.++..+
T Consensus 250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 3457899999999999999999986 3445666666543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=409.00 Aligned_cols=253 Identities=24% Similarity=0.362 Sum_probs=217.5
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHh-cCCCCceeeEeeEEEcCCCeE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMS-ELRHPNIVCLLGVCLSGEPMC 130 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~-~l~HpnIv~l~g~~~~~~~~~ 130 (422)
++|++.+.||+|+||+||+|+... .++.||||+++... .....+.+.+|..++. .++|||||++++++.+++.+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~--t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKK--TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT--TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECC--CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCcee
Confidence 468999999999999999998754 46889999986432 1223456777877765 689999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecC
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDF 210 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DF 210 (422)
+|||||++|+|.+++... ..+++.++..++.||+.||+|||+++|+||||||+|||+++++.+||+||
T Consensus 80 ivmEy~~~g~L~~~i~~~------------~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DF 147 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSC------------HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADF 147 (320)
T ss_dssp EEEECCTTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEeecCCCcHHHHhhcc------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceecccc
Confidence 999999999999999765 35899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPCP 290 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p 290 (422)
|+++....... ......||+.|||||++.+..|+.++|||||||++|||++ |..||.+.+..++...+..+. ++.|
T Consensus 148 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~-~~~p 223 (320)
T d1xjda_ 148 GMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI-GQSPFHGQDEEELFHSIRMDN-PFYP 223 (320)
T ss_dssp TTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCC-CCCC
T ss_pred chhhhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCC
Confidence 99986543322 2344568999999999999999999999999999999999 999999999999999998764 5678
Q ss_pred CCCCcchhhhcccccccccchhhHH--HHhhhhhhh
Q psy7289 291 EDCPPRMYSLMMECWHEVPVAAGMA--YLCSHHYVH 324 (422)
Q Consensus 291 ~~~p~~~~~l~~~cw~~~P~~r~~~--~lh~~~~i~ 324 (422)
..+|+++.+|+++||..+|..|+-. .+.+|.++.
T Consensus 224 ~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~ 259 (320)
T d1xjda_ 224 RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 259 (320)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGT
T ss_pred ccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhc
Confidence 8999999999999999999999632 355555553
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.6e-52 Score=391.42 Aligned_cols=254 Identities=22% Similarity=0.336 Sum_probs=215.2
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC--------HHhHHHHHHHHHHHhcCC-CCceeeEeeEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN--------QKTASDFRREVDLMSELR-HPNIVCLLGVC 123 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~il~~l~-HpnIv~l~g~~ 123 (422)
..+|++.+.||+|+||+||+|+... +++.||||+++.... ....+.+.+|+.+|++++ |||||++++++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~--~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 79 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKP--TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 79 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred cccCEEceEEecCcCeEEEEEEECC--CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec
Confidence 3578999999999999999998644 468899999864321 123356889999999997 99999999999
Q ss_pred EcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC
Q psy7289 124 LSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL 203 (422)
Q Consensus 124 ~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~ 203 (422)
.+++.+|+|||||++|||.++|..+ .++++.++..++.||+.||+|||++||+||||||+|||++.++
T Consensus 80 ~~~~~~~ivmE~~~~g~L~~~l~~~------------~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~ 147 (277)
T d1phka_ 80 ETNTFFFLVFDLMKKGELFDYLTEK------------VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM 147 (277)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred ccCcceEEEEEcCCCchHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCC
Confidence 9999999999999999999999765 3699999999999999999999999999999999999999999
Q ss_pred eEEEecCcccccccCCcceEeccCCCCCccccCcccccc------CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHH
Q psy7289 204 TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY------GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEV 277 (422)
Q Consensus 204 ~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~ 277 (422)
.+||+|||+++...... ......+|+.|+|||.+.. ..++.++||||+||++|||++ |..||.+.+..++
T Consensus 148 ~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~-g~~Pf~~~~~~~~ 223 (277)
T d1phka_ 148 NIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA-GSPPFWHRKQMLM 223 (277)
T ss_dssp CEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHH
T ss_pred CeEEccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhcc-CCCCCCCCCHHHH
Confidence 99999999998764332 2234568899999998863 347889999999999999999 9999999999999
Q ss_pred HHHHHcCCCC-C--CCCCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 278 IEMIRSRQML-P--CPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 278 ~~~i~~~~~~-~--~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
...+.++... + .+.++|+++.+|+.+||..+|..|+ ++.+.+|.++.
T Consensus 224 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~ 274 (277)
T d1phka_ 224 LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274 (277)
T ss_dssp HHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHH
Confidence 9888876543 2 2347899999999999999999995 44455555543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.8e-52 Score=392.44 Aligned_cols=247 Identities=21% Similarity=0.328 Sum_probs=205.0
Q ss_pred cccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC--CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC-
Q psy7289 52 IETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA--NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP- 128 (422)
Q Consensus 52 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~- 128 (422)
+.++|++.+.||+|+||.||+|+... .++.||||+++... +....+.|.+|+++|+.++|||||++++++...+.
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~ 82 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLR--LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 82 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSS
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECC--CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCC
Confidence 35679999999999999999998754 35789999987543 34556789999999999999999999999876543
Q ss_pred ---eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 129 ---MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 129 ---~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
+|+|||||++|+|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~~------------~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~ 150 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHTE------------GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAV 150 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCE
T ss_pred CceEEEEEECCCCCEehhhhccc------------CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccc
Confidence 79999999999999998765 358999999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcc-eEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC
Q psy7289 206 KISDFGLSRDVYASDY-YRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR 284 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~ 284 (422)
+|+|||+++....... ........||+.|||||++.+..++.++|||||||++|||+| |.+||.+.+..++...+...
T Consensus 151 ~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyellt-G~~Pf~~~~~~~~~~~~~~~ 229 (277)
T d1o6ya_ 151 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPFTGDSPVSVAYQHVRE 229 (277)
T ss_dssp EECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHC
T ss_pred eeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHh-CCCCCCCcCHHHHHHHHHhc
Confidence 9999999876543221 122344568999999999999999999999999999999999 99999999988887776655
Q ss_pred CCCC---CCCCCCcchhhhcccccccccchhh
Q psy7289 285 QMLP---CPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 285 ~~~~---~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
...+ .++++|+++.+++.+||..||..|+
T Consensus 230 ~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~ 261 (277)
T d1o6ya_ 230 DPIPPSARHEGLSADLDAVVLKALAKNPENRY 261 (277)
T ss_dssp CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSC
T ss_pred CCCCCchhccCCCHHHHHHHHHHccCCHhHCH
Confidence 4332 3467899999999999999999996
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-52 Score=400.27 Aligned_cols=256 Identities=21% Similarity=0.328 Sum_probs=218.1
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
-++|++++.||+|+||+||+|++.. +++.||||+++... .....+.+|+++|+.++|||||++++++.+++.+|+|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~--~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETS--SKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECC--CCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 3579999999999999999998754 35789999997543 3345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC--CeEEEecC
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG--LTVKISDF 210 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~--~~vKl~DF 210 (422)
||||++|+|.+++.... ..+++.++..++.||+.||+|||++||+||||||+|||++.+ ..+||+||
T Consensus 80 mE~~~gg~L~~~i~~~~-----------~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DF 148 (321)
T d1tkia_ 80 FEFISGLDIFERINTSA-----------FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEF 148 (321)
T ss_dssp ECCCCCCBHHHHHTSSS-----------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred EecCCCCcHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEccc
Confidence 99999999999996532 358999999999999999999999999999999999999854 48999999
Q ss_pred cccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC-
Q psy7289 211 GLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQMLPC- 289 (422)
Q Consensus 211 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~- 289 (422)
|+++........ ....+|+.|||||.+....|+.++||||+||++|||++ |..||.+.+..+++..|.++.....
T Consensus 149 G~~~~~~~~~~~---~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~-G~~Pf~~~~~~~~~~~i~~~~~~~~~ 224 (321)
T d1tkia_ 149 GQARQLKPGDNF---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS-GINPFLAETNQQIIENIMNAEYTFDE 224 (321)
T ss_dssp TTCEECCTTCEE---EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHTCCCCCH
T ss_pred chhhccccCCcc---cccccccccccchhccCCCCCchhhcccHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCCh
Confidence 999876544322 23356789999999999999999999999999999999 9999999999999999987654322
Q ss_pred --CCCCCcchhhhcccccccccchhh-HHHHhhhhhhhhhc
Q psy7289 290 --PEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRDL 327 (422)
Q Consensus 290 --p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~dL 327 (422)
+..+++++.+|+.+||..||..|+ +..+.+|.++.+.+
T Consensus 225 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 265 (321)
T d1tkia_ 225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCc
Confidence 247899999999999999999986 33455677765543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.9e-52 Score=406.69 Aligned_cols=252 Identities=22% Similarity=0.339 Sum_probs=208.4
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-----CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCC
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-----NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEP 128 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 128 (422)
++|++.+.||+|+||.||+|+...+ +..||||++.... .........+|+++++.++|||||++++++.+++.
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t--~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADT--GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTT--CCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCC--CCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 4689999999999999999987543 5789999985321 11112223345778888899999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
+|+|||||++|+|.++|... ..+++.++..++.||+.||+|||+++||||||||+|||++.++.+||+
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~------------~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~ 149 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQH------------GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRIS 149 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEEC
T ss_pred EEEEEEecCCCcHHHHHHhc------------ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEe
Confidence 99999999999999999775 358899999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH--cCC
Q psy7289 209 DFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR--SRQ 285 (422)
Q Consensus 209 DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~--~~~ 285 (422)
|||+|+...... .....||+.|||||++.. ..|+.++|||||||++|||++ |..||.+.+..+...... ...
T Consensus 150 DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemlt-G~~Pf~~~~~~~~~~~~~~~~~~ 224 (364)
T d1omwa3 150 DLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEIDRMTLTM 224 (364)
T ss_dssp CCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHH-SSCSSCSSCSSCHHHHHHHSSSC
T ss_pred eeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccC
Confidence 999998664432 234568999999999975 468999999999999999999 999998766544333222 233
Q ss_pred CCCCCCCCCcchhhhcccccccccchhh------HHHHhhhhhhh
Q psy7289 286 MLPCPEDCPPRMYSLMMECWHEVPVAAG------MAYLCSHHYVH 324 (422)
Q Consensus 286 ~~~~p~~~p~~~~~l~~~cw~~~P~~r~------~~~lh~~~~i~ 324 (422)
..+.|..+|+++.+|+.+||..||..|+ .+.+.+|.++.
T Consensus 225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~ 269 (364)
T d1omwa3 225 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269 (364)
T ss_dssp CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGT
T ss_pred CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCcccc
Confidence 4556788999999999999999999996 36677777764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-51 Score=386.95 Aligned_cols=250 Identities=24% Similarity=0.326 Sum_probs=200.1
Q ss_pred cccccccccceeEEEEEEecCCCCeEEEEEEccCcCCH----HhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEEE
Q psy7289 58 FLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQ----KTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 58 ~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv~ 133 (422)
.++.||+|+||+||+|+... .++.||||+++..... ...+.+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivm 79 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKN--TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF 79 (299)
T ss_dssp EEEEEEEETTEEEEEEECSS--CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEE
T ss_pred cceEeccCcCeEEEEEEECC--CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehh
Confidence 36789999999999998654 4578999998643221 12346889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCccc
Q psy7289 134 EFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLS 213 (422)
Q Consensus 134 E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGla 213 (422)
|||.+|++..+.... ..+++.++..++.||+.||+|||++||+||||||+|||+++++.+||+|||+|
T Consensus 80 E~~~~~~~~~~~~~~------------~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a 147 (299)
T d1ua2a_ 80 DFMETDLEVIIKDNS------------LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA 147 (299)
T ss_dssp ECCSEEHHHHHTTCC------------SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred hhhcchHHhhhhhcc------------cCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccc
Confidence 999988777665432 35889999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC-----
Q psy7289 214 RDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQML----- 287 (422)
Q Consensus 214 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~~----- 287 (422)
+....... ......+|+.|||||++... .|+.++|||||||++|||++ |.+||.+.+..+.+..|......
T Consensus 148 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~-g~~pf~~~~~~~~l~~i~~~~~~~~~~~ 224 (299)
T d1ua2a_ 148 KSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRIFETLGTPTEEQ 224 (299)
T ss_dssp STTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccCCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHh-CcCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 86544321 22345678999999998754 57999999999999999999 99999999998887776531100
Q ss_pred -----------------CC-----CCCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 288 -----------------PC-----PEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 288 -----------------~~-----p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
.. .+..++++.+|+.+||..||..|+ +..+.+|.++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~ 284 (299)
T d1ua2a_ 225 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284 (299)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred ccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhC
Confidence 00 124567889999999999999986 33455566654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-51 Score=393.10 Aligned_cols=254 Identities=21% Similarity=0.370 Sum_probs=201.5
Q ss_pred cccCccccc-ccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhc-CCCCceeeEeeEEEc----
Q psy7289 52 IETKPRFLQ-ELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSE-LRHPNIVCLLGVCLS---- 125 (422)
Q Consensus 52 ~~~~~~~~~-~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~-l~HpnIv~l~g~~~~---- 125 (422)
+-.+|+++. .||+|+||.||+|+...+ ++.||||+++.. ..+.+|+.++.+ ++|||||++++++.+
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~--~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRT--QEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTT--CCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCC--CCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence 345788875 599999999999987543 578999998642 356789998765 489999999999865
Q ss_pred CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC---C
Q psy7289 126 GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD---G 202 (422)
Q Consensus 126 ~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~---~ 202 (422)
...+|+|||||++|+|.++|..+.. ..+++.++..++.||+.||+|||++||+||||||+|||+++ .
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~~----------~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~ 150 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRGD----------QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPN 150 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCSC----------CCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTT
T ss_pred CCEEEEEEECCCCCcHHHHHHhcCC----------CCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccc
Confidence 3568999999999999999976421 35899999999999999999999999999999999999985 4
Q ss_pred CeEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q psy7289 203 LTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282 (422)
Q Consensus 203 ~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~ 282 (422)
+.+||+|||+|+...... ......||+.|||||++.+..|+.++|||||||++|||++ |.+||.+.+..+....+.
T Consensus 151 ~~~Kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~llt-g~~Pf~~~~~~~~~~~~~ 226 (335)
T d2ozaa1 151 AILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC-GYPPFYSNHGLAISPGMK 226 (335)
T ss_dssp CCEEECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTT-SSCSCEETTCC-------
T ss_pred ccccccccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhh-CCCCCCCCCHHHHHHHHH
Confidence 679999999998765432 2334568999999999999999999999999999999998 999999887766655443
Q ss_pred cCC---CCCCC----CCCCcchhhhcccccccccchhh-HHHHhhhhhhhhhc
Q psy7289 283 SRQ---MLPCP----EDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRDL 327 (422)
Q Consensus 283 ~~~---~~~~p----~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~dL 327 (422)
... ....| ..+++++.+|+++||..+|..|+ +..+.+|.++....
T Consensus 227 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 227 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp -CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 321 11222 25788999999999999999986 44566666665433
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-50 Score=378.33 Aligned_cols=246 Identities=22% Similarity=0.319 Sum_probs=202.1
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCH-----HhHHHHHHHHHHHhcCC--CCceeeEeeEEEc
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQ-----KTASDFRREVDLMSELR--HPNIVCLLGVCLS 125 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~il~~l~--HpnIv~l~g~~~~ 125 (422)
..+|++.+.||+|+||+||+|+...+ +..||||+++..... .....+.+|+.+|++++ |||||++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~ 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSD--NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTT--CCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCC--CCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee
Confidence 56799999999999999999987543 578999998643211 11234678999999996 8999999999999
Q ss_pred CCCeEEEEEecCC-CCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC-CC
Q psy7289 126 GEPMCMLFEFMVR-GDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD-GL 203 (422)
Q Consensus 126 ~~~~~lv~E~~~~-G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~-~~ 203 (422)
++..++||||+.+ +++.+++..+ ..+++.++..++.||+.||+|||+++|+||||||+|||++. ++
T Consensus 81 ~~~~~lv~e~~~~~~~l~~~~~~~------------~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~ 148 (273)
T d1xwsa_ 81 PDSFVLILERPEPVQDLFDFITER------------GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG 148 (273)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT
T ss_pred CCeEEEEEEeccCcchHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCC
Confidence 9999999999976 6888888764 35899999999999999999999999999999999999985 57
Q ss_pred eEEEecCcccccccCCcceEeccCCCCCccccCccccccCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q psy7289 204 TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKF-TTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR 282 (422)
Q Consensus 204 ~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~ 282 (422)
.+||+|||+|+..... ..+...||+.|||||++....+ +.++||||+||++|||++ |..||.+.+ + +.
T Consensus 149 ~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~-g~~Pf~~~~--~----i~ 217 (273)
T d1xwsa_ 149 ELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC-GDIPFEHDE--E----II 217 (273)
T ss_dssp EEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH-SSCSCCSHH--H----HH
T ss_pred eEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhh-CCCCCCCch--H----Hh
Confidence 9999999999865432 2234568999999999987765 567899999999999999 999997632 2 33
Q ss_pred cCCCCCCCCCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 283 SRQMLPCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 283 ~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
.+ ....|..+|+++.+|+++||..||..|+ +..+.+|.++.
T Consensus 218 ~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~ 259 (273)
T d1xwsa_ 218 RG-QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259 (273)
T ss_dssp HC-CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred hc-ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhC
Confidence 33 3456788999999999999999999996 34455666653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=377.43 Aligned_cols=254 Identities=26% Similarity=0.403 Sum_probs=202.3
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
++|+++++||+|+||+||+|+...+ ++.||||+++... .....+.+.+|+++|++++|||||++++++.+++.+|+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLT--GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTT--CCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCC--CCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 4789999999999999999987543 4689999986432 223356899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
||||.+ ++.+++.... ...+++.++..++.||+.||+|||++|||||||||+|||++.++.+||+|||+
T Consensus 80 ~e~~~~-~~~~~~~~~~----------~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~ 148 (298)
T d1gz8a_ 80 FEFLHQ-DLKKFMDASA----------LTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 148 (298)
T ss_dssp EECCSE-EHHHHHHHTT----------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred EeecCC-chhhhhhhhc----------ccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCc
Confidence 999975 4555554332 13589999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC-----
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM----- 286 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~----- 286 (422)
|+...... .......+|+.|+|||.+.... ++.++|||||||++|||++ |..||.+.+..+.+..+.....
T Consensus 149 a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~-G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 225 (298)
T d1gz8a_ 149 ARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEV 225 (298)
T ss_dssp HHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ceeccCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhh-CCCCCCCCCHHHHHHHHHHhcCCCchh
Confidence 98654332 2234456789999999877665 5789999999999999999 9999999888877666532100
Q ss_pred ------------CCC-----------CCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 287 ------------LPC-----------PEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 287 ------------~~~-----------p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
... ...+++++.+|+.+|+..||..|+ +..+.+|.++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff 286 (298)
T d1gz8a_ 226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286 (298)
T ss_dssp TSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred hccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhh
Confidence 000 013456788999999999999986 3345566665
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=378.39 Aligned_cols=255 Identities=25% Similarity=0.405 Sum_probs=203.1
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcC---CCCceeeEeeEEEc---
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSEL---RHPNIVCLLGVCLS--- 125 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l---~HpnIv~l~g~~~~--- 125 (422)
..+|+++++||+|+||+||+|++..+ +++.||||+++... .......+.+|+.+|+.| +|||||++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKN-GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT-TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECC-CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 35899999999999999999987443 35779999986432 222233566788877665 79999999999863
Q ss_pred --CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC
Q psy7289 126 --GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL 203 (422)
Q Consensus 126 --~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~ 203 (422)
...++++||||.+|++....... ...+++..+..++.|++.||+|||+++|+||||||+|||+++++
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~ 153 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVP-----------EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG 153 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSC-----------TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC
T ss_pred ccCceEEEEEEeccCCchhhhhhcc-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCC
Confidence 23689999999988776554332 13589999999999999999999999999999999999999999
Q ss_pred eEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc
Q psy7289 204 TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS 283 (422)
Q Consensus 204 ~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~ 283 (422)
.+||+|||+++...... ......||+.|||||++....|+.++||||+||++|||++ |.+||.+.+..+.+..+..
T Consensus 154 ~~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~ 229 (305)
T d1blxa_ 154 QIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGKILD 229 (305)
T ss_dssp CEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHH
T ss_pred Ceeecchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHH-CCCCCCCCCHHHHHHHHHH
Confidence 99999999998654332 2345678999999999999999999999999999999999 9999999998887776642
Q ss_pred CCC--------------------------CCCCCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 284 RQM--------------------------LPCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 284 ~~~--------------------------~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
... ...+..+++.+.+|+.+||..||..|+ +..+.+|.++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff 296 (305)
T d1blxa_ 230 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296 (305)
T ss_dssp HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred hhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence 100 012345677889999999999999986 3345555554
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-49 Score=377.10 Aligned_cols=249 Identities=22% Similarity=0.346 Sum_probs=191.7
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHH--HHHHHhcCCCCceeeEeeEEEcCC---
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRR--EVDLMSELRHPNIVCLLGVCLSGE--- 127 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~--E~~il~~l~HpnIv~l~g~~~~~~--- 127 (422)
+.+|.+.+.||+|+||.||+|++ ++..||||+++... .+.+.+ |+..+..++|||||+++++|.+.+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~----~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~ 73 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW----RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE----TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE----CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcc
Confidence 34677889999999999999986 24789999986432 234444 455556789999999999998654
Q ss_pred -CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHh--------CCccccCCCCCcee
Q psy7289 128 -PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCS--------HHYVHRDLAARNCL 198 (422)
Q Consensus 128 -~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~--------~~ivHrDlKp~NiL 198 (422)
.+++|||||++|+|.++|++. .+++.++.+++.|+|.||+|||+ ++||||||||+|||
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~-------------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NIL 140 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRY-------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 140 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-------------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEE
T ss_pred eEEEEEEecccCCCHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceE
Confidence 479999999999999999763 48899999999999999999996 58999999999999
Q ss_pred ecCCCeEEEecCcccccccCCcceE--eccCCCCCccccCccccccCC------CCCchhHHhHHHHHHHHHhCCCCCCC
Q psy7289 199 VGDGLTVKISDFGLSRDVYASDYYR--IQSKSLLPVRWMPPESILYGK------FTTESDVWSYGVVLWEVYSYGLQPYY 270 (422)
Q Consensus 199 l~~~~~vKl~DFGla~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~------~~~~~DvwS~Gvil~El~t~g~~Pf~ 270 (422)
|++++.+||+|||+++......... ......+|+.|||||++.... ++.++|||||||++|||+| |..||.
T Consensus 141 l~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~t-g~~~~~ 219 (303)
T d1vjya_ 141 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGG 219 (303)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHH-TBCBTT
T ss_pred EcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhh-CCCCCC
Confidence 9999999999999998765433221 223456899999999987542 5778999999999999998 766653
Q ss_pred C---------------CChHHHHHHHHcCCC-CCCCCC-----CCcchhhhcccccccccchhhHHHHhhhhhhhhhcc
Q psy7289 271 G---------------YSNQEVIEMIRSRQM-LPCPED-----CPPRMYSLMMECWHEVPVAAGMAYLCSHHYVHRDLA 328 (422)
Q Consensus 271 ~---------------~~~~~~~~~i~~~~~-~~~p~~-----~p~~~~~l~~~cw~~~P~~r~~~~lh~~~~i~~dLk 328 (422)
. .+..++...+..+.. +++|.. ++..+.+||.+||..+|..|+ ++..+.+.|+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~ei~~~L~ 293 (303)
T d1vjya_ 220 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL-----TALRIKKTLS 293 (303)
T ss_dssp BCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSC-----CHHHHHHHHH
T ss_pred cccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCc-----CHHHHHHHHH
Confidence 2 122344444444333 333332 234588999999999999999 7777766654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-50 Score=384.32 Aligned_cols=257 Identities=21% Similarity=0.348 Sum_probs=211.8
Q ss_pred ccCcccccccccccceeEEEEEEec-CCCCeEEEEEEccCcC---CHHhHHHHHHHHHHHhcCCC-CceeeEeeEEEcCC
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCT-SEGPSLVAIKTLKENA---NQKTASDFRREVDLMSELRH-PNIVCLLGVCLSGE 127 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~H-pnIv~l~g~~~~~~ 127 (422)
-++|++++.||+|+||+||+|+... ...++.||||+++... +....+.+.+|+++|++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 3679999999999999999998754 3356889999986431 12234568899999999977 89999999999999
Q ss_pred CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEE
Q psy7289 128 PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKI 207 (422)
Q Consensus 128 ~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl 207 (422)
.++++|||+.+|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~------------~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL 170 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQR------------ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVL 170 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEE
T ss_pred ceeeeeecccccHHHHHHHhc------------ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEE
Confidence 999999999999999999775 35788999999999999999999999999999999999999999999
Q ss_pred ecCcccccccCCcceEeccCCCCCccccCccccccC--CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH---
Q psy7289 208 SDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG--KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR--- 282 (422)
Q Consensus 208 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~--- 282 (422)
+|||+|+........ ......+++.|+|||.+... .++.++|||||||++|||++ |..||.+.+..+....+.
T Consensus 171 ~DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyellt-G~~PF~~~~~~~~~~~i~~~~ 248 (322)
T d1vzoa_ 171 TDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT-GASPFTVDGEKNSQAEISRRI 248 (322)
T ss_dssp SCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH-SSCTTSCTTSCCCHHHHHHHH
T ss_pred eeccchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhc
Confidence 999999865433221 22345678899999998754 47889999999999999999 999998876554433332
Q ss_pred cCCCCCCCCCCCcchhhhcccccccccchhh------HHHHhhhhhh
Q psy7289 283 SRQMLPCPEDCPPRMYSLMMECWHEVPVAAG------MAYLCSHHYV 323 (422)
Q Consensus 283 ~~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~------~~~lh~~~~i 323 (422)
....++.|..+++++.+|+.+||..||..|. ++.+.+|.++
T Consensus 249 ~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff 295 (322)
T d1vzoa_ 249 LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295 (322)
T ss_dssp HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred ccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhh
Confidence 2345677889999999999999999999995 5566667665
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=9.5e-49 Score=370.74 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=203.2
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
++|+++++||+|+||+||+|++. +++.||||+++... .....+.+.+|+.+|++++|||||++++++.+++..+++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN---YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET---TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC---CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 47899999999999999999863 35789999986543 233357899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
|||+.++++..+.... ..+++.++..++.||+.||+|||+++||||||||+|||++.++.+||+|||+
T Consensus 79 ~e~~~~~~~~~~~~~~------------~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~ 146 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCE------------GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGL 146 (286)
T ss_dssp EECCSEEHHHHHHTST------------TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred EEeehhhhHHHHHhhc------------CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEeccccc
Confidence 9999987777766432 3699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC-----
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM----- 286 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~----- 286 (422)
|........ ......+++.|+|||.+... .++.++|||||||++|||++ |..||.+.+..+.+.++.....
T Consensus 147 a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~-G~~pf~~~~~~~~~~~i~~~~~~~~~~ 223 (286)
T d1ob3a_ 147 ARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN-GTPLFPGVSEADQLMRIFRILGTPNSK 223 (286)
T ss_dssp HHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ceecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHH-CCCCCCCCCHHHHHHHHHHhhCCCChh
Confidence 986543322 12234567889999998754 57899999999999999998 9999999988877666532100
Q ss_pred -----------------------CCCCCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 287 -----------------------LPCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 287 -----------------------~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
...+..+++.+.+|+++|+..||..|+ +..+.+|.++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f 284 (286)
T d1ob3a_ 224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284 (286)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred hccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 012345677888999999999999995 3445555554
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=373.14 Aligned_cols=261 Identities=23% Similarity=0.316 Sum_probs=204.3
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC----C
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE----P 128 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~----~ 128 (422)
.++|+++++||+|+||+||+|+... +++.||||+++........+.+.+|+.+|++|+|||||++++++.... .
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETT--TCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECC--CCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 3679999999999999999998643 357899999976555666778999999999999999999999997653 2
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEe
Q psy7289 129 MCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKIS 208 (422)
Q Consensus 129 ~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~ 208 (422)
.++++||+.+|+|.+++..+ .+++..++.++.||+.||+|||++|||||||||+|||+++++.+||+
T Consensus 85 ~~~l~~~~~~g~L~~~l~~~-------------~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~ 151 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKTQ-------------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 151 (345)
T ss_dssp CEEEEEECCCEEHHHHHHHC-------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEEC
T ss_pred eEEEEEeecCCchhhhhhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEc
Confidence 35566677899999999753 48999999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCcce-EeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC-
Q psy7289 209 DFGLSRDVYASDYY-RIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ- 285 (422)
Q Consensus 209 DFGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~- 285 (422)
|||+|+........ .......+|+.|+|||++.. ..++.++||||+||++|||++ |..||.+.+..+.........
T Consensus 152 DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~-g~~pf~~~~~~~~~~~~~~~~~ 230 (345)
T d1pmea_ 152 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-NRPIFPGKHYLDQLNHILGILG 230 (345)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhh-CCCCCCCCCHHHHHHHHhhhcc
Confidence 99999865433221 12234567899999999854 467899999999999999999 999999887665554432100
Q ss_pred --------------------------CCC---CCCCCCcchhhhcccccccccchhh-HHHHhhhhhhhhhccc
Q psy7289 286 --------------------------MLP---CPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHRDLAA 329 (422)
Q Consensus 286 --------------------------~~~---~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~dLk~ 329 (422)
..+ ....+++++.+|+.+|+..||..|+ +..+.+|.++.....+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred CCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 000 1234567889999999999999885 3446666666544444
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=369.11 Aligned_cols=250 Identities=25% Similarity=0.379 Sum_probs=199.8
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCC----
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSGE---- 127 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~---- 127 (422)
..+|+++++||+|+||+||+|+... .++.||||+++.. .+....+.+.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGR--TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETT--TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred CCcEEEEEEEecCCCeEEEEEEECC--CCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 5689999999999999999998654 3578999999753 34455678999999999999999999999998655
Q ss_pred --CeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeE
Q psy7289 128 --PMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTV 205 (422)
Q Consensus 128 --~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~v 205 (422)
.+|+||||| +++|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~~-------------~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~ 160 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMKH-------------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCEL 160 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH-------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCE
T ss_pred cceEEEEEecc-cccHHHHHHh-------------ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccccc
Confidence 479999999 5678777654 259999999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSR 284 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~ 284 (422)
||+|||+|+..... .....+|+.|+|||++.+. .++.++||||+||++|||++ |..||.+.+..+.+..+...
T Consensus 161 kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~ 234 (346)
T d1cm8a_ 161 KILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT-GKTLFKGSDHLDQLKEIMKV 234 (346)
T ss_dssp EECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHH
T ss_pred ccccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHH-CcCCCCCCChHHHHHHHHhc
Confidence 99999999865432 2345678999999998764 57899999999999999998 99999988877665444321
Q ss_pred C------------------------------CCCCCCCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 285 Q------------------------------MLPCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 285 ~------------------------------~~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
. ....+..+++.+.+|+.+|+..||..|+ +..+.+|.++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~ 305 (346)
T d1cm8a_ 235 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305 (346)
T ss_dssp HCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred cCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhC
Confidence 0 0112345678889999999999999996 44566666654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=365.93 Aligned_cols=258 Identities=20% Similarity=0.336 Sum_probs=201.0
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEc------
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLS------ 125 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------ 125 (422)
.++|+++++||+|+||+||+|++.. .++.||||++... ........+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRK--TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT--TCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECC--CCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 3689999999999999999998754 3578999998543 223345678999999999999999999999865
Q ss_pred --CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC
Q psy7289 126 --GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL 203 (422)
Q Consensus 126 --~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~ 203 (422)
...+|+|||||.++++..+.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~------------~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~ 154 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVL------------VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG 154 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTT------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS
T ss_pred ccCceEEEEEeccCCCccchhhhcc------------cccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCC
Confidence 34689999999988776554322 3589999999999999999999999999999999999999999
Q ss_pred eEEEecCcccccccCCcce--EeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHH
Q psy7289 204 TVKISDFGLSRDVYASDYY--RIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEM 280 (422)
Q Consensus 204 ~vKl~DFGla~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~ 280 (422)
.+||+|||+++........ .......+|+.|+|||++... .|+.++||||+||++|||++ |..||.+.+..+....
T Consensus 155 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~-g~~pf~~~~~~~~~~~ 233 (318)
T d3blha1 155 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLAL 233 (318)
T ss_dssp CEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHH
T ss_pred cEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhh-CCCCCCCCCHHHHHHH
Confidence 9999999999765433221 122334679999999998765 68999999999999999999 9999999888877766
Q ss_pred HHcCCCCCCCC-------------------------------CCCcchhhhcccccccccchhh-HHHHhhhhhhhh
Q psy7289 281 IRSRQMLPCPE-------------------------------DCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVHR 325 (422)
Q Consensus 281 i~~~~~~~~p~-------------------------------~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~~ 325 (422)
+......+.++ ..++.+.+|+.+||..||..|+ +..+.+|.++..
T Consensus 234 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 234 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp HHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred HHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 54311111000 0234567899999999999984 555667777643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-47 Score=363.50 Aligned_cols=245 Identities=20% Similarity=0.246 Sum_probs=200.6
Q ss_pred ccccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCC-CceeeEeeEEEcCCCe
Q psy7289 51 VIETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRH-PNIVCLLGVCLSGEPM 129 (422)
Q Consensus 51 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~g~~~~~~~~ 129 (422)
++..+|++.+.||+|+||+||+|++.. +++.||||+++..... ..+.+|+++++.|+| +||+.+++++.++...
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~--~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLL--NNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETT--TTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECC--CCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence 456789999999999999999998754 3578999988654322 346789999999975 8999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecC-----CCe
Q psy7289 130 CMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGD-----GLT 204 (422)
Q Consensus 130 ~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~-----~~~ 204 (422)
++||||+ +|+|.+++.... ..++..++..++.|++.||+|||++||+||||||+|||++. ++.
T Consensus 77 ~~vme~~-~~~l~~~~~~~~-----------~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~ 144 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLCG-----------RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANM 144 (293)
T ss_dssp EEEEECC-CCBHHHHHHHTT-----------TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTC
T ss_pred EEEEEec-CCCHHHHHHhhc-----------cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCc
Confidence 9999999 689999987642 35899999999999999999999999999999999999974 568
Q ss_pred EEEecCcccccccCCcc-----eEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCCh---HH
Q psy7289 205 VKISDFGLSRDVYASDY-----YRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSN---QE 276 (422)
Q Consensus 205 vKl~DFGla~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~---~~ 276 (422)
+||+|||+|+....... ........||+.|||||++.+..++.++|||||||++|||++ |..||.+.+. .+
T Consensus 145 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~Pf~~~~~~~~~~ 223 (293)
T d1csna_ 145 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLR-GSLPWQGLKAATNKQ 223 (293)
T ss_dssp EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTSSCCSCCHHH
T ss_pred eEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHh-CCCcCCCccchhHHH
Confidence 99999999986543211 112334568999999999999999999999999999999999 9999986543 33
Q ss_pred HHHHHHcCCC----CCCCCCCCcchhhhcccccccccchhh
Q psy7289 277 VIEMIRSRQM----LPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 277 ~~~~i~~~~~----~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
....+..... ...+.++|+++.++|..||..+|..||
T Consensus 224 ~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP 264 (293)
T d1csna_ 224 KYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATP 264 (293)
T ss_dssp HHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCC
T ss_pred HHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCc
Confidence 3333432211 123467999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-47 Score=364.23 Aligned_cols=243 Identities=20% Similarity=0.253 Sum_probs=190.6
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCce-eeEeeEEEcCCCeEE
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI-VCLLGVCLSGEPMCM 131 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~g~~~~~~~~~l 131 (422)
..+|++.+.||+|+||+||+|++..+ ++.||||++...... ..+.+|+++++.++|+|+ +.+.++..+++..++
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~--~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAA--GEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTT--TEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCC--CCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 45799999999999999999987543 578999987654322 357889999999987665 555566677788999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec---CCCeEEEe
Q psy7289 132 LFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVG---DGLTVKIS 208 (422)
Q Consensus 132 v~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~---~~~~vKl~ 208 (422)
||||+ +|+|.+.+.... ..+++..+..++.|++.||+|||++||+||||||+|||++ .+..+||+
T Consensus 81 vme~~-~~~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~ 148 (299)
T d1ckia_ 81 VMELL-GPSLEDLFNFCS-----------RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYII 148 (299)
T ss_dssp EEECC-CCBHHHHHHHTT-----------TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEEC
T ss_pred EEEEc-CCchhhhhhhcc-----------CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeee
Confidence 99998 466766665432 3589999999999999999999999999999999999875 35579999
Q ss_pred cCcccccccCCcc-----eEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHH-
Q psy7289 209 DFGLSRDVYASDY-----YRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIR- 282 (422)
Q Consensus 209 DFGla~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~- 282 (422)
|||+|+....... ........||+.|||||++.+..++.++|||||||++|||++ |..||.+.+..+....+.
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~t-g~~P~~~~~~~~~~~~~~~ 227 (299)
T d1ckia_ 149 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL-GSLPWQGLKAATKRQKYER 227 (299)
T ss_dssp CCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHH-SSCTTCCCC-------HHH
T ss_pred ccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHh-CCCcccccchHHHHHHHHH
Confidence 9999987643321 122344568999999999999999999999999999999999 999998876654433221
Q ss_pred --c----CCCCCCCCCCCcchhhhcccccccccchhh
Q psy7289 283 --S----RQMLPCPEDCPPRMYSLMMECWHEVPVAAG 313 (422)
Q Consensus 283 --~----~~~~~~p~~~p~~~~~l~~~cw~~~P~~r~ 313 (422)
. ......+.++|+++.++|..||..+|..||
T Consensus 228 ~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP 264 (299)
T d1ckia_ 228 ISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKP 264 (299)
T ss_dssp HHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCC
T ss_pred hhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCc
Confidence 1 111123468999999999999999999998
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-47 Score=367.11 Aligned_cols=252 Identities=25% Similarity=0.352 Sum_probs=197.8
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC------
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG------ 126 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------ 126 (422)
+.+|+.+++||+|+||+||+|++..+ ++.||||+++.... .+.+|+++|++++|||||++++++...
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~--~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDS--GELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTT--CCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCC--CCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 34688899999999999999987543 57899999865432 234799999999999999999998543
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCC-eE
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGL-TV 205 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~-~v 205 (422)
..+|+|||||++|.+..+...... ...+++.++..++.||+.||+|||++||+||||||+|||++.++ .+
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~---------~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~ 162 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRA---------KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL 162 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHT---------TCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCE
T ss_pred eEEEEEEeccCCccHHHHHhhhhc---------cCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCce
Confidence 347899999987644443322111 13699999999999999999999999999999999999999764 89
Q ss_pred EEecCcccccccCCcceEeccCCCCCccccCcccccc-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHc-
Q psy7289 206 KISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY-GKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRS- 283 (422)
Q Consensus 206 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~- 283 (422)
||+|||+++....... .....+|+.|+|||.+.. ..++.++||||+||++|||++ |.+||.+.+..+.+..+..
T Consensus 163 kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~-g~~pf~~~~~~~~l~~i~~~ 238 (350)
T d1q5ka_ 163 KLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKV 238 (350)
T ss_dssp EECCCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-TSCSSCCSSHHHHHHHHHHH
T ss_pred eEecccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhh-CCCCCCCCCHHHHHHHHHHH
Confidence 9999999987654332 234567889999998775 468999999999999999998 9999998888776665532
Q ss_pred -C----------------CCCC----------CCCCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 284 -R----------------QMLP----------CPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 284 -~----------------~~~~----------~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
+ ...+ ....+++++.+|+.+|+..||..|+ +..+.+|.++.
T Consensus 239 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~ 307 (350)
T d1q5ka_ 239 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307 (350)
T ss_dssp HCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred hCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence 0 0000 1235678899999999999999986 44566666663
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-46 Score=353.00 Aligned_cols=253 Identities=24% Similarity=0.376 Sum_probs=204.1
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcCCCeEEE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lv 132 (422)
.+|+++++||+|+||+||+|++.. +++.||||+++... .......+.+|+.+|+.++|||||++++++.+....+++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRE--THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT--TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECC--CCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 478999999999999999998754 45789999986433 344567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEEEecCcc
Q psy7289 133 FEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGL 212 (422)
Q Consensus 133 ~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vKl~DFGl 212 (422)
||++.+++|..++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||.
T Consensus 80 ~~~~~~~~l~~~~~~~------------~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~ 147 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCN------------GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp EECCSEEHHHHHHHTT------------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred eeeccccccccccccc------------cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecch
Confidence 9999999998887653 3588999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcceEeccCCCCCccccCccccccCC-CCCchhHHhHHHHHHHHHhCCCCC-CCCCChHHHHHHHHcCC-----
Q psy7289 213 SRDVYASDYYRIQSKSLLPVRWMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQP-YYGYSNQEVIEMIRSRQ----- 285 (422)
Q Consensus 213 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwS~Gvil~El~t~g~~P-f~~~~~~~~~~~i~~~~----- 285 (422)
|+....... ......+++.|+|||.+.... ++.++||||+||++|||++ |..| |.+.+..+.+..+....
T Consensus 148 a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (292)
T d1unla_ 148 ARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN-AGRPLFPGNDVDDQLKRIFRLLGTPTE 224 (292)
T ss_dssp CEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTT-TSCCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred hhcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhh-CCCCCCCCCCHHHHHHHHHhhcCCCCh
Confidence 987654332 122334567899999887665 6899999999999999998 6666 55566666665553210
Q ss_pred -----------------------CCCCCCCCCcchhhhcccccccccchhh-HHHHhhhhhh
Q psy7289 286 -----------------------MLPCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYV 323 (422)
Q Consensus 286 -----------------------~~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i 323 (422)
....+...++.+.+|+++|+..||..|+ +..+.+|.++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f 286 (292)
T d1unla_ 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286 (292)
T ss_dssp TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred hhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhh
Confidence 0112334567788999999999999996 2345555554
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-46 Score=360.89 Aligned_cols=251 Identities=22% Similarity=0.315 Sum_probs=201.4
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcC-CHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC-----
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENA-NQKTASDFRREVDLMSELRHPNIVCLLGVCLSG----- 126 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~----- 126 (422)
.++|+++++||+|+||+||+|+... .++.||||+++... +....+.+.+|+++|++++|||||++++++...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETT--TTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred CCCeEEEEEEecCCCeEEEEEEECC--CCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence 3579999999999999999998653 46889999987543 445567889999999999999999999998643
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEE
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vK 206 (422)
...+++|||+.+|+|.+++..+ .+++.++..++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~~-------------~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~k 161 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKCQ-------------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELK 161 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTTC-------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred CceEEEEEeecCCchhhhcccc-------------cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccccc
Confidence 3346778888999999998542 589999999999999999999999999999999999999999999
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCccccccCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK-FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQ 285 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~ 285 (422)
++|||++...... .....+|+.|+|||.+.... ++.++|||||||++|||++ |.+||.+.+.......+....
T Consensus 162 l~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~-g~~pF~~~~~~~~~~~i~~~~ 235 (348)
T d2gfsa1 162 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLILRLV 235 (348)
T ss_dssp ECCC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHH
T ss_pred ccccchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhc
Confidence 9999999754322 23455678999999877654 6889999999999999999 999999988877766654211
Q ss_pred CC----------------------CC--------CCCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 286 ML----------------------PC--------PEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 286 ~~----------------------~~--------p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
.. .. ...+++++.+|+.+|+..||..|+ +..+.+|.++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~ 305 (348)
T d2gfsa1 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305 (348)
T ss_dssp CCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred CCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhC
Confidence 10 00 135678889999999999999986 34455666664
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.6e-45 Score=355.25 Aligned_cols=246 Identities=17% Similarity=0.306 Sum_probs=194.4
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC-CCceeeEeeEEEcC--CCeE
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR-HPNIVCLLGVCLSG--EPMC 130 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~--~~~~ 130 (422)
++|+++++||+|+||+||+|+... +++.||||+++... .+.+.+|+++|++++ ||||+++++++... ..++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~--~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINIT--NNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECC--CCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 579999999999999999998654 45889999986432 356889999999995 99999999999743 5699
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCC-CeEEEec
Q psy7289 131 MLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDG-LTVKISD 209 (422)
Q Consensus 131 lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~-~~vKl~D 209 (422)
+|||||.+|+|.++. ..+++.++..++.||+.||+|||++||+||||||+|||++.+ +.+||+|
T Consensus 109 ~v~e~~~~~~L~~~~---------------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~D 173 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY---------------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLID 173 (328)
T ss_dssp EEEECCCSCBGGGTT---------------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred EEEeecCCCcHHHHh---------------cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecc
Confidence 999999999997653 248999999999999999999999999999999999999864 5799999
Q ss_pred CcccccccCCcceEeccCCCCCccccCccccccC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHc----
Q psy7289 210 FGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWSYGVVLWEVYSYGLQPYYGYSN-QEVIEMIRS---- 283 (422)
Q Consensus 210 FGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~-~~~~~~i~~---- 283 (422)
||+|+...... ......+|+.|+|||.+... .++.++||||+||++|||++ |..||..... .+....+..
T Consensus 174 FG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~-g~~pf~~~~~~~~~~~~i~~~~g~ 249 (328)
T d3bqca1 174 WGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF-RKEPFFHGHDNYDQLVRIAKVLGT 249 (328)
T ss_dssp GGGCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-TCSSSSCCSSHHHHHHHHHHHHCH
T ss_pred cccceeccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhcc-CCCCCCCCchhHHHHHHHHHHHCC
Confidence 99998654432 22345678899999998765 47999999999999999998 8889976543 222211110
Q ss_pred ---------CCC-----------------------CCCCCCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 284 ---------RQM-----------------------LPCPEDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 284 ---------~~~-----------------------~~~p~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
... .+.+..+++++.+|+++|+..||..|+ +..+.+|.++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~ 323 (328)
T d3bqca1 250 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323 (328)
T ss_dssp HHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred chhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 000 001123667889999999999999984 44555666553
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-46 Score=361.85 Aligned_cols=256 Identities=25% Similarity=0.313 Sum_probs=195.7
Q ss_pred cCcccccccccccceeEEEEEEecCCCCeEEEEEEccCc-CCHHhHHHHHHHHHHHhcCCCCceeeEeeEEEcC------
Q psy7289 54 TKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN-ANQKTASDFRREVDLMSELRHPNIVCLLGVCLSG------ 126 (422)
Q Consensus 54 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------ 126 (422)
.+|+++++||+|+||+||+|++.. .+..||||+++.. .+....+.+.+|+.+|++++|||||++++++...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~--t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAV--LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETT--TTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred CCeEEEEEeecCcCeEEEEEEECC--CCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 579999999999999999998754 3588999999754 3445567899999999999999999999999643
Q ss_pred CCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecCCCeEE
Q psy7289 127 EPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLVGDGLTVK 206 (422)
Q Consensus 127 ~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl~~~~~vK 206 (422)
..+|+|||||.+|. .+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 95 ~~~~iv~Ey~~~~l-~~~~~--------------~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~k 159 (355)
T d2b1pa1 95 QDVYLVMELMDANL-CQVIQ--------------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 159 (355)
T ss_dssp CEEEEEEECCSEEH-HHHHT--------------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEE
T ss_pred ceeEEEEeccchHH-HHhhh--------------cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccccccccee
Confidence 57899999997654 44443 2489999999999999999999999999999999999999999999
Q ss_pred EecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC
Q psy7289 207 ISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGYSNQEVIEMIRSRQM 286 (422)
Q Consensus 207 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~~~~~~~~~i~~~~~ 286 (422)
++|||+++...... ......+|+.|+|||++.+..++.++||||+||++|||++ |..||.+.+.......+.....
T Consensus 160 l~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~-g~~pF~~~~~~~~~~~i~~~~~ 235 (355)
T d2b1pa1 160 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKVIEQLG 235 (355)
T ss_dssp ECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHHHC
T ss_pred eechhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhh-CCCCCCCCCHHHHHHHHHHhcc
Confidence 99999988654322 2234457889999999999999999999999999999998 9999998887766555432111
Q ss_pred CCCC-----------------------------------------CCCCcchhhhcccccccccchhh-HHHHhhhhhhh
Q psy7289 287 LPCP-----------------------------------------EDCPPRMYSLMMECWHEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 287 ~~~p-----------------------------------------~~~p~~~~~l~~~cw~~~P~~r~-~~~lh~~~~i~ 324 (422)
.+.| ...++++.+|+++|+..||..|+ ++.+.+|.++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~ 315 (355)
T d2b1pa1 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 315 (355)
T ss_dssp CCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred CCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccC
Confidence 0000 01234678899999999999994 55677777776
Q ss_pred hhcccc
Q psy7289 325 RDLAAR 330 (422)
Q Consensus 325 ~dLk~~ 330 (422)
....++
T Consensus 316 ~~~~~~ 321 (355)
T d2b1pa1 316 VWYDPA 321 (355)
T ss_dssp GGCCHH
T ss_pred CCCCcc
Confidence 544333
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-38 Score=310.69 Aligned_cols=253 Identities=17% Similarity=0.261 Sum_probs=185.9
Q ss_pred ccCcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC-----------CCceeeEee
Q psy7289 53 ETKPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR-----------HPNIVCLLG 121 (422)
Q Consensus 53 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-----------HpnIv~l~g 121 (422)
..+|+++++||+|+||+||+|+... +++.||||+++.. ....+.+.+|+++++.++ |||||++++
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~--~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~ 87 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMV--NNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 87 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence 3579999999999999999998654 4578999998643 334467788999988875 578999998
Q ss_pred EEEc--CCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcee
Q psy7289 122 VCLS--GEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCS-HHYVHRDLAARNCL 198 (422)
Q Consensus 122 ~~~~--~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlKp~NiL 198 (422)
++.. ....+++|+++..+........... ...+++..+..++.||+.||+|||+ +||+||||||+|||
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIl 158 (362)
T d1q8ya_ 88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYE---------HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 158 (362)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHHTT---------TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEE
T ss_pred Eeeeccccceeeeeeeccccccccccccccc---------ccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHee
Confidence 8764 3456777777766544333322211 2468899999999999999999998 89999999999999
Q ss_pred ecCCC------eEEEecCcccccccCCcceEeccCCCCCccccCccccccCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Q psy7289 199 VGDGL------TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSYGVVLWEVYSYGLQPYYGY 272 (422)
Q Consensus 199 l~~~~------~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwS~Gvil~El~t~g~~Pf~~~ 272 (422)
++.++ .+|++|||.|+..... .....+|+.|+|||++....++.++||||+||+++||++ |..||...
T Consensus 159 l~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pF~~~ 232 (362)
T d1q8ya_ 159 MEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT-GDFLFEPD 232 (362)
T ss_dssp EEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHH-SSCCC---
T ss_pred eeccCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHH-CCCCCCCC
Confidence 97654 4999999999754322 234567899999999999999999999999999999999 99999754
Q ss_pred ChH------HHHHHH-Hc-CC---------------------------------------CCCCCCCCCcchhhhccccc
Q psy7289 273 SNQ------EVIEMI-RS-RQ---------------------------------------MLPCPEDCPPRMYSLMMECW 305 (422)
Q Consensus 273 ~~~------~~~~~i-~~-~~---------------------------------------~~~~p~~~p~~~~~l~~~cw 305 (422)
+.. +.+... .. +. ....+...++++.+|+.+|+
T Consensus 233 ~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL 312 (362)
T d1q8ya_ 233 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312 (362)
T ss_dssp ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred ccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHC
Confidence 321 111111 00 00 00011223467889999999
Q ss_pred ccccchhh-HHHHhhhhhhh
Q psy7289 306 HEVPVAAG-MAYLCSHHYVH 324 (422)
Q Consensus 306 ~~~P~~r~-~~~lh~~~~i~ 324 (422)
..||..|+ +..+.+|.++.
T Consensus 313 ~~dP~~Rpta~e~L~Hp~f~ 332 (362)
T d1q8ya_ 313 QLDPRKRADAGGLVNHPWLK 332 (362)
T ss_dssp CSSTTTCBCHHHHHTCGGGT
T ss_pred CCChhHCcCHHHHhcCcccC
Confidence 99999995 45566666665
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=2.9e-26 Score=202.57 Aligned_cols=164 Identities=18% Similarity=0.145 Sum_probs=119.2
Q ss_pred ccccccccccceeEEEEEEecCCCCeEEEEEEccCcCC-----------------HHhHHHHHHHHHHHhcCCCCceeeE
Q psy7289 57 RFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENAN-----------------QKTASDFRREVDLMSELRHPNIVCL 119 (422)
Q Consensus 57 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~-----------------~~~~~~~~~E~~il~~l~HpnIv~l 119 (422)
.+.++||+|+||+||+|+.. +++.||||+++.... ........+|...+.++.|+|++..
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~---~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~ 79 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE---KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKV 79 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET---TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCE
T ss_pred hhCCEeeeCcceEEEEEECC---CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceE
Confidence 35789999999999999752 357899998653210 0112345678999999999999998
Q ss_pred eeEEEcCCCeEEEEEecCCCCHHHHHhhcCCCCCCCCCCccCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceee
Q psy7289 120 LGVCLSGEPMCMLFEFMVRGDLHEFLMSRSPRSDISGSQVQAPLSQQDFSHIALQVAAGMAYLCSHHYVHRDLAARNCLV 199 (422)
Q Consensus 120 ~g~~~~~~~~~lv~E~~~~G~L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlKp~NiLl 199 (422)
+++. ..+++|||++++.+. .++...+..++.|++.||+|||++||+||||||+|||+
T Consensus 80 ~~~~----~~~lvme~~~~~~~~-------------------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv 136 (191)
T d1zara2 80 YAWE----GNAVLMELIDAKELY-------------------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV 136 (191)
T ss_dssp EEEE----TTEEEEECCCCEEGG-------------------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE
T ss_pred EEec----CCEEEEEeecccccc-------------------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheee
Confidence 8763 237999999876542 24445567899999999999999999999999999999
Q ss_pred cCCCeEEEecCcccccccCCcceEeccCCCCCccccCc--cc---cccCCCCCchhHHhHHHH
Q psy7289 200 GDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP--ES---ILYGKFTTESDVWSYGVV 257 (422)
Q Consensus 200 ~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~t~~y~aP--E~---~~~~~~~~~~DvwS~Gvi 257 (422)
+++ .++|+|||+|+....+.. ..|... +. +..+.|+.++|+||..--
T Consensus 137 ~~~-~~~liDFG~a~~~~~~~~----------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 137 SEE-GIWIIDFPQSVEVGEEGW----------REILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp ETT-EEEECCCTTCEETTSTTH----------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred eCC-CEEEEECCCcccCCCCCc----------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 965 589999999975432211 011111 00 113568899999997543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=1.7e-24 Score=206.93 Aligned_cols=106 Identities=51% Similarity=0.958 Sum_probs=91.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
++.++.|||+++++||||||+||+++.+..+|++|||+|+............+..+|+.|||||++..+.|+.++|||||
T Consensus 173 i~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~ 252 (325)
T d1rjba_ 173 VAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 252 (325)
T ss_dssp HHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccch
Confidence 57899999999999999999999999999999999999986554443444445556889999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhhhc
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEFLK 415 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~~~ 415 (422)
||+||||++.|+.||.+.+..+.+.+
T Consensus 253 Gvil~emlt~g~~Pf~~~~~~~~~~~ 278 (325)
T d1rjba_ 253 GILLWEIFSLGVNPYPGIPVDANFYK 278 (325)
T ss_dssp HHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred hHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999889999999887765443
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=3.8e-24 Score=199.69 Aligned_cols=103 Identities=34% Similarity=0.596 Sum_probs=82.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCcccccc---CCCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY---GKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv 386 (422)
++++++|||+++++||||||+|||++.+..+|++|||+|+...............+|+.|||||++.. +.|+.++||
T Consensus 113 i~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDi 192 (276)
T d1uwha_ 113 TAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDV 192 (276)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHH
T ss_pred HHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhh
Confidence 57899999999999999999999999999999999999986443322222344567899999999864 358999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
|||||+||||++ |+.||.+.++.+..
T Consensus 193 wS~Gv~l~el~t-g~~Pf~~~~~~~~~ 218 (276)
T d1uwha_ 193 YAFGIVLYELMT-GQLPYSNINNRDQI 218 (276)
T ss_dssp HHHHHHHHHHHH-SSCTTTTCCCHHHH
T ss_pred hhhHHHHHHHHH-CCCCCCCCChHHHH
Confidence 999999999997 99999998776543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=4.7e-24 Score=201.48 Aligned_cols=105 Identities=50% Similarity=0.923 Sum_probs=85.2
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+++|+.|||+++++||||||+|||++.+..+||+|||+|+...........+...+|+.|||||++.++.|+.++|||||
T Consensus 143 i~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~ 222 (299)
T d1ywna1 143 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 222 (299)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeeh
Confidence 67899999999999999999999999999999999999986544433333445667899999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEFL 414 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~~ 414 (422)
||++|||++.+..||.+.+..+.+.
T Consensus 223 Gvil~ellt~~~~p~~~~~~~~~~~ 247 (299)
T d1ywna1 223 GVLLWEIFSLGASPYPGVKIDEEFC 247 (299)
T ss_dssp HHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999987788999887776554
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=1.3e-23 Score=197.24 Aligned_cols=103 Identities=21% Similarity=0.477 Sum_probs=84.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
...++.|||+++++||||||+||+++.+..+|++|||+|+...............+|+.|||||++.+..|+.++||||+
T Consensus 117 i~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSl 196 (288)
T d1uu3a_ 117 IVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWAL 196 (288)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHH
T ss_pred HHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehh
Confidence 46799999999999999999999999999999999999986543322223344568899999999998899999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||+||||++ |..||.+.+..+.+
T Consensus 197 Gvilyell~-g~~Pf~~~~~~~~~ 219 (288)
T d1uu3a_ 197 GCIIYQLVA-GLPPFRAGNEYLIF 219 (288)
T ss_dssp HHHHHHHHH-SSCSSCCSSHHHHH
T ss_pred hHHHHHHhh-CCCCCCCcCHHHHH
Confidence 999999996 99999987665543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=1.2e-23 Score=195.76 Aligned_cols=102 Identities=30% Similarity=0.472 Sum_probs=86.5
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCC-CcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKF-TTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dvws 388 (422)
+..+++|||+++++||||||+|||++....+|++|||+|+....++.....+...+|+.|||||++.+..+ +.++||||
T Consensus 112 i~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwS 191 (271)
T d1nvra_ 112 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 191 (271)
T ss_dssp HHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHH
T ss_pred HHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeH
Confidence 46799999999999999999999999988999999999986544433344455678999999999988776 56799999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
+||++|||++ |+.||.+.++...
T Consensus 192 lGvilyeml~-G~~pf~~~~~~~~ 214 (271)
T d1nvra_ 192 CGIVLTAMLA-GELPWDQPSDSCQ 214 (271)
T ss_dssp HHHHHHHHHH-SSCSCSSSSTTSH
T ss_pred hHHHHHHHHh-CCCCCCCCChHHH
Confidence 9999999997 9999988765543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=1.7e-23 Score=193.85 Aligned_cols=100 Identities=30% Similarity=0.518 Sum_probs=86.0
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
++.+++|||+++++||||||+|||++.+..+|++|||+|+...... .....+|+.|||||++.+..|+.++|||||
T Consensus 115 i~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSl 190 (263)
T d2j4za1 115 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSL 190 (263)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHH
T ss_pred HHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhH
Confidence 5779999999999999999999999999999999999998643322 223457889999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEFL 414 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~~ 414 (422)
||+||||++ |+.||.+.+..+.+.
T Consensus 191 Gvilyell~-G~~Pf~~~~~~~~~~ 214 (263)
T d2j4za1 191 GVLCYEFLV-GKPPFEANTYQETYK 214 (263)
T ss_dssp HHHHHHHHH-SSCTTCCSSHHHHHH
T ss_pred hHHHHHHhc-CCCCCCCCCHHHHHH
Confidence 999999997 999999877665443
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=1.7e-23 Score=199.25 Aligned_cols=103 Identities=46% Similarity=0.770 Sum_probs=85.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+++|+.|||+++++||||||+||+++.+..+|++|||+|+...............+|+.|+|||++.++.|+.++|||||
T Consensus 120 i~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~ 199 (317)
T d1xkka_ 120 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 199 (317)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhH
Confidence 57899999999999999999999999999999999999986544333333344557889999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||++|||+|.|..||.+.+..+.
T Consensus 200 Gvil~el~t~g~~p~~~~~~~~~ 222 (317)
T d1xkka_ 200 GVTVWELMTFGSKPYDGIPASEI 222 (317)
T ss_dssp HHHHHHHHTTSCCTTTTSCGGGH
T ss_pred HHHHHHHHHCCCCCCCCCCHHHH
Confidence 99999999889999999776653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=1.9e-23 Score=195.75 Aligned_cols=104 Identities=48% Similarity=0.857 Sum_probs=89.7
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcce-eeccccCCCcccCCccccccCCCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYY-RIQSKSLLPVRWMPPESILYGKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 388 (422)
++.|++|||+++++||||||+||+++.+..+|++|||+|+........ ...+...+|+.|||||++..+.|+.++||||
T Consensus 118 i~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS 197 (285)
T d1u59a_ 118 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWS 197 (285)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHH
T ss_pred HHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhc
Confidence 578999999999999999999999999999999999999865443322 2234456788999999999999999999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
|||++|||+|.|+.||.+.+..+..
T Consensus 198 ~Gv~l~E~lt~G~~Pf~~~~~~~~~ 222 (285)
T d1u59a_ 198 YGVTMWEALSYGQKPYKKMKGPEVM 222 (285)
T ss_dssp HHHHHHHHHTTSCCTTTTCCTHHHH
T ss_pred chHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999998899999998877643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=3.5e-23 Score=194.65 Aligned_cols=101 Identities=26% Similarity=0.520 Sum_probs=86.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++||||||+|||++.+..+|++|||+|+....+.. ......+|+.|+|||++.++.|+.++||||+
T Consensus 125 i~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 202 (293)
T d1yhwa1 125 CLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 202 (293)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHH
T ss_pred HHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc--cccccccCCCccChhhhcCCCCCchhceehH
Confidence 46799999999999999999999999999999999999986543321 2344567899999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||++|||++ |..||.+.+..+..
T Consensus 203 Gvilyemlt-G~~Pf~~~~~~~~~ 225 (293)
T d1yhwa1 203 GIMAIEMIE-GEPPYLNENPLRAL 225 (293)
T ss_dssp HHHHHHHHH-SSCTTTTSCHHHHH
T ss_pred hHHHHHHhh-CCCCCCCCCHHHHH
Confidence 999999997 99999987766543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.87 E-value=2.3e-23 Score=196.63 Aligned_cols=103 Identities=53% Similarity=0.938 Sum_probs=78.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcce---eeccccCCCcccCCccccccCCCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYY---RIQSKSLLPVRWMPPESILYGKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 386 (422)
+++|+.|||+++++||||||+|||++.+..+|++|||+|+........ .......+|+.|||||.+..+.|+.++||
T Consensus 137 ia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv 216 (299)
T d1jpaa_ 137 IAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDV 216 (299)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHH
T ss_pred HHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCccccc
Confidence 578999999999999999999999999999999999999865432211 11223446789999999999999999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
|||||++|||+|+|+.||.+.+..+.
T Consensus 217 wS~Gvvl~el~t~g~~Pf~~~~~~~~ 242 (299)
T d1jpaa_ 217 WSYGIVMWEVMSYGERPYWDMTNQDV 242 (299)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred ccchHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999889999999877664
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=1.9e-23 Score=195.13 Aligned_cols=103 Identities=50% Similarity=0.914 Sum_probs=87.2
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcc-eeeccccCCCcccCCccccccCCCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDY-YRIQSKSLLPVRWMPPESILYGKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 388 (422)
+++++.|||+++++||||||+|||++....+|++|||+|+....... ........+|+.|||||++.++.|+.++||||
T Consensus 116 i~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS 195 (277)
T d1xbba_ 116 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWS 195 (277)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHH
T ss_pred HHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhcc
Confidence 57899999999999999999999999999999999999986543322 22233456788999999999999999999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
|||++|||++.|+.||.+.+..+.
T Consensus 196 ~Gv~l~ellt~g~~Pf~~~~~~~~ 219 (277)
T d1xbba_ 196 FGVLMWEAFSYGQKPYRGMKGSEV 219 (277)
T ss_dssp HHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred chhhhhHHhhCCCCCCCCCCHHHH
Confidence 999999999889999999877663
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=3.6e-23 Score=197.38 Aligned_cols=98 Identities=31% Similarity=0.505 Sum_probs=83.3
Q ss_pred chhhHHHHhh-hhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHH
Q psy7289 310 VAAGMAYLCS-HHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~-~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 388 (422)
..+++.|||+ ++++|||+||+|||++....+|++|||+|+..... ...+..+|+.|+|||++.++.|+.++||||
T Consensus 113 il~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWS 188 (322)
T d1s9ja_ 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWS 188 (322)
T ss_dssp HHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHH
T ss_pred HHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHH
Confidence 4679999997 68999999999999999999999999999854322 123456789999999999999999999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
+||++|||++ |+.||.+.+..+.
T Consensus 189 lGvil~ell~-G~~Pf~~~~~~~~ 211 (322)
T d1s9ja_ 189 MGLSLVEMAV-GRYPIPPPDAKEL 211 (322)
T ss_dssp HHHHHHHHHH-SSCCSSCCCTTHH
T ss_pred HHHHHHHHHH-CCCCCCCCCHHHH
Confidence 9999999997 9999998766543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=7.9e-23 Score=195.90 Aligned_cols=101 Identities=25% Similarity=0.494 Sum_probs=86.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..+++|||+++++||||||+|||++.++.+|++|||+|+....... .....++|+.|+|||++.+..|+.++||||+
T Consensus 114 il~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSl 191 (337)
T d1o6la_ 114 IVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 191 (337)
T ss_dssp HHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHH
T ss_pred HhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccch
Confidence 46799999999999999999999999999999999999986433221 2234567899999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||++|||++ |+.||.+.+..+.+
T Consensus 192 Gvilyeml~-G~~pf~~~~~~~~~ 214 (337)
T d1o6la_ 192 GVVMYEMMC-GRLPFYNQDHERLF 214 (337)
T ss_dssp HHHHHHHHH-SSCSSCCSSHHHHH
T ss_pred hhHHHHHHH-CCCCCCCcCHHHHH
Confidence 999999996 99999997766543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=4.3e-23 Score=191.75 Aligned_cols=101 Identities=25% Similarity=0.453 Sum_probs=76.9
Q ss_pred chhhHHHHhhhh-----hhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcch
Q psy7289 310 VAAGMAYLCSHH-----YVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTES 384 (422)
Q Consensus 310 ~~r~~~~lh~~~-----~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 384 (422)
++.++.|||+.+ ++||||||+|||++.+..+|++|||+|+...... .......+|+.|||||++.++.|+.++
T Consensus 118 i~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~ 195 (269)
T d2java1 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKS 195 (269)
T ss_dssp HHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHH
T ss_pred HHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHH
Confidence 567999999865 9999999999999999999999999998643322 123345678899999999988999999
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 385 DVWSYGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 385 Dvws~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
|||||||++|||++ |+.||.+.+..+..
T Consensus 196 DIwSlGvilyel~t-g~~Pf~~~~~~~~~ 223 (269)
T d2java1 196 DIWSLGCLLYELCA-LMPPFTAFSQKELA 223 (269)
T ss_dssp HHHHHHHHHHHHHH-SSCSCCCSSHHHHH
T ss_pred HHHhhCHHHHHHhh-CCCCCCCCCHHHHH
Confidence 99999999999997 99999987766643
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=6.8e-23 Score=190.78 Aligned_cols=101 Identities=46% Similarity=0.874 Sum_probs=85.0
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+++++.|||+++++||||||+|||++.+..+|++|||+|+....+. ........+++.|||||++..+.|+.++|||||
T Consensus 118 i~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~ 196 (272)
T d1qpca_ 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 196 (272)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHH
T ss_pred HHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc-cccccccCCcccccChHHHhCCCCCchhhhhhh
Confidence 5789999999999999999999999999999999999998654332 233445567889999999998999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||++|||+|.|..||.+.+..+
T Consensus 197 Gvvl~ellt~~~~~~~~~~~~~ 218 (272)
T d1qpca_ 197 GILLTEIVTHGRIPYPGMTNPE 218 (272)
T ss_dssp HHHHHHHHTTTCCSSTTCCHHH
T ss_pred HHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999986666666655444
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=8.8e-23 Score=191.15 Aligned_cols=102 Identities=54% Similarity=0.955 Sum_probs=76.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcce-eeccccCCCcccCCccccccCCCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYY-RIQSKSLLPVRWMPPESILYGKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 388 (422)
++++++|||+++++||||||+|||++.+..+||+|||+|+........ .......+|+.|||||++..+.|+.++||||
T Consensus 119 i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S 198 (283)
T d1mqba_ 119 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWS 198 (283)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHH
T ss_pred HHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccc
Confidence 578999999999999999999999999999999999999865433222 1223445688999999999999999999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
|||++|||++.|..||.+.+..+
T Consensus 199 ~Gvil~el~t~~~~~~~~~~~~~ 221 (283)
T d1mqba_ 199 FGIVMWEVMTYGERPYWELSNHE 221 (283)
T ss_dssp HHHHHHHHHTTSCCTTTTCCHHH
T ss_pred cHHHHHHHHhCCCCccccCCHHH
Confidence 99999999985655665544443
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=7.6e-23 Score=191.95 Aligned_cols=102 Identities=26% Similarity=0.427 Sum_probs=85.2
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccc-----cCCCCcch
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESIL-----YGKFTTES 384 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~ 384 (422)
+..++.|||+++++||||||+|||++.+..+|++|||+|+..... ........+|+.|||||++. .+.|+.++
T Consensus 119 i~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~ 196 (288)
T d2jfla1 119 TLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKA 196 (288)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHH
T ss_pred HHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC--cccccccccccccCCHHHHhhcccCCCCCChhh
Confidence 567999999999999999999999999999999999999753321 11233456788999999984 44589999
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCchhhhh
Q psy7289 385 DVWSYGVVLWEVYSYGLQPYYGYSNQEEFL 414 (422)
Q Consensus 385 Dvws~Gv~l~el~~~g~~p~~~~~~~~~~~ 414 (422)
|||||||++|||++ |+.||.+.+..+.+.
T Consensus 197 DiwSlGvilyemlt-g~~Pf~~~~~~~~~~ 225 (288)
T d2jfla1 197 DVWSLGITLIEMAE-IEPPHHELNPMRVLL 225 (288)
T ss_dssp HHHHHHHHHHHHHH-SSCTTTTSCGGGHHH
T ss_pred hHHHHHHHHHHHhh-CCCCCCCCCHHHHHH
Confidence 99999999999997 999999987776554
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=8.9e-23 Score=189.04 Aligned_cols=101 Identities=48% Similarity=0.932 Sum_probs=76.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
++.|+.|+|+++++||||||+||+++.+..+|++|||+|+....... .......+|+.|+|||++..+.|+.++|||||
T Consensus 110 ia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~ 188 (263)
T d1sm2a_ 110 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 188 (263)
T ss_dssp HHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------------CTTSCCHHHHTTCCCCHHHHHHHH
T ss_pred HHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc-eeecceecCcccCChHHhcCCCCCchhhhcch
Confidence 57899999999999999999999999999999999999986543322 22334557889999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||++|||++.|..||.+.+..+
T Consensus 189 Gvil~el~t~~~~~~~~~~~~~ 210 (263)
T d1sm2a_ 189 GVLMWEVFSEGKIPYENRSNSE 210 (263)
T ss_dssp HHHHHHHHTTSCCTTCSCCHHH
T ss_pred HHHHHHHHHCCCCCCCCCCHHH
Confidence 9999999987777777655544
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.85 E-value=1.4e-22 Score=192.71 Aligned_cols=98 Identities=26% Similarity=0.536 Sum_probs=85.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
++.++.|||+++++||||||+|||++.++.+|++|||+|+..... .....+|+.|||||++.+..|+.++||||+
T Consensus 113 i~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSl 187 (316)
T d1fota_ 113 VCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSF 187 (316)
T ss_dssp HHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHH
T ss_pred HHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-----cccccCcccccCHHHHcCCCCCchhhcccc
Confidence 567999999999999999999999999999999999999864322 234567889999999988889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||++|||++ |+.||.+.+..+..
T Consensus 188 Gvilyemlt-G~~Pf~~~~~~~~~ 210 (316)
T d1fota_ 188 GILIYEMLA-GYTPFYDSNTMKTY 210 (316)
T ss_dssp HHHHHHHHH-SSCTTCCSSHHHHH
T ss_pred chhHHHHHh-CCCCCCCcCHHHHH
Confidence 999999997 99999997766544
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.85 E-value=7.1e-23 Score=193.51 Aligned_cols=104 Identities=64% Similarity=1.312 Sum_probs=87.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
++.+++|||+++++||||||+|||++.+..+||+|||+|+...........+...+++.|+|||.+..+.||.++|||||
T Consensus 149 i~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~ 228 (301)
T d1lufa_ 149 VAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAY 228 (301)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccc
Confidence 57899999999999999999999999999999999999986554444444445667789999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||++|||++.+..||.+.+..+..
T Consensus 229 Gvvl~ell~~~~~p~~~~~~~e~~ 252 (301)
T d1lufa_ 229 GVVLWEIFSYGLQPYYGMAHEEVI 252 (301)
T ss_dssp HHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred hhhHHHHHccCCCCCCCCCHHHHH
Confidence 999999998556789887766643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=2.3e-22 Score=186.80 Aligned_cols=100 Identities=26% Similarity=0.444 Sum_probs=83.0
Q ss_pred chhhHHHHhhhh--hhhhhccccccccc-CCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhH
Q psy7289 310 VAAGMAYLCSHH--YVHRDLAARNCLVG-DGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~--~i~~dLk~~nil~~-~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 386 (422)
++.+++|||+++ ++||||||+|||++ ....+|++|||+|+...... .....+|+.|||||++. +.|+.++||
T Consensus 121 i~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~----~~~~~GT~~Y~aPE~~~-~~~~~~~DI 195 (270)
T d1t4ha_ 121 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDV 195 (270)
T ss_dssp HHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHH
T ss_pred HHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc----cCCcccCccccCHHHhC-CCCCCcCch
Confidence 578999999998 99999999999996 46789999999998533221 22345789999999876 569999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchhhhhc
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQEEFLK 415 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~~~~~ 415 (422)
|||||++|||++ |+.||.+..+.+...+
T Consensus 196 wSlGvilyel~~-g~~Pf~~~~~~~~~~~ 223 (270)
T d1t4ha_ 196 YAFGMCMLEMAT-SEYPYSECQNAAQIYR 223 (270)
T ss_dssp HHHHHHHHHHHH-SSCTTTTCSSHHHHHH
T ss_pred hhHHHHHHHHHH-CCCCCCCcccHHHHHH
Confidence 999999999996 9999998777665443
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.85 E-value=1.2e-22 Score=195.70 Aligned_cols=98 Identities=23% Similarity=0.459 Sum_probs=84.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+.+++.|||+++++||||||+|||++.+..+||+|||+++..... .....+|+.|||||++.+..|+.++|||||
T Consensus 150 i~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSl 224 (350)
T d1rdqe_ 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWAL 224 (350)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred HHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-----cccccCccccCCHHHHcCCCCCccccccch
Confidence 468999999999999999999999999999999999999864322 123456789999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||+||||++ |..||.+.+..+.+
T Consensus 225 Gvilyemlt-G~~Pf~~~~~~~~~ 247 (350)
T d1rdqe_ 225 GVLIYEMAA-GYPPFFADQPIQIY 247 (350)
T ss_dssp HHHHHHHHH-SSCSSCCSSHHHHH
T ss_pred hHHHHHHHh-CCCCCCCcCHHHHH
Confidence 999999997 99999986655543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=2.1e-22 Score=185.98 Aligned_cols=104 Identities=51% Similarity=0.976 Sum_probs=90.2
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+++|++|||+++++|+||||+||+++.+..+|++|||+++...... ........+|+.|+|||.+..+.|+.++|||||
T Consensus 109 i~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~ 187 (258)
T d1k2pa_ 109 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 187 (258)
T ss_dssp HHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCC-ceeecccCCCCCcCCcHHhcCCCCCcceeeccc
Confidence 5789999999999999999999999999999999999998654432 222344567889999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEFL 414 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~~ 414 (422)
||++|||+|.|+.||.+.++.+...
T Consensus 188 G~~l~el~t~g~~Pf~~~~~~~~~~ 212 (258)
T d1k2pa_ 188 GVLMWEIYSLGKMPYERFTNSETAE 212 (258)
T ss_dssp HHHHHHHHTTSCCTTTTSCHHHHHH
T ss_pred chhhHhHHhcCCCCCCCCCHHHHHH
Confidence 9999999988999999988777543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.85 E-value=1.4e-22 Score=190.06 Aligned_cols=100 Identities=46% Similarity=0.984 Sum_probs=82.7
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+++|++|||+++++||||||+|||++.+..+|++|||+|+....+. ....+...+++.|+|||++.++.|+.++|||||
T Consensus 124 i~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~ 202 (287)
T d1opja_ 124 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 202 (287)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHH
T ss_pred HHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC-ceeeccccccccccChHHHcCCCCCchhhhhhH
Confidence 5789999999999999999999999999999999999998654432 233344556788999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCch
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQ 410 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~ 410 (422)
||++|||++.|..||.+.+..
T Consensus 203 Gv~l~ell~~~~p~~~~~~~~ 223 (287)
T d1opja_ 203 GVLLWEIATYGMSPYPGIDLS 223 (287)
T ss_dssp HHHHHHHHTTSCCSSTTCCHH
T ss_pred HHHHHHHHhCCCCCCCcchHH
Confidence 999999997554455554443
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.85 E-value=2.3e-22 Score=190.52 Aligned_cols=98 Identities=32% Similarity=0.556 Sum_probs=83.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCcccccc---CCCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY---GKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv 386 (422)
++.|+.|||+++++||||||+|||++.+..+|++|||+|+.... .....+|+.|||||++.. +.|+.++||
T Consensus 124 i~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~Di 197 (309)
T d1u5ra_ 124 ALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDV 197 (309)
T ss_dssp HHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHH
T ss_pred HHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------CCccccCccccCHHHHhccCCCCcCchhhh
Confidence 46799999999999999999999999999999999999985432 123457899999999863 468999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchhhhh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQEEFL 414 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~~~~ 414 (422)
|||||++|||++ |..||.+.+..+...
T Consensus 198 wSlGvilyel~~-g~~Pf~~~~~~~~~~ 224 (309)
T d1u5ra_ 198 WSLGITCIELAE-RKPPLFNMNAMSALY 224 (309)
T ss_dssp HHHHHHHHHHHH-SSCTTTTSCHHHHHH
T ss_pred hhHHHHHHHHHH-CCCCCCCCCHHHHHH
Confidence 999999999996 999999877666443
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=1.5e-22 Score=188.47 Aligned_cols=103 Identities=47% Similarity=0.872 Sum_probs=78.5
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+++++.|||+++++||||||+||+++....+|++|||+|+...... ....+...+|+.|+|||++..+.|+.++|||||
T Consensus 117 i~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSl 195 (273)
T d1mp8a_ 117 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMF 195 (273)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHH
T ss_pred HHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc-ceeccceecCcccchhhHhccCCCCCccccccc
Confidence 4789999999999999999999999999999999999998643322 223344567889999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||++|||++.|..||.+.+..+..
T Consensus 196 Gvil~e~lt~g~~P~~~~~~~~~~ 219 (273)
T d1mp8a_ 196 GVCMWEILMHGVKPFQGVKNNDVI 219 (273)
T ss_dssp HHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred hHHHHHHHhcCCCCCCCCCHHHHH
Confidence 999999998899999998877654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.84 E-value=4.5e-22 Score=192.72 Aligned_cols=97 Identities=26% Similarity=0.457 Sum_probs=83.4
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccC-CCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws 388 (422)
+..++.|||+++++||||||+|||++..+.+|++|||+|+...... .....+|+.|+|||++..+ .|+.++||||
T Consensus 116 i~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwS 191 (364)
T d1omwa3 116 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFS 191 (364)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHH
T ss_pred HHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhH
Confidence 4679999999999999999999999999999999999998643322 2345678999999999765 5899999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
|||+||||++ |+.||.+.+..+
T Consensus 192 lGvilyemlt-G~~Pf~~~~~~~ 213 (364)
T d1omwa3 192 LGCMLFKLLR-GHSPFRQHKTKD 213 (364)
T ss_dssp HHHHHHHHHH-SSCSSCSSCSSC
T ss_pred HHHHHHHHHh-CCCCCCCCCHHH
Confidence 9999999997 999998866544
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.84 E-value=7e-22 Score=186.76 Aligned_cols=99 Identities=29% Similarity=0.532 Sum_probs=85.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..+++|||+++++|||+||+|||++....+|++|||+++...... ......+|+.|+|||++.+..|+.++||||+
T Consensus 125 i~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSl 201 (305)
T d1blxa_ 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSV 201 (305)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHH
T ss_pred HHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhch
Confidence 4679999999999999999999999999999999999987543322 2345567899999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||++|||++ |+.||.+.+..+.
T Consensus 202 G~il~ell~-g~~pf~~~~~~~~ 223 (305)
T d1blxa_ 202 GCIFAEMFR-RKPLFRGSSDVDQ 223 (305)
T ss_dssp HHHHHHHHH-SSCSCCCSSHHHH
T ss_pred HHHHHHHHH-CCCCCCCCCHHHH
Confidence 999999997 9999998766553
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.84 E-value=2.7e-22 Score=186.76 Aligned_cols=104 Identities=43% Similarity=0.824 Sum_probs=86.7
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcc-eeeccccCCCcccCCccccccCCCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDY-YRIQSKSLLPVRWMPPESILYGKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 388 (422)
++.|+.|||+++++||||||+||+++.+..+|++|||+++....+.. ........+|..|+|||++.++.++.++||||
T Consensus 120 i~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S 199 (273)
T d1u46a_ 120 VAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWM 199 (273)
T ss_dssp HHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHH
T ss_pred HHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhh
Confidence 67899999999999999999999999999999999999986544322 22233445678999999999999999999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
|||++|||+|+|+.||.+.+..+..
T Consensus 200 ~Gvil~emlt~G~~Pf~~~~~~~~~ 224 (273)
T d1u46a_ 200 FGVTLWEMFTYGQEPWIGLNGSQIL 224 (273)
T ss_dssp HHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred hHHHHHHHHhCCCCCCCCcCHHHHH
Confidence 9999999998899999998777753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.84 E-value=8.6e-22 Score=187.46 Aligned_cols=101 Identities=31% Similarity=0.553 Sum_probs=86.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
++.++.|||+++++|||+||+|||++....+|++|||+++...... ...+...+|+.|+|||++.++.|+.++||||+
T Consensus 112 i~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 189 (320)
T d1xjda_ 112 IILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSF 189 (320)
T ss_dssp HHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred HHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhh
Confidence 5679999999999999999999999999999999999998543322 22344567899999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||++|||++ |+.||.+.+..+.+
T Consensus 190 Gvilyemlt-G~~PF~~~~~~~~~ 212 (320)
T d1xjda_ 190 GVLLYEMLI-GQSPFHGQDEEELF 212 (320)
T ss_dssp HHHHHHHHH-SSCSSCCSSHHHHH
T ss_pred hHHHHHHHh-CCCCCCCCCHHHHH
Confidence 999999997 99999997766643
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.84 E-value=6e-22 Score=187.46 Aligned_cols=100 Identities=29% Similarity=0.497 Sum_probs=74.2
Q ss_pred chhhHHHHhhhhhhhhhccccccccc---CCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVG---DGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~---~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 386 (422)
+..++.|||+++++|||+||+||++. .+..+|++|||+|+...... ......+|+.|||||++.++.|+.++||
T Consensus 116 i~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~Di 192 (307)
T d1a06a_ 116 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDC 192 (307)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------------------CTTSCHHHHTTCCCCTHHHH
T ss_pred HHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHh
Confidence 56799999999999999999999984 46789999999998543222 2234567899999999998899999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||+||++|||++ |..||.+.+..+..
T Consensus 193 wSlGvilyell~-g~~Pf~~~~~~~~~ 218 (307)
T d1a06a_ 193 WSIGVIAYILLC-GYPPFYDENDAKLF 218 (307)
T ss_dssp HHHHHHHHHHHH-SSCSCCCSSHHHHH
T ss_pred hhhhHHHHHHHh-CCCCCCCCCHHHHH
Confidence 999999999996 99999987666543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=1e-21 Score=185.19 Aligned_cols=104 Identities=50% Similarity=0.946 Sum_probs=88.7
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
++.+++|||+++++|||+||+|||++.+..+|++|||+++...............+++.|+|||.+.++.|+.++|||||
T Consensus 144 i~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~ 223 (299)
T d1fgka_ 144 VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 223 (299)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHh
Confidence 57899999999999999999999999999999999999986544332222344556788999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||++|||++.|..||.+.+..+.+
T Consensus 224 Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 224 GVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp HHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred HHHHHHhccCCCCCCCCCCHHHHH
Confidence 999999998889999887766543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=1.2e-21 Score=184.69 Aligned_cols=101 Identities=25% Similarity=0.482 Sum_probs=84.7
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccC-CCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws 388 (422)
+..+++|||+++++||||||+||+++....+|++|||+|+...... .......+|+.|+|||++..+ .|+.++||||
T Consensus 109 il~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS 186 (299)
T d1ua2a_ 109 TLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWA 186 (299)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHH
T ss_pred HHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc--ccccceecChhhccHHHHccCCCCChhhhhhh
Confidence 4679999999999999999999999999999999999998643322 222345678899999998765 5799999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
+||++|||++ |..||.+.++.+..
T Consensus 187 lGvil~el~~-g~~pf~~~~~~~~l 210 (299)
T d1ua2a_ 187 VGCILAELLL-RVPFLPGDSDLDQL 210 (299)
T ss_dssp HHHHHHHHHH-SSCSSCCSSHHHHH
T ss_pred cchHHHHHHh-CcCCCCCCCHHHHH
Confidence 9999999997 99999987766543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.83 E-value=1.2e-21 Score=188.60 Aligned_cols=100 Identities=26% Similarity=0.441 Sum_probs=84.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccccC--CcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGD--GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVW 387 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~--~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 387 (422)
+..++.|||+++++||||||+|||+.. +..+|++|||+|+....... .....+|+.|||||++.+..|+.++|||
T Consensus 133 i~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~Diw 209 (350)
T d1koaa2 133 VCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMW 209 (350)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHH
T ss_pred HHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc---cceecCcccccCHHHHcCCCCChhHhhh
Confidence 467999999999999999999999853 56899999999986543322 2334568899999999988899999999
Q ss_pred HHHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 388 SYGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
|+||++|||++ |+.||.+.+..+.+
T Consensus 210 SlGvilyell~-G~~Pf~~~~~~~~~ 234 (350)
T d1koaa2 210 SVGVLSYILLS-GLSPFGGENDDETL 234 (350)
T ss_dssp HHHHHHHHHHH-SSCSSCCSSHHHHH
T ss_pred hhhHHHHHHHh-CCCCCCCCCHHHHH
Confidence 99999999997 99999987666543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.82 E-value=1.5e-21 Score=188.15 Aligned_cols=100 Identities=25% Similarity=0.457 Sum_probs=84.9
Q ss_pred chhhHHHHhhhhhhhhhccccccccc--CCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVG--DGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVW 387 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~--~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 387 (422)
+..++.|||+++++||||||+|||++ ....+|++|||+|+....... .....+++.|+|||++.+..|+.++|||
T Consensus 136 i~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Diw 212 (352)
T d1koba_ 136 ACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMW 212 (352)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHH
T ss_pred HHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCc---eeeccCcccccCHHHHcCCCCCCccchH
Confidence 56799999999999999999999997 457899999999986543322 2334567899999999988899999999
Q ss_pred HHHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 388 SYGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
|+||++|||++ |+.||.+.+..+.+
T Consensus 213 SlGvilyellt-G~~Pf~~~~~~~~~ 237 (352)
T d1koba_ 213 AIGVLGYVLLS-GLSPFAGEDDLETL 237 (352)
T ss_dssp HHHHHHHHHHH-SCCSSCCSSHHHHH
T ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHH
Confidence 99999999996 99999997776654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=1.7e-21 Score=182.38 Aligned_cols=101 Identities=47% Similarity=0.896 Sum_probs=78.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
++.+++|||+++++|+||||+|||++.+..+|++|||+++....+. ........+|+.|+|||++..+.++.++|||||
T Consensus 122 i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~ 200 (285)
T d1fmka3 122 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 200 (285)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC-ceeeccccccccccChHHHhCCCCCcHHhhhcc
Confidence 6789999999999999999999999999999999999998643322 223344567889999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||++|||++.|..||.+....+
T Consensus 201 Giil~el~t~~~p~~~~~~~~~ 222 (285)
T d1fmka3 201 GILLTELTTKGRVPYPGMVNRE 222 (285)
T ss_dssp HHHHHHHHTTTCCSSTTCCHHH
T ss_pred hHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999985665666544443
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=2.4e-21 Score=183.47 Aligned_cols=104 Identities=61% Similarity=1.111 Sum_probs=90.4
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
.++|+.|||+++++||||||+|||++.+.++||+|||+|+...........+...+++.|+|||.+.++.++.++|||||
T Consensus 142 ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~ 221 (308)
T d1p4oa_ 142 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 221 (308)
T ss_dssp HHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccH
Confidence 57899999999999999999999999999999999999986655444444455567899999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||++|||++.+..||.+.+..+.+
T Consensus 222 G~il~El~t~~~~p~~~~~~~~~~ 245 (308)
T d1p4oa_ 222 GVVLWEIATLAEQPYQGLSNEQVL 245 (308)
T ss_dssp HHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999998667899988777654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.82 E-value=2.4e-21 Score=180.65 Aligned_cols=104 Identities=25% Similarity=0.424 Sum_probs=80.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCc-ceeeccccCCCcccCCccccccCCCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASD-YYRIQSKSLLPVRWMPPESILYGKFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 388 (422)
+..++.|||+++++||||||+||+++.....+++|||+++...... .........+|+.|+|||++.++.|+.++||||
T Consensus 120 i~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwS 199 (277)
T d1o6ya_ 120 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYS 199 (277)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHH
T ss_pred HHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceeccc
Confidence 5779999999999999999999999999999999999987543322 112233456789999999999888999999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhhhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEEFL 414 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~~~ 414 (422)
+||++|||++ |+.||.+.+..+.+.
T Consensus 200 lGvilyellt-G~~Pf~~~~~~~~~~ 224 (277)
T d1o6ya_ 200 LGCVLYEVLT-GEPPFTGDSPVSVAY 224 (277)
T ss_dssp HHHHHHHHHH-SSCSCCCSSHHHHHH
T ss_pred chHHHHHHHh-CCCCCCCcCHHHHHH
Confidence 9999999997 999999877666543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=4e-21 Score=180.63 Aligned_cols=100 Identities=30% Similarity=0.519 Sum_probs=83.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCc----ceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchh
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGL----TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESD 385 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~----~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 385 (422)
+..+++|||+++++|||+||+||+++... .+|++|||+|+...... ......+++.|+|||++.++.|+.++|
T Consensus 122 i~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~D 198 (293)
T d1jksa_ 122 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEAD 198 (293)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHH
T ss_pred HHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCccc
Confidence 46799999999999999999999997554 59999999998643322 123455678999999999888999999
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 386 VWSYGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 386 vws~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
|||+||++|||++ |+.||.+.+..+.+
T Consensus 199 iwSlGvilyell~-g~~Pf~~~~~~~~~ 225 (293)
T d1jksa_ 199 MWSIGVITYILLS-GASPFLGDTKQETL 225 (293)
T ss_dssp HHHHHHHHHHHHH-SSCSSCCSSHHHHH
T ss_pred chhhhHHHHHHHc-CCCCCCCCCHHHHH
Confidence 9999999999996 99999997766643
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=2.3e-21 Score=185.66 Aligned_cols=98 Identities=23% Similarity=0.528 Sum_probs=82.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccC---CcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGD---GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~---~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 386 (422)
+..+++|||+++++||||||+|||++. ...+|++|||+++...... ......+|+.|||||++.+..|+.++||
T Consensus 120 i~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~Di 196 (335)
T d2ozaa1 120 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDM 196 (335)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHH
T ss_pred HHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHH
Confidence 467999999999999999999999975 4569999999998644332 1234567899999999988889999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||+||+||||++ |+.||.+.+..+
T Consensus 197 wSlGvily~llt-g~~Pf~~~~~~~ 220 (335)
T d2ozaa1 197 WSLGVIMYILLC-GYPPFYSNHGLA 220 (335)
T ss_dssp HHHHHHHHHHTT-SSCSCEETTCC-
T ss_pred HhhchhHHHHhh-CCCCCCCCCHHH
Confidence 999999999996 999998865543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=3.9e-21 Score=182.25 Aligned_cols=105 Identities=50% Similarity=0.927 Sum_probs=90.4
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
++++++|||+++++||||||+||+++....+|++|||+++...............+|+.|+|||.+..+.++.++|||||
T Consensus 154 i~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~ 233 (311)
T d1t46a_ 154 VAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 233 (311)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccch
Confidence 67899999999999999999999999999999999999986554444444455667889999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEFL 414 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~~ 414 (422)
||++|||++.|..||.+.+..+.+.
T Consensus 234 G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 234 GIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp HHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999987888888877766543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.80 E-value=1.3e-20 Score=177.61 Aligned_cols=101 Identities=27% Similarity=0.400 Sum_probs=81.3
Q ss_pred chhhHHHHhhhhhhhhhccccccccc---CCcceeecccccccccccCcc-----eeeccccCCCcccCCccccccCCCC
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVG---DGLTVKISDFGLSRDVYASDY-----YRIQSKSLLPVRWMPPESILYGKFT 381 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~---~~~~~ki~Dfgls~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~ 381 (422)
+..+++|||+++++||||||+||+++ .+..+|++|||+|+....... ........+|+.|||||++.+..|+
T Consensus 112 i~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 191 (299)
T d1ckia_ 112 MISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS 191 (299)
T ss_dssp HHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC
T ss_pred HHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCC
Confidence 46799999999999999999999864 455799999999986533221 1122345678999999999988899
Q ss_pred cchhHHHHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 382 TESDVWSYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 382 ~~~Dvws~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
.++|||||||++|||++ |+.||.+.+..+
T Consensus 192 ~~~DiwSlG~~l~el~t-g~~P~~~~~~~~ 220 (299)
T d1ckia_ 192 RRDDLESLGYVLMYFNL-GSLPWQGLKAAT 220 (299)
T ss_dssp HHHHHHHHHHHHHHHHH-SSCTTCCCC---
T ss_pred ChhhEEecCHHHHHHHh-CCCcccccchHH
Confidence 99999999999999996 999998876554
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=6.7e-21 Score=177.22 Aligned_cols=92 Identities=24% Similarity=0.396 Sum_probs=77.7
Q ss_pred chhhHHHHhhhhhhhhhcccccccccC-CcceeecccccccccccCcceeeccccCCCcccCCccccccCCC-CcchhHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGD-GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKF-TTESDVW 387 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~-~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dvw 387 (422)
+..++.|||+++++|||+||+||+++. ...+|++|||+|+..... ..+...+|+.|+|||++.+..+ +.++|||
T Consensus 119 i~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~Diw 194 (273)
T d1xwsa_ 119 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVW 194 (273)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHH
T ss_pred HHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccc
Confidence 467999999999999999999999984 468999999999753322 2334567899999999987765 5678999
Q ss_pred HHHHHHHHHHhcCCCCCCC
Q psy7289 388 SYGVVLWEVYSYGLQPYYG 406 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~ 406 (422)
|+||++|||++ |+.||.+
T Consensus 195 SlGvilyell~-g~~Pf~~ 212 (273)
T d1xwsa_ 195 SLGILLYDMVC-GDIPFEH 212 (273)
T ss_dssp HHHHHHHHHHH-SSCSCCS
T ss_pred cceeeehhHhh-CCCCCCC
Confidence 99999999997 9999976
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=1.1e-20 Score=174.58 Aligned_cols=99 Identities=45% Similarity=0.882 Sum_probs=80.5
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
++.++.|||+.+++|+||+|+||+++.+..+|++|||+++..... .....++..|+|||++.++.|+.++|||||
T Consensus 112 i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSf 186 (262)
T d1byga_ 112 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSF 186 (262)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHH
T ss_pred HHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhH
Confidence 678999999999999999999999999999999999999864322 122345678999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||++|||++.|+.||.+.+..+..
T Consensus 187 G~il~el~t~~~~p~~~~~~~~~~ 210 (262)
T d1byga_ 187 GILLWEIYSFGRVPYPRIPLKDVV 210 (262)
T ss_dssp HHHHHHHHTTSCCSCTTSCGGGHH
T ss_pred HHHHHHHHHCCCCCCCCCCHHHHH
Confidence 999999998899999987766643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.79 E-value=2.3e-20 Score=175.39 Aligned_cols=100 Identities=20% Similarity=0.258 Sum_probs=81.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccC-----CcceeecccccccccccCcce-----eeccccCCCcccCCccccccCC
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGD-----GLTVKISDFGLSRDVYASDYY-----RIQSKSLLPVRWMPPESILYGK 379 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~-----~~~~ki~Dfgls~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~ 379 (422)
...++.+||+++++|||+||+||+++. ...+|++|||+|+........ .......+|+.|||||++.+..
T Consensus 110 ~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~ 189 (293)
T d1csna_ 110 MLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE 189 (293)
T ss_dssp HHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC
T ss_pred HHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCC
Confidence 356999999999999999999999964 457999999999854322111 1122345789999999999888
Q ss_pred CCcchhHHHHHHHHHHHHhcCCCCCCCCCch
Q psy7289 380 FTTESDVWSYGVVLWEVYSYGLQPYYGYSNQ 410 (422)
Q Consensus 380 ~~~~~Dvws~Gv~l~el~~~g~~p~~~~~~~ 410 (422)
++.++|||||||++|||++ |..||.+.+..
T Consensus 190 ~~~~~DiwSlG~~l~ellt-g~~Pf~~~~~~ 219 (293)
T d1csna_ 190 QSRRDDLEALGHVFMYFLR-GSLPWQGLKAA 219 (293)
T ss_dssp CCHHHHHHHHHHHHHHHHH-SSCTTSSCCSC
T ss_pred CChHHHHHHhhHHHHHHHh-CCCcCCCccch
Confidence 9999999999999999997 99999886554
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=2.6e-20 Score=176.94 Aligned_cols=102 Identities=24% Similarity=0.475 Sum_probs=83.4
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcce--eeccccCCCcccCCccccccC-CCCcchhH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYY--RIQSKSLLPVRWMPPESILYG-KFTTESDV 386 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv 386 (422)
+..++.|||+++++||||||+|||++.+..+|++|||+++........ ....+..+|+.|+|||++... .|+.++||
T Consensus 126 il~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~Di 205 (318)
T d3blha1 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDL 205 (318)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHH
T ss_pred HHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHc
Confidence 467999999999999999999999999999999999999754322211 112334578999999998765 58999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 387 WSYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 387 ws~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
||+||++|||++ |+.||.+.++.+.
T Consensus 206 wSlGvil~el~~-g~~pf~~~~~~~~ 230 (318)
T d3blha1 206 WGAGCIMAEMWT-RSPIMQGNTEQHQ 230 (318)
T ss_dssp HHHHHHHHHHHH-SSCSCCCSSHHHH
T ss_pred ccCCceeeeHhh-CCCCCCCCCHHHH
Confidence 999999999997 9999998766554
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=2.8e-20 Score=175.22 Aligned_cols=101 Identities=29% Similarity=0.529 Sum_probs=84.0
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCC-CCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK-FTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dvws 388 (422)
+..+++|||+++++||||||+||+++....+|++|||+|+...... .......+++.|+|||.+.... ++.++|+||
T Consensus 111 il~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwS 188 (298)
T d1gz8a_ 111 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWS 188 (298)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHH
T ss_pred HHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc--ccceeecccceeeehhhhccccCCCccccccc
Confidence 4679999999999999999999999999999999999998543321 2234456788999999877665 578999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
+||++|||++ |+.||.+.++.+..
T Consensus 189 lGvily~m~~-G~~Pf~~~~~~~~~ 212 (298)
T d1gz8a_ 189 LGCIFAEMVT-RRALFPGDSEIDQL 212 (298)
T ss_dssp HHHHHHHHHH-SSCSCCCSSHHHHH
T ss_pred cchhhhHHhh-CCCCCCCCCHHHHH
Confidence 9999999997 99999987655543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=2.3e-20 Score=176.74 Aligned_cols=101 Identities=52% Similarity=0.904 Sum_probs=83.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+++|+.|+|+++++||||||+|||++....+|++|||+++..... .......+|..|+|||.+.++.|+.++|||||
T Consensus 136 ia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSf 212 (309)
T d1fvra_ 136 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 212 (309)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHH
T ss_pred HHHHHHhhhcCCccccccccceEEEcCCCceEEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehh
Confidence 578999999999999999999999999999999999999753221 11223456788999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
||++|||++.|..||.+.+..+..
T Consensus 213 Gvil~ell~~~~~p~~~~~~~~~~ 236 (309)
T d1fvra_ 213 GVLLWEIVSLGGTPYCGMTCAELY 236 (309)
T ss_dssp HHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred HHHHHHHHhcCCCCCCCCCHHHHH
Confidence 999999997566788887766643
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=5.3e-20 Score=174.25 Aligned_cols=100 Identities=50% Similarity=0.923 Sum_probs=80.1
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcce--eeccccCCCcccCCccccccCCCCcchhHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYY--RIQSKSLLPVRWMPPESILYGKFTTESDVW 387 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 387 (422)
.+.++.|+|+.+++||||||+|||++.+..+|++|||+++........ ...+...+|..|+|||.+..+.++.++|||
T Consensus 139 ia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~ 218 (311)
T d1r0pa_ 139 VAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 218 (311)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHH
T ss_pred HHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhh
Confidence 578999999999999999999999999999999999999865433221 122345568899999999999999999999
Q ss_pred HHHHHHHHHHhcCCCCCCCCCch
Q psy7289 388 SYGVVLWEVYSYGLQPYYGYSNQ 410 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~~~~~ 410 (422)
||||++|||++ |+.||....+.
T Consensus 219 SfGivl~El~t-~~~p~~~~~~~ 240 (311)
T d1r0pa_ 219 SFGVLLWELMT-RGAPPYPDVNT 240 (311)
T ss_dssp HHHHHHHHHHT-TSCCSCC----
T ss_pred hhHHHHHHHHH-CCCCCCCCCCH
Confidence 99999999997 44555554433
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=8.9e-20 Score=175.29 Aligned_cols=102 Identities=27% Similarity=0.454 Sum_probs=83.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcc-eeeccccCCCcccCCccccccC-CCCcchhHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDY-YRIQSKSLLPVRWMPPESILYG-KFTTESDVW 387 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvw 387 (422)
...+++|||+++++||||||+|||++.+..+|++|||+++....... ........+|+.|+|||++..+ .|+.++|||
T Consensus 118 il~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~Diw 197 (345)
T d1pmea_ 118 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 197 (345)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHH
T ss_pred HHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhh
Confidence 46799999999999999999999999999999999999975433221 1123445578899999998654 578899999
Q ss_pred HHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 388 SYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
|+||++|||++ |+.||.+.+..+.
T Consensus 198 SlG~il~eml~-g~~pf~~~~~~~~ 221 (345)
T d1pmea_ 198 SVGCILAEMLS-NRPIFPGKHYLDQ 221 (345)
T ss_dssp HHHHHHHHHHH-SSCSCCCSSHHHH
T ss_pred ccCceehHHhh-CCCCCCCCCHHHH
Confidence 99999999996 9999988765543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=7.7e-20 Score=176.06 Aligned_cols=100 Identities=27% Similarity=0.462 Sum_probs=82.7
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCC-cceeecccccccccccCcceeeccccCCCcccCCccccccC-CCCcchhHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDG-LTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVW 387 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~-~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvw 387 (422)
+..|++|||+++++||||||+|||++.+ ..+|++|||+++....... .....++..|+|||.+... .|+.++|||
T Consensus 131 il~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIw 207 (350)
T d1q5ka_ 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVW 207 (350)
T ss_dssp HHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHH
T ss_pred HHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCcc---cccccccccccChHHhhcccCCCcceeec
Confidence 4679999999999999999999999865 4899999999986543321 2334567889999988754 689999999
Q ss_pred HHHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 388 SYGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
|+||++|||++ |+.||.+.+..+.+
T Consensus 208 SlG~il~el~~-g~~pf~~~~~~~~l 232 (350)
T d1q5ka_ 208 SAGCVLAELLL-GQPIFPGDSGVDQL 232 (350)
T ss_dssp HHHHHHHHHHH-TSCSSCCSSHHHHH
T ss_pred ccceEEEehhh-CCCCCCCCCHHHHH
Confidence 99999999996 99999987766543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.77 E-value=7.9e-20 Score=170.15 Aligned_cols=99 Identities=25% Similarity=0.472 Sum_probs=83.0
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCcccccc------CCCCcc
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILY------GKFTTE 383 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~ 383 (422)
+..+++|||+++++||||||+||+++.+..+|++|||+++...... ......+|..|+|||.+.. ..|+.+
T Consensus 119 i~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~ 195 (277)
T d1phka_ 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKE 195 (277)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTH
T ss_pred HHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCch
Confidence 5679999999999999999999999999999999999998643322 1234557889999998863 347889
Q ss_pred hhHHHHHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 384 SDVWSYGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 384 ~Dvws~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
+||||+||+||||++ |+.||.+.+..+.
T Consensus 196 ~DiwslGvilyeml~-g~~Pf~~~~~~~~ 223 (277)
T d1phka_ 196 VDMWSTGVIMYTLLA-GSPPFWHRKQMLM 223 (277)
T ss_dssp HHHHHHHHHHHHHHH-SSCSSCCSSHHHH
T ss_pred heEcccchhhhhhcc-CCCCCCCCCHHHH
Confidence 999999999999997 9999999776553
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=6.9e-20 Score=174.21 Aligned_cols=100 Identities=26% Similarity=0.497 Sum_probs=83.0
Q ss_pred chhhHHHHhhhhhhhhhcccccccccC--CcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGD--GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVW 387 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~--~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 387 (422)
+..++.|||+++++||||||+||+++. ...+|++|||+++........ ....+++.|+|||.+.+..|+.++|||
T Consensus 111 i~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~---~~~~~t~~y~ape~~~~~~~~~~~DiW 187 (321)
T d1tkia_ 111 VCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQHDVVSTATDMW 187 (321)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE---EEEESCGGGSCHHHHTTCEECHHHHHH
T ss_pred HHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcc---cccccccccccchhccCCCCCchhhcc
Confidence 467999999999999999999999974 457999999999865433221 223457889999999888899999999
Q ss_pred HHHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 388 SYGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
|+||++|||++ |..||.+.+..+.+
T Consensus 188 SlGvily~ll~-G~~Pf~~~~~~~~~ 212 (321)
T d1tkia_ 188 SLGTLVYVLLS-GINPFLAETNQQII 212 (321)
T ss_dssp HHHHHHHHHHH-SSCTTCCSSHHHHH
T ss_pred cHHHHHHHHHh-CCCCCCCCCHHHHH
Confidence 99999999997 99999987665543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.77 E-value=8.4e-20 Score=170.76 Aligned_cols=101 Identities=28% Similarity=0.539 Sum_probs=80.5
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccC-CCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws 388 (422)
+..+++|||+++++||||||+||+++.+..+|++|||+|....... .......+++.|+|||.+... .++.++||||
T Consensus 109 i~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~Diws 186 (286)
T d1ob3a_ 109 LLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWS 186 (286)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHH
T ss_pred HHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc--cccceecccchhhhHHHHhCCCCCCcceeehh
Confidence 4679999999999999999999999999999999999997543221 112333467789999998754 4789999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
+||++|||++ |+.||.+.++.+..
T Consensus 187 lGv~l~el~~-G~~pf~~~~~~~~~ 210 (286)
T d1ob3a_ 187 VGCIFAEMVN-GTPLFPGVSEADQL 210 (286)
T ss_dssp HHHHHHHHHH-SSCSCCCSSHHHHH
T ss_pred cCcHHHHHHH-CCCCCCCCCHHHHH
Confidence 9999999996 99999987766543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=1.3e-19 Score=172.48 Aligned_cols=100 Identities=23% Similarity=0.418 Sum_probs=81.9
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccC--CCCcchhHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG--KFTTESDVW 387 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dvw 387 (422)
+..++.|+|+++++||||||+||+++....+|++|||+++...... ........+++.|+|||.+... .++.++|||
T Consensus 138 i~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIW 216 (322)
T d1vzoa_ 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWW 216 (322)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHH
T ss_pred HHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcccc-cccccccccccccchhHHhhcCCcCCCchhhhH
Confidence 5679999999999999999999999999999999999997543322 1223345567889999999765 367899999
Q ss_pred HHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 388 SYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
|+||+||||++ |+.||.+.+..+
T Consensus 217 SlG~iLyellt-G~~PF~~~~~~~ 239 (322)
T d1vzoa_ 217 SLGVLMYELLT-GASPFTVDGEKN 239 (322)
T ss_dssp HHHHHHHHHHH-SSCTTSCTTSCC
T ss_pred HHHHHHHHHHh-CCCCCCCCCHHH
Confidence 99999999997 999999876554
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=1.9e-19 Score=172.94 Aligned_cols=97 Identities=28% Similarity=0.527 Sum_probs=82.8
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccC-CCCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYG-KFTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvws 388 (422)
+..++.|||+++++||||||+|||++.+..+|++|||+|+..... .+...+++.|+|||++.+. .++.++||||
T Consensus 130 i~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwS 204 (346)
T d1cm8a_ 130 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWS 204 (346)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHH
T ss_pred HHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhc
Confidence 577999999999999999999999999999999999999854321 2345577899999998764 4688999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
+||++|||++ |+.||.+.+..+.
T Consensus 205 lGvil~ell~-g~~pf~~~~~~~~ 227 (346)
T d1cm8a_ 205 VGCIMAEMIT-GKTLFKGSDHLDQ 227 (346)
T ss_dssp HHHHHHHHHH-SSCSSCCSSHHHH
T ss_pred chHHHHHHHH-CcCCCCCCChHHH
Confidence 9999999996 9999998765543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=1.5e-19 Score=170.56 Aligned_cols=96 Identities=26% Similarity=0.320 Sum_probs=75.0
Q ss_pred chhhHHHHhh--------hhhhhhhcccccccccCCcceeecccccccccccCcce-e-eccccCCCcccCCccccccCC
Q psy7289 310 VAAGMAYLCS--------HHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYY-R-IQSKSLLPVRWMPPESILYGK 379 (422)
Q Consensus 310 ~~r~~~~lh~--------~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~-~-~~~~~~~~~~y~aPE~~~~~~ 379 (422)
+++++.|+|+ .+++||||||+|||++.+..+|++|||+++........ . ......+|+.|+|||++....
T Consensus 109 ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 188 (303)
T d1vjya_ 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 188 (303)
T ss_dssp HHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCS
T ss_pred HHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccc
Confidence 4678999986 59999999999999999999999999999865432211 1 123456789999999887542
Q ss_pred ------CCcchhHHHHHHHHHHHHhcCCCCCCC
Q psy7289 380 ------FTTESDVWSYGVVLWEVYSYGLQPYYG 406 (422)
Q Consensus 380 ------~~~~~Dvws~Gv~l~el~~~g~~p~~~ 406 (422)
++.++|||||||+||||++ |..||..
T Consensus 189 ~~~~~~~~~k~Di~S~Gvvl~el~t-g~~~~~~ 220 (303)
T d1vjya_ 189 NMKHFESFKRADIYAMGLVFWEIAR-RCSIGGI 220 (303)
T ss_dssp CTTCHHHHHHHHHHHHHHHHHHHHH-TBCBTTB
T ss_pred cccCCCcCcchhhhhhHHHHHHHhh-CCCCCCc
Confidence 5778999999999999997 8777644
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.72 E-value=1.9e-18 Score=164.54 Aligned_cols=98 Identities=17% Similarity=0.330 Sum_probs=80.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccC-CcceeecccccccccccCcceeeccccCCCcccCCccccccCC-CCcchhHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGD-GLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK-FTTESDVW 387 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~-~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dvw 387 (422)
+..++.|||+++++|||+||+|||++. +..+|++|||+|+...... ......+|..|+|||.+.... |+.++|||
T Consensus 138 il~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 214 (328)
T d3bqca1 138 ILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMW 214 (328)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHH
T ss_pred HHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC---cccccccCccccCcccccCCCCCCcccchh
Confidence 567999999999999999999999975 4569999999998543322 123445678899999987654 79999999
Q ss_pred HHHHHHHHHHhcCCCCCCCCCchh
Q psy7289 388 SYGVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 388 s~Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
|+||+++||++ |+.||....+..
T Consensus 215 slG~~l~e~~~-g~~pf~~~~~~~ 237 (328)
T d3bqca1 215 SLGCMLASMIF-RKEPFFHGHDNY 237 (328)
T ss_dssp HHHHHHHHHHH-TCSSSSCCSSHH
T ss_pred hhhhhhHHhcc-CCCCCCCCchhH
Confidence 99999999996 999998765543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=1.8e-18 Score=161.79 Aligned_cols=101 Identities=24% Similarity=0.478 Sum_probs=81.0
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCC-CCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK-FTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dvws 388 (422)
...+++|||+++++||||||+||+++....+|++|||.++....... ......++..|+|||.+.... ++.++||||
T Consensus 110 ~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwS 187 (292)
T d1unla_ 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS 187 (292)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHH
T ss_pred HHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccc
Confidence 46799999999999999999999999888999999999986433221 123344567899999887665 688999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEEF 413 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~~ 413 (422)
+||++|||++ |+.||....+....
T Consensus 188 lG~il~ell~-g~~p~~~~~~~~~~ 211 (292)
T d1unla_ 188 AGCIFAELAN-AGRPLFPGNDVDDQ 211 (292)
T ss_dssp HHHHHHHHTT-TSCCSCCCSSHHHH
T ss_pred cchHHHHHhh-CCCCCCCCCCHHHH
Confidence 9999999996 88887665555433
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=4.1e-18 Score=164.13 Aligned_cols=98 Identities=29% Similarity=0.415 Sum_probs=76.6
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCCCCcchhHHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTTESDVWSY 389 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws~ 389 (422)
+..++.|||+++++||||||+||+++.+..+|++|||+++...... ......+|..|+|||++.+..++.++||||+
T Consensus 128 il~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSl 204 (355)
T d2b1pa1 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSV 204 (355)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHH
T ss_pred HHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccc
Confidence 4679999999999999999999999999899999999987543221 2233456788999999998889999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCchh
Q psy7289 390 GVVLWEVYSYGLQPYYGYSNQE 411 (422)
Q Consensus 390 Gv~l~el~~~g~~p~~~~~~~~ 411 (422)
||+++||++ |+.||.+.+...
T Consensus 205 G~~l~ell~-g~~pF~~~~~~~ 225 (355)
T d2b1pa1 205 GCIMGEMVR-HKILFPGRDYID 225 (355)
T ss_dssp HHHHHHHHH-SSCSSCCSSHHH
T ss_pred cchHHHHhh-CCCCCCCCCHHH
Confidence 999999996 999998865444
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=4e-18 Score=163.63 Aligned_cols=97 Identities=27% Similarity=0.497 Sum_probs=77.3
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCccccccCC-CCcchhHHH
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGK-FTTESDVWS 388 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dvws 388 (422)
+..++.|||+++++||||||+|||++.+..+|++|||++...... .....++..|+|||.+.... ++.++||||
T Consensus 130 il~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwS 204 (348)
T d2gfsa1 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWS 204 (348)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHH
T ss_pred HHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcc-----cccccccccccCchhhcCCccCCcccchhh
Confidence 467999999999999999999999999999999999998753221 22344567899999877654 688999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCchhh
Q psy7289 389 YGVVLWEVYSYGLQPYYGYSNQEE 412 (422)
Q Consensus 389 ~Gv~l~el~~~g~~p~~~~~~~~~ 412 (422)
+||++|||++ |+.||.+.+..+.
T Consensus 205 lGv~l~~ll~-g~~pF~~~~~~~~ 227 (348)
T d2gfsa1 205 VGCIMAELLT-GRTLFPGTDHIDQ 227 (348)
T ss_dssp HHHHHHHHHH-SSCSCCCSSHHHH
T ss_pred hhHHHHHHHh-CCCCCCCCCHHHH
Confidence 9999999996 9999998765543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.65 E-value=3.1e-17 Score=158.01 Aligned_cols=93 Identities=20% Similarity=0.336 Sum_probs=75.7
Q ss_pred chhhHHHHhh-hhhhhhhcccccccccCCc------ceeecccccccccccCcceeeccccCCCcccCCccccccCCCCc
Q psy7289 310 VAAGMAYLCS-HHYVHRDLAARNCLVGDGL------TVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPPESILYGKFTT 382 (422)
Q Consensus 310 ~~r~~~~lh~-~~~i~~dLk~~nil~~~~~------~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 382 (422)
+..+++|||+ ++++||||||+|||++... .+|++|||.|+..... .....+++.|+|||++..+.|+.
T Consensus 134 il~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~ 208 (362)
T d1q8ya_ 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGC 208 (362)
T ss_dssp HHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCT
T ss_pred HHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCc
Confidence 5679999998 8899999999999996543 3899999998753221 23455778999999999999999
Q ss_pred chhHHHHHHHHHHHHhcCCCCCCCCC
Q psy7289 383 ESDVWSYGVVLWEVYSYGLQPYYGYS 408 (422)
Q Consensus 383 ~~Dvws~Gv~l~el~~~g~~p~~~~~ 408 (422)
++|+||+||+++||++ |+.||....
T Consensus 209 ~~DiwSlG~il~el~~-g~~pF~~~~ 233 (362)
T d1q8ya_ 209 GADIWSTACLIFELIT-GDFLFEPDE 233 (362)
T ss_dssp HHHHHHHHHHHHHHHH-SSCCC----
T ss_pred cccccchHHHHHHHHH-CCCCCCCCc
Confidence 9999999999999997 999997643
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=98.36 E-value=2.3e-08 Score=86.05 Aligned_cols=70 Identities=24% Similarity=0.228 Sum_probs=50.2
Q ss_pred chhhHHHHhhhhhhhhhcccccccccCCcceeecccccccccccCcceeeccccCCCcccCCc------cccccCCCCcc
Q psy7289 310 VAAGMAYLCSHHYVHRDLAARNCLVGDGLTVKISDFGLSRDVYASDYYRIQSKSLLPVRWMPP------ESILYGKFTTE 383 (422)
Q Consensus 310 ~~r~~~~lh~~~~i~~dLk~~nil~~~~~~~ki~Dfgls~~~~~~~~~~~~~~~~~~~~y~aP------E~~~~~~~~~~ 383 (422)
..+++.+||+++++|+|+||+|||++.+. ++++|||+|.......... |... +.+ .+.|+.+
T Consensus 112 l~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~a~~~~~~~~~~----------~l~rd~~~~~~~f-~r~y~~~ 179 (191)
T d1zara2 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWRE----------ILERDVRNIITYF-SRTYRTE 179 (191)
T ss_dssp HHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTTCEETTSTTHHH----------HHHHHHHHHHHHH-HHHHCCC
T ss_pred HHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCCcccCCCCCcHH----------HHHHHHHHHHHHH-cCCCCCc
Confidence 46789999999999999999999998664 7899999987543221100 1111 122 2568889
Q ss_pred hhHHHHHH
Q psy7289 384 SDVWSYGV 391 (422)
Q Consensus 384 ~Dvws~Gv 391 (422)
+|+||..-
T Consensus 180 ~d~~s~~~ 187 (191)
T d1zara2 180 KDINSAID 187 (191)
T ss_dssp CCHHHHHH
T ss_pred ccHHHHHH
Confidence 99999754
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.22 E-value=3.5e-06 Score=75.27 Aligned_cols=85 Identities=21% Similarity=0.055 Sum_probs=54.1
Q ss_pred CcccccccccccceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC-CCceeeEeeEEEcCCCeEEEE
Q psy7289 55 KPRFLQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR-HPNIVCLLGVCLSGEPMCMLF 133 (422)
Q Consensus 55 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~lv~ 133 (422)
.++..+..+.++.+.||+.. . + +..+.+|....... .....+.+|...++.|. +--+.+++.+..+++..++||
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~--~-~-~~~~vlk~~~~~~~-~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~ 89 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLV--G-E-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEE--C-S-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred ceEEEEcCCCCCCCcEEEEE--e-C-CCeEEEEEcCCCcc-cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEE
Confidence 44555555555567899753 2 2 33466776543221 11234667888877764 433567778877888889999
Q ss_pred EecCCCCHHHH
Q psy7289 134 EFMVRGDLHEF 144 (422)
Q Consensus 134 E~~~~G~L~~~ 144 (422)
|+++|.++.+.
T Consensus 90 ~~l~G~~~~~~ 100 (263)
T d1j7la_ 90 SEADGVLCSEE 100 (263)
T ss_dssp ECCSSEEHHHH
T ss_pred Eeccccccccc
Confidence 99999877543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.66 E-value=0.0001 Score=65.05 Aligned_cols=73 Identities=19% Similarity=0.180 Sum_probs=47.7
Q ss_pred ccccc-ceeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC--CCceeeEeeEEEcCCCeEEEEEecCC
Q psy7289 62 LGEGA-FGKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELR--HPNIVCLLGVCLSGEPMCMLFEFMVR 138 (422)
Q Consensus 62 LG~G~-fg~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~g~~~~~~~~~lv~E~~~~ 138 (422)
+..|. -+.||+... .++..+.+|...... ...+.+|+..++.|. .-.+.+++.+..+++..++|||+++|
T Consensus 18 ~~~G~s~~~v~r~~~---~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSA---QGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp CSCTTSSCEEEEEEC---TTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred cCCcccCCeEEEEEe---CCCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 34444 367887542 334457778754332 124667888887764 33467788888888889999999987
Q ss_pred CCH
Q psy7289 139 GDL 141 (422)
Q Consensus 139 G~L 141 (422)
-++
T Consensus 91 ~~~ 93 (255)
T d1nd4a_ 91 QDL 93 (255)
T ss_dssp EET
T ss_pred ccc
Confidence 654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.40 E-value=0.00033 Score=66.29 Aligned_cols=78 Identities=18% Similarity=0.089 Sum_probs=47.4
Q ss_pred ccccccccceeEEEEEEecCCCCeEEEEEEccCc------CCHHhHHHHHHHHHHHhcCC-C--CceeeEeeEEEcCCCe
Q psy7289 59 LQELGEGAFGKVYKGEVCTSEGPSLVAIKTLKEN------ANQKTASDFRREVDLMSELR-H--PNIVCLLGVCLSGEPM 129 (422)
Q Consensus 59 ~~~LG~G~fg~Vy~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~~E~~il~~l~-H--pnIv~l~g~~~~~~~~ 129 (422)
.+.||.|....||+... ..++..+.||.-... .-+....+..+|.+.|+.+. + ..+.+++.+. ++..
T Consensus 31 ~~eig~G~~N~vfrV~~--~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYD--QEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMA 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTT
T ss_pred EEEeCCCceEeEEEEEe--CCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCC
Confidence 45789999999998653 233456888864321 01112234556888777662 3 3466676653 4556
Q ss_pred EEEEEecCCCC
Q psy7289 130 CMLFEFMVRGD 140 (422)
Q Consensus 130 ~lv~E~~~~G~ 140 (422)
++|||++.+..
T Consensus 107 ~lvmE~L~~~~ 117 (392)
T d2pula1 107 VTVMEDLSHLK 117 (392)
T ss_dssp EEEECCCTTSE
T ss_pred EEEEeccCCcc
Confidence 79999997654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.78 E-value=0.019 Score=53.61 Aligned_cols=76 Identities=16% Similarity=0.182 Sum_probs=47.7
Q ss_pred ccccccccceeEEEEEEecC-----CCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCC-CCceeeEeeEEEcCCCeEEE
Q psy7289 59 LQELGEGAFGKVYKGEVCTS-----EGPSLVAIKTLKENANQKTASDFRREVDLMSELR-HPNIVCLLGVCLSGEPMCML 132 (422)
Q Consensus 59 ~~~LG~G~fg~Vy~~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~lv 132 (422)
++.|+.|--=.+|+...... .....|.+++... .. ...+..+|..+++.+. +.-..++++++.+ .+|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 35788888889999765432 1234466666532 21 1234567999988885 4334477887642 689
Q ss_pred EEecCCCCH
Q psy7289 133 FEFMVRGDL 141 (422)
Q Consensus 133 ~E~~~~G~L 141 (422)
+||+++-.|
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.07 E-value=0.019 Score=52.06 Aligned_cols=67 Identities=15% Similarity=0.111 Sum_probs=38.9
Q ss_pred eeEEEEEEecCCCCeEEEEEEccCcCCHHhHHHHHHHHHHHhcCCCCce-----eeEe--eEEEcCCCeEEEEEecCCC
Q psy7289 68 GKVYKGEVCTSEGPSLVAIKTLKENANQKTASDFRREVDLMSELRHPNI-----VCLL--GVCLSGEPMCMLFEFMVRG 139 (422)
Q Consensus 68 g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~l~--g~~~~~~~~~lv~E~~~~G 139 (422)
-.||+.+. +++..+++|+.+... ....++..|...|..|....| +..- .........+.++++++|.
T Consensus 36 N~vy~v~~---~dg~~~VlK~~rp~~--~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQD---EDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECC---TTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEc---CCCCEEEEEEeCCCC--CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 37898643 345668899875432 133557778888877642221 1111 1223345578889998764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=90.98 E-value=0.038 Score=49.46 Aligned_cols=30 Identities=20% Similarity=0.182 Sum_probs=26.6
Q ss_pred CCccccCCCCCceeecCCCeEEEecCcccc
Q psy7289 185 HHYVHRDLAARNCLVGDGLTVKISDFGLSR 214 (422)
Q Consensus 185 ~~ivHrDlKp~NiLl~~~~~vKl~DFGla~ 214 (422)
.|+||.|+.+.||+++.+...-|.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 469999999999999988777899999874
|